<SEC-DOCUMENT>0001179929-21-000024.txt : 20210216
<SEC-HEADER>0001179929-21-000024.hdr.sgml : 20210216
<ACCEPTANCE-DATETIME>20210216090518
ACCESSION NUMBER:		0001179929-21-000024
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		128
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210216
DATE AS OF CHANGE:		20210216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MOLINA HEALTHCARE, INC.
		CENTRAL INDEX KEY:			0001179929
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				134204626
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31719
		FILM NUMBER:		21633127

	BUSINESS ADDRESS:	
		STREET 1:		200 OCEANGATE, SUITE 100
		CITY:			LONG BEACH
		STATE:			CA
		ZIP:			90802
		BUSINESS PHONE:		5624353666

	MAIL ADDRESS:	
		STREET 1:		200 OCEANGATE, SUITE 100
		CITY:			LONG BEACH
		STATE:			CA
		ZIP:			90802

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MOLINA HEALTHCARE INC
		DATE OF NAME CHANGE:	20020812
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>moh-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:47c0ca76-68d6-49cb-bbea-26491dea6a9b,g:4ece894a-24af-4e0b-a6cb-0ef0dba60516,d:f790247689124308855d86d82384a359--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:moh="http://www.molinahealthcare.com/20201231" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>moh-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV80L2ZyYWc6YjQwZjZjNjFhYmVkNGI2MGEzNGUwMjM4Y2I0ODc2MGYvdGFibGU6MzAwMDBhMmU0YzdkNDllYzg3MDdkNjg5NzlhNzI0OTMvdGFibGVyYW5nZTozMDAwMGEyZTRjN2Q0OWVjODcwN2Q2ODk3OWE3MjQ5M18xLTEtMS0xLTA_04ff6ae7-24ac-4237-a927-3512b22805b2">0001179929</ix:nonNumeric><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV80L2ZyYWc6YjQwZjZjNjFhYmVkNGI2MGEzNGUwMjM4Y2I0ODc2MGYvdGFibGU6MzAwMDBhMmU0YzdkNDllYzg3MDdkNjg5NzlhNzI0OTMvdGFibGVyYW5nZTozMDAwMGEyZTRjN2Q0OWVjODcwN2Q2ODk3OWE3MjQ5M18yLTEtMS0xLTA_f0ad12c6-1d9d-442a-8091-50b92553aff2">false</ix:nonNumeric><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV80L2ZyYWc6YjQwZjZjNjFhYmVkNGI2MGEzNGUwMjM4Y2I0ODc2MGYvdGFibGU6MzAwMDBhMmU0YzdkNDllYzg3MDdkNjg5NzlhNzI0OTMvdGFibGVyYW5nZTozMDAwMGEyZTRjN2Q0OWVjODcwN2Q2ODk3OWE3MjQ5M18zLTEtMS0xLTA_8b6718c2-059a-4446-98db-88f133c25d04">2020</ix:nonNumeric><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV80L2ZyYWc6YjQwZjZjNjFhYmVkNGI2MGEzNGUwMjM4Y2I0ODc2MGYvdGFibGU6MzAwMDBhMmU0YzdkNDllYzg3MDdkNjg5NzlhNzI0OTMvdGFibGVyYW5nZTozMDAwMGEyZTRjN2Q0OWVjODcwN2Q2ODk3OWE3MjQ5M180LTEtMS0xLTA_a6ba7b6c-dd9f-4183-be4e-4d9178eaa3e1">FY</ix:nonNumeric><ix:nonNumeric contextRef="i507906be57d848b78ab7e7f688853ed8_D20200101-20201231" name="moh:HealthPlanContractTerm" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2Xzg0NA_2a1d4052-6221-4b74-b359-9ff02580423e">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i16e27438908a47a6b4b7849782a9d9b1_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4NDY_345e2136-02de-45cb-a7d6-760278ca92ed">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i9d8f3a194cee466289eb18cac107e905_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzU0OTc1NTgxMzk3OTA_0da1da73-4926-4eb9-bdb8-ab2cd7f10bb6">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="iff1128ec0a004258a1175acf34f59bcb_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzUzOA_e80b42ea-bec2-44ee-9782-16517f1bf477">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV8yLTEtMS0xLTE1NDgw_0dc9e7a4-3f5a-4cc9-87ca-c2638c16af2b">us-gaap:OtherAssets</ix:nonNumeric><ix:nonNumeric contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV8yLTEtMS0xLTE1NDgw_1f62e1d0-af90-4d7b-8809-7a047b977efc">us-gaap:OtherAssets</ix:nonNumeric><ix:nonNumeric contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV8yLTItMS0xLTIyODgy_2e574176-1cbe-4054-bd4e-2a9d621bac76">us-gaap:OtherAssets</ix:nonNumeric><ix:nonNumeric contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV80LTEtMS0xLTE1NDg1_edfa4705-7eb0-453b-a982-12638eda7aaa">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV80LTItMS0xLTIyOTI0_d9251e4d-cbae-41b5-b155-16a91ec5c960">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV81LTEtMS0xLTE1NDg3_45a0d7e9-c547-4061-ac70-bbd8abfe8078">us-gaap:OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV81LTItMS0xLTIyOTE5_fc52a198-532b-4ae9-81a7-1a3b2154e063">us-gaap:OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV8xMC0xLTEtMS0yMjkyOQ_c1467140-d607-4448-b47c-60f2b7109f2a">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV8xMC0yLTEtMS0yMjkzMQ_a24f2cbd-007a-4317-818f-e2fb528c8af5">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="moh-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i02376445555642e5babc277d1c377aa8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i87711e21c9a446419ccfe038aeb1835b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="id8ecbcccccbd40c5a50d0279cba6e06e_I20210212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91290aace81d4332aae71ba1a693cbba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">moh:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29d5d2b833564b80aea7dee755e0e3dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia63feda4ad7347288920b133e5dbddb3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i849cbae5a8cc41beab243b6cc6768e11_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fb34386ae3248e083608739601dbacc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:PremiumTaxRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ceb7faf3f854c239783915d36ad2084_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:PremiumTaxRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f79365bc994640a161617bd7d8a916_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:PremiumTaxRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c49bd707ea342d29798c305bec30c3d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:HealthcareInsurerFeeReimbursedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec0f306ac4604ee3a72ab17c719868e8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:HealthcareInsurerFeeReimbursedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286b19feb9c8495591834c5d364e760a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:HealthcareInsurerFeeReimbursedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5cc2203bcc1458383a2cacf8cb24107_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MarketplaceRiskCorridorSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i910d706f29214cf989874f3c7c9bdc97_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MarketplaceRiskCorridorSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57e45a9715ee49d6b1b20a8101922bed_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MarketplaceRiskCorridorSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a3782192ac74e9fa0c0cbe786a6c7f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc6d37095e148f38283ad63b84f7dbb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i146b66c41bd848eb8c57a3034d4d91d3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i234e4841fc374ed0ada5e87b17f10a96_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MedicalCareCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38e404a0791d4aceab81d9b4037b1443_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MedicalCareCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d89685788cc4fd09db979d7c5b577ba_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MedicalCareCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c4aed327cc445c2a43b20960c6bced9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id81240d8e0324ade9d13dfaaff5b72b2_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4380ffd8981440aab0b911f97c293b09_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8aea4f34a3747f088cc40ece091110d_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d321ff569ec4e909207a3511e1de822_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5276df7533a434dba724ca46fb6260b_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6084d3cc32ce4e868de7c430f423cecb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5875c847748b49b7ae809be69c6d6256_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7fb1e9375a549e9ad146d29588db2b9_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7987d66d3a0c45c991e3cab20c4fb866_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c6270cdd3704644bda480c6fd42c68a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e7ec975f1cc4e07b1655f6681e39bae_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a7ae69397d149d284b0dd9f61b2d2c2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2faff66f6e7145caa224e62f23b8c597_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dafc291a0c24a16b8316afe33f2004b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25c94a4e11864ff08869c043de0f5f6d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65f9657d27d4a009acb818ef3881bcc_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38b4b862a7374893891ea3a84e6c4743_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02bdadf188dc494b844595ad20923df0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabcc9c4754784b398a5fc79d9a7ebbf7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73b8d399d58241d1bd9c438042e73b99_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3ba89712ec942c09668e856ab29712f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97919dee5de246a0b50148ddae7888fb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0d1799cc9734f13b9ac873259cad7c6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e22f922c9a84243aa86afcf1b64ac08_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaee8551fee24ee384c466fe5ef25b9c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fa5f12c2da940d8b68187f4bdf87af7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4047b057d87547648b481f3fb3ba62d7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeaaeaba3f3849a081f3527f07ae1b82_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b04a987b49d48ef8c1cc6f8485617e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5396d9352d1442a99bb72088a0b7ca0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i860bc85e749a4e47b38f4a7988debbe7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e975e9f87c74535bf3d7c5035bcba82_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i183e269a3450453ab9a54b55cee9c2ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fbc4f7185694bff8ff72e5ae4a739ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8327c36af50243d39623edb7b5bcb06f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">moh:CallOptionDerivativeAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb902f5430db4cec865e03899ec0a22a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">moh:CallOptionDerivativeAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07b1e43b622b42d9b75e1ccb92389132_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">moh:CallOptionDerivativeAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80c02cdb9f7a420cb8aedf486216882d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d11a4d46cec445aa76d23295e7aa22d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb861312d6ab444ca32cfee48e0fd8a0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>moh:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>moh:state</xbrli:measure></xbrli:unit><xbrli:unit id="member"><xbrli:measure>moh:member</xbrli:measure></xbrli:unit><xbrli:context id="i39fce2981d2c41c1a14d47dafdc5e356_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc8845b2df0142a6ad693b5b696a900f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i507906be57d848b78ab7e7f688853ed8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50a1c2e5665543b3bda779ef36e5094b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i41056d0891344bfeb906ddd9f525ea3d_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761083592e2c455daabbcd09515b7402_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:AffinityHealthPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d73a7217fd343aba05c738abeb42788_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:GovernmentReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fd3259008f84de5b99bebc752d5714d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:GovernmentReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30812037b820437fa3a3e705d6ffa4d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:PharmacyRebateReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia17d974ef4c94bf497db882cd7110332_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:PharmacyRebateReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bf6535594b64a3d916a78b3ed7e6f86_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:HealthInsurerFeeReimbursementReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib010fc19559144a59d49603a7da5ab41_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:HealthInsurerFeeReimbursementReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea74ee4ad54b4f3c9e6446ba883edad3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:OtherReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49f572caee0440c88a9769d8359294a4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:OtherReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3a81fff009c4556869db8332ba98850_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:CompleteCareReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750cbea67aa745698f4ce14305876548_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:CompleteCareReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e27438908a47a6b4b7849782a9d9b1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac48d7b081c44878865a5a148b146630_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic98f3f2874c74deca389d0f762617730_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">moh:COVID19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MedicareMedicaidPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03c303598694422daa4534e5d0775ae3_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">moh:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8765abff68ce42c6992ad5c81c209878_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">moh:MaineCommunityHealthOptionsv.UnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67312f647d5c42f885c6bf5c0fb8c961_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25973257ed1e4cdfa54404c69e26ac16_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11f1f4ff7526429394959a5edcf1f480_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id49fb40faab249ee88628b7ca31ab180_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:StructuredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i932eecd9dd8942a8930602c75ed75579_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic51cb18d6d6c41eeab7d71df5f748b8b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie971c5d38e9f4081bdcce44e29b31e8e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i794b72519ef741a4b1e5b3b064789239_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e0308fdfb84b5cabb834a5d7d38846_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ea8b394a2d04647a92ee82b142ff55e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i010f47d9164d4401aaf7500b3414201c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id99ab9a99c8b48109cb2e67859f4f1ca_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b7453f2890d4ea8a57191c7b738e0ac_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f146b00c28c496fab54a890e503b593_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafd4a77f957a452ba104472004ee03d3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7501a92677af42b3bbf91f05377b6a79_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff54c36d85a740d29de6dfed243ff5ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c3a468249ee4c1f924f960fd9a0e7b6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a12870bdcc84902a115a5c52be47a49_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24117b22bd104e47bb18575a3e1087d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f2abcdca8654dca825ae09845834f08_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe7cd5fa2a6c4ee4893fa7aeea12f184_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49d06937156847b795ad5d126b43c272_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c749426a22d4f45b998723c923108b0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i963a1ad740774ea39b16fa5a48fc788a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98c68a644f8043128dc74552813a54c6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a53f8a4f88b471ca3904508a5f37fb1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b530889282e4734a8cea1ff62dd4eb8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i623d20d86025415b904356ce36b3ec7a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">moh:OtherGeographicalAreasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife4529f238f148c6a7085542f5807c4c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">moh:OtherGeographicalAreasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ed8f3b768cc45ce808afd1e8a44ddd3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">moh:OtherGeographicalAreasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68756a4786524fe5b9fabbe3f97257d2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fe995e49c0b4274a5ede86b839b44d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="business_combination"><xbrli:measure>moh:business_combination</xbrli:measure></xbrli:unit><xbrli:context id="if30ced8758e642af8985042651d6cdb1_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i064898df32bb409d9725c5271969d63b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>moh:security</xbrli:measure></xbrli:unit><xbrli:context id="i5c05b89a6f0144e3b67780794556b45d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id47bfbaa31f34e6cbbc46b397397ad22_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:HealthPlansSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d9ad5f0f8564470964511585ae558dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:PassportHealthPlanIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbd3989bdd36411bb81f15405becbc0a_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:PassportHealthPlanIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib80e56cc81004ffb9a966b132d1c37ce_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55464af26be84fb3820ca5c44e160c32_I20200901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:PassportHealthPlanIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72b43b1a1b4b4f1082ad9d20416d588c_D20200701-20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:YourCareHealthPlanIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c8feb8bc88a45bab6f5586d910050f1_I20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:YourCareHealthPlanIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ac1df93bc0c4894960ea1adb84e0024_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20850a7f15e24400b1b3bf58d9e096d9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb7db7e5903548c1b07be8df527ac95f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if958004bf9004127b3dfe774c1c93182_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i733eec69c1db4095a58047c500e1ec76_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ProviderNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f80aa6d34e346a1a3b5dbdaeab0b9a9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ProviderNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6531b793e0c64805a9f24b4ce452eb0d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:TradeNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc5130895c0f47929310c0ab60eb616a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:TradeNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebc139137e204e638a9cb2d71ee5dea9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:TradeNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a7800a872f64f3fb068791db99f8252_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:TradeNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1537007f8b454c3b99a90841baabc2fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e7b354db3f541ca96ec5db2b700dd49_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i620ff45e952445d1ac715d4144df7597_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f297a74be174b0cb53664e81273fc7b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3db9d935bc9944d79fac14b03b028e17_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b1296e99cd47e4bf03290b7a26a478_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia70e312008164e878e7157499eee87d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if330308388ae40ac9a6862c3c5bacd95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5ade1a543bf4bed873e58b761ad56ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff7c00132f94480c9854cfa010a9b0ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75ace7c20ffa424295b84956415a9b16_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11c3150f158849b7981e3f9bd3362f4e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12998aefc9ee4f1faa798f4661c61421_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f2e1498903647dfb8ed82f5dfb635f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0df2d07f1c4f49239d8e7fce08146428_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1248d546adf44c31b8e4c83bc5671814_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00ecaf4e4c7420280c26ee32500e9c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4965915628104e2ab8fff975a58ce821_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddc3e419bf45401eb1c8ee9d956b9590_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ed4091dd7014489aae0cf9acc2daec5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i410a5c9397b240a48b11ed2e55a3ca0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b5f410a090c46058072e3908f0200f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b1b9c15fe24bcea302eea32219b2dc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i323373c939a744309b13b44c10d4e64f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2807d22440ef4fcf924a3e296c024baa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29d022afd4104a10b3d38dc48db285a3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ad2854387a044388a14a10a50f7d60a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28bc7ef03bb44205a24ac42c766d0ec2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e4f73d258de45c09c5dc40f3889ded5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b3ea3a00aa745fa8d3fe8db9188348f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida3322a79f8149fe818ac4b37b7f1c22_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i673e1f4e113146bfb5c486ae12b9ee45_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b5d62a6819c41fa87480dace92027a3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i675f941940f34275b7ad7964d3615d58_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c4f690f2e3741049e287513d54671cc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13016843f45e401db644115e95be6a87_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88ac1c81d1544708baba1124ced26c15_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f46b98577243ef93fe68df78a68dd0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1662ee2010e44146a4d125c47e8f6ba3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89400aeee60c4b3f858de5d8bf088e81_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73d7f9a5342e4d09bca467416cea6034_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa18c08b497d4e83bd718272cfc7f575_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6471a4d8ab49424e8b4300ddd8991da5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7633ecb19354446b41403e6360d771a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21e3e7333e904417952db8fcc93f2434_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie720443e514340f9bf863ab49f657949_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95da47a8ff274392a557100219edc18a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6935a499d294baea85bb268e45f2965_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia75c8c84b6ae4319bd2ad5f13d5930f5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7fe95986da143f49cb9ff1cd45fb414_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:OtherSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2a2b0056a32471e8f7d05fa87adc1e2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:OtherSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76cc5c31e1ec457890186adff5d88ff6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:OtherSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e37ac84dde34f9a9f5a34dc6fbb3503_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:OtherSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2dfcce27ab44c888f802f59df6a8678_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ebfad9e8de34bc282edd8a903fd15de_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f1b6888bbaf41ef9d90d37617270d74_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia041924286c54d5c9513011d94e51068_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0f8e19fba6a41b68b87ceb41afcceb5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06fa0c3851d7487d95bc374550545ed5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb8e220321748cea721890a15c24a39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i445acdb4c3684477acd4591ac4c9235f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93e298da77bc4141b95fdec3026f4403_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8db366cd71ed4aed8d17341c92a27bac_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf0aad8ca2a944c285080bae467d9769_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01750e761ae449108d5498ba2a542db0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">moh:CallOptionDerivativeAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">moh:CurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i169c45e71a6541939a44bc98b6a6744c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">moh:CallOptionDerivativeAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">moh:CurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifac907d76e3e42f58ad857eb2576f9c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">moh:CurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee5e05e95b1a426bae4671defcf57905_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">moh:CurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01207b776cf34d6d9e20d09853472272_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ae2b394952c4f1e8142cffc59c02e8f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9be126012c2743e3ba1f0448a68c6d21_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2eae161ddce94e7a9ff33f9b5d6e8751_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i347dbbc9bc8f47e98ec6c35325f9f494_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f291c050ef34a17be70dc97c24d7607_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic488eae93102457d8235e5620bd84f27_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if330db6dda754503989d1aee6433ae6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c02998f42dd4ce08ba11f14f2a84902_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib544842b96f248be91c9c250b5519403_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e24a47d3dc649d78aba307fc1ad28a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bc3d20ccc074e70bfc86059723e9c9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3f70d3c50d8437b98e3dcf567cac5be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76f180467919400fb5d1a49a30bb070c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia680941a7dcb4c90a8f6a94a3df241c5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6897a665bfe944c0b1720f8066bd97ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfb7000b50d34cc1ae6870b923bd53f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c00276ec6e247479e4d6b157f91a10c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea08d8a8150f424a91d5763de41e3ca2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id811eeb6af45438199143b6905407f9f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac8de3a5e55d44a38a5f28fe244aa185_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie144cacfc85e4897bf8661dd85794604_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83cfa0b110a145789605caf934c004c3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89aaa5cc1e6416d91ce575532477772_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id63dd203dce74ef786b9059a9384be45_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6557af215244a238cc88c1fb4cb335f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91288d1537ff4a1cad628bfe99f8ec61_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife6d8824de274a12aafb6c18f80be57d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdcae3ccabb049d7a79f1464026d3c79_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e000c4aefc74c68842dcf99d6e91fa4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cf635a3f8d840cab2a3e2097d60a7cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b30ecc6f739406885acf51ceed648e0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1ef1a869ebc488a81b5bae288c74176_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i722c9c386c5745aa9a967036f8eff284_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b0143db7f344f8ca8d09c528fa76f93_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia61210df5ac84ab7ad7f93c5f4e1bc4a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0251b790bfc84ca9901e5dec4b2e552c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3900f99d76c4cb088f0ec753bdfe4ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e08cf3843ee433da07c69c76c66c194_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i709876b469e94acf8f45ce2cc1c0ac99_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0be8dd8b617b44a2b44ea2ff3f0f2d73_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4ce85ece03c4fd596e2b5d2647de430_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36836d1ebed34cdb88ec412d28f3f1ab_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83d73631ecf445f48b591cb49c5daf0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">moh:OtherGeographicalAreasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5bb7caa6db34dff90cd3316865e8139_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">moh:OtherGeographicalAreasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9d2df1abcb045c4a451a671e263475d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:CompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22a6ede7687e4ab8b717166f0bb9a215_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:CompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d8f3a194cee466289eb18cac107e905_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15fb3622b8d3400b91bfd0af1a0403f4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1570351e39be47e894e41c5bc71b785f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff1128ec0a004258a1175acf34f59bcb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28c21a0ce6c540ada2399b7535c810c3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78a27e51a7f04cb99838d4b8e20f08b7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c544b48981f4cdd80e392c5b90a7935_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b70afc8228d42e2bf32567a3f21f342_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3c9a83c837e4ca1bcccd5809c8e0fb1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id064c81564b14be391016eff3d91eb4e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a2dc6980ae14fe8a3654f7ca74e4f2f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib23e7d7b485a4481833c3bac81769de4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a95ccf41eba4147ba12e954b58ab8ab_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib808ff3f56ce4af1ba94833304546a52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida59b5bf5dbb43f1bf41bc98cba8b6a9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1df2247780e463a9f7026841ac4a307_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i966b162be69a4b1b9e916931cc469f10_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd31c651704242e2a915e56d0e9febd4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9831a12c6edb4660aade4906b3716c8c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibea9e886beab43f7b589f21f3657b645_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:CompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd67197e811747ddae7d6a41e1699670_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:CompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22759a2f8b054c96ad50791de93ca29f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cd7c232959048c3b7533cbe17fd7a2a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e9747d2ea6b431d91b4e794f7c6a0f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ContractRightsandLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i746a8ef0f806409da219017e26b4a03c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ContractRightsandLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50c25fe7c83049a784e28473dfa5db7f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i402bcd1f7eb94207a725a00271ec919d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0aecf877b59419e91398282765cd1a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba830af20e004480a455ba22d8490b81_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21b5a4474fe742708d34076ef171bbc6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:CompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ba8deca9f384a07ac55d4d78555ed46_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">moh:CMSSubsidiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia31b475498df425a8b4d174081e15148_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7f38b6017a44991a39f98bf263f1207_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4da076c6c0e14403bba261ee5a1752cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8038f20097384f9e833965528d07e1cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>moh:claim</xbrli:measure></xbrli:unit><xbrli:context id="iadfee5a2ce3745aaaf4b546d03d4d801_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i136f903b1c064277a3b1c8f8da5021b5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34d4bab4b5564cbb89d2dde161392e50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide648b3dad0d4ab18e81c2b7529401b1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe0ee42eef33462bb6cd3e32f7bf3d52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65eb832ddf7446ad95dac7eeb4907da3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84ed48f2ecee4fde8a88bcac9e3387b6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f74264414a473b851cd390764a5469_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f87c0eee5ef4388a13337f6de7a4672_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54ca304db2314cb0aa1e9531302dd99f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f794012ffba4b20bb19204c1871558d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8dbc94d3d2941ddb0a236c2e6aa7418_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if24fe855595e4f419b39b5ca7946f9a1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82aa8b8e3d40448a968a16db82de1fe0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8662ae4a2ad4fd59034705718e300f7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i919a4ba85b4d4dfaa5d02f1908cbd481_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i350e29537cb34f48978b5b0e7e5cc142_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdd1a32b458947b1801cc3505a82b626_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">moh:SwinglineSubFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6fee39dad244f2c88eadb065bc81d50_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">moh:LetterOfCreditSubFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1abe71b87a6542f0870a99e5a099279f_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:IncrementalTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c82c5064b8f4eb08577141f723fd705_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:IncrementalTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2dd3e9ee2ce44a4919d0cf6b7a9cd2f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:IncrementalTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i357b4ee3df3041a6bcafb18e3531d2e9_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e22eda33bbd4bab854db88001835a0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib62871823c48445589be9d732dff0753_I20200602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5588d925bf774eb08f9ffc4e6643dcb4_D20200602-20200602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-02</xbrli:startDate><xbrli:endDate>2020-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1abb910e6fa946c3a5cc16ae002d542f_I20201117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id33b880a743e45e296852cb1c96f23f9_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71e356cb28064ce08d2b5e2365a4e623_D20200101-20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i777fc2beee3c4a10b06e4fde2ab42f6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ce9e160ed604a74a1a9a4c25add9c6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31b468479ec6404c8a870d751d8727e0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1127fb6f8661484e9a2afce5e70e881c_D20201101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20fed1f62d734cc294821cf3b9a1b49a_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19562697a92c4804a128c7d53a9fca1c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c2f88ae28624d2d83b180b3207c2ee4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i405b0566313b404d88d226953fb10b4b_D20210101-20210211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-02-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i230e39d7097f4f04ac9d6a41de9ad215_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">moh:CashConvertibleSeniorNotesDue2020WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f8dcd5ceb6c487f9c1bdf9a574307f8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">moh:CashConvertibleSeniorNotesDue2020WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96a5b2f5752d4c3d8f85ea9e8b1da0ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ac5351ddca146c7888f5e88c0fb0733_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e5144ba022d44d493772c715fe5aa45_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:RestrictedandPerformanceStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcae5fc25c5d4bfe9751f1e0b6a647e4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:RestrictedandPerformanceStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09bb25d620c34957a416d46cefe3fae8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:RestrictedandPerformanceStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76f621f530a7426ebac680c21dabf01e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:EmployeeStockPurchasePlanandStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f8a559e0b7d4a32b56f7a92d9cc722b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:EmployeeStockPurchasePlanandStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bc80c4169054f6d86a4e10b0c36c602_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:EmployeeStockPurchasePlanandStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i292647db232f497088463dcb696a6bc4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">moh:EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4aca872bf92456a9a20db5fae524392_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89fe848546204fe2b34f89e0a78c161d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i572ceba4cf6044c5902601a01b0ea881_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36ed381ff8654ca990008ef6dcd3154b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28cf707559d6450aabd54eb6691a6598_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i372cfd6a471f48bcbd14fd8e83885c92_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba5202a65ac342848cf80d5efc7a35c9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd75881230294473867aed8c11c46a5b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4d57c51df1f4304bfc986fb72585507_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib82194307d804f828b55b0572af7065d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb6f3b120b6c45aabfabfd970687858d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife21f4c2287b449c80bf5cbcb34cfee4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3f96ca2a41b497882c4e2decff210d8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">moh:ExercisePriceRange1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f5a36308730434eb22cb4ec367111c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">moh:ExercisePriceRange1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f4bfa5083c14dc982d7f30f9c3f2c76_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">moh:ExercisePriceRange2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0bfeb88842e48c681d6c147892747da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">moh:ExercisePriceRange2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec02edc64cf748bcb7c0886f12b109e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ecb8708d5464ab498156c0718152e7f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14669561f20444379f482d5083c58318_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d1a64b1a8eb4587b76303fc21830afa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb82ea68bb9f468a8a464320367c5ad1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib36184f360254be581851e722b97e9d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1045ef059c7b4c1e91a31c1aa6854984_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20c4b45d16f349f9b877a338daec69b7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43079259dd7042118ae6a2d5dd9a7b6e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bab7abe7dde44eaa74ac090521003ed_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i169ab145200a473eb3a97472b0dc04f9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4c8ceca643b4549bee173f83e97bb0e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d0049c77d2742749f53b11e47a5ada1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c46ea96ec424a059820a38726b434de_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a859cbf0a6e4e259e5149dffa498108_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90fb32a216454bb3b23113825fc89cb0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia21e20ebfeb1411abf65ca9fca917694_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55bfd4d59fce43ea933cfb8bceac4a25_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b95e6dc88844104b5365f3801ba598e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad1475cc48dc4edc8d1b28832265b1ea_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0373257f2d34963a2a34bdff8836086_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11fdd1fe2faf42efb90bc577c9070717_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c26bfb9e6774f078083f6dc03b05363_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001179929</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if790247689124308855d86d82384a359_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.722%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTQ4_4b4dd36e-a362-4ba7-ac7b-f4d6000a166f">10-K</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:4.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6OWFjYzU3ZTgwZDA3NGFhZjg0YTZlMjlmMmUyZmNhMjkvdGFibGVyYW5nZTo5YWNjNTdlODBkMDc0YWFmODRhNmUyOWYyZTJmY2EyOV8wLTAtMS0xLTA_83fa7f09-3fa3-4580-99ef-f27f9e7cbb94">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FOR THE FISCAL YEAR ENDED <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18xMjk_6f9b9ec1-0429-435f-b48b-5600066b83a4"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18xMjk_5a7899fa-f924-4ae6-ba67-7e0172e3f80e">DECEMBER 31</ix:nonNumeric>, 2020</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6ZTk1MDYzMjY0YzgxNDNkOGFmN2YxMjE4NzdlNzQzMTAvdGFibGVyYW5nZTplOTUwNjMyNjRjODE0M2Q4YWY3ZjEyMTg3N2U3NDMxMF8wLTAtMS0xLTA_fb6a99b7-6904-427d-904f-9bba1913d140">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTU3_3b869e85-7127-42b3-ba79-e6a780c797b7">1-31719</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><img src="moh-20201231_g1.jpg" alt="moh-20201231_g1.jpg" style="height:94px;margin-bottom:5pt;vertical-align:text-bottom;width:270px"/></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTU4_fc3ef1ce-fbfc-4b0c-afeb-1a82057b5292">MOLINA HEALTHCARE, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:252.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:252.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6YzZhYmFjNThmMmY5NGE1MGI1NmE5NWJjYWE4MTY1NTMvdGFibGVyYW5nZTpjNmFiYWM1OGYyZjk0YTUwYjU2YTk1YmNhYTgxNjU1M18wLTAtMS0xLTA_520cbf25-3435-4c76-b115-21c627ed40de">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6YzZhYmFjNThmMmY5NGE1MGI1NmE5NWJjYWE4MTY1NTMvdGFibGVyYW5nZTpjNmFiYWM1OGYyZjk0YTUwYjU2YTk1YmNhYTgxNjU1M18wLTItMS0xLTA_128cf0b2-3af4-4e98-a5db-9d04842f1727">13-4204626</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></td></tr></table></div><div style="margin-top:14pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTYz_9bd31fa2-fb20-4281-a353-77dad5fb4a17">200 Oceangate</ix:nonNumeric>, <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTUw_a0de8029-3027-4ba7-90c8-e9ae6c737c8a">Suite 100</ix:nonNumeric>, <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTY0_fa12dd35-9753-42f4-b43d-ac63e2e4154d">Long Beach</ix:nonNumeric>, <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTUx_ce46f540-3b35-40db-aa17-dffa12ecbdf9">California</ix:nonNumeric> <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTQ5_53768f05-58b3-4711-9d1a-09c78555b62d">90802</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTUy_efbf9019-00c1-48b2-bfbc-205fc86f6524">562</ix:nonNumeric>) <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTUz_eef28402-30a7-4207-b571-0cdad7e81408">435-3666</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:169.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:154.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:181.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Each Exchange on Which Registered</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6ZTU3NDYwMTY5NTgxNDU5Y2FhOTk5ZWE0NDJmMTJlOTUvdGFibGVyYW5nZTplNTc0NjAxNjk1ODE0NTljYWE5OTllYTQ0MmYxMmU5NV8xLTAtMS0xLTA_5212fa7e-1018-4617-812e-6010f552dadf">Common Stock, $0.001 Par Value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6ZTU3NDYwMTY5NTgxNDU5Y2FhOTk5ZWE0NDJmMTJlOTUvdGFibGVyYW5nZTplNTc0NjAxNjk1ODE0NTljYWE5OTllYTQ0MmYxMmU5NV8xLTEtMS0xLTA_e5dee5b0-a1f7-452d-8554-3f9450f57aaa">MOH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6ZTU3NDYwMTY5NTgxNDU5Y2FhOTk5ZWE0NDJmMTJlOTUvdGFibGVyYW5nZTplNTc0NjAxNjk1ODE0NTljYWE5OTllYTQ0MmYxMmU5NV8xLTItMS0xLTA_5be64726-51d3-4e3e-b744-07d786ff3978">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:28.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.184%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTYw_d757d5a4-9c1f-49e3-801d-f3b28995a991">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Yes&#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTU0_927dbb01-4aac-42f9-8792-9fe8c3d0e337">No</ix:nonNumeric> </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTYx_90383ac3-2524-4745-866c-98ecf27c06e8">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTYy_889c34a2-5163-466a-bdac-e041575c0c2d">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6MWQ3ODY1NTY4MmRmNGFjZGFmN2Q3ZGY0ZWJjMjgzNjQvdGFibGVyYW5nZToxZDc4NjU1NjgyZGY0YWNkYWY3ZDdkZjRlYmMyODM2NF8wLTAtMS0xLTA_b8414afc-5bf6-4c73-86c1-27bf4c497ab1">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6MWQ3ODY1NTY4MmRmNGFjZGFmN2Q3ZGY0ZWJjMjgzNjQvdGFibGVyYW5nZToxZDc4NjU1NjgyZGY0YWNkYWY3ZDdkZjRlYmMyODM2NF8wLTctMS0xLTA_1dbf22db-8e34-4abc-bee4-c3cc27382260">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6MWQ3ODY1NTY4MmRmNGFjZGFmN2Q3ZGY0ZWJjMjgzNjQvdGFibGVyYW5nZToxZDc4NjU1NjgyZGY0YWNkYWY3ZDdkZjRlYmMyODM2NF8wLTktMS0xLTM4MTA_03705cda-7d20-41c4-82d2-d137c95c88a7">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY183Njk2NTgxMzk4Mzgx_2e92ef76-eabb-41ee-97d0-06ff4df28f73">&#9746;</ix:nonNumeric></span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the  Act).&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTU1_fcf8b024-1bf4-42df-85df-2bea0b946517">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Yes&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of Common Stock held by non-affiliates of the registrant as of June&#160;30, 2020, the last business day of our most recently completed second fiscal quarter, was approximately $<ix:nonFraction unitRef="usd" contextRef="i87711e21c9a446419ccfe038aeb1835b_I20200630" decimals="-8" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yNDQx_e833424e-5563-4721-8b9f-f3be2c821f11">10.5</ix:nonFraction> billion (based upon the closing price for shares of the registrant&#8217;s Common Stock as reported by the New York Stock Exchange, Inc. on June&#160;30, 2020).</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;12, 2021, approximately <ix:nonFraction unitRef="shares" contextRef="id8ecbcccccbd40c5a50d0279cba6e06e_I20210212" decimals="-5" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yNjA4_467e2096-92ca-4378-b2fd-5b6b33480731">58,000,000</ix:nonFraction> shares of the registrant&#8217;s Common Stock, $0.001 par value per share, were outstanding.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:28.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.184%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTU2_ddaa5a1e-336e-4a46-9010-486073428a97" escape="true">Portions of the registrant&#8217;s Proxy Statement for the 2021 Annual Meeting of Stockholders to be held on May 6, 2021, are incorporated by reference into Part III of this Form 10-K, to the extent described therein.</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if790247689124308855d86d82384a359_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">MOLINA HEALTHCARE, INC. 2020 FORM 10-K </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.371%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part I</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Item Number</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_13">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_2354">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_2354">19</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unresolved Staff Comments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not Applicable.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_46">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_46">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_49">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_49">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Mine Safety Disclosures</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not Applicable.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part&#160;II</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_52">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_52">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selected Consolidated Financial Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not Applicable.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_58">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_58">35</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_106">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_106">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_109">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_109">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not Applicable.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_241">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_241">90</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_250">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_250">96</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part&#160;III</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_253">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_253">96</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_253">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_253">96</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_253">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_253">96</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_253">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_253">96</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_253">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_253">96</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part&#160;IV</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_256">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_256">97</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form 10-K Summary </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not Applicable.</span></td></tr></table></div><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline" href="#if790247689124308855d86d82384a359_259">Signatures</a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if790247689124308855d86d82384a359_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORWARD LOOKING STATEMENTS</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K (this &#8220;Form 10-K&#8221;) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Many of the forward-looking statements are located under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as &#8220;guidance,&#8221; &#8220;future,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;growth,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;may,&#8221; and similar terms. Readers are cautioned not to place undue reliance on any forward-looking statements, as forward-looking statements are not guarantees of future performance and the Company&#8217;s actual results may differ significantly due to numerous known and unknown risks and uncertainties. Those known risks and uncertainties include, but are not limited to, the risk factors identified in the section of this Form 10-K titled &#8220;Risk Factors,&#8221; as well as the following:  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic and its associated or indirect effects on our business, operations, and financial results;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the numerous political, judicial, and market-based uncertainties associated with the Affordable Care Act (the &#8220;ACA&#8221;), including the ultimate outcome of the California et al. v Texas et al. matter currently pending for decision before the United States Supreme Court;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">significant budget pressures on state governments from diminished tax revenues incidental to the COVID-19 pandemic and their efforts to reduce rates or limit rate increases, to impose profit caps or risk corridors, or to recoup previously paid premium amounts on a retroactive basis; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the market dynamics surrounding the ACA Marketplaces, including issues impacting enrollment, risk adjustment estimates and results, the potential for disproportionate enrollment of higher acuity members, and the discontinuation of premium tax credits;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the outcome of the legal proceedings in Kentucky with regard to the Medicaid contract award to our Kentucky health plan and our acquisition of certain assets of Passport;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the success of our efforts to retain existing or awarded government contracts, and the success of any bid submissions in response to requests for proposal, including our contracts in Ohio, California, and Texas; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">subsequent adjustments to reported premium revenue based upon subsequent developments or new information, including changes to estimated amounts payable or receivable related to Marketplace risk adjustment; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of adequate financing on acceptable terms to fund and capitalize our expansion and growth, repay our outstanding indebtedness at maturity, and meet our general liquidity needs;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to consummate, integrate, and realize benefits from acquisitions, including the completed acquisitions of Magellan Complete Care and Passport, and announced acquisition of Affinity;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">effective management of our medical costs; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to predict with a reasonable degree of accuracy utilization rates, including utilization rates associated with COVID-19; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">cyber-attacks, ransomware attacks, or other privacy or data security incidents resulting in an inadvertent unauthorized disclosure of protected information;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to manage our operations, including maintaining and creating adequate internal systems and controls relating to authorizations, approvals, provider payments, and the overall success of our care management initiatives; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our receipt of adequate premium rates to support increasing pharmacy costs, including costs associated with specialty drugs and costs resulting from formulary changes that allow the option of higher-priced non-generic drugs; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to operate profitably in an environment where the trend in premium rate increases lags behind the trend in increasing medical costs; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the interpretation and implementation of federal or state medical cost expenditure floors, administrative cost and profit ceilings, premium stabilization programs, profit-sharing arrangements, and risk adjustment provisions and requirements; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates of amounts owed for such cost expenditure floors, administrative cost and profit ceilings, premium stabilization programs, profit-sharing arrangements, and risk adjustment provisions and requirements; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the Medicaid expansion medical cost corridor, and any other retroactive adjustment to revenue where methodologies and procedures are subject to interpretation or dependent upon information about the health status of participants other than Molina members; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the interpretation and implementation of at-risk premium rules and state contract performance requirements regarding the achievement of certain quality measures, and our ability to recognize revenue amounts associated therewith; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the success and renewal of our duals demonstration programs in California, Illinois, Michigan, Ohio, South Carolina, and Texas; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the accurate estimation of incurred but not reported or paid medical costs across our health plans;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">efforts by states to recoup previously paid and recognized premium amounts; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">complications, member confusion, eligibility redeterminations, or enrollment backlogs related to the renewal of Medicaid coverage;   </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">fraud, waste and abuse matters, government audits or reviews, comment letters, or potential investigations, and any fine, sanction, enrollment freeze, corrective action plan, monitoring program, or premium recovery that may result therefrom;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our exit from Puerto Rico, including the payment in full of our outstanding accounts receivable, the effective run-out of claims, and the return of our capital;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">changes with respect to our provider contracts and the loss of providers; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">approval by state regulators of dividends and distributions by our health plan subsidiaries;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">changes in funding under our contracts as a result of regulatory changes, programmatic adjustments, or other reforms;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">high dollar claims related to catastrophic illness; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the favorable resolution of litigation, arbitration, or administrative proceedings;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the relatively small number of states in which we operate health plans, including the greater scale and revenues of our California, Ohio, Texas, and Washington health plans;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the failure to comply with the financial or other covenants in our credit agreement or the indentures governing our outstanding notes;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the sufficiency of funds on hand to pay the amounts due upon maturity of our outstanding notes;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the failure of a state in which we operate to renew its federal Medicaid waiver;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">changes generally affecting the managed care industry; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">increases in government surcharges, taxes, and assessments;  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the unexpected loss of the leadership of one or more of our senior executives; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">increasing competition and consolidation in the Medicaid industry.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the terms &#8220;Molina Healthcare, Inc.&#8221; &#8220;Molina Healthcare,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; and &#8220;us,&#8221; as used herein, refers collectively to Molina Healthcare, Inc. and its wholly owned subsidiaries, unless otherwise stated. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 2</span></div></div></div><div id="if790247689124308855d86d82384a359_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_16"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">ABOUT MOLINA HEALTHCARE</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces (the &#8220;Marketplace&#8221;). Molina was founded in 1980 as a provider organization serving low-income families in Southern California.&#160;We were originally organized in California as a health plan holding company and reincorporated in Delaware in 2002.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our locally operated health plans in 15 states, we served approximately 4.0 million members as of December 31, 2020. In addition, in connection with our acquisition of Magellan Complete Care on December 31, 2020, we added approximately 200,000 members, and now operate health plans in 18 states. These health plans are generally operated by our respective wholly owned subsidiaries in those states, and licensed as health maintenance organizations (&#8220;HMOs&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">FINANCIAL HIGHLIGHTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Dollars in millions, except per-share amounts)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premium Revenue</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$18,299</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16,208</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$19,423</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16,829</span></td></tr><tr><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Care Ratio (&#8220;MCR&#8221;) </span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86.5%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">85.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After-Tax Margin </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.4%</span></td></tr><tr><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income per Diluted Share</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$11.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#0f7c7f;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$11.47</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_______________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Medical care ratio represents medical care costs as a percentage of premium revenue.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">After-tax margin represents net income as a percentage of total revenue. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">2020 EXECUTIVE SUMMARY</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we drove strong operating performance in a challenging COVID-19 pandemic environment, particularly in the following areas:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Response</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operated remotely for majority of the year in unprecedented pandemic environment;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Effected transition of workforce to remote status in March while maintaining or improving operating metrics;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Addressed workforce hardships by implementing assistance programs, including dependent-care and other stipends, and a short-term incentive program for eligible non-executive employees; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Did not reduce workforce.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Plan Portfolio</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Announced health plan acquisitions including Magellan Complete Care (in Arizona, Florida, Massachusetts, New York, Virginia and Wisconsin), Affinity (in New York) and Passport (in Kentucky), representing annualized aggregate premium revenues exceeding $6 billion;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Closed on acquisitions of Magellan Complete Care, Passport and YourCare (in New York);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Established a dedicated integration management function to help ensure that we achieve the expected business results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Exited Puerto Rico operations without financial hardship; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Won the Medicaid contract request for proposal (&#8220;RFP&#8221;) in Kentucky, and successfully protested the outcome of the Medicaid RFP awards for certain regions of Texas, preserving our Medicaid membership in that state.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Notable Achievements</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Organized, announced and initially funded the &#8220;MolinaCares&#8221; Molina Healthcare Charitable Foundation, an independent charitable organization;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Drove over 20% improvement in annual employee engagement survey;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Completed capital structure overhaul with the issuance of two high-yield senior notes amounting to $1.5 billion, in the aggregate, and increased credit facility capacity to $1 billion; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Further bolstered senior and middle management talent.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business footprint, as of December&#160;31, 2020, is illustrated below.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="moh-20201231_g2.jpg" alt="moh-20201231_g2.jpg" style="height:375px;margin-bottom:5pt;vertical-align:text-bottom;width:500px"/></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">OUR SEGMENTS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had two reportable segments: the Health Plans segment, and the Other segment. Our reportable segments are consistent with how we currently manage the business and view the markets we serve. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Plans reportable segment includes our regulated health plan operating segments, along with the recently acquired Magellan Complete Care health plans operating segment. Because this acquisition closed on December 31, 2020, Magellan Complete Care&#8217;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020. Management will continue to evaluate the composition of its operating and reportable segments for future filings. The Other segment, which is insignificant to our consolidated results of operations, includes certain corporate amounts not associated with or allocated to the Health Plans segment. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Notes to Consolidated Financial Statements, Note 16, &#8220;Segments,&#8221; for further information, including segment revenue and profit information, and Note 2, &#8220;Significant Accounting Policies&#8221; for premium revenue information by health plan.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MEMBERSHIP BY HEALTH PLAN</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">California</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">593,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">565,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Illinois</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kentucky</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michigan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ohio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">357,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Washington</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">832,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">574,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,032,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,331,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">&#8220;Other&#8221; includes the Idaho, Mississippi, New Mexico, New York, Puerto Rico, South Carolina, Utah, and Wisconsin health plans, which were individually insignificant to our consolidated operating results for the periods presented.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">The 2020 totals for both &#8220;Membership by Health Plan,&#8221; and &#8220;Membership by Program,&#8221; do not include approximately 200,000 Magellan Complete Care members from the acquisition closed on December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MEMBERSHIP BY PROGRAM</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,599,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,956,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketplace</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,032,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,331,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="if790247689124308855d86d82384a359_19"></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">MISSION</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We improve the health and lives of our members by delivering high-quality healthcare. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">VISION</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will distinguish ourselves as the low cost, most effective and reliable health plan delivering government-sponsored care. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">STRATEGY</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth strategy continues to be anchored by our capital allocation priorities: first, organic growth of our core businesses; second, inorganic growth through accretive acquisitions; and third, programmatically returning excess capital to shareholders, for example, in the form of targeted share repurchase programs. The key capabilities that enable our growth strategy follow: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Low Cost</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We provide low-cost health plans to our state customers for Medicaid, and to our members in the MMP and Marketplace programs. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">High Quality and Appropriate Access to Care</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We provide our members effective and appropriate access to care at the right time and in the right setting. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Service and Seamless Experience</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We offer our state customers, members, and providers reliable service and a seamless experience.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 5</span></div></div></div><div id="if790247689124308855d86d82384a359_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">OUR BUSINESS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MEDICAID</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid was established in 1965 under the U.S.&#160;Social Security Act to provide healthcare and long-term care services and support to low-income Americans. Although jointly funded by federal and state governments, Medicaid is a state-operated and state-implemented program. Subject to federal laws and regulations, states have significant flexibility to structure their own programs in terms of eligibility, benefits, delivery of services, and provider payments. As a result, there are 56 separate Medicaid programs&#8212;one for each U.S. state, each U.S. territory, and the District of Columbia.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government guarantees matching funds to states for qualifying Medicaid expenditures based on each state&#8217;s federal medical assistance percentage (&#8220;FMAP&#8221;). A state&#8217;s FMAP is calculated annually and varies inversely with average personal income in the state. The approximate average FMAP across all jurisdictions is currently 60%, and currently ranges from a federally established FMAP floor of 50% to as high as 78%. See further discussion regarding the FMAP below in &#8220;COVID-19 Pandemic&#8212;Federal Economic Stabilization Programs.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in the following Medicaid programs:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Temporary Assistance for Needy Families (&#8220;TANF&#8221;) - This is the most common Medicaid program. It primarily covers low-income families with children.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicaid Aged, Blind or Disabled (&#8220;ABD&#8221;) - ABD programs cover low-income persons with chronic physical disabilities or behavioral health impairments. ABD beneficiaries typically use more services than those served by other Medicaid programs because of their critical health issues.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Children&#8217;s Health Insurance Program (&#8220;CHIP&#8221;) - CHIP is a joint federal and state matching program that provides healthcare coverage to children whose families earn too much to qualify for Medicaid coverage. States have the option of administering CHIP through their Medicaid programs.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicaid Expansion -</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In states that have elected to participate, Medicaid Expansion provides eligibility to nearly all low-income individuals under age 65 with incomes at or below 138% of the federal poverty line. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our state Medicaid contracts typically have terms of three to five years, contain renewal options exercisable by the state Medicaid agency, and allow either the state or the health plan to terminate the contract with or without cause. Such contracts are subject to risk of loss in states that issue requests for proposal (&#8220;RFP&#8221;) open to competitive bidding by other health plans. If one of our health plans is not a successful responsive bidder to a state RFP, its contract may not be renewed. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to contract renewal, our state Medicaid contracts may be periodically amended to include or exclude certain health benefits (such as pharmacy services, behavioral health services, or long-term care services); populations such as the aged, blind or disabled; and regions or service areas. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Status of Significant Contracts</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated Medicaid premium revenue constituted 73% of our total revenue in the year ended December 31, 2020. Our Medicaid contracts with each of the states of California, Ohio, Texas and Washington accounted for approximately 10% or more of our consolidated Medicaid premium revenues in each of the years ended December 31, 2020, and 2019. The current status of each of these contracts is described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">California</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our managed care contracts with the California Department of Health Care Services (&#8220;DHCS&#8221;) cover six regions in northern and southern California (including Los Angeles County, California, as a subcontractor to another health plan holding a direct contract with the state). These contracts are effective through December 31, 2021, which we expect to be renewed annually until the effectiveness of new forms of contract following RFP awards. DHCS has publicly indicated it expects to release the final Medicaid RFP in 2021, for implementation in January 2024. Our California Medicaid contracts represented premium revenue of approximately $1,694 million, or 12%, of our consolidated Medicaid premium revenue in 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ohio</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our managed care contract with the Ohio Department of Medicaid (&#8220;ODM&#8221;) is effective through July 1, 2021. In September 2020, the ODM released the RFP for the Ohio Medicaid program, which will be regionally based on the current three regions (Central/Southeast, Northeast and West). Health plans were able to bid on one or all regions, and be awarded one or all regions. As of February&#160;16, 2021, ODM had not announced the winning bidders </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the RFP. Our Ohio Medicaid contract represented approximately $2,231 million, or 16%, of our consolidated Medicaid premium revenue in 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Texas.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In March 2020, the Texas Health and Human Services Commission (&#8220;HHSC&#8221;) notified our Texas health plan that HHSC had upheld our protest and had canceled all previously awarded contracts associated with the re-procurement awards announced in October 2019 for the ABD program (known in Texas as &#8220;STAR+PLUS&#8221;). In addition, HHSC canceled the pending re-procurement associated with the TANF and CHIP programs (known in Texas as &#8220;STAR/CHIP&#8221;). HHSC has indicated that the STAR+PLUS RFP will be posted in late 2021 or early 2022, with awards estimated to be announced in the second quarter of 2022, and start of operations in the fourth quarter of 2023. HHSC has also indicated that the STAR/CHIP RFP will be posted in the fourth quarter of 2022, with awards estimated to be announced in late 2022 or early 2023, and start of operations in the third quarter of 2024. Our Texas Medicaid contracts represented approximately $2,151 million, or 15%, of consolidated Medicaid premium revenue in 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Washington. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our managed care contract with the Washington State Health Care Authority (&#8220;HCA&#8221;) covers all ten regions of the state&#8217;s Apple Health Integrated Managed Care program, and is effective through December&#160;31, 2021. We expect the HCA to exercise its renewal option for at least one year, through December 31, 2022. Our Washington Medicaid contract represented approximately $2,804 million, or 20%, of consolidated Medicaid premium revenue in 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A loss of any of our significant Medicaid contracts could have a material adverse effect on our business, financial condition, cash flows, and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Developments</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Magellan Complete Care</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On December 31, 2020, we closed on our acquisition of 100% of the outstanding equity interests of the Magellan Complete Care line of business of Magellan Health, Inc., for total purchase consideration of approximately $1,037&#160;million. Total purchase consideration paid in cash amounted to $1,008&#160;million, which consisted of the base purchase price of $850&#160;million, plus approximately $158&#160;million in preliminary closing adjustments, primarily relating to excess regulatory capital. Total purchase consideration also included assumed liabilities of $29&#160;million. Magellan Complete Care is a managed care organization serving members in six states, including Medicaid members in Arizona and statewide in Virginia, and integrated acute care members in Florida. Through its Senior Whole Health branded plans, Magellan Complete Care provides fully integrated plans for Medicaid and Medicare dual beneficiaries in Massachusetts, as well as managed long-term care in New York. As of December 31, 2020, Magellan Complete Care served approximately 200,000 members in its managed care plans. Magellan Complete Care also provides consultative services to participants who self-direct their care through Wisconsin&#8217;s long-term services and supports (&#8220;LTSS&#8221;) program. For the year ended December 31, 2020, Magellan Complete Care&#8217;s total 2020 revenue was approximately $2.9&#160;billion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a definitive agreement to acquire substantially all the assets of Affinity Health Plan, Inc. The net purchase price for the transaction is approximately $380&#160;million, subject to various adjustments at closing, which we intend to fund with cash on hand. We currently expect the transaction to close as early as the second quarter of 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2020, we closed on the acquisition of certain assets of YourCare Health Plan, Inc., a Medicaid health plan operating in certain regions of New York, for a cash purchase price of $42&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kentucky</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In May 2020, our Kentucky health plan was selected as an awardee pursuant to the statewide Medicaid managed care RFP issued by the Kentucky Cabinet for Health and Family Services, Department of Medicaid Services. On September 1, 2020, we closed on the acquisition of certain assets of Passport Health Plan, Inc., a Medicaid health plan, for a purchase price of $66 million. Effective on that same date, the Kentucky Medicaid agency approved the novation of Passport&#8217;s Medicaid contract to Molina Healthcare of Kentucky, Inc., thereby ensuring continuity of care for Passport&#8217;s Medicaid members. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Member Enrollment and Marketing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most states allow eligible Medicaid members to select the Medicaid plan of their choice. This opportunity to choose a plan is typically afforded to the member at the time of first enrollment and, at a minimum, annually thereafter.&#160;In some of the states in which we operate, a substantial majority of new Medicaid members voluntarily select a plan with the remainder subject to the auto-assignment process described below, while in other states less than half of new members voluntarily choose a plan.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicaid health plans may benefit from auto-assignment of individuals who do not choose a plan, but for whom participation in managed care programs is mandatory. Each state differs in its approach to auto-assignment, but one </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or more of the following criteria is typical in auto-assignment algorithms: a Medicaid beneficiary's previous enrollment with a health plan or experience with a particular provider contracted with a health plan, enrolling family members in the same plan, a plan's quality or performance status, a plan&#8217;s network and enrollment size, awarding all auto-assignments to a plan with the lowest bid in a county or region, and equal assignment of individuals who do not choose a plan in a specified county or region. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicaid marketing efforts are regulated by the states in which we operate, each of which imposes different requirements for, or restrictions on, Medicaid sales and marketing. These requirements and restrictions are revised from time to time. None of the jurisdictions in which we operate permit direct sales by Medicaid health plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MEDICARE</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Advantage.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Medicare is a federal program that provides eligible persons age&#160;65 and over and some disabled persons with a variety of hospital, medical insurance, and prescription drug benefits. Medicare is funded by Congress, and administered by the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;). Medicare beneficiaries may enroll in a Medicare Advantage plan, under which managed care plans contract with CMS to provide benefits that are comparable to original Medicare. Such benefits are provided in exchange for a fixed per-member per-month (&#8220;PMPM&#8221;) premium payment that varies based on the county in which a member resides, the demographics of the member, and the member&#8217;s health condition. Since 2006, Medicare beneficiaries have had the option of selecting a prescription drug benefit from an existing Medicare Advantage plan. The drug benefit, available to beneficiaries for a monthly premium, is subject to certain cost sharing depending upon the specific benefit design of the selected plan. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare-Medicaid Plans, or MMPs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Over 12 million low-income elderly and disabled people qualify for both the Medicare and Medicaid programs (&#8220;dual eligible&#8221; individuals). These beneficiaries are more likely than other Medicare beneficiaries to be frail, live with multiple chronic conditions, and have functional and cognitive impairments. Medicare is their primary source of health insurance coverage. Medicaid supplements Medicare by paying for services not covered by Medicare, such as dental care and long-term care services and supports, and by helping to cover Medicare&#8217;s premiums and cost-sharing requirements. Together, these two programs help to shield very low-income Medicare beneficiaries from potentially unaffordable out-of-pocket medical and long-term care costs. To coordinate care and deliver services in a more financially efficient manner, some states have undertaken demonstration programs to integrate Medicare and Medicaid services for dual-eligible individuals. The health plans participating in such demonstrations are referred to as MMPs. We operate MMPs in six states, as described further below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contracts</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into Medicare and MMP contracts with CMS, in partnership with each state&#8217;s department of health and human services. Such contracts typically have terms of one to three years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Status of MMP Contracts</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our California, Illinois and Ohio MMP contracts are effective through December&#160;31, 2022, which represented aggregate premium revenue of approximately $947 million in 2020. Our South Carolina and Texas MMP contracts are effective through December 31, 2023, which represented aggregate premium revenue of approximately $492 million in 2020. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Michigan, we have a one-year contract extension effective through December 31, 2021, which represented premium revenue of approximately $281 million in 2020. The state has submitted a formal letter of intent to extend the contract for five years through 2026; the five-year contract extension is under development.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Developments</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, CMS announced its introduction of a new direct contracting model aimed at utilizing Medicaid Managed Care Organizations (&#8220;MCOs&#8221;) to increase holistic care coordination and improve outcomes for the dually eligible population. The new model will roll out in January 2022, with requests for applications expected to be released in early 2021. Participating MCO-based direct contracting entities will have new incentives to provide whole-person care and better serve their full-benefit dually eligible enrollees. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Member Enrollment and Marketing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare members may be enrolled through auto-assignment, as described above in &#8220;Medicaid&#8212;Member Enrollment and Marketing,&#8221; or by enrolling in our plans with the assistance of insurance agents employed by Molina, outside brokers, or via the Internet.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare marketing and sales activities are regulated by CMS and the states in which we operate. CMS has oversight over all marketing materials used by Medicare Advantage plans, and in some cases has imposed advance approval requirements. CMS generally limits sales activities to those conveying information regarding benefits, describing the operations of our managed care plans, and providing information about eligibility requirements. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ our own insurance agents and contract with independent, licensed insurance agents to market our Medicare Advantage products. We have continued to expand our use of independent agents because the cost of these agents is largely variable and we believe the use of independent, licensed agents is more conducive to the shortened Medicare selling season and the open enrollment period. The activities of our independent, licensed insurance agents are also regulated by CMS. We also use direct mail, mass media and the Internet to market our Medicare Advantage products.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MARKETPLACE</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2014, the Affordable Care Act (&#8220;ACA&#8221;) authorized the creation of Marketplace insurance exchanges, allowing individuals and small groups to purchase federally subsidized health insurance. We</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> offer Marketplace plans in many of the states where we offer Medicaid health plans. Our plans allow our Medicaid members to stay with their providers as they transition between Medicaid and the Marketplace. Additionally, our plans remove financial barriers to quality care and seek to minimize members' out-of-pocket expenses. In 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we are participating in the Marketplace in all our markets except Idaho, Illinois, Kentucky, New York, and the Magellan Complete Care markets in Arizona, Massachusetts, and Virginia.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we expect Marketplace enrollment to grow approximately 25%, to a total of 400,000 members at the end of 2021.This would represent premium revenue growth of approximately $485 million in 2021. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contracts</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into contracts with CMS annually for the state Marketplace programs. These contracts have a one-year term ending on December 31, and must be renewed annually.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Developments</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Special Enrollment Period. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, President Biden issued the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Order on Strengthening Medicaid and the Affordable Care Act</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result of the order, a new three-month special enrollment period will be launched to allow uninsured and under-insured individuals to obtain Marketplace coverage. The special enrollment period will be open from February 15, 2021 to May 15, 2021.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketplace Risk Corridor Judgment. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the United States Supreme Court held that &#167;1342 of the Affordable Care Act obligated the federal government to pay participating insurers the full Marketplace risk corridor amounts calculated by that statute, and that impacted insurers may sue the federal government in the U.S. Court of Federal Claims to recover damages for breach of that obligation. In June 2020, the Claims Court granted us judgment in the amount of $128&#160;million for 2014, 2015, and 2016 Marketplace risk corridor claims, which we received in October 2020. Consistent with the timing of the cash receipt, the gain was recognized in our fourth quarter 2020 financial results and reported in &#8220;Marketplace risk corridor judgment&#8221; in our consolidated statements of income. The judgment did not create additional Minimum MLR rebates.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Member Enrollment and Marketing</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Marketplace members enroll in our plans with the assistance of insurance agents employed by Molina, outside brokers, vendors, direct to consumer marketing and via the Internet.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our Marketplace sales activities are regulated by CMS (such as eligibility determinations), our marketing activities are regulated by the individual states in which we operate. Some states require us to obtain prior approval of our marketing materials, others simply require us to provide them with copies of our marketing materials, and some states do not request our marketing materials.&#160;We are able to freely contact our members and provide them with marketing materials as long as those materials are fair and do not discriminate.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Marketplace sales and marketing strategy is to provide high quality, affordable, compliant and consumer centric Marketplace products through a variety of distribution channels. Our Marketplace products are displayed on the Federally Facilitated Marketplace (&#8220;FFM&#8221;) and the State Based Marketplace (&#8220;SBM&#8221;) in the states in which we participate in the Marketplace. We also contract with independent, licensed insurance agents to market our Marketplace products. The activities of our independently licensed insurance agents are also regulated by both CMS and the departments of insurance in the states in which we participate. Our sales cycle typically peaks during the annual Open Enrollment Period (&#8220;OEP&#8221;) as defined and regulated by CMS and the applicable FFM and SBM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">BASIS FOR PREMIUM RATES</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our consolidated premium revenue by program for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:72.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketplace</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,208&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicaid</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Medicaid contracts, state government agencies pay our health plans fixed PMPM rates that vary by state, line of business, demographics and, in most instances, health risk factors. CMS requires these rates to be actuarially sound. In exchange for the payment received, Molina arranges, pays for, and manages healthcare services provided to Medicaid beneficiaries. Therefore, our health plans are at risk for the medical costs associated with their members&#8217; healthcare. Payments to us under each of our Medicaid contracts are subject to each state&#8217;s annual appropriation process. The amount of the premiums paid to our health plans may vary substantially between states and among various government programs. For the year ended December 31, 2020, Medicaid program PMPM premium revenues ranged from $190.00 to $1,560.00.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Medicare Advantage, managed care plans contract with CMS to provide benefits in exchange for a fixed PMPM premium payment that varies based on health plan star rating and member demographics, including county residence and health risk factors. CMS also considers inflation, changes in utilization patterns and average per capita fee-for-service Medicare costs in the calculation of the fixed PMPM premium payment. Amounts payable to us under the Medicare Advantage contracts are subject to annual revision by CMS, including any federal budget cuts or tax changes applicable to Medicare. We elect to participate in each Medicare service area or region on an annual basis. Medicare Advantage premiums paid to us are subject to federal government reviews and audits which can result, and have resulted, in retroactive and prospective premium adjustments. Compared with our Medicaid plans, Medicare Advantage and MMP contracts generate higher average PMPM revenues and healthcare costs. For the year ended December 31, 2020, Medicare program PMPM premium revenues ranged from $1,060.00 to $3,150.00.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketplace</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Marketplace, we develop each state&#8217;s premium rates during the spring of each year for policies effective in the following calendar year. Premium rates are based on our estimates of utilization of services and unit costs, anticipated member risk acuity and related federal risk adjustment transfer amounts, and non-benefit expenses such as administrative costs, taxes, and fees. The premium rates are filed for approval with the various state and federal authorities in accordance with the rules and regulations applicable to the ACA individual market, including, but not limited to,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">minimum loss ratio thresholds and adjustments for permissible rate variations by age, geographic area, and variations in plan design. In the year ended December 31, 2020, Marketplace program PMPM premium revenues ranged from $310.00 to $590.00, excluding the risk corridor judgment described above. </span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_2199"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">COVID-19 PANDEMIC</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic continues to evolve, its ultimate impact to our business, results of operations, financial condition and cash flows is uncertain and difficult to predict. Specific trends and uncertainties related to our Health Plans segment follow. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Federal Economic Stabilization Programs</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the pandemic, various stabilization programs were enacted beginning in March 2020, which may impact our business directly or indirectly, including the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coronavirus Preparedness and Response Supplemental Appropriations Act. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enacted on March 6, 2020, this legislation provided $8.3 billion in COVID-19 response funding for developing a vaccine and preventing further spread of the virus.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Families First Coronavirus Response Act</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Enacted on March 18, 2020, this legislation provided $100 billion in worker assistance, temporarily increased each qualifying state and territory&#8217;s FMAP by 6.2% beginning January 1, 2020, and waived cost sharing for COVID-19 testing. The federal government guarantees matching funds to states for qualifying Medicaid expenditures based on each state&#8217;s FMAP. The enhanced FMAP rate has been extended through the end of the second quarter of 2021. The accompanying requirement that bans the loss of coverage from state eligibility redeterminations has been extended through the end of April 2021. Redetermination is the process through which Medicaid enrollees demonstrate whether they continue to meet the requirements for participation in the Medicaid program, in particular maximum household income. This is likely a positive indicator for continued membership gains, and to provide more support for an actuarially sound rate environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Enacted on March 27, 2020, the CARES Act provided an estimated $2 trillion to fight the COVID-19 pandemic and stimulate the U.S. economy. This assistance included loans and support to major industries, including airlines and small businesses, direct payments to individuals and families, and $175 billion in relief funds to hospitals and other healthcare providers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paycheck Protection Program and Health Care Enhancement Act</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Enacted on April 24, 2020, this legislation provided $310 billion for the depleted Paycheck Protection Program, and additional funding for hospitals and testing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coronavirus Response and Relief Supplemental Appropriations Act. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enacted on December 27, 2020, this $900 billion economic stimulus package was attached to a $1.4 trillion omnibus spending bill to fund the U.S. government through September 30, 2021. The legislation aims to support the U.S. economy by reauthorizing and providing additional funding for the fiscal support programs established by the CARES Act, and included small business relief funding of $325 billion, $82 billion in school funding, $69 billion for vaccine procurement and distribution, direct payments to individuals and families, and extended unemployment benefits, among other relief funding.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty as to the duration and breadth of the COVID-19 pandemic, we are unable to reasonably estimate the ultimate impact of the economic stabilization programs to our business, financial condition, and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Health Plan Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic has impacted our business, and we currently expect it to further impact our business in the areas described below. In 2020, the combination of COVID-related impacts netted to a significant negative impact on earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Care Costs and Demand for Healthcare Services.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Beginning in early 2020 the pandemic, along with the related quarantine and social distancing measures, reduced demand for certain routine and non-critical medical services, while at the same time increased demand for other medical services, such as COVID-19 testing and emergency services. Early in the second quarter of 2020, we began to experience significantly lower utilization in a variety of cost categories, representing approximately two-thirds of our total medical cost spend, with utilization levels increasing slowly as the year progressed. We experienced several significant COVID-related impacts on medical care costs in 2020 as follows:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Direct costs to care for COVID patients totaled $205 million in 2020, as a resurgence of COVID infections and episodes occurred in places such as Texas and California, and also disproportionately impacted certain of our Marketplace members. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In 2020, utilization was curtailed, and generally remained below normal levels for the remainder of the year. The effect of the curtailed utilization, net of the direct cost to care discussed above, reduced medical care costs and increased pretax earnings by approximately $420 million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excluding acquisitions and our planned exit from Puerto Rico, we have added approximately 415,000 new Medicaid members since March 31, 2020, and we believe that the acuity of that population is lower than our average.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With regard to the recently approved vaccines, all such vaccines are purchased by the federal government, at no cost to us or our members. For our Medicaid and Marketplace members, we will cover the costs to administer the vaccine, which we do not expect to be significant. The costs to administer the vaccine to our Medicare members is generally covered by CMS.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicaid Premium Actions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In 2020, various states enacted temporary premium refunds and related actions in response to the reduced demand for medical services stemming from COVID-19, which resulted in a reduction of our medical margin. In some cases, these premium actions were retroactive to earlier periods in 2020, or as early as the beginning of the states&#8217; fiscal years in 2019. Beginning in the second quarter of 2020, we have recognized retroactive premium actions that we believe to be probable, and where the ultimate premium amount is reasonably estimable. We recognized $<ix:nonFraction unitRef="usd" contextRef="i91290aace81d4332aae71ba1a693cbba_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTk5L2ZyYWc6M2QxOTg0MDAxZTRmNDg0Yzg1NDdjODc0YTJkNGM4YjIvdGV4dHJlZ2lvbjozZDE5ODQwMDFlNGY0ODRjODU0N2M4NzRhMmQ0YzhiMl8xMDk5NTExNjMzMTAz_fd28d8f1-5ae0-44bf-b3d3-04ddf604aee1">564</ix:nonFraction>&#160;million related to these retroactive premium refunds, in the aggregate, in 2020, including approximately $37&#160;million related to MMP plans.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is possible that certain states could increase the level of existing premium refunds, and it is also possible that other states could implement some form of retroactive premium refund in the future. Due to these uncertainties, the ultimate outcomes could differ materially from our estimates as a result of changes in facts or further developments, which could have an adverse effect on our consolidated financial position, results of operations, or cash flows. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our position on rate adequacy has been consistent:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We do not intend, nor do we want, to keep state Medicaid money that was supposed to be spent on medical benefits but was not due to utilization curtailment caused by COVID;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In many of our legacy Medicaid states, there are already mechanisms in place to protect against a surplus margin, as there are Minimum MLRs in seven of our states and profit caps in two others; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Once the COVID-19 pandemic abates, we believe that the traditional process of establishing prospective actuarially sound rates based on a credible medical cost baseline and cost trend off that baseline will resume. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicaid premium actions, COVID may impact premium revenue in our Medicare and Marketplace programs. For these programs, which utilize risk adjustment methodologies, medical care patterns disrupted by COVID may temporarily affect our ability to obtain complete member health status information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Member Enrollment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Excluding acquisitions and our planned exit from Puerto Rico, we have added approximately 415,000 new Medicaid members since March 31, 2020, when we first began to report on the impacts of the pandemic. We believe this membership increase was mainly due to the suspension of redeterminations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It remains unclear how high the COVID-related membership peak will be, how quickly it will fall as the economy recovers, and where it will ultimately settle. However it does now appear that since unemployment nationally has fallen to 6.3% as of January 2021, the initial industry estimates of unemployment-related Medicaid membership increases were somewhat overstated. On a related note, the declaration of the extension of the public health emergency period to April 2021, with a potential extension from the Biden administration for the public health emergency to remain in place for all of 2021, will also likely have an impact. Therefore, we are currently unable to predict the timing or amount of the expected increases in enrollment. Increased membership would increase our premium revenue, but would also likely result in a significant increase in medical care claims and related costs. We believe that we have the scalability necessary to both serve new members, and ably partner with our state customers for increases in membership.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital and Financial Resources</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to &#8220;Liquidity and Financial Condition&#8221; below for a discussion of our capital and financial resources.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor and assess the estimated operating and financial impact of the COVID-19 pandemic, and as it evolves, we continue to process, assemble, and assess member utilization information. We believe that our cash resources, borrowing capacity available under the Credit Agreement, and cash flow generated from operations will be sufficient to withstand the financial impact of the pandemic, and will enable us to continue to support our operations, regulatory requirements, debt repayment obligations, and capital expenditures for the foreseeable future.  </span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_25"></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">LEGISLATIVE AND POLITICAL ENVIRONMENT</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">PRESSURES ON MEDICAID FUNDING</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to states&#8217; budget challenges, including shortfalls resulting from the COVID-19 pandemic, and political agendas at both the state and federal levels, there are a number of different legislative proposals being considered, some of which would involve significantly reduced federal or state spending on the Medicaid program, constitute a fundamental change to the federal role in healthcare and, if enacted, could have a material adverse effect on our business, financial condition, cash flows, or results of operations. These proposals include elements such as the following, as well as numerous other potential changes and reforms:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the entitlement nature of Medicaid (and perhaps Medicare as well) by capping future increases in federal health spending for these programs, and shifting much more of the risk for health costs in the future to states and consumers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reversing the ACA&#8217;s expansion of Medicaid that enables states to cover low-income childless adults;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changing Medicaid to a state block grant program, including potentially capping spending on a per-enrollee basis;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Requiring Medicaid beneficiaries to work; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Limiting the amount of lifetime benefits for Medicaid beneficiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">AFFORDABLE CARE ACT</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Status of Constitutionality Court Case</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, in a case brought by the state of Texas and nineteen other states, a federal judge in Texas held that the individual mandate of the Affordable Care Act (the &#8220;ACA&#8221;) is unconstitutional. He further held that since the individual mandate is inseverable from the entire body of the ACA, the entire ACA is&#160;unconstitutional. The effect of his ruling was stayed pending the appeal of the ruling to the Fifth Circuit Court of Appeals. In December 2019, a three-judge panel of the Fifth Circuit Court of Appeal, in a two to one decision, affirmed the District Court&#8217;s ruling that the individual mandate is unconstitutional, but remanded the case back to the District Court for further consideration of the severability issue. The intervenor defendant states led by California subsequently appealed the case to the U.S. Supreme Court, and the Supreme Court heard oral arguments in the case on November 10, 2020. The Supreme Court&#8217;s decision is expected by June 2021. If the Supreme Court were to rule that the individual mandate is unconstitutional, and that the individual mandate is not severable from the balance of the ACA, or that the entirety of the ACA is unconstitutional, that ruling could have a material adverse effect on our business, financial condition, cash flows, or results of operations.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we served a significant number of members enrolled in programs created by the ACA, including approximately 771,000 Medicaid Expansion members and 318,000 Marketplace members. In the year ended December 31, 2020, premium revenue associated with these members amounted to $4,904 million, and contributed Medical Margin of $826&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Proposed Changes and Reforms</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other proposed changes and reforms to the ACA have included, or may include the following:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prohibiting the federal government from operating Marketplaces;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Eliminating the advanced premium tax credits, and cost sharing reductions for low income individuals who purchase their health insurance through the Marketplaces;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expanding and encouraging the use of private health savings accounts;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Providing for insurance plans that offer fewer and less extensive health insurance benefits than under the ACA&#8217;s essential health benefits package, including broader use of catastrophic coverage plans, or short-term health insurance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Establishing and funding high risk pools or reinsurance programs for individuals with chronic or high cost conditions; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Allowing insurers to sell insurance across state lines.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The passage of any of these changes or other reforms could have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_28"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">OPERATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">QUALITY</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term success depends, to a significant degree, on the quality of the services we provide. As of December&#160;31, 2020, 13 of our health plans were accredited by the National Committee for Quality Assurance (&#8220;NCQA&#8221;), of which 12 of those health plans also received the Multicultural Health Care Distinction, which is awarded to organizations that meet or exceed NCQA&#8217;s rigorous requirements for multicultural healthcare.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the states where our health plans are accredited by the NCQA and/or have Medicare Star Ratings, the table below presents such health plans&#8217; NCQA status, as well as their current scores as part of the Medicare Star Ratings, which measures the quality of Medicare plans across the country using a 5-star rating system. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that these objective measures of quality are important to state Medicaid agencies, as a growing number of states link reimbursement and patient assignment to quality scores. Additionally, Medicare pays quality bonuses to health plans that achieve high quality.</span></div><div style="text-align:center"><img src="moh-20201231_g3.jpg" alt="moh-20201231_g3.jpg" style="height:455px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div><div style="margin-bottom:3pt;padding-left:54pt;padding-right:36pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:6pt;padding-left:63pt;padding-right:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.5pt">NCQA Health Insurance Plan Ratings for 2020-2021 (Medicaid) have not been released due to COVID-19.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">PROVIDERS</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We arrange healthcare services for our members through contracts with a vast network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies. We strive to ensure that our providers have the appropriate expertise and cultural and linguistic experience. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quality, depth and scope of our provider network are essential if we are to ensure quality, cost-effective care for our members. In partnering with quality, cost-effective providers, we utilize clinical and financial information derived by our medical informatics function, as well as the experience we have gained in serving Medicaid members, to gain insight into the needs of both our members and our providers. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physicians</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contract with both primary care physicians and specialists, many of whom are organized into medical groups or independent practice associations. Primary care physicians provide office-based primary care services. Primary care physicians may be paid under capitation or fee-for-service contracts and may receive additional compensation by providing certain preventive care services. Under capitation payment arrangements, healthcare providers receive fixed, pre-arranged monthly payments per enrolled member, whereas under fee-for-service payment arrangements, healthcare providers are paid a fee for each particular service rendered. Our specialists care for patients for a specific episode or condition, usually upon referral from a primary care physician, and are usually compensated on a fee-for-service basis. When we contract with groups of physicians on a capitated basis, we monitor their solvency. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hospitals</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally contract with hospitals that have significant experience dealing with the medical needs of the Medicaid population. We reimburse hospitals under a variety of payment methods, including fee-for-service, per diems, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic-related groups, capitation, and case rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ancillary Providers</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ancillary agreements provide coverage of medically-necessary care, including laboratory services, home health, physical, speech and occupational therapy, durable medical equipment, radiology, ambulance and transportation services, and are reimbursed on a capitation and fee-for-service basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We outsource pharmacy benefit management services, including claims processing, pharmacy network contracting, rebate processing and mail and specialty pharmacy fulfillment services.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates consolidated medical care costs by type for the periods indicated: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PMPM</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of<br/>Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PMPM</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of<br/>Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except PMPM amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356.65&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,905&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340.99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">&#8220;Other&#8221; includes all medically-related administrative costs, certain provider incentive costs, provider claims, and other healthcare expenses. Medically-related administrative costs include, for example, expenses relating to health education, quality assurance, case management, care coordination, disease management, and 24-hour on-call nurses. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MEDICAL MANAGEMENT</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission is to improve the health and lives of our members by delivering high-quality healthcare. We believe our singular focus on government-sponsored healthcare enables us to identify and implement efficiencies that distinguish us as the low-cost, high-quality health plan of choice. We emphasize primary care physicians as the central point of delivery for routine and preventive care, coordination of referrals to specialists, and appropriate assessment of the need for hospital care. This model has proved to be an effective method of coordinating medical care for our members.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Utilization Management </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is to optimize access to low-cost, high-quality care. This is achieved by sound clinical policy based on current evidence-based practices. Additionally, we continuously monitor utilization patterns and strive to identify new opportunities to reduce cost and improve quality of care. Our utilization management process serves as a bridge to identify at-risk members for referral into internally developed case management programs such as &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transitions of Care</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; which facilitates post-discharge safety and appropriate outcomes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Population Management </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe high-quality, affordable care is achieved through a variety of programs tailored to our members&#8217; emerging needs. Individuals are identified for interventions, and programs are customized, based on predictive analytics and our member assessment process. These tools ensure that the appropriate level of services and support are provided to address physical health, behavioral health, and social determinants of health.&#160;This comprehensive and customized approach is designed to help members achieve their goals and improve their overall quality of life.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Management </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pharmacy programs are designed to make us a trusted partner in improving member health and healthcare affordability. We strategically partner with physicians and other healthcare providers who treat our members. This collaboration results in drug formularies and clinical initiatives that promote improved patient care. We employ full-time pharmacists and pharmacy technicians who work closely with providers to educate them about our formulary products, clinical programs, and the importance of cost-effective care.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">INFORMATION TECHNOLOGY</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is dependent on effective and secure information systems that assist us in processing provider claims, monitoring utilization and other cost factors, supporting our medical management techniques, providing data to our regulators, and implementing our data security measures. Our members and providers also depend upon our information systems for enrollment, premium processing, primary care and specialist physician roster access, membership verifications, claims status, provider payments, and other information.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have partnered with third parties to support our information technology systems. This makes our operations vulnerable to adverse effects if such third parties fail to perform adequately. In 2019, we entered into an agreement with a third-party vendor who manages certain of our information technology services including, among other things, our infrastructure operations, end-user services, data centers, public cloud and application management.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the agreement, we were able to reduce our administrative expenses, while improving the reliability of our information technology functions, and maintain targeted levels of service and operating performance. A segment of these services are provided on our premises, while other portions of the services are performed at the vendor&#8217;s facilities. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information systems require an ongoing commitment of significant resources to maintain, protect, and enhance existing systems and develop new systems to keep pace with continuing changes in information processing technology, evolving systems and regulatory standards, changing customer preferences, acquisitions and increased security risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">CENTRALIZED SERVICES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and administration, underwriting, claims processing, customer service, certain care management services, human resources, marketing, purchasing, risk management, actuarial, finance, accounting, compliance, legal and public relations. </span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_31"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">COMPETITIVE CONDITIONS AND ENVIRONMENT</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face varying levels of competition. Healthcare reform proposals may cause organizations to enter or exit the market for government-sponsored health programs. However, the licensing requirements and bidding and contracting procedures in some states may present partial barriers to entry into our industry.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete for government contracts, renewals of those government contracts, members, and providers. State agencies consider many factors in awarding contracts to health plans. Among such factors are the health plan&#8217;s provider network, quality scores, medical management, degree of member satisfaction, timeliness of claims payment, and financial resources. Potential members typically choose a health plan based on a specific provider being a part of the network, the quality of care and services available, accessibility of services, and reputation or name recognition of the health plan. We believe factors that providers consider in deciding whether to contract with a health plan include potential member volume, payment methods, timeliness and accuracy of claims payment, and administrative service capabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicaid</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid managed care industry is subject to ongoing changes as a result of healthcare reform, business consolidations and new strategic alliances. We compete with national, regional, and local Medicaid service providers, principally on the basis of size, location, quality of the provider network, quality of service, and reputation. Our primary competitors in the Medicaid managed care industry include Centene Corporation, UnitedHealth Group Incorporated, Anthem,&#160;Inc., Aetna Inc., and other large not-for-profit healthcare organizations. Competition can vary considerably from state to state. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicare market is highly competitive across the country, with large competitors, such as UnitedHealth Group Incorporated, Humana Inc., and Aetna Inc., holding significant market share.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketplace</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Low-income members who receive government subsidies comprise the vast majority of Marketplace membership, which is served by a limited number of health plans. Our primary competitor for low-income Marketplace membership is Centene Corporation.</span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_34"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">REGULATION</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans are highly regulated by both state and federal government agencies. Regulation of managed care products and healthcare services varies from jurisdiction to jurisdiction, and changes in applicable laws and rules occur frequently. Regulatory agencies generally have discretion to issue regulations and interpret and enforce laws and rules. Such agencies have become increasingly active in recent years in their review and scrutiny of health insurers and managed care organizations, including those operating in the Medicaid and Medicare programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">HIPAA AND THE HITECH ACT </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1996, Congress enacted the Health Insurance Portability and Accountability Act (&#8220;HIPAA&#8221;). All health plans are subject to HIPAA, including ours. HIPAA generally requires health plans to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Establish the capability to receive and transmit electronically certain administrative healthcare transactions, such as claims payments, in a standardized format;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Afford privacy to patient health information;&#160;and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Protect the privacy of patient health information through physical and electronic security measures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;) imposed requirements on uses and disclosures of health information; included requirements for HIPAA business associate agreements; extended parts of HIPAA privacy and security provisions to business associates; added data breach notification requirements for covered entities and business associates and reporting requirements to the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) and, in some cases, to the media; strengthened enforcement; and imposed higher financial penalties for HIPAA violations. In the conduct of our business, depending on the circumstances, we may act as either a covered entity and/or a business associate.&#160;HIPAA privacy regulations do not preempt more stringent state laws and regulations that may apply to us.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a HIPAA compliance program, which we believe complies with HIPAA privacy and security regulations, and have dedicated resources to monitor compliance with this program.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare reform created additional tools for fraud prevention, including increased oversight of providers and suppliers participating or enrolling in Medicaid, CHIP, and Medicare. Those enhancements included mandatory licensure for all providers, and site visits, fingerprinting, and criminal background checks for higher risk providers. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">FRAUD AND ABUSE LAWS AND THE FALSE CLAIMS ACT</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we receive payments from federal and state governmental agencies, we are subject to various laws commonly referred to as &#8220;fraud and abuse&#8221; laws, including federal and state anti-kickback statutes, prohibited referrals, and the federal False Claims Act, which permit agencies and enforcement authorities to institute a suit against us for violations and, in some cases, to seek treble damages, criminal and civil fines, penalties, and assessments. Violations of these laws can also result in exclusion, debarment, temporary or permanent suspension from participation in government healthcare programs, or the institution of corporate integrity agreements. Liability under such federal and state statutes and regulations may arise if we know, or it is determined that we should have known, that information we provide to form the basis for a claim for government payment is false or fraudulent, and some courts have permitted False Claims Act suits to proceed if the claimant was out of compliance with program requirements. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fraud, waste and abuse prohibitions encompass a wide range of operating activities, including kickbacks or other inducements for referral of members or for the coverage of products (such as prescription drugs) by a plan, billing for unnecessary medical services by a provider, upcoding, payments made to excluded providers, improper marketing, and the violation of patient privacy rights. In particular, there has recently been increased scrutiny by the Department of Justice on health plans&#8217; risk adjustment practices, particularly in the Medicare program. Companies involved in public healthcare programs such as Medicaid and Medicare are required to maintain compliance programs to detect and deter fraud, waste and abuse, and are often the subject of fraud, waste and abuse investigations and audits. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government has taken the position that claims presented in violation of the federal anti-kickback statute may be considered a violation of the federal False Claims Act. In addition, under the federal civil monetary penalty statute, the HHS Office of Inspector General has the authority to impose civil penalties against any person who, among other things, knowingly presents, or causes to be presented, certain false or otherwise improper claims. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Qui tam </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">actions under federal and state law can be brought by any individual on behalf of the government. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Qui tam </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">actions have increased significantly in recent years, causing greater numbers of healthcare companies to have to defend a false claim action, pay fines, or be excluded from the Medicare, Medicaid, or other state or federal healthcare programs as a result of an investigation arising out of such action.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">LICENSING AND SOLVENCY</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans are generally licensed by the insurance departments in the states in which they operate, except the following: our California health plan is licensed by the California Department of Managed Health Care; one of our New York health plans is licensed as a prepaid health services plan by the New York State Department of Health; and our Massachusetts Plan acquired on December 31, 2020, is regulated as a risk-bearing entity by the Massachusetts Executive Office of Health and Human Services.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans are subject to stringent requirements to maintain a minimum amount of statutory capital determined by statute or regulation, and restrictions that limit their ability to pay dividends to us. For further information, refer to the Notes to Consolidated Financial Statements, Note 15, &#8220;Commitments and Contingencies&#8212;Regulatory Capital Requirements and Dividend Restrictions.&#8221;</span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_37"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">HUMAN CAPITAL </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had approximately 10,500 employees, and added approximately 2,500 employees from the Magellan Complete Care and Passport acquisitions, effective January 1, 2021. Our employee base is multicultural and reflects the diverse membership we serve.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past few years, management has launched a workplace modernization program that regularly introduces new human capital programs related to development, compensation and other workplace practices. We believe this workplace modernization program will allow us to achieve our overarching goal to become a destination employer in the government-sponsored healthcare industry.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of recent programs include a cash bonus plan for all non-executive employees, improvements to our employee benefits, development resources for all employees, enhanced employee recognition programs, and the launch of a formal diversity, equity, and inclusion program. Additionally, we routinely engage with employees through use of engagement surveys, to evaluate employee satisfaction and obtain feedback on various facets of employee-related matters including workplace modernization programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management continually evaluates human capital opportunities such as employee retention, engagement, succession planning and talent pipelines, performance rating distributions, and associated compensation actions. The board of directors is updated regularly on employee engagement, key executive vacancies, succession planning and workplace modernization progress.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer formal leadership development programs such as new leader orientation, executive onboarding, front- line leadership essentials, and experienced leader training. We have targeted development plans for critical roles in the organization with an emphasis on leadership and business skills.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in our workforce by offering competitive salaries and wages, as well as other employee benefits. Our compensation programs are designed to attract, retain, motivate, and reward employees, and recruit new employees. In addition, to foster a stronger sense of ownership and align the interests of employees with shareholders, we offer employees ownership in Molina through an employee stock purchase program, and grant eligible employees equity-based compensation under our equity incentive plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer a comprehensive suite of benefits to all eligible employees, including, among others:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Comprehensive health insurance coverage for employees working 30 hours or more per week;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">401(k) matching contributions of up to 100% on the first 4% contributed by the employee;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Personal time off that provides employees with paid time away from work, combining vacation and sick leave;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">COVID-19 time off that provides employees with up to 80 hours of paid time away from work to recover from COVID-19;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volunteer time off that provides employees with paid time away from work to build strong community partnerships and connect with the people we serve;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Employee wellness programs that provide tools and incentives to live a healthy life focusing on physical, emotional, financial and work well-being;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Up to ten dependent-care back-up visits per year for a low co-pay, and five hours of homework and tutoring support per child per month at no cost;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Employee assistance program benefits that provides up to six confidential counseling sessions per rolling 12-month period and includes assistance with physical, emotional, and financial related matters; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Employee discount and other programs, including tuition reimbursement.</span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_40"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 200 Oceangate, Suite 100, Long Beach, California 90802, and our telephone number is (562) 435-3666. The Company also maintains corporate offices in New York City, New York.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You can access our website at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.molinahealthcare.com</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to learn more about our Company. From that site, you can download and print copies of our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, along with amendments to those reports. You can also download our Corporate Governance Guidelines, board of directors committee charters, and Code of Business Conduct and Ethics. We make periodic reports and amendments available, free of charge, as soon as reasonably practicable after we file or furnish these reports to the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). We will also provide a copy of any of our corporate governance policies published on our website free of charge, upon request. To request a copy of any of these documents, please submit your request to: Molina Healthcare, Inc., 200 Oceangate, Suite 100, Long Beach, California 90802, Attn: Investor Relations. Information on or linked to our website is neither part of nor incorporated by reference into this Form 10-K or any other SEC filings.  </span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_2354"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">RISK FACTORS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the risks described below and all of the other information set forth in this Form 10-K, including our consolidated financial statements and accompanying notes. These risks and other factors may affect our forward-looking statements, including those we make in this Form 10-K or elsewhere, such as in press releases, presentations to securities analysts or investors, or other communications made by or with the approval of one of our executive officers. The risks described in the following section are not the only risks facing our Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional risks that we are unaware of, or that we currently believe are not material, may also become important factors that adversely affect our business. In addition to the risks relating to the COVID-19 pandemic that are specifically described in these risk factors, the effects of the COVID-19 pandemic may also have the effect of significantly heightening many of the other risks associated with our business, including those described below. If any of the following risks actually occurs, our business, financial condition, results of operations, and future prospects could be materially and adversely affected. In that event, among other effects, the trading price of our common stock could decline, and you could lose part or all of your investment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">RISKS RELATED TO OUR INDUSTRY</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business, financial condition, cash flows, and results of operations will continue to be impacted by the COVID-19 pandemic, and the extent of such impact cannot be reasonably foreseen at this time.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently expect that the COVID-19 pandemic will continue to impact our business, financial condition, cash flows, and results of operations in a number of ways, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">It will have an adverse impact on the health of an indeterminate number of our members, resulting in increases in their medical care costs, as well as increased costs related to testing and vaccination protocols;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Uncertainty and variability associated with the demand for medical services may lead states to pursue retroactive rate refunds (as has already occurred in certain instances), or to impose medical cost risk corridors or rate cuts that exceed the ultimate demand for medical services;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disrupted care patterns, as a result of the pandemic, may temporarily affect the ability to obtain complete member health status information, impacting future revenue in our Medicare and Marketplace lines of business, which utilize risk adjustment methodologies;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As a result of the pandemic&#8217;s impact on the national economy, state tax revenues have declined significantly and may not recover in 2021, resulting in the extension of risk corridors or rate cuts, and also threatening the ability of states to make timely monthly capitation payments to us; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The reduced demand for certain routine and non-critical medical services has created financial stress for certain providers and could result in the insolvency of such providers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The pandemic may continue to cause increased volatility in the capital markets and such volatility could have a negative impact on our ability to access those markets on acceptable terms;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will continue to incur increased costs associated with the measures we are currently implementing and planning to implement to mitigate the implications of the COVID-19 pandemic; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The continuing work-from-home status of our workforce may heighten the risk of a cybersecurity incident or HIPAA (as defined below) breach; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The pandemic may impact the ability of our outsourced information technology service providers, and other third-party vendors, to perform contracted services.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty around the duration and breadth of the COVID-19 pandemic and its broad cascading effects, the ultimate impact on our business, financial condition, cash flows, and operating results cannot be reasonably estimated at this time.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in an uncertain political and judicial environment which creates uncertainties with regard to our future prospects.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, in a case brought by the state of Texas and nineteen other states, a federal judge in Texas held that the individual mandate of the Affordable Care Act (the &#8220;ACA&#8221;) is unconstitutional. He further held that since the individual mandate is inseverable from the entire body of the ACA, the entire ACA is&#160;unconstitutional. The effect of his ruling was stayed pending the appeal of the ruling to the Fifth Circuit Court of Appeals. In December 2019, a three-judge panel of the Fifth Circuit Court of Appeal, in a two to one decision, affirmed the District Court&#8217;s ruling that the individual mandate is unconstitutional, but remanded the case back to the District Court for further consideration of the severability issue. The intervenor defendant states led by California subsequently appealed the case to the U.S. Supreme Court, and the Supreme Court heard oral arguments in the case on November 10, 2020.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Supreme Court&#8217;s decision is expected by June 2021. If the Supreme Court were to rule that the individual mandate is unconstitutional, and that the individual mandate is not severable from the balance of the ACA, or that the entirety of the ACA is unconstitutional, that ruling could have a material adverse effect on our business, financial condition, cash flows, or results of operations.   </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State and federal budget deficits may result in Medicaid, CHIP, or Medicare funding cuts which could have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Nearly all of our premium revenues come from the joint federal and state funding of the Medicaid, Medicare, and CHIP programs. The states in which we operate regularly face significant budgetary pressures. State budgetary pressures may result in unexpected Medicaid, CHIP, or Medicare rate cuts which could reduce our revenues and profit margins. For example, in 2020, various states enacted temporary premium refunds and related actions in response to the reduced demand for medical services stemming from COVID-19, which resulted in a reduction of our medical margin. In some cases, these premium actions were retroactive to earlier periods in 2020, or as early as the beginning of the states&#8217; fiscal years in 2019. Beginning in the second quarter of 2020, we have recognized retroactive premium actions that we believe to be probable, and where the ultimate premium amount is reasonably estimable. We recognized $564&#160;million related to these retroactive premium actions, in the aggregate, in 2020. It is possible that certain states could increase the level of existing premium refunds, and it is also possible that other states could implement some form of retroactive premium refund in the future. Due to these uncertainties, the ultimate outcomes could differ materially from our estimates as a result of changes in facts or further developments, which could have an adverse effect on our consolidated financial position, results of operations, or cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The Medicare-Medicaid Duals Demonstration Pilot Programs could be discontinued or altered, resulting in a loss of premium revenue.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To coordinate care for those who qualify to receive both Medicare and Medicaid services (the &#8220;dual eligibles&#8221;), and to deliver services to these individuals in a more financially efficient manner, under the direction of CMS some states implemented demonstration pilot programs to integrate Medicare and Medicaid services for the dual eligibles. The health plans participating in such demonstrations are referred to as Medicare-Medicaid Plans (&#8220;MMPs&#8221;). We operate MMPs in six states: California, Illinois, Michigan, Ohio, South Carolina, and Texas. At December&#160;31, 2020, our membership included approximately 62,000 integrated MMP members, representing approximately 2% of our total membership. However, the capitation paid to us for dual eligibles is significantly higher than the capitation paid for other members, representing 9% of our total premium revenues in 2020. If the states running the MMP pilot programs conclude that the demonstration pilot programs are not delivering better coordinated care and reduced </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">costs, they could decide to discontinue or substantially alter such programs, resulting in a reduction to our premium revenues.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If state regulators do not approve payments of dividends and distributions by our subsidiaries, it may negatively affect our ability to meet our debt service and other obligations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a corporate parent holding company and hold most of our assets in, and conduct most of our operations through, our direct subsidiaries. As a holding company, our results of operations depend on the results of operations of our subsidiaries. Moreover, we are dependent on dividends or other intercompany transfers of funds from our subsidiaries to meet our debt service and other obligations. The ability of our subsidiaries to pay dividends or make other payments or advances to us will depend on their operating results and will be subject to applicable laws and restrictions contained in agreements governing the debt of such subsidiaries. In addition, our health plan subsidiaries are subject to laws and regulations that limit the amount of ordinary dividends and distributions that they can pay to us without prior approval of, or notification to, state regulators. In general, our health plans must give thirty days&#8217; advance notice and the opportunity to disapprove &#8220;extraordinary&#8221; dividends to the respective state departments of insurance for amounts that exceed either (a)&#160;ten percent of surplus or net worth at the prior year end or (b)&#160;the net income for the prior year, depending on the respective state statute. The discretion of the state regulators, if any, in approving or disapproving a dividend is not clearly defined. Our health plans generally must provide notice to the applicable state regulator prior to paying a dividend or other distribution to us. Our parent company received $635 million and $1,373 million in dividends from our regulated health plan subsidiaries during 2020 and 2019, respectively. If the regulators were to deny or significantly restrict our subsidiaries&#8217; requests to pay dividends to us, the funds available to our Company as a whole would be limited, which could have a material adverse effect on our business, financial condition, cash flows, or results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our use and disclosure of personally identifiable information and other non-public information, including protected health information or PHI, is subject to federal and state privacy and security regulations, and our failure to comply with those regulations or to adequately secure the information we hold could result in significant liability or reputational harm. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State and federal laws and regulations including, but not limited to, the Health Insurance Portability and Accountability Act, as amended by the Health Information Technology for Economic and Clinical Health Act, and all regulations promulgated thereunder (collectively, &#8220;HIPAA&#8221;), the California Consumer Privacy Act (the &#8220;CCPA&#8221;) and the Gramm-Leach-Bliley Act, govern the collection, dissemination, use, privacy, confidentiality, security, availability, and integrity of personally identifiable information (&#8220;PII&#8221;), including protected health information (&#8220;PHI&#8221;). HIPAA establishes basic national privacy and security standards for protection of PHI by covered entities and business associates, including health plans such as ours. HIPAA requires covered entities like us to develop and maintain policies and procedures regarding PHI, and to adopt administrative, physical, and technical safeguards to protect PHI. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA violations may result in significant civil penalties. HIPAA authorizes state attorneys general to file suit under HIPAA on behalf of state residents. Courts can award damages, costs, and attorneys&#8217; fees related to violations of HIPAA in such cases. We have experienced HIPAA breaches in the past, including breaches affecting over 500 individuals.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even when HIPAA does not apply, according to the Federal Trade Commission (the &#8220;FTC&#8221;), failing to take appropriate steps to keep consumers&#8217; personal information secure constitutes unfair acts or practices in or affecting commerce in violation of Section 5(a) of the Federal Trade Commission Act, 15 U.S.C &#167; 45(a). The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. Individually identifiable health information is considered sensitive data that merits stronger safeguards. The FTC&#8217;s guidance for appropriately securing consumers&#8217; personal information is similar to what is required by the HIPAA security regulations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain state laws govern the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways, thus complicating compliance efforts. For example, California enacted the CCPA, which became effective on January 1, 2020. The CCPA, among other things, creates new data privacy obligations for covered companies and provides new privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not comply with existing or new laws and regulations related to PHI, PII, or non-public information, we could be subject to criminal or civil sanctions. Any security breach involving the misappropriation, loss, or other unauthorized disclosure or use of confidential member information, whether by us or a third party, such as our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vendors, could subject us to civil and criminal penalties, divert management&#8217;s time and energy, and have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unforeseen changes in pharmaceutical regulations or market conditions may impact our revenues and adversely affect our results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical products and services are a significant component of our healthcare costs. Evolving regulations and state and federal mandates regarding coverage may impact the ability of our health plans to continue to receive existing price discounts on pharmaceutical products for our members. Other factors affecting our pharmaceutical costs include, but are not limited to, the price of pharmaceuticals, geographic variation in utilization of new and existing pharmaceuticals, and changes in discounts. The unpredictable nature of these factors may have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The exorbitant cost of specialty drugs and new generic drugs could have a material adverse effect on the level of our medical costs and our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Introduction of new high cost specialty drugs and sudden cost spikes for existing drugs increase the risk that the pharmacy cost assumptions used to develop our capitation rates are not adequate to cover the actual pharmacy costs, which jeopardizes the overall actuarial soundness of our rates. Bearing the high costs of new specialty drugs or the high cost inflation of generic drugs without an appropriate rate adjustment or other reimbursement mechanism would have an adverse impact on our financial condition and results of operations. In addition, evolving regulations and state and federal mandates regarding coverage may impact the ability of our health plans to continue to receive existing price discounts on pharmaceutical products for our members. Other factors affecting our pharmaceutical costs include, but are not limited to, geographic variation in utilization of new and existing pharmaceuticals, and changes in discounts. Although we will continue to work with state Medicaid agencies in an effort to ensure that we receive appropriate and actuarially sound reimbursement for all new drug therapies and pharmaceuticals trends, there can be no assurance that we will be successful in this regard.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Large-scale medical emergencies in one or more states in which we operate our health plans could significantly increase utilization rates and medical costs. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large-scale medical emergencies can take many forms and be associated with widespread illness or medical conditions. For example, natural disasters, such as a major earthquake or wildfire in California, or a major hurricane affecting Florida, South Carolina or Texas, could have a significant impact on the health of a large number of our covered members. Other conditions that could impact our members include a virulent flu season or epidemic, newly emergent mosquito-borne illnesses, such as the Zika virus, the West Nile virus, or the Chikungunya virus, or new viruses such as COVID-19, conditions for which vaccines may not exist, are not effective, or have not been widely administered.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, federal and state law enforcement officials have issued warnings about potential terrorist activity involving biological or other weapons of mass destruction. All of these conditions, and others, could have a significant impact on the health of the population of wide-spread areas. If one of the states in which we operate were to experience a large-scale natural disaster, a significant terrorist attack, or some other large-scale event affecting the health of a large number of our members, our covered medical expenses in that state would rise, which could have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face various risks inherent in the government contracting process that could materially and adversely affect our business and profitability, including periodic routine and non-routine reviews, audits, and investigations by government agencies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various risks inherent in the government contracting process. These risks include routine and non-routine governmental reviews, audits, and investigations, and compliance with government reporting requirements. Violation of the laws, regulations, or contract provisions governing our operations, or changes in interpretations of those laws and regulations, could result in the imposition of civil or criminal penalties, the cancellation of our government contracts, the suspension or revocation of our licenses, the exclusion from participation in government sponsored health programs, or the revision and recoupment of past payments made based on audit findings. If we are unable to correct any noted deficiencies, or become subject to material fines or other sanctions, we could suffer a substantial reduction in profitability, and could also lose one or more of our government contracts. In addition, government receivables are subject to government audit and negotiation, and government contracts are vulnerable to disagreements with the government. The final amounts we ultimately receive under government contracts may be different from the amounts we initially recognize in our financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any changes to the laws and regulations governing our business, or the interpretation and enforcement of those laws or regulations, could require us to modify our operations and could negatively impact our operating results.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is extensively regulated by the federal government and the states in which we operate. The laws and regulations governing our operations are generally intended to benefit and protect health plan members and providers rather than managed care organizations. The government agencies administering these laws and regulations have broad latitude in interpreting and applying them. These laws and regulations, along with the terms of our government contracts, regulate how we do business, what services we offer, and how we interact with our members and the public. For instance, some states mandate minimum medical expense levels as a percentage of premium revenues. These laws and regulations, and their interpretations, are subject to frequent change. The interpretation of certain contract provisions by our governmental regulators may also change. Changes in existing laws or regulations, or their interpretations, or the enactment of new laws or regulations, could reduce our profitability by imposing additional capital requirements, increasing our liability, increasing our administrative and other costs, increasing mandated benefits, forcing us to restructure our relationships with providers, requiring us to implement additional or different programs and systems, or making it more difficult to predict future results. Changes in the interpretation of our contracts could also reduce our profitability if we have detrimentally relied on a prior interpretation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive fraud and abuse laws that may give rise to lawsuits and claims against us, the outcome of which may have a material adverse effect on our business, financial condition, cash flows, or results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we receive payments from federal and state governmental agencies, we are subject to various laws commonly referred to as &#8220;fraud and abuse&#8221; laws, including federal and state anti-kickback statutes, prohibited referrals, and the federal False Claims Act, which permit agencies and enforcement authorities to institute a suit against us for violations and, in some cases, to seek treble damages, criminal and civil fines, penalties, and assessments. Violations of these laws can also result in exclusion, debarment, temporary or permanent suspension from participation in government healthcare programs, or the institution of corporate integrity agreements. Liability under such federal and state statutes and regulations may arise if we know, or it is determined that we should have known, that information we provide to form the basis for a claim for government payment is false or fraudulent, and some courts have permitted False Claims Act suits to proceed if the claimant was out of compliance with program requirements. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fraud, waste and abuse prohibitions encompass a wide range of operating activities, including kickbacks or other inducements for referral of members or for the coverage of products (such as prescription drugs) by a plan, billing for unnecessary medical services by a provider, upcoding, payments made to excluded providers, improper marketing, and the violation of patient privacy rights. In particular, there has recently been increased scrutiny by the Department of Justice on health plans&#8217; risk adjustment practices, particularly in the Medicare program. Companies involved in public healthcare programs such as Medicaid and Medicare are required to maintain compliance programs to detect and deter fraud, waste and abuse, and are often the subject of fraud, waste and abuse investigations and audits. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government has taken the position that claims presented in violation of the federal anti-kickback statute may be considered a violation of the federal False Claims Act. In addition, under the federal civil monetary penalty statute, the U.S. Department of Health and Human Services&#8217; Office of Inspector General has the authority to impose civil penalties against any person who, among other things, knowingly presents, or causes to be presented, certain false or otherwise improper claims. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Qui tam </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">actions under federal and state law can be brought by any individual on behalf of the government. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Qui tam </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">actions have increased significantly in recent years, causing greater numbers of healthcare companies to have to defend a false claim action, pay fines, or be excluded from the Medicare, Medicaid, or other state or federal healthcare programs as a result of an investigation arising out of such action. We have been the subject of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions in the past and other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions may be filed against us in the future. If we are subject to liability under a </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">actions, our business, financial condition, cash flows, or results of operations could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">RISKS RELATED TO OUR BUSINESS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The May 2020 contract award to our Kentucky Medicaid plan, and its acquisition of Passport, is the subject of a legal challenge.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, pursuant to the appeal of a protest denial with regard to the May 2020 Kentucky RFP awards, a court ordered the addition of a sixth health plan to the Kentucky Medicaid program for 2021. That ruling did not </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rescind the Medicaid contract award to our Kentucky health plan for 2021, nor did it impact the earlier novation of the Passport Medicaid contract to us. On October 27, 2020, a different health plan filed an appeal with regard to the court&#8217;s October 2020 order. In addition, another health plan filed a legal challenge with regard to our acquisition of Passport.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcome of this litigation and any appellate proceedings is inherently unpredictable. In the event the contract award to our Kentucky health plan or the novation of the Passport Medicaid contract is overturned, the business and revenues of our Kentucky health plan may be materially affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the responsive bids of our health plans for new or renewed Medicaid contracts are not successful, or if our government contracts are terminated or are not renewed on favorable terms, our premium revenues could be materially reduced and our operating results could be negatively impacted.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently derive our premium revenues from health plans that operate in 18 states, including the states added in our acquisition of Magellan Complete Care on December 31, 2020. Our consolidated Medicaid premium revenue constituted 73% of our total revenue in the year ended December 31, 2020. Measured by Medicaid premium revenue by health plan, our top four health plans were in California, Ohio, Texas, and Washington, with aggregate Medicaid premium revenue of $8.9 billion, or approximately 63% of consolidated Medicaid premium revenue, in the year ended December 31, 2020. If we are unable to continue to operate in any of our existing jurisdictions, or if our current operations in those jurisdictions or any portions of those jurisdictions are significantly curtailed or terminated entirely, our revenues could decrease materially.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our government contracts are effective only for a fixed period of time and will only be extended for an additional period of time if the contracting entity elects to do so. For example, our contract in California is expected to be subject to re-procurement in late 2021. When our government contracts expire, they may be opened for bidding by competing health plans, and there is no guarantee that the contracts will be renewed or extended. Even if our contracts are renewed or extended, there can be no assurance that they will be renewed or extended on the same terms or without a reduction in the applicable service areas. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if our responsive bids are successful, the bids may be based upon assumptions regarding enrollment, utilization, medical costs, or other factors which could result in the contract being less profitable than we had expected or could result in a net loss. Furthermore, our contracts contain certain provisions regarding, among other things, eligibility, enrollment and dis-enrollment processes for covered services, eligible providers, periodic financial and information reporting, quality assurance and timeliness of claims payment, and are subject to cancellation if we fail to perform in accordance with the standards set by regulatory agencies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we sustain a cyber-attack or suffer data privacy or security breaches that disrupt our information systems or operations, or result in the dissemination of sensitive personal or confidential information, we could suffer increased costs, exposure to significant liability, reputational harm, loss of business, and other serious negative consequences.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our normal operations, we routinely collect, process, store, and transmit large amounts of data, including sensitive personal information as well as proprietary or confidential information relating to our business or third parties. To ensure information security, we have implemented controls designed to protect the confidentiality, integrity and availability of this data and the systems that store and transmit such data. However, our information technology systems and safety control systems are subject to a growing number of threats from computer programmers, hackers, and other adversaries that may be able to penetrate our network security and misappropriate our confidential information or that of third parties, create system disruptions, or cause damage, security issues, or shutdowns. They also may be able to develop and deploy viruses, worms, and other malicious software programs that attack our systems or otherwise exploit security vulnerabilities. As a result of the COVID-19 pandemic, we may face increased cybersecurity risks due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities. Because the techniques used to circumvent, gain access to, or sabotage security systems can be highly sophisticated and change frequently, they often are not recognized until launched against a target, and may originate from less regulated and remote areas around the world. We may be unable to anticipate these techniques or implement adequate preventive measures, resulting in potential data loss and damage to our systems. Our systems are also subject to compromise from internal threats such as improper action by employees, including malicious insiders, or by vendors, counterparties, and other third parties with otherwise legitimate access to our systems. Our policies, employee training (including phishing prevention training), procedures and technical safeguards may not prevent all improper access to our network or proprietary or confidential information by employees, vendors, counterparties, or other third parties. Our facilities may also be vulnerable to security incidents or security attacks, acts of vandalism or theft, misplaced or lost data, human errors, or other similar events that could negatively affect our systems and our and our members&#8217; data.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, we face the ongoing challenge of managing access controls in a complex environment. The process of enhancing our protective measures can itself create a risk of systems disruptions and security issues. Given the breadth of our operations and the increasing sophistication of cyberattacks, a particular incident could occur and persist for an extended period of time before being detected. The extent of a particular cyberattack and the steps that we may need to take to investigate the attack may take a significant amount of time before such an investigation could be completed and full and reliable information about the incident is known. During such time, the extent of any harm or how best to remediate it might not be known, which could further increase the risks, costs, and consequences of a data security incident. In addition, our systems must be routinely updated, patched, and upgraded to protect against known vulnerabilities. The volume of new software vulnerabilities has increased substantially, as has the importance of patches and other remedial measures. In addition to remediating newly identified vulnerabilities, previously identified vulnerabilities must also be updated. We are at risk that cyber attackers exploit these known vulnerabilities before they have been addressed. The complexity of our systems and platforms, the increased frequency at which vendors are issuing security patches to their products, our need to test patches, and in some instances, coordinate with third-parties before they can be deployed, all could further increase our risks.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to successfully integrate our acquisitions or realize the anticipated benefits of such acquisitions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth strategy includes the pursuit of targeted inorganic growth opportunities that we believe will provide a strategic fit, leverage operational synergies, and lead to incremental earnings accretion. For example, in the third quarter of 2020, we closed on two business combinations, the acquisition of certain assets of YourCare Health Plan, Inc. and the acquisition of certain assets of Passport Health Plan, Inc. On December 31, 2020, we closed on our acquisition of the Magellan Complete Care line of business of Magellan Health, Inc. and, in the second quarter of 2021, we expect to close on our pending acquisition of substantially all of the assets of Affinity Health Plan, Inc. The integration of acquired businesses with our existing business is a complex, costly and time-consuming process. The success of acquisitions we make will depend, in part, on our ability to successfully combine our existing business with such acquired businesses and realize the anticipated benefits, including synergies, cost savings, growth in earnings, innovation, and operational efficiencies, from the combinations. If we are unable to achieve these objectives within the anticipated time frame, or at all, the anticipated benefits may not be realized fully or at all, or may take longer to realize than expected.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our acquisitions and the related integration activities involve a number of risks, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The transition services that a seller may have agreed to provide following the closing, such as those Magellan Health, Inc. has agreed to provide following the closing of the Magellan Complete Care transaction, may not be provided in a timely or efficient manner, or certain necessary transition services may not be provided at all;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unforeseen expenses or delays associated with the acquisition and/or integration;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The assumptions underlying our expectations regarding the integration process or the expected benefits to be achieved from an acquisition may prove to be incorrect;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Maintaining employee morale and retaining key management and other employees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Difficulties retaining the business and operational relationships of the acquired business, and attracting new business and operational relationships;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unanticipated attrition in the membership of the acquired business pending the completion of the proposed transaction or after the closing of the transaction;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unanticipated difficulties or costs in integrating information technology, communications and other systems, consolidating corporate and administrative infrastructures, and eliminating duplicative operations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Attention to integration activities may divert management&#8217;s attention from ongoing business concerns, which could result in performance shortfalls;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Successfully addressing the challenges inherent in managing a larger company and coordinating geographically separate organizations; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Delays in obtaining, or inability to obtain, necessary state or federal regulatory approvals, or such approvals may impose conditions that were not anticipated.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of these factors are outside of our control and any one of them could result in delays, increased costs, decreases in the amount of expected revenues, and diversion of management's time and energy, which could materially affect our financial position, results of operations, or cash flows. There can be no assurances that we will be successful in managing our expanded operations as a result of acquisitions or that we will realize the expected growth in earnings, operating efficiencies, cost savings, or other benefits. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we lose contracts that constitute a significant amount of our premium revenue, we will lose the administrative cost efficiencies or cost leverage that is inherent in a larger revenue base. In such circumstances, we may not be able to reduce fixed costs proportionally with our lower revenue, and the financial impact of lost contracts may exceed the net income ascribed to those contracts.     </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently spread the cost of centralized services over a large revenue base. Many of our administrative costs are fixed in nature, and will be incurred at the same level regardless of the size of our revenue base. If we lose contracts that constitute a significant amount of our revenue, we may not be able to reduce the expense of centralized services in a manner that is proportional to that loss of revenue. In such circumstances, not only will our total dollar margins decline, but our percentage margins, measured as a percentage of revenue, will also decline. This loss of cost efficiency or cost leverage, and the resulting stranded administrative costs, could have a material and adverse impact on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our health plans operate with very low profit margins, and small changes in operating performance or slight changes to our accounting estimates will have a disproportionate impact on our reported net income.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our premium revenue is subject to contract provisions pertaining to medical cost expenditure floors and corridors, administrative cost and profit ceilings, premium stabilization programs, and cost-plus and performance-based reimbursement programs. Many of these contract provisions are complex, or are poorly or ambiguously drafted, and thus are subject to differing interpretations by us and the relevant government agency with whom we contract. If the applicable government agency disagrees with our interpretation or implementation of a particular contract provision, we could be required to adjust the amount of our obligation under that provision. Any such adjustment could have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many of our contracts contain provisions pertaining to at-risk premiums that require us to meet certain quality performance measures to earn all of our contract revenues. If we are unsuccessful in achieving the stated performance measure, we will be unable to recognize the revenue associated with that measure, which could have a material adverse effect on our business, financial condition, cash flows, or results of operations.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to retroactive adjustment to our Medicaid premium revenue as a result of retroactive risk adjustment; retroactive changes to contract terms and the resolution of differing interpretations of those terms; the difficulty of estimating performance-based premium.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The complexity of some of our Medicaid contract provisions, imprecise language in those contracts, the desire of state Medicaid agencies in some circumstances to retroactively adjust for the acuity of the medical needs of our members, and state delays in processing rate changes, can create uncertainty around the amount of revenue we should recognize. Any circumstance such as those described above could have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If, in the interest of long-term profitability, we decide to exit certain state contractual arrangements, make changes to our provider networks, or make changes to our administrative infrastructure, we may incur disruptions to our business that could in the short term materially reduce our premium revenues and our net income.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Decisions that we make with regard to retaining or exiting our portfolio of state or federal contracts, and changes to the manner in which we serve the members of those contracts, could generate substantial expenses associated with the run out of existing operations and the restructuring of those operations that remain. Such expenses could include, but would not be limited to, goodwill and intangible asset impairment charges, restructuring costs, additional medical costs incurred due to the inability to leverage long-term relationships with medical providers, and costs incurred to finish the run out of businesses that have ceased to generate revenue, all of which could materially reduce our premium revenues and net income.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A failure to accurately estimate incurred but not paid medical care costs may negatively impact our results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the lag in time between when medical services are actually rendered by our providers and when we receive, process, and pay a claim for those medical services, we must continually estimate our medical claims liability at particular points in time and establish claims reserves related to such estimates. Our estimated reserves for such incurred but not paid, or IBNP, medical care costs are based on numerous assumptions. We estimate our medical claims liabilities using actuarial methods based on historical data adjusted for claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known incidence of disease, including COVID-19, or increased incidence of illness such as the flu, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provider contract changes, changes to Medicaid fee schedules, and the incidence of high dollar or catastrophic claims. Our ability to accurately estimate claims for our newer lines of business or populations is negatively impacted by the more limited experience we have had with those newer lines of business or populations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IBNP estimation methods we use and the resulting reserves that we establish are reviewed and updated, and adjustments, if deemed necessary, are reflected in the current period. Given the numerous uncertainties inherent in such estimates, our actual claims liabilities for a particular quarter or other period could differ significantly from the amounts estimated and reserved for that quarter or period. Our actual claims liabilities have varied and will continue to vary from our estimates, particularly in times of significant changes in utilization, medical cost trends, and populations and markets served.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our actual liability for claims payments is higher than previously estimated, our earnings in any particular quarter or annual period could be negatively affected. Our estimates of IBNP may be inadequate in the future, which would negatively affect our results of operations for the relevant time period. Furthermore, if we are unable to accurately estimate IBNP, our ability to take timely corrective actions may be limited, further exacerbating the extent of the negative impact on our results.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to accurately predict and effectively manage our medical care costs, our operating results could be materially and adversely affected.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability depends to a significant degree on our ability to accurately predict and effectively manage our medical care costs. Historically, our medical care ratio, meaning our medical care costs as a percentage of our premium revenue, has fluctuated substantially, and has varied across our health plans. Because the premium payments we receive are generally fixed in advance and we operate with a narrow profit margin, relatively small changes in our medical care ratio can create significant changes in our overall financial results. For example, if our overall medical care ratio of 86.5% for the year ended December&#160;31, 2020, had been one percentage point higher, or 87.5%, our net income per diluted share for the year ended December&#160;31, 2020 would have been approximately $8.88 rather than our actual net income per diluted share of $11.23, a difference of $2.35. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many factors may affect our medical care costs, including:</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of utilization of healthcare services; </span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic;</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the underlying risk acuity of our membership;</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected patterns in the annual flu season; </span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in hospital costs; </span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased incidences or acuity of high dollar claims related to catastrophic illnesses or medical conditions for which we do not have adequate reinsurance coverage;</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased maternity costs;</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in state eligibility certification methodologies;</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">relatively low levels of hospital and specialty provider competition in certain geographic areas;</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in the cost of pharmaceutical products and services;</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in healthcare regulations and practices;</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">epidemics;</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new medical technologies; and</span></div><div style="padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other various external factors. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of these factors are beyond our control. The inability to forecast and manage our medical care costs or to establish and maintain a satisfactory medical care ratio, either with respect to a particular health plan or across the consolidated entity, could have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to deliver quality care, and maintain good relations with the physicians, hospitals, and other providers with whom we contract, or if we are unable to enter into cost-effective contracts with such providers, our profitability could be adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contract with physicians, hospitals, and other providers as a means to ensure access to healthcare services for our members, to manage medical care costs and utilization, and to better monitor the quality of care being delivered. We compete with other health plans to contract with these providers. We believe providers select plans in which they participate based on criteria including reimbursement rates, timeliness and accuracy of claims payment, potential to deliver new patient volume and/or retain existing patients, effectiveness of resolution of calls and complaints, and other factors. There can be no assurance that we will be able to successfully attract and retain providers to maintain a competitive network in the geographic areas we serve. In addition, in any particular market, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">providers could refuse to contract with us, demand higher payments, or take other actions which could result in higher medical care costs, disruption to provider access for current members, a decline in our growth rate, or difficulty in meeting regulatory or accreditation requirements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid program generally pays doctors and hospitals at levels well below those of Medicare and private insurance. Large numbers of doctors, therefore, do not accept Medicaid patients. In the face of fiscal pressures, some states may reduce rates paid to providers, which may further discourage participation in the Medicaid program.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some markets, certain providers, particularly hospitals and some specialists, may have significant market positions or even monopolies. If these providers refuse to contract with us or utilize their market position to negotiate favorable contracts which are disadvantageous to us, our profitability in those areas could be adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some providers that render services to our members are not contracted with our health plans. In those cases, there is no pre-established understanding between the provider and our health plan about the amount of compensation that is due to the provider. In some states, the amount of compensation is defined by law or regulation, but in most instances it is either not defined or it is established by a standard that is not clearly translatable into dollars. In such instances, providers may claim they are underpaid for their services and may either litigate or arbitrate their dispute with our health plan. The uncertainty of the amount to pay to such providers and the possibility of subsequent adjustment of the payment or litigation with the provider that results in an adverse decision could adversely affect our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on the accuracy of eligibility lists provided by state governments. Inaccuracies in those lists would negatively affect our results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium payments to our health plans are based upon eligibility lists produced by state governments. From time to time, states require us to reimburse them for premiums paid to us based on an eligibility list that a state later discovers contains individuals who are not in fact eligible for a government sponsored program or are eligible for a different premium category or a different program. Alternatively, a state could fail to pay us for members for whom we are entitled to payment. Our results of operations would be adversely affected as a result of such reimbursement to the state if we make or have made related payments to providers and are unable to recoup such payments from the providers.  Further, when a state implements new programs to determine eligibility, establishes new processes to assign or enroll eligible members into health plans, or chooses new subcontractors, there is an increased potential for an unanticipated impact on the overall number of members assigned to managed care health plans.&#160;Whenever a state effects an eligibility redetermination for any reason, there is generally an associated reduction in Medicaid membership, which could have an adverse effect on our premium revenues and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The insolvency of a delegated provider could obligate us to pay its referral claims, which could have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our primary care physicians and a small portion of our specialists and hospitals are paid on a capitated basis. Under capitation arrangements, we pay a fixed amount per member per month to the provider without regard to the frequency, extent, or nature of the medical services actually furnished. Due to insolvency or other circumstances, such providers may be unable or unwilling to pay claims they have incurred with third parties in connection with referral services provided to our members. The inability or unwillingness of delegated providers to pay referral claims presents us with both immediate financial risk and potential disruption to member care, as well as potential loss of members. Depending on states&#8217; laws, we may be held liable for such unpaid referral claims even though the delegated provider has contractually assumed such risk. Additionally, competitive pressures or practical regulatory considerations may force us to pay such claims even when we have no legal obligation to do so; or we have already paid claims to a delegated provider and such payments cannot be recouped when the delegated provider becomes insolvent. Liabilities incurred or losses suffered as a result of provider insolvency or other circumstances could have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receipt of inadequate or significantly delayed premiums could negatively affect our business, financial condition, cash flows, or results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our premium revenues consist of fixed monthly payments per member, and supplemental payments for other services such as maternity deliveries. These premiums are fixed by contract, and we are obligated during the contract periods to provide healthcare services as established by the state governments. We use a large portion of our revenues to pay the costs of healthcare services delivered to our members. If premiums do not increase when </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenses related to healthcare services rise, our medical margins will be compressed, and our earnings will be negatively affected. A state could increase hospital or other provider rates without making a commensurate increase in the rates paid to us, or could lower our rates without making a commensurate reduction in the rates paid to hospitals or other providers. In addition, if the actuarial assumptions made by a state in implementing a rate or benefit change are incorrect or are at variance with the particular utilization patterns of the members of one or more of our health plans, our medical margins could be reduced. Any of these rate adjustments in one or more of the states in which we operate could have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If a state fails to renew its federal waiver application for mandated Medicaid enrollment into managed care or such application is denied, our membership in that state will likely decrease. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States may only mandate Medicaid enrollment into managed care under federal waivers or demonstrations. Waivers and programs under demonstrations are approved for two- to five-year periods and can be renewed on an ongoing basis if the state applies and the waiver request is approved or renewed by CMS. We have no control over this renewal process. If a state in which we operate does not renew its mandated program or the federal government denies the state&#8217;s application for renewal, our business would suffer as a result of a likely decrease in membership.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to attain profitability in any newly acquired health plans or new start-up operations could negatively affect our results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Start-up costs associated with a new business can be substantial. For example, to obtain a certificate of authority to operate as a health maintenance organization in most jurisdictions, we must first establish a provider network, have infrastructure and required systems in place, and demonstrate our ability to obtain a state contract and process claims. Often, we are also required to contribute significant capital to fund mandated net worth requirements, performance bonds or escrows, or contingency guaranties. If we are unsuccessful in obtaining the certificate of authority, winning the bid to provide services, or attracting members in sufficient numbers to cover our costs, the new business could fail. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expenses associated with starting up a health plan in a new jurisdiction, expanding a health plan in an existing jurisdiction, or acquiring a new health plan, could have a material adverse effect on our business, financial condition, cash flows, or results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business depends on our information and medical management systems, and our inability to effectively integrate, manage, update, and keep secure our information and medical management systems could disrupt our operations. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is dependent on effective and secure information systems that assist us in processing provider claims, monitoring utilization and other cost factors, supporting our medical management techniques, providing data to our regulators, and implementing our data security measures. Our members and providers also depend upon our information systems for enrollment, premium processing, primary care and specialist physician roster access, membership verifications, claims status, provider payments, and other information. If we experience a reduction in the performance, reliability, or availability of our information and medical management systems, our operations, ability to pay claims, ability to produce timely and accurate reports, and ability to maintain proper security measures could be adversely affected. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have partnered with third parties to support our information technology systems. This makes our operations vulnerable to adverse effects if such third parties fail to perform adequately. For example, in February 2019, we entered into a master services agreement with a third party vendor who manages certain of our information technology infrastructure services including, among other things, our information technology operations, end-user services, and data centers. If any licensor or vendor of any technology which is integral to our operations were to become insolvent or otherwise fail to support the technology sufficiently, our operations could be negatively affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks associated with outsourcing services and functions to third parties. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contract with third party vendors and service providers who provide services to us and our subsidiaries or to whom we delegate selected functions. Some of these third-parties have direct access to our systems. Our arrangements with third party vendors and service providers may make our operations vulnerable if those third parties fail to satisfy their obligations to us, including their obligations to maintain and protect the security and confidentiality of our information and data or the information and data relating to our members or customers. We are also at risk of a data security incident involving a vendor or third party, which could result in a breakdown of such third party&#8217;s data protection processes or cyber-attackers gaining access to our infrastructure through the third party. To the extent that a vendor or third party suffers a data security incident that compromises its operations, we could incur significant costs and possible service interruption. Any contractual remedies and/or indemnification obligations </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we may have for vendor or service provider failures or incidents may not be adequate to fully compensate us for any losses suffered as a result of any vendor&#8217;s failure to satisfy its obligations to us or under applicable law. Violations of, or noncompliance with, laws and/or regulations governing our business or noncompliance with contract terms by third party vendors and service providers could increase our exposure to liability to our members, providers, or other third parties, or could result in sanctions and/or fines from the regulators that oversee our business. In turn, this could increase the costs associated with the operation of our business or have an adverse impact on our business and reputation. Moreover, if these vendor and service provider relationships were terminated for any reason, we may not be able to find alternative partners in a timely manner or on acceptable financial terms, and may incur significant costs and/or experience significant disruption to our operations in connection with any such vendor or service provider transition. As a result, we may not be able to meet the full demands of our members or customers and, in turn, our business, financial condition, and results of operations may be harmed. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our encounter data may be inaccurate or incomplete, which could have a material adverse effect on our results of operations, financial condition, cash flows and ability to bid for, and continue to participate in, certain programs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts require the submission of complete and correct encounter data. The accurate and timely reporting of encounter data is increasingly important to the success of our programs because more states are using encounter data to determine compliance with performance standards and to set premium rates. We have been, and continue to be, exposed to operating sanctions and financial fines and penalties for noncompliance. In some instances, our government clients have established retroactive requirements for the encounter data we must submit. There also may be periods of time in which we are unable to meet existing requirements. In either case, it may be prohibitively expensive or impossible for us to collect or reconstruct this historical data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced challenges in obtaining complete and accurate encounter data, due to difficulties with providers and third-party vendors submitting claims in a timely fashion in the proper format, and with state agencies in coordinating such submissions. As states increase their reliance on encounter data, these difficulties could adversely affect the premium rates we receive and how membership is assigned to us and subject us to financial penalties, which could have a material adverse effect on our business, financial condition, cash flows, or results of operations, and on our ability to bid for, and continue to participate in, certain programs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our substantial indebtedness could adversely affect our ability to raise additional capital to fund our growth strategy.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had $2,352 million of indebtedness outstanding, including long-term finance lease liabilities. As of December 31, 2020, we also had approximately $1 billion available for borrowings under our Revolving Credit Facility.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our substantial indebtedness could have a material adverse effect on our business, financial condition, cash flows, or results of operations by, among other things:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our vulnerability to adverse economic, industry, or competitive developments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring a substantial portion of our cash flows from operations to be dedicated to the payment of principal and interest on our indebtedness, therefore reducing our ability to use our cash flows to fund operations, capital expenditures, and future acquisitions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">making it more difficult for us to satisfy our obligations with respect to our indebtedness, including under our Credit Agreement and our outstanding senior notes, and any failure to comply with the obligations of any of our debt instruments, including restrictive covenants and borrowing conditions, could result in an event of default under our Credit Agreement or the indenture governing our outstanding senior notes;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to obtain additional financing; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our flexibility in planning for, or reacting to, changes in our business or market conditions and placing us at a competitive disadvantage compared to our competitors who are less highly leveraged and who, therefore, may be able to take advantage of opportunities that our substantial indebtedness may prevent us from exploiting.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An impairment charge with respect to our recorded goodwill, or our finite-lived intangible assets, could have a material impact on our financial results. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the carrying amount of goodwill was $692 million, and intangible assets, net, were $249 million. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase consideration over the fair value of net assets acquired in business combinations. Goodwill is not amortized but is tested for impairment on an annual basis and more frequently if impairment indicators are present. Impairment indicators may include experienced or expected operating cash-flow </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deterioration or losses, significant losses of membership, loss of state funding, loss of state contracts, and other factors. Goodwill is impaired if the carrying amount of the reporting unit (one of our state health plans) exceeds its estimated fair value. This excess is recorded as an impairment loss and adjusted if necessary for the impact of tax-deductible goodwill. The loss recognized may not exceed the total goodwill allocated to the reporting unit.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An event could occur that would cause us to revise our estimates and assumptions used in analyzing the value of our goodwill, and intangible assets, net. For example, if the responsive bid of one or more of our health plans is not successful, we will lose our Medicaid contract in the applicable state or states. If such state health plans have recorded goodwill and intangible assets, net, the contract loss would result in a non-cash impairment charge. Such a non-cash impairment charge could have a material adverse impact on our financial results. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">GENERAL RISK FACTORS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on the leadership of our chief executive officer and other executive officers and key employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our business and the ability to execute our strategy are highly dependent on the efforts of Mr. Zubretsky, our chief executive officer, and our other key executive officers and employees. The loss of their leadership, expertise, and experience could negatively impact our operations. Our ability to replace them or any other key employee may be difficult and may take an extended period of time because of the limited number of individuals in the healthcare industry who have the breadth and depth of skills and experience necessary to operate and lead a business such as ours. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain, or motivate these personnel. If we are unsuccessful in recruiting, retaining, managing, and motivating such personnel, our business, financial condition, cash flows, or results of operations could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face claims related to litigation which could result in substantial monetary damages.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a variety of legal actions, including provider claims, employment related disputes, healthcare regulatory law-based litigation and enforcement actions, breach of contract actions, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or False Claims Act actions, and securities class actions. If we incur liability materially in excess of the amount for which we have insurance coverage, our profitability would suffer. Even if any claims brought against us are unsuccessful or without merit, we may have to defend ourselves against such claims. The defense of any such actions may be time-consuming and costly, and may distract our management&#8217;s attention. Such legal actions could have a material adverse effect on our business, financial condition, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because our corporate headquarters are located in Southern California, our business operations may be significantly disrupted as a result of a major earthquake or wildfire.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located in Long Beach, California. In addition, some of our health plans&#8217; claims are processed in Long Beach, California. Southern California is exposed to a statistically greater risk of a major earthquake and wildfires than most other parts of the United States. If a major earthquake or wildfire were to strike Southern California, our corporate functions and claims processing could be significantly impaired for a substantial period of time. If there is a major Southern California earthquake or wildfire, there can be no assurances that our disaster recovery plan will be successful or that the business operations of our health plans, including those that are remote from any such event, would not be substantially impacted.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to maintain effective internal controls over financial reporting could have a material adverse effect on our business, operating results, and stock price, and could subject us to sanctions by regulatory authorities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. We have identified material weaknesses in our internal control over financial reporting in the past, which have subsequently been remediated. If additional material weaknesses in our internal control over financial reporting are discovered or occur in the future, our consolidated financial statements may contain material misstatements and we could be required to restate our financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 31</span></div></div></div><div id="if790247689124308855d86d82384a359_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">PROPERTIES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own and lease certain real properties to support the business operations of our reportable segments. While we believe our current and anticipated facilities are adequate to meet our operational needs in the near term, we continually evaluate the adequacy of our properties for our anticipated future needs.</span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_49"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kentucky RFP. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 4, 2020, Anthem Kentucky Managed Care Plan, Inc. brought an action in Franklin County Circuit Court against the Kentucky Finance and Administration Cabinet, the Kentucky Cabinet for Health and Family Services and all of the winning bidder health plans, including Molina Healthcare of Kentucky, Inc., Civil Action No. 20-CI-00719. In its action, Anthem requested that the court disqualify Molina Healthcare of Kentucky, find that the Kentucky RFP scoring was erroneous and violated procedures or was arbitrary and capricious, set aside the contract awards and conduct a new RFP evaluation process, and award injunctive relief, including stopping the implementation of the contracts awarded under the RFP. On September 28, 2020, the court issued a temporary restraining order preserving the status quo, and on October 23, 2020, the court issued a temporary injunction directing that the RFP readiness review and open enrollment proceed with six health plans, including both Anthem and Molina Healthcare. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2020, the court granted a motion by UnitedHealthcare of Kentucky LTD. to assert a cross-claim against the Kentucky Cabinet for Health and Family Services, which sought in part a disqualification of Anthem or Molina Healthcare and a declaratory judgment that the Kentucky Medicaid program proceed with only five health plans. On December 23, 2020, Humana Health Plan, Inc. brought a separate action against the Commonwealth of Kentucky and the winning bidder health plans, including Molina Healthcare of Kentucky, Civil Action 20-CI-00987. On January 11, 2021, both actions were consolidated before the Franklin County Circuit Court. Humana requests a declaratory judgment finding that the Commonwealth violated the Medicaid contract by allocating Passport members to Molina Healthcare for 2021 so that Passport members would instead be allocated to Humana and other winning health plans, or, in the alternative, monetary damages from the Commonwealth. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare believes it has meritorious defenses to the claims of Anthem, United, and Humana, and intends to vigorously defend its position, including its twice being a winning bidder of the Kentucky Medicaid RFP, and its protection of the continuity of care for Passport Medicaid members. This matter remains subject to significant additional legal proceedings, and no assurances can be given regarding the ultimate outcome.  Under the court&#8217;s temporary injunction, Molina Healthcare of Kentucky continues to operate under its contract and provide care to Kentucky Medicaid members.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the Notes to Consolidated Financial Statements, Note 15, &#8220;Commitments and Contingencies&#8212;Legal Proceedings,&#8221; for further information.</span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_52"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">STOCK REPURCHASE PROGRAMS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of common stock made by us, or on our behalf during the quarter ended December&#160;31, 2020, including shares withheld by us to satisfy our employees&#8217; income tax obligations, are set forth below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:33.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">of Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Price Paid per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Purchased&#160;as</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part of Publicly</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Announced Plans or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Programs </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Approximate Dollar&#160;Value of Shares That May Yet Be Purchased Under the Plans or Programs </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October&#160;1 &#8212; October&#160;31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November&#160;1 &#8212; November&#160;30</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December&#160;1 &#8212; December&#160;31</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">443,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">During the three months ended December 31, 2020, we withheld approximately 1,000 shares of common stock to settle employee income tax obligations for releases of awards granted under the Molina Healthcare, Inc. 2019 Equity Incentive Plan. For further information refer to Notes to Consolidated Financial Statements, Note 13, &#8220;Stockholders' Equity.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">In September 2020, our board of directors authorized the purchase of up to $500&#160;million, in the aggregate, of our common stock. This program is funded with cash on hand and extends through December 31, 2021. The exact timing and amount of any repurchase is determined by management based on market conditions and share price, in addition to other factors, and subject to the restrictions relating to volume, price, and timing under applicable law. Under this program, pursuant to a Rule 10b5-1 trading plan, we purchased approximately 766,000 shares of our common stock for $159 million in November and December 2020 (average cost of $208.37 per share).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">STOCK PERFORMANCE GRAPH</span></div><div style="margin-bottom:6pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following graph and related discussion are being furnished solely to accompany this Annual Report on Form 10-K pursuant to Item 201(e) of Regulation S-K and shall not be deemed to be &#8220;soliciting materials&#8221; or to be &#8220;filed&#8221; with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) (other than as provided in Item 201) nor shall this information be incorporated by reference into any future filing under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language contained therein, except to the extent that we specifically incorporate it by reference into a filing.</span></div><div style="margin-bottom:6pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following line graph compares the percentage change in the cumulative total return on our common stock against the cumulative total return of the Standard&#160;&amp; Poor&#8217;s Corporation Composite 500 Index (the &#8220;S&amp;P 500&#8221;) and a peer group index for the five-year period from December&#160;31, 2015 to December&#160;31, 2020. The comparison assumes $100 was invested on December 31, 2015, in our common stock and in each of the foregoing indices and assumes reinvestment of dividends. The stock performance shown on the graph below represents historical stock performance and is not necessarily indicative of future stock price performance. </span></div><div style="margin-bottom:6pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><img src="moh-20201231_g4.gif" alt="moh-20201231_g4.gif" style="height:426px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div><div style="margin-bottom:6pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 peer group index consists of Acadia Healthcare Company, Inc. (ACHC), Anthem, Inc. (ANTM), Centene Corporation (CNC), Cigna Corporation (CI), Community Health Systems, Inc. (CYH), HCA Healthcare, Inc. (HCA), Humana, Inc. (HUM), Laboratory Corporation of America Holdings (LH), Magellan Health, Inc. (MGLN), Quest Diagnostics Incorporated (DGX), Tenet Healthcare Corporation (THC) and Universal Health Services, Inc. (UHS). </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 peer group index, used in last year&#8217;s Annual Report on Form 10-K and also set forth above, consists of Centene Corporation (CNC), Cigna Corporation (CI), DaVita HealthCare Partners, Inc. (DVA), Humana Inc. (HUM), Magellan Health, Inc. (MGLN), Team Health Holdings, Inc. (TMH), Tenet Healthcare Corporation (THC), Triple-S Management Corporation (GTS), Universal American Corporation (UAM), Universal Health Services, Inc. (UHS) and WellCare Health Plans, Inc. (WCG).</span></div><div style="margin-bottom:6pt;margin-top:8pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">STOCK TRADING SYMBOL AND DIVIDENDS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on the New York Stock Exchange under the trading symbol &#8220;MOH.&#8221; As of February&#160;12, 2021, there were 12 registered holders of record of our common stock, including Cede &amp; Co. To date we have not paid cash dividends on our common stock. We currently intend to retain any future earnings to fund our projected business operations. However, we intend to periodically evaluate our cash position to determine whether to pay a cash dividend in the future. Our ability to pay dividends is partially dependent on, among other things, our receipt of cash dividends from our regulated subsidiaries. The ability of our regulated subsidiaries to pay dividends to us is limited by the state departments of insurance in the states in which we operate or may operate, as well as requirements of the government-sponsored health programs in which we participate. Additionally, the indentures governing our outstanding senior notes and credit agreement contain various covenants that limit our ability to pay dividends on our common stock. Any future determination to pay dividends will be at the discretion of our board of directors and will depend upon, among other factors, our results of operations, financial condition, capital requirements and contractual and regulatory restrictions. For more information regarding restrictions on the ability of our regulated subsidiaries to pay dividends to us, please see the Notes to Consolidated Financial Statements, Note 15, &#8220;Commitments and Contingencies&#8212;Regulatory Capital Requirements and Dividend Restrictions.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 34</span></div></div></div><div id="if790247689124308855d86d82384a359_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (&#8220;MD&amp;A&#8221;)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations as of and for the years ended December 31, 2020 and 2019, are presented in the sections that follow. Our MD&amp;A as of and for the year ended December 31, 2018, may be found in our 2019 Annual Report on Form 10-K, which prior disclosure is incorporated by reference herein.</span></div><div id="if790247689124308855d86d82384a359_61"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces (the &#8220;Marketplace&#8221;). Through our locally operated health plans in 15 states, we served approximately 4.0 million members as of December 31, 2020. In addition, in connection with our acquisition of Magellan Complete Care on December 31, 2020, we added approximately 200,000 members, and now operate health plans in 18 states. These health plans are generally operated by our respective wholly owned subsidiaries in those states, and licensed as health maintenance organizations (&#8220;HMOs&#8221;).</span></div><div id="if790247689124308855d86d82384a359_64"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">2020 HIGHLIGHTS </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Highlights of our 2020 results included the following:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net income per diluted share of $11.23, with net income of $673 million;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenue of $19.4 billion, which increased 15% compared to 2019;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Premium revenue of $18.3 billion, which increased 13% compared to 2019;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Consolidated medical care ratio (&#8220;MCR&#8221;) of 86.5%, compared to 85.8% in 2019;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We estimate the net effect of COVID decreased net income for the full year 2020 by $2.30 per diluted share, and increased the MCR by approximately 50 basis points;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Results were positively impacted by certain non-recurring and other items, mainly including the proceeds from the Marketplace risk corridor judgment;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Membership, including Magellan Complete Care, increased approximately 900,000 members to 4.2 million at December 31, 2020. Roughly half of this increase was from our recent acquisitions of Magellan Complete Care, Passport in Kentucky and YourCare in New York, with the balance from suspension of Medicaid redeterminations noted below;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General and administrative expense ratio (&#8220;G&amp;A ratio&#8221;) of 7.6%, compared to 7.7% in 2019; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After-tax margin of 3.5%, despite the underperformance of our Marketplace business.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID Impacts</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, the combined net effect of COVID-related impacts reduced our 2020 earnings and included:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A decrease in medical costs due to COVID-related utilization curtailment throughout most of year of approximately $420 million, which was partially offset by direct care related to COVID patients;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Premium refunds and related actions enacted by a number of our state customers in response to the COVID-related utilization curtailment of approximately $564 million, including $401 million recognized in the fourth quarter, mostly associated with recently-enacted risk sharing corridors; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in our G&amp;A spending on activities related to COVID; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Membership growth due to suspension of redeterminations in Medicaid.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Growth Initiatives</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We made major strides in 2020 related to our growth strategy. On December 31, 2020, we closed on the acquisition of Magellan Complete Care. In September 2020, we signed a definitive agreement to purchase the net assets of Affinity Health Plan in New York, which we expect to close as early as the second quarter of 2021. We closed on the Passport acquisition in Kentucky on September 1, 2020, and we closed on the YourCare acquisition in upstate New York on July 1, 2020. Each of these acquisitions involve financially underperforming health plans, but with stable membership and revenue bases. We believe they provide attractive opportunities for margin improvement, operating leverage and membership growth. Our growth initiatives continue to be anchored by our capital allocation priorities: first, organic growth; second, inorganic growth through accretive acquisitions; and third, programmatically returning excess capital to shareholders.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, we continue to perform well, our fundamentals remain strong, and we continue to grow revenue as a result of our focus on top-line growth.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 35</span></div></div></div><div id="if790247689124308855d86d82384a359_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FINANCIAL RESULTS SUMMARY</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per-share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premium revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: medical care costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical margin </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">MCR </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premium tax revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health insurer fees reimbursed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment income and other revenue </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketplace risk corridor judgment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">G&amp;A ratio </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premium tax expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health insurer fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per diluted share </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Key Statistics:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending Membership </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After-tax margin </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">MCR represents medical care costs as a percentage of premium revenue.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">G&amp;A ratio represents general and administrative expenses as a percentage of total revenue. After-tax margin represents net income as a percentage of total revenue.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Does not include approximately 200,000 Magellan Complete Care members from the acquisition closed on December 31, 2020. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 36</span></div></div></div><div id="if790247689124308855d86d82384a359_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CONSOLIDATED RESULTS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">NET INCOME AND OPERATING INCOME</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income amounted to $673 million, or $11.23 per diluted share in 2020, compared with net income of $737 million, or $11.47 per diluted share, in 2019. Our after-tax margin decreased to 3.5% for 2020, compared to 4.4% for 2019.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income was $1,078 million in 2020, compared with $1,044 million in 2019. We estimate that the net effect of COVID-19 decreased pretax income in 2020 by approximately $180 million, or $2.30 per diluted share. Operating income increased in 2020, despite the net effect of COVID-19, due to growth in membership and premiums, and a $128 million legal judgment for Marketplace risk corridor claims related to prior years, partially offset by a year-over-year decline in the underlying performance of our Marketplace business. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income per share in 2020 was favorably impacted by the reduction in common shares outstanding as a result of our share repurchase programs in 2020. See further discussion and information in &#8220;Liquidity and Financial Condition,&#8221; below, and in the Notes to Consolidated Financial Statements, Note 3, &#8220;Net Income Per Share.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">PREMIUM REVENUE</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenue increased $2,091 million, or 13%, in 2020, when compared with 2019. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The higher premium revenues reflect increased membership, primarily in Medicaid, and include the impact from the YourCare and Passport acquisitions. In 2020, we added 337,000 members from our acquisition of the Kentucky Passport business on September 1, 2020, and 47,000 members from our acquisition of the New York YourCare business on July 1, 2020. Suspension of redeterminations in Medicaid was also a driver for membership growth in 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in premium revenues from these acquisitions was slightly offset by the decline in membership associated with our exit of operations in Puerto Rico in 2020. The increase in premium revenue was net of approximately $564&#160;million recognized for COVID-related premium refunds and related actions that were enacted in several states in response to lower utilization of medical services resulting from COVID-19.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MEDICAL CARE RATIO</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The consolidated MCR in 2020 increased to 86.5%, compared to 85.8% in 2019, primarily due to the unfavorable net effect of COVID-19 impacts in all our lines of business. We estimate that the net effect of COVID-19 increased our consolidated MCR in 2020 by approximately 50 basis points.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year reserve development in 2020 was not material. The year ended December 31, 2019, was positively impacted by 80 basis points of favorable reserve development, primarily in the Medicaid program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">PREMIUM TAX REVENUE AND EXPENSES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The premium tax ratio increased to 3.4% in 2020, compared with 2.9% in 2019. The current year ratio increase was mainly due to the state of Illinois&#8217; implementation of a managed care organization provider assessment in the third quarter of 2019. Additionally, the state of California implemented a new managed care organization assessment, effective January 1, 2020, after the prior assessment mechanism expired on June 30, 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">HEALTH INSURER FEES (&#8220;HIF&#8221;)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, HIF expense amounted to  $277 million and HIF reimbursements amounted to $271 million. Public Law No. 115-120 provided for a HIF moratorium in 2019; therefore, there was no HIF incurred or reimbursed in that year. Due to the reinstatement of the HIF in 2020, our effective tax rate was higher in 2020 compared with 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Further Consolidated Appropriations Act, 2020, repealed the HIF effective for years after 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">INVESTMENT INCOME AND OTHER REVENUE</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income and other revenue decreased to $76 million in 2020, compared with $132 million in 2019. The year-over-year decrease was consistent with our expectation and was due to the low interest rate environment. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MARKETPLACE RISK CORRIDOR JUDGMENT</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the U.S. Court of Federal Claims granted us judgment in the amount of $128&#160;million for 2014, 2015, and 2016 Marketplace risk corridor claims, following a favorable U.S. Supreme Court decision in April 2020 which </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">held &#167;1342 of the Affordable Care Act obligated the federal government to pay participating insurers the full Marketplace risk corridor amounts calculated by that statute. We received the judgment in October 2020 and, consistent with the timing of the cash receipt, the gain was recognized in our fourth quarter 2020 financial results and reported in &#8220;Marketplace risk corridor judgment&#8221; in our consolidated statements of income. The judgment did not create additional Minimum MLR rebates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">GENERAL AND ADMINISTRATIVE (&#8220;G&amp;A&#8221;) EXPENSES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The G&amp;A expense ratio decreased slightly to 7.6% in 2020 compared with 7.7% in 2019, due to increased revenues, partially offset by increased costs associated with the COVID-19 pandemic, due to added operational protocols, technology implementations, and benefits for our employees, and also from increased costs associated with acquisitions. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">INTEREST EXPENSE</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased to $102 million in 2020, compared with $87 million in 2019. Additional interest expense relating to the 4.375% Notes issued in June 2020, and the 3.875% Notes issued in November 2020, was partially offset by the decrease in interest expense resulting from the settlement of the convertible senior notes in January 2020. As further described below in &#8220;Liquidity,&#8221; a portion of the net proceeds from the 4.375% Notes offering was used to repay $600 million principal amount outstanding under the term loan facility of our prior credit agreement. Additionally, a portion of the net proceeds from the 3.875% Notes offering was used to repay the $330 million principal amount outstanding under the 4.875% Notes. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">OTHER EXPENSES (INCOME), NET</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we recognized losses on debt repayment of&#160;$15 million in connection with repayment of our term loan facility and other financing transactions. In 2019, we recognized a gain on debt repayment of $15 million, in connection with convertible senior notes repayment transactions. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">INCOME TAXES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense amounted to $288 million in 2020, or 30.0% of pretax income, compared with income tax expense of $235 million in 2019, or 24.2% of the pretax income. The effective tax rate was higher in 2020 due to higher nondeductible expenses in 2020, primarily related to the nondeductible HIF. As discussed above, the HIF was not applicable in 2019 and has been repealed for years after 2020. </span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_73"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">REPORTABLE SEGMENTS</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had two reportable segments: the Health Plans segment, and the Other segment. Our reportable segments are consistent with how we currently manage the business and view the markets we serve. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">HOW WE ASSESS PERFORMANCE</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive our revenues primarily from health insurance premiums. Our primary customers are state Medicaid agencies and the federal government.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key metrics used to assess the performance of our Health Plans segment are premium revenue, margin and MCR. MCR represents the amount of medical care costs as a percentage of premium revenue. Therefore, the underlying margin, or the amount earned by the Health Plans segment after medical costs are deducted from premium revenue, is the most important measure of earnings reviewed by management.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Margin for our Health Plans segment is also referred to as &#8220;Medical Margin.&#8221; Medical Margin amounted to $2.5 billion and $2.3 billion in 2020 and 2019, respectively for the Health Plans segment. Management&#8217;s discussion and analysis of the changes in Medical Margin is discussed below under &#8220;Financial Performance.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Consolidated Financial Statements, Note 16, &#8220;Segments,&#8221; for more information.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 38</span></div></div></div><div id="if790247689124308855d86d82384a359_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">HEALTH PLANS</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Health Plans segment consisted of health plans operating in 15 states, and served approximately 4.0 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs for low-income families and individuals, including Marketplace members, most of whom receive government premium subsidies. In addition, in connection with our acquisition of Magellan Complete Care on December 31, 2020, we added approximately 200,000 members, and now operate health plans in 18 states.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Plans reportable segment includes our regulated health plan operating segments, along with the recently acquired Magellan Complete Care health plans operating segment. Because this acquisition closed on December 31, 2020, Magellan Complete Care&#8217;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">TRENDS AND UNCERTAINTIES</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the Health Plans segment&#8217;s trends, uncertainties and other developments, refer to &#8220;Item 1. Business&#8212;Our Business,&#8221; &#8220;&#8212;COVID-19 Pandemic,&#8221; and &#8220;&#8212;Legislative and Political Environment.&#8221;</span></div><div id="if790247689124308855d86d82384a359_79"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">FINANCIAL PERFORMANCE</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize premium revenue, Medical Margin, and MCR by state health plan and by government  program for the periods indicated (dollars in millions):</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HEALTH PLANS</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:33.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Premium Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Margin</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MCR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Premium Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Margin</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MCR</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">California</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Illinois</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kentucky</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michigan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ohio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Washington</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,208&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">&#8220;Other&#8221; includes the Idaho, Mississippi, New Mexico, New York, Puerto Rico, South Carolina, Utah, and Wisconsin health plans, whose results are not individually significant to our consolidated operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, the combination of all the COVID-19 pandemic-related impacts decreased pretax income in 2020 and increased our consolidated MCR in 2020 by approximately 50 basis points. Some of these items increased earnings, such as lower than expected medical costs from the curtailment of utilization that benefited all our state health plans, and a meaningful increase in Medicaid membership, while others served to decrease earnings, such as the temporary, retroactive Medicaid premium refunds and related actions enacted by certain states.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comments relating to the performance of our health plans in California, Ohio, Texas and Washington, which represent our largest health plans from a premium revenue standpoint, follow:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">California. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, Medical Margin declined when compared with 2019, as the lower medical care costs from the curtailment of utilization were more than offset by retroactive Medicaid premium refunds and underperformance in the Marketplace program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ohio. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, Medical Margin was higher when compared with 2019, due to higher premiums and improved operating performance in Medicaid. Premium revenues were higher year-over-year, mainly due to increased membership, program changes and rate increases in Medicaid established before COVID-19. The </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net effects of COVID-19 had an unfavorable impact on Medical Margins in all programs in 2020, as the retroactive premium refunds exceeded the benefit from lower medical costs due to the curtailment of utilization.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Texas. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, premium revenues and Medical Margin were both slightly higher when compared with 2019. Medical Margin increased due to higher premium revenues and a lower MCR in Medicaid, mostly driven by curtailment of utilization related to COVID-19 premiums, partially offset by underperformance in Marketplace. The decline in Marketplace resulted mainly from lower premiums and higher acuity mix for the new members we served. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Washington. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, Medical Margin was higher when compared with 2019, mainly due to improved results in Medicaid. Medicaid premium revenues increased in the year ended December 31, 2020, due to membership growth. In addition, results in the year ended December 31, 2020, benefited modestly from lower medical costs due to the curtailment of utilization driven by COVID-19, which was partially offset by COVID-related provider payments mandated by the state in the second quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROGRAMS</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:34.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Premium Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Margin</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MCR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Premium Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Margin</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MCR</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketplace</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,208&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicaid</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid premium revenue increased $1,799 million&#160;in 2020, when compared with 2019, mainly due to membership growth and premium increases in several states, and the impact from suspension of redeterminations due to COVID-19. Excluding acquisitions and our planned exit from Puerto Rico, we have added approximately 415,000 new Medicaid members since March 31, 2020, when we first began to report on the impacts of the pandemic. We believe this membership increase was mainly due to the suspension of redeterminations. These premium increases were partially offset by premium refunds and related actions enacted in several states in response to the lower utilization of medical services stemming from COVID-19.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical Margin of our Medicaid program increased $307 million, or 21%, in 2020 when compared with 2019. The increase was driven by increased premium revenues and margin associated with the membership growth discussed above, and from a reduction in the MCR.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid MCR decreased to 87.4% in 2020, from 88.0% in 2019, or 60 basis points. The decrease in the Medicaid MCR in 2020 was due to improvements across all programs. The MCR benefited from operational improvements and premium increases in several states, but was partially offset by unfavorable effects of COVID-19, including the impact of the premium refunds and related actions, net of lower medical costs due to the curtailment of utilization.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, we recognized a $10&#160;million premium deficiency reserve (&#8220;PDR&#8221;) associated with the Puerto Rico Medicaid business. We exited this business on October 31, 2020. The PDR represents the estimated remaining claims and administrative costs that exceed the estimated remaining premiums associated with the contract. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These improvements were partially offset by unfavorable year-over-year changes in prior year reserve development. Prior year reserve development in 2020 was not material; however, 2019 was positively impacted by 100 basis points of favorable reserve development.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare premium revenue increased $269 million in 2020, when compared with 2019, primarily due to increases in premium revenue PMPM and member months. PMPMs improved due to increased revenue resulting from risk scores that are more commensurate with the acuity of our population and increases in quality incentive premium revenues. These increases were partially offset by premium refunds, mainly in MMP, enacted in response to the lower utilization of medical services stemming from COVID-19.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical Margin for Medicare increased $21 million, or 6%, in 2020 when compared with 2019, primarily due to the increase in premium revenue discussed above, partially offset by increases in medical costs PMPM.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicare MCR increased from 85.3% in 2019 to 86.0% in 2020, or 70 basis points. The increase was primarily driven by an increase in medical care costs PMPM, which was mainly attributed to unfavorable changes in member mix, including higher acuity populations. The medical cost PMPM also reflected modestly lower utilization of medical services stemming from COVID-19. The impact of increased medical costs on the MCR was partially offset by the increase in the premium revenue PMPM discussed above.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketplace</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketplace premium revenue increased $23 million in 2020, when compared with 2019, mainly due to increased membership, partially offset by a decrease in premium revenue PMPM. The decrease in premium revenue PMPM was mainly driven by lower pricing, in an effort to be more competitive and generate membership growth, and the impact of more health plans being subject to minimum medical loss ratio rebates when compared with the prior year. The factors decreasing premium revenue PMPM were partially offset by the impact of higher risk adjustment premiums, resulting from higher acuity of our membership.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Marketplace Medical Margin decreased $152 million in 2020, despite the increase in premium revenues, due to an increase in the MCR compared to 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Marketplace MCR increased to 78.7% in 2020, compared to 68.2% in 2019. The increase in MCR was driven by the impact of the decrease in premium revenue PMPM discussed above, combined with an increase in medical cost PMPM when compared with 2019. The higher medical cost PMPM was primarily due to a higher member acuity mix and increased medical costs related to COVID-19. The rebound in utilization for Marketplace, following the curtailment from COVID-19, has been much more pronounced than our Medicaid and Medicare programs. Additionally, our risk scores, though increased compared to 2019, continue to lag the acuity of our membership. </span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_82"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">OTHER</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Other segment includes certain corporate amounts not allocated to the Health Plans segment. In 2020 and 2019, such amounts were immaterial to our consolidated results of operations.</span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_85"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">LIQUIDITY AND FINANCIAL CONDITION</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">LIQUIDITY</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our cash, investments, and capital structure to meet the short- and long-term obligations of our business while maintaining liquidity and financial flexibility. We forecast, analyze, and monitor our cash flows to enable prudent investment management and financing within the confines of our financial strategy.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain liquidity at two levels: 1) the regulated health plan subsidiaries; and 2) the parent company. Our regulated health plan subsidiaries generate significant cash flows from premium revenue and net income. Such cash flows are our primary source of liquidity. Thus, any future decline in our profitability may have a negative impact on our liquidity. We generally receive premium revenue a short time before we pay for the related healthcare services. The majority of the assets held by our regulated health plan subsidiaries is in the form of cash, cash equivalents, and investments. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When available and as permitted by applicable regulations, cash in excess of the capital needs of our regulated health plan subsidiaries is generally paid in the form of dividends to our parent company to be used for general corporate purposes. The regulated health plan subsidiaries paid dividends to the parent company amounting to $635 million in 2020, and $1,373 million in 2019, respectively. The parent company contributed capital of $107 million and $43 million in 2020 and 2019, respectively, to our regulated health plan subsidiaries to satisfy statutory capital and surplus requirements.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and investments at the parent company amounted to $644 million and $997 million as of December 31, 2020, and 2019, respectively. The decrease in 2020 was mainly due to cash used for Magellan Complete Care and other acquisitions, and common stock repurchases. These outflows were partially offset by inflows from net debt financing transactions, and dividends received from regulated health plan subsidiaries, net of contributions, as described above. See further discussion below, in &#8220;Investing Activities,&#8221; and &#8220;Financing Activities.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After considering expected cash flows from operating activities, we generally invest cash of regulated subsidiaries that exceeds our expected short-term obligations in longer term, investment-grade, and marketable debt securities to improve our overall investment return. These investments are made pursuant to board-approved investment policies which conform to applicable state laws and regulations. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policies are designed to provide liquidity, preserve capital, and maximize total return on invested assets, all in a manner consistent with state requirements that prescribe the types of instruments in which our subsidiaries may invest. These investment policies require that our investments have final maturities of less than 10 years, or less than 10 years average life for structured securities. Professional portfolio managers operating under documented guidelines manage our investments and a portion of our cash equivalents. Our portfolio managers must obtain our prior approval before selling investments where the loss position of those investments exceeds certain levels. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the risks of the COVID-19 pandemic, as they relate to our investments, are minimal. The overall rating of our portfolio remains strong and is rated AA. Our investment policy has directives in conjunction with state guidelines to minimize risks and exposures in volatile markets. Additionally, our portfolio managers assist us in navigating the current volatility in the capital markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our restricted investments are invested principally in cash, cash equivalents, and U.S. Treasury securities; we have the ability to hold such restricted investments until maturity. All of our unrestricted investments are classified as current assets. </span></div><div id="if790247689124308855d86d82384a359_88"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash flows are summarized as follows:</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(418)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically receive capitation payments monthly, in advance of payments for medical claims; however, government payors may adjust their payment schedules, positively or negatively impacting our reported cash flows from operating activities in any given period. For example, government payors may delay our premium payments, or they may prepay the following month&#8217;s premium payment. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operations was $1,890 million in 2020, compared with $427 million of net cash provided in 2019. The&#160;$1,463 million&#160;increase in year-over-year cash flow was due to cash flow timing benefits from the growth in membership in 2020, and the net impact of timing differences in governmental receivables and payables. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investing Activities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $400 million in 2020, compared with $293 million of net cash used in 2019, a decrease in year-over-year cash flow of $107 million. The decrease was mainly attributable to net cash paid in the YourCare, Passport and Magellan Complete Care acquisitions, partially offset by decreased purchases of investments in 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financing Activities</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was&#160;$225 million&#160;in 2020, compared with&#160;$552 million&#160;of net cash used in 2019, an increase in year-over-year cash flow of $777 million. In 2020, cash inflows included $1,429 million from the issuance of the 4.375% and 3.875% Notes and $380 million borrowed under the term loan facility. Cash outflows included the $600 million repayment of the term loan facility, common stock purchases of $606 million, which included $7 million to settle shares purchased in late December 2019, and net cash paid for the aggregate convertible senior notes</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8209;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related transactions amounting to $42 million. In 2019, cash outflows included net cash paid for the aggregate convertible senior notes-related transactions of $754 million, and $47 million paid for common stock purchases, partially offset by proceeds of $220 million borrowed under the term loan facility.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 42</span></div></div></div><div id="if790247689124308855d86d82384a359_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">FINANCIAL CONDITION</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash resources, borrowing capacity available under our Credit Agreement as discussed further below in &#8220;Future Sources and Uses of Liquidity&#8212;Future Sources,&#8221; and internally generated funds will be sufficient to support our operations, regulatory requirements, debt repayment obligations and capital expenditures for at least the next 12 months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a consolidated basis, as of December&#160;31, 2020, our working capital was $2,911 million compared with $2,698 million as of December&#160;31, 2019. At December&#160;31, 2020, our cash and investments amounted to $6,165 million, compared with $4,477 million of cash and investments at December&#160;31, 2019.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the statutory restrictions that inhibit the ability of our health plans to transfer net assets to us, the amount of retained earnings readily available to pay dividends to our stockholders is generally limited to cash, cash equivalents and investments held by our unregulated parent. For more information, see the &#8220;Liquidity&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discussion presented above.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Capital and Dividend Restrictions </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our regulated, wholly owned subsidiaries must maintain a minimum amount of statutory capital determined by statute or regulations. Such statutes, regulations and capital requirements also restrict the timing, payment and amount of dividends and other distributions, loans or advances that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. Based upon current statutes and regulations, the minimum capital and surplus requirement for these subsidiaries (not including the Magellan Complete Care subsidiaries) was estimated to be approximately $1,310&#160;million at December&#160;31, 2020, compared with $1,110&#160;million at December&#160;31, 2019. We estimate the Magellan Complete Care subsidiaries&#8217; minimum capital and surplus requirement amounted to approximately $230&#160;million at December 31, 2020. The aggregate capital and surplus of our wholly owned subsidiaries was in excess of these minimum capital requirements as of both dates. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under applicable regulatory requirements, the amount of dividends that may be paid by our wholly owned subsidiaries without prior approval by regulatory authorities as of December&#160;31, 2020, was approximately $60 million in the aggregate. The subsidiaries may pay dividends over this amount, but only after approval is granted by the regulatory authorities. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our cash and investments balances as of December&#160;31, 2020, management believes that its regulated wholly owned subsidiaries remain well capitalized and exceed their regulatory minimum requirements. We have the ability, and have committed to provide, additional capital to each of our health plans as necessary to ensure compliance with statutory capital and surplus requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Ratings</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our high-yield senior notes is rated &#8220;BB-&#8221; by Standard &amp; Poor&#8217;s, and &#8220;Ba3&#8221; by Moody&#8217;s Investor Service, Inc. A downgrade in our ratings could adversely affect our borrowing capacity and increase our borrowing costs. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Covenants</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary non-financial and financial covenants, including a net leverage ratio and an interest coverage ratio. Such ratios are computed as defined by the terms of the Credit Agreement. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the indentures governing each of our outstanding high-yield senior notes contain cross-default provisions that are triggered upon default by us or any of our subsidiaries on any indebtedness in excess of the amount specified in the applicable indenture. As of December&#160;31, 2020, we were in compliance with all financial and non-financial covenants under the Credit Agreement and other long-term debt.</span></div><div id="if790247689124308855d86d82384a359_94"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">FUTURE SOURCES AND USES OF LIQUIDITY</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Sources</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Health Plans segment regulated subsidiaries generate significant cash flows from premium revenue, which is generally received a short time before related healthcare services are paid. Premium revenue is our primary source of liquidity. Thus, any decline in the receipt of premium revenue, and our profitability, could have a negative impact on our liquidity.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Potential Impact of COVID-19 Pandemic</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Excluding acquisitions and our planned exit from Puerto Rico, we have added approximately 415,000 new Medicaid members since March 31, 2020, when we first began to report on the impacts of the pandemic. We believe this membership increase was mainly due to the suspension of redeterminations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It remains unclear how high the COVID-related membership peak will be, how quickly it will fall as the economy recovers, and where it will ultimately settle. However it does now appear that since unemployment nationally has fallen to 6.3% as of January 2021, the initial industry estimates of unemployment-related Medicaid membership increases were somewhat overstated. On a related note, the declaration of the extension of the public health emergency period to April 2021, with a potential extension from the Biden administration for the public health emergency to remain in place for all of 2021, will also likely have an impact. Therefore, we are currently unable to predict the timing or amount of the expected increases in enrollment. Increased membership would increase our premium revenue, but would also likely result in a significant increase in medical care claims and related costs. We believe that we have the scalability necessary to both serve new members, and ably partner with our state customers for increases in membership.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends from Subsidiaries. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When available and as permitted by applicable regulations, cash in excess of the capital needs of our regulated health plans is generally paid in the form of dividends to our unregulated parent company to be used for general corporate purposes. As a result of the COVID-19 pandemic, state regulators could restrict the ability of our regulated health plan subsidiaries to pay dividends to the parent company, which could reduce the liquidity of the parent company. For more information on our regulatory capital requirements and dividend restrictions, refer to Notes to Consolidated Financial Statements, Note 15, &#8220;Commitments and Contingencies&#8212;Regulatory Capital Requirements and Dividend Restrictions,&#8221; and Note 17, &#8220;Condensed Financial Information of Registrant&#8212;Note&#160;C&#160;- Dividends and Capital Contributions.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement Borrowing Capacity.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2020, we had available borrowing capacity of $1&#160;billion under the revolving credit facility of our Credit Agreement. In addition, the Credit Agreement provides for a $15&#160;million swingline sub-facility and a $100&#160;million letter of credit sub-facility, as well as incremental term loans available to finance certain acquisitions up to $500&#160;million, plus an unlimited amount of such term loans as long as we maintain a minimum consolidated net leverage ratio. See further discussion in the Notes to Consolidated Financial Statements, Note 11, &#8220;Debt.&#8221; </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Uses</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Stock Purchases. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, our board of directors authorized the purchase of up to $500&#160;million, in the aggregate, of our common stock. This program is funded with cash on hand and extends through December 31, 2021. The exact timing and amount of any repurchase is determined by management based on market conditions and share price, in addition to other factors, and subject to the restrictions relating to volume, price, and timing under applicable law. Following the purchases completed under a Rule 10b5-1 trading plan from November 2020 through February 11, 2021, there is approximately $219 million remaining available to purchase our common stock through December 31, 2021. See further information in the Notes to Consolidated Financial Statements, Note 13, &#8220;Stockholders&#8217; Equity.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have a disciplined and steady approach to growth. Organic growth, which includes leveraging our existing health plan portfolio and winning new territories, is our highest priority. In addition to organic growth, we will consider targeted acquisitions that are a strategic fit that we believe will leverage operational synergies, and lead to incremental earnings accretion. For further information on our acquisitions, refer to the Notes to Consolidated Financial Statements, Note 4, &#8220;Business Combinations.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a definitive agreement to acquire substantially all the assets of Affinity Health Plan, Inc. The net purchase price for the transaction is approximately $380&#160;million, subject to various adjustments at closing, which we intend to fund with cash on hand. We currently expect the transaction to close as early as the second quarter of 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we completed the acquisition of certain assets of Passport Health Plan, Inc. The purchase consideration included estimated contingent consideration of approximately $46&#160;million as of December 31, 2020. Half this amount is payable later in 2021, with the remainder payable in early 2022, subject to review and agreement among us and the seller. The second half payment is contingent upon the outcome of certain legal challenges.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Outcome of ACA Litigation.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As described above in &#8220;Health Plans Segment&#8212;Trends and Uncertainties,&#8221; the U.S. Supreme Court has accepted the appeal of the Fifth Circuit Court&#8217;s decision regarding the constitutionality and severability of the individual mandate. The ACA remains in effect pending the issuance of the Supreme Court&#8217;s opinion.  A decision by the Supreme Court that the entirety of the ACA is unconstitutional could have a material adverse effect on our business, financial condition, cash flows, or results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Potential Impact of COVID-19 Pandemic</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Beginning in early 2020 the pandemic, along with the related quarantine and social distancing measures, reduced demand for certain routine and non-critical medical services, while at the same time increased demand for other medical services, such as COVID-19 testing and emergency services. In 2020, utilization was curtailed, but could rebound to more normal levels in 2021. Increased demand for medical services, which we are presently unable to predict the timing or magnitude, could result in a significant increase in medical care costs and related provider claims payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, as described above in &#8220;Item 1. Business&#8212;COVID-19 Pandemic,&#8221; we have been subject to premium refunds and related actions as a result of the pandemic. In 2020, various states enacted temporary premium refunds and related actions in response to the reduced demand for medical services stemming from COVID-19, which resulted in a reduction of our medical margin. In some cases, these premium actions were retroactive to earlier periods in 2020, or as early as the beginning of the states&#8217; fiscal years in 2019. Beginning in the second quarter of 2020, we have recognized retroactive premium actions that we believe to be probable, and where the ultimate premium amount is reasonably estimable. We recognized $564&#160;million related to these retroactive premium actions, in the aggregate, in 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is possible that certain states could increase the level of existing premium refunds, and it is also possible that other states could implement some form of retroactive premium refund in the future. Due to these uncertainties, the ultimate outcomes could differ materially from our estimates as a result of changes in facts or further developments, which could have an adverse effect on our consolidated financial position, results of operations, or cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Capital Requirements and Dividend Restrictions. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the ability, and have committed to provide, additional capital to each of our health plans as necessary to ensure compliance with minimum statutory capital requirements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Molina Healthcare Charitable Foundation. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, we announced our commitment of $150 million to fund The Molina Healthcare Charitable Foundation (the &#8220;Foundation&#8221;), an independent not-for-profit charitable foundation. We contributed $15 million to the Foundation in the fourth quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_97"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we prepare our consolidated financial statements, we use estimates and assumptions that may affect reported amounts and disclosures. Actual results could differ from these estimates, and some differences could be material. Our most significant accounting estimates, which include a higher degree of judgment and/or complexity, include the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medical claims and benefits payable. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See discussion below, and refer to the Notes to Consolidated Financial Statements, Notes 2, &#8220;Significant Accounting Policies,&#8221; and 10, &#8220;Medical Claims and Benefits Payable&#8221; for more information.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Contractual provisions that may adjust or limit revenue or profit.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For a discussion of this topic, including amounts recorded in our consolidated financial statements, refer to the Notes to Consolidated Financial Statements, Note 2, &#8220;Significant Accounting Policies.&#8221;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Quality incentives.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For a discussion of this topic, refer to the Notes to Consolidated Financial Statements, Note 2, &#8220;Significant Accounting Policies.&#8221; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Business Combinations, and Goodwill and intangible assets, net. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, goodwill and intangible assets, net, represented approximately 10% of total assets and 45% of total stockholders&#8217; equity, compared with 3% and 9%, respectively, at December&#160;31, 2019.</span><span style="color:#828282;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a comprehensive discussion of this topic, including amounts recorded in our consolidated financial statements, refer to the Notes to Consolidated Financial Statements, Note 2, &#8220;Significant Accounting Policies,&#8221; Note 4, &#8220;Business Combinations,&#8221; and Note 9, &#8220;Goodwill and Intangible Assets, Net.&#8221; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MEDICAL CARE COSTS, MEDICAL CLAIMS AND BENEFITS PAYABLE</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical care costs are recognized in the period in which services are provided and include fee-for-service claims, pharmacy benefits, capitation payments to providers, and various other medically-related costs. Under fee-for-service claims arrangements with providers, we retain the financial responsibility for medical care provided and incur costs based on actual utilization of hospital and physician services. Such medical care costs include amounts paid by us as well as estimated medical claims and benefits payable for costs that were incurred but not paid as of the reporting date (&#8220;IBNP&#8221;). Pharmacy benefits represent payments for members' prescription drug costs, net of rebates from drug manufacturers. We estimate pharmacy rebates based on historical and current utilization of prescription drugs and contractual provisions. Capitation payments represent monthly contractual fees paid to providers, who are responsible for providing medical care to members, which could include medical or ancillary costs like dental, vision and other supplemental health benefits. Such capitation costs are fixed in advance of the periods covered and are not subject to significant accounting estimates. Other medical care costs include all medically-related administrative costs, amounts due to providers pursuant to risk-sharing or other incentive arrangements, provider claims, and other healthcare expenses. Examples of medically-related administrative costs include expenses relating to health education, quality assurance, case management, care coordination, disease management, and 24-hour on-call nurses. Additionally, we include an estimate for the cost of settling claims incurred through the reporting date in our medical claims and benefits payable liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical claims and benefits payable consist mainly of fee-for-service IBNP, unpaid pharmacy claims, capitation costs, other medical costs, including amounts payable to providers pursuant to risk-sharing or other incentive arrangements and amounts payable to providers on behalf of certain state agencies for certain state assessments in which we assume no financial risk. IBNP includes the costs of claims incurred as of the balance sheet date which have been reported to us, and our best estimate of the cost of claims incurred but not yet reported to us. We also include an additional reserve to ensure that our overall IBNP liability is sufficient under moderately adverse conditions. We reflect changes in these estimates in the consolidated results of operations in the period in which they are determined.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimation of the IBNP liability requires a significant degree of judgment in applying actuarial methods, determining the appropriate assumptions and considering numerous factors. Of those factors, we consider estimated completion factors (measures the cumulative percentage of claims expense that will ultimately be paid for a given month of service based on historical payment patterns) and the assumed healthcare cost trend (the year-over-year change in per-member per-month medical care costs) to be the most critical assumptions. Other relevant factors also include, but are not limited to, healthcare service utilization trends, claim inventory levels, changes in membership, product mix, seasonality, benefit changes or changes in Medicaid fee schedules, provider contract changes, prior authorizations and the incidence of catastrophic or pandemic cases.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For claims incurred more than three months before the financial statement date, we mainly use estimated completion factors to estimate the ultimate cost of those claims. Completion factors measure the cumulative percentage of claims expense that will ultimately be paid for a given month of service based on historical claims payment patterns. We analyze historical claims payment patterns by comparing claim incurred dates to claim payment dates to estimate completion factors. The estimated completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claims cost for a given month&#8217;s incurred claim activity. The difference between the estimated ultimate claims cost and the claims paid through the financial statement date represents our estimate of claims remaining to be paid as of the financial statement date and is included in our IBNP liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For claims incurred within three months before the financial statement date, actual claims paid are a less reliable measure of our ultimate cost since a large portion of medical claims are not submitted to us until several months after services have been submitted. Accordingly, we estimate our IBNP liability for claims incurred during these months based on a blend of estimated completion factors and assumed medical care cost trend. The assumed medical care cost trend represents the year-over-year change in per-member per-month medical care costs, which can be affected by many factors including, but not limited to, our ability and practices to manage medical and pharmaceutical costs, changes in level and mix of services utilized, mix of benefits offered, including the impact of co-pays and deductibles, changes in medical practices, changes in member demographics, catastrophes and epidemics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and other relevant factors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial standards of practice generally require a level of confidence such that our overall best estimate of the IBNP liability has a greater probability of being adequate versus being insufficient, where the liability is sufficient to account for moderately adverse conditions. Adverse conditions are situations that may cause actual claims to be higher than the otherwise estimated value of such claims at the time of the estimate, such as changes in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">magnitude or severity of claims, uncertainties related to our entry into new geographical markets or provision of services to new populations, changes in state-controlled fee schedules, and modifications or upgrades to our claims processing systems and practices. Therefore, in many situations, the claim amounts ultimately settled will be less than the estimate that satisfies the actuarial standards of practice. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When subsequent actual claims payments are less than we estimated, we recognize a benefit for favorable prior period development that is reported as part of &#8220;Components of medical care costs related to: &#8220;Prior years&#8221; in the table presented in Note 10, &#8220;Medical Claims and Benefits Payable.&#8221; Our reserving practice is to consistently recognize the actuarial best estimate including a provision for moderately adverse conditions for each current period. This provision is reported as part of &#8220;Components of medical care costs related to: Current year&#8221; in the table presented in Note 10. Assuming stability in the size of our membership, the use of this consistent methodology, during any given period, usually results in the replenishment of reserves at a level that generally offsets the benefit of favorable prior period development in that period. In the case of material growth or decline of membership, replenishment can exceed or fall short of the favorable development, assuming all other factors remain unchanged.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the significant degree of judgment involved in estimation of our IBNP liability, there is considerable variability and uncertainty inherent in such estimates. The following table reflects the hypothetical change in our estimate of claims liability as of December&#160;31, 2020 that would result if we change our completion factors for the fourth through the twelfth months preceding December&#160;31, 2020, by the percentages indicated. A reduction in the completion factor results in an increase in medical claims liabilities. The following tables do not include amounts relating to our recent acquisitions of Magellan Complete Care and Passport. Dollar amounts are in millions.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Increase (Decrease) in Estimated Completion Factors</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Increase&#160;<br/>(Decrease)&#160;<br/>in Medical Claims <br/>and<br/>Benefits Payable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(327)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects the hypothetical change in our estimate of claims liability as of December&#160;31, 2020 that would result if we alter our assumed medical care cost trend factors by the percentages indicated. An increase in the PMPM costs results in an increase in medical claims liabilities. Dollar amounts are in millions.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Decrease) Increase in Trended Per Member Per Month Cost Estimates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Decrease)&#160;<br/>Increase&#160;<br/>in Medical Claims <br/>and<br/>Benefits Payable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are many related factors working in conjunction with one another that determine the accuracy of our estimates, some of which are qualitative in nature rather than quantitative. Therefore, we are seldom able to quantify the impact that any single factor has on a change in estimate. Given the variability inherent in the reserving process, we will only be able to identify specific factors if they represent a significant departure from expectations. As a result, we do not expect to be able to fully quantify the impact of individual factors on changes in estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">RECENTLY ISSUED ACCOUNTING STANDARDS</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the Notes to Consolidated Financial Statements, Note 2, &#8220;Significant Accounting Policies,&#8221; for a discussion of recent accounting pronouncements that affect us.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_100"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CONTRACTUAL OBLIGATIONS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the table below, we present our contractual obligations as of December 31, 2020. Some of the amounts included in this table are based on management&#8217;s estimates and assumptions about these obligations, including their duration, the possibility of renewal, anticipated actions by third parties, and other factors. Because these estimates and assumptions are necessarily subjective, the contractual obligations we will actually pay in future periods may vary from those reflected in the table.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we have a variety of other contractual agreements related to acquiring services used in our operations. However, we believe these other agreements do not contain material non-cancelable commitments.&#160;We are not a party to off-balance sheet financing arrangements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:30.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022-2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024-2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2026&#160;and&#160;after</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of debt </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due government agencies </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase commitments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration liability </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,619&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,934&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">As of December 31, 2020, we had recorded approximately $20 million&#160;of unrecognized tax benefits. The table does not contain this amount because we cannot reasonably estimate when or if such amount may be settled. For further information, refer to Notes to Consolidated Financial Statements, Note&#160;12, &#8220;Income Taxes.&#8221;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Represents the principal amounts due on the 4.375% Notes due 2028, 5.375% Notes due 2022 and 3.875% Notes due 2030. For further information, refer to Notes to Consolidated Financial Statements, Note&#160;11, &#8220;Debt.&#8221;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Represents the estimate of contingent consideration due to the seller in connection with a business combination completed in 2020. For further information, refer to Notes to Consolidated Financial Statements, Note 4, &#8220;Business Combinations.&#8221;</span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_103"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">INFLATION</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use various strategies to mitigate the negative effects of healthcare cost inflation. Specifically, our health plans try to control medical care costs through contracts with independent providers of healthcare services. Through these contracted providers, our health plans emphasize preventive healthcare and appropriate use of specialty and hospital services. There can be no assurance, however, that our strategies to mitigate medical care cost inflation will be successful. Competitive pressures, new healthcare and pharmaceutical product introductions, demands from healthcare providers and customers, applicable regulations, or other factors may affect our ability to control medical care costs.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">COMPLIANCE COSTS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans are regulated by both state and federal government agencies. Regulation of managed care products and healthcare services is an evolving area of law that varies from jurisdiction to jurisdiction. Regulatory agencies generally have discretion to issue regulations and interpret and enforce laws and rules. Changes in applicable laws and rules occur frequently. Compliance with such laws and rules may lead to additional costs related to the implementation of additional systems, procedures and programs that we have not yet identified.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 48</span></div></div></div><div id="if790247689124308855d86d82384a359_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our earnings and financial position are exposed to financial market risk relating to changes in interest rates, and the resulting impact on investment income and interest expense.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our investments and restricted investments are subject to interest rate risk and will decrease in value if market interest rates increase. Assuming a hypothetical and immediate 1% increase in market interest rates at December&#160;31, 2020, the fair value of our fixed income investments would decrease by approximately $39 million.&#160;Declines in interest rates over time will reduce our investment income.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information on fair value measurements and our investment portfolio, please refer to the Notes to Consolidated Financial Statements, Note 5, &#8220;Fair Value Measurements,&#8221; and Note 6, &#8220;Investments.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Credit Agreement bear interest based, at our election, on a base rate or other defined rate, plus, in each case, the applicable margin. For further information, see Notes to Consolidated Financial Statements, Note 11, &#8220;Debt.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 49</span></div></div></div><div id="if790247689124308855d86d82384a359_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">MOLINA HEALTHCARE, INC.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_112">Consolidated Statements of Income</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_112">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_118">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_118">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_124">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_124">52</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_130">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_130">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_133">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_133">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_139">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if790247689124308855d86d82384a359_139">56</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 50</span></div></div></div><div id="if790247689124308855d86d82384a359_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except per-share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premium revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29d5d2b833564b80aea7dee755e0e3dd_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzQtMS0xLTEtMA_6d08d387-4ff0-4973-bdfd-9c7e95bf6051">18,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia63feda4ad7347288920b133e5dbddb3_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzQtMy0xLTEtMA_fc6d2533-9685-459d-a31a-e376e415a17d">16,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i849cbae5a8cc41beab243b6cc6768e11_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzQtNS0xLTEtMA_85ffae9d-62e2-4932-9dc1-c3ca9c60cfa9">17,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premium tax revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb34386ae3248e083608739601dbacc_D20200101-20201231" decimals="-6" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzUtMS0xLTEtMA_c4c08034-a6ff-485d-acd6-f108cfb53ee1">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ceb7faf3f854c239783915d36ad2084_D20190101-20191231" decimals="-6" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzUtMy0xLTEtMA_c002c12c-410c-45e3-9e39-68e33bef5181">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f79365bc994640a161617bd7d8a916_D20180101-20181231" decimals="-6" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzUtNS0xLTEtMA_ea5e21b0-db66-4b6e-92f0-84c9bd71fc4a">417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health insurer fees reimbursed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c49bd707ea342d29798c305bec30c3d_D20200101-20201231" decimals="-6" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzYtMS0xLTEtMA_1896b5b0-cb5a-4cf5-9ef5-a99e487736d7">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec0f306ac4604ee3a72ab17c719868e8_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzYtMy0xLTEtMA_2336127c-7d53-46f5-bb61-5a79e8efc344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286b19feb9c8495591834c5d364e760a_D20180101-20181231" decimals="-6" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzYtNS0xLTEtMA_c5248b0b-5b04-47ba-b0a0-2b0de6602da2">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketplace risk corridor judgment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5cc2203bcc1458383a2cacf8cb24107_D20200101-20201231" decimals="-6" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctMS0xLTEtMTQ2MDE_5b73290f-96a0-443c-b4fd-9287f966f605">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i910d706f29214cf989874f3c7c9bdc97_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctMy0xLTEtMTQ2MDE_2d5bf102-4d13-405c-b5ea-4acb570277cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57e45a9715ee49d6b1b20a8101922bed_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctNS0xLTEtMTQ2MDQ_bd5448a0-a899-4309-afdc-04720427a257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a3782192ac74e9fa0c0cbe786a6c7f9_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctMS0xLTEtMA_ac28a9e7-aaca-458f-b749-44f7859c422b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc6d37095e148f38283ad63b84f7dbb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctMy0xLTEtMA_2b9c5a26-bf63-4464-8305-9f147fd032c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i146b66c41bd848eb8c57a3034d4d91d3_D20180101-20181231" decimals="-6" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctNS0xLTEtMA_1e975e3e-d112-4178-b624-665e8306c141">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment income and other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzgtMS0xLTEtMA_0cfc8424-6e0c-4765-a70f-1e56cea6a74f">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzgtMy0xLTEtMA_d498c689-221b-4162-9cdc-1c8005454aba">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzgtNS0xLTEtMA_f13fd06b-53cf-4395-9e0e-6cd1eb174b8d">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzktMS0xLTEtMA_83314e8c-9a59-48df-9ebf-9d9a21345adc">19,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzktMy0xLTEtMA_f578871b-1918-4808-9951-8a9a59ce8c92">16,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzktNS0xLTEtMA_bcf31237-2c40-463b-956f-126831fd06e5">18,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical care costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234e4841fc374ed0ada5e87b17f10a96_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzExLTEtMS0xLTA_abe0284f-7ce3-4553-8bfe-839537051999">15,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38e404a0791d4aceab81d9b4037b1443_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzExLTMtMS0xLTA_553ccba6-b40d-44f6-9ad9-f07e66a4663b">13,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d89685788cc4fd09db979d7c5b577ba_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzExLTUtMS0xLTA_a5337044-331a-4f40-ad95-48e078fa820d">15,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEyLTEtMS0xLTA_ee14f402-6900-4aad-a479-111bf3381fe1">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEyLTMtMS0xLTA_1615a691-3a9d-442d-8b70-864b12b0c7e1">1,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEyLTUtMS0xLTA_10dae7cc-bb2a-4d6e-8f13-6e5aea678bc9">1,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premium tax expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:PremiumTaxExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEzLTEtMS0xLTA_86c82487-cd65-45af-9632-84a314bcf899">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="moh:PremiumTaxExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEzLTMtMS0xLTA_b1e45f10-be55-4832-a07a-c145937471f9">489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:PremiumTaxExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEzLTUtMS0xLTA_d178cfcb-2d5d-409f-8a57-e80d8a3d88ca">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health insurer fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:HealthCareOrganizationInsurerFeeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE0LTEtMS0xLTA_f713db49-8fda-45eb-adc5-cb4b68cafaff">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="moh:HealthCareOrganizationInsurerFeeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE0LTMtMS0xLTA_d45b52fc-9c36-4fca-a128-b0bd2ecc9dcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:HealthCareOrganizationInsurerFeeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE0LTUtMS0xLTA_50a046c0-a97d-4c2f-8f78-b61b5789920a">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE1LTEtMS0xLTA_dd876942-b863-4de6-a361-bdc17e85e46c">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE1LTMtMS0xLTA_8fe11cd1-790a-4706-93c0-1ac8ae8a0208">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE1LTUtMS0xLTA_8900af22-e383-45ef-bb15-166b4391c180">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE2LTEtMS0xLTA_e2412441-5263-48ab-b55d-160ae57f6ee6">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE2LTMtMS0xLTA_2afa1f47-0f70-4e19-a9ef-f2bf7cadf00e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE2LTUtMS0xLTA_b498aa48-8442-4a75-9dbc-0cd4e06851c8">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a3782192ac74e9fa0c0cbe786a6c7f9_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE3LTEtMS0xLTA_93109410-2171-4dc1-a311-5b4ab0f38acb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc6d37095e148f38283ad63b84f7dbb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE3LTMtMS0xLTA_50949254-86e4-49c2-90c1-c0d652ab7a5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i146b66c41bd848eb8c57a3034d4d91d3_D20180101-20181231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE3LTUtMS0xLTA_c59700b6-40da-4495-ab7b-54a05d6add4d">364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE4LTEtMS0xLTA_9c9b0a6a-9aa1-4396-a2e6-4c8507bb6527">18,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE4LTMtMS0xLTA_86ed49bf-ca7a-4e7d-8bb0-f5b5af6e1048">15,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE4LTUtMS0xLTA_23830298-a317-4561-b4ea-31ef6f1a18b5">17,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIwLTEtMS0xLTA_84d376f5-06f2-4910-86b0-686ffa024e60">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIwLTMtMS0xLTA_a161b398-bb09-4a4b-9a8d-5670b9f13bd8">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIwLTUtMS0xLTA_07564c29-bdc2-4572-8cf9-806aaaed81a4">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIyLTEtMS0xLTA_789e33c1-cd95-4632-bcbc-f7904cc71c30">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIyLTMtMS0xLTA_0e3a9397-1997-4d2a-abf0-12f41e447d32">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIyLTUtMS0xLTA_67a8fb65-286d-4266-bb66-f1c19e415ebf">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIzLTEtMS0xLTA_87fe416d-9717-4e70-9bdf-ad99af0a82ac">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIzLTMtMS0xLTA_aabba660-a453-4df1-8a45-0120f7c97e00">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIzLTUtMS0xLTA_b2c68849-ca62-4fc1-adeb-003117a74df8">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other expenses, net </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI0LTEtMS0xLTA_53de23e3-c815-4391-bd9c-dc25f9089864">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI0LTMtMS0xLTA_75cd2d2c-00d9-4347-9f2b-e80f291ead09">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI0LTUtMS0xLTA_53f07c61-07e9-4da6-96d6-2507f318e362">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI1LTEtMS0xLTA_1e1e1a9a-4ed0-4a98-a1bd-3e6bcd266fe9">961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI1LTMtMS0xLTA_cb22bd93-bf79-4461-a1cc-8fa47b7b6ef0">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI1LTUtMS0xLTA_2a9b6edf-fb68-418c-8c3f-ff06d2d4aae8">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI2LTEtMS0xLTA_39285191-a2cd-4265-97a4-6d0906a171f4">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI2LTMtMS0xLTA_9c2d6241-6ffb-4d4f-bb7a-8e265e2a5380">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI2LTUtMS0xLTA_13856664-34c0-44ae-bbc4-2ac42c1a3ee0">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI3LTEtMS0xLTE5MDY_e15b855a-6049-4c13-a3f3-caa3d485e4d6">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI3LTMtMS0xLTA_ffff84d8-0db9-4aee-831f-ec69cfdf47d0">737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI3LTUtMS0xLTA_1a8d95b5-aa5c-47d4-add0-a0a463e6d75c">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMwLTEtMS0xLTA_8d610cf1-c1c7-47c3-921e-39662a2d4497">11.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMwLTMtMS0xLTA_b6a72f24-5249-48b0-b5cf-f89252ae056f">11.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMwLTUtMS0xLTA_219d3721-c4d4-4b5b-a8aa-a8e484e6bcdd">11.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMxLTEtMS0xLTA_2539d682-eded-4b97-8b1d-8e41a43d2434">11.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMxLTMtMS0xLTA_ca0f4dd6-0198-4ec0-a27c-9cd566090fac">11.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMxLTUtMS0xLTA_92938ae1-2947-4ee9-94bc-8d5629b5ba6e">10.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMzLTEtMS0xLTA_06eebf84-b6e0-4e19-b9fe-3bca234deb0a">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMzLTMtMS0xLTA_a3eaea18-13a0-4767-b6f9-6e690c976aaf">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMzLTUtMS0xLTA_5706d2be-cfa1-472c-bc21-769392f36662">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzM0LTEtMS0xLTA_31617773-3c29-4bea-b474-124648b24fb3">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzM0LTMtMS0xLTA_8cd8599d-1e44-4519-961d-897fe4b2eaa1">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzM0LTUtMS0xLTA_a2765265-f747-40d7-8fc4-a604f8f05600">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="if790247689124308855d86d82384a359_118"></div><div style="margin-top:21pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzMtMS0xLTEtMA_81b6441b-0b57-4d38-8241-716c3330ff5a">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzMtMy0xLTEtMA_7025ca55-f395-4edc-a2c2-d8e7bd3d4b8a">737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzMtNS0xLTEtMA_30a86d83-4a91-400a-bab0-5410b2625cb2">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzUtMS0xLTEtMA_79dd4c33-0937-481d-a14e-58693911ecbe">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzUtMy0xLTEtMA_4266b273-392e-4c22-857b-b02796d77de2">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzUtNS0xLTEtMA_223d3bb7-d466-4f08-9c26-9ec7547566a2">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: effect of income taxes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzYtMS0xLTEtMA_45691318-5919-43c0-a34b-d071ab86aded">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzYtMy0xLTEtMA_e7e4c506-76de-4ad5-84fa-c1bceddee607">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzYtNS0xLTEtMA_1e40563d-339c-4cbb-a3fe-3ad478485a70">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzctMS0xLTEtMA_fadd450f-eb6b-49a6-9717-42b76b6663ff">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzctMy0xLTEtMA_9b6397c9-fe4c-4e5e-849b-b6c6eb5f1dd7">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzctNS0xLTEtMA_928a2062-7533-44a0-be72-28385dcbacbb">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzgtMS0xLTEtMA_14d7d381-dca3-424e-b337-31b263fa14e7">706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzgtMy0xLTEtMA_7504834e-b7c9-4fc0-a722-0cadaff66080">749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzgtNS0xLTEtMA_2580fe45-2787-4ae6-b1c0-9f4a16477569">705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 51</span></div></div></div><div id="if790247689124308855d86d82384a359_124"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions,<br/>except per-share amounts)</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzUtMS0xLTEtMA_d19d1e6a-8fc2-4327-b8c0-063b69ab8618">4,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzUtMy0xLTEtMA_ecbdd71a-def5-4e68-b433-8462d1246238">2,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzYtMS0xLTEtMA_e98100a9-1a97-48f2-b4f6-55d71c9c833d">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzYtMy0xLTEtMA_93f71f78-950a-402b-a851-2bbb80f9477b">1,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzctMS0xLTEtMA_560680db-a3cd-424b-b638-50458ea8d455">1,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzctMy0xLTEtMA_ac0a2313-f82b-4e35-a46e-58f12252c705">1,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzgtMS0xLTEtMA_5c44eebf-95b5-41d4-a668-bd3730fc9d80">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzgtMy0xLTEtMA_c5bf74ad-8031-44a3-9715-21401b65f347">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEwLTEtMS0xLTA_4bbcebeb-9b26-467a-b9ec-8d96a5133762">7,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEwLTMtMS0xLTA_64867d4a-b8aa-4c74-9bdc-48a832ccc7a3">5,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzExLTEtMS0xLTA_7ea24fe6-f94c-45b7-a478-a65ec9ec8b9c">391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzExLTMtMS0xLTA_9a6773d6-447f-43bb-ba8c-bf1646f8a4d7">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEyLTEtMS0xLTA_acc7ef07-dfd0-423d-9a4a-123ddaa13796">941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEyLTMtMS0xLTA_416fab27-410e-4077-96ed-c853c2e68709">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEzLTEtMS0xLTA_4bb73555-5962-4069-baa3-3331a038e593">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEzLTMtMS0xLTA_35a0b40d-c94b-4d27-b2de-6277ea196a86">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE0LTEtMS0xLTA_3f42ff56-71f9-4a46-8073-a04dd973b20e">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE0LTMtMS0xLTA_777d8f16-95fa-449e-854d-80caf7409a99">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE1LTEtMS0xLTA_26f800a3-2961-414a-8239-5ee46e34e34b">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE1LTMtMS0xLTA_73eb091a-b8c7-4333-9e43-d4201278a099">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE2LTEtMS0xLTA_e1b6bba6-b8a9-4cf8-ac14-cc0c6f593aef">9,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE2LTMtMS0xLTA_0137308f-9112-4eca-ab21-f81f590045dc">6,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIwLTEtMS0xLTA_086ffda1-e4bf-4a51-8371-4070f6ac4acf">2,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIwLTMtMS0xLTA_a7f39570-957d-4d82-8f7a-5fdf951b9a91">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due government agencies </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="moh:MedicalPremiumLiabilityDueToAgency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIxLTEtMS0xLTA_661414c9-4f65-4bae-88a3-78a951a1efbc">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:MedicalPremiumLiabilityDueToAgency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIxLTMtMS0xLTA_2542dc64-c011-4b30-ba75-d30d612be9c1">664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIyLTEtMS0xLTA_36f30461-bda0-4909-9b04-4eafecf98523">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIyLTMtMS0xLTA_92cfe86d-8b0a-4fe1-b84d-25c5be368f3a">502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIzLTEtMS0xLTA_6b845812-f829-4964-865b-93e71307d6a1">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIzLTMtMS0xLTA_7cd9bc55-dcad-417b-a364-660ac2bf34f0">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI2LTEtMS0xLTA_2bcacf11-78bd-4dfc-acc6-cb216af8a9ef">4,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI2LTMtMS0xLTA_bcc09bdf-c8f9-4bdd-8bb9-81f08b069d71">3,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI3LTEtMS0xLTA_04560cb8-a46f-4a8d-be17-dcfcfd53787e">2,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI3LTMtMS0xLTA_fc011574-5eeb-46e2-904b-a59998c9fa20">1,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI4LTEtMS0xLTA_a5084176-789a-4770-addd-f88989dfcbb7">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI4LTMtMS0xLTA_a5a435f4-c675-415f-a45e-510733cb1766">231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI5LTEtMS0xLTA_98355150-57d9-43ee-9d84-be6f362ced8d">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI5LTMtMS0xLTA_9ef6a706-c9bb-479b-bb76-7c8448aef339">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMwLTEtMS0xLTA_6f88f92c-ae03-44da-9983-1e222ce721da">7,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMwLTMtMS0xLTA_4e90a1fa-4c19-4d4a-893f-c0144fbbf45b">4,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDUx_5b270c78-439c-493b-a0eb-258936870709"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDUx_ac76518c-b992-429b-bf7b-9d05a89d0788">0.001</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDU0_cf133e69-b668-4145-a173-ed5efb9db305"><ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDU0_fd5abec7-5b2f-4ea3-9f22-a243c819a803">150</ix:nonFraction></ix:nonFraction> million shares authorized; outstanding: <ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDc5_78406bc6-5b6b-4305-bb82-6a0c523689bc">59</ix:nonFraction> million shares at December 31, 2020, and <ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDkz_30b80f88-f3b6-47e8-86e0-460f28b699fe">62</ix:nonFraction> million at December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTEtMS0xLTA_d461ba6a-a03a-458c-9881-46511c849edc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTMtMS0xLTA_534b93cc-4498-4936-80a3-5432260b9388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM4OTk4_863c57a2-fdf6-4866-bb57-6689358a0f92"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM4OTk4_b5f56231-ae73-4196-8046-7236a44f70e6">0.001</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTE0_5c4dabd2-7652-4ada-9999-d5b6bb48a7f1"><ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTE0_7403b34a-344f-4789-9b8a-978db9cb8170">20</ix:nonFraction></ix:nonFraction> million shares authorized, <ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTIw_1e1d4305-74ee-4e12-b95f-6c0836481c69"><ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTIw_1ff4be3e-9c98-4b08-a68f-3e7eb366442d"><ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTIw_2a3d9ad1-fae5-4316-9d2d-4ccdefc9eb10"><ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTIw_41b18ba0-7f8d-45ac-bfb2-33641736f877">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTEtMS0xLTA_e4d5951c-0b70-405c-8d9d-2ceca3cf6de2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTMtMS0xLTA_d2677111-e0af-4f43-9964-97a0c1652cab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM0LTEtMS0xLTA_f777323a-f407-4a77-a106-4896f5cf7436">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM0LTMtMS0xLTA_1140b06f-3ccd-4803-a5b7-6103a63bfe53">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM1LTEtMS0xLTA_1d431a7f-33d0-43c9-8694-708d8f070eb0">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM1LTMtMS0xLTA_1b743cfd-05c7-45dd-85e6-d10195614852">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM2LTEtMS0xLTA_35582369-19a2-4dda-a1a8-ba49735c2fb6">1,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM2LTMtMS0xLTA_6df80d6a-7ad1-4fa7-84ec-5b796da856f9">1,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM3LTEtMS0xLTA_61205926-19e3-46f2-8c9d-c3e0c0161e3b">2,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM3LTMtMS0xLTA_22474478-30c8-4300-8ef1-4eb84fe4293f">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM4LTEtMS0xLTA_49304e85-d9e5-4e45-988b-b72de38dbb76">9,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM4LTMtMS0xLTA_02d9aa95-a501-48ee-8dd7-74e95fc8ac27">6,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 52</span></div></div></div><div id="if790247689124308855d86d82384a359_130"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:38.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.127%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2017</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id81240d8e0324ade9d13dfaaff5b72b2_I20171231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtMS0xLTEtMA_93285687-d2eb-472c-8ca0-4cadfaef5517">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id81240d8e0324ade9d13dfaaff5b72b2_I20171231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtMy0xLTEtMA_61d2bc2f-3a7d-42e2-abdc-c93186322983">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4380ffd8981440aab0b911f97c293b09_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtNS0xLTEtMA_51b1a38b-aa70-4869-a04e-b53a383129a3">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8aea4f34a3747f088cc40ece091110d_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtNy0xLTEtMA_40ce855b-d654-4a34-82fe-1b7c39241619">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d321ff569ec4e909207a3511e1de822_I20171231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtOS0xLTEtMA_44906cfc-061e-4ab5-bb41-49dd397f235a">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5276df7533a434dba724ca46fb6260b_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtMTEtMS0xLTA_3698517b-8d8c-4089-a778-853968c4a159">1,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6084d3cc32ce4e868de7c430f423cecb_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzQtOS0xLTEtMA_869b85c4-85a5-4f90-8103-a4560100df70">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzQtMTEtMS0xLTA_cff1d27f-dd43-4169-861d-6fd0c9949957">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adoption of new accounting standards</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5875c847748b49b7ae809be69c6d6256_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzUtNy0xLTEtNDk1Nw_72511879-61bc-4f43-9d41-70b3430ee5f9">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7fb1e9375a549e9ad146d29588db2b9_I20171231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzUtOS0xLTEtNDk0MA_236abe7b-43ab-47e0-a216-829c314a481e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7987d66d3a0c45c991e3cab20c4fb866_I20171231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzUtMTEtMS0xLTQ5NDA_81af881a-189c-4633-8acb-1976116ee582">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Partial termination of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c6270cdd3704644bda480c6fd42c68a_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzYtNS0xLTEtNDk0NA_a3e89626-3716-4697-bc22-f899f1af3880">550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzYtMTEtMS0xLTQ5NDQ_7f1ac2cc-5447-4a2d-95c6-9a79b2ace343">550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exchange of convertible senior notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e7ec975f1cc4e07b1655f6681e39bae_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzctMS0xLTEtMA_54291568-3ed6-42d1-ad25-0f3d74e52b5d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c6270cdd3704644bda480c6fd42c68a_D20180101-20181231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzctNS0xLTEtMA_6b284928-a485-4e7c-b775-55595989370e">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzctMTEtMS0xLTA_321667da-294f-4e60-a0ac-de5bb3737620">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion of convertible senior notes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c6270cdd3704644bda480c6fd42c68a_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzgtNS0xLTEtNDk0Ng_c702e4b5-335b-4f08-b94b-5e6f9b2ae524">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzgtMTEtMS0xLTQ5NDg_0cdb923a-146a-47cc-871f-3efa4494efea">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a7ae69397d149d284b0dd9f61b2d2c2_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzktNy0xLTEtMA_09315c8a-c749-4f16-a9a6-ca30d0eba35d">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzktMTEtMS0xLTA_a2d297e7-204a-449e-b0ee-eee90d4ac01d">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c6270cdd3704644bda480c6fd42c68a_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEwLTUtMS0xLTA_89d6f2c4-e8d0-405f-8b41-62d947c25e69">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEwLTExLTEtMS0w_c9e321f3-30a4-41cb-94a0-d04ea9664b35">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2faff66f6e7145caa224e62f23b8c597_I20181231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTEtMS0xLTA_89ad2e32-d87a-492d-9cb6-43b8cf5805ec">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2faff66f6e7145caa224e62f23b8c597_I20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTMtMS0xLTA_472e2274-df3c-4b91-ac46-f272dff79bd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dafc291a0c24a16b8316afe33f2004b_I20181231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTUtMS0xLTA_89e9896c-b0ad-4a80-bcda-e60e3d036615">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25c94a4e11864ff08869c043de0f5f6d_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTctMS0xLTA_bfce02db-5175-4a1b-ac77-2e2520e91142">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65f9657d27d4a009acb818ef3881bcc_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTktMS0xLTA_d674e141-62ee-46a4-b0a4-17e4d1bb432f">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTExLTEtMS0w_5b26e129-fb59-4ce4-b60f-d5c25f100607">1,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02bdadf188dc494b844595ad20923df0_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEyLTktMS0xLTA_c8b2413b-bd7a-47d3-bfa3-4b7fa18e43e6">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEyLTExLTEtMS0w_638579fc-713c-4f86-8c41-41805d4066f6">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabcc9c4754784b398a5fc79d9a7ebbf7_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEzLTUtMS0xLTQ5NTA_d8120f7a-4301-40d1-91fd-859281b34458">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02bdadf188dc494b844595ad20923df0_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEzLTktMS0xLTQ5NTI_352dc916-e6e8-4660-9d42-7063167c9027">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEzLTExLTEtMS00OTU0_2cf6900c-64aa-46bf-8e44-b640c7ba4774">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adoption of new accounting standards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73b8d399d58241d1bd9c438042e73b99_I20181231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE0LTktMS0xLTA_2dbd779d-b954-4018-bf7a-2d0ab5def99c">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3ba89712ec942c09668e856ab29712f_I20181231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE0LTExLTEtMS0w_3d323410-503e-4709-bec9-1520b37ee379">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Partial termination of warrants</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabcc9c4754784b398a5fc79d9a7ebbf7_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE1LTUtMS0xLTA_1e5e76a3-ac22-4521-bbd1-967655c21dec">514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE1LTExLTEtMS0w_57266c57-ff8f-48cf-b195-c21c3e95b892">514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97919dee5de246a0b50148ddae7888fb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE2LTctMS0xLTA_4c07f705-43c1-439f-98de-d4f345e522e2">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE2LTExLTEtMS0w_f9251bc5-c302-4bbc-bb8f-dd0b5a023f68">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabcc9c4754784b398a5fc79d9a7ebbf7_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE3LTUtMS0xLTA_de5c7dab-b21d-46db-bf51-f9577a9f09df">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE3LTExLTEtMS0w_17d0cd53-864d-435a-982b-909d2fdfeab1">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0d1799cc9734f13b9ac873259cad7c6_I20191231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTEtMS0xLTA_1493cf14-46a0-49ff-bd1b-82ed84ed855a">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d1799cc9734f13b9ac873259cad7c6_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTMtMS0xLTA_d947baea-6945-4d03-9700-8fdb3f97c5f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e22f922c9a84243aa86afcf1b64ac08_I20191231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTUtMS0xLTA_0676957d-26f7-47ac-9ae2-8ae7839bb57e">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaee8551fee24ee384c466fe5ef25b9c_I20191231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTctMS0xLTA_037509bc-2b54-486d-b778-9e1f6e42c440">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa5f12c2da940d8b68187f4bdf87af7_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTktMS0xLTA_72ae195b-6be1-4591-93cd-818178bbe243">1,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTExLTEtMS0w_caefb7b3-545d-4894-bfd2-12cac2ab5b99">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE5LTktMS0xLTA_e15b855a-6049-4c13-a3f3-caa3d485e4d6">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE5LTExLTEtMS0w_4896f3e7-d416-4009-a778-a911b6951131">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock purchases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4047b057d87547648b481f3fb3ba62d7_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIwLTEtMS0xLTA_e3e8a170-1488-4868-b5a4-92d32ff51751">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifeaaeaba3f3849a081f3527f07ae1b82_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIwLTUtMS0xLTA_d250dbe2-20df-42be-9b3c-f586c847351d">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b04a987b49d48ef8c1cc6f8485617e8_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIwLTktMS0xLTA_67647c81-9b20-4222-a2c8-8d9a43d87203">594</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIwLTExLTEtMS04OTA5_b21faddb-ba79-447c-8bc3-e5160c943c97">605</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination of warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifeaaeaba3f3849a081f3527f07ae1b82_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIxLTUtMS0xLTA_113a51a9-749c-49c8-8d50-4e2eb3afa79d">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIxLTExLTEtMS0w_a07ddf13-806c-4b36-82ee-c95403e949f9">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5396d9352d1442a99bb72088a0b7ca0_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIyLTctMS0xLTA_19039901-1210-44e2-8d89-875326548820">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIyLTExLTEtMS0w_88f764ea-f0fe-46ba-b98f-d1515bde8ead">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4047b057d87547648b481f3fb3ba62d7_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIzLTEtMS0xLTA_0388ee1a-e4a4-4dde-8c07-5897d395c282">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeaaeaba3f3849a081f3527f07ae1b82_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIzLTUtMS0xLTA_46295313-6045-48d2-887c-daa102c899b8">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIzLTExLTEtMS0w_3adeaecc-fb76-4e04-910c-b476c7fdbd53">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i860bc85e749a4e47b38f4a7988debbe7_I20201231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTEtMS0xLTA_be41d3f3-7935-452a-9ee4-83a053950adc">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i860bc85e749a4e47b38f4a7988debbe7_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTMtMS0xLTA_07e4f388-79f0-4a07-96f1-47ef34b31e06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e975e9f87c74535bf3d7c5035bcba82_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTUtMS0xLTA_306638ba-2a05-4b27-b9c7-754de48a8243">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i183e269a3450453ab9a54b55cee9c2ee_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTctMS0xLTA_4518bc41-8168-42b3-b338-67ab16a7581f">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fbc4f7185694bff8ff72e5ae4a739ee_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTktMS0xLTA_f9da8f1e-5bf0-457b-a62f-b766b77a2955">1,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTExLTEtMS0w_6fdc5a59-c5d0-4fb0-8f62-37bd6e58e420">2,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 53</span></div></div></div><div id="if790247689124308855d86d82384a359_133"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQtMS0xLTEtMTkyNA_6219d01a-62d8-4ecb-883e-4ddcdc542076">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQtMy0xLTEtMA_bd6c83da-db12-41c8-b90b-8bdab10cab1f">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQtNS0xLTEtMTkyNA_f24bfe64-faca-407a-b1f3-e73f127177dd">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzYtMS0xLTEtMA_8606ad70-0d63-450d-bcbb-2b778cf80a49">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzYtMy0xLTEtMA_48aeeac3-66b4-4dc3-b6e9-4f48deb77eb6">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzYtNS0xLTEtMTkzMQ_02c5eb35-f16e-4858-9878-0bc78190eaf7">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzctMS0xLTEtMA_96748f47-299d-47b3-b823-4effcd7e12dc">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzctMy0xLTEtMA_93ae9714-6607-4e8c-aaee-7b04105adcbe">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzctNS0xLTEtMTkzMQ_832a2e1d-0367-4984-9009-10a9e367bd5e">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzgtMS0xLTEtMA_fab291ad-a7dc-4168-a054-3c17c1edfaa3">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzgtMy0xLTEtMA_cdb291a1-ab3f-49e5-ac56-f6a965b17e9d">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzgtNS0xLTEtMTkzMQ_12df860f-3c0c-4c1b-a0e4-d6fc90dfa117">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on debt repayment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="moh:GainLossOnDebtRepayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzktMS0xLTEtMA_b1006630-7981-4874-95a5-e19afdd69972">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="moh:GainLossOnDebtRepayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzktMy0xLTEtMA_4023052a-b40a-4eb2-9378-7c54e8845011">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="moh:GainLossOnDebtRepayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzktNS0xLTEtMTkzNQ_564c20a5-f93b-4af6-a991-754665170975">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sales of subsidiaries, net of gain</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEwLTEtMS0xLTA_98ee5300-7774-47c5-b85f-faaa63aadce2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEwLTMtMS0xLTA_ab8c7373-5df5-4acf-b1cf-d331dca32f4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEwLTUtMS0xLTE5Mzk_d8edaf93-1ec5-47a4-b143-5c36238a9174">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash restructuring charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="moh:NoncashRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzExLTEtMS0xLTA_3719a87c-dcc2-4813-828d-a9e849ba41aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="moh:NoncashRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzExLTMtMS0xLTA_78cf6139-9afd-4ccd-bdc0-c6ea5788061a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:NoncashRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzExLTUtMS0xLTE5NDI_fa6e2962-032e-401a-b2a8-f67278752c31">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEyLTEtMS0xLTA_143fbbbd-2107-4ad4-a8fb-0d09b74366ed">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEyLTMtMS0xLTA_20a5513f-f575-491b-949a-26c4bde52dad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEyLTUtMS0xLTA_bc0f5faa-a619-4257-af96-04c9ce06fac8">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of the effect of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE0LTEtMS0xLTA_39c298f7-f1a9-4ac6-9acf-86c58ee6160e">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE0LTMtMS0xLTA_021a6ca9-91b5-426e-9577-77e051b502a4">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE0LTUtMS0xLTE5NDc_306ec3f6-63a0-4393-bc3b-3ae3356bdd77">530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE1LTEtMS0xLTA_15575daf-fcb1-40e3-ac68-32e9b56c6b73">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE1LTMtMS0xLTA_8f218f3c-11a6-4255-9aab-d79f7b2c8d9e">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE1LTUtMS0xLTE5NDc_03173f39-f61d-497a-8d64-9c7da516e7d9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE2LTEtMS0xLTA_3a4f217b-153a-4266-a03d-d1e26cd92272">544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE2LTMtMS0xLTA_51b263ab-21d9-4938-bf63-98e98b0c0d05">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE2LTUtMS0xLTE5NDc_8b83f410-7b67-4d1d-94ba-726219d127e3">226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due government agencies </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE3LTEtMS0xLTA_1048eb4f-9e36-45cd-a6ca-86e24ceaf68b">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="moh:IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE3LTMtMS0xLTA_79e62c23-5552-4896-8ba8-708eb96dbfe5">303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="moh:IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE3LTUtMS0xLTE5NDc_13b4410f-bce0-4a94-8952-34fc3a83c6ca">574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE4LTEtMS0xLTA_be8e70b5-7d9e-46ce-9965-cf7858ef352d">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE4LTMtMS0xLTA_b745a4c8-84fa-498f-8954-7267afc4c30d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE4LTUtMS0xLTE5NDc_e38a48a8-e799-441a-8906-7af5c30ad4ec">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE5LTEtMS0xLTA_9f98d5cd-1209-4aa8-90c1-7f851c0ec016">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE5LTMtMS0xLTA_debdd2dc-f1c3-4df8-bf31-b05c22e15737">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE5LTUtMS0xLTE5NDc_f8d012d5-1225-45a0-a815-2e9856ce8d81">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIwLTEtMS0xLTA_3af884de-f669-4061-a936-bce70440845b">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIwLTMtMS0xLTA_88cb0f3e-851b-414a-b64b-5285d328c4de">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIwLTUtMS0xLTE5NDc_f97e2eb9-aa0d-4d71-a961-47c9075b42fd">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIxLTEtMS0xLTA_8dfe0458-a811-41e3-ad8c-597b21ae71a4">1,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIxLTMtMS0xLTA_52d02a62-3bc7-4877-abfc-da7c51c9df06">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIxLTUtMS0xLTA_3f083fb1-7bcb-4df2-9932-46ef4e5ae0cc">314</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIzLTEtMS0xLTA_8d3cc0a5-db6e-4d16-b4e4-fecc7506d19b">670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIzLTMtMS0xLTA_c4c091bb-2466-47e1-8766-a0cf8e8d48e5">2,536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIzLTUtMS0xLTE5NTE_bd53eaa2-507b-4e6c-9ec6-add1cec09df5">1,444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI0LTEtMS0xLTA_4f422032-a521-40bd-97aa-17d40e769807">1,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI0LTMtMS0xLTA_ad671e9f-3b51-4b19-9e73-14f0074f6550">2,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI0LTUtMS0xLTE5NTE_fa8f9805-bcf7-4262-969d-138057dd5117">2,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash paid in business combinations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTEtMS0xLTIyNzQ5_6eab3429-0386-4349-ae80-97141a7ce2de">755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTMtMS0xLTIyNzQ5_81cdf0aa-bf22-4f27-b94c-8910d2ecc69a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTUtMS0xLTIyNzQ5_22306799-d980-4857-b3e6-94021cadef4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTEtMS0xLTA_b3a2ab07-c88e-44c6-afbb-eff0b0bd0d7a">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTMtMS0xLTA_5de72850-f8a6-47f8-a61a-b34205671c5e">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTUtMS0xLTE5NjA_508431b1-abfc-480a-8e05-989a481e8741">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash received from sale of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI3LTEtMS0xLTA_83a4842b-bf4b-4ddb-bfa7-b15cd363e569">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI3LTMtMS0xLTA_7e83b321-5b08-4b37-9aa1-973806e7cc06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI3LTUtMS0xLTE5NTc_2e8c0894-1402-4d37-ad61-f8f9e2ab3383">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI4LTEtMS0xLTA_1f244e0d-6e94-4669-8592-2d630a9539c5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI4LTMtMS0xLTA_b31fbb85-9b2f-4292-8d13-5e40ad9bfa4b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI4LTUtMS0xLTE5NjM_24ea9d48-72e6-4437-a7d8-fb44e0f70b73">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI5LTEtMS0xLTA_1f274533-9d31-4d44-bfe7-da8be985b61a">400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI5LTMtMS0xLTA_201b5ce6-2077-4a4c-9c1a-d1d43424ee2f">293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI5LTUtMS0xLTA_d25c9586-e6a9-4dc1-ad13-a86763da91ee">1,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from senior notes offerings, net of issuance costs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMxLTEtMS0xLTE5NjY_7c7e03ca-b083-40b0-86e1-6b97e931f577">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMxLTMtMS0xLTE5NjY_a595250f-f1aa-4a70-8482-94c021eca3cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMxLTUtMS0xLTE5NjY_11ce07d3-3b8c-4544-8dc8-bd458a0c319e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock purchases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTEtMS0xLTE0NjEy_17b2a935-ad34-4299-bac3-c3bcb1c32300">606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTMtMS0xLTE0NjEy_05b7e288-cd9d-4f84-ae2d-1144fd959eb0">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTUtMS0xLTE0NjEy_d824245d-7b7b-4d6a-a2a9-a5d932980453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTEtMS0xLTE5NjY_333582ac-70a2-4b60-aac6-d9ee635310a8">600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTMtMS0xLTE5NjY_d78c96ed-471d-4ab7-b271-a56a8bb8d3fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTUtMS0xLTE5NjY_09c81136-6f2e-4e1a-bc1b-ca43845d18f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from borrowings under term loan facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM0LTEtMS0xLTY5Nw_9a8edd26-1d1d-4c54-be80-4292a520df73">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM0LTMtMS0xLTY5Nw_216f22be-79ec-4319-8c34-268c54fd1267">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM0LTUtMS0xLTE5Njk_51c5ae25-33c1-48b6-a4f7-f614a2c5d4fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTEtMS0xLTI1NTY_297dcf1b-d4c5-439e-a3a0-c63edcacf26d">338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTMtMS0xLTI1NTY_cd4572be-1b03-44ee-a7da-c052cb8920a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTUtMS0xLTI1NTY_0359ea36-1ffa-42a8-8420-2444d64a519c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for partial termination of warrants</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMzLTEtMS0xLTA_f3c6c7e8-7edf-4398-aafd-545c3dad1e82">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMzLTMtMS0xLTA_86a19b57-c1dc-4697-970c-ddc39c468511">514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTUtMS0xLTE5Nzc_6b5cb32d-ab60-4830-b9fa-aecaf8731f3c">549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for partial settlement of conversion option</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:CashPaidForSettlementOfConversionOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM0LTEtMS0xLTA_50dd5c51-bfbd-49d1-a65e-f54dec484cd1">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="moh:CashPaidForSettlementOfConversionOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM0LTMtMS0xLTA_4e7ec5f9-2764-4b67-8205-dfce786e7a07">578</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:CashPaidForSettlementOfConversionOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM2LTUtMS0xLTE5ODA_2768720f-2a77-4afd-82e0-f53c52a089b8">623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash received for partial settlement of call option</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTEtMS0xLTA_6e025ee7-7bd9-402c-ba4d-78fdc62b04f9">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTMtMS0xLTA_9fce792e-2ad0-4211-8bf3-d3641af045d4">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM3LTUtMS0xLTE5ODA_a7d06737-1450-4135-8be8-7ffe4ffce2d1">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of principal amount of convertible senior notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM3LTEtMS0xLTA_34acb870-7d12-483e-80a4-ec7aaabf07fd">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM3LTMtMS0xLTA_16834e2a-0341-4dc0-80ec-0ec87e9dc5d1">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM4LTUtMS0xLTE5ODM_71dec73c-68d7-4e46-a4ef-f7cc457e8cdb">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of credit facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM5LTEtMS0xLTA_5c570acb-95fb-43d4-b6b1-96bc223db5cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM5LTMtMS0xLTA_2c08d372-0924-4137-a6a3-e953b2daa0c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM5LTUtMS0xLTE5ODc_0d12ea12-4474-43b3-bf17-417f52f0c7a1">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQwLTEtMS0xLTA_2f9f3736-0f7e-4d52-adea-6b7386636ee0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQwLTMtMS0xLTA_81dc79c7-0f37-4b81-adec-6cb646f31970">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQwLTUtMS0xLTE5ODc_17d9c005-2033-4cfa-8f98-70a305e430bc">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQxLTEtMS0xLTA_828029c0-9ce0-49b0-9f32-9b2673d6d249">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQxLTMtMS0xLTA_93f952c0-04d0-45c5-b041-2d81f9a5ffb6">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQxLTUtMS0xLTA_daaaf839-055f-4efc-8dd1-a1301feeb46e">1,193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQyLTEtMS0xLTA_6fa468d8-89d5-46b3-bbe9-a9239af21461">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQyLTMtMS0xLTA_f3c5d383-284a-4d1c-a500-cdff11757894">418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQyLTUtMS0xLTA_3232d6f3-dc79-4391-908e-b2e0e4c27b3b">364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQzLTEtMS0xLTA_94470d03-73df-4022-9b6a-d478a89fb1c1">2,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQzLTMtMS0xLTA_2abbc005-a1bd-4818-96e2-3d1072489af4">2,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5276df7533a434dba724ca46fb6260b_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQ0LTUtMS0xLTQ5Njg_b6d8febe-ebf4-499f-9049-7febd9893541">3,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, and restricted cash and cash equivalents at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQ0LTEtMS0xLTA_d1421e46-7973-4558-bc4e-2ab1d0bf8d63">4,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQ0LTMtMS0xLTA_f9f8951a-8b57-40ef-b161-87e2eccabc69">2,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQ0LTUtMS0xLTA_8388abc1-7b75-473c-9b02-9f2d871ef14c">2,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div><span><br/></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">(continued)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid during the period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzctMS0xLTEtMA_67ba5916-ecfd-4ac0-afa0-d81a729349f7">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzctMy0xLTEtMA_a3e79fb3-bb76-4751-b9c1-cd323b5d35c9">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzctNS0xLTEtMA_4ef77a7d-4b8c-4be7-973e-e2b800fd0719">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzgtMS0xLTEtMA_8c46dddc-c823-4291-9b6f-56a29b330483">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzgtMy0xLTEtMA_228319c6-d9e1-4f78-8161-039bfd6f1f35">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzgtNS0xLTEtMA_f7c9f60c-0a3e-4bec-bb58-a95d583813cd">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Schedule of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Details of business combinations: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEyLTEtMS0xLTcxMzM_b2215434-846b-4e98-af3a-849f7583963f">1,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEyLTMtMS0xLTcxMzM_8a84006b-bc9e-4d67-bd79-9d66b23d28fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEyLTUtMS0xLTcxMzM_800d986f-8682-46d2-80df-f3a5b03f34e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTEtMS0xLTcxMzM_be9ecbe7-fa16-4658-944d-ac54a5f360a6">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="moh:FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTMtMS0xLTcxMzM_60caddd5-6f1f-44d5-864e-b4be1ac61b98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="moh:FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTUtMS0xLTcxMzM_10f20f0f-cd0c-4f7a-9bc2-a488343346ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTEtMS0xLTcxMzM_f089c35c-dde9-434c-a2db-452f66e5d938">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTMtMS0xLTcxMzM_56b1c69d-df98-43e6-9cec-ba2f2c93d41c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTUtMS0xLTcxMzM_aee0d385-8a83-4535-8384-6a717a4feae5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash paid in business combinations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTEtMS0xLTcxMzM_ca04f34c-79c8-4afb-816f-06980f34cd0a">755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTMtMS0xLTcxMzM_b5e7e4e6-0c3e-470d-9124-127d96d8a42c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTUtMS0xLTcxMzM_521a296c-12fa-4907-a6c8-df6b9f1de8ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible senior notes exchange transaction: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued in exchange for convertible senior notes</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:NotesIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTEtMS0xLTA_44c51a8a-811c-4fb9-a8a5-8ba285a22403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:NotesIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTMtMS0xLTA_c4a64e9d-ed32-49a1-ae4c-c234afe46f20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:NotesIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTUtMS0xLTA_ee8cdc15-4a91-4f73-8b98-d1f5180447c9">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Component of convertible senior notes allocated to additional paid-in capital, net of income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="moh:NotesIssuedFairValueAdjustmentIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTEtMS0xLTA_2ad94e1b-2162-4971-9a38-5528a1764abf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="moh:NotesIssuedFairValueAdjustmentIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTMtMS0xLTA_75c4a839-4e20-4c1a-806e-fcc6e31b2105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="moh:NotesIssuedFairValueAdjustmentIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTUtMS0xLTA_64238b13-2bf2-41fd-b9fb-cdd16bdabc38">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase to additional paid-in capital</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTEtMS0xLTA_04880406-a5e2-47a7-af19-39aa0d67286f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTMtMS0xLTA_0910fcaa-cd14-4b06-84d3-c72610b29c49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTUtMS0xLTA_a17e58c0-6a10-499e-85c8-56ef3b97045b">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock used for stock-based compensation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:StockIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE3LTEtMS0xLTA_cdcecba0-30f4-45e3-bd91-1079876f05e6">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:StockIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE3LTMtMS0xLTA_033e4f70-8b1d-441c-b8b1-7e8dc89a4b96">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:StockIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE3LTUtMS0xLTA_0b6f0ed5-c188-48ec-925c-07a4f0dd09ea">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock purchases not settled at end of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:CommonStockPurchasesNotSettledAtEndOfPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE5LTEtMS0xLTA_57b7e79c-eb7d-4c0b-99d9-c8569ada1121">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="moh:CommonStockPurchasesNotSettledAtEndOfPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE5LTMtMS0xLTA_472518aa-6df0-4c18-b76a-5ad6cd7ad08f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="moh:CommonStockPurchasesNotSettledAtEndOfPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE5LTUtMS0xLTA_286c5e17-cf6d-4fc2-a710-4a1aad314852">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Details of change in fair value of derivatives, net:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Loss) gain on call option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8327c36af50243d39623edb7b5bcb06f_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTEtMS0xLTczMQ_0af542f5-6f40-4b7f-b319-56e3e900b359">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb902f5430db4cec865e03899ec0a22a_D20190101-20191231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTMtMS0xLTczMQ_6fa9329b-69ca-49e9-b81c-2bba7e01d61a">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07b1e43b622b42d9b75e1ccb92389132_D20180101-20181231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTUtMS0xLTczMQ_1227166b-cc07-4d44-8ec5-43502d279177">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on conversion option</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80c02cdb9f7a420cb8aedf486216882d_D20200101-20201231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTEtMS0xLTczMQ_d4320305-3e3b-4c68-96bf-b43896faf905">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d11a4d46cec445aa76d23295e7aa22d_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTMtMS0xLTczMQ_050f7570-d8fe-46ab-ba3a-897dfa27a2c7">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb861312d6ab444ca32cfee48e0fd8a0_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTUtMS0xLTczMQ_156182f7-7dc4-4acd-a7aa-a60dd931b6ab">577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivatives, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTEtMS0xLTczMQ_8485851b-dbaf-478a-8c42-f9924ec200dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTMtMS0xLTczMQ_af99995e-0a1f-4164-b75d-ba2b132641cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTUtMS0xLTczMQ_6ea58ea9-0bbe-4788-a479-3e1c1be24b31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Details of sales of subsidiaries: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease in carrying amount of assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="moh:IncreaseDecreaseinCarryingAmountofAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTEtMS0xLTA_770b2cfe-464a-4cda-b0e8-cc793ae643a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="moh:IncreaseDecreaseinCarryingAmountofAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTMtMS0xLTA_3a9994cc-56b2-472c-8eb1-8403647923c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="moh:IncreaseDecreaseinCarryingAmountofAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTUtMS0xLTA_a09fb76d-e61d-485d-949f-fbb7c88a209b">327</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease in carrying amount of liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="moh:GainLossonDispositionofLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTEtMS0xLTA_44471e0b-cd7c-42c0-9ec4-3a1651b8b815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="moh:GainLossonDispositionofLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTMtMS0xLTA_2897edea-71e9-418d-abd7-7dd4de7c40f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:GainLossonDispositionofLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTUtMS0xLTA_fbc24857-18e6-42b4-acb3-b31f30e96c1b">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="moh:DispositionofBusinessTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTEtMS0xLTA_588400a3-b057-49e4-a0f3-64e80e235f13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="moh:DispositionofBusinessTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTMtMS0xLTA_915ab008-8719-44f3-ac2d-3aa55595252e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:DispositionofBusinessTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTUtMS0xLTA_e4ed8cdd-b095-4eb6-8d15-06926de95c7e">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash received from buyers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="moh:DispositionofBusinessReceivablefromBuyer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMxLTEtMS0xLTA_04cbb59b-06c9-42b2-a722-5b4e9cb8fd95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="moh:DispositionofBusinessReceivablefromBuyer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMxLTMtMS0xLTA_4ea60348-7e1e-45d4-80c8-804bf17dc637">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:DispositionofBusinessReceivablefromBuyer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMxLTUtMS0xLTA_7efe611f-cfe1-4863-bcb0-fd02cea78c99">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of subsidiaries, net of gain</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMyLTEtMS0xLTA_4c32e325-6079-4c3c-a3fc-951199e6a2ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMyLTMtMS0xLTA_0007f5f3-fcb9-48fd-aef8-ba27598d9b2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMyLTUtMS0xLTA_935d9f80-133c-4e07-ae9d-c867035ca383">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 55</span></div></div></div><div id="if790247689124308855d86d82384a359_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="if790247689124308855d86d82384a359_142"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">1. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzY0MTY_fa4ebefc-4560-4c8e-8efb-0281ca66a7c4" continuedAt="i473077ac93a24da0a9b81afa27d8bad1" escape="true">Organization and Basis of Presentation </ix:nonNumeric></span></div><ix:continuation id="i473077ac93a24da0a9b81afa27d8bad1" continuedAt="i74f740d48b6d4f3dbf5ba1f89fa676ad"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization and Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. provides managed healthcare services under the Medicaid and Medicare programs, through the state insurance marketplaces (the &#8220;Marketplace&#8221;), and under other government-sponsored healthcare programs for low-income families and individuals, most of whom receive government subsidies for premiums. As of December 31, 2020, we had <ix:nonFraction unitRef="segment" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzIxMw_996a3170-4e0c-4aaa-8da0-8e978fefe709">two</ix:nonFraction> reportable segments: the Health Plans segment, and the Other segment. Our reportable segments are consistent with how we currently manage the business and view the markets we serve. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our locally operated health plans in <ix:nonFraction unitRef="state" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" name="moh:NumberOfStatesForOperatedHealthPlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzEwOTk1MTE2NDkzMDg_8e15e101-9a3e-4a57-9af1-fa4115261ee6">15</ix:nonFraction> states, we served approximately <ix:nonFraction unitRef="member" contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231" decimals="-5" format="ixt:numdotdecimal" name="moh:NumberOfMembersEligibleForTheHealthCarePrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzYwNDczMTM5NzI1OTA_083a3d2a-1aa5-4dbf-a8bf-a21bfa284548">4.0</ix:nonFraction> million members as of December 31, 2020. In addition, in connection with our acquisition of Magellan Complete Care on December 31, 2020, we added approximately <ix:nonFraction unitRef="member" contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231" decimals="-5" format="ixt:numdotdecimal" name="moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzEwOTk1MTE2NDk0OTE_104d0b81-95f7-49bb-a2d9-8340c90af9f4">200,000</ix:nonFraction> members, and now operate health plans in <ix:nonFraction unitRef="state" contextRef="idc8845b2df0142a6ad693b5b696a900f_I20201231" decimals="INF" name="moh:NumberOfStatesForOperatedHealthPlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzEwOTk1MTE2NDk1MDA_3a08f146-f88b-4cf6-8e76-85669fd1a24d">18</ix:nonFraction> states. These health plans are generally operated by our respective wholly owned subsidiaries in those states, and licensed as health maintenance organizations (&#8220;HMOs&#8221;). </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our state Medicaid contracts typically have terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2Xzg0NA_2a1d4052-6221-4b74-b359-9ff02580423e">three</span> to <ix:nonNumeric contextRef="i50a1c2e5665543b3bda779ef36e5094b_D20200101-20201231" format="ixt-sec:durwordsen" name="moh:HealthPlanContractTerm" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2Xzg1MA_8d640d52-e838-4026-85e7-22f935df04ff">five years</ix:nonNumeric>, contain renewal options exercisable by the state Medicaid agency, and allow either the state or the health plan to terminate the contract with or without cause. Such contracts are subject to risk of loss in states that issue requests for proposal (&#8220;RFP&#8221;) open to competitive bidding by other health plans. If one of our health plans is not a successful responsive bidder to a state RFP, its contract may not be renewed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to contract renewal, our state Medicaid contracts may be periodically amended to include or exclude certain health benefits (such as pharmacy services, behavioral health services, or long-term care services); populations such as the aged, blind or disabled; and regions or service areas.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Developments &#8211; Health Plans Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Magellan Complete Care. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, we closed on our acquisition of <ix:nonFraction unitRef="number" contextRef="idc8845b2df0142a6ad693b5b696a900f_I20201231" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzEwOTk1MTE2NDc0NjI_edee7e04-76a9-4d51-a685-4ee8811ada5c">100</ix:nonFraction>% of the outstanding equity interests of the Magellan Complete Care line of business of Magellan Health, Inc., for total purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="i41056d0891344bfeb906ddd9f525ea3d_D20201201-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzE2NDkyNjc0NTQ2NjM_cc4ca022-6eb2-4bb3-a223-e5b451067cd6">1,037</ix:nonFraction>&#160;million. Because this acquisition closed on December 31, 2020, Magellan Complete Care&#8217;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020. See Note 4, &#8220;Business Combinations,&#8221; for further information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a definitive agreement to acquire substantially all the assets of Affinity Health Plan, Inc. The net purchase price for the transaction is approximately $<ix:nonFraction unitRef="usd" contextRef="i761083592e2c455daabbcd09515b7402_D20200901-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzEwOTk1MTE2Mzg3NTI_81e13435-6f19-4388-9c62-69fefd76d7a9">380</ix:nonFraction>&#160;million, subject to various adjustments at closing, which we intend to fund with cash on hand. We currently expect the transaction to close as early as the second quarter of 2021.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we completed the acquisition of certain assets of YourCare Health Plan, Inc. See Note 4, &#8220;Business Combinations,&#8221; for further information. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kentucky. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, our Kentucky health plan was selected as an awardee pursuant to the statewide Medicaid managed care RFP issued by the Kentucky Cabinet for Health and Family Services, Department of Medicaid Services. The new Medicaid contract began on January 1, 2021. In connection with this RFP award, we completed the acquisition of certain assets of Passport Health Plan, Inc. (&#8220;Passport&#8221;) in September 2020. See Note 4, &#8220;Business Combinations,&#8221; for further information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Texas.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In March 2020, the Texas Health and Human Services Commission (&#8220;HHSC&#8221;) notified our Texas health plan that HHSC had upheld our protest and had canceled all previously awarded contracts associated with the re-procurement awards announced in October 2019 for the ABD program (known in Texas as &#8220;STAR+PLUS&#8221;). In addition, HHSC canceled the pending re-procurement associated with the TANF and CHIP programs (known in Texas as &#8220;STAR/CHIP&#8221;). HHSC has indicated that the STAR+PLUS RFP will be posted in late 2021 or early 2022, with awards estimated to be announced in the second quarter of 2022, and start of operations in the fourth quarter of 2023. HHSC has also indicated that the STAR/CHIP RFP will be posted in the fourth quarter of 2022, with awards estimated to be announced in late 2022 or early 2023, and start of operations in the third quarter of 2024.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Puerto Rico</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We exited Puerto Rico&#8217;s Medicaid program when our contract expired on October 31, 2020. We have been working with the regulatory authorities and the provider community to ensure that our former members in Puerto Rico have reliable continuity of care.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i74f740d48b6d4f3dbf5ba1f89fa676ad" continuedAt="i7b1a693093c948b0b84c4910dda5a51a"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzY0MTg_86fd4af8-4184-4369-bb50-c6685fa830d4" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidation and Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Molina Healthcare, Inc., and its subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. Financial information related to subsidiaries acquired during any year is included only for periods subsequent to their acquisition. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the periods presented have been included; such adjustments consist of normal recurring adjustments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzY0MjU_f9cbba33-47ac-4c96-93a2-e4698e6c4081" continuedAt="ib976293d17014c68b8ce959d74572011" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Principal areas requiring the use of estimates include:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of medical claims and benefits payable of our Health Plans segment;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Plans segment contractual provisions that may limit revenue recognition based upon the costs incurred or the profits realized under a specific contract;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Plans segment quality incentives that allow us to recognize incremental revenue if certain quality standards are met;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Settlements under risk or savings sharing programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Purchase price allocations relating to business combinations, including the determination of contingent consideration;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The assessment of long-lived and intangible assets, and goodwill, for impairment;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of reserves for potential absorption of claims unpaid by insolvent providers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of reserves for the outcome of litigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of valuation allowances for deferred tax assets;&#160;and</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7b1a693093c948b0b84c4910dda5a51a" continuedAt="ib016270602cb4bec8dcf2e25bb0a0261"><ix:continuation id="ib976293d17014c68b8ce959d74572011" continuedAt="id1e9a3dd8f864d23bd987fb62f366af4">&#8226;</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:continuation id="ib016270602cb4bec8dcf2e25bb0a0261"><ix:continuation id="id1e9a3dd8f864d23bd987fb62f366af4">The determination of unrecognized tax benefits.</ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_148"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">2. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjcw_ef5eab4e-cde5-4435-af45-60565590e515" continuedAt="i801c09b75abe40b1bf2ea811de2071cb" escape="true">Significant Accounting Policies</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i801c09b75abe40b1bf2ea811de2071cb" continuedAt="ie67e77ee29f34c43b9b20385c4605aea"> </ix:continuation></span></div><ix:continuation id="ie67e77ee29f34c43b9b20385c4605aea" continuedAt="i2e4a915478264123875ab4e4de52991b"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjYy_ffac97cb-e481-42bd-9697-296b96babc90" continuedAt="i4db313c3d24b42c6b9fce1564353b3d4" escape="true">Cash and Cash Equivalents</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4db313c3d24b42c6b9fce1564353b3d4">Cash and cash equivalents consist of cash and short-term, highly liquid investments that are both readily convertible into known amounts of cash and have a maturity of three months or less on the date of purchase. The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjQw_7a271aca-1702-429a-9cca-42785c206c7c" continuedAt="i6d2fdc69a0244a77991a1b41a959a471" escape="true"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNzg5_68a74d2e-3c1b-4c15-a647-d0544af8609f" continuedAt="ie0cb668b4af14c498f5bfab557c10d5a" escape="true">The restricted cash and cash equivalents presented below are included in &#8220;Restricted investments&#8221; in the accompanying consolidated balance sheets.</ix:nonNumeric></ix:nonNumeric></ix:continuation><ix:continuation id="i6d2fdc69a0244a77991a1b41a959a471" continuedAt="i8da95e6142b64570a3aba80129d02ba9"><ix:continuation id="ie0cb668b4af14c498f5bfab557c10d5a" continuedAt="i1a7211d6358444fda1b8130b6331f26e"> </ix:continuation></ix:continuation></span></div><div style="margin-bottom:3pt;text-align:center"><ix:continuation id="i8da95e6142b64570a3aba80129d02ba9"><ix:continuation id="i1a7211d6358444fda1b8130b6331f26e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzMtMS0xLTEtMA_d19d1e6a-8fc2-4327-b8c0-063b69ab8618">4,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzMtMy0xLTEtMA_ecbdd71a-def5-4e68-b433-8462d1246238">2,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzMtNS0xLTEtMA_3f8487bc-4a2d-4e96-ba46-85debb6ea31f">2,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzQtMS0xLTEtMA_67944a02-23a7-465d-a354-34534cad5db7">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzQtMy0xLTEtMA_48a5e923-bcc4-47f3-9c3f-a5defe9fdee2">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzQtNS0xLTEtMA_d6e33ffd-fa90-44d1-bc34-74a72dc1a13b">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzUtMS0xLTEtMA_d1421e46-7973-4558-bc4e-2ab1d0bf8d63">4,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzUtMy0xLTEtMA_f9f8951a-8b57-40ef-b161-87e2eccabc69">2,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzUtNS0xLTEtMA_8388abc1-7b75-473c-9b02-9f2d871ef14c">2,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjEx_7f9b892b-5ba5-4cfb-8a15-1edec8e691f4" continuedAt="i671e529311f947f78fe47602646e0dd0" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments are principally held in debt securities, which are grouped into two separate categories for accounting and reporting purposes: available-for-sale securities, and held-to-maturity securities. Available-for-sale (&#8220;AFS&#8221;) securities are recorded at fair value and unrealized gains and losses, if any, are recorded in stockholders&#8217; equity as other comprehensive income, net of applicable income taxes. Held-to-maturity (&#8220;HTM&#8221;) securities are recorded at amortized cost, which approximates fair value, and unrealized holding gains or losses are not generally recognized. Realized gains and losses and unrealized losses arising from credit-related factors with respect to AFS and HTM securities are included in the determination of net income. The cost of securities sold is determined using the specific-identification method.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy requires that all of our investments have final maturities of less than <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:duryear" name="moh:InvestmentsMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE2NDQ_5ce7d1b0-ebb3-4230-a042-1ab9540e2daa">10</ix:nonNumeric> years, or less than <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:duryear" name="moh:InvestmentsAverageMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE2Njc_02bb38bb-3e40-40dc-b3c5-585e54de440a">10</ix:nonNumeric> years average life for structured securities. Investments and restricted investments are subject to interest rate risk and will decrease in value if market rates increase. Declines in interest rates over time will reduce our investment income. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2e4a915478264123875ab4e4de52991b" continuedAt="i77d0df07a7334a2fac0932506a61674e"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i671e529311f947f78fe47602646e0dd0">In general, our AFS securities are classified as current assets without regard to the securities&#8217; contractual maturity dates because they may be readily liquidated. We monitor our investments for credit-related impairment.</ix:continuation> For comprehensive discussions of the fair value and classification of our investments, see Note&#160;5, &#8220;Fair Value Measurements,&#8221; and Note&#160;6, &#8220;Investments.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest receivable relating to our AFS and HTM securities is presented within &#8220;Prepaid expenses and other current assets&#8221; in the accompanying consolidated balance sheets, and amounted to $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE2NzM4NDU_2c5577b6-185b-447f-af92-7fc29923548f">10</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE2NzM4NzA_146d4dd5-0ceb-479c-bcf1-1ce1a48a3e0d">12</ix:nonFraction>&#160;million at December 31, 2020, and 2019, respectively. We do not measure an allowance for credit losses on accrued interest receivable. Instead, we write off accrued interest receivable that has not been collected within 90 days of the interest payment due date. We recognize such write offs as a reversal of interest income. No accrued interest was written off during the year ended December 31, 2020.</span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MDQyNDMwMzA3MTYw_e7a85bca-bd4e-4c8b-81da-b9c8723adb7f" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables consist primarily of premium amounts due from government agencies, which may be subject to potential retroactive adjustments. Because substantially all of our receivable amounts are readily determinable and substantially all of our creditors are governmental authorities, our allowance for doubtful accounts is insignificant. Any amounts determined to be uncollectible are charged to expense when such determination is made.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MDQyNDMwMzA3MTY0_4ca1568c-36d0-4554-98f4-02370ce2f9c8" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:72.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d73a7217fd343aba05c738abeb42788_I20201231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzMtMS0xLTEtMTMyNjc_193b7d57-ed6f-4d72-83f8-16bcf48ca9e8">969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fd3259008f84de5b99bebc752d5714d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzMtMy0xLTEtMTMyNzk_36f321bc-d54b-4578-9efd-a19c15dd9664">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmacy rebate receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30812037b820437fa3a3e705d6ffa4d5_I20201231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzQtMS0xLTEtMTMyNjk_bbab6489-cd3e-4e3f-a15c-d44c6c268aa2">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17d974ef4c94bf497db882cd7110332_I20191231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzQtMy0xLTEtMTMyODE_6c41a257-f57b-46a7-8280-8a003f7d41a0">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health insurer fee reimbursement receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bf6535594b64a3d916a78b3ed7e6f86_I20201231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzUtMS0xLTEtMTMyNzE_1867d0f1-3817-4d26-96bf-d0dcd57dc39c">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib010fc19559144a59d49603a7da5ab41_I20191231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzUtMy0xLTEtMTMyODM_321dac8b-81d9-4a3a-86bf-80d536703b3d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea74ee4ad54b4f3c9e6446ba883edad3_I20201231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzYtMS0xLTEtMTMyNzM_e0a0ae91-f6f4-4008-941b-995674d6fa62">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49f572caee0440c88a9769d8359294a4_I20191231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzYtMy0xLTEtMTMyODU_a460666e-577e-4280-8299-0b771955d8be">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a81fff009c4556869db8332ba98850_I20201231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzctMS0xLTEtMTMyNzU_fa25fc1b-f010-47a1-88bc-d0275007956b">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750cbea67aa745698f4ce14305876548_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzctMy0xLTEtMTMyODc_f76ea186-95d1-468b-b471-a1324a0a5a99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzgtMS0xLTEtMTMyNzc_48bf3104-020c-45a8-8f82-3df71bdd4297">1,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzgtMy0xLTEtMTMyODk_9851f1d2-933a-48da-b5c0-e22dfad50430">1,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI1Mjg4NzY3NTI1Njc1_f1079634-5006-4f75-9609-b69e069b6e8a" continuedAt="ie5e918a8913a41a5847aa39a0b251ef6" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for business combinations using the acquisition method of accounting, which requires us to recognize the assets acquired and the liabilities assumed at their acquisition date fair values. As discussed below, the excess of the purchase consideration transferred over the fair value of the net tangible and intangible assets acquired is recorded as goodwill. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the final determination of the values of assets acquired or liabilities assumed, or one year after the date of acquisition, whichever comes first, any subsequent adjustments are recorded within our consolidated results of operations. Refer to Note 4, Business Combinations, and Note 9, &#8220;Goodwill and Intangible Assets, Net,&#8221; for further details.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNzUz_7321941d-0bf2-417a-8730-2e8a53fccfb6" continuedAt="ie6abf4b5edab4477935c5bb8e1865347" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets, including Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets consist primarily of property, equipment, capitalized software (see Note 7, &#8220;Property, Equipment, and Capitalized Software, Net&#8221;), and intangible assets resulting from acquisitions. Finite-lived, separately-identified intangible assets acquired in business combinations are assets that represent future expected benefits but lack physical substance (such as purchased contract rights and provider contracts). Intangible assets are initially recorded at fair value and are then amortized on a straight-line basis over their expected useful lives, generally between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4NDY_345e2136-02de-45cb-a7d6-760278ca92ed">five</span> and <ix:nonNumeric contextRef="iac48d7b081c44878865a5a148b146630_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4NTM_3ae31eb3-b252-4220-960f-e7447662a73d">16</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Determining the fair value of identifiable assets acquired, particularly intangible assets, and liabilities assumed,  requires management to make estimates, which are based on all available information and in some cases assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Determining the useful life of an intangible asset also requires judgment, as different types of intangible assets will have different useful lives. The most significant intangible asset we typically record in a business combination is contract rights associated with membership assumed. In determining the estimated fair value of the intangible assets, we typically apply the income approach, which discounts the projected future net cash flows using an appropriate discount rate that reflects the risk associated with such projected future cash flows. The most critical assumptions used in determining the fair value of contract rights include forecasted operating margins and the weighted average cost of capital.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i77d0df07a7334a2fac0932506a61674e" continuedAt="i32314b0b212c4bc28d046ab0b736c18e"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjY0_365117cd-ca60-4901-be8f-ab73b3e78971" escape="true">Our intangible assets are subject to impairment tests when events or circumstances indicate that a finite-lived intangible asset&#8217;s (or asset group&#8217;s) carrying value may not be recoverable. Consideration is given to a number of potential impairment indicators, including the ability of our health plan subsidiaries to obtain the renewal by amendment of their contracts in each state prior to the actual expiration of their contracts. However, there can be no assurance that these contracts will continue to be renewed. Following the identification of any potential impairment indicators, to determine whether an impairment exists, we would compare the carrying amount of a finite-lived intangible asset with the greater of the undiscounted cash flows that are expected to result from the use of the asset or related group of assets, or its value under the asset liquidation method. If it is determined that the carrying amount of the asset is not recoverable, the amount by which the carrying value exceeds the estimated fair value is recorded as an impairment.</ix:nonNumeric> Refer to Note 9, &#8220;Goodwill and Intangible Assets, Net,&#8221; for further details.</span></div><ix:continuation id="ie5e918a8913a41a5847aa39a0b251ef6"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase consideration over the fair value of net assets acquired in business combinations. Goodwill is not amortized but is tested for impairment on an annual basis and more frequently if impairment indicators are present. Impairment indicators may include experienced or expected operating cash-flow deterioration or losses, significant losses of membership, loss of state funding, loss of state contracts, and other factors. Goodwill is impaired if the carrying amount of the reporting unit (one of our state health plans) exceeds its estimated fair value. This excess is recorded as an impairment loss and adjusted if necessary for the impact of tax-deductible goodwill. The loss recognized may not exceed the total goodwill allocated to the reporting unit. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When testing goodwill for impairment, we may first assess qualitative factors, such as industry and market factors, the dynamic economic and political environments in which we operate, cost factors, and changes in overall performance, to determine if it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value. If our qualitative assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, we perform the quantitative assessment. We may also elect to bypass the qualitative assessment and proceed directly to the quantitative assessment. If performing a quantitative assessment, we generally estimate the fair values of our reporting units by applying the income approach, using discounted cash flows. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the annual impairment test under a quantitative assessment, the base year in the reporting units&#8217; discounted cash flows is derived from the annual financial planning cycle, which commences in the fourth quarter of the year. When computing discounted cash flows, we make assumptions about a wide variety of internal and external factors, and consider what the reporting unit&#8217;s selling price would be in an orderly transaction between market participants at the measurement date. Significant assumptions include financial projections of free cash flow (including significant assumptions about membership, premium rates, healthcare and operating cost trends, contract renewal and the procurement of new contracts, capital requirements and income taxes), long-term growth rates for determining terminal value beyond the discretely forecasted periods, and discount rates. When determining the discount rate, we consider the overall level of inherent risk of the reporting unit, and the expected rate an outside investor would expect to earn. As part of a quantitative assessment, we may also apply the asset liquidation method to estimate the fair value of individual reporting units, which is computed as total assets minus total liabilities, excluding intangible assets and deferred taxes. Finally, we apply a market approach to reconcile the value of our reporting units to our consolidated market value. Under the market approach, we consider publicly traded comparable company information to determine revenue and earnings multiples which are used to estimate our reporting units&#8217; fair values. The assumptions used are consistent with those used in our long-range business plan and annual planning process. However, if these assumptions differ from actual results, the outcome of our goodwill impairment tests could be adversely affected.</span></div></ix:continuation><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MDQyNDMwMzA3MTYx_f6cb9e96-e1a9-479c-8715-317faa72a095" continuedAt="i662d8d4e2c1343f6ae8fd705baf42129" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use (&#8220;ROU&#8221;) assets represent our right to use the underlying assets over the lease term, and lease liabilities represent our obligation for lease payments arising from the related leases. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease terms may include options to extend or terminate the lease when we believe it is reasonably certain that we will exercise such options. If applicable, we account for lease and non-lease components within a lease as a single lease component.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because most of our leases do not provide an implicit interest rate, we generally use our incremental borrowing rate to determine the present value of lease payments. Lease expenses for operating lease payments are recognized on a straight-line basis over the lease term, and the related ROU assets and liabilities are reduced to the present value of the remaining lease payments at the end of each period. Finance lease payments reduce finance lease liabilities, </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i32314b0b212c4bc28d046ab0b736c18e" continuedAt="i31a25afdfb7b484eb817a57bb4c9d0a1"><ix:continuation id="i662d8d4e2c1343f6ae8fd705baf42129" continuedAt="i077a90b54d8a4979b3b67e48581dedfa"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the related ROU assets are amortized on a straight-line basis over the lease term, and interest expense is recognized using the effective interest method.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant majority of our operating leases consist of long-term operating leases for office space. Short-term leases (those with terms of 12 months or less) are not recorded as ROU assets or liabilities in the consolidated balance sheets. For certain leases that represent a portfolio of similar assets, such as a fleet of vehicles, we apply a portfolio approach to account for the related ROU assets and liabilities, rather than account for such assets and the related liabilities individually. A nominal number of our lease agreements include rental payments that adjust periodically for inflation. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. </span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i077a90b54d8a4979b3b67e48581dedfa">For further information, including the amount and location of the ROU assets and lease liabilities recognized in the accompanying consolidated balance sheets, see Note 8, &#8220;Leases.</ix:continuation>&#8221;</span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzg3OTYwOTMwOTkxMTc_83337443-028a-41d3-97f0-8e609579e3a0" continuedAt="i70985cb363954351bbcda4ab33f13ca1" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Claims and Benefits Payable</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical care costs are recognized in the period in which services are provided and include fee-for-service claims, pharmacy benefits, capitation payments to providers, and various other medically-related costs. Under fee-for-service claims arrangements with providers, we retain the financial responsibility for medical care provided and incur costs based on actual utilization of hospital and physician services. Such medical care costs include amounts paid by us as well as estimated medical claims and benefits payable for costs that were incurred but not paid as of the reporting date (&#8220;IBNP&#8221;). Pharmacy benefits represent payments for members' prescription drug costs, net of rebates from drug manufacturers. We estimate pharmacy rebates based on historical and current utilization of prescription drugs and contractual provisions. Capitation payments represent monthly contractual fees paid to providers, who are responsible for providing medical care to members, which could include medical or ancillary costs like dental, vision and other supplemental health benefits. Such capitation costs are fixed in advance of the periods covered and are not subject to significant accounting estimates. Other medical care costs include all medically-related administrative costs, amounts due to providers pursuant to risk-sharing or other incentive arrangements, provider claims, and other healthcare expenses. Examples of medically-related administrative costs include expenses relating to health education, quality assurance, case management, care coordination, disease management, and 24-hour on-call nurses. Additionally, we include an estimate for the cost of settling claims incurred through the reporting date in our medical claims and benefits payable liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical claims and benefits payable consist mainly of fee-for-service IBNP, unpaid pharmacy claims, capitation costs, other medical costs, including amounts payable to providers pursuant to risk-sharing or other incentive arrangements and amounts payable to providers on behalf of certain state agencies for certain state assessments in which we assume no financial risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IBNP includes the costs of claims incurred as of the balance sheet date which have been reported to us, and our best estimate of the cost of claims incurred but not yet reported to us. We also include an additional reserve to ensure that our overall IBNP liability is sufficient under moderately adverse conditions. We reflect changes in these estimates in the consolidated results of operations in the period in which they are determined. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimation of the IBNP liability requires a significant degree of judgment in applying actuarial methods, determining the appropriate assumptions and considering numerous factors. Of those factors, we consider estimated completion factors and the assumed healthcare cost trend to be the most critical assumptions. Other relevant factors also include, but are not limited to, healthcare service utilization trends, claim inventory levels, changes in membership, product mix, seasonality, benefit changes or changes in Medicaid fee schedules, provider contract changes, prior authorizations and the incidence of catastrophic or pandemic cases.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the significant degree of judgment involved in estimation of our IBNP liability, there is considerable variability and uncertainty inherent in such estimates. Each reporting period, the recognized IBNP liability represents our best estimate of the total amount of unpaid claims incurred as of the balance sheet date using a consistent methodology in estimating our IBNP liability. We believe our current estimates are reasonable and adequate; however, the development of our estimate is a continuous process that we monitor and update as more complete claims payment information and healthcare cost trend data becomes available. Actual medical care costs may be less than we previously estimated (favorable development) or more than we previously estimated (unfavorable development), and any differences could be material. Any adjustments to reflect favorable development would be recognized as a decrease to medical care costs, and any adjustments to reflect unfavorable development would be recognized as an increase to medical care costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the period in which the adjustments are determined. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 10, &#8220;Medical Claims and Benefits Payable,&#8221; for a table presenting the components of the change in our medical claims and benefits payable, for all periods presented in the accompanying consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i31a25afdfb7b484eb817a57bb4c9d0a1" continuedAt="ibbcb177bfc774a39b8b64f91774aeab8"><ix:continuation id="i70985cb363954351bbcda4ab33f13ca1" continuedAt="ib26944d0c362458d9e059df0bd26cbb0"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Premium Revenue Recognition and Amounts Due Government Agencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenue is generated from our Health Plans segment contracts, for our participation in the Medicaid, Medicare and Marketplace programs. Premium revenue is generally received based on per member per month (&#8220;PMPM&#8221;) rates established in advance of the periods covered. These premium revenues are recognized in the month that members are entitled to receive healthcare services, and premiums collected in advance are deferred. State Medicaid programs and the federal Medicare program periodically adjust premium rates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain components of premium revenue are subject to accounting estimates and are described below, under &#8220;Contractual Provisions That May Adjust or Limit Revenue or Profit,&#8221; and &#8220;Quality Incentives.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Provisions That May Adjust or Limit Revenue or Profit</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib26944d0c362458d9e059df0bd26cbb0" continuedAt="i3bc2b00c993443a1894e1e43876fd8d6">Many of our contracts contain provisions that may adjust or limit revenue or profit, as described below. Consequently, we recognize premium revenue as it is earned under such provisions. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ReservesReportedToOtherAgenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzU0OTc1NTgxOTM1NDg_5f72d82d-1f38-4f2c-a9b5-0199bbe50a35" continuedAt="i0475e29c98054c86903a9ef974648d05" escape="true">Liabilities accrued for premiums to be returned under such provisions are reported in the aggregate as &#8220;Amounts due government agencies&#8221; in the accompanying consolidated balance sheets.</ix:nonNumeric></ix:continuation><ix:continuation id="i0475e29c98054c86903a9ef974648d05" continuedAt="ib7db111136264a3899efb4bfadbba574"> Categorized by program, such amounts due government agencies included the following:</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><ix:continuation id="ib7db111136264a3899efb4bfadbba574"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:71.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid program:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Minimum MLR and profit sharing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:MedicalPremiumsLiabilityMedicalCareCostsThreshold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzUtMS0xLTEtNTIzNg_33f666fc-2195-418f-814f-c3168bc2871b">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:MedicalPremiumsLiabilityMedicalCareCostsThreshold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzUtMy0xLTEtNTI1Nw_d4793593-5336-4e02-a301-8a0bc3c54f32">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:AmountsDueToGovernmentAgenciesMedicaidOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzYtMS0xLTEtNTIzNg_e4ed5c3e-9bdf-4f84-940a-e7eac975cfb2">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:AmountsDueToGovernmentAgenciesMedicaidOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzYtMy0xLTEtNTI1Nw_39c4ce27-b49a-4824-be0d-c4af45ed7121">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk adjustment and Part D risk sharing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzgtMS0xLTEtNTIzNg_4695acc1-11cd-4164-927e-1cf6af7f9b04">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzgtMy0xLTEtNTI1Nw_0dabf11e-9dab-4804-9ac7-c034d2449bec">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Minimum MLR and profit sharing </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzktMS0xLTEtNTIzNg_fd58accb-1c48-4fa8-9131-e1ec3e6a9d7b">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzktMy0xLTEtNTI1Nw_b09020fa-c863-4d7b-99d5-eb87431c7e5b">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:OtherMedicareProgram" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEwLTEtMS0xLTUyMzY_ca4ecd94-9306-4ce8-aee9-e65b41c7c4b2">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:OtherMedicareProgram" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEwLTMtMS0xLTUyNTc_e68eb7a2-6964-40d3-9438-4b9daf115576">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketplace program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:AmountsDuetoGovernmentAgenciesRiskAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEyLTEtMS0xLTUyMzY_66693e22-b0ad-4d02-9515-407d2b51443e">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:AmountsDuetoGovernmentAgenciesRiskAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEyLTMtMS0xLTUyNTc_2d35cd50-9f7b-4775-aff9-8ed754d7bc7b">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Minimum MLR</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEzLTEtMS0xLTUyMzY_ea454a3f-63bd-4024-9f94-29b89e377265">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEzLTMtMS0xLTUyNTc_2aead3bc-a678-4130-8ab9-fdf6a4fe5b0c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:AmountsDuetoGovernmentAgenciesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE1LTEtMS0xLTUyMzY_a2c5c463-6911-43d0-9012-93d54656a4a1">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:AmountsDuetoGovernmentAgenciesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE1LTMtMS0xLTUyNTc_12269a92-01b6-4270-be88-4ab9e1a210fb">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:AmountsDueToGovernmentAgenciesBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE2LTEtMS0xLTE0NDc0_38e9a62d-28a4-4a93-a9ca-ef9b1a54a578">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:zerodash" name="moh:AmountsDueToGovernmentAgenciesBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE2LTMtMS0xLTE0NDc0_f46561c3-6866-4b74-b4a1-db7a5a9059e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts due government agencies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="moh:MedicalPremiumLiabilityDueToAgency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE2LTEtMS0xLTUyMzY_fdae8a04-dc94-4522-913d-b25a79913ac2">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:MedicalPremiumLiabilityDueToAgency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE2LTMtMS0xLTUyNTc_b6d5a881-e869-4d2b-813f-06c195ed2ae8">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:continuation id="i3bc2b00c993443a1894e1e43876fd8d6" continuedAt="i066361595f0d4e4985a3fa0f4f3cd750"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicaid Program</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum MLR and Medical Cost Corridors. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our premium revenue may be returned if certain minimum amounts are not spent on defined medical care costs. Under certain medical cost corridor provisions, the health plans may receive additional premiums if amounts spent on medical care costs exceed a defined maximum threshold.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Profit Sharing. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with certain states contain profit sharing provisions under which we refund amounts to the states if our health plans generate profit above a certain specified percentage. In some cases, we are limited in the amount of administrative costs that we may deduct in calculating the refund, if any.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retroactive Premium Adjustments. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Medicaid programs periodically adjust premium rates on a retroactive basis. In these cases, we adjust our premium revenue in the period in which we determine that the adjustment is probable and reasonably estimable, and is based on our best estimate of the ultimate premium we expect to realize for the period being adjusted.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i066361595f0d4e4985a3fa0f4f3cd750" continuedAt="i06f17e2e844f492a9cbfc368b07f719e">In 2020, various states enacted temporary premium refunds and related actions in response to the reduced demand for medical services stemming from COVID-19, which resulted in a reduction of our medical margin. In some cases, these premium actions were retroactive to earlier periods in 2020, or as early as the beginning of the states&#8217; fiscal years in 2019. Beginning in the second quarter of 2020, we have recognized retroactive premium actions that we believe to be probable, and where the ultimate premium amount is reasonably estimable. </ix:continuation>We recognized $<ix:nonFraction unitRef="usd" contextRef="i91290aace81d4332aae71ba1a693cbba_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE2NjczNTA_fd28d8f1-5ae0-44bf-b3d3-04ddf604aee1">564</ix:nonFraction>&#160;million related to these retroactive premium actions, in the aggregate, in 2020, including $<ix:nonFraction unitRef="usd" contextRef="ic98f3f2874c74deca389d0f762617730_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE3MDU2MTE_31a481c0-20b7-4b1c-9148-9f5f47f14fdf">37</ix:nonFraction>&#160;million related to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibbcb177bfc774a39b8b64f91774aeab8" continuedAt="i2f988ad371b741d6b2c4e287b950b090"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MMP plans. Approximately $<ix:nonFraction unitRef="usd" contextRef="i03c303598694422daa4534e5d0775ae3_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE3MDg1OTA_cc413d64-b3c0-40a1-974a-71ef4ec09ce3">401</ix:nonFraction>&#160;million was recognized in the fourth quarter of 2020, mostly associated with recently enacted risk-sharing corridors.</span></div><ix:continuation id="i06f17e2e844f492a9cbfc368b07f719e" continuedAt="i6641feae80494e53891d20b76259bbdc"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is possible that certain states could increase the level of existing premium refunds, and it is also possible that other states could implement some form of retroactive premium refund in the future. Due to these uncertainties, the ultimate outcomes could differ materially from our estimates as a result of changes in facts or further developments, which could have an adverse effect on our consolidated financial position, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Medicare premiums are subject to retroactive increase or decrease based on the health status of our Medicare members (as measured by member risk score). We estimate our members&#8217; risk scores and the related amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members&#8217; health status, risk scores and Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) practices.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum MLR.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Affordable Care Act (&#8220;ACA&#8221;) established a minimum annual medical loss ratio (&#8220;Minimum MLR&#8221;) of 85% for Medicare. The medical loss ratio represents medical costs as a percentage of premium revenue. Federal regulations define what constitutes medical costs and premium revenue. If the Minimum MLR is not met, we may be required to pay rebates to the federal government. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Marketplace Program</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i6641feae80494e53891d20b76259bbdc" continuedAt="ia7bc3cf3fea7465e89d8464b31cc2998">Risk Corridor Judgment. </ix:continuation></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia7bc3cf3fea7465e89d8464b31cc2998" continuedAt="i292f200591ce47cba8b4a457bde39ec2">In April 2020, the United States Supreme Court held that &#167;1342 of the Affordable Care Act obligated the federal government to pay participating insurers the full Marketplace risk corridor amounts calculated by that statute, and that impacted insurers may sue the federal government in the U.S. Court of Federal Claims to recover damages for breach of that obligation.</ix:continuation> In June 2020, the Claims Court granted us judgment in the amount of $<ix:nonFraction unitRef="usd" contextRef="i8765abff68ce42c6992ad5c81c209878_D20200601-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE2NzAyNDk_0177e672-3e15-4490-9bff-9116f612bcc6">128</ix:nonFraction>&#160;million for 2014, 2015, and 2016 Marketplace risk corridor claims, which we received in October 2020. <ix:continuation id="i292f200591ce47cba8b4a457bde39ec2" continuedAt="i4739752dd441402082acc1919abc3fcb">Consistent with the timing of the cash receipt, the gain was recognized in our fourth quarter 2020 financial results and reported in &#8220;Marketplace risk corridor judgment&#8221; in our consolidated statements of income. The judgment did not create additional Minimum MLR rebates.</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i4739752dd441402082acc1919abc3fcb" continuedAt="ie240df913ea34790a940201172da2742">Risk Adjustment.</ix:continuation></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie240df913ea34790a940201172da2742" continuedAt="i53d3ef27cf164801a9f2dbe4c1d8540a"> Under this program, our health plans&#8217; composite risk scores are compared with the overall average risk score for the relevant state and market pool. Generally, our health plans will make a risk adjustment payment into the pool if their composite risk scores are below the average risk score (risk adjustment payable), and will receive a risk adjustment payment from the pool if their composite risk scores are above the average risk score (risk adjustment receivable). We estimate our ultimate premium based on insurance policy year-to-date experience, and recognize estimated premiums relating to the risk adjustment program as an adjustment to premium revenue in our consolidated statements of income.</ix:continuation> As of December&#160;31, 2020, Marketplace risk adjustment payables amounted to $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3Mjkx_3069ef9a-15ca-4585-a0f3-247beb41baa1">326</ix:nonFraction> million and related receivables amounted to $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MzMw_e0c0019f-fec7-4044-953a-a11115b6cbc2">20</ix:nonFraction> million, for a net payable of $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MzU1_5d91921d-c6f5-493e-bcb8-f66e7d9484f2">306</ix:nonFraction> million. As of December 31, 2019, Marketplace risk adjustment payables amounted to $<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3NDMz_3f318f66-7d96-439e-9cd0-a96390bd759c">368</ix:nonFraction> million and related receivables amounted to $<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3NDcy_a8d258e2-9026-4cca-aa62-3c2d1f7b03c4">63</ix:nonFraction> million, for a net payable of $<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3NDk3_31e610ec-9744-4aeb-ba72-8b1b03b1c10e">305</ix:nonFraction> million, which relates primarily to 2019 and prior periods.</span></div><ix:continuation id="i53d3ef27cf164801a9f2dbe4c1d8540a" continuedAt="i3a011b1ad8614d9882a9fce82ad0e6d1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum MLR.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The ACA has established a Minimum MLR of 80% for the Marketplace. If the Minimum MLR is not met, we may be required to pay rebates to our Marketplace policyholders. The Marketplace risk adjustment program is taken into consideration when computing the Minimum MLR. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quality Incentives</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3a011b1ad8614d9882a9fce82ad0e6d1">At many of our health plans, revenue ranging from approximately <ix:nonFraction unitRef="number" contextRef="i67312f647d5c42f885c6bf5c0fb8c961_D20200101-20201231" decimals="2" name="moh:PercentageOfAdditionalIncrementalRevenueEarned" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE4MDQ2_de201041-bfac-4589-a3fc-f8de4d1db355">1</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i25973257ed1e4cdfa54404c69e26ac16_D20200101-20201231" decimals="2" name="moh:PercentageOfAdditionalIncrementalRevenueEarned" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE4MDUy_8c82d4be-f25d-4fa6-af96-10c691f6356f">4</ix:nonFraction>% of certain health plan premiums is earned only if certain performance measures are met. Such performance measures are generally found in our Medicaid and MMP contracts. As described in Note 1, &#8220;Organization and Basis of Presentation&#8211;Use of Estimates,&#8221; recognition of quality incentive premium revenue is subject to the use of estimates.</ix:continuation> </span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ReinsuranceAccountingPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzg3OTYwOTMwOTkxMjI_73600305-9f0d-465c-8a88-0f58dc76c559" continuedAt="i6d80e3b38c034bf3864abff2373fea6d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We bear underwriting and reserving risks associated with our health plan subsidiaries. We limit our risk of significant catastrophic losses by maintaining high deductible reinsurance coverage with a highly-rated, unaffiliated insurance company (the &#8220;third-party reinsurer&#8221;).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we remain liable to our policyholders in the event the third-party reinsurer is unable to pay its portion of the losses, we continually monitor the third-party reinsurer&#8217;s financial condition, including its ability to maintain high credit ratings. Intercompany transactions with our captive are eliminated in consolidation.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2f988ad371b741d6b2c4e287b950b090" continuedAt="i269daf6f60324dfb9ec0eb3ebce9ead1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6d80e3b38c034bf3864abff2373fea6d">We report reinsurance premiums as a reduction to premium revenue, while related reinsurance recoveries are reported as a reduction to medical care costs.</ix:continuation> Reinsurance premiums amounted to $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidReinsurancePremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NDY3_2ff57979-9f04-40fb-8aa8-2b8833ab2edf">9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidReinsurancePremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NDcx_4e126cba-3ea3-4890-a5f8-14062f2948f0">17</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidReinsurancePremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NDc5_8768e6da-45ce-4a55-a5dd-f21a90114c91">16</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019, and 2018, respectively. Reinsurance recoveries amounted to $<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InsuranceRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NTg2_48133553-2f5f-4845-b57a-6ffb3971339b">23</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InsuranceRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NTkw_2a60e141-7475-4374-a288-9e5b80b4463f">18</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InsuranceRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NTk4_9b5976ed-a960-4a85-bffb-c328085144e7">33</ix:nonFraction> million for the years ended December 31, 2020, 2019, and 2018, respectively. Reinsurance recoverable of $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0Njk3_a084cc9b-47a5-4a4b-bd06-d9169250b657">17</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NzAx_5998ff2b-91aa-4345-a266-356e99406545">21</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NzA5_b129468d-d6c2-4d99-8372-21bbbcaa2edd">31</ix:nonFraction> million, as of December 31, 2020, 2019, and 2018, respectively, is included in &#8220;Receivables&#8221; in the accompanying consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Premium Deficiency Reserves on Loss Contracts</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the profitability of our contracts to determine if it is probable that a loss will be incurred in the future by reviewing current results and forecasts. For purposes of this assessment, contracts are grouped in a manner consistent with our method of acquiring, servicing and measuring the profitability of such contracts. A premium deficiency is recognized if anticipated future medical care and administrative costs exceed anticipated future premium revenue, investment income and reinsurance recoveries. In the third quarter of 2020, we recognized a premium deficiency reserve (&#8220;PDR&#8221;) of $<ix:nonFraction unitRef="usd" contextRef="i11f1f4ff7526429394959a5edcf1f480_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MDQyNDMwMzA3MTY3_517c991d-7a0c-4e04-8b2b-98aaab768ec2">10</ix:nonFraction>&#160;million for our Medicaid contract in Puerto Rico, $<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE3MDQ2OTU_8a03d2c2-7012-4e5e-a943-b3814b1c75ce">4</ix:nonFraction>&#160;million of which was amortized in the fourth quarter of 2020 to offset losses the PDR was established to cover. As described in Note 1, &#8220;Organization and Basis of Presentation,&#8221; we exited Puerto Rico&#8217;s Medicaid program when our contract expired on October 31, 2020. No premium deficiency reserves were recorded as of December 31, 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNzU5_40d1e026-cac4-4ade-93db-87771601c45d" continuedAt="ic0aa7855f5e441f185a88d3fe2295aa1" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic0aa7855f5e441f185a88d3fe2295aa1">We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates expected to be in effect during the year in which the basis differences reverse. Valuation allowances are established when management determines it is more likely than not that some portion, or all, of the deferred tax assets will not be realized.</ix:continuation> For further discussion and disclosure, see Note 12, &#8220;Income Taxes.&#8221;</span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="moh:TaxesBasedOnPremiumsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjMw_e89c6644-a8b1-4c1d-aab5-3be1e77e5a24" continuedAt="id3819b02a3b94512bd6d4993885a5787" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes Based on Premiums</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee (&#8220;HIF&#8221;). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Affordable Care Act, the federal government imposed an annual fee, or excise tax, on health insurers for each calendar year (the &#8220;HIF&#8221;).</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id3819b02a3b94512bd6d4993885a5787">The HIF was allocated to health insurers based on each health insurer's share of net premiums for all U.S. health insurers in the year preceding the assessment, and was not deductible for income tax purposes.</ix:continuation> Our HIF liability for 2020 was $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="moh:HealthCareInsuranceFeeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzU0OTc1NTgxOTM1MDk_7a5cb10c-f083-4c0e-9fe2-f7e94a776947">277</ix:nonFraction>&#160;million, which was settled in September 2020. Public Law No. 115-120 provided for a HIF moratorium in 2019; therefore, there was no HIF incurred or reimbursed in that year. Due to the reinstatement of the HIF in 2020, our effective tax rate was higher in 2020 compared with 2019. The Further Consolidated Appropriations Act, 2020 repealed the HIF effective for years after 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premium and Use Tax. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our health plans are assessed a tax based on premium revenue collected. The premium revenues we receive from these states include the premium tax assessment. We have reported these taxes on a gross basis, as premium tax revenue and as premium tax expenses in the consolidated statements of income. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjM5_bbe6330a-1e32-432b-8bee-57a99c693143" continuedAt="i9841e5f4a7a54fab85a72cb5ac49569e" escape="true">Concentrations of Credit Risk</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9841e5f4a7a54fab85a72cb5ac49569e">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. Our portfolio managers must obtain our prior approval before selling investments where the loss position of those investments exceeds certain levels. Our investments consist primarily of investment-grade debt securities with final maturities of less than <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:duryear" name="moh:InvestmentsMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4OTU4_8eef951f-188f-4a64-a2a7-a975d828c1b2">10</ix:nonNumeric> years, or less than <ix:nonNumeric contextRef="id49fb40faab249ee88628b7ca31ab180_D20200101-20201231" format="ixt-sec:duryear" name="moh:InvestmentsAverageMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4OTYz_5999d82c-a42c-4253-a047-faebe87cffa9">10</ix:nonNumeric> years average life for structured securities. Restricted investments are invested principally in cash, cash equivalents and U.S. Treasury securities. Concentration of credit risk with respect to accounts receivable is limited because our payors consist principally of the federal government, and governments of each state in which our health plan subsidiaries operate.</ix:continuation> </span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="moh:RisksAndUncertaintiesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNzY1_5476860d-4444-474b-8d3e-b7959346b753" continuedAt="ied71cf9ef0274703ad4e9a04844d7ae2" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability depends in large part on our ability to accurately predict and effectively manage medical care costs. We continually review our medical costs in light of our underlying claims experience and revised actuarial data. However, several factors could adversely affect medical care costs. These factors, which include changes in healthcare practices, inflation, new technologies, major epidemics, natural disasters, and malpractice litigation, are beyond our control and may have an adverse effect on our ability to accurately predict and effectively control medical care costs. Costs in excess of those anticipated could have a material adverse effect on our financial condition, results of operations, or cash flows.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i269daf6f60324dfb9ec0eb3ebce9ead1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ied71cf9ef0274703ad4e9a04844d7ae2">We operate health plans primarily as a direct contractor with the states, and in Los Angeles County, California, as a subcontractor to another health plan holding a direct contract with the state. We are therefore dependent upon a relatively small number of contracts to support our revenue. The loss of any one of those contracts could have a material adverse effect on our financial position, results of operations, or cash flows. In addition, our ability to arrange for the provision of medical services to our members is dependent upon our ability to develop and maintain adequate provider networks. Our inability to develop or maintain such networks might, in certain circumstances, have a material adverse effect on our financial position, results of operations, or cash flows.</ix:continuation></span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="moh:SummarizedPremiumRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MDQyNDMwMzA3MTY1_5226b4d8-a201-4840-af1a-488057c31a61" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes premium revenue by state health plan for the periods presented:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">California</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i932eecd9dd8942a8930602c75ed75579_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtMS0xLTEtMTE2NjU_e71f4c75-9109-40b2-bc40-72d5c823b77d">2,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i932eecd9dd8942a8930602c75ed75579_D20200101-20201231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtMy0xLTEtMTE2NTY_53acd2f9-81e7-4d3f-a229-149593b4095f">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic51cb18d6d6c41eeab7d71df5f748b8b_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtNS0xLTEtMTMwODI_5321c0e1-e696-4943-9d85-4709d0d8aea9">2,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic51cb18d6d6c41eeab7d71df5f748b8b_D20190101-20191231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtNy0xLTEtMTMxMDc_9461ad0c-a247-4d51-8daf-3cbd2ba01904">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie971c5d38e9f4081bdcce44e29b31e8e_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtOS0xLTEtMTMxMjk_a1974b1e-0f58-49bc-a6e3-ef10919aa081">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie971c5d38e9f4081bdcce44e29b31e8e_D20180101-20181231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtMTEtMS0xLTEzMTUx_9af098ca-07d7-483e-8a84-65adc97460cc">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i794b72519ef741a4b1e5b3b064789239_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtMS0xLTEtMTE2NjU_f82a86e8-c59c-45c0-bf37-67cbb1d370a2">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i794b72519ef741a4b1e5b3b064789239_D20200101-20201231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtMy0xLTEtMTE2NTY_9fed9292-ac7d-4850-9cfe-1d4e3f280f43">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e0308fdfb84b5cabb834a5d7d38846_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtNS0xLTEtMTMwODQ_c4032097-48b2-409c-891d-3114fdf64164">734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i98e0308fdfb84b5cabb834a5d7d38846_D20190101-20191231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtNy0xLTEtMTMxMDk_4cc5d81c-8d9a-4443-ad20-be43a3a50489">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea8b394a2d04647a92ee82b142ff55e_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtOS0xLTEtMTMxMzE_4ffce64c-df2c-465e-b0db-a8bd5862fdf1">1,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ea8b394a2d04647a92ee82b142ff55e_D20180101-20181231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtMTEtMS0xLTEzMTUz_1597887f-472a-4b71-9498-c50b4f0f713d">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Illinois </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010f47d9164d4401aaf7500b3414201c_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtMS0xLTEtMTE2NjU_ef7e6006-a313-4541-b4f0-fb69b11b1c62">1,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i010f47d9164d4401aaf7500b3414201c_D20200101-20201231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtMy0xLTEtMTE2NTY_54ec0216-afbf-4c62-8d89-1e78056c0735">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id99ab9a99c8b48109cb2e67859f4f1ca_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtNS0xLTEtMTMwODY_70889f07-fff9-43d7-8c33-d26c48435e30">1,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id99ab9a99c8b48109cb2e67859f4f1ca_D20190101-20191231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtNy0xLTEtMTMxMTE_faa24387-2b7d-4349-b572-99e6325f88fb">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b7453f2890d4ea8a57191c7b738e0ac_D20180101-20181231" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtOS0xLTEtMTMxMzM_afc704a5-161a-45ca-a0bc-d376d7f6966d">793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b7453f2890d4ea8a57191c7b738e0ac_D20180101-20181231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtMTEtMS0xLTEzMTU1_bc606ff8-45fe-4259-a095-5d1cdcda87f7">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kentucky</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f146b00c28c496fab54a890e503b593_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctMS0xLTEtMTE2NjU_d5ce8e2f-a7ae-41a0-92f7-268c9727fb70">654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f146b00c28c496fab54a890e503b593_D20200101-20201231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctMy0xLTEtMTE2NTY_715cf6e1-94a4-4b22-837c-6e2c9da82936">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd4a77f957a452ba104472004ee03d3_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctNS0xLTEtMTMwODg_8fc4db80-2ba4-443b-926e-a1c8844a0cc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iafd4a77f957a452ba104472004ee03d3_D20190101-20191231" decimals="3" format="ixt:zerodash" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctNy0xLTEtMTMxMTM_5ac8552b-8475-44a5-9248-b9cdc657b700">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7501a92677af42b3bbf91f05377b6a79_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctOS0xLTEtMTMxMzU_e8a47c90-1bcf-403f-9803-564b1d78bffb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7501a92677af42b3bbf91f05377b6a79_D20180101-20181231" decimals="3" format="ixt:zerodash" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctMTEtMS0xLTEzMTU3_2adda6d8-f7fc-4753-be00-2adf64eb4f37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michigan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff54c36d85a740d29de6dfed243ff5ee_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtMS0xLTEtMTE2NjU_a913daed-7545-4f08-8249-86f2483a927f">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff54c36d85a740d29de6dfed243ff5ee_D20200101-20201231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtMy0xLTEtMTE2NTY_7ec15cdf-4e61-41a2-abd6-5efee5d0b07f">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3a468249ee4c1f924f960fd9a0e7b6_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtNS0xLTEtMTMwOTA_2db212b3-28a3-4c92-b4de-69fda30b003a">1,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c3a468249ee4c1f924f960fd9a0e7b6_D20190101-20191231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtNy0xLTEtMTMxMTU_551266a9-1d61-46bf-ba91-99788830b941">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a12870bdcc84902a115a5c52be47a49_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtOS0xLTEtMTMxMzc_820af12a-7740-4819-9a93-844f711b7085">1,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a12870bdcc84902a115a5c52be47a49_D20180101-20181231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtMTEtMS0xLTEzMTU5_8f1b0b1b-c740-486d-b332-bf979f915156">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ohio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24117b22bd104e47bb18575a3e1087d1_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktMS0xLTEtMTE2NjU_2db9dcf8-6891-41dc-8729-0c28c81d8d14">2,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24117b22bd104e47bb18575a3e1087d1_D20200101-20201231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktMy0xLTEtMTE2NTk_cf79897c-a178-4b60-87c6-825cef9121c6">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2abcdca8654dca825ae09845834f08_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktNS0xLTEtMTMwOTU_2c9e4179-0939-44aa-a6e8-b5981fe02e08">2,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3f2abcdca8654dca825ae09845834f08_D20190101-20191231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktNy0xLTEtMTMxMTc_d86b5fb2-6c79-4d0b-8e89-0136be5e98ea">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7cd5fa2a6c4ee4893fa7aeea12f184_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktOS0xLTEtMTMxMzk_7af0bc07-d504-4284-9398-08a5584dac89">2,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe7cd5fa2a6c4ee4893fa7aeea12f184_D20180101-20181231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktMTEtMS0xLTEzMTYx_5238d5eb-d3b3-4f89-b145-020a25e6a95a">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d06937156847b795ad5d126b43c272_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTEtMS0xLTExNjY3_113dcfd9-758e-4f14-8acb-ead4985a69c3">3,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49d06937156847b795ad5d126b43c272_D20200101-20201231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTMtMS0xLTExNjYx_0002fe72-ecf0-44c2-be14-f41d519a995e">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c749426a22d4f45b998723c923108b0_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTUtMS0xLTEzMDk5_0c2b9ec4-69a4-4d37-85c8-45226113cfe0">2,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c749426a22d4f45b998723c923108b0_D20190101-20191231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTctMS0xLTEzMTIx_f670fcba-c993-4fe5-8436-c4b4064bbcad">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i963a1ad740774ea39b16fa5a48fc788a_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTktMS0xLTEzMTQz_d7e2029d-0b30-4d2a-b329-3e77fd49c763">3,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i963a1ad740774ea39b16fa5a48fc788a_D20180101-20181231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTExLTEtMS0xMzE2NQ_0fd73676-3808-49a2-9c54-556fd1310808">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Washington</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c68a644f8043128dc74552813a54c6_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTEtMS0xLTExNjY3_179c7272-99af-4690-8d80-32b1241649b0">3,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i98c68a644f8043128dc74552813a54c6_D20200101-20201231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTMtMS0xLTExNjYx_0065d51d-8c4f-4176-b65c-07bca6ad9513">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a53f8a4f88b471ca3904508a5f37fb1_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTUtMS0xLTEzMTAx_b4438249-a02f-45ed-b21e-affc37dbc706">2,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a53f8a4f88b471ca3904508a5f37fb1_D20190101-20191231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTctMS0xLTEzMTIz_d2934065-06a0-4870-8c8b-e52e7a4dce67">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b530889282e4734a8cea1ff62dd4eb8_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTktMS0xLTEzMTQ1_6b5f6810-91f0-4fb5-a271-5041af58d950">2,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b530889282e4734a8cea1ff62dd4eb8_D20180101-20181231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTExLTEtMS0xMzE2Nw_b448e1fb-44b8-45fe-8a72-4a35ecc1c9d3">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i623d20d86025415b904356ce36b3ec7a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTEtMS0xLTExNjY3_69f82dd2-b253-4620-9f4c-ba44ab9aee81">2,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i623d20d86025415b904356ce36b3ec7a_D20200101-20201231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTMtMS0xLTExNjYz_74bed555-2a8f-4339-9f10-62f492707982">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4529f238f148c6a7085542f5807c4c_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTUtMS0xLTEzMTAz_7f3e1f54-f75a-4b68-bf71-416521f6a2ee">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife4529f238f148c6a7085542f5807c4c_D20190101-20191231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTctMS0xLTEzMTI1_624eb023-6c0e-458e-af9a-2e514f752580">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed8f3b768cc45ce808afd1e8a44ddd3_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTktMS0xLTEzMTQ3_95b9d207-f87d-4ec4-ab20-e28c1bdd54ff">3,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ed8f3b768cc45ce808afd1e8a44ddd3_D20180101-20181231" decimals="3" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTExLTEtMS0xMzE2OQ_8e6ad495-dca3-4a7e-9c60-8bd8cd846f5d">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTEtMS0xLTExNjY3_ca442df8-1ba9-4e4a-976a-4707e31b0711">18,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231" decimals="INF" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTMtMS0xLTEzMDky_575767e7-b954-4c8f-a9ab-6de53a9e3763">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTUtMS0xLTEzMTA1_a7ec00fe-2546-44e5-9b6c-e9c0ed63abd7">16,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231" decimals="INF" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTctMS0xLTEzMTI3_2a2a829f-3bc2-42af-8484-189e17e0043d">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68756a4786524fe5b9fabbe3f97257d2_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTktMS0xLTEzMTQ5_180b177f-04ea-4d63-aa74-e17a0400c138">17,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i68756a4786524fe5b9fabbe3f97257d2_D20180101-20181231" decimals="INF" name="moh:HealthCareOrganizationRevenuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTExLTEtMS0xMzE3MQ_3427ad81-1aeb-4758-8cb9-8ff6dbe39db6">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">&#8220;Other&#8221; includes the Idaho, Mississippi, New Mexico, New York, Puerto Rico, South Carolina, Utah and Wisconsin health plans, which were immaterial to our consolidated results of operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNzY2_41809de4-6421-4b08-b822-7993ee69b626" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was subsequently modified by several ASUs issued in 2018 and 2019. We adopted Topic 326 effective January 1, 2020, using the modified retrospective approach. Under this method we recognized the cumulative effect of adopting the standard as an adjustment to the opening balance of retained earnings on January 1, 2020, which was immaterial.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by a change in the reference rate from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) or another reference rate expected to be discontinued, if certain conditions are met. ASU 2020-04 is effective immediately and expires after December 31, 2022. We are evaluating the effect of reference rate reform and this guidance on our contracts and other transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (&#8220;SEC&#8221;) did not have, nor does management expect such pronouncements to have, a significant impact on our present or future consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 64</span></div></div></div><div id="if790247689124308855d86d82384a359_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">3. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90ZXh0cmVnaW9uOjlhNDJmM2MzZjYwNTQ0YThhYzJhNmVhOTNmMDdkYTRiXzcxNg_bfb440bb-003b-410f-9636-8494991196be" continuedAt="iac16d69e602d40e0b9239edcfc9fd3d1" escape="true">Net Income Per Share </ix:nonNumeric></span></div><ix:continuation id="iac16d69e602d40e0b9239edcfc9fd3d1" continuedAt="i978d736d2bd84a1ca2888281fb7cf260"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90ZXh0cmVnaW9uOjlhNDJmM2MzZjYwNTQ0YThhYzJhNmVhOTNmMDdkYTRiXzcyMQ_412fb800-deeb-4207-ac32-564c11ab84e3" continuedAt="ibdef2b0c0226433dad7b46ed8e72ef94" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net income per share:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except net income per share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzQtMS0xLTEtMA_32e62495-36d3-4bf8-a599-bfb527231c78">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzQtMy0xLTEtMA_95db9dd5-9036-4972-bade-f71a31209013">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzQtNS0xLTEtMA_dc168577-d27d-416a-ad06-b8ae58ceb2b8">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzYtMS0xLTEtMA_ea08436e-72aa-445c-acc2-c4c71ed4c95e">61.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzYtMy0xLTEtMA_b9f831e1-3154-40d7-af96-5b7fb23f2283">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5276df7533a434dba724ca46fb6260b_I20171231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzYtNS0xLTEtMA_46dea3ad-dd41-466f-ae1e-329c6c6417f9">59.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average number of shares issued:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtMS0xLTEtMTgwNA_1301d29b-cc03-4b5f-979e-129bde6dcd09">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtMy0xLTEtMTgwNA_433c9b01-cba7-43aa-96d2-cdc7ea1bd057">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtNS0xLTEtMTgwNA_d0497aeb-2015-4f88-b9c2-bddb21dc404b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-5" name="moh:WeightedAverageNumberofSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktMS0xLTEtMjIzNw_a7aba26a-efe7-4d78-98ed-780ba480f858">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-5" name="moh:WeightedAverageNumberofSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktMy0xLTEtMjIzNw_59e560ef-0a9d-45c3-a4e0-fee2937edf7c">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-5" name="moh:WeightedAverageNumberofSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktNS0xLTEtMjIzNw_c876fb44-0a6a-4bb1-8e3f-af052df4bfe4">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exchange of convertible senior notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtMS0xLTEtMA_880394f8-04be-43f8-8fa0-d14d408014fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtMy0xLTEtMA_d841fc5a-81d8-4afc-93c0-99deb1a97c38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtNS0xLTEtMA_db0dc7fb-6614-483e-b99a-c2baa7699623">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion of convertible senior notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="moh:WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktMS0xLTEtMA_733c3b00-5ba4-4a22-8ec3-f295e0819428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="moh:WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktMy0xLTEtMA_a82c4587-5b6b-4d7d-95d8-48a9e0c47b4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-5" name="moh:WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktNS0xLTEtMA_dbd96c4e-ef52-4bbd-ae28-d728628fb534">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator for basic net income per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzExLTEtMS0xLTA_a1f6f74b-5797-4c5a-9d29-dbb3adff60ed">59.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzExLTMtMS0xLTA_128d4666-23e6-459c-b574-65a6cfad61e0">62.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzExLTUtMS0xLTA_238eab48-9357-4917-83e8-3c8fe3dc198d">61.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTEtMS0xLTIyNDU_7262b775-6263-4563-a3d0-d7059716fe27">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTMtMS0xLTIyNDU_e297c61a-5d0e-4bfe-af38-b5e0767da2f6">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTUtMS0xLTIyNDU_8ea36ee5-876e-4ffc-83bf-82fce6240408">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzEzLTEtMS0xLTA_5997f4c8-d046-43cf-87cf-142c01f587b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzEzLTMtMS0xLTA_daee69e1-ca07-4f0a-98ce-ff026a524b56">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzEzLTUtMS0xLTA_f773d0c7-305e-45b0-8f46-33d802d647db">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible senior notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTEtMS0xLTA_7e0df86a-ce49-40e1-bbe4-2ec0bca00fa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTMtMS0xLTA_f395140e-f2de-4f94-b820-cd14bdfa92a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTUtMS0xLTA_ada2a592-8799-4723-80dd-806b3ea3275e">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator for diluted net income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE2LTEtMS0xLTA_76f436ad-9806-4ac2-85a9-c8845c263556">59.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE2LTMtMS0xLTA_a8f99fd2-4343-4101-a0dd-c16785675cd6">64.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE2LTUtMS0xLTA_099d239a-9f61-4925-be1b-21ba85d8223c">66.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per share - Basic </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE5LTEtMS0xLTA_8d610cf1-c1c7-47c3-921e-39662a2d4497">11.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE5LTMtMS0xLTA_b6a72f24-5249-48b0-b5cf-f89252ae056f">11.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE5LTUtMS0xLTA_219d3721-c4d4-4b5b-a8aa-a8e484e6bcdd">11.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per share - Diluted </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzIwLTEtMS0xLTA_2539d682-eded-4b97-8b1d-8e41a43d2434">11.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzIwLTMtMS0xLTA_ca0f4dd6-0198-4ec0-a27c-9cd566090fac">11.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzIwLTUtMS0xLTA_92938ae1-2947-4ee9-94bc-8d5629b5ba6e">10.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">&#8220;Convertible senior notes&#8221; in this table refer to the <ix:nonFraction unitRef="number" contextRef="i2fe995e49c0b4274a5ede86b839b44d2_I20201231" decimals="INF" name="moh:ClassOfWarrantOrRightStatedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90ZXh0cmVnaW9uOjlhNDJmM2MzZjYwNTQ0YThhYzJhNmVhOTNmMDdkYTRiXzIwMA_433c8bb7-c3b8-46ba-a781-c7dd40e20974">1.625</ix:nonFraction>% convertible senior notes due 2044 that were settled in 2018.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">For more information regarding the warrants, including partial termination transactions, refer to Note 13, &#8220;Stockholders' Equity.&#8221; The dilutive effect of all potentially dilutive common shares is calculated using the treasury stock method. Certain potentially dilutive common shares issuable are not included in the computation of diluted net income per share because to do so would have been anti-dilutive.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i978d736d2bd84a1ca2888281fb7cf260" continuedAt="ib5eb85022eeb41d7b8ed0547eec72b13"><ix:continuation id="ibdef2b0c0226433dad7b46ed8e72ef94" continuedAt="ifcd5b3c4dc554b9295c1d6bd28f9ac22">(3)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"><ix:continuation id="ib5eb85022eeb41d7b8ed0547eec72b13"><ix:continuation id="ifcd5b3c4dc554b9295c1d6bd28f9ac22">Source data for calculations in thousands.</ix:continuation></ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_160"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">4. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzExNTQ0ODcyMTEzMTAz_f65abe79-90e1-4da7-82ed-1d0532a62b80" continuedAt="if09b53157ad0412caaae7df5fad914b3" escape="true">Business Combinations </ix:nonNumeric></span></div><ix:continuation id="if09b53157ad0412caaae7df5fad914b3" continuedAt="i5aa82b45035c4d3caed5597ca5ff8552"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the last half of 2020, we closed on <ix:nonFraction unitRef="business_combination" contextRef="if30ced8758e642af8985042651d6cdb1_D20200701-20201231" decimals="INF" format="ixt-sec:numwordsen" name="moh:BusinessCombinationNumberOfBusinessCombinations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2MzY1OTE_3ebb1ef6-cfb4-483e-ae33-6d6c68ee2b2d">three</ix:nonFraction> business combinations in the Health Plans segment, consistent with our strategy to grow in our existing markets and expand into new markets. For these transactions, we applied the acquisition method of accounting, where the total purchase price was allocated, or preliminarily allocated, to the tangible and intangible assets acquired and liabilities assumed, based on their fair values as of the acquisition dates. We expect to complete the final determination of the purchase price allocations as soon as practicable, but no later than one year following the acquisitions&#8217; closing dates in accordance with Accounting Standards Codification Topic 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Measurement period adjustments will be recorded in the period in which they are determined, as if they had been completed at the acquisition date.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition costs amounted to $<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AcquisitionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2Nzg4MzI_f9ef490a-93a5-4ef6-89da-8f13ccc4d069">16</ix:nonFraction>&#160;million in the aggregate for the year ended December 31, 2020, and were recorded as &#8220;General and administrative expenses&#8221; in the accompanying consolidated statements of income.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Magellan Complete Care. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, we closed on our acquisition of <ix:nonFraction unitRef="number" contextRef="idc8845b2df0142a6ad693b5b696a900f_I20201231" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODEwMzg_edee7e04-76a9-4d51-a685-4ee8811ada5c">100</ix:nonFraction>% of the outstanding equity interests of the Magellan Complete Care line of business of Magellan Health, Inc., for total purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="i41056d0891344bfeb906ddd9f525ea3d_D20201201-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzU3ODc_cc4ca022-6eb2-4bb3-a223-e5b451067cd6">1,037</ix:nonFraction>&#160;million. Total purchase consideration paid in cash amounted to $<ix:nonFraction unitRef="usd" contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODUwOTg_18c31a90-c5c4-47b6-8e3c-ccff04f6a12c">1,008</ix:nonFraction>&#160;million, which consisted of the base purchase price of $<ix:nonFraction unitRef="usd" contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODUxMTU_c53d8a26-201d-4745-8cbd-9aa7909168e3">850</ix:nonFraction>&#160;million, plus approximately $<ix:nonFraction unitRef="usd" contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODUxMzA_c61b01ae-18c5-4156-bf55-9707044675f0">158</ix:nonFraction>&#160;million in preliminary closing adjustments, primarily relating to excess regulatory capital. Total purchase consideration also included assumed liabilities of $<ix:nonFraction unitRef="usd" contextRef="idc8845b2df0142a6ad693b5b696a900f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODUxNDU_8b80bf83-20ab-40f0-b08b-a28e3417b7d3">29</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5aa82b45035c4d3caed5597ca5ff8552" continuedAt="i3b08f9b253fd454886d8c2a73ca2120b"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Magellan Complete Care is a managed care organization serving members in <ix:nonFraction unitRef="security" contextRef="idc8845b2df0142a6ad693b5b696a900f_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzU0OTc1NTgxOTI5MzA_d89b3809-0f4d-42d5-9034-ea7143ec2a76">six</ix:nonFraction> states, including Medicaid members in Arizona and statewide in Virginia, and integrated acute care members in Florida. Through its Senior Whole Health branded plans, Magellan Complete Care provides fully integrated plans for Medicaid and Medicare dual beneficiaries in Massachusetts, as well as managed long-term care in New York. As of December 31, 2020, Magellan Complete Care served approximately <ix:nonFraction unitRef="member" contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231" decimals="-5" format="ixt:numdotdecimal" name="moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODU3Mzg_6ffab041-c1f2-4e28-8af2-b6cc62677e7b">200,000</ix:nonFraction> members in its managed care plans. Magellan Complete Care also provides consultative services to participants who self-direct their care through Wisconsin&#8217;s long-term services and supports (&#8220;LTSS&#8221;) program. For the year ended December 31, 2020, Magellan Complete Care&#8217;s total 2020 revenue was approximately $<ix:nonFraction unitRef="usd" contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODU3MDg_cca682fc-f53e-4ea9-a867-609b28013e8b">2.9</ix:nonFraction>&#160;billion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because this acquisition closed on December 31, 2020, Magellan Complete Care&#8217;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020. If we had acquired Magellan Complete Care on January 1, 2019, our total revenue and earnings for the year ended December 31, 2019, would have been approximately $<ix:nonFraction unitRef="usd" contextRef="i5c05b89a6f0144e3b67780794556b45d_D20190101-20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODI0MDY_492f3c81-adc3-4210-9cfe-05dbb0f88a68">19.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i5c05b89a6f0144e3b67780794556b45d_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzExNTQ0ODcyMTQyNDY4_476e2f4d-6aa3-462e-a161-2f60d2e0622b">772</ix:nonFraction> million, respectively, and our total revenue and earnings for the year ended December 31, 2020, would have been approximately $<ix:nonFraction unitRef="usd" contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTQwMDc4NDY_dd4d2350-e86b-4f9f-9475-c493873b9787">22.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTQwMDc4NTQ_68e38705-c1e4-42e6-8786-7f4c1e65802a">833</ix:nonFraction> million, respectively. These amounts were computed after adjusting the results of Magellan Complete Care to reflect the additional amortization that would have been charged assuming the fair value adjustments to intangible assets and liabilities had been applied beginning on January 1, 2019, together with the consequential tax effects. The pro forma results do not reflect any anticipated synergies, efficiencies, or other cost savings of the acquisition. Accordingly, the unaudited pro forma financial information is not indicative of the results if the acquisition had been completed on January 1, 2020, or January 1, 2019, and is not a projection of future results. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of the assets acquired, and liabilities assumed has not yet been finalized because the acquisition closed on December 31, 2020. As a result, provisional estimates have been recorded and are subject to change, primarily for accounts that include the use of estimates, such as medical claims and benefits payable, receivables, amounts due government agencies, certain acquired intangible assets, and certain tax assets and liabilities. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Such assets include synergies we expect to achieve, such as the use of our existing infrastructure to support the added membership, and future economic benefits arising from the assembled workforce. Approximately <ix:nonFraction unitRef="number" contextRef="id47bfbaa31f34e6cbbc46b397397ad22_D20201201-20201231" decimals="2" name="moh:BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzExNTQ0ODcyMTQyNDg2_4ffa3b47-a1b8-4347-b31c-3f2f9e639731">27</ix:nonFraction>% of the goodwill is deductible for income tax purposes. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEyMDk0NjI3OTI3MDE2_015ea89a-4a9a-490c-b262-a9ebc471aff4" continuedAt="i8b820e2e53504ac7b4fbb8119c88cdf9" escape="true">The following table summarizes the provisional fair values assigned to assets acquired and liabilities assumed.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i8b820e2e53504ac7b4fbb8119c88cdf9"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzMtMS0xLTEtODk4Nw_09e0d11f-0548-4b0a-96d7-eef3f1c25620">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzQtMS0xLTEtODk4Nw_46e171f5-e73a-4b20-9a82-145c82c66910">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzUtMS0xLTEtODk4Nw_1a7c1494-8f5d-4530-89d9-20a470fdc83b">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzYtMS0xLTEtODk4Nw_521c0d9e-3fe6-424d-b5bb-389196570f1f">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzctMS0xLTEtODk4Nw_973ba756-6341-49a4-b254-d66e8be2f0b3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzgtMS0xLTEtODk4Nw_5efc1d70-59ad-42a2-86c9-7465f6cd693b">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzktMS0xLTEtNDYyNQ_2c055c09-c110-43aa-8fac-7f05656c8959">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzEwLTEtMS0xLTEzMzEz_b6030b04-32df-45ed-947a-a412b999af3f">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzEwLTEtMS0xLTg5ODc_1398d60e-60ca-42c2-9100-77aa3832ad23">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities assumed: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzEyLTEtMS0xLTg5ODc_c3ae75ba-4ff1-4372-b0b9-99e4c9f9a374">294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzEzLTEtMS0xLTg5ODc_ab647fdd-5fc3-4644-a519-a413568745f2">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued and other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzE0LTEtMS0xLTg5ODc_72a88c43-814b-40c2-817c-3ea25376200d">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzE2LTEtMS0xLTIwOTQz_a167e606-8999-41b0-bee0-97f120056c2e">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net purchase price paid</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzE1LTEtMS0xLTg5ODc_d9da44d8-c394-428b-bf36-d7fbe03a8fca">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kentucky. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2020, we closed on the acquisition of certain assets of Passport Health Plan, Inc., a Medicaid health plan. Effective on that same date, the Kentucky Medicaid agency approved the novation of Passport&#8217;s Medicaid contract to Molina Healthcare of Kentucky, Inc., thereby ensuring continuity of care for Passport&#8217;s Medicaid members. As of December 31, 2020, our Kentucky health plan had <ix:nonFraction unitRef="member" contextRef="i4d9ad5f0f8564470964511585ae558dc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzY1OTcwNjk4MjA4ODI_c208a163-1a4c-4f83-843f-9f7af1cb6207">337,000</ix:nonFraction> Medicaid </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3b08f9b253fd454886d8c2a73ca2120b"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">members. The total purchase price was $<ix:nonFraction unitRef="usd" contextRef="idbd3989bdd36411bb81f15405becbc0a_D20200901-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2NTQ3OTg_20e84f72-60fe-4ef5-93e6-f93b63e6d23c">66</ix:nonFraction> million, which included our initial cash payment of $<ix:nonFraction unitRef="usd" contextRef="idbd3989bdd36411bb81f15405becbc0a_D20200901-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5Njk4OTY_4db03b6f-afab-4eb9-8451-91c679c772d0">20</ix:nonFraction> million in September 2020, plus $<ix:nonFraction unitRef="usd" contextRef="ib80e56cc81004ffb9a966b132d1c37ce_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2Nzg3NDI_6160bbff-bb67-49f9-bed5-2529b31e2de4">46</ix:nonFraction>&#160;million in contingent consideration payable to the seller. See further information regarding contingent consideration in Note 5, &#8220;Fair Value Measurements.&#8221; We recorded goodwill of $<ix:nonFraction unitRef="usd" contextRef="i55464af26be84fb3820ca5c44e160c32_I20200901" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzA3ODI_b406f958-c2fc-46af-bd9f-d37202386b58">30</ix:nonFraction> million, all of which is deductible for income tax purposes. The goodwill recorded relates to future economic benefits arising from the assembled workforce, and the future growth associated with the member contract rights that are incremental to the contract rights identified.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2020, we closed on the acquisition of certain assets of YourCare Health Plan, Inc., a Medicaid health plan operating in certain regions of New York, for a cash purchase price of $<ix:nonFraction unitRef="usd" contextRef="i72b43b1a1b4b4f1082ad9d20416d588c_D20200701-20200701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzE5NDU_61848025-c393-4039-b5d0-d4ff68b062e2">42</ix:nonFraction>&#160;million. As a result of this transaction, we added approximately <ix:nonFraction unitRef="member" contextRef="i5c8feb8bc88a45bab6f5586d910050f1_I20200701" decimals="-3" format="ixt:numdotdecimal" name="moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzIwMTE_844c6548-3708-487a-aac8-e02cf1923820">47,000</ix:nonFraction> Medicaid members in New York. We recorded goodwill of $<ix:nonFraction unitRef="usd" contextRef="i5c8feb8bc88a45bab6f5586d910050f1_I20200701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzIwNzA_aabaf68d-021c-4854-8329-588708a1cb22">31</ix:nonFraction> million, substantially all of which is deductible for income tax purposes. The goodwill recorded relates to future economic benefits arising from expected synergies to be achieved, including the use of our existing infrastructure to support the added membership.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets Acquired</span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEyMDk0NjI3OTI3MDE1_c6134a92-0cda-4b6d-a2de-d09257433eae" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents intangible assets acquired, by major class, for the <ix:nonFraction unitRef="business_combination" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="moh:BusinessCombinationNumberOfBusinessCombinations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzQ3MDI_246f7d10-0928-4be5-bba2-676e3480c457">three</ix:nonFraction> acquisitions. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Life</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract rights - member list</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ac1df93bc0c4894960ea1adb84e0024_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtMS0xLTEtNDU3Ng_f0f15940-6b01-45d2-b1df-dcf0552cdf41">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i20850a7f15e24400b1b3bf58d9e096d9_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtMy0xLTEtODk4Mw_b8343f06-c933-45b3-b433-a8f887d99a7d">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibb7db7e5903548c1b07be8df527ac95f_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtNS0xLTEtNDU3Ng_841231bd-2a82-4d05-9ded-b7382fd5d314">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if958004bf9004127b3dfe774c1c93182_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzMtNy0xLTEtMTA5MjU_fe1f6fca-95d7-4ae9-8877-ab255ad3e51f">5.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provider network</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i733eec69c1db4095a58047c500e1ec76_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtMS0xLTEtMjAyMTk_7e0e0029-b098-49c4-bff7-83821863609e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7f80aa6d34e346a1a3b5dbdaeab0b9a9_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtNS0xLTEtMjAyMTk_9aa8f490-5965-4d0c-9b5f-2422b1bdc745">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7f80aa6d34e346a1a3b5dbdaeab0b9a9_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtNy0xLTEtMjAyMTk_77ee3d6a-075d-40ff-9591-a2fab32223c9">10.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6531b793e0c64805a9f24b4ce452eb0d_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzUtMS0xLTEtNDU3Ng_14cea807-3436-4bc6-b2e3-2c5f077570ef">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idc5130895c0f47929310c0ab60eb616a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzUtMy0xLTEtMjA5NDc_eb73a018-b96e-46c0-b85a-7430cc863994">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iebc139137e204e638a9cb2d71ee5dea9_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzUtNS0xLTEtNDU3Ng_7365a9d2-7e30-4a7b-bd41-176550c26553">16</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0a7800a872f64f3fb068791db99f8252_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtNy0xLTEtMTMzMDk_c29bb582-4c0f-4124-9d55-6f59dbd68489">15.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzctMS0xLTEtNDU3Ng_92769fc7-6585-42bb-bc7f-7e9790f82013">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzYtNy0xLTEtMTA5MDY_5473622b-65f1-4286-a5f3-9e963c1c300a">6.5</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_163"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">5. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzMzOTU_ee68f9da-f78b-4312-95b2-7ecb908c2250" continuedAt="i86a87d982fc444cb88c73fce04b1862e" escape="true"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzU0OTc1NTgxNTMzNTg_c715db25-0f42-46be-810b-ddb3e00f769a" continuedAt="idabea71d7f4443418cd0af8f63e8c8e9" escape="true">Fair Value Measurements </ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i86a87d982fc444cb88c73fce04b1862e" continuedAt="i456c60debcb44e4ab341473587048aa7"><ix:continuation id="idabea71d7f4443418cd0af8f63e8c8e9"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of current assets and current liabilities to approximate their fair values because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For our financial instruments measured at fair value on a recurring basis, we prioritize the inputs used in measuring fair value according to a three-tier fair value hierarchy as follows:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1 &#8212; Observable Inputs.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 financial instruments are actively traded and therefore the fair value for these securities is based on quoted market prices for identical securities in active markets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2 &#8212; Directly or Indirectly Observable Inputs. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value for these investments is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3 &#8212; Unobservable Inputs. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 financial instruments are valued using unobservable inputs that represent management&#8217;s best estimate of what market participants would use in pricing the financial instrument at the measurement date. As of December 31, 2020, our Level 3 financial instruments consisted of contingent consideration liabilities. As of December 31, 2019, our Level 3 financial instruments consisted of derivative financial instruments.</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net changes in fair value of Level 3 financial instruments are reported in &#8220;Other&#8221; operating expenses in our consolidated statements of income. In the year ended December 31, 2020, we recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzYwNDczMTM5NjY4NDM_315e21ae-d950-4389-8faf-4c4554dbc92a">6</ix:nonFraction>&#160;million, primarily for the increase in the fair value of the contingent consideration liability described below, because the opening 2021 enrollment for our Kentucky health plan was higher than our estimate as of September 30, 2020. In the year ended December 31, 2019, the net changes in fair value of Level 3 financial instruments were insignificant to our results of operations.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i456c60debcb44e4ab341473587048aa7" continuedAt="ib8cd765b9ec44ee3a837dccc0f3d02e2"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzMzODE_bd004bea-914e-4058-a75e-96902e0cf8bc" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments measured at fair value on a recurring basis at December&#160;31, 2020, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzItMS0xLTEtMA_d5052fc6-d239-4ba9-8ac6-8fab4cc023d0">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1537007f8b454c3b99a90841baabc2fe_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzItMy0xLTEtMA_f75a3185-0e36-4bde-91a9-cc144c5b6ba9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7b354db3f541ca96ec5db2b700dd49_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzItNS0xLTEtMA_c51a5d25-3f3a-4dab-99d7-dba93fe84d68">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i620ff45e952445d1ac715d4144df7597_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzItNy0xLTEtMA_b49e6a0f-a659-48d0-b6da-64a7b708626a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f297a74be174b0cb53664e81273fc7b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzMtMS0xLTEtMA_08acf477-318b-4703-ba07-05e4e70d05aa">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db9d935bc9944d79fac14b03b028e17_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzMtMy0xLTEtMA_42ba4fe9-2d3c-461b-bfd7-e14240445361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b1296e99cd47e4bf03290b7a26a478_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzMtNS0xLTEtMA_3f4e6ac3-3523-492a-9c08-b6b0bf23e154">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70e312008164e878e7157499eee87d7_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzMtNy0xLTEtMA_7ecbc7b4-67bf-4a08-96d5-7f486b8e3b60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if330308388ae40ac9a6862c3c5bacd95_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzQtMS0xLTEtMA_301a6990-aeb6-41e0-96fa-d910c522d958">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5ade1a543bf4bed873e58b761ad56ff_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzQtMy0xLTEtMA_b510d2f4-128e-4a1c-aed8-c796fb612e3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff7c00132f94480c9854cfa010a9b0ab_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzQtNS0xLTEtMA_9d490e09-639b-4907-b39f-6aa582b76f71">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75ace7c20ffa424295b84956415a9b16_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzQtNy0xLTEtMA_13261e8f-f0b5-4afc-8ec2-0e43005ecbbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3150f158849b7981e3f9bd3362f4e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzUtMS0xLTEtMA_9d88bcdd-7350-4c7a-9a9a-888a7203f48d">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12998aefc9ee4f1faa798f4661c61421_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzUtMy0xLTEtMA_a2e2f97e-c4cb-4bea-8a66-2284ccd8248d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f2e1498903647dfb8ed82f5dfb635f4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzUtNS0xLTEtMA_ee3c0753-8cbe-48c4-8e8d-da27b4331122">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df2d07f1c4f49239d8e7fce08146428_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzUtNy0xLTEtMA_07e7def0-4c18-4dc9-9c2a-0c50a30ea114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1248d546adf44c31b8e4c83bc5671814_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzctMS0xLTEtMA_da5c5e5c-5cd4-44d7-b1a2-884fd7e775c0">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00ecaf4e4c7420280c26ee32500e9c4_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzctMy0xLTEtMA_2577cfee-24d6-421f-8faf-e14e05dc3810">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4965915628104e2ab8fff975a58ce821_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzctNS0xLTEtMA_9e2b4fc5-199d-468a-b3e1-f4f021a55480">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddc3e419bf45401eb1c8ee9d956b9590_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzctNy0xLTEtMA_109a4d07-6aeb-49f3-95f3-198361485481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEwLTEtMS0xLTA_4cf41006-ee29-4872-bfb6-b296f1726fdc">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed4091dd7014489aae0cf9acc2daec5_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEwLTMtMS0xLTA_6ba92430-20b8-469d-8cde-12b1b63d6aca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410a5c9397b240a48b11ed2e55a3ca0f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEwLTUtMS0xLTA_7d4052a3-3a9a-4020-bab3-c80ffade6189">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b5f410a090c46058072e3908f0200f2_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEwLTctMS0xLTA_7ce828a0-a2b7-4f24-8ebe-5cfd5f1f2ffb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEyLTEtMS0xLTE4MjA_f6f05b1a-72d9-4ed6-b0d4-96ba673a43fd">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed4091dd7014489aae0cf9acc2daec5_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEyLTMtMS0xLTE4MjA_b0b74294-c60d-4f54-bbc1-cae15a14f12d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410a5c9397b240a48b11ed2e55a3ca0f_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEyLTUtMS0xLTE4MjA_c730c3ab-c3ce-41f7-9b08-ac3891b629fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b5f410a090c46058072e3908f0200f2_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEyLTctMS0xLTE4MjA_3d071f0f-048f-435a-9a9c-7237fdd09e16">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEzLTEtMS0xLTE4MjA_12759190-1ac0-4f57-893d-32ee916c13bd">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed4091dd7014489aae0cf9acc2daec5_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEzLTMtMS0xLTE4MjA_da5a2abf-f7bc-49e6-8076-8725141cded1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410a5c9397b240a48b11ed2e55a3ca0f_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEzLTUtMS0xLTE4MjA_c369cd65-43a7-474a-a460-e2ad770d4958">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b5f410a090c46058072e3908f0200f2_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEzLTctMS0xLTE4MjA_99f19b02-9139-43ad-a451-062bc4e8397b">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments measured at fair value on a recurring basis at December&#160;31, 2019, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzItMS0xLTEtMA_d3b3b930-53de-450d-871c-b5cd72e461e5">1,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i323373c939a744309b13b44c10d4e64f_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzItMy0xLTEtMA_899c8a77-257f-4622-b23b-8b3b8585dae0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2807d22440ef4fcf924a3e296c024baa_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzItNS0xLTEtMA_e2130309-b1b7-4900-9b21-1fdce4d12dcc">1,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29d022afd4104a10b3d38dc48db285a3_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzItNy0xLTEtMA_22434246-ce73-42bd-8da4-e69455dc788d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ad2854387a044388a14a10a50f7d60a_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzMtMS0xLTEtMA_3e58b801-aa27-40fa-bbb9-d9e5afa9fd89">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28bc7ef03bb44205a24ac42c766d0ec2_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzMtMy0xLTEtMA_3cb0c019-3036-4071-9510-7d5e531bd836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4f73d258de45c09c5dc40f3889ded5_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzMtNS0xLTEtMA_c0969d7d-0445-4c0d-b8dd-12b728215432">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3ea3a00aa745fa8d3fe8db9188348f_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzMtNy0xLTEtMA_083bed6d-10df-4f9b-9a3d-8b7213e7011c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3322a79f8149fe818ac4b37b7f1c22_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzQtMS0xLTEtMA_fe1ab15f-979b-42ca-9551-c295713d6338">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673e1f4e113146bfb5c486ae12b9ee45_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzQtMy0xLTEtMA_93b567a0-3f7a-4d6f-8d87-ceb9da418800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5d62a6819c41fa87480dace92027a3_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzQtNS0xLTEtMA_20503da5-72d9-47bb-93cf-b07c210ee467">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i675f941940f34275b7ad7964d3615d58_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzQtNy0xLTEtMA_627c6118-c527-407a-a88e-773019efe849">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4f690f2e3741049e287513d54671cc_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzUtMS0xLTEtMA_8baf1d75-c74e-4211-ab4c-d1e5b525f89e">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13016843f45e401db644115e95be6a87_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzUtMy0xLTEtMA_1530c416-9627-4fd9-9081-b9dd1596426c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88ac1c81d1544708baba1124ced26c15_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzUtNS0xLTEtMA_ee537691-1c3f-4c3e-bf7d-a81047dcdb4e">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f46b98577243ef93fe68df78a68dd0_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzUtNy0xLTEtMA_a3685efa-f7e6-439d-86be-1cfd4f71795c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1662ee2010e44146a4d125c47e8f6ba3_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzYtMS0xLTEtMA_3599e074-c75d-43ec-a245-214732fe4068">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89400aeee60c4b3f858de5d8bf088e81_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzYtMy0xLTEtMA_b340f810-a8af-4da1-834c-d99c6981c9c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d7f9a5342e4d09bca467416cea6034_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzYtNS0xLTEtMA_0927138b-e3c9-4d5b-a0cc-5810d6214b0a">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa18c08b497d4e83bd718272cfc7f575_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzYtNy0xLTEtMA_6df48381-991f-4a23-888b-35e4a8006b94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government-sponsored enterprise securities (&#8220;GSEs&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6471a4d8ab49424e8b4300ddd8991da5_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzctMS0xLTEtMA_aba60a4f-d568-4c28-bffc-542e0f563217">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7633ecb19354446b41403e6360d771a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzctMy0xLTEtMA_6fec1316-97f3-4340-8d1a-7ffb17093431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21e3e7333e904417952db8fcc93f2434_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzctNS0xLTEtMA_923e8b3a-8905-4eb6-a426-2b777dc15101">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie720443e514340f9bf863ab49f657949_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzctNy0xLTEtMA_9be0e12a-6cd4-457f-b4a7-186f64608009">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzgtMS0xLTEtMA_b606bbf3-60b2-40dc-b659-2153bf54301a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95da47a8ff274392a557100219edc18a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzgtMy0xLTEtMA_579c25d8-ae74-42a7-9a49-442fbfc4a18e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6935a499d294baea85bb268e45f2965_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzgtNS0xLTEtMA_0ee7c92e-224a-4de0-a2cb-79a85fb5efb7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia75c8c84b6ae4319bd2ad5f13d5930f5_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzgtNy0xLTEtMA_ef7ef24e-dcee-4b3c-8eb4-4a2386cbe851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7fe95986da143f49cb9ff1cd45fb414_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzktMS0xLTEtMA_8f4c3717-b278-4d86-ad04-0553cf5a1740">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2a2b0056a32471e8f7d05fa87adc1e2_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzktMy0xLTEtMA_ca98556e-f82f-41ee-b4af-bc67c20ef383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cc5c31e1ec457890186adff5d88ff6_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzktNS0xLTEtMA_e32ae96c-2421-4af7-bb13-25f5914e97bc">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e37ac84dde34f9a9f5a34dc6fbb3503_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzktNy0xLTEtMA_e7fec083-8648-4b64-a0a3-16eb75390b11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEwLTEtMS0xLTA_5529e98c-07b8-4cb8-ad21-4de302853106">1,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2dfcce27ab44c888f802f59df6a8678_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEwLTMtMS0xLTA_bea3a128-6306-427f-a332-933f9086ba2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebfad9e8de34bc282edd8a903fd15de_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEwLTUtMS0xLTA_cd0c5989-ed5c-4c86-ab1c-e497007a1850">1,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1b6888bbaf41ef9d90d37617270d74_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEwLTctMS0xLTA_01d6a898-8055-45e7-96ba-0e7fd5d28118">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call option derivative asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia041924286c54d5c9513011d94e51068_I20191231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzExLTEtMS0xLTA_e0bc6586-aeb3-43a4-b733-be313ff182d5">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f8e19fba6a41b68b87ceb41afcceb5_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzExLTMtMS0xLTA_ec19f103-d2e2-4d14-bdbc-05a940569b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06fa0c3851d7487d95bc374550545ed5_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzExLTUtMS0xLTA_809b0bd8-a678-45f0-8797-62ce73551048">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb8e220321748cea721890a15c24a39_I20191231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzExLTctMS0xLTA_c4b64aa6-2ccb-4eed-a136-51ae96a49644">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEyLTEtMS0xLTE4NTM_3d0395c5-92c3-4762-98a2-61064ce73367">1,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2dfcce27ab44c888f802f59df6a8678_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEyLTMtMS0xLTE4NTM_ab245df5-eb9e-4e48-bc2f-27f0a98f7792">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebfad9e8de34bc282edd8a903fd15de_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEyLTUtMS0xLTE4NTM_a2680a62-7429-4237-80b1-1377b2b39d51">1,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1b6888bbaf41ef9d90d37617270d74_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEyLTctMS0xLTE4NTM_57748179-03b2-44a1-ab7f-7bd5bc0363e0">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion option derivative liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i445acdb4c3684477acd4591ac4c9235f_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE0LTEtMS0xLTA_c13f6ef5-7c5b-409f-ab50-b6825c00d725">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93e298da77bc4141b95fdec3026f4403_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE0LTMtMS0xLTA_71a70db6-07d9-4ef8-ba7d-1102cc5977f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8db366cd71ed4aed8d17341c92a27bac_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE0LTUtMS0xLTA_fce64e6c-ce0d-4f62-b615-80460a711666">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0aad8ca2a944c285080bae467d9769_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE0LTctMS0xLTA_15060bdb-b56b-4f4c-bf98-160480d6b4dd">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE1LTEtMS0xLTE4NTM_33608073-5151-4798-aeb5-486c7e15e2bd">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2dfcce27ab44c888f802f59df6a8678_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE1LTMtMS0xLTE4NTM_5cf18661-8eae-480b-9892-954e86cdcd56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebfad9e8de34bc282edd8a903fd15de_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE1LTUtMS0xLTE4NTM_6b7509d5-a93f-47f7-9474-c765918df946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1b6888bbaf41ef9d90d37617270d74_I20191231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE1LTctMS0xLTE4NTM_8f5d2088-b524-4e6f-84f5-01ce79fab5a5">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Liabilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, our Level 3 financial instruments recorded at fair value on a recurring basis included contingent consideration liabilities of $<ix:nonFraction unitRef="usd" contextRef="i5b5f410a090c46058072e3908f0200f2_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzYwNDczMTM5NjQ2Mzk_3d071f0f-048f-435a-9a9c-7237fdd09e16">46</ix:nonFraction> million, in connection with the Kentucky acquisition described in Note 4, &#8220;Business Combinations.&#8221; As of December 31, 2020, the contingent consideration fair value was estimated primarily based on an amount we expect to pay the seller for members enrolled in our Kentucky health plan as of January 1, 2021, over a minimum threshold. Half this amount is payable later in 2021, with the remainder payable in early 2022, subject to review and agreement among us and the seller. The second half payment is contingent upon the outcome of certain legal challenges. The current portion is reported in &#8220;Accounts payable, accrued liabilities and other,&#8221; and the non-current portion is reported in &#8220;Other long-term liabilities,&#8221; in the accompanying consolidated balance sheets. Contingent consideration liabilities are remeasured to fair value each quarter until the contingencies are resolved with fair value adjustments, if any, recorded to operations.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib8cd765b9ec44ee3a837dccc0f3d02e2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivatives </span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzEyMDk0NjI3OTExMzM5_62fa2050-b32e-42a0-ba23-23a7f99e59ed" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair values and the presentation of our derivative financial instruments in the accompanying consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative asset:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call Option</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets: Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01750e761ae449108d5498ba2a542db0_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo5ZTY2N2IwMmM4ODI0OTE1OTQ4ZWMxYTc0MmMyZmI0Yi90YWJsZXJhbmdlOjllNjY3YjAyYzg4MjQ5MTU5NDhlYzFhNzQyYzJmYjRiXzQtMy0xLTEtMTMzMTc_be07a46f-a0bb-4fea-87bb-6f07271571d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169c45e71a6541939a44bc98b6a6744c_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo5ZTY2N2IwMmM4ODI0OTE1OTQ4ZWMxYTc0MmMyZmI0Yi90YWJsZXJhbmdlOjllNjY3YjAyYzg4MjQ5MTU5NDhlYzFhNzQyYzJmYjRiXzQtNS0xLTEtNzYzMg_c4dc715c-b7fd-4cfa-8fea-e11bebe9f407">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion Option</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities: Accounts payable, accrued liabilities and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac907d76e3e42f58ad857eb2576f9c8_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo5ZTY2N2IwMmM4ODI0OTE1OTQ4ZWMxYTc0MmMyZmI0Yi90YWJsZXJhbmdlOjllNjY3YjAyYzg4MjQ5MTU5NDhlYzFhNzQyYzJmYjRiXzYtMy0xLTEtMTMzMTk_80c49572-c41a-4c0c-990a-872f9fac5d9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee5e05e95b1a426bae4671defcf57905_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo5ZTY2N2IwMmM4ODI0OTE1OTQ4ZWMxYTc0MmMyZmI0Yi90YWJsZXJhbmdlOjllNjY3YjAyYzg4MjQ5MTU5NDhlYzFhNzQyYzJmYjRiXzYtNS0xLTEtNzYzMg_b4a646de-d343-4d38-ac3b-6956f7ce9629">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our derivative financial instruments did not qualify for hedge treatment. Gains and losses for our derivative financial instruments are presented individually in the accompanying consolidated statements of cash flows, &#8220;Supplemental cash flow information.&#8221; </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the year ended December 31, 2020, we received $<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzE2NDkyNjc0NDcxOTM_6e025ee7-7bd9-402c-ba4d-78fdc62b04f9">27</ix:nonFraction> million for the settlement of the call option derivative asset, and we paid $<ix:nonFraction unitRef="usd" contextRef="i01207b776cf34d6d9e20d09853472272_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzE2NDkyNjc0NDcyNjU_3844ca58-4052-41db-a79b-0f5a7b53aa54">39</ix:nonFraction> million to settle the outstanding $<ix:nonFraction unitRef="usd" contextRef="i7ae2b394952c4f1e8142cffc59c02e8f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzE2NDkyNjc0NDcyOTU_9d58a327-06a8-4463-b538-19db4f9b1af1">12</ix:nonFraction> million principal amount of the <ix:nonFraction unitRef="number" contextRef="i7ae2b394952c4f1e8142cffc59c02e8f_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzExNTQ0ODcyMTAwMDIy_077483fa-80dc-4f92-b2f1-410761ebd78d">1.125</ix:nonFraction>% Convertible Notes, and settle the related conversion option. For more information, refer to Notes 11, &#8220;Debt,&#8221; and 13 &#8220;Stockholders' Equity.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements &#8211; Disclosure Only</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and estimated fair values of our notes payable are classified as Level 2 financial instruments. Fair value for these securities is determined using a market approach based on quoted market prices for similar securities in active markets or quoted prices for identical securities in inactive markets. </span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzMzNzU_bf85a2a0-be45-49a1-bebc-cd54c90cfd8f" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzQtMC0xLTEtNTA4Ny90ZXh0cmVnaW9uOjY0YmRhNTAzNTkxNjQ5ZWQ5YTdjYWU5MmIyOTZjNzYyXzU0OTc1NTgxMzg5MDI_3b360b17-406a-4d98-9962-db0cd0ddc832">4.375</ix:nonFraction>% Notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eae161ddce94e7a9ff33f9b5d6e8751_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzQtMS0xLTEtMTg3NQ_b735dbc4-89cd-4958-b585-205685471372">789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i347dbbc9bc8f47e98ec6c35325f9f494_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzQtMy0xLTEtMTg3NQ_f313c917-2557-4150-996d-48c0eadd9dd0">843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f291c050ef34a17be70dc97c24d7607_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzQtNS0xLTEtNTA4Mg_c40581e2-7c2d-484d-b904-b91133c12216">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic488eae93102457d8235e5620bd84f27_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzQtNy0xLTEtNTA4Mg_2242b7c9-12aa-470f-9ebc-abc0d6ad670b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjE2NzM0ZTYxZDEzMDRjNWQ4MWFjZDViZWQ4YTAyODA3XzU0OTc1NTgxMzg5MDM_534078d7-ba28-4e8c-8a9b-39ce5b87ccda">5.375</ix:nonFraction>% Notes </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if330db6dda754503989d1aee6433ae6c_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzUtMS0xLTEtMA_e80bf18a-1d37-405d-9284-4610194cad32">697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c02998f42dd4ce08ba11f14f2a84902_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzUtMy0xLTEtMA_0a069371-c8bf-4cf3-a667-f1a4252c2461">742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib544842b96f248be91c9c250b5519403_I20191231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzUtNS0xLTEtMA_8b445dae-bb0a-4fc0-af22-9590eb7b2af6">696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e24a47d3dc649d78aba307fc1ad28a5_I20191231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzUtNy0xLTEtMA_8a609ba2-9d9e-44de-b1c7-2b214ec28f65">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMC0xLTEtNTA4OS90ZXh0cmVnaW9uOjJmMGUyYjNmOThlZDQ0YjY4NGU4NTA4YmNmZjI5YjMzXzU0OTc1NTgxMzg5MDI_55435b9b-c833-47df-80bb-ee345b578771">3.875</ix:nonFraction>% Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc3d20ccc074e70bfc86059723e9c9d_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMS0xLTEtMTg4MA_af418c52-63db-4153-8e9b-1612e7cad237">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3f70d3c50d8437b98e3dcf567cac5be_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMy0xLTEtMTg4MA_a05b226e-a501-4091-86b9-8d1e92bd9cf5">691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f180467919400fb5d1a49a30bb070c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtNS0xLTEtNTA4NQ_17dbb49b-1d81-4835-9796-f8b68062b671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia680941a7dcb4c90a8f6a94a3df241c5_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtNy0xLTEtNTA4NQ_3e72df29-6fe9-4fcd-b48d-567bb5c95eb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6897a665bfe944c0b1720f8066bd97ce_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMC0xLTEtMC90ZXh0cmVnaW9uOmZjNGVlNzcyOGQ1ODQ3ZTY4MTBjNmU2ODMxNjVjZTU0XzU0OTc1NTgxMzg5MDI_d7c503be-ad51-4b06-a4b7-d6ba9ba345c3">4.875</ix:nonFraction>% Notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb7000b50d34cc1ae6870b923bd53f9_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMS0xLTEtMA_94941775-179c-4619-bbe0-1e6d5a4a8a8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c00276ec6e247479e4d6b157f91a10c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMy0xLTEtMA_cd2f9982-42bd-48ef-83f5-cf746015f2fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea08d8a8150f424a91d5763de41e3ca2_I20191231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtNS0xLTEtMA_5afc33e4-348e-4296-9ccb-8337f281743e">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id811eeb6af45438199143b6905407f9f_I20191231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtNy0xLTEtMA_84baeb00-8f06-4955-81df-15da8cbcfd1a">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan Facility </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac8de3a5e55d44a38a5f28fe244aa185_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzctMS0xLTEtMA_db2d70af-834c-4f3d-803b-799b9fa4fdf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie144cacfc85e4897bf8661dd85794604_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzctMy0xLTEtMA_94f6ba6d-8a66-4a50-bbe2-b26944e12aed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83cfa0b110a145789605caf934c004c3_I20191231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzctNS0xLTEtMA_0fb37e88-de70-4dc3-9b67-eb4f1d49e688">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89aaa5cc1e6416d91ce575532477772_I20191231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzctNy0xLTEtMA_62421f46-f87f-4556-bd14-659a5e85ece3">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id63dd203dce74ef786b9059a9384be45_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzktMC0xLTEtNTA5MS90ZXh0cmVnaW9uOjVjNzgwYjMwOTQzODQ1ZjNiODM4OWJhNjhhYzdhMWUxXzU0OTc1NTgxMzg5MTk_d480031b-8cbd-4933-a0c0-77f168541f53">1.125</ix:nonFraction>% Convertible Notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6557af215244a238cc88c1fb4cb335f_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzgtMS0xLTEtMA_fab39fb8-158f-4251-a7a8-032e5cfaf0ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91288d1537ff4a1cad628bfe99f8ec61_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzgtMy0xLTEtMA_2b1eab62-ca9a-41f2-a285-f9fcf65af5b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6d8824de274a12aafb6c18f80be57d_I20191231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzgtNS0xLTEtMA_3b0f6488-e38d-46a2-a5e8-ac732bbf8787">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdcae3ccabb049d7a79f1464026d3c79_I20191231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzgtNy0xLTEtMA_75eb02d5-d678-4d43-a248-2e0f039cbffb">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e000c4aefc74c68842dcf99d6e91fa4_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzktMS0xLTEtMA_36004a54-9e7f-4590-829d-5eec7ec6ead6">2,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf635a3f8d840cab2a3e2097d60a7cd_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzktMy0xLTEtMA_e23f8858-3a99-4075-bfd6-6b642b3a704b">2,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b30ecc6f739406885acf51ceed648e0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzktNS0xLTEtMA_82c69020-74b7-43be-92c7-6b2cc3d8ee35">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ef1a869ebc488a81b5bae288c74176_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzktNy0xLTEtMA_78ef56ff-5333-41d4-8946-2ad22f81dd0d">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;For more information on debt repayments, refer to Note 11, &#8220;Debt.&#8221;</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 69</span></div></div></div><div id="if790247689124308855d86d82384a359_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">6. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90ZXh0cmVnaW9uOmYzY2VjNjU3OTk2OTQxNzU4NzE0NmVmNWNlMWZhMzYwXzI3NjI_15df2bdc-8f33-4b64-a5b6-ddfdad3a2207" continuedAt="i59eafa1ab92d43d9b8de3a43ab80b15b" escape="true">Investments </ix:nonNumeric></span></div><ix:continuation id="i59eafa1ab92d43d9b8de3a43ab80b15b" continuedAt="i2ba830c1d6c94fc1860d50125ccbe03a"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Available-for-Sale</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all of our investments classified as current assets to be available-for-sale. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90ZXh0cmVnaW9uOmYzY2VjNjU3OTk2OTQxNzU4NzE0NmVmNWNlMWZhMzYwXzI3Nzg_f95aac53-54a2-41fd-a8a6-45b6d5acd6cd" continuedAt="i51116bd81c984280a6184d04b4d1210f" escape="true">The following tables summarize our current investments as of the dates indicated:</ix:nonNumeric></span></div><ix:continuation id="i51116bd81c984280a6184d04b4d1210f"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzQtMS0xLTEtMA_e46705f6-02ad-44c4-9454-a5f99e43dadc">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzQtMy0xLTEtMA_5d400bcb-1060-4741-ae38-3e2b39dd176d">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzQtNS0xLTEtMA_1a36a424-c1ad-4570-be72-fd6f799ef619">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzQtNy0xLTEtMA_829a4b6f-eb84-4991-83e3-fda79de297c5">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzUtMS0xLTEtMA_8eaece6a-7b19-4803-b75b-17ccacafdd22">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzUtMy0xLTEtMA_092ded28-b71a-47f4-afc9-7e4ec35bdd27">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzUtNS0xLTEtMA_4dc95bd7-8b4c-4661-9091-c528e6c3685c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzUtNy0xLTEtMA_cf2cb43f-38e3-4251-805a-715bd39715fd">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if330308388ae40ac9a6862c3c5bacd95_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzYtMS0xLTEtMA_1fba3a85-16ea-4456-be87-26e524e3faf2">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if330308388ae40ac9a6862c3c5bacd95_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzYtMy0xLTEtMA_61be6213-4a69-422d-a8dc-bbb0be6c187d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if330308388ae40ac9a6862c3c5bacd95_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzYtNS0xLTEtMA_59a6066a-f0c2-43b4-8d6b-0d52e16b6b5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if330308388ae40ac9a6862c3c5bacd95_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzYtNy0xLTEtMA_f384f7bd-74f5-4501-9ec0-ff00a80f1bad">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3150f158849b7981e3f9bd3362f4e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzctMS0xLTEtMA_f0e643a1-eb0e-4304-a8e7-6559ce59f8e1">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3150f158849b7981e3f9bd3362f4e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzctMy0xLTEtMA_eb9868b3-0362-4352-8d6e-210bfbb11e22">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3150f158849b7981e3f9bd3362f4e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzctNS0xLTEtMA_498b80d7-54c1-4d74-aed4-562ea1de99ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c3150f158849b7981e3f9bd3362f4e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzctNy0xLTEtMA_47d05a62-ce9a-49b6-b876-47f2d74cc382">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1248d546adf44c31b8e4c83bc5671814_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzktMS0xLTEtMA_f2105370-a198-4bde-8690-83deb3f93516">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1248d546adf44c31b8e4c83bc5671814_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzktMy0xLTEtMA_3a7b5a4d-dcf9-48ec-b562-9f8ab1986333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1248d546adf44c31b8e4c83bc5671814_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzktNS0xLTEtMA_eebe6559-cd04-4683-82a4-b6656ae8fff2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1248d546adf44c31b8e4c83bc5671814_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzktNy0xLTEtMA_b1ec155a-3085-40f7-8982-3907f900784f">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzEyLTEtMS0xLTIyNzg_6b2b9750-0231-4263-a6d0-256725394d0f">1,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzEyLTMtMS0xLTIyNzg_da15f280-87fe-4eb6-9e14-c05cee1b5251">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzEyLTUtMS0xLTIyNzg_8f08277c-d0f4-4582-82c6-74d246a19d14">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzEyLTctMS0xLTIyNzg_de248fd3-9115-4ff3-ba35-6adf0fb579d2">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzQtMS0xLTEtMA_373af3a8-b5d0-4fa9-9885-01ac38a357ec">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzQtMy0xLTEtMA_72c44909-085a-49de-beba-92b2e72e0ab5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzQtNS0xLTEtMA_85a4fe1c-8fe5-46a8-9ce1-6d26506a7176">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzQtNy0xLTEtMA_8b42b0f8-d909-4ec3-a63a-db7f31f60954">1,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzUtMS0xLTEtMjI4NQ_b158c985-4d31-44f2-bb7f-f4a96dce01f1">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzUtMy0xLTEtMjI4NQ_e8770641-460e-416e-86ca-24cd60e296ed">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzUtNS0xLTEtMjI4NQ_041b8e61-984d-498b-bdf4-ec37b41cec7b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzUtNy0xLTEtMjI4NQ_6c2a39c6-3ccb-472d-9c66-2cb5703e3424">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3322a79f8149fe818ac4b37b7f1c22_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzYtMS0xLTEtMA_3bad8ba6-5774-4290-ac10-3cb1ccef851a">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3322a79f8149fe818ac4b37b7f1c22_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzYtMy0xLTEtMA_44139937-c37a-4c3c-8d14-0fadd3c53030">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3322a79f8149fe818ac4b37b7f1c22_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzYtNS0xLTEtMA_906f9423-fed8-4e39-8737-444d68bcbf67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3322a79f8149fe818ac4b37b7f1c22_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzYtNy0xLTEtMA_154d71ad-4d35-46dd-9561-430c9c0fc23b">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4f690f2e3741049e287513d54671cc_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzctMS0xLTEtMA_53eaa8ad-5d94-41df-815e-9a4e0893c34b">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4f690f2e3741049e287513d54671cc_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzctMy0xLTEtMA_d63feb7e-8066-4f81-b7fa-2714a1aa33b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4f690f2e3741049e287513d54671cc_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzctNS0xLTEtMA_7a60bc4f-3500-41b3-95b4-7d5c6b65e927">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4f690f2e3741049e287513d54671cc_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzctNy0xLTEtMA_5037a925-94f4-464a-8956-d923acad9505">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1662ee2010e44146a4d125c47e8f6ba3_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzgtMS0xLTEtMA_41be82ea-0308-462c-a901-c47eae2122d8">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1662ee2010e44146a4d125c47e8f6ba3_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzgtMy0xLTEtMA_664a3b25-0d4b-48c6-be14-dea8e47e5ea4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1662ee2010e44146a4d125c47e8f6ba3_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzgtNS0xLTEtMA_7a8ceaaa-4e73-4f84-9d8d-1d15d9d216dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1662ee2010e44146a4d125c47e8f6ba3_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzgtNy0xLTEtMA_0866f52e-22df-4803-8a17-ec6d171056ba">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GSEs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6471a4d8ab49424e8b4300ddd8991da5_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzktMS0xLTEtMA_75af4ca7-f015-4330-b741-f5c8694ea336">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6471a4d8ab49424e8b4300ddd8991da5_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzktMy0xLTEtMA_6044140e-db8c-40e9-9333-c05f851817dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6471a4d8ab49424e8b4300ddd8991da5_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzktNS0xLTEtMA_59dad7b6-5a2f-4532-9952-0c1fa4dae79e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6471a4d8ab49424e8b4300ddd8991da5_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzktNy0xLTEtMA_b86ee5a6-95cb-4343-86cd-760527522237">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEwLTEtMS0xLTA_a80a9a22-8493-4647-a955-8f7fd33eed8f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEwLTMtMS0xLTA_414e4121-ae6d-43ad-93f3-897d91c40b57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEwLTUtMS0xLTA_c843f7a8-68e2-4bc2-b9e1-b8cab5ad24b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEwLTctMS0xLTA_a73ea042-780f-4df4-932b-c2bb41d238c1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7fe95986da143f49cb9ff1cd45fb414_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzExLTEtMS0xLTA_b4c0baad-a38b-45f7-98d8-8049e6b0e12c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7fe95986da143f49cb9ff1cd45fb414_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzExLTMtMS0xLTA_a620dba2-60a8-4a0a-bc1a-39824a221ebc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7fe95986da143f49cb9ff1cd45fb414_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzExLTUtMS0xLTA_db550d08-3cbc-4b0e-affd-467f990c0601">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7fe95986da143f49cb9ff1cd45fb414_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzExLTctMS0xLTA_1e1a15eb-67f6-448e-a987-f07c91318387">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEyLTEtMS0xLTA_ca785132-8dcd-4476-bfe1-1417ecbf35d8">1,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEyLTMtMS0xLTA_e96b655e-bbfd-4567-be4b-1ba6f1634014">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEyLTUtMS0xLTA_d5434e97-48c2-40e8-8fb8-233f33d2238c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEyLTctMS0xLTA_fdf16e96-b07c-462f-a807-d926d7ae2c56">1,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90ZXh0cmVnaW9uOmYzY2VjNjU3OTk2OTQxNzU4NzE0NmVmNWNlMWZhMzYwXzI3NjA_98f42aec-2a98-4762-9cec-456d6ae83671" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of our current investments as of December&#160;31, 2020 are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzItMS0xLTEtMA_6c301e96-0018-4c53-a45f-12a0256a295f">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzItMy0xLTEtMA_bc3594eb-ae5d-4a44-b890-b239ab753e76">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzMtMS0xLTEtMA_b1fe011e-953f-458f-af37-35d0e2d1e85c">892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzMtMy0xLTEtMA_3acc2c38-b820-42de-ba2b-ad6bda80a2d2">926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzQtMS0xLTEtMA_170da89a-c9ec-4741-96e6-2bbe11ebbedc">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzQtMy0xLTEtMA_76adee10-21f8-4ac9-9a28-19aaa78d7abb">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzUtMS0xLTEtMA_6c04f5b1-3df9-45d0-b5af-743ef0555e3f">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzUtMy0xLTEtMA_17b62ece-7e42-4041-965d-f491e72c1a28">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzYtMS0xLTEtMA_3541c5bf-cc62-43bc-82d3-99629a01f812">1,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzYtMy0xLTEtMA_9e566cd5-e838-4dcf-88d2-d95a08bcb427">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross realized gains and losses from sales of available-for-sale securities are calculated under the specific identification method and are included in investment income. Gross realized investment gains amounted to $<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90ZXh0cmVnaW9uOmYzY2VjNjU3OTk2OTQxNzU4NzE0NmVmNWNlMWZhMzYwXzEwOTk1MTE2MzMyNzA_5cf7704e-e2e9-4101-9f27-44c00e29f2b0">6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90ZXh0cmVnaW9uOmYzY2VjNjU3OTk2OTQxNzU4NzE0NmVmNWNlMWZhMzYwXzUyMw_324c4586-3d30-44be-acbc-505272138eb5">13</ix:nonFraction> million in the years ended December&#160;31, 2020 and 2019, respectively. Gross realized investment losses were insignificant in the years ended December&#160;31, 2020 and 2019. Gross realized investment gains and losses for the year ended December 31, 2018 were insignificant. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that unrealized losses at December&#160;31, 2020 and 2019 primarily resulted from fluctuating interest rates, rather than a deterioration of the creditworthiness of the issuers. Therefore, we determined that an allowance for credit losses was not necessary. So long as we maintain the intent and ability to hold these securities to maturity, we are unlikely to experience losses. In the event that we dispose of these securities before maturity, we expect that realized losses, if any, will be insignificant.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 70</span></div></div></div><div id="if790247689124308855d86d82384a359_2291"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2ba830c1d6c94fc1860d50125ccbe03a" continuedAt="i0c5d7bfb0a5a4abc86e90319ca81b216"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGV4dHJlZ2lvbjozMDQ2ODNhMDgzNTg0MDNlYmRiZjdmY2Q4NGU2NDMxN18xMzE5NDEzOTUzMzU1OA_09ef5818-2dac-4e38-9fe3-ad5444783fae" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes those available-for-sale investments that have been in a continuous loss position for less than 12 months. No investments have been in a continuous loss position for 12 months or more as of December&#160;31, 2020, and 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In&#160;a&#160;Continuous&#160;Loss Position for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than&#160;12&#160;Months as of December 31, 2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In&#160;a&#160;Continuous&#160;Loss Position for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than&#160;12&#160;Months as of December 31, 2019</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Positions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTEtMS0xLTc1MTY_6cfee3c0-46a6-477b-b401-b536fda5e8e3">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTMtMS0xLTc1MTY_4dbf21c4-3fa5-4b47-bf2a-3da5487190bf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTUtMS0xLTc1MTY_dee39589-581c-41f5-9fee-800577f77537">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTctMS0xLTc1MTY_421f1963-38d9-45ff-8b81-b726c373acb2">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTktMS0xLTc1MTY_c3e589e1-469f-4b62-8ebf-b0b1799298cd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTExLTEtMS03NTE2_bfe0b512-5e45-4c0e-a040-3ea3d3573eea">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTEtMS0xLTc1MTY_e322df21-ac0c-4a8b-8891-99157459446e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTMtMS0xLTc1MTY_1adc1379-af81-4c6a-b365-3d67e38b4b0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTUtMS0xLTc1MTY_c9646e8c-a8e7-4848-8bd5-e5862cc96914">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTctMS0xLTc1MTY_8ba4dffa-af49-4a91-827d-fbbd9b5a2290">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTktMS0xLTc1MTY_a21c78b3-0672-4610-bbc1-df876ea72239">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTExLTEtMS03NTE2_9346e569-e455-4e23-b3f9-0cb89899f01e">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS0xLTEtMS03NTE2_c6e566c7-0159-4a1a-bef3-d4323fc140b6">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS0zLTEtMS03NTE2_56f862d3-7827-4c59-ad01-a595fb10005f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS01LTEtMS03NTE2_938afaba-d374-47bf-b72e-424c84d41c90">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS03LTEtMS03NTE2_1fd0e922-f7e8-4f56-801a-b7baed5c64b2">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS05LTEtMS03NTE2_99cf69ce-0856-4154-831d-c28eb8755e6a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS0xMS0xLTEtNzUxNg_752d799a-1c4d-4b2b-814f-c6abdd8645de">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="if790247689124308855d86d82384a359_2298"></div><ix:continuation id="i0c5d7bfb0a5a4abc86e90319ca81b216"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Held-to-Maturity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the regulations governing our Health Plans segment</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsidiaries, we maintain statutory deposits and deposits required by government authorities primarily in cash, cash equivalents, and U.S. Treasury securities. We also maintain restricted investments as protection against the insolvency of certain capitated providers. The use of these funds is limited as required by regulation in the various states in which we operate, or as needed in the event of insolvency of capitated providers. Therefore, such investments are reported as &#8220;Restricted investments&#8221; in the accompanying consolidated balance sheets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the ability to hold these restricted investments until maturity, and as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. Our held-to-maturity restricted investments are carried at amortized cost, which approximates fair value, of which $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGV4dHJlZ2lvbjo1OTAzZGQ2OTg0N2Y0NzY0OGFiNmJkZmIyYzM5NGFlNl8xMDk5NTExNjI4OTYx_9d2c2239-21ea-4972-85f4-dc0f66201cae">134</ix:nonFraction>&#160;million will mature in one year or less, and $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGV4dHJlZ2lvbjo1OTAzZGQ2OTg0N2Y0NzY0OGFiNmJkZmIyYzM5NGFlNl8xMDk5NTExNjI4OTc1_e2c64896-e125-45d1-9673-9922cc52b158">2</ix:nonFraction>&#160;million will mature in after one through five years. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="moh:RestrictionsOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGV4dHJlZ2lvbjo1OTAzZGQ2OTg0N2Y0NzY0OGFiNmJkZmIyYzM5NGFlNl8xMzE5NDEzOTUzNDQwMw_10de7b5d-502b-4237-8634-25708e756963" continuedAt="icc2dbbfb201a4248a31ca6b2881718e2" escape="true">The following table presents the balances of restricted investments:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="icc2dbbfb201a4248a31ca6b2881718e2"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia61210df5ac84ab7ad7f93c5f4e1bc4a_I20201231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV80LTEtMS0xLTc0NzY_422e661a-bf59-4e0a-a29d-c7d815004616">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0251b790bfc84ca9901e5dec4b2e552c_I20191231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV80LTMtMS0xLTc0NzY_6bbeb0bc-fbcb-4531-93be-3aae17911de7">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3900f99d76c4cb088f0ec753bdfe4ea_I20201231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV83LTEtMS0xLTc0NzY_211c145d-90dc-45c5-af79-7c3c07e988b2">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e08cf3843ee433da07c69c76c66c194_I20191231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV83LTMtMS0xLTc0NzY_e4217823-3ad5-48a1-8c5f-50355c47c26a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i709876b469e94acf8f45ce2cc1c0ac99_I20201231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV85LTEtMS0xLTE1MzAw_f8b4d97d-cb67-4d66-a456-cc93e4281722">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0be8dd8b617b44a2b44ea2ff3f0f2d73_I20191231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV85LTMtMS0xLTE1MzA1_20e32c0e-7e8e-4599-982c-e1f7c9c24d08">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ohio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ce85ece03c4fd596e2b5d2647de430_I20201231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV85LTEtMS0xLTc0NzY_39f139bb-c2ff-4ab1-9b64-962811d77f63">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36836d1ebed34cdb88ec412d28f3f1ab_I20191231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV85LTMtMS0xLTc0NzY_031e2566-6f3f-4555-b50e-58048ff16f5f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d73631ecf445f48b591cb49c5daf0f_I20201231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNC0xLTEtMS03NDc2_d1387a5f-de4c-4ef2-9b7c-f899ded51d1c">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5bb7caa6db34dff90cd3316865e8139_I20191231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNC0zLTEtMS03NDc2_7dafa779-f47d-4bf8-9650-b161862e8e2b">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d2df1abcb045c4a451a671e263475d_I20201231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNS0xLTEtMS0xNDU3MA_db621dc2-e836-4cb7-a181-4fc4da2f6799">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a6ede7687e4ab8b717166f0bb9a215_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNS0zLTEtMS0xNDU3MQ_1d67b39e-7e08-4adb-a179-789fbddde70d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Health Plans segment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNS0xLTEtMS03NDc2_1a0455a5-301c-435b-b5d7-d224815c82fc">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:RestrictedInvestmentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNS0zLTEtMS03NDc2_d9c5c844-d35e-4db1-81dd-94c3a4c52c37">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_175"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">7.&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5Xzg4NA_36737c23-5df1-47dd-b0b1-412705682511" continuedAt="ic4604515547f4d879229479e420b14b9" escape="true">Property, Equipment, and Capitalized Software, Net </ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie6abf4b5edab4477935c5bb8e1865347"><ix:continuation id="ic4604515547f4d879229479e420b14b9" continuedAt="idc08e4adcc09469c8143ab881e0bae53">Property and equipment are stated at historical cost. Replacements and major improvements are capitalized, and repairs and maintenance are charged to expense as incurred. Software developed for internal use is capitalized. Furniture and equipment are generally depreciated using the straight-line method over estimated useful lives ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzU0OTc1NTgxMzk3OTA_0da1da73-4926-4eb9-bdb8-ab2cd7f10bb6">three</span> to <ix:nonNumeric contextRef="i15fb3622b8d3400b91bfd0af1a0403f4_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzMxNQ_2d593b43-805a-4e12-96d5-a4074f316b4b">seven years</ix:nonNumeric>. Software is generally amortized over its estimated useful life of <ix:nonNumeric contextRef="i1570351e39be47e894e41c5bc71b785f_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzQzNw_e733a7f9-cb2a-4bf7-b67a-d3d069b5416e">three years</ix:nonNumeric>. Leasehold improvements are amortized over the term of the lease, or over their useful lives from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzUzOA_e80b42ea-bec2-44ee-9782-16517f1bf477">five</span> to <ix:nonNumeric contextRef="i28c21a0ce6c540ada2399b7535c810c3_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzU0NA_927ebd8f-1d7c-45d0-94fc-02e83a1d286c">10</ix:nonNumeric>&#160;years, whichever is shorter. Buildings are depreciated over their estimated useful lives of <ix:nonNumeric contextRef="i78a27e51a7f04cb99838d4b8e20f08b7_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzYzOQ_4156458b-535d-4512-815d-92c6be385b33">31.5</ix:nonNumeric> to <ix:nonNumeric contextRef="i2c544b48981f4cdd80e392c5b90a7935_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzY0NQ_b5087f58-8b44-48c6-b99d-0641e1ced28e">40</ix:nonNumeric>&#160;years.</ix:continuation></ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idc08e4adcc09469c8143ab881e0bae53"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5Xzg3Mg_23f0872a-edd1-4b1b-be9e-cee6d078a74b" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment, and capitalized software is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized software</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b70afc8228d42e2bf32567a3f21f342_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzMtMS0xLTEtMA_7726f178-f11a-4e5d-b8e6-222b77dce66a">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c9a83c837e4ca1bcccd5809c8e0fb1_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzMtMy0xLTEtMA_f7195df8-e5f7-4b47-8d5b-556e9a93ce50">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id064c81564b14be391016eff3d91eb4e_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzQtMS0xLTEtMA_355c03a8-0a24-4131-8547-9f8285f9595c">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2dc6980ae14fe8a3654f7ca74e4f2f_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzQtMy0xLTEtMA_4b81d4ac-220e-488a-8cc5-710147a2fb91">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib23e7d7b485a4481833c3bac81769de4_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzUtMS0xLTEtMA_05a43785-a4b6-4520-98dd-5c9c9497b223">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a95ccf41eba4147ba12e954b58ab8ab_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzUtMy0xLTEtMA_650303bc-221a-4c8b-b9eb-0fcc939739f0">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808ff3f56ce4af1ba94833304546a52_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzYtMS0xLTEtMA_f492afee-7791-49b0-bf35-f0705f8cd498">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida59b5bf5dbb43f1bf41bc98cba8b6a9_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzYtMy0xLTEtMA_1df6e6f9-67d3-4f08-8cb4-9841cc5af40a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1df2247780e463a9f7026841ac4a307_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzctMS0xLTEtMTAwNjQ_d572b8ca-c8f3-4d00-bd28-228205478243">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966b162be69a4b1b9e916931cc469f10_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzctMy0xLTEtMTAwNjQ_8e6d081b-9fcb-4cf3-99e4-4ad15610ca0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzctMS0xLTEtMA_1a5fee17-e7c5-4961-a8ba-df19e203f591">752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzctMy0xLTEtMA_acaabc87-3b80-466e-b2ab-9a1f0f153b57">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: accumulated amortization - capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzgtMS0xLTEtMA_3aaa17f7-6a63-437a-b24f-92640d7df6f0">385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzgtMy0xLTEtMA_8d58a5c4-5080-429f-9963-a0392e77d129">351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization - furniture, equipment, building, and improvements</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzktMS0xLTEtMA_0cebe465-ee2b-45c9-b864-58772641dab9">192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzktMy0xLTEtMA_845d0100-c567-4cf6-81bc-9d14278ab29b">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzEwLTEtMS0xLTA_ab9fb71f-a954-4a70-af6a-bb64cbf8baff">577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzEwLTMtMS0xLTA_e9814c99-b895-4922-af6b-424644c45c0a">530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets - finance leases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzExLTEtMS0xLTA_ef18029e-6a39-4429-8a34-c7de5cbe1d7e">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzExLTMtMS0xLTA_3e69da24-ec88-4348-813a-d9e150ce72cb">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzEyLTEtMS0xLTA_35b60fd8-0814-4ba7-929b-376f08f01a43">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzEyLTMtMS0xLTA_f5686206-4952-4260-aed5-75c03e92b1f6">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents all depreciation and amortization recognized in our consolidated statements of income:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recorded in depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of capitalized software</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:DepreciationAndAmortizationOfCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzQtMS0xLTEtMA_e569a82c-181a-412f-9c4b-07d87eb05c49">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="moh:DepreciationAndAmortizationOfCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzQtMy0xLTEtMA_f8cee65c-ad8a-4db6-8637-239404d4e3f1">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:DepreciationAndAmortizationOfCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzQtNS0xLTEtMA_b24ab6ad-9bcc-4761-807e-280a50a2618f">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtMS0xLTEtMTY5Mjc_4ae87c30-fdc2-4f36-968f-269bd158c6c6">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtMy0xLTEtMTY5Mjc_349ff4ca-3802-4db5-9128-476f03197b41">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtNS0xLTEtMTY5Mjc_78258a6c-8572-4345-80a1-79b30f57c1c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization of furniture, equipment, building, and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtMS0xLTEtMA_75d5d7a3-96d2-42c7-b3eb-df6358404258">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtMy0xLTEtMA_8d0a37c3-4001-4e34-96e7-881f70daadd4">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtNS0xLTEtMA_2b55bf79-9069-4ff6-97e4-7a54dd3156c2">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzYtMS0xLTEtMA_bda9fbbf-c3c6-43eb-8ad1-2faab6e0f9b6">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzYtMy0xLTEtMA_1eaf4e2a-70f3-4e74-a14a-333ed78fa261">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzYtNS0xLTEtMA_c1036da9-3db5-43cd-9cde-63d802d9d757">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:DepreciationandAmortizationContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzgtMS0xLTEtMA_5c8ee27c-d8fe-4f3a-ae54-ed2dc33c21c2">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="moh:DepreciationandAmortizationContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzgtMy0xLTEtMA_ef09cfe4-8475-4f4d-b82c-14d35bd0556f">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:DepreciationandAmortizationContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzgtNS0xLTEtMA_0cf64ca6-1b6b-47b1-80cd-23110e09b219">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recorded in cost of service revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of capitalized software and deferred contract costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzEwLTEtMS0xLTA_738163ca-ab4c-4053-91c5-e7d6d35e65a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzEwLTMtMS0xLTA_a0ab6f08-6953-42cb-9ef1-1bd55b80ec79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzEwLTUtMS0xLTA_ef954453-f0b0-42db-a1b1-3bbae41c637b">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total depreciation and amortization recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzExLTEtMS0xLTA_4e211b9c-4383-487f-b856-a02b55e1f137">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzExLTMtMS0xLTA_2732acfe-fd77-4e6d-b946-14b6278e78c5">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzExLTUtMS0xLTA_c0b6250b-0749-4e48-b4dc-c5180fb2c4f0">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_181"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">8.&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDU_9b7a6778-3685-4458-9661-f026cec05a01" continuedAt="i5ccb1e67dd2e48f192e65822d026d26e" escape="true"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDY_b639fbe8-abf2-4e06-a121-bf10d501bef9" continuedAt="i5f124614bf9842cabe4df30b232b1b9a" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i5ccb1e67dd2e48f192e65822d026d26e" continuedAt="i938772541ab1497bbd211fa62aae9c65"><ix:continuation id="i5f124614bf9842cabe4df30b232b1b9a" continuedAt="i6635c69b9de84349bce570582e9da2a2"> </ix:continuation></ix:continuation></span></div><ix:continuation id="i938772541ab1497bbd211fa62aae9c65" continuedAt="i2c1041d75d77490295a1bb2019e094e7"><ix:continuation id="i6635c69b9de84349bce570582e9da2a2" continuedAt="i7aee774717614f0cb9ea39c8c080ee91"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to operating and finance leases primarily for our corporate and health plan offices. Our operating leases have remaining lease terms up to <ix:nonNumeric contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzE2Nw_066afa1b-6eac-4c8b-8935-ca912882e201">8</ix:nonNumeric> years, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzIzOA_3a2466eb-9d1c-48fa-b6c1-b315a9b93568">10</ix:nonNumeric> years. As of December&#160;31, 2020, the weighted average remaining operating lease term is <ix:nonNumeric contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzE2NDkyNjc0NDI4Mjc_884acfee-1160-4193-9853-0f265abdaa6e">4</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our finance leases have remaining lease terms of <ix:nonNumeric contextRef="idd31c651704242e2a915e56d0e9febd4_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeFinanceLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzM2Nw_3faa041e-ca4a-4a1f-abd5-672183860fdd">1</ix:nonNumeric> year to <ix:nonNumeric contextRef="i9831a12c6edb4660aade4906b3716c8c_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeFinanceLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzM3OQ_eec02890-d772-4497-b129-5fdbf36b8930">18</ix:nonNumeric> years, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeFinanceLeaseRenewalTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzQ1MA_317c50f5-bf53-48b8-8a22-60e77abf9bb1">25</ix:nonNumeric> years. As of December&#160;31, 2020, the weighted average remaining finance lease term is <ix:nonNumeric contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzUyMw_0e96b5cf-c64d-44d2-b865-20f4db4498d2">15</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the weighted-average discount rate used to compute the present value of lease payments was <ix:nonFraction unitRef="number" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzYzNA_695ebce0-73e9-4e6d-874c-0fade91ab1f2">5.2</ix:nonFraction>% for operating lease liabilities, and <ix:nonFraction unitRef="number" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzY3NA_2a78d72d-b01c-4ad2-ae99-7b1b774a0f02">6.5</ix:nonFraction>% for finance lease liabilities. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDc_baf7cbf3-0809-4d45-bb07-226ea892907f" continuedAt="id9a9588a8f15444d816dc3df294dbbba" escape="true">The components of lease expense for the years ended December 31, 2020, and 2019, are presented in the following table. Rental expense related to operating leases amounted to $<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzYwNDczMTM5NTQ1NDc_692353fc-dc22-4588-a9e1-cac2d9bd9888">62</ix:nonFraction> million for the year ended December 31, 2018.</ix:nonNumeric></span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2c1041d75d77490295a1bb2019e094e7" continuedAt="ib426343feb984e8cb9826c0d3539512a"><ix:continuation id="i7aee774717614f0cb9ea39c8c080ee91" continuedAt="i4ccec5c90e0746db9b9cc88432793df5"><ix:continuation id="id9a9588a8f15444d816dc3df294dbbba"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzMtMy0xLTEtMA_d89467ce-68ab-4261-9336-01135ff929e1">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzMtNS0xLTEtNTM4Mw_0e6eda61-a9c0-4634-b52d-3abe9135791b">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease expense: </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of ROU assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzYtMy0xLTEtMA_145d1cee-8aa4-425e-9d99-43f62b712daf">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzYtNS0xLTEtNTM4Mw_01734d6e-d117-4f8e-b012-3f9854fb0faf">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzctMy0xLTEtMA_09639574-a8b1-4273-a71d-354e35d88546">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzctNS0xLTEtNTM4Mw_9b643261-dd00-4557-bf2e-3d8e4214f793">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzgtMy0xLTEtMA_703f715d-0898-471a-b775-a1f51d235401">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="moh:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzgtNS0xLTEtNTM4Mw_1cea7f4c-5b64-4150-a38c-ecb2124177dd">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental consolidated cash flow information related to leases follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzQtMS0xLTEtMA_9a8fd17d-fec9-4886-aaf4-cd2389bc2b34">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzQtMy0xLTEtNTM4Nw_bdc8c9f6-1b5e-4bd0-909b-d77be722b3cb">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzUtMS0xLTEtMA_b77d705c-69a3-45e1-b29e-0437cbad2982">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzUtMy0xLTEtNTM4Nw_cc836e4e-08b3-4b97-916d-9d0b781886d6">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash used in financing activities: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzctMS0xLTEtMA_d8a84762-0318-4f89-9068-6e5932f7dbf2">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzctMy0xLTEtNTM4Nw_69486641-6a25-49a3-a86a-b0ae9a0d0ae3">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets recognized in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzktMS0xLTEtMA_0d45f6b5-4885-43d8-80a9-e41c8bfdf2d7">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzktMy0xLTEtNTM4Nw_d6429c5d-9980-4547-982c-7e5fe800b793">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzEwLTEtMS0xLTA_9e0a4edb-c764-4bcf-9c74-e12d48dd1293">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzEwLTMtMS0xLTUzODc_929bf5a7-b085-43ec-9912-dbc4976d0f43">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="moh:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDI_0e121711-03a9-425f-b84e-9f6521f2689a" escape="true"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases, including location of amounts reported in the accompanying consolidated balance sheets, follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:OperatingLeaseRightOfUseAssetExcludingLeasesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzUtMS0xLTEtMTAwNzU_b4c75acb-5fca-4709-9b94-1d81de4d39d0">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:OperatingLeaseRightOfUseAssetExcludingLeasesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzUtMy0xLTEtMTMzNDY_936394cc-b770-44b9-95d2-042811db06e5">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets - Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea9e886beab43f7b589f21f3657b645_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzYtMS0xLTEtMTAwNzU_f66e7525-0e06-4df0-acb7-9a256e984931">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd67197e811747ddae7d6a41e1699670_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzYtMy0xLTEtMTMzNTE_dde27b01-c57c-4592-9619-11146f2f8c05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzUtMS0xLTEtMA_296b9df1-e696-4d7d-9841-40606e3885be">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzUtMy0xLTEtNTM4OQ_86ed2ebc-bfd8-4c40-9bb0-2693a1f94fc7">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities (current)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzctMS0xLTEtMA_c69ec23f-6540-4bad-81ac-39ae7e819f10">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzctMy0xLTEtNTM4OQ_5a1e27cd-71ba-4026-8f78-680ad8abda60">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities (non-current)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzgtMS0xLTEtMA_cd35510d-f066-4a35-b6d4-5ab366907ccf">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzgtMy0xLTEtNTM4OQ_99fd5b8d-4bc8-44f0-83a5-2e372778ed2f">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea9e886beab43f7b589f21f3657b645_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzExLTEtMS0xLTEwMDg0_86407e37-5ace-493a-9b4b-4647e14392f2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd67197e811747ddae7d6a41e1699670_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzExLTMtMS0xLTEzMzU2_26bec3a9-8a67-4f09-a0dc-a9f9b028d45a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzktMS0xLTEtMA_d1bc8437-f395-4c6d-b135-6021778bbcf3">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzktMy0xLTEtNTM4OQ_02332a20-6e8c-4e9f-9e1c-351dfef4e4cb">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzEyLTEtMS0xLTA_ef18029e-6a39-4429-8a34-c7de5cbe1d7e">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzEyLTMtMS0xLTUzODk_b1c1f3a6-99be-4b8a-b623-43040b5bf1cd">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities (current)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE0LTEtMS0xLTA_3eb1e064-6bf7-4357-954e-b4d1ddd38984">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE0LTMtMS0xLTUzODk_f74a627d-6ec6-44c5-8b92-52965ecc6d10">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE1LTEtMS0xLTA_a5084176-789a-4770-addd-f88989dfcbb7">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE1LTMtMS0xLTUzODk_222c7eba-f4de-4554-a796-9eb4955d2640">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:92.25pt;text-indent:-76.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE2LTEtMS0xLTA_f7c3d5ea-a206-46af-9abb-3ef74aa929f9">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE2LTMtMS0xLTUzODk_d492a7b9-a8ff-4dab-a5c5-fb524794d606">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib426343feb984e8cb9826c0d3539512a"><ix:continuation id="i4ccec5c90e0746db9b9cc88432793df5"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDM_4df170e4-d7e0-4794-aa20-188a0dcd8a7c" escape="true"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDQ_dfbc764c-c639-4596-a876-2cde18753beb" escape="true"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzItMS0xLTEtMA_85ff01ae-05f1-4ce1-aed5-70fc3f48c0bb">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzItMy0xLTEtMA_bc35018e-d450-42df-afeb-9c8f5d5a74b4">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzMtMS0xLTEtMA_a5518f67-c36d-4be3-bf8f-1c16994ed957">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzMtMy0xLTEtMA_6e2bd1af-4ba2-4970-9b3f-25e0ad6cb14a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzQtMS0xLTEtMA_dc4e87de-3d95-4f38-8c80-5b203014fe77">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzQtMy0xLTEtMA_23fbb734-d023-4c52-8782-ff97625a042a">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzUtMS0xLTEtMA_cc67455c-a02c-4279-80e0-2e8750334f36">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzUtMy0xLTEtMA_fd6a2699-264c-484d-b05a-480148af966f">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzYtMS0xLTEtMA_aee5ccb9-f880-434e-9ea8-bf6afc5673f1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzYtMy0xLTEtMA_89864c98-c43f-4768-9d27-7e96697a03e9">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzctMS0xLTEtMA_529edd61-1525-41fb-b63a-57c7feade8b6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzctMy0xLTEtMA_875c43d1-a648-4a81-ac74-50947eccbda6">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal - undiscounted lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzgtMS0xLTEtMA_53d77862-fc89-46b6-9575-e05fa9b90232">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzgtMy0xLTEtMA_28145b85-acca-4457-a148-2d52017995e9">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzktMS0xLTEtMA_c7acc467-c933-4437-8b02-f847f0878e49">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzktMy0xLTEtMA_cea618d4-c3e4-4993-a189-08a1c10e9ffe">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzEwLTEtMS0xLTA_795fe973-4434-4ecb-9efd-f63d22408de3">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzEwLTMtMS0xLTA_d0b17059-b1f1-4fd4-bba4-aa42d95991d5">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_184"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">9.&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5Xzc5Nw_0fc74d1d-e820-4afd-bb11-13046b1f9e64" continuedAt="i2f343b88a4934c94ba4bcf27bbd3d35c" escape="true">Goodwill and Intangible Assets, Net</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i2f343b88a4934c94ba4bcf27bbd3d35c" continuedAt="id0785b48466149aba55211849379409b"> </ix:continuation></span></div><ix:continuation id="id0785b48466149aba55211849379409b"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzgwNQ_c49c6c2d-f26e-45d1-90e7-6376c578e2b7" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amounts of goodwill, for the periods presented. All goodwill is recorded in the Health Plans segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22759a2f8b054c96ad50791de93ca29f_I20181231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzItMS0xLTEtMA_7e347dc9-c0d0-4c77-a264-2d7becaa8d83">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzMtMS0xLTEtMA_cedb2c0f-5dc8-4610-b706-0862aaa6fa3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dispositions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzQtMS0xLTEtMA_0f553c2e-7554-475f-9645-e5399747ec81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzUtMS0xLTEtMA_d1bd3e7c-cd9f-4377-8136-31a3e33d234e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd7c232959048c3b7533cbe17fd7a2a_I20191231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzYtMS0xLTEtMA_a3183d4f-6f5f-463f-ba48-3a3f0486a02b">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzctMS0xLTEtMA_a03c84df-c1eb-4cfc-aec1-fefb81ffc678">549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dispositions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzgtMS0xLTEtMA_9473fa5c-1b50-4c71-bf48-f196b41685ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzktMS0xLTEtMA_10aa3bc6-2298-416a-93dd-ca41fb1100f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzEwLTEtMS0xLTA_c4e37af4-5721-45a1-aaeb-10f503f7c98e">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Health Plans segment, gross goodwill amounted to $<ix:nonFraction unitRef="usd" contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzE2NDkyNjc0NDI0OTM_0b40f9b0-3398-420e-923d-53fe3ee77c7e">994</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9cd7c232959048c3b7533cbe17fd7a2a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzE2NDkyNjc0NDI0Nzk_625c0e30-0b7f-48bb-9290-667f92c4683e">445</ix:nonFraction>&#160;million, as of December 31, 2020 and 2019, respectively. Accumulated impairment losses amounted to $<ix:nonFraction unitRef="usd" contextRef="i9cd7c232959048c3b7533cbe17fd7a2a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzE2NDkyNjc0NDI1MDU_3a0a3925-3cab-4d5b-915d-cc052bbd594d"><ix:nonFraction unitRef="usd" contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzE2NDkyNjc0NDI1MDU_68b6604f-a3a4-4012-8be8-2e001e36614e">302</ix:nonFraction></ix:nonFraction>&#160;million at each of December 31, 2020 and 2019, respectively. The changes in the carrying amounts of both goodwill and intangible assets, net, in 2020, was due to the acquisitions described in Note 4, &#8220;Business Combinations.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5Xzc5Ng_e5e4908d-dfd8-426f-b0fc-5b497eee098b" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the details of identified intangible assets, by major class, for the periods presented. All intangible assets, net, are recorded in the Health Plans segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:23.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.505%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract rights and licenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9747d2ea6b431d91b4e794f7c6a0f8_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtMS0xLTEtMA_e0ebde53-860a-42ed-a1e1-5f9ab5e94dcd">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9747d2ea6b431d91b4e794f7c6a0f8_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtMy0xLTEtMA_ad47e614-f44b-47e3-a3c5-068af5a2a2df">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9747d2ea6b431d91b4e794f7c6a0f8_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtNS0xLTEtMA_80cd4d32-bc64-49f2-9def-7d1de26e9132">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746a8ef0f806409da219017e26b4a03c_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtNy0xLTEtMA_d758c212-e1f6-43b7-8dec-b378bda7e135">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746a8ef0f806409da219017e26b4a03c_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtOS0xLTEtMA_f0c50814-1e96-47e1-925b-e6481ad87ea3">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746a8ef0f806409da219017e26b4a03c_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtMTEtMS0xLTA_8dcb1682-fd6c-4413-beca-c5ff6db160dc">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c25fe7c83049a784e28473dfa5db7f_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtMS0xLTEtMA_9c3a20ef-f181-4157-959b-bf948f93f38c">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c25fe7c83049a784e28473dfa5db7f_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtMy0xLTEtMA_dbcdc0f4-f2fd-4c0d-a232-bda960c513c4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c25fe7c83049a784e28473dfa5db7f_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtNS0xLTEtMA_091a1e5f-1c46-4c7c-bb1c-9066409bd776">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402bcd1f7eb94207a725a00271ec919d_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtNy0xLTEtMA_772bd400-04a3-4a3b-b0ec-424994f28b28">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402bcd1f7eb94207a725a00271ec919d_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtOS0xLTEtMA_046c8de2-fc7b-4c94-ba7b-474f552395c0">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402bcd1f7eb94207a725a00271ec919d_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtMTEtMS0xLTA_2b6db739-4912-4ebd-bbb4-28bbf454cd5e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0aecf877b59419e91398282765cd1a6_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMS0xLTEtMjc4Ng_8fa63975-57ba-4d2a-bcc9-9a692bfae72b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0aecf877b59419e91398282765cd1a6_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMy0xLTEtMjc4Ng_ab4a3193-4952-4cca-8437-19a978345efa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0aecf877b59419e91398282765cd1a6_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtNS0xLTEtMjc4Ng_318eca85-c971-480d-ad0a-3bb8483851ef">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba830af20e004480a455ba22d8490b81_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtNy0xLTEtNTM5Mw_2f56e59c-8dfb-43ea-adf7-782f3d92a649">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba830af20e004480a455ba22d8490b81_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtOS0xLTEtNTM5Mw_0ea4d1f6-be1f-47de-aed0-0628ea892993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba830af20e004480a455ba22d8490b81_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMTEtMS0xLTUzOTM_cabedb03-843d-4052-97ed-a80db3530c7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMS0xLTEtMA_354cb753-15db-4dab-a7e3-c4a509160ab7">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMy0xLTEtMA_df7af37e-f04d-4e03-ade0-5e935403914d">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtNS0xLTEtMA_94e7c37b-c769-4d6a-a07a-591085d10927">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtNy0xLTEtMA_fce85e12-22ce-4fd8-9c8f-e691e7858aac">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtOS0xLTEtMA_76f9047e-39bb-42db-b1e8-35face0fba9d">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMTEtMS0xLTA_72888e38-b71b-40e0-9ce8-670d89c0edd6">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we estimate that our intangible asset amortization will be approximately $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzY0OA_df56940b-c000-4599-a862-84d6e92dc39b">46</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzY1OA_2806b740-8fe2-4429-bddf-de96922e3d82"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzY1OA_8ac3bd73-63ac-47a1-8fed-5ec7e50d2029"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzY1OA_e7a64ab1-0eb5-4cf0-8792-a557f9c3d529">44</ix:nonFraction></ix:nonFraction></ix:nonFraction> million in 2022, 2023 and 2024, and $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzEwOTk1MTE2Mjk3Mjk_2ab0e937-c844-40a9-94c7-b0de6ba41182">43</ix:nonFraction> million in 2025.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 74</span></div></div></div><div id="if790247689124308855d86d82384a359_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">10.&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzI5NDI_d3ba5b43-11d4-4d24-a6ec-5f63727b2f89" continuedAt="i1bac885e5ac045ffb7cd2ad1e0d9082f" escape="true">Medical Claims and Benefits Payable </ix:nonNumeric></span></div><ix:continuation id="i1bac885e5ac045ffb7cd2ad1e0d9082f" continuedAt="i7d8845cbf92c43d5b2635afc5123469b"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzI5NDM_9936b4de-6d0f-42e9-b50e-4ef537548733" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the details of our medical claims and benefits payable as of the dates indicated.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fee-for-service claims incurred but not paid (&#8220;IBNP&#8221;)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzMtMS0xLTEtMA_20fb1c5c-237f-4dd6-ad15-d06ce75a8f01">1,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzMtMy0xLTEtMA_48e6e904-6a50-47bb-8d93-c86b5d101564">1,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzMtNS0xLTEtMA_ec904e5c-9727-43ab-96ae-a3b9c5226f60">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmacy payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:PharmacyClaimsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzQtMS0xLTEtMA_6ae1b7c5-bca1-4511-a82b-d751807bec9a">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:PharmacyClaimsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzQtMy0xLTEtMA_acd07df2-be18-4e90-914c-31ca490b25e1">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" name="moh:PharmacyClaimsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzQtNS0xLTEtMA_185f44e2-249e-40cb-bc47-cd573e24a2b4">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitation payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:CapitationClaimsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzUtMS0xLTEtMA_09ab495a-9b48-47c3-a8c6-cf03be71e708">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:CapitationClaimsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzUtMy0xLTEtMA_4e93f05b-ab7e-4802-a6ec-df8a2d3d4995">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" name="moh:CapitationClaimsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzUtNS0xLTEtMA_be91eae9-b996-4e71-ab36-8d0eabb8bc26">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:OtherClaimsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzYtMS0xLTEtMA_2c1aaa4b-e929-438e-8b9c-e82fc9908bde">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:OtherClaimsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzYtMy0xLTEtMA_39e2a161-0336-464e-8f3f-df38633eb8ba">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" name="moh:OtherClaimsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzYtNS0xLTEtMA_dc0cc4a7-b510-4542-ba15-9a1ed96470a8">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea9e886beab43f7b589f21f3657b645_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctMS0xLTEtMTAwNjA_32799738-b07e-41c2-ba59-628b9458068a">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd67197e811747ddae7d6a41e1699670_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctMy0xLTEtMTAwNjA_b394b080-91f6-4238-8595-5f5d66b12311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b5a4474fe742708d34076ef171bbc6_I20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctNS0xLTEtMTAwNjA_41b0eec5-5905-4636-8ed1-25b129bbc9cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctMS0xLTEtMA_f06da88f-5794-4d95-a1d8-34d74f991932">2,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctMy0xLTEtMA_940c9e53-3714-42d4-b3f5-a0b757f8290c">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctNS0xLTEtMA_ed63d73d-dc84-4bbd-9e4b-f4163ec7726f">1,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Other&#8221; medical claims and benefits payable include amounts payable to certain providers for which we act as an intermediary on behalf of various government agencies without assuming financial risk. Such receipts and payments do not impact our consolidated statements of income. Non-risk provider payables amounted to $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="moh:MedicalClaimsAndBenefitsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzQ0OA_1e848241-3764-44f0-a3ea-c2a599293e4b">235</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="moh:MedicalClaimsAndBenefitsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzQ1Mg_52bdd0aa-863c-460c-845c-448d805b1b74">132</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="moh:MedicalClaimsAndBenefitsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzQ1OQ_914bc6f7-f464-43bc-bc6f-d2b0b78b4476">107</ix:nonFraction> million, as of December&#160;31, 2020, 2019, and 2018, respectively.</span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="moh:ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzI5MTM_7f109459-0dc6-4a4a-84e3-0fc97182c6cc" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the change in our medical claims and benefits payable for the periods indicated. The amounts presented for &#8220;Components of medical care costs related to: Prior years&#8221; represent the amount by which our original estimate of medical claims and benefits payable at the beginning of the year were more than the actual liabilities, based on information (principally the payment of claims) developed since those liabilities were first reported.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable, beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzMtMS0xLTEtMA_fab40a6c-3464-4e75-8865-b0cd4d3b8c27">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzMtMy0xLTEtMA_7ffa512d-8f19-4c94-8a1a-1142329dfdb7">1,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5276df7533a434dba724ca46fb6260b_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzMtNS0xLTEtMA_e6e7067a-aa78-4003-ba48-9c7084668c8c">2,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Components of medical care costs related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzUtMS0xLTEtMA_bf84668f-53cc-4c28-8ae9-c2bdefe14c37">15,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzUtMy0xLTEtMA_2fc0a942-7e6c-4f50-9524-045d8103ea18">14,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzUtNS0xLTEtMA_456dd0be-36c8-4bf1-baad-890195e01c19">15,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzYtMS0xLTEtMA_fc1d8095-9bd2-455c-9dee-1e1641c5a61d">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzYtMy0xLTEtMA_196430db-fbff-4105-a4c1-9db3611553e2">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzYtNS0xLTEtMA_7cabd0f8-6909-4072-995e-fa279841be70">341</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total medical care costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzctMS0xLTEtMA_d6a08c21-5430-4e6c-b3ee-bc22a573ffdc">15,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzctMy0xLTEtMA_b0c08e0c-6887-4402-9380-350e2271fc1d">13,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzctNS0xLTEtMA_f2b38794-7cfd-45a4-b0fa-033367e69a4f">15,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for medical care costs related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEyLTEtMS0xLTA_fc7a6887-a62c-4c9b-8e37-a5dbfd177625">13,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEyLTMtMS0xLTA_e498f89a-f7fc-46c5-8edf-df42067feb86">12,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEyLTUtMS0xLTA_ea1c751b-67e8-445d-96fd-b06e06616dcd">13,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTEtMS0xLTA_7860ab9f-3a7f-4855-8a14-012c12292a88">1,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTMtMS0xLTA_aa3097b2-ece0-4a3c-b0f4-c8524f84a447">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTUtMS0xLTA_c08a42a5-4ccf-41de-97cd-6817516f84dc">1,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTEtMS0xLTA_2e5957dd-c0cd-4e61-98c2-011208909e57">15,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTMtMS0xLTA_8b389489-9c25-45ea-81ba-b0d08aaef1c2">14,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTUtMS0xLTA_66dad328-5215-4f5a-bb61-3a795a4b5060">15,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition - Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTEtMS0xLTIwOTE3_89b23047-e7b8-4275-b049-df7267d5830b">294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTMtMS0xLTIwOTE3_92529b3b-b782-4e86-afb8-74554cd4d6ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTUtMS0xLTIwOTE3_3d287fe0-20a0-4460-8c3a-ca725187ca8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in non-risk and other provider payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTEtMS0xLTE0MDM2_a149aabb-a0c8-4f35-a097-4c77065e31cf">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="moh:MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTMtMS0xLTE0MDM2_cf94bcc5-39d3-4f70-ba9f-274ed9acea51">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTUtMS0xLTE0MDM2_a5140645-fc50-4b19-80c3-dcfb4b452f4a">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable, ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE1LTEtMS0xLTA_6711d257-f902-482f-ad98-e13e0a3780e2">2,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE1LTMtMS0xLTA_1426a7a7-7b18-46e8-80e4-c4c5038a3871">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE1LTUtMS0xLTA_1d9b3354-550e-4b01-8983-9df2aacafc09">1,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">December 31, 2018, includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $<ix:nonFraction unitRef="usd" contextRef="i8ba8deca9f384a07ac55d4d78555ed46_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzExMTI_a09657f2-c664-4257-8812-82be3512ec94">81</ix:nonFraction> million.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates of medical claims and benefits payable recorded at December 31, 2020, 2019 and 2018 developed favorably by approximately $<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzYwNDczMTM5NTkzNzc_bedab393-d422-4085-b16e-79e625ab3bff">119</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzYwNDczMTM5NTkzODI_c52985cf-a9c0-4e99-b936-c0dd762104a8">271</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzYwNDczMTM5NTkzOTA_bb1995db-3fc1-4269-812c-66b4bcf21223">341</ix:nonFraction> million in 2020, 2019 and 2018, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable prior year development recognized in 2020 was primarily due to lower than expected utilization of medical services by our Medicaid members, and improved operating performance. Consequently, the ultimate costs recognized in 2020 were lower than our original estimates in 2019, which was not discernible until additional information was provided, and as claims payments were processed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable prior year development recognized in 2019 was primarily due to lower than expected utilization of medical services by our Medicaid members, and improved operating performance. Consequently, the ultimate costs recognized in 2019 were lower than our original estimates in 2018, which was not discernible until additional information was provided, and as claims payments were processed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable prior year development recognized in 2018 includes a benefit of approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i8ba8deca9f384a07ac55d4d78555ed46_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzYwNDczMTM5NjAzMTU_a09657f2-c664-4257-8812-82be3512ec94">81</ix:nonFraction> million&#160;in reduced medical care costs relating to Marketplace CSR subsidies for 2017 dates of service. The remainder of the favorable </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7d8845cbf92c43d5b2635afc5123469b"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prior period development was primarily due to lower than expected utilization of medical services by our Medicaid and Marketplace members and improved operating performance.&#160;Consequently, the ultimate costs recognized in 2018 were lower than our original estimates in 2017, which was not discernible until additional information was provided, and as claims payments were processed.</span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzI5MzA_f3166c5d-c138-4547-8cfa-473878329cb6" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about incurred and paid claims development as of December&#160;31, 2020, as well as cumulative claims frequency and the total of incurred but not paid claims liabilities. The cumulative claim frequency is measured by claim event, and includes claims covered under capitated arrangements.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims and Allocated Claims Adjustment Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total IBNP</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative number of reported claims</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31b475498df425a8b4d174081e15148_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzUtMi0xLTEtMA_a6504950-1415-4d27-b848-2376bc46eeb4">15,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f38b6017a44991a39f98bf263f1207_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzUtNC0xLTEtMA_74f03c2b-190d-4739-94ad-6aefcef7ad4e">15,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4da076c6c0e14403bba261ee5a1752cb_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzUtNi0xLTEtMA_5da1b5f9-ef8c-421b-8805-d51c07150367">15,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8038f20097384f9e833965528d07e1cc_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzUtOC0xLTEtMA_6d8a4a94-4602-4f1c-b3b6-c7857733af4c">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i8038f20097384f9e833965528d07e1cc_I20201231" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzUtMTAtMS0xLTA_ba372535-8174-435a-83c5-ee52013b60f6">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadfee5a2ce3745aaaf4b546d03d4d801_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzYtNC0xLTEtMA_92dbd29f-ba17-4647-9cc6-aab802219e87">14,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i136f903b1c064277a3b1c8f8da5021b5_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzYtNi0xLTEtMA_6bd07f25-60a1-44a3-89aa-4929d32d94a0">14,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d4bab4b5564cbb89d2dde161392e50_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzYtOC0xLTEtMA_951d7d68-c076-442b-a1b9-a2c03ed3cbb0">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i34d4bab4b5564cbb89d2dde161392e50_I20201231" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzYtMTAtMS0xLTA_534a2152-c83d-4eb2-ad74-56205d960417">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide648b3dad0d4ab18e81c2b7529401b1_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzctNi0xLTEtMA_a1c96098-3f24-422d-81e7-ff93c9e59b3e">15,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe0ee42eef33462bb6cd3e32f7bf3d52_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzctOC0xLTEtMA_7d958166-561e-4b36-9da8-a0b90757ad82">1,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ibe0ee42eef33462bb6cd3e32f7bf3d52_I20201231" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzctMTAtMS0xLTA_b967998b-a9c7-4a08-a95e-4450e68417f9">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="moh:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzgtNi0xLTEtMA_e72fe112-70f0-4b43-8bd6-bee7cee5c90f">45,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzgtOC0xLTEtMA_c2dfa872-a196-4f97-b645-35438f103104">1,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.462%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Claims Adjustment Expenses</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65eb832ddf7446ad95dac7eeb4907da3_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzUtMi0xLTEtMA_c6f5c035-279f-46be-b1dc-b76b6fe8f330">13,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84ed48f2ecee4fde8a88bcac9e3387b6_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzUtNC0xLTEtMA_00539f38-4da2-4c54-b90a-4f24252abe20">15,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8038f20097384f9e833965528d07e1cc_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzUtNi0xLTEtMA_59a21e9d-1980-4d1c-bb69-042c2e7201a8">15,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f74264414a473b851cd390764a5469_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzYtNC0xLTEtMA_5ba54349-f8d8-464a-ad3f-11abd858c0f7">12,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d4bab4b5564cbb89d2dde161392e50_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzYtNi0xLTEtMA_5c3b4680-496b-4e34-8a88-13404ad26bcb">14,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe0ee42eef33462bb6cd3e32f7bf3d52_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzctNi0xLTEtMA_88d99202-a9c9-4d5f-a328-7f8f9c3e8b19">13,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzgtNi0xLTEtMA_f4b04537-12bf-407e-ae85-fd09b699d385">43,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzI5NDY_a8c96902-7542-44bd-9b0b-b5c814624c3f" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of claims development to the aggregate carrying amount of the liability for medical claims and benefits payable.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.462%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incurred claims and allocated claims adjustment expenses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzItNi0xLTEtMA_b0bc0b17-9f76-4b7f-a8d5-e9a7ea0ebf91">45,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: cumulative paid claims and allocated claims adjustment expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzMtNi0xLTEtMA_13a9a2b8-5396-41e5-a0fe-2bd7f5396c12">43,149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All outstanding liabilities before 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzQtNi0xLTEtMA_6fe8e4c1-de69-4a21-a234-608550d8e887">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzUtNi0xLTEtNzUzNg_fe51833f-2540-4ba5-95ae-d381f54e68eb">294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-risk and other provider payables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzUtNi0xLTEtMA_dd5cbafe-d847-4019-bb76-e7a93c479953">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzYtNi0xLTEtMA_666ea401-b185-4f6f-abf5-6f01aa1c8b81">2,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_193"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">11. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzgwODI_0c229fa1-207d-47fd-ae5c-7200f33b6d63" continuedAt="ibf585c78769c4322b2f78662ccde86f5" escape="true">Debt </ix:nonNumeric></span></div><ix:continuation id="ibf585c78769c4322b2f78662ccde86f5" continuedAt="i2a7a8ee855634fd1b1dbf3e3cf4a1099"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzgwODY_ff29b702-99a1-45e3-b7b7-f85aab4536f2" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of debt, as of December&#160;31, 2020, are illustrated in the following table. All amounts represent the principal amounts of the debt instruments outstanding.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:23.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtMC0xLTEtNTU0MC90ZXh0cmVnaW9uOjYzNzNjNjQwNjAyYzQ3YWJiOGJlMjgzNmE2ZmFjMmYwXzU0OTc1NTgxMzg5MDI_a88d747a-4ee0-4f79-89b3-fc4703d1d916">4.375</ix:nonFraction>% Notes due 2028</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtMS0xLTEtMA_77428ee7-3141-4fe4-b971-cc173038c7a5">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtMy0xLTEtNTQ1Nw_40fe52b8-7f8f-4549-8a6c-568c1f77c71d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtNS0xLTEtNTQ2MQ_c379cc3f-d6dd-4577-9348-2e529b73e5c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtNy0xLTEtNTQ2Mw_1b30270c-93d6-45d7-9184-b49e75567912">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtOS0xLTEtNTQ2NQ_f28f7e61-5e8f-448e-baba-70441f26b00c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtMTEtMS0xLTU0Njc_585bb413-3435-4354-93df-c10abb3078cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtMTMtMS0xLTU0Njk_a5288f9c-ebaa-4da7-aacd-d9f28a93a165">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MjU1ZmFlM2Y1OTRiODc4OGUxNWFjYjUxNzRiYzNjXzU0OTc1NTgxMzg5MDI_02da3411-9932-4ff5-85b0-f974d24c2506">5.375</ix:nonFraction>% Notes due 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtMS0xLTEtMA_f741b749-c459-4c54-8633-51c054b460bd">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtMy0xLTEtNTQ1Nw_2be1a3c4-068e-4335-a08a-c34db31210b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtNS0xLTEtNTQ2MQ_2fe28852-a777-4010-8ced-246bea0f4c83">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtNy0xLTEtNTQ2Mw_ec292fb5-0e04-4a89-a303-a80aaa6df298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtOS0xLTEtNTQ2NQ_fb728d9e-4a9d-43e3-861e-0dc3da28551e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtMTEtMS0xLTU0Njc_b69006dc-9c5d-42b3-a366-e560154ec124">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtMTMtMS0xLTU0Njk_5cee4cb8-e49d-4dc6-9cb8-c6d330d33626">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtMC0xLTEtNTU0Ny90ZXh0cmVnaW9uOmI0NTg1MjNjM2MxMDQwMDc4NDk1ZTM2YmY4MjBkYjZkXzU0OTc1NTgxMzg5MDM_55435b9b-c833-47df-80bb-ee345b578771">3.875</ix:nonFraction>% Notes due 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtMS0xLTEtODUw_fb27f257-6596-47b5-b011-2a03eb8e5520">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtMy0xLTEtNTQ1Nw_5b802107-d3c3-4082-9547-1b1c8807826a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtNS0xLTEtNTQ2MQ_4498ec08-c3f9-49da-a364-4370b6229847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtNy0xLTEtNTQ2Mw_71b0c1ff-71d2-4d85-a480-d6a2cff51538">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtOS0xLTEtNTQ2NQ_f760a7ab-94ea-453f-b396-99f0eac6a654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtMTEtMS0xLTU0Njc_b5b3af9b-879f-446c-b21a-d5e122aa0606">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtMTMtMS0xLTU0Njk_562b0e0d-088b-4abf-81dd-36d86256acb8">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtMS0xLTEtMA_b2e7a53f-81de-48da-b198-959b48d7ecbf">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtMy0xLTEtNTQ1Nw_25e760e4-6f3f-4fb9-9fa8-2be30a600460">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtNS0xLTEtNTQ2MQ_59942aff-4132-4303-99e6-fb6e376411f3">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtNy0xLTEtNTQ2Mw_3be52b2a-182a-4803-8d9f-b82e1c86cacd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtOS0xLTEtNTQ2NQ_8a318979-4ab7-4035-a9d7-9af0462d8bca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtMTEtMS0xLTU0Njc_1fe993bd-e5e7-45a2-95d1-7b2fc59aa5da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtMTMtMS0xLTU0Njk_7b77a69e-f7af-4325-a3a0-c2b751ea1229">1,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2a7a8ee855634fd1b1dbf3e3cf4a1099" continuedAt="i0548fabfba8249429ad1b0088ef63235"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All debt is held at the parent which is reported in the Other segment. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzgwNzY_76e6174b-26e1-4744-8b1b-4dd691c5b5be" continuedAt="i942eafdcce0d40139d03bae813ea397c" escape="true">The following table summarizes our outstanding debt obligations and their classification in the accompanying consolidated balance sheets:</ix:nonNumeric></span></div><ix:continuation id="i942eafdcce0d40139d03bae813ea397c"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f87c0eee5ef4388a13337f6de7a4672_I20200131" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzQtMC0xLTEtMTU1MzkvdGV4dHJlZ2lvbjozOGRiZmM0MGIxMWU0YTFmODJkNDJkY2NkOTYwYWYxMF81NDk3NTU4MTM4OTM0_48a28ce9-ed28-44ea-a8eb-de4f9240758e">1.125</ix:nonFraction>% Convertible Notes, net of unamortized discount</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id63dd203dce74ef786b9059a9384be45_I20201231" decimals="-6" format="ixt:zerodash" name="moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzQtMS0xLTEtMA_e78344e6-e949-4411-a3e0-2498d82c498c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae2b394952c4f1e8142cffc59c02e8f_I20191231" decimals="-6" name="moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzQtMy0xLTEtMA_9d58a327-06a8-4463-b538-19db4f9b1af1">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ca304db2314cb0aa1e9531302dd99f_I20201231" decimals="-6" format="ixt:zerodash" name="moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzUtMS0xLTEtMA_ca683608-ada1-46e2-9765-cded1e78fe35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f794012ffba4b20bb19204c1871558d_I20191231" decimals="-6" name="moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzUtMy0xLTEtMA_03d30960-144e-4519-9763-0e8dc593c922">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzYtMS0xLTEtMA_96685d17-b369-4100-9d95-0b95dd71463b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzYtMy0xLTEtMA_2ddd92ee-139a-4503-9991-4c20330385de">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzgtMC0xLTEtNTU1MS90ZXh0cmVnaW9uOjVkZWE5YjZmODZkNTQ5ZTRiYTE0ZTExNDVlZDBhZWI5XzU0OTc1NTgxMzg5MTE_3b360b17-406a-4d98-9962-db0cd0ddc832">4.375</ix:nonFraction>% Notes due 2028</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="-6" name="moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzgtMS0xLTEtMA_38f96f54-7802-4eac-986c-6409174cd2f5">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8dbc94d3d2941ddb0a236c2e6aa7418_I20191231" decimals="-6" format="ixt:zerodash" name="moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzgtMy0xLTEtNTQ1NA_503dd1a1-0088-490b-9a3f-6e3d65b3c45a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzktMC0xLTEtNTU1My90ZXh0cmVnaW9uOmRhZGM3NmFlYzBhYTQzNDdhYzNhNGNmOWUzNWZkYjIzXzU0OTc1NTgxMzg5MTE_534078d7-ba28-4e8c-8a9b-39ce5b87ccda">5.375</ix:nonFraction>% Notes due 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="-6" name="moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzktMS0xLTEtMA_b0e9e5df-e2d5-4bde-923e-2d64e1bf49c4">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if24fe855595e4f419b39b5ca7946f9a1_I20191231" decimals="-6" name="moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzktMy0xLTEtMA_d5fac211-4008-4f10-ad72-a592ba4c3e14">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEwLTAtMS0xLTU1NDkvdGV4dHJlZ2lvbjoyNWU0M2UwNGEwMWQ0NjJkYWQ2MDdkN2Q1MDkyYWI4ZV81NDk3NTU4MTM4OTEx_55435b9b-c833-47df-80bb-ee345b578771">3.875</ix:nonFraction>% Notes due 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="-6" name="moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEwLTEtMS0xLTg4Mw_725ac1d2-a620-4366-b220-4341baeb63db">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82aa8b8e3d40448a968a16db82de1fe0_I20191231" decimals="-6" format="ixt:zerodash" name="moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEwLTMtMS0xLTg4Mw_335d9dcc-38c5-4f57-878c-ea49f15be017">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6897a665bfe944c0b1720f8066bd97ce_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzExLTAtMS0xLTU1NTUvdGV4dHJlZ2lvbjo3NjQxYjA1ZjEyYzg0OWY2YWJmNjZmMWY2NjljNDU0Zl81NDk3NTU4MTM4OTEx_d7c503be-ad51-4b06-a4b7-d6ba9ba345c3">4.875</ix:nonFraction>% Notes due 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231" decimals="-6" format="ixt:zerodash" name="moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEwLTEtMS0xLTA_792b7f4d-e7a1-4263-9398-78fa85734f6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8662ae4a2ad4fd59034705718e300f7_I20191231" decimals="-6" name="moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEwLTMtMS0xLTA_39d67d7b-8a8e-4279-a663-2397401c51f1">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ca304db2314cb0aa1e9531302dd99f_I20201231" decimals="-6" format="ixt:zerodash" name="moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzExLTEtMS0xLTA_71c1eb46-8ef2-4ad1-89e9-e33e052c2a61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f794012ffba4b20bb19204c1871558d_I20191231" decimals="-6" name="moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzExLTMtMS0xLTA_5f8aa780-2421-42de-9918-ab3e5aaf9461">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: debt issuance costs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEzLTEtMS0xLTA_84b24151-628c-459e-b8b3-3761a09bd5b9">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEzLTMtMS0xLTA_4df2f333-42cc-470e-9595-1d068590fefb">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzE0LTEtMS0xLTA_63bb3533-3b1b-43d9-ba3a-e1112d4d5011">2,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzE0LTMtMS0xLTA_373f9077-860c-4637-ad89-abf23eb69ae2">1,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Reported in &#8220;Accounts payable, accrued liabilities and other.&#8221;</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we entered into a credit agreement (the &#8220;Credit Agreement&#8221;) that replaced our prior credit agreement. The terms of the Credit Agreement are substantially similar to the terms of the prior agreement. Among various provisions, significant changes incorporated to the Credit Agreement included:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase of the revolving credit facility (the &#8220;Credit Facility&#8221;) from $<ix:nonFraction unitRef="usd" contextRef="i919a4ba85b4d4dfaa5d02f1908cbd481_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgxNzM_22fa516f-011f-4fdd-a0b5-49f6f676dd82">500</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i350e29537cb34f48978b5b0e7e5cc142_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgxODA_719baa9a-ad52-4026-ba38-cdb0f44fbf8f">1.0</ix:nonFraction> billion;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $<ix:nonFraction unitRef="usd" contextRef="icdd1a32b458947b1801cc3505a82b626_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgxODc_719c6176-c9d1-4a8c-a817-1790f4564de3">15</ix:nonFraction>&#160;million swingline sub-facility and a $<ix:nonFraction unitRef="usd" contextRef="if6fee39dad244f2c88eadb065bc81d50_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgyMjA_4f07d29a-fd5e-4fb6-8255-d80b5df0cd88">100</ix:nonFraction>&#160;million letter of credit sub-facility;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase of incremental term loans available to finance certain acquisitions from $<ix:nonFraction unitRef="usd" contextRef="i1abe71b87a6542f0870a99e5a099279f_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgzNDA_1513d1e2-e21a-43d7-92b8-b0ebb320a00b">150</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i9c82c5064b8f4eb08577141f723fd705_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgzNDc_66df0137-0db2-4379-a4e6-3bcc8d251287">500</ix:nonFraction>&#160;million, plus an unlimited amount as long as our consolidated net leverage ratio is not greater than <ix:nonFraction unitRef="number" contextRef="ie2dd3e9ee2ce44a4919d0cf6b7a9cd2f_I20201231" decimals="INF" name="moh:ConsolidatedNetLeverage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDg0NDQ_d4647cc2-8291-4405-b0e4-0dd6805a00c8">3</ix:nonFraction>:1;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ability to engage in acquisitions where the consummation of such acquisitions is not conditioned on the availability of, or on obtaining, third-party financing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Termination of the term loan facility under the prior credit agreement; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LIBOR succession provisions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement has a term of <ix:nonNumeric contextRef="i357b4ee3df3041a6bcafb18e3531d2e9_D20200601-20200630" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDg3OTM_27295caa-154d-43a8-bf7f-e72889c9ed33">five years</ix:nonNumeric>, and all amounts outstanding will be due and payable on June 8, 2025. Borrowings under the Credit Agreement bear interest based, at our election, on a base rate or other defined rate, plus in each case, the applicable margin. In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Credit Agreement, we are required to pay a quarterly commitment fee. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary non-financial and financial covenants. As of December&#160;31, 2020, we were in compliance with all financial and non-financial covenants under the Credit Agreement and other long-term debt. As of December&#160;31, 2020, <ix:nonFraction unitRef="usd" contextRef="i8e22eda33bbd4bab854db88001835a0c_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDkyNzY_507791ab-c2cf-48a8-b38c-f9f35d662cf7">no</ix:nonFraction> amounts were outstanding under the Credit Facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">High-Yield Senior Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our high-yield senior notes are described below. Each of these notes are senior unsecured obligations of Molina and rank equally in right of payment with all existing and future senior debt, and senior to all existing and future subordinated debt of Molina. In addition, each of the notes contain customary non-financial covenants and change of control provisions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indentures governing the high-yield senior notes contain cross-default provisions that are triggered upon default by us or any of our subsidiaries on any indebtedness in excess of the amount specified in the applicable indenture. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzY3Mzg_a88d747a-4ee0-4f79-89b3-fc4703d1d916">4.375</ix:nonFraction>% Notes due 2028. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2020, we completed the private offering of $<ix:nonFraction unitRef="usd" contextRef="ib62871823c48445589be9d732dff0753_I20200602" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzY3NTQ_3e6bdfe3-d3a3-48b2-8abf-8a2f86f820c3">800</ix:nonFraction> million aggregate principal amount of senior notes (the &#8220;<ix:nonFraction unitRef="number" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzY3NjM_a88d747a-4ee0-4f79-89b3-fc4703d1d916">4.375</ix:nonFraction>% Notes&#8221;) due June 15, 2028, unless earlier redeemed. The <ix:nonFraction unitRef="number" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0MTI_a88d747a-4ee0-4f79-89b3-fc4703d1d916">4.375</ix:nonFraction>% Notes contain optional early redemption provisions, with redemption prices in excess of par. Interest, at a rate of <ix:nonFraction unitRef="number" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0MjE_a88d747a-4ee0-4f79-89b3-fc4703d1d916">4.375</ix:nonFraction>% </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0548fabfba8249429ad1b0088ef63235" continuedAt="ie3014b506d2e48688ba3f362c8fd748c"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per annum, is payable semiannually in arrears on June 15 and December 15 of each year. A portion of the net proceeds from the <ix:nonFraction unitRef="number" contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0NDU_a88d747a-4ee0-4f79-89b3-fc4703d1d916">4.375</ix:nonFraction>% Notes offering was used to repay $<ix:nonFraction unitRef="usd" contextRef="i5588d925bf774eb08f9ffc4e6643dcb4_D20200602-20200602" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0MzY_5beb2ee3-ea71-46b4-a731-130fcd80aed3">600</ix:nonFraction>&#160;million principal amount outstanding under the term loan facility of our prior credit agreement, and the balance is intended to be used for general corporate purposes. Deferred issuance costs amounted to $<ix:nonFraction unitRef="usd" contextRef="ib62871823c48445589be9d732dff0753_I20200602" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE2NDkyNjc0NjQyMDk_f8e9bf29-6982-4f84-81b0-7c94b6c0a226">11</ix:nonFraction>&#160;million. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0NTA_02da3411-9932-4ff5-85b0-f974d24c2506">5.375</ix:nonFraction>% Notes due 2022. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have $<ix:nonFraction unitRef="usd" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzI4ODk_f00acbb1-4a52-4c67-9504-a2e5d1b53e91">700</ix:nonFraction> million aggregate principal amount of senior notes (the &#8220;<ix:nonFraction unitRef="number" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0NTQ_02da3411-9932-4ff5-85b0-f974d24c2506">5.375</ix:nonFraction>% Notes&#8221;) outstanding as of December&#160;31, 2020, which are due November&#160;15,&#160;2022, unless earlier redeemed. Interest at a rate of <ix:nonFraction unitRef="number" contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0NTg_02da3411-9932-4ff5-85b0-f974d24c2506">5.375</ix:nonFraction>% per annum, is payable semiannually in arrears on May 15 and November 15. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0MTY_55435b9b-c833-47df-80bb-ee345b578771">3.875</ix:nonFraction>% Notes due 2030. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2020, we completed the private offering of $<ix:nonFraction unitRef="usd" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0OTM_fb27f257-6596-47b5-b011-2a03eb8e5520">650</ix:nonFraction> million aggregate principal amount of senior notes (the &#8220;<ix:nonFraction unitRef="number" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0MjU_55435b9b-c833-47df-80bb-ee345b578771">3.875</ix:nonFraction>% Notes&#8221;) due November 15, 2030, unless earlier redeemed. The <ix:nonFraction unitRef="number" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0NTI_55435b9b-c833-47df-80bb-ee345b578771">3.875</ix:nonFraction>% Notes contain optional early redemption provisions, with redemption prices in excess of par. Interest, at a rate of <ix:nonFraction unitRef="number" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0NDM_55435b9b-c833-47df-80bb-ee345b578771">3.875</ix:nonFraction>% per annum, is payable semiannually in arrears on May 15 and November 15 of each year, commencing on May 15, 2021. A portion of the net proceeds from the <ix:nonFraction unitRef="number" contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0MzQ_55435b9b-c833-47df-80bb-ee345b578771">3.875</ix:nonFraction>% Notes offering was used to repay $<ix:nonFraction unitRef="usd" contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0Nzg_3ff92867-9dd7-4e8c-8363-111b8a76df97">330</ix:nonFraction> million principal amount outstanding under the <ix:nonFraction unitRef="number" contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0NjI_c47a07cb-7dec-4162-a382-e8cd56ad49e3">4.875</ix:nonFraction>% Notes, and the balance is intended to be used for general corporate purposes. Deferred issuance costs amounted to $<ix:nonFraction unitRef="usd" contextRef="i1abb910e6fa946c3a5cc16ae002d542f_I20201117" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NTA5NzY_b5f6c341-f6e1-4928-a6e0-7e3b91ebaa50">10</ix:nonFraction>&#160;million. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0Njc_c47a07cb-7dec-4162-a382-e8cd56ad49e3">4.875</ix:nonFraction>% Notes due 2025. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we completed the early redemption of the entire $<ix:nonFraction unitRef="usd" contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzMyNDY_3ff92867-9dd7-4e8c-8363-111b8a76df97">330</ix:nonFraction> million aggregate principal amount of senior notes (the &#8220;<ix:nonFraction unitRef="number" contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0NzE_c47a07cb-7dec-4162-a382-e8cd56ad49e3">4.875</ix:nonFraction>% Notes&#8221;) that would have been due June 15, 2025. In accordance with the indenture governing such notes, the <ix:nonFraction unitRef="number" contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE3MDQyNDMwMjU3OTIz_21f4ceac-511d-444e-aba4-655f1db1f874">4.875</ix:nonFraction>% Notes were settled at <ix:nonFraction unitRef="number" contextRef="id33b880a743e45e296852cb1c96f23f9_D20201201-20201231" decimals="INF" name="moh:RedemptionPremiumSettledPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE3MDQyNDMwMjU3OTE3_15156fa1-fd24-47cf-9b11-620b011d3d06">100</ix:nonFraction>% of par, plus an early redemption premium which amounted to $<ix:nonFraction unitRef="usd" contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepositLiabilitiesAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NTUxNTE_e91e5342-c5d4-4b94-be1e-477a67efc329">8</ix:nonFraction>&#160;million, plus accrued and unpaid interest. In conjunction with the redemption, we wrote off $<ix:nonFraction unitRef="usd" contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NTUxMzk_338ca48e-f172-47ff-a12b-fd70179ef7f7">3</ix:nonFraction>&#160;million in unamortized deferred issuance costs directly related to the <ix:nonFraction unitRef="number" contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE3MDQyNDMwMjU3OTMx_93a2d817-6f42-4a14-adf7-075752e4de97">4.875</ix:nonFraction>% Notes. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i7f87c0eee5ef4388a13337f6de7a4672_I20200131" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzM1NzU_48a28ce9-ed28-44ea-a8eb-de4f9240758e">1.125</ix:nonFraction>% Cash Convertible Senior Notes due 2020  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, we paid $<ix:nonFraction unitRef="usd" contextRef="i71e356cb28064ce08d2b5e2365a4e623_D20200101-20200131" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzgzMjE_b1542e9b-93e9-41e6-b61d-9eb90a5e7c75">39</ix:nonFraction>&#160;million to settle the $<ix:nonFraction unitRef="usd" contextRef="i7f87c0eee5ef4388a13337f6de7a4672_I20200131" decimals="-6" format="ixt:numdotdecimal" name="moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzgzMzQ_db591ee5-5133-4a44-b144-86f14de6cd00">12</ix:nonFraction>&#160;million remaining principal amount outstanding of the <ix:nonFraction unitRef="number" contextRef="i7f87c0eee5ef4388a13337f6de7a4672_I20200131" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzgzNTM_48a28ce9-ed28-44ea-a8eb-de4f9240758e">1.125</ix:nonFraction>% cash convertible senior notes due January 15, 2020 (the &#8220;<ix:nonFraction unitRef="number" contextRef="i7f87c0eee5ef4388a13337f6de7a4672_I20200131" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzIxOTkwMjMyNzgzNzc_48a28ce9-ed28-44ea-a8eb-de4f9240758e">1.125</ix:nonFraction>% Convertible Notes&#8221;), and settled the related conversion option. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Expenses (Income), Net</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie3014b506d2e48688ba3f362c8fd748c">In the year ended December 31, 2020, we recognized an aggregate loss on debt repayment of $<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzYwNDczMTM5NzkzODg_80e6550d-ead3-4f14-a284-0c327f5bde0a">15</ix:nonFraction> million including costs incurred in repayment of the term loan facility, the <ix:nonFraction unitRef="number" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE3MDQyNDMwMjU3OTM5_56c2f1df-1331-4639-8c23-ef7d7cfb1f4b">4.875</ix:nonFraction>% Notes repayment costs described above, and other financing transactions. In the year ended December 31, 2019, we recognized a gain on debt repayment of $<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="moh:GainLossOnDebtRepayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzYwNDczMTM5Nzk1Nzg_423cf68a-fb9b-408b-9f00-64c28db8f527">15</ix:nonFraction> million in connection with the <ix:nonFraction unitRef="number" contextRef="i7ae2b394952c4f1e8142cffc59c02e8f_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE3MDQyNDMwMjU3OTQ3_99e0661e-d2a5-458f-aec2-8453be1ebf42">1.125</ix:nonFraction>% Convertible Notes repayment transactions. These amounts are reported in &#8220;Other expenses (income), net&#8221; in the accompanying consolidated statements of income.</ix:continuation> </span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_202"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">12.&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQ4OTk_792b179d-45e4-4778-85bd-1f91b27755dc" continuedAt="i74cbc2bc05074482b5cf9925b0b8a025" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="i74cbc2bc05074482b5cf9925b0b8a025" continuedAt="i73d617c753d348c3a6e807b1c2c4d660"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQ5NDU_84592dbb-bc37-48fb-b924-890d09c860db" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense for continuing operations consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzQtMS0xLTEtMA_e5c2c4a3-7b11-401b-adda-4a534d5c6a11">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzQtMy0xLTEtMA_ebbbc8df-7844-4612-9eac-77487c0f73ab">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzQtNS0xLTEtMA_22675c30-db37-4891-aa9e-4527cdad04a8">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzUtMS0xLTEtMA_d7a60f60-da40-4e23-b332-1427bac4e66f">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzUtMy0xLTEtMA_a82dce69-efa4-4d68-8c08-e153c440bd38">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzUtNS0xLTEtMA_be8314d3-3eed-4b5e-8fb7-a9c1a745deeb">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzYtMS0xLTEtMA_5210bd04-1edf-4ff9-84fa-3a2176684b07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzYtMy0xLTEtMA_5627fd57-2563-434b-ab52-242354aa2fda">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzYtNS0xLTEtMA_4c63e04f-15e4-49fc-8d31-e777983a8a29">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzctMS0xLTEtMA_348ce020-e1d5-4036-9b0c-adc5babe5a83">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzctMy0xLTEtMA_8db3145c-2093-4483-95ec-4a221ef4b8bc">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzctNS0xLTEtMA_b807d36c-c3bf-4a8e-b9ca-ae5fc5701997">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzktMS0xLTEtMA_1db22182-92da-4e23-a1e5-bf866c2ee1e2">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzktMy0xLTEtMA_225b127a-893f-486f-baec-59190080c233">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzktNS0xLTEtMA_17b2687d-306a-4d84-9ac8-a3320f888112">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEwLTEtMS0xLTA_92885936-bf7e-4e4d-b948-8135cd93216b">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEwLTMtMS0xLTA_0815621f-159d-48c5-bbcc-a728479dacf4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEwLTUtMS0xLTA_5d792877-ba4f-4402-9c40-736a3929d4ec">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzExLTEtMS0xLTA_764e0987-f7bf-4dfa-84cb-071ecb496f4b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzExLTMtMS0xLTA_d102b2c6-f5f9-4c9b-81ed-0dff323757e3">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzExLTUtMS0xLTA_fb6962ac-e677-4ba0-8757-def23aac4b20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEyLTEtMS0xLTA_f723aebe-af8e-4ac4-ab21-e01d4cf0f130">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEyLTMtMS0xLTA_d5d84579-28b7-4633-90a8-595592139804">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEyLTUtMS0xLTA_b26ce469-fd85-420a-bc14-fc9acea9bd42">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEzLTEtMS0xLTA_8a466da8-7274-4de3-b4ba-eb0111bfb5d0">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEzLTMtMS0xLTA_0aee4728-53ca-46ee-8561-27c379d0d0e6">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEzLTUtMS0xLTA_33444bdc-8b74-40cc-a41c-49b1e3046aa8">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i73d617c753d348c3a6e807b1c2c4d660" continuedAt="if1f4af4928064ee297063f8e4503ad0d"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQ5MDE_3d87cdf9-47c3-4458-9528-ceb72f40f31b" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. federal statutory income tax rate to the combined effective income tax rate for continuing operations is as follows:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Statutory federal tax (benefit) rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzItMS0xLTEtMA_608a2365-c949-4bb6-bbda-8775d388c91d">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzItMy0xLTEtMA_dee04a1e-a753-461b-a061-fe8eeb270138">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzItNS0xLTEtMA_95d7c7c2-0461-4bdf-a664-605c5463ef04">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income provision (benefit), net of federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzMtMS0xLTEtMA_dbf16387-2ecb-44d2-8b60-80e1423c5451">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzMtMy0xLTEtMA_f1641699-3c41-4578-81bd-852ecff303bd">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzMtNS0xLTEtMA_4fad909b-eeed-4a6d-ad8f-9bd3203ccee7">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible health insurer fee (&#8220;HIF&#8221;)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="3" name="moh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzUtMS0xLTEtMA_4c6d760e-1e7a-4099-9aa7-00a5e5f70a35">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="3" format="ixt:zerodash" name="moh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzUtMy0xLTEtMA_11a0cb1d-bb5d-4817-8172-3b6a008c4629">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="3" name="moh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzUtNS0xLTEtMA_77fd408e-d18f-4997-ab4b-61f693e5ef41">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzYtMS0xLTEtMA_cd45bab2-2ccb-42b8-b7e2-5195b70d1421">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzYtMy0xLTEtMA_914990ab-0eed-4316-bf60-c738c0169a6b">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzYtNS0xLTEtMA_95795cc3-b753-4d48-97ab-1f2baf2ff26f">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Worthless stock deduction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="3" format="ixt:zerodash" name="moh:EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzktMS0xLTEtMA_1bf66230-6075-4713-988d-7c9b71c45a56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="3" format="ixt:zerodash" name="moh:EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzktMy0xLTEtMA_20d6b7d5-64d6-47d3-bbf7-dae3c0ae275f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="3" name="moh:EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzktNS0xLTEtMA_312b6725-30e4-4786-8f2f-1576e45657cc">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE0LTEtMS0xLTA_bdd70234-f288-4650-9002-a3e577189edc">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE0LTMtMS0xLTA_e5b79c73-120f-4b2d-bf87-3d43f917d9a1">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE0LTUtMS0xLTA_0cf94be5-31be-4302-a22e-bea3570b8fce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax expense rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE1LTEtMS0xLTA_67a1ec42-508c-4ed7-8c43-555457d3d247">30.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE1LTMtMS0xLTA_fb849a46-ba20-4392-8a8a-6f00525ee2af">24.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE1LTUtMS0xLTA_583d560f-8ae9-4e48-a14a-887c2b30287d">29.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate was not impacted by the HIF in 2019 given the HIF moratorium. Our effective tax rate is based on expected income, statutory tax rates, and tax planning opportunities available to us in the various jurisdictions in which we operate. Management estimates and judgments are required in determining our effective tax rate. We are routinely under audit by federal, state, or local authorities regarding the timing and amount of deductions, nexus of income among various tax jurisdictions, and compliance with federal, state, foreign, and local tax laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are classified as non-current. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQ5MTM_0abd3a20-e1bf-48f7-9738-39981f50bc49" continuedAt="i462c1f5343f04662bbbae5002b27a92e" escape="true">Significant components of our deferred tax assets and liabilities as of December&#160;31, 2020 and 2019 were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i462c1f5343f04662bbbae5002b27a92e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and reserve liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzMtMS0xLTEtMA_0a9b9983-b648-4a48-a21b-06fdf8ef7cda">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzMtMy0xLTEtMA_97943fd7-ccc8-4e86-8a58-4106a4998968">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued medical costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzQtMS0xLTEtMA_2efd3dcd-ba7b-4f76-845d-85a9d435f0b6">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzQtMy0xLTEtMA_1920812c-f275-4437-8b49-34cffd7b7024">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzUtMS0xLTEtMA_5dcf0170-2d11-4c90-8b2e-5bc730b2d1c7">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzUtMy0xLTEtMA_961dbb7b-69bf-43fe-be7e-8d782acee8d0">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets and intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:zerodash" name="moh:DeferredTaxAssetsFixedAssetsAndIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzYtMS0xLTEtMA_6b2656ad-a60f-4233-89f4-2d8c365c1532">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="moh:DeferredTaxAssetsFixedAssetsAndIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzYtMy0xLTEtMA_746d3937-1a66-40e5-93bf-2b14b8085bbc">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzctMS0xLTEtMA_e7e7ac15-68c9-438a-b336-3850215c55c7">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzctMy0xLTEtMA_1e215524-615a-48be-b3ac-8bc7dc58c428">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease financing obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzgtMS0xLTEtMA_a8cfe1ed-f396-495b-ab38-5f8ea07a735e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzgtMy0xLTEtMA_d9f28ec3-df81-4b85-abc7-e32fd87e4431">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credit carryover</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzktMS0xLTEtMA_5c0da48b-3bf6-492c-b7e9-50214c021591">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzktMy0xLTEtMA_7fcc4f70-7c6c-4108-8970-b34f12409edf">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEwLTEtMS0xLTA_e8d04fe2-56dc-4dc4-8136-76ed9a950df4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEwLTMtMS0xLTA_cd1a42e7-1957-471e-af55-c3140741e2c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzExLTEtMS0xLTA_f5433c58-c8a1-4d82-b3f8-5e8b24d99bf9">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzExLTMtMS0xLTA_5bcae8c3-b873-4f63-ba35-cb63955df888">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred income tax assets, net of valuation allowance </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEyLTEtMS0xLTA_278a9e77-e0c9-4dcd-8cdb-13badce79537">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEyLTMtMS0xLTA_0b3680d1-4c99-43d6-8d97-9b698a757f51">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets and intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="moh:DeferredTaxLiabilitiesFixedAssetsAndIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEzLTEtMS0xLTIwMzA1_e821329e-ca45-48a8-9fd6-832660cbb3e4">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-3" format="ixt:zerodash" name="moh:DeferredTaxLiabilitiesFixedAssetsAndIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEzLTMtMS0xLTIwMzA1_39446931-a634-427b-8a96-2d2619c35e2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEzLTEtMS0xLTA_c7f7cde6-7fb6-4cd8-b4fa-434dfc029020">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEzLTMtMS0xLTA_c2b069bd-5f2e-4262-8088-b03171d55145">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains and losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE0LTEtMS0xLTE2ODM5_94ce9aac-6042-4535-8f23-e74b9f0cd3e2">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE0LTMtMS0xLTE2ODM5_539094f4-7964-4b94-bc26-bf1f519f5936">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE2LTEtMS0xLTA_69bc2588-0ffc-48d4-8086-15d58b27b2db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE2LTMtMS0xLTA_9dd06ae3-42cf-4b72-8c73-6447ed27b001">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred income tax liabilities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE3LTEtMS0xLTA_1d7d2eda-76a3-487d-93de-116548f597ef">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE3LTMtMS0xLTA_2b36a4c2-bbd8-4baf-b028-2d2281cb269e">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred income tax asset</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE4LTEtMS0xLTA_3b9ea30f-f965-4d35-8e43-0bf02ce4b773">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE4LTMtMS0xLTA_29922d8b-c362-46f3-8777-e7888e2ac3b4">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had state net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i777fc2beee3c4a10b06e4fde2ab42f6b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzIyNDA_09fbb055-aa37-4d75-a7a4-bd9b7e66e6eb">189</ix:nonFraction> million, which begin expiring in 2035.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had foreign net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i0ce9e160ed604a74a1a9a4c25add9c6a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzEwOTk1MTE2MzQxMjA_395e3f63-44c2-4a38-a439-0683d8deb399">5</ix:nonFraction>&#160;million, which expire in 2031. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had California research and development and enterprise zone tax credit carryovers of $<ix:nonFraction unitRef="usd" contextRef="i777fc2beee3c4a10b06e4fde2ab42f6b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzIzNjk_a9357204-7dc1-4598-b571-1ad19e97f672">3</ix:nonFraction> million, which will begin to expire in 2024, and foreign tax credit carryovers of $<ix:nonFraction unitRef="usd" contextRef="i0ce9e160ed604a74a1a9a4c25add9c6a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzI0NDY_769bd4e2-b8f1-412e-b7bc-ca28ca2adb41">5</ix:nonFraction> million, which expire in 2030.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary differences. We have determined that as of December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzI3NDU_36e4a3e3-58bc-451d-8825-0cdf627f36b8">17</ix:nonFraction> million of deferred tax assets did not satisfy the recognition criteria. Therefore, we decreased our valuation allowance by $<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzI4NjQ_8f17082b-1aaa-411f-aeb7-8e3fb7f9482f">7</ix:nonFraction> million, from $<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzI4NzM_99aaed14-7166-42ff-9cee-a738766b4165">24</ix:nonFraction> million at December&#160;31, 2019, to $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzI4ODY_370f237d-d924-436e-9524-0ed5d2095541">17</ix:nonFraction> million as of December&#160;31, 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if1f4af4928064ee297063f8e4503ad0d"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize tax benefits only if the tax position is more likely than not to be sustained. We are subject to income taxes in the United States, Puerto Rico,&#160;and numerous state jurisdictions. Significant judgment is required in evaluating our tax positions and determining our provision for income taxes. During the ordinary course of business, there are many transactions and calculations for which the ultimate tax determination is uncertain. We establish reserves for tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves are established when we believe that certain positions might be challenged despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances, such as the outcome of tax audits. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.</span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQ5MDQ_a2a682a4-69c0-4989-9867-59e4efc9aa87" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The roll forward of our unrecognized tax benefits is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzMtMS0xLTEtMA_e1d43b81-9bba-44b4-a2c9-fc58ce3705b6">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzMtMy0xLTEtMA_153e7c5e-2170-4513-ae45-f4a5f37b6085">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5276df7533a434dba724ca46fb6260b_I20171231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzMtNS0xLTEtMA_20255057-59ac-4165-948d-18558b804d5b">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increases in tax positions for current year </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzQtMS0xLTEtMA_0ebc76fd-217e-4a51-a2bb-694ea953d44f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzQtMy0xLTEtMA_eabab83a-af95-4116-a818-12dda4f88c50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzQtNS0xLTEtMA_431f7e6b-0ec4-4f3f-b01c-d6232944101d">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse in statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzctMS0xLTEtMA_a66b0295-257f-416b-b587-6a27effd14fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzctMy0xLTEtMA_24df9227-3621-4d94-be77-49a0bfbcd696">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzctNS0xLTEtMA_ad3be38c-473e-436a-9583-f093e353b3f7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzExLTEtMS0xLTA_af7c225e-af50-4a16-91b8-038014c4765f">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzExLTMtMS0xLTA_ccd1f365-783e-48ea-add6-5c4a3405d8f0">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzExLTUtMS0xLTA_ee0a9063-5a91-4d7c-9e55-adbb38d19f95">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount of unrecognized tax benefits at December&#160;31, 2020, 2019 and 2018 that, if recognized, would affect the effective tax rates is $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQwNzE_9ea2888c-32c1-412f-ae10-f8884d1dd25a">18</ix:nonFraction> million in each of those respective years. We expect that during the next 12 months it is reasonably possible that unrecognized tax benefit liabilities may decrease by as much as $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQyMzc_45ee50d5-f3cd-47ab-9387-6adc046832b7">10</ix:nonFraction> million due to resolution of exams and refund claims.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our continuing practice is to recognize interest and/or penalties related to unrecognized tax benefits in income tax expense. Amounts accrued for the payment of interest and penalties as of December&#160;31, 2020, 2019 and 2018 were insignificant.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are under examination by the IRS for calendar years 2015 through 2017 and may be subject to examination for calendar years 2018 and 2019. With a few exceptions, which are immaterial in the aggregate, we no longer are subject to state, local, and Puerto Rico tax examinations for years before 2015.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_205"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">13. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2Mzg_bc2e39cd-620d-4f41-af64-eb3575aec0c2" continuedAt="i562613f17c154838afe45361f3953a92" escape="true">Stockholders' Equity</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i562613f17c154838afe45361f3953a92" continuedAt="i7bd98097c79c4b60a294dc48457207a4"> </ix:continuation></span></div><ix:continuation id="i7bd98097c79c4b60a294dc48457207a4" continuedAt="i4fb63ee3b8414d778848ab66fc998f51"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Purchase Programs</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, our board of directors authorized the purchase of up to $<ix:nonFraction unitRef="usd" contextRef="i31b468479ec6404c8a870d751d8727e0_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzIxOTkwMjMyNjQ0OTM_50182fb9-c81f-4bad-887d-8690bee78ba9">500</ix:nonFraction> million, in the aggregate, of our common stock. This program is funded with cash on hand and extends through December 31, 2021. The exact timing and amount of any repurchase is determined by management based on market conditions and share price, in addition to other factors, and subject to the restrictions relating to volume, price, and timing under applicable law. Under this program, pursuant to a Rule 10b5-1 trading plan, we purchased approximately <ix:nonFraction unitRef="shares" contextRef="i1127fb6f8661484e9a2afce5e70e881c_D20201101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzIxOTkwMjMyNjQ1MjI_511aeb1d-cfee-4716-b49b-b73a1fe498b6">766,000</ix:nonFraction> shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="i1127fb6f8661484e9a2afce5e70e881c_D20201101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzIxOTkwMjMyNjQ1MTc_5abad43f-3fa9-44de-a29e-a243c88e6a72">159</ix:nonFraction> million in November and December 2020 (average cost of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1127fb6f8661484e9a2afce5e70e881c_D20201101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzIxOTkwMjMyNjQ1MzI_ddeaf7be-7459-4371-a0c2-271ffdb0dfdb">208.37</ix:nonFraction> per share), including approximately <ix:nonFraction unitRef="shares" contextRef="i20fed1f62d734cc294821cf3b9a1b49a_D20201201-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzEwOTk1MTE2Mzk4NjA_d332a651-b371-4e6d-bcd5-af2ea71b1bcb">29,000</ix:nonFraction> shares purchased for $<ix:nonFraction unitRef="usd" contextRef="i20fed1f62d734cc294821cf3b9a1b49a_D20201201-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzEwOTk1MTE2Mzk3Njk_bc1467d3-8de3-4a20-bcaa-d27f441af95f">6</ix:nonFraction> million in late December 2020, and settled in early January 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, our board of directors authorized the purchase of up to $<ix:nonFraction unitRef="usd" contextRef="ib0d1799cc9734f13b9ac873259cad7c6_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzExNg_a79dbcf7-4823-4345-9791-80a721589dad">500</ix:nonFraction> million, in the aggregate, of our common stock. This program was funded with existing cash on hand and was completed in March 2020. Under this program, pursuant to a Rule 10b5-1 trading plan, we purchased approximately <ix:nonFraction unitRef="shares" contextRef="i19562697a92c4804a128c7d53a9fca1c_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzMyOQ_92721b51-b2b9-4641-8636-27035a3e7359">3.4</ix:nonFraction> million shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="i19562697a92c4804a128c7d53a9fca1c_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzM2Mw_1ccea1d5-39c9-4419-aabc-1bf951206187">446</ix:nonFraction> million in the first quarter of 2020 (average cost of $<ix:nonFraction unitRef="usdPerShare" contextRef="i19562697a92c4804a128c7d53a9fca1c_D20200101-20200331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzQxMg_f5558456-620f-4bb5-af09-37e9e08be969">132.45</ix:nonFraction> per share). In the first quarter of 2020, we also paid $<ix:nonFraction unitRef="usd" contextRef="i6c2f88ae28624d2d83b180b3207c2ee4_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzE2NDkyNjc0NTQwOTg_cb265f59-e0e8-4dac-afab-038d382ef8bb">7</ix:nonFraction>&#160;million to settle shares purchased in late December 2019.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsequent Event</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From January 1, 2021 through February 11, 2021, we purchased approximately <ix:nonFraction unitRef="shares" contextRef="i405b0566313b404d88d226953fb10b4b_D20210101-20210211" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzEwOTk1MTE2Mzk4Nzc_169badeb-61e5-4852-b4aa-22911c97f308">577,000</ix:nonFraction> shares for $<ix:nonFraction unitRef="usd" contextRef="i405b0566313b404d88d226953fb10b4b_D20210101-20210211" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzEwOTk1MTE2Mzk4OTI_7fa06e84-6335-4f73-93c5-a277f49d1069">122</ix:nonFraction> million (average cost of $<ix:nonFraction unitRef="usdPerShare" contextRef="i405b0566313b404d88d226953fb10b4b_D20210101-20210211" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzEwOTk1MTE2Mzk5MDM_d90f0ac2-8d63-4f89-88e5-97b410c7b16c">211.65</ix:nonFraction> per share).</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the <ix:nonFraction unitRef="number" contextRef="i230e39d7097f4f04ac9d6a41de9ad215_I20201231" decimals="INF" name="moh:ClassOfWarrantOrRightStatedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzU0OTc1NTgxNTExODY_f946c1c1-672d-48cb-a567-477f0f53a9ea">1.125</ix:nonFraction>% Convertible Notes settlement transaction described in Note 11, &#8220;Debt,&#8221; in the first quarter of 2020 we entered into privately negotiated agreements to terminate the associated <ix:nonFraction unitRef="shares" contextRef="i230e39d7097f4f04ac9d6a41de9ad215_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYwNDczMTM5NjU1NDg_9f2daafb-e073-4e02-8f06-e860e79a1bf3">310,000</ix:nonFraction> warrants outstanding for $<ix:nonFraction unitRef="usd" contextRef="i0f8dcd5ceb6c487f9c1bdf9a574307f8_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzIxOTkwMjMyNjYwNDM_745209ef-bf18-4b41-a006-a383356eed9e">30</ix:nonFraction>&#160;million, which resulted in a reduction of additional paid-in-capital for the same amount.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4fb63ee3b8414d778848ab66fc998f51" continuedAt="i246833c1da9b4a8c9dd98a849fda64b0"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our employee stock plans, approximately <ix:nonFraction unitRef="shares" contextRef="i96a5b2f5752d4c3d8f85ea9e8b1da0ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY1OTcwNjk3ODAxMTU_9dfbe22a-9017-4eb1-8ca2-6857b91bb8b7">244,000</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i3ac5351ddca146c7888f5e88c0fb0733_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY1OTcwNjk3ODAxMzA_497a7e12-57c7-4b6d-a68e-26f231341c7f">242,000</ix:nonFraction> shares of common stock were issued, net of shares used to settle employees&#8217; income tax obligations, during the years ended December&#160;31, 2020, and 2019, respectively. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY1OTg_d032ff41-5580-4d1e-b850-48e1a08290f1" continuedAt="ic3e359ddb05f461cb2e89d8e41b418ab" escape="true">Total share-based compensation expense is reported in &#8220;General and administrative expenses&#8221; in the accompanying consolidated statements of income, and summarized below.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><ix:continuation id="ic3e359ddb05f461cb2e89d8e41b418ab"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax<br/>Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net-of-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax<br/>Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net-of-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax<br/>Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net-of-Tax<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSAs, PSAs and PSUs (defined below)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5144ba022d44d493772c715fe5aa45_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtMS0xLTEtMA_2908f00a-2f56-4bff-a3ab-1e88d0a8d792">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5144ba022d44d493772c715fe5aa45_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtMy0xLTEtMA_18a51a50-8838-483e-865a-74b068279a0f">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcae5fc25c5d4bfe9751f1e0b6a647e4_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtNS0xLTEtMA_11a46f23-b38b-4aa4-8efd-38fbf733c0d6">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcae5fc25c5d4bfe9751f1e0b6a647e4_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtNy0xLTEtMA_36c44383-4829-4ec6-82f1-eaefac7537ea">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09bb25d620c34957a416d46cefe3fae8_D20180101-20181231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtOS0xLTEtMA_a2827c7f-662f-4143-9ba6-269834734e91">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09bb25d620c34957a416d46cefe3fae8_D20180101-20181231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtMTEtMS0xLTA_4a34e49f-2cfd-4ec3-af54-ecaaad34c813">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee stock purchase plan and stock options </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f621f530a7426ebac680c21dabf01e_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtMS0xLTEtMA_d0818814-38c9-438e-a8d7-086b10d72693">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f621f530a7426ebac680c21dabf01e_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtMy0xLTEtMA_61c29558-03e5-49c0-bb3a-e44993c38ea8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f8a559e0b7d4a32b56f7a92d9cc722b_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtNS0xLTEtMA_4e5ebb4b-a36b-434b-bbf3-eca6d3f5522d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f8a559e0b7d4a32b56f7a92d9cc722b_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtNy0xLTEtMA_72f6ecfb-91c4-41c4-850f-8f696c01b481">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bc80c4169054f6d86a4e10b0c36c602_D20180101-20181231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtOS0xLTEtMA_056e8b17-74bf-4275-8636-ef575988f1a9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bc80c4169054f6d86a4e10b0c36c602_D20180101-20181231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtMTEtMS0xLTA_92e7242c-85f1-4811-bbc5-4587839ddff3">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtMS0xLTEtMA_9ca84a72-5bb7-4fc7-8b72-b6c4e68c3e11">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtMy0xLTEtMA_5587d967-eab2-4a51-8999-aba462f639c5">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtNS0xLTEtMA_8abd3af8-ca7f-4001-aff6-523162f74ebc">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtNy0xLTEtMA_20029c79-08e9-44a3-a45d-cf9fe8b429db">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtOS0xLTEtMA_dc1093f8-bafe-4a03-9c5b-77ee55ad1d59">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtMTEtMS0xLTA_71aef67b-1d40-4363-b607-c5ae444e77a9">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Incentive Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had employee equity incentives outstanding under our 2019 Equity Incentive Plan (the &#8220;2019 EIP&#8221;). The 2019 EIP provides for awards, in the form of restricted and performance stock awards (&#8220;RSAs&#8221; and &#8220;PSAs&#8221;), performance units (&#8220;PSUs&#8221;), stock options, and other stock&#8211; or cash&#8211;based awards, to eligible persons who perform services for us. The 2019 EIP provides for the issuance of up to <ix:nonFraction unitRef="shares" contextRef="i292647db232f497088463dcb696a6bc4_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzMxNjc_09605f12-32a5-4a07-aef6-35cc6147620f">2.9</ix:nonFraction> million shares of our common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based awards</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. RSAs, PSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to <ix:nonNumeric contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzM0MzY_851268c7-d871-4cb5-aae4-6990c1ff5be4">four years</ix:nonNumeric> from the date of grant. Certain PSUs may vest in their entirety at the end of <ix:nonNumeric contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzU0OTc1NTgxNTEyMDc_0620f3f5-c428-4811-8e50-74803f3a2b87">three-year</ix:nonNumeric> performance periods, if their performance conditions are met. We generally recognize expense for RSAs, PSAs and PSUs on a straight-line basis. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2MjM_86c48cf7-ebc9-41aa-95b3-f7a6804aab2a" continuedAt="i7e9019b994a146ed8f816bb50e2617fa" escape="true">Activity for stock-based awards in the year ended December&#160;31, 2020, is summarized below.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i7e9019b994a146ed8f816bb50e2617fa"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:40.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSAs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant&#160;Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant&#160;Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested balance, December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4aca872bf92456a9a20db5fae524392_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzEtMS0xLTEtMTc5Ng_cf0f3603-7b2e-45e1-8758-060b01731201">447,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4aca872bf92456a9a20db5fae524392_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzEtMy0xLTEtNTU4Mg_6836cf0d-6af5-46ee-8309-86eef2cedc4a">102.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i89fe848546204fe2b34f89e0a78c161d_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzEtNS0xLTEtMTc5Ng_81448c2c-839b-41ad-b4d9-911a9309aef3">324,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i89fe848546204fe2b34f89e0a78c161d_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzEtNy0xLTEtNTU4NA_4d072bd0-0ac2-42c6-a58d-b9f904c7fab6">101.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzItMS0xLTEtMTc5Ng_0c327815-235a-4c19-a646-636c23f3567a">344,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzItMy0xLTEtNTU4Mg_f8db93e1-cee5-4253-917b-304dc6f05139">127.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzItNS0xLTEtMTc5Ng_f94c5882-f330-4073-9ee1-b7ffab9a82fc">188,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzItNy0xLTEtNTU4NA_183ed248-70d3-4248-8773-a8b6d65dd4f7">123.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzMtMS0xLTEtMTc5Ng_38ce8e39-67b5-45fd-8c49-9e39f4045274">172,675</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzMtMy0xLTEtNTU4Mg_688a2dfd-a6ce-4282-800a-9b264e9c2a76">98.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzMtNS0xLTEtMTc5Ng_ff6a721a-ba55-421c-a51b-242861a22a4a">7,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzMtNy0xLTEtNTU4NA_2e37a783-65fe-497f-910a-1614f2a599d8">68.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzQtMS0xLTEtMTc5Ng_53a182fb-891a-460e-981a-69d66fda0771">34,660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzQtMy0xLTEtNTU4Mg_bb872ede-c2a0-46aa-b616-f6f0ffc5131d">113.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzQtNS0xLTEtMTc5Ng_ae3918ad-4cf3-434c-b6f4-4463ca13bde7">33,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzQtNy0xLTEtNTU4NA_b4661896-3a08-4822-876b-ec78eeb12c1c">98.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested balance, December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i572ceba4cf6044c5902601a01b0ea881_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzUtMS0xLTEtMTc5Ng_d1cd1068-a214-4461-a033-481326654dbb">585,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i572ceba4cf6044c5902601a01b0ea881_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzUtMy0xLTEtNTU4Mg_93e08116-840b-4b47-8af2-69d13fe886aa">118.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36ed381ff8654ca990008ef6dcd3154b_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzUtNS0xLTEtMTc5Ng_f3041690-5c26-4221-b2bf-b4c53c242baf">471,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i36ed381ff8654ca990008ef6dcd3154b_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzUtNy0xLTEtNTU4NA_38587b9c-2681-4d39-ab3d-f2628b36170e">111.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, total unrecognized compensation expense related to unvested RSAs and PSUs was $<ix:nonFraction unitRef="usd" contextRef="i572ceba4cf6044c5902601a01b0ea881_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzM4MzU_08a010c8-2a7b-4f48-8da9-f00b8441772c">42</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i36ed381ff8654ca990008ef6dcd3154b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzE2NDkyNjc0NTU0OTQ_a20c6dbd-e501-4293-b073-d5d6e34b19bc">23</ix:nonFraction> million, respectively, which we expect to recognize over a remaining weighted-average period of <ix:nonNumeric contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzM5MTI_3359ce9a-2d9e-43a2-9631-7a800fa8920c">2.2</ix:nonNumeric> years, and <ix:nonNumeric contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzM5MjA_67c0c943-e31a-46a2-aa55-275281ac75c1">1.2</ix:nonNumeric> years, respectively. This unrecognized compensation cost assumes an estimated forfeiture rate of <ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="3" name="moh:UnrecognizedCompensationForfeitedRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzQwMTQ_409a0520-2260-4d04-bb3d-1ec7dafda7cf">12.2</ix:nonFraction>% for non-executive employees as of December&#160;31, 2020, based on actual forfeitures over the last <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzU0OTc1NTgxNDk3NDg_0a0dc098-ff01-4261-b5cb-f342d5488ad5">4</ix:nonNumeric> years. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i246833c1da9b4a8c9dd98a849fda64b0"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY1OTk_a6cc51f0-8312-47c2-bcb1-90b530898338" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total grant date fair value of awards granted and vested is presented in the following table.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSAs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231" decimals="-6" name="moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzQtMS0xLTEtMA_4c1791eb-0530-4d4c-9ae4-1fbef3f75e1d">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28cf707559d6450aabd54eb6691a6598_D20190101-20191231" decimals="-6" name="moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzQtMy0xLTEtMA_a5ead032-3919-4b90-8e76-431a7e449a3f">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i372cfd6a471f48bcbd14fd8e83885c92_D20180101-20181231" decimals="-6" name="moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzQtNS0xLTEtMA_e56c0559-dada-4baa-8fd8-43135c8515d2">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231" decimals="-6" name="moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzUtMS0xLTEtMA_3c95d38e-da4f-46fe-8fa3-475a260af7b1">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba5202a65ac342848cf80d5efc7a35c9_D20190101-20191231" decimals="-6" name="moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzUtMy0xLTEtMA_a7a11b96-0cf5-4e57-b633-860f6f5a3c24">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd75881230294473867aed8c11c46a5b_D20180101-20181231" decimals="-6" name="moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzUtNS0xLTEtMA_655ce6c2-1782-4620-bc2e-2c6ac2f30576">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total granted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzYtMS0xLTEtMA_9946bc1d-301d-4b85-bf9b-3a8fbf22d967">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzYtMy0xLTEtMA_59843c5c-ce9d-4bc3-a021-305c2a2836fa">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzYtNS0xLTEtMA_de73bf26-c58c-455b-82af-78efa26a0033">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSAs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzgtMS0xLTEtMA_dd76ee06-7825-4f6c-931c-9a444edaf09d">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28cf707559d6450aabd54eb6691a6598_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzgtMy0xLTEtMA_1a77a60c-eed5-4e34-91d2-da82c75ee529">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i372cfd6a471f48bcbd14fd8e83885c92_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzgtNS0xLTEtMA_e8390ce1-558f-4609-8791-ddf566f543fb">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4d57c51df1f4304bfc986fb72585507_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzktMS0xLTEtMA_87649c56-841c-40c7-9b45-d30b78f6c2fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82194307d804f828b55b0572af7065d_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzktMy0xLTEtMA_00996588-b755-449d-9291-87f08fd4ae15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6f3b120b6c45aabfabfd970687858d_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzktNS0xLTEtMA_2386817d-80bd-4b7a-bdc8-d7b346c87d2c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzEwLTEtMS0xLTA_06982750-f297-430d-848b-03ef2544b9a0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba5202a65ac342848cf80d5efc7a35c9_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzEwLTMtMS0xLTA_2c20dc06-188b-4e86-aa80-0abf33754179">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd75881230294473867aed8c11c46a5b_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzEwLTUtMS0xLTA_83263f0e-96ec-4b01-9514-b9921269e0b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total vested</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzExLTEtMS0xLTA_e498ba89-e35d-4995-a429-843fdbb666bb">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzExLTMtMS0xLTA_b69a1893-dcef-4562-9ef3-cdc76661e7a3">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzExLTUtMS0xLTA_37583b65-009c-41f3-8d87-07b944e0e169">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Stock option awards generally have an exercise price equal to the fair market value of our common stock on the date of grant, vest in equal annual installments over periods up to <ix:nonNumeric contextRef="ife21f4c2287b449c80bf5cbcb34cfee4_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzQ0MDE_63356a67-a1a1-40b7-9de8-1b77228cab60">four years</ix:nonNumeric> from the date of grant, and have a maximum term of <ix:nonNumeric contextRef="ife21f4c2287b449c80bf5cbcb34cfee4_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzQ0NTU_0b2f0405-1bf9-4bd1-b73c-6427fcc9aa2d">ten years</ix:nonNumeric> from the date of grant. Stock option activity for the year ended December&#160;31, 2020, is summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual term</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Per share)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options outstanding as of December 31, 2019 and December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtMS0xLTEtMA_81a00482-1b66-439f-bf3f-fa6267f7852a"><ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtMS0xLTEtMA_b81b2957-85a5-4d82-a0e0-96af174b0058">405,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtMy0xLTEtMA_3e04aaae-eb12-4b0d-a8d9-a2df790b8697"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtMy0xLTEtMA_74e574eb-36a8-443a-87f3-1fb48d0a55d8">64.79</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtNS0xLTEtMA_73a9483b-488c-4dd7-9b95-da74ad487135"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtNS0xLTEtMA_b75d2c90-618a-41c7-bb76-b751240c3af0">60</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtNy0xLTEtMA_18d58092-6643-4f0b-b117-5d40336e979a"><ix:nonNumeric contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtNy0xLTEtMA_99f19a5b-8c28-418e-ba48-862659580dde">6.4</ix:nonNumeric></ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options exercisable and expected to vest as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzYtMS0xLTEtMA_34745060-0a70-4025-a5f3-7603aed61c30">405,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzYtMy0xLTEtMA_84371e75-eb11-4602-8504-d00fedbe8152">64.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzYtNS0xLTEtMA_00367667-2064-46ba-af0f-1d26c5df79c9">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzYtNy0xLTEtMA_5b7f83a4-1d99-43e9-8be6-980d5184138c">6.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzctMS0xLTEtMA_b3337934-9f2a-4a37-bfbb-b6bd295872bd">405,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzctMy0xLTEtMA_da8f14c4-f426-49a1-8537-26682cabc167">64.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzctNS0xLTEtMA_2d9eddee-e87b-47b4-8ece-246b8dbc585a">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzctNy0xLTEtMA_874de56b-0f75-4ed9-8c0a-6885c0f18f0d">6.4</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2MzA_a5bac1d9-202d-4cce-9e1a-c5360be62d1f"><ix:nonFraction unitRef="shares" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2MzA_c29dfc3f-4048-418d-9a6c-00c6c258728b"><ix:nonFraction unitRef="shares" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2MzA_f98c17a1-d411-4df5-8d2a-11de74ecf312">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> stock options were granted or exercised in 2020, 2019, or 2018, and as of December&#160;31, 2020, there was no unrecognized compensation expense related to unvested stock options.</span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2MTg_5d10967a-b7d8-4142-ba31-8f2e562123ef" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of information about stock options outstanding and exercisable at December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding and Exercisable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Per share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Range of Exercise Prices</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ic3f96ca2a41b497882c4e2decff210d8_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzQtMC0xLTEtMjE1MDYvdGV4dHJlZ2lvbjozZDU4MjIwOGQwOTE0OTEyOWE3ZDgwOGNiNTQzOGY2Y18xMDk5NTExNjI3Nzkw_829d2b1f-8f8f-4656-af27-257aae4e440f">33.02</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f5a36308730434eb22cb4ec367111c0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzMtMS0xLTEtMA_410da17c-89f9-416a-a982-99f6cb188c61">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic3f96ca2a41b497882c4e2decff210d8_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzMtMy0xLTEtMA_022995e2-7529-4ad1-8011-4eed14deb9c0">2.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f5a36308730434eb22cb4ec367111c0_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzMtNS0xLTEtMA_9b83321f-9da3-44b2-a7ee-e405160cea73">33.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0f4bfa5083c14dc982d7f30f9c3f2c76_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzUtMC0xLTEtMjE1MTEvdGV4dHJlZ2lvbjo1Yzk5MzMxNWU3YTU0MGZiYWMzYWQ1MTFiZjE1Yjg1Ml8xMDk5NTExNjI3Nzkw_e87a51fc-b6f5-469e-a97d-a398b5c0a059">67.33</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0bfeb88842e48c681d6c147892747da_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzQtMS0xLTEtMA_07d26a6a-83e7-489a-b5fa-aecbb70ef35a">375,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f4bfa5083c14dc982d7f30f9c3f2c76_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzQtMy0xLTEtMA_a7ec8331-cc78-4d0e-bdff-3cb01b14f748">6.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic0bfeb88842e48c681d6c147892747da_I20201231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzQtNS0xLTEtMA_b2c36aba-66cb-4dbc-8fb1-307b3fabf33a">67.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzUtMS0xLTEtMA_e4f5ac12-3add-4a1e-b44f-fe99062748d4">405,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee Stock Purchase Plans (&#8220;ESPP&#8221;)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our ESPP, eligible employees may purchase common shares at <ix:nonFraction unitRef="number" contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231" decimals="INF" name="moh:FairMarketValueOfCommonStockPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzU1OTQ_683e1e2b-6d6e-4380-8532-333cfb4fae6d">85</ix:nonFraction>% of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a maximum purchase of $<ix:nonFraction unitRef="usd" contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzU3ODM_1ac02c72-6e04-4de6-bafa-391777811635">25,000</ix:nonFraction> (as measured by the fair value of the stock acquired) per year through payroll deductions. We estimate the fair value of the stock issued using a standard option pricing model. For the years ended December&#160;31, 2020, 2019, and 2018, the inputs to this model were as follows: risk-free interest rates of approximately <ix:nonFraction unitRef="number" contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYwOTA_2cb63c97-c1a5-4ab4-995d-53add487e935">0.2</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYwOTY_07902ab4-57ce-4351-be9b-b37f9b52b86c">2.3</ix:nonFraction>%; expected volatility of approximately <ix:nonFraction unitRef="number" contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYxNDk_84fb0dc6-b37e-4dfa-a5b5-ebb74189869a">31</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYxNTU_6a47d57c-a17a-4a47-bedd-538e49c8152b">51</ix:nonFraction>%, dividend yields of <ix:nonFraction unitRef="number" contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYxNzg_798b128a-3c6e-48a7-8c7a-88c94834c238">0</ix:nonFraction>%, and an average expected life of <ix:nonNumeric contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYyMTQ_b6dbfbf6-06e2-4cf8-b466-d01d8b375f33">0.5</ix:nonNumeric> years.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 82</span></div></div></div><div id="if790247689124308855d86d82384a359_217"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">14.&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzc2Ng_fe65695f-8a62-4473-a07c-bb5c0e7a2d38" continuedAt="ibda9d5dc883a4d1f872f6461f8dcb52e" escape="true">Employee Benefit Plans</ix:nonNumeric></span></div><ix:continuation id="ibda9d5dc883a4d1f872f6461f8dcb52e"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first <ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzI1Nw_e3b21ac6-302f-4c45-9e21-e4dcfaefa235">4</ix:nonFraction>% of compensation contributed by employees. Expense recognized in connection with our contributions to the 401(k) plans amounted to $<ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzM5MA_917f0226-2e7e-4756-9a42-a7d5683db5ba">28</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzM5NA_803cceb2-d19a-46ec-9270-260d2752fa8d">28</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzQwMg_6d62cdcb-46f2-413e-8f5c-b3c4270710ee">36</ix:nonFraction> million in the years ended December&#160;31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a non-qualified deferred compensation plan for certain key employees. Under this plan, eligible participants may defer up to <ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="INF" name="moh:DeferredCompensationPlanDeferralPercentageOfBasicSalary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzU5Mw_ae8cd113-7769-41af-bba9-8edbc44e1f5c">75</ix:nonFraction>% of their base salary and <ix:nonFraction unitRef="number" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="INF" name="moh:DeferredCompensationPlanDeferralPercentageOfBonus" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzYyMQ_18778c3b-aace-40dd-9b50-7ec3ef4f714d">90</ix:nonFraction>% of their bonus to provide tax-deferred growth.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_220"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">15.&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzQxNzI_fdb88b85-2030-4357-af8a-5da93094cdc3" continuedAt="ib26b6e150bb849eeb70e57f2ce4dc3fc" escape="true">Commitments and Contingencies </ix:nonNumeric></span></div><ix:continuation id="ib26b6e150bb849eeb70e57f2ce4dc3fc" continuedAt="i4633dd125ebf4fbf90668e47ef46e179"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Capital Requirements and Dividend Restrictions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans, which are generally operated by our respective wholly owned subsidiaries in those states, are subject to state laws and regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state. The National Association of Insurance Commissioners (&#8220;NAIC&#8221;), has adopted rules which, if implemented by the states, set minimum capitalization requirements for insurance companies, HMOs, and other entities bearing risk for healthcare coverage. The requirements take the form of risk-based capital (&#8220;RBC&#8221;) rules which may vary from state to state. Regulators in some states may also enforce capital requirements that require the retention of net worth in excess of amounts formally required by statute or regulation. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the states in which our health plans operate, except California, Florida, Massachusetts and New York, have adopted the RBC rules. The RBC rules, if adopted by California, Florida, Massachusetts or New York, could increase the minimum capital required for those states. Our Massachusetts health plan, acquired on December 31, 2020, maintains a $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SpecialAssessmentBond" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzE3MDQyNDMwMjM5MDQ2_c67d6641-a582-46b6-93b5-93d876bba07a">35</ix:nonFraction>&#160;million performance bond, effective through December 31, 2021, to partially satisfy minimum net worth requirements in that state.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. Based on current statutes and regulations, the net assets in these subsidiaries (not including the Magellan Complete Care subsidiaries and after intercompany eliminations), which may not be transferable to us in the form of loans, advances, or cash dividends was approximately $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzIxMDk_cae0f30b-2104-43cf-8686-72151db2a3d8">1,960</ix:nonFraction> million at December&#160;31, 2020, and $<ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzIxMjM_8a811ba5-3cde-4813-972b-e09bc5f62633">1,810</ix:nonFraction> million at December&#160;31, 2019. We estimate the Magellan Complete Care subsidiaries&#8217; net assets that may not be transferable amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="iec02edc64cf748bcb7c0886f12b109e5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzE3MDQyNDMwMjQwOTI0_f7759d27-b649-42d6-84fd-4ccd3d38c102">420</ix:nonFraction>&#160;million at December 31, 2020. Because of the statutory restrictions that inhibit the ability of our health plans to transfer net assets to us, the amount of retained earnings readily available to pay dividends to our stockholders is generally limited to cash, cash equivalents and investments held by the parent company&#8212;Molina Healthcare, Inc. Such cash, cash equivalents and investments amounted to $<ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzI1MDU_39772075-1e28-46e6-9e71-c87c98082940">644</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzI1MTI_3f252ac4-798a-4d28-95e3-f5050d701476">997</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, our health plans (not including the Magellan Complete Care subsidiaries) had aggregate statutory capital and surplus of approximately $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzYwNDczMTM5NTk4MDA_8c3bda13-704c-440e-8fa1-92b09c12a3db">2,020</ix:nonFraction> million compared with the required minimum aggregate statutory capital and surplus of approximately $<ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzYwNDczMTM5NTk4OTY_3b14976e-5b95-419c-8bd9-dd5c896a5024">1,310</ix:nonFraction> million. As of December 31, 2020, the aggregate and minimum capital and surplus of the Magellan Complete Care subsidiaries amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="iec02edc64cf748bcb7c0886f12b109e5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzE3MDQyNDMwMjQwOTM4_0e1735bf-5bbb-46a5-a9da-45a6dc141149">420</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i14669561f20444379f482d5083c58318_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzYwNDczMTM5NjMxMjI_65888935-c4c3-4757-8592-7d77494bcda2">230</ix:nonFraction>&#160;million, respectively. The aggregate capital and surplus of our wholly owned subsidiaries was in excess of these minimum capital requirements as of December&#160;31, 2020.  We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor and assess the estimated operating and financial impact of the COVID-19 pandemic, and as it evolves, we continue to process, assemble, and assess member utilization information. We believe that our cash resources, borrowing capacity available under the Credit Agreement, and cash flow generated from operations will be sufficient to withstand the financial impact of the pandemic, and will enable us to continue to support our operations, regulatory requirements, debt repayment obligations, and capital expenditures for the foreseeable future.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4633dd125ebf4fbf90668e47ef46e179" continuedAt="ie505605d019d48c2849e9288635301c4"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines and penalties, exclusion from participating in publicly funded programs, and the repayment of previously billed and collected revenues. </span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in legal actions in the ordinary course of business including, but not limited to, various employment claims, vendor disputes and provider claims. Some of these legal actions seek monetary damages, including claims for punitive damages, which may not be covered by insurance. We review legal matters and update our estimates of reasonably possible losses and related disclosures, as necessary. We have accrued liabilities for legal matters for which we deem the loss to be both probable and reasonably estimable. These liability estimates could change as a result of further developments of the matters. The outcome of legal actions is inherently uncertain. An adverse determination in one or more of these pending matters could have an adverse effect on our consolidated financial position, results of operations, or cash flows.&#160; </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kentucky RFP. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 4, 2020, Anthem Kentucky Managed Care Plan, Inc. brought an action in Franklin County Circuit Court against the Kentucky Finance and Administration Cabinet, the Kentucky Cabinet for Health and Family Services and all of the winning bidder health plans, including Molina Healthcare of Kentucky, Inc., Civil Action No. 20-CI-00719. In its action, Anthem requested that the court disqualify Molina Healthcare of Kentucky, find that the Kentucky RFP scoring was erroneous and violated procedures or was arbitrary and capricious, set aside the contract awards and conduct a new RFP evaluation process, and award injunctive relief, including stopping the implementation of the contracts awarded under the RFP. On September 28, 2020, the court issued a temporary restraining order preserving the status quo, and on October 23, 2020, the court issued a temporary injunction directing that the RFP readiness review and open enrollment proceed with six health plans, including both Anthem and Molina Healthcare. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2020, the court granted a motion by UnitedHealthcare of Kentucky LTD. to assert a cross-claim against the Kentucky Cabinet for Health and Family Services, which sought in part a disqualification of Anthem or Molina Healthcare and a declaratory judgment that the Kentucky Medicaid program proceed with only five health plans. On December 23, 2020, Humana Health Plan, Inc. brought a separate action against the Commonwealth of Kentucky and the winning bidder health plans, including Molina Healthcare of Kentucky, Civil Action 20-CI-00987. On January 11, 2021, both actions were consolidated before the Franklin County Circuit Court. Humana requests a declaratory judgment finding that the Commonwealth violated the Medicaid contract by allocating Passport members to Molina Healthcare for 2021 so that Passport members would instead be allocated to Humana and other winning health plans, or, in the alternative, monetary damages from the Commonwealth. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare believes it has meritorious defenses to the claims of Anthem, United, and Humana, and intends to vigorously defend its position, including its twice being a winning bidder of the Kentucky Medicaid RFP, and its protection of the continuity of care for Passport Medicaid members. This matter remains subject to significant additional legal proceedings, and no assurances can be given regarding the ultimate outcome.  Under the court&#8217;s temporary injunction, Molina Healthcare of Kentucky continues to operate under its contract and provide care to Kentucky Medicaid members.   </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Professional Liability Insurance</span></div></ix:continuation><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie505605d019d48c2849e9288635301c4">We carry medical professional liability insurance for healthcare services rendered in the primary care institutions that we manage. In addition, we carry managed care errors and omissions insurance for all managed care services that we provide.</ix:continuation> </span></div><div><span><br/></span></div><div id="if790247689124308855d86d82384a359_223"></div><div style="margin-bottom:5pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">16. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90ZXh0cmVnaW9uOjhjNjg0MTJmYzZiMjRkZTBhZGQwMTM3ZmU1OGY5YmZkXzE3MDQyNDMwMjM2MjEw_ccc8b165-1bc2-4efa-9eb4-0629a815c169" continuedAt="ib2783e293cd84716a7b93ebf6d54b192" escape="true">Segments </ix:nonNumeric></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib2783e293cd84716a7b93ebf6d54b192" continuedAt="i28a1b68823d34729bf012488b605e7da">As of December 31, 2020, we had <ix:nonFraction unitRef="segment" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90ZXh0cmVnaW9uOjhjNjg0MTJmYzZiMjRkZTBhZGQwMTM3ZmU1OGY5YmZkXzMx_996a3170-4e0c-4aaa-8da0-8e978fefe709">two</ix:nonFraction> reportable segments: the Health Plans segment, and the Other segment. Our reportable segments are consistent with how we currently manage the business and view the markets we serve.  The Health Plans reportable segment includes our regulated health plan operating segments, along with the recently acquired Magellan Complete Care health plans operating segment. Because this acquisition closed on December 31, 2020, Magellan Complete Care&#8217;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020. Management will continue to evaluate the composition of its operating and reportable segments for future filings. The Other segment, which is insignificant to our consolidated results of operations, includes certain corporate amounts not associated with or allocated to the Health Plans segment. In 2018, the Other segment also included the results of certain unregulated subsidiaries we sold in late 2018.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i28a1b68823d34729bf012488b605e7da"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Margin is the appropriate earnings measure for our reportable segments, based on how our chief operating decision maker currently reviews results, assesses performance, and allocates resources.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key metrics used to assess the performance of our Health Plans segment are premium revenue, medical margin and MCR. MCR represents the amount of medical care costs as a percentage of premium revenue. Therefore, the underlying margin, or the amount earned by the Health Plans segment after medical costs are deducted from premium revenue, is the most important measure of earnings reviewed by management. <ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90ZXh0cmVnaW9uOjhjNjg0MTJmYzZiMjRkZTBhZGQwMTM3ZmU1OGY5YmZkXzI1Mjg4NzY3NDQ0NTY0_1dab0d53-542b-4e4e-a8f7-c505b742aa1e" continuedAt="if5dfff625c74423d805c6d87324c22b4" escape="true">Margin for our Health Plans segment is also referred to as &#8220;Medical Margin.&#8221;</ix:nonNumeric></span></div><ix:continuation id="if5dfff625c74423d805c6d87324c22b4"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzMtMi0xLTEtNTYxMw_de3b8abe-0543-4f06-9731-d77859555971">19,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d1a64b1a8eb4587b76303fc21830afa_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzMtNi0xLTEtNTYxNw_898d6dd3-9313-4f0d-bf09-b8d73a92b04d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzMtNi0xLTEtMA_f266fae2-bb57-43fb-83e2-f98bf30ee6ad">19,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb82ea68bb9f468a8a464320367c5ad1_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzQtMi0xLTEtMA_ad206049-3057-4a54-9d64-0ae9b1df2409">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d1a64b1a8eb4587b76303fc21830afa_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzQtNC0xLTEtMA_6a15d3fc-3ba7-4402-89ee-d1a79296c9d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzQtNi0xLTEtMA_10472702-5410-4fe1-b2af-9ca34b42aaf4">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzYtMi0xLTEtNTYxMw_c9e636cb-30c5-4e6d-88a2-237befe3255d">8,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36184f360254be581851e722b97e9d6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzYtNi0xLTEtNTYxNw_0fe80382-8d6b-413e-9c67-234d3d366888">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzYtNi0xLTEtMA_08df5510-fb14-4e2b-96e3-fc4bb8b50fbb">9,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzgtMi0xLTEtNTYxMw_6625cfd8-c382-4d15-9375-5d1cf52d1f96">16,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1045ef059c7b4c1e91a31c1aa6854984_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzgtNi0xLTEtNTYxNw_3888af6d-73d6-40bc-bffb-e0e931cccd89">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzgtNi0xLTEtMA_c5da5f11-9a97-48ee-9d56-231ce219e1fe">16,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c4b45d16f349f9b877a338daec69b7_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzktMi0xLTEtMA_94eae49c-fe1e-4f7d-bcec-6db21e28e43e">2,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1045ef059c7b4c1e91a31c1aa6854984_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzktNC0xLTEtMA_8f16ddc9-4ded-4be3-8836-dc791fc951f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzktNi0xLTEtMA_66fd1893-e446-436a-b32f-396b59872657">2,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd7c232959048c3b7533cbe17fd7a2a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzExLTItMS0xLTA_de6d94b8-59de-4581-9bfa-db48d2167bea">5,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43079259dd7042118ae6a2d5dd9a7b6e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzExLTQtMS0xLTA_616a0e54-3e25-4fc2-9d13-b1092299c0d9">1,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzExLTYtMS0xLTA_92919185-7539-4d4c-ad3c-64d6d03e91bb">6,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68756a4786524fe5b9fabbe3f97257d2_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzEzLTItMS0xLTA_a896a428-580d-41d2-85f9-c53fdcc758b9">18,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bab7abe7dde44eaa74ac090521003ed_D20180101-20181231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzEzLTQtMS0xLTA_0aa2f7b0-b8fb-4ac0-b47d-2e709be83225">419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzEzLTYtMS0xLTA_3d9de637-5e1d-43d1-9a0c-361bb82bfcab">18,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169ab145200a473eb3a97472b0dc04f9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE0LTItMS0xLTA_cd315d36-675e-4101-bedc-00434d6dcff3">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bab7abe7dde44eaa74ac090521003ed_D20180101-20181231" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE0LTQtMS0xLTA_927c02ee-4a73-4658-8305-853627d05840">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE0LTYtMS0xLTA_62b7c963-1340-4712-bba1-abd01242f550">2,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22759a2f8b054c96ad50791de93ca29f_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE2LTItMS0xLTA_c4845e12-4446-4775-a547-e73626fce16f">6,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4c8ceca643b4549bee173f83e97bb0e_I20181231" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE2LTQtMS0xLTA_2870eefa-875f-41e5-ad33-4b0d00ae1e10">989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE2LTYtMS0xLTA_7f8efe48-e8e0-47c6-ade8-eb645b3f4e7c">7,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles margin by segment to consolidated income before income tax expense:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb82ea68bb9f468a8a464320367c5ad1_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzQtMS0xLTEtMA_ad206049-3057-4a54-9d64-0ae9b1df2409">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c4b45d16f349f9b877a338daec69b7_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzQtMy0xLTEtMA_94eae49c-fe1e-4f7d-bcec-6db21e28e43e">2,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169ab145200a473eb3a97472b0dc04f9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzQtNS0xLTEtMA_cd315d36-675e-4101-bedc-00434d6dcff3">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d0049c77d2742749f53b11e47a5ada1_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzUtMS0xLTEtMA_5882936f-3268-4068-a21f-f55237342d01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c46ea96ec424a059820a38726b434de_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzUtMy0xLTEtMA_bcadb3fa-3981-4734-8d63-f951515187e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a859cbf0a6e4e259e5149dffa498108_D20180101-20181231" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzUtNS0xLTEtMA_998fb2fb-9abf-4016-b0e6-0b4aefb08505">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90fb32a216454bb3b23113825fc89cb0_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzYtMS0xLTEtMA_6900693c-155e-4eda-bae8-06fda697e04e">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia21e20ebfeb1411abf65ca9fca917694_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzYtMy0xLTEtMA_e6ba9c0e-417c-42e2-b004-f277585ad9e0">2,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55bfd4d59fce43ea933cfb8bceac4a25_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzYtNS0xLTEtMA_fbcc5338-1fc5-44ea-bf2b-11167e70afb3">2,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: other operating revenues </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b95e6dc88844104b5365f3801ba598e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzctMS0xLTEtMA_766568fc-b4c4-4245-bae4-37c3c1e6e928">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad1475cc48dc4edc8d1b28832265b1ea_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzctMy0xLTEtMA_043e1acc-76e4-45b2-9f06-c686b7f53ac6">621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0373257f2d34963a2a34bdff8836086_D20180101-20181231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzctNS0xLTEtMA_3d9bd3a7-ee84-440e-a23e-b992eaee0751">871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: other operating expenses </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b95e6dc88844104b5365f3801ba598e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzgtMS0xLTEtMA_a97bc16a-3c8a-4128-97d6-1bf6d02b961d">2,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad1475cc48dc4edc8d1b28832265b1ea_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzgtMy0xLTEtMA_4eed14ae-ac36-42e9-bd55-cae4da8a81f1">1,880</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0373257f2d34963a2a34bdff8836086_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzgtNS0xLTEtMA_01f3bad5-217d-4d79-835f-bfe329dd3e57">2,258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEwLTEtMS0xLTA_fe604bc1-e7ff-41e6-820f-8b48503feeb9">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEwLTMtMS0xLTA_dad50c87-0ec4-4477-bd3d-5faf08ea28af">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEwLTUtMS0xLTA_1ac72f02-9eef-4449-a1a7-029b778f355f">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: other expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzExLTEtMS0xLTA_53de23e3-c815-4391-bd9c-dc25f9089864">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzExLTMtMS0xLTA_75cd2d2c-00d9-4347-9f2b-e80f291ead09">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzExLTUtMS0xLTA_53f07c61-07e9-4da6-96d6-2507f318e362">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEyLTEtMS0xLTA_4f868706-cab6-483e-b8da-c072a2270593">961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEyLTMtMS0xLTA_090e5d6e-253c-4979-8f4a-5a8226171541">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEyLTUtMS0xLTA_eb914402-75be-4500-8fd6-f06d4bda5a8a">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Other operating revenues include premium tax revenue, health insurer fees reimbursed, Marketplace risk corridor judgment, investment income and other revenue.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Other operating expenses include general and administrative expenses, premium tax expenses, health insurer fees, depreciation and amortization, and other costs.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 85</span></div></div></div><div id="if790247689124308855d86d82384a359_229"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">17.&#160;<ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90ZXh0cmVnaW9uOmRjMWEzZTAyMjc1OTRlZTRhMjEyNTQwMGE2YmMyNzUxXzU2Mw_84363a07-bfab-444a-8b7e-f6c332c04122" continuedAt="ibadc5f1ce47e4e7cb332a17fbcc7ddde" escape="true">Condensed Financial Information of Registrant </ix:nonNumeric></span></div><ix:continuation id="ibadc5f1ce47e4e7cb332a17fbcc7ddde" continuedAt="ieaa2d1b5077f4c01a4bb3c538fdbd9ff"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed balance sheets as of December&#160;31, 2020 and 2019, and the related condensed statements of income, comprehensive income and cash flows for each of the three years in the period ended December&#160;31, 2020 for our parent company Molina Healthcare, Inc. (the &#8220;Registrant&#8221;), are presented below. </span></div><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90ZXh0cmVnaW9uOmRjMWEzZTAyMjc1OTRlZTRhMjEyNTQwMGE2YmMyNzUxXzU0Nw_cd7cac77-558f-4dfb-ab39-f44d33d9a25e" escape="true"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except per-share data)</span></div></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzUtMS0xLTEtMA_50742023-d2b5-477f-a55f-7ab6045f9047">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzUtMy0xLTEtMA_bc76a1ea-0902-4226-acaa-4f4b97ef1842">836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzYtMS0xLTEtMA_9da53d20-216e-4b19-bf63-59f70f915558">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzYtMy0xLTEtMA_e4467c81-fba7-4d49-86fa-336a5046d8e6">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzctMS0xLTEtMA_ffa2fb21-df60-4d3f-94a3-b1c700cc0266">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzctMy0xLTEtMA_95d14d00-779c-4f85-b988-f75104d03529">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due from affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzgtMS0xLTEtMA_31fd2be5-ee2a-4d2b-9388-fb6cae13e6a8">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzgtMy0xLTEtMA_eeec1274-419d-491f-ae29-4860b70ff7bd">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzktMS0xLTEtMA_14323541-b406-442e-94ba-c064a96bd6f9">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzktMy0xLTEtMA_666c96bb-57e0-47ee-9a18-a8602106625c">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzExLTEtMS0xLTA_43f24b51-463a-4e70-8441-9f1287e48588">825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzExLTMtMS0xLTA_c54c7916-b74e-4fa3-ba5a-6ab23fea1c82">1,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzEyLTEtMS0xLTA_fae20908-cece-48db-9723-2c801275ec19">339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzEyLTMtMS0xLTA_12f61e10-324c-4959-88cd-87589ec18c04">327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzEzLTEtMS0xLTA_38c36c8d-4f3c-4d44-a6f5-d02babb517a8">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzEzLTMtMS0xLTA_0d8d5113-6433-4a54-9797-49c185e6c0f4">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE0LTEtMS0xLTA_fd770ca9-6dff-46c1-b01c-c2279c069cc6">3,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE0LTMtMS0xLTA_803287d5-d33a-4f5a-b4e3-76483413288c">2,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE1LTEtMS0xLTA_91551b29-2f21-4760-8992-78830b796223">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE1LTMtMS0xLTA_0f4dd8f9-3ea3-4b3d-804f-6f1157f8af41">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advances to related parties and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="moh:AdvancesToRelatedPartiesAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE2LTEtMS0xLTA_a386aecf-ffab-40a2-a0fc-b3683cadf63f">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="moh:AdvancesToRelatedPartiesAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE2LTMtMS0xLTA_759ad87d-3976-4bc4-a06f-84cceecef8bf">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE3LTEtMS0xLTA_fe61556e-9dbc-455b-9288-a1922b8973f0">4,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE3LTMtMS0xLTA_35561ee1-c51b-4c25-aa5b-e89442e9f8ce">3,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzIxLTEtMS0xLTA_ad37880d-8a8c-448c-8e9d-c7c945f4a5ba">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzIxLTMtMS0xLTA_f5f245b8-dbe0-414c-bf13-1509133c8e03">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI0LTEtMS0xLTA_0adc725d-112d-4b05-a7a5-5626f5f4f6cb">338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI0LTMtMS0xLTA_4bd2bb31-8c12-4227-8e35-c832ca41b2ce">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI1LTEtMS0xLTA_45b16b84-a4e4-478c-9ff2-13648e6d1f5b">2,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI1LTMtMS0xLTA_62909d83-17b7-448d-b733-99597ba07bb3">1,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI2LTEtMS0xLTA_ebd73185-ef93-4e5f-808d-fcfbd30a25be">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI2LTMtMS0xLTA_21ed0f58-3bd9-46e3-85e9-37eab4d85f43">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI3LTEtMS0xLTA_89b5b59c-e2a0-4999-8649-ca410f027992">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI3LTMtMS0xLTA_8ad819c1-7965-4483-ae32-a9fd3ce7e2b5">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI4LTEtMS0xLTA_93abd777-de80-41f7-b9b9-d0520a9cfa56">2,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI4LTMtMS0xLTA_2e253550-7ead-44f6-824b-e2dc18c1b8e0">1,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MDcw_5b270c78-439c-493b-a0eb-258936870709"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MDcw_ac76518c-b992-429b-bf7b-9d05a89d0788">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MDg0_cf133e69-b668-4145-a173-ed5efb9db305"><ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MDg0_fd5abec7-5b2f-4ea3-9f22-a243c819a803">150</ix:nonFraction></ix:nonFraction> million shares authorized; outstanding: <ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MDk4_78406bc6-5b6b-4305-bb82-6a0c523689bc">59</ix:nonFraction> million shares at December 31, 2020, and <ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MTE0_30b80f88-f3b6-47e8-86e0-460f28b699fe">62</ix:nonFraction> million at December 31, 2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTEtMS0xLTA_abb195d0-9cea-4ee1-b86d-6b76dde75a65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTMtMS0xLTA_4619307a-574e-4b11-b5af-5712e708f808">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM4OTg4_863c57a2-fdf6-4866-bb57-6689358a0f92"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM4OTg4_b5f56231-ae73-4196-8046-7236a44f70e6">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MDk0_5c4dabd2-7652-4ada-9999-d5b6bb48a7f1"><ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MDk0_7403b34a-344f-4789-9b8a-978db9cb8170">20</ix:nonFraction></ix:nonFraction> million shares authorized, <ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MTAw_1e1d4305-74ee-4e12-b95f-6c0836481c69"><ix:nonFraction unitRef="shares" contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MTAw_1ff4be3e-9c98-4b08-a68f-3e7eb366442d"><ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MTAw_2a3d9ad1-fae5-4316-9d2d-4ccdefc9eb10"><ix:nonFraction unitRef="shares" contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MTAw_41b18ba0-7f8d-45ac-bfb2-33641736f877">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTEtMS0xLTA_8be9dc74-09e2-47bd-a34f-6f3e51d05cc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTMtMS0xLTA_28732cfe-df59-4682-80c5-fcf521c1d56d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMyLTEtMS0xLTA_f980a1b0-a0d7-49d6-b027-8cd757015f23">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMyLTMtMS0xLTA_b60642bd-9604-44d7-ad92-39fae85875cb">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMzLTEtMS0xLTA_a340d9a6-e52d-405c-8df8-74a923707d03">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMzLTMtMS0xLTA_a30c6eda-9fb2-437e-8343-8bc1f8a7abf4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM0LTEtMS0xLTA_81c40934-5c07-4d89-8423-a0ee14466346">1,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM0LTMtMS0xLTA_583a2a7e-b128-4cb8-9098-98df4d46f5fa">1,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM1LTEtMS0xLTA_244b0fab-97aa-4676-850b-0a1f9b0f9576">2,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM1LTMtMS0xLTA_3f864040-9cb3-44a0-a904-db5f01562a73">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM2LTEtMS0xLTA_8738acc6-e66a-4984-b501-02c3b6990090">4,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM2LTMtMS0xLTA_6b3cead8-3754-458a-a459-603d6aa35f86">3,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ieaa2d1b5077f4c01a4bb3c538fdbd9ff" continuedAt="if030d39e78014a00b5f6c7bf3a24b8eb"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90ZXh0cmVnaW9uOmRjMWEzZTAyMjc1OTRlZTRhMjEyNTQwMGE2YmMyNzUxXzU2NQ_b5490018-01f1-4315-a751-fdc32aee362e" escape="true"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administrative services fees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InsuranceAgencyManagementFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzQtMS0xLTEtMA_b9a75c46-19ec-4e21-8fcd-ede957f8f975">1,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InsuranceAgencyManagementFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzQtMy0xLTEtMA_08c172b0-fee6-4048-ac11-9ed5cfaf1580">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InsuranceAgencyManagementFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzQtNS0xLTEtMA_95e24ab6-3638-47bb-922c-f6867988d932">1,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment income and other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzUtMS0xLTEtMA_d4a0be59-9c11-468e-b043-efbc7775f73f">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzUtMy0xLTEtMA_8842f505-c463-417f-aa50-aa9af38c1ece">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzUtNS0xLTEtMA_e4bbec3a-fff2-4b59-8833-1f023e5ffcc9">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzYtMS0xLTEtMA_8a864bdb-152b-411b-9245-f3e4caba4c7b">1,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzYtMy0xLTEtMA_686a5d2e-39dd-4aaa-81cf-3310708440cf">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzYtNS0xLTEtMA_c4cdd03a-efe2-40b8-bebc-c87a785e9d3c">1,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzgtMS0xLTEtMA_db580162-8544-4ebd-9928-b7238453abde">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzgtMy0xLTEtMA_513114f9-ce1a-40da-844c-43f3b76fb090">937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzgtNS0xLTEtMA_db44b7d3-c80d-43f1-b4c0-c37ba8e15504">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzktMS0xLTEtMA_f0bd6a1d-aa72-4589-832b-5f9d085604a7">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzktMy0xLTEtMA_e8277dc6-b4a9-4f64-b348-2315acfe4bbf">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzktNS0xLTEtMA_8cef0e3a-7200-4a28-9ad5-d87e5a87a569">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEwLTEtMS0xLTA_b0ed3044-7b86-4aeb-bdc0-d5f6716ab60f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEwLTMtMS0xLTA_1d8a4b81-4838-4521-ac6c-a3b1262bf2c6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEwLTUtMS0xLTA_833269fe-0ce5-4d02-9076-7d980a980ec7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEzLTEtMS0xLTA_aab67817-9b21-4af7-bace-9298f2a26644">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEzLTMtMS0xLTA_8950d916-19f7-42a6-8650-1db722c35ada">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEzLTUtMS0xLTA_21147276-81e3-4f8e-b4a0-8a6e7c975131">1,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTEtMS0xLTA_1f6896b0-979b-48b1-ab95-5cb00053a121">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTMtMS0xLTA_21087d60-4724-4083-b1c7-28b27cc72f62">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTUtMS0xLTA_a181396f-9d32-4336-9f20-18e27fede0d1">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE2LTEtMS0xLTA_077fceba-9bf6-4c61-9eab-59b90c3b4611">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE2LTMtMS0xLTA_ea3a287b-8e03-4b11-be0d-76e9bf2154ec">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE2LTUtMS0xLTA_a9f4e6a1-6715-4995-bfd8-6335098aa7b5">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE3LTEtMS0xLTA_61fe0732-ca39-4f5c-92fa-6c068789297e">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE3LTMtMS0xLTA_6488a2f2-81b2-4d04-bd16-3e386b935cba">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE3LTUtMS0xLTA_0e6fcadd-d322-46eb-9d93-451b40b30b17">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other expenses, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" decimals="-6" name="us-gaap:OtherExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTEtMS0xLTE2ODEy_052b60db-2658-43a1-92f4-507372d95b90">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231" decimals="-6" name="us-gaap:OtherExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTMtMS0xLTE2ODEy_388c2c08-e96e-4322-bb49-020424d1eb47">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231" decimals="-6" name="us-gaap:OtherExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTUtMS0xLTE2ODEy_9579bbf0-8743-45d1-a944-6a27f0c63441">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income tax (benefit) expense and equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" sign="-" name="moh:IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE4LTEtMS0xLTA_65923e6e-efd8-4732-8db6-df25bfaedcc3">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" sign="-" name="moh:IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE4LTMtMS0xLTA_ed10bb39-bf30-4a03-8c8f-82fc68857294">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" sign="-" name="moh:IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE4LTUtMS0xLTA_a3bd6cf4-6157-40ff-94c6-46cae70ab798">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE5LTEtMS0xLTA_e1ae6eff-d979-4e95-82b4-ffd0ecb45233">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE5LTMtMS0xLTA_285462fb-a8a9-4113-91a0-1a05e4b2e96f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE5LTUtMS0xLTA_1bf02afa-6adf-478e-a8ab-f46b4828df19">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss before equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" sign="-" name="moh:NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIwLTEtMS0xLTA_251aacb1-cb5f-45cc-b494-2afd15bbe29f">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" sign="-" name="moh:NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIwLTMtMS0xLTA_b20faba3-0e4b-4d78-993e-b17ba459a4f0">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" sign="-" name="moh:NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIwLTUtMS0xLTA_40957f8c-64fa-43fd-94dd-5df3d29db2fb">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromSubsidiariesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIxLTEtMS0xLTA_bdf83ae8-05cc-48a3-9ea4-2746b8910689">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromSubsidiariesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIxLTMtMS0xLTA_4cb6d31e-7711-451f-b419-1a26a1b52d88">766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromSubsidiariesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIxLTUtMS0xLTA_0cb293f4-8f2c-4b4c-bac6-d6d8b1f8fccf">751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIyLTEtMS0xLTA_68a0e0bb-7acb-4d5f-94f4-3e54a3b362b8">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIyLTMtMS0xLTA_0439f2b0-1c06-4522-b3e6-d62148b85529">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIyLTUtMS0xLTA_e04044e4-f574-4ed3-928c-164358bf7c6f">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90ZXh0cmVnaW9uOmRjMWEzZTAyMjc1OTRlZTRhMjEyNTQwMGE2YmMyNzUxXzU1Mg_dbe63702-b00f-40f4-9585-2e2b71bfd56d" escape="true"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Comprehensive Income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzMtMS0xLTEtMA_68a0e0bb-7acb-4d5f-94f4-3e54a3b362b8">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzMtMy0xLTEtMA_0439f2b0-1c06-4522-b3e6-d62148b85529">737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzMtNS0xLTEtMA_e04044e4-f574-4ed3-928c-164358bf7c6f">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized investment income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzUtMS0xLTEtMA_a06130d1-ca3e-46fc-a574-232ffd49123f">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzUtMy0xLTEtMA_9b697f69-e8bd-444b-a68e-11c8155234e8">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzUtNS0xLTEtMA_19e87d7c-0e2e-406c-8ab0-880f4ff4d3e4">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: effect of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzYtMS0xLTEtMA_8542c733-56d6-452a-9c19-cc99e7e878e4">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzYtMy0xLTEtMA_6054357c-2e3e-4a8e-ab00-a98622fd1b58">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzYtNS0xLTEtMA_f920045f-99b5-4ace-90ce-d0c0b6f71141">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzctMS0xLTEtMA_f47ef399-fe2d-4542-a701-4a9ccb533ad9">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzctMy0xLTEtMA_ae9d30c2-2502-45a9-b8a4-984fe300e724">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzctNS0xLTEtMA_c06f731f-aac7-4bb1-ba17-4467f99c560c">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzgtMS0xLTEtMA_5cc286b1-0c3a-4377-a53f-d615b89b1ea5">706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzgtMy0xLTEtMA_e1c46fa6-0930-4047-9b16-309e90c0c0a6">749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzgtNS0xLTEtMA_f101e9d9-4313-47a9-8bdb-491ab646cd5e">705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div></ix:continuation><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if030d39e78014a00b5f6c7bf3a24b8eb" continuedAt="i638aac267e114996a810d51f02662088"><ix:nonNumeric contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231" name="srt:ScheduleOfCondensedCashFlowStatementTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90ZXh0cmVnaW9uOmRjMWEzZTAyMjc1OTRlZTRhMjEyNTQwMGE2YmMyNzUxXzU1OA_bacd3fd4-8696-4fc3-a6d7-0c6b77da039e" escape="true"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzQtMS0xLTEtMA_569187b3-2351-4928-bb5f-53d02078ca33">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzQtMy0xLTEtMA_ab1b1c35-9aa4-47d6-8763-a9646e8d5fc6">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzQtNS0xLTEtMA_5ae28241-4a77-4649-b130-8e83da9df640">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzYtMS0xLTEtMA_20dab99e-33ba-45e6-8a6b-4d59920a4541">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzYtMy0xLTEtMA_8937d964-252d-42ad-8c1b-10303d38dc50">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzYtNS0xLTEtMA_dff15399-82ab-4285-b904-eed29731e8bc">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends received from subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzctMS0xLTEtMA_8caef69a-c222-44a6-8782-7c3a18296aae">635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzctMy0xLTEtMA_c7c20cdc-49c3-4ef8-8e62-253e422df8a6">1,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzctNS0xLTEtMA_7d0d8202-f4c9-4f70-baf9-6828acf28e6a">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzgtMS0xLTEtMA_3b5c09b1-78b2-4595-866f-9447fad6997b">188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzgtMy0xLTEtMA_a9ac4357-fa43-4775-8449-4b9f316bd3b8">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzgtNS0xLTEtMA_795f8551-937f-46b5-af01-a1920f780fcf">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzktMS0xLTEtMA_75eecdaa-fe5f-428b-81d2-419761865c20">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzktMy0xLTEtMA_a81180f3-64ca-4b20-a5e0-95fee8236f73">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzktNS0xLTEtMA_f57b84db-b1f6-4e62-887e-ed104d25e482">388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEwLTEtMS0xLTA_2bcb56af-43c8-4472-a2fe-f37d45d87823">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEwLTMtMS0xLTA_7d2a6d41-649c-4455-8319-8d153068174b">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEwLTUtMS0xLTA_9c138a18-6706-4b5d-b77f-1050f31604f4">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash paid in business combinations </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTEtMS0xLTc3Njc_88d9923f-ff22-4cd5-a2fb-8d01193c0254">1,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTMtMS0xLTc3Njc_8aecd3d3-0997-4b5e-a0e7-3cf730308215">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTUtMS0xLTc3Njc_0b8d016d-9f99-495d-acf2-6c05253e0226">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash received from sale of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTEtMS0xLTA_45a0205a-b919-4dd3-83ed-fb4c57cd1e97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTMtMS0xLTA_c35057e8-cd58-49fa-b233-f035e7194e89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTUtMS0xLTA_68f90cf8-062b-46bc-83d8-38316ceaab75">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in amounts due to/from affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" sign="-" name="moh:ChangesInAmountsDueToAndDueFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEyLTEtMS0xLTA_89c1add5-e451-4831-a513-11e6904e16eb">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="moh:ChangesInAmountsDueToAndDueFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEyLTMtMS0xLTA_214c86db-c5a5-4c99-813d-1944b8a5e629">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="moh:ChangesInAmountsDueToAndDueFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEyLTUtMS0xLTA_6e5a2282-8086-4b8d-b184-2ee901ecadf0">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEzLTEtMS0xLTA_31dc741e-6a06-4676-a649-3cf4ee678b75">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEzLTMtMS0xLTA_d6e7ab66-5421-46f7-b0d2-e758eef2a545">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEzLTUtMS0xLTA_df38d31d-bed9-48c2-966f-1a607b8905a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE0LTEtMS0xLTA_2203d4ed-9e82-446b-93c1-f7b21792d088">545</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE0LTMtMS0xLTA_7cb34826-fa7e-47bb-9c83-59a7cf0c593d">1,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE0LTUtMS0xLTA_de671047-ea2c-4164-9203-1f85c2d7d23d">631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from senior notes offering, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE2LTEtMS0xLTI1NzE_2bfce8cb-415e-4faf-bb00-61d803d67fa1">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE2LTMtMS0xLTI1NzE_56e3fe20-bad0-4595-92c6-27a6a74a1414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE2LTUtMS0xLTI1NzE_eb607a97-9b6b-486b-a6de-da9c65509c8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock purchases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE4LTEtMS0xLTIxMDEx_20dc2d76-60b0-456c-b564-71f6caf32437">606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE4LTMtMS0xLTIxMDEx_81e1a4a8-f5db-4a3b-bd26-95aebcefe5b5">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE4LTUtMS0xLTIxMDEx_495e1142-df03-4f48-b18a-2244b9d301c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE3LTEtMS0xLTI1NzE_f5e28ac7-0b9f-48e1-8502-44eb4967646a">600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE3LTMtMS0xLTI1NzE_3e76a741-e33c-41b1-ba7e-64b71442b02f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE3LTUtMS0xLTI1NzE_deadbe6b-c59e-47d4-bde8-be496f9331b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from borrowings under term loan facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE5LTEtMS0xLTI1NzE_41bab421-661c-4f40-8da2-6bd87d5f393e">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE5LTMtMS0xLTI1MjU_d136436b-c871-46b6-98d7-bc791821d669">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE5LTUtMS0xLTI1MjU_53a5bd54-c5b3-46d9-83be-d177f0148115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTEtMS0xLTI1Njk_cd8e7c4f-e88d-4ec4-95c6-6e9f10467d93">338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTMtMS0xLTI1Njk_25166aed-5060-4f45-b61d-f11138aaf8a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTUtMS0xLTI1Njk_8964e895-0b53-4e24-9e24-6f6ddac8473c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for partial termination of warrants</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIxLTEtMS0xLTI1ODM_4f6b4e68-7b5f-4b0b-9acf-d3843096b8c2">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTMtMS0xLTI1Mjk_9c6c0934-457c-402e-aa34-c0df9822ab65">514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTUtMS0xLTI1Mjk_473c8b6a-829e-4ae7-9fec-3ba44e515470">549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for partial settlement of conversion option</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="moh:CashPaidForSettlementOfConversionOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIyLTEtMS0xLTI1OTI_ae6301a3-d4a1-4f49-ac46-0b40b0cf1a40">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="moh:CashPaidForSettlementOfConversionOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE5LTMtMS0xLTA_7a63898c-7494-40ba-998c-29617dd43e49">578</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="moh:CashPaidForSettlementOfConversionOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE5LTUtMS0xLTA_2d9e826f-9037-49c1-8012-e6c4289a6627">623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash received for partial settlement of call option</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIzLTEtMS0xLTI1OTI_0464461c-35c3-49cb-a1e8-6ef058d45fc2">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTMtMS0xLTA_2b47308f-e795-42a4-b0fe-9a30d69723ca">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTUtMS0xLTA_a76bfc05-defb-42d7-9d5e-4d8a9f8463ef">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of principal amount of convertible notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI0LTEtMS0xLTI1ODg_398bd1af-bcb9-4fbb-9bd9-b5bf616790a7">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIxLTMtMS0xLTA_a132fe07-d268-4aeb-8806-3f2fe8f7483f">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIxLTUtMS0xLTA_94902746-d8c1-4fdd-863b-bd0dcb5a3870">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of credit facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI0LTEtMS0xLTA_13db0070-6f26-4058-b153-6a05c5aff22b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI0LTMtMS0xLTA_6dd3bd3f-32db-4737-a65c-963bf87320e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI0LTUtMS0xLTA_52a8e98d-f4d9-4784-a7ae-317776a9c018">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI3LTEtMS0xLTA_044789a2-e32a-4376-8c1b-5d5397c6a60f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI3LTMtMS0xLTA_be8338b5-88de-43db-9954-76b83d6ab5b4">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI3LTUtMS0xLTA_97ae1a14-98bd-41f9-b5e2-570be6635237">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI4LTEtMS0xLTA_4b7eec30-f763-4492-a880-6e0769a6e994">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI4LTMtMS0xLTA_d4594b72-ec6a-4adb-a2d6-2fbbdbe9992e">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI4LTUtMS0xLTA_4540d4a0-cfbd-49fd-9029-4d5a7dc1e628">1,192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI5LTEtMS0xLTA_04d661f5-63d3-415e-8daa-1d27c222f3be">261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI5LTMtMS0xLTA_ee974af6-0abb-4105-938a-22ad396677fd">766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI5LTUtMS0xLTA_c350aa37-8187-4862-ab25-719a6e9694f6">443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMwLTEtMS0xLTA_a5411ef3-4ea5-4ab0-8faf-232f8caf32b3">836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11fdd1fe2faf42efb90bc577c9070717_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMwLTMtMS0xLTA_9f769291-563f-426c-8d43-0054c8a26a84">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c26bfb9e6774f078083f6dc03b05363_I20171231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMwLTUtMS0xLTA_d9bb334f-fcf2-452a-85f4-aecb37b0c324">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMxLTEtMS0xLTA_61b22a58-410f-4ed2-a2d2-ce4e5301ebcf">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMxLTMtMS0xLTA_f32cfeb2-9d8a-432c-997a-eb82f8b799b1">836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11fdd1fe2faf42efb90bc577c9070717_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMxLTUtMS0xLTA_13f760bb-f1fd-4907-b55c-a0005a2388d1">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="if790247689124308855d86d82384a359_232"></div><ix:continuation id="i638aac267e114996a810d51f02662088" continuedAt="ib2332337fad0480cb67d2541fc9170ab"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Information of Registrant </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#160;A&#160;- Basis of Presentation </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Registrant was incorporated in 2002. Prior to that date, Molina Healthcare of California (formerly known as Molina Medical Centers) operated as a California health plan and as the parent company for three other state health plans. In June 2003, the employees and operations of the corporate entity were transferred from Molina Healthcare of California to the Registrant. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Registrant&#8217;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries since the date of acquisition. The accompanying condensed financial information of the Registrant should be read in conjunction with the consolidated financial statements and accompanying notes. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#160;B&#160;- Transactions with Subsidiaries </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Registrant provides certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and administration, underwriting, claims processing, customer service, certain care management services, human </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib2332337fad0480cb67d2541fc9170ab" continuedAt="i45fbebed6d944616af3c6cfedf2b80a3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resources, marketing, purchasing, risk management, actuarial, finance, accounting, compliance, legal and public relations. Fees are based on the fair market value of services rendered and are recorded as operating revenue. Payment is subordinated to the subsidiaries&#8217; ability to comply with minimum capital and other restrictive financial requirements of the states in which they operate. Charges in 2020, 2019, and 2018 for these services amounted to $<ix:nonFraction unitRef="usd" contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzIvZnJhZzpiYzBlMjE0ZmYzMGM0YWYzODUxNzQ3YmQwZjljYTJkZi90ZXh0cmVnaW9uOmJjMGUyMTRmZjMwYzRhZjM4NTE3NDdiZDBmOWNhMmRmXzExNzI_d0eac4a2-ccdb-462d-8854-d90722b9aa34">1,208</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzIvZnJhZzpiYzBlMjE0ZmYzMGM0YWYzODUxNzQ3YmQwZjljYTJkZi90ZXh0cmVnaW9uOmJjMGUyMTRmZjMwYzRhZjM4NTE3NDdiZDBmOWNhMmRmXzExNzY_f4c4a070-3d0c-49a1-b880-1c9ec63437b3">1,038</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzIvZnJhZzpiYzBlMjE0ZmYzMGM0YWYzODUxNzQ3YmQwZjljYTJkZi90ZXh0cmVnaW9uOmJjMGUyMTRmZjMwYzRhZjM4NTE3NDdiZDBmOWNhMmRmXzExODQ_52ba5658-e371-411d-8100-8b467bdcdf8c">1,137</ix:nonFraction> million, respectively, and are included in operating revenue. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Registrant and its subsidiaries are included in the consolidated federal and state income tax returns filed by the Registrant. Income taxes are allocated to each subsidiary in accordance with an intercompany tax allocation agreement. The agreement allocates income taxes in an amount generally equivalent to the amount which would be expensed by the subsidiary if it filed a separate tax return. Net operating loss benefits are paid to the subsidiary by the Registrant to the extent such losses are utilized in the consolidated tax returns. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#160;C&#160;- Dividends and Capital Contributions </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Registrant receives dividends from its subsidiaries, such amounts are recorded as a reduction to the investments in the respective subsidiaries.</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i45fbebed6d944616af3c6cfedf2b80a3">For all periods presented, the Registrant made capital contributions to certain subsidiaries primarily to comply with minimum net worth requirements and to fund business combinations. Such amounts have been recorded as an increase in investment in the respective subsidiaries.</ix:continuation> </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 89</span></div></div></div><div id="if790247689124308855d86d82384a359_241"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MANAGEMENT&#8217;S EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act), that are designed to provide reasonable assurance that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of any possible controls and procedures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, we carried out an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Form 10-K pursuant to Rule 13a-15(b) and Rule 15d-15(b) of the Exchange Act. Based on this evaluation, our chief executive officer and our chief financial officer concluded that our disclosure controls and procedures were effective as of December&#160;31, 2020, at the reasonable assurance level. In addition, management concluded that our consolidated financial statements included in this Annual Report on Form 10-K are fairly stated in all material respects in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for each of the periods presented herein.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">MANAGEMENT&#8217;S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule&#160;13a-15(f) under the Exchange Act. Our internal control over financial reporting includes those policies and procedures that (1)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (2)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (3)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on our financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements prepared for external purposes in accordance with GAAP. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of the effectiveness of our internal control over financial reporting to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management concluded that we maintained effective internal control over financial reporting as of December&#160;31, 2020, based on criteria described in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control-Integrated Framework </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2013)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2020, we completed our acquisition of certain assets of Passport Health Plan, Inc. (&#8220;Passport&#8221;). On December 31, 2020, we completed our acquisition of the Magellan Complete Care line of business of Magellan Health, Inc. We are in the process of evaluating the existing controls and procedures of Passport and Magellan Complete Care, and integrating Passport and Magellan Complete Care into our internal control over financial reporting. In accordance with SEC Staff guidance permitting a company to exclude an acquired business from management&#8217;s assessment of the effectiveness of internal control over financial reporting for the year in which the acquisition is completed, we have excluded the business that we acquired in the Passport and Magellan Complete Care acquisitions from our assessment of the effectiveness of internal control over financial reporting as of December 31, 2020. The business that we acquired in the Passport and Magellan Complete Care acquisitions, in the aggregate, constituted 11% and 19% of our total and net assets, respectively, as of December 31, 2020, and 3% and 1% of our revenues and net income, respectively, for the year ended December 31, 2020. The scope of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">management&#8217;s assessment of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2020, includes all of our consolidated operations except for those disclosure controls and procedures of Passport and Magellan Complete Care that are subsumed by internal control over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst &amp; Young, LLP, the independent registered public accounting firm who audited our Consolidated Financial Statements included in this Form 10-K, has issued a report on our internal control over financial reporting, which is included herein.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) during the quarter ended December 31, 2020, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 91</span></div></div></div><div id="if790247689124308855d86d82384a359_244"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To the Stockholders and the Board of Directors of Molina Healthcare, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Molina Healthcare, Inc.&#8217;s internal control over financial reporting as of December&#160;31, 2020, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the &#8220;COSO criteria&#8221;). In our opinion, Molina Healthcare, Inc. (the &#8220;Company&#8221;) maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2020, based on the COSO criteria. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As indicated in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting, management&#8217;s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of the Passport operations and Magellan Complete Care, which are included in the 2020 consolidated financial statements of Molina Healthcare, Inc. and constituted 11% and 19% of total and net assets, respectively, as of December 31, 2020 and 3% and 1% of revenues and net income, respectively, for the year then ended. Our audit of internal control over financial reporting of Molina Healthcare, Inc. also did not include an evaluation of the internal control over financial reporting of the Passport operations and Magellan Complete Care.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the consolidated balance sheets of the Company as of December&#160;31, 2020 and 2019, the related consolidated statements of income, comprehensive income, stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2020, and the related notes and our report dated February&#160;16, 2021, expressed an unqualified opinion thereon. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;Ernst&#160;&amp; Young LLP</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Los Angeles, California</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;16, 2021 </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 93</span></div></div></div><div id="if790247689124308855d86d82384a359_247"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To the Stockholders and the Board of Directors of Molina Healthcare, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Molina Healthcare, Inc. (the &#8220;Company&#8221;) as of December&#160;31, 2020 and 2019, the&#160;related consolidated statements of income, comprehensive income, stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2020, and the&#160;related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In&#160;our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2020, in conformity with U.S. generally accepted accounting principles. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2020, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February&#160;16, 2021, expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8216;s management. Our&#160;responsibility is to express an opinion on the Company&#8216;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:2pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that&#160;were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that&#160;are material to the financial statements and (2)&#160;involved our especially challenging, subjective or complex judgments. The&#160;communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing a separate opinion on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of incurred but not paid fee-for-service claims</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">As of December&#160;31, 2020, the Company&#8217;s liability for fee-for-service claims incurred but not paid (&#8220;IBNP&#8221;), excluding IBNP acquired from the Magellan Complete Care (&#8220;MCC&#8221;) acquisition, comprised $1,647 million of the $2,696 million of Medical Claims and Benefits Payable. As discussed in Note 10 to the consolidated financial statements, the Company&#8217;s IBNP liability is determined using actuarial methods that include a number of factors and assumptions, including completion factors, which seek to measure the cumulative percentage of claims expense that will have been paid for a given month of service as of the reporting date, based on historical payment patterns, and assumed health care cost trend factors, which represent an estimate of claims expense based on recent claims expense levels and healthcare cost levels. There is significant uncertainty inherent in determining management&#8217;s best estimate of completion and trend factors, which are used to calculate actuarial estimates of incurred but not paid claims.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 217pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Auditing management&#8217;s best estimate of the IBNP liability was complex and required the involvement of our actuarial specialists due to the highly judgmental nature of completion and trend factor assumptions used in the valuation process. These assumptions have a significant effect on the valuation of the IBNP liability.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How we addressed the matter in our audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of the Company&#8217;s controls over the process for estimating the IBNP liability. This included testing management review controls over completion and trend factor assumptions, and management&#8217;s review and approval of actuarial methods used to calculate IBNP liability, including the data inputs and outputs of those models.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">To test IBNP liability, our audit procedures included, among others, testing the completeness and accuracy of data used in the calculation by testing reconciliations of underlying claims and membership data recorded in source systems to the actuarial reserving calculations, and comparing a sample of claims to source documentation. With the assistance of EY actuarial specialists, we evaluated the Company&#8217;s selection and weighting of actuarial methods by comparing the weightings used in the current estimate to those used in prior periods and those used in the industry for the specific types of insurance. To evaluate significant assumptions used by management in the actuarial methods, we compared assumptions to current and historical claims trends, to those used historically and to current industry benchmarks. We also compared management&#8217;s recorded IBNP liability to a range of reasonable IBNP estimates calculated independently by our EY actuarial specialists. Additionally, we performed a review of the prior period estimates using subsequent claims development, and we reviewed and evaluated management&#8217;s disclosures surrounding fee-for-service claims IBNP.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of intangibles</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of the matter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company completed its acquisition of MCC for net consideration of $1,037&#160;million, as disclosed in Note 4 to the consolidated financial statements. The transaction was accounted for as a business combination using the acquisition method.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Auditing the Company&#8217;s accounting for its acquisition of MCC was complex due to the significant estimation uncertainty in the Company&#8217;s determination of the fair value of acquired contract rights which comprised $171 million of the acquired identified intangible assets of $191 million. The Company used a discounted cash flow model to measure contract rights. The significant estimation uncertainty was primarily due to the sensitivity of the fair value to underlying assumptions, specifically changes in forecasted operating margins, and the weighted average cost of capital, which are affected by expectations about future market or economic conditions.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How we addressed the matter in our audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of the Company&#8217;s controls over its accounting for acquisitions. This included testing management review controls over the estimation process supporting the recognition and measurement of contract rights. We also tested management&#8217;s review of assumptions used in the valuation models.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">To test the estimated fair value of contract rights, our audit procedures included, among others, evaluating the Company's selection of the valuation methodology and significant assumptions used by the Company's valuation specialist, and evaluating the completeness and accuracy of the underlying data supporting the significant assumptions and estimates. We involved our valuation specialists to assist with our evaluation of the methodology used by the Company and significant assumptions included in the fair value estimates. We compared the significant assumptions used by management to current industry and economic trends, changes to the company&#8217;s business, markets, membership retention and growth rates, and other factors.  Additionally, we reviewed and evaluated management&#8217;s disclosures surrounding determination of the intangible assets.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;Ernst&#160;&amp; Young LLP</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2000. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Los Angeles, California</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;16, 2021 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 95</span></div></div></div><div id="if790247689124308855d86d82384a359_250"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="if790247689124308855d86d82384a359_253"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by Item 10 of Part III will be included in our Proxy Statement relating to our 2021 Annual Meeting of Stockholders, and is incorporated herein by reference. This information is included in the following sections of the Proxy Statement:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">PROPOSAL 1 - Election of Directors</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Information About Director Nominees</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Information About Directors Continuing in Office</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Additional Information About Directors</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Corporate Governance and Board of Directors Matters</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Information About the Executive Officers of the Company</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Section 16(a) Beneficial Ownership Reporting Compliance</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information relating to our Code of Business Conduct and Ethics and compliance with Section 16(a) of the 1934 Act is set forth in our Proxy Statement relating to our 2021 Annual Meeting of Stockholders and is incorporated herein by reference. To the extent permissible under NYSE rules, we intend to disclose amendments to our Code of Business Conduct and Ethics, as well as waivers of the provisions thereof, on our investor relations website under the heading &#8220;Investor Information&#8212;Corporate Governance&#8221; at molinahealthcare.com. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by Item 11 of Part III will be included in our Proxy Statement relating to our 2021 Annual Meeting of Stockholders in the section entitled &#8220;Executive Compensation,&#8221; and is incorporated herein by reference. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by Item 12 of Part III will be included in our Proxy Statement relating to our 2021 Annual Meeting of Stockholders in the section entitled &#8220;Security Ownership of Certain Beneficial Owners and Management,&#8221; and is incorporated herein by reference. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by Item 13 of Part III will be included in our Proxy Statement relating to our 2021 Annual Meeting of Stockholders in the sections entitled &#8220;Related Party Transactions,&#8221; and &#8220;Corporate Governance and Board of Directors Matters&#8212;Director Independence,&#8221; and is incorporated herein by reference.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by Item 14 of Part III will be included in our Proxy Statement relating to our 2021 Annual Meeting of Stockholders in the section entitled &#8220;Fees Paid to Independent Registered Public Accounting Firm,&#8221; and is incorporated herein by reference.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 96</span></div></div></div><div id="if790247689124308855d86d82384a359_256"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA </span></div><div style="margin-bottom:6pt;margin-top:7.5pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The consolidated financial statements are included in this report in the section entitled &#8220;Financial Statements and Supplementary Data.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:7.5pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Financial Statement Schedules: </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:49.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedules for which provision is made in the applicable accounting regulations of the SEC are not required under the related instructions, are inapplicable, or the required information is included in the consolidated financial statements, and therefore have been omitted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#828282;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">EXHIBITS</span></div><div style="margin-bottom:6pt;margin-top:7.5pt;padding-left:24.75pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the accompanying &#8220;Index to Exhibits.&#8221; </span></div><div style="margin-bottom:6pt;margin-top:7.5pt;padding-left:24.75pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 97</span></div></div></div><div id="if790247689124308855d86d82384a359_259"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the undersigned registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 16th day of February, 2021.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:40.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MOLINA HEALTHCARE, INC.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Joseph M. Zubretsky</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joseph M. Zubretsky</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities as indicated, as of February&#160;16, 2021. </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.657%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Joseph M. Zubretsky</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief&#160;Executive&#160;Officer,&#160;President and Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joseph M. Zubretsky</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas L. Tran</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Treasurer</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thomas L. Tran</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Maurice S. Hebert</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maurice S. Hebert</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Garrey E. Carruthers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Garrey E. Carruthers, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel Cooperman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Daniel Cooperman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Barbara L. Brasier</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Barbara L. Brasier</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Steven J. Orlando</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Steven J. Orlando</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ronna E. Romney</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ronna E. Romney</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Richard M. Schapiro</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard M. Schapiro</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dale B. Wolf</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dale B. Wolf</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Richard C. Zoretic</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard C. Zoretic</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                         </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 98</span></div></div></div><div id="if790247689124308855d86d82384a359_262"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibits, which are furnished with this Annual Report on Form 10-K (this &#8220;Form 10-K&#8221;) or incorporated herein by reference, are filed as part of this annual report.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements included or incorporated by reference as exhibits to this Form&#160;10-K may contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties were made solely for the benefit of the other parties to the applicable agreement and (i)&#160;were not intended to be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii)&#160;may have been qualified in such agreement by disclosures that were made to the other party in connection with the negotiation of the applicable agreement; (iii)&#160;may apply contract standards of &#8220;materiality&#8221; that are different from &#8220;materiality&#8221; under the applicable securities laws; and (iv)&#160;were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement. The Company acknowledges that, notwithstanding the inclusion of the foregoing cautionary statements, it is responsible for considering whether additional specific disclosures of material information regarding material contractual provisions are required to make the statements in this Form&#160;10-K not misleading.</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Method&#160;of&#160;Filing</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000115752320000679/a52215020ex2_1.htm">2.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock and Asset Purchase Agreement, dated as of April 30, 2020, by and between Molina Healthcare, Inc. and Magellan Health, Inc.**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 2.1 to registrant&#8217;s Form 8-K filed May 6, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992920000139/exhibit21affinity-apa.htm">2.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset Purchase Agreement, dated as of September 28, 2020, by and between Molina Healthcare, Inc. and Affinity Health Plan, Inc.**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 2.1 to registrant&#8217;s Form 10-Q filed October 29, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000089843002004683/dex32.txt">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of Incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit&#160;3.2 to registrant&#8217;s Registration Statement on Form&#160;S-1 filed December&#160;30, 2002</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000119312513124378/d494218ddef14a.htm">3.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of Amendment to Certificate of Incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Appendix A to registrant&#8217;s Definitive Proxy Statement on Form DEF 14A filed March 25, 2013</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992919000060/a2019definitiveproxy.htm">3.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of Amendment to Certificate of Incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Appendix A to registrant&#8217;s Definitive Proxy Statement on Form DEF 14A filed March 25, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992919000032/moh-12312018xex33.htm">3.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sixth Amended and Restated Bylaws of Molina Healthcare, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 3.3 to registrant&#8217;s Form 10-K filed February 19, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000119312515373583/d72756dex41.htm">4.</a><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000119312515373583/d72756dex41.htm">1</a> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indenture dated November 10, 2015, by and among Molina Healthcare, Inc., the guarantor parties thereto and U.S. Bank National Association, as Trustee</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 4.1 to registrant&#8217;s Form 8-K filed November 10, 2015</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000119312515373583/d72756dex41.htm">4.</a><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000119312515373583/d72756dex41.htm">2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of 5.375% Senior Notes due 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 4.1 to registrant&#8217;s Form 8-K filed November 10, 2015</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000119312515373583/d72756dex41.htm">4.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Guarantee pursuant to Indenture, dated as of November 10, 2015, by and among Molina Healthcare, Inc., the guarantors party thereto and U.S. Bank National Association, as Trustee</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 4.1 to registrant&#8217;s Form 8-K filed November 10, 2015</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000119312516468372/d138921dex41.htm">4.</a><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000119312516468372/d138921dex41.htm">4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">First Supplemental Indenture, dated as of February 16, 2016, by and among Molina Healthcare, Inc., the guarantors party thereto and U.S. Bank National Association, as Trustee</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 4.1 to registrant&#8217;s Form 8-K filed February 18, 2016 </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000115752320000848/a52229102ex4_1.htm">4.</a><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000115752320000848/a52229102ex4_1.htm">5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indenture, dated as of June 2, 2020, by and between Molina Healthcare, Inc. and U.S. Bank National Association, as Trustee. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 4.1 to registrant&#8217;s Form 8-K filed June 2, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000115752320000848/a52229102ex4_1.htm">4.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of 4.375% Notes (included in Exhibit 4.5). </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 4.2 to registrant&#8217;s Form 8-K filed June 2, 2020 (Included in Exhibit 4.1 to registrant&#8217;s Form 8-K filed June 2, 2020)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000115752320001511/a52328971ex4_1.htm">4.</a><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000115752320001511/a52328971ex4_1.htm">7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indenture, dated as of November 17, 2020, by and between Molina Healthcare, Inc. and U.S. Bank National Association, as Trustee.  </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 4.1 to registrant&#8217;s Form 8-K filed November 17, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000115752320001511/a52328971ex4_1.htm">4.</a><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000115752320001511/a52328971ex4_1.htm">8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of 3.875% Notes (included in Exhibit 4.7). </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 4.2 to registrant&#8217;s Form 8-K filed November 17, 2020 (Included in Exhibit 4.1 to registrant&#8217;s Form 8-K filed November 17, 2020)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="descriptionofregistrantsse.htm">4.9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description of Registrant&#8217;s Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000115752320000874/a52231626ex10_1.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit Agreement, dated as of June 8, 2020, by and among Molina Healthcare, Inc., as the Borrower, Truist Bank, as Administrative Agent, Issuing Bank and Swingline Lender, and the Lenders party thereto. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.1 to registrant&#8217;s Form 8-K filed June 8, 2020</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Method&#160;of&#160;Filing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992915000007/moh-12312014x10kex106.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Molina Healthcare, Inc. 2011 Employee Stock Purchase Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.6 to registrant&#8217;s Form 10-K filed February 26, 2015</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992914000004/moh-12312013x10kex108.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Molina Healthcare, Inc. 2011 Equity Incentive Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.8 to registrant&#8217;s Form 10-K filed February 26, 2014</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992917000099/exhibit102-2011equityincen.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan - Form of Stock Option Agreement (Director)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.2 to registrant&#8217;s Form 10-Q filed May 4, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992917000099/exhibit103-2011equityincen.htm">10.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan - Form of Restricted Stock Award Agreement (Employee)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.3 to registrant&#8217;s Form 10-Q filed May 4, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992917000099/exhibit104-2011equityincen.htm">10.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan - Form of Performance Unit Award Agreement 1 (Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.4 to registrant&#8217;s Form 10-Q filed May 4, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992917000099/exhibit105-2011equityincen.htm">10.7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan - Form of Performance Unit Award Agreement 2 (Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.5 to registrant&#8217;s Form 10-Q filed May 4, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992919000060/a2019definitiveproxy.htm">10.8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 Employee Stock Purchase Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Appendix C to registrant&#8217;s Definitive Proxy Statement on Form DEF 14A filed March 25, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992919000060/a2019definitiveproxy.htm">10.9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Molina Healthcare, Inc. 2019 Equity Incentive Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Appendix B to registrant&#8217;s Definitive Proxy Statement on Form DEF 14A filed March 25, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992919000134/ex101_2019-rsa.htm">10.10</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 Equity Incentive Plan - Form of Restricted Stock Award Agreement (Employee/Officer with No Employment Agreement)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.1 to registrant&#8217;s Form 10-Q filed July 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992919000134/a2019equityincentiveplan.htm">10.11</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 Equity Incentive Plan - Form of Performance Stock Unit Award Agreement (Employee/Officer with No Employment Agreement)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.2 to registrant&#8217;s Form 10-Q filed July 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992919000134/ex103_2019eip-rsa.htm">10.12</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 Equity Incentive Plan - Form of Restricted Stock Award Agreement (Officer with Employment Agreement)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.3 to registrant&#8217;s Form 10-Q filed July 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992919000134/ex104_2019eip-psu.htm">10.13</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 Equity Incentive Plan - Form of Performance Stock Unit Award Agreement (Officer with Employment Agreement)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.4 to registrant&#8217;s Form 10-Q filed July 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2ndamendedchangeincontrol.htm">10.14</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Molina Healthcare, Inc. Second Amended and Restated Change in Control Severance Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000119312507054663/dex1014.htm">10.15</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form of Indemnification Agreement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.14 to registrant&#8217;s Form 10-K filed March 14, 2007</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992918000145/moh-06302018xex102.htm">10.16</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2018)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.2 to registrant&#8217;s Form 10-Q filed August 1, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992920000026/moh-12312019xex1025.htm">10.17</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amendment No. One to the Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2018)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.25 to registrant&#8217;s Form 10-K filed February 14, 2020 </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2ndamendto2018deferredcom.htm">*10.18</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amendment No. Two to the Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2018)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000119312513259609/d554295dex103.htm">10.19</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employment Agreement with Jeff Barlow dated June 14, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.3 to registrant&#8217;s Form 8-K filed June 14, 2013</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000144530513000387/moh-12312012x10kex1016.htm">10.20</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in Control Agreement with Jeff D. Barlow, dated as of September 18, 2012</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.16 to registrant&#8217;s Form 10-K filed February 28, 2013</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992917000206/exhibit101_zubretskyemploy.htm">10.21</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employment Agreement, dated October 9, 2017, by and between Molina Healthcare, Inc. and Joseph M. Zubretsky</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.1 to registrant&#8217;s Form 8-K filed October 10, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">*<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000115752318001189/a51811417ex10_1.htm">10.22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Offer Letter, dated May 4, 2018, by and between Molina Healthcare, Inc. and Thomas L. Tran</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.1 to registrant&#8217;s Form 8-K filed May 24, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">+<a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992919000032/moh-12312018xex1036.htm">10.23</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Master Services Agreement for Information Technology Services, dated February 4, 2019, by and between Molina Healthcare, Inc. and Infosys Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.36 to registrant&#8217;s Form 10-K filed February 19, 2019<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1179929/000117992919000160/moh-09302019ex101.htm">10.24</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">First Amendment, dated August 1, 2019, to the Master Services Agreement for Information Technology Services, dated February 4, 2019, by and between Molina Healthcare, Inc. and Infosys Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed as Exhibit 10.1 to registrant&#8217;s Form 10-Q filed October 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="moh4q20_ex211.htm">21.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">List of subsidiaries</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="moh4q20_ex231.htm">23.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consent of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="moh4q20_ex311.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Section 302 Certification of Chief Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="moh4q20_ex312.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Section 302 Certification of Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="moh4q20_ex321.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of Chief Executive Officer pursuant to 18&#160;U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Method&#160;of&#160;Filing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0f7c7f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="moh4q20_ex322.htm">32.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of Chief Financial Officer pursuant to 18&#160;U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data file (formatted as Inline XBRL and embedded within Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management contract or compensatory plan or arrangement required to be filed (and/or incorporated by reference) as an exhibit to this Annual Report on Form 10-K pursuant to Item&#160;15(b) of Form 10-K.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certain portions of this agreement have been omitted in accordance with Item 601(b)(10) of Regulation S-K. A copy of any omitted portion will be furnished to the Securities and Exchange Commission upon request. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission under Rule 24b-2. The omitted confidential material has been filed separately. The location of the redacted confidential information is indicated in the exhibit as &#8220;[redacted]&#8221;.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. 2020 Form 10-K | 101</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.9
<SEQUENCE>2
<FILENAME>descriptionofregistrantsse.htm
<DESCRIPTION>EX-4.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0524d8aee56647b68407ced4b7a081f3_57"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES REGISTERED PURSUANT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Common Stock of Molina Healthcare, Inc., a Delaware corporation (the &#8220;Company&#8221;), is registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following description of the Company&#8217;s Common Stock is a summary, does not purport to be complete, and is subject to and qualified in its entirety by reference to the Company&#8217;s certificate of incorporation, as amended (the &#8220;Certificate of Incorporation&#8221;), and the Company&#8217;s Sixth Amended and Restated Bylaws (the &#8220;Bylaws&#8221;), each of which is incorporated herein by reference as an exhibit to the Annual Report on Form 10-K for the year ended December 31, 2020 filed with the Securities and Exchange Commission, of which this Exhibit 4.9 is a part.  Please refer to the Certificate of Incorporation, the Bylaws and the applicable provisions of the General Corporation Law of the State of Delaware for additional information.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Authorized Capital Stock</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s authorized capital stock consists of 170,000,000 shares, with a par value of $0.001 per share, of which 150,000,000 shares are designated as Common Stock and 20,000,000 shares are designated as Preferred Stock. No shares of Preferred Stock are currently outstanding.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Fully Paid and Nonassessable</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All of the outstanding shares of Common Stock are fully paid and nonassessable.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Rights</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The holders of shares of Common Stock are entitled to one vote per share on all matters to be voted on by such holders. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to preferences that may be applicable to any preferred stock outstanding at the time, the holders of Common Stock are entitled to receive dividends, if any, declared from time to time by the Company&#8217;s board of directors (the &#8220;Board&#8221;) out of legally available funds. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Right to Receive Liquidation Distributions</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Upon liquidation, dissolution or winding up of the Company, holders of Common Stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding shares of preferred stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Preemptive or Similar Rights</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The holders of Common Stock have no preemptive or other subscription rights, and there are no conversion rights or redemption or sinking fund provisions with respect to such shares of Common Stock</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Delaware Anti-Takeover Statute</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company is subject to the provisions of Section 203 of the Delaware General Corporation Law regulating corporate takeovers. In general, Section 203 prohibits a publicly held Delaware corporation from engaging, under certain circumstances, in a business combination with an interested stockholder for a period of three years following the date the person became an interested stockholder unless&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">prior to the date of the transaction, the corporation&#8217;s board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, calculated as provided under Section 203&#59; or</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">at or subsequent to the date of the transaction, the business combination is approved by the corporation&#8217;s board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Generally, a business combination includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation&#8217;s outstanding voting stock. The existence of this provision could delay, defer or prevent a change of control of the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Advance Notice Requirements for Stockholder Proposals and Director Nominations</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Bylaws provide that stockholders seeking to bring business before an annual meeting of stockholders, or to nominate candidates for election as directors at an annual meeting of stockholders, must provide timely notice in writing. To be timely, a stockholder's notice shall be delivered to the Secretary of the Company at the principal executive offices of the Company not later than the close of business on the ninetieth (90th) day nor earlier than the close of business on the one hundred twentieth (120th) day prior to the first anniversary of the preceding year's annual meeting of the stockholders&#59; provided, however, that in the event that the date of the annual meeting is scheduled more than thirty (30) days prior to the anniversary of the preceding </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">year's annual meeting, notice by the stockholder, to be timely, must be so delivered not earlier than the close of business on the one hundred twentieth (120th) day prior to such annual meeting and not later than the close of business on the later of the ninetieth (90th) day prior to such annual meeting or the tenth (10th) day following the day on which public announcement of the date of such meeting is first made. The Bylaws also specify requirements as to the form and content of a stockholder&#8217;s notice. These provisions may preclude, delay or discourage stockholders from bringing matters before an annual meeting of stockholders or from making nominations for directors at an annual meeting of stockholders.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Stockholder Action&#59; Special Meeting of Stockholders</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Certificate of Incorporation eliminates the ability of stockholders to act by written consent. It further provides that special meetings of the Company&#8217;s stockholders may be called only by our Chairman of the Board, Chief Executive Officer, President, a majority of the Company&#8217;s directors or a committee of the board of directors specifically designated to call special meetings of stockholders. These provisions may limit the ability of stockholders to remove current management or approve transactions that stockholders may deem to be in their best interests.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Authorized but Unissued Shares</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s authorized but unissued shares of Common Stock and preferred stock will be available for future issuance without stockholder approval. These additional shares may be utilized for a variety of corporate purposes, including public or private offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of Common Stock and preferred stock could render more difficult or discourage an attempt to effect a change in the Company&#8217;s control or a change in the Company&#8217;s management by means of a proxy contest, tender offer, merger or otherwise.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Charter Amendments</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Delaware law provides generally that the affirmative vote of a majority of the shares entitled to vote on any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">matter is required to amend a corporation&#8217;s certificate of incorporation or bylaws, unless either a corporation&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">certificate of incorporation or bylaws requires a greater percentage.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Elimination of Classified Board of Directors</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Historically, the Board was divided into three classes, designated as Class I, Class II, and Class III, with each class having three Board seats. However, on the recommendation of the Board, at the Company&#8217;s 2019 annual meeting of stockholders, the Company&#8217;s stockholders voted to eliminate the classification of the Board over a three-year period beginning at the 2020 annual meeting of stockholders, and provide for the annual election of all directors beginning at the 2022 annual meeting of stockholders. Thus, beginning with the 2020 election, the classified Board began &#8220;rolling off&#8221; in stages over the following two years. For 2020, the three Class III </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">directors are subject to election to only a one-year term expiring at the 2021 annual meeting of stockholders. Both the three Class I directors and once again the three Class III directors will be subject to election at the 2021 annual meeting of stockholders to a one-year term expiring at the 2022 annual meeting of stockholders. From and after the Company&#8217;s 2022 annual meeting of stockholders, the Board will no longer be divided into classes, and all nine directors will be elected for a one-year term expiring at the next annual meeting of stockholders in 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cumulative Voting</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Under cumulative voting, a minority stockholder holding a sufficient percentage of a class of shares may be</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">able to ensure the election of one or more directors. The Certificate of Incorporation expressly denies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">stockholders the right to cumulative voting in the election of directors.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer Agent Registrar</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The transfer agent and registrar for the Common Stock is American Stock Transfer &#38; Trust Company, LLC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Listing</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Common Stock is listed on the New York Stock Exchange under the symbol &#8220;MOH&#8221;.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>3
<FILENAME>a2ndamendedchangeincontrol.htm
<DESCRIPTION>EX-10.14
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic549b7f4699c47e4bb8ac464cbc2c826_57"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">MOLINA HEALTHCARE, INC.</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">SECOND AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE PLAN</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">(As Amended and Restated as of February 9, 2021)</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">I.&#160;&#160;&#160;&#160;INTRODUCTION </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Molina Healthcare, Inc. considers the maintenance of a sound management to be essential to protecting and enhancing the best interests of the Company and its stockholders.  Thus, the Company recognizes that the possibility of a Change in Control may exist from time to time, and that this possibility, and the uncertainty and questions it may raise among management, may result in the departure or distraction of management personnel to the detriment of the Company and its stockholders. Accordingly, the Company has determined that appropriate steps should be taken to encourage the continued attention and dedication of members of the Company&#8217;s management to their assigned duties without the distraction which may arise from the possibility of a Change in Control.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">The Company&#8217;s Change in Control Severance Plan was originally effective as of May 3, 2017, amended and restated as of February 18, 2019, and is hereby further amended and restated effective as of February 9, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221;).  This Second Amended and Restated Change in Control Severance Plan (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221;) does not alter the status of Participants as at-will employees of the Company.  Just as Participants remain free to leave the employ of the Company at any time, so too does the Company retain its right to terminate the employment of Participants without notice, at any time, for any reason, except to the extent otherwise provided in a written employment agreement between the Company and the Participant. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">However, the Company believes that, both prior to and at the time a Change in Control is anticipated or occurring, it is necessary to have the continued attention and dedication of Participants to their assigned duties without distraction, and this Plan is intended as an inducement for Participants&#8217; willingness to continue to serve as employees of the Company (subject, however, to either party&#8217;s right to terminate such employment at any time). Therefore, should a Participant still be an employee of the Company at the time of a Change in Control, the Company agrees that such Participant shall receive the severance benefits hereinafter set forth in the event the Participant&#8217;s employment with the Company terminates under the circumstances described below. </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">II.&#160;&#160;&#160;&#160;DEFINITIONS </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">As used herein the following words and phrases shall have the following respective meanings unless the context clearly indicates otherwise. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Any entity which controls, is controlled by, or is under common control with the Company. </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Annual Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The Participant&#8217;s annual base salary paid or payable, including any base salary that is subject to deferral, to the Participant by the Company or any of its Affiliates at the rate in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"> (or required to be in effect before any diminution that is a basis of the Participant&#8217;s termination for Good Reason) on the Date of Termination or immediately prior to the Change in Control if the Participant&#8217;s annual base salary was higher at such time. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.  The Participant&#8217;s target annual bonus.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Applicable Multiple</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(i)&#160;&#160;&#160;&#160;With respect to any Participant who is at or above the level of Senior Vice President, two (2). </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(ii)&#160;&#160;&#160;&#160;With respect to any Participant who is at or above the level of Associate Vice President, but below the level of Senior Vice President, one (1). </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;With respect to any Participant, other than a Participant identified in clause (i) or (ii) of this Section 2(d), one (1). </font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The Board of Directors of the Company. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. With respect to any Participant&#58; </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(i)&#160;&#160;&#160;&#160;the Participant&#8217;s willful engaging in illegal conduct or gross misconduct which is materially and demonstrably injurious to the Company&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(ii)&#160;&#160;&#160;&#160;the Participant&#8217;s material violation of any policy or code of conduct of the Company or any of its Affiliates, and failure to correct (if possible) following notification of such violation&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the Participant&#8217;s unauthorized use or disclosure of confidential information or trade secrets&#59;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;the Participant&#8217;s engaging in competition with the Company&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;any material breach by the Participant of his or her fiduciary duty to the Company&#59; or</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;the willful and continued failure of the Participant to perform substantially the Participant&#8217;s duties with the Company or one of its Affiliates to the extent, degree and level of performance as expected of the Participant (other than any such failure resulting from incapacity due to physical or mental illness), after a written demand for substantial performance is delivered to the Participant by the Board or the Chief Executive Officer of the Company which specifically identifies the manner in which the Board or Chief Executive Officer believes that the Participant has not substantially performed the Participant&#8217;s duties. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The occurrence of any of the following events after the Effective Date&#58; </font></div><div><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(i)&#160;&#160;&#160;&#160;the acquisition (other than by an Excluded Person), directly or indirectly, in one or more transactions, by any person or by any group of persons, within the meaning of Section 13(d) or 14(d) of the Exchange Act, of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of more than fifty percent (50%) of either the outstanding shares of common stock or the combined voting power of the Company&#8217;s outstanding voting securities entitled to vote generally, whether or not the acquisition was previously approved by the existing directors, other than an acquisition that complies with clause (x) of paragraph (ii)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(ii)&#160;&#160;&#160;&#160;consummation of a reorganization, merger, or consolidation of the Company or the sale or other disposition of all or substantially all of the Company&#8217;s assets unless, (x) immediately following such event, all or substantially all of the stockholders of the Company immediately prior to such event own, directly or indirectly, more than fifty percent (50%) of the then outstanding voting securities of the resulting company (including without limitation, a corporation which as a result of such event owns the Company or all or substantially all of the Company&#8217;s assets either directly or indirectly through one or more subsidiaries)&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(iii)&#160;&#160;&#160;&#160;the complete liquidation or dissolution of the Company&#59; or</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(iv)&#160;&#160;&#160;&#160;a change in the composition of a majority of the directors on the Company&#8217;s Board within twelve (12) months if not approved by a majority of the pre-existing directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The Internal Revenue Code of 1986, as amended from time to time. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The Compensation Committee of the Board.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Molina Healthcare, Inc., a Delaware corporation, and any successor thereto.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Date of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.  The Date of Termination shall mean&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(i)&#160;&#160;&#160;&#160;except in the case of the Participant&#8217;s termination of employment by reason of death or Disability, the date of receipt of the Notice of Termination by the Company or the Participant, as the case may be, or such later date specified in the Notice of Termination, as the case may be&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;if the Participant&#8217;s employment is terminated by reason of death, the date of death&#59; or</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160; if the Participant&#8217;s employment is terminated by reason of Disability, the thirtieth (30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day after receipt of such Notice of Termination by the Participant.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, in no event shall the Date of Termination occur until the Participant experiences a &#8220;separation from service&#8221; within the meaning of Section 409A, and the date on which such separation from service takes place shall be the &#8220;Date of Termination.&#8221; </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(l)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. A condition such that the Participant by reason of physical or mental disability becomes entitled to benefits under the Company&#8217;s long-term disability plan. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The Effective Date shall be as defined in the introductory section hereof.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Any full-time, regular employee of the Company or any of its Subsidiaries whose employment is not the subject of a collective bargaining agreement, including any such employees who may be on a leave of absence approved by the Company or any of its Subsidiaries, respectively. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The Employee Retirement Income Security Act of 1974, as amended from time to time. </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(p)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The Securities Exchange Act of 1934. </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(q)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Excluded Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Excluded Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221; means&#58;</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;any person described in and satisfying the conditions of Rule 13d-1(b)(1) under the Exchange Act&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the Company&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;an employee benefit plan (or related trust) sponsored or maintained by the Company or its successor&#59; or</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;any person who is the beneficial owner (as defined in Rule 13d-3 under the Exchange Act) of more than fifteen percent (15%) of the common stock of the Company on the Effective Date (or any affiliate, successor, heir, descendant, or related party of or to such person).</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(r)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The occurrence of any one (1) or more of the following, without the express written consent of the Participant&#58; </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the Participant&#8217;s position, authority, duties or responsibilities are materially diminished from those in effect during the ninety (90)-day period immediately preceding a Change in Control (whether or not occurring solely as a result of the Company ceasing to be a publicly traded entity)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;a material reduction in the Participant&#8217;s (x) Annual Base Salary or (y) total annual compensation opportunity, from such total annual compensation opportunity as in effect during the ninety (90)-day period immediately prior to the Change in Control, or as the same may be increased from time to time&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the Company requires the Participant regularly to perform such Participant&#8217;s duties of employment beyond a fifty (50) mile radius from the location of the Participant&#8217;s employment immediately prior to the Change in Control&#59; or</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;a material breach by the Company of the terms of a Participant&#8217;s written employment agreement. </font></div><div><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">In order to invoke a termination of employment for Good Reason, the Participant shall provide a Notice of Termination pursuant to Section 7.4 to the Company&#8217;s Chief Legal Officer of the existence of one or more of the conditions described in clauses (i) through (iv) within ninety (90) days following the initial existence of such condition or conditions, specifying in reasonable detail the conditions constituting Good Reason (hereinafter, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Notice of Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221;), and the Company shall have thirty (30) days following receipt of such written notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Cure Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221;) during which it may remedy the condition. In the event that the Company fails to remedy the condition constituting Good Reason during the applicable Cure Period, the effective date of the Participant&#8217;s Termination of Employment shall be as specified in such notice, but in no event later than thirty (30) days thereafter.  The Participant&#8217;s mental or physical incapacity following the occurrence of an event described above in clauses (i) through (iv) shall not affect the Participant&#8217;s ability to terminate employment for Good Reason and the Participant&#8217;s death following delivery of a Notice of Good Reason shall not affect the Participant&#8217;s estate&#8217;s entitlement to Separation Benefits provided hereunder. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(s)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;In the case of the Company, a written notice that (x) indicates the basis under the Plan for termination and (y) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Participant&#8217;s employment under the Plan, as indicated. The failure by the Company to set forth in the Notice of Termination any fact or circumstance that contributes to a showing of Good Reason or Cause shall not waive any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">right of the Company hereunder or preclude the Company, respectively, from asserting such fact or circumstance in enforcing the Company&#8217;s respective rights hereunder. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;In the case of a Participant, a notice from a Participant to the Company that shall indicate the specific termination provision or provisions of the Plan relied upon and shall set forth in reasonable detail the facts and in the case of a Notice of Termination for Good Reason, the circumstances claimed to provide a basis for termination for Good Reason. Such Notice of Termination for Good Reason must be given no later than ninety (90) days from the initial existence of the condition and shall provide for a date of termination not less than thirty (30) nor more than sixty (60) days after the date such Notice of Termination for Good Reason is delivered to and acknowledged by the General Counsel of the Company.   </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(t)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. An individual who qualifies to participate in this Plan pursuant to Section 3.1.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(u)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. At any time following a Change in Control and prior to the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:133%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">) anniversary of the Change in Control, the Participant&#8217;s employment with the Company or any of its Subsidiaries is terminated (i) involuntarily by the Company for any reason other than Cause, death, or Disability&#59; or (ii) by the Participant for Good Reason. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Section 409A of the Code, and the rules and regulations issued thereunder.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"> </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(w)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The benefits described in Sections 4.2(a)(iii), (iv) and (v) and Sections 4.2(b) and 4.2(c) that are provided to qualifying Participants under the Plan. </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(x)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Any corporation, limited liability company, or any other entity in which the Company, directly or indirectly, holds a majority of the voting power of such corporation&#8217;s, limited liability company&#8217;s, or such other entity&#8217;s outstanding equity interests. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">III.&#160;&#160;&#160;&#160;ELIGIBILITY </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Each Employee (a) who has a position of Associate Vice President or above, or (b) who has a position lower than Associate Vice President, but has been designated in writing as a Participant by the Committee or the Board, shall be a Participant in this Plan. Notwithstanding the foregoing, if a Participant who is eligible to participate in this Plan has entered into an agreement with the Company that provides for benefits in the event of a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">termination of employment following a Change in Control, such Participant shall be entitled to receive Separation Benefits (or any other benefits under the Plan) only to the extent that such Separation Benefits are in addition to or in excess of the benefits provided under such Participant&#8217;s agreement with the Company. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Duration of Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The Committee may remove an Employee as a Participant by providing written notice of removal to such Employee&#59; provided that no such removal shall be effective (a) during the two (2) year period following a Change in Control, (b) if effectuated prior to a Change in Control, but after a letter of intent with respect to such Change in Control has been entered into between the Company and a third party or (c) at such time as the Participant is entitled to payment of a Separation Benefit or any other amounts payable under the Plan.  In addition, a Participant shall cease to be a Participant in the Plan as a result of an amendment or termination of the Plan complying with Article VI of the Plan, or when the Participant ceases to be an Employee or no longer qualifies as a Participant under Section 3.1, unless, at the time the Participant ceases to be an Employee or no longer qualifies as a Participant under Section 3.1, such Participant is entitled to payment of a Separation Benefit or any other amounts payable under the Plan or there has been an event or occurrence constituting Good Reason that would enable the Participant to terminate employment and receive a Separation Benefit. A Participant entitled to payment of a Separation Benefit or any other amounts payable under the Plan shall remain a Participant in the Plan until the full amount of the Separation Benefit and any other amounts payable under the Plan have been paid to the Participant. </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">IV.&#160;&#160;&#160;&#160;SEPARATION BENEFITS </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Terminations of Employment which Give Rise to Separation Benefits under this Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.  Provided that a Participant is in compliance with the terms of this Plan and satisfies all conditions herein, such Participant shall be entitled to Separation Benefits as set forth in Section 4.2 below if the Participant experiences a Qualifying Termination. For purposes of this Plan, any purported termination by the Company or by the Participant shall be communicated by written Notice of Termination to the other in accordance with Section 7.4 hereof and, to the extent applicable, Section 2(s) hereof. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(a)&#160;&#160;&#160;&#160;If a Participant experiences a Qualifying Termination, then the Company shall pay to the Participant, in a lump sum in cash on the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:133%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">) day after the Date of Termination (or on such earlier date as may be required by applicable law), subject to the Participant&#8217;s compliance with Section 4.2(e) below, the aggregate of the following amounts which benefits, except as provided in Section 7.3 below, shall be in addition to any other benefits to which the Participant is entitled other than by reason of this Plan&#58; </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;unpaid salary with respect to any paid time off accrued but not taken as of the Date of Termination&#59; </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;accrued but unpaid salary through the Date of Termination&#59; </font></div><div><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(iii)&#160;&#160;&#160;&#160;any earned but unpaid annual incentive bonuses from the fiscal year immediately preceding the year in which the Date of Termination occurs (unless (x) such annual incentive bonus is &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A, in which case such bonus shall be paid at the time that bonuses with respect to such fiscal year are or otherwise would be paid in accordance with the terms of the applicable plan or (y) the Participant has made an irrevocable election under any deferred compensation arrangement subject to Section 409A to defer any portion of such annual incentive bonuses, in which case any such deferred bonuses shall be paid in accordance with such election)&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(iv)&#160;&#160;&#160;&#160;an amount equal to the Applicable Multiple times the Participant&#8217;s Annual Base Salary&#59; and </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;an amount equal to the Participant&#8217;s Annual Bonus for the year in which the Participant&#8217;s employment is terminated based on the assumption that target performance had been achieved, and based on the number of entire months of such year that have elapsed through the date of the Participant&#8217;s termination of employment as a fraction of twelve (12).</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(b)&#160;&#160;&#160;&#160;If the Participant&#8217;s employment is terminated under circumstances which entitle the Participant to Separation Benefits under this Section 4.2 and the Participant and the Participant&#8217;s eligible dependents are eligible for extended continued health care, dental and&#47;or vision coverage under the Company&#8217;s benefit plans (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">COBRA Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221;) as required by Code Section 4980B, then, if the Participant complies with all terms and conditions of the applicable plans, timely and properly elects COBRA Coverage and timely pays the applicable COBRA contributions for the elected COBRA Coverage, except as provided below, for a period of eighteen (18) months following the Date of Termination (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Benefit Continuation Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221;), the Company shall pay directly to the applicable plans or, to the extent paid by the Participant, reimburse Participant, an amount equal to the difference between the full cost for such COBRA Coverage and the amount the Participant would be required to pay for such coverage as an active employee.  Such payment shall be paid (or reimbursed) and reported as taxable compensation to the Participant and shall be subject to applicable tax withholding. Notwithstanding the above, if the Participant becomes employed by another employer and becomes eligible for health care, dental and&#47;or vision coverage under another employer-provided plan before the end of the Benefit Continuation Period, the Company will cease the premium reimbursements and&#47;or payments described above for the corresponding COBRA Coverage.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(c)&#160;&#160;&#160;&#160;If the Participant is entitled to Separation Benefits under this Plan and notwithstanding anything to the contrary in any equity incentive, stock option, stock appreciation right (SAR), performance units, phantom stock awards, or deferred compensation plan or retirement plan or agreements, then&#58; </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:21.6pt;padding-right:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(i) all outstanding time-vesting Company equity or equity-based awards held by the Participant shall immediately vest in full&#59;</font></div><div style="padding-left:21.6pt;padding-right:21.6pt"><font><br></font></div><div style="padding-left:21.6pt;padding-right:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(ii) all outstanding performance-vesting Company equity or equity-based awards held by the Participant shall immediately vest based upon the greater of&#58; (1) target performance, based on the assumption that such target performance had been achieved, or (2) the projected final achievement of the performance metric through the measurement period, provided that where applicable, such projected final achievement shall be based on straight-line extrapolation of actual achievement (as of the Date of Termination) through the end of the respective performance metric period&#59; except to the extent vesting is determined by reference to any completed fiscal year, then actual performance for such completed fiscal year shall be used&#59; and</font></div><div style="padding-left:21.6pt;padding-right:21.6pt"><font><br></font></div><div style="padding-left:21.6pt;padding-right:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(iii) the Participant (or his personal representative if applicable) shall be permitted to exercise any of the Participant&#8217;s vested stock options&#47;SARs until the earlier of&#58; (1) one (1) year after the Participant&#8217;s termination of employment, and (2) the term of such unexercised stock options, warrants, or SARs.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(d)&#160;&#160;&#160;&#160;Except as provided in Section 4.2(b) and Section 7.3, the Participant shall not be required to mitigate the amount of any payment provided for in this Section 4.2 by seeking other employment or otherwise, nor shall the amount of any payment or benefit provided for in this Section 4.2 be reduced by any compensation earned by the Participant as the result of employment by another employer or by retirement benefits paid by the Company after the Date of Termination, or otherwise, or by any set-off, counterclaim, recoupment, or other claim, right or action the Company may have against the Participant or others. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(e)&#160;&#160;&#160;&#160;All Severance Benefits are conditioned on the Participant&#8217;s continuing compliance with this Plan and the Company&#8217;s policies.  All Severance Benefits are also conditioned on, and in consideration for, the following actions being completed no later than sixty (60) days following the Participant&#8217;s termination of employment&#58; the Participant&#8217;s execution (and effectiveness) of a release of claims and covenant not to sue substantially in the form provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">, any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">revocation period required by law has run, and the Participant has not revoked the release of claims and covenant not to sue. In the event a Participant fails to return such release within such time period, or revokes the release, the Participant shall forfeit his Severance Benefits hereunder.  In the event that the period for consideration or revocation overlaps two (2) tax years, any payment of Severance Benefits under Section 4.2(a) due hereunder shall not commence until the later tax year.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Limitation on Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(a)&#160;&#160;&#160;&#160; Anything in this Plan to the contrary notwithstanding, in the event it shall be determined that any payment or distribution made, or benefit provided, by the Company to or for the benefit of the Participant under this Plan or any other agreement between the Company and the Participant or plan of the Company would constitute a &#8220;parachute payment&#8221; as defined in Section 280G of the Code, then the benefits payable pursuant to this Plan shall be reduced so that the aggregate present value of all payments in the nature of compensation to (or for the benefit of) the Participant which are contingent on a change of control (as defined in Section 280G(b)(2)(A) of the Code) is One Dollar ($1.00) less than the amount which the Participant could receive without being considered to have received any parachute payment (the amount of this reduction in the benefits payable is referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Excess Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221;).  The determination of the amount of any reduction required by this Section 4.3(a) shall be made by a nationally recognized tax counsel selected by the Company, and such determination shall be conclusive and binding on the parties hereto.  </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(b)&#160;&#160;&#160;&#160;Notwithstanding the provisions of Section 4.3(a), if it is established, pursuant to a final determination of a court or an Internal Revenue Service proceeding which has been finally and conclusively resolved, that an Excess Amount was received by the Participant from the Company, then the Participant shall be obligated to repay such Excess Amount to the Company on demand (but no less than ten (10) days after written demand is received by the Participant).  </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">V.&#160;&#160;&#160;&#160;SUCCESSOR TO COMPANY </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">This Plan shall inure to the benefit of and be binding upon the Company and its successors and assigns. The Company shall require any corporation, entity, individual, or other person who is the successor (whether direct or indirect by purchase, merger, consolidation, reorganization or otherwise) to all or substantially all the business and&#47;or assets of the Company to expressly assume and agree to perform, by a written agreement in form and in substance satisfactory to the Company, all of the obligations of the Company under this Plan.  It is a condition of this Plan, and all rights of each person eligible to receive benefits under this Plan shall be subject hereto, that no right or interest of any such person in this Plan shall be assignable or transferable in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">whole or in part, except by operation of law, including, but not by way of limitation, lawful execution, levy, garnishment, attachment, pledge, bankruptcy, alimony, child support or qualified domestic relations order. </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">VI.&#160;&#160;&#160;&#160;DURATION, AMENDMENT AND TERMINATION </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">6.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Duration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Unless earlier terminated pursuant to Section 6.2, if a Change in Control has not occurred, this Plan shall expire three (3) years from the Effective Date&#59; provided, that upon each annual anniversary of the Effective Date (each such annual anniversary a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Renewal Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221;), the Plan shall be extended for an additional year, unless pursuant to a resolution adopted by the Board prior to the Renewal Date the Company determines not to so extend the Plan. If a Change in Control occurs while this Plan is in effect, this Plan shall continue in full force and effect for at least two (2) years following such Change in Control, and shall not terminate or expire until after all Participants who become entitled to any payments or benefits hereunder shall have received such payments and benefits in full. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">6.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Amendment or Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The Company reserves the right to amend, modify, suspend or terminate the Plan at any time by action of a majority of the Board&#59; provided that no such amendment, modification, suspension or termination that has the effect of reducing or diminishing the right of any Participant shall be effective without the written consent of such Participant for a period of two (2) years following the Change in Control if adopted after a Change in Control or in anticipation of a Change in Control.  Any amendment, modification, suspension or termination of this Plan adopted after a Change in Control or in anticipation of a Change in Control shall not affect the right of any Participant to payments or benefits to be paid or provided as a result of events that occur prior to the second anniversary of the Change in Control. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">6.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Procedure for Extension, Amendment or Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Any extension, amendment or termination of this Plan by the Board in accordance with this Article VI shall be made by action of the Board in accordance with the Company&#8217;s charter documents and applicable law. </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">VII.&#160;&#160;&#160;&#160;MISCELLANEOUS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"> </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Default in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Any payment not made within ten (10) days after it is due in accordance with this Plan shall thereafter bear interest, compounded annually, at the U.S. prime rate from time to time then in effect. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">No Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. No interest of any Participant or spouse of any Participant or any other beneficiary under this Plan, or any right to receive payment hereunder, shall be subject in any manner to sale, transfer, assignment, pledge, attachment, garnishment, or other alienation or encumbrance of any kind, nor may such interest or right to receive a payment or distribution be taken, voluntarily or involuntarily, for the satisfaction of the obligations or debts of, or other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">claims against, a Participant or spouse of a Participant or other beneficiary, including for alimony. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Effect on Other Plans, Agreements and Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Except to the extent expressly set forth herein, any benefit or compensation to which a Participant is entitled under any agreement between the Participant and the Company or any of its Subsidiaries or under any plan maintained by the Company or any of its Subsidiaries in which the Participant participates or participated shall not be modified or lessened in any way, but shall be payable according to the terms of the applicable plan or agreement. Notwithstanding the foregoing, any benefits received by a Participant pursuant to this Plan shall be in lieu of any severance benefits to which the Participant would otherwise be entitled under any general severance policy or other severance plan maintained by the Company and, upon consummation of a Change in Control, Participants in this Plan shall in no event be entitled to participate in any such severance policy or other severance plan maintained by the Company. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.4 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. For the purpose of this Plan, notices and all other communications provided for in this Plan shall be in writing and shall be deemed to have been duly given when actually delivered or mailed by United States registered mail, return receipt requested, postage prepaid, addressed to the Company&#8217;s Chief Legal Officer at the Company&#8217;s corporate headquarters address, and to the Participant (at the last address of the Participant on the Company&#8217;s books and records). </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.5 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Employment Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. This Plan does not constitute a contract of employment or impose on the Participant or the Company any obligation for the Participant to remain an Employee or change the status of the Participant&#8217;s employment or the policies of the Company and its Affiliates regarding termination of employment, nor does it alter or exterminate the agreement that employment is at-will.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.6 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Nondisparagement&#59; Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.  On the Effective Date and thereafter, the Participant agrees that the Participant will not disparage the Company or its directors, officers, employees, affiliates, subsidiaries, predecessors, successors or assigns in any written or oral communications to any third party.  The Participant further agrees that he&#47;she will not direct anyone to make any disparaging oral or written remarks to any third parties.  During the Participant&#8217;s employment and following the Participant&#8217;s termination of employment for any reason, the Participant agrees to not use or disclose the confidential information or trade secrets of the Company.  Notwithstanding the foregoing, nothing herein or in the release of claims described in Section 4.2(e) above is intended to or shall prevent any Participant from communicating directly with, cooperating with, or providing information (including trade secrets) in confidence to, any federal, state or local government regulator (including, but not limited to, the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, or the U.S. Department of Justice) for the purpose of reporting or investigating a suspected violation of law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Nonsolicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.  During the Participant&#8217;s employment with Company and for twelve (12) months after the Participant&#8217;s termination of employment and payment of the Severance Benefits hereunder, the Participant shall not, directly or indirectly, either as an individual or as an employee, agent, consultant, advisor, independent contractor, general partner, officer, director, stockholder, investor, lender, or in any other capacity whatsoever, of any person, firm, corporation, or partnership, (i) induce or attempt to induce any person who at the time of such inducement or hire is an employee of the Company (or who was, within six (6) months prior to such inducement or hire, an employee) to perform work or service for any other person or entity other than the Company, or (ii) through the use of confidential information or trade secrets, solicit customers, suppliers, or clients of the Company to reduce or discontinue their business with the Company or to engage in business with any competing entity.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Compensation and benefits payable under Sections 4.2(a)(iv), 4.2(a)(v), 4.2(b) and 4.2(c) are subject to a right of recoupment by the Company in the event of a violation of the provisions of Sections 7.6 and 7.7, as provided in this Section 7.8.  The Company may seek recovery of any and all compensation and benefits paid under Sections 4.2(a)(iv), 4.2(a)(v), 4.2(b) and 4.2(c) from a Participant during the period commencing twelve (12) months immediately prior to such violation. The Company shall have the right to sue for repayment, and enforce the repayment through the reduction or cancellation of outstanding equity awards.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Plan Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. This Plan shall be administered by the Committee&#59; provided that in the event of an impending Change in Control, the Committee may appoint a person (or persons) independent of the third-party effectuating the Change in Control to be the Committee effective upon the occurrence of a Change in Control and such Committee shall not be removed or modified following a Change in Control, other than at its own initiative (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Independent Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221;). Except as otherwise provided in this Plan, the decision of the Committee (including the Independent Committee) upon all matters within the scope of its authority shall be conclusive and binding on all parties, provided that in the event that no Independent Committee is appointed, any determination by the Committee of whether &#8220;Cause&#8221; or &#8220;Good Reason&#8221; exists shall be subject to de novo review. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.10 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Unfunded Plan Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. This Plan is intended to be an unfunded plan maintained primarily for the purpose of providing deferred compensation for a select group of management or highly compensated employees, within the meaning of Section 401 of ERISA.  All payments pursuant to the Plan shall be made from the general funds of the Company and no special or separate fund shall be established or other segregation of assets made to assure payment.  No Participant or other person shall have under any circumstances any interest in any particular property or assets of the Company as a result of participating in the Plan.  Notwithstanding the foregoing, the Company may (but shall not be obligated to) create one (1) or more grantor trusts, the assets of which are subject to the claims of the Company&#8217;s creditors, to assist it in accumulating funds to pay its obligations under the Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.11 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.  All payments made under this Plan shall be subject to reduction to reflect taxes required to be withheld by law.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Validity and Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The invalidity or unenforceability of any provision of this Plan shall not affect the validity or enforceability of any other provision of this Plan, which shall remain in full force and effect, and any prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.13 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(a)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. This Plan is intended to be exempt from the requirements of Section 409A and shall in all respects be administered in accordance with the &#8220;short-term deferral&#8221; exception in the regulations promulgated under Section 409A.  In no event may the Participant, directly or indirectly, designate the calendar year of any payment under this Plan. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">In-Kind Benefits and Reimbursements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.  Notwithstanding anything to the contrary in this Plan, all reimbursements and in-kind benefits provided under this Plan shall be made or provided in accordance with the requirements of the regulations promulgated under Section 409A, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during the Participant&#8217;s lifetime (or during a shorter period of time specified in this Plan)&#59; (ii) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year, except, if such benefits consist of the reimbursement of expenses referred to in Section 105(b) of the Code, a maximum, if provided under the terms of the plan providing such medical benefit, may be imposed on the amount of such reimbursements over some or all of the period in which such benefit is to be provided to the Participant as described in Treasury Regulation Section 1.409A-3(i)(1)(iv)(B)&#59; (iii) the reimbursement of an eligible expense will be made no later than the last day of the calendar year following the year in which the expense is incurred, provided that the Participant shall have submitted an invoice for such fees and expenses at least ten (10) days before the end of the calendar year next following the calendar year in which such fees and expenses were incurred&#59; and (iv) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit. </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Delay of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. Notwithstanding any other provision of this Plan to the contrary, if the Participant is considered a &#8220;specified employee&#8221; for purposes of Section 409A (as determined by the Company in accordance with Section 409A), any payment that constitutes nonqualified deferred compensation within the meaning of Section 409A that is otherwise due to the Participant under this Plan during the six-month period following the Participant&#8217;s separation from service (as determined in accordance with Section 409A) on account of the Participant&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">separation from service shall be accumulated and paid to the Participant on the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:133%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">) business day after the date that is six (6) months following the Participant&#8217;s separation from service (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Delayed Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221;). The Participant shall be entitled to interest (at the applicable rate in effect for the month in which the separation from service occurs) on any cash payments so delayed from the scheduled date of payment to the Delayed Payment Date. If the Participant dies during the postponement period, the amounts and entitlements delayed on account of Section 409A shall be paid to the personal representative of the Participant&#8217;s estate on the first to occur of the Delayed Payment Date or thirty (30) days after the date of the Participant&#8217;s death. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">7.14 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">. The validity, interpretation, construction and performance of this Plan shall in all respects be governed by the laws of Delaware, without reference to principles of conflict of law, except to the extent pre-empted by federal law.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Form of Release of Claims and Covenant Not To Sue</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In consideration of the payments and other benefits that Molina Healthcare, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), is providing to _____________ (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) under the Company&#8217;s Second Amended and Restated Change in Control Severance Plan, the Employee, on his&#47;her own behalf and on behalf of Employee&#8217;s representatives, agents, heirs and assigns, waives, releases, discharges and promises never to assert any and all claims, demands, actions, costs, rights, liabilities, damages or obligations of every kind and nature, whether known or unknown, suspected or unsuspected that Employee ever had, now have or might have as of the date of Employee&#8217;s termination of employment with the Company against the Company or its predecessors, parent, affiliates, subsidiaries, stockholders, owners, directors, officers, employees, agents, attorneys, insurers, successors, or assigns (including all such persons or entities that have a current and&#47;or former relationship with the Company) for any claims arising from or related to Employee&#8217;s employment with the Company, its parent or any of its affiliates and subsidiaries and the termination of that employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">These released claims also specifically include, but are not limited to, any claims arising under any federal, state and local statutory or common law, such as (as amended and as applicable) Title VII of the Civil Rights Act, the Age Discrimination in Employment Act, the Americans With Disabilities Act, the Employee Retirement Income Security Act, the Family Medical Leave Act, the Equal Pay Act, the Fair Labor Standards Act, the Industrial Welfare Commission&#8217;s Orders, the California Fair Employment and Housing Act, the California Constitution, the California Government Code, the California Labor Code and any other federal, state or local constitution, law, regulation or ordinance governing the terms and conditions of employment or the termination of employment, and the law of contract and tort and any claim for attorneys&#8217; fees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Furthermore, the Employee acknowledges that this waiver and release is knowing and voluntary and that the consideration given for this waiver and release is in addition to anything of value to which Employee was already entitled.  Employee acknowledges that there may exist facts or claims in addition to or different from those which are now known or believed by Employee to exist.  Nonetheless, this Agreement extends to all claims of every nature and kind whatsoever, whether known or unknown, suspected or unsuspected, past or present.  Employee also expressly waives the provisions of California Civil Code section 1542, which provides&#58; &#8220;A general release does not extend to claims which the creditor does not know or suspect to exist in his&#47;her favor at the time of executing the release, which if known by him&#47;her must have materially affected his&#47;her settlement with the debtor.&#8221; With respect to the claims released in the preceding sentences, the Employee will not initiate or maintain any legal action or proceeding of any kind against the Company or its predecessors, parent, affiliates, subsidiaries, stockholders, owners, directors, officers, employees, agents, successors, or assigns (including all such persons or entities that have a current or former relationship with the Company), for the purpose of obtaining any personal relief, nor assist or participate in any such proceedings, including any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">proceedings brought by any third parties (except as otherwise required or permitted by law).  The Employee further acknowledges that he&#47;she has been advised by this writing that&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">he&#47;she should consult with an attorney prior to executing this release&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">he&#47;she has at least &#91;twenty-one (21) or forty-five (45) days, as required under applicable law&#93; within which to consider this release&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">he&#47;she has up to seven (7) days following the execution of this release by the parties to revoke the release&#59; and</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">this release shall not be effective until such seven (7) day revocation period has expired.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee agrees that the release set forth above shall be and remain in effect in all respects as a complete general release as to the matters released.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EMPLOYEE</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Name&#93;</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;18</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>4
<FILENAME>a2ndamendto2018deferredcom.htm
<DESCRIPTION>EX-10.18
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i64faaa8c791844d590bce84066108eb7_37"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">AMENDMENT NO. TWO</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">TO THE</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MOLINA HEALTHCARE, INC.</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">AMENDED AND RESTATED</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">DEFERRED COMPENSATION PLAN (2018)</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Section 7 of the Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2018) effective for amounts earned and deferred on or after January 1, 2018 (the &#8220;Plan&#8221;) allows Molina Healthcare, Inc. (the &#8220;Company&#8221;) to amend the terms of the Plan, at any time by resolution of the Plan Committee.  Accordingly, the Plan Committee amends the Plan as follows, effective January 1, 2021. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Section 5.3 is amended to read as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;a.&#160;&#160;&#160;&#160;If a Participant dies while still employed by the Company or a Subsidiary, the following provisions shall apply&#58; </font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.&#160;&#160;&#160;&#160;If the Participant first began participating in the Plan on or before December 31, 2020, the Company will pay the Participant&#8217;s designated Beneficiary the greatest of&#58; (x) twice the Participant&#8217;s base salary as of October 1, 2019 or, if later, the Participant&#8217;s effective date of enrollment in the Plan&#59; (y) $500,000&#59; or (z) the Participant&#8217;s Separation from Service Benefit, in the applicable form elected by the Participant in his Written Election&#59; or </font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.&#160;&#160;&#160;&#160;If the Participant first began participating in the Plan on or after January 1, 2021, the Company will pay the Participant&#8217;s designated Beneficiary the Participant&#8217;s Separation from Service Benefit, in the applicable form elected by the Participant in his Written Election.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;If a Participant dies after a Separation from Service, the Company will commence or otherwise continue the payments of the Separation from Service Benefit otherwise due to the Participant to his designated Beneficiary, in the applicable form elected by the Participant in his Written Election.&#8221;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except as amended hereby, the terms of the Plan shall remain in full force and effect.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MOLINA HEALTHCARE, INC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47;Joseph M. Zubretsky&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Joseph M. Zubretsky</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; President and Chief Executive Officer</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;1</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>5
<FILENAME>moh4q20_ex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ide74765aacb74745a6f32bd88e4d99c5_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 21.1</font></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIST OF SUBSIDIARIES </font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Jurisdiction of Incorporation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 West Broadway, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare Data Center, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Arizona, Inc.*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of California</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Florida, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Georgia, Inc.*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Illinois, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Kentucky, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Louisiana, Inc.*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Michigan, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Mississippi, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississippi</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Nevada, Inc.*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of New Mexico, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of New York, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Ohio, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Oklahoma, Inc.*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Pennsylvania, Inc.*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Puerto Rico, Inc. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico&#47;Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of South Carolina, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Tennessee, Inc.*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Texas, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Texas Insurance Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Utah, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Washington, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Healthcare of Wisconsin, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Clinical Services, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Hospital Management, LLC*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Pathways, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Care Connections, LLC+</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molina Youth Academy*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oceangate Reinsurance, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pathways Community Corrections, LLC*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida MHS, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magellan Complete Care of Arizona, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magellan Complete Care of Virginia, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SWH Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Health Holdings, LLC++</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Health Holdings, Inc.+++</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AlphaCare Holdings, Inc.++++</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Whole Health of New York, Inc.+++++</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Whole Health, LLC++++</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Whole Health Management Company, Inc.+++</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Management Group, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 21.1</font></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-top:7.5pt;padding-left:24.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;    Non-operational entity</font></div><div style="margin-top:7.5pt;padding-left:24.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;    Wholly owned subsidiary of Molina Pathways, LLC</font></div><div style="margin-top:7.5pt;padding-left:24.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">++&#160;&#160;&#160;&#160;     Wholly owned subsidiary of SWH Holdings, Inc.</font></div><div style="margin-top:7.5pt;padding-left:24.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+++&#160;&#160;&#160;&#160;     Wholly owned subsidiary of Senior Health Holdings, LLC</font></div><div style="margin-top:7.5pt;padding-left:24.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">++++     Wholly owned subsidiary of Senior Health Holdings, Inc. </font></div><div style="margin-top:7.5pt;padding-left:24.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+++++   Wholly owned subsidiary of AlphaCare Holdings, Inc.</font></div><div style="margin-top:7.5pt;padding-left:24.75pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>moh4q20_ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i56698fe9eb34405ebcd2f1a248a42096_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%">EXHIBIT 23.1  </font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:9.67pt">Registration Statement (Form S-8 No. 333-174912) pertaining to the Molina Healthcare, Inc. 2011 Equity Incentive Plan and 2011 Employee Stock Purchase Plan&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:9.67pt">Registration Statement (Form S-8 No. 333-231385) pertaining to the Molina Healthcare, Inc. 2019 Equity Incentive Plan and 2019 Employee Stock Purchase Plan,</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">of our reports dated February&#160;16, 2021, with respect to the consolidated financial statements of Molina Healthcare, Inc., and the effectiveness of internal control over financial reporting of Molina Healthcare, Inc., included in this Annual Report (Form&#160;10-K) for the year ended December&#160;31,&#160;2020. </font></div><div style="text-align:justify;text-indent:24.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#47;s&#47;&#160;ERNST&#160;&#38; YOUNG LLP </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Los Angeles, California </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">February&#160;16, 2021 </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>moh4q20_ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i330c95fb6d3d4d0a978de2fa5416fae1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACT OF 1934, AS AMENDED</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Joseph M. Zubretsky, certify that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed the report on Form 10-K for the period ended December&#160;31, 2020, of Molina Healthcare, Inc.&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, the report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report&#59;</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in the report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in the report&#59;</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended), and internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934, as amended), for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period for which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in the report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by the report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in the report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and to the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.622%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; February 16, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Joseph M. Zubretsky</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joseph M. Zubretsky</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer, President and Director</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>moh4q20_ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie9274c0167c94820b13e01f83f261a61_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2 </font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACT OF 1934, AS AMENDED</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas L. Tran, certify that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed the report on Form 10-K for the period ended December&#160;31, 2020, of Molina Healthcare, Inc.&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, the report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in the report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in the report&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended), and internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934, as amended), for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period for which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in the report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by the report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in the report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and to the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.850%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; February 16, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas L. Tran</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thomas L. Tran</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>moh4q20_ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic8833ab17636401ebce1f704446cf6aa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the report of Molina Healthcare, Inc. (the &#8220;Company&#8221;) on Form 10-K for the period ended December&#160;31, 2020 (the &#8220;Report&#8221;), I, Joseph M. Zubretsky, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.622%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; February 16, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Joseph M. Zubretsky</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joseph M. Zubretsky</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer, President and Director</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>moh4q20_ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i21ff61fe4f5d46ef9c10dcaa6f2e5885_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the report of Molina Healthcare, Inc. (the &#8220;Company&#8221;) on Form 10-K for the period ended December&#160;31, 2020 (the &#8220;Report&#8221;), I, Thomas L. Tran, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.622%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; February 16, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas L. Tran</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thomas L. Tran</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>moh-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:47c0ca76-68d6-49cb-bbea-26491dea6a9b,g:4ece894a-24af-4e0b-a6cb-0ef0dba60516-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:moh="http://www.molinahealthcare.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.molinahealthcare.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="moh-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="moh-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="moh-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="moh-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.molinahealthcare.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome">
        <link:definition>1001002 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>1002003 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets">
        <link:definition>1003004 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1004005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBasisofPresentation" roleURI="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation">
        <link:definition>2101101 - Disclosure - Organization and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBasisofPresentationDetails" roleURI="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails">
        <link:definition>2402401 - Disclosure - Organization and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2406402 - Disclosure - Significant Accounting Policies - Cash, Cash Equivalents, and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>2407403 - Disclosure - Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesDetails" roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails">
        <link:definition>2408404 - Disclosure - Significant Accounting Policies - Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails" roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails">
        <link:definition>2409405 - Disclosure - Significant Accounting Policies - Amounts Due To Government Agencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesScheduleofPremiumRevenueDetails" roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails">
        <link:definition>2410406 - Disclosure - Significant Accounting Policies - Schedule of Premium Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.molinahealthcare.com/role/NetIncomePerShare">
        <link:definition>2111103 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.molinahealthcare.com/role/NetIncomePerShareTables">
        <link:definition>2312302 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareDetails" roleURI="http://www.molinahealthcare.com/role/NetIncomePerShareDetails">
        <link:definition>2413407 - Disclosure - Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.molinahealthcare.com/role/BusinessCombinations">
        <link:definition>2114104 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsTables">
        <link:definition>2315303 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeDetails" roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails">
        <link:definition>2416408 - Disclosure - Business Combinations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails" roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails">
        <link:definition>2417409 - Disclosure - Business Combinations - Summarizes the Preliminary Values of the Assets acquired and Liabilities Assumed at the Date of Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsIntangibleAssetsDetails" roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails">
        <link:definition>2418410 - Disclosure - Business Combinations - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.molinahealthcare.com/role/FairValueMeasurements">
        <link:definition>2119105 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsTables">
        <link:definition>2320304 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetails" roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails">
        <link:definition>2421411 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails" roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails">
        <link:definition>2422412 - Disclosure - Fair Value Measurements - Financial Instruments on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsBalanceSheetGroupingDetails" roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails">
        <link:definition>2423413 - Disclosure - Fair Value Measurements - Balance Sheet Grouping (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsLongTermDebtDetails" roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails">
        <link:definition>2424414 - Disclosure - Fair Value Measurements - Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.molinahealthcare.com/role/Investments">
        <link:definition>2125106 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.molinahealthcare.com/role/InvestmentsTables">
        <link:definition>2326305 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofInvestmentsDetails" roleURI="http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails">
        <link:definition>2427415 - Disclosure - Investments - Schedule of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsContractualMaturitiesDetails" roleURI="http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails">
        <link:definition>2428416 - Disclosure - Investments - Contractual Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails">
        <link:definition>2429417 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAvailableforSaleDetails" roleURI="http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails">
        <link:definition>2430418 - Disclosure - Investments - Available-for-Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsBalancesofRestrictedInvestmentsDetails" roleURI="http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails">
        <link:definition>2431419 - Disclosure - Investments - Balances of Restricted Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyEquipmentandCapitalizedSoftwareNet" roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet">
        <link:definition>2132107 - Disclosure - Property, Equipment, and Capitalized Software, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyEquipmentandCapitalizedSoftwareNetTables" roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetTables">
        <link:definition>2333306 - Disclosure - Property, Equipment, and Capitalized Software, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails" roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails">
        <link:definition>2434420 - Disclosure - Property, Equipment, and Capitalized Software, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails" roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails">
        <link:definition>2435421 - Disclosure - Property, Equipment, and Capitalized Software, Net - Summary of Property, Equipment, and Capitalized Software (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails" roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails">
        <link:definition>2436422 - Disclosure - Property, Equipment, and Capitalized Software, Net - Depreciation and Amortization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.molinahealthcare.com/role/Leases">
        <link:definition>2137108 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.molinahealthcare.com/role/LeasesTables">
        <link:definition>2338307 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.molinahealthcare.com/role/LeasesNarrativeDetails">
        <link:definition>2439423 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsofLeaseExpenseDetails" roleURI="http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails">
        <link:definition>2440424 - Disclosure - Leases - Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowDetails" roleURI="http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails">
        <link:definition>2441425 - Disclosure - Leases - Supplemental Cash Flow (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>2442426 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails" roleURI="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails">
        <link:definition>2443427 - Disclosure - Leases - Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails_1" roleURI="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1">
        <link:definition>2443427 - Disclosure - Leases - Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>2144109 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>2345308 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails" roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails">
        <link:definition>2446428 - Disclosure - Goodwill and Intangible Assets, Net - Balances of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetAdditionalInformationDetails" roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails">
        <link:definition>2447429 - Disclosure - Goodwill and Intangible Assets, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails" roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails">
        <link:definition>2448430 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsandBenefitsPayable" roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable">
        <link:definition>2149110 - Disclosure - Medical Claims and Benefits Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsandBenefitsPayableTables" roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables">
        <link:definition>2350309 - Disclosure - Medical Claims and Benefits Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails" roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails">
        <link:definition>2451431 - Disclosure - Medical Claims and Benefits Payable - Medical Claims and Future Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsandBenefitsPayableAdditionalInformationDetails" roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails">
        <link:definition>2452432 - Disclosure - Medical Claims and Benefits Payable - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails" roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails">
        <link:definition>2453433 - Disclosure - Medical Claims and Benefits Payable - Components of the Change (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails" roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails">
        <link:definition>2454434 - Disclosure - Medical Claims and Benefits Payable - Incurred Claims and Allocated Adjustment Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails" roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails">
        <link:definition>2455435 - Disclosure - Medical Claims and Benefits Payable - Cumulative Paid Claims and Allocated Claims Adjustment Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails" roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails">
        <link:definition>2456436 - Disclosure - Medical Claims and Benefits Payable - Reconciliation of Claims Development (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.molinahealthcare.com/role/Debt">
        <link:definition>2157111 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.molinahealthcare.com/role/DebtTables">
        <link:definition>2358310 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtMaturitiesDetails" roleURI="http://www.molinahealthcare.com/role/DebtMaturitiesDetails">
        <link:definition>2459437 - Disclosure - Debt - Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofLongTermDebtDetails" roleURI="http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails">
        <link:definition>2460438 - Disclosure - Debt - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtCreditAgreementDetails" roleURI="http://www.molinahealthcare.com/role/DebtCreditAgreementDetails">
        <link:definition>2461439 - Disclosure - Debt - Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSeniorNotesDetails" roleURI="http://www.molinahealthcare.com/role/DebtSeniorNotesDetails">
        <link:definition>2462440 - Disclosure - Debt - Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConvertibleNotesDetails" roleURI="http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails">
        <link:definition>2463441 - Disclosure - Debt - Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.molinahealthcare.com/role/IncomeTaxes">
        <link:definition>2164112 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.molinahealthcare.com/role/IncomeTaxesTables">
        <link:definition>2365311 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesProvisionforIncomeTaxesDetails" roleURI="http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails">
        <link:definition>2466442 - Disclosure - Income Taxes - Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails" roleURI="http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails">
        <link:definition>2467443 - Disclosure - Income Taxes - Reconciliation of the U.S. Federal Statutory Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>2468444 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>2469445 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>2470446 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.molinahealthcare.com/role/StockholdersEquity">
        <link:definition>2171113 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.molinahealthcare.com/role/StockholdersEquityTables">
        <link:definition>2372312 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAdditionalInformationDetails" roleURI="http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails">
        <link:definition>2473447 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityComponentsofSharebasedCompensationDetails" roleURI="http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails">
        <link:definition>2474448 - Disclosure - Stockholders' Equity - Components of Share-based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityRestrictedandPerformanceStockActivityDetails" roleURI="http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails">
        <link:definition>2475449 - Disclosure - Stockholders' Equity - Restricted and Performance Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityFairValueofAwardsGrantedandVestedDetails" roleURI="http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails">
        <link:definition>2476450 - Disclosure - Stockholders' Equity - Fair Value of Awards Granted and Vested (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionActivityDetails" roleURI="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails">
        <link:definition>2477451 - Disclosure - Stockholders' Equity - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionsbyExercisePriceDetails" roleURI="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails">
        <link:definition>2478452 - Disclosure - Stockholders' Equity - Stock Options by Exercise Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlans" roleURI="http://www.molinahealthcare.com/role/EmployeeBenefitPlans">
        <link:definition>2179114 - Disclosure - Employee Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansDetails" roleURI="http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails">
        <link:definition>2480453 - Disclosure - Employee Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.molinahealthcare.com/role/CommitmentsandContingencies">
        <link:definition>2181115 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2482454 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segments" roleURI="http://www.molinahealthcare.com/role/Segments">
        <link:definition>2183116 - Disclosure - Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsTables" roleURI="http://www.molinahealthcare.com/role/SegmentsTables">
        <link:definition>2384313 - Disclosure - Segments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsNarrativeDetails" roleURI="http://www.molinahealthcare.com/role/SegmentsNarrativeDetails">
        <link:definition>2485455 - Disclosure - Segments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsScheduleofOperatingSegmentInformationDetails" roleURI="http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails">
        <link:definition>2486456 - Disclosure - Segments - Schedule of Operating Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails" roleURI="http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails">
        <link:definition>2487457 - Disclosure - Segments - Reconciliation of Gross Margin to Consolidated Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrant" roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant">
        <link:definition>2188117 - Disclosure - Condensed Financial Information of Registrant</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantTables" roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables">
        <link:definition>2389314 - Disclosure - Condensed Financial Information of Registrant (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails">
        <link:definition>2490458 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails" roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails">
        <link:definition>2491459 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails">
        <link:definition>2492460 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails" roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails">
        <link:definition>2493461 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails">
        <link:definition>2494462 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails" roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails">
        <link:definition>2495463 - Disclosure - Condensed Financial Information of Registrant - Notes to Condensed Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" abstract="false" name="EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold" abstract="false" name="AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_MagellanCompleteCareMember" abstract="true" name="MagellanCompleteCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired" abstract="false" name="OperatingLeaseRightOfUseAssetExcludingLeasesAcquired" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_CapitationClaimsPayable" abstract="false" name="CapitationClaimsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_OtherMedicareProgram" abstract="false" name="OtherMedicareProgram" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_CurrentAssetsMember" abstract="true" name="CurrentAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_PremiumTaxRevenueMember" abstract="true" name="PremiumTaxRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" abstract="false" name="LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_RestrictedandPerformanceStockMember" abstract="true" name="RestrictedandPerformanceStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_AffinityHealthPlanMember" abstract="true" name="AffinityHealthPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_OtherGeographicalAreasMember" abstract="true" name="OtherGeographicalAreasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_MedicalPremiumLiabilityDueToAgency" abstract="false" name="MedicalPremiumLiabilityDueToAgency" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_AmountsDuetoGovernmentAgenciesRiskAdjustment" abstract="false" name="AmountsDuetoGovernmentAgenciesRiskAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" abstract="false" name="LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_RedemptionPremiumSettledPercentage" abstract="false" name="RedemptionPremiumSettledPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_AmountsDueToGovernmentAgenciesBusinessCombination" abstract="false" name="AmountsDueToGovernmentAgenciesBusinessCombination" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_SummarizedPremiumRevenueTableTextBlock" abstract="false" name="SummarizedPremiumRevenueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="moh_DeferredCompensationPlanDeferralPercentageOfBonus" abstract="false" name="DeferredCompensationPlanDeferralPercentageOfBonus" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_NumberOfMembersEligibleForTheHealthCarePrograms" abstract="false" name="NumberOfMembersEligibleForTheHealthCarePrograms" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="moh_ThreePointEightSevenFivePercentSeniorNotesMember" abstract="true" name="ThreePointEightSevenFivePercentSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_LetterOfCreditSubFacilityMember" abstract="true" name="LetterOfCreditSubFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_A4375SeniorNotesMember" abstract="true" name="A4375SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" abstract="false" name="MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears" abstract="false" name="ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_CashPaidDuringThePeriodAbstract" abstract="true" name="CashPaidDuringThePeriodAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_SwinglineSubFacilityMember" abstract="true" name="SwinglineSubFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="moh_HealthPlansMember" abstract="true" name="HealthPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles" abstract="false" name="DeferredTaxLiabilitiesFixedAssetsAndIntangibles" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_PremiumTaxExpenses" abstract="false" name="PremiumTaxExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_InvestmentsMaturityPeriod" abstract="false" name="InvestmentsMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="moh_BusinessCombinationNumberOfBusinessCombinations" abstract="false" name="BusinessCombinationNumberOfBusinessCombinations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" abstract="false" name="IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold" abstract="false" name="AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_ProviderNetworksMember" abstract="true" name="ProviderNetworksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" abstract="false" name="BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="moh_CashConvertibleSeniorNotesDue2020Member" abstract="true" name="CashConvertibleSeniorNotesDue2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_OperatingLeaseLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock" abstract="false" name="ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="moh_PharmacyClaimsPayable" abstract="false" name="PharmacyClaimsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable" abstract="false" name="AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_FairMarketValueOfCommonStockPercentage" abstract="false" name="FairMarketValueOfCommonStockPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary" abstract="false" name="DeferredCompensationPlanDeferralPercentageOfBasicSalary" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_DispositionofBusinessTransactionCosts" abstract="false" name="DispositionofBusinessTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_CompleteCareReceivablesMember" abstract="true" name="CompleteCareReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_BasisOfPresentationLineItems" abstract="true" name="BasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_OtherClaimsPayable" abstract="false" name="OtherClaimsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_DetailsofchangeinfairvalueofderivativesAbstract" abstract="true" name="DetailsofchangeinfairvalueofderivativesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_FinanceLeaseLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable" abstract="false" name="AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_IncrementalTermLoanMember" abstract="true" name="IncrementalTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_ExercisePriceRange2Member" abstract="true" name="ExercisePriceRange2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_ConvertibleSeniorNotesMember" abstract="true" name="ConvertibleSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" abstract="false" name="WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="moh_WeightedAverageNumberofSharesShareBasedCompensation" abstract="false" name="WeightedAverageNumberofSharesShareBasedCompensation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="moh_HealthPlansSegmentMember" abstract="true" name="HealthPlansSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_FinanceLeaseAssetsLesseeAbstract" abstract="true" name="FinanceLeaseAssetsLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" abstract="false" name="FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_MedicaidMember" abstract="true" name="MedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_MedicareMedicaidPlansMember" abstract="true" name="MedicareMedicaidPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_A4.875SeniorNotesMember" abstract="true" name="A4.875SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing" abstract="false" name="AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_HealthCareInsuranceFeeLiability" abstract="false" name="HealthCareInsuranceFeeLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_NotesIssuedFairValueAdjustmentIncreaseDecrease" abstract="false" name="NotesIssuedFairValueAdjustmentIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_TradeNameMember" abstract="true" name="TradeNameMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_RecordedInDepreciationAndAmortizationAbstract" abstract="true" name="RecordedInDepreciationAndAmortizationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_NumberOfStatesForOperatedHealthPlans" abstract="false" name="NumberOfStatesForOperatedHealthPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="moh_DepreciationAndAmortizationOfCapitalizedSoftware" abstract="false" name="DepreciationAndAmortizationOfCapitalizedSoftware" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_CovertibleSeniorNotesExchangeTransactionAbstract" abstract="true" name="CovertibleSeniorNotesExchangeTransactionAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_RisksAndUncertaintiesPolicyTextBlock" abstract="false" name="RisksAndUncertaintiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract" abstract="true" name="AmountsDueToGovernmentAgenciesMedicaidProgramAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_MunicipalSecuritiesMember" abstract="true" name="MunicipalSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_CompleteCareMember" abstract="true" name="CompleteCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_HealthInsurerFeeReimbursementReceivablesMember" abstract="true" name="HealthInsurerFeeReimbursementReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_ConsolidatedNetLeverage" abstract="false" name="ConsolidatedNetLeverage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="moh_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_GovernmentReceivablesMember" abstract="true" name="GovernmentReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_HealthcareInsurerFeeReimbursedMember" abstract="true" name="HealthcareInsurerFeeReimbursedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_MarketplaceRiskCorridorSettlementMember" abstract="true" name="MarketplaceRiskCorridorSettlementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_GainLossOnDebtRepayment" abstract="false" name="GainLossOnDebtRepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold" abstract="false" name="MedicalPremiumsLiabilityMedicalCareCostsThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_HealthCareOrganizationRevenuePercentage" abstract="false" name="HealthCareOrganizationRevenuePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_CommonStockPurchasesNotSettledAtEndOfPeriod" abstract="false" name="CommonStockPurchasesNotSettledAtEndOfPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_TaxesBasedOnPremiumsPolicyTextBlock" abstract="false" name="TaxesBasedOnPremiumsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="moh_CMSSubsidiesMember" abstract="true" name="CMSSubsidiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_ContractRightsandLicensingAgreementsMember" abstract="true" name="ContractRightsandLicensingAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract" abstract="true" name="AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_HealthPlanContractTerm" abstract="false" name="HealthPlanContractTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="moh_RestrictionsOnInvestmentsTableTextBlock" abstract="false" name="RestrictionsOnInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="moh_CashConvertibleSeniorNotesDue2020WarrantsMember" abstract="true" name="CashConvertibleSeniorNotesDue2020WarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_AdvancesToRelatedPartiesAndOtherAssets" abstract="false" name="AdvancesToRelatedPartiesAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_CallOptionDerivativeAssetMember" abstract="true" name="CallOptionDerivativeAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_CurrentLiabilitiesMember" abstract="true" name="CurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_PassportHealthPlanIncMember" abstract="true" name="PassportHealthPlanIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_OtherSecuritiesMember" abstract="true" name="OtherSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_MedicalCareCostsMember" abstract="true" name="MedicalCareCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable" abstract="false" name="AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_EmployeeStockPurchasePlanandStockOptionsMember" abstract="true" name="EmployeeStockPurchasePlanandStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_AmountsDueToGovernmentAgenciesMedicaidOther" abstract="false" name="AmountsDueToGovernmentAgenciesMedicaidOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage" abstract="false" name="BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_ClassOfWarrantOrRightStatedInterestRate" abstract="false" name="ClassOfWarrantOrRightStatedInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" abstract="false" name="IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_InvestmentsAverageMaturityPeriod" abstract="false" name="InvestmentsAverageMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="moh_AssetsAcquiredAbstract" abstract="true" name="AssetsAcquiredAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_GainLossonDispositionofLiabilities" abstract="false" name="GainLossonDispositionofLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_PercentageOfAdditionalIncrementalRevenueEarned" abstract="false" name="PercentageOfAdditionalIncrementalRevenueEarned" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_UnrecognizedCompensationForfeitedRate" abstract="false" name="UnrecognizedCompensationForfeitedRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="moh_CashPaidForSettlementOfConversionOption" abstract="false" name="CashPaidForSettlementOfConversionOption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" abstract="false" name="LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_PharmacyRebateReceivablesMember" abstract="true" name="PharmacyRebateReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_LiabilitiesAssumedAbstract" abstract="true" name="LiabilitiesAssumedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_RecordedInCostOfServiceRevenueAbstract" abstract="true" name="RecordedInCostOfServiceRevenueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_EquityIncentivePlanMember" abstract="true" name="EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_OperatingLeaseAssetsLesseeAbstract" abstract="true" name="OperatingLeaseAssetsLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_StructuredSecuritiesMember" abstract="true" name="StructuredSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_YourCareHealthPlanIncMember" abstract="true" name="YourCareHealthPlanIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_ProviderNetworkMember" abstract="true" name="ProviderNetworkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" abstract="false" name="NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_OtherReceivablesMember" abstract="true" name="OtherReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_SeniorNotesDue2022Member" abstract="true" name="SeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_COVID19Member" abstract="true" name="COVID19Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_MaineCommunityHealthOptionsv.UnitedStatesMember" abstract="true" name="MaineCommunityHealthOptionsv.UnitedStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_NoncashRestructuringCharges" abstract="false" name="NoncashRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_IncreaseDecreaseinCarryingAmountofAssets" abstract="false" name="IncreaseDecreaseinCarryingAmountofAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract" abstract="true" name="AmountsDueToGovernmentAgenciesMedicareProgramAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_DepreciationandAmortizationContinuingOperations" abstract="false" name="DepreciationandAmortizationContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_HealthCareOrganizationInsurerFeeExpense" abstract="false" name="HealthCareOrganizationInsurerFeeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_BasisOfPresentationTable" abstract="true" name="BasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="moh_MedicalClaimsAndBenefitsPayable" abstract="false" name="MedicalClaimsAndBenefitsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_ExercisePriceRange1Member" abstract="true" name="ExercisePriceRange1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_AmountsDuetoGovernmentAgenciesOther" abstract="false" name="AmountsDuetoGovernmentAgenciesOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_DeferredTaxAssetsFixedAssetsAndIntangibles" abstract="false" name="DeferredTaxAssetsFixedAssetsAndIntangibles" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract" abstract="true" name="RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="moh_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="moh_ChangesInAmountsDueToAndDueFromAffiliates" abstract="false" name="ChangesInAmountsDueToAndDueFromAffiliates" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="moh_DispositionofBusinessReceivablefromBuyer" abstract="false" name="DispositionofBusinessReceivablefromBuyer" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>moh-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:47c0ca76-68d6-49cb-bbea-26491dea6a9b,g:4ece894a-24af-4e0b-a6cb-0ef0dba60516-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CoverPage" xlink:type="simple" xlink:href="moh-20201231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_09f4f9a3-3f5a-4e96-bd9c-1f57280e0bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PremiumTaxExpenses_763131c7-0dcc-4829-9ae7-031b34c59fed" xlink:href="moh-20201231.xsd#moh_PremiumTaxExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_09f4f9a3-3f5a-4e96-bd9c-1f57280e0bc7" xlink:to="loc_moh_PremiumTaxExpenses_763131c7-0dcc-4829-9ae7-031b34c59fed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8773e86e-b0a4-4274-99ad-766461caf863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_09f4f9a3-3f5a-4e96-bd9c-1f57280e0bc7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8773e86e-b0a4-4274-99ad-766461caf863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthCareOrganizationInsurerFeeExpense_a1eb0e8c-f17d-42d3-a918-9ecea62b2610" xlink:href="moh-20201231.xsd#moh_HealthCareOrganizationInsurerFeeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_09f4f9a3-3f5a-4e96-bd9c-1f57280e0bc7" xlink:to="loc_moh_HealthCareOrganizationInsurerFeeExpense_a1eb0e8c-f17d-42d3-a918-9ecea62b2610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_c7f79c19-f9b3-46a9-8f61-0d305aebfa0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_09f4f9a3-3f5a-4e96-bd9c-1f57280e0bc7" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_c7f79c19-f9b3-46a9-8f61-0d305aebfa0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d7f6d304-f763-466a-99c2-bd9c3bdce1da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_09f4f9a3-3f5a-4e96-bd9c-1f57280e0bc7" xlink:to="loc_us-gaap_DepreciationAndAmortization_d7f6d304-f763-466a-99c2-bd9c3bdce1da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_55e287cb-971e-443d-866e-02f8ef0939c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_09f4f9a3-3f5a-4e96-bd9c-1f57280e0bc7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_55e287cb-971e-443d-866e-02f8ef0939c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_74403ce3-5110-4271-8a72-854e4c8e0fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_0dedb514-b9a1-4d5a-b368-78d2cef46805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_74403ce3-5110-4271-8a72-854e4c8e0fc5" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_0dedb514-b9a1-4d5a-b368-78d2cef46805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_53246eb3-eaf3-4097-8f60-859debcd6d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_74403ce3-5110-4271-8a72-854e4c8e0fc5" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_53246eb3-eaf3-4097-8f60-859debcd6d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c3925543-2f2a-40f8-a260-ab47bcb31926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dfc3c895-2311-4cc2-90e1-2514b37038d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c3925543-2f2a-40f8-a260-ab47bcb31926" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dfc3c895-2311-4cc2-90e1-2514b37038d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0ab99c0f-247d-45d1-875a-0a7a2820aec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c3925543-2f2a-40f8-a260-ab47bcb31926" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0ab99c0f-247d-45d1-875a-0a7a2820aec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2381fc81-1870-4cec-8132-9c580bbb8aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d305791c-e874-40c9-a05c-b81e67b44ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2381fc81-1870-4cec-8132-9c580bbb8aa2" xlink:to="loc_us-gaap_OperatingIncomeLoss_d305791c-e874-40c9-a05c-b81e67b44ed5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0a31d441-ecf4-4e1b-b54b-0574a734e720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2381fc81-1870-4cec-8132-9c580bbb8aa2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0a31d441-ecf4-4e1b-b54b-0574a734e720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_16a51836-0fa6-45dd-a912-d9823b09d27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5459b263-a421-4498-8139-0edcbc585c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_16a51836-0fa6-45dd-a912-d9823b09d27c" xlink:to="loc_us-gaap_InterestExpense_5459b263-a421-4498-8139-0edcbc585c5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8f8a8d21-a1c8-48d8-986e-52b75bdfc678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_16a51836-0fa6-45dd-a912-d9823b09d27c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8f8a8d21-a1c8-48d8-986e-52b75bdfc678" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f8252902-a134-497f-989e-e0492b7b8bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c61051ac-453c-4dec-902b-dbf0527f7be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f8252902-a134-497f-989e-e0492b7b8bc1" xlink:to="loc_us-gaap_Revenues_c61051ac-453c-4dec-902b-dbf0527f7be0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_c0933834-f88d-444b-90d0-66723965aa7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f8252902-a134-497f-989e-e0492b7b8bc1" xlink:to="loc_us-gaap_CostsAndExpenses_c0933834-f88d-444b-90d0-66723965aa7c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_544077f7-6a54-4271-b801-3d8899db7830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7eda7383-7a8c-458c-942c-80ea8f216bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_544077f7-6a54-4271-b801-3d8899db7830" xlink:to="loc_us-gaap_NetIncomeLoss_7eda7383-7a8c-458c-942c-80ea8f216bab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_73584764-21a0-4459-961a-358f2dedfd03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_544077f7-6a54-4271-b801-3d8899db7830" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_73584764-21a0-4459-961a-358f2dedfd03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f070397b-5114-443a-893d-8f80e3b99ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3d11ff0f-1685-44e9-865a-568bdd2cdf61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f070397b-5114-443a-893d-8f80e3b99ba8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3d11ff0f-1685-44e9-865a-568bdd2cdf61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_c516fce0-9608-493e-b774-be4d32655d1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f070397b-5114-443a-893d-8f80e3b99ba8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_c516fce0-9608-493e-b774-be4d32655d1e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1fd20091-3e90-47c8-b181-036e0e054a88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_bf3cd214-fb34-4a08-a8b0-e4c7ec5bf81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1fd20091-3e90-47c8-b181-036e0e054a88" xlink:to="loc_us-gaap_PreferredStockValue_bf3cd214-fb34-4a08-a8b0-e4c7ec5bf81f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_82d251e7-83e0-4512-83b0-f05f4d062068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1fd20091-3e90-47c8-b181-036e0e054a88" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_82d251e7-83e0-4512-83b0-f05f4d062068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_77b119a4-dd03-4b16-af58-5cbff3cb47cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1fd20091-3e90-47c8-b181-036e0e054a88" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_77b119a4-dd03-4b16-af58-5cbff3cb47cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9a06a016-20fb-4b60-bb10-81435afa1736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1fd20091-3e90-47c8-b181-036e0e054a88" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9a06a016-20fb-4b60-bb10-81435afa1736" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_7b0a30e7-92a0-4b53-90ed-e6feca6f985b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1fd20091-3e90-47c8-b181-036e0e054a88" xlink:to="loc_us-gaap_CommonStockValueOutstanding_7b0a30e7-92a0-4b53-90ed-e6feca6f985b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b1ff644d-96c4-4579-9a68-8a8ed753ec4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c7180d3a-654c-4069-8ff8-568df345a1ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b1ff644d-96c4-4579-9a68-8a8ed753ec4d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c7180d3a-654c-4069-8ff8-568df345a1ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_59ad9bb4-b75c-4021-9985-490f460b3798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b1ff644d-96c4-4579-9a68-8a8ed753ec4d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_59ad9bb4-b75c-4021-9985-490f460b3798" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6cf2353b-517a-4411-99da-6686907d89a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b1ff644d-96c4-4579-9a68-8a8ed753ec4d" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6cf2353b-517a-4411-99da-6686907d89a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalPremiumLiabilityDueToAgency_d277922e-a1b3-4b23-986a-b4ed1b0c5766" xlink:href="moh-20201231.xsd#moh_MedicalPremiumLiabilityDueToAgency"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b1ff644d-96c4-4579-9a68-8a8ed753ec4d" xlink:to="loc_moh_MedicalPremiumLiabilityDueToAgency_d277922e-a1b3-4b23-986a-b4ed1b0c5766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_97cf4971-e32b-4fc0-bc90-bbe14cf22550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_760ffb97-81c9-4c4a-8ed3-7af8090f887f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_97cf4971-e32b-4fc0-bc90-bbe14cf22550" xlink:to="loc_us-gaap_LiabilitiesCurrent_760ffb97-81c9-4c4a-8ed3-7af8090f887f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4e4818af-510a-40da-86fc-91cc23c49474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_97cf4971-e32b-4fc0-bc90-bbe14cf22550" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4e4818af-510a-40da-86fc-91cc23c49474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b4a22ec5-a694-448f-b6a6-3e15c7983d40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_97cf4971-e32b-4fc0-bc90-bbe14cf22550" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b4a22ec5-a694-448f-b6a6-3e15c7983d40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_da3b788f-9bef-4ef4-bd35-df25a26214a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_97cf4971-e32b-4fc0-bc90-bbe14cf22550" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_da3b788f-9bef-4ef4-bd35-df25a26214a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c3829213-2548-4210-8a1d-7fd76f8c49bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6f8d86e8-6a34-4514-92fa-8848d6390026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3829213-2548-4210-8a1d-7fd76f8c49bb" xlink:to="loc_us-gaap_AssetsCurrent_6f8d86e8-6a34-4514-92fa-8848d6390026" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_afbf1066-3d08-42f0-ac0d-1c8911563e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3829213-2548-4210-8a1d-7fd76f8c49bb" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_afbf1066-3d08-42f0-ac0d-1c8911563e28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsNoncurrent_faff7720-06ce-4d2d-b88c-8db772a406de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3829213-2548-4210-8a1d-7fd76f8c49bb" xlink:to="loc_us-gaap_RestrictedInvestmentsNoncurrent_faff7720-06ce-4d2d-b88c-8db772a406de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_091d8be4-aef0-4e09-9de8-ef2cf5655484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3829213-2548-4210-8a1d-7fd76f8c49bb" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_091d8be4-aef0-4e09-9de8-ef2cf5655484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_83d4297b-0ebf-44b4-80b8-ffaa0ee4e676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3829213-2548-4210-8a1d-7fd76f8c49bb" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_83d4297b-0ebf-44b4-80b8-ffaa0ee4e676" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1e1a88f1-69f7-47c5-95f7-12714d13b150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3829213-2548-4210-8a1d-7fd76f8c49bb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1e1a88f1-69f7-47c5-95f7-12714d13b150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f3ade183-3d92-462c-b03a-f928f1d57687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5c717e68-1323-4635-b5b7-4e8332746c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f3ade183-3d92-462c-b03a-f928f1d57687" xlink:to="loc_us-gaap_Liabilities_5c717e68-1323-4635-b5b7-4e8332746c1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e2d5cf12-d8c4-43b3-b38f-d93e26d4ac5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f3ade183-3d92-462c-b03a-f928f1d57687" xlink:to="loc_us-gaap_StockholdersEquity_e2d5cf12-d8c4-43b3-b38f-d93e26d4ac5e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c0e841ff-6275-4f51-839d-f303470a43ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_9e787407-1237-49f7-a112-2bfebed43369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c0e841ff-6275-4f51-839d-f303470a43ca" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_9e787407-1237-49f7-a112-2bfebed43369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f4edfce4-4422-4936-b549-22b2601e7d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c0e841ff-6275-4f51-839d-f303470a43ca" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f4edfce4-4422-4936-b549-22b2601e7d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b13459d8-d074-464a-ae61-4c7330a2fc88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c0e841ff-6275-4f51-839d-f303470a43ca" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b13459d8-d074-464a-ae61-4c7330a2fc88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_2a31d53b-5a8b-4a41-921f-4e782c347e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c0e841ff-6275-4f51-839d-f303470a43ca" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_2a31d53b-5a8b-4a41-921f-4e782c347e1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_104ca123-1fc6-4bff-954d-caad4b349408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c0e841ff-6275-4f51-839d-f303470a43ca" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_104ca123-1fc6-4bff-954d-caad4b349408" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_72045433-c23d-4556-b37e-bb94f228f2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c0e841ff-6275-4f51-839d-f303470a43ca" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_72045433-c23d-4556-b37e-bb94f228f2ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_a1684ba8-8a83-4b5a-9fdf-e1a5733a9850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesIssued1_e022dd0b-4173-4de1-9372-b7cd725e2a82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesIssued1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_a1684ba8-8a83-4b5a-9fdf-e1a5733a9850" xlink:to="loc_us-gaap_NotesIssued1_e022dd0b-4173-4de1-9372-b7cd725e2a82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease_13ddba1c-1f6d-4403-843c-dbcdddf293f1" xlink:href="moh-20201231.xsd#moh_NotesIssuedFairValueAdjustmentIncreaseDecrease"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_a1684ba8-8a83-4b5a-9fdf-e1a5733a9850" xlink:to="loc_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease_13ddba1c-1f6d-4403-843c-dbcdddf293f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0b59e306-9da1-4e45-84e9-ec325538de09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2951f35e-a1d7-4828-95ad-e3ac6f1aacfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0b59e306-9da1-4e45-84e9-ec325538de09" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2951f35e-a1d7-4828-95ad-e3ac6f1aacfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_69415984-af3b-418f-8459-715f30b50b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0b59e306-9da1-4e45-84e9-ec325538de09" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_69415984-af3b-418f-8459-715f30b50b37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6f354350-c5e0-4372-8130-ba9c4265e337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0b59e306-9da1-4e45-84e9-ec325538de09" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6f354350-c5e0-4372-8130-ba9c4265e337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_83f4c6ba-0b83-40b0-ab36-9d65eea05a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DispositionofBusinessReceivablefromBuyer_2d44d207-ee45-4afa-a225-ef20eaf8cfbf" xlink:href="moh-20201231.xsd#moh_DispositionofBusinessReceivablefromBuyer"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness_83f4c6ba-0b83-40b0-ab36-9d65eea05a22" xlink:to="loc_moh_DispositionofBusinessReceivablefromBuyer_2d44d207-ee45-4afa-a225-ef20eaf8cfbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DispositionofBusinessTransactionCosts_8e92c331-c028-49b9-a0be-09176c83c19b" xlink:href="moh-20201231.xsd#moh_DispositionofBusinessTransactionCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness_83f4c6ba-0b83-40b0-ab36-9d65eea05a22" xlink:to="loc_moh_DispositionofBusinessTransactionCosts_8e92c331-c028-49b9-a0be-09176c83c19b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GainLossonDispositionofLiabilities_61520daf-0660-48fe-a480-d1866d6b37bc" xlink:href="moh-20201231.xsd#moh_GainLossonDispositionofLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness_83f4c6ba-0b83-40b0-ab36-9d65eea05a22" xlink:to="loc_moh_GainLossonDispositionofLiabilities_61520daf-0660-48fe-a480-d1866d6b37bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncreaseDecreaseinCarryingAmountofAssets_3f79239e-36ef-425b-b614-b6d8cde6ccba" xlink:href="moh-20201231.xsd#moh_IncreaseDecreaseinCarryingAmountofAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness_83f4c6ba-0b83-40b0-ab36-9d65eea05a22" xlink:to="loc_moh_IncreaseDecreaseinCarryingAmountofAssets_3f79239e-36ef-425b-b614-b6d8cde6ccba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_3cb3b285-fa16-4d75-a1c1-67d7eff5c2dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_3cb3b285-fa16-4d75-a1c1-67d7eff5c2dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_421ca53d-50d0-417b-8817-f784b56e1b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_421ca53d-50d0-417b-8817-f784b56e1b47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashPaidForSettlementOfConversionOption_02dc8c48-ec80-4bdf-81d9-ab52e39730da" xlink:href="moh-20201231.xsd#moh_CashPaidForSettlementOfConversionOption"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_moh_CashPaidForSettlementOfConversionOption_02dc8c48-ec80-4bdf-81d9-ab52e39730da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_3883b618-5aac-459f-855c-ce00ef395c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_3883b618-5aac-459f-855c-ce00ef395c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c5e4f909-17dc-4f0c-8084-796b32ca3b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c5e4f909-17dc-4f0c-8084-796b32ca3b16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_750a950b-1763-4c8a-853c-c050a6ce0b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_750a950b-1763-4c8a-853c-c050a6ce0b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_5c9e8cc1-6896-4267-9af7-a3e9b097b1b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_5c9e8cc1-6896-4267-9af7-a3e9b097b1b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants_6eb230a5-89dc-4e66-9ac7-3d7c0dc8373f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfWarrants_6eb230a5-89dc-4e66-9ac7-3d7c0dc8373f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a5dea087-6091-4adf-99c9-5891f16b68cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a5dea087-6091-4adf-99c9-5891f16b68cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_e82500e3-fe5c-46bd-87fd-d90b695a1b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_e82500e3-fe5c-46bd-87fd-d90b695a1b27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a2d34527-33ed-41ab-93a7-bf807b66853a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47570632-e963-497e-af85-5ebdb2046269" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a2d34527-33ed-41ab-93a7-bf807b66853a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f6a4a80d-e6d2-49bd-ba28-840015da3af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f6a4a80d-e6d2-49bd-ba28-840015da3af5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_54166acf-c4da-4437-848a-11dd4f9095c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_54166acf-c4da-4437-848a-11dd4f9095c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e916d7b2-da07-437f-8696-3719aba1fca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e916d7b2-da07-437f-8696-3719aba1fca0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cdeaa661-2284-473c-988c-feb973056632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_ShareBasedCompensation_cdeaa661-2284-473c-988c-feb973056632" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5dd76557-a7ec-4b3e-9a2a-79885aaca1bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5dd76557-a7ec-4b3e-9a2a-79885aaca1bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_68215885-5e48-4319-a0e3-04e02bd5f71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_68215885-5e48-4319-a0e3-04e02bd5f71a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GainLossOnDebtRepayment_1bcc254b-04c7-47ea-a3db-726a7d712ab4" xlink:href="moh-20201231.xsd#moh_GainLossOnDebtRepayment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_moh_GainLossOnDebtRepayment_1bcc254b-04c7-47ea-a3db-726a7d712ab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency_2afb5136-33b9-486b-928a-8dda406fc23d" xlink:href="moh-20201231.xsd#moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency_2afb5136-33b9-486b-928a-8dda406fc23d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3373280c-f103-4099-b264-eef3aa4a28ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3373280c-f103-4099-b264-eef3aa4a28ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a7ec286e-3414-43fb-939e-d6c688178385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_NetIncomeLoss_a7ec286e-3414-43fb-939e-d6c688178385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_83dc2416-5fb9-4c02-8b56-6162e9af9905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_83dc2416-5fb9-4c02-8b56-6162e9af9905" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_b65f4a25-eeab-403c-b779-1153e3059705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_b65f4a25-eeab-403c-b779-1153e3059705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NoncashRestructuringCharges_062651ed-d925-4f04-809b-1ed30d4980c8" xlink:href="moh-20201231.xsd#moh_NoncashRestructuringCharges"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_moh_NoncashRestructuringCharges_062651ed-d925-4f04-809b-1ed30d4980c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_773f033d-2e34-4a68-a139-ad9218b396f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_773f033d-2e34-4a68-a139-ad9218b396f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_eb215d1e-e241-428d-850a-cbad637291f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fb10d77-6c31-43e1-8577-703019d67eb2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_eb215d1e-e241-428d-850a-cbad637291f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation" xlink:type="simple" xlink:href="moh-20201231.xsd#OrganizationandBasisofPresentation"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#OrganizationandBasisofPresentationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a56096f-0965-443b-a05f-fa45004845e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2012cba4-2f91-4241-a4dd-6b3c9af4c8f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a56096f-0965-443b-a05f-fa45004845e8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2012cba4-2f91-4241-a4dd-6b3c9af4c8f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_5b5201ac-6bbd-4ea3-9eb0-0885c4f7abc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a56096f-0965-443b-a05f-fa45004845e8" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_5b5201ac-6bbd-4ea3-9eb0-0885c4f7abc8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalPremiumLiabilityDueToAgency_e274e2af-71c3-44b6-a3df-9218fbcb0fdc" xlink:href="moh-20201231.xsd#moh_MedicalPremiumLiabilityDueToAgency"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesBusinessCombination_37e5a3bc-ec2c-49c8-ab5c-cea5d5614fdd" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesBusinessCombination"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_MedicalPremiumLiabilityDueToAgency_e274e2af-71c3-44b6-a3df-9218fbcb0fdc" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesBusinessCombination_37e5a3bc-ec2c-49c8-ab5c-cea5d5614fdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold_c8a6ee0a-2e4f-48a0-ba1d-a7aea0696892" xlink:href="moh-20201231.xsd#moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_MedicalPremiumLiabilityDueToAgency_e274e2af-71c3-44b6-a3df-9218fbcb0fdc" xlink:to="loc_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold_c8a6ee0a-2e4f-48a0-ba1d-a7aea0696892" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold_4866bf68-a651-461f-84d6-77e7f947f64a" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_MedicalPremiumLiabilityDueToAgency_e274e2af-71c3-44b6-a3df-9218fbcb0fdc" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold_4866bf68-a651-461f-84d6-77e7f947f64a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMedicaidOther_ac89efd5-f423-42f2-943f-dc2370a50bbc" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMedicaidOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_MedicalPremiumLiabilityDueToAgency_e274e2af-71c3-44b6-a3df-9218fbcb0fdc" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesMedicaidOther_ac89efd5-f423-42f2-943f-dc2370a50bbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDuetoGovernmentAgenciesOther_0eca97d2-86df-4505-8453-f6a1fd316da1" xlink:href="moh-20201231.xsd#moh_AmountsDuetoGovernmentAgenciesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_MedicalPremiumLiabilityDueToAgency_e274e2af-71c3-44b6-a3df-9218fbcb0fdc" xlink:to="loc_moh_AmountsDuetoGovernmentAgenciesOther_0eca97d2-86df-4505-8453-f6a1fd316da1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment_f37bf6ba-00bf-4fa9-a692-849603ba87f1" xlink:href="moh-20201231.xsd#moh_AmountsDuetoGovernmentAgenciesRiskAdjustment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_MedicalPremiumLiabilityDueToAgency_e274e2af-71c3-44b6-a3df-9218fbcb0fdc" xlink:to="loc_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment_f37bf6ba-00bf-4fa9-a692-849603ba87f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherMedicareProgram_29c9a218-f96f-43a6-beef-3a09d34f4799" xlink:href="moh-20201231.xsd#moh_OtherMedicareProgram"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_MedicalPremiumLiabilityDueToAgency_e274e2af-71c3-44b6-a3df-9218fbcb0fdc" xlink:to="loc_moh_OtherMedicareProgram_29c9a218-f96f-43a6-beef-3a09d34f4799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold_91701369-d0f7-4c31-8cd8-2f53620f3cd0" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_MedicalPremiumLiabilityDueToAgency_e274e2af-71c3-44b6-a3df-9218fbcb0fdc" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold_91701369-d0f7-4c31-8cd8-2f53620f3cd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing_49ce3cd7-34ec-4462-b136-7cefd55aaa4d" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_MedicalPremiumLiabilityDueToAgency_e274e2af-71c3-44b6-a3df-9218fbcb0fdc" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing_49ce3cd7-34ec-4462-b136-7cefd55aaa4d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="moh-20201231.xsd#NetIncomePerShare"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/NetIncomePerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="moh-20201231.xsd#NetIncomePerShareTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/NetIncomePerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#NetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9c2bbc4-4bfe-41ed-af4e-cee51fb8b546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b57e146-3add-4f4e-81aa-c345de9b2c6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9c2bbc4-4bfe-41ed-af4e-cee51fb8b546" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b57e146-3add-4f4e-81aa-c345de9b2c6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6e6286cc-fa94-46b4-8de4-37c5fc9871f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9c2bbc4-4bfe-41ed-af4e-cee51fb8b546" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6e6286cc-fa94-46b4-8de4-37c5fc9871f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_411fb517-05a2-4d81-8890-88b620ac0420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9c2bbc4-4bfe-41ed-af4e-cee51fb8b546" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_411fb517-05a2-4d81-8890-88b620ac0420" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_141a4cce-53a8-45ba-ab49-0f850a3d7a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9c2bbc4-4bfe-41ed-af4e-cee51fb8b546" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_141a4cce-53a8-45ba-ab49-0f850a3d7a44" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinations" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinations"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinations" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b9e4bccf-1079-447f-921d-417174cc4aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b9e4bccf-1079-447f-921d-417174cc4aa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a7370308-2b53-4ee9-9dd7-5a05f59f1293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a7370308-2b53-4ee9-9dd7-5a05f59f1293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3805f3f6-f227-41d1-97c2-b24f7c9b4660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3805f3f6-f227-41d1-97c2-b24f7c9b4660" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment_c6470c51-04ee-4385-8d0e-b180a4f994c3" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment_c6470c51-04ee-4385-8d0e-b180a4f994c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d4e1718c-f248-4a4e-aea6-3e691ff9894b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d4e1718c-f248-4a4e-aea6-3e691ff9894b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable_2eb3ab5a-10ee-456b-a5eb-540eb2d6b778" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable_2eb3ab5a-10ee-456b-a5eb-540eb2d6b778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_9d9768eb-b209-4c5b-95f8-88df7dc268de" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_9d9768eb-b209-4c5b-95f8-88df7dc268de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e96be6f9-c43c-4c20-8508-453e941482db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e96be6f9-c43c-4c20-8508-453e941482db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies_b4229f75-53e1-4e84-9500-7e187d2bbe33" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies_b4229f75-53e1-4e84-9500-7e187d2bbe33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2681c18c-d5be-4105-b28c-7af71a5a143b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_us-gaap_Goodwill_2681c18c-d5be-4105-b28c-7af71a5a143b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_766a585d-991e-4885-aa4d-e29ea376a4c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_766a585d-991e-4885-aa4d-e29ea376a4c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_fcbda0cd-2178-4287-94ed-f031b932cc65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_fcbda0cd-2178-4287-94ed-f031b932cc65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5dcb5cbb-e2e4-4096-964d-c59e27594d0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_48e291d9-ffe4-49ef-bdf4-b7761481b91b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5dcb5cbb-e2e4-4096-964d-c59e27594d0f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9db3f528-a4d0-4b04-a2db-330ba9181084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_27c40625-6dd4-4ca8-8d20-edaeed77b877" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9db3f528-a4d0-4b04-a2db-330ba9181084" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_27c40625-6dd4-4ca8-8d20-edaeed77b877" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_b7018f3b-30f2-4c57-bb26-09b13726fa5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9db3f528-a4d0-4b04-a2db-330ba9181084" xlink:to="loc_us-gaap_DerivativeAssets_b7018f3b-30f2-4c57-bb26-09b13726fa5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_a85ae61f-6bea-43ea-ab3f-8ad03f43571e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4e2f959f-acd6-41c6-87a0-97fa2b8aa491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_a85ae61f-6bea-43ea-ab3f-8ad03f43571e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4e2f959f-acd6-41c6-87a0-97fa2b8aa491" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsBalanceSheetGroupingDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Investments" xlink:type="simple" xlink:href="moh-20201231.xsd#Investments"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/Investments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsScheduleofInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsContractualMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35afd500-95cd-42e9-a379-d140ecef24f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_3bb3c9b6-8321-4e12-871b-79df86fb1698" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35afd500-95cd-42e9-a379-d140ecef24f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_3bb3c9b6-8321-4e12-871b-79df86fb1698" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_ef946c8c-69b0-4066-9df4-b7e90d9f55b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35afd500-95cd-42e9-a379-d140ecef24f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_ef946c8c-69b0-4066-9df4-b7e90d9f55b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_07ffd0b7-e72a-41ba-9cbc-18d675aadb11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35afd500-95cd-42e9-a379-d140ecef24f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_07ffd0b7-e72a-41ba-9cbc-18d675aadb11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_fc3999f8-a5f7-483c-9c03-ed0b9212ff01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35afd500-95cd-42e9-a379-d140ecef24f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_fc3999f8-a5f7-483c-9c03-ed0b9212ff01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_06291a89-c27e-4c74-8ba3-c4785ee83cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c3b29e64-ce79-4e3d-971a-bf738c4002ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_06291a89-c27e-4c74-8ba3-c4785ee83cf4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c3b29e64-ce79-4e3d-971a-bf738c4002ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_198c9d14-a3e9-4bc1-a1fa-66f76a98792c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_06291a89-c27e-4c74-8ba3-c4785ee83cf4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_198c9d14-a3e9-4bc1-a1fa-66f76a98792c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_01b8a3e6-3664-4fbd-9116-b99d5e496096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_06291a89-c27e-4c74-8ba3-c4785ee83cf4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_01b8a3e6-3664-4fbd-9116-b99d5e496096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0f15336c-d34e-4efb-8c87-f1bdb11a811c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_06291a89-c27e-4c74-8ba3-c4785ee83cf4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0f15336c-d34e-4efb-8c87-f1bdb11a811c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsAvailableforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsBalancesofRestrictedInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNet"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetTables" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_59767f39-f1fa-43e7-8d63-be0a95d9d6b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0a4371d9-6a43-4c37-b0d2-7372bc1f63de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_59767f39-f1fa-43e7-8d63-be0a95d9d6b4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0a4371d9-6a43-4c37-b0d2-7372bc1f63de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b0d9f0f9-0af1-487f-a0a9-51ad4c154984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_59767f39-f1fa-43e7-8d63-be0a95d9d6b4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b0d9f0f9-0af1-487f-a0a9-51ad4c154984" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_f47d2ea9-2dd0-4683-b62a-cf829842d3d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_59767f39-f1fa-43e7-8d63-be0a95d9d6b4" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_f47d2ea9-2dd0-4683-b62a-cf829842d3d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_58640f3d-3172-48b0-a6d1-b2b5a6f39866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_fd3008cd-8c12-4353-91eb-7f5c224c970c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_58640f3d-3172-48b0-a6d1-b2b5a6f39866" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_fd3008cd-8c12-4353-91eb-7f5c224c970c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_9436090f-071c-4cd6-aeb9-1d7a4d537dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_58640f3d-3172-48b0-a6d1-b2b5a6f39866" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_9436090f-071c-4cd6-aeb9-1d7a4d537dfd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_moh_DepreciationandAmortizationContinuingOperations_1b11c19f-6e1c-46bc-a7e5-80f39d99405f" xlink:href="moh-20201231.xsd#moh_DepreciationandAmortizationContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DepreciationAndAmortizationOfCapitalizedSoftware_6c2f39db-7c62-4b9d-bb72-662046a909bf" xlink:href="moh-20201231.xsd#moh_DepreciationAndAmortizationOfCapitalizedSoftware"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_DepreciationandAmortizationContinuingOperations_1b11c19f-6e1c-46bc-a7e5-80f39d99405f" xlink:to="loc_moh_DepreciationAndAmortizationOfCapitalizedSoftware_6c2f39db-7c62-4b9d-bb72-662046a909bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f6bcea64-8c9b-4792-ae3a-d3aebafbe47c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_DepreciationandAmortizationContinuingOperations_1b11c19f-6e1c-46bc-a7e5-80f39d99405f" xlink:to="loc_us-gaap_Depreciation_f6bcea64-8c9b-4792-ae3a-d3aebafbe47c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9bc818a5-3a4d-43ed-a7e1-24bf82cbc6ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_DepreciationandAmortizationContinuingOperations_1b11c19f-6e1c-46bc-a7e5-80f39d99405f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9bc818a5-3a4d-43ed-a7e1-24bf82cbc6ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_11cc7d4f-f01d-4073-9911-8d070ba34346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_DepreciationandAmortizationContinuingOperations_1b11c19f-6e1c-46bc-a7e5-80f39d99405f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_11cc7d4f-f01d-4073-9911-8d070ba34346" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_a76e2bf4-dc78-4d58-a194-c15aa1043fa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_b7e9e952-dca7-43b8-8d7c-7c7669ff833d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_a76e2bf4-dc78-4d58-a194-c15aa1043fa0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_b7e9e952-dca7-43b8-8d7c-7c7669ff833d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DepreciationandAmortizationContinuingOperations_e90ebc88-f71a-4b4b-a549-d5c21faf20bd" xlink:href="moh-20201231.xsd#moh_DepreciationandAmortizationContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_a76e2bf4-dc78-4d58-a194-c15aa1043fa0" xlink:to="loc_moh_DepreciationandAmortizationContinuingOperations_e90ebc88-f71a-4b4b-a549-d5c21faf20bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Leases" xlink:type="simple" xlink:href="moh-20201231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesTables" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_moh_FinanceLeaseCost_535d1d03-cc03-448c-b292-dce8e6bdf222" xlink:href="moh-20201231.xsd#moh_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7e0098f0-fc20-40bd-88a3-11859ba1139c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_FinanceLeaseCost_535d1d03-cc03-448c-b292-dce8e6bdf222" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7e0098f0-fc20-40bd-88a3-11859ba1139c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_2c03dc62-893f-472a-91ef-901bbb193f28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_FinanceLeaseCost_535d1d03-cc03-448c-b292-dce8e6bdf222" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_2c03dc62-893f-472a-91ef-901bbb193f28" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesSupplementalCashFlowDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c9bbf5ea-6d8a-416b-b142-2921bea7d87f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_287d7ea1-5be2-49a4-87f5-33dea42ee19d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c9bbf5ea-6d8a-416b-b142-2921bea7d87f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_287d7ea1-5be2-49a4-87f5-33dea42ee19d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5fee3d81-a737-442b-b757-fdd0de8316a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c9bbf5ea-6d8a-416b-b142-2921bea7d87f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5fee3d81-a737-442b-b757-fdd0de8316a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fe4a84d0-1d79-4b46-ab0f-a4f06bae7223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_da85a106-8949-42d1-8c80-2149cf96de86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_fe4a84d0-1d79-4b46-ab0f-a4f06bae7223" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_da85a106-8949-42d1-8c80-2149cf96de86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_194b22e0-ccda-45f7-ac00-a255f78cadb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_fe4a84d0-1d79-4b46-ab0f-a4f06bae7223" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_194b22e0-ccda-45f7-ac00-a255f78cadb1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_676d23d9-1e60-4bb2-9163-bda97d17d8ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_66f82f94-67e5-4b63-ad15-d69b6bced16e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_676d23d9-1e60-4bb2-9163-bda97d17d8ff" xlink:to="loc_us-gaap_FinanceLeaseLiability_66f82f94-67e5-4b63-ad15-d69b6bced16e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1ec8945b-e2da-47e4-824b-f887943c4f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_676d23d9-1e60-4bb2-9163-bda97d17d8ff" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1ec8945b-e2da-47e4-824b-f887943c4f3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_38b9e8bb-ac97-4cb0-a356-7c6c458bae80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d9f842f0-6540-4e46-a0af-5842d1b7cd96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_38b9e8bb-ac97-4cb0-a356-7c6c458bae80" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d9f842f0-6540-4e46-a0af-5842d1b7cd96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1d0b0f28-8db2-4035-8b30-0f043f6c35a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_38b9e8bb-ac97-4cb0-a356-7c6c458bae80" xlink:to="loc_us-gaap_OperatingLeaseLiability_1d0b0f28-8db2-4035-8b30-0f043f6c35a7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_baef48c2-c545-4b27-93d6-3b6607422e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_3766798c-02db-499c-aed9-9b0dca506389" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_baef48c2-c545-4b27-93d6-3b6607422e53" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_3766798c-02db-499c-aed9-9b0dca506389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4f505a12-c7f0-48d1-ac04-bab0f89a7211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_baef48c2-c545-4b27-93d6-3b6607422e53" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4f505a12-c7f0-48d1-ac04-bab0f89a7211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2aefa4a0-09fd-4b64-a10b-fdc8599c230f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_baef48c2-c545-4b27-93d6-3b6607422e53" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2aefa4a0-09fd-4b64-a10b-fdc8599c230f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3ad39c19-92cf-444e-a4a2-14af3a217b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_baef48c2-c545-4b27-93d6-3b6607422e53" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3ad39c19-92cf-444e-a4a2-14af3a217b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d351a33f-1367-413a-9f9e-150ae6827a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_baef48c2-c545-4b27-93d6-3b6607422e53" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d351a33f-1367-413a-9f9e-150ae6827a80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_d81b21b0-63b1-46e5-a19f-e5f032392037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_baef48c2-c545-4b27-93d6-3b6607422e53" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_d81b21b0-63b1-46e5-a19f-e5f032392037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f9a44c24-327e-40c9-9d5d-61da1d921222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_691c22a7-3464-49f6-a1a2-faa05545dac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f9a44c24-327e-40c9-9d5d-61da1d921222" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_691c22a7-3464-49f6-a1a2-faa05545dac9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5aef44cb-fe06-4e17-addb-21016a343109" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f9a44c24-327e-40c9-9d5d-61da1d921222" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5aef44cb-fe06-4e17-addb-21016a343109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6a4b9109-8dab-4a63-95d2-995643a5206e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f9a44c24-327e-40c9-9d5d-61da1d921222" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6a4b9109-8dab-4a63-95d2-995643a5206e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_34f4bc5f-a13a-4e42-93a3-003ee8cf6da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f9a44c24-327e-40c9-9d5d-61da1d921222" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_34f4bc5f-a13a-4e42-93a3-003ee8cf6da3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_03dbf36e-7017-4487-8c42-f685d604e7d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f9a44c24-327e-40c9-9d5d-61da1d921222" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_03dbf36e-7017-4487-8c42-f685d604e7d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_bbb7e678-7a41-4639-aa0d-c3fd5a22173f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f9a44c24-327e-40c9-9d5d-61da1d921222" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_bbb7e678-7a41-4639-aa0d-c3fd5a22173f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f161b53c-f117-427d-9aeb-2135fdfd0f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e9d4421d-fcb4-437e-b14e-d5f23cdaaef6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f161b53c-f117-427d-9aeb-2135fdfd0f16" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e9d4421d-fcb4-437e-b14e-d5f23cdaaef6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_68c4e0f4-299f-4100-8aaf-812abdfa6d38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f161b53c-f117-427d-9aeb-2135fdfd0f16" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_68c4e0f4-299f-4100-8aaf-812abdfa6d38" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayable"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_1c4d211e-3c89-4af9-8a2d-ac575f06e85c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_a7090e40-0c78-4880-a905-4cda85193c4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_1c4d211e-3c89-4af9-8a2d-ac575f06e85c" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_a7090e40-0c78-4880-a905-4cda85193c4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_eb686c75-915b-4ac1-85c7-1718a77a5fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_1c4d211e-3c89-4af9-8a2d-ac575f06e85c" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_eb686c75-915b-4ac1-85c7-1718a77a5fe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_ed123552-0e54-44cd-836d-96cbcda8b98f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_adf4fe4e-76fc-4f7c-a90d-cdee73f2a120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_ed123552-0e54-44cd-836d-96cbcda8b98f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_adf4fe4e-76fc-4f7c-a90d-cdee73f2a120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_76e60bda-e012-45cc-8a5b-e056eb9ad117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_ed123552-0e54-44cd-836d-96cbcda8b98f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_76e60bda-e012-45cc-8a5b-e056eb9ad117" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Debt" xlink:type="simple" xlink:href="moh-20201231.xsd#Debt"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtTables" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/DebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtMaturitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/DebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c9fc9266-1bc8-453a-958b-210ef32194f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e7eb7aaf-49fd-4560-951c-a04d284cd54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c9fc9266-1bc8-453a-958b-210ef32194f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e7eb7aaf-49fd-4560-951c-a04d284cd54a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b5c0ae32-c46e-43ea-bddc-313515d65c99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c9fc9266-1bc8-453a-958b-210ef32194f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b5c0ae32-c46e-43ea-bddc-313515d65c99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_607ddaf4-c1b2-4cf5-a3b4-15b63c5c0fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c9fc9266-1bc8-453a-958b-210ef32194f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_607ddaf4-c1b2-4cf5-a3b4-15b63c5c0fbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c1c3ad90-62d4-400b-b9c6-e2f20d8c7de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c9fc9266-1bc8-453a-958b-210ef32194f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c1c3ad90-62d4-400b-b9c6-e2f20d8c7de1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1c573c33-240c-4c2a-8829-16df4f948fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c9fc9266-1bc8-453a-958b-210ef32194f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1c573c33-240c-4c2a-8829-16df4f948fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d6eed668-1630-48dc-8a93-334b1f1a0d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c9fc9266-1bc8-453a-958b-210ef32194f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d6eed668-1630-48dc-8a93-334b1f1a0d02" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_fb6faf84-22b7-4cd5-8055-0c6e05bfc61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_59c60f6d-8679-4983-9949-9a582cb51907" xlink:href="moh-20201231.xsd#moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtCurrent_fb6faf84-22b7-4cd5-8055-0c6e05bfc61e" xlink:to="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_59c60f6d-8679-4983-9949-9a582cb51907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8792bf62-f6b6-4f89-973d-e72004745295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount_39df1538-b024-430d-8ed4-70a2e4da4fd6" xlink:href="moh-20201231.xsd#moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_8792bf62-f6b6-4f89-973d-e72004745295" xlink:to="loc_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount_39df1538-b024-430d-8ed4-70a2e4da4fd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_aad42855-dcc0-47ca-a801-db3ed13ebf70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_8792bf62-f6b6-4f89-973d-e72004745295" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_aad42855-dcc0-47ca-a801-db3ed13ebf70" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtCreditAgreementDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtCreditAgreementDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/DebtCreditAgreementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtSeniorNotesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtSeniorNotesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/DebtSeniorNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxes" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_2494e097-3394-4cc6-a27e-a3e213e5bdfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f382f75f-1c5f-4868-8638-91dbf67dd53d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_2494e097-3394-4cc6-a27e-a3e213e5bdfc" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f382f75f-1c5f-4868-8638-91dbf67dd53d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2b4d621e-cd0a-4563-b363-6f5341d16cf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_2494e097-3394-4cc6-a27e-a3e213e5bdfc" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2b4d621e-cd0a-4563-b363-6f5341d16cf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_802aa78b-50fc-495b-a024-d2ea784f4343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_2494e097-3394-4cc6-a27e-a3e213e5bdfc" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_802aa78b-50fc-495b-a024-d2ea784f4343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_62e90d44-2081-41ad-bbeb-5a460289d0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ffa91aac-710a-4dde-a832-66185b8dd530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_62e90d44-2081-41ad-bbeb-5a460289d0d8" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ffa91aac-710a-4dde-a832-66185b8dd530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ac7c958d-3ca1-4796-8bca-b77c89fd51fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_62e90d44-2081-41ad-bbeb-5a460289d0d8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ac7c958d-3ca1-4796-8bca-b77c89fd51fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cd84d2b5-84e5-43c6-9d02-654919a621dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7eded465-3dcd-48c5-9de4-138447c0e9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cd84d2b5-84e5-43c6-9d02-654919a621dd" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7eded465-3dcd-48c5-9de4-138447c0e9e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_bb59772d-68be-4c51-ba5a-7b95cc945f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cd84d2b5-84e5-43c6-9d02-654919a621dd" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_bb59772d-68be-4c51-ba5a-7b95cc945f6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_df1b10fd-d091-482e-a2a9-85da2835d2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cd84d2b5-84e5-43c6-9d02-654919a621dd" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_df1b10fd-d091-482e-a2a9-85da2835d2ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_50812269-81e3-4065-9d90-18a6b4c890a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_bbc55d0e-ecc6-441a-9977-13b07d1fbeae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_50812269-81e3-4065-9d90-18a6b4c890a9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_bbc55d0e-ecc6-441a-9977-13b07d1fbeae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f44b5344-f522-4527-86b9-3af96e369745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_50812269-81e3-4065-9d90-18a6b4c890a9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f44b5344-f522-4527-86b9-3af96e369745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_62426752-a8c0-4f17-bf1b-28a20bcdebf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_50812269-81e3-4065-9d90-18a6b4c890a9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_62426752-a8c0-4f17-bf1b-28a20bcdebf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction_aaad1344-38fc-47e0-be28-dbbb0237a014" xlink:href="moh-20201231.xsd#moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_50812269-81e3-4065-9d90-18a6b4c890a9" xlink:to="loc_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction_aaad1344-38fc-47e0-be28-dbbb0237a014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_80c7437e-a543-4a5f-9e6c-a86520fc0801" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_50812269-81e3-4065-9d90-18a6b4c890a9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_80c7437e-a543-4a5f-9e6c-a86520fc0801" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent_9495cf18-5f0d-4e7e-934b-0a2c09d81be4" xlink:href="moh-20201231.xsd#moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_50812269-81e3-4065-9d90-18a6b4c890a9" xlink:to="loc_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent_9495cf18-5f0d-4e7e-934b-0a2c09d81be4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6cb10c22-9e90-4314-ae7b-800374afb054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_e6ea0dd7-8b75-41df-baf0-1ae1bb1bf88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6cb10c22-9e90-4314-ae7b-800374afb054" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_e6ea0dd7-8b75-41df-baf0-1ae1bb1bf88c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_8cbbd927-7ea4-46b9-9f94-447b292f0d3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6cb10c22-9e90-4314-ae7b-800374afb054" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_8cbbd927-7ea4-46b9-9f94-447b292f0d3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles_b08dcf90-b217-4e87-8f70-55889774fe29" xlink:href="moh-20201231.xsd#moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6cb10c22-9e90-4314-ae7b-800374afb054" xlink:to="loc_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles_b08dcf90-b217-4e87-8f70-55889774fe29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_d7acddd1-bb75-4dab-9ad0-97ad443f52a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6cb10c22-9e90-4314-ae7b-800374afb054" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_d7acddd1-bb75-4dab-9ad0-97ad443f52a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_96a9573c-ccb3-4227-a982-8520ddf812d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_6af3050a-fedd-41e6-80e1-7f391c38051c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_96a9573c-ccb3-4227-a982-8520ddf812d5" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_6af3050a-fedd-41e6-80e1-7f391c38051c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_15bc55ad-e39d-46b5-90c1-e734121c8b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_96a9573c-ccb3-4227-a982-8520ddf812d5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_15bc55ad-e39d-46b5-90c1-e734121c8b36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_d24d6073-0815-484c-a780-0a7e0048e901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_5855b891-4ba0-49e2-9834-b960b5b71484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_d24d6073-0815-484c-a780-0a7e0048e901" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_5855b891-4ba0-49e2-9834-b960b5b71484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_3d56a2e8-8bcc-46df-a71b-69f7f76d0b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_d24d6073-0815-484c-a780-0a7e0048e901" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_3d56a2e8-8bcc-46df-a71b-69f7f76d0b27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e2784b31-e2ca-4a1c-a65f-5a41496c0c92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_d24d6073-0815-484c-a780-0a7e0048e901" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e2784b31-e2ca-4a1c-a65f-5a41496c0c92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DeferredTaxAssetsFixedAssetsAndIntangibles_1ff8c45c-e33c-48e7-bfff-6928dd7c23cd" xlink:href="moh-20201231.xsd#moh_DeferredTaxAssetsFixedAssetsAndIntangibles"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_d24d6073-0815-484c-a780-0a7e0048e901" xlink:to="loc_moh_DeferredTaxAssetsFixedAssetsAndIntangibles_1ff8c45c-e33c-48e7-bfff-6928dd7c23cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_845e92b6-9519-4762-9ba9-22a75b772b01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_d24d6073-0815-484c-a780-0a7e0048e901" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_845e92b6-9519-4762-9ba9-22a75b772b01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_5f9200dc-d695-4b76-9358-08ad8f9c57a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_d24d6073-0815-484c-a780-0a7e0048e901" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_5f9200dc-d695-4b76-9358-08ad8f9c57a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f0963ba6-6c70-4f52-8add-9dcc553ac4d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_d24d6073-0815-484c-a780-0a7e0048e901" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f0963ba6-6c70-4f52-8add-9dcc553ac4d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_d9ca7ac9-9411-43ef-a08a-8deb80cb60cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_d24d6073-0815-484c-a780-0a7e0048e901" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_d9ca7ac9-9411-43ef-a08a-8deb80cb60cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_735f80d4-8624-4aaa-886e-ee193525977e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_d24d6073-0815-484c-a780-0a7e0048e901" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_735f80d4-8624-4aaa-886e-ee193525977e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquity" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityComponentsofSharebasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityRestrictedandPerformanceStockActivityDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityFairValueofAwardsGrantedandVestedDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityStockOptionActivityDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityStockOptionsbyExercisePriceDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="moh-20201231.xsd#EmployeeBenefitPlans"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/EmployeeBenefitPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#EmployeeBenefitPlansDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="moh-20201231.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Segments" xlink:type="simple" xlink:href="moh-20201231.xsd#Segments"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/Segments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SegmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SegmentsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsScheduleofOperatingSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrant"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantTables"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1d3e1433-e060-4128-a63e-b3584d5b5066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_90174b0d-e0ea-40b5-8cfb-f51fa493e5cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d3e1433-e060-4128-a63e-b3584d5b5066" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_90174b0d-e0ea-40b5-8cfb-f51fa493e5cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_9acaa683-0ba0-4cc3-835b-21fd79598a1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d3e1433-e060-4128-a63e-b3584d5b5066" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_9acaa683-0ba0-4cc3-835b-21fd79598a1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_11e3e84c-765f-4c0b-b4e7-83f96e77e19e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d3e1433-e060-4128-a63e-b3584d5b5066" xlink:to="loc_us-gaap_ReceivablesNetCurrent_11e3e84c-765f-4c0b-b4e7-83f96e77e19e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_02703b6c-d852-4f43-a1b2-63991f93150e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d3e1433-e060-4128-a63e-b3584d5b5066" xlink:to="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_02703b6c-d852-4f43-a1b2-63991f93150e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4dde1039-8038-46d3-9225-8ca8abce3237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d3e1433-e060-4128-a63e-b3584d5b5066" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4dde1039-8038-46d3-9225-8ca8abce3237" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7aee9e57-a5ec-4ded-8245-bce8702ae76f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_38fdb0fb-743a-4787-bd02-2c6498f9f732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7aee9e57-a5ec-4ded-8245-bce8702ae76f" xlink:to="loc_us-gaap_DepreciationAndAmortization_38fdb0fb-743a-4787-bd02-2c6498f9f732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_e9423c49-dd97-4e8a-8990-d15b2e38f093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7aee9e57-a5ec-4ded-8245-bce8702ae76f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_e9423c49-dd97-4e8a-8990-d15b2e38f093" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_58206a23-a0fc-4466-9ec6-6188151e74dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7aee9e57-a5ec-4ded-8245-bce8702ae76f" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_58206a23-a0fc-4466-9ec6-6188151e74dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_b4152a77-61f3-45a2-9e50-f4b438ac8b64" xlink:href="moh-20201231.xsd#moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_d78b0876-2d28-460a-96df-1655c02c2f80" xlink:href="moh-20201231.xsd#moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_b4152a77-61f3-45a2-9e50-f4b438ac8b64" xlink:to="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_d78b0876-2d28-460a-96df-1655c02c2f80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_089a868b-611d-496c-bc2e-e570a2a41744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_b4152a77-61f3-45a2-9e50-f4b438ac8b64" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_089a868b-611d-496c-bc2e-e570a2a41744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_43966c64-9e50-432f-b1a5-bddcfe86e426" xlink:href="moh-20201231.xsd#moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ca4cd68d-9ef5-49b7-9898-bb84d5d8bd19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_43966c64-9e50-432f-b1a5-bddcfe86e426" xlink:to="loc_us-gaap_OperatingIncomeLoss_ca4cd68d-9ef5-49b7-9898-bb84d5d8bd19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_26111228-008d-4c44-94a0-b0b2caaad34f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_43966c64-9e50-432f-b1a5-bddcfe86e426" xlink:to="loc_us-gaap_InterestExpense_26111228-008d-4c44-94a0-b0b2caaad34f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c56894be-5bf1-41dd-a79e-89aa5245a657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_43966c64-9e50-432f-b1a5-bddcfe86e426" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c56894be-5bf1-41dd-a79e-89aa5245a657" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_994f8d7c-361a-4763-af58-774281a828dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_fb79c243-dc5b-4b31-86cb-459d5347692b" xlink:href="moh-20201231.xsd#moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_994f8d7c-361a-4763-af58-774281a828dc" xlink:to="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_fb79c243-dc5b-4b31-86cb-459d5347692b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromSubsidiariesNetOfTax_bfc86a05-38ac-4cae-82c0-3f2ee5cc6225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromSubsidiariesNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_994f8d7c-361a-4763-af58-774281a828dc" xlink:to="loc_us-gaap_IncomeLossFromSubsidiariesNetOfTax_bfc86a05-38ac-4cae-82c0-3f2ee5cc6225" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2b38b084-1091-4ca5-8ae7-30decab7e085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAgencyManagementFee_9ba1c9f5-f429-484e-aa20-444207e20e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAgencyManagementFee"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_2b38b084-1091-4ca5-8ae7-30decab7e085" xlink:to="loc_us-gaap_InsuranceAgencyManagementFee_9ba1c9f5-f429-484e-aa20-444207e20e20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_eaf60aa7-87fe-438c-93f4-a7de2f1eca1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_2b38b084-1091-4ca5-8ae7-30decab7e085" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_eaf60aa7-87fe-438c-93f4-a7de2f1eca1b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>moh-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:47c0ca76-68d6-49cb-bbea-26491dea6a9b,g:4ece894a-24af-4e0b-a6cb-0ef0dba60516-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CoverPage" xlink:type="simple" xlink:href="moh-20201231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CoverPage" xlink:type="extended" id="i8877b916fb7842cbbd8d7a339ab673bf_CoverPage"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofIncome"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome" xlink:type="extended" id="i8aa37b70d451459aa84c7bcd67ea130e_ConsolidatedStatementsofIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_230d88fb-bfb2-4dfb-b7a1-57185a894a76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_RevenuesAbstract_230d88fb-bfb2-4dfb-b7a1-57185a894a76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_e33fb8c0-dd2f-4d61-a7a4-1da09724ec35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_230d88fb-bfb2-4dfb-b7a1-57185a894a76" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_e33fb8c0-dd2f-4d61-a7a4-1da09724ec35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_db8386ed-1d15-48ac-9218-ba6cc556c5b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_230d88fb-bfb2-4dfb-b7a1-57185a894a76" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_db8386ed-1d15-48ac-9218-ba6cc556c5b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_68544105-5e15-4529-aec6-3324a544e4ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_230d88fb-bfb2-4dfb-b7a1-57185a894a76" xlink:to="loc_us-gaap_Revenues_68544105-5e15-4529-aec6-3324a544e4ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1f39798e-ebf3-4332-a109-a45618875ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1f39798e-ebf3-4332-a109-a45618875ca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_83844d03-c1a0-44a6-87da-9efaa29aac3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_83844d03-c1a0-44a6-87da-9efaa29aac3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PremiumTaxExpenses_bf508e44-3f27-4861-9592-9f44ddc8481e" xlink:href="moh-20201231.xsd#moh_PremiumTaxExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_moh_PremiumTaxExpenses_bf508e44-3f27-4861-9592-9f44ddc8481e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthCareOrganizationInsurerFeeExpense_e272e949-2326-4f55-bb5c-ff655ba5aaf0" xlink:href="moh-20201231.xsd#moh_HealthCareOrganizationInsurerFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_moh_HealthCareOrganizationInsurerFeeExpense_e272e949-2326-4f55-bb5c-ff655ba5aaf0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_e483adf5-ab2a-476f-b232-36284e3c1c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_us-gaap_DepreciationAndAmortization_e483adf5-ab2a-476f-b232-36284e3c1c59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_9f4f7f30-7d20-4ada-b5c0-7b8e024a6a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_9f4f7f30-7d20-4ada-b5c0-7b8e024a6a2a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_487f306b-a245-44c9-9e58-2730baf6c529" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_us-gaap_CostsAndExpenses_487f306b-a245-44c9-9e58-2730baf6c529" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8eceef58-dee4-495a-b22a-db6241b82184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_OperatingIncomeLoss_8eceef58-dee4-495a-b22a-db6241b82184" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_3570f640-8042-4749-bd59-2d5b8469ed71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_3570f640-8042-4749-bd59-2d5b8469ed71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_887cf7c9-8496-49a5-82f3-dc86ba7fec75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_3570f640-8042-4749-bd59-2d5b8469ed71" xlink:to="loc_us-gaap_InterestExpense_887cf7c9-8496-49a5-82f3-dc86ba7fec75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6d53dd6f-118a-4d2d-b118-952411cdee83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_3570f640-8042-4749-bd59-2d5b8469ed71" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6d53dd6f-118a-4d2d-b118-952411cdee83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_46391a04-c29f-4496-8762-6bd5c639477f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_3570f640-8042-4749-bd59-2d5b8469ed71" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_46391a04-c29f-4496-8762-6bd5c639477f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1a207ab9-844a-4042-8236-c073e8f32a79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1a207ab9-844a-4042-8236-c073e8f32a79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0f3f6b98-e392-40f7-9be2-c74301b7fd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0f3f6b98-e392-40f7-9be2-c74301b7fd2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_16bb8d17-f248-4c02-af5d-6042ca397dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_NetIncomeLoss_16bb8d17-f248-4c02-af5d-6042ca397dca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2f5c32d2-af21-47fe-a5c5-c5ea2542bdcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_EarningsPerShareAbstract_2f5c32d2-af21-47fe-a5c5-c5ea2542bdcb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_57e9ad64-cacc-4a60-8967-88c6fd101ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2f5c32d2-af21-47fe-a5c5-c5ea2542bdcb" xlink:to="loc_us-gaap_EarningsPerShareBasic_57e9ad64-cacc-4a60-8967-88c6fd101ff8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_65bbace5-fdbc-45de-a1d8-46919c946996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2f5c32d2-af21-47fe-a5c5-c5ea2542bdcb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_65bbace5-fdbc-45de-a1d8-46919c946996" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_82257e66-64d1-4ca4-b707-ff21ec350c26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_82257e66-64d1-4ca4-b707-ff21ec350c26" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0090cba-c141-4049-a949-b8d9e6a37dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_82257e66-64d1-4ca4-b707-ff21ec350c26" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0090cba-c141-4049-a949-b8d9e6a37dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bc106f6b-1e33-49c5-9188-45b1a37d05f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_82257e66-64d1-4ca4-b707-ff21ec350c26" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bc106f6b-1e33-49c5-9188-45b1a37d05f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_aa69ab54-38d2-4607-940d-053d332ce8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_StatementTable_aa69ab54-38d2-4607-940d-053d332ce8a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3f21203a-821b-4f3b-ae7d-35752f1cb5b0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_aa69ab54-38d2-4607-940d-053d332ce8a3" xlink:to="loc_srt_ProductOrServiceAxis_3f21203a-821b-4f3b-ae7d-35752f1cb5b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3f21203a-821b-4f3b-ae7d-35752f1cb5b0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3f21203a-821b-4f3b-ae7d-35752f1cb5b0" xlink:to="loc_srt_ProductsAndServicesDomain_3f21203a-821b-4f3b-ae7d-35752f1cb5b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3f21203a-821b-4f3b-ae7d-35752f1cb5b0" xlink:to="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePremiumMember_66ac9339-fc76-4c88-ad4b-3b5589b59887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCarePremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_us-gaap_HealthCarePremiumMember_66ac9339-fc76-4c88-ad4b-3b5589b59887" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PremiumTaxRevenueMember_6e474224-4fba-40a9-b5c1-0efa4b00e3c5" xlink:href="moh-20201231.xsd#moh_PremiumTaxRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_moh_PremiumTaxRevenueMember_6e474224-4fba-40a9-b5c1-0efa4b00e3c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthcareInsurerFeeReimbursedMember_fdace0e9-9cb0-42cf-8dee-ee52c80dfa44" xlink:href="moh-20201231.xsd#moh_HealthcareInsurerFeeReimbursedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_moh_HealthcareInsurerFeeReimbursedMember_fdace0e9-9cb0-42cf-8dee-ee52c80dfa44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MarketplaceRiskCorridorSettlementMember_8849a0d4-7e02-4122-a0e0-164f7216c187" xlink:href="moh-20201231.xsd#moh_MarketplaceRiskCorridorSettlementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_moh_MarketplaceRiskCorridorSettlementMember_8849a0d4-7e02-4122-a0e0-164f7216c187" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_1f3e1fff-a18f-4d28-9845-72696772929d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_us-gaap_ServiceMember_1f3e1fff-a18f-4d28-9845-72696772929d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalCareCostsMember_fa8fc7f3-5613-41ea-9c61-e4e7e06c338f" xlink:href="moh-20201231.xsd#moh_MedicalCareCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_moh_MedicalCareCostsMember_fa8fc7f3-5613-41ea-9c61-e4e7e06c338f" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="i65fa9d002833485eb4f59625fe0becd2_ConsolidatedStatementsofComprehensiveIncome"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="ic9fad61ce4264182956a42d7776082d7_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i0236825d464849b6ae98cc81bbf86f41_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i6f18a3c839a94d0f9db1bd0b1133cf1e_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_37192e0b-16d8-4a77-804d-6fe7bd256523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37192e0b-16d8-4a77-804d-6fe7bd256523" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4d4a28d4-5ff0-4772-a4d6-cacf9bcafbe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_SharesOutstanding_4d4a28d4-5ff0-4772-a4d6-cacf9bcafbe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1122dfcf-59d1-4188-89f3-a9f4a784148c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockholdersEquity_1122dfcf-59d1-4188-89f3-a9f4a784148c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_22058faa-7ee0-4d4f-9b11-bfc1e6d65d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_NetIncomeLoss_22058faa-7ee0-4d4f-9b11-bfc1e6d65d5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_6ed4b309-3be9-4e78-8d8c-2002a9965068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_6ed4b309-3be9-4e78-8d8c-2002a9965068" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_4b9abb38-8a52-402c-8411-3aa1679315a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_4b9abb38-8a52-402c-8411-3aa1679315a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_e1bfc907-e942-47d8-b32e-1bcf3d32f5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_e1bfc907-e942-47d8-b32e-1bcf3d32f5be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_583f0300-8e3a-45c9-bb25-7fd0a69771ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_583f0300-8e3a-45c9-bb25-7fd0a69771ec" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_4299a4b8-aa24-4ac3-abbe-c6c7076d0a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_4299a4b8-aa24-4ac3-abbe-c6c7076d0a7f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_129c1df3-3077-49fc-a6e6-9c9a3edd40f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_129c1df3-3077-49fc-a6e6-9c9a3edd40f7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_207783d7-5d43-41ab-8970-9645e528478a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_207783d7-5d43-41ab-8970-9645e528478a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c2516812-f706-49ee-9ec8-b31caf0021ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c2516812-f706-49ee-9ec8-b31caf0021ca" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3b54245b-c787-4ee9-a699-186f48520cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3b54245b-c787-4ee9-a699-186f48520cb5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_06c27e82-b6ec-46aa-a52c-906d42dffc0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2cb8ec9f-c5b0-4809-b25d-d3ff7591f6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_10c590e1-8d6a-4297-b7a7-5e942d2fc55d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_37192e0b-16d8-4a77-804d-6fe7bd256523" xlink:to="loc_us-gaap_StatementTable_10c590e1-8d6a-4297-b7a7-5e942d2fc55d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7962aef3-dcf0-4c2a-92ec-3ee586041763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_10c590e1-8d6a-4297-b7a7-5e942d2fc55d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7962aef3-dcf0-4c2a-92ec-3ee586041763" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7962aef3-dcf0-4c2a-92ec-3ee586041763_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7962aef3-dcf0-4c2a-92ec-3ee586041763" xlink:to="loc_us-gaap_EquityComponentDomain_7962aef3-dcf0-4c2a-92ec-3ee586041763_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7962aef3-dcf0-4c2a-92ec-3ee586041763" xlink:to="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_904690e0-0946-41d0-a596-1e62b2b51adc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:to="loc_us-gaap_CommonStockMember_904690e0-0946-41d0-a596-1e62b2b51adc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_aff1c0b4-b4e0-4a08-9351-b29148245ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_aff1c0b4-b4e0-4a08-9351-b29148245ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c1e3e6c4-e6c3-4231-88c4-b1522d5eba7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c1e3e6c4-e6c3-4231-88c4-b1522d5eba7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_bea30339-c3b6-49c9-aa35-dbee5f8d9334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:to="loc_us-gaap_RetainedEarningsMember_bea30339-c3b6-49c9-aa35-dbee5f8d9334" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_115856e7-9098-4e6f-8cde-e9c25275151a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_10c590e1-8d6a-4297-b7a7-5e942d2fc55d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_115856e7-9098-4e6f-8cde-e9c25275151a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_115856e7-9098-4e6f-8cde-e9c25275151a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_115856e7-9098-4e6f-8cde-e9c25275151a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_115856e7-9098-4e6f-8cde-e9c25275151a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_de5b0848-b0f7-456f-be07-e5ea062319a0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_115856e7-9098-4e6f-8cde-e9c25275151a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_de5b0848-b0f7-456f-be07-e5ea062319a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b9d2f48f-3530-48d4-9973-b0e8e9692da7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_de5b0848-b0f7-456f-be07-e5ea062319a0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b9d2f48f-3530-48d4-9973-b0e8e9692da7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i7f4f65271e9343c6972ee19ed15da664_ConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8e68d530-db4b-461e-b08a-c8937e82ff69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8e68d530-db4b-461e-b08a-c8937e82ff69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e7ad1bf4-841c-4a7b-9196-1c41c8b5aec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8e68d530-db4b-461e-b08a-c8937e82ff69" xlink:to="loc_us-gaap_NetIncomeLoss_e7ad1bf4-841c-4a7b-9196-1c41c8b5aec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8e68d530-db4b-461e-b08a-c8937e82ff69" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_95a85346-164b-43b1-8797-8320ad9f2d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_95a85346-164b-43b1-8797-8320ad9f2d7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_e5bbca24-8899-488f-ae91-4da2060e073e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_e5bbca24-8899-488f-ae91-4da2060e073e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_daafd1fb-3655-43d8-9231-f1a408160b8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_ShareBasedCompensation_daafd1fb-3655-43d8-9231-f1a408160b8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GainLossOnDebtRepayment_26a32b72-40da-4a7e-9ad0-b906ae65242b" xlink:href="moh-20201231.xsd#moh_GainLossOnDebtRepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_moh_GainLossOnDebtRepayment_26a32b72-40da-4a7e-9ad0-b906ae65242b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_270c8916-4c50-4c80-9407-cd51ee91dccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_270c8916-4c50-4c80-9407-cd51ee91dccd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NoncashRestructuringCharges_b22c32b1-3014-4b82-b2e7-b57ba4986332" xlink:href="moh-20201231.xsd#moh_NoncashRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_moh_NoncashRestructuringCharges_b22c32b1-3014-4b82-b2e7-b57ba4986332" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_543d5b7f-5b68-4a25-a8eb-415987dcabc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_543d5b7f-5b68-4a25-a8eb-415987dcabc4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_46e6a3a1-edb1-4c61-a86b-deba0cbe09c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_46e6a3a1-edb1-4c61-a86b-deba0cbe09c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f425ad5c-4802-4276-8c3d-7d862be17799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f425ad5c-4802-4276-8c3d-7d862be17799" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_ae3de7b9-78ca-4d52-b36c-6c01c24f5639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_ae3de7b9-78ca-4d52-b36c-6c01c24f5639" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency_e3f2e8e0-881d-4053-baf2-6a20c6773e47" xlink:href="moh-20201231.xsd#moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency_e3f2e8e0-881d-4053-baf2-6a20c6773e47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_75702ad7-b6ff-4f50-a72d-923b072713fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_75702ad7-b6ff-4f50-a72d-923b072713fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_681d194d-0aa5-47e0-82f4-10955b77f720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_681d194d-0aa5-47e0-82f4-10955b77f720" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bf36d27a-2db8-48d9-9287-69b946e0dd3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bf36d27a-2db8-48d9-9287-69b946e0dd3a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19938b30-f305-4a7c-9fc3-e432d2bb74ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8e68d530-db4b-461e-b08a-c8937e82ff69" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19938b30-f305-4a7c-9fc3-e432d2bb74ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_b5ee4489-5635-4ff7-b346-08c8f295c71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_b5ee4489-5635-4ff7-b346-08c8f295c71f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ef300d6a-857a-4d99-b165-8efb550bea10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ef300d6a-857a-4d99-b165-8efb550bea10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_38485fce-7f1d-4ce9-bfa6-f87debc3f101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_38485fce-7f1d-4ce9-bfa6-f87debc3f101" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0b8db371-3a09-4aec-801d-2b54c7a74130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0b8db371-3a09-4aec-801d-2b54c7a74130" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_8040c7fc-4ab7-4d7e-b3bb-2f2f938df01e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_8040c7fc-4ab7-4d7e-b3bb-2f2f938df01e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_43162f11-425e-4f26-8de7-ae464bdc9c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_43162f11-425e-4f26-8de7-ae464bdc9c6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d5de81f3-238e-411f-8a5b-fc3d582b7a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d5de81f3-238e-411f-8a5b-fc3d582b7a18" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_26601f77-6031-4352-b0ba-9f7a139c7a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_26601f77-6031-4352-b0ba-9f7a139c7a96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_21937aa7-f246-4da6-bb9c-8078ed378994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_21937aa7-f246-4da6-bb9c-8078ed378994" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_9101e7c7-1d7d-411e-a383-3c86b2c54135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_9101e7c7-1d7d-411e-a383-3c86b2c54135" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_58e984d1-7fa1-48c3-98e3-71007c2d0562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_58e984d1-7fa1-48c3-98e3-71007c2d0562" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_a0302614-b684-4f15-a28a-67e0b0cf5709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_a0302614-b684-4f15-a28a-67e0b0cf5709" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants_25324ed0-5807-4fc5-bf2b-ca7b2e002c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfWarrants_25324ed0-5807-4fc5-bf2b-ca7b2e002c34" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashPaidForSettlementOfConversionOption_066c844a-af93-45ed-836c-81580850bc4f" xlink:href="moh-20201231.xsd#moh_CashPaidForSettlementOfConversionOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_moh_CashPaidForSettlementOfConversionOption_066c844a-af93-45ed-836c-81580850bc4f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a3c890af-b7d8-420d-ad54-5d0bc1945491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a3c890af-b7d8-420d-ad54-5d0bc1945491" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_81bf59d2-5e0c-4ac8-9d6f-27d970c59dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_81bf59d2-5e0c-4ac8-9d6f-27d970c59dc8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_4b12fada-0a76-4e36-8915-02cdc5ee8cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_4b12fada-0a76-4e36-8915-02cdc5ee8cfe" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_36a1040a-f3dd-483a-aee2-bd92b8d5243b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_36a1040a-f3dd-483a-aee2-bd92b8d5243b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8a2ed05-60e0-4446-8e66-c4173738e584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8a2ed05-60e0-4446-8e66-c4173738e584" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_89304d01-db07-4b56-b577-c77c3060f430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_89304d01-db07-4b56-b577-c77c3060f430" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f05f79b9-2e45-4fff-905a-4ca9422063b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f05f79b9-2e45-4fff-905a-4ca9422063b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bc465c39-7d3c-4588-8eab-c06656c01100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_d3a6a567-9868-41b1-8293-1a15bcd280bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_d3a6a567-9868-41b1-8293-1a15bcd280bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashPaidDuringThePeriodAbstract_59170768-7c82-4aa8-ba2a-a6270190b3bf" xlink:href="moh-20201231.xsd#moh_CashPaidDuringThePeriodAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d3a6a567-9868-41b1-8293-1a15bcd280bf" xlink:to="loc_moh_CashPaidDuringThePeriodAbstract_59170768-7c82-4aa8-ba2a-a6270190b3bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_fe684da1-6050-4713-9a73-c57a121fec59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_CashPaidDuringThePeriodAbstract_59170768-7c82-4aa8-ba2a-a6270190b3bf" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_fe684da1-6050-4713-9a73-c57a121fec59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_c8f99fc3-4866-4ec4-8438-6e82a4fa90a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_CashPaidDuringThePeriodAbstract_59170768-7c82-4aa8-ba2a-a6270190b3bf" xlink:to="loc_us-gaap_InterestPaidNet_c8f99fc3-4866-4ec4-8438-6e82a4fa90a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_9cdd4db6-8408-429c-8a2e-bde8b97eb1aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_9cdd4db6-8408-429c-8a2e-bde8b97eb1aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities_d26e7869-a694-467e-bd84-4852d233bd0c" xlink:href="moh-20201231.xsd#moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities_d26e7869-a694-467e-bd84-4852d233bd0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_198604d1-e2ad-402f-918e-23b125aab2a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_us-gaap_LiabilitiesAssumed1_198604d1-e2ad-402f-918e-23b125aab2a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1762c5e9-e22e-4f97-bd21-a48b4f1a3f5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract_80258447-c5b8-49e2-a464-383e1271a03a" xlink:href="moh-20201231.xsd#moh_CovertibleSeniorNotesExchangeTransactionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract_80258447-c5b8-49e2-a464-383e1271a03a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesIssued1_1b229696-91d9-46da-92f7-aecc64b84bbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract_80258447-c5b8-49e2-a464-383e1271a03a" xlink:to="loc_us-gaap_NotesIssued1_1b229696-91d9-46da-92f7-aecc64b84bbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease_b037707d-edc4-4bed-938f-8d162262ea4d" xlink:href="moh-20201231.xsd#moh_NotesIssuedFairValueAdjustmentIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract_80258447-c5b8-49e2-a464-383e1271a03a" xlink:to="loc_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease_b037707d-edc4-4bed-938f-8d162262ea4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_26b01c35-a714-4f2e-b6b6-3952f39fa03f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract_80258447-c5b8-49e2-a464-383e1271a03a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_26b01c35-a714-4f2e-b6b6-3952f39fa03f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_fabb2726-526d-439b-ab12-de079362c425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_us-gaap_StockIssued1_fabb2726-526d-439b-ab12-de079362c425" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CommonStockPurchasesNotSettledAtEndOfPeriod_e8730148-938a-4641-8112-4ce8b325ee60" xlink:href="moh-20201231.xsd#moh_CommonStockPurchasesNotSettledAtEndOfPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_moh_CommonStockPurchasesNotSettledAtEndOfPeriod_e8730148-938a-4641-8112-4ce8b325ee60" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DetailsofchangeinfairvalueofderivativesAbstract_07d26442-c6f8-4ef9-b5e8-2d429a0f30a9" xlink:href="moh-20201231.xsd#moh_DetailsofchangeinfairvalueofderivativesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_moh_DetailsofchangeinfairvalueofderivativesAbstract_07d26442-c6f8-4ef9-b5e8-2d429a0f30a9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_57c1e245-7b0c-4b63-acbc-14d2dfdca5c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_DetailsofchangeinfairvalueofderivativesAbstract_07d26442-c6f8-4ef9-b5e8-2d429a0f30a9" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_57c1e245-7b0c-4b63-acbc-14d2dfdca5c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncreaseDecreaseinCarryingAmountofAssets_d9bbac29-8249-4c9e-84ee-1c86436eaa52" xlink:href="moh-20201231.xsd#moh_IncreaseDecreaseinCarryingAmountofAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:to="loc_moh_IncreaseDecreaseinCarryingAmountofAssets_d9bbac29-8249-4c9e-84ee-1c86436eaa52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GainLossonDispositionofLiabilities_76602475-fa63-4468-829e-749f042074a9" xlink:href="moh-20201231.xsd#moh_GainLossonDispositionofLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:to="loc_moh_GainLossonDispositionofLiabilities_76602475-fa63-4468-829e-749f042074a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DispositionofBusinessTransactionCosts_3da77c53-aaa7-4780-82b7-983712e47b83" xlink:href="moh-20201231.xsd#moh_DispositionofBusinessTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:to="loc_moh_DispositionofBusinessTransactionCosts_3da77c53-aaa7-4780-82b7-983712e47b83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DispositionofBusinessReceivablefromBuyer_f5bd60cd-ecd1-480f-b69a-c0e90b7f6607" xlink:href="moh-20201231.xsd#moh_DispositionofBusinessReceivablefromBuyer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:to="loc_moh_DispositionofBusinessReceivablefromBuyer_f5bd60cd-ecd1-480f-b69a-c0e90b7f6607" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_a2777577-6a85-4b01-9cf5-34c79a12f420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dd93dd4e-6c6e-40b6-89a0-a38b7d2ca7b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_StatementTable_dd93dd4e-6c6e-40b6-89a0-a38b7d2ca7b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_aed34102-1e36-483f-a106-da45bb9d13d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dd93dd4e-6c6e-40b6-89a0-a38b7d2ca7b7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_aed34102-1e36-483f-a106-da45bb9d13d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_aed34102-1e36-483f-a106-da45bb9d13d9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_aed34102-1e36-483f-a106-da45bb9d13d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_aed34102-1e36-483f-a106-da45bb9d13d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9464ac96-60da-46b2-9aae-0b0dbb5c9577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_aed34102-1e36-483f-a106-da45bb9d13d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9464ac96-60da-46b2-9aae-0b0dbb5c9577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CallOptionDerivativeAssetMember_3d5c74a1-93d6-4c5a-bb93-e971b8d123fb" xlink:href="moh-20201231.xsd#moh_CallOptionDerivativeAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9464ac96-60da-46b2-9aae-0b0dbb5c9577" xlink:to="loc_moh_CallOptionDerivativeAssetMember_3d5c74a1-93d6-4c5a-bb93-e971b8d123fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_79ca596a-7592-4065-a990-b0bf86823b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9464ac96-60da-46b2-9aae-0b0dbb5c9577" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_79ca596a-7592-4065-a990-b0bf86823b1a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation" xlink:type="simple" xlink:href="moh-20201231.xsd#OrganizationandBasisofPresentation"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation" xlink:type="extended" id="i5194e6ffe1b247d788e3294933738245_OrganizationandBasisofPresentation"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#OrganizationandBasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails" xlink:type="extended" id="id74cc198fbf74f2aa0a0fe9b719cfd1a_OrganizationandBasisofPresentationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:href="moh-20201231.xsd#moh_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a6a51617-9d12-4df5-b88c-2f242d585d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_us-gaap_NumberOfReportableSegments_a6a51617-9d12-4df5-b88c-2f242d585d25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NumberOfStatesForOperatedHealthPlans_1f2c34cf-8785-41e6-8e44-064f59029160" xlink:href="moh-20201231.xsd#moh_NumberOfStatesForOperatedHealthPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_moh_NumberOfStatesForOperatedHealthPlans_1f2c34cf-8785-41e6-8e44-064f59029160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NumberOfMembersEligibleForTheHealthCarePrograms_10bff1bc-b405-4760-a855-ab0f7b5544ee" xlink:href="moh-20201231.xsd#moh_NumberOfMembersEligibleForTheHealthCarePrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_moh_NumberOfMembersEligibleForTheHealthCarePrograms_10bff1bc-b405-4760-a855-ab0f7b5544ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_4e7766bd-d29d-446a-ab36-bf5fc825154f" xlink:href="moh-20201231.xsd#moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_4e7766bd-d29d-446a-ab36-bf5fc825154f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlanContractTerm_4e73776d-86c7-44a0-939b-89d64e15321f" xlink:href="moh-20201231.xsd#moh_HealthPlanContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_moh_HealthPlanContractTerm_4e73776d-86c7-44a0-939b-89d64e15321f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_341f1a6b-37f6-40b3-b38e-389d03843985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_341f1a6b-37f6-40b3-b38e-389d03843985" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e0634fc5-e109-435c-a929-478dd9dd5512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e0634fc5-e109-435c-a929-478dd9dd5512" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:href="moh-20201231.xsd#moh_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_98c4de67-d16a-4974-9851-334306b1a193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_98c4de67-d16a-4974-9851-334306b1a193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98c4de67-d16a-4974-9851-334306b1a193_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98c4de67-d16a-4974-9851-334306b1a193" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98c4de67-d16a-4974-9851-334306b1a193_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b8f893f-ad66-43fe-a798-7378aa700170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98c4de67-d16a-4974-9851-334306b1a193" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b8f893f-ad66-43fe-a798-7378aa700170" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MagellanCompleteCareMember_6d6d3a40-d27d-4f8f-bdd8-39cf3c9991ea" xlink:href="moh-20201231.xsd#moh_MagellanCompleteCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b8f893f-ad66-43fe-a798-7378aa700170" xlink:to="loc_moh_MagellanCompleteCareMember_6d6d3a40-d27d-4f8f-bdd8-39cf3c9991ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffinityHealthPlanMember_541ae9a7-3c4a-43b3-a4b6-05c3b7ea3228" xlink:href="moh-20201231.xsd#moh_AffinityHealthPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b8f893f-ad66-43fe-a798-7378aa700170" xlink:to="loc_moh_AffinityHealthPlanMember_541ae9a7-3c4a-43b3-a4b6-05c3b7ea3228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_71cd0bd3-aa52-4b0a-a74c-f6b423d65f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_71cd0bd3-aa52-4b0a-a74c-f6b423d65f40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_71cd0bd3-aa52-4b0a-a74c-f6b423d65f40_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_71cd0bd3-aa52-4b0a-a74c-f6b423d65f40" xlink:to="loc_us-gaap_SegmentDomain_71cd0bd3-aa52-4b0a-a74c-f6b423d65f40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1a549075-7679-4124-825b-0a5c5afd970a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_71cd0bd3-aa52-4b0a-a74c-f6b423d65f40" xlink:to="loc_us-gaap_SegmentDomain_1a549075-7679-4124-825b-0a5c5afd970a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_a9bd47e9-ab00-4e08-9865-87989d0af265" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1a549075-7679-4124-825b-0a5c5afd970a" xlink:to="loc_moh_HealthPlansMember_a9bd47e9-ab00-4e08-9865-87989d0af265" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7e533043-5eec-40b7-a55d-d95bde646ce2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:to="loc_srt_RangeAxis_7e533043-5eec-40b7-a55d-d95bde646ce2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7e533043-5eec-40b7-a55d-d95bde646ce2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7e533043-5eec-40b7-a55d-d95bde646ce2" xlink:to="loc_srt_RangeMember_7e533043-5eec-40b7-a55d-d95bde646ce2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7332359d-46a6-4b09-87f4-9057b923bb9a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7e533043-5eec-40b7-a55d-d95bde646ce2" xlink:to="loc_srt_RangeMember_7332359d-46a6-4b09-87f4-9057b923bb9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_47319d71-5364-41e5-8be4-c36b7acd604c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7332359d-46a6-4b09-87f4-9057b923bb9a" xlink:to="loc_srt_MinimumMember_47319d71-5364-41e5-8be4-c36b7acd604c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_498561fd-540b-494f-b67b-bf0ccf34da68" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7332359d-46a6-4b09-87f4-9057b923bb9a" xlink:to="loc_srt_MaximumMember_498561fd-540b-494f-b67b-bf0ccf34da68" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPolicies" xlink:type="extended" id="ie6d3723210db4679b1b276df5f2b5e3e_SignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended" id="ia4a0ee60bf2e42deb26a564d962f2f40_SignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables" xlink:type="extended" id="i23b5ac9ce7344c9f820f0f6483c48405_SignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended" id="i96d8b481372f4aa684ca0aebc763492f_SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended" id="i5da00d963ce545899ee25f01144c9f3b_SignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_InvestmentsMaturityPeriod_b508f8c7-4769-4a18-b844-564673fa3b1d" xlink:href="moh-20201231.xsd#moh_InvestmentsMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_InvestmentsMaturityPeriod_b508f8c7-4769-4a18-b844-564673fa3b1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_InvestmentsAverageMaturityPeriod_15e120d0-b04c-472f-9ae7-bb85a29b9b91" xlink:href="moh-20201231.xsd#moh_InvestmentsAverageMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_InvestmentsAverageMaturityPeriod_15e120d0-b04c-472f-9ae7-bb85a29b9b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_f4ae5ab6-0ee3-4bcc-adc9-f9939a81b8f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_InterestReceivable_f4ae5ab6-0ee3-4bcc-adc9-f9939a81b8f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4ca5b8cf-ed50-4acd-9d9f-396833490e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4ca5b8cf-ed50-4acd-9d9f-396833490e34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_7abef7bc-cc36-4890-8d8b-23330c65beac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_7abef7bc-cc36-4890-8d8b-23330c65beac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_1fc91af5-d20d-4cb8-a6a8-b3aa6db45a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_1fc91af5-d20d-4cb8-a6a8-b3aa6db45a45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable_8d546af6-ca87-4958-876b-b2b515f4090d" xlink:href="moh-20201231.xsd#moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable_8d546af6-ca87-4958-876b-b2b515f4090d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable_123d2fe7-267b-4a40-863d-45caf7abf3d5" xlink:href="moh-20201231.xsd#moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable_123d2fe7-267b-4a40-863d-45caf7abf3d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable_f4ae5848-a8f0-479e-94d9-71d527c0a89d" xlink:href="moh-20201231.xsd#moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable_f4ae5848-a8f0-479e-94d9-71d527c0a89d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PercentageOfAdditionalIncrementalRevenueEarned_08fbdca0-54d5-4e69-8e12-8183a27bf95d" xlink:href="moh-20201231.xsd#moh_PercentageOfAdditionalIncrementalRevenueEarned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_PercentageOfAdditionalIncrementalRevenueEarned_08fbdca0-54d5-4e69-8e12-8183a27bf95d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidReinsurancePremiums_a37cf283-0f83-4bb2-aed4-7418d61fe14a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidReinsurancePremiums"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_PrepaidReinsurancePremiums_a37cf283-0f83-4bb2-aed4-7418d61fe14a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRecoveries_539b3ceb-d911-4b81-be8b-59fd32eef9df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_InsuranceRecoveries_539b3ceb-d911-4b81-be8b-59fd32eef9df" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_7e81e0a3-f7d1-4b56-ae70-6c68e7e428f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_7e81e0a3-f7d1-4b56-ae70-6c68e7e428f7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_a383f9dc-ca27-4e0f-86ca-328dcd805a08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_a383f9dc-ca27-4e0f-86ca-328dcd805a08" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthCareInsuranceFeeLiability_5035448c-28cd-4981-a21b-5c08260547df" xlink:href="moh-20201231.xsd#moh_HealthCareInsuranceFeeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_HealthCareInsuranceFeeLiability_5035448c-28cd-4981-a21b-5c08260547df" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cb572aee-1487-4407-85d2-01d756597c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cb572aee-1487-4407-85d2-01d756597c2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb572aee-1487-4407-85d2-01d756597c2f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cb572aee-1487-4407-85d2-01d756597c2f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb572aee-1487-4407-85d2-01d756597c2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3bb8ded-1fa6-4719-8f4c-2a958d8853a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cb572aee-1487-4407-85d2-01d756597c2f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3bb8ded-1fa6-4719-8f4c-2a958d8853a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_StructuredSecuritiesMember_a8599b10-c722-4af3-9348-3ff6e78d70aa" xlink:href="moh-20201231.xsd#moh_StructuredSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3bb8ded-1fa6-4719-8f4c-2a958d8853a4" xlink:to="loc_moh_StructuredSecuritiesMember_a8599b10-c722-4af3-9348-3ff6e78d70aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ce15fbb7-ab45-4ae9-919b-02a22b443198" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_srt_RangeAxis_ce15fbb7-ab45-4ae9-919b-02a22b443198" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ce15fbb7-ab45-4ae9-919b-02a22b443198_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ce15fbb7-ab45-4ae9-919b-02a22b443198" xlink:to="loc_srt_RangeMember_ce15fbb7-ab45-4ae9-919b-02a22b443198_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0adc58f-30ba-486e-9c68-81060d1c8974" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ce15fbb7-ab45-4ae9-919b-02a22b443198" xlink:to="loc_srt_RangeMember_b0adc58f-30ba-486e-9c68-81060d1c8974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4f4fbbc8-480f-48b4-bf34-34138ffcd5bd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b0adc58f-30ba-486e-9c68-81060d1c8974" xlink:to="loc_srt_MinimumMember_4f4fbbc8-480f-48b4-bf34-34138ffcd5bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4bcc62e6-ef8c-493c-aa7b-7fdc2f600fbc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b0adc58f-30ba-486e-9c68-81060d1c8974" xlink:to="loc_srt_MaximumMember_4bcc62e6-ef8c-493c-aa7b-7fdc2f600fbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_77488145-9264-43cc-8c04-7b49ea19586f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_srt_StatementGeographicalAxis_77488145-9264-43cc-8c04-7b49ea19586f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_77488145-9264-43cc-8c04-7b49ea19586f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_77488145-9264-43cc-8c04-7b49ea19586f" xlink:to="loc_srt_SegmentGeographicalDomain_77488145-9264-43cc-8c04-7b49ea19586f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8e158408-8961-4ed4-befe-648591f7f772" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_77488145-9264-43cc-8c04-7b49ea19586f" xlink:to="loc_srt_SegmentGeographicalDomain_8e158408-8961-4ed4-befe-648591f7f772" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_c3bdb426-e164-4479-bf60-2186b0b759fe" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_PR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8e158408-8961-4ed4-befe-648591f7f772" xlink:to="loc_country_PR_c3bdb426-e164-4479-bf60-2186b0b759fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_124367f0-af6d-4bf1-9d1b-a6e89ce88a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_124367f0-af6d-4bf1-9d1b-a6e89ce88a1d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_124367f0-af6d-4bf1-9d1b-a6e89ce88a1d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_124367f0-af6d-4bf1-9d1b-a6e89ce88a1d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_124367f0-af6d-4bf1-9d1b-a6e89ce88a1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_f3fe1821-98b4-4bb0-9081-8dfad43f3a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_124367f0-af6d-4bf1-9d1b-a6e89ce88a1d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_f3fe1821-98b4-4bb0-9081-8dfad43f3a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_COVID19Member_125a2417-125a-4822-bc6f-2f3517f4035e" xlink:href="moh-20201231.xsd#moh_COVID19Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_f3fe1821-98b4-4bb0-9081-8dfad43f3a5f" xlink:to="loc_moh_COVID19Member_125a2417-125a-4822-bc6f-2f3517f4035e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_91ad73f9-afd8-48b6-ba0a-f1d28d4547a7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_srt_LitigationCaseAxis_91ad73f9-afd8-48b6-ba0a-f1d28d4547a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_91ad73f9-afd8-48b6-ba0a-f1d28d4547a7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_91ad73f9-afd8-48b6-ba0a-f1d28d4547a7" xlink:to="loc_srt_LitigationCaseTypeDomain_91ad73f9-afd8-48b6-ba0a-f1d28d4547a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7505f5d8-f9bd-4be8-854c-36168bfae8af" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_91ad73f9-afd8-48b6-ba0a-f1d28d4547a7" xlink:to="loc_srt_LitigationCaseTypeDomain_7505f5d8-f9bd-4be8-854c-36168bfae8af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MaineCommunityHealthOptionsv.UnitedStatesMember_1f9e2c8c-41c6-4ef4-a879-d5f840198549" xlink:href="moh-20201231.xsd#moh_MaineCommunityHealthOptionsv.UnitedStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7505f5d8-f9bd-4be8-854c-36168bfae8af" xlink:to="loc_moh_MaineCommunityHealthOptionsv.UnitedStatesMember_1f9e2c8c-41c6-4ef4-a879-d5f840198549" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_28044ac5-df18-4590-b5ee-95c0b6dfcebb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_srt_ProductOrServiceAxis_28044ac5-df18-4590-b5ee-95c0b6dfcebb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_28044ac5-df18-4590-b5ee-95c0b6dfcebb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_28044ac5-df18-4590-b5ee-95c0b6dfcebb" xlink:to="loc_srt_ProductsAndServicesDomain_28044ac5-df18-4590-b5ee-95c0b6dfcebb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8b6bc5d7-7847-498c-b04a-47d81537759b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_28044ac5-df18-4590-b5ee-95c0b6dfcebb" xlink:to="loc_srt_ProductsAndServicesDomain_8b6bc5d7-7847-498c-b04a-47d81537759b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicareMedicaidPlansMember_b71fb807-6547-4f9a-a63a-8bf9122453a8" xlink:href="moh-20201231.xsd#moh_MedicareMedicaidPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8b6bc5d7-7847-498c-b04a-47d81537759b" xlink:to="loc_moh_MedicareMedicaidPlansMember_b71fb807-6547-4f9a-a63a-8bf9122453a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePremiumMember_a38afdc3-a043-4253-93cd-3c3b799e8022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCarePremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8b6bc5d7-7847-498c-b04a-47d81537759b" xlink:to="loc_us-gaap_HealthCarePremiumMember_a38afdc3-a043-4253-93cd-3c3b799e8022" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicaidMember_038bea75-3f16-4db4-aa9b-57be205c2bc0" xlink:href="moh-20201231.xsd#moh_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8b6bc5d7-7847-498c-b04a-47d81537759b" xlink:to="loc_moh_MedicaidMember_038bea75-3f16-4db4-aa9b-57be205c2bc0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesReceivablesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails" xlink:type="extended" id="i5e37b01f2e2f47b893d90de643068256_SignificantAccountingPoliciesReceivablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_30d9ac9f-79fb-4fe0-8a94-1072f8b5e87a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_09207ef9-72df-43ca-abcb-0eea67565a34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_30d9ac9f-79fb-4fe0-8a94-1072f8b5e87a" xlink:to="loc_us-gaap_ReceivablesNetCurrent_09207ef9-72df-43ca-abcb-0eea67565a34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_244a7296-80ae-473a-838e-f48e1a562a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_30d9ac9f-79fb-4fe0-8a94-1072f8b5e87a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_244a7296-80ae-473a-838e-f48e1a562a8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_741951ca-bc4b-4210-aa3e-02e9eb782820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_244a7296-80ae-473a-838e-f48e1a562a8e" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_741951ca-bc4b-4210-aa3e-02e9eb782820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_741951ca-bc4b-4210-aa3e-02e9eb782820_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_741951ca-bc4b-4210-aa3e-02e9eb782820" xlink:to="loc_us-gaap_ReceivableTypeDomain_741951ca-bc4b-4210-aa3e-02e9eb782820_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_741951ca-bc4b-4210-aa3e-02e9eb782820" xlink:to="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GovernmentReceivablesMember_025f8196-7160-43ee-9ab8-fea25dd8c9f0" xlink:href="moh-20201231.xsd#moh_GovernmentReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:to="loc_moh_GovernmentReceivablesMember_025f8196-7160-43ee-9ab8-fea25dd8c9f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PharmacyRebateReceivablesMember_5170fe56-24a1-45c7-9557-7ab3a9d34239" xlink:href="moh-20201231.xsd#moh_PharmacyRebateReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:to="loc_moh_PharmacyRebateReceivablesMember_5170fe56-24a1-45c7-9557-7ab3a9d34239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthInsurerFeeReimbursementReceivablesMember_534df5cb-e1cb-4c97-9d87-81feffe1f838" xlink:href="moh-20201231.xsd#moh_HealthInsurerFeeReimbursementReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:to="loc_moh_HealthInsurerFeeReimbursementReceivablesMember_534df5cb-e1cb-4c97-9d87-81feffe1f838" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherReceivablesMember_10d22142-fe8b-4464-9c11-1b0205003dbe" xlink:href="moh-20201231.xsd#moh_OtherReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:to="loc_moh_OtherReceivablesMember_10d22142-fe8b-4464-9c11-1b0205003dbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CompleteCareReceivablesMember_fc43b285-c300-43fc-b731-343faa893943" xlink:href="moh-20201231.xsd#moh_CompleteCareReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:to="loc_moh_CompleteCareReceivablesMember_fc43b285-c300-43fc-b731-343faa893943" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails" xlink:type="extended" id="i299357aa3f1840fa9377f898630022b7_SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails" xlink:type="extended" id="i151d075fcdf44aa69dd58150891f4f20_SignificantAccountingPoliciesScheduleofPremiumRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_178b0da5-a680-4cbf-b1da-b0be7a16ff08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_43d8525c-382e-4fda-8367-c44fc037a8b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_178b0da5-a680-4cbf-b1da-b0be7a16ff08" xlink:to="loc_us-gaap_PremiumsEarnedNet_43d8525c-382e-4fda-8367-c44fc037a8b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthCareOrganizationRevenuePercentage_bee987c1-c12e-4f1d-ac96-1964f422dce0" xlink:href="moh-20201231.xsd#moh_HealthCareOrganizationRevenuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_178b0da5-a680-4cbf-b1da-b0be7a16ff08" xlink:to="loc_moh_HealthCareOrganizationRevenuePercentage_bee987c1-c12e-4f1d-ac96-1964f422dce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_81739f1d-fb1d-4bfa-919f-d0d63227722e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_178b0da5-a680-4cbf-b1da-b0be7a16ff08" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_81739f1d-fb1d-4bfa-919f-d0d63227722e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_01060ab1-0c44-4340-a581-e172fc502891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_81739f1d-fb1d-4bfa-919f-d0d63227722e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_01060ab1-0c44-4340-a581-e172fc502891" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_01060ab1-0c44-4340-a581-e172fc502891_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_01060ab1-0c44-4340-a581-e172fc502891" xlink:to="loc_us-gaap_SegmentDomain_01060ab1-0c44-4340-a581-e172fc502891_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9e614ff8-e7a5-4909-9b36-361e65e3b3fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_01060ab1-0c44-4340-a581-e172fc502891" xlink:to="loc_us-gaap_SegmentDomain_9e614ff8-e7a5-4909-9b36-361e65e3b3fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_9668229c-401f-4e36-9644-5c85fe4b8227" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9e614ff8-e7a5-4909-9b36-361e65e3b3fa" xlink:to="loc_moh_HealthPlansMember_9668229c-401f-4e36-9644-5c85fe4b8227" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_967de090-e55f-49b2-83a9-73bebe521901" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_81739f1d-fb1d-4bfa-919f-d0d63227722e" xlink:to="loc_srt_StatementGeographicalAxis_967de090-e55f-49b2-83a9-73bebe521901" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_967de090-e55f-49b2-83a9-73bebe521901_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_967de090-e55f-49b2-83a9-73bebe521901" xlink:to="loc_srt_SegmentGeographicalDomain_967de090-e55f-49b2-83a9-73bebe521901_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_967de090-e55f-49b2-83a9-73bebe521901" xlink:to="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_35c9d430-446f-4840-8d44-a580891cc578" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_CA_35c9d430-446f-4840-8d44-a580891cc578" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_e1e9a4f8-5c42-43c4-96c5-1bcdfb3b2fc3" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_FL_e1e9a4f8-5c42-43c4-96c5-1bcdfb3b2fc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_f8a0bd3f-3f3e-453b-9751-34e0d97b9656" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_IL_f8a0bd3f-3f3e-453b-9751-34e0d97b9656" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KY_78489470-561c-4548-ae39-94c47742bf64" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_KY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_KY_78489470-561c-4548-ae39-94c47742bf64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI_c46ae891-1f42-423a-8c80-2917c549f61c" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_MI_c46ae891-1f42-423a-8c80-2917c549f61c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_0f155dc0-03f4-4762-8002-c824935c8ed4" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_OH_0f155dc0-03f4-4762-8002-c824935c8ed4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_8fdc8d5a-5729-42bd-a48a-356b66a977f3" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_TX_8fdc8d5a-5729-42bd-a48a-356b66a977f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA_a4585396-0ec8-4a1a-9d5f-2bf2bc9acfbb" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_WA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_WA_a4585396-0ec8-4a1a-9d5f-2bf2bc9acfbb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherGeographicalAreasMember_c851c4b4-cbad-49ee-b8b3-e7fe605734e3" xlink:href="moh-20201231.xsd#moh_OtherGeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_moh_OtherGeographicalAreasMember_c851c4b4-cbad-49ee-b8b3-e7fe605734e3" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="moh-20201231.xsd#NetIncomePerShare"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/NetIncomePerShare" xlink:type="extended" id="i3b363542c2bd4c01b3e0cf84039a9550_NetIncomePerShare"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="moh-20201231.xsd#NetIncomePerShareTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/NetIncomePerShareTables" xlink:type="extended" id="ib40f6e7dd2ac47d7b6ba87a3b1a050cc_NetIncomePerShareTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#NetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/NetIncomePerShareDetails" xlink:type="extended" id="i136be6d9109440dda46090cf99d99ce3_NetIncomePerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_2dcd1e14-e17a-4cf6-a196-1a9137d767d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ClassOfWarrantOrRightStatedInterestRate_a19f3a6f-44a4-44e0-924c-1fca8dbdca9b" xlink:href="moh-20201231.xsd#moh_ClassOfWarrantOrRightStatedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_2dcd1e14-e17a-4cf6-a196-1a9137d767d7" xlink:to="loc_moh_ClassOfWarrantOrRightStatedInterestRate_a19f3a6f-44a4-44e0-924c-1fca8dbdca9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_76dedb6c-3452-413b-8966-b3bca8dc0618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_2dcd1e14-e17a-4cf6-a196-1a9137d767d7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_76dedb6c-3452-413b-8966-b3bca8dc0618" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7781fbbf-2c2f-4d24-9b86-15ef85cb6dfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_76dedb6c-3452-413b-8966-b3bca8dc0618" xlink:to="loc_us-gaap_DebtInstrumentAxis_7781fbbf-2c2f-4d24-9b86-15ef85cb6dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7781fbbf-2c2f-4d24-9b86-15ef85cb6dfb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7781fbbf-2c2f-4d24-9b86-15ef85cb6dfb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7781fbbf-2c2f-4d24-9b86-15ef85cb6dfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ed5f73a5-d597-472b-b8b6-8acdaa4bd9ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7781fbbf-2c2f-4d24-9b86-15ef85cb6dfb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ed5f73a5-d597-472b-b8b6-8acdaa4bd9ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ConvertibleSeniorNotesMember_b618e3fd-b222-450e-bdc5-b9c460d09d4b" xlink:href="moh-20201231.xsd#moh_ConvertibleSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ed5f73a5-d597-472b-b8b6-8acdaa4bd9ff" xlink:to="loc_moh_ConvertibleSeniorNotesMember_b618e3fd-b222-450e-bdc5-b9c460d09d4b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinations" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinations"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinations" xlink:type="extended" id="i544c453af083437eb5a115f16fc1d5c9_BusinessCombinations"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsTables" xlink:type="extended" id="i3df70126e59a47b58bf6f8d90a1697db_BusinessCombinationsTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended" id="i74e015794639485c8c1054228f8531bd_BusinessCombinationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationNumberOfBusinessCombinations_7eb1b7de-9a1f-416b-ae6f-3138dbb7ad55" xlink:href="moh-20201231.xsd#moh_BusinessCombinationNumberOfBusinessCombinations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_moh_BusinessCombinationNumberOfBusinessCombinations_7eb1b7de-9a1f-416b-ae6f-3138dbb7ad55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_a76ca028-d80a-453c-833b-36b069eeea68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_AcquisitionCosts_a76ca028-d80a-453c-833b-36b069eeea68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cca8d09c-d327-4fd0-bc83-e93806e677d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cca8d09c-d327-4fd0-bc83-e93806e677d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_763f702a-5e50-4d64-a356-be8bbd13c8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_763f702a-5e50-4d64-a356-be8bbd13c8c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_ac81dbdf-50ab-411f-a5c3-1e72144c49cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_ac81dbdf-50ab-411f-a5c3-1e72144c49cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_da53e7e5-6db2-45d6-b1cc-48b77c4fc3b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_da53e7e5-6db2-45d6-b1cc-48b77c4fc3b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8d0f1f5e-96b3-4356-808c-02e5366e58fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8d0f1f5e-96b3-4356-808c-02e5366e58fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a3a9fddc-aab9-4a3f-9368-9c302862a4c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a3a9fddc-aab9-4a3f-9368-9c302862a4c6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_df18f899-57a0-4a24-a5f0-f55b94898fa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_df18f899-57a0-4a24-a5f0-f55b94898fa0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_bcc2dca6-665b-4a3d-bdb2-93f78e9585a1" xlink:href="moh-20201231.xsd#moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_bcc2dca6-665b-4a3d-bdb2-93f78e9585a1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_8e47770f-e0a5-4fec-a728-1123ebabba7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_8e47770f-e0a5-4fec-a728-1123ebabba7b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_482d1eeb-87db-4061-8ffa-0465d75b2f89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_482d1eeb-87db-4061-8ffa-0465d75b2f89" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b714a326-d062-4da3-8cdb-e3f98f5e8518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b714a326-d062-4da3-8cdb-e3f98f5e8518" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage_e8fa106c-3de5-48e7-bad2-41901b92dda1" xlink:href="moh-20201231.xsd#moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage_e8fa106c-3de5-48e7-bad2-41901b92dda1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_34effb01-572b-40ae-9b63-2d1f08ee18b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_Goodwill_34effb01-572b-40ae-9b63-2d1f08ee18b4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_532be3dc-ac5a-46b0-9f4a-f3e4d7397d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_532be3dc-ac5a-46b0-9f4a-f3e4d7397d2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c05413e4-4324-4fb9-a851-1439cb1df048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_532be3dc-ac5a-46b0-9f4a-f3e4d7397d2f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c05413e4-4324-4fb9-a851-1439cb1df048" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05413e4-4324-4fb9-a851-1439cb1df048_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c05413e4-4324-4fb9-a851-1439cb1df048" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05413e4-4324-4fb9-a851-1439cb1df048_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad50dfb7-022c-4f29-977b-37b7ead246f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c05413e4-4324-4fb9-a851-1439cb1df048" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad50dfb7-022c-4f29-977b-37b7ead246f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MagellanCompleteCareMember_068c066d-4377-43e5-9dd0-5d9df2e0878e" xlink:href="moh-20201231.xsd#moh_MagellanCompleteCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad50dfb7-022c-4f29-977b-37b7ead246f7" xlink:to="loc_moh_MagellanCompleteCareMember_068c066d-4377-43e5-9dd0-5d9df2e0878e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PassportHealthPlanIncMember_1b135597-9311-4d52-9788-f6a0cacf8fea" xlink:href="moh-20201231.xsd#moh_PassportHealthPlanIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad50dfb7-022c-4f29-977b-37b7ead246f7" xlink:to="loc_moh_PassportHealthPlanIncMember_1b135597-9311-4d52-9788-f6a0cacf8fea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_YourCareHealthPlanIncMember_267c9ca8-6e36-4c3b-839d-0307320e4203" xlink:href="moh-20201231.xsd#moh_YourCareHealthPlanIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad50dfb7-022c-4f29-977b-37b7ead246f7" xlink:to="loc_moh_YourCareHealthPlanIncMember_267c9ca8-6e36-4c3b-839d-0307320e4203" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a684da08-770b-41cf-8da6-cf9516dad019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_532be3dc-ac5a-46b0-9f4a-f3e4d7397d2f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a684da08-770b-41cf-8da6-cf9516dad019" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a684da08-770b-41cf-8da6-cf9516dad019_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a684da08-770b-41cf-8da6-cf9516dad019" xlink:to="loc_us-gaap_SegmentDomain_a684da08-770b-41cf-8da6-cf9516dad019_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2f9d0154-c2c4-433d-979e-8bf1c6ffa4ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a684da08-770b-41cf-8da6-cf9516dad019" xlink:to="loc_us-gaap_SegmentDomain_2f9d0154-c2c4-433d-979e-8bf1c6ffa4ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_013a2e7d-7d89-432f-bdbd-60374dc0a099" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2f9d0154-c2c4-433d-979e-8bf1c6ffa4ce" xlink:to="loc_moh_HealthPlansMember_013a2e7d-7d89-432f-bdbd-60374dc0a099" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails" xlink:type="extended" id="ieaf1982fca9940508d691c97d40d95ca_BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5dbee90d-4afb-4d9d-b616-76808f0db391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:href="moh-20201231.xsd#moh_AssetsAcquiredAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5dbee90d-4afb-4d9d-b616-76808f0db391" xlink:to="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4e0188a5-402e-4ae4-b37c-21263a718b8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4e0188a5-402e-4ae4-b37c-21263a718b8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_9c0a3235-259c-4e4b-bc69-3b8094f652bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_9c0a3235-259c-4e4b-bc69-3b8094f652bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_71f6a96a-79b4-4112-a4de-6ab243992624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_71f6a96a-79b4-4112-a4de-6ab243992624" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_67603f88-bc1f-4fc2-ad0b-b46b3c4e3f2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_67603f88-bc1f-4fc2-ad0b-b46b3c4e3f2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_48ba098c-08fe-4509-bc07-b9f0442ac710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_48ba098c-08fe-4509-bc07-b9f0442ac710" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_44eddb82-22ba-44a1-9e23-fc126d2ebba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_44eddb82-22ba-44a1-9e23-fc126d2ebba8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9e142d81-3396-49e5-a678-db02179169cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_Goodwill_9e142d81-3396-49e5-a678-db02179169cc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment_59bcdbf3-6a5c-4622-8ddb-6fc3ea274e76" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment_59bcdbf3-6a5c-4622-8ddb-6fc3ea274e76" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_720dbced-e9f4-44dc-a777-2b8a1509ebca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_720dbced-e9f4-44dc-a777-2b8a1509ebca" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:href="moh-20201231.xsd#moh_LiabilitiesAssumedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5dbee90d-4afb-4d9d-b616-76808f0db391" xlink:to="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable_913dcc6f-a5a4-4c75-8f12-8a1f534b8bb2" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable_913dcc6f-a5a4-4c75-8f12-8a1f534b8bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies_77b84aca-0da0-4569-9b73-93bb5a84930b" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies_77b84aca-0da0-4569-9b73-93bb5a84930b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_24b72140-2a44-4c37-9233-46e425654856" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_24b72140-2a44-4c37-9233-46e425654856" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ee874acc-ed45-4f56-8fd7-2aecb6193c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ee874acc-ed45-4f56-8fd7-2aecb6193c37" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ea3422ab-51f6-435d-bcb4-34c480774c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ea3422ab-51f6-435d-bcb4-34c480774c6e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d514224-8ca3-4976-a46b-6a6e220725bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5dbee90d-4afb-4d9d-b616-76808f0db391" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d514224-8ca3-4976-a46b-6a6e220725bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2ae16b1d-1485-44d2-8724-bdf8b8d15d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d514224-8ca3-4976-a46b-6a6e220725bf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2ae16b1d-1485-44d2-8724-bdf8b8d15d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2ae16b1d-1485-44d2-8724-bdf8b8d15d8a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2ae16b1d-1485-44d2-8724-bdf8b8d15d8a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2ae16b1d-1485-44d2-8724-bdf8b8d15d8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_172bbff5-ed7a-447a-bef0-f27040fd3793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2ae16b1d-1485-44d2-8724-bdf8b8d15d8a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_172bbff5-ed7a-447a-bef0-f27040fd3793" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansSegmentMember_87bb21e1-eb67-44d4-beaf-4bf39adddba0" xlink:href="moh-20201231.xsd#moh_HealthPlansSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_172bbff5-ed7a-447a-bef0-f27040fd3793" xlink:to="loc_moh_HealthPlansSegmentMember_87bb21e1-eb67-44d4-beaf-4bf39adddba0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails" xlink:type="extended" id="i00a96aeb5e1c435fbe3ac57024b41092_BusinessCombinationsIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_038f333c-b8fd-4f34-92b2-2dd8de33e131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e515e3f5-9054-4c4b-a284-d37ea7c5b19b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_038f333c-b8fd-4f34-92b2-2dd8de33e131" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e515e3f5-9054-4c4b-a284-d37ea7c5b19b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c66447f8-64ab-4c51-af8e-988e195e4e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_038f333c-b8fd-4f34-92b2-2dd8de33e131" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c66447f8-64ab-4c51-af8e-988e195e4e03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_7b1c4d81-3532-4936-9c60-ba8597648466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_038f333c-b8fd-4f34-92b2-2dd8de33e131" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_7b1c4d81-3532-4936-9c60-ba8597648466" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_8e71ea21-0535-465d-9fd3-1b45f1e832fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_038f333c-b8fd-4f34-92b2-2dd8de33e131" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_8e71ea21-0535-465d-9fd3-1b45f1e832fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e06e3e6-8188-4bd9-9ce6-245f5184ffbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_8e71ea21-0535-465d-9fd3-1b45f1e832fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e06e3e6-8188-4bd9-9ce6-245f5184ffbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6e06e3e6-8188-4bd9-9ce6-245f5184ffbe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e06e3e6-8188-4bd9-9ce6-245f5184ffbe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6e06e3e6-8188-4bd9-9ce6-245f5184ffbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c0430c7-a373-4759-9dd5-5a10aac74f69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e06e3e6-8188-4bd9-9ce6-245f5184ffbe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c0430c7-a373-4759-9dd5-5a10aac74f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_9cc94d33-71be-48c4-9f7d-329912112052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c0430c7-a373-4759-9dd5-5a10aac74f69" xlink:to="loc_us-gaap_ContractualRightsMember_9cc94d33-71be-48c4-9f7d-329912112052" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ProviderNetworkMember_97690f7e-cd78-48b0-ace1-c9186efe5ce7" xlink:href="moh-20201231.xsd#moh_ProviderNetworkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c0430c7-a373-4759-9dd5-5a10aac74f69" xlink:to="loc_moh_ProviderNetworkMember_97690f7e-cd78-48b0-ace1-c9186efe5ce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_TradeNameMember_051c8cfc-5562-4d8b-b0d2-9c60e0162e1b" xlink:href="moh-20201231.xsd#moh_TradeNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c0430c7-a373-4759-9dd5-5a10aac74f69" xlink:to="loc_moh_TradeNameMember_051c8cfc-5562-4d8b-b0d2-9c60e0162e1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ede9cbdd-9435-44ae-a875-54c1a214e718" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_8e71ea21-0535-465d-9fd3-1b45f1e832fa" xlink:to="loc_srt_RangeAxis_ede9cbdd-9435-44ae-a875-54c1a214e718" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ede9cbdd-9435-44ae-a875-54c1a214e718_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ede9cbdd-9435-44ae-a875-54c1a214e718" xlink:to="loc_srt_RangeMember_ede9cbdd-9435-44ae-a875-54c1a214e718_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eb7519ed-24c6-44eb-b95e-727f17a3daac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ede9cbdd-9435-44ae-a875-54c1a214e718" xlink:to="loc_srt_RangeMember_eb7519ed-24c6-44eb-b95e-727f17a3daac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_845b66a6-6dc0-4f7a-9a47-0b6e5ee3b131" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_eb7519ed-24c6-44eb-b95e-727f17a3daac" xlink:to="loc_srt_MinimumMember_845b66a6-6dc0-4f7a-9a47-0b6e5ee3b131" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2989b711-f464-48e5-986e-b7aa6201f842" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_eb7519ed-24c6-44eb-b95e-727f17a3daac" xlink:to="loc_srt_MaximumMember_2989b711-f464-48e5-986e-b7aa6201f842" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurements" xlink:type="extended" id="i1f0e576273ae4b3dacdc15397a7285c4_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsTables" xlink:type="extended" id="ic2b530ff9e52480d97cf77e3696dcdf3_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended" id="i309bfb37ff954dcf8ea91d012dea4a37_FairValueMeasurementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_20dd8cc6-3552-48bd-859f-0462cd240dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_20dd8cc6-3552-48bd-859f-0462cd240dc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_2911bd9a-581b-4754-ac59-d5f5753c7e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_2911bd9a-581b-4754-ac59-d5f5753c7e21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_7b958d24-6c3d-4399-944b-6f922cd54828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_us-gaap_RepaymentsOfDebt_7b958d24-6c3d-4399-944b-6f922cd54828" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_c2dfe2e1-9a38-4fd8-9fac-a2dd76f74e0f" xlink:href="moh-20201231.xsd#moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_c2dfe2e1-9a38-4fd8-9fac-a2dd76f74e0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_72b4fa60-46e8-483b-9dfa-8ae412cf5bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_72b4fa60-46e8-483b-9dfa-8ae412cf5bf8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1325c0cd-f319-459f-ae16-2c5150b05c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1325c0cd-f319-459f-ae16-2c5150b05c7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1325c0cd-f319-459f-ae16-2c5150b05c7e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1325c0cd-f319-459f-ae16-2c5150b05c7e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1325c0cd-f319-459f-ae16-2c5150b05c7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3040a03e-a29b-4bb4-aa06-404ada2cd558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1325c0cd-f319-459f-ae16-2c5150b05c7e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3040a03e-a29b-4bb4-aa06-404ada2cd558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PassportHealthPlanIncMember_fe52c077-ed4b-407d-9423-4b2c1a4ae530" xlink:href="moh-20201231.xsd#moh_PassportHealthPlanIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3040a03e-a29b-4bb4-aa06-404ada2cd558" xlink:to="loc_moh_PassportHealthPlanIncMember_fe52c077-ed4b-407d-9423-4b2c1a4ae530" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0d5d2d0a-95dd-4ec7-9a73-d85fd978fef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:to="loc_us-gaap_DebtInstrumentAxis_0d5d2d0a-95dd-4ec7-9a73-d85fd978fef9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0d5d2d0a-95dd-4ec7-9a73-d85fd978fef9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0d5d2d0a-95dd-4ec7-9a73-d85fd978fef9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0d5d2d0a-95dd-4ec7-9a73-d85fd978fef9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_132dc0bd-8277-47a0-8b86-54fe9bfdc8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0d5d2d0a-95dd-4ec7-9a73-d85fd978fef9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_132dc0bd-8277-47a0-8b86-54fe9bfdc8f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020Member_8474c80c-3f42-4599-a22b-e125754cba17" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_132dc0bd-8277-47a0-8b86-54fe9bfdc8f1" xlink:to="loc_moh_CashConvertibleSeniorNotesDue2020Member_8474c80c-3f42-4599-a22b-e125754cba17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f6f4269c-abe6-46db-b6d1-4cbcbc896369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f6f4269c-abe6-46db-b6d1-4cbcbc896369" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f6f4269c-abe6-46db-b6d1-4cbcbc896369_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f6f4269c-abe6-46db-b6d1-4cbcbc896369" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f6f4269c-abe6-46db-b6d1-4cbcbc896369_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8b04198e-55fa-441d-9c6f-cecc5b7915a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f6f4269c-abe6-46db-b6d1-4cbcbc896369" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8b04198e-55fa-441d-9c6f-cecc5b7915a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_fb7c5e8c-e405-4d80-8345-4479c6d656be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b04198e-55fa-441d-9c6f-cecc5b7915a3" xlink:to="loc_us-gaap_ConvertibleDebtMember_fb7c5e8c-e405-4d80-8345-4479c6d656be" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails" xlink:type="extended" id="idd06f1c57e084aefb06836746ca564a1_FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2aeef426-8a4f-48d4-9bb4-4dee24e8a6f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2aeef426-8a4f-48d4-9bb4-4dee24e8a6f6" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e822e10a-e64a-4028-87d4-b5f59dfa8ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e822e10a-e64a-4028-87d4-b5f59dfa8ba8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_efded736-fed9-478d-9f42-76def68502b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_DerivativeAssets_efded736-fed9-478d-9f42-76def68502b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_01234d29-12e7-4183-aa38-78c8f2afbcc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_01234d29-12e7-4183-aa38-78c8f2afbcc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f7fb7208-4073-42ba-9ff4-db3b52a81ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f7fb7208-4073-42ba-9ff4-db3b52a81ace" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_8b4ced83-8827-4fa7-bb2c-aa06b249c549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_DerivativeLiabilities_8b4ced83-8827-4fa7-bb2c-aa06b249c549" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_31b3968d-43a5-4fd0-b312-4d3728f57c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_31b3968d-43a5-4fd0-b312-4d3728f57c62" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6453c4b7-09ec-48c8-9c2c-c2a4f9feb5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2aeef426-8a4f-48d4-9bb4-4dee24e8a6f6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6453c4b7-09ec-48c8-9c2c-c2a4f9feb5e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b918f16c-1b96-4142-a920-ebacfd56da6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6453c4b7-09ec-48c8-9c2c-c2a4f9feb5e0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b918f16c-1b96-4142-a920-ebacfd56da6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b918f16c-1b96-4142-a920-ebacfd56da6a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b918f16c-1b96-4142-a920-ebacfd56da6a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b918f16c-1b96-4142-a920-ebacfd56da6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_554c60df-0213-427e-8488-98ec21321b21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b918f16c-1b96-4142-a920-ebacfd56da6a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_554c60df-0213-427e-8488-98ec21321b21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_31033922-9308-4cf2-a2a4-10af6551896e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_554c60df-0213-427e-8488-98ec21321b21" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_31033922-9308-4cf2-a2a4-10af6551896e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0182139d-435f-429c-a6d0-5d5936a487f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_554c60df-0213-427e-8488-98ec21321b21" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0182139d-435f-429c-a6d0-5d5936a487f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_debfebac-135a-4e93-9a11-a156488d8cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_554c60df-0213-427e-8488-98ec21321b21" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_debfebac-135a-4e93-9a11-a156488d8cd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_004ed947-4e2e-4a13-a87d-ba18205a694b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6453c4b7-09ec-48c8-9c2c-c2a4f9feb5e0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_004ed947-4e2e-4a13-a87d-ba18205a694b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_004ed947-4e2e-4a13-a87d-ba18205a694b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_004ed947-4e2e-4a13-a87d-ba18205a694b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_004ed947-4e2e-4a13-a87d-ba18205a694b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_004ed947-4e2e-4a13-a87d-ba18205a694b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_0153a1f6-bfac-4b92-9fa0-24e1538eb17e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_0153a1f6-bfac-4b92-9fa0-24e1538eb17e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c0e1bb65-ea8c-4f37-96d0-fc008826eac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c0e1bb65-ea8c-4f37-96d0-fc008826eac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MunicipalSecuritiesMember_0723a880-9c70-411e-9531-c44e4ac0efcc" xlink:href="moh-20201231.xsd#moh_MunicipalSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_moh_MunicipalSecuritiesMember_0723a880-9c70-411e-9531-c44e4ac0efcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_31b9adcf-3708-4d96-8b0d-42d0ceaee411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_31b9adcf-3708-4d96-8b0d-42d0ceaee411" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_f9e977c2-577f-4250-9d4b-35e4f20a5e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_CertificatesOfDepositMember_f9e977c2-577f-4250-9d4b-35e4f20a5e30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember_9a3135a1-b184-4e40-bd8d-7886ef836c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_USTreasuryNotesSecuritiesMember_9a3135a1-b184-4e40-bd8d-7886ef836c7c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_1923c4a3-631c-45be-a319-e455f91bc685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_1923c4a3-631c-45be-a319-e455f91bc685" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherSecuritiesMember_f955d007-db6b-4028-9942-65af938dc1b4" xlink:href="moh-20201231.xsd#moh_OtherSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_moh_OtherSecuritiesMember_f955d007-db6b-4028-9942-65af938dc1b4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_f5ce3e7c-859b-43e2-ada8-b09eda3a5731" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_f5ce3e7c-859b-43e2-ada8-b09eda3a5731" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_3da183c9-4149-4bd8-8ae3-cc95f5f2ae93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_3da183c9-4149-4bd8-8ae3-cc95f5f2ae93" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsBalanceSheetGroupingDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails" xlink:type="extended" id="ib0375b77b3ce44f2a185745364d328f1_FairValueMeasurementsBalanceSheetGroupingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_69254234-e80f-4c02-8b98-580265ff698f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e24bb0c-949c-412e-819d-cc823c0b2e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_69254234-e80f-4c02-8b98-580265ff698f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e24bb0c-949c-412e-819d-cc823c0b2e30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_24e032e5-8d53-47f9-8b2a-035674aee350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_69254234-e80f-4c02-8b98-580265ff698f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_24e032e5-8d53-47f9-8b2a-035674aee350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8259dc91-2852-4bbb-9634-ccdce4115cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_69254234-e80f-4c02-8b98-580265ff698f" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8259dc91-2852-4bbb-9634-ccdce4115cda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2ea102be-1427-42c1-b4bf-4a0efe2bb236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8259dc91-2852-4bbb-9634-ccdce4115cda" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2ea102be-1427-42c1-b4bf-4a0efe2bb236" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2ea102be-1427-42c1-b4bf-4a0efe2bb236_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2ea102be-1427-42c1-b4bf-4a0efe2bb236" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2ea102be-1427-42c1-b4bf-4a0efe2bb236_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_81ea9a33-734a-47d1-936d-e097f5aca185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2ea102be-1427-42c1-b4bf-4a0efe2bb236" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_81ea9a33-734a-47d1-936d-e097f5aca185" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CurrentAssetsMember_9c937524-fd02-49d8-81e9-8e635fa88560" xlink:href="moh-20201231.xsd#moh_CurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_81ea9a33-734a-47d1-936d-e097f5aca185" xlink:to="loc_moh_CurrentAssetsMember_9c937524-fd02-49d8-81e9-8e635fa88560" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CurrentLiabilitiesMember_88acb63e-d281-4722-bf7a-141313cb5aa0" xlink:href="moh-20201231.xsd#moh_CurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_81ea9a33-734a-47d1-936d-e097f5aca185" xlink:to="loc_moh_CurrentLiabilitiesMember_88acb63e-d281-4722-bf7a-141313cb5aa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_36436f0b-1b9f-4f21-b902-6d5acc617e4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8259dc91-2852-4bbb-9634-ccdce4115cda" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_36436f0b-1b9f-4f21-b902-6d5acc617e4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_36436f0b-1b9f-4f21-b902-6d5acc617e4d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_36436f0b-1b9f-4f21-b902-6d5acc617e4d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_36436f0b-1b9f-4f21-b902-6d5acc617e4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f0043470-71b5-4c22-9de3-dbd14c6d14d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_36436f0b-1b9f-4f21-b902-6d5acc617e4d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f0043470-71b5-4c22-9de3-dbd14c6d14d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CallOptionDerivativeAssetMember_c8496426-3ac7-4e07-abde-0ce6c278f632" xlink:href="moh-20201231.xsd#moh_CallOptionDerivativeAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f0043470-71b5-4c22-9de3-dbd14c6d14d8" xlink:to="loc_moh_CallOptionDerivativeAssetMember_c8496426-3ac7-4e07-abde-0ce6c278f632" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_e38847f5-b6ab-45f0-9c10-765c17c33500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f0043470-71b5-4c22-9de3-dbd14c6d14d8" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_e38847f5-b6ab-45f0-9c10-765c17c33500" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails" xlink:type="extended" id="i135a9a0c0fb74eb696e591d5c43d60ae_FairValueMeasurementsLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a09e75e-8398-41e6-88a1-f2583d3c3ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_89356430-1766-4590-a0f8-d27b7cef1eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a09e75e-8398-41e6-88a1-f2583d3c3ec7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_89356430-1766-4590-a0f8-d27b7cef1eeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_72377263-de96-4bd9-ab9c-f1bbe7a1081c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a09e75e-8398-41e6-88a1-f2583d3c3ec7" xlink:to="loc_us-gaap_DebtInstrumentFairValue_72377263-de96-4bd9-ab9c-f1bbe7a1081c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a09e75e-8398-41e6-88a1-f2583d3c3ec7" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_aa1df200-a5ab-4d1d-9205-b34f0db3fef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_aa1df200-a5ab-4d1d-9205-b34f0db3fef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_aa1df200-a5ab-4d1d-9205-b34f0db3fef9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_aa1df200-a5ab-4d1d-9205-b34f0db3fef9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_aa1df200-a5ab-4d1d-9205-b34f0db3fef9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c1c212a1-f455-422b-b33d-b42ea3b605bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_aa1df200-a5ab-4d1d-9205-b34f0db3fef9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c1c212a1-f455-422b-b33d-b42ea3b605bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_15f434bd-0bc7-459a-b1fc-4a94c961fdf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c1c212a1-f455-422b-b33d-b42ea3b605bf" xlink:to="loc_us-gaap_SeniorNotesMember_15f434bd-0bc7-459a-b1fc-4a94c961fdf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_43879067-5bf2-4833-9afb-abdc4617c125" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c1c212a1-f455-422b-b33d-b42ea3b605bf" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_43879067-5bf2-4833-9afb-abdc4617c125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_21ddd982-438a-42dd-9773-3a1d8e57b0a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c1c212a1-f455-422b-b33d-b42ea3b605bf" xlink:to="loc_us-gaap_ConvertibleDebtMember_21ddd982-438a-42dd-9773-3a1d8e57b0a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ce3cfc16-c8a4-4360-9bb3-a4f5d1aa22f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:to="loc_us-gaap_DebtInstrumentAxis_ce3cfc16-c8a4-4360-9bb3-a4f5d1aa22f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ce3cfc16-c8a4-4360-9bb3-a4f5d1aa22f6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ce3cfc16-c8a4-4360-9bb3-a4f5d1aa22f6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ce3cfc16-c8a4-4360-9bb3-a4f5d1aa22f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ce3cfc16-c8a4-4360-9bb3-a4f5d1aa22f6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4375SeniorNotesMember_22421842-cb43-4a42-832c-846f46305ed3" xlink:href="moh-20201231.xsd#moh_A4375SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:to="loc_moh_A4375SeniorNotesMember_22421842-cb43-4a42-832c-846f46305ed3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SeniorNotesDue2022Member_3c06eb4e-0c66-4ace-9a95-4aa2b23f4401" xlink:href="moh-20201231.xsd#moh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:to="loc_moh_SeniorNotesDue2022Member_3c06eb4e-0c66-4ace-9a95-4aa2b23f4401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_eb35d226-0a05-403e-84da-8676d3d4b9c3" xlink:href="moh-20201231.xsd#moh_ThreePointEightSevenFivePercentSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:to="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_eb35d226-0a05-403e-84da-8676d3d4b9c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4.875SeniorNotesMember_fbbb58d4-5320-4cf8-837d-52958dee2ef2" xlink:href="moh-20201231.xsd#moh_A4.875SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:to="loc_moh_A4.875SeniorNotesMember_fbbb58d4-5320-4cf8-837d-52958dee2ef2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020Member_fc18c901-284e-44e4-acf8-7a0c023d8e97" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:to="loc_moh_CashConvertibleSeniorNotesDue2020Member_fc18c901-284e-44e4-acf8-7a0c023d8e97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_8885df2f-b7b3-47e4-b9d5-dc55858bf53a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_8885df2f-b7b3-47e4-b9d5-dc55858bf53a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8885df2f-b7b3-47e4-b9d5-dc55858bf53a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_8885df2f-b7b3-47e4-b9d5-dc55858bf53a" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8885df2f-b7b3-47e4-b9d5-dc55858bf53a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_871279e1-6bd1-404e-b643-cc3a9898a4bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_8885df2f-b7b3-47e4-b9d5-dc55858bf53a" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_871279e1-6bd1-404e-b643-cc3a9898a4bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5e95026d-cadd-4183-b4ea-46de038d52e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_871279e1-6bd1-404e-b643-cc3a9898a4bd" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5e95026d-cadd-4183-b4ea-46de038d52e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b4c5ebc7-56f3-4a80-a2b1-084236dfee43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_871279e1-6bd1-404e-b643-cc3a9898a4bd" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b4c5ebc7-56f3-4a80-a2b1-084236dfee43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_be7c57a9-bdaa-4b14-9842-a27a6d22f8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_871279e1-6bd1-404e-b643-cc3a9898a4bd" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_be7c57a9-bdaa-4b14-9842-a27a6d22f8fe" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Investments" xlink:type="simple" xlink:href="moh-20201231.xsd#Investments"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/Investments" xlink:type="extended" id="iecb4c176a71044ad8d37412c9bd7f896_Investments"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsTables" xlink:type="extended" id="i9735dc480a6d43a3bb462479b80b2510_InvestmentsTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsScheduleofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="extended" id="ie4df56272ea24f9db1aeae1b8d6deed5_InvestmentsScheduleofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_27ef43b5-5bd2-46bc-b814-4982f1bf4872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_27ef43b5-5bd2-46bc-b814-4982f1bf4872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a55fac8f-7b73-4c1f-a764-4435200072b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a55fac8f-7b73-4c1f-a764-4435200072b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4769aa8d-3076-4a3d-ada1-9a4444713a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4769aa8d-3076-4a3d-ada1-9a4444713a5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_43dbabe1-84e0-496f-a93e-c1de47aa60bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_43dbabe1-84e0-496f-a93e-c1de47aa60bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7def3f23-aa22-4baa-b986-a1b447eb7d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7def3f23-aa22-4baa-b986-a1b447eb7d6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8d994d1a-e4fc-4a07-ad59-16c95219f857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7def3f23-aa22-4baa-b986-a1b447eb7d6a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8d994d1a-e4fc-4a07-ad59-16c95219f857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8d994d1a-e4fc-4a07-ad59-16c95219f857_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8d994d1a-e4fc-4a07-ad59-16c95219f857" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8d994d1a-e4fc-4a07-ad59-16c95219f857_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8d994d1a-e4fc-4a07-ad59-16c95219f857" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_fb3fdf5a-f102-4f85-b35a-522b479682eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_fb3fdf5a-f102-4f85-b35a-522b479682eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_9ea980f7-10d7-435a-8a98-7f537212503e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_9ea980f7-10d7-435a-8a98-7f537212503e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MunicipalSecuritiesMember_58111610-cbea-4420-8e63-7fc1d93dc882" xlink:href="moh-20201231.xsd#moh_MunicipalSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_moh_MunicipalSecuritiesMember_58111610-cbea-4420-8e63-7fc1d93dc882" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_0cb2cb1c-e0da-4d62-8fef-2f4c146157d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_0cb2cb1c-e0da-4d62-8fef-2f4c146157d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember_5a544a0d-a501-4b1c-be1b-215cbde52ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_USTreasuryNotesSecuritiesMember_5a544a0d-a501-4b1c-be1b-215cbde52ed9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_c63c0a1e-3a27-48d6-aa70-54cea9728268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_c63c0a1e-3a27-48d6-aa70-54cea9728268" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_bebb2936-79f1-483a-90b2-258aec5b44e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_CertificatesOfDepositMember_bebb2936-79f1-483a-90b2-258aec5b44e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherSecuritiesMember_fa78aa4d-6c11-42cf-b0dc-741fb88b942c" xlink:href="moh-20201231.xsd#moh_OtherSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_moh_OtherSecuritiesMember_fa78aa4d-6c11-42cf-b0dc-741fb88b942c" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsContractualMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails" xlink:type="extended" id="iccb0ceb2ec85421b936a5a9dff7585b5_InvestmentsContractualMaturitiesDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="if9377397a5144e4b91d7b796358c9ef3_InvestmentsNarrativeDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsAvailableforSaleDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails" xlink:type="extended" id="i6cbb8c2f155c425799cc8d3356d5febe_InvestmentsAvailableforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9ea30497-2ea3-4b9b-8101-413173b06268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_e28db63a-2194-4b64-b311-03385fcdc460" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9ea30497-2ea3-4b9b-8101-413173b06268" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_e28db63a-2194-4b64-b311-03385fcdc460" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_dcc629f2-6092-4e49-b2f4-ddd79e452a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9ea30497-2ea3-4b9b-8101-413173b06268" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_dcc629f2-6092-4e49-b2f4-ddd79e452a50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_07ba094b-b6af-4b1d-92be-6a3050099a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9ea30497-2ea3-4b9b-8101-413173b06268" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_07ba094b-b6af-4b1d-92be-6a3050099a4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a44ff32d-8381-4c71-8350-c72199ac9522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9ea30497-2ea3-4b9b-8101-413173b06268" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a44ff32d-8381-4c71-8350-c72199ac9522" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_19dd259f-6793-4973-ae5a-6151ac3f4668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a44ff32d-8381-4c71-8350-c72199ac9522" xlink:to="loc_us-gaap_FinancialInstrumentAxis_19dd259f-6793-4973-ae5a-6151ac3f4668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_19dd259f-6793-4973-ae5a-6151ac3f4668_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_19dd259f-6793-4973-ae5a-6151ac3f4668" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_19dd259f-6793-4973-ae5a-6151ac3f4668_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92c3eb77-9e0b-4d78-b6bc-2a25486ef3bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_19dd259f-6793-4973-ae5a-6151ac3f4668" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92c3eb77-9e0b-4d78-b6bc-2a25486ef3bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_60f1231d-0943-491b-b95c-abe868c340c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92c3eb77-9e0b-4d78-b6bc-2a25486ef3bc" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_60f1231d-0943-491b-b95c-abe868c340c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_d72c640c-e547-451e-83c2-0366f1e71b0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92c3eb77-9e0b-4d78-b6bc-2a25486ef3bc" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_d72c640c-e547-451e-83c2-0366f1e71b0e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsBalancesofRestrictedInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails" xlink:type="extended" id="i20fd823669e149109410b7ae921801a6_InvestmentsBalancesofRestrictedInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_b5743582-4e1b-419f-ae7e-8f21b1e5f703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsNoncurrent_a81f290f-5b63-4340-8144-da6f45b44560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_b5743582-4e1b-419f-ae7e-8f21b1e5f703" xlink:to="loc_us-gaap_RestrictedInvestmentsNoncurrent_a81f290f-5b63-4340-8144-da6f45b44560" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_c302e10b-34ca-4730-9db9-8239519ac5bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_b5743582-4e1b-419f-ae7e-8f21b1e5f703" xlink:to="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_c302e10b-34ca-4730-9db9-8239519ac5bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_13345090-59b6-4750-86da-302f7a86d0c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_c302e10b-34ca-4730-9db9-8239519ac5bd" xlink:to="loc_srt_StatementGeographicalAxis_13345090-59b6-4750-86da-302f7a86d0c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_13345090-59b6-4750-86da-302f7a86d0c4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_13345090-59b6-4750-86da-302f7a86d0c4" xlink:to="loc_srt_SegmentGeographicalDomain_13345090-59b6-4750-86da-302f7a86d0c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_13345090-59b6-4750-86da-302f7a86d0c4" xlink:to="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_6038189c-0339-4382-a6ab-e279fcb6f887" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:to="loc_stpr_FL_6038189c-0339-4382-a6ab-e279fcb6f887" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_7da7aaef-f1bf-44af-999f-ae529a2487b2" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NM"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:to="loc_stpr_NM_7da7aaef-f1bf-44af-999f-ae529a2487b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_4874ad88-4b8c-4e5b-ac19-ece2dd44aa9b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:to="loc_stpr_NY_4874ad88-4b8c-4e5b-ac19-ece2dd44aa9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_b37753a0-163e-4938-aa21-5840fc7d32d7" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:to="loc_stpr_OH_b37753a0-163e-4938-aa21-5840fc7d32d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherGeographicalAreasMember_841752d6-55f9-4d3e-bf1b-5ccc7892dea9" xlink:href="moh-20201231.xsd#moh_OtherGeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:to="loc_moh_OtherGeographicalAreasMember_841752d6-55f9-4d3e-bf1b-5ccc7892dea9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_63aca4cd-ad86-4e29-81c9-3b3eea863af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_c302e10b-34ca-4730-9db9-8239519ac5bd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_63aca4cd-ad86-4e29-81c9-3b3eea863af6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_63aca4cd-ad86-4e29-81c9-3b3eea863af6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_63aca4cd-ad86-4e29-81c9-3b3eea863af6" xlink:to="loc_us-gaap_SegmentDomain_63aca4cd-ad86-4e29-81c9-3b3eea863af6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e4e0589d-6098-407f-900b-dcca755778ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_63aca4cd-ad86-4e29-81c9-3b3eea863af6" xlink:to="loc_us-gaap_SegmentDomain_e4e0589d-6098-407f-900b-dcca755778ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CompleteCareMember_7b0a1089-27cb-4ad1-b6d1-a900d99c8689" xlink:href="moh-20201231.xsd#moh_CompleteCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e4e0589d-6098-407f-900b-dcca755778ee" xlink:to="loc_moh_CompleteCareMember_7b0a1089-27cb-4ad1-b6d1-a900d99c8689" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNet"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet" xlink:type="extended" id="i31dec82c48404afe81436ff04f7d1483_PropertyEquipmentandCapitalizedSoftwareNet"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetTables" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetTables" xlink:type="extended" id="ia20a73e7d8cf48728c8fa434b5f54cf3_PropertyEquipmentandCapitalizedSoftwareNetTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails" xlink:type="extended" id="i6936c5526e3549c5b997d3eb5dab7846_PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7494c1d9-1b91-4c94-a45f-d7046550bf35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1385412d-f35c-4900-a083-f9565ab70cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7494c1d9-1b91-4c94-a45f-d7046550bf35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1385412d-f35c-4900-a083-f9565ab70cef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6a69ab4-df0e-49d4-a724-5de6e3292c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7494c1d9-1b91-4c94-a45f-d7046550bf35" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6a69ab4-df0e-49d4-a724-5de6e3292c6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_37b4767f-4861-4a6a-8ca2-64d1cfcc4f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6a69ab4-df0e-49d4-a724-5de6e3292c6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_37b4767f-4861-4a6a-8ca2-64d1cfcc4f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_37b4767f-4861-4a6a-8ca2-64d1cfcc4f97_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_37b4767f-4861-4a6a-8ca2-64d1cfcc4f97" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_37b4767f-4861-4a6a-8ca2-64d1cfcc4f97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_37b4767f-4861-4a6a-8ca2-64d1cfcc4f97" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_172e5bbd-0d21-4eaf-bb47-a1bb95ca23e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_172e5bbd-0d21-4eaf-bb47-a1bb95ca23e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_7218e1c9-f24f-40d3-8efb-7b11dca7d7ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_7218e1c9-f24f-40d3-8efb-7b11dca7d7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_ee835fdd-54ef-4a19-add4-bbf304e1ec14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_ee835fdd-54ef-4a19-add4-bbf304e1ec14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_f347e0d6-e595-4313-85e7-0cc9da4f9bec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_f347e0d6-e595-4313-85e7-0cc9da4f9bec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e8ad4727-d3ca-42bb-af5c-296504568601" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6a69ab4-df0e-49d4-a724-5de6e3292c6a" xlink:to="loc_srt_RangeAxis_e8ad4727-d3ca-42bb-af5c-296504568601" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e8ad4727-d3ca-42bb-af5c-296504568601_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e8ad4727-d3ca-42bb-af5c-296504568601" xlink:to="loc_srt_RangeMember_e8ad4727-d3ca-42bb-af5c-296504568601_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1be69557-46a5-4f1b-a0c2-a92e89c51ea9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e8ad4727-d3ca-42bb-af5c-296504568601" xlink:to="loc_srt_RangeMember_1be69557-46a5-4f1b-a0c2-a92e89c51ea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a75e8cfc-9366-474d-9a38-36e94c1f32dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1be69557-46a5-4f1b-a0c2-a92e89c51ea9" xlink:to="loc_srt_MinimumMember_a75e8cfc-9366-474d-9a38-36e94c1f32dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bb681bdc-1314-40ca-869e-c9ee5978b6bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1be69557-46a5-4f1b-a0c2-a92e89c51ea9" xlink:to="loc_srt_MaximumMember_bb681bdc-1314-40ca-869e-c9ee5978b6bb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails" xlink:type="extended" id="i90141b24c6d74530ab4b4d4f676fd47a_PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_3ea3c499-49f7-452d-acbe-efa707ca9f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_3ea3c499-49f7-452d-acbe-efa707ca9f07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_64dd7ff0-09fd-4433-bd05-fea839c987e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_64dd7ff0-09fd-4433-bd05-fea839c987e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_30fba1fc-9584-43ec-bdf7-9d8a6f1a526c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_30fba1fc-9584-43ec-bdf7-9d8a6f1a526c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_19989df0-f758-436d-875b-e8c4ad18dc07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_19989df0-f758-436d-875b-e8c4ad18dc07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_88b9bf7a-c1e6-481b-967e-359ed6834527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_88b9bf7a-c1e6-481b-967e-359ed6834527" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_404453f3-849c-46cb-8b02-854d24e1a7b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_404453f3-849c-46cb-8b02-854d24e1a7b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd4ce934-784b-43e3-8a91-7d4083b31e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd4ce934-784b-43e3-8a91-7d4083b31e4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_426d11fb-81f0-403e-b958-aab316fb4e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd4ce934-784b-43e3-8a91-7d4083b31e4b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_426d11fb-81f0-403e-b958-aab316fb4e67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_426d11fb-81f0-403e-b958-aab316fb4e67_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_426d11fb-81f0-403e-b958-aab316fb4e67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_426d11fb-81f0-403e-b958-aab316fb4e67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_426d11fb-81f0-403e-b958-aab316fb4e67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_d17bbd39-9956-4b16-8e53-b36bfa0e515e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_d17bbd39-9956-4b16-8e53-b36bfa0e515e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_aa85c2a6-ab23-47af-8e99-8ec0f8843710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_aa85c2a6-ab23-47af-8e99-8ec0f8843710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_32da2fa0-523e-4e02-ac22-2fe49ea1fba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_32da2fa0-523e-4e02-ac22-2fe49ea1fba4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_25f5d766-2c51-4747-9f11-bf9ba6da4c30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:to="loc_us-gaap_LandMember_25f5d766-2c51-4747-9f11-bf9ba6da4c30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_aa5881bd-13f9-4c42-a8c2-ef780d107d08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_aa5881bd-13f9-4c42-a8c2-ef780d107d08" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails" xlink:type="extended" id="ibfd8a2505e10495ba84c90444e321d0b_PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Leases" xlink:type="simple" xlink:href="moh-20201231.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/Leases" xlink:type="extended" id="iff8559c3e609411bbc7bdb902ef7ed18_Leases"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesTables" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/LeasesTables" xlink:type="extended" id="i8c78272834bc4bdd939766214b5e4c7a_LeasesTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i23bad84dea8b4570947382534f7f1fb7_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_c9a94010-8360-4f90-b3de-a03958f48870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_c9a94010-8360-4f90-b3de-a03958f48870" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7c57a1dc-3bb4-4518-84cb-368e3ad82837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7c57a1dc-3bb4-4518-84cb-368e3ad82837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1bca1dfc-8e21-482a-ba98-af6f18d24bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1bca1dfc-8e21-482a-ba98-af6f18d24bdd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_9b67c579-6da4-4744-8f3d-ae73b931ca89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_9b67c579-6da4-4744-8f3d-ae73b931ca89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_452b07d4-632f-4056-8e8b-86d233bd7a52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_452b07d4-632f-4056-8e8b-86d233bd7a52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_af5b4818-f8aa-4aaa-85ed-9104c0e0c1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_af5b4818-f8aa-4aaa-85ed-9104c0e0c1d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2bf4ce90-6d22-4360-a97f-66a58f90f9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2bf4ce90-6d22-4360-a97f-66a58f90f9ea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_d612c8ba-74eb-4d70-8f00-4644fb03b3db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_d612c8ba-74eb-4d70-8f00-4644fb03b3db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_4136974e-e388-41fe-b680-68570a40e9d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_OperatingLeaseExpense_4136974e-e388-41fe-b680-68570a40e9d3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_96c336bd-35b7-4af7-b0b1-ea02ee090ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_96c336bd-35b7-4af7-b0b1-ea02ee090ae4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_37c978d6-b31e-4cb7-b25a-4b4028f4fde3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_96c336bd-35b7-4af7-b0b1-ea02ee090ae4" xlink:to="loc_srt_RangeAxis_37c978d6-b31e-4cb7-b25a-4b4028f4fde3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37c978d6-b31e-4cb7-b25a-4b4028f4fde3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_37c978d6-b31e-4cb7-b25a-4b4028f4fde3" xlink:to="loc_srt_RangeMember_37c978d6-b31e-4cb7-b25a-4b4028f4fde3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_53868dca-8e33-4623-81da-91e5d287b42b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_37c978d6-b31e-4cb7-b25a-4b4028f4fde3" xlink:to="loc_srt_RangeMember_53868dca-8e33-4623-81da-91e5d287b42b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f37b0166-5c8e-4268-b051-b52219477089" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_53868dca-8e33-4623-81da-91e5d287b42b" xlink:to="loc_srt_MinimumMember_f37b0166-5c8e-4268-b051-b52219477089" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d8b8196e-2a15-405e-9214-967fc759538b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_53868dca-8e33-4623-81da-91e5d287b42b" xlink:to="loc_srt_MaximumMember_d8b8196e-2a15-405e-9214-967fc759538b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended" id="i2b64b3cee9e9431d9b31badec554a396_LeasesComponentsofLeaseExpenseDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesSupplementalCashFlowDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails" xlink:type="extended" id="ib4912a5671ab42d69ff0119bdd60f474_LeasesSupplementalCashFlowDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="iab1feb000c654e32a880dea3e638ba4c_LeasesSupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDescriptionAbstract_244f6770-6228-40fa-860c-c1f4b5e84592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_LesseeOperatingLeaseDescriptionAbstract_244f6770-6228-40fa-860c-c1f4b5e84592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OperatingLeaseAssetsLesseeAbstract_6a2a870a-d1eb-4325-86ae-bcdec382ab3f" xlink:href="moh-20201231.xsd#moh_OperatingLeaseAssetsLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeOperatingLeaseDescriptionAbstract_244f6770-6228-40fa-860c-c1f4b5e84592" xlink:to="loc_moh_OperatingLeaseAssetsLesseeAbstract_6a2a870a-d1eb-4325-86ae-bcdec382ab3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired_9750141d-24ee-428e-99f7-d0d6b09a01b5" xlink:href="moh-20201231.xsd#moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_OperatingLeaseAssetsLesseeAbstract_6a2a870a-d1eb-4325-86ae-bcdec382ab3f" xlink:to="loc_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired_9750141d-24ee-428e-99f7-d0d6b09a01b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_29e02e8a-32d2-4881-8b8e-37c6321e6d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_OperatingLeaseAssetsLesseeAbstract_6a2a870a-d1eb-4325-86ae-bcdec382ab3f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_29e02e8a-32d2-4881-8b8e-37c6321e6d7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract_ade2357b-30dd-4280-887d-f7670c168201" xlink:href="moh-20201231.xsd#moh_OperatingLeaseLiabilitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeOperatingLeaseDescriptionAbstract_244f6770-6228-40fa-860c-c1f4b5e84592" xlink:to="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract_ade2357b-30dd-4280-887d-f7670c168201" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f372b995-3dbd-474f-86e1-a686fc831e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract_ade2357b-30dd-4280-887d-f7670c168201" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f372b995-3dbd-474f-86e1-a686fc831e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_37c80846-6916-4700-bd95-01b9f63a3949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract_ade2357b-30dd-4280-887d-f7670c168201" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_37c80846-6916-4700-bd95-01b9f63a3949" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_dfd0ac2d-b163-4df3-9f4c-54c2ad791b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract_ade2357b-30dd-4280-887d-f7670c168201" xlink:to="loc_us-gaap_OperatingLeaseLiability_dfd0ac2d-b163-4df3-9f4c-54c2ad791b3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_12fa6fba-e0e0-4a34-9bb2-b6e7f0c0570b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_12fa6fba-e0e0-4a34-9bb2-b6e7f0c0570b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FinanceLeaseAssetsLesseeAbstract_df09eef6-42a3-48da-aa62-89584f2f2f2e" xlink:href="moh-20201231.xsd#moh_FinanceLeaseAssetsLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_12fa6fba-e0e0-4a34-9bb2-b6e7f0c0570b" xlink:to="loc_moh_FinanceLeaseAssetsLesseeAbstract_df09eef6-42a3-48da-aa62-89584f2f2f2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_3968cf58-8835-42ca-ac39-8a77768845ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_FinanceLeaseAssetsLesseeAbstract_df09eef6-42a3-48da-aa62-89584f2f2f2e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_3968cf58-8835-42ca-ac39-8a77768845ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract_0127f3d6-f3d6-4f7c-938e-12eae7734782" xlink:href="moh-20201231.xsd#moh_FinanceLeaseLiabilitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_12fa6fba-e0e0-4a34-9bb2-b6e7f0c0570b" xlink:to="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract_0127f3d6-f3d6-4f7c-938e-12eae7734782" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b8d3b0a7-8502-4dc5-9d89-c9f3b487b747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract_0127f3d6-f3d6-4f7c-938e-12eae7734782" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b8d3b0a7-8502-4dc5-9d89-c9f3b487b747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_11596150-f16c-4f08-b3ed-549438476b51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract_0127f3d6-f3d6-4f7c-938e-12eae7734782" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_11596150-f16c-4f08-b3ed-549438476b51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_41380381-5ef7-4b89-95cb-48ab0d5265a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract_0127f3d6-f3d6-4f7c-938e-12eae7734782" xlink:to="loc_us-gaap_FinanceLeaseLiability_41380381-5ef7-4b89-95cb-48ab0d5265a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f6f5c1f8-f9fa-4591-94fe-a7a502b93940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f6f5c1f8-f9fa-4591-94fe-a7a502b93940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b1be4c66-81f6-4ea5-bb23-4f2baeba4d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b1be4c66-81f6-4ea5-bb23-4f2baeba4d90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_e2b9d539-c523-4e16-bdcd-b9beedea3611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_e2b9d539-c523-4e16-bdcd-b9beedea3611" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d4866b52-86c4-44e9-841f-4e10ab040737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d4866b52-86c4-44e9-841f-4e10ab040737" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_065093cb-7adf-48da-a494-e0aa3aa91d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_065093cb-7adf-48da-a494-e0aa3aa91d95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d49bde85-8367-4be3-883a-e8b273b09928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_065093cb-7adf-48da-a494-e0aa3aa91d95" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d49bde85-8367-4be3-883a-e8b273b09928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d49bde85-8367-4be3-883a-e8b273b09928_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d49bde85-8367-4be3-883a-e8b273b09928" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d49bde85-8367-4be3-883a-e8b273b09928_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_337e6af6-a55b-40ce-be89-f5b0e6e94754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d49bde85-8367-4be3-883a-e8b273b09928" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_337e6af6-a55b-40ce-be89-f5b0e6e94754" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CompleteCareMember_abe45d99-992e-4a1d-8fb4-60848135af5b" xlink:href="moh-20201231.xsd#moh_CompleteCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_337e6af6-a55b-40ce-be89-f5b0e6e94754" xlink:to="loc_moh_CompleteCareMember_abe45d99-992e-4a1d-8fb4-60848135af5b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended" id="i17542861e03540579af212846bd383dc_LeasesLeaseMaturitiesDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended" id="ib2337163fa884fe4bd0c2f1d96cf26c7_GoodwillandIntangibleAssetsNet"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended" id="i5f221262f96b4b11ba3ce78b26994d59_GoodwillandIntangibleAssetsNetTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails" xlink:type="extended" id="i7c8efbafdf4b42e090859603e80881ca_GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d593375a-bcc1-4be8-acf1-452d4a77652e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d593375a-bcc1-4be8-acf1-452d4a77652e" xlink:to="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e7988137-cae2-4b67-834c-7d4aa115ce67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:to="loc_us-gaap_Goodwill_e7988137-cae2-4b67-834c-7d4aa115ce67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_c7111fd1-c896-4ed4-b23d-e0066d4f81e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_c7111fd1-c896-4ed4-b23d-e0066d4f81e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_f3689f17-9aca-4da5-acb1-b42966d5aa94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_f3689f17-9aca-4da5-acb1-b42966d5aa94" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_730ae707-7db7-4f7a-997a-1d06d752a67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_730ae707-7db7-4f7a-997a-1d06d752a67b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b4f2b930-0a2e-4ade-ad73-f55d1e3b5bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_6a777d11-8698-434d-a82b-c8ac623a4dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_d593375a-bcc1-4be8-acf1-452d4a77652e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_6a777d11-8698-434d-a82b-c8ac623a4dc0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0fd975e0-24fc-40ea-b590-d53d1c37d79d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6a777d11-8698-434d-a82b-c8ac623a4dc0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0fd975e0-24fc-40ea-b590-d53d1c37d79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0fd975e0-24fc-40ea-b590-d53d1c37d79d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fd975e0-24fc-40ea-b590-d53d1c37d79d" xlink:to="loc_us-gaap_SegmentDomain_0fd975e0-24fc-40ea-b590-d53d1c37d79d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0f56483b-21c2-4bab-be60-62368e85b0ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fd975e0-24fc-40ea-b590-d53d1c37d79d" xlink:to="loc_us-gaap_SegmentDomain_0f56483b-21c2-4bab-be60-62368e85b0ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_39ffd4b8-9284-4bb0-85b6-57fecfeb7272" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0f56483b-21c2-4bab-be60-62368e85b0ec" xlink:to="loc_moh_HealthPlansMember_39ffd4b8-9284-4bb0-85b6-57fecfeb7272" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails" xlink:type="extended" id="ifeeba44570294160988ec355ec370e05_GoodwillandIntangibleAssetsNetAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f1fd0eb-0dcf-4434-be03-ba5c776d8f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_69fbf791-982a-4a7e-a809-8966a1d6b635" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f1fd0eb-0dcf-4434-be03-ba5c776d8f59" xlink:to="loc_us-gaap_GoodwillGross_69fbf791-982a-4a7e-a809-8966a1d6b635" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_3003d8d8-13b4-434f-9cbb-51a3e9309117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f1fd0eb-0dcf-4434-be03-ba5c776d8f59" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_3003d8d8-13b4-434f-9cbb-51a3e9309117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f1fd0eb-0dcf-4434-be03-ba5c776d8f59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1d37775b-626f-42ff-b738-b0c1f55dd8ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1d37775b-626f-42ff-b738-b0c1f55dd8ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ee44f264-6fd7-48c8-aead-c8c28d861b01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ee44f264-6fd7-48c8-aead-c8c28d861b01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d5c5fab8-0f69-43d0-8199-8b4a0938dd9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d5c5fab8-0f69-43d0-8199-8b4a0938dd9e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_486d277b-e8fe-4707-a051-7fb89a2fe7fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_486d277b-e8fe-4707-a051-7fb89a2fe7fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7a13fb4c-c071-4568-908f-de62033153c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7a13fb4c-c071-4568-908f-de62033153c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586c8891-c9ab-4d91-bff9-f437e29863c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f1fd0eb-0dcf-4434-be03-ba5c776d8f59" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586c8891-c9ab-4d91-bff9-f437e29863c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e0653403-d3d1-4d5e-bda8-ea5015353d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586c8891-c9ab-4d91-bff9-f437e29863c3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e0653403-d3d1-4d5e-bda8-ea5015353d4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e0653403-d3d1-4d5e-bda8-ea5015353d4c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e0653403-d3d1-4d5e-bda8-ea5015353d4c" xlink:to="loc_us-gaap_SegmentDomain_e0653403-d3d1-4d5e-bda8-ea5015353d4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f65d5975-734e-46cd-ae76-d722a97cdf66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e0653403-d3d1-4d5e-bda8-ea5015353d4c" xlink:to="loc_us-gaap_SegmentDomain_f65d5975-734e-46cd-ae76-d722a97cdf66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_56f9c2e2-e276-4f9c-8441-5e0a5dd214d6" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f65d5975-734e-46cd-ae76-d722a97cdf66" xlink:to="loc_moh_HealthPlansMember_56f9c2e2-e276-4f9c-8441-5e0a5dd214d6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails" xlink:type="extended" id="ia6be846e1a1f4e13a5060e898a64e18b_GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f8fec3c-5745-45e3-9b0e-be95fec1e48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d496eaba-24db-4950-a058-7d8581976bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f8fec3c-5745-45e3-9b0e-be95fec1e48e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d496eaba-24db-4950-a058-7d8581976bb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_af3d9404-c9be-4ab0-a5f5-42fe6044da0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f8fec3c-5745-45e3-9b0e-be95fec1e48e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_af3d9404-c9be-4ab0-a5f5-42fe6044da0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_24ca5f47-d02f-4b3f-9872-69622704d7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f8fec3c-5745-45e3-9b0e-be95fec1e48e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_24ca5f47-d02f-4b3f-9872-69622704d7c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_28cacee6-32c5-478d-8030-fbaae6564cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f8fec3c-5745-45e3-9b0e-be95fec1e48e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_28cacee6-32c5-478d-8030-fbaae6564cb0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c233ecc-6ea2-45a4-a067-37c828ce0c26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_28cacee6-32c5-478d-8030-fbaae6564cb0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c233ecc-6ea2-45a4-a067-37c828ce0c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c233ecc-6ea2-45a4-a067-37c828ce0c26_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c233ecc-6ea2-45a4-a067-37c828ce0c26" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c233ecc-6ea2-45a4-a067-37c828ce0c26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7de91d0a-a2b8-4e90-b40c-cc9624398410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c233ecc-6ea2-45a4-a067-37c828ce0c26" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7de91d0a-a2b8-4e90-b40c-cc9624398410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ContractRightsandLicensingAgreementsMember_225c6225-45f7-47ac-a1e5-18e1fd5d7261" xlink:href="moh-20201231.xsd#moh_ContractRightsandLicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7de91d0a-a2b8-4e90-b40c-cc9624398410" xlink:to="loc_moh_ContractRightsandLicensingAgreementsMember_225c6225-45f7-47ac-a1e5-18e1fd5d7261" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ProviderNetworksMember_41724138-7f48-47cd-9880-e0ce4b28bb82" xlink:href="moh-20201231.xsd#moh_ProviderNetworksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7de91d0a-a2b8-4e90-b40c-cc9624398410" xlink:to="loc_moh_ProviderNetworksMember_41724138-7f48-47cd-9880-e0ce4b28bb82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_de02d445-17d1-419d-b4af-947b0e9a6d5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7de91d0a-a2b8-4e90-b40c-cc9624398410" xlink:to="loc_us-gaap_TradeNamesMember_de02d445-17d1-419d-b4af-947b0e9a6d5a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayable"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable" xlink:type="extended" id="i5b457595c7074577888bfadd0a14e924_MedicalClaimsandBenefitsPayable"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables" xlink:type="extended" id="i36e9631e64804d328b9dc37e58bcd8c7_MedicalClaimsandBenefitsPayableTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails" xlink:type="extended" id="i75121db82935482dabbbb81fee5628b5_MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount_35e68704-762d-492f-b996-a62068d0b258" xlink:href="moh-20201231.xsd#moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount_35e68704-762d-492f-b996-a62068d0b258" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PharmacyClaimsPayable_55145663-0f16-4bd3-b3cd-9eb48fa2e04a" xlink:href="moh-20201231.xsd#moh_PharmacyClaimsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_moh_PharmacyClaimsPayable_55145663-0f16-4bd3-b3cd-9eb48fa2e04a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CapitationClaimsPayable_491d4d52-5886-47f6-b9cc-66c9820f5d55" xlink:href="moh-20201231.xsd#moh_CapitationClaimsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_moh_CapitationClaimsPayable_491d4d52-5886-47f6-b9cc-66c9820f5d55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherClaimsPayable_7f74010a-1b79-4d76-969f-2c1855e4b2c3" xlink:href="moh-20201231.xsd#moh_OtherClaimsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_moh_OtherClaimsPayable_7f74010a-1b79-4d76-969f-2c1855e4b2c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_830b6755-cbd2-4a7b-8e5c-b7118d46d86c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_830b6755-cbd2-4a7b-8e5c-b7118d46d86c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9059082b-4d5d-4261-b0aa-8d29118e868f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9059082b-4d5d-4261-b0aa-8d29118e868f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2733baf4-d533-4b14-8f06-8d7896df37b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9059082b-4d5d-4261-b0aa-8d29118e868f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2733baf4-d533-4b14-8f06-8d7896df37b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2733baf4-d533-4b14-8f06-8d7896df37b9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2733baf4-d533-4b14-8f06-8d7896df37b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2733baf4-d533-4b14-8f06-8d7896df37b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dd3c03a8-ae7c-4660-ad1b-3f96ed842ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2733baf4-d533-4b14-8f06-8d7896df37b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dd3c03a8-ae7c-4660-ad1b-3f96ed842ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CompleteCareMember_26631b83-e922-4f7a-bde1-a0e2e8fc1ea5" xlink:href="moh-20201231.xsd#moh_CompleteCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dd3c03a8-ae7c-4660-ad1b-3f96ed842ef5" xlink:to="loc_moh_CompleteCareMember_26631b83-e922-4f7a-bde1-a0e2e8fc1ea5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails" xlink:type="extended" id="icd81b690da03457cb92147305e9339bd_MedicalClaimsandBenefitsPayableAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_33a2edd3-9e2e-4e81-b1a4-7ffd90e1fbe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_66647922-acd9-42da-8394-5233ef5d9f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_33a2edd3-9e2e-4e81-b1a4-7ffd90e1fbe3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_66647922-acd9-42da-8394-5233ef5d9f44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_ddf5ce4e-4620-4339-8887-914a64e5bca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_33a2edd3-9e2e-4e81-b1a4-7ffd90e1fbe3" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_ddf5ce4e-4620-4339-8887-914a64e5bca9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_1e63e599-2b60-47cd-af8b-35203098bab9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_ddf5ce4e-4620-4339-8887-914a64e5bca9" xlink:to="loc_srt_MajorCustomersAxis_1e63e599-2b60-47cd-af8b-35203098bab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_1e63e599-2b60-47cd-af8b-35203098bab9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_1e63e599-2b60-47cd-af8b-35203098bab9" xlink:to="loc_srt_NameOfMajorCustomerDomain_1e63e599-2b60-47cd-af8b-35203098bab9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a4bf6725-8790-417d-87f8-1367be8b5503" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_1e63e599-2b60-47cd-af8b-35203098bab9" xlink:to="loc_srt_NameOfMajorCustomerDomain_a4bf6725-8790-417d-87f8-1367be8b5503" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CMSSubsidiesMember_27e4686b-43cc-4042-8f06-a27ef466051e" xlink:href="moh-20201231.xsd#moh_CMSSubsidiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a4bf6725-8790-417d-87f8-1367be8b5503" xlink:to="loc_moh_CMSSubsidiesMember_27e4686b-43cc-4042-8f06-a27ef466051e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails" xlink:type="extended" id="i768f85cc45c74c32a84e379b13e607f1_MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_28c76bf6-a7c7-4fa7-9cc4-d47bae10aaac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_d338e8f0-61ac-4095-84e1-0b605829bc0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_28c76bf6-a7c7-4fa7-9cc4-d47bae10aaac" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_d338e8f0-61ac-4095-84e1-0b605829bc0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_28529a00-0586-455b-9801-28743ccddaa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_28c76bf6-a7c7-4fa7-9cc4-d47bae10aaac" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_28529a00-0586-455b-9801-28743ccddaa3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_402d8aa7-dbb9-4913-b226-a62811952b85" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_28529a00-0586-455b-9801-28743ccddaa3" xlink:to="loc_srt_MajorCustomersAxis_402d8aa7-dbb9-4913-b226-a62811952b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_402d8aa7-dbb9-4913-b226-a62811952b85_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_402d8aa7-dbb9-4913-b226-a62811952b85" xlink:to="loc_srt_NameOfMajorCustomerDomain_402d8aa7-dbb9-4913-b226-a62811952b85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_28d3f01a-0349-476c-bd7c-a88fb8aa34e8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_402d8aa7-dbb9-4913-b226-a62811952b85" xlink:to="loc_srt_NameOfMajorCustomerDomain_28d3f01a-0349-476c-bd7c-a88fb8aa34e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CMSSubsidiesMember_edb001b6-d6e2-4a4b-a92a-edac01305b8a" xlink:href="moh-20201231.xsd#moh_CMSSubsidiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_28d3f01a-0349-476c-bd7c-a88fb8aa34e8" xlink:to="loc_moh_CMSSubsidiesMember_edb001b6-d6e2-4a4b-a92a-edac01305b8a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails" xlink:type="extended" id="ic6ad80c11fbc434abd430f85b6717214_MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_24662f7f-4e8a-49c7-8b9f-91c06a0d0603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_24662f7f-4e8a-49c7-8b9f-91c06a0d0603" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment_5597cd3b-f777-4336-b8fb-7a875c475cf3" xlink:href="moh-20201231.xsd#moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:to="loc_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment_5597cd3b-f777-4336-b8fb-7a875c475cf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_42c28a9f-d550-454e-ac56-7685163a1afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_42c28a9f-d550-454e-ac56-7685163a1afc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_c58fffdd-69db-42d6-9976-d3c3700b7a52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_c58fffdd-69db-42d6-9976-d3c3700b7a52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_f084fd32-3e6d-45d3-a1f9-8ce11cfbe654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_f084fd32-3e6d-45d3-a1f9-8ce11cfbe654" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6175d126-027a-4c94-80f1-9585a5fae770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_f084fd32-3e6d-45d3-a1f9-8ce11cfbe654" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6175d126-027a-4c94-80f1-9585a5fae770" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_6175d126-027a-4c94-80f1-9585a5fae770_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6175d126-027a-4c94-80f1-9585a5fae770" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_6175d126-027a-4c94-80f1-9585a5fae770_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ed4a8f2c-f4a3-4890-ad99-97e9fbe12965" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6175d126-027a-4c94-80f1-9585a5fae770" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ed4a8f2c-f4a3-4890-ad99-97e9fbe12965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_fff70df0-52be-4868-ae2f-eac704d79065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ed4a8f2c-f4a3-4890-ad99-97e9fbe12965" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_fff70df0-52be-4868-ae2f-eac704d79065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_a31131fb-07b1-4e65-b47e-d3e7d0ca4d36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ed4a8f2c-f4a3-4890-ad99-97e9fbe12965" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_a31131fb-07b1-4e65-b47e-d3e7d0ca4d36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_2eea9091-db07-4c56-9485-fa2fd1ad7330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ed4a8f2c-f4a3-4890-ad99-97e9fbe12965" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_2eea9091-db07-4c56-9485-fa2fd1ad7330" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails" xlink:type="extended" id="i5572cd2fceb74afb9d45d5bbdbf3256d_MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_dbcb8922-bf0f-460b-9db9-522047755470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_1a64e1fb-9edd-43e7-a0b6-cec0526acc68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_dbcb8922-bf0f-460b-9db9-522047755470" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_1a64e1fb-9edd-43e7-a0b6-cec0526acc68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_cc14fc4d-ee37-4935-b0ac-7a83b04cf296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_dbcb8922-bf0f-460b-9db9-522047755470" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_cc14fc4d-ee37-4935-b0ac-7a83b04cf296" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_bc88e317-da9e-4f79-a703-9310dc80aff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_cc14fc4d-ee37-4935-b0ac-7a83b04cf296" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_bc88e317-da9e-4f79-a703-9310dc80aff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_bc88e317-da9e-4f79-a703-9310dc80aff7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_bc88e317-da9e-4f79-a703-9310dc80aff7" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_bc88e317-da9e-4f79-a703-9310dc80aff7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_452adfcc-f7ea-4401-bc88-38c3ffabb605" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_bc88e317-da9e-4f79-a703-9310dc80aff7" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_452adfcc-f7ea-4401-bc88-38c3ffabb605" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_1923e4d3-9f77-4335-8cb1-7564670d9931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_452adfcc-f7ea-4401-bc88-38c3ffabb605" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_1923e4d3-9f77-4335-8cb1-7564670d9931" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_3c4bd5ea-1f84-455f-9c7b-3c7951d5afd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_452adfcc-f7ea-4401-bc88-38c3ffabb605" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_3c4bd5ea-1f84-455f-9c7b-3c7951d5afd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_9343a54a-37e8-429b-9381-321bb2e28349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_452adfcc-f7ea-4401-bc88-38c3ffabb605" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_9343a54a-37e8-429b-9381-321bb2e28349" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails" xlink:type="extended" id="ifd6fcebacc73420a8bb455841efbf38d_MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Debt" xlink:type="simple" xlink:href="moh-20201231.xsd#Debt"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/Debt" xlink:type="extended" id="i57eb288feecc4a42bc96d2d491c7cae7_Debt"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtTables" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/DebtTables" xlink:type="extended" id="i17c0a8b01cef4b3286b6b458964e7956_DebtTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtMaturitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/DebtMaturitiesDetails" xlink:type="extended" id="i62e4a20f4bdb49e181b9a90a934d2e8d_DebtMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_80afccbb-75ff-4147-903b-297a499f81e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_80afccbb-75ff-4147-903b-297a499f81e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9bcddd0d-2667-45ce-baf6-2108e6d4e605" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_9bcddd0d-2667-45ce-baf6-2108e6d4e605" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e051f20d-ad43-483b-8b91-ddf54b1ecb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e051f20d-ad43-483b-8b91-ddf54b1ecb04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6707a7bd-9b00-445f-ae67-00f7c9aa24bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6707a7bd-9b00-445f-ae67-00f7c9aa24bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9d817e75-09f3-4a39-bb4c-9e94a2c22610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9d817e75-09f3-4a39-bb4c-9e94a2c22610" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7cbb3c0c-0d76-4f12-865b-16650af5b081" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7cbb3c0c-0d76-4f12-865b-16650af5b081" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_d5630b50-b8a7-4741-ba74-d1f64b4fe9be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_d5630b50-b8a7-4741-ba74-d1f64b4fe9be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_dfb03269-914e-4c48-a99c-460404741b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_dfb03269-914e-4c48-a99c-460404741b84" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fdd269d0-b71f-4972-ba7c-75203ee71990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_DebtInstrumentTable_fdd269d0-b71f-4972-ba7c-75203ee71990" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_40132b27-b785-4c72-a29b-00fe7235f0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fdd269d0-b71f-4972-ba7c-75203ee71990" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_40132b27-b785-4c72-a29b-00fe7235f0b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_40132b27-b785-4c72-a29b-00fe7235f0b7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_40132b27-b785-4c72-a29b-00fe7235f0b7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_40132b27-b785-4c72-a29b-00fe7235f0b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_059c03e8-fd0d-47c9-b6c4-122de1e4df02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_40132b27-b785-4c72-a29b-00fe7235f0b7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_059c03e8-fd0d-47c9-b6c4-122de1e4df02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_5fd1fded-28a3-4c02-96b7-2eeb88ec7771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_059c03e8-fd0d-47c9-b6c4-122de1e4df02" xlink:to="loc_us-gaap_SeniorNotesMember_5fd1fded-28a3-4c02-96b7-2eeb88ec7771" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f81507f0-5ccd-4b84-98fe-788176afe493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fdd269d0-b71f-4972-ba7c-75203ee71990" xlink:to="loc_us-gaap_DebtInstrumentAxis_f81507f0-5ccd-4b84-98fe-788176afe493" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f81507f0-5ccd-4b84-98fe-788176afe493_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f81507f0-5ccd-4b84-98fe-788176afe493" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f81507f0-5ccd-4b84-98fe-788176afe493_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_89cae545-9653-4a0a-aa51-51beb767fd1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f81507f0-5ccd-4b84-98fe-788176afe493" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_89cae545-9653-4a0a-aa51-51beb767fd1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4375SeniorNotesMember_898f9982-a075-4751-b590-75bbdda0c5a5" xlink:href="moh-20201231.xsd#moh_A4375SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_89cae545-9653-4a0a-aa51-51beb767fd1b" xlink:to="loc_moh_A4375SeniorNotesMember_898f9982-a075-4751-b590-75bbdda0c5a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SeniorNotesDue2022Member_26cd68f8-74f8-4e6a-81b4-f8ac44118a10" xlink:href="moh-20201231.xsd#moh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_89cae545-9653-4a0a-aa51-51beb767fd1b" xlink:to="loc_moh_SeniorNotesDue2022Member_26cd68f8-74f8-4e6a-81b4-f8ac44118a10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_da6f7ea8-8c36-473f-a614-e07f22d15859" xlink:href="moh-20201231.xsd#moh_ThreePointEightSevenFivePercentSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_89cae545-9653-4a0a-aa51-51beb767fd1b" xlink:to="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_da6f7ea8-8c36-473f-a614-e07f22d15859" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails" xlink:type="extended" id="i9e5499ec172a43c7b2dc89ec5351a31f_DebtScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_38a10b9a-491d-471f-9466-6bdc76ad5f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_38a10b9a-491d-471f-9466-6bdc76ad5f05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_ce2d3d76-206f-403b-93e3-7710ce8d1a9b" xlink:href="moh-20201231.xsd#moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_ce2d3d76-206f-403b-93e3-7710ce8d1a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5942c323-1416-4d93-8bd8-f8bc8609ca40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_us-gaap_LongTermDebtCurrent_5942c323-1416-4d93-8bd8-f8bc8609ca40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount_00ca4983-0397-4e50-b885-c224f28c89e2" xlink:href="moh-20201231.xsd#moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount_00ca4983-0397-4e50-b885-c224f28c89e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_53ac49bd-1d7e-405c-94ea-b4c69722b091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_53ac49bd-1d7e-405c-94ea-b4c69722b091" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ca8a2374-4412-4d56-b168-3cc84a9d56bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ca8a2374-4412-4d56-b168-3cc84a9d56bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ab45f21d-6b74-4141-bf83-47e3f3c3de71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_us-gaap_DebtInstrumentTable_ab45f21d-6b74-4141-bf83-47e3f3c3de71" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ee327ff3-d243-4d7c-85cb-e357c4bee863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ab45f21d-6b74-4141-bf83-47e3f3c3de71" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ee327ff3-d243-4d7c-85cb-e357c4bee863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ee327ff3-d243-4d7c-85cb-e357c4bee863_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ee327ff3-d243-4d7c-85cb-e357c4bee863" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ee327ff3-d243-4d7c-85cb-e357c4bee863_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6cdb14e5-b116-4bbf-9ca0-7e8f81e62fd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ee327ff3-d243-4d7c-85cb-e357c4bee863" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6cdb14e5-b116-4bbf-9ca0-7e8f81e62fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_27b279ea-6aee-4e33-b632-057512c3187c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6cdb14e5-b116-4bbf-9ca0-7e8f81e62fd4" xlink:to="loc_us-gaap_ConvertibleDebtMember_27b279ea-6aee-4e33-b632-057512c3187c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_88d5469c-e489-4b8e-94de-c39e202f6b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6cdb14e5-b116-4bbf-9ca0-7e8f81e62fd4" xlink:to="loc_us-gaap_LineOfCreditMember_88d5469c-e489-4b8e-94de-c39e202f6b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_fef3a251-b276-4c0d-8a01-f14a14ffcebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6cdb14e5-b116-4bbf-9ca0-7e8f81e62fd4" xlink:to="loc_us-gaap_SeniorNotesMember_fef3a251-b276-4c0d-8a01-f14a14ffcebf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9fbe00f2-68a4-4cf9-9d56-d146e3f00235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ab45f21d-6b74-4141-bf83-47e3f3c3de71" xlink:to="loc_us-gaap_DebtInstrumentAxis_9fbe00f2-68a4-4cf9-9d56-d146e3f00235" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9fbe00f2-68a4-4cf9-9d56-d146e3f00235_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9fbe00f2-68a4-4cf9-9d56-d146e3f00235" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9fbe00f2-68a4-4cf9-9d56-d146e3f00235_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9fbe00f2-68a4-4cf9-9d56-d146e3f00235" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020Member_3d61b8e0-ccc2-4a6c-95db-bf564fac4c51" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_CashConvertibleSeniorNotesDue2020Member_3d61b8e0-ccc2-4a6c-95db-bf564fac4c51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_TermLoanMember_a78a5091-ae70-4218-9ea9-48ae5fcb6eec" xlink:href="moh-20201231.xsd#moh_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_TermLoanMember_a78a5091-ae70-4218-9ea9-48ae5fcb6eec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4375SeniorNotesMember_547f0cff-a065-40f3-b6f8-9348e6d5aa98" xlink:href="moh-20201231.xsd#moh_A4375SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_A4375SeniorNotesMember_547f0cff-a065-40f3-b6f8-9348e6d5aa98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SeniorNotesDue2022Member_cf72b26c-6b56-4b1c-aeb3-42be52fadffb" xlink:href="moh-20201231.xsd#moh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_SeniorNotesDue2022Member_cf72b26c-6b56-4b1c-aeb3-42be52fadffb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_1cc063db-8897-4e20-a641-e92286de8ac7" xlink:href="moh-20201231.xsd#moh_ThreePointEightSevenFivePercentSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_1cc063db-8897-4e20-a641-e92286de8ac7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4.875SeniorNotesMember_983957ba-4032-426f-b516-93fd1bb3a752" xlink:href="moh-20201231.xsd#moh_A4.875SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_A4.875SeniorNotesMember_983957ba-4032-426f-b516-93fd1bb3a752" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtCreditAgreementDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/DebtCreditAgreementDetails" xlink:type="extended" id="i65f1ce8cd85b4a068d150a64e6b3d4b9_DebtCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f64f1965-9128-46d5-8ab0-6990b93f8d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f64f1965-9128-46d5-8ab0-6990b93f8d5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4e1a3dfb-65cb-460a-afce-acf2f0c7dc17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4e1a3dfb-65cb-460a-afce-acf2f0c7dc17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ConsolidatedNetLeverage_086b5e03-5a48-4bd4-b36f-299a17b60697" xlink:href="moh-20201231.xsd#moh_ConsolidatedNetLeverage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_moh_ConsolidatedNetLeverage_086b5e03-5a48-4bd4-b36f-299a17b60697" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_d30668c7-5b46-4d1f-97de-9e6e608d9fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_us-gaap_DebtInstrumentTerm_d30668c7-5b46-4d1f-97de-9e6e608d9fea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b9f6c64b-3336-4b26-b8cc-9ec8308f2de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_us-gaap_LineOfCredit_b9f6c64b-3336-4b26-b8cc-9ec8308f2de0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_464dba79-f18a-4ea6-87e0-76a9e7df2540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_464dba79-f18a-4ea6-87e0-76a9e7df2540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_464dba79-f18a-4ea6-87e0-76a9e7df2540_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_464dba79-f18a-4ea6-87e0-76a9e7df2540" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_464dba79-f18a-4ea6-87e0-76a9e7df2540_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0298dc94-9cf5-4f66-a26a-14e1c7cc8543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_464dba79-f18a-4ea6-87e0-76a9e7df2540" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0298dc94-9cf5-4f66-a26a-14e1c7cc8543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_46000865-ae28-4940-94da-5b68fb09a1b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0298dc94-9cf5-4f66-a26a-14e1c7cc8543" xlink:to="loc_us-gaap_LineOfCreditMember_46000865-ae28-4940-94da-5b68fb09a1b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_601a3f7e-3c0a-4ce6-8540-3c28e039005d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:to="loc_us-gaap_CreditFacilityAxis_601a3f7e-3c0a-4ce6-8540-3c28e039005d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_601a3f7e-3c0a-4ce6-8540-3c28e039005d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_601a3f7e-3c0a-4ce6-8540-3c28e039005d" xlink:to="loc_us-gaap_CreditFacilityDomain_601a3f7e-3c0a-4ce6-8540-3c28e039005d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5048223c-e577-4693-abf5-494c6c0d2cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_601a3f7e-3c0a-4ce6-8540-3c28e039005d" xlink:to="loc_us-gaap_CreditFacilityDomain_5048223c-e577-4693-abf5-494c6c0d2cf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_878ec2ae-f264-4bcb-952c-01708d2aed96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5048223c-e577-4693-abf5-494c6c0d2cf4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_878ec2ae-f264-4bcb-952c-01708d2aed96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SwinglineSubFacilityMember_a16e974d-32e2-4a3f-be9c-669cc6b74c8c" xlink:href="moh-20201231.xsd#moh_SwinglineSubFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5048223c-e577-4693-abf5-494c6c0d2cf4" xlink:to="loc_moh_SwinglineSubFacilityMember_a16e974d-32e2-4a3f-be9c-669cc6b74c8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LetterOfCreditSubFacilityMember_da4fa43a-9d01-4cbf-8601-b4913efca982" xlink:href="moh-20201231.xsd#moh_LetterOfCreditSubFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5048223c-e577-4693-abf5-494c6c0d2cf4" xlink:to="loc_moh_LetterOfCreditSubFacilityMember_da4fa43a-9d01-4cbf-8601-b4913efca982" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4352d2e8-8c37-4025-a885-e050b20dbc4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:to="loc_us-gaap_DebtInstrumentAxis_4352d2e8-8c37-4025-a885-e050b20dbc4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4352d2e8-8c37-4025-a885-e050b20dbc4c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4352d2e8-8c37-4025-a885-e050b20dbc4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4352d2e8-8c37-4025-a885-e050b20dbc4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b5d69841-e081-4c35-b230-9fb9563491ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4352d2e8-8c37-4025-a885-e050b20dbc4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b5d69841-e081-4c35-b230-9fb9563491ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncrementalTermLoanMember_ed30411b-4e26-4c77-81fd-44f648e00157" xlink:href="moh-20201231.xsd#moh_IncrementalTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b5d69841-e081-4c35-b230-9fb9563491ec" xlink:to="loc_moh_IncrementalTermLoanMember_ed30411b-4e26-4c77-81fd-44f648e00157" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtSeniorNotesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/DebtSeniorNotesDetails" xlink:type="extended" id="ie44cde33040e4952bb195e604426c137_DebtSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ed1cacaa-07a5-4408-b62a-18fbfcc123ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ed1cacaa-07a5-4408-b62a-18fbfcc123ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2d5ce594-1086-42c1-bdc9-6c115645e2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2d5ce594-1086-42c1-bdc9-6c115645e2cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_8914373e-162d-46bb-a25a-c996a7e893c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_8914373e-162d-46bb-a25a-c996a7e893c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7792b6ed-8f72-4778-9bcc-c2c271133430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7792b6ed-8f72-4778-9bcc-c2c271133430" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_455d47d5-d709-493b-9f68-dc7de53908f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_455d47d5-d709-493b-9f68-dc7de53908f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RedemptionPremiumSettledPercentage_c546df51-2e6e-42ad-ab67-f0867b8ceff4" xlink:href="moh-20201231.xsd#moh_RedemptionPremiumSettledPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_moh_RedemptionPremiumSettledPercentage_c546df51-2e6e-42ad-ab67-f0867b8ceff4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositLiabilitiesAccruedInterest_cbb857c1-a67d-4cf9-a1c1-15c70e6b38c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DepositLiabilitiesAccruedInterest_cbb857c1-a67d-4cf9-a1c1-15c70e6b38c4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_e20fd350-c5ab-4508-9359-0fb7a0deac57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_e20fd350-c5ab-4508-9359-0fb7a0deac57" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_32c6e47f-37af-4d99-8746-1eae6cc04628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DebtInstrumentTable_32c6e47f-37af-4d99-8746-1eae6cc04628" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_130e30c7-8031-4701-a138-b9cc289e7f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_32c6e47f-37af-4d99-8746-1eae6cc04628" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_130e30c7-8031-4701-a138-b9cc289e7f62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_130e30c7-8031-4701-a138-b9cc289e7f62_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_130e30c7-8031-4701-a138-b9cc289e7f62" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_130e30c7-8031-4701-a138-b9cc289e7f62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2fb3419e-1b15-4301-8a0a-5e4c1382122e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_130e30c7-8031-4701-a138-b9cc289e7f62" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2fb3419e-1b15-4301-8a0a-5e4c1382122e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_fb8afbc8-01c5-4ca1-a542-ae4481b1a472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2fb3419e-1b15-4301-8a0a-5e4c1382122e" xlink:to="loc_us-gaap_SeniorNotesMember_fb8afbc8-01c5-4ca1-a542-ae4481b1a472" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_77efa3b5-d5cb-4fe5-812e-41129de6d13d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2fb3419e-1b15-4301-8a0a-5e4c1382122e" xlink:to="loc_us-gaap_ConvertibleDebtMember_77efa3b5-d5cb-4fe5-812e-41129de6d13d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7078c864-1fba-4b04-8231-c95f9fe18c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_32c6e47f-37af-4d99-8746-1eae6cc04628" xlink:to="loc_us-gaap_DebtInstrumentAxis_7078c864-1fba-4b04-8231-c95f9fe18c67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7078c864-1fba-4b04-8231-c95f9fe18c67_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7078c864-1fba-4b04-8231-c95f9fe18c67" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7078c864-1fba-4b04-8231-c95f9fe18c67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7078c864-1fba-4b04-8231-c95f9fe18c67" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4375SeniorNotesMember_589a5552-d9e4-49af-a28d-3ffed334a0b6" xlink:href="moh-20201231.xsd#moh_A4375SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:to="loc_moh_A4375SeniorNotesMember_589a5552-d9e4-49af-a28d-3ffed334a0b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SeniorNotesDue2022Member_3ee80152-77b0-40f6-bc01-08e2770d92ff" xlink:href="moh-20201231.xsd#moh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:to="loc_moh_SeniorNotesDue2022Member_3ee80152-77b0-40f6-bc01-08e2770d92ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_c53dc246-bbed-4842-a984-ff080afef41b" xlink:href="moh-20201231.xsd#moh_ThreePointEightSevenFivePercentSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:to="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_c53dc246-bbed-4842-a984-ff080afef41b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4.875SeniorNotesMember_0f81d204-803a-47b4-9d95-7fc90a3d142d" xlink:href="moh-20201231.xsd#moh_A4.875SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:to="loc_moh_A4.875SeniorNotesMember_0f81d204-803a-47b4-9d95-7fc90a3d142d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails" xlink:type="extended" id="i0c48e8b2a865467292afd207580557af_DebtConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0db0cf32-f077-424e-9384-536724f95e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0db0cf32-f077-424e-9384-536724f95e67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_4784f8f5-c59f-4116-90f8-daf3a0b0c0d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_us-gaap_RepaymentsOfDebt_4784f8f5-c59f-4116-90f8-daf3a0b0c0d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_7807b976-2cf0-453c-8d9d-812eb1e681f8" xlink:href="moh-20201231.xsd#moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_7807b976-2cf0-453c-8d9d-812eb1e681f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GainLossOnDebtRepayment_cc041b9e-0583-4924-b9d3-76ee3777bfb5" xlink:href="moh-20201231.xsd#moh_GainLossOnDebtRepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_moh_GainLossOnDebtRepayment_cc041b9e-0583-4924-b9d3-76ee3777bfb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_56550e34-d7d7-4a96-8586-13ea0c8f2478" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_56550e34-d7d7-4a96-8586-13ea0c8f2478" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e27c422b-bcf1-465d-83ec-49cfec7fb495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_us-gaap_DebtInstrumentTable_e27c422b-bcf1-465d-83ec-49cfec7fb495" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5ed9a29c-43e5-4288-a3ab-755a3531bf5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e27c422b-bcf1-465d-83ec-49cfec7fb495" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5ed9a29c-43e5-4288-a3ab-755a3531bf5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5ed9a29c-43e5-4288-a3ab-755a3531bf5f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5ed9a29c-43e5-4288-a3ab-755a3531bf5f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5ed9a29c-43e5-4288-a3ab-755a3531bf5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4f2c4506-00b1-4053-869c-97cef27be77d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5ed9a29c-43e5-4288-a3ab-755a3531bf5f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4f2c4506-00b1-4053-869c-97cef27be77d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_4fe8f664-69b8-4000-9d45-be0bf640ed36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4f2c4506-00b1-4053-869c-97cef27be77d" xlink:to="loc_us-gaap_ConvertibleDebtMember_4fe8f664-69b8-4000-9d45-be0bf640ed36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a6cabfe5-4b63-4033-803f-a9d6021e10a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e27c422b-bcf1-465d-83ec-49cfec7fb495" xlink:to="loc_us-gaap_DebtInstrumentAxis_a6cabfe5-4b63-4033-803f-a9d6021e10a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a6cabfe5-4b63-4033-803f-a9d6021e10a1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a6cabfe5-4b63-4033-803f-a9d6021e10a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a6cabfe5-4b63-4033-803f-a9d6021e10a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_107f1c3e-d8b1-4991-b710-d733056695ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a6cabfe5-4b63-4033-803f-a9d6021e10a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_107f1c3e-d8b1-4991-b710-d733056695ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020Member_1017739b-1c59-401c-8110-9b1217053031" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_107f1c3e-d8b1-4991-b710-d733056695ff" xlink:to="loc_moh_CashConvertibleSeniorNotesDue2020Member_1017739b-1c59-401c-8110-9b1217053031" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxes" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxes" xlink:type="extended" id="ibdb7b5ded4074e20aeb78d02b0333332_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesTables" xlink:type="extended" id="icbe513ced3b44282839ebf77a7a72ae4_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails" xlink:type="extended" id="i4bc140b2f63649e6a5610b0deb29e70c_IncomeTaxesProvisionforIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails" xlink:type="extended" id="ic0bab0bfbe324d3d84931084ecb116c8_IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="id49c6743055f400c8989feb54d5e67a7_IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended" id="i62ea5389ab4b4510ab78348013c3e6f4_IncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_10d7a43f-2572-4cd9-b89b-00a5260efbb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_10d7a43f-2572-4cd9-b89b-00a5260efbb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_102a2d36-fd63-44f2-ab22-2da24ef10b5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_102a2d36-fd63-44f2-ab22-2da24ef10b5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_18f89db5-c121-40f2-89da-acf60e258efa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_18f89db5-c121-40f2-89da-acf60e258efa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_73d9f724-3e6f-4df2-b494-b155c14c3828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_73d9f724-3e6f-4df2-b494-b155c14c3828" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d29be9fe-6331-4862-8e95-ce501452fac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d29be9fe-6331-4862-8e95-ce501452fac9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_bd2f85d4-7802-4667-9376-8c6aa5ed54f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_bd2f85d4-7802-4667-9376-8c6aa5ed54f5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d8b2486a-16e5-4787-ac60-560c38055270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d8b2486a-16e5-4787-ac60-560c38055270" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_c282c365-6bd7-40b5-84c1-1c4c231d480a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_c282c365-6bd7-40b5-84c1-1c4c231d480a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_fd207f73-2bb1-4bc4-b5b8-cdf4925c724e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_c282c365-6bd7-40b5-84c1-1c4c231d480a" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_fd207f73-2bb1-4bc4-b5b8-cdf4925c724e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_fd207f73-2bb1-4bc4-b5b8-cdf4925c724e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_fd207f73-2bb1-4bc4-b5b8-cdf4925c724e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_fd207f73-2bb1-4bc4-b5b8-cdf4925c724e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_29f2c85f-d362-45f0-a017-cce5cfc4a7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_fd207f73-2bb1-4bc4-b5b8-cdf4925c724e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_29f2c85f-d362-45f0-a017-cce5cfc4a7c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_b6c7700b-f784-4665-98d4-00f6a7619b62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_29f2c85f-d362-45f0-a017-cce5cfc4a7c4" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_b6c7700b-f784-4665-98d4-00f6a7619b62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_f0c900b5-9b76-4dae-b33b-25eeedaaad8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_29f2c85f-d362-45f0-a017-cce5cfc4a7c4" xlink:to="loc_us-gaap_ForeignCountryMember_f0c900b5-9b76-4dae-b33b-25eeedaaad8b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended" id="i1aee25fc4f5247a29961438920653983_IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquity" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquity" xlink:type="extended" id="i37c24c7223054458a640433ee55179fe_StockholdersEquity"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityTables" xlink:type="extended" id="i86ff8d84431f4116ae066f6fe1773fab_StockholdersEquityTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended" id="i7e72971ac0bd42dfbc5fc86278fbb803_StockholdersEquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be24526c-2bac-4794-8242-1b52c558a897" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be24526c-2bac-4794-8242-1b52c558a897" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_9ea4b97c-8172-4467-97d9-931b1ba46f81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_9ea4b97c-8172-4467-97d9-931b1ba46f81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_7ac712a0-4a3a-432b-a861-7c58d1b66096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_7ac712a0-4a3a-432b-a861-7c58d1b66096" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6aaae793-da75-4fbf-afd3-055521accffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6aaae793-da75-4fbf-afd3-055521accffe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_993e85c0-d34e-4ad9-9829-6757079ea6c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_993e85c0-d34e-4ad9-9829-6757079ea6c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ClassOfWarrantOrRightStatedInterestRate_3ee19dee-9449-4c13-8c93-cf45dc5912ea" xlink:href="moh-20201231.xsd#moh_ClassOfWarrantOrRightStatedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_moh_ClassOfWarrantOrRightStatedInterestRate_3ee19dee-9449-4c13-8c93-cf45dc5912ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_a4f62945-0730-4057-969c-8b569e98c76c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_a4f62945-0730-4057-969c-8b569e98c76c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants_e92d44b3-ba8f-4e35-a24a-4454c5cbd3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfWarrants_e92d44b3-ba8f-4e35-a24a-4454c5cbd3fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ClassOfWarrantOrRightStatedInterestRate_2ce51a47-ba39-4575-b345-1f999f9602a7" xlink:href="moh-20201231.xsd#moh_ClassOfWarrantOrRightStatedInterestRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_58ec11c9-b3d2-4650-9899-952b91a65fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_58ec11c9-b3d2-4650-9899-952b91a65fb6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_876661ca-76c0-46cf-9225-dadc477ee891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_876661ca-76c0-46cf-9225-dadc477ee891" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dd8bd545-d41b-48a4-8ebb-271c020f7884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dd8bd545-d41b-48a4-8ebb-271c020f7884" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a4b3449c-473d-4268-81a7-b35e4023f44d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a4b3449c-473d-4268-81a7-b35e4023f44d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b57456b7-f97f-43ee-a09d-c0d668d2b1ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_UnrecognizedCompensationForfeitedRate_4097376f-0920-4adb-bafe-7348e3a85ef6" xlink:href="moh-20201231.xsd#moh_UnrecognizedCompensationForfeitedRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_moh_UnrecognizedCompensationForfeitedRate_4097376f-0920-4adb-bafe-7348e3a85ef6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_312998dc-b34b-414c-8c5e-95dc2289cc9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_312998dc-b34b-414c-8c5e-95dc2289cc9b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_031bb3a5-cee9-4411-9955-3b6ff30031e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_031bb3a5-cee9-4411-9955-3b6ff30031e5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FairMarketValueOfCommonStockPercentage_0bc08553-7e24-4ad4-9c90-d8acc2a086da" xlink:href="moh-20201231.xsd#moh_FairMarketValueOfCommonStockPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_moh_FairMarketValueOfCommonStockPercentage_0bc08553-7e24-4ad4-9c90-d8acc2a086da" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee_0ae87406-9f65-4a84-ae9d-c184a14227e0" xlink:href="moh-20201231.xsd#moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee_0ae87406-9f65-4a84-ae9d-c184a14227e0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1fecea80-f650-44f6-b542-7b6196e7e6f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1fecea80-f650-44f6-b542-7b6196e7e6f8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1ebcb33a-e506-4daf-b4b6-47a18a113e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1ebcb33a-e506-4daf-b4b6-47a18a113e1e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_408d53d0-1728-402e-800f-1629bda0ac12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_408d53d0-1728-402e-800f-1629bda0ac12" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_5539ddf5-2da5-415e-89f7-4f34f232abef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_5539ddf5-2da5-415e-89f7-4f34f232abef" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_34fd5545-63ae-43a8-b65c-55433cdd716b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_34fd5545-63ae-43a8-b65c-55433cdd716b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_17dc8e72-81ba-46cd-a260-b4c802d60cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_17dc8e72-81ba-46cd-a260-b4c802d60cd4" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_60cba121-206e-4ca7-845d-72e4dd90f7db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_60cba121-206e-4ca7-845d-72e4dd90f7db" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1338ab82-5efd-438c-a131-b309468ef71d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1338ab82-5efd-438c-a131-b309468ef71d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1338ab82-5efd-438c-a131-b309468ef71d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1338ab82-5efd-438c-a131-b309468ef71d" xlink:to="loc_us-gaap_EquityComponentDomain_1338ab82-5efd-438c-a131-b309468ef71d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d6fe6db8-1b6d-4979-b0f4-47c256d011b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1338ab82-5efd-438c-a131-b309468ef71d" xlink:to="loc_us-gaap_EquityComponentDomain_d6fe6db8-1b6d-4979-b0f4-47c256d011b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_51d09fe5-e9a9-40c9-9df3-23b5b0731ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d6fe6db8-1b6d-4979-b0f4-47c256d011b7" xlink:to="loc_us-gaap_CommonStockMember_51d09fe5-e9a9-40c9-9df3-23b5b0731ea2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6e379d7d-9736-4dad-80b9-003255b4668c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6e379d7d-9736-4dad-80b9-003255b4668c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6e379d7d-9736-4dad-80b9-003255b4668c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6e379d7d-9736-4dad-80b9-003255b4668c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6e379d7d-9736-4dad-80b9-003255b4668c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5f67a1f3-7563-4470-a7a6-ba578a83769e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6e379d7d-9736-4dad-80b9-003255b4668c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5f67a1f3-7563-4470-a7a6-ba578a83769e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6cc8f9c5-532e-4620-b0e2-6e8f788be3e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5f67a1f3-7563-4470-a7a6-ba578a83769e" xlink:to="loc_us-gaap_SubsequentEventMember_6cc8f9c5-532e-4620-b0e2-6e8f788be3e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_9570164f-f472-4a42-9d66-663a5fb40f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_9570164f-f472-4a42-9d66-663a5fb40f22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_9570164f-f472-4a42-9d66-663a5fb40f22_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_9570164f-f472-4a42-9d66-663a5fb40f22" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_9570164f-f472-4a42-9d66-663a5fb40f22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a7f21d7c-a9be-48e3-94f2-ed280fba1e6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_9570164f-f472-4a42-9d66-663a5fb40f22" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a7f21d7c-a9be-48e3-94f2-ed280fba1e6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020WarrantsMember_a4aec248-fc6c-4706-b35c-e8fd3ec50f3d" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020WarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a7f21d7c-a9be-48e3-94f2-ed280fba1e6e" xlink:to="loc_moh_CashConvertibleSeniorNotesDue2020WarrantsMember_a4aec248-fc6c-4706-b35c-e8fd3ec50f3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c750c694-fb91-431b-9ce9-edc908103d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_PlanNameAxis_c750c694-fb91-431b-9ce9-edc908103d57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c750c694-fb91-431b-9ce9-edc908103d57_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_c750c694-fb91-431b-9ce9-edc908103d57" xlink:to="loc_us-gaap_PlanNameDomain_c750c694-fb91-431b-9ce9-edc908103d57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_577a2830-faa6-4924-aafa-faa1ea79c9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_c750c694-fb91-431b-9ce9-edc908103d57" xlink:to="loc_us-gaap_PlanNameDomain_577a2830-faa6-4924-aafa-faa1ea79c9a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EquityIncentivePlanMember_7c5cadcc-46bd-4ee4-a67e-4e725a2f1873" xlink:href="moh-20201231.xsd#moh_EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_577a2830-faa6-4924-aafa-faa1ea79c9a0" xlink:to="loc_moh_EquityIncentivePlanMember_7c5cadcc-46bd-4ee4-a67e-4e725a2f1873" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e61d796f-b6fb-45d2-92ea-967e14a8353a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_AwardTypeAxis_e61d796f-b6fb-45d2-92ea-967e14a8353a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e61d796f-b6fb-45d2-92ea-967e14a8353a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e61d796f-b6fb-45d2-92ea-967e14a8353a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e61d796f-b6fb-45d2-92ea-967e14a8353a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e61d796f-b6fb-45d2-92ea-967e14a8353a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b13ea2df-f769-46fe-94ee-80d5b0c4236e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:to="loc_us-gaap_RestrictedStockMember_b13ea2df-f769-46fe-94ee-80d5b0c4236e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_328e92af-a11c-4995-b12b-7ff7bd8187ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_328e92af-a11c-4995-b12b-7ff7bd8187ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1b84f073-39fa-4356-9c34-a185311dc79b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1b84f073-39fa-4356-9c34-a185311dc79b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_20b13c06-8998-4ef5-994b-48d0b694551b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:to="loc_us-gaap_EmployeeStockMember_20b13c06-8998-4ef5-994b-48d0b694551b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityComponentsofSharebasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails" xlink:type="extended" id="ie422f912e1af4be38c81446eb1a19dcd_StockholdersEquityComponentsofSharebasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6b015d83-26ad-42fe-af3d-c88d6ac28914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_89efc044-b723-4ea1-b66a-e5c56b0baa7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6b015d83-26ad-42fe-af3d-c88d6ac28914" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_89efc044-b723-4ea1-b66a-e5c56b0baa7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ece46e42-6b65-4315-b1c1-31b062208a92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6b015d83-26ad-42fe-af3d-c88d6ac28914" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ece46e42-6b65-4315-b1c1-31b062208a92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85700add-96fb-446d-83d5-5edfc9a7fd77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6b015d83-26ad-42fe-af3d-c88d6ac28914" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85700add-96fb-446d-83d5-5edfc9a7fd77" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_91372829-73e0-4e31-ac27-266d33828f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85700add-96fb-446d-83d5-5edfc9a7fd77" xlink:to="loc_us-gaap_AwardTypeAxis_91372829-73e0-4e31-ac27-266d33828f21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91372829-73e0-4e31-ac27-266d33828f21_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_91372829-73e0-4e31-ac27-266d33828f21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91372829-73e0-4e31-ac27-266d33828f21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e5e07493-109d-4017-8ef8-dc93948e4baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_91372829-73e0-4e31-ac27-266d33828f21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e5e07493-109d-4017-8ef8-dc93948e4baf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RestrictedandPerformanceStockMember_5849ff30-0238-405a-980a-6c8d7d0e2ddc" xlink:href="moh-20201231.xsd#moh_RestrictedandPerformanceStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e5e07493-109d-4017-8ef8-dc93948e4baf" xlink:to="loc_moh_RestrictedandPerformanceStockMember_5849ff30-0238-405a-980a-6c8d7d0e2ddc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EmployeeStockPurchasePlanandStockOptionsMember_bfa1cd86-93b8-4d55-b77c-eb3073386b79" xlink:href="moh-20201231.xsd#moh_EmployeeStockPurchasePlanandStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e5e07493-109d-4017-8ef8-dc93948e4baf" xlink:to="loc_moh_EmployeeStockPurchasePlanandStockOptionsMember_bfa1cd86-93b8-4d55-b77c-eb3073386b79" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityRestrictedandPerformanceStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails" xlink:type="extended" id="ida409d6de8094cfbb5ce6cab86783cc3_StockholdersEquityRestrictedandPerformanceStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_55bc2806-3b74-43d7-88a2-0b7142d0315c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_55bc2806-3b74-43d7-88a2-0b7142d0315c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0072f850-3d1b-454a-99c3-07222cafb748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0072f850-3d1b-454a-99c3-07222cafb748" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9c29ef24-98ff-467b-88e4-db56a3baab4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9c29ef24-98ff-467b-88e4-db56a3baab4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_42eed57e-a605-4d7f-ac78-eef799781211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_42eed57e-a605-4d7f-ac78-eef799781211" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_014b9deb-67f6-47fb-86e6-09aa21832baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_014b9deb-67f6-47fb-86e6-09aa21832baf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_90e1a6f4-1739-4060-acb1-057c2960a051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_55bc2806-3b74-43d7-88a2-0b7142d0315c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_97296e0e-2f63-4ff4-aabf-523ec3d43173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_97296e0e-2f63-4ff4-aabf-523ec3d43173" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cc42bf24-b9c9-4b44-949a-d7f461478661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cc42bf24-b9c9-4b44-949a-d7f461478661" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7f432661-cc44-4666-a9f3-6c762daea23c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7f432661-cc44-4666-a9f3-6c762daea23c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2bd275f5-1ead-4007-9e80-e88b70a0fa18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2bd275f5-1ead-4007-9e80-e88b70a0fa18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2ee8a1a4-f602-42db-9500-636dfeb6dd39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_053ae052-f2a1-4e2a-bb08-17f04f1707bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_55bc2806-3b74-43d7-88a2-0b7142d0315c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_053ae052-f2a1-4e2a-bb08-17f04f1707bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_24346a2b-2d69-48e7-9f81-e9523093caeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_053ae052-f2a1-4e2a-bb08-17f04f1707bd" xlink:to="loc_us-gaap_AwardTypeAxis_24346a2b-2d69-48e7-9f81-e9523093caeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_24346a2b-2d69-48e7-9f81-e9523093caeb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_24346a2b-2d69-48e7-9f81-e9523093caeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_24346a2b-2d69-48e7-9f81-e9523093caeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f3d46e6-7ad5-4d74-88d2-90c78e600fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_24346a2b-2d69-48e7-9f81-e9523093caeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f3d46e6-7ad5-4d74-88d2-90c78e600fa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6012ff2f-1071-44b1-bffe-d6dd3f798fa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f3d46e6-7ad5-4d74-88d2-90c78e600fa9" xlink:to="loc_us-gaap_RestrictedStockMember_6012ff2f-1071-44b1-bffe-d6dd3f798fa1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_27d1c884-d3a3-40dc-8e2d-6cc8b816c37b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f3d46e6-7ad5-4d74-88d2-90c78e600fa9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_27d1c884-d3a3-40dc-8e2d-6cc8b816c37b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityFairValueofAwardsGrantedandVestedDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails" xlink:type="extended" id="ie0e5694ff2e743fb9562c0afe39ac13d_StockholdersEquityFairValueofAwardsGrantedandVestedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e277963-4e17-4ed2-b645-bc7e92946744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_b2679cfb-535d-4283-b65f-375d8dc5aa67" xlink:href="moh-20201231.xsd#moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e277963-4e17-4ed2-b645-bc7e92946744" xlink:to="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_b2679cfb-535d-4283-b65f-375d8dc5aa67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_92a257e6-eb64-40cd-8971-6b7ed530155b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e277963-4e17-4ed2-b645-bc7e92946744" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_92a257e6-eb64-40cd-8971-6b7ed530155b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ea1dfade-9e23-406c-88b3-fb0336c19048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e277963-4e17-4ed2-b645-bc7e92946744" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ea1dfade-9e23-406c-88b3-fb0336c19048" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9fdade61-36dd-4282-acdb-1c751f720488" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ea1dfade-9e23-406c-88b3-fb0336c19048" xlink:to="loc_us-gaap_AwardTypeAxis_9fdade61-36dd-4282-acdb-1c751f720488" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fdade61-36dd-4282-acdb-1c751f720488_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9fdade61-36dd-4282-acdb-1c751f720488" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fdade61-36dd-4282-acdb-1c751f720488_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48b5c7b1-a5bb-42ee-adb0-09669e51b925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9fdade61-36dd-4282-acdb-1c751f720488" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48b5c7b1-a5bb-42ee-adb0-09669e51b925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_66ccf5e3-bf99-4f27-915b-5d53990af494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48b5c7b1-a5bb-42ee-adb0-09669e51b925" xlink:to="loc_us-gaap_RestrictedStockMember_66ccf5e3-bf99-4f27-915b-5d53990af494" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_edf17930-6205-404d-b1b7-9128a252544f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48b5c7b1-a5bb-42ee-adb0-09669e51b925" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_edf17930-6205-404d-b1b7-9128a252544f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_ca03276d-78b7-4f31-8924-d632fc92161b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48b5c7b1-a5bb-42ee-adb0-09669e51b925" xlink:to="loc_us-gaap_PerformanceSharesMember_ca03276d-78b7-4f31-8924-d632fc92161b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails" xlink:type="extended" id="i8c43c71c71f140ea896af4831039f26d_StockholdersEquityStockOptionActivityDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityStockOptionsbyExercisePriceDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails" xlink:type="extended" id="i030d863b2e4b4fe59607e5e5f4c28934_StockholdersEquityStockOptionsbyExercisePriceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_d8334b8d-59da-450c-97dc-aef9b8196e7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_d8334b8d-59da-450c-97dc-aef9b8196e7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_bc24526d-9e5d-4302-b41c-e3ac39228df5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_bc24526d-9e5d-4302-b41c-e3ac39228df5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_725dac26-fe14-4eab-bfe9-a28f86570c8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_725dac26-fe14-4eab-bfe9-a28f86570c8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_8b95bd6d-6d81-481b-a077-28321ada1145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_8b95bd6d-6d81-481b-a077-28321ada1145" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1321ac94-04a4-44d4-8edd-94a8dddfc42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1321ac94-04a4-44d4-8edd-94a8dddfc42a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4a861d2f-f404-440f-9c3f-f9d77076cdc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4a861d2f-f404-440f-9c3f-f9d77076cdc7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a4e263ef-f5fb-4725-9cdc-c76cdb23b135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4a861d2f-f404-440f-9c3f-f9d77076cdc7" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a4e263ef-f5fb-4725-9cdc-c76cdb23b135" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_a4e263ef-f5fb-4725-9cdc-c76cdb23b135_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a4e263ef-f5fb-4725-9cdc-c76cdb23b135" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_a4e263ef-f5fb-4725-9cdc-c76cdb23b135_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ca280e8b-0446-45b1-9657-17245ca72724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a4e263ef-f5fb-4725-9cdc-c76cdb23b135" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ca280e8b-0446-45b1-9657-17245ca72724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ExercisePriceRange1Member_a5d01195-a740-4454-92a1-fc6b6705f343" xlink:href="moh-20201231.xsd#moh_ExercisePriceRange1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ca280e8b-0446-45b1-9657-17245ca72724" xlink:to="loc_moh_ExercisePriceRange1Member_a5d01195-a740-4454-92a1-fc6b6705f343" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ExercisePriceRange2Member_ee630069-262c-40ac-bca1-3c2e67e8bd28" xlink:href="moh-20201231.xsd#moh_ExercisePriceRange2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ca280e8b-0446-45b1-9657-17245ca72724" xlink:to="loc_moh_ExercisePriceRange2Member_ee630069-262c-40ac-bca1-3c2e67e8bd28" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="moh-20201231.xsd#EmployeeBenefitPlans"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/EmployeeBenefitPlans" xlink:type="extended" id="ib9a8550faf1b48ffb26d25eec7ad5605_EmployeeBenefitPlans"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#EmployeeBenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails" xlink:type="extended" id="ie993024c1bd340efbaf46214b809dd5a_EmployeeBenefitPlansDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="moh-20201231.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CommitmentsandContingencies" xlink:type="extended" id="i605923edf439496981bd507346ad0401_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i181b348daf9e40a68225af222e26ac2f_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SpecialAssessmentBond_3bc658e2-4675-443f-9840-40721f9a901c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SpecialAssessmentBond"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_SpecialAssessmentBond_3bc658e2-4675-443f-9840-40721f9a901c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_e62c648c-7677-486c-8ea4-ee0767cdac87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_e62c648c-7677-486c-8ea4-ee0767cdac87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_60a9c434-e742-429c-a9a1-05aa2f6df304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_60a9c434-e742-429c-a9a1-05aa2f6df304" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b88f11ce-2f6c-4c82-b558-7bdfd8c39a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b88f11ce-2f6c-4c82-b558-7bdfd8c39a0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_f45ab08a-f6ae-46f5-ad80-368059298f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_f45ab08a-f6ae-46f5-ad80-368059298f15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable_5556df88-65c6-4dc3-8811-ea3ef01c3ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_StatutoryAccountingPracticesTable_5556df88-65c6-4dc3-8811-ea3ef01c3ad3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_b1b8808f-38c4-44a6-a139-63be87c90906" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_5556df88-65c6-4dc3-8811-ea3ef01c3ad3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_b1b8808f-38c4-44a6-a139-63be87c90906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b1b8808f-38c4-44a6-a139-63be87c90906_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b1b8808f-38c4-44a6-a139-63be87c90906" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b1b8808f-38c4-44a6-a139-63be87c90906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d9aa8d89-21e3-4f35-8258-af8bdf6264a4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b1b8808f-38c4-44a6-a139-63be87c90906" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d9aa8d89-21e3-4f35-8258-af8bdf6264a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_cbcc9b94-a1c7-4b79-8293-847413a1bd77" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_d9aa8d89-21e3-4f35-8258-af8bdf6264a4" xlink:to="loc_srt_ParentCompanyMember_cbcc9b94-a1c7-4b79-8293-847413a1bd77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MagellanCompleteCareMember_f013a9cc-17fd-4a06-8230-b2fa39bdc240" xlink:href="moh-20201231.xsd#moh_MagellanCompleteCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_d9aa8d89-21e3-4f35-8258-af8bdf6264a4" xlink:to="loc_moh_MagellanCompleteCareMember_f013a9cc-17fd-4a06-8230-b2fa39bdc240" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Segments" xlink:type="simple" xlink:href="moh-20201231.xsd#Segments"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/Segments" xlink:type="extended" id="i3586cbf0c65c4ffbb2f876ed71c2ec8a_Segments"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SegmentsTables" xlink:type="extended" id="ibbaac40c1e26449e8df03d2046573f14_SegmentsTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SegmentsNarrativeDetails" xlink:type="extended" id="ib9e4ea8ba6dd44e58d0e0c64b83fa061_SegmentsNarrativeDetails"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsScheduleofOperatingSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails" xlink:type="extended" id="i5551de0fd30f49d3aeff1dafa036ab3c_SegmentsScheduleofOperatingSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d331a9aa-7819-476c-b59f-31ae44c15552" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_abf5dd1f-8370-4392-99b2-e1dfc9490b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d331a9aa-7819-476c-b59f-31ae44c15552" xlink:to="loc_us-gaap_Revenues_abf5dd1f-8370-4392-99b2-e1dfc9490b5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a7bfd486-679a-4c00-8be1-6fc9d56ad011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d331a9aa-7819-476c-b59f-31ae44c15552" xlink:to="loc_us-gaap_GrossProfit_a7bfd486-679a-4c00-8be1-6fc9d56ad011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_71311bc5-893f-42e8-a58c-0584d577180a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d331a9aa-7819-476c-b59f-31ae44c15552" xlink:to="loc_us-gaap_Assets_71311bc5-893f-42e8-a58c-0584d577180a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd79e9b7-2da6-47ce-8f59-ffebefe0ba92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d331a9aa-7819-476c-b59f-31ae44c15552" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd79e9b7-2da6-47ce-8f59-ffebefe0ba92" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1ea92c44-a305-4ab4-8bfd-d35f3bda0320" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd79e9b7-2da6-47ce-8f59-ffebefe0ba92" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1ea92c44-a305-4ab4-8bfd-d35f3bda0320" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1ea92c44-a305-4ab4-8bfd-d35f3bda0320_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1ea92c44-a305-4ab4-8bfd-d35f3bda0320" xlink:to="loc_us-gaap_SegmentDomain_1ea92c44-a305-4ab4-8bfd-d35f3bda0320_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a7a367db-89ae-4481-8d6c-4391054755e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1ea92c44-a305-4ab4-8bfd-d35f3bda0320" xlink:to="loc_us-gaap_SegmentDomain_a7a367db-89ae-4481-8d6c-4391054755e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_0013fb12-0fde-4413-8928-49d38d8c229f" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a7a367db-89ae-4481-8d6c-4391054755e1" xlink:to="loc_moh_HealthPlansMember_0013fb12-0fde-4413-8928-49d38d8c229f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_6fd6375a-9b3e-4eeb-8cf1-06de4becc34f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a7a367db-89ae-4481-8d6c-4391054755e1" xlink:to="loc_us-gaap_AllOtherSegmentsMember_6fd6375a-9b3e-4eeb-8cf1-06de4becc34f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails" xlink:type="extended" id="iedaf8b751b94475c9af7cddf9998e6c5_SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e690d4ae-289b-4677-9efb-21137b2c77fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_GrossProfit_e690d4ae-289b-4677-9efb-21137b2c77fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4d6b28d4-e2d2-460b-a81b-ca22f62f6d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_Revenues_4d6b28d4-e2d2-460b-a81b-ca22f62f6d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e2720f39-f5f9-4d24-8408-b901e84b437c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_CostsAndExpenses_e2720f39-f5f9-4d24-8408-b901e84b437c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b4bb1dce-e95f-4ac8-847d-039265f51f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_OperatingIncomeLoss_b4bb1dce-e95f-4ac8-847d-039265f51f6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2ba12ced-0c18-40ca-841b-281268ec8bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2ba12ced-0c18-40ca-841b-281268ec8bd1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2014af2f-43d2-4395-b481-26bb68403363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2014af2f-43d2-4395-b481-26bb68403363" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0ff7394c-f82d-441d-bb57-ffe6b1ea72fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0ff7394c-f82d-441d-bb57-ffe6b1ea72fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5485a7b7-6ed3-4fa7-874c-7db2570fdffa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0ff7394c-f82d-441d-bb57-ffe6b1ea72fa" xlink:to="loc_srt_ConsolidationItemsAxis_5485a7b7-6ed3-4fa7-874c-7db2570fdffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5485a7b7-6ed3-4fa7-874c-7db2570fdffa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5485a7b7-6ed3-4fa7-874c-7db2570fdffa" xlink:to="loc_srt_ConsolidationItemsDomain_5485a7b7-6ed3-4fa7-874c-7db2570fdffa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_77e1788b-6614-4628-bc09-1a73bc538e02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5485a7b7-6ed3-4fa7-874c-7db2570fdffa" xlink:to="loc_srt_ConsolidationItemsDomain_77e1788b-6614-4628-bc09-1a73bc538e02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_13684a69-0143-40aa-9730-d02c93addcd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_77e1788b-6614-4628-bc09-1a73bc538e02" xlink:to="loc_us-gaap_OperatingSegmentsMember_13684a69-0143-40aa-9730-d02c93addcd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_27abd9cb-151a-404f-b669-bf3228828f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_77e1788b-6614-4628-bc09-1a73bc538e02" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_27abd9cb-151a-404f-b669-bf3228828f84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c8d2bc12-ee98-46bc-99b8-7f0bf56a04b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0ff7394c-f82d-441d-bb57-ffe6b1ea72fa" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c8d2bc12-ee98-46bc-99b8-7f0bf56a04b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c8d2bc12-ee98-46bc-99b8-7f0bf56a04b4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c8d2bc12-ee98-46bc-99b8-7f0bf56a04b4" xlink:to="loc_us-gaap_SegmentDomain_c8d2bc12-ee98-46bc-99b8-7f0bf56a04b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8f7dd6bf-3d2b-443f-a599-09da54d0f46b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c8d2bc12-ee98-46bc-99b8-7f0bf56a04b4" xlink:to="loc_us-gaap_SegmentDomain_8f7dd6bf-3d2b-443f-a599-09da54d0f46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_67b3c07f-a369-49ef-b0e2-7089161fa924" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8f7dd6bf-3d2b-443f-a599-09da54d0f46b" xlink:to="loc_moh_HealthPlansMember_67b3c07f-a369-49ef-b0e2-7089161fa924" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_d37d5458-3aad-4588-b23a-d3de2b4a4e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8f7dd6bf-3d2b-443f-a599-09da54d0f46b" xlink:to="loc_us-gaap_AllOtherSegmentsMember_d37d5458-3aad-4588-b23a-d3de2b4a4e43" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrant"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant" xlink:type="extended" id="if2939b8d28c74acbaf39bcd6bdec32e5_CondensedFinancialInformationofRegistrant"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantTables"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables" xlink:type="extended" id="ibbf9225cf5d441cfb3016bb8bae4dbd5_CondensedFinancialInformationofRegistrantTables"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="extended" id="iecf14f01ea5d4df5b55aad455ea64bd8_CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_7ed094b5-06d0-4593-9320-61bc48f2ab64" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0975d961-0b30-41c0-b99c-6df12624fe58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_7ed094b5-06d0-4593-9320-61bc48f2ab64" xlink:to="loc_us-gaap_StatementOfFinancialPositionAbstract_0975d961-0b30-41c0-b99c-6df12624fe58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0975d961-0b30-41c0-b99c-6df12624fe58" xlink:to="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4870d41-6877-4e71-95ce-b7c49e8f2999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4870d41-6877-4e71-95ce-b7c49e8f2999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_3e8948a1-ea1a-4b44-918d-c292a20cca2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_3e8948a1-ea1a-4b44-918d-c292a20cca2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_4937ed40-1f59-4847-9280-adbda6fdadd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_ReceivablesNetCurrent_4937ed40-1f59-4847-9280-adbda6fdadd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_64bc41e1-54a1-4fee-b93c-9707ddcc9e1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_64bc41e1-54a1-4fee-b93c-9707ddcc9e1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c3743fd8-8e17-4ef0-900d-cb384edf9639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c3743fd8-8e17-4ef0-900d-cb384edf9639" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_454df0d7-9637-41d2-8757-d718f16189a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_AssetsCurrent_454df0d7-9637-41d2-8757-d718f16189a0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1a0760d2-85fe-4096-99e0-132752ce41ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1a0760d2-85fe-4096-99e0-132752ce41ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9d223f63-19f3-4695-850e-54ea4ce90814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9d223f63-19f3-4695-850e-54ea4ce90814" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ad297f31-c7fc-4041-87f4-a1df7e1806b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ad297f31-c7fc-4041-87f4-a1df7e1806b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e72e50c-53de-425d-ab0e-2f6cb1124c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e72e50c-53de-425d-ab0e-2f6cb1124c95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AdvancesToRelatedPartiesAndOtherAssets_bbe80383-85bd-4be1-b11e-c68d2ae2ae61" xlink:href="moh-20201231.xsd#moh_AdvancesToRelatedPartiesAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_moh_AdvancesToRelatedPartiesAndOtherAssets_bbe80383-85bd-4be1-b11e-c68d2ae2ae61" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ab47f2e7-8b74-43da-910e-c80b4ca09477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_Assets_ab47f2e7-8b74-43da-910e-c80b4ca09477" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0975d961-0b30-41c0-b99c-6df12624fe58" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3fc376fc-02a1-46fb-b4df-9d101d31c669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3fc376fc-02a1-46fb-b4df-9d101d31c669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_08ed325a-ecc9-427e-a348-201c5516f6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fc376fc-02a1-46fb-b4df-9d101d31c669" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_08ed325a-ecc9-427e-a348-201c5516f6cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bca13ce3-01dd-4c74-976b-f10a567b8ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fc376fc-02a1-46fb-b4df-9d101d31c669" xlink:to="loc_us-gaap_LiabilitiesCurrent_bca13ce3-01dd-4c74-976b-f10a567b8ed2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_04d9910d-f890-4cd2-bee2-e96b122dd88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_04d9910d-f890-4cd2-bee2-e96b122dd88c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7e75a4a3-be32-4b1f-a593-3025f4558d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7e75a4a3-be32-4b1f-a593-3025f4558d8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_31af1342-3f73-4a1e-a391-a6c23908921f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_31af1342-3f73-4a1e-a391-a6c23908921f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d1fd0ed1-2560-4d0a-b153-9dc169646b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_Liabilities_d1fd0ed1-2560-4d0a-b153-9dc169646b1b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_65e8c6f7-342e-4e6e-aaaf-b820281f3088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_CommonStockValueOutstanding_65e8c6f7-342e-4e6e-aaaf-b820281f3088" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_267a106b-a2cb-401c-8ac4-8e8157acdc73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_PreferredStockValue_267a106b-a2cb-401c-8ac4-8e8157acdc73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b9b44f3b-88ba-47f2-8728-27cf1260414f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b9b44f3b-88ba-47f2-8728-27cf1260414f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_06e0e8bc-03de-40ac-89b7-db6a64237f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_06e0e8bc-03de-40ac-89b7-db6a64237f71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84ffde3c-7ef3-4f7f-872d-fdd03f745457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84ffde3c-7ef3-4f7f-872d-fdd03f745457" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2d302998-dddc-4174-9386-20b40e210a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_StockholdersEquity_2d302998-dddc-4174-9386-20b40e210a99" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f3125f50-b46b-4f97-967c-66783c9c7939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f3125f50-b46b-4f97-967c-66783c9c7939" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_977f3d22-7b99-40ac-9d06-5428f1e48676" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_7ed094b5-06d0-4593-9320-61bc48f2ab64" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_977f3d22-7b99-40ac-9d06-5428f1e48676" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_dfbcc498-61a5-41b3-9bad-154ca9cbb085" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_977f3d22-7b99-40ac-9d06-5428f1e48676" xlink:to="loc_srt_ConsolidatedEntitiesAxis_dfbcc498-61a5-41b3-9bad-154ca9cbb085" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_dfbcc498-61a5-41b3-9bad-154ca9cbb085_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_dfbcc498-61a5-41b3-9bad-154ca9cbb085" xlink:to="loc_srt_ConsolidatedEntitiesDomain_dfbcc498-61a5-41b3-9bad-154ca9cbb085_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2061d320-2e1e-4d9f-bc5e-5eb1597f139d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_dfbcc498-61a5-41b3-9bad-154ca9cbb085" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2061d320-2e1e-4d9f-bc5e-5eb1597f139d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_e69193dd-51bf-47f7-8829-97718af772cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_2061d320-2e1e-4d9f-bc5e-5eb1597f139d" xlink:to="loc_srt_ParentCompanyMember_e69193dd-51bf-47f7-8829-97718af772cb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails" xlink:type="extended" id="id21b15306bac401e88f4740ff47aa4b2_CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4cab5e91-dadd-4456-b2db-cd5fb1a1d773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4cab5e91-dadd-4456-b2db-cd5fb1a1d773" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_dc9b69c9-cb59-4894-b9c3-9e740e761744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_dc9b69c9-cb59-4894-b9c3-9e740e761744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_195d210c-2875-4c22-a357-e4411cc40076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_195d210c-2875-4c22-a357-e4411cc40076" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_334818c1-254f-47c1-b168-5bdb0eefb0d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_334818c1-254f-47c1-b168-5bdb0eefb0d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_75bdfc99-b9b0-451a-8e4b-8ea33e3b9a61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_75bdfc99-b9b0-451a-8e4b-8ea33e3b9a61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_d02ac5f1-8806-4d6f-9b13-41f4df41af1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_PreferredStockSharesIssued_d02ac5f1-8806-4d6f-9b13-41f4df41af1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_c0820a9b-9e0e-408a-92cf-952c0220cda1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_c0820a9b-9e0e-408a-92cf-952c0220cda1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d0814138-13d0-4334-8c87-e681ff9c99e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d0814138-13d0-4334-8c87-e681ff9c99e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ee3df065-887a-44b9-9f14-af8970e9ab5c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d0814138-13d0-4334-8c87-e681ff9c99e1" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ee3df065-887a-44b9-9f14-af8970e9ab5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ee3df065-887a-44b9-9f14-af8970e9ab5c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ee3df065-887a-44b9-9f14-af8970e9ab5c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ee3df065-887a-44b9-9f14-af8970e9ab5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_941d242f-f2a1-4c13-a0d8-1b309272830d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ee3df065-887a-44b9-9f14-af8970e9ab5c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_941d242f-f2a1-4c13-a0d8-1b309272830d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_7c4c5ecb-c31b-4a37-9e93-6edbf8fee8f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_941d242f-f2a1-4c13-a0d8-1b309272830d" xlink:to="loc_srt_ParentCompanyMember_7c4c5ecb-c31b-4a37-9e93-6edbf8fee8f0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="extended" id="i0b86a9c16c604185911741ab26d535a1_CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_0f51af37-ed36-479a-ad2f-d75afb6b3b35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_0f51af37-ed36-479a-ad2f-d75afb6b3b35" xlink:to="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_fcee75ab-1ad2-4162-9168-a4f487b2550f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_RevenuesAbstract_fcee75ab-1ad2-4162-9168-a4f487b2550f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAgencyManagementFee_24e0c62b-4497-4cdb-b2cc-a23d6ea28818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAgencyManagementFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_fcee75ab-1ad2-4162-9168-a4f487b2550f" xlink:to="loc_us-gaap_InsuranceAgencyManagementFee_24e0c62b-4497-4cdb-b2cc-a23d6ea28818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_0308e7df-feba-4ee3-b850-5a7afd62b0ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_fcee75ab-1ad2-4162-9168-a4f487b2550f" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_0308e7df-feba-4ee3-b850-5a7afd62b0ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7b7d7553-663c-4a24-a5de-b57496df1806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_fcee75ab-1ad2-4162-9168-a4f487b2550f" xlink:to="loc_us-gaap_Revenues_7b7d7553-663c-4a24-a5de-b57496df1806" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_bcf5ab04-aaa8-4fc1-822e-8bfbabdaf407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_bcf5ab04-aaa8-4fc1-822e-8bfbabdaf407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_6757b79f-5ad3-42cf-bebc-5d7e432b6eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:to="loc_us-gaap_DepreciationAndAmortization_6757b79f-5ad3-42cf-bebc-5d7e432b6eed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_bea66a39-d40f-436c-baa7-dc2c86c6d1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_bea66a39-d40f-436c-baa7-dc2c86c6d1c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e0442d1f-e21c-4feb-b281-7fbcb55a4b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:to="loc_us-gaap_CostsAndExpenses_e0442d1f-e21c-4feb-b281-7fbcb55a4b0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a1a38866-2392-4f56-9438-57712af4c72f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_OperatingIncomeLoss_a1a38866-2392-4f56-9438-57712af4c72f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_616e5799-069f-46d3-9a35-f14af5f5b4e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_InterestExpense_616e5799-069f-46d3-9a35-f14af5f5b4e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fdbda9cf-37bf-4722-bacb-cdc70399e202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fdbda9cf-37bf-4722-bacb-cdc70399e202" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_dd3dc7f2-5db8-4ea8-aadb-9620d3fb7a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_OtherExpenses_dd3dc7f2-5db8-4ea8-aadb-9620d3fb7a40" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_32a2d7d5-eb01-4ca6-a176-7da4996d9099" xlink:href="moh-20201231.xsd#moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_32a2d7d5-eb01-4ca6-a176-7da4996d9099" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_620c5178-c232-4ffe-8e80-734cdb965888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_620c5178-c232-4ffe-8e80-734cdb965888" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_05209efb-0b7d-47fb-8ac2-85ae431a8b1f" xlink:href="moh-20201231.xsd#moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_05209efb-0b7d-47fb-8ac2-85ae431a8b1f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromSubsidiariesNetOfTax_17cee45a-5c05-4ed6-9dce-2d23be7427a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromSubsidiariesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_IncomeLossFromSubsidiariesNetOfTax_17cee45a-5c05-4ed6-9dce-2d23be7427a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_36149232-9d27-4881-b973-bbed3618beac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_NetIncomeLoss_36149232-9d27-4881-b973-bbed3618beac" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d8793188-8701-4403-8709-146d59e8cd4d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_0f51af37-ed36-479a-ad2f-d75afb6b3b35" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d8793188-8701-4403-8709-146d59e8cd4d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_7dd269e4-049f-4105-b00d-3a78a0a77f3c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d8793188-8701-4403-8709-146d59e8cd4d" xlink:to="loc_srt_ConsolidatedEntitiesAxis_7dd269e4-049f-4105-b00d-3a78a0a77f3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7dd269e4-049f-4105-b00d-3a78a0a77f3c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_7dd269e4-049f-4105-b00d-3a78a0a77f3c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7dd269e4-049f-4105-b00d-3a78a0a77f3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f9291a6a-31b2-4c38-8b30-cb87e7756945" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_7dd269e4-049f-4105-b00d-3a78a0a77f3c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f9291a6a-31b2-4c38-8b30-cb87e7756945" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_c031a60a-7cb2-49fe-9f1f-330fc15c0aa3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f9291a6a-31b2-4c38-8b30-cb87e7756945" xlink:to="loc_srt_ParentCompanyMember_c031a60a-7cb2-49fe-9f1f-330fc15c0aa3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails" xlink:type="extended" id="ic807e12775fa4d74bb472f6072f3cd48_CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_1922d0d8-5b70-41b8-8e8c-01e61174058f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b64c53b-9faf-4470-b250-8546eff4f5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_1922d0d8-5b70-41b8-8e8c-01e61174058f" xlink:to="loc_us-gaap_NetIncomeLoss_1b64c53b-9faf-4470-b250-8546eff4f5a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfOtherComprehensiveIncomeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_1922d0d8-5b70-41b8-8e8c-01e61174058f" xlink:to="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3a4fd20d-1312-4c24-915f-62d83d970612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3a4fd20d-1312-4c24-915f-62d83d970612" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_517423e4-7b63-4484-a52e-f9ab7b000ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_517423e4-7b63-4484-a52e-f9ab7b000ce9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bb1a935c-f227-478f-a09f-db96a751bc18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bb1a935c-f227-478f-a09f-db96a751bc18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7271917a-d3bc-463c-84c6-dde064a147ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7271917a-d3bc-463c-84c6-dde064a147ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_e40d9974-b284-4d23-8d8e-796e8c36af84" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_1922d0d8-5b70-41b8-8e8c-01e61174058f" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_e40d9974-b284-4d23-8d8e-796e8c36af84" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_04b9a158-e994-4194-9517-e60b70275428" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_e40d9974-b284-4d23-8d8e-796e8c36af84" xlink:to="loc_srt_ConsolidatedEntitiesAxis_04b9a158-e994-4194-9517-e60b70275428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_04b9a158-e994-4194-9517-e60b70275428_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_04b9a158-e994-4194-9517-e60b70275428" xlink:to="loc_srt_ConsolidatedEntitiesDomain_04b9a158-e994-4194-9517-e60b70275428_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_939443b9-56cb-4778-8710-df79eec27ce4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_04b9a158-e994-4194-9517-e60b70275428" xlink:to="loc_srt_ConsolidatedEntitiesDomain_939443b9-56cb-4778-8710-df79eec27ce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_77b8a574-aae6-435c-88f0-9d0fc0105e6f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_939443b9-56cb-4778-8710-df79eec27ce4" xlink:to="loc_srt_ParentCompanyMember_77b8a574-aae6-435c-88f0-9d0fc0105e6f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="extended" id="i65943dc401b7499db95e1c5f2d390faa_CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ea113ea9-2d8f-4cb7-8120-76896935a1c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ea113ea9-2d8f-4cb7-8120-76896935a1c0" xlink:to="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a66e863f-4388-4e6c-88c0-aff5ff183e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a66e863f-4388-4e6c-88c0-aff5ff183e06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_116919fe-5d90-4716-8ce7-d3306ddae8bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a66e863f-4388-4e6c-88c0-aff5ff183e06" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_116919fe-5d90-4716-8ce7-d3306ddae8bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_11df8118-c010-49ec-885f-8a01d0f9ffa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_11df8118-c010-49ec-885f-8a01d0f9ffa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_b3d81ea8-1c3a-4079-a33d-3732168c8091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_b3d81ea8-1c3a-4079-a33d-3732168c8091" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_1d774369-4899-4042-9bfc-24ce0c77d1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_1d774369-4899-4042-9bfc-24ce0c77d1f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f64c9880-e0dc-4cb2-a5e0-f4bfeeee5272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f64c9880-e0dc-4cb2-a5e0-f4bfeeee5272" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_114d0223-e3ee-451a-b7dc-a57cc14fcaf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_114d0223-e3ee-451a-b7dc-a57cc14fcaf1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1e4da96f-1b25-47c3-8fa3-87ab060375f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1e4da96f-1b25-47c3-8fa3-87ab060375f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_817ee971-e5fd-43ee-b279-cf9d5238af88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_817ee971-e5fd-43ee-b279-cf9d5238af88" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ChangesInAmountsDueToAndDueFromAffiliates_6b18a949-8b0a-4ec2-8ae7-28187f601b34" xlink:href="moh-20201231.xsd#moh_ChangesInAmountsDueToAndDueFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_moh_ChangesInAmountsDueToAndDueFromAffiliates_6b18a949-8b0a-4ec2-8ae7-28187f601b34" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c67f6878-4a5d-4c8f-b313-97886b6dd81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c67f6878-4a5d-4c8f-b313-97886b6dd81d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70b21940-79ff-46df-8bb4-4e36f6c44cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70b21940-79ff-46df-8bb4-4e36f6c44cfd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_37c25981-64ce-4f9e-ab2c-1b0bd2634a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_37c25981-64ce-4f9e-ab2c-1b0bd2634a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_fdbf1b4a-f657-4914-b430-a1ecb092038c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_fdbf1b4a-f657-4914-b430-a1ecb092038c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_ef6cee8d-2182-49d9-a4cc-d637716ccbb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_ef6cee8d-2182-49d9-a4cc-d637716ccbb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c2a5d5b5-9773-4505-8780-931a5dbd7145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c2a5d5b5-9773-4505-8780-931a5dbd7145" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_8ea1bf5f-a402-4774-9d2e-96590bbf4fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_8ea1bf5f-a402-4774-9d2e-96590bbf4fb7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants_db507e5f-edd6-47ab-be97-997620389afe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfWarrants_db507e5f-edd6-47ab-be97-997620389afe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashPaidForSettlementOfConversionOption_a8984707-42bc-433e-aa5d-02e59da3b060" xlink:href="moh-20201231.xsd#moh_CashPaidForSettlementOfConversionOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_moh_CashPaidForSettlementOfConversionOption_a8984707-42bc-433e-aa5d-02e59da3b060" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_ce2541bb-4596-44df-a262-e065ae82fa64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_ce2541bb-4596-44df-a262-e065ae82fa64" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_1b0ab4da-6a6a-42e4-9845-15d5b047b60d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_1b0ab4da-6a6a-42e4-9845-15d5b047b60d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_fa554471-c1a4-444c-807d-6ec228da72d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_fa554471-c1a4-444c-807d-6ec228da72d4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b389df71-277b-4316-a5b4-dc6d9e3ca077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b389df71-277b-4316-a5b4-dc6d9e3ca077" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b71bbd7c-fe28-4d02-8bd5-ebfc60a615e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b71bbd7c-fe28-4d02-8bd5-ebfc60a615e3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d597bc82-c0c8-4528-82c3-d83839c22d09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d597bc82-c0c8-4528-82c3-d83839c22d09" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82b1be96-bada-4a41-b58e-2702f3d93ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82b1be96-bada-4a41-b58e-2702f3d93ad8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cf685ed9-fc30-4dea-ac77-f1e6564108e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d9d339d5-5e45-4cc2-b5eb-b79a71de1bf2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ea113ea9-2d8f-4cb7-8120-76896935a1c0" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d9d339d5-5e45-4cc2-b5eb-b79a71de1bf2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_c4a9bf0e-4a61-49ce-9a92-7da8dd1dd6a0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d9d339d5-5e45-4cc2-b5eb-b79a71de1bf2" xlink:to="loc_srt_ConsolidatedEntitiesAxis_c4a9bf0e-4a61-49ce-9a92-7da8dd1dd6a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c4a9bf0e-4a61-49ce-9a92-7da8dd1dd6a0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c4a9bf0e-4a61-49ce-9a92-7da8dd1dd6a0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c4a9bf0e-4a61-49ce-9a92-7da8dd1dd6a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b1c50568-fb7d-4778-b9a1-916a3681f760" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c4a9bf0e-4a61-49ce-9a92-7da8dd1dd6a0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b1c50568-fb7d-4778-b9a1-916a3681f760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_8457e00b-f3e8-460c-9cc5-59b4e79ccebe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b1c50568-fb7d-4778-b9a1-916a3681f760" xlink:to="loc_srt_ParentCompanyMember_8457e00b-f3e8-460c-9cc5-59b4e79ccebe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails" xlink:type="extended" id="i824dc1626b3744be90ee0139e9e8dc16_CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_df0e0309-28c4-4f0f-85dc-3f4b9b397ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_68717359-55b8-41de-b6a6-104e01e53593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df0e0309-28c4-4f0f-85dc-3f4b9b397ffa" xlink:to="loc_us-gaap_RevenueFromRelatedParties_68717359-55b8-41de-b6a6-104e01e53593" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ad72f4d3-0c92-4742-a0ab-c3e5c48a546f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df0e0309-28c4-4f0f-85dc-3f4b9b397ffa" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ad72f4d3-0c92-4742-a0ab-c3e5c48a546f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_34048cfe-0c01-4733-a70c-e4e92a95bfd3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ad72f4d3-0c92-4742-a0ab-c3e5c48a546f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_34048cfe-0c01-4733-a70c-e4e92a95bfd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_34048cfe-0c01-4733-a70c-e4e92a95bfd3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_34048cfe-0c01-4733-a70c-e4e92a95bfd3" xlink:to="loc_srt_ConsolidatedEntitiesDomain_34048cfe-0c01-4733-a70c-e4e92a95bfd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f07cb64e-d475-4e80-86d0-7e766d37bd15" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_34048cfe-0c01-4733-a70c-e4e92a95bfd3" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f07cb64e-d475-4e80-86d0-7e766d37bd15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_95eca7c1-7b7a-44c7-90d1-af9efcf5520e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f07cb64e-d475-4e80-86d0-7e766d37bd15" xlink:to="loc_srt_ParentCompanyMember_95eca7c1-7b7a-44c7-90d1-af9efcf5520e" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>moh-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:47c0ca76-68d6-49cb-bbea-26491dea6a9b,g:4ece894a-24af-4e0b-a6cb-0ef0dba60516-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ee6edce0-b8d7-4644-a3df-1315c1580103_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_19c4db07-7bbf-46ab-b029-9ab7322b7487_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_be29dba1-823c-4138-a5df-f6cee839de99_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8a55caac-f652-4fd6-ae3b-d9fa12d1183f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_OtherClaimsPayable_15825def-ff9d-4871-85bd-56f3f66246ce_terseLabel_en-US" xlink:label="lab_moh_OtherClaimsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_moh_OtherClaimsPayable_label_en-US" xlink:label="lab_moh_OtherClaimsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Claims Payable</link:label>
    <link:label id="lab_moh_OtherClaimsPayable_documentation_en-US" xlink:label="lab_moh_OtherClaimsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Claims Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherClaimsPayable" xlink:href="moh-20201231.xsd#moh_OtherClaimsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_OtherClaimsPayable" xlink:to="lab_moh_OtherClaimsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_cc20570a-b585-4c0f-980e-9225e4d63cd8_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesTable_989c78d6-24e5-42e0-b83e-512d04155c32_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Table]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesTable_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable" xlink:to="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CashConvertibleSeniorNotesDue2020WarrantsMember_7876822d-574e-476e-8e1d-a222e36ff75b_terseLabel_en-US" xlink:label="lab_moh_CashConvertibleSeniorNotesDue2020WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.125% Warrants</link:label>
    <link:label id="lab_moh_CashConvertibleSeniorNotesDue2020WarrantsMember_label_en-US" xlink:label="lab_moh_CashConvertibleSeniorNotesDue2020WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Convertible Senior Notes Due 2020, Warrants [Member]</link:label>
    <link:label id="lab_moh_CashConvertibleSeniorNotesDue2020WarrantsMember_documentation_en-US" xlink:label="lab_moh_CashConvertibleSeniorNotesDue2020WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Convertible Senior Notes Due 2020, Warrants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020WarrantsMember" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020WarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CashConvertibleSeniorNotesDue2020WarrantsMember" xlink:to="lab_moh_CashConvertibleSeniorNotesDue2020WarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_41c4e8ed-2556-4bdb-a79e-eb62ff7a80bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d704c609-70f4-4468-b8a6-754d4fa21285_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_0be1cec4-67a7-4667-86b0-05f095cfff1a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceRecoveries_731e7553-e943-427c-a167-dad7d46f598f_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoveries</link:label>
    <link:label id="lab_us-gaap_InsuranceRecoveries_label_en-US" xlink:label="lab_us-gaap_InsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Recoveries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRecoveries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceRecoveries" xlink:to="lab_us-gaap_InsuranceRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_768bedfb-cc70-4ffb-92e4-c8cc3c6ee30d_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expenses</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_05862c1f-f82a-49c7-9425-ab3fc9df8975_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c70c0727-0e22-40a8-b934-6056c15c72ab_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77d45592-2e1f-4f97-9a6c-422a67aa0979_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction_9ae4087d-99f1-4645-9868-a92ce78740e3_negatedTerseLabel_en-US" xlink:label="lab_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Worthless stock deduction</link:label>
    <link:label id="lab_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction_label_en-US" xlink:label="lab_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Worthless Stock Deduction</link:label>
    <link:label id="lab_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction_documentation_en-US" xlink:label="lab_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Worthless Stock Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" xlink:href="moh-20201231.xsd#moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" xlink:to="lab_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f6085961-115c-4c7f-978a-d6d58af32e32_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_d35aec63-33b5-48bc-98e7-aed37c45e4e0_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of ROU assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_HealthCareInsuranceFeeLiability_392b5e14-96a8-4eb8-99d5-aee3577aefc5_terseLabel_en-US" xlink:label="lab_moh_HealthCareInsuranceFeeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIF liabilities</link:label>
    <link:label id="lab_moh_HealthCareInsuranceFeeLiability_label_en-US" xlink:label="lab_moh_HealthCareInsuranceFeeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Insurance, Fee, Liability</link:label>
    <link:label id="lab_moh_HealthCareInsuranceFeeLiability_documentation_en-US" xlink:label="lab_moh_HealthCareInsuranceFeeLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Insurance, Fee, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthCareInsuranceFeeLiability" xlink:href="moh-20201231.xsd#moh_HealthCareInsuranceFeeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_HealthCareInsuranceFeeLiability" xlink:to="lab_moh_HealthCareInsuranceFeeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_20bfcbc7-df86-4800-9c31-e116501589b1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_b57c3338-9af5-48e9-b09d-f028b2db1696_verboseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_ccd17847-98a9-4b1f-9417-77222627abdc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_c772fdd4-a75a-4748-8c36-12042f0d28dc_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Year 2018</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_HealthPlansSegmentMember_3a9add5e-dfa1-4ece-a2c6-7a2762b0747f_terseLabel_en-US" xlink:label="lab_moh_HealthPlansSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Plans Segment</link:label>
    <link:label id="lab_moh_HealthPlansSegmentMember_label_en-US" xlink:label="lab_moh_HealthPlansSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Plans Segment [Member]</link:label>
    <link:label id="lab_moh_HealthPlansSegmentMember_documentation_en-US" xlink:label="lab_moh_HealthPlansSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Plans Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansSegmentMember" xlink:href="moh-20201231.xsd#moh_HealthPlansSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_HealthPlansSegmentMember" xlink:to="lab_moh_HealthPlansSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_732f0a71-d2a6-4ffc-bb81-cbe514378de8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_3df48eab-a968-4f01-9119-228df659822c_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSAs</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c8984cba-eb34-47b9-b027-38cd39ce32c1_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1a4f91ba-c342-40ec-980e-966b5b93f18d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested balance, beginning balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_45c34d11-da34-43a5-b974-a2a4a3c010d0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested balance, ending balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_8a2b8bb6-51fa-459d-97ed-38cdfa8c138a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromSubsidiariesNetOfTax_8f11b29b-3eff-46a9-8323-14014cb18c77_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromSubsidiariesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net earnings of subsidiaries</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromSubsidiariesNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromSubsidiariesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Subsidiaries, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromSubsidiariesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromSubsidiariesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromSubsidiariesNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromSubsidiariesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MaineCommunityHealthOptionsv.UnitedStatesMember_937829b2-cd10-49b5-8785-8870b1d6b71a_terseLabel_en-US" xlink:label="lab_moh_MaineCommunityHealthOptionsv.UnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maine Community Health Options v. United States</link:label>
    <link:label id="lab_moh_MaineCommunityHealthOptionsv.UnitedStatesMember_label_en-US" xlink:label="lab_moh_MaineCommunityHealthOptionsv.UnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maine Community Health Options v. United States [Member]</link:label>
    <link:label id="lab_moh_MaineCommunityHealthOptionsv.UnitedStatesMember_documentation_en-US" xlink:label="lab_moh_MaineCommunityHealthOptionsv.UnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maine Community Health Options v. United States [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MaineCommunityHealthOptionsv.UnitedStatesMember" xlink:href="moh-20201231.xsd#moh_MaineCommunityHealthOptionsv.UnitedStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MaineCommunityHealthOptionsv.UnitedStatesMember" xlink:to="lab_moh_MaineCommunityHealthOptionsv.UnitedStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_afeed53e-c30d-4ae8-ae03-99d69ce82efd_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal - undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_e71a4b8c-5fed-4b9f-aa31-0a5037741671_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4a68ea7e-d1f7-480e-ac90-cab1d106950a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_d38767ea-0104-4d31-b845-60333751443f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8900375f-a452-47a0-956a-ebe2f6f61adc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_586f92a3-c136-401e-94af-9da2c9a4e9f7_verboseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed statements of cash flows</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_b11c635a-6b50-42ff-8702-3c0235ee98a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ConvertibleSeniorNotesMember_cf3b9a82-7037-4b35-a3d2-280b3060a32d_terseLabel_en-US" xlink:label="lab_moh_ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_moh_ConvertibleSeniorNotesMember_label_en-US" xlink:label="lab_moh_ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes [Member]</link:label>
    <link:label id="lab_moh_ConvertibleSeniorNotesMember_documentation_en-US" xlink:label="lab_moh_ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ConvertibleSeniorNotesMember" xlink:href="moh-20201231.xsd#moh_ConvertibleSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ConvertibleSeniorNotesMember" xlink:to="lab_moh_ConvertibleSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_bf5f27b7-9f53-41a2-b5ce-f72830022d07_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b851f336-0c43-487b-aca7-87846e40a684_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f27c8099-8446-4495-aff7-3be200f7eb84_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4422bb9b-4ce2-44cc-acf2-f1eb9fd9f96f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6f6a76da-d6a6-409e-84dd-8e4ea1ec9c03_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1848127c-0250-4731-9ab2-16be87c612b2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a9458ab6-07f6-4427-8678-ac31e0889707_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_UnrecognizedCompensationForfeitedRate_e651be77-29f4-4cd8-b938-70320d7dad01_verboseLabel_en-US" xlink:label="lab_moh_UnrecognizedCompensationForfeitedRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation forfeited rate</link:label>
    <link:label id="lab_moh_UnrecognizedCompensationForfeitedRate_label_en-US" xlink:label="lab_moh_UnrecognizedCompensationForfeitedRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Forfeited Rate</link:label>
    <link:label id="lab_moh_UnrecognizedCompensationForfeitedRate_documentation_en-US" xlink:label="lab_moh_UnrecognizedCompensationForfeitedRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation forfeited rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_UnrecognizedCompensationForfeitedRate" xlink:href="moh-20201231.xsd#moh_UnrecognizedCompensationForfeitedRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_UnrecognizedCompensationForfeitedRate" xlink:to="lab_moh_UnrecognizedCompensationForfeitedRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ddae6c17-9dcc-482f-b546-3dad1eff3ca9_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_9d277cc0-15d2-4844-8f6e-69cd156d0c06_verboseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryovers</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_4a81a072-4f89-4e47-a1a9-efdbdd078d7a_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_b8d23435-63d4-4bbc-bf64-d50135410519_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_f43cd49a-bcfb-49b9-999f-1b1359008f42_terseLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding at the beginning of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_e44cdc76-a2d1-4111-869d-4ce14d00bd8f_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_aa54aa54-a1bb-4d33-8e4d-9449dc5b63f7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AssetsAndLiabilitiesLesseeTableTextBlock_bece152b-4513-4625-81b0-78f524125593_terseLabel_en-US" xlink:label="lab_moh_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental lease information</link:label>
    <link:label id="lab_moh_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_moh_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_moh_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_moh_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="moh-20201231.xsd#moh_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_moh_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_8c449459-1a2f-4509-94db-404141a0f5b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lower end of range (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5b78391c-a41c-4a2c-b92c-17bc3e845c3a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_42e13c6c-9c6c-4568-8690-6cf2e9783467_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_c2313893-55a7-49bb-9dd5-e6bbc6655a44_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_8b8108ba-555e-47f2-b3b0-964b18ec9e84_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8e64943a-455d-4681-8def-1e6c3f7907d0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_6842e9cc-3ed0-491d-b534-6a6c869e514e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_f7217a0b-5918-4a17-9d12-475aae700687_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_23e3c832-8fcc-4195-b4e0-70c79d4b5a1c_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_630f798f-1798-45ec-a082-1b881ce160d4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_aaef4b32-79f9-4671-9b40-1f29d9cdeb48_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0cddb4fd-8e4c-4cbf-975a-de051d9a30b5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_f7f14c11-5712-4095-bba1-671b51325197_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims and benefits payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Health Care Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_430c8e2f-0aa9-424c-9990-08e8cd657d70_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_d0654b69-c762-4847-a456-b277ad918083_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_HealthInsurerFeeReimbursementReceivablesMember_5f48243a-b715-4465-ad6a-4e154dbddbf4_terseLabel_en-US" xlink:label="lab_moh_HealthInsurerFeeReimbursementReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee reimbursement receivables</link:label>
    <link:label id="lab_moh_HealthInsurerFeeReimbursementReceivablesMember_label_en-US" xlink:label="lab_moh_HealthInsurerFeeReimbursementReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee Reimbursement Receivables [Member]</link:label>
    <link:label id="lab_moh_HealthInsurerFeeReimbursementReceivablesMember_documentation_en-US" xlink:label="lab_moh_HealthInsurerFeeReimbursementReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee Reimbursement Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthInsurerFeeReimbursementReceivablesMember" xlink:href="moh-20201231.xsd#moh_HealthInsurerFeeReimbursementReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_HealthInsurerFeeReimbursementReceivablesMember" xlink:to="lab_moh_HealthInsurerFeeReimbursementReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_688e2fb0-71d1-4914-9a0d-5f1c5a7e066c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_36ad647c-5996-453b-af8a-f83bcb0bb830_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued medical costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_58761f51-b963-4dd4-b86a-531dbdc87ad2_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold_b7d99726-bd48-421b-82d5-6dafdd73595a_terseLabel_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum MLR</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold_label_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies, Marketplace, Medical Loss Ratio Threshold</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold_documentation_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies, Marketplace, Medical Loss Ratio Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold" xlink:to="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_FinanceLeaseLiabilitiesLesseeAbstract_1ce66863-f52f-4e54-8df2-5e77d44ea4cc_terseLabel_en-US" xlink:label="lab_moh_FinanceLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_moh_FinanceLeaseLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_moh_FinanceLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_moh_FinanceLeaseLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_moh_FinanceLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract" xlink:href="moh-20201231.xsd#moh_FinanceLeaseLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract" xlink:to="lab_moh_FinanceLeaseLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract_dc117e94-ee73-49d3-80d6-89af9df31488_terseLabel_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid program:</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract_label_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies, Medicaid Program [Abstract]</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract_documentation_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies, Medicaid Program [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract" xlink:to="lab_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_81fc0191-d3c6-48fd-aea5-fb45036d7205_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_13e5cb28-0074-4b1d-a9ff-b1a6eaaa7271_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_717f0f9f-06e0-4206-99d1-c3babe8b6f3a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_4108ef1a-29fe-411b-b973-981959e7ecf6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions to subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Additional Interest in Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:to="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b47848f3-9906-4f59-99a0-b17bfd6b04df_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_855a0569-1c0d-4542-9d65-2b26e67c0fd3_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation and Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_c4fc0c09-c9f0-4bd1-95b2-5d6527a58c76_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims and Benefits Payable</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance and Deposit Contracts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:to="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_57c42dc6-59b7-48d0-9525-6b4b22a5e93f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_8cefe730-8d22-412c-9c81-f163c1a108a1_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income and other revenue</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:to="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1accfa95-f6d8-4892-a223-5366b99438bb_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_3752e439-694d-4285-8129-0814982f8f04_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8b9f487d-2265-48f1-925c-24d3d18b1eea_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_90e5c2aa-bbfd-4cd4-821b-06d3497507f2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32a62a7d-7429-4933-aeaa-06755c403bfb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePremiumMember_5c42b04d-a77a-481a-85c9-90f470e0288c_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePremiumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePremiumMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePremiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Premium [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePremiumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCarePremiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePremiumMember" xlink:to="lab_us-gaap_HealthCarePremiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4323e02c-0ae1-4805-ba9f-32d2f2c7369e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued under ESPP (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_NumberOfMembersEligibleForTheHealthCarePrograms_d5503d1e-030b-4d59-ba95-faa7bb549a6f_terseLabel_en-US" xlink:label="lab_moh_NumberOfMembersEligibleForTheHealthCarePrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of served members</link:label>
    <link:label id="lab_moh_NumberOfMembersEligibleForTheHealthCarePrograms_label_en-US" xlink:label="lab_moh_NumberOfMembersEligibleForTheHealthCarePrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Members Eligible For The Health Care Programs</link:label>
    <link:label id="lab_moh_NumberOfMembersEligibleForTheHealthCarePrograms_documentation_en-US" xlink:label="lab_moh_NumberOfMembersEligibleForTheHealthCarePrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of members eligible for the health care programs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NumberOfMembersEligibleForTheHealthCarePrograms" xlink:href="moh-20201231.xsd#moh_NumberOfMembersEligibleForTheHealthCarePrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_NumberOfMembersEligibleForTheHealthCarePrograms" xlink:to="lab_moh_NumberOfMembersEligibleForTheHealthCarePrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_InvestmentsAverageMaturityPeriod_029f8ffd-e198-43f3-911e-f9e04f5ea589_terseLabel_en-US" xlink:label="lab_moh_InvestmentsAverageMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average maturity period (less than)</link:label>
    <link:label id="lab_moh_InvestmentsAverageMaturityPeriod_label_en-US" xlink:label="lab_moh_InvestmentsAverageMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Average Maturity Period</link:label>
    <link:label id="lab_moh_InvestmentsAverageMaturityPeriod_documentation_en-US" xlink:label="lab_moh_InvestmentsAverageMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Average Maturity Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_InvestmentsAverageMaturityPeriod" xlink:href="moh-20201231.xsd#moh_InvestmentsAverageMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_InvestmentsAverageMaturityPeriod" xlink:to="lab_moh_InvestmentsAverageMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e14801df-cf67-4e8b-a5c6-b3de1822a41a_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_6b082ecd-09b2-4f22-a3df-5a91f940cbab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, by balance sheet grouping</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_8ff973c2-87f1-4c8b-871c-6fb7b5e6fd07_verboseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate statutory capital and surplus</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_ac59e6e6-eab1-4775-9626-00f8dbbfa866_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivatives, net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedInvestmentsNoncurrent_90f0fae6-dc0a-42ef-9f2b-5b72b767abe9_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted investments</link:label>
    <link:label id="lab_us-gaap_RestrictedInvestmentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Investments, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedInvestmentsNoncurrent" xlink:to="lab_us-gaap_RestrictedInvestmentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_7d6fc2bb-536e-4b15-9986-bb26399429d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_0ffbcc7a-74a0-413e-9c13-1d26fc17a6fe_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease financing obligation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_PremiumTaxRevenueMember_daeda8a2-f2bd-4609-93c5-3a1bdb3fafa5_terseLabel_en-US" xlink:label="lab_moh_PremiumTaxRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium tax revenue</link:label>
    <link:label id="lab_moh_PremiumTaxRevenueMember_label_en-US" xlink:label="lab_moh_PremiumTaxRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Tax Revenue [Member]</link:label>
    <link:label id="lab_moh_PremiumTaxRevenueMember_documentation_en-US" xlink:label="lab_moh_PremiumTaxRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Tax Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PremiumTaxRevenueMember" xlink:href="moh-20201231.xsd#moh_PremiumTaxRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_PremiumTaxRevenueMember" xlink:to="lab_moh_PremiumTaxRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_TermLoanMember_d1988e38-5a47-49a9-b588-24bf7fd97497_verboseLabel_en-US" xlink:label="lab_moh_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan facility</link:label>
    <link:label id="lab_moh_TermLoanMember_label_en-US" xlink:label="lab_moh_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_moh_TermLoanMember_documentation_en-US" xlink:label="lab_moh_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_TermLoanMember" xlink:href="moh-20201231.xsd#moh_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_TermLoanMember" xlink:to="lab_moh_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1fb6ff02-d4a2-44f2-aab1-c7be083f0f4d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_HealthPlanContractTerm_6b21ea20-dafe-40dd-8beb-2d235d913a82_terseLabel_en-US" xlink:label="lab_moh_HealthPlanContractTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract term</link:label>
    <link:label id="lab_moh_HealthPlanContractTerm_label_en-US" xlink:label="lab_moh_HealthPlanContractTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Plan, Contract Term</link:label>
    <link:label id="lab_moh_HealthPlanContractTerm_documentation_en-US" xlink:label="lab_moh_HealthPlanContractTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Plan, Contract Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlanContractTerm" xlink:href="moh-20201231.xsd#moh_HealthPlanContractTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_HealthPlanContractTerm" xlink:to="lab_moh_HealthPlanContractTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_16de869e-eaa5-46e4-950a-520e7dbb8183_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_935e84bc-0175-42df-997b-5856d2adb3bc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable_7f6543a7-c817-4be9-926d-f2fe08fcdd28_terseLabel_en-US" xlink:label="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk adjustment, net payable</link:label>
    <link:label id="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable_label_en-US" xlink:label="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Net Payable</link:label>
    <link:label id="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable_documentation_en-US" xlink:label="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Net Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable" xlink:href="moh-20201231.xsd#moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable" xlink:to="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_7e729421-db61-4aa9-b155-abf93ecd7733_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_a4f29d66-d230-485f-930a-6ed012acd8e0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e8305cd5-36e1-4d30-b9a0-42fd1d215058_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_beed71a3-1d09-4094-9b1b-e786d6b61bec_verboseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required minimum statutory capital surplus</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_c139ceb4-1656-42f6-80df-5f3a45feef79_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f60f19fd-1ad0-4563-91d1-7bc2d7ac74c4_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a349fd51-1174-43e1-b62f-fe559238752d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used in financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_3e1439f9-8e3d-469b-b95e-e0efd3462bb2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition - Magellan Complete Care</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AdvancesToRelatedPartiesAndOtherAssets_0a6e557e-729f-4205-a322-f566deb40ac7_verboseLabel_en-US" xlink:label="lab_moh_AdvancesToRelatedPartiesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to related parties and other assets</link:label>
    <link:label id="lab_moh_AdvancesToRelatedPartiesAndOtherAssets_label_en-US" xlink:label="lab_moh_AdvancesToRelatedPartiesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances To Related Parties And Other Assets</link:label>
    <link:label id="lab_moh_AdvancesToRelatedPartiesAndOtherAssets_documentation_en-US" xlink:label="lab_moh_AdvancesToRelatedPartiesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to related parties and other assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AdvancesToRelatedPartiesAndOtherAssets" xlink:href="moh-20201231.xsd#moh_AdvancesToRelatedPartiesAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AdvancesToRelatedPartiesAndOtherAssets" xlink:to="lab_moh_AdvancesToRelatedPartiesAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_5f84f271-ba61-4ff4-bf64-2950c36c0c9d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of lease expense and supplemental consolidated cash flow information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aebe2cc4-3793-40a2-8e8b-c345d438a98c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7cb389cb-2eb8-40f1-869e-ec6b97c7bdb2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_7e3083d8-6695-4803-b304-689cc6f21715_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_88695b3d-2a74-4fc5-87f2-1d18221f1568_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_DispositionofBusinessReceivablefromBuyer_b9a85be8-8091-46b1-8cfa-605bdc2f44a9_terseLabel_en-US" xlink:label="lab_moh_DispositionofBusinessReceivablefromBuyer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from buyers</link:label>
    <link:label id="lab_moh_DispositionofBusinessReceivablefromBuyer_label_en-US" xlink:label="lab_moh_DispositionofBusinessReceivablefromBuyer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition of Business, Receivable from Buyer</link:label>
    <link:label id="lab_moh_DispositionofBusinessReceivablefromBuyer_documentation_en-US" xlink:label="lab_moh_DispositionofBusinessReceivablefromBuyer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition of Business, Receivable from Buyer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DispositionofBusinessReceivablefromBuyer" xlink:href="moh-20201231.xsd#moh_DispositionofBusinessReceivablefromBuyer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_DispositionofBusinessReceivablefromBuyer" xlink:to="lab_moh_DispositionofBusinessReceivablefromBuyer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_54842d12-e006-4ecd-a690-6179ac0a76ff_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_53c323d4-638e-4c7e-8e61-9823d7a13f6b_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_5e3f4770-9dde-48e6-99d5-60184af880e2_verboseLabel_en-US" xlink:label="lab_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets of subsidiaries subject to restrictions</link:label>
    <link:label id="lab_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Restricted Net Assets for Consolidated and Unconsolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" xlink:to="lab_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0827215d-5ce5-4263-b30a-2fee2e124bf8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_d666f78a-ac19-4bfb-abd9-ff3fb94c7026_totalLabel_en-US" xlink:label="lab_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income tax (benefit) expense and equity in net earnings of subsidiaries</link:label>
    <link:label id="lab_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_label_en-US" xlink:label="lab_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Before Income Taxes And Equity In Net Income Of Subsidiaries</link:label>
    <link:label id="lab_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_documentation_en-US" xlink:label="lab_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Before Income Taxes And Equity In Net Income Of Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" xlink:href="moh-20201231.xsd#moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" xlink:to="lab_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_702e9136-a4d3-42a1-8e88-167ff9c87e83_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested balance, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_243d373e-9a9d-4630-9749-3d82a44caad3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested balance, shares end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_e895851c-cde8-4e87-b58f-79904bac25f0_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Year 2020</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_fa1537e2-431e-4a8e-945a-b8d29207449b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Year 2020</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_de84ecf3-32b1-44bb-9f37-e5e73b005c44_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease expense:</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_692d60f0-39bf-4927-be55-46f850ca0e28_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_bb9cd25e-d6de-4a6c-9a35-71a4a37fd4f3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_7de9a9b0-18be-4d88-a1b8-8a1f58e68a5c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_143d0e78-0fc4-4ab2-b866-1f9c1ae6a9d6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_a5b8ad1c-b58a-4958-a475-e34fd8996ac1_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_9ed83829-e378-4b1b-ad74-b580fd0907ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_61085caf-5a0b-4402-ac05-3d9d89a5b071_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b107f1fd-22e6-401b-9066-d79cac09564d_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_YourCareHealthPlanIncMember_c7299809-e95f-4d3d-a5ee-58aa81dba7dc_terseLabel_en-US" xlink:label="lab_moh_YourCareHealthPlanIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Your Care Health Plan Inc</link:label>
    <link:label id="lab_moh_YourCareHealthPlanIncMember_label_en-US" xlink:label="lab_moh_YourCareHealthPlanIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Your Care Health Plan Inc [Member]</link:label>
    <link:label id="lab_moh_YourCareHealthPlanIncMember_documentation_en-US" xlink:label="lab_moh_YourCareHealthPlanIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Your Care Health Plan Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_YourCareHealthPlanIncMember" xlink:href="moh-20201231.xsd#moh_YourCareHealthPlanIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_YourCareHealthPlanIncMember" xlink:to="lab_moh_YourCareHealthPlanIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_IncreaseDecreaseinCarryingAmountofAssets_6cf15dca-8bbb-4abb-b1ea-79e60cf6faa5_terseLabel_en-US" xlink:label="lab_moh_IncreaseDecreaseinCarryingAmountofAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in carrying amount of assets</link:label>
    <link:label id="lab_moh_IncreaseDecreaseinCarryingAmountofAssets_label_en-US" xlink:label="lab_moh_IncreaseDecreaseinCarryingAmountofAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Carrying Amount of Assets</link:label>
    <link:label id="lab_moh_IncreaseDecreaseinCarryingAmountofAssets_documentation_en-US" xlink:label="lab_moh_IncreaseDecreaseinCarryingAmountofAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Carrying Amount of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncreaseDecreaseinCarryingAmountofAssets" xlink:href="moh-20201231.xsd#moh_IncreaseDecreaseinCarryingAmountofAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_IncreaseDecreaseinCarryingAmountofAssets" xlink:to="lab_moh_IncreaseDecreaseinCarryingAmountofAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_8adfcbd0-8548-40bf-a9d0-16da391d958b_verboseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_606ced13-f232-43f1-ac30-5a439f062461_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_41312d55-d52e-4ccd-a6a6-0ddb85b2ed0a_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_c843ce51-816a-469a-961d-0d610e117a5c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Weighted Average Remaining Contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_34650a7b-a82e-413e-b154-b77271651410_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f8dbef3c-de17-4c9e-bc05-d43b96e76c97_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_21719602-6682-4886-9e7e-b00c11bb905d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_06abe2c3-9228-4503-a7ec-5b921d5ab0ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes_c8125b8d-a0c3-4e02-8f8e-5944ffa731b1_terseLabel_en-US" xlink:label="lab_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible senior notes (in shares)</link:label>
    <link:label id="lab_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes_label_en-US" xlink:label="lab_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Conversion of Senior Notes</link:label>
    <link:label id="lab_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes_documentation_en-US" xlink:label="lab_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Conversion of Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" xlink:href="moh-20201231.xsd#moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" xlink:to="lab_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_d6f3ec6d-4db2-4511-8b53-d3f271ece32f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which company operates (in state)</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_2ca29ef6-019a-4aa4-953c-1e5e1a0bbd41_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_RisksAndUncertaintiesPolicyTextBlock_9b9e4ce5-29e1-4765-8ad1-3d39224a3221_verboseLabel_en-US" xlink:label="lab_moh_RisksAndUncertaintiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties</link:label>
    <link:label id="lab_moh_RisksAndUncertaintiesPolicyTextBlock_label_en-US" xlink:label="lab_moh_RisksAndUncertaintiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks And Uncertainties [Policy Text Block]</link:label>
    <link:label id="lab_moh_RisksAndUncertaintiesPolicyTextBlock_documentation_en-US" xlink:label="lab_moh_RisksAndUncertaintiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and uncertainties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RisksAndUncertaintiesPolicyTextBlock" xlink:href="moh-20201231.xsd#moh_RisksAndUncertaintiesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_RisksAndUncertaintiesPolicyTextBlock" xlink:to="lab_moh_RisksAndUncertaintiesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_29befedb-1722-46ff-a3b5-16df2b8c31ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs and PSUs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_SeniorNotesDue2022Member_e0845f6b-d06f-48e2-98f3-49b1f688105f_terseLabel_en-US" xlink:label="lab_moh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.375% Notes</link:label>
    <link:label id="lab_moh_SeniorNotesDue2022Member_label_en-US" xlink:label="lab_moh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Due 2022 [Member]</link:label>
    <link:label id="lab_moh_SeniorNotesDue2022Member_documentation_en-US" xlink:label="lab_moh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SeniorNotesDue2022Member" xlink:href="moh-20201231.xsd#moh_SeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_SeniorNotesDue2022Member" xlink:to="lab_moh_SeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CompleteCareReceivablesMember_6e9a99f7-cacc-4d03-860b-818feaacca5f_terseLabel_en-US" xlink:label="lab_moh_CompleteCareReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Complete Care</link:label>
    <link:label id="lab_moh_CompleteCareReceivablesMember_label_en-US" xlink:label="lab_moh_CompleteCareReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete Care Receivables [Member]</link:label>
    <link:label id="lab_moh_CompleteCareReceivablesMember_documentation_en-US" xlink:label="lab_moh_CompleteCareReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete Care Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CompleteCareReceivablesMember" xlink:href="moh-20201231.xsd#moh_CompleteCareReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CompleteCareReceivablesMember" xlink:to="lab_moh_CompleteCareReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_158ffede-cb32-4d84-b247-f36bed136dde_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in deferred tax asset valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_26324d01-60a0-4947-985f-71e70206dd6b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryNotesSecuritiesMember_fc62a3b1-f4ee-4a73-8e69-d5c1be4226e4_netLabel_en-US" xlink:label="lab_us-gaap_USTreasuryNotesSecuritiesMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury notes</link:label>
    <link:label id="lab_us-gaap_USTreasuryNotesSecuritiesMember_6559c904-fec6-43a0-8bd6-a9d9f7bcf82e_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryNotesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury notes</link:label>
    <link:label id="lab_us-gaap_USTreasuryNotesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryNotesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Notes Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryNotesSecuritiesMember" xlink:to="lab_us-gaap_USTreasuryNotesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_f5d7467a-7616-473a-b797-8f7ffc6ca968_verboseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost, Due in one year or less</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_6a27754c-2c2e-43e0-8c56-6a8e88bbd5df_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_eaa832aa-a370-4a9d-b0e3-e328be41aece_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_DeferredCompensationPlanDeferralPercentageOfBonus_4a00f4d1-83e4-42e2-9413-2c432db119f2_verboseLabel_en-US" xlink:label="lab_moh_DeferredCompensationPlanDeferralPercentageOfBonus" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan deferral percentage of bonus</link:label>
    <link:label id="lab_moh_DeferredCompensationPlanDeferralPercentageOfBonus_label_en-US" xlink:label="lab_moh_DeferredCompensationPlanDeferralPercentageOfBonus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Deferral Percentage Of Bonus</link:label>
    <link:label id="lab_moh_DeferredCompensationPlanDeferralPercentageOfBonus_documentation_en-US" xlink:label="lab_moh_DeferredCompensationPlanDeferralPercentageOfBonus" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan deferral percentage of bonus.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DeferredCompensationPlanDeferralPercentageOfBonus" xlink:href="moh-20201231.xsd#moh_DeferredCompensationPlanDeferralPercentageOfBonus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_DeferredCompensationPlanDeferralPercentageOfBonus" xlink:to="lab_moh_DeferredCompensationPlanDeferralPercentageOfBonus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_cc9ef94d-4a63-4157-9bb4-882cfb7b144d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5af7d689-771c-4254-be0f-541329e4d151_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares, outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_82d2947f-c22c-42ae-9f7a-6101dd1b2c47_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_bf4e25a6-48dc-4a4e-b348-8dcd5f28086f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0eb8f7f1-8383-41e9-8437-3efc2bece846_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_57ee2081-9446-45a9-9668-e2e3a9430721_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_fd848293-4dc1-4389-afe9-a5910cae31fc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Complete Care</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_25d33af5-f7bf-4766-a4fa-a6197d515b1e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, outstanding (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b3061658-5f96-4d7d-a240-636a61016af8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, outstanding (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_78ebfd56-fa1f-4988-ad1f-b1aec449964d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash paid in business combinations</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f8c940cb-5353-461b-816a-0366b6c248a3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash paid in business combinations</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_dc45f46d-7b97-443b-8a2a-50364fb65443_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount_8bad4df0-8d6a-4ccc-a913-c52e75e76176_terseLabel_en-US" xlink:label="lab_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service claims incurred but not paid (&#8220;IBNP&#8221;)</link:label>
    <link:label id="lab_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount_label_en-US" xlink:label="lab_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Paid (IBNP), Fee-for-service Claims, Amount</link:label>
    <link:label id="lab_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount_documentation_en-US" xlink:label="lab_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Paid (IBNP), Fee-for-service Claims, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" xlink:href="moh-20201231.xsd#moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" xlink:to="lab_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable_06195902-0cb5-4432-b0a1-b97f0c8c4d62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in premiums</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Premiums Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_PR_02b38447-fcb5-4158-9f9a-f35cd502765d_terseLabel_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PUERTO RICO</link:label>
    <link:label id="lab_country_PR_label_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PUERTO RICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_PR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_PR" xlink:to="lab_country_PR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_45c160fd-561e-4603-9d06-ac4cf94a60c6_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_03ab29bf-7c54-4dd6-baa3-f86f51ffc031_verboseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1bd44aaf-4087-4d40-9953-7a84de2640fb_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_91a63ce3-8f63-4e1a-8f3f-ed63fc515874_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AmountsDuetoGovernmentAgenciesOther_d9d90035-b193-4800-87a6-ea4af794f25f_terseLabel_en-US" xlink:label="lab_moh_AmountsDuetoGovernmentAgenciesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_moh_AmountsDuetoGovernmentAgenciesOther_label_en-US" xlink:label="lab_moh_AmountsDuetoGovernmentAgenciesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due to Government Agencies, Other</link:label>
    <link:label id="lab_moh_AmountsDuetoGovernmentAgenciesOther_documentation_en-US" xlink:label="lab_moh_AmountsDuetoGovernmentAgenciesOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due to Government Agencies, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDuetoGovernmentAgenciesOther" xlink:href="moh-20201231.xsd#moh_AmountsDuetoGovernmentAgenciesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AmountsDuetoGovernmentAgenciesOther" xlink:to="lab_moh_AmountsDuetoGovernmentAgenciesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f051a792-f480-4db5-bec4-cfa375d815f3_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating segment information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_1159acab-57e8-46fc-bce5-335544b6c087_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_2b77455d-1855-4504-985f-f55647c1844a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statements of Income</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f98a3bc5-372c-4729-b9e2-be931ddd7b90_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_debe6416-734a-453c-9e69-652920559ec6_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual maturities of investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c3122dc8-c627-4270-923b-0fa069159a0c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_e053dba5-0f44-4324-be87-e61fd0406aeb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_77fb89b7-8509-4552-8e11-f9af99e27849_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_00b2f778-b3c4-4c82-9e20-e61ee8549ec4_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold_f37dee29-e6b9-47b9-a613-747b3bfe3202_terseLabel_en-US" xlink:label="lab_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum MLR and profit sharing</link:label>
    <link:label id="lab_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold_label_en-US" xlink:label="lab_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Premiums Liability, Medical Care Costs Threshold</link:label>
    <link:label id="lab_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold_documentation_en-US" xlink:label="lab_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Premiums Liability, Medical Care Costs Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold" xlink:href="moh-20201231.xsd#moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold" xlink:to="lab_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_4bf03ca5-1b11-4c0d-9c56-6e54132bd85d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_11f85722-7c5e-4222-a4fa-8647f52e0be1_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_25be3065-9b37-4a2c-9960-0727447842b7_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenses_afbcc564-879c-451f-b93f-80d0a0cd0518_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expenses, net</link:label>
    <link:label id="lab_us-gaap_OtherExpenses_label_en-US" xlink:label="lab_us-gaap_OtherExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenses" xlink:to="lab_us-gaap_OtherExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1d85bac9-4757-4caf-8fcd-616f4b8dff46_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, equipment and capitalized software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_d39e8a4a-60ee-4799-a078-3ca86ac89aca_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_02b30c37-22f2-4401-a048-89d310ff668a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_f47a4102-da2e-4491-9573-4482714bfc34_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_d33a3b91-fef4-44e6-82c6-1b71c5bab110_verboseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_937186ae-23ca-4197-9a4c-81c3e623ec31_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1dc2ef5f-a725-4f13-b3f6-5a7eafcac8af_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_739561e9-ed9d-4eb7-98f3-765a5edb5fcf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_ae276d7e-fa09-4e5e-b0f2-36b7573c14d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c93b1867-d292-4276-af3f-3a282ff6d6de_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b14d9f45-a5ae-4550-a320-dac7873b9f0e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_bb9dd322-05ec-49a1-beaf-1d40dbef915c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_a1e97fe7-7c03-4190-82f9-3275721dc4da_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_2d9ab794-43a9-4dce-b911-b9b7133317da_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from senior notes offerings, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_DeferredTaxAssetsFixedAssetsAndIntangibles_7eed9148-7a27-4add-8a87-c93e460bf0f8_terseLabel_en-US" xlink:label="lab_moh_DeferredTaxAssetsFixedAssetsAndIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets and intangibles</link:label>
    <link:label id="lab_moh_DeferredTaxAssetsFixedAssetsAndIntangibles_label_en-US" xlink:label="lab_moh_DeferredTaxAssetsFixedAssetsAndIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Fixed Assets and Intangibles</link:label>
    <link:label id="lab_moh_DeferredTaxAssetsFixedAssetsAndIntangibles_documentation_en-US" xlink:label="lab_moh_DeferredTaxAssetsFixedAssetsAndIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Fixed Assets and Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DeferredTaxAssetsFixedAssetsAndIntangibles" xlink:href="moh-20201231.xsd#moh_DeferredTaxAssetsFixedAssetsAndIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_DeferredTaxAssetsFixedAssetsAndIntangibles" xlink:to="lab_moh_DeferredTaxAssetsFixedAssetsAndIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ThreePointEightSevenFivePercentSeniorNotesMember_197e9abb-15d7-4624-a952-e6f3762cc6e6_terseLabel_en-US" xlink:label="lab_moh_ThreePointEightSevenFivePercentSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% Notes</link:label>
    <link:label id="lab_moh_ThreePointEightSevenFivePercentSeniorNotesMember_label_en-US" xlink:label="lab_moh_ThreePointEightSevenFivePercentSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Eight Seven Five Percent Senior Notes [Member]</link:label>
    <link:label id="lab_moh_ThreePointEightSevenFivePercentSeniorNotesMember_documentation_en-US" xlink:label="lab_moh_ThreePointEightSevenFivePercentSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Eight Seven Five Percent Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember" xlink:href="moh-20201231.xsd#moh_ThreePointEightSevenFivePercentSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember" xlink:to="lab_moh_ThreePointEightSevenFivePercentSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_03eb7d54-1105-47f9-bca7-747ffcb52946_negatedTerseLabel_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued and other long-term liabilities</link:label>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Liabilities</link:label>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_documentation_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:to="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_c95c11c8-1e55-4319-aa38-069b1033502a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_0eb57a25-b591-41bf-a5db-77a098e82994_totalLabel_en-US" xlink:label="lab_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss before equity in net earnings of subsidiaries</link:label>
    <link:label id="lab_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) From Continuing Operations Before Equity Method Investments, Extraordinary Items, Noncontrolling Interest</link:label>
    <link:label id="lab_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_documentation_en-US" xlink:label="lab_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) From Continuing Operations Before Equity Method Investments, Extraordinary Items, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" xlink:href="moh-20201231.xsd#moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_bc0f79f4-2e83-45ba-b191-d33e8d4c7ae1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of property plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_e94ec1b4-0f46-4c22-b7ff-c445e210cd60_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_56ece45d-b53a-428b-8393-a92b5476d13a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_3a95c23d-313f-4746-837b-4ed4b69590ba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_af0584c3-e702-4280-94f4-4e00f5c92b3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_2833e92a-1b5a-41d6-94d0-342012db95d2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_90910f75-b2bd-4594-8c36-9d80435288e1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AffinityHealthPlanMember_ce25653b-e5f8-4375-8818-d4cf62add530_terseLabel_en-US" xlink:label="lab_moh_AffinityHealthPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affinity Health Plan</link:label>
    <link:label id="lab_moh_AffinityHealthPlanMember_label_en-US" xlink:label="lab_moh_AffinityHealthPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affinity Health Plan [Member]</link:label>
    <link:label id="lab_moh_AffinityHealthPlanMember_documentation_en-US" xlink:label="lab_moh_AffinityHealthPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affinity Health Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffinityHealthPlanMember" xlink:href="moh-20201231.xsd#moh_AffinityHealthPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AffinityHealthPlanMember" xlink:to="lab_moh_AffinityHealthPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MedicalCareCostsMember_b535f219-a01e-4dfa-9b16-bc905d8a41ae_terseLabel_en-US" xlink:label="lab_moh_MedicalCareCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical care costs</link:label>
    <link:label id="lab_moh_MedicalCareCostsMember_label_en-US" xlink:label="lab_moh_MedicalCareCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Care Costs [Member]</link:label>
    <link:label id="lab_moh_MedicalCareCostsMember_documentation_en-US" xlink:label="lab_moh_MedicalCareCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Care Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalCareCostsMember" xlink:href="moh-20201231.xsd#moh_MedicalCareCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MedicalCareCostsMember" xlink:to="lab_moh_MedicalCareCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_4ece5111-9b3b-4527-84e4-c299c6bc3bed_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d59a1344-5a9a-466b-af6d-e6bc1f6f9863_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_31fd51b2-6e4d-492b-b0ea-e9e11f71e427_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_3dcc982f-6218-4302-9d1b-a591329b60c6_totalLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total depreciation and amortization recognized</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_95f43f7b-1b70-47bb-ae92-9be0678efe0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract_2ee7d0ae-4a86-482e-a0c4-c3a5eea3aed1_terseLabel_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketplace program:</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract_label_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies, Marketplace Program [Abstract]</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract_documentation_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies, Marketplace Program [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract" xlink:to="lab_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_7420b22a-336e-48a7-90f3-322751fcc67b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6802a771-28e1-4e9d-9140-79648eb9a2b0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_4c75c331-5023-497f-8454-bfbaf1d22416_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_3dd621c0-438f-486b-81af-48867ab61afe_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_5b41c2df-f660-49de-800e-2b37aa8acde6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities (current)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_a180f47a-ab55-4062-803f-1dea7e26c5d5_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_PassportHealthPlanIncMember_8605808f-c995-4dea-b4bc-e54896ee61a5_terseLabel_en-US" xlink:label="lab_moh_PassportHealthPlanIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Passport Health Plan Inc</link:label>
    <link:label id="lab_moh_PassportHealthPlanIncMember_label_en-US" xlink:label="lab_moh_PassportHealthPlanIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Passport Health Plan Inc [Member]</link:label>
    <link:label id="lab_moh_PassportHealthPlanIncMember_documentation_en-US" xlink:label="lab_moh_PassportHealthPlanIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Passport Health Plan Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PassportHealthPlanIncMember" xlink:href="moh-20201231.xsd#moh_PassportHealthPlanIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_PassportHealthPlanIncMember" xlink:to="lab_moh_PassportHealthPlanIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2ff85b0c-2f29-43ff-b2e4-ee5534b49f91_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_044fbdd9-3feb-4a6b-9481-30d28debccc9_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_f64ec16b-c376-476b-8b3f-2030f105c0a5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_8a03e166-fc5e-49d2-9a03-6d7e9d3175ef_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_98af3555-13e6-4adf-a5d4-c6b931d3bbc9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_69efe396-be44-4933-ab52-3763731162f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_859e85fe-f0e2-4668-b962-c66deabba27e_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2af23bc2-7784-44b7-b584-e661c2c6ce74_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of new accounting standards</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_65b7b9e8-f831-42d2-b3c9-7ea2fdacaa87_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_619be87b-21dc-404c-b4c3-d05458ce4586_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_d75e6b8b-8703-47d9-8785-ad2275e8150d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_6e85bdde-ce46-4c7d-b594-b48e6cfb424b_verboseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost, Due one year through five years</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_0141e551-c79f-4696-a294-bbfc66953634_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue of acquired business</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Revenue Reported by Acquired Entity for Last Annual Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:to="lab_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CashPaidDuringThePeriodAbstract_31c194d7-c26e-43e7-a4bc-504fa0bf3499_terseLabel_en-US" xlink:label="lab_moh_CashPaidDuringThePeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for:</link:label>
    <link:label id="lab_moh_CashPaidDuringThePeriodAbstract_label_en-US" xlink:label="lab_moh_CashPaidDuringThePeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid During The Period [Abstract]</link:label>
    <link:label id="lab_moh_CashPaidDuringThePeriodAbstract_documentation_en-US" xlink:label="lab_moh_CashPaidDuringThePeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid During The Period [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashPaidDuringThePeriodAbstract" xlink:href="moh-20201231.xsd#moh_CashPaidDuringThePeriodAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CashPaidDuringThePeriodAbstract" xlink:to="lab_moh_CashPaidDuringThePeriodAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2a11bf41-0fe1-4080-b987-33db845d16fb_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_f7db72e4-176e-469d-8f50-bb180aa87e87_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_be949cb8-39df-494f-8f06-111669599869_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_006ceed9-1513-4784-b3d7-f0617f3fcbaf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for medical care costs related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1ea579f3-e36c-4c13-aead-a3ce613cf84e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_1709a5f7-d2fd-4d4f-9849-eb7d7a2d536e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets measured on recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_afa11a22-9ec6-48a6-b7ef-94dd0c06c428_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_97f9cd56-3b06-45c1-adc4-05f99f99fc6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_f336a6a3-0032-42b5-971f-d423a2782961_verboseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_829784ab-687f-4e6f-9ddd-5dd15a12217a_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_06a2bc4c-ff47-4e14-b149-e97ab569498b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_InvestmentsMaturityPeriod_e0699b69-3c84-427a-a7b1-89b42e45fa7e_terseLabel_en-US" xlink:label="lab_moh_InvestmentsMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity period (less than)</link:label>
    <link:label id="lab_moh_InvestmentsMaturityPeriod_label_en-US" xlink:label="lab_moh_InvestmentsMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Maturity Period</link:label>
    <link:label id="lab_moh_InvestmentsMaturityPeriod_documentation_en-US" xlink:label="lab_moh_InvestmentsMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Maturity Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_InvestmentsMaturityPeriod" xlink:href="moh-20201231.xsd#moh_InvestmentsMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_InvestmentsMaturityPeriod" xlink:to="lab_moh_InvestmentsMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesBusinessCombination_b0b0e89a-c161-431b-9714-da2d7ba0c16c_terseLabel_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Complete Care</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesBusinessCombination_label_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due to Government Agencies, Business Combination</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesBusinessCombination_documentation_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due to Government Agencies, Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesBusinessCombination" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesBusinessCombination" xlink:to="lab_moh_AmountsDueToGovernmentAgenciesBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d0185d7d-3e30-42c0-930b-67e75155502c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_b063edcc-aae4-4fae-8ca7-e7ac1d791138_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_e458cdd5-f408-4e0e-84c1-92916db3bc73_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_12be8adc-d153-4b4d-a489-328321c0bb28_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_0661702e-2f3e-487b-b4bf-b951ca2a2b92_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, remaining lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_2955c01f-5c1f-46fd-8d75-1510e135caad_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_47e736ea-2ec5-45f1-8bcb-29cb2cb0b99f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities_033834ae-c87e-47b8-93f1-b06ff99aef79_terseLabel_en-US" xlink:label="lab_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration liabilities</link:label>
    <link:label id="lab_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities_label_en-US" xlink:label="lab_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Contingent Consideration Liabilities Assumed In Noncash Investing Or Financing Activities</link:label>
    <link:label id="lab_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities_documentation_en-US" xlink:label="lab_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Contingent Consideration Liabilities Assumed In Noncash Investing Or Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" xlink:href="moh-20201231.xsd#moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" xlink:to="lab_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_28cbc7be-a560-44ef-aa1e-301731f9d3f7_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets, net of valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_015b03b8-cb87-4f31-9ef0-68bce8fb1c22_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed statements of comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles_e505153f-cb67-4885-9bbb-bca2f6589640_negatedTerseLabel_en-US" xlink:label="lab_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets and intangibles</link:label>
    <link:label id="lab_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles_label_en-US" xlink:label="lab_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Fixed Assets And Intangibles</link:label>
    <link:label id="lab_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles_documentation_en-US" xlink:label="lab_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Fixed Assets And Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles" xlink:href="moh-20201231.xsd#moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles" xlink:to="lab_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_277f2edc-351e-44a3-88ea-d152744f779e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_7287e96d-6f0a-4afa-afaa-b12d5c828d37_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_9d45a780-2e2d-4271-97e3-61088c1296fa_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f3bef3bf-dbea-45d7-a8bf-660002ca9703_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4cbc369b-7dbb-4842-b53e-6b2f19e85dea_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_745e37dc-e38d-44ae-96cf-e2224c9d5d85_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_92d55a9c-2129-42a2-bff8-e6fe2406bdfc_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_076a3abf-241f-4b0e-a2b5-5935068308d1_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_dd1e0736-3c82-4b14-913f-8bf44bd0049a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_103f5259-7be9-4079-bac2-af0022fbc611_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CapitationClaimsPayable_9aab5072-7d16-4b22-bbb0-a81f530d2da5_terseLabel_en-US" xlink:label="lab_moh_CapitationClaimsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation payable</link:label>
    <link:label id="lab_moh_CapitationClaimsPayable_label_en-US" xlink:label="lab_moh_CapitationClaimsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Claims Payable</link:label>
    <link:label id="lab_moh_CapitationClaimsPayable_documentation_en-US" xlink:label="lab_moh_CapitationClaimsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Claims Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CapitationClaimsPayable" xlink:href="moh-20201231.xsd#moh_CapitationClaimsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CapitationClaimsPayable" xlink:to="lab_moh_CapitationClaimsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_394de47f-7946-4202-a702-14296b10b781_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental term loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_c2ba7382-5799-4c9e-a2d0-cfa52cf775c9_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount of notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_TaxesBasedOnPremiumsPolicyTextBlock_251dad40-41bb-42a8-89d3-0da0adf9f0e8_verboseLabel_en-US" xlink:label="lab_moh_TaxesBasedOnPremiumsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Based on Premiums</link:label>
    <link:label id="lab_moh_TaxesBasedOnPremiumsPolicyTextBlock_label_en-US" xlink:label="lab_moh_TaxesBasedOnPremiumsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Based On Premiums [Policy Text Block]</link:label>
    <link:label id="lab_moh_TaxesBasedOnPremiumsPolicyTextBlock_documentation_en-US" xlink:label="lab_moh_TaxesBasedOnPremiumsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes based on premiums.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_TaxesBasedOnPremiumsPolicyTextBlock" xlink:href="moh-20201231.xsd#moh_TaxesBasedOnPremiumsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_TaxesBasedOnPremiumsPolicyTextBlock" xlink:to="lab_moh_TaxesBasedOnPremiumsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_66cddda4-acf0-4b70-a32e-5a5a48bc8e20_verboseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_d275b096-25bc-40b8-b545-b47c2cbbe7ed_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_7a172081-539d-44c8-a36b-0dde9d3b078a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_c00bc909-6045-49db-ac3f-6d2723d5a0ff_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_51464ea2-13ce-479a-8dcd-5aef36147304_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_1231509c-f76a-4a99-89e3-561776d3edbe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_54682ce5-ca53-4465-b090-199d9df8ab47_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_c6e78f29-1501-48aa-9613-cdc6ebc36f96_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_852a3306-d467-4f1e-b623-c3c763a70813_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_e97339f8-2942-4309-9fbc-9dc1d157ceab_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c495be60-e968-497b-b826-e663edb56533_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9f5fc0e2-3953-4485-a681-64f9119e3fb4_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary_ae145fbc-1df9-4baa-a31f-039c71d88ea6_verboseLabel_en-US" xlink:label="lab_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan deferral percentage of basic salary</link:label>
    <link:label id="lab_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary_label_en-US" xlink:label="lab_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Deferral Percentage Of Basic Salary</link:label>
    <link:label id="lab_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary_documentation_en-US" xlink:label="lab_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan deferral percentage of basic salary.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary" xlink:href="moh-20201231.xsd#moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary" xlink:to="lab_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_b89b6281-7588-4934-97da-dbcfefa8dae3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurements of senior notes</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_6d2e0a4c-4ceb-434c-8a1c-8c5c11927ca4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses, net:</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing_99cc7427-7529-44e7-9720-2bea7ff1211b_terseLabel_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk adjustment and Part D risk sharing</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing_label_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due to Government Agencies, Risk Adjustment and Part D risk sharing</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing_documentation_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due to Government Agencies, Risk Adjustment and Part D risk sharing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing" xlink:to="lab_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8e797cfb-155e-4277-b966-a07654c840f3_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_04326a8b-9f51-4124-bc16-27edbe3cde89_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_fb3cd723-26e4-42e0-a07f-d6a13649c841_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ContractRightsandLicensingAgreementsMember_6971c5ec-f427-4b1a-8422-1dbf9d7d18a4_terseLabel_en-US" xlink:label="lab_moh_ContractRightsandLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract rights and licenses</link:label>
    <link:label id="lab_moh_ContractRightsandLicensingAgreementsMember_label_en-US" xlink:label="lab_moh_ContractRightsandLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Rights and Licensing Agreements [Member]</link:label>
    <link:label id="lab_moh_ContractRightsandLicensingAgreementsMember_documentation_en-US" xlink:label="lab_moh_ContractRightsandLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Rights and Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ContractRightsandLicensingAgreementsMember" xlink:href="moh-20201231.xsd#moh_ContractRightsandLicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ContractRightsandLicensingAgreementsMember" xlink:to="lab_moh_ContractRightsandLicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_74bd905e-5543-43f6-b766-5fac123baa30_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and reserve liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_518cd891-e0ff-4f78-96ba-67da777d7b91_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_6cd101bb-5364-4061-b90f-aa84c61526bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option plans, by exercise price range</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_LiabilitiesAssumedAbstract_b2eed4e4-7eaf-439c-968e-65f3657d7bea_terseLabel_en-US" xlink:label="lab_moh_LiabilitiesAssumedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed:</link:label>
    <link:label id="lab_moh_LiabilitiesAssumedAbstract_label_en-US" xlink:label="lab_moh_LiabilitiesAssumedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed [Abstract]</link:label>
    <link:label id="lab_moh_LiabilitiesAssumedAbstract_documentation_en-US" xlink:label="lab_moh_LiabilitiesAssumedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LiabilitiesAssumedAbstract" xlink:href="moh-20201231.xsd#moh_LiabilitiesAssumedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_LiabilitiesAssumedAbstract" xlink:to="lab_moh_LiabilitiesAssumedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_7d72f0b2-384d-4738-b722-6a60f381ccb0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_a48c56e9-49e2-4079-be00-5adf0d763c91_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits at beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_60af3da8-0204-4d30-8377-03e684259073_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits at end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_7ba94558-0cbb-413c-a3cb-75bae9a29706_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c2b85c1f-8e96-4c01-950f-a9ecb18fc84f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_af45dde1-63b0-4ceb-a14f-a80c86f11a89_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future amortization expense, 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_cf5dc70f-8a6c-49d0-a570-902555923634_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (1)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_9b32bb37-5cb3-45eb-942f-5a920c0bb1f0_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold_62c67e79-d39e-4382-8aec-b8976a12690b_terseLabel_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum MLR and profit sharing</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold_label_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies, Medicare, Medical Loss Ratio And Profit Sharing, Threshold</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold_documentation_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies, Medicare, Medical Loss Ratio And Profit Sharing, Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold" xlink:to="lab_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider_711fcc56-1bbd-400e-b201-baeb263640d4_terseLabel_en-US" xlink:label="lab_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in non-risk and other provider payables</link:label>
    <link:label id="lab_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider_label_en-US" xlink:label="lab_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims And Benefits Payable, Adjustments, Change In Provider</link:label>
    <link:label id="lab_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider_documentation_en-US" xlink:label="lab_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims and Benefits Payable, Adjustments, Change in Provider</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" xlink:href="moh-20201231.xsd#moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" xlink:to="lab_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_2b277fda-4d62-471f-b60d-287418e4bc01_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_4478fa18-4ac1-473f-bb7e-ff3e19cb57ad_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_DispositionofBusinessTransactionCosts_3a925db0-629c-4c35-875e-c542a0806421_negatedTerseLabel_en-US" xlink:label="lab_moh_DispositionofBusinessTransactionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_moh_DispositionofBusinessTransactionCosts_label_en-US" xlink:label="lab_moh_DispositionofBusinessTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition of Business, Transaction Costs</link:label>
    <link:label id="lab_moh_DispositionofBusinessTransactionCosts_documentation_en-US" xlink:label="lab_moh_DispositionofBusinessTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition of Business, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DispositionofBusinessTransactionCosts" xlink:href="moh-20201231.xsd#moh_DispositionofBusinessTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_DispositionofBusinessTransactionCosts" xlink:to="lab_moh_DispositionofBusinessTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CovertibleSeniorNotesExchangeTransactionAbstract_2c880817-1baf-483f-999a-ff727097e7ff_terseLabel_en-US" xlink:label="lab_moh_CovertibleSeniorNotesExchangeTransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes exchange transaction:</link:label>
    <link:label id="lab_moh_CovertibleSeniorNotesExchangeTransactionAbstract_label_en-US" xlink:label="lab_moh_CovertibleSeniorNotesExchangeTransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covertible Senior Notes Exchange Transaction [Abstract]</link:label>
    <link:label id="lab_moh_CovertibleSeniorNotesExchangeTransactionAbstract_documentation_en-US" xlink:label="lab_moh_CovertibleSeniorNotesExchangeTransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covertible Senior Notes Exchange Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract" xlink:href="moh-20201231.xsd#moh_CovertibleSeniorNotesExchangeTransactionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract" xlink:to="lab_moh_CovertibleSeniorNotesExchangeTransactionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1ac1648d-3be7-4468-afd4-10aa94429f87_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock purchases (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_17fb5bed-ca19-42ab-b96a-7ab1f125ea8c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b43e2429-dcfb-41bc-8afe-003ff7b0dd56_netLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_04d483e7-98d8-4636-ac9d-060876b66c52_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_5f6b7e6b-997e-4724-af7a-87a78b414c2c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding, Number (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears_a547009f-7b60-4127-9f64-f21899016779_terseLabel_en-US" xlink:label="lab_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All outstanding liabilities before 2018</link:label>
    <link:label id="lab_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears_label_en-US" xlink:label="lab_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Outstanding Liabilities Relating to Prior Years</link:label>
    <link:label id="lab_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears_documentation_en-US" xlink:label="lab_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Outstanding Liabilities Relating to Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears" xlink:href="moh-20201231.xsd#moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears" xlink:to="lab_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_SwinglineSubFacilityMember_673fb49e-ec2f-42cf-9307-772b374ea186_terseLabel_en-US" xlink:label="lab_moh_SwinglineSubFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Sub Facility</link:label>
    <link:label id="lab_moh_SwinglineSubFacilityMember_label_en-US" xlink:label="lab_moh_SwinglineSubFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Sub Facility [Member]</link:label>
    <link:label id="lab_moh_SwinglineSubFacilityMember_documentation_en-US" xlink:label="lab_moh_SwinglineSubFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Sub Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SwinglineSubFacilityMember" xlink:href="moh-20201231.xsd#moh_SwinglineSubFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_SwinglineSubFacilityMember" xlink:to="lab_moh_SwinglineSubFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_ddce8aa1-6a11-4983-aac8-b13d1c19f652_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b0b6245e-f001-4ee5-9d90-6b3b02fb14bc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency_f34d6044-ca18-4668-8626-39aeaa8db366_terseLabel_en-US" xlink:label="lab_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due government agencies</link:label>
    <link:label id="lab_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency_label_en-US" xlink:label="lab_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Medical Premium Liability Due To Agency</link:label>
    <link:label id="lab_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency_documentation_en-US" xlink:label="lab_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Medical Premium Liability Due to Agency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" xlink:href="moh-20201231.xsd#moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" xlink:to="lab_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_9bc5038b-ac93-4a3f-8b88-5d10324aeada_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_d6ed45a7-68d6-4080-81af-c2a43b361305_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_f9dc90da-60e2-4942-84cc-aadb2c5e94bb_netLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_6992f33d-a70e-465a-8d24-16f385529009_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_RecordedInDepreciationAndAmortizationAbstract_351a49e9-9700-41df-a250-890ba310b91b_terseLabel_en-US" xlink:label="lab_moh_RecordedInDepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded in depreciation and amortization:</link:label>
    <link:label id="lab_moh_RecordedInDepreciationAndAmortizationAbstract_label_en-US" xlink:label="lab_moh_RecordedInDepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded In Depreciation And Amortization [Abstract]</link:label>
    <link:label id="lab_moh_RecordedInDepreciationAndAmortizationAbstract_documentation_en-US" xlink:label="lab_moh_RecordedInDepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded In Depreciation And Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RecordedInDepreciationAndAmortizationAbstract" xlink:href="moh-20201231.xsd#moh_RecordedInDepreciationAndAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_RecordedInDepreciationAndAmortizationAbstract" xlink:to="lab_moh_RecordedInDepreciationAndAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_42cab076-b915-47f7-b70b-73ba17e43327_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b430df6e-fec0-4584-b4c9-f8a84cf5683f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d2ad30b4-adc6-4762-b0eb-da1c4db78d92_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_146c2008-f595-47fe-a4b0-5682033c95d7_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_2424f47d-334f-41df-9ed9-5042ce9b6463_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_OperatingLeaseAssetsLesseeAbstract_d3cb5a3c-a5a4-488b-bbbc-8aa7e3ea023f_terseLabel_en-US" xlink:label="lab_moh_OperatingLeaseAssetsLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets</link:label>
    <link:label id="lab_moh_OperatingLeaseAssetsLesseeAbstract_label_en-US" xlink:label="lab_moh_OperatingLeaseAssetsLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets, Lessee [Abstract]</link:label>
    <link:label id="lab_moh_OperatingLeaseAssetsLesseeAbstract_documentation_en-US" xlink:label="lab_moh_OperatingLeaseAssetsLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OperatingLeaseAssetsLesseeAbstract" xlink:href="moh-20201231.xsd#moh_OperatingLeaseAssetsLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_OperatingLeaseAssetsLesseeAbstract" xlink:to="lab_moh_OperatingLeaseAssetsLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_692c8257-57be-4f34-ac20-bd2bffe2a4c3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_FinanceLeaseCost_71c0b0bc-29fb-4c23-a916-659e51793c84_totalLabel_en-US" xlink:label="lab_moh_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease expense</link:label>
    <link:label id="lab_moh_FinanceLeaseCost_label_en-US" xlink:label="lab_moh_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_moh_FinanceLeaseCost_documentation_en-US" xlink:label="lab_moh_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FinanceLeaseCost" xlink:href="moh-20201231.xsd#moh_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_FinanceLeaseCost" xlink:to="lab_moh_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e9815ea-2379-463b-a5f4-e6ddbb9848d8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_915ab98c-068b-48d5-9531-67beb0e5cdce_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_0cf7ec93-4d27-49a7-b647-e989888cffe5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary judgement</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3b48c597-1c58-497f-ade2-b1483636f241_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities and other</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_93005627-b264-41b5-921d-3dcf6d0971c5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_1b040a09-50c5-4afd-a830-c3676e1491d6_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_PercentageOfAdditionalIncrementalRevenueEarned_638f9846-fa8f-414e-a094-f271d947a4f4_verboseLabel_en-US" xlink:label="lab_moh_PercentageOfAdditionalIncrementalRevenueEarned" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of additional incremental revenue earned</link:label>
    <link:label id="lab_moh_PercentageOfAdditionalIncrementalRevenueEarned_label_en-US" xlink:label="lab_moh_PercentageOfAdditionalIncrementalRevenueEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Additional Incremental Revenue Earned</link:label>
    <link:label id="lab_moh_PercentageOfAdditionalIncrementalRevenueEarned_documentation_en-US" xlink:label="lab_moh_PercentageOfAdditionalIncrementalRevenueEarned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of additional incremental revenue earned.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PercentageOfAdditionalIncrementalRevenueEarned" xlink:href="moh-20201231.xsd#moh_PercentageOfAdditionalIncrementalRevenueEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_PercentageOfAdditionalIncrementalRevenueEarned" xlink:to="lab_moh_PercentageOfAdditionalIncrementalRevenueEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_d2e51f90-f956-4076-93d6-71e1e87a2e8c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred and paid claims development</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_BasisOfPresentationLineItems_11705f80-1b14-42f2-b8d0-3ba4ee877dc4_terseLabel_en-US" xlink:label="lab_moh_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation [Line Items]</link:label>
    <link:label id="lab_moh_BasisOfPresentationLineItems_label_en-US" xlink:label="lab_moh_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation [Line Items]</link:label>
    <link:label id="lab_moh_BasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_moh_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BasisOfPresentationLineItems" xlink:href="moh-20201231.xsd#moh_BasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_BasisOfPresentationLineItems" xlink:to="lab_moh_BasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_6b4430af-182a-460c-b06f-6055e9e86ee9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_9c6b961a-be92-4daa-8710-0050dae2e1a1_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4d59cfe7-6126-48a4-8600-4731914cd87b_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_cb628da4-7805-4ec9-a869-a3e395e8bac3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims and Benefits Payable</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_230d38ec-f028-498a-9f68-902dffae37a4_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium deficiency reserve</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CMSSubsidiesMember_4eb2e094-4241-49db-8fae-88f4cad72416_terseLabel_en-US" xlink:label="lab_moh_CMSSubsidiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS Subsidies</link:label>
    <link:label id="lab_moh_CMSSubsidiesMember_label_en-US" xlink:label="lab_moh_CMSSubsidiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS Subsidies [Member]</link:label>
    <link:label id="lab_moh_CMSSubsidiesMember_documentation_en-US" xlink:label="lab_moh_CMSSubsidiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS Subsidies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CMSSubsidiesMember" xlink:href="moh-20201231.xsd#moh_CMSSubsidiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CMSSubsidiesMember" xlink:to="lab_moh_CMSSubsidiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_WeightedAverageNumberofSharesShareBasedCompensation_95d2d76c-7542-4de5-a977-3b3dd5d312ce_terseLabel_en-US" xlink:label="lab_moh_WeightedAverageNumberofSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (in shares)</link:label>
    <link:label id="lab_moh_WeightedAverageNumberofSharesShareBasedCompensation_label_en-US" xlink:label="lab_moh_WeightedAverageNumberofSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Share Based Compensation</link:label>
    <link:label id="lab_moh_WeightedAverageNumberofSharesShareBasedCompensation_documentation_en-US" xlink:label="lab_moh_WeightedAverageNumberofSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Share Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_WeightedAverageNumberofSharesShareBasedCompensation" xlink:href="moh-20201231.xsd#moh_WeightedAverageNumberofSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_WeightedAverageNumberofSharesShareBasedCompensation" xlink:to="lab_moh_WeightedAverageNumberofSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_1ab3d1c0-89e0-492b-a468-bc7b332185d2_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_c37f6e92-69d9-40e3-bce2-29d3387b8e1b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities (non-current)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_66dfc399-b270-43d5-810d-79f7f35a0fcf_netLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_OtherSecuritiesMember_caf25bc4-b9a3-408a-bc15-c83fb0869f22_terseLabel_en-US" xlink:label="lab_moh_OtherSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_moh_OtherSecuritiesMember_label_en-US" xlink:label="lab_moh_OtherSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Securities [Member]</link:label>
    <link:label id="lab_moh_OtherSecuritiesMember_documentation_en-US" xlink:label="lab_moh_OtherSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherSecuritiesMember" xlink:href="moh-20201231.xsd#moh_OtherSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_OtherSecuritiesMember" xlink:to="lab_moh_OtherSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CompleteCareMember_bd0650a0-2f40-4724-a645-f751b26a435c_terseLabel_en-US" xlink:label="lab_moh_CompleteCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Complete Care</link:label>
    <link:label id="lab_moh_CompleteCareMember_label_en-US" xlink:label="lab_moh_CompleteCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete Care [Member]</link:label>
    <link:label id="lab_moh_CompleteCareMember_documentation_en-US" xlink:label="lab_moh_CompleteCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CompleteCareMember" xlink:href="moh-20201231.xsd#moh_CompleteCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CompleteCareMember" xlink:to="lab_moh_CompleteCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_c8e4fa6f-8531-459d-b7ed-da1565d68078_terseLabel_en-US" xlink:label="lab_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_label_en-US" xlink:label="lab_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities, Net Of Unamortized Premium (Discount)</link:label>
    <link:label id="lab_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_documentation_en-US" xlink:label="lab_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities, Net Of Unamortized Premium (Discount)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" xlink:href="moh-20201231.xsd#moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" xlink:to="lab_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_fe8d901e-47d5-4bcd-980f-16730570ff38_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_463f344d-36be-430e-a7bf-b807752ad49d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_91b982eb-d6fb-46ff-bf0b-83339281a5db_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_09d8aac6-74fd-48c2-80c0-d537809feb4f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ce6c06e3-7d6c-441a-9dff-2df2f12e57e7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_2e3cf806-ee09-4e25-8858-af8becf96544_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_218999fa-42f4-41dc-b62e-46b390323d8e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_a30ec0ae-1118-471e-acf3-f7f9919b4458_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e50362b8-bad1-4233-a3c0-35edd5c7335b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_d2340166-15b5-4010-9d94-495b927b3892_verboseLabel_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Registrant</link:label>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:to="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a34f1d35-4c15-411f-88de-ee80eb100af1_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant components of deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_61e9e5f3-3908-453f-ab3e-347f8c167f29_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income provision (benefit), net of federal</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_89ad7eec-1063-4422-9dc4-8ee0c0db322b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sales of subsidiaries, net of gain</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_2d96a993-0ab2-4a44-95d0-c23e444ac932_totalLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of subsidiaries, net of gain</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_31963332-0e6f-41d4-b3b3-80727b6eea63_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_cbd76884-38d9-4700-94e5-f1564d93cbd3_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6dceb183-d143-4ea9-b074-b4fbc24966d7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_00d488fc-a73a-4cdd-b27e-1046061374dd_verboseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_a0fca344-644a-4bed-b7eb-3603f86e8597_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificate of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_eb6088b9-86a1-426f-af0a-13cb5f42390d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_d5091a2a-e12f-4c15-a5c2-93babf0297fa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0cc62486-7aeb-4574-9645-372862a0f3a5_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_42464f4f-72e3-42ab-94a9-5736051501fa_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense recognized in connection with contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_c5c21d12-55bb-4dfe-aa2e-3ff5d56b1e98_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_40bcb36f-ccb5-44da-aee5-a2451103c9ee_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, remaining lease term</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_1ab618ca-dc2a-4853-9d22-693ce42ee6c5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_7f66c02f-4787-4194-a42f-659b65ffddc9_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_b3b24fcb-c952-44b4-8306-e7d83fef26b4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_47c3ad49-eb64-4fbd-8b68-e8f107b61f20_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of contractual interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_646fdbda-4f2e-43c3-bf15-fbf63110c20c_netLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of contractual interest rate on notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_OtherMedicareProgram_4fd5cf79-8ca1-44bc-acef-3cd9aa8a84c0_terseLabel_en-US" xlink:label="lab_moh_OtherMedicareProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_moh_OtherMedicareProgram_label_en-US" xlink:label="lab_moh_OtherMedicareProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Medicare Program</link:label>
    <link:label id="lab_moh_OtherMedicareProgram_documentation_en-US" xlink:label="lab_moh_OtherMedicareProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Medicare Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherMedicareProgram" xlink:href="moh-20201231.xsd#moh_OtherMedicareProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_OtherMedicareProgram" xlink:to="lab_moh_OtherMedicareProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable_114bdc45-5c73-4174-b08d-58a3118c030c_terseLabel_en-US" xlink:label="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketplace risk adjustment payables</link:label>
    <link:label id="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable_label_en-US" xlink:label="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Premium Stabilization Program, Risk Adjustment, (Payable)</link:label>
    <link:label id="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable_documentation_en-US" xlink:label="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Premium Stabilization Program, Risk Adjustment, (Payable)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable" xlink:href="moh-20201231.xsd#moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable" xlink:to="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract_d3491674-69d0-40db-9049-3e4c400e3869_terseLabel_en-US" xlink:label="lab_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets recognized in exchange for lease obligations:</link:label>
    <link:label id="lab_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract_label_en-US" xlink:label="lab_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability [Abstract]</link:label>
    <link:label id="lab_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract" xlink:href="moh-20201231.xsd#moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract" xlink:to="lab_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0c63c636-0217-4898-bf2d-e0360192e687_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_0b91a76e-d982-4b0c-82d3-554f63fdb372_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_bd743161-30a2-41b6-b90d-6be52a9e210e_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expenses, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_d30107df-f249-4df1-8754-018e144b2887_negatedLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: other expenses, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_GainLossOnDebtRepayment_d8e570e9-0670-4113-9dfd-7b469cd75906_negatedLabel_en-US" xlink:label="lab_moh_GainLossOnDebtRepayment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on debt repayment</link:label>
    <link:label id="lab_moh_GainLossOnDebtRepayment_25f493f3-5b0f-470c-89dd-7eb2ca77463f_terseLabel_en-US" xlink:label="lab_moh_GainLossOnDebtRepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on debt repayment</link:label>
    <link:label id="lab_moh_GainLossOnDebtRepayment_label_en-US" xlink:label="lab_moh_GainLossOnDebtRepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Debt Repayment</link:label>
    <link:label id="lab_moh_GainLossOnDebtRepayment_documentation_en-US" xlink:label="lab_moh_GainLossOnDebtRepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Debt Repayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GainLossOnDebtRepayment" xlink:href="moh-20201231.xsd#moh_GainLossOnDebtRepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_GainLossOnDebtRepayment" xlink:to="lab_moh_GainLossOnDebtRepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_55ca358f-1cb6-4e1e-930c-3db6e26c179a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized investment income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_0e1a97c1-1497-4e26-9872-f3a7100f5050_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized investment income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_be3ac1ee-da91-467f-bc22-d373f742b204_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_3af6dcf6-a281-4464-ac3a-99f570e617f5_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_4505450b-5b78-477a-a54a-67f269010e9d_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_label_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionCosts_a8420778-8086-447b-b82d-69283d2ec395_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition costs</link:label>
    <link:label id="lab_us-gaap_AcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Costs, Period Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionCosts" xlink:to="lab_us-gaap_AcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_17e1f53f-68fb-4dd1-b7b7-9939681fb94a_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_93060f10-a4a3-4870-a386-9519dd3e37d5_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on conversion option</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_60e7683c-209d-4911-8cf9-2cfd02a18eb8_verboseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion option derivative liability</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative Financial Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:to="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_047a3e99-83c5-4049-b2f9-15d327a05aec_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAgencyManagementFee_a72c5f31-7fd3-4b9b-a48c-2e98536ee70e_verboseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAgencyManagementFee" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administrative services fees</link:label>
    <link:label id="lab_us-gaap_InsuranceAgencyManagementFee_label_en-US" xlink:label="lab_us-gaap_InsuranceAgencyManagementFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Agency Management Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAgencyManagementFee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAgencyManagementFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAgencyManagementFee" xlink:to="lab_us-gaap_InsuranceAgencyManagementFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_5a5a9084-fcf1-40d0-8ab3-8a21b9010b2d_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_HealthcareInsurerFeeReimbursedMember_ac976658-3785-4ba9-88e5-1510dad8d348_terseLabel_en-US" xlink:label="lab_moh_HealthcareInsurerFeeReimbursedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fees reimbursed</link:label>
    <link:label id="lab_moh_HealthcareInsurerFeeReimbursedMember_label_en-US" xlink:label="lab_moh_HealthcareInsurerFeeReimbursedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurer Fee Reimbursed [Member]</link:label>
    <link:label id="lab_moh_HealthcareInsurerFeeReimbursedMember_documentation_en-US" xlink:label="lab_moh_HealthcareInsurerFeeReimbursedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurer Fee Reimbursed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthcareInsurerFeeReimbursedMember" xlink:href="moh-20201231.xsd#moh_HealthcareInsurerFeeReimbursedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_HealthcareInsurerFeeReimbursedMember" xlink:to="lab_moh_HealthcareInsurerFeeReimbursedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_34836a17-b92f-4298-a55e-915870d63c38_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Other Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_19c49883-1bcd-4466-b710-5c0aa63c2203_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum expected volatility rate inputs for fair value measurement</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3da9e5ea-ff34-41ee-9dc1-6fd064a3c6e9_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_541f1284-68a2-47fd-942d-b1ac86689752_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future amortization expense, 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_d3447716-c584-4fc6-8f85-e5e31d0d6797_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_bbfbae8b-321a-4b44-9693-06763222b0a0_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_4acb28d0-2a2a-4c0c-b40f-353760dd3fe9_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Other operating revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_8f9c495a-56c1-451b-9043-102f8c151197_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_98e2ca2f-d073-416c-a4ea-d1a1d912eb8e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_FairMarketValueOfCommonStockPercentage_ef9e20f6-5359-410f-b141-3bc6722a160c_terseLabel_en-US" xlink:label="lab_moh_FairMarketValueOfCommonStockPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee purchase price as a percentage of stock price</link:label>
    <link:label id="lab_moh_FairMarketValueOfCommonStockPercentage_label_en-US" xlink:label="lab_moh_FairMarketValueOfCommonStockPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Market Value Of Common Stock Percentage</link:label>
    <link:label id="lab_moh_FairMarketValueOfCommonStockPercentage_documentation_en-US" xlink:label="lab_moh_FairMarketValueOfCommonStockPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair market value of common stock, Percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FairMarketValueOfCommonStockPercentage" xlink:href="moh-20201231.xsd#moh_FairMarketValueOfCommonStockPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_FairMarketValueOfCommonStockPercentage" xlink:to="lab_moh_FairMarketValueOfCommonStockPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_9686709d-1b1d-4354-aa71-cd30d5389cac_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a4fc2dcd-4e1c-4c17-9b0e-2a875df09c57_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_EquityIncentivePlanMember_e10f913e-104d-4667-9efb-47be35e13331_terseLabel_en-US" xlink:label="lab_moh_EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 EIP</link:label>
    <link:label id="lab_moh_EquityIncentivePlanMember_label_en-US" xlink:label="lab_moh_EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_moh_EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_moh_EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EquityIncentivePlanMember" xlink:href="moh-20201231.xsd#moh_EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_EquityIncentivePlanMember" xlink:to="lab_moh_EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d33627ae-05d2-4ca3-a0ec-a5fb5becc722_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_6409344f-0bb1-4a35-aa87-b572731d3e21_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of furniture, equipment, building, and improvements</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_318d843d-dc5f-404e-a7d2-c1696b3c93d9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_ea7f2072-672f-4286-a089-5e04b6c2a1ae_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2db87005-a1be-4e31-a62c-b6e337d7b6e1_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_69565a8d-71d6-4310-af00-777cd274875e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_010f4f00-c75b-4431-bb7d-f16ae8b8e30b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_62c7dfb6-aee5-46dc-9a2b-c09a7e051847_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDividendsReceived_58866a2b-6d02-4fb4-a06b-6dfeab073913_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends received from subsidiaries</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_087c2286-b729-4ac1-80ed-51cd79e005de_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_57cf691c-8d93-4b5f-ad48-ba98248088db_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_392c2993-e81f-4f50-ab5f-8c4bf353e2f7_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_86cf48cb-369e-4f03-a8c5-84dc8bdf4541_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of medical care costs related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fa8ca619-bce0-44a7-89d5-31acc60ec31c_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax expense rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cbdd353a-3f99-49a5-9bfb-475d9307365f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7a891732-908c-44ce-bc82-405219783d5e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_8d4124e0-dc60-476d-b8ec-4181d891f740_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash received from sale of subsidiaries</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b8e0c7a7-7e59-46e3-b3ae-a989faef7d82_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_2dec6297-0289-4e0d-b40a-dc6d71095848_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services revenue from subsidiaries</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_938496ed-49fd-4385-8d3d-9e546cb2fc17_verboseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed balance sheets</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_1440f577-25ca-4028-a68b-4914357ff20c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares issued:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDescriptionAbstract_76f30196-5310-496a-a511-4b0b0e1b90a7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_7b86899c-2acd-42d0-9fe6-6d1e483c72cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_9a77af74-5a0a-44b6-9113-2a5ac00ed4bd_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned premiums</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Unearned Premiums Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4ddf55e3-f78c-4754-97cd-d290fb1793b2_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_f69bdb8b-88b7-4fc3-8878-0222882267b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of liability for unpaid claims and claims adjustment expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_3cf76e50-71c9-4bbc-92f9-63f4a84fa3b7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_7b4ba869-feb0-4bf9-aaea-240874c60b4e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_RestrictedandPerformanceStockMember_7d5176f3-b2d7-42af-b914-5b7213a51df4_terseLabel_en-US" xlink:label="lab_moh_RestrictedandPerformanceStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs, PSAs and PSUs (defined below)</link:label>
    <link:label id="lab_moh_RestrictedandPerformanceStockMember_label_en-US" xlink:label="lab_moh_RestrictedandPerformanceStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted and Performance Stock [Member]</link:label>
    <link:label id="lab_moh_RestrictedandPerformanceStockMember_documentation_en-US" xlink:label="lab_moh_RestrictedandPerformanceStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted and Performance Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RestrictedandPerformanceStockMember" xlink:href="moh-20201231.xsd#moh_RestrictedandPerformanceStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_RestrictedandPerformanceStockMember" xlink:to="lab_moh_RestrictedandPerformanceStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidReinsurancePremiums_338563de-9b33-44bc-9549-79d63c521fe1_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidReinsurancePremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid reinsurance premiums</link:label>
    <link:label id="lab_us-gaap_PrepaidReinsurancePremiums_label_en-US" xlink:label="lab_us-gaap_PrepaidReinsurancePremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Reinsurance Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidReinsurancePremiums" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidReinsurancePremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidReinsurancePremiums" xlink:to="lab_us-gaap_PrepaidReinsurancePremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_dd2dbe97-ebbe-4749-b95f-28613591b91d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_f9230527-5a9e-4e2e-906f-8504b78251d8_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_7907415d-6a33-4b84-9758-c2203153e438_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations and Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_17dd03ab-a207-4a4b-8b56-050b74b57c4c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_ec0c811c-e2ea-489e-a934-423dfeb013cb_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_0cffff3c-f9ce-44b3-a9d3-76dfc37cf035_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses (income), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_47acb8f5-a30b-42a1-bbc6-f5756c12c122_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses (income), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_822583e7-ff5f-457e-af6d-c4de973762fc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_02539790-16c3-4c3c-8ff6-514d2db0cf40_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of claims development to liability</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d525bcf0-625b-46c8-bd18-5554f67081f0_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_22fe1546-e540-440a-8a09-8edb150f0142_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims and benefits payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_dd738afc-f07f-4ccc-b5c3-de964ec7e12b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_cd8aa502-4c05-4de3-ade6-8a7654d8ccee_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims and benefits payable, beginning balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f72c6c15-5a0d-452e-989c-6aceada3ec00_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims and benefits payable, ending balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_HealthCareOrganizationRevenuePercentage_655f66e3-c8b2-43b9-9156-755fd944cac4_terseLabel_en-US" xlink:label="lab_moh_HealthCareOrganizationRevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium revenue percentage</link:label>
    <link:label id="lab_moh_HealthCareOrganizationRevenuePercentage_label_en-US" xlink:label="lab_moh_HealthCareOrganizationRevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Percentage</link:label>
    <link:label id="lab_moh_HealthCareOrganizationRevenuePercentage_documentation_en-US" xlink:label="lab_moh_HealthCareOrganizationRevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthCareOrganizationRevenuePercentage" xlink:href="moh-20201231.xsd#moh_HealthCareOrganizationRevenuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_HealthCareOrganizationRevenuePercentage" xlink:to="lab_moh_HealthCareOrganizationRevenuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_0b900ba4-ada2-42d8-a369-e655549da214_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_OperatingLeaseLiabilitiesLesseeAbstract_745fa3e2-394d-4e51-8694-87c04d6c754b_terseLabel_en-US" xlink:label="lab_moh_OperatingLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_moh_OperatingLeaseLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_moh_OperatingLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_moh_OperatingLeaseLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_moh_OperatingLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract" xlink:href="moh-20201231.xsd#moh_OperatingLeaseLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract" xlink:to="lab_moh_OperatingLeaseLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_3d6c4fad-b274-43f2-8e66-b5efa248c51a_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_adad32ef-469c-4e32-88d8-4d1fd1406bcc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MagellanCompleteCareMember_572ca84e-b435-4d7d-9350-c1906ac33cc0_terseLabel_en-US" xlink:label="lab_moh_MagellanCompleteCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Complete Care</link:label>
    <link:label id="lab_moh_MagellanCompleteCareMember_label_en-US" xlink:label="lab_moh_MagellanCompleteCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Complete Care [Member]</link:label>
    <link:label id="lab_moh_MagellanCompleteCareMember_documentation_en-US" xlink:label="lab_moh_MagellanCompleteCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Complete Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MagellanCompleteCareMember" xlink:href="moh-20201231.xsd#moh_MagellanCompleteCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MagellanCompleteCareMember" xlink:to="lab_moh_MagellanCompleteCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_cb4e779a-be63-489d-862d-f058cd448980_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_822baceb-8cbd-4cb1-a588-5acd0fd84762_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment_6ebbdfb9-9924-4823-9e0f-3d1f335501e0_terseLabel_en-US" xlink:label="lab_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred Claims and Allocated Claims Adjustment Expenses</link:label>
    <link:label id="lab_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment_label_en-US" xlink:label="lab_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Incurred Claims Including Acquisition Adjustment</link:label>
    <link:label id="lab_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment_documentation_en-US" xlink:label="lab_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Incurred Claims Including Acquisition Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment" xlink:href="moh-20201231.xsd#moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment" xlink:to="lab_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_ff763da9-b51d-40db-ab5c-786852bfe590_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_b7439867-4e0c-4caa-99e8-d15622b2f4d9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_2f1b6d47-02a2-46ab-8ac8-477704e209e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock purchases (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_6d3f32d6-6b30-412e-8f6e-c206120fce72_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_9654487e-9d64-4378-978a-2747c06bd6c7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call option derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c4cc81af-7e5a-42e2-8e05-410a9e62c533_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_bc19da59-8dd9-4ca4-8bf2-3e7884beef7e_netLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_622b2c64-65cd-477d-a0d1-51713d1c8af2_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable_0446eb81-e2b6-47a7-b60c-313ed5840e4f_terseLabel_en-US" xlink:label="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk adjustment receivable</link:label>
    <link:label id="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable_label_en-US" xlink:label="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Receivable</link:label>
    <link:label id="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable_documentation_en-US" xlink:label="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable" xlink:href="moh-20201231.xsd#moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable" xlink:to="lab_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MedicalPremiumLiabilityDueToAgency_9d605bfd-bbc9-4111-b711-e669f1c8f4a4_terseLabel_en-US" xlink:label="lab_moh_MedicalPremiumLiabilityDueToAgency" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due government agencies</link:label>
    <link:label id="lab_moh_MedicalPremiumLiabilityDueToAgency_bd36755f-3f6c-4b51-abcc-38b7952aab37_totalLabel_en-US" xlink:label="lab_moh_MedicalPremiumLiabilityDueToAgency" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amounts due government agencies</link:label>
    <link:label id="lab_moh_MedicalPremiumLiabilityDueToAgency_label_en-US" xlink:label="lab_moh_MedicalPremiumLiabilityDueToAgency" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Premium Liability Due To Agency</link:label>
    <link:label id="lab_moh_MedicalPremiumLiabilityDueToAgency_documentation_en-US" xlink:label="lab_moh_MedicalPremiumLiabilityDueToAgency" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Premium Liability Due to Agency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalPremiumLiabilityDueToAgency" xlink:href="moh-20201231.xsd#moh_MedicalPremiumLiabilityDueToAgency"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MedicalPremiumLiabilityDueToAgency" xlink:to="lab_moh_MedicalPremiumLiabilityDueToAgency" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable_22049faf-d2f6-4bfe-9973-b5b3878eb72f_negatedTerseLabel_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims and benefits payable</link:label>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable_label_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims and Benefits Payable</link:label>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable_documentation_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims and Benefits Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable" xlink:to="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ed037d4c-55e3-494a-b3f8-6fb9b268a9d0_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_57221baa-130c-48eb-b5ad-dac015c47452_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received for partial settlement of call option</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfWarrants_02005c76-3750-4a6d-9e8c-e95d34e81c38_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for partial termination of warrants</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfWarrants_521d4a53-6bac-41f0-8401-7fd12cd08bc4_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for partial termination of 1.125% Warrants</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfWarrants_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1846d29c-9cc4-4b82-a0f5-a8ce8b093c65_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_191b4d1a-1b6e-4012-a5ab-78fc592ac31c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_6cf03a95-8701-40c0-a4d3-573dab126bf7_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_934e9eea-96b0-4f3a-a75a-fbba437aa211_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding, Weighted-Average Exercise Price (usd per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_SummarizedPremiumRevenueTableTextBlock_6c9fbefb-2ed8-42e2-8ba6-ae529b969219_terseLabel_en-US" xlink:label="lab_moh_SummarizedPremiumRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized premium revenue</link:label>
    <link:label id="lab_moh_SummarizedPremiumRevenueTableTextBlock_label_en-US" xlink:label="lab_moh_SummarizedPremiumRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SummarizedPremiumRevenue [Table Text Block]</link:label>
    <link:label id="lab_moh_SummarizedPremiumRevenueTableTextBlock_documentation_en-US" xlink:label="lab_moh_SummarizedPremiumRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized Premium Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SummarizedPremiumRevenueTableTextBlock" xlink:href="moh-20201231.xsd#moh_SummarizedPremiumRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_SummarizedPremiumRevenueTableTextBlock" xlink:to="lab_moh_SummarizedPremiumRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b22df196-8f5d-453f-ad59-fb21aa7fbe64_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_a08b1f74-8ca7-40fa-b4a6-7d79f355bb61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock purchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_52b7eeca-67d8-4b4a-8c32-fe7d5c3a9fb0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock purchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_41791d9d-531c-444b-9553-91610f9e73c3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases:</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b3d2a120-9dfa-4dac-b0fe-ca5a658ba784_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_cb02094e-3b02-4b48-9998-acde45735a11_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_3ba755d7-8903-4012-9e78-d587625ff3de_verboseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_46eaf476-f0f1-43e4-bd1d-0e0f1c5c6ad2_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_cf5bacb1-5c7e-44da-8b5e-aa707c6abdc7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e47711f7-5d07-4adf-918e-a7b3c53f5447_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceAccountingPolicy_63280955-ce3e-47b4-84a1-ffc55efff17a_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceAccountingPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceAccountingPolicy" xlink:to="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_5835c82b-4f95-4da9-b812-a4e8f4eaa747_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5ae844a2-39b7-415a-a11e-69cc95f7a46c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_495ea154-208b-43e3-8d0f-d665bcb8ea73_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_b86dbf9d-d52f-454b-b926-2ac2f6437921_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2a9c1bf6-eb5b-42de-970e-a9f934c1f6a3_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt repayment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember_b9bd12f4-ac8d-49a9-98cc-a7efb28c9e63_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call option derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember_label_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:to="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a96e759e-8ee6-407b-9af3-355b0c174917_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1a5c4e2e-59de-4706-9a22-6202b77b80ef_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_09956a04-9c25-407d-bbe2-2785d91a3a06_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_StructuredSecuritiesMember_25fce108-3227-4aff-9f66-d12a2ae5c6b8_terseLabel_en-US" xlink:label="lab_moh_StructuredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Structured Securities</link:label>
    <link:label id="lab_moh_StructuredSecuritiesMember_label_en-US" xlink:label="lab_moh_StructuredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Structured Securities [Member]</link:label>
    <link:label id="lab_moh_StructuredSecuritiesMember_documentation_en-US" xlink:label="lab_moh_StructuredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Structured Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_StructuredSecuritiesMember" xlink:href="moh-20201231.xsd#moh_StructuredSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_StructuredSecuritiesMember" xlink:to="lab_moh_StructuredSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_459bb2bb-8e89-4bcc-977d-3baf5c7c39f2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1f49aa47-4bca-4e2e-913c-2090ebd980ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5ff61eed-33ef-4efd-a3c5-10ef99f26600_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_40fb1d88-4ea7-4917-89dd-704f24e2d2ff_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MedicareMedicaidPlansMember_500917a1-1a5d-4e99-8759-14dc2234e42e_terseLabel_en-US" xlink:label="lab_moh_MedicareMedicaidPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MMP Plans</link:label>
    <link:label id="lab_moh_MedicareMedicaidPlansMember_label_en-US" xlink:label="lab_moh_MedicareMedicaidPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare-Medicaid Plans [Member]</link:label>
    <link:label id="lab_moh_MedicareMedicaidPlansMember_documentation_en-US" xlink:label="lab_moh_MedicareMedicaidPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare-Medicaid Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicareMedicaidPlansMember" xlink:href="moh-20201231.xsd#moh_MedicareMedicaidPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MedicareMedicaidPlansMember" xlink:to="lab_moh_MedicareMedicaidPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_510174c5-c07a-4307-b61e-c6b0a8a4fa6a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_c57afe42-11f4-447f-b72c-51ea8710c65d_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_b5a1a990-b4f8-4e5f-a527-da51da93e5ec_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_5acb8ef7-d520-4496-80cf-5eecaf552bf9_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_c8b69d33-0cd7-4286-98c7-b8e36e317746_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9484563e-5d40-45df-bbd0-4a9a1b900639_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cb2c50fc-0bb3-4877-af7f-650e3953b17a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WA_d288105e-e735-498c-9e10-1f2438ae03b5_terseLabel_en-US" xlink:label="lab_stpr_WA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Washington</link:label>
    <link:label id="lab_stpr_WA_label_en-US" xlink:label="lab_stpr_WA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WASHINGTON</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_WA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WA" xlink:to="lab_stpr_WA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_cbd25d4f-2457-4b31-b748-fe0a200ed5ba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_39a1e4ec-8948-4f99-8da0-d5eae4975084_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_e64206ec-6859-49d7-9e0b-adf19f533e5f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from affiliates</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Due from (to) Related Party, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:to="lab_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_9d72f2f9-3093-4c32-9e58-56e83db6c1c8_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_97dd7040-1224-47c2-a1ae-39b650134a5a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair values of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_82dc93f9-5ffc-48aa-8bd5-eb116cf1c517_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_cd78ded4-9ffc-4172-96ff-9f18c71cca77_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_85323d24-cf35-4819-a06c-da88d74651e9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_17f91b3b-82ac-46e9-828c-b7d2499d11a4_totalLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase to additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_fbad28f0-686d-459c-94fd-df8e0dc738d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum expected volatility rate inputs for fair value measurement</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_39065147-d8b3-495c-9400-a0d140ddc7c6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_3cd19eee-b350-43bf-82da-966ff6d8cf66_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_80a67b53-52e8-4df9-89d1-1180bc7aeab8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5eb33743-f243-434f-91ff-2a929edad69e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_e1c9c9ea-f9d9-4e71-b1d1-c2f68e34504e_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized issuance cost</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_IncrementalTermLoanMember_b3e93a56-6112-4e4a-92b1-acfbdbb343a9_terseLabel_en-US" xlink:label="lab_moh_IncrementalTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Term Loan</link:label>
    <link:label id="lab_moh_IncrementalTermLoanMember_label_en-US" xlink:label="lab_moh_IncrementalTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Term Loan [Member]</link:label>
    <link:label id="lab_moh_IncrementalTermLoanMember_documentation_en-US" xlink:label="lab_moh_IncrementalTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncrementalTermLoanMember" xlink:href="moh-20201231.xsd#moh_IncrementalTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_IncrementalTermLoanMember" xlink:to="lab_moh_IncrementalTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_189d1e0b-c8e5-4934-a9af-5c44c8f4c3d2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, Weighted Average Remaining Contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_992fc451-735b-4d39-a8e6-0270c4ab67fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims paid</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_940c649e-511b-44c8-ace3-3a51b090328e_negatedLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: cumulative paid claims and allocated claims adjustment expenses</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_2db01df0-652b-4e04-a4aa-ec85517e6652_negatedLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization - capitalized software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_e36ada64-cd3c-4e45-8db1-d7c1f4e7b026_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6f6519fe-0281-403b-8728-71a08399ca39_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of denominators for the computation of basic and diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CallOptionDerivativeAssetMember_3cffc9d5-0730-47df-b771-5654b51fec36_terseLabel_en-US" xlink:label="lab_moh_CallOptionDerivativeAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) gain on call option</link:label>
    <link:label id="lab_moh_CallOptionDerivativeAssetMember_label_en-US" xlink:label="lab_moh_CallOptionDerivativeAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option, Derivative Asset [Member]</link:label>
    <link:label id="lab_moh_CallOptionDerivativeAssetMember_documentation_en-US" xlink:label="lab_moh_CallOptionDerivativeAssetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option, Derivative Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CallOptionDerivativeAssetMember" xlink:href="moh-20201231.xsd#moh_CallOptionDerivativeAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CallOptionDerivativeAssetMember" xlink:to="lab_moh_CallOptionDerivativeAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_f2a852bd-a90b-4584-b78a-88e364bce6eb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_3ccd68e6-fd1d-41ce-95cd-f4b0d547ca35_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1514055d-87c8-4563-8bc5-aac879f9e805_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets measured on recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_24b22353-ed51-4103-80b5-ab2f227e76ce_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount outstanding under Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_40eed33e-5f02-4abd-8592-c9ab9108c1f4_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_ead36acb-aa7d-46aa-8325-637370615c81_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_0e2ad1d4-234a-466f-b11a-f0f90c6feb0c_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Texas</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_BusinessCombinationNumberOfBusinessCombinations_6d6f5996-5aa4-4067-8dfe-2787512f4696_terseLabel_en-US" xlink:label="lab_moh_BusinessCombinationNumberOfBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business combinations</link:label>
    <link:label id="lab_moh_BusinessCombinationNumberOfBusinessCombinations_label_en-US" xlink:label="lab_moh_BusinessCombinationNumberOfBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Business Combinations</link:label>
    <link:label id="lab_moh_BusinessCombinationNumberOfBusinessCombinations_documentation_en-US" xlink:label="lab_moh_BusinessCombinationNumberOfBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Business Combinations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationNumberOfBusinessCombinations" xlink:href="moh-20201231.xsd#moh_BusinessCombinationNumberOfBusinessCombinations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_BusinessCombinationNumberOfBusinessCombinations" xlink:to="lab_moh_BusinessCombinationNumberOfBusinessCombinations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb47ddd1-0ed6-44c7-aeae-0c6293d19ed5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_fedc29d9-391a-4acf-8822-8549b66ab34e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_1cb8d150-f442-4a6d-ba7a-d271f43c213f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Favorable (unfavorable) adjustment</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_cbf5e779-45ef-4863-988a-19ed7a5d6567_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior periods</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_afcfd50b-08ab-4c58-8111-79974e97fcdc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_EmployeeStockPurchasePlanandStockOptionsMember_73565c41-9116-4b28-9b75-b833a8f0bbac_terseLabel_en-US" xlink:label="lab_moh_EmployeeStockPurchasePlanandStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan and stock options</link:label>
    <link:label id="lab_moh_EmployeeStockPurchasePlanandStockOptionsMember_label_en-US" xlink:label="lab_moh_EmployeeStockPurchasePlanandStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan and Stock Options [Member]</link:label>
    <link:label id="lab_moh_EmployeeStockPurchasePlanandStockOptionsMember_documentation_en-US" xlink:label="lab_moh_EmployeeStockPurchasePlanandStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan and Stock Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EmployeeStockPurchasePlanandStockOptionsMember" xlink:href="moh-20201231.xsd#moh_EmployeeStockPurchasePlanandStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_EmployeeStockPurchasePlanandStockOptionsMember" xlink:to="lab_moh_EmployeeStockPurchasePlanandStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_c95cb9bf-9708-477d-b875-46502e03d4a7_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_e051fe49-b970-47a4-89b8-e81711fa1580_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_b528e3bf-8985-4fa0-a4cb-b82533433a81_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_250ca1b0-2f2a-4e9a-89b0-b0258745f640_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_31dbc878-f9ec-49b8-b7e5-6cf8ee45e352_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2a698747-f24a-4af7-97dc-684962456aba_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of identified intangible assets, by major class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_912a9bbe-b73c-4355-9967-8e69e5b7b333_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_5f8004ee-4e44-476a-ad57-d97264d248ba_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_54260b45-9718-4faa-97a1-b00441374a45_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a94d05fb-97b8-42b1-9a0c-eb9c3a3fb068_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_42b7a78b-6714-42c4-8dc7-f528f27bdbb5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a2252a1b-1b83-4ae1-a4f3-ede6bb77bacd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_6f57272a-d7c0-48c9-98ca-9fa359134866_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statements of Cash Flows</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_43950885-a9a8-42ff-b0f5-5894d456b6aa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma earnings</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c4486909-5001-4192-86b4-2dfd5ba0b761_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_02311d76-b4ec-405f-8a0b-2f13e1e806ec_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding, Weighted Average Remaining Contractual Life (Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ad24b511-ffb8-4cf6-9539-45ec340b9542_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_GovernmentReceivablesMember_e4cea34c-bd41-43ed-ae09-a53f91852f76_terseLabel_en-US" xlink:label="lab_moh_GovernmentReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government receivables</link:label>
    <link:label id="lab_moh_GovernmentReceivablesMember_label_en-US" xlink:label="lab_moh_GovernmentReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Receivables [Member]</link:label>
    <link:label id="lab_moh_GovernmentReceivablesMember_documentation_en-US" xlink:label="lab_moh_GovernmentReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GovernmentReceivablesMember" xlink:href="moh-20201231.xsd#moh_GovernmentReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_GovernmentReceivablesMember" xlink:to="lab_moh_GovernmentReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6d9186bf-6e2a-4a56-a002-8914fe8781fb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average cost (USD per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_a0fccb4d-ad56-4fe0-9bf9-5dd103a0a64a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_ebc1965a-330b-4966-912a-558701d3c0f3_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_fe2929dc-ef9f-450a-a294-0a91b5eb78d7_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_3348a20a-9e7c-45ef-8176-46bacecc5de0_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_91a97b31-4790-4870-8a98-bc5454369b8a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d9b352f9-84db-411d-b85c-4d0166917cd8_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_HealthPlansMember_69cd0fd1-5d04-495b-b3a9-55989d07dc2c_terseLabel_en-US" xlink:label="lab_moh_HealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Plans</link:label>
    <link:label id="lab_moh_HealthPlansMember_a995b485-0f7f-4f8c-8fac-a330c00a0c63_verboseLabel_en-US" xlink:label="lab_moh_HealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Plans</link:label>
    <link:label id="lab_moh_HealthPlansMember_label_en-US" xlink:label="lab_moh_HealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Plans [Member]</link:label>
    <link:label id="lab_moh_HealthPlansMember_documentation_en-US" xlink:label="lab_moh_HealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_HealthPlansMember" xlink:to="lab_moh_HealthPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_3a637608-8fe1-4f5d-8179-8456453b391d_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_e58ca75e-3f05-4b41-ae3c-315e0194b0ea_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_5775374c-8f23-476a-a31d-15a4da11c020_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_99b9e0a1-268f-4772-aa32-149ce453ac92_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains and losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Unrealized Gains on Trading Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_476bb648-5859-4ab1-a772-d2ad713d1b75_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses, net</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_DepreciationandAmortizationContinuingOperations_32b8854b-8c85-4b2e-a23a-96f7260990f7_totalLabel_en-US" xlink:label="lab_moh_DepreciationandAmortizationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_moh_DepreciationandAmortizationContinuingOperations_label_en-US" xlink:label="lab_moh_DepreciationandAmortizationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization, Continuing Operations</link:label>
    <link:label id="lab_moh_DepreciationandAmortizationContinuingOperations_documentation_en-US" xlink:label="lab_moh_DepreciationandAmortizationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DepreciationandAmortizationContinuingOperations" xlink:href="moh-20201231.xsd#moh_DepreciationandAmortizationContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_DepreciationandAmortizationContinuingOperations" xlink:to="lab_moh_DepreciationandAmortizationContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a49e49ae-9d65-4f62-8af3-809f3d5a3bd1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_07b5ede0-9297-4f48-b977-4d77fde237f9_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_IL_56b1efb9-8694-4098-bf89-140b0744fa82_terseLabel_en-US" xlink:label="lab_stpr_IL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Illinois</link:label>
    <link:label id="lab_stpr_IL_label_en-US" xlink:label="lab_stpr_IL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ILLINOIS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_IL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_IL" xlink:to="lab_stpr_IL" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ChangesInAmountsDueToAndDueFromAffiliates_8f07a8b0-037d-4a72-80da-c2bf9b7256c9_verboseLabel_en-US" xlink:label="lab_moh_ChangesInAmountsDueToAndDueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in amounts due to/from affiliates</link:label>
    <link:label id="lab_moh_ChangesInAmountsDueToAndDueFromAffiliates_label_en-US" xlink:label="lab_moh_ChangesInAmountsDueToAndDueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Amounts Due To And Due From Affiliates</link:label>
    <link:label id="lab_moh_ChangesInAmountsDueToAndDueFromAffiliates_documentation_en-US" xlink:label="lab_moh_ChangesInAmountsDueToAndDueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in amounts due to and due from affiliates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ChangesInAmountsDueToAndDueFromAffiliates" xlink:href="moh-20201231.xsd#moh_ChangesInAmountsDueToAndDueFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ChangesInAmountsDueToAndDueFromAffiliates" xlink:to="lab_moh_ChangesInAmountsDueToAndDueFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_36927805-bb84-4589-b0af-430f3b8eb6e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: effect of income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_6fb4bd32-e674-47e4-a5a6-cd5ecda59903_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: effect of income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_24366fe3-f105-42f6-9c06-bcf013e4c7a2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease maturities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_deaae38f-149a-4ae7-8d98-9a6c1f7fa1af_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_825a57b2-623f-4827-9ad1-53b745b91942_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits roll forward</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_c022fec8-7b50-43e7-a926-9d55ae7b6b3f_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_df1461ff-4966-4877-afe4-80a7080b54aa_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_68dfb9fc-7afc-4e6e-a72c-2fc6ceaf0e52_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_a7ab6294-e46f-4af8-b1ee-95190178b1c4_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_7451dbb2-6117-4957-8481-7c7aeb7c199a_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0e8b32b2-622f-4277-8f78-69926c89e040_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_467de023-d7ab-486f-af9c-315293d0f6fb_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period of unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1f7a24f4-3c98-49c8-88c9-89d8f2d2e232_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_FinanceLeaseAssetsLesseeAbstract_04d62fc2-5674-40cc-8465-82eca87895ca_terseLabel_en-US" xlink:label="lab_moh_FinanceLeaseAssetsLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets</link:label>
    <link:label id="lab_moh_FinanceLeaseAssetsLesseeAbstract_label_en-US" xlink:label="lab_moh_FinanceLeaseAssetsLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets, Lessee [Abstract]</link:label>
    <link:label id="lab_moh_FinanceLeaseAssetsLesseeAbstract_documentation_en-US" xlink:label="lab_moh_FinanceLeaseAssetsLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FinanceLeaseAssetsLesseeAbstract" xlink:href="moh-20201231.xsd#moh_FinanceLeaseAssetsLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_FinanceLeaseAssetsLesseeAbstract" xlink:to="lab_moh_FinanceLeaseAssetsLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_223bc99e-a7d2-4da6-aa97-35483fabbc0e_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_020fc533-7d53-4769-9a39-38142708aab0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e5295ada-a0d1-4e6a-9d13-e81322a3f31a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_4ca83c72-ebb6-422c-829d-f54ce6be1846_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized investment gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_57707616-5d75-4dd3-a3c2-9b6d2fbadb8c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred claims and allocated claims adjustment expenses</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_cdcaa7fd-c825-4aab-b95b-793f27d82224_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AssetsAcquiredAbstract_2e5ea5be-5d40-4d7b-a9c0-2d71fac0cace_terseLabel_en-US" xlink:label="lab_moh_AssetsAcquiredAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired:</link:label>
    <link:label id="lab_moh_AssetsAcquiredAbstract_label_en-US" xlink:label="lab_moh_AssetsAcquiredAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Acquired [Abstract]</link:label>
    <link:label id="lab_moh_AssetsAcquiredAbstract_documentation_en-US" xlink:label="lab_moh_AssetsAcquiredAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AssetsAcquiredAbstract" xlink:href="moh-20201231.xsd#moh_AssetsAcquiredAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AssetsAcquiredAbstract" xlink:to="lab_moh_AssetsAcquiredAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_bb9306f9-7596-4f52-9f35-848dface3a49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_GainLossonDispositionofLiabilities_0cd21683-5794-4c69-8020-78a58ffaf6af_terseLabel_en-US" xlink:label="lab_moh_GainLossonDispositionofLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in carrying amount of liabilities</link:label>
    <link:label id="lab_moh_GainLossonDispositionofLiabilities_label_en-US" xlink:label="lab_moh_GainLossonDispositionofLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Liabilities</link:label>
    <link:label id="lab_moh_GainLossonDispositionofLiabilities_documentation_en-US" xlink:label="lab_moh_GainLossonDispositionofLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GainLossonDispositionofLiabilities" xlink:href="moh-20201231.xsd#moh_GainLossonDispositionofLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_GainLossonDispositionofLiabilities" xlink:to="lab_moh_GainLossonDispositionofLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_f2cdb6f7-fee8-4ed2-b988-1562681cbf2f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_db2fe3ed-8b27-4140-8b92-bc567e4c113f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase consideration paid</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_20876710-551e-49ed-a2d1-bdad01924f3a_verboseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:to="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_8112faf0-0d52-478a-a91b-c9dbeb203efb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion option derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bf459ea-fdfb-4477-bbf5-679bad191151_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_2e12f79e-94b4-4ae9-8d66-5ced8d7501e0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Number of Positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_OtherGeographicalAreasMember_3705e1f5-3630-494e-bbf8-a50cd8fb8e3e_verboseLabel_en-US" xlink:label="lab_moh_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_moh_OtherGeographicalAreasMember_33eaf9b2-b1b6-4374-945c-a726de2cb67c_terseLabel_en-US" xlink:label="lab_moh_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_moh_OtherGeographicalAreasMember_label_en-US" xlink:label="lab_moh_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographical Areas [Member]</link:label>
    <link:label id="lab_moh_OtherGeographicalAreasMember_documentation_en-US" xlink:label="lab_moh_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographical Areas.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherGeographicalAreasMember" xlink:href="moh-20201231.xsd#moh_OtherGeographicalAreasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_OtherGeographicalAreasMember" xlink:to="lab_moh_OtherGeographicalAreasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_6451fbf1-a0f5-4c69-8d05-90b1565e8f53_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MarketplaceRiskCorridorSettlementMember_ab4e6f2e-b636-42a8-932d-1a5630dc961c_terseLabel_en-US" xlink:label="lab_moh_MarketplaceRiskCorridorSettlementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketplace risk corridor judgment</link:label>
    <link:label id="lab_moh_MarketplaceRiskCorridorSettlementMember_label_en-US" xlink:label="lab_moh_MarketplaceRiskCorridorSettlementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketplace Risk Corridor Settlement [Member]</link:label>
    <link:label id="lab_moh_MarketplaceRiskCorridorSettlementMember_documentation_en-US" xlink:label="lab_moh_MarketplaceRiskCorridorSettlementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketplace Risk Corridor Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MarketplaceRiskCorridorSettlementMember" xlink:href="moh-20201231.xsd#moh_MarketplaceRiskCorridorSettlementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MarketplaceRiskCorridorSettlementMember" xlink:to="lab_moh_MarketplaceRiskCorridorSettlementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_A4375SeniorNotesMember_e1132544-86e6-463f-99a3-40769b34b809_terseLabel_en-US" xlink:label="lab_moh_A4375SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% Notes</link:label>
    <link:label id="lab_moh_A4375SeniorNotesMember_label_en-US" xlink:label="lab_moh_A4375SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% Senior Notes [Member]</link:label>
    <link:label id="lab_moh_A4375SeniorNotesMember_documentation_en-US" xlink:label="lab_moh_A4375SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4375SeniorNotesMember" xlink:href="moh-20201231.xsd#moh_A4375SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_A4375SeniorNotesMember" xlink:to="lab_moh_A4375SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_08e6ae3b-8598-4ab1-89e7-0e930f5a5b8a_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CurrentAssetsMember_151f80a8-dadf-4d6d-862f-afe86cae1297_terseLabel_en-US" xlink:label="lab_moh_CurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_moh_CurrentAssetsMember_label_en-US" xlink:label="lab_moh_CurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets [Member]</link:label>
    <link:label id="lab_moh_CurrentAssetsMember_documentation_en-US" xlink:label="lab_moh_CurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CurrentAssetsMember" xlink:href="moh-20201231.xsd#moh_CurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CurrentAssetsMember" xlink:to="lab_moh_CurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_8f8b0e73-4d2d-48f3-a5d2-86ca83ad766e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_64c08486-6cc6-465a-a63e-e7fdb4739030_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, operating expense</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OH_c36f04aa-9afc-4e36-a552-ff2935596614_terseLabel_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ohio</link:label>
    <link:label id="lab_stpr_OH_54885bdc-7db2-4533-835c-a9b5becc7484_verboseLabel_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ohio</link:label>
    <link:label id="lab_stpr_OH_label_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OHIO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OH" xlink:to="lab_stpr_OH" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CashConvertibleSeniorNotesDue2020Member_372644c2-8708-4824-b4b9-b8002986740e_terseLabel_en-US" xlink:label="lab_moh_CashConvertibleSeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.125% Convertible Notes</link:label>
    <link:label id="lab_moh_CashConvertibleSeniorNotesDue2020Member_25b335b3-02a6-41bf-a3a6-127cdeb916e1_verboseLabel_en-US" xlink:label="lab_moh_CashConvertibleSeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.125% Convertible Notes</link:label>
    <link:label id="lab_moh_CashConvertibleSeniorNotesDue2020Member_label_en-US" xlink:label="lab_moh_CashConvertibleSeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Convertible Senior Notes due 2020 [Member]</link:label>
    <link:label id="lab_moh_CashConvertibleSeniorNotesDue2020Member_documentation_en-US" xlink:label="lab_moh_CashConvertibleSeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Convertible Senior Notes due 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020Member" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CashConvertibleSeniorNotesDue2020Member" xlink:to="lab_moh_CashConvertibleSeniorNotesDue2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_8de53963-4cb8-4d23-b656-1efee5601b24_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_13181b07-2f7a-4a76-8a20-c26449d2d1b8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired_618aa8ac-97e5-4269-8a9e-866f29e4d6f5_terseLabel_en-US" xlink:label="lab_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired_label_en-US" xlink:label="lab_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Right Of Use Asset, Excluding Leases Acquired</link:label>
    <link:label id="lab_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired_documentation_en-US" xlink:label="lab_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Right Of Use Asset, Excluding Leases Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired" xlink:href="moh-20201231.xsd#moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired" xlink:to="lab_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NY_3dfa5967-449a-4f90-8583-3685d562288d_terseLabel_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York</link:label>
    <link:label id="lab_stpr_NY_label_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NY" xlink:to="lab_stpr_NY" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ClassOfWarrantOrRightStatedInterestRate_060f2470-b09d-4fd2-a56f-dd28a7d9b5dd_terseLabel_en-US" xlink:label="lab_moh_ClassOfWarrantOrRightStatedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_moh_ClassOfWarrantOrRightStatedInterestRate_9400cf0f-a222-4705-8803-13d3db81f3e4_verboseLabel_en-US" xlink:label="lab_moh_ClassOfWarrantOrRightStatedInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated percentage of warrants</link:label>
    <link:label id="lab_moh_ClassOfWarrantOrRightStatedInterestRate_label_en-US" xlink:label="lab_moh_ClassOfWarrantOrRightStatedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Stated Interest Rate</link:label>
    <link:label id="lab_moh_ClassOfWarrantOrRightStatedInterestRate_documentation_en-US" xlink:label="lab_moh_ClassOfWarrantOrRightStatedInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Stated Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ClassOfWarrantOrRightStatedInterestRate" xlink:href="moh-20201231.xsd#moh_ClassOfWarrantOrRightStatedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ClassOfWarrantOrRightStatedInterestRate" xlink:to="lab_moh_ClassOfWarrantOrRightStatedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_465f5fce-59cd-47eb-b853-8069d35b9bb8_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_b5781131-2836-486c-882c-027b18994c4c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ce53314c-84db-4c0e-ad30-e03c922c37db_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities (non-current)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a01b292a-3585-4128-9b30-df5a60a1d721_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7a37fc9d-a713-4b2b-a393-190a99138d6b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MedicalClaimsAndBenefitsPayable_5e62673f-ff85-4ac6-b97a-f3cf2633b905_terseLabel_en-US" xlink:label="lab_moh_MedicalClaimsAndBenefitsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-risk provide payables</link:label>
    <link:label id="lab_moh_MedicalClaimsAndBenefitsPayable_label_en-US" xlink:label="lab_moh_MedicalClaimsAndBenefitsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims And Benefits Payable</link:label>
    <link:label id="lab_moh_MedicalClaimsAndBenefitsPayable_documentation_en-US" xlink:label="lab_moh_MedicalClaimsAndBenefitsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims and Benefits Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalClaimsAndBenefitsPayable" xlink:href="moh-20201231.xsd#moh_MedicalClaimsAndBenefitsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MedicalClaimsAndBenefitsPayable" xlink:to="lab_moh_MedicalClaimsAndBenefitsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NM_97900aa5-60d0-4bc5-aac9-c2bccea90e14_terseLabel_en-US" xlink:label="lab_stpr_NM" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Mexico</link:label>
    <link:label id="lab_stpr_NM_label_en-US" xlink:label="lab_stpr_NM" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW MEXICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NM"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NM" xlink:to="lab_stpr_NM" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_2692fc01-219a-4209-a882-74edc8f378ca_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total medical care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_e6a7a8a5-3d8b-4ef1-af34-df16e4e044a0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred Claims and Allocated Claims Adjustment Expenses</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_97451b6f-8082-4435-a2fe-c75627bc4896_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ProviderNetworkMember_ed5e9ba3-be2d-47ea-983a-d04975fd274f_terseLabel_en-US" xlink:label="lab_moh_ProviderNetworkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider network</link:label>
    <link:label id="lab_moh_ProviderNetworkMember_label_en-US" xlink:label="lab_moh_ProviderNetworkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Network [Member]</link:label>
    <link:label id="lab_moh_ProviderNetworkMember_documentation_en-US" xlink:label="lab_moh_ProviderNetworkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Network</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ProviderNetworkMember" xlink:href="moh-20201231.xsd#moh_ProviderNetworkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ProviderNetworkMember" xlink:to="lab_moh_ProviderNetworkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage_d7be3780-11a0-4f37-b0f9-117fc62323b2_terseLabel_en-US" xlink:label="lab_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination goodwill is deductible for income tax purposes</link:label>
    <link:label id="lab_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage_label_en-US" xlink:label="lab_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Goodwill Deductible For Income Tax Purposes, Percentage</link:label>
    <link:label id="lab_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage_documentation_en-US" xlink:label="lab_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Goodwill Deductible For Income Tax Purposes, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage" xlink:href="moh-20201231.xsd#moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage" xlink:to="lab_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_4a128502-6702-40a0-b3f0-f6fb8370bd23_terseLabel_en-US" xlink:label="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of restricted shares granted</link:label>
    <link:label id="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_label_en-US" xlink:label="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value</link:label>
    <link:label id="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_documentation_en-US" xlink:label="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:href="moh-20201231.xsd#moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:to="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_7dc84764-de6c-4347-a5a3-56856a5b83b8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_de8d1fc4-0dbd-475e-b618-8575558b44bb_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_d2595f4a-64e9-4ccf-b242-bdb8b116e030_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_OtherReceivablesMember_c7f2483c-ab87-4c19-a33d-59b0700d8683_terseLabel_en-US" xlink:label="lab_moh_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_moh_OtherReceivablesMember_label_en-US" xlink:label="lab_moh_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables [Member]</link:label>
    <link:label id="lab_moh_OtherReceivablesMember_documentation_en-US" xlink:label="lab_moh_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherReceivablesMember" xlink:href="moh-20201231.xsd#moh_OtherReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_OtherReceivablesMember" xlink:to="lab_moh_OtherReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_df230fff-8899-4c84-8ec6-2d43bf67bd02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_93cd42f9-205c-461c-8976-48a5f6d527b5_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a82c12cb-3b83-4243-a217-59e6444327cf_netLabel_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government-sponsored enterprise securities (&#8220;GSEs&#8221;)</link:label>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_b6779a83-c36e-4ea2-8d52-02d815faef95_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GSEs</link:label>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government-sponsored Enterprises Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_410c0a19-21a8-42a4-8040-c8355ffcfef3_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_7421707c-8bdd-42fa-8476-378d198fe711_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation to the statutory federal income tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_bc27f788-2560-45e7-af8c-3585f4810f43_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MedicaidMember_fac66611-6ae9-4fb6-8fe5-fd0fcff3d2ab_terseLabel_en-US" xlink:label="lab_moh_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_moh_MedicaidMember_label_en-US" xlink:label="lab_moh_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:label id="lab_moh_MedicaidMember_documentation_en-US" xlink:label="lab_moh_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicaidMember" xlink:href="moh-20201231.xsd#moh_MedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MedicaidMember" xlink:to="lab_moh_MedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_3f0f0cec-8768-46c8-ac27-574fb430e235_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_d03de99b-11f2-4c9c-a7d6-197746dd9d5f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_92d47c33-8a97-4b15-a7de-9ed20aa75077_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MI_13ea123c-e668-4632-b012-d73c2b71fe19_terseLabel_en-US" xlink:label="lab_stpr_MI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michigan</link:label>
    <link:label id="lab_stpr_MI_label_en-US" xlink:label="lab_stpr_MI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MICHIGAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MI" xlink:to="lab_stpr_MI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_35feef0d-7249-4604-b55d-7df9b6c06792_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_1f3c0bc6-39e1-4fe0-a2c0-518d161be0d0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_cee54393-5992-469b-abc8-42df74a91323_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Held-to-maturity Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Held-to-maturity Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_205efc82-9c73-45bc-87ec-089b21e35769_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f151f6e8-0e4a-4af3-9c52-43df39332fcd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_c29db04c-a1a8-460f-80ec-c95057768729_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock purchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_87ed6371-13e1-4b50-a3ed-d7b913a68a4d_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_ec8d8a44-8071-4700-90bf-09a027760698_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization - furniture, equipment, building, and improvements</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment, Owned, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_992d2fe0-af89-4b84-b709-0e3b546a8bd8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_c59ea1a3-7ca7-4d62-9ae8-87bf310a6bf2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_504d032a-3c0b-4289-a04c-69d74480de0c_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum matching contribution by employer under defined contribution plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CurrentLiabilitiesMember_3e04e4b6-5073-41be-bb18-20c02d447aa3_terseLabel_en-US" xlink:label="lab_moh_CurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_moh_CurrentLiabilitiesMember_label_en-US" xlink:label="lab_moh_CurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities [Member]</link:label>
    <link:label id="lab_moh_CurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_moh_CurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CurrentLiabilitiesMember" xlink:href="moh-20201231.xsd#moh_CurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CurrentLiabilitiesMember" xlink:to="lab_moh_CurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_KY_ff7d6f5b-d1aa-4ac0-b0ff-394f9862feb6_terseLabel_en-US" xlink:label="lab_stpr_KY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kentucky</link:label>
    <link:label id="lab_stpr_KY_label_en-US" xlink:label="lab_stpr_KY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KENTUCKY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KY" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_KY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_KY" xlink:to="lab_stpr_KY" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_DetailsofchangeinfairvalueofderivativesAbstract_b46a2815-eca9-4c0d-9f1c-18bda7c58471_terseLabel_en-US" xlink:label="lab_moh_DetailsofchangeinfairvalueofderivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of change in fair value of derivatives, net:</link:label>
    <link:label id="lab_moh_DetailsofchangeinfairvalueofderivativesAbstract_label_en-US" xlink:label="lab_moh_DetailsofchangeinfairvalueofderivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of change in fair value of derivatives [Abstract]</link:label>
    <link:label id="lab_moh_DetailsofchangeinfairvalueofderivativesAbstract_documentation_en-US" xlink:label="lab_moh_DetailsofchangeinfairvalueofderivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of change in fair value of derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DetailsofchangeinfairvalueofderivativesAbstract" xlink:href="moh-20201231.xsd#moh_DetailsofchangeinfairvalueofderivativesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_DetailsofchangeinfairvalueofderivativesAbstract" xlink:to="lab_moh_DetailsofchangeinfairvalueofderivativesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_HealthCareOrganizationInsurerFeeExpense_b1632e0f-72f8-4c44-a906-090db9a61c7e_terseLabel_en-US" xlink:label="lab_moh_HealthCareOrganizationInsurerFeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fees</link:label>
    <link:label id="lab_moh_HealthCareOrganizationInsurerFeeExpense_label_en-US" xlink:label="lab_moh_HealthCareOrganizationInsurerFeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Insurer Fee Expense</link:label>
    <link:label id="lab_moh_HealthCareOrganizationInsurerFeeExpense_documentation_en-US" xlink:label="lab_moh_HealthCareOrganizationInsurerFeeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Insurer Fee Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthCareOrganizationInsurerFeeExpense" xlink:href="moh-20201231.xsd#moh_HealthCareOrganizationInsurerFeeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_HealthCareOrganizationInsurerFeeExpense" xlink:to="lab_moh_HealthCareOrganizationInsurerFeeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_514a8957-9762-47d0-9465-fa2f8d0dfce9_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_03fed984-1416-48cb-aa75-fd5764e2b8bc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositLiabilitiesAccruedInterest_a8ff98fc-8b66-49f0-9265-cf7c4fe9401e_terseLabel_en-US" xlink:label="lab_us-gaap_DepositLiabilitiesAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid interest</link:label>
    <link:label id="lab_us-gaap_DepositLiabilitiesAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DepositLiabilitiesAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Liabilities, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositLiabilitiesAccruedInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositLiabilitiesAccruedInterest" xlink:to="lab_us-gaap_DepositLiabilitiesAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_d975a050-977a-46a6-bf64-465f1b8530da_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_31e4a6db-b3a6-4238-b77a-b8c2b91c6743_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_4f7f59fc-ac99-4720-8e29-ad7f4ce1d6df_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_d1b71b63-fd5a-4da8-8912-8bdf773538e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Other operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_ee591f4e-6f70-471e-a64b-32f8467990e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2f77756c-caaa-496a-a78a-dd572f19de87_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_1b328ca8-50a9-4f26-92b3-2123965b2482_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_edb26ab5-8455-45dc-94db-d898454be789_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_e18bc210-fcf9-4e6a-bac7-468ff11d0ef4_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, equipment, and capitalized software, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_9e973537-23a6-4113-a2af-1c939d13d5f1_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, equipment, and capitalized software, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a337c89d-a465-4614-ac9b-bfb61b21ac71_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, equipment, and capitalized software, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_8c40e814-3ddb-4a96-82c2-fcbb9e53983c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract rights - member list</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_1b1b84cb-bdf5-4b8d-9bd0-1c6b4ba86897_netLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_5f2609d3-cb9e-4561-81b8-45890b5c7edd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReservesReportedToOtherAgenciesTextBlock_bed167da-60e8-4316-9ea4-867bac50441c_terseLabel_en-US" xlink:label="lab_us-gaap_ReservesReportedToOtherAgenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due to government agencies</link:label>
    <link:label id="lab_us-gaap_ReservesReportedToOtherAgenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_ReservesReportedToOtherAgenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves Reported to Other Agencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReservesReportedToOtherAgenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReservesReportedToOtherAgenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReservesReportedToOtherAgenciesTextBlock" xlink:to="lab_us-gaap_ReservesReportedToOtherAgenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_13c955b1-da59-40bc-817f-b76d2ff6076b_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_70512f67-d88f-484e-a044-0b9ffd54e459_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_3f1d9007-8c4a-49cd-96ec-4a4145d46df7_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_62b39ce1-4fbf-456a-8d3f-b14d67e2a64b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3ca9ceff-27a3-4192-aa1a-feb738008d7e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bc93c6a8-5f97-4b52-b493-e66db09bd211_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_414ecb16-3df2-49f1-939a-796020697a28_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_c9ac7a86-0203-4fb2-9e6c-7fabd4c005f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options, activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_cc8193e8-48aa-4b6c-9258-f2c6d6427ecd_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_44a1e33c-cf9d-4545-937f-f32523f96a05_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_c1494d1d-28e5-4698-b2cb-52fecf8383dd_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_2621ee5c-7546-4f90-ab25-d3e3132a14b3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of sales of subsidiaries:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Subsidiaries and Affiliates [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1_4e3b35f2-e985-429e-834b-1c4d1ee471d1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_6af2993d-d67a-471d-9104-38092109488d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_5eaf482e-b8d5-4bfb-afec-dbb597f64a2d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_6a718e1a-fcb3-4a30-bd3a-5d98a52f5441_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_44737527-9106-4581-9f40-c85472fcc762_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_DepreciationAndAmortizationOfCapitalizedSoftware_7a2b72ca-08fa-4359-bca5-8308d040e785_verboseLabel_en-US" xlink:label="lab_moh_DepreciationAndAmortizationOfCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of capitalized software</link:label>
    <link:label id="lab_moh_DepreciationAndAmortizationOfCapitalizedSoftware_label_en-US" xlink:label="lab_moh_DepreciationAndAmortizationOfCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Of Capitalized Software</link:label>
    <link:label id="lab_moh_DepreciationAndAmortizationOfCapitalizedSoftware_documentation_en-US" xlink:label="lab_moh_DepreciationAndAmortizationOfCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, and amortization of capitalized software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DepreciationAndAmortizationOfCapitalizedSoftware" xlink:href="moh-20201231.xsd#moh_DepreciationAndAmortizationOfCapitalizedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_DepreciationAndAmortizationOfCapitalizedSoftware" xlink:to="lab_moh_DepreciationAndAmortizationOfCapitalizedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_d261129d-026f-4bc1-9623-c8a58e3e5524_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_label_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_ef305a06-7c27-44c7-a50d-ccd087bad78a_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_8e88d239-5bf5-4b8d-a2c9-258abf226cb7_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1db3d48e-a18b-4cb2-8fe0-ada29217b038_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_875b5a5c-3595-4b5c-bd88-75402b536637_verboseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for unrecognized tax benefits, potential decrease</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ProviderNetworksMember_ccc1f9ed-8828-497f-ae36-792070e72162_netLabel_en-US" xlink:label="lab_moh_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider networks</link:label>
    <link:label id="lab_moh_ProviderNetworksMember_label_en-US" xlink:label="lab_moh_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Networks [Member]</link:label>
    <link:label id="lab_moh_ProviderNetworksMember_documentation_en-US" xlink:label="lab_moh_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider networks.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ProviderNetworksMember" xlink:href="moh-20201231.xsd#moh_ProviderNetworksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ProviderNetworksMember" xlink:to="lab_moh_ProviderNetworksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_f5b38e89-8e20-46f1-9719-3ffa91cbb29d_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_8e04878e-fb29-4ea1-a6d0-1ef74b1ba431_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange of convertible senior notes (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_c62825e6-1b79-437e-a5cd-31b57ed30ac6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment and other</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9b78cd0-b019-4a91-9429-6fad0d824a1a_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal - undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_9ca00d50-9866-4bd5-ae19-d506b7451941_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_d2784bd6-4fc0-4aa9-8cc2-134f8dea53ca_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_39e9364b-f401-40b1-b905-f57728270507_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_BasisOfPresentationTable_d8c235d4-d6d4-4f1d-983b-2d3d8cf64e24_terseLabel_en-US" xlink:label="lab_moh_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation [Table]</link:label>
    <link:label id="lab_moh_BasisOfPresentationTable_label_en-US" xlink:label="lab_moh_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation [Table]</link:label>
    <link:label id="lab_moh_BasisOfPresentationTable_documentation_en-US" xlink:label="lab_moh_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BasisOfPresentationTable" xlink:href="moh-20201231.xsd#moh_BasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_BasisOfPresentationTable" xlink:to="lab_moh_BasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies_3e8be93a-b232-4d53-b4f7-bf9588262ba9_negatedTerseLabel_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due government agencies</link:label>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies_label_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Amounts Due Government Agencies</link:label>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies_documentation_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Amounts Due Government Agencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies" xlink:to="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d757be11-ca2e-4393-a35b-8306d5bb0094_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_902c65e2-5ba9-44b1-989a-26458e3ab901_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_03d215b0-92c9-46f5-b12a-c0b581096659_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_f2a137f9-8f74-4f95-aea3-d07f980e9e08_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_94123b00-018e-4d5f-bb6d-052aec706750_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_be56d326-1379-4367-abed-18e5d8012ffd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_255790ea-f379-4f81-9961-f43a8d960520_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_fee03617-9117-4069-b8d3-f2799999db57_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_5b574356-be08-4010-9eb4-b5fdc8c60eff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicaidOther_115bb1d1-4829-4755-b337-ea97e07a8fcb_terseLabel_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicaidOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicaidOther_label_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicaidOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies, Medicaid, Other</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicaidOther_documentation_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicaidOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies, Medicaid, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMedicaidOther" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMedicaidOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMedicaidOther" xlink:to="lab_moh_AmountsDueToGovernmentAgenciesMedicaidOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_9b1d13ee-f076-4910-b0ad-f5f6a63afac4_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6a15027d-7883-4468-a510-fad982209276_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_6909497a-123b-479d-8d06-194c3b434928_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_9f06526b-867b-4906-bce7-1b2fcb52711e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_abe95d0c-892a-42aa-a98c-e63535226d0c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options exercisable and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_9c41035b-47e1-4a88-84f0-37603b676c5d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_FL_25688702-5e5a-4f19-a553-c4de0d336076_terseLabel_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Florida</link:label>
    <link:label id="lab_stpr_FL_676f7763-b513-414f-ac59-f054c8fc4159_netLabel_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Florida</link:label>
    <link:label id="lab_stpr_FL_label_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FLORIDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_FL" xlink:to="lab_stpr_FL" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_34532868-ec90-4504-bb94-40e37098c495_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_562accc7-97cd-44ff-a24a-44d1de1c6617_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount_5d2c384a-ac69-4fd6-bc7c-e7f127282570_terseLabel_en-US" xlink:label="lab_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of long-term debt</link:label>
    <link:label id="lab_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount_label_en-US" xlink:label="lab_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Noncurrent, Net Of Unamortized Debt Discount</link:label>
    <link:label id="lab_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount_documentation_en-US" xlink:label="lab_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Noncurrent, Net Of Unamortized Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" xlink:href="moh-20201231.xsd#moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" xlink:to="lab_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f6ee1b24-0969-451b-af8e-bc6a36ebbdf9_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact on effective tax rate if tax benefits are recognized</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c5ba30a8-bb45-40e8-8136-36ea7d9cbaee_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term of awards</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_272e6e3f-63a0-4f6d-a2a8-3246fb2360d2_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of capitalized software and deferred contract costs</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_59bfd330-3c81-48da-bc67-a4917fe299a8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c348bef4-3567-4c7d-8396-0b0071e6e683_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease_9e2db6c2-72af-44bd-b5cf-cdbe88227444_terseLabel_en-US" xlink:label="lab_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Component of convertible senior notes allocated to additional paid-in capital, net of income taxes</link:label>
    <link:label id="lab_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease_label_en-US" xlink:label="lab_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Issued, Fair Value Adjustment Increase (Decrease)</link:label>
    <link:label id="lab_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease_documentation_en-US" xlink:label="lab_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Issued, Fair Value Adjustment Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease" xlink:href="moh-20201231.xsd#moh_NotesIssuedFairValueAdjustmentIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease" xlink:to="lab_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_52d4cf9f-e0b5-4b24-95b8-38bea70a29ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_7911ca70-615c-4539-ade5-557d0bea8fef_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_a91cae1c-6037-46d2-bb13-e0d919f0ab07_netLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_NumberOfStatesForOperatedHealthPlans_39e447d7-8933-4379-9bb1-14eaa2bb4d30_terseLabel_en-US" xlink:label="lab_moh_NumberOfStatesForOperatedHealthPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states for operated health plans</link:label>
    <link:label id="lab_moh_NumberOfStatesForOperatedHealthPlans_label_en-US" xlink:label="lab_moh_NumberOfStatesForOperatedHealthPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States For Operated Health Plans</link:label>
    <link:label id="lab_moh_NumberOfStatesForOperatedHealthPlans_documentation_en-US" xlink:label="lab_moh_NumberOfStatesForOperatedHealthPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States For Operated Health Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NumberOfStatesForOperatedHealthPlans" xlink:href="moh-20201231.xsd#moh_NumberOfStatesForOperatedHealthPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_NumberOfStatesForOperatedHealthPlans" xlink:to="lab_moh_NumberOfStatesForOperatedHealthPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_82a2a554-749a-4a9c-8158-8cdee4cc39b4_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pretax Charges</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee_a06c0ee5-1345-49b0-9a6d-8bf8bcd00ebe_terseLabel_en-US" xlink:label="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum annual contribution per employee</link:label>
    <link:label id="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee_label_en-US" xlink:label="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Maximum Amount Per Employee</link:label>
    <link:label id="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee_documentation_en-US" xlink:label="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation arrangement by share based payment award maximum amount per employee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee" xlink:href="moh-20201231.xsd#moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee" xlink:to="lab_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ConsolidatedNetLeverage_d7457e84-b816-4528-8737-869ff545b062_terseLabel_en-US" xlink:label="lab_moh_ConsolidatedNetLeverage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net leverage</link:label>
    <link:label id="lab_moh_ConsolidatedNetLeverage_label_en-US" xlink:label="lab_moh_ConsolidatedNetLeverage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Net Leverage</link:label>
    <link:label id="lab_moh_ConsolidatedNetLeverage_documentation_en-US" xlink:label="lab_moh_ConsolidatedNetLeverage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Net Leverage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ConsolidatedNetLeverage" xlink:href="moh-20201231.xsd#moh_ConsolidatedNetLeverage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ConsolidatedNetLeverage" xlink:to="lab_moh_ConsolidatedNetLeverage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_b46b034a-5165-4c49-bf47-4880f822ae5e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_32d585fe-a8f3-4714-b89c-8a7263f7405f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_f7aa4dd9-40ec-4432-a246-a13c256eff8a_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ff14df50-fd75-4a13-9794-c2ca9b90b61e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d2663a03-013f-401b-8828-7765aa528649_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of receivables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5e96d0c6-4efe-4bc0-80da-a880a1277e86_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_be82e250-f6a6-4a29-92ed-a8d3281bbb38_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_A4.875SeniorNotesMember_19c6cde1-e263-48e1-8397-439e180d4749_terseLabel_en-US" xlink:label="lab_moh_A4.875SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% Notes</link:label>
    <link:label id="lab_moh_A4.875SeniorNotesMember_label_en-US" xlink:label="lab_moh_A4.875SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% Senior Notes [Member]</link:label>
    <link:label id="lab_moh_A4.875SeniorNotesMember_documentation_en-US" xlink:label="lab_moh_A4.875SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4.875SeniorNotesMember" xlink:href="moh-20201231.xsd#moh_A4.875SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_A4.875SeniorNotesMember" xlink:to="lab_moh_A4.875SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e5458e42-1bcb-47f2-8d39-509f38eec88b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_83e522e7-8881-43e5-bc82-5be68574a9ae_verboseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits roll forward</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_57c717a0-10f2-446f-bed4-c5b8b8f9f4b9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_47c1fd16-4cd7-4192-9548-03c776d8fa75_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8423b597-085f-4c81-a447-22bae5c68104_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_09013cbd-a109-435f-be69-42b1652a0c2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_be716520-5c00-4306-893a-f293b0e2942c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_7f3ba535-7983-4623-b477-e1ec0eca2024_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateralized Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CommonStockPurchasesNotSettledAtEndOfPeriod_2730b1a6-1ac3-4b15-94d4-069b61e9c30a_terseLabel_en-US" xlink:label="lab_moh_CommonStockPurchasesNotSettledAtEndOfPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock purchases not settled at end of period</link:label>
    <link:label id="lab_moh_CommonStockPurchasesNotSettledAtEndOfPeriod_label_en-US" xlink:label="lab_moh_CommonStockPurchasesNotSettledAtEndOfPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Purchases Not Settled At End Of Period</link:label>
    <link:label id="lab_moh_CommonStockPurchasesNotSettledAtEndOfPeriod_documentation_en-US" xlink:label="lab_moh_CommonStockPurchasesNotSettledAtEndOfPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Purchases Not Settled At End Of Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CommonStockPurchasesNotSettledAtEndOfPeriod" xlink:href="moh-20201231.xsd#moh_CommonStockPurchasesNotSettledAtEndOfPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CommonStockPurchasesNotSettledAtEndOfPeriod" xlink:to="lab_moh_CommonStockPurchasesNotSettledAtEndOfPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5241a902-29fd-46ae-8e8f-e6c0a426e2b2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_ef75fd8e-76d9-4f71-acba-d9845f4866dc_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Year 2019</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_PharmacyClaimsPayable_3c0c2c54-a740-4fc3-b243-fee47384f47d_terseLabel_en-US" xlink:label="lab_moh_PharmacyClaimsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy payable</link:label>
    <link:label id="lab_moh_PharmacyClaimsPayable_label_en-US" xlink:label="lab_moh_PharmacyClaimsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims Payable</link:label>
    <link:label id="lab_moh_PharmacyClaimsPayable_documentation_en-US" xlink:label="lab_moh_PharmacyClaimsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PharmacyClaimsPayable" xlink:href="moh-20201231.xsd#moh_PharmacyClaimsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_PharmacyClaimsPayable" xlink:to="lab_moh_PharmacyClaimsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_a5287eb4-157d-4592-8174-b09ffb3b89fe_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized loss</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_accd23df-5f90-4ee3-9722-753ebf7da191_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_99894f49-69fc-4a11-b845-13983fd724a5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_590b69ac-fc1d-487a-8784-c26aec611541_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fbac09c0-5581-4a49-b35d-69b217801e34_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d91aba5c-8b46-492e-93ea-7ce7025e9de2_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock_7ed67ad1-03e2-4897-bc7c-f66a47188fe9_verboseLabel_en-US" xlink:label="lab_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of the change in medical claims and benefits payable</link:label>
    <link:label id="lab_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock_label_en-US" xlink:label="lab_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components Of Change In Medical Claims And Benefits Payable [Table Text Block]</link:label>
    <link:label id="lab_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock_documentation_en-US" xlink:label="lab_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components Of Change In Medical Claims And Benefits Payable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock" xlink:href="moh-20201231.xsd#moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock" xlink:to="lab_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_dc5e6917-daaa-45bf-954a-2ce4312318b2_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fba01811-2ad7-42d1-bdf6-9a8e75695783_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lapse in statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_b2a94e1b-1507-4a8e-b605-39cad206595d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4187c0c6-2da9-4191-b5ba-692f948255d7_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net purchase price paid</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_9815e424-7925-4387-a9b6-27dd50a22f57_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_5ed410b4-5395-4ee5-9c71-93c0246b0b2b_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_8f02782c-99c9-4fad-9df0-8bbd12f44897_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_84cfda89-d5e2-43c3-b93c-f1970c7712cc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_48561684-1158-4140-9e53-de3d4e01f419_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases in tax positions for current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a9f70f0e-3633-46c4-9443-cd1f7d86d591_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d494e6b6-20c6-4897-8821-b9642c624a89_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_87a51424-13d8-4dcc-a9ca-1940e5325af6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_0f629df8-4117-4f0e-96e9-a4601093ac89_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and investments</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent_4c962254-eab8-438b-9dad-dcc6aff669d6_terseLabel_en-US" xlink:label="lab_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible health insurer fee (&#8220;HIF&#8221;)</link:label>
    <link:label id="lab_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent_label_en-US" xlink:label="lab_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Health Insurance, Percent</link:label>
    <link:label id="lab_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent_documentation_en-US" xlink:label="lab_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Health Insurance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" xlink:href="moh-20201231.xsd#moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" xlink:to="lab_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_ddf1ac7a-74a6-4a50-890b-f2e88450381d_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_2ed7b9d4-7d0b-4457-b475-5434247e0971_verboseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_PremiumTaxExpenses_e6ad7547-855d-4890-816e-f872a432ac93_terseLabel_en-US" xlink:label="lab_moh_PremiumTaxExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium tax expenses</link:label>
    <link:label id="lab_moh_PremiumTaxExpenses_label_en-US" xlink:label="lab_moh_PremiumTaxExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Tax Expenses</link:label>
    <link:label id="lab_moh_PremiumTaxExpenses_documentation_en-US" xlink:label="lab_moh_PremiumTaxExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An assessment levied by a state government on the net premium income collected.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PremiumTaxExpenses" xlink:href="moh-20201231.xsd#moh_PremiumTaxExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_PremiumTaxExpenses" xlink:to="lab_moh_PremiumTaxExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3c48bb0f-4c3f-4ad4-9a1d-3497c4ed748b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_caf1bae4-2dd5-4f3e-bd05-7c76b164b694_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_1760feb4-4431-45c4-9c32-74305ed9f7ba_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_50bf5093-4923-4fdf-8136-4ee1e9fc618d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6fb42a40-92e0-47c6-bcc9-b4318e1e0c0a_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1c18032a-eee4-43a0-80a9-a80f79ec0d86_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of the effect of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ExercisePriceRange2Member_c3a942c3-f4c1-4a1c-9d3d-a56607cb659e_terseLabel_en-US" xlink:label="lab_moh_ExercisePriceRange2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$67.33</link:label>
    <link:label id="lab_moh_ExercisePriceRange2Member_label_en-US" xlink:label="lab_moh_ExercisePriceRange2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 2 [Member]</link:label>
    <link:label id="lab_moh_ExercisePriceRange2Member_documentation_en-US" xlink:label="lab_moh_ExercisePriceRange2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ExercisePriceRange2Member" xlink:href="moh-20201231.xsd#moh_ExercisePriceRange2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ExercisePriceRange2Member" xlink:to="lab_moh_ExercisePriceRange2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_1f009020-1e2c-4006-8104-4ca66c730ec8_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract_99df7e38-71fb-458d-b92a-781cc0cc7833_terseLabel_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare program:</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract_label_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies Medicare Program [Abstract]</link:label>
    <link:label id="lab_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract_documentation_en-US" xlink:label="lab_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due To Government Agencies Medicare Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract" xlink:to="lab_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9a6922f1-d671-448a-b6d7-156de93354c9_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_07cc84a1-a311-4061-ad60-3378fafb2632_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_d5cadb67-3f73-430b-afce-8a3fd22a4d03_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_df447fe4-2440-455f-a437-ca82cb1c27d2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems_25a1bcd5-a364-4f52-9870-fd861a8fc7c0_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-risk and other provider payables</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Aggregate Reconciling Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d49235a0-e7ae-4d7c-8cc5-0a262ed152ce_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_55e7f4dc-0512-4c4a-b91c-840f664dae53_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_3f3d7f1c-ae52-4c5e-a482-cf89f98417b0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryover</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_04bb47f2-9a04-4641-a540-fac730856fb3_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_23e0fae4-5ae0-4c03-a421-573ebac784d3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_a3bbb625-1a2c-4897-87dd-33738653ba04_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_24dd2c65-1e00-4691-8ff1-d1dd5672722e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_81542bc1-6508-4e48-a55d-416d5d088ba6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_61e0a45d-26f2-49a9-9616-8cfb895a7abd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_f5dd9f73-ab1f-4f3f-ac7b-600424255959_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_2cb50876-f1a7-446a-bb2d-53724cfbe08c_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_e9673ab5-5c61-4eac-b725-f6ead9cd9a81_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of property and equipment and depreciation and amortization recognized</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_TradeNameMember_ff1fd841-896b-4346-98d4-814ea3c08295_terseLabel_en-US" xlink:label="lab_moh_TradeNameMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_moh_TradeNameMember_label_en-US" xlink:label="lab_moh_TradeNameMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Name [Member]</link:label>
    <link:label id="lab_moh_TradeNameMember_documentation_en-US" xlink:label="lab_moh_TradeNameMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_TradeNameMember" xlink:href="moh-20201231.xsd#moh_TradeNameMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_TradeNameMember" xlink:to="lab_moh_TradeNameMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_NoncashRestructuringCharges_813c2833-744c-4209-9371-82fbf1b36b75_terseLabel_en-US" xlink:label="lab_moh_NoncashRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash restructuring charges</link:label>
    <link:label id="lab_moh_NoncashRestructuringCharges_label_en-US" xlink:label="lab_moh_NoncashRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Restructuring Charges</link:label>
    <link:label id="lab_moh_NoncashRestructuringCharges_documentation_en-US" xlink:label="lab_moh_NoncashRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NoncashRestructuringCharges" xlink:href="moh-20201231.xsd#moh_NoncashRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_NoncashRestructuringCharges" xlink:to="lab_moh_NoncashRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_e8bf0a11-d0f8-4dd7-b513-33988d2db41b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_a69f64e7-1e7f-4003-b36b-35630b4803ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative number of reported claims (in claim)</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contract, Cumulative Number of Reported Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_95dd113c-f06c-449d-8e89-9ea22e3572fe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_ExercisePriceRange1Member_762ddc4c-bb53-4741-92da-63aeeb7f1c5c_terseLabel_en-US" xlink:label="lab_moh_ExercisePriceRange1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$33.02</link:label>
    <link:label id="lab_moh_ExercisePriceRange1Member_label_en-US" xlink:label="lab_moh_ExercisePriceRange1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 1 [Member]</link:label>
    <link:label id="lab_moh_ExercisePriceRange1Member_documentation_en-US" xlink:label="lab_moh_ExercisePriceRange1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ExercisePriceRange1Member" xlink:href="moh-20201231.xsd#moh_ExercisePriceRange1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_ExercisePriceRange1Member" xlink:to="lab_moh_ExercisePriceRange1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_0736911e-6fcc-4a4b-a195-76d4ae54d7c6_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange of convertible senior notes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9078efb9-70c4-46eb-88f3-9b50da0c1367_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_45a1e62a-e556-4f7e-9477-a71a74ea341c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_73bc4573-2172-46a4-9892-9b1f552eedc8_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted and performance stock activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_80d1d298-a44b-4a31-b4fd-eadfc73be6b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of principal amount of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_a5597de7-b667-49ec-9d62-6e6a9597021d_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of principal amount of convertible notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_78a168b4-491e-43b4-b244-e061fc559a7e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets - finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_798a077d-2551-47fe-88c6-440b40057440_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, equipment, and capitalized software, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_RedemptionPremiumSettledPercentage_35b37e9f-e773-4544-a483-4894c65432f6_terseLabel_en-US" xlink:label="lab_moh_RedemptionPremiumSettledPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled percent</link:label>
    <link:label id="lab_moh_RedemptionPremiumSettledPercentage_label_en-US" xlink:label="lab_moh_RedemptionPremiumSettledPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption Premium, Settled Percentage</link:label>
    <link:label id="lab_moh_RedemptionPremiumSettledPercentage_documentation_en-US" xlink:label="lab_moh_RedemptionPremiumSettledPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption Premium, Settled Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RedemptionPremiumSettledPercentage" xlink:href="moh-20201231.xsd#moh_RedemptionPremiumSettledPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_RedemptionPremiumSettledPercentage" xlink:to="lab_moh_RedemptionPremiumSettledPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8fee8af9-e41b-4922-a4d8-7c696d9110e2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease maturities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_fd43d33f-5cdb-47be-9768-b226012862ae_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total IBNP</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_d5d28083-592c-4354-9c75-a8f03930240d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock used for stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aa298475-6c1d-454c-a3ef-9817d87f2998_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b15ff6f3-129a-4932-ba30-be7311046b19_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for basic net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_71264ec9-7620-43fe-a60a-03ee8893d6b5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in subsidiaries</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_COVID19Member_2d10e2d2-ccc8-4148-8229-f614c3d3b49f_terseLabel_en-US" xlink:label="lab_moh_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19</link:label>
    <link:label id="lab_moh_COVID19Member_label_en-US" xlink:label="lab_moh_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:label id="lab_moh_COVID19Member_documentation_en-US" xlink:label="lab_moh_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_COVID19Member" xlink:href="moh-20201231.xsd#moh_COVID19Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_COVID19Member" xlink:to="lab_moh_COVID19Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_42280a9f-8658-4420-9aad-28361356ed27_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_c878a9c9-46f1-49d9-abb6-2e5247a9c717_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_5f7a03dc-1ab5-42ae-9485-15f00e71e412_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_9ce360f0-7d40-409e-a954-08e2de8bfaee_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedIncomeStatementTableTextBlock_4819125d-cb73-4273-927f-6a03495d6d01_verboseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed statements of income</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedIncomeStatementTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Income Statement [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c01f64ad-635c-4307-a8fa-b2ad39b1e964_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c87306ce-2dd8-4730-8a0b-69f6b20bde30_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ba34d066-8790-4f30-a790-28458adec07a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d5cb9190-177b-4aa4-8414-7a42a65c95f6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_30957960-87da-41ea-b319-3de58a9203f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_887f442a-d8fe-41a0-a7b4-8dccfe9b1aa6_terseLabel_en-US" xlink:label="lab_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of members eligible for the health care programs, approximately</link:label>
    <link:label id="lab_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_label_en-US" xlink:label="lab_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Members Eligible For The Health Care Programs</link:label>
    <link:label id="lab_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_documentation_en-US" xlink:label="lab_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of members eligible for the health care programs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" xlink:href="moh-20201231.xsd#moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" xlink:to="lab_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_509cf990-99e6-497b-98e8-96695bb593fe_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_53583c69-4bed-410d-bdcd-08a9dffa2887_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, and restricted cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c43d6508-577b-4058-b8aa-cc3ab71405c2_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ac0fec22-5ca1-4dfe-8be2-b809d404f7bd_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets, including Intangible Assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_a25ede97-777b-4d99-b2e7-392e7f83de23_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_58ba140b-f9e6-45fe-bf53-57c261e1d466_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_5b746ca7-7a29-4088-8331-158668811994_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_CashPaidForSettlementOfConversionOption_d0c4d437-4b89-46e7-96db-2c7abe361e3a_negatedTerseLabel_en-US" xlink:label="lab_moh_CashPaidForSettlementOfConversionOption" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for partial settlement of conversion option</link:label>
    <link:label id="lab_moh_CashPaidForSettlementOfConversionOption_label_en-US" xlink:label="lab_moh_CashPaidForSettlementOfConversionOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Settlement Of Conversion Option</link:label>
    <link:label id="lab_moh_CashPaidForSettlementOfConversionOption_documentation_en-US" xlink:label="lab_moh_CashPaidForSettlementOfConversionOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Settlement Of Conversion Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashPaidForSettlementOfConversionOption" xlink:href="moh-20201231.xsd#moh_CashPaidForSettlementOfConversionOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_CashPaidForSettlementOfConversionOption" xlink:to="lab_moh_CashPaidForSettlementOfConversionOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_48775269-b058-416a-9a09-3f4d8fc7cc82_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities (current)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_33561ee6-9bef-4fa9-adea-bace9af94046_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_fb4257b7-d79a-4f48-a1b1-b972f3446617_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preliminary closing adjustments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_94574527-7e1e-44b8-98e9-0312468df835_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash paid in business combinations</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_36229897-fa52-4b82-9de6-9528b27ed79e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_4592d9c4-a274-4fa5-8f7c-48868015d56f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upper end of range (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_9c44d31d-3ca0-4e47-8eae-937b3091f98b_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_039e350e-2dc7-4ee1-92eb-49fcf837949f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_MunicipalSecuritiesMember_7b2d799b-3505-41d7-adbb-68c9949035f9_verboseLabel_en-US" xlink:label="lab_moh_MunicipalSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_moh_MunicipalSecuritiesMember_34e6316c-7293-435e-acf3-d3175e99f184_terseLabel_en-US" xlink:label="lab_moh_MunicipalSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_moh_MunicipalSecuritiesMember_label_en-US" xlink:label="lab_moh_MunicipalSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Securities [Member]</link:label>
    <link:label id="lab_moh_MunicipalSecuritiesMember_documentation_en-US" xlink:label="lab_moh_MunicipalSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MunicipalSecuritiesMember" xlink:href="moh-20201231.xsd#moh_MunicipalSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_MunicipalSecuritiesMember" xlink:to="lab_moh_MunicipalSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_RecordedInCostOfServiceRevenueAbstract_e683579a-1f17-4342-a0dc-70aa7459fb9e_terseLabel_en-US" xlink:label="lab_moh_RecordedInCostOfServiceRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded in cost of service revenue:</link:label>
    <link:label id="lab_moh_RecordedInCostOfServiceRevenueAbstract_label_en-US" xlink:label="lab_moh_RecordedInCostOfServiceRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded In Cost Of Service Revenue [Abstract]</link:label>
    <link:label id="lab_moh_RecordedInCostOfServiceRevenueAbstract_documentation_en-US" xlink:label="lab_moh_RecordedInCostOfServiceRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded In Cost Of Service Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RecordedInCostOfServiceRevenueAbstract" xlink:href="moh-20201231.xsd#moh_RecordedInCostOfServiceRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_RecordedInCostOfServiceRevenueAbstract" xlink:to="lab_moh_RecordedInCostOfServiceRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_142e0c1f-0a81-4e24-9c9f-b8f0e3fecbe5_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net-of-Tax Amount</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_381f6b8e-36d2-4129-9fa5-2673e58a500d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_RestrictionsOnInvestmentsTableTextBlock_b89fadf9-9e86-476f-8b66-8c174fc7badd_terseLabel_en-US" xlink:label="lab_moh_RestrictionsOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances of restricted investments</link:label>
    <link:label id="lab_moh_RestrictionsOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_moh_RestrictionsOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions On Investments [Table Text Block]</link:label>
    <link:label id="lab_moh_RestrictionsOnInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_moh_RestrictionsOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions On Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RestrictionsOnInvestmentsTableTextBlock" xlink:href="moh-20201231.xsd#moh_RestrictionsOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_RestrictionsOnInvestmentsTableTextBlock" xlink:to="lab_moh_RestrictionsOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment_866dcdde-9b51-4d2d-9542-61cf50506338_terseLabel_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted investments</link:label>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment_label_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Investment</link:label>
    <link:label id="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment_documentation_en-US" xlink:label="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment" xlink:to="lab_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e798d508-97c8-403a-bdda-686bd0ed12c7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_1a71e5b6-5c8d-441c-82bb-3676465209ce_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9dbd8a8-d8bd-4f97-b3ac-d054c7aa8fed_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant&#160;Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_PharmacyRebateReceivablesMember_47303915-3279-451e-9ad5-c41bf6a28b27_terseLabel_en-US" xlink:label="lab_moh_PharmacyRebateReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy rebate receivables</link:label>
    <link:label id="lab_moh_PharmacyRebateReceivablesMember_label_en-US" xlink:label="lab_moh_PharmacyRebateReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebate Receivables [Member]</link:label>
    <link:label id="lab_moh_PharmacyRebateReceivablesMember_documentation_en-US" xlink:label="lab_moh_PharmacyRebateReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebate Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PharmacyRebateReceivablesMember" xlink:href="moh-20201231.xsd#moh_PharmacyRebateReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_PharmacyRebateReceivablesMember" xlink:to="lab_moh_PharmacyRebateReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_ea68a1d8-7872-471c-a91d-909538916d4d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of restricted shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8e075799-869d-4d8e-b2ac-617aecd46784_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SpecialAssessmentBond_bb488842-571f-433d-88f3-6c8a680cbfed_terseLabel_en-US" xlink:label="lab_us-gaap_SpecialAssessmentBond" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance bond</link:label>
    <link:label id="lab_us-gaap_SpecialAssessmentBond_label_en-US" xlink:label="lab_us-gaap_SpecialAssessmentBond" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Assessment Bond</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SpecialAssessmentBond" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SpecialAssessmentBond"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SpecialAssessmentBond" xlink:to="lab_us-gaap_SpecialAssessmentBond" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f7be77d1-09cb-4abf-b04c-f546edb31459_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_535894b9-20c9-4a32-b2af-36864bb98722_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dispositions</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_5fe599f3-5278-417e-9e00-7ef5520a1a65_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_14c3bbac-89eb-4884-88e2-39be82022a14_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_6c17ebeb-a173-4463-9470-843a0e1799c2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_8c21a227-91a6-4866-955d-40cffe43bc53_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_77be04f7-7130-4d2c-8980-6a46dc0420cd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e00a9c9a-b53e-413a-bfca-b922f366bf8f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_32bf39d5-029f-4e8f-801d-1e0c583b3d21_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_1fc30b34-8941-46ea-9935-23f76a48b8f1_netLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_0796ac9c-20cf-4b34-b9ff-3d1b2e729811_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ddae8be0-7407-4af0-b611-9be501871bdb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Exercisable (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesIssued1_d4574158-be25-4418-8de3-c328e8fafee1_terseLabel_en-US" xlink:label="lab_us-gaap_NotesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in exchange for convertible senior notes</link:label>
    <link:label id="lab_us-gaap_NotesIssued1_label_en-US" xlink:label="lab_us-gaap_NotesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesIssued1" xlink:to="lab_us-gaap_NotesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_eb9aa723-e4fb-452a-a02b-f3bca8558e1f_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Equipment, and Capitalized Software, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_9afda554-cfdf-413a-b723-683b8ae839a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_b82073d6-628c-4305-83a8-0e2aa520cdd4_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_LetterOfCreditSubFacilityMember_72fda79f-06dd-4f59-a444-7bd6564b077f_terseLabel_en-US" xlink:label="lab_moh_LetterOfCreditSubFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter Of Credit Sub-Facility</link:label>
    <link:label id="lab_moh_LetterOfCreditSubFacilityMember_label_en-US" xlink:label="lab_moh_LetterOfCreditSubFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter Of Credit Sub-Facility [Member]</link:label>
    <link:label id="lab_moh_LetterOfCreditSubFacilityMember_documentation_en-US" xlink:label="lab_moh_LetterOfCreditSubFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter Of Credit Sub-Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LetterOfCreditSubFacilityMember" xlink:href="moh-20201231.xsd#moh_LetterOfCreditSubFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_LetterOfCreditSubFacilityMember" xlink:to="lab_moh_LetterOfCreditSubFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment_3447f1c5-9aef-48e5-86f1-8aa03fcdbe1c_terseLabel_en-US" xlink:label="lab_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk adjustment</link:label>
    <link:label id="lab_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment_label_en-US" xlink:label="lab_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due to Government Agencies, Risk Adjustment</link:label>
    <link:label id="lab_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment_documentation_en-US" xlink:label="lab_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Due to Government Agencies, Risk Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment" xlink:href="moh-20201231.xsd#moh_AmountsDuetoGovernmentAgenciesRiskAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment" xlink:to="lab_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_f03340f4-480c-4995-8158-b1b24ac002a0_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_777fc47c-113e-459e-aa51-82411e08c2be_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory federal tax (benefit) rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a1fbdfc1-ad79-4394-9139-1f6bb729982c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Stock options exercisable and expected to vest (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_ca1e2b5a-25c8-4e0a-a553-ce4b138b08db_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium revenue</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ee35c8f5-f981-4f55-9fd4-4b9a5955bfeb_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements Adopted and Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_04ed1c6a-d74f-4f14-adf3-d4b77c77b59b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings under term loan facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_74cef302-2d93-493b-a657-74b4f773f645_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_5bcb0275-6050-4191-921c-d5ce5239507a_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheets</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesLineItems_54182b76-475d-4e4f-ba50-3857177e714c_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesLineItems_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems" xlink:to="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>moh-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:47c0ca76-68d6-49cb-bbea-26491dea6a9b,g:4ece894a-24af-4e0b-a6cb-0ef0dba60516-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CoverPage" xlink:type="simple" xlink:href="moh-20201231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cd300700-6c7a-478d-9bc7-ef60d41f12e7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_DocumentType_cd300700-6c7a-478d-9bc7-ef60d41f12e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_6e0cb524-04ea-46db-87bd-9e841655ab0f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_DocumentAnnualReport_6e0cb524-04ea-46db-87bd-9e841655ab0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f341b913-55b7-4e8f-96dc-b61267abed6f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_DocumentPeriodEndDate_f341b913-55b7-4e8f-96dc-b61267abed6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e150fe8d-e436-41d7-8c3d-3848b87bba5c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_CurrentFiscalYearEndDate_e150fe8d-e436-41d7-8c3d-3848b87bba5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_7c58114c-63bd-418e-89fc-1c1ffddce131" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_DocumentTransitionReport_7c58114c-63bd-418e-89fc-1c1ffddce131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_898597a8-7547-4924-872b-1e776a5c1c48" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityFileNumber_898597a8-7547-4924-872b-1e776a5c1c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3d21efc0-cb2d-4332-8cb7-f67371b39672" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityRegistrantName_3d21efc0-cb2d-4332-8cb7-f67371b39672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fdff25c6-7406-44ac-afac-b5a4250e5fdf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fdff25c6-7406-44ac-afac-b5a4250e5fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_926e52df-60c5-43cf-8dbd-8891538fa476" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityTaxIdentificationNumber_926e52df-60c5-43cf-8dbd-8891538fa476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bd97f7c3-9812-4421-a8c5-d30f83ac07c7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityAddressAddressLine1_bd97f7c3-9812-4421-a8c5-d30f83ac07c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_8234b304-9079-437a-8f95-597e5e923ff8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityAddressAddressLine2_8234b304-9079-437a-8f95-597e5e923ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a5200324-97a3-43a0-814e-e9e728acaf9c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityAddressCityOrTown_a5200324-97a3-43a0-814e-e9e728acaf9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_624905f3-ecf1-4d97-8552-2952cb0e2ca1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityAddressStateOrProvince_624905f3-ecf1-4d97-8552-2952cb0e2ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e390240f-21c2-41b1-9cf7-679026e1ef91" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityAddressPostalZipCode_e390240f-21c2-41b1-9cf7-679026e1ef91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_29aa8f93-d840-4c04-88e3-6f0d6506c90f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_CityAreaCode_29aa8f93-d840-4c04-88e3-6f0d6506c90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6dffd075-6aaf-467b-93d6-9f4c48f4bba6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_LocalPhoneNumber_6dffd075-6aaf-467b-93d6-9f4c48f4bba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_fcd01c96-0b51-476f-b01e-3ab68d90190d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_Security12bTitle_fcd01c96-0b51-476f-b01e-3ab68d90190d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_05979ad1-100c-44c9-8020-1cb20c3b385a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_TradingSymbol_05979ad1-100c-44c9-8020-1cb20c3b385a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_775d8745-d48a-47cb-a472-4d6471207cef" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_SecurityExchangeName_775d8745-d48a-47cb-a472-4d6471207cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_9ea1a4ec-a418-4d5c-9609-3ba027d78072" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_9ea1a4ec-a418-4d5c-9609-3ba027d78072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_1406359f-741b-409a-b545-71944e5e384e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityVoluntaryFilers_1406359f-741b-409a-b545-71944e5e384e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_648992fa-2c3d-43d9-81e4-ddbfae76a3fa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityCurrentReportingStatus_648992fa-2c3d-43d9-81e4-ddbfae76a3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a7b49205-ca92-4494-9a7c-298ff2c33429" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityInteractiveDataCurrent_a7b49205-ca92-4494-9a7c-298ff2c33429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_35334a40-31df-42ce-b292-95d4554cea8a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityFilerCategory_35334a40-31df-42ce-b292-95d4554cea8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a3b08e6a-779b-4eb0-910c-34dc84e2aaea" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntitySmallBusiness_a3b08e6a-779b-4eb0-910c-34dc84e2aaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a45ca45b-918f-4f95-afd1-0da07f5edccb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityEmergingGrowthCompany_a45ca45b-918f-4f95-afd1-0da07f5edccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_50507287-a3b5-4e60-9568-440b507e9f9e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_IcfrAuditorAttestationFlag_50507287-a3b5-4e60-9568-440b507e9f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_83d44c80-d228-46d5-a5ea-f8ec7d8a9d50" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityShellCompany_83d44c80-d228-46d5-a5ea-f8ec7d8a9d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_bea44dc3-9327-40a9-8061-b4229a5c7143" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityPublicFloat_bea44dc3-9327-40a9-8061-b4229a5c7143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_4456d5e8-e216-4eae-ba1e-a8e784d6300d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_4456d5e8-e216-4eae-ba1e-a8e784d6300d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d997194e-433d-447c-9d3d-8165d5240225" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d997194e-433d-447c-9d3d-8165d5240225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1ac6adf7-89a3-4c2a-baae-aec6262e2d33" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_EntityCentralIndexKey_1ac6adf7-89a3-4c2a-baae-aec6262e2d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a79b74ce-d47d-4a41-a879-637666a64f0c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_AmendmentFlag_a79b74ce-d47d-4a41-a879-637666a64f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_26bc5f75-7965-4408-ab71-f0ef86285ff7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_DocumentFiscalYearFocus_26bc5f75-7965-4408-ab71-f0ef86285ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10b1ad71-12e2-407c-ba36-bcbcd3fa351b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ff717c0-563c-49f2-bf18-1b9aa9a4a457" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10b1ad71-12e2-407c-ba36-bcbcd3fa351b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_da304e38-9526-411e-bf26-7e329e8220e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_aa69ab54-38d2-4607-940d-053d332ce8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da304e38-9526-411e-bf26-7e329e8220e8" xlink:to="loc_us-gaap_StatementTable_aa69ab54-38d2-4607-940d-053d332ce8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3f21203a-821b-4f3b-ae7d-35752f1cb5b0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_aa69ab54-38d2-4607-940d-053d332ce8a3" xlink:to="loc_srt_ProductOrServiceAxis_3f21203a-821b-4f3b-ae7d-35752f1cb5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3f21203a-821b-4f3b-ae7d-35752f1cb5b0" xlink:to="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePremiumMember_66ac9339-fc76-4c88-ad4b-3b5589b59887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCarePremiumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_us-gaap_HealthCarePremiumMember_66ac9339-fc76-4c88-ad4b-3b5589b59887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PremiumTaxRevenueMember_6e474224-4fba-40a9-b5c1-0efa4b00e3c5" xlink:href="moh-20201231.xsd#moh_PremiumTaxRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_moh_PremiumTaxRevenueMember_6e474224-4fba-40a9-b5c1-0efa4b00e3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthcareInsurerFeeReimbursedMember_fdace0e9-9cb0-42cf-8dee-ee52c80dfa44" xlink:href="moh-20201231.xsd#moh_HealthcareInsurerFeeReimbursedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_moh_HealthcareInsurerFeeReimbursedMember_fdace0e9-9cb0-42cf-8dee-ee52c80dfa44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MarketplaceRiskCorridorSettlementMember_8849a0d4-7e02-4122-a0e0-164f7216c187" xlink:href="moh-20201231.xsd#moh_MarketplaceRiskCorridorSettlementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_moh_MarketplaceRiskCorridorSettlementMember_8849a0d4-7e02-4122-a0e0-164f7216c187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_1f3e1fff-a18f-4d28-9845-72696772929d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_us-gaap_ServiceMember_1f3e1fff-a18f-4d28-9845-72696772929d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalCareCostsMember_fa8fc7f3-5613-41ea-9c61-e4e7e06c338f" xlink:href="moh-20201231.xsd#moh_MedicalCareCostsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4022d1aa-2ede-4691-999d-99d1dd9ce5f6" xlink:to="loc_moh_MedicalCareCostsMember_fa8fc7f3-5613-41ea-9c61-e4e7e06c338f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_aa69ab54-38d2-4607-940d-053d332ce8a3" xlink:to="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_230d88fb-bfb2-4dfb-b7a1-57185a894a76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_RevenuesAbstract_230d88fb-bfb2-4dfb-b7a1-57185a894a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_e33fb8c0-dd2f-4d61-a7a4-1da09724ec35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_230d88fb-bfb2-4dfb-b7a1-57185a894a76" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_e33fb8c0-dd2f-4d61-a7a4-1da09724ec35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_db8386ed-1d15-48ac-9218-ba6cc556c5b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_230d88fb-bfb2-4dfb-b7a1-57185a894a76" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_db8386ed-1d15-48ac-9218-ba6cc556c5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_68544105-5e15-4529-aec6-3324a544e4ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_230d88fb-bfb2-4dfb-b7a1-57185a894a76" xlink:to="loc_us-gaap_Revenues_68544105-5e15-4529-aec6-3324a544e4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1f39798e-ebf3-4332-a109-a45618875ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1f39798e-ebf3-4332-a109-a45618875ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_83844d03-c1a0-44a6-87da-9efaa29aac3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_83844d03-c1a0-44a6-87da-9efaa29aac3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PremiumTaxExpenses_bf508e44-3f27-4861-9592-9f44ddc8481e" xlink:href="moh-20201231.xsd#moh_PremiumTaxExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_moh_PremiumTaxExpenses_bf508e44-3f27-4861-9592-9f44ddc8481e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthCareOrganizationInsurerFeeExpense_e272e949-2326-4f55-bb5c-ff655ba5aaf0" xlink:href="moh-20201231.xsd#moh_HealthCareOrganizationInsurerFeeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_moh_HealthCareOrganizationInsurerFeeExpense_e272e949-2326-4f55-bb5c-ff655ba5aaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_e483adf5-ab2a-476f-b232-36284e3c1c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_us-gaap_DepreciationAndAmortization_e483adf5-ab2a-476f-b232-36284e3c1c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_9f4f7f30-7d20-4ada-b5c0-7b8e024a6a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_9f4f7f30-7d20-4ada-b5c0-7b8e024a6a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_487f306b-a245-44c9-9e58-2730baf6c529" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9261968a-a447-4e18-b363-939e92cb019d" xlink:to="loc_us-gaap_CostsAndExpenses_487f306b-a245-44c9-9e58-2730baf6c529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8eceef58-dee4-495a-b22a-db6241b82184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_OperatingIncomeLoss_8eceef58-dee4-495a-b22a-db6241b82184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_3570f640-8042-4749-bd59-2d5b8469ed71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_3570f640-8042-4749-bd59-2d5b8469ed71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_887cf7c9-8496-49a5-82f3-dc86ba7fec75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_3570f640-8042-4749-bd59-2d5b8469ed71" xlink:to="loc_us-gaap_InterestExpense_887cf7c9-8496-49a5-82f3-dc86ba7fec75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6d53dd6f-118a-4d2d-b118-952411cdee83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_3570f640-8042-4749-bd59-2d5b8469ed71" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6d53dd6f-118a-4d2d-b118-952411cdee83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_46391a04-c29f-4496-8762-6bd5c639477f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_3570f640-8042-4749-bd59-2d5b8469ed71" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_46391a04-c29f-4496-8762-6bd5c639477f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1a207ab9-844a-4042-8236-c073e8f32a79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1a207ab9-844a-4042-8236-c073e8f32a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0f3f6b98-e392-40f7-9be2-c74301b7fd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0f3f6b98-e392-40f7-9be2-c74301b7fd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_16bb8d17-f248-4c02-af5d-6042ca397dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_NetIncomeLoss_16bb8d17-f248-4c02-af5d-6042ca397dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2f5c32d2-af21-47fe-a5c5-c5ea2542bdcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_EarningsPerShareAbstract_2f5c32d2-af21-47fe-a5c5-c5ea2542bdcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_57e9ad64-cacc-4a60-8967-88c6fd101ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2f5c32d2-af21-47fe-a5c5-c5ea2542bdcb" xlink:to="loc_us-gaap_EarningsPerShareBasic_57e9ad64-cacc-4a60-8967-88c6fd101ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_65bbace5-fdbc-45de-a1d8-46919c946996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2f5c32d2-af21-47fe-a5c5-c5ea2542bdcb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_65bbace5-fdbc-45de-a1d8-46919c946996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_82257e66-64d1-4ca4-b707-ff21ec350c26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6f504dcd-c55e-474a-9b6b-29d2612a0750" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_82257e66-64d1-4ca4-b707-ff21ec350c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0090cba-c141-4049-a949-b8d9e6a37dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_82257e66-64d1-4ca4-b707-ff21ec350c26" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0090cba-c141-4049-a949-b8d9e6a37dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bc106f6b-1e33-49c5-9188-45b1a37d05f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_82257e66-64d1-4ca4-b707-ff21ec350c26" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bc106f6b-1e33-49c5-9188-45b1a37d05f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6548947a-d7cf-45e9-a596-4bc2313537f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c230cfed-5acb-4d7b-acdd-098820cafc7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6548947a-d7cf-45e9-a596-4bc2313537f8" xlink:to="loc_us-gaap_NetIncomeLoss_c230cfed-5acb-4d7b-acdd-098820cafc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_410a0272-0b6b-4ea1-90f1-4fce6e5bf522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6548947a-d7cf-45e9-a596-4bc2313537f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_410a0272-0b6b-4ea1-90f1-4fce6e5bf522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_334b39a9-fe2e-43aa-b7bd-aadc28ecc27a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_410a0272-0b6b-4ea1-90f1-4fce6e5bf522" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_334b39a9-fe2e-43aa-b7bd-aadc28ecc27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_b3edb5a7-85eb-410d-9850-b5a339a2823c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_410a0272-0b6b-4ea1-90f1-4fce6e5bf522" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_b3edb5a7-85eb-410d-9850-b5a339a2823c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f125e0ae-4aba-4bc3-aca9-9ef3abc03b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_410a0272-0b6b-4ea1-90f1-4fce6e5bf522" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f125e0ae-4aba-4bc3-aca9-9ef3abc03b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2e324432-7b86-4c1e-80ef-72413a9f60a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6548947a-d7cf-45e9-a596-4bc2313537f8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_2e324432-7b86-4c1e-80ef-72413a9f60a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_92b63e1d-7130-4878-9d4f-8bb131f45687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4bcbc489-a0e4-48c3-9921-c2a3185b86f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92b63e1d-7130-4878-9d4f-8bb131f45687" xlink:to="loc_us-gaap_AssetsAbstract_4bcbc489-a0e4-48c3-9921-c2a3185b86f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_10442b40-1632-48d0-bc10-5fc351fec5ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4bcbc489-a0e4-48c3-9921-c2a3185b86f5" xlink:to="loc_us-gaap_AssetsCurrentAbstract_10442b40-1632-48d0-bc10-5fc351fec5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b15e7030-ef7b-4aa7-b777-edf15bf0f68b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_10442b40-1632-48d0-bc10-5fc351fec5ad" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b15e7030-ef7b-4aa7-b777-edf15bf0f68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_32864e58-1fe9-4f75-81c3-26cd0b967b4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_10442b40-1632-48d0-bc10-5fc351fec5ad" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_32864e58-1fe9-4f75-81c3-26cd0b967b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_d4fe8787-deb4-431f-8f5a-d874c6e80f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_10442b40-1632-48d0-bc10-5fc351fec5ad" xlink:to="loc_us-gaap_ReceivablesNetCurrent_d4fe8787-deb4-431f-8f5a-d874c6e80f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0aa28e9d-2828-491e-87df-5d134754a869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_10442b40-1632-48d0-bc10-5fc351fec5ad" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0aa28e9d-2828-491e-87df-5d134754a869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4d31fa11-5daa-48f2-aeaf-0a2b4189654b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_10442b40-1632-48d0-bc10-5fc351fec5ad" xlink:to="loc_us-gaap_AssetsCurrent_4d31fa11-5daa-48f2-aeaf-0a2b4189654b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_e41eb47d-adcb-4c97-b9b4-20ce96c16b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4bcbc489-a0e4-48c3-9921-c2a3185b86f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_e41eb47d-adcb-4c97-b9b4-20ce96c16b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_8d69f2f3-316f-4041-8f5d-0e7b17b92979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4bcbc489-a0e4-48c3-9921-c2a3185b86f5" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_8d69f2f3-316f-4041-8f5d-0e7b17b92979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsNoncurrent_ec229fe4-013d-49b5-b981-f4a0af86050a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4bcbc489-a0e4-48c3-9921-c2a3185b86f5" xlink:to="loc_us-gaap_RestrictedInvestmentsNoncurrent_ec229fe4-013d-49b5-b981-f4a0af86050a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_6a481c4a-69cb-4c82-b552-5472eca31439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4bcbc489-a0e4-48c3-9921-c2a3185b86f5" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_6a481c4a-69cb-4c82-b552-5472eca31439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_69f0a2f6-9d8c-4cb7-80c3-fe06f8628874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4bcbc489-a0e4-48c3-9921-c2a3185b86f5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_69f0a2f6-9d8c-4cb7-80c3-fe06f8628874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b3ebcc1b-5ac8-4196-8689-04e942b4cbfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4bcbc489-a0e4-48c3-9921-c2a3185b86f5" xlink:to="loc_us-gaap_Assets_b3ebcc1b-5ac8-4196-8689-04e942b4cbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fab83f68-814c-4a58-ab74-41e9b4d32702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92b63e1d-7130-4878-9d4f-8bb131f45687" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fab83f68-814c-4a58-ab74-41e9b4d32702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_0d9cba7d-c8a9-4ec5-b1bd-81b8eb25b460" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fab83f68-814c-4a58-ab74-41e9b4d32702" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_0d9cba7d-c8a9-4ec5-b1bd-81b8eb25b460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_4d050026-ea38-4743-9ba5-0ca694639d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0d9cba7d-c8a9-4ec5-b1bd-81b8eb25b460" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_4d050026-ea38-4743-9ba5-0ca694639d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalPremiumLiabilityDueToAgency_9e36aeb4-82bd-4eba-856f-182cd7499b4f" xlink:href="moh-20201231.xsd#moh_MedicalPremiumLiabilityDueToAgency"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0d9cba7d-c8a9-4ec5-b1bd-81b8eb25b460" xlink:to="loc_moh_MedicalPremiumLiabilityDueToAgency_9e36aeb4-82bd-4eba-856f-182cd7499b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e1088577-9ef9-4f4d-bc32-c91020978da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0d9cba7d-c8a9-4ec5-b1bd-81b8eb25b460" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e1088577-9ef9-4f4d-bc32-c91020978da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6d29e023-d668-4fa5-bbf2-d789f9e86d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0d9cba7d-c8a9-4ec5-b1bd-81b8eb25b460" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6d29e023-d668-4fa5-bbf2-d789f9e86d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_19862d50-2778-48ec-b203-76a240958026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0d9cba7d-c8a9-4ec5-b1bd-81b8eb25b460" xlink:to="loc_us-gaap_LiabilitiesCurrent_19862d50-2778-48ec-b203-76a240958026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_42153086-8285-4f10-ba47-71ea80497630" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fab83f68-814c-4a58-ab74-41e9b4d32702" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_42153086-8285-4f10-ba47-71ea80497630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ec66ab25-ffeb-46ca-a34d-3f3a6a56e617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fab83f68-814c-4a58-ab74-41e9b4d32702" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ec66ab25-ffeb-46ca-a34d-3f3a6a56e617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7cd4b50a-8f99-4de6-9b92-9fb64aaedda5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fab83f68-814c-4a58-ab74-41e9b4d32702" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7cd4b50a-8f99-4de6-9b92-9fb64aaedda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_939061d5-6d92-4a0b-b9e6-a517ad71b962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fab83f68-814c-4a58-ab74-41e9b4d32702" xlink:to="loc_us-gaap_Liabilities_939061d5-6d92-4a0b-b9e6-a517ad71b962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6e1fa59f-4256-47ff-9603-c3af9f53a93e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fab83f68-814c-4a58-ab74-41e9b4d32702" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6e1fa59f-4256-47ff-9603-c3af9f53a93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_cb47a522-4bbd-4ac5-981e-af88681c6d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6e1fa59f-4256-47ff-9603-c3af9f53a93e" xlink:to="loc_us-gaap_CommonStockValueOutstanding_cb47a522-4bbd-4ac5-981e-af88681c6d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_d8bb359b-9993-40db-8420-648be24f3fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6e1fa59f-4256-47ff-9603-c3af9f53a93e" xlink:to="loc_us-gaap_PreferredStockValue_d8bb359b-9993-40db-8420-648be24f3fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_16237198-1a59-40fb-a2c6-6d5362ce9e74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6e1fa59f-4256-47ff-9603-c3af9f53a93e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_16237198-1a59-40fb-a2c6-6d5362ce9e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fcd3b621-9f03-44ba-93e1-89d92be5afbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6e1fa59f-4256-47ff-9603-c3af9f53a93e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fcd3b621-9f03-44ba-93e1-89d92be5afbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1aef7070-d972-46df-8205-8c6ee464bf97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6e1fa59f-4256-47ff-9603-c3af9f53a93e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1aef7070-d972-46df-8205-8c6ee464bf97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f5935a8b-2215-4f80-918e-520e9595d060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6e1fa59f-4256-47ff-9603-c3af9f53a93e" xlink:to="loc_us-gaap_StockholdersEquity_f5935a8b-2215-4f80-918e-520e9595d060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0420952f-e4f7-41d3-be9b-f810d69c25e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fab83f68-814c-4a58-ab74-41e9b4d32702" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0420952f-e4f7-41d3-be9b-f810d69c25e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_51a86098-388d-4f1f-b386-70658d4aa9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3388a282-97a8-4219-9b41-f1e5204d417e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_51a86098-388d-4f1f-b386-70658d4aa9d1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3388a282-97a8-4219-9b41-f1e5204d417e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_c521368d-1480-496b-b288-9599a1669548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_51a86098-388d-4f1f-b386-70658d4aa9d1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_c521368d-1480-496b-b288-9599a1669548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8b7b0f89-42c3-4ed1-9656-c3ffdcf39757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_51a86098-388d-4f1f-b386-70658d4aa9d1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8b7b0f89-42c3-4ed1-9656-c3ffdcf39757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e0b747e6-c9b6-4fd0-982c-c58694645431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_51a86098-388d-4f1f-b386-70658d4aa9d1" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e0b747e6-c9b6-4fd0-982c-c58694645431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f78cea13-aca2-4bbd-b172-63a830185002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_51a86098-388d-4f1f-b386-70658d4aa9d1" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f78cea13-aca2-4bbd-b172-63a830185002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_ddee91e7-71f7-4b17-be0c-5e136037e050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_51a86098-388d-4f1f-b386-70658d4aa9d1" xlink:to="loc_us-gaap_PreferredStockSharesIssued_ddee91e7-71f7-4b17-be0c-5e136037e050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_69b2a5ed-98ac-46a6-bd7d-7a89ff2f226b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_51a86098-388d-4f1f-b386-70658d4aa9d1" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_69b2a5ed-98ac-46a6-bd7d-7a89ff2f226b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6b21325c-217b-4b07-840f-35da27966692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_10c590e1-8d6a-4297-b7a7-5e942d2fc55d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6b21325c-217b-4b07-840f-35da27966692" xlink:to="loc_us-gaap_StatementTable_10c590e1-8d6a-4297-b7a7-5e942d2fc55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7962aef3-dcf0-4c2a-92ec-3ee586041763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_10c590e1-8d6a-4297-b7a7-5e942d2fc55d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7962aef3-dcf0-4c2a-92ec-3ee586041763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7962aef3-dcf0-4c2a-92ec-3ee586041763" xlink:to="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_904690e0-0946-41d0-a596-1e62b2b51adc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:to="loc_us-gaap_CommonStockMember_904690e0-0946-41d0-a596-1e62b2b51adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_aff1c0b4-b4e0-4a08-9351-b29148245ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_aff1c0b4-b4e0-4a08-9351-b29148245ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c1e3e6c4-e6c3-4231-88c4-b1522d5eba7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c1e3e6c4-e6c3-4231-88c4-b1522d5eba7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_bea30339-c3b6-49c9-aa35-dbee5f8d9334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ecdb0741-a945-4339-b0c3-86f1e2322857" xlink:to="loc_us-gaap_RetainedEarningsMember_bea30339-c3b6-49c9-aa35-dbee5f8d9334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_115856e7-9098-4e6f-8cde-e9c25275151a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_10c590e1-8d6a-4297-b7a7-5e942d2fc55d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_115856e7-9098-4e6f-8cde-e9c25275151a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_de5b0848-b0f7-456f-be07-e5ea062319a0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_115856e7-9098-4e6f-8cde-e9c25275151a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_de5b0848-b0f7-456f-be07-e5ea062319a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b9d2f48f-3530-48d4-9973-b0e8e9692da7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_de5b0848-b0f7-456f-be07-e5ea062319a0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b9d2f48f-3530-48d4-9973-b0e8e9692da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_37192e0b-16d8-4a77-804d-6fe7bd256523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_10c590e1-8d6a-4297-b7a7-5e942d2fc55d" xlink:to="loc_us-gaap_StatementLineItems_37192e0b-16d8-4a77-804d-6fe7bd256523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37192e0b-16d8-4a77-804d-6fe7bd256523" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4d4a28d4-5ff0-4772-a4d6-cacf9bcafbe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_SharesOutstanding_4d4a28d4-5ff0-4772-a4d6-cacf9bcafbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1122dfcf-59d1-4188-89f3-a9f4a784148c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockholdersEquity_1122dfcf-59d1-4188-89f3-a9f4a784148c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_22058faa-7ee0-4d4f-9b11-bfc1e6d65d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_NetIncomeLoss_22058faa-7ee0-4d4f-9b11-bfc1e6d65d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_6ed4b309-3be9-4e78-8d8c-2002a9965068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_6ed4b309-3be9-4e78-8d8c-2002a9965068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_4b9abb38-8a52-402c-8411-3aa1679315a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_4b9abb38-8a52-402c-8411-3aa1679315a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_e1bfc907-e942-47d8-b32e-1bcf3d32f5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_e1bfc907-e942-47d8-b32e-1bcf3d32f5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_583f0300-8e3a-45c9-bb25-7fd0a69771ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_583f0300-8e3a-45c9-bb25-7fd0a69771ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_4299a4b8-aa24-4ac3-abbe-c6c7076d0a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_4299a4b8-aa24-4ac3-abbe-c6c7076d0a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_129c1df3-3077-49fc-a6e6-9c9a3edd40f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_129c1df3-3077-49fc-a6e6-9c9a3edd40f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_207783d7-5d43-41ab-8970-9645e528478a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_207783d7-5d43-41ab-8970-9645e528478a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c2516812-f706-49ee-9ec8-b31caf0021ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c2516812-f706-49ee-9ec8-b31caf0021ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3b54245b-c787-4ee9-a699-186f48520cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3b54245b-c787-4ee9-a699-186f48520cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_06c27e82-b6ec-46aa-a52c-906d42dffc0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_SharesOutstanding_06c27e82-b6ec-46aa-a52c-906d42dffc0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2cb8ec9f-c5b0-4809-b25d-d3ff7591f6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_311be856-e860-41e1-8cc5-fea15cd0a212" xlink:to="loc_us-gaap_StockholdersEquity_2cb8ec9f-c5b0-4809-b25d-d3ff7591f6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="moh-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_538d9bf6-67e5-44ca-b70d-c34b30c73d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dd93dd4e-6c6e-40b6-89a0-a38b7d2ca7b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_538d9bf6-67e5-44ca-b70d-c34b30c73d88" xlink:to="loc_us-gaap_StatementTable_dd93dd4e-6c6e-40b6-89a0-a38b7d2ca7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_aed34102-1e36-483f-a106-da45bb9d13d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dd93dd4e-6c6e-40b6-89a0-a38b7d2ca7b7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_aed34102-1e36-483f-a106-da45bb9d13d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9464ac96-60da-46b2-9aae-0b0dbb5c9577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_aed34102-1e36-483f-a106-da45bb9d13d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9464ac96-60da-46b2-9aae-0b0dbb5c9577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CallOptionDerivativeAssetMember_3d5c74a1-93d6-4c5a-bb93-e971b8d123fb" xlink:href="moh-20201231.xsd#moh_CallOptionDerivativeAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9464ac96-60da-46b2-9aae-0b0dbb5c9577" xlink:to="loc_moh_CallOptionDerivativeAssetMember_3d5c74a1-93d6-4c5a-bb93-e971b8d123fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_79ca596a-7592-4065-a990-b0bf86823b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9464ac96-60da-46b2-9aae-0b0dbb5c9577" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_79ca596a-7592-4065-a990-b0bf86823b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dd93dd4e-6c6e-40b6-89a0-a38b7d2ca7b7" xlink:to="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8e68d530-db4b-461e-b08a-c8937e82ff69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8e68d530-db4b-461e-b08a-c8937e82ff69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e7ad1bf4-841c-4a7b-9196-1c41c8b5aec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8e68d530-db4b-461e-b08a-c8937e82ff69" xlink:to="loc_us-gaap_NetIncomeLoss_e7ad1bf4-841c-4a7b-9196-1c41c8b5aec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8e68d530-db4b-461e-b08a-c8937e82ff69" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_95a85346-164b-43b1-8797-8320ad9f2d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_95a85346-164b-43b1-8797-8320ad9f2d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_e5bbca24-8899-488f-ae91-4da2060e073e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_e5bbca24-8899-488f-ae91-4da2060e073e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_daafd1fb-3655-43d8-9231-f1a408160b8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_ShareBasedCompensation_daafd1fb-3655-43d8-9231-f1a408160b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GainLossOnDebtRepayment_26a32b72-40da-4a7e-9ad0-b906ae65242b" xlink:href="moh-20201231.xsd#moh_GainLossOnDebtRepayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_moh_GainLossOnDebtRepayment_26a32b72-40da-4a7e-9ad0-b906ae65242b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_270c8916-4c50-4c80-9407-cd51ee91dccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_270c8916-4c50-4c80-9407-cd51ee91dccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NoncashRestructuringCharges_b22c32b1-3014-4b82-b2e7-b57ba4986332" xlink:href="moh-20201231.xsd#moh_NoncashRestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_moh_NoncashRestructuringCharges_b22c32b1-3014-4b82-b2e7-b57ba4986332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_543d5b7f-5b68-4a25-a8eb-415987dcabc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_543d5b7f-5b68-4a25-a8eb-415987dcabc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bccdc71-0322-4943-9b75-41dc4d2444a8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_46e6a3a1-edb1-4c61-a86b-deba0cbe09c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_46e6a3a1-edb1-4c61-a86b-deba0cbe09c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f425ad5c-4802-4276-8c3d-7d862be17799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f425ad5c-4802-4276-8c3d-7d862be17799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_ae3de7b9-78ca-4d52-b36c-6c01c24f5639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_ae3de7b9-78ca-4d52-b36c-6c01c24f5639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency_e3f2e8e0-881d-4053-baf2-6a20c6773e47" xlink:href="moh-20201231.xsd#moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency_e3f2e8e0-881d-4053-baf2-6a20c6773e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_75702ad7-b6ff-4f50-a72d-923b072713fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_75702ad7-b6ff-4f50-a72d-923b072713fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_681d194d-0aa5-47e0-82f4-10955b77f720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_681d194d-0aa5-47e0-82f4-10955b77f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bf36d27a-2db8-48d9-9287-69b946e0dd3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d5b9141-18aa-4627-a0af-12401572b67d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bf36d27a-2db8-48d9-9287-69b946e0dd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19938b30-f305-4a7c-9fc3-e432d2bb74ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8e68d530-db4b-461e-b08a-c8937e82ff69" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19938b30-f305-4a7c-9fc3-e432d2bb74ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_b5ee4489-5635-4ff7-b346-08c8f295c71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_b5ee4489-5635-4ff7-b346-08c8f295c71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ef300d6a-857a-4d99-b165-8efb550bea10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ef300d6a-857a-4d99-b165-8efb550bea10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_38485fce-7f1d-4ce9-bfa6-f87debc3f101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_38485fce-7f1d-4ce9-bfa6-f87debc3f101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0b8db371-3a09-4aec-801d-2b54c7a74130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0b8db371-3a09-4aec-801d-2b54c7a74130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_8040c7fc-4ab7-4d7e-b3bb-2f2f938df01e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_8040c7fc-4ab7-4d7e-b3bb-2f2f938df01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_43162f11-425e-4f26-8de7-ae464bdc9c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_43162f11-425e-4f26-8de7-ae464bdc9c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d5de81f3-238e-411f-8a5b-fc3d582b7a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c28dccef-7705-434c-913a-e6e86dee2401" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d5de81f3-238e-411f-8a5b-fc3d582b7a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_26601f77-6031-4352-b0ba-9f7a139c7a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_26601f77-6031-4352-b0ba-9f7a139c7a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_21937aa7-f246-4da6-bb9c-8078ed378994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_21937aa7-f246-4da6-bb9c-8078ed378994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_9101e7c7-1d7d-411e-a383-3c86b2c54135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_9101e7c7-1d7d-411e-a383-3c86b2c54135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_58e984d1-7fa1-48c3-98e3-71007c2d0562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_58e984d1-7fa1-48c3-98e3-71007c2d0562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_a0302614-b684-4f15-a28a-67e0b0cf5709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_a0302614-b684-4f15-a28a-67e0b0cf5709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants_25324ed0-5807-4fc5-bf2b-ca7b2e002c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfWarrants_25324ed0-5807-4fc5-bf2b-ca7b2e002c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashPaidForSettlementOfConversionOption_066c844a-af93-45ed-836c-81580850bc4f" xlink:href="moh-20201231.xsd#moh_CashPaidForSettlementOfConversionOption"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_moh_CashPaidForSettlementOfConversionOption_066c844a-af93-45ed-836c-81580850bc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a3c890af-b7d8-420d-ad54-5d0bc1945491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a3c890af-b7d8-420d-ad54-5d0bc1945491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_81bf59d2-5e0c-4ac8-9d6f-27d970c59dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_81bf59d2-5e0c-4ac8-9d6f-27d970c59dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_4b12fada-0a76-4e36-8915-02cdc5ee8cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_4b12fada-0a76-4e36-8915-02cdc5ee8cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_36a1040a-f3dd-483a-aee2-bd92b8d5243b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_36a1040a-f3dd-483a-aee2-bd92b8d5243b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8a2ed05-60e0-4446-8e66-c4173738e584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b73019c3-7226-42c4-b316-6e5dd91b08f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e8a2ed05-60e0-4446-8e66-c4173738e584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_89304d01-db07-4b56-b577-c77c3060f430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_89304d01-db07-4b56-b577-c77c3060f430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f05f79b9-2e45-4fff-905a-4ca9422063b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f05f79b9-2e45-4fff-905a-4ca9422063b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bc465c39-7d3c-4588-8eab-c06656c01100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bc465c39-7d3c-4588-8eab-c06656c01100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_d3a6a567-9868-41b1-8293-1a15bcd280bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_d3a6a567-9868-41b1-8293-1a15bcd280bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashPaidDuringThePeriodAbstract_59170768-7c82-4aa8-ba2a-a6270190b3bf" xlink:href="moh-20201231.xsd#moh_CashPaidDuringThePeriodAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d3a6a567-9868-41b1-8293-1a15bcd280bf" xlink:to="loc_moh_CashPaidDuringThePeriodAbstract_59170768-7c82-4aa8-ba2a-a6270190b3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_fe684da1-6050-4713-9a73-c57a121fec59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_CashPaidDuringThePeriodAbstract_59170768-7c82-4aa8-ba2a-a6270190b3bf" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_fe684da1-6050-4713-9a73-c57a121fec59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_c8f99fc3-4866-4ec4-8438-6e82a4fa90a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_CashPaidDuringThePeriodAbstract_59170768-7c82-4aa8-ba2a-a6270190b3bf" xlink:to="loc_us-gaap_InterestPaidNet_c8f99fc3-4866-4ec4-8438-6e82a4fa90a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_48782280-f25e-4b3c-82b6-7130398ee9c0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_9cdd4db6-8408-429c-8a2e-bde8b97eb1aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_9cdd4db6-8408-429c-8a2e-bde8b97eb1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities_d26e7869-a694-467e-bd84-4852d233bd0c" xlink:href="moh-20201231.xsd#moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities_d26e7869-a694-467e-bd84-4852d233bd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_198604d1-e2ad-402f-918e-23b125aab2a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_us-gaap_LiabilitiesAssumed1_198604d1-e2ad-402f-918e-23b125aab2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1762c5e9-e22e-4f97-bd21-a48b4f1a3f5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1762c5e9-e22e-4f97-bd21-a48b4f1a3f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract_80258447-c5b8-49e2-a464-383e1271a03a" xlink:href="moh-20201231.xsd#moh_CovertibleSeniorNotesExchangeTransactionAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract_80258447-c5b8-49e2-a464-383e1271a03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesIssued1_1b229696-91d9-46da-92f7-aecc64b84bbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract_80258447-c5b8-49e2-a464-383e1271a03a" xlink:to="loc_us-gaap_NotesIssued1_1b229696-91d9-46da-92f7-aecc64b84bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease_b037707d-edc4-4bed-938f-8d162262ea4d" xlink:href="moh-20201231.xsd#moh_NotesIssuedFairValueAdjustmentIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract_80258447-c5b8-49e2-a464-383e1271a03a" xlink:to="loc_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease_b037707d-edc4-4bed-938f-8d162262ea4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_26b01c35-a714-4f2e-b6b6-3952f39fa03f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_CovertibleSeniorNotesExchangeTransactionAbstract_80258447-c5b8-49e2-a464-383e1271a03a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_26b01c35-a714-4f2e-b6b6-3952f39fa03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_fabb2726-526d-439b-ab12-de079362c425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_us-gaap_StockIssued1_fabb2726-526d-439b-ab12-de079362c425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CommonStockPurchasesNotSettledAtEndOfPeriod_e8730148-938a-4641-8112-4ce8b325ee60" xlink:href="moh-20201231.xsd#moh_CommonStockPurchasesNotSettledAtEndOfPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_moh_CommonStockPurchasesNotSettledAtEndOfPeriod_e8730148-938a-4641-8112-4ce8b325ee60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DetailsofchangeinfairvalueofderivativesAbstract_07d26442-c6f8-4ef9-b5e8-2d429a0f30a9" xlink:href="moh-20201231.xsd#moh_DetailsofchangeinfairvalueofderivativesAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_moh_DetailsofchangeinfairvalueofderivativesAbstract_07d26442-c6f8-4ef9-b5e8-2d429a0f30a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_57c1e245-7b0c-4b63-acbc-14d2dfdca5c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_DetailsofchangeinfairvalueofderivativesAbstract_07d26442-c6f8-4ef9-b5e8-2d429a0f30a9" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_57c1e245-7b0c-4b63-acbc-14d2dfdca5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33a38811-81fd-4821-a697-0670fc1a4a43" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncreaseDecreaseinCarryingAmountofAssets_d9bbac29-8249-4c9e-84ee-1c86436eaa52" xlink:href="moh-20201231.xsd#moh_IncreaseDecreaseinCarryingAmountofAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:to="loc_moh_IncreaseDecreaseinCarryingAmountofAssets_d9bbac29-8249-4c9e-84ee-1c86436eaa52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GainLossonDispositionofLiabilities_76602475-fa63-4468-829e-749f042074a9" xlink:href="moh-20201231.xsd#moh_GainLossonDispositionofLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:to="loc_moh_GainLossonDispositionofLiabilities_76602475-fa63-4468-829e-749f042074a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DispositionofBusinessTransactionCosts_3da77c53-aaa7-4780-82b7-983712e47b83" xlink:href="moh-20201231.xsd#moh_DispositionofBusinessTransactionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:to="loc_moh_DispositionofBusinessTransactionCosts_3da77c53-aaa7-4780-82b7-983712e47b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DispositionofBusinessReceivablefromBuyer_f5bd60cd-ecd1-480f-b69a-c0e90b7f6607" xlink:href="moh-20201231.xsd#moh_DispositionofBusinessReceivablefromBuyer"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:to="loc_moh_DispositionofBusinessReceivablefromBuyer_f5bd60cd-ecd1-480f-b69a-c0e90b7f6607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_a2777577-6a85-4b01-9cf5-34c79a12f420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract_5de93ead-7039-4df0-b241-73a1153d5d05" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_a2777577-6a85-4b01-9cf5-34c79a12f420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation" xlink:type="simple" xlink:href="moh-20201231.xsd#OrganizationandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f26bae94-2193-451e-a950-71e27d6856b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_803de959-0622-4351-bf6d-34bc3c1dd36c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f26bae94-2193-451e-a950-71e27d6856b9" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_803de959-0622-4351-bf6d-34bc3c1dd36c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#OrganizationandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59d3e8c6-864d-4a28-b1d0-d819757b96b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:href="moh-20201231.xsd#moh_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59d3e8c6-864d-4a28-b1d0-d819757b96b1" xlink:to="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_98c4de67-d16a-4974-9851-334306b1a193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_98c4de67-d16a-4974-9851-334306b1a193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b8f893f-ad66-43fe-a798-7378aa700170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98c4de67-d16a-4974-9851-334306b1a193" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b8f893f-ad66-43fe-a798-7378aa700170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MagellanCompleteCareMember_6d6d3a40-d27d-4f8f-bdd8-39cf3c9991ea" xlink:href="moh-20201231.xsd#moh_MagellanCompleteCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b8f893f-ad66-43fe-a798-7378aa700170" xlink:to="loc_moh_MagellanCompleteCareMember_6d6d3a40-d27d-4f8f-bdd8-39cf3c9991ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffinityHealthPlanMember_541ae9a7-3c4a-43b3-a4b6-05c3b7ea3228" xlink:href="moh-20201231.xsd#moh_AffinityHealthPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b8f893f-ad66-43fe-a798-7378aa700170" xlink:to="loc_moh_AffinityHealthPlanMember_541ae9a7-3c4a-43b3-a4b6-05c3b7ea3228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_71cd0bd3-aa52-4b0a-a74c-f6b423d65f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_71cd0bd3-aa52-4b0a-a74c-f6b423d65f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1a549075-7679-4124-825b-0a5c5afd970a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_71cd0bd3-aa52-4b0a-a74c-f6b423d65f40" xlink:to="loc_us-gaap_SegmentDomain_1a549075-7679-4124-825b-0a5c5afd970a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_a9bd47e9-ab00-4e08-9865-87989d0af265" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1a549075-7679-4124-825b-0a5c5afd970a" xlink:to="loc_moh_HealthPlansMember_a9bd47e9-ab00-4e08-9865-87989d0af265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7e533043-5eec-40b7-a55d-d95bde646ce2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:to="loc_srt_RangeAxis_7e533043-5eec-40b7-a55d-d95bde646ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7332359d-46a6-4b09-87f4-9057b923bb9a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7e533043-5eec-40b7-a55d-d95bde646ce2" xlink:to="loc_srt_RangeMember_7332359d-46a6-4b09-87f4-9057b923bb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_47319d71-5364-41e5-8be4-c36b7acd604c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7332359d-46a6-4b09-87f4-9057b923bb9a" xlink:to="loc_srt_MinimumMember_47319d71-5364-41e5-8be4-c36b7acd604c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_498561fd-540b-494f-b67b-bf0ccf34da68" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7332359d-46a6-4b09-87f4-9057b923bb9a" xlink:to="loc_srt_MaximumMember_498561fd-540b-494f-b67b-bf0ccf34da68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:href="moh-20201231.xsd#moh_BasisOfPresentationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationTable_3616f326-e304-4fb8-b268-0381504a55a6" xlink:to="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a6a51617-9d12-4df5-b88c-2f242d585d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_us-gaap_NumberOfReportableSegments_a6a51617-9d12-4df5-b88c-2f242d585d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NumberOfStatesForOperatedHealthPlans_1f2c34cf-8785-41e6-8e44-064f59029160" xlink:href="moh-20201231.xsd#moh_NumberOfStatesForOperatedHealthPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_moh_NumberOfStatesForOperatedHealthPlans_1f2c34cf-8785-41e6-8e44-064f59029160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NumberOfMembersEligibleForTheHealthCarePrograms_10bff1bc-b405-4760-a855-ab0f7b5544ee" xlink:href="moh-20201231.xsd#moh_NumberOfMembersEligibleForTheHealthCarePrograms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_moh_NumberOfMembersEligibleForTheHealthCarePrograms_10bff1bc-b405-4760-a855-ab0f7b5544ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_4e7766bd-d29d-446a-ab36-bf5fc825154f" xlink:href="moh-20201231.xsd#moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_4e7766bd-d29d-446a-ab36-bf5fc825154f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlanContractTerm_4e73776d-86c7-44a0-939b-89d64e15321f" xlink:href="moh-20201231.xsd#moh_HealthPlanContractTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_moh_HealthPlanContractTerm_4e73776d-86c7-44a0-939b-89d64e15321f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_341f1a6b-37f6-40b3-b38e-389d03843985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_341f1a6b-37f6-40b3-b38e-389d03843985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e0634fc5-e109-435c-a929-478dd9dd5512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_BasisOfPresentationLineItems_c0ca26c8-0a8b-4893-8b97-0c52f0a2e5e5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e0634fc5-e109-435c-a929-478dd9dd5512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9f8e01fa-8bd4-4032-b30d-8abe8dfcf2ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_58479aac-5b44-42e0-bfdb-fbd7fa3ca87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9f8e01fa-8bd4-4032-b30d-8abe8dfcf2ea" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_58479aac-5b44-42e0-bfdb-fbd7fa3ca87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_3d8dcaf4-fb7d-4513-acf8-92262a0990fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_3d8dcaf4-fb7d-4513-acf8-92262a0990fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_674fd854-6d6f-4a53-8e69-08f48b2e5b17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_UseOfEstimates_674fd854-6d6f-4a53-8e69-08f48b2e5b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a519e9a0-126d-4ea6-802a-efff2902300e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a519e9a0-126d-4ea6-802a-efff2902300e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_9c818356-0e8c-4406-bc13-3ef1c292dc90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_9c818356-0e8c-4406-bc13-3ef1c292dc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_731ba61a-8816-4909-b29c-ffe4025a5aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_731ba61a-8816-4909-b29c-ffe4025a5aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0ff24c6d-45c2-410c-a65d-00b0e95a92ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0ff24c6d-45c2-410c-a65d-00b0e95a92ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_ba518330-3559-4351-b704-05427a91e591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_ba518330-3559-4351-b704-05427a91e591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_04351c13-1b80-4e78-8263-7796ea08a5a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_04351c13-1b80-4e78-8263-7796ea08a5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_ac8b2ef6-611c-400c-82c9-9385b7408168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_ac8b2ef6-611c-400c-82c9-9385b7408168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_323c4352-6327-4cdd-bab5-7197bfd7e66a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_323c4352-6327-4cdd-bab5-7197bfd7e66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceAccountingPolicy_1fb8d479-0b15-4518-8c3a-d731210628ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceAccountingPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_ReinsuranceAccountingPolicy_1fb8d479-0b15-4518-8c3a-d731210628ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_3dcf79ef-35f3-4890-a557-3540f87ab455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_3dcf79ef-35f3-4890-a557-3540f87ab455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_TaxesBasedOnPremiumsPolicyTextBlock_65207c23-7151-4cea-8dca-66a86baddb2c" xlink:href="moh-20201231.xsd#moh_TaxesBasedOnPremiumsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_moh_TaxesBasedOnPremiumsPolicyTextBlock_65207c23-7151-4cea-8dca-66a86baddb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_244a2570-84a8-4d16-b093-a0a2e50bb39f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_244a2570-84a8-4d16-b093-a0a2e50bb39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RisksAndUncertaintiesPolicyTextBlock_a06c280a-73b6-4b46-b266-e323e36ef1c0" xlink:href="moh-20201231.xsd#moh_RisksAndUncertaintiesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_moh_RisksAndUncertaintiesPolicyTextBlock_a06c280a-73b6-4b46-b266-e323e36ef1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_35e3d4e7-222f-4b2f-81bd-9ac42d988d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_35e3d4e7-222f-4b2f-81bd-9ac42d988d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fceb71a9-cd40-489a-8470-b54c4884e7e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a540f276-4763-4009-876a-eed81172118e" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fceb71a9-cd40-489a-8470-b54c4884e7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8c1b14e7-9374-4a02-ba0d-0762bad735be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_ef60aed3-f55e-4a04-84b5-82aa4b87bca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c1b14e7-9374-4a02-ba0d-0762bad735be" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_ef60aed3-f55e-4a04-84b5-82aa4b87bca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_e48e828b-9074-41fe-900d-28f96a7d5f9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c1b14e7-9374-4a02-ba0d-0762bad735be" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_e48e828b-9074-41fe-900d-28f96a7d5f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_8e76c7b1-e4e5-4d60-bab8-11c2025ffd3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c1b14e7-9374-4a02-ba0d-0762bad735be" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_8e76c7b1-e4e5-4d60-bab8-11c2025ffd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReservesReportedToOtherAgenciesTextBlock_b5df1bea-8102-4ac9-a31d-7b567514b75c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReservesReportedToOtherAgenciesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c1b14e7-9374-4a02-ba0d-0762bad735be" xlink:to="loc_us-gaap_ReservesReportedToOtherAgenciesTextBlock_b5df1bea-8102-4ac9-a31d-7b567514b75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SummarizedPremiumRevenueTableTextBlock_47fc887e-4524-4583-b9e4-0e8b6631d0b7" xlink:href="moh-20201231.xsd#moh_SummarizedPremiumRevenueTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c1b14e7-9374-4a02-ba0d-0762bad735be" xlink:to="loc_moh_SummarizedPremiumRevenueTableTextBlock_47fc887e-4524-4583-b9e4-0e8b6631d0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_acf31197-1094-444c-965d-1006b7f09528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c1e8d8ae-5f39-4256-b46e-aeac8f4178ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acf31197-1094-444c-965d-1006b7f09528" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c1e8d8ae-5f39-4256-b46e-aeac8f4178ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_726fd3e4-ecf7-4f9f-ad5f-564fbbc46bce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acf31197-1094-444c-965d-1006b7f09528" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_726fd3e4-ecf7-4f9f-ad5f-564fbbc46bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dba60f91-bb41-4936-a547-42cbc95eb017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acf31197-1094-444c-965d-1006b7f09528" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dba60f91-bb41-4936-a547-42cbc95eb017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4ef776be-9628-4b14-934b-a5d16620845d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4ef776be-9628-4b14-934b-a5d16620845d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cb572aee-1487-4407-85d2-01d756597c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cb572aee-1487-4407-85d2-01d756597c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3bb8ded-1fa6-4719-8f4c-2a958d8853a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cb572aee-1487-4407-85d2-01d756597c2f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3bb8ded-1fa6-4719-8f4c-2a958d8853a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_StructuredSecuritiesMember_a8599b10-c722-4af3-9348-3ff6e78d70aa" xlink:href="moh-20201231.xsd#moh_StructuredSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3bb8ded-1fa6-4719-8f4c-2a958d8853a4" xlink:to="loc_moh_StructuredSecuritiesMember_a8599b10-c722-4af3-9348-3ff6e78d70aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ce15fbb7-ab45-4ae9-919b-02a22b443198" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_srt_RangeAxis_ce15fbb7-ab45-4ae9-919b-02a22b443198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0adc58f-30ba-486e-9c68-81060d1c8974" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ce15fbb7-ab45-4ae9-919b-02a22b443198" xlink:to="loc_srt_RangeMember_b0adc58f-30ba-486e-9c68-81060d1c8974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4f4fbbc8-480f-48b4-bf34-34138ffcd5bd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0adc58f-30ba-486e-9c68-81060d1c8974" xlink:to="loc_srt_MinimumMember_4f4fbbc8-480f-48b4-bf34-34138ffcd5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4bcc62e6-ef8c-493c-aa7b-7fdc2f600fbc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0adc58f-30ba-486e-9c68-81060d1c8974" xlink:to="loc_srt_MaximumMember_4bcc62e6-ef8c-493c-aa7b-7fdc2f600fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_77488145-9264-43cc-8c04-7b49ea19586f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_srt_StatementGeographicalAxis_77488145-9264-43cc-8c04-7b49ea19586f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8e158408-8961-4ed4-befe-648591f7f772" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_77488145-9264-43cc-8c04-7b49ea19586f" xlink:to="loc_srt_SegmentGeographicalDomain_8e158408-8961-4ed4-befe-648591f7f772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_c3bdb426-e164-4479-bf60-2186b0b759fe" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_PR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8e158408-8961-4ed4-befe-648591f7f772" xlink:to="loc_country_PR_c3bdb426-e164-4479-bf60-2186b0b759fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_124367f0-af6d-4bf1-9d1b-a6e89ce88a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_124367f0-af6d-4bf1-9d1b-a6e89ce88a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_f3fe1821-98b4-4bb0-9081-8dfad43f3a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_124367f0-af6d-4bf1-9d1b-a6e89ce88a1d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_f3fe1821-98b4-4bb0-9081-8dfad43f3a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_COVID19Member_125a2417-125a-4822-bc6f-2f3517f4035e" xlink:href="moh-20201231.xsd#moh_COVID19Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_f3fe1821-98b4-4bb0-9081-8dfad43f3a5f" xlink:to="loc_moh_COVID19Member_125a2417-125a-4822-bc6f-2f3517f4035e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_91ad73f9-afd8-48b6-ba0a-f1d28d4547a7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_srt_LitigationCaseAxis_91ad73f9-afd8-48b6-ba0a-f1d28d4547a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7505f5d8-f9bd-4be8-854c-36168bfae8af" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_91ad73f9-afd8-48b6-ba0a-f1d28d4547a7" xlink:to="loc_srt_LitigationCaseTypeDomain_7505f5d8-f9bd-4be8-854c-36168bfae8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MaineCommunityHealthOptionsv.UnitedStatesMember_1f9e2c8c-41c6-4ef4-a879-d5f840198549" xlink:href="moh-20201231.xsd#moh_MaineCommunityHealthOptionsv.UnitedStatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7505f5d8-f9bd-4be8-854c-36168bfae8af" xlink:to="loc_moh_MaineCommunityHealthOptionsv.UnitedStatesMember_1f9e2c8c-41c6-4ef4-a879-d5f840198549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_28044ac5-df18-4590-b5ee-95c0b6dfcebb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_srt_ProductOrServiceAxis_28044ac5-df18-4590-b5ee-95c0b6dfcebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8b6bc5d7-7847-498c-b04a-47d81537759b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_28044ac5-df18-4590-b5ee-95c0b6dfcebb" xlink:to="loc_srt_ProductsAndServicesDomain_8b6bc5d7-7847-498c-b04a-47d81537759b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicareMedicaidPlansMember_b71fb807-6547-4f9a-a63a-8bf9122453a8" xlink:href="moh-20201231.xsd#moh_MedicareMedicaidPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8b6bc5d7-7847-498c-b04a-47d81537759b" xlink:to="loc_moh_MedicareMedicaidPlansMember_b71fb807-6547-4f9a-a63a-8bf9122453a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePremiumMember_a38afdc3-a043-4253-93cd-3c3b799e8022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCarePremiumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8b6bc5d7-7847-498c-b04a-47d81537759b" xlink:to="loc_us-gaap_HealthCarePremiumMember_a38afdc3-a043-4253-93cd-3c3b799e8022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicaidMember_038bea75-3f16-4db4-aa9b-57be205c2bc0" xlink:href="moh-20201231.xsd#moh_MedicaidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8b6bc5d7-7847-498c-b04a-47d81537759b" xlink:to="loc_moh_MedicaidMember_038bea75-3f16-4db4-aa9b-57be205c2bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72d8ccdb-4ef2-4a54-a409-c5d824ac0747" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_InvestmentsMaturityPeriod_b508f8c7-4769-4a18-b844-564673fa3b1d" xlink:href="moh-20201231.xsd#moh_InvestmentsMaturityPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_InvestmentsMaturityPeriod_b508f8c7-4769-4a18-b844-564673fa3b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_InvestmentsAverageMaturityPeriod_15e120d0-b04c-472f-9ae7-bb85a29b9b91" xlink:href="moh-20201231.xsd#moh_InvestmentsAverageMaturityPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_InvestmentsAverageMaturityPeriod_15e120d0-b04c-472f-9ae7-bb85a29b9b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_f4ae5ab6-0ee3-4bcc-adc9-f9939a81b8f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_InterestReceivable_f4ae5ab6-0ee3-4bcc-adc9-f9939a81b8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4ca5b8cf-ed50-4acd-9d9f-396833490e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4ca5b8cf-ed50-4acd-9d9f-396833490e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_7abef7bc-cc36-4890-8d8b-23330c65beac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_7abef7bc-cc36-4890-8d8b-23330c65beac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_1fc91af5-d20d-4cb8-a6a8-b3aa6db45a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_1fc91af5-d20d-4cb8-a6a8-b3aa6db45a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable_8d546af6-ca87-4958-876b-b2b515f4090d" xlink:href="moh-20201231.xsd#moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable_8d546af6-ca87-4958-876b-b2b515f4090d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable_123d2fe7-267b-4a40-863d-45caf7abf3d5" xlink:href="moh-20201231.xsd#moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable_123d2fe7-267b-4a40-863d-45caf7abf3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable_f4ae5848-a8f0-479e-94d9-71d527c0a89d" xlink:href="moh-20201231.xsd#moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable_f4ae5848-a8f0-479e-94d9-71d527c0a89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PercentageOfAdditionalIncrementalRevenueEarned_08fbdca0-54d5-4e69-8e12-8183a27bf95d" xlink:href="moh-20201231.xsd#moh_PercentageOfAdditionalIncrementalRevenueEarned"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_PercentageOfAdditionalIncrementalRevenueEarned_08fbdca0-54d5-4e69-8e12-8183a27bf95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidReinsurancePremiums_a37cf283-0f83-4bb2-aed4-7418d61fe14a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidReinsurancePremiums"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_PrepaidReinsurancePremiums_a37cf283-0f83-4bb2-aed4-7418d61fe14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRecoveries_539b3ceb-d911-4b81-be8b-59fd32eef9df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceRecoveries"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_InsuranceRecoveries_539b3ceb-d911-4b81-be8b-59fd32eef9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_7e81e0a3-f7d1-4b56-ae70-6c68e7e428f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_7e81e0a3-f7d1-4b56-ae70-6c68e7e428f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_a383f9dc-ca27-4e0f-86ca-328dcd805a08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_a383f9dc-ca27-4e0f-86ca-328dcd805a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthCareInsuranceFeeLiability_5035448c-28cd-4981-a21b-5c08260547df" xlink:href="moh-20201231.xsd#moh_HealthCareInsuranceFeeLiability"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_579e5432-4dab-47d6-b750-64647b9f3ccf" xlink:to="loc_moh_HealthCareInsuranceFeeLiability_5035448c-28cd-4981-a21b-5c08260547df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5818f5e2-4210-414f-be5d-4dfafd004acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_244a7296-80ae-473a-838e-f48e1a562a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5818f5e2-4210-414f-be5d-4dfafd004acb" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_244a7296-80ae-473a-838e-f48e1a562a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_741951ca-bc4b-4210-aa3e-02e9eb782820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_244a7296-80ae-473a-838e-f48e1a562a8e" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_741951ca-bc4b-4210-aa3e-02e9eb782820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_741951ca-bc4b-4210-aa3e-02e9eb782820" xlink:to="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GovernmentReceivablesMember_025f8196-7160-43ee-9ab8-fea25dd8c9f0" xlink:href="moh-20201231.xsd#moh_GovernmentReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:to="loc_moh_GovernmentReceivablesMember_025f8196-7160-43ee-9ab8-fea25dd8c9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PharmacyRebateReceivablesMember_5170fe56-24a1-45c7-9557-7ab3a9d34239" xlink:href="moh-20201231.xsd#moh_PharmacyRebateReceivablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:to="loc_moh_PharmacyRebateReceivablesMember_5170fe56-24a1-45c7-9557-7ab3a9d34239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthInsurerFeeReimbursementReceivablesMember_534df5cb-e1cb-4c97-9d87-81feffe1f838" xlink:href="moh-20201231.xsd#moh_HealthInsurerFeeReimbursementReceivablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:to="loc_moh_HealthInsurerFeeReimbursementReceivablesMember_534df5cb-e1cb-4c97-9d87-81feffe1f838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherReceivablesMember_10d22142-fe8b-4464-9c11-1b0205003dbe" xlink:href="moh-20201231.xsd#moh_OtherReceivablesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:to="loc_moh_OtherReceivablesMember_10d22142-fe8b-4464-9c11-1b0205003dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CompleteCareReceivablesMember_fc43b285-c300-43fc-b731-343faa893943" xlink:href="moh-20201231.xsd#moh_CompleteCareReceivablesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_e7e33552-5322-477a-a131-0d2d484d8d15" xlink:to="loc_moh_CompleteCareReceivablesMember_fc43b285-c300-43fc-b731-343faa893943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_30d9ac9f-79fb-4fe0-8a94-1072f8b5e87a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_244a7296-80ae-473a-838e-f48e1a562a8e" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_30d9ac9f-79fb-4fe0-8a94-1072f8b5e87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_09207ef9-72df-43ca-abcb-0eea67565a34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_30d9ac9f-79fb-4fe0-8a94-1072f8b5e87a" xlink:to="loc_us-gaap_ReceivablesNetCurrent_09207ef9-72df-43ca-abcb-0eea67565a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b93f7515-30b5-4403-a303-a963c76169dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract_e16338be-f909-4f85-b09e-59bd2789680f" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b93f7515-30b5-4403-a303-a963c76169dd" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract_e16338be-f909-4f85-b09e-59bd2789680f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold_0e6837a9-2b01-49cf-9961-f0bda7bdbc76" xlink:href="moh-20201231.xsd#moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract_e16338be-f909-4f85-b09e-59bd2789680f" xlink:to="loc_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold_0e6837a9-2b01-49cf-9961-f0bda7bdbc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMedicaidOther_ee72b866-a0a5-4958-99f9-5ca93ae7eac5" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMedicaidOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract_e16338be-f909-4f85-b09e-59bd2789680f" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesMedicaidOther_ee72b866-a0a5-4958-99f9-5ca93ae7eac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract_43536d29-84ca-4b18-9a9b-c3de64cbf440" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b93f7515-30b5-4403-a303-a963c76169dd" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract_43536d29-84ca-4b18-9a9b-c3de64cbf440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing_e8d08197-5baa-4a86-9cb4-3e26c35dbe79" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract_43536d29-84ca-4b18-9a9b-c3de64cbf440" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing_e8d08197-5baa-4a86-9cb4-3e26c35dbe79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold_c5681cfc-780e-47f9-96a3-94bfcafbd275" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract_43536d29-84ca-4b18-9a9b-c3de64cbf440" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold_c5681cfc-780e-47f9-96a3-94bfcafbd275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherMedicareProgram_f5797f14-4eda-499e-9210-971fcfeb92e3" xlink:href="moh-20201231.xsd#moh_OtherMedicareProgram"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract_43536d29-84ca-4b18-9a9b-c3de64cbf440" xlink:to="loc_moh_OtherMedicareProgram_f5797f14-4eda-499e-9210-971fcfeb92e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract_7e70c594-1a80-470b-8b93-18013803493f" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b93f7515-30b5-4403-a303-a963c76169dd" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract_7e70c594-1a80-470b-8b93-18013803493f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment_333121e4-1569-4ae6-86a1-7a6cb9772a65" xlink:href="moh-20201231.xsd#moh_AmountsDuetoGovernmentAgenciesRiskAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract_7e70c594-1a80-470b-8b93-18013803493f" xlink:to="loc_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment_333121e4-1569-4ae6-86a1-7a6cb9772a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold_f621c6c8-09d3-4ac1-b643-fa64dfa908b7" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract_7e70c594-1a80-470b-8b93-18013803493f" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold_f621c6c8-09d3-4ac1-b643-fa64dfa908b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDuetoGovernmentAgenciesOther_c71fed54-3b15-437e-84ec-a3fb2410df8d" xlink:href="moh-20201231.xsd#moh_AmountsDuetoGovernmentAgenciesOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract_7e70c594-1a80-470b-8b93-18013803493f" xlink:to="loc_moh_AmountsDuetoGovernmentAgenciesOther_c71fed54-3b15-437e-84ec-a3fb2410df8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AmountsDueToGovernmentAgenciesBusinessCombination_948da744-c740-4e79-8368-2493e24c2991" xlink:href="moh-20201231.xsd#moh_AmountsDueToGovernmentAgenciesBusinessCombination"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract_7e70c594-1a80-470b-8b93-18013803493f" xlink:to="loc_moh_AmountsDueToGovernmentAgenciesBusinessCombination_948da744-c740-4e79-8368-2493e24c2991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalPremiumLiabilityDueToAgency_756ebce6-3612-4cfd-825d-342d4aeec2d1" xlink:href="moh-20201231.xsd#moh_MedicalPremiumLiabilityDueToAgency"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b93f7515-30b5-4403-a303-a963c76169dd" xlink:to="loc_moh_MedicalPremiumLiabilityDueToAgency_756ebce6-3612-4cfd-825d-342d4aeec2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_13fa90e9-03b1-4d5d-a6d1-225896f20b0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_81739f1d-fb1d-4bfa-919f-d0d63227722e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_13fa90e9-03b1-4d5d-a6d1-225896f20b0e" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_81739f1d-fb1d-4bfa-919f-d0d63227722e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_01060ab1-0c44-4340-a581-e172fc502891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_81739f1d-fb1d-4bfa-919f-d0d63227722e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_01060ab1-0c44-4340-a581-e172fc502891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9e614ff8-e7a5-4909-9b36-361e65e3b3fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_01060ab1-0c44-4340-a581-e172fc502891" xlink:to="loc_us-gaap_SegmentDomain_9e614ff8-e7a5-4909-9b36-361e65e3b3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_9668229c-401f-4e36-9644-5c85fe4b8227" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9e614ff8-e7a5-4909-9b36-361e65e3b3fa" xlink:to="loc_moh_HealthPlansMember_9668229c-401f-4e36-9644-5c85fe4b8227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_967de090-e55f-49b2-83a9-73bebe521901" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_81739f1d-fb1d-4bfa-919f-d0d63227722e" xlink:to="loc_srt_StatementGeographicalAxis_967de090-e55f-49b2-83a9-73bebe521901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_967de090-e55f-49b2-83a9-73bebe521901" xlink:to="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_35c9d430-446f-4840-8d44-a580891cc578" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_CA_35c9d430-446f-4840-8d44-a580891cc578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_e1e9a4f8-5c42-43c4-96c5-1bcdfb3b2fc3" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_FL_e1e9a4f8-5c42-43c4-96c5-1bcdfb3b2fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_f8a0bd3f-3f3e-453b-9751-34e0d97b9656" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_IL"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_IL_f8a0bd3f-3f3e-453b-9751-34e0d97b9656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KY_78489470-561c-4548-ae39-94c47742bf64" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_KY"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_KY_78489470-561c-4548-ae39-94c47742bf64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI_c46ae891-1f42-423a-8c80-2917c549f61c" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MI"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_MI_c46ae891-1f42-423a-8c80-2917c549f61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_0f155dc0-03f4-4762-8002-c824935c8ed4" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OH"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_OH_0f155dc0-03f4-4762-8002-c824935c8ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_8fdc8d5a-5729-42bd-a48a-356b66a977f3" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TX"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_TX_8fdc8d5a-5729-42bd-a48a-356b66a977f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA_a4585396-0ec8-4a1a-9d5f-2bf2bc9acfbb" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_WA"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_stpr_WA_a4585396-0ec8-4a1a-9d5f-2bf2bc9acfbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherGeographicalAreasMember_c851c4b4-cbad-49ee-b8b3-e7fe605734e3" xlink:href="moh-20201231.xsd#moh_OtherGeographicalAreasMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_39e307f7-ff85-445e-9a28-28909862d929" xlink:to="loc_moh_OtherGeographicalAreasMember_c851c4b4-cbad-49ee-b8b3-e7fe605734e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_178b0da5-a680-4cbf-b1da-b0be7a16ff08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_81739f1d-fb1d-4bfa-919f-d0d63227722e" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_178b0da5-a680-4cbf-b1da-b0be7a16ff08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_43d8525c-382e-4fda-8367-c44fc037a8b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_178b0da5-a680-4cbf-b1da-b0be7a16ff08" xlink:to="loc_us-gaap_PremiumsEarnedNet_43d8525c-382e-4fda-8367-c44fc037a8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthCareOrganizationRevenuePercentage_bee987c1-c12e-4f1d-ac96-1964f422dce0" xlink:href="moh-20201231.xsd#moh_HealthCareOrganizationRevenuePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_178b0da5-a680-4cbf-b1da-b0be7a16ff08" xlink:to="loc_moh_HealthCareOrganizationRevenuePercentage_bee987c1-c12e-4f1d-ac96-1964f422dce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="moh-20201231.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d78d5946-11e2-41f5-8153-7796f5796319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_0f4c3804-9693-4111-96d0-2c7c628ec660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d78d5946-11e2-41f5-8153-7796f5796319" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_0f4c3804-9693-4111-96d0-2c7c628ec660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="moh-20201231.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5eba3978-f980-4797-a955-c31754a97dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_29f16e34-cb0c-49f7-985d-1b8b7d6d4896" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5eba3978-f980-4797-a955-c31754a97dc7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_29f16e34-cb0c-49f7-985d-1b8b7d6d4896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#NetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_84721c51-6fc0-4e55-b107-b3eee93aecc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_1fb706e5-b61e-4b2c-82c5-7eab65b72c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_84721c51-6fc0-4e55-b107-b3eee93aecc3" xlink:to="loc_us-gaap_NetIncomeLossAbstract_1fb706e5-b61e-4b2c-82c5-7eab65b72c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_54be78dc-0d73-4586-b0f5-e0d455561b75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_1fb706e5-b61e-4b2c-82c5-7eab65b72c27" xlink:to="loc_us-gaap_NetIncomeLoss_54be78dc-0d73-4586-b0f5-e0d455561b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f6a25f86-cac1-483d-b92a-e2c70db4aa71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_84721c51-6fc0-4e55-b107-b3eee93aecc3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f6a25f86-cac1-483d-b92a-e2c70db4aa71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_3766f27f-688a-4bc1-97a3-d96fbca5def8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f6a25f86-cac1-483d-b92a-e2c70db4aa71" xlink:to="loc_us-gaap_SharesOutstanding_3766f27f-688a-4bc1-97a3-d96fbca5def8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bbb7fb01-1e7a-42e8-a5fd-30245dbe1763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f6a25f86-cac1-483d-b92a-e2c70db4aa71" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bbb7fb01-1e7a-42e8-a5fd-30245dbe1763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_d1a597ce-0974-4b4a-8d3c-30568dc7f7f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bbb7fb01-1e7a-42e8-a5fd-30245dbe1763" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_d1a597ce-0974-4b4a-8d3c-30568dc7f7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_WeightedAverageNumberofSharesShareBasedCompensation_f4e92c69-34aa-40a3-8bed-924d52e4b5c4" xlink:href="moh-20201231.xsd#moh_WeightedAverageNumberofSharesShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bbb7fb01-1e7a-42e8-a5fd-30245dbe1763" xlink:to="loc_moh_WeightedAverageNumberofSharesShareBasedCompensation_f4e92c69-34aa-40a3-8bed-924d52e4b5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_fe41671a-220f-470f-a0ee-16a746550346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bbb7fb01-1e7a-42e8-a5fd-30245dbe1763" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_fe41671a-220f-470f-a0ee-16a746550346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes_5d6fcf90-d2d7-4310-8bda-01af60f854a7" xlink:href="moh-20201231.xsd#moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bbb7fb01-1e7a-42e8-a5fd-30245dbe1763" xlink:to="loc_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes_5d6fcf90-d2d7-4310-8bda-01af60f854a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77965218-a1fe-46db-a8bf-dcf7ac0ea9a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bbb7fb01-1e7a-42e8-a5fd-30245dbe1763" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77965218-a1fe-46db-a8bf-dcf7ac0ea9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_bae56de1-3667-47b1-9546-6929ca43376a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f6a25f86-cac1-483d-b92a-e2c70db4aa71" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_bae56de1-3667-47b1-9546-6929ca43376a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e8c2fa57-37a5-4687-ba29-847a584ebf80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_bae56de1-3667-47b1-9546-6929ca43376a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e8c2fa57-37a5-4687-ba29-847a584ebf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_6066f61a-3128-4889-a529-9df11fe76f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_bae56de1-3667-47b1-9546-6929ca43376a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_6066f61a-3128-4889-a529-9df11fe76f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_5e69bc61-0233-41b2-a4e5-261092587e6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_bae56de1-3667-47b1-9546-6929ca43376a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_5e69bc61-0233-41b2-a4e5-261092587e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a4d7e63f-1b45-4725-82f0-fd8156d16bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_bae56de1-3667-47b1-9546-6929ca43376a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a4d7e63f-1b45-4725-82f0-fd8156d16bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6d50d591-c909-45b4-b5ca-9c1738b6f35d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_84721c51-6fc0-4e55-b107-b3eee93aecc3" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6d50d591-c909-45b4-b5ca-9c1738b6f35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_5eb5eb31-090a-4ea8-a001-563043b5b03d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6d50d591-c909-45b4-b5ca-9c1738b6f35d" xlink:to="loc_us-gaap_EarningsPerShareBasic_5eb5eb31-090a-4ea8-a001-563043b5b03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_39226e1d-170e-4d26-bf19-33b4c61acda8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6d50d591-c909-45b4-b5ca-9c1738b6f35d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_39226e1d-170e-4d26-bf19-33b4c61acda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_76dedb6c-3452-413b-8966-b3bca8dc0618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_84721c51-6fc0-4e55-b107-b3eee93aecc3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_76dedb6c-3452-413b-8966-b3bca8dc0618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7781fbbf-2c2f-4d24-9b86-15ef85cb6dfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_76dedb6c-3452-413b-8966-b3bca8dc0618" xlink:to="loc_us-gaap_DebtInstrumentAxis_7781fbbf-2c2f-4d24-9b86-15ef85cb6dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ed5f73a5-d597-472b-b8b6-8acdaa4bd9ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7781fbbf-2c2f-4d24-9b86-15ef85cb6dfb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ed5f73a5-d597-472b-b8b6-8acdaa4bd9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ConvertibleSeniorNotesMember_b618e3fd-b222-450e-bdc5-b9c460d09d4b" xlink:href="moh-20201231.xsd#moh_ConvertibleSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ed5f73a5-d597-472b-b8b6-8acdaa4bd9ff" xlink:to="loc_moh_ConvertibleSeniorNotesMember_b618e3fd-b222-450e-bdc5-b9c460d09d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_2dcd1e14-e17a-4cf6-a196-1a9137d767d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_76dedb6c-3452-413b-8966-b3bca8dc0618" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_2dcd1e14-e17a-4cf6-a196-1a9137d767d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ClassOfWarrantOrRightStatedInterestRate_a19f3a6f-44a4-44e0-924c-1fca8dbdca9b" xlink:href="moh-20201231.xsd#moh_ClassOfWarrantOrRightStatedInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_2dcd1e14-e17a-4cf6-a196-1a9137d767d7" xlink:to="loc_moh_ClassOfWarrantOrRightStatedInterestRate_a19f3a6f-44a4-44e0-924c-1fca8dbdca9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinations" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_11f1799a-cb2d-423f-9bd9-446f1833e994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b637fd9d-c131-40b9-8d30-46365362c862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_11f1799a-cb2d-423f-9bd9-446f1833e994" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b637fd9d-c131-40b9-8d30-46365362c862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_18d5b6bd-76a1-481d-b5f2-ae13f5e1e7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_a2f0a8ed-4d40-46e2-b326-16ec0bae227b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_18d5b6bd-76a1-481d-b5f2-ae13f5e1e7fa" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_a2f0a8ed-4d40-46e2-b326-16ec0bae227b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_b9885f9e-58f5-4750-ae61-ac445a7307a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_18d5b6bd-76a1-481d-b5f2-ae13f5e1e7fa" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_b9885f9e-58f5-4750-ae61-ac445a7307a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_82096211-dd5d-44ba-9f1c-e971257d4310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_532be3dc-ac5a-46b0-9f4a-f3e4d7397d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_82096211-dd5d-44ba-9f1c-e971257d4310" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_532be3dc-ac5a-46b0-9f4a-f3e4d7397d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c05413e4-4324-4fb9-a851-1439cb1df048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_532be3dc-ac5a-46b0-9f4a-f3e4d7397d2f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c05413e4-4324-4fb9-a851-1439cb1df048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad50dfb7-022c-4f29-977b-37b7ead246f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c05413e4-4324-4fb9-a851-1439cb1df048" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad50dfb7-022c-4f29-977b-37b7ead246f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MagellanCompleteCareMember_068c066d-4377-43e5-9dd0-5d9df2e0878e" xlink:href="moh-20201231.xsd#moh_MagellanCompleteCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad50dfb7-022c-4f29-977b-37b7ead246f7" xlink:to="loc_moh_MagellanCompleteCareMember_068c066d-4377-43e5-9dd0-5d9df2e0878e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PassportHealthPlanIncMember_1b135597-9311-4d52-9788-f6a0cacf8fea" xlink:href="moh-20201231.xsd#moh_PassportHealthPlanIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad50dfb7-022c-4f29-977b-37b7ead246f7" xlink:to="loc_moh_PassportHealthPlanIncMember_1b135597-9311-4d52-9788-f6a0cacf8fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_YourCareHealthPlanIncMember_267c9ca8-6e36-4c3b-839d-0307320e4203" xlink:href="moh-20201231.xsd#moh_YourCareHealthPlanIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad50dfb7-022c-4f29-977b-37b7ead246f7" xlink:to="loc_moh_YourCareHealthPlanIncMember_267c9ca8-6e36-4c3b-839d-0307320e4203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a684da08-770b-41cf-8da6-cf9516dad019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_532be3dc-ac5a-46b0-9f4a-f3e4d7397d2f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a684da08-770b-41cf-8da6-cf9516dad019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2f9d0154-c2c4-433d-979e-8bf1c6ffa4ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a684da08-770b-41cf-8da6-cf9516dad019" xlink:to="loc_us-gaap_SegmentDomain_2f9d0154-c2c4-433d-979e-8bf1c6ffa4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_013a2e7d-7d89-432f-bdbd-60374dc0a099" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2f9d0154-c2c4-433d-979e-8bf1c6ffa4ce" xlink:to="loc_moh_HealthPlansMember_013a2e7d-7d89-432f-bdbd-60374dc0a099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_532be3dc-ac5a-46b0-9f4a-f3e4d7397d2f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationNumberOfBusinessCombinations_7eb1b7de-9a1f-416b-ae6f-3138dbb7ad55" xlink:href="moh-20201231.xsd#moh_BusinessCombinationNumberOfBusinessCombinations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_moh_BusinessCombinationNumberOfBusinessCombinations_7eb1b7de-9a1f-416b-ae6f-3138dbb7ad55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_a76ca028-d80a-453c-833b-36b069eeea68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquisitionCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_AcquisitionCosts_a76ca028-d80a-453c-833b-36b069eeea68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cca8d09c-d327-4fd0-bc83-e93806e677d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cca8d09c-d327-4fd0-bc83-e93806e677d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_763f702a-5e50-4d64-a356-be8bbd13c8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_763f702a-5e50-4d64-a356-be8bbd13c8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_ac81dbdf-50ab-411f-a5c3-1e72144c49cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_ac81dbdf-50ab-411f-a5c3-1e72144c49cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_da53e7e5-6db2-45d6-b1cc-48b77c4fc3b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_da53e7e5-6db2-45d6-b1cc-48b77c4fc3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8d0f1f5e-96b3-4356-808c-02e5366e58fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8d0f1f5e-96b3-4356-808c-02e5366e58fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a3a9fddc-aab9-4a3f-9368-9c302862a4c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a3a9fddc-aab9-4a3f-9368-9c302862a4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_df18f899-57a0-4a24-a5f0-f55b94898fa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_df18f899-57a0-4a24-a5f0-f55b94898fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_bcc2dca6-665b-4a3d-bdb2-93f78e9585a1" xlink:href="moh-20201231.xsd#moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms_bcc2dca6-665b-4a3d-bdb2-93f78e9585a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_8e47770f-e0a5-4fec-a728-1123ebabba7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_8e47770f-e0a5-4fec-a728-1123ebabba7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_482d1eeb-87db-4061-8ffa-0465d75b2f89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_482d1eeb-87db-4061-8ffa-0465d75b2f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b714a326-d062-4da3-8cdb-e3f98f5e8518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b714a326-d062-4da3-8cdb-e3f98f5e8518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage_e8fa106c-3de5-48e7-bad2-41901b92dda1" xlink:href="moh-20201231.xsd#moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage_e8fa106c-3de5-48e7-bad2-41901b92dda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_34effb01-572b-40ae-9b63-2d1f08ee18b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b9faec7f-f902-4c0e-a99b-153e16bbc3d3" xlink:to="loc_us-gaap_Goodwill_34effb01-572b-40ae-9b63-2d1f08ee18b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b7153a30-afdd-40f2-bc02-55f089c70991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d514224-8ca3-4976-a46b-6a6e220725bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b7153a30-afdd-40f2-bc02-55f089c70991" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d514224-8ca3-4976-a46b-6a6e220725bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2ae16b1d-1485-44d2-8724-bdf8b8d15d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d514224-8ca3-4976-a46b-6a6e220725bf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2ae16b1d-1485-44d2-8724-bdf8b8d15d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_172bbff5-ed7a-447a-bef0-f27040fd3793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2ae16b1d-1485-44d2-8724-bdf8b8d15d8a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_172bbff5-ed7a-447a-bef0-f27040fd3793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansSegmentMember_87bb21e1-eb67-44d4-beaf-4bf39adddba0" xlink:href="moh-20201231.xsd#moh_HealthPlansSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_172bbff5-ed7a-447a-bef0-f27040fd3793" xlink:to="loc_moh_HealthPlansSegmentMember_87bb21e1-eb67-44d4-beaf-4bf39adddba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5dbee90d-4afb-4d9d-b616-76808f0db391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d514224-8ca3-4976-a46b-6a6e220725bf" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5dbee90d-4afb-4d9d-b616-76808f0db391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:href="moh-20201231.xsd#moh_AssetsAcquiredAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5dbee90d-4afb-4d9d-b616-76808f0db391" xlink:to="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4e0188a5-402e-4ae4-b37c-21263a718b8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4e0188a5-402e-4ae4-b37c-21263a718b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_9c0a3235-259c-4e4b-bc69-3b8094f652bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_9c0a3235-259c-4e4b-bc69-3b8094f652bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_71f6a96a-79b4-4112-a4de-6ab243992624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_71f6a96a-79b4-4112-a4de-6ab243992624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_67603f88-bc1f-4fc2-ad0b-b46b3c4e3f2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_67603f88-bc1f-4fc2-ad0b-b46b3c4e3f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_48ba098c-08fe-4509-bc07-b9f0442ac710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_48ba098c-08fe-4509-bc07-b9f0442ac710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_44eddb82-22ba-44a1-9e23-fc126d2ebba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_44eddb82-22ba-44a1-9e23-fc126d2ebba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9e142d81-3396-49e5-a678-db02179169cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_Goodwill_9e142d81-3396-49e5-a678-db02179169cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment_59bcdbf3-6a5c-4622-8ddb-6fc3ea274e76" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment_59bcdbf3-6a5c-4622-8ddb-6fc3ea274e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_720dbced-e9f4-44dc-a777-2b8a1509ebca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_AssetsAcquiredAbstract_9ede87c2-f3c6-4bea-b8f1-a78895a430cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_720dbced-e9f4-44dc-a777-2b8a1509ebca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:href="moh-20201231.xsd#moh_LiabilitiesAssumedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5dbee90d-4afb-4d9d-b616-76808f0db391" xlink:to="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable_913dcc6f-a5a4-4c75-8f12-8a1f534b8bb2" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable_913dcc6f-a5a4-4c75-8f12-8a1f534b8bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies_77b84aca-0da0-4569-9b73-93bb5a84930b" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies_77b84aca-0da0-4569-9b73-93bb5a84930b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_24b72140-2a44-4c37-9233-46e425654856" xlink:href="moh-20201231.xsd#moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:to="loc_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_24b72140-2a44-4c37-9233-46e425654856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ee874acc-ed45-4f56-8fd7-2aecb6193c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ee874acc-ed45-4f56-8fd7-2aecb6193c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ea3422ab-51f6-435d-bcb4-34c480774c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_LiabilitiesAssumedAbstract_ae58df39-0109-47fc-9273-fd77dde86e7c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ea3422ab-51f6-435d-bcb4-34c480774c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#BusinessCombinationsIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e9d27229-e003-4e58-be14-5a1532465f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_8e71ea21-0535-465d-9fd3-1b45f1e832fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e9d27229-e003-4e58-be14-5a1532465f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_8e71ea21-0535-465d-9fd3-1b45f1e832fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e06e3e6-8188-4bd9-9ce6-245f5184ffbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_8e71ea21-0535-465d-9fd3-1b45f1e832fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e06e3e6-8188-4bd9-9ce6-245f5184ffbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c0430c7-a373-4759-9dd5-5a10aac74f69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e06e3e6-8188-4bd9-9ce6-245f5184ffbe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c0430c7-a373-4759-9dd5-5a10aac74f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_9cc94d33-71be-48c4-9f7d-329912112052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c0430c7-a373-4759-9dd5-5a10aac74f69" xlink:to="loc_us-gaap_ContractualRightsMember_9cc94d33-71be-48c4-9f7d-329912112052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ProviderNetworkMember_97690f7e-cd78-48b0-ace1-c9186efe5ce7" xlink:href="moh-20201231.xsd#moh_ProviderNetworkMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c0430c7-a373-4759-9dd5-5a10aac74f69" xlink:to="loc_moh_ProviderNetworkMember_97690f7e-cd78-48b0-ace1-c9186efe5ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_TradeNameMember_051c8cfc-5562-4d8b-b0d2-9c60e0162e1b" xlink:href="moh-20201231.xsd#moh_TradeNameMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c0430c7-a373-4759-9dd5-5a10aac74f69" xlink:to="loc_moh_TradeNameMember_051c8cfc-5562-4d8b-b0d2-9c60e0162e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ede9cbdd-9435-44ae-a875-54c1a214e718" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_8e71ea21-0535-465d-9fd3-1b45f1e832fa" xlink:to="loc_srt_RangeAxis_ede9cbdd-9435-44ae-a875-54c1a214e718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eb7519ed-24c6-44eb-b95e-727f17a3daac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ede9cbdd-9435-44ae-a875-54c1a214e718" xlink:to="loc_srt_RangeMember_eb7519ed-24c6-44eb-b95e-727f17a3daac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_845b66a6-6dc0-4f7a-9a47-0b6e5ee3b131" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_eb7519ed-24c6-44eb-b95e-727f17a3daac" xlink:to="loc_srt_MinimumMember_845b66a6-6dc0-4f7a-9a47-0b6e5ee3b131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2989b711-f464-48e5-986e-b7aa6201f842" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_eb7519ed-24c6-44eb-b95e-727f17a3daac" xlink:to="loc_srt_MaximumMember_2989b711-f464-48e5-986e-b7aa6201f842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_038f333c-b8fd-4f34-92b2-2dd8de33e131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_8e71ea21-0535-465d-9fd3-1b45f1e832fa" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_038f333c-b8fd-4f34-92b2-2dd8de33e131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e515e3f5-9054-4c4b-a284-d37ea7c5b19b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_038f333c-b8fd-4f34-92b2-2dd8de33e131" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e515e3f5-9054-4c4b-a284-d37ea7c5b19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c66447f8-64ab-4c51-af8e-988e195e4e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_038f333c-b8fd-4f34-92b2-2dd8de33e131" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c66447f8-64ab-4c51-af8e-988e195e4e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_7b1c4d81-3532-4936-9c60-ba8597648466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_038f333c-b8fd-4f34-92b2-2dd8de33e131" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_7b1c4d81-3532-4936-9c60-ba8597648466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fb574944-09ee-47cf-b709-22cda362fb58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_80dc57b4-1911-4e4b-bdcd-bc3b244e80a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fb574944-09ee-47cf-b709-22cda362fb58" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_80dc57b4-1911-4e4b-bdcd-bc3b244e80a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2c31ccd7-3f68-44b3-9363-43c064660a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_764af238-88f1-4112-b51f-d5f75ccd8ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2c31ccd7-3f68-44b3-9363-43c064660a13" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_764af238-88f1-4112-b51f-d5f75ccd8ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_44c502b8-282c-4b7e-a0ed-969cd74c0d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2c31ccd7-3f68-44b3-9363-43c064660a13" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_44c502b8-282c-4b7e-a0ed-969cd74c0d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_8baf30a3-2fa8-4afc-b064-3db35b4303b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2c31ccd7-3f68-44b3-9363-43c064660a13" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_8baf30a3-2fa8-4afc-b064-3db35b4303b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dd7c0d62-4905-4b72-8c1a-b4400caffd6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dd7c0d62-4905-4b72-8c1a-b4400caffd6a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1325c0cd-f319-459f-ae16-2c5150b05c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1325c0cd-f319-459f-ae16-2c5150b05c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3040a03e-a29b-4bb4-aa06-404ada2cd558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1325c0cd-f319-459f-ae16-2c5150b05c7e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3040a03e-a29b-4bb4-aa06-404ada2cd558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PassportHealthPlanIncMember_fe52c077-ed4b-407d-9423-4b2c1a4ae530" xlink:href="moh-20201231.xsd#moh_PassportHealthPlanIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3040a03e-a29b-4bb4-aa06-404ada2cd558" xlink:to="loc_moh_PassportHealthPlanIncMember_fe52c077-ed4b-407d-9423-4b2c1a4ae530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0d5d2d0a-95dd-4ec7-9a73-d85fd978fef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:to="loc_us-gaap_DebtInstrumentAxis_0d5d2d0a-95dd-4ec7-9a73-d85fd978fef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_132dc0bd-8277-47a0-8b86-54fe9bfdc8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0d5d2d0a-95dd-4ec7-9a73-d85fd978fef9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_132dc0bd-8277-47a0-8b86-54fe9bfdc8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020Member_8474c80c-3f42-4599-a22b-e125754cba17" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_132dc0bd-8277-47a0-8b86-54fe9bfdc8f1" xlink:to="loc_moh_CashConvertibleSeniorNotesDue2020Member_8474c80c-3f42-4599-a22b-e125754cba17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f6f4269c-abe6-46db-b6d1-4cbcbc896369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f6f4269c-abe6-46db-b6d1-4cbcbc896369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8b04198e-55fa-441d-9c6f-cecc5b7915a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f6f4269c-abe6-46db-b6d1-4cbcbc896369" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8b04198e-55fa-441d-9c6f-cecc5b7915a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_fb7c5e8c-e405-4d80-8345-4479c6d656be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b04198e-55fa-441d-9c6f-cecc5b7915a3" xlink:to="loc_us-gaap_ConvertibleDebtMember_fb7c5e8c-e405-4d80-8345-4479c6d656be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_034a14ff-9778-49aa-8f9a-3f255d4c5643" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_20dd8cc6-3552-48bd-859f-0462cd240dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_20dd8cc6-3552-48bd-859f-0462cd240dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_2911bd9a-581b-4754-ac59-d5f5753c7e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_2911bd9a-581b-4754-ac59-d5f5753c7e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_7b958d24-6c3d-4399-944b-6f922cd54828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_us-gaap_RepaymentsOfDebt_7b958d24-6c3d-4399-944b-6f922cd54828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_c2dfe2e1-9a38-4fd8-9fac-a2dd76f74e0f" xlink:href="moh-20201231.xsd#moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_c2dfe2e1-9a38-4fd8-9fac-a2dd76f74e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_72b4fa60-46e8-483b-9dfa-8ae412cf5bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2c6e23f-518d-4e83-b564-1bbe957e806b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_72b4fa60-46e8-483b-9dfa-8ae412cf5bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2c483a0c-b64a-4ab1-9e28-77c9ed9dde6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6453c4b7-09ec-48c8-9c2c-c2a4f9feb5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2c483a0c-b64a-4ab1-9e28-77c9ed9dde6e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6453c4b7-09ec-48c8-9c2c-c2a4f9feb5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b918f16c-1b96-4142-a920-ebacfd56da6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6453c4b7-09ec-48c8-9c2c-c2a4f9feb5e0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b918f16c-1b96-4142-a920-ebacfd56da6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_554c60df-0213-427e-8488-98ec21321b21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b918f16c-1b96-4142-a920-ebacfd56da6a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_554c60df-0213-427e-8488-98ec21321b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_31033922-9308-4cf2-a2a4-10af6551896e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_554c60df-0213-427e-8488-98ec21321b21" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_31033922-9308-4cf2-a2a4-10af6551896e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0182139d-435f-429c-a6d0-5d5936a487f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_554c60df-0213-427e-8488-98ec21321b21" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0182139d-435f-429c-a6d0-5d5936a487f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_debfebac-135a-4e93-9a11-a156488d8cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_554c60df-0213-427e-8488-98ec21321b21" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_debfebac-135a-4e93-9a11-a156488d8cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_004ed947-4e2e-4a13-a87d-ba18205a694b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6453c4b7-09ec-48c8-9c2c-c2a4f9feb5e0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_004ed947-4e2e-4a13-a87d-ba18205a694b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_004ed947-4e2e-4a13-a87d-ba18205a694b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_0153a1f6-bfac-4b92-9fa0-24e1538eb17e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_0153a1f6-bfac-4b92-9fa0-24e1538eb17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c0e1bb65-ea8c-4f37-96d0-fc008826eac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c0e1bb65-ea8c-4f37-96d0-fc008826eac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MunicipalSecuritiesMember_0723a880-9c70-411e-9531-c44e4ac0efcc" xlink:href="moh-20201231.xsd#moh_MunicipalSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_moh_MunicipalSecuritiesMember_0723a880-9c70-411e-9531-c44e4ac0efcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_31b9adcf-3708-4d96-8b0d-42d0ceaee411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_31b9adcf-3708-4d96-8b0d-42d0ceaee411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_f9e977c2-577f-4250-9d4b-35e4f20a5e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_CertificatesOfDepositMember_f9e977c2-577f-4250-9d4b-35e4f20a5e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember_9a3135a1-b184-4e40-bd8d-7886ef836c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_USTreasuryNotesSecuritiesMember_9a3135a1-b184-4e40-bd8d-7886ef836c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_1923c4a3-631c-45be-a319-e455f91bc685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_1923c4a3-631c-45be-a319-e455f91bc685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherSecuritiesMember_f955d007-db6b-4028-9942-65af938dc1b4" xlink:href="moh-20201231.xsd#moh_OtherSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_moh_OtherSecuritiesMember_f955d007-db6b-4028-9942-65af938dc1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_f5ce3e7c-859b-43e2-ada8-b09eda3a5731" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_f5ce3e7c-859b-43e2-ada8-b09eda3a5731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_3da183c9-4149-4bd8-8ae3-cc95f5f2ae93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cf32cc91-af62-4519-8be7-af44e6eee138" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_3da183c9-4149-4bd8-8ae3-cc95f5f2ae93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2aeef426-8a4f-48d4-9bb4-4dee24e8a6f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6453c4b7-09ec-48c8-9c2c-c2a4f9feb5e0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2aeef426-8a4f-48d4-9bb4-4dee24e8a6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2aeef426-8a4f-48d4-9bb4-4dee24e8a6f6" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e822e10a-e64a-4028-87d4-b5f59dfa8ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e822e10a-e64a-4028-87d4-b5f59dfa8ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_efded736-fed9-478d-9f42-76def68502b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_DerivativeAssets_efded736-fed9-478d-9f42-76def68502b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_01234d29-12e7-4183-aa38-78c8f2afbcc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_01234d29-12e7-4183-aa38-78c8f2afbcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f7fb7208-4073-42ba-9ff4-db3b52a81ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f7fb7208-4073-42ba-9ff4-db3b52a81ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_8b4ced83-8827-4fa7-bb2c-aa06b249c549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_DerivativeLiabilities_8b4ced83-8827-4fa7-bb2c-aa06b249c549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_31b3968d-43a5-4fd0-b312-4d3728f57c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_49eb7466-31f3-43b9-b4e3-e303e9edc5ca" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_31b3968d-43a5-4fd0-b312-4d3728f57c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsBalanceSheetGroupingDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_70a31b6c-b4bc-4bc8-a00d-2efea5766a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8259dc91-2852-4bbb-9634-ccdce4115cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_70a31b6c-b4bc-4bc8-a00d-2efea5766a58" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8259dc91-2852-4bbb-9634-ccdce4115cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2ea102be-1427-42c1-b4bf-4a0efe2bb236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8259dc91-2852-4bbb-9634-ccdce4115cda" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2ea102be-1427-42c1-b4bf-4a0efe2bb236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_81ea9a33-734a-47d1-936d-e097f5aca185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2ea102be-1427-42c1-b4bf-4a0efe2bb236" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_81ea9a33-734a-47d1-936d-e097f5aca185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CurrentAssetsMember_9c937524-fd02-49d8-81e9-8e635fa88560" xlink:href="moh-20201231.xsd#moh_CurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_81ea9a33-734a-47d1-936d-e097f5aca185" xlink:to="loc_moh_CurrentAssetsMember_9c937524-fd02-49d8-81e9-8e635fa88560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CurrentLiabilitiesMember_88acb63e-d281-4722-bf7a-141313cb5aa0" xlink:href="moh-20201231.xsd#moh_CurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_81ea9a33-734a-47d1-936d-e097f5aca185" xlink:to="loc_moh_CurrentLiabilitiesMember_88acb63e-d281-4722-bf7a-141313cb5aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_36436f0b-1b9f-4f21-b902-6d5acc617e4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8259dc91-2852-4bbb-9634-ccdce4115cda" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_36436f0b-1b9f-4f21-b902-6d5acc617e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f0043470-71b5-4c22-9de3-dbd14c6d14d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_36436f0b-1b9f-4f21-b902-6d5acc617e4d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f0043470-71b5-4c22-9de3-dbd14c6d14d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CallOptionDerivativeAssetMember_c8496426-3ac7-4e07-abde-0ce6c278f632" xlink:href="moh-20201231.xsd#moh_CallOptionDerivativeAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f0043470-71b5-4c22-9de3-dbd14c6d14d8" xlink:to="loc_moh_CallOptionDerivativeAssetMember_c8496426-3ac7-4e07-abde-0ce6c278f632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_e38847f5-b6ab-45f0-9c10-765c17c33500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f0043470-71b5-4c22-9de3-dbd14c6d14d8" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_e38847f5-b6ab-45f0-9c10-765c17c33500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_69254234-e80f-4c02-8b98-580265ff698f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8259dc91-2852-4bbb-9634-ccdce4115cda" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_69254234-e80f-4c02-8b98-580265ff698f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e24bb0c-949c-412e-819d-cc823c0b2e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_69254234-e80f-4c02-8b98-580265ff698f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e24bb0c-949c-412e-819d-cc823c0b2e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_24e032e5-8d53-47f9-8b2a-035674aee350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_69254234-e80f-4c02-8b98-580265ff698f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_24e032e5-8d53-47f9-8b2a-035674aee350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#FairValueMeasurementsLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3eb89a4d-edc1-4154-9c80-ae8f1308ddbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3eb89a4d-edc1-4154-9c80-ae8f1308ddbc" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_aa1df200-a5ab-4d1d-9205-b34f0db3fef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_aa1df200-a5ab-4d1d-9205-b34f0db3fef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c1c212a1-f455-422b-b33d-b42ea3b605bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_aa1df200-a5ab-4d1d-9205-b34f0db3fef9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c1c212a1-f455-422b-b33d-b42ea3b605bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_15f434bd-0bc7-459a-b1fc-4a94c961fdf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c1c212a1-f455-422b-b33d-b42ea3b605bf" xlink:to="loc_us-gaap_SeniorNotesMember_15f434bd-0bc7-459a-b1fc-4a94c961fdf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_43879067-5bf2-4833-9afb-abdc4617c125" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c1c212a1-f455-422b-b33d-b42ea3b605bf" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_43879067-5bf2-4833-9afb-abdc4617c125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_21ddd982-438a-42dd-9773-3a1d8e57b0a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c1c212a1-f455-422b-b33d-b42ea3b605bf" xlink:to="loc_us-gaap_ConvertibleDebtMember_21ddd982-438a-42dd-9773-3a1d8e57b0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ce3cfc16-c8a4-4360-9bb3-a4f5d1aa22f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:to="loc_us-gaap_DebtInstrumentAxis_ce3cfc16-c8a4-4360-9bb3-a4f5d1aa22f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ce3cfc16-c8a4-4360-9bb3-a4f5d1aa22f6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4375SeniorNotesMember_22421842-cb43-4a42-832c-846f46305ed3" xlink:href="moh-20201231.xsd#moh_A4375SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:to="loc_moh_A4375SeniorNotesMember_22421842-cb43-4a42-832c-846f46305ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SeniorNotesDue2022Member_3c06eb4e-0c66-4ace-9a95-4aa2b23f4401" xlink:href="moh-20201231.xsd#moh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:to="loc_moh_SeniorNotesDue2022Member_3c06eb4e-0c66-4ace-9a95-4aa2b23f4401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_eb35d226-0a05-403e-84da-8676d3d4b9c3" xlink:href="moh-20201231.xsd#moh_ThreePointEightSevenFivePercentSeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:to="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_eb35d226-0a05-403e-84da-8676d3d4b9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4.875SeniorNotesMember_fbbb58d4-5320-4cf8-837d-52958dee2ef2" xlink:href="moh-20201231.xsd#moh_A4.875SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:to="loc_moh_A4.875SeniorNotesMember_fbbb58d4-5320-4cf8-837d-52958dee2ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020Member_fc18c901-284e-44e4-acf8-7a0c023d8e97" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9808ce16-1491-476e-8202-6eb129db4cbd" xlink:to="loc_moh_CashConvertibleSeniorNotesDue2020Member_fc18c901-284e-44e4-acf8-7a0c023d8e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_8885df2f-b7b3-47e4-b9d5-dc55858bf53a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_8885df2f-b7b3-47e4-b9d5-dc55858bf53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_871279e1-6bd1-404e-b643-cc3a9898a4bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_8885df2f-b7b3-47e4-b9d5-dc55858bf53a" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_871279e1-6bd1-404e-b643-cc3a9898a4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5e95026d-cadd-4183-b4ea-46de038d52e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_871279e1-6bd1-404e-b643-cc3a9898a4bd" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5e95026d-cadd-4183-b4ea-46de038d52e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b4c5ebc7-56f3-4a80-a2b1-084236dfee43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_871279e1-6bd1-404e-b643-cc3a9898a4bd" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b4c5ebc7-56f3-4a80-a2b1-084236dfee43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_be7c57a9-bdaa-4b14-9842-a27a6d22f8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_871279e1-6bd1-404e-b643-cc3a9898a4bd" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_be7c57a9-bdaa-4b14-9842-a27a6d22f8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a09e75e-8398-41e6-88a1-f2583d3c3ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_b495c1df-8d8e-468d-b4bd-652949797617" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a09e75e-8398-41e6-88a1-f2583d3c3ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_89356430-1766-4590-a0f8-d27b7cef1eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a09e75e-8398-41e6-88a1-f2583d3c3ec7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_89356430-1766-4590-a0f8-d27b7cef1eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_72377263-de96-4bd9-ab9c-f1bbe7a1081c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a09e75e-8398-41e6-88a1-f2583d3c3ec7" xlink:to="loc_us-gaap_DebtInstrumentFairValue_72377263-de96-4bd9-ab9c-f1bbe7a1081c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Investments" xlink:type="simple" xlink:href="moh-20201231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3e38069c-fc3d-4161-b27c-4528d7be9cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_71e5c009-3d6e-43dc-83e6-870d28d8a336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3e38069c-fc3d-4161-b27c-4528d7be9cdf" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_71e5c009-3d6e-43dc-83e6-870d28d8a336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f892abb4-ef80-4366-9e92-70fd36fd0047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_9acbc8e4-1472-4344-8961-a029563f1e80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f892abb4-ef80-4366-9e92-70fd36fd0047" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_9acbc8e4-1472-4344-8961-a029563f1e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_38073c0d-fa1f-4114-a02b-78acc952d12e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f892abb4-ef80-4366-9e92-70fd36fd0047" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_38073c0d-fa1f-4114-a02b-78acc952d12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_82cbb089-3a13-4c29-87a1-e7895b02e890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f892abb4-ef80-4366-9e92-70fd36fd0047" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_82cbb089-3a13-4c29-87a1-e7895b02e890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RestrictionsOnInvestmentsTableTextBlock_676d2c4e-c55f-407e-b18b-87d4250bb2d5" xlink:href="moh-20201231.xsd#moh_RestrictionsOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f892abb4-ef80-4366-9e92-70fd36fd0047" xlink:to="loc_moh_RestrictionsOnInvestmentsTableTextBlock_676d2c4e-c55f-407e-b18b-87d4250bb2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsScheduleofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9d97e142-4791-4db6-8f39-224a65a6cb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7def3f23-aa22-4baa-b986-a1b447eb7d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9d97e142-4791-4db6-8f39-224a65a6cb67" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7def3f23-aa22-4baa-b986-a1b447eb7d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8d994d1a-e4fc-4a07-ad59-16c95219f857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7def3f23-aa22-4baa-b986-a1b447eb7d6a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8d994d1a-e4fc-4a07-ad59-16c95219f857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8d994d1a-e4fc-4a07-ad59-16c95219f857" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_fb3fdf5a-f102-4f85-b35a-522b479682eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_fb3fdf5a-f102-4f85-b35a-522b479682eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_9ea980f7-10d7-435a-8a98-7f537212503e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_9ea980f7-10d7-435a-8a98-7f537212503e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MunicipalSecuritiesMember_58111610-cbea-4420-8e63-7fc1d93dc882" xlink:href="moh-20201231.xsd#moh_MunicipalSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_moh_MunicipalSecuritiesMember_58111610-cbea-4420-8e63-7fc1d93dc882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_0cb2cb1c-e0da-4d62-8fef-2f4c146157d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_0cb2cb1c-e0da-4d62-8fef-2f4c146157d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember_5a544a0d-a501-4b1c-be1b-215cbde52ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_USTreasuryNotesSecuritiesMember_5a544a0d-a501-4b1c-be1b-215cbde52ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_c63c0a1e-3a27-48d6-aa70-54cea9728268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_c63c0a1e-3a27-48d6-aa70-54cea9728268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_bebb2936-79f1-483a-90b2-258aec5b44e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_us-gaap_CertificatesOfDepositMember_bebb2936-79f1-483a-90b2-258aec5b44e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherSecuritiesMember_fa78aa4d-6c11-42cf-b0dc-741fb88b942c" xlink:href="moh-20201231.xsd#moh_OtherSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f90decc4-4afd-4176-ae13-6d01e8bf8236" xlink:to="loc_moh_OtherSecuritiesMember_fa78aa4d-6c11-42cf-b0dc-741fb88b942c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7def3f23-aa22-4baa-b986-a1b447eb7d6a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_27ef43b5-5bd2-46bc-b814-4982f1bf4872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_27ef43b5-5bd2-46bc-b814-4982f1bf4872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a55fac8f-7b73-4c1f-a764-4435200072b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a55fac8f-7b73-4c1f-a764-4435200072b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4769aa8d-3076-4a3d-ada1-9a4444713a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4769aa8d-3076-4a3d-ada1-9a4444713a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_43dbabe1-84e0-496f-a93e-c1de47aa60bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e4a3f4d-d5e4-401f-9764-04fce98237e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_43dbabe1-84e0-496f-a93e-c1de47aa60bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsContractualMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_28774c2f-ca27-434c-88de-2bf8d58039d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_036d7981-5268-4234-8408-4ce31737a990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_28774c2f-ca27-434c-88de-2bf8d58039d7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_036d7981-5268-4234-8408-4ce31737a990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_29553d15-7043-41ee-b287-acd8e1e983fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_036d7981-5268-4234-8408-4ce31737a990" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_29553d15-7043-41ee-b287-acd8e1e983fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_09743ade-feb1-4fd7-97e9-e392374d5ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_036d7981-5268-4234-8408-4ce31737a990" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_09743ade-feb1-4fd7-97e9-e392374d5ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_6e30d94c-7faa-4125-ae09-8a22278945c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_036d7981-5268-4234-8408-4ce31737a990" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_6e30d94c-7faa-4125-ae09-8a22278945c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_e1c031b9-4738-48e1-a2ac-2a2b4a0366ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_036d7981-5268-4234-8408-4ce31737a990" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_e1c031b9-4738-48e1-a2ac-2a2b4a0366ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_bac4f2f3-5cea-42f1-bbe7-61429e829242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_036d7981-5268-4234-8408-4ce31737a990" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_bac4f2f3-5cea-42f1-bbe7-61429e829242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_68149c38-d13a-4b1f-a4f4-87ddc29be7ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_28774c2f-ca27-434c-88de-2bf8d58039d7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_68149c38-d13a-4b1f-a4f4-87ddc29be7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_23e7a0eb-6989-485a-8495-0de4a33b6593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_68149c38-d13a-4b1f-a4f4-87ddc29be7ea" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_23e7a0eb-6989-485a-8495-0de4a33b6593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_33ac44cf-5201-4abe-a352-b7d99f3b979f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_68149c38-d13a-4b1f-a4f4-87ddc29be7ea" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_33ac44cf-5201-4abe-a352-b7d99f3b979f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_94cb0f5c-1e28-4c43-90cb-5003f187f43f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_68149c38-d13a-4b1f-a4f4-87ddc29be7ea" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_94cb0f5c-1e28-4c43-90cb-5003f187f43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_59405afa-e5f5-47cd-8dd1-32ab81175b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_68149c38-d13a-4b1f-a4f4-87ddc29be7ea" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_59405afa-e5f5-47cd-8dd1-32ab81175b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3e0af577-ecf0-466e-b2fe-92f8bd028695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_68149c38-d13a-4b1f-a4f4-87ddc29be7ea" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3e0af577-ecf0-466e-b2fe-92f8bd028695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bbb5e1a6-956d-4354-b258-701469af86ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_09d0697e-fffd-46bb-9362-48cd5a3836a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bbb5e1a6-956d-4354-b258-701469af86ac" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_09d0697e-fffd-46bb-9362-48cd5a3836a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_ffafc1f5-0549-494a-9b8f-4dc10ad3c71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bbb5e1a6-956d-4354-b258-701469af86ac" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_ffafc1f5-0549-494a-9b8f-4dc10ad3c71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_04915345-ffff-4f3f-9423-c7f33b328fca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bbb5e1a6-956d-4354-b258-701469af86ac" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_04915345-ffff-4f3f-9423-c7f33b328fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsAvailableforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9cc3f52a-9ac4-415c-aba7-6243d58700d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a44ff32d-8381-4c71-8350-c72199ac9522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9cc3f52a-9ac4-415c-aba7-6243d58700d4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a44ff32d-8381-4c71-8350-c72199ac9522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_19dd259f-6793-4973-ae5a-6151ac3f4668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a44ff32d-8381-4c71-8350-c72199ac9522" xlink:to="loc_us-gaap_FinancialInstrumentAxis_19dd259f-6793-4973-ae5a-6151ac3f4668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92c3eb77-9e0b-4d78-b6bc-2a25486ef3bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_19dd259f-6793-4973-ae5a-6151ac3f4668" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92c3eb77-9e0b-4d78-b6bc-2a25486ef3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_60f1231d-0943-491b-b95c-abe868c340c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92c3eb77-9e0b-4d78-b6bc-2a25486ef3bc" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_60f1231d-0943-491b-b95c-abe868c340c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_d72c640c-e547-451e-83c2-0366f1e71b0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92c3eb77-9e0b-4d78-b6bc-2a25486ef3bc" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_d72c640c-e547-451e-83c2-0366f1e71b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9ea30497-2ea3-4b9b-8101-413173b06268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a44ff32d-8381-4c71-8350-c72199ac9522" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9ea30497-2ea3-4b9b-8101-413173b06268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_e28db63a-2194-4b64-b311-03385fcdc460" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9ea30497-2ea3-4b9b-8101-413173b06268" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_e28db63a-2194-4b64-b311-03385fcdc460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_dcc629f2-6092-4e49-b2f4-ddd79e452a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9ea30497-2ea3-4b9b-8101-413173b06268" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_dcc629f2-6092-4e49-b2f4-ddd79e452a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_07ba094b-b6af-4b1d-92be-6a3050099a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9ea30497-2ea3-4b9b-8101-413173b06268" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_07ba094b-b6af-4b1d-92be-6a3050099a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#InvestmentsBalancesofRestrictedInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b6b2611d-6220-429e-8f02-d4c0c5f58a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_c302e10b-34ca-4730-9db9-8239519ac5bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b6b2611d-6220-429e-8f02-d4c0c5f58a16" xlink:to="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_c302e10b-34ca-4730-9db9-8239519ac5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_13345090-59b6-4750-86da-302f7a86d0c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_c302e10b-34ca-4730-9db9-8239519ac5bd" xlink:to="loc_srt_StatementGeographicalAxis_13345090-59b6-4750-86da-302f7a86d0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_13345090-59b6-4750-86da-302f7a86d0c4" xlink:to="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_6038189c-0339-4382-a6ab-e279fcb6f887" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:to="loc_stpr_FL_6038189c-0339-4382-a6ab-e279fcb6f887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_7da7aaef-f1bf-44af-999f-ae529a2487b2" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NM"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:to="loc_stpr_NM_7da7aaef-f1bf-44af-999f-ae529a2487b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_4874ad88-4b8c-4e5b-ac19-ece2dd44aa9b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NY"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:to="loc_stpr_NY_4874ad88-4b8c-4e5b-ac19-ece2dd44aa9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_b37753a0-163e-4938-aa21-5840fc7d32d7" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OH"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:to="loc_stpr_OH_b37753a0-163e-4938-aa21-5840fc7d32d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherGeographicalAreasMember_841752d6-55f9-4d3e-bf1b-5ccc7892dea9" xlink:href="moh-20201231.xsd#moh_OtherGeographicalAreasMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_28c6e03a-2bf1-44a1-9e69-e2853f83f66c" xlink:to="loc_moh_OtherGeographicalAreasMember_841752d6-55f9-4d3e-bf1b-5ccc7892dea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_63aca4cd-ad86-4e29-81c9-3b3eea863af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_c302e10b-34ca-4730-9db9-8239519ac5bd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_63aca4cd-ad86-4e29-81c9-3b3eea863af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e4e0589d-6098-407f-900b-dcca755778ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_63aca4cd-ad86-4e29-81c9-3b3eea863af6" xlink:to="loc_us-gaap_SegmentDomain_e4e0589d-6098-407f-900b-dcca755778ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CompleteCareMember_7b0a1089-27cb-4ad1-b6d1-a900d99c8689" xlink:href="moh-20201231.xsd#moh_CompleteCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e4e0589d-6098-407f-900b-dcca755778ee" xlink:to="loc_moh_CompleteCareMember_7b0a1089-27cb-4ad1-b6d1-a900d99c8689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_b5743582-4e1b-419f-ae7e-8f21b1e5f703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_c302e10b-34ca-4730-9db9-8239519ac5bd" xlink:to="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_b5743582-4e1b-419f-ae7e-8f21b1e5f703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsNoncurrent_a81f290f-5b63-4340-8144-da6f45b44560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_b5743582-4e1b-419f-ae7e-8f21b1e5f703" xlink:to="loc_us-gaap_RestrictedInvestmentsNoncurrent_a81f290f-5b63-4340-8144-da6f45b44560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNet"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a414ffad-8ab2-4695-923f-d02240d2cec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_584fd654-ceba-44c0-8593-941639639a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a414ffad-8ab2-4695-923f-d02240d2cec3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_584fd654-ceba-44c0-8593-941639639a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetTables" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c837fbd8-1b5c-4261-8b9c-a6f769ed65d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_e739348d-dcbe-4c97-becd-1068238a182c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c837fbd8-1b5c-4261-8b9c-a6f769ed65d2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_e739348d-dcbe-4c97-becd-1068238a182c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_685961a1-2a9f-4693-97c7-cd0fb935fc31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6a69ab4-df0e-49d4-a724-5de6e3292c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_685961a1-2a9f-4693-97c7-cd0fb935fc31" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6a69ab4-df0e-49d4-a724-5de6e3292c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_37b4767f-4861-4a6a-8ca2-64d1cfcc4f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6a69ab4-df0e-49d4-a724-5de6e3292c6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_37b4767f-4861-4a6a-8ca2-64d1cfcc4f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_37b4767f-4861-4a6a-8ca2-64d1cfcc4f97" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_172e5bbd-0d21-4eaf-bb47-a1bb95ca23e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_172e5bbd-0d21-4eaf-bb47-a1bb95ca23e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_7218e1c9-f24f-40d3-8efb-7b11dca7d7ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_7218e1c9-f24f-40d3-8efb-7b11dca7d7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_ee835fdd-54ef-4a19-add4-bbf304e1ec14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_ee835fdd-54ef-4a19-add4-bbf304e1ec14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_f347e0d6-e595-4313-85e7-0cc9da4f9bec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769d7792-d023-4254-b40f-39c55c2e925e" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_f347e0d6-e595-4313-85e7-0cc9da4f9bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e8ad4727-d3ca-42bb-af5c-296504568601" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6a69ab4-df0e-49d4-a724-5de6e3292c6a" xlink:to="loc_srt_RangeAxis_e8ad4727-d3ca-42bb-af5c-296504568601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1be69557-46a5-4f1b-a0c2-a92e89c51ea9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e8ad4727-d3ca-42bb-af5c-296504568601" xlink:to="loc_srt_RangeMember_1be69557-46a5-4f1b-a0c2-a92e89c51ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a75e8cfc-9366-474d-9a38-36e94c1f32dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1be69557-46a5-4f1b-a0c2-a92e89c51ea9" xlink:to="loc_srt_MinimumMember_a75e8cfc-9366-474d-9a38-36e94c1f32dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bb681bdc-1314-40ca-869e-c9ee5978b6bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1be69557-46a5-4f1b-a0c2-a92e89c51ea9" xlink:to="loc_srt_MaximumMember_bb681bdc-1314-40ca-869e-c9ee5978b6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7494c1d9-1b91-4c94-a45f-d7046550bf35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f6a69ab4-df0e-49d4-a724-5de6e3292c6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7494c1d9-1b91-4c94-a45f-d7046550bf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1385412d-f35c-4900-a083-f9565ab70cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7494c1d9-1b91-4c94-a45f-d7046550bf35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1385412d-f35c-4900-a083-f9565ab70cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c97f7ac6-7070-4ccc-a86a-c13bbab6b0e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd4ce934-784b-43e3-8a91-7d4083b31e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c97f7ac6-7070-4ccc-a86a-c13bbab6b0e5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd4ce934-784b-43e3-8a91-7d4083b31e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_426d11fb-81f0-403e-b958-aab316fb4e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd4ce934-784b-43e3-8a91-7d4083b31e4b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_426d11fb-81f0-403e-b958-aab316fb4e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_426d11fb-81f0-403e-b958-aab316fb4e67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_d17bbd39-9956-4b16-8e53-b36bfa0e515e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_d17bbd39-9956-4b16-8e53-b36bfa0e515e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_aa85c2a6-ab23-47af-8e99-8ec0f8843710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_aa85c2a6-ab23-47af-8e99-8ec0f8843710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_32da2fa0-523e-4e02-ac22-2fe49ea1fba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_32da2fa0-523e-4e02-ac22-2fe49ea1fba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_25f5d766-2c51-4747-9f11-bf9ba6da4c30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:to="loc_us-gaap_LandMember_25f5d766-2c51-4747-9f11-bf9ba6da4c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_aa5881bd-13f9-4c42-a8c2-ef780d107d08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_77a4b5fb-d533-456f-88c6-b52791de65bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_aa5881bd-13f9-4c42-a8c2-ef780d107d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd4ce934-784b-43e3-8a91-7d4083b31e4b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_3ea3c499-49f7-452d-acbe-efa707ca9f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_3ea3c499-49f7-452d-acbe-efa707ca9f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_64dd7ff0-09fd-4433-bd05-fea839c987e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_64dd7ff0-09fd-4433-bd05-fea839c987e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_30fba1fc-9584-43ec-bdf7-9d8a6f1a526c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_30fba1fc-9584-43ec-bdf7-9d8a6f1a526c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_19989df0-f758-436d-875b-e8c4ad18dc07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_19989df0-f758-436d-875b-e8c4ad18dc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_88b9bf7a-c1e6-481b-967e-359ed6834527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_88b9bf7a-c1e6-481b-967e-359ed6834527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_404453f3-849c-46cb-8b02-854d24e1a7b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b60a85e5-017c-491a-ad45-02ac9e5f8482" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_404453f3-849c-46cb-8b02-854d24e1a7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c1fa9177-dbad-463c-a109-ca7a50e25673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RecordedInDepreciationAndAmortizationAbstract_03cce7cd-4599-4f24-adfd-d2695cb5d9bb" xlink:href="moh-20201231.xsd#moh_RecordedInDepreciationAndAmortizationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c1fa9177-dbad-463c-a109-ca7a50e25673" xlink:to="loc_moh_RecordedInDepreciationAndAmortizationAbstract_03cce7cd-4599-4f24-adfd-d2695cb5d9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DepreciationAndAmortizationOfCapitalizedSoftware_bd8f9faa-d139-4dd4-9a3d-1fe17612f527" xlink:href="moh-20201231.xsd#moh_DepreciationAndAmortizationOfCapitalizedSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_RecordedInDepreciationAndAmortizationAbstract_03cce7cd-4599-4f24-adfd-d2695cb5d9bb" xlink:to="loc_moh_DepreciationAndAmortizationOfCapitalizedSoftware_bd8f9faa-d139-4dd4-9a3d-1fe17612f527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1323d1b6-1b3e-4e25-aefa-f9ea4ea75648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_RecordedInDepreciationAndAmortizationAbstract_03cce7cd-4599-4f24-adfd-d2695cb5d9bb" xlink:to="loc_us-gaap_Depreciation_1323d1b6-1b3e-4e25-aefa-f9ea4ea75648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a4380cd2-75e2-43a5-b554-8f804cd67306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_RecordedInDepreciationAndAmortizationAbstract_03cce7cd-4599-4f24-adfd-d2695cb5d9bb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a4380cd2-75e2-43a5-b554-8f804cd67306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f1920448-0f2a-4d96-bb7c-982f9e81a485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_RecordedInDepreciationAndAmortizationAbstract_03cce7cd-4599-4f24-adfd-d2695cb5d9bb" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f1920448-0f2a-4d96-bb7c-982f9e81a485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DepreciationandAmortizationContinuingOperations_5eebb3f3-e0a5-4b10-9dbd-b020386c97bf" xlink:href="moh-20201231.xsd#moh_DepreciationandAmortizationContinuingOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_RecordedInDepreciationAndAmortizationAbstract_03cce7cd-4599-4f24-adfd-d2695cb5d9bb" xlink:to="loc_moh_DepreciationandAmortizationContinuingOperations_5eebb3f3-e0a5-4b10-9dbd-b020386c97bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RecordedInCostOfServiceRevenueAbstract_4a6eea3b-8915-4f1b-8aa9-f574b8444fdd" xlink:href="moh-20201231.xsd#moh_RecordedInCostOfServiceRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c1fa9177-dbad-463c-a109-ca7a50e25673" xlink:to="loc_moh_RecordedInCostOfServiceRevenueAbstract_4a6eea3b-8915-4f1b-8aa9-f574b8444fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_e62b212b-453d-48a4-8d21-1187746a3443" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_RecordedInCostOfServiceRevenueAbstract_4a6eea3b-8915-4f1b-8aa9-f574b8444fdd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_e62b212b-453d-48a4-8d21-1187746a3443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_0ad0734e-ee37-4176-a640-6f379910d054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_RecordedInCostOfServiceRevenueAbstract_4a6eea3b-8915-4f1b-8aa9-f574b8444fdd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_0ad0734e-ee37-4176-a640-6f379910d054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Leases" xlink:type="simple" xlink:href="moh-20201231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_aafc926f-c2f2-4c46-aeb3-210c4a432b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_d345dc98-6c2d-4872-b92c-f78f79e5775e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aafc926f-c2f2-4c46-aeb3-210c4a432b00" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_d345dc98-6c2d-4872-b92c-f78f79e5775e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_00400296-1dcc-4c18-939d-4a312b9ee18e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aafc926f-c2f2-4c46-aeb3-210c4a432b00" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_00400296-1dcc-4c18-939d-4a312b9ee18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesTables" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c14f843e-2dcb-4b40-9d15-1e72f413912b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_5bbc3735-59a4-4e50-86c8-af1959b110d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c14f843e-2dcb-4b40-9d15-1e72f413912b" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_5bbc3735-59a4-4e50-86c8-af1959b110d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AssetsAndLiabilitiesLesseeTableTextBlock_e18dad18-61a9-42bc-b8af-3c2dc5a81975" xlink:href="moh-20201231.xsd#moh_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c14f843e-2dcb-4b40-9d15-1e72f413912b" xlink:to="loc_moh_AssetsAndLiabilitiesLesseeTableTextBlock_e18dad18-61a9-42bc-b8af-3c2dc5a81975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_278cba91-a1fd-4edf-9a40-2753335d314b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c14f843e-2dcb-4b40-9d15-1e72f413912b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_278cba91-a1fd-4edf-9a40-2753335d314b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_867c4332-ccf1-4ef8-a9e5-3438b2d5621a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c14f843e-2dcb-4b40-9d15-1e72f413912b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_867c4332-ccf1-4ef8-a9e5-3438b2d5621a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e27dfce5-31bf-4084-bcf6-6fafc37477b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_96c336bd-35b7-4af7-b0b1-ea02ee090ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e27dfce5-31bf-4084-bcf6-6fafc37477b3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_96c336bd-35b7-4af7-b0b1-ea02ee090ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_37c978d6-b31e-4cb7-b25a-4b4028f4fde3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_96c336bd-35b7-4af7-b0b1-ea02ee090ae4" xlink:to="loc_srt_RangeAxis_37c978d6-b31e-4cb7-b25a-4b4028f4fde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_53868dca-8e33-4623-81da-91e5d287b42b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_37c978d6-b31e-4cb7-b25a-4b4028f4fde3" xlink:to="loc_srt_RangeMember_53868dca-8e33-4623-81da-91e5d287b42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f37b0166-5c8e-4268-b051-b52219477089" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_53868dca-8e33-4623-81da-91e5d287b42b" xlink:to="loc_srt_MinimumMember_f37b0166-5c8e-4268-b051-b52219477089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d8b8196e-2a15-405e-9214-967fc759538b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_53868dca-8e33-4623-81da-91e5d287b42b" xlink:to="loc_srt_MaximumMember_d8b8196e-2a15-405e-9214-967fc759538b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_96c336bd-35b7-4af7-b0b1-ea02ee090ae4" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_c9a94010-8360-4f90-b3de-a03958f48870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_c9a94010-8360-4f90-b3de-a03958f48870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7c57a1dc-3bb4-4518-84cb-368e3ad82837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7c57a1dc-3bb4-4518-84cb-368e3ad82837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1bca1dfc-8e21-482a-ba98-af6f18d24bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1bca1dfc-8e21-482a-ba98-af6f18d24bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_9b67c579-6da4-4744-8f3d-ae73b931ca89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_9b67c579-6da4-4744-8f3d-ae73b931ca89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_452b07d4-632f-4056-8e8b-86d233bd7a52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_452b07d4-632f-4056-8e8b-86d233bd7a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_af5b4818-f8aa-4aaa-85ed-9104c0e0c1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_af5b4818-f8aa-4aaa-85ed-9104c0e0c1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2bf4ce90-6d22-4360-a97f-66a58f90f9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2bf4ce90-6d22-4360-a97f-66a58f90f9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_d612c8ba-74eb-4d70-8f00-4644fb03b3db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_d612c8ba-74eb-4d70-8f00-4644fb03b3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_4136974e-e388-41fe-b680-68570a40e9d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2e0d3c84-3ac1-404c-b1c4-c6d0b884466f" xlink:to="loc_us-gaap_OperatingLeaseExpense_4136974e-e388-41fe-b680-68570a40e9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dd38e0cc-a28e-453e-8180-2e21638595df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_d9f56a03-9d92-45d9-b64d-34c413e5c4a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd38e0cc-a28e-453e-8180-2e21638595df" xlink:to="loc_us-gaap_OperatingLeaseCost_d9f56a03-9d92-45d9-b64d-34c413e5c4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f2fdccb0-ae29-4f6d-9d4a-a1534c9b8ecb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd38e0cc-a28e-453e-8180-2e21638595df" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f2fdccb0-ae29-4f6d-9d4a-a1534c9b8ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4719a92e-3cab-4fef-af14-51f468d50b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f2fdccb0-ae29-4f6d-9d4a-a1534c9b8ecb" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4719a92e-3cab-4fef-af14-51f468d50b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_f17ce682-f4ab-430a-b551-ddd77af35f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f2fdccb0-ae29-4f6d-9d4a-a1534c9b8ecb" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_f17ce682-f4ab-430a-b551-ddd77af35f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FinanceLeaseCost_0928b486-727f-476a-9a04-b8502f7a340d" xlink:href="moh-20201231.xsd#moh_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f2fdccb0-ae29-4f6d-9d4a-a1534c9b8ecb" xlink:to="loc_moh_FinanceLeaseCost_0928b486-727f-476a-9a04-b8502f7a340d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesSupplementalCashFlowDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7cc344c8-8260-462e-b708-39bb8c4d398f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_28d2c01a-8040-4619-a1d5-8c943707b8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cc344c8-8260-462e-b708-39bb8c4d398f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_28d2c01a-8040-4619-a1d5-8c943707b8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f96d3fb0-0df8-45c0-923f-e445e1d640bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_28d2c01a-8040-4619-a1d5-8c943707b8f1" xlink:to="loc_us-gaap_OperatingLeasePayments_f96d3fb0-0df8-45c0-923f-e445e1d640bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_ee94bb5b-20b5-4d3e-9b18-4469954d959e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_28d2c01a-8040-4619-a1d5-8c943707b8f1" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_ee94bb5b-20b5-4d3e-9b18-4469954d959e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28c90bd0-4272-45f2-98ca-905fdd27194b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cc344c8-8260-462e-b708-39bb8c4d398f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28c90bd0-4272-45f2-98ca-905fdd27194b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_88ce7765-e2bc-40c2-a168-974bc9c83758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28c90bd0-4272-45f2-98ca-905fdd27194b" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_88ce7765-e2bc-40c2-a168-974bc9c83758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract_d564874d-7e51-48a4-b577-74045a44db21" xlink:href="moh-20201231.xsd#moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cc344c8-8260-462e-b708-39bb8c4d398f" xlink:to="loc_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract_d564874d-7e51-48a4-b577-74045a44db21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_34073566-3be8-4201-879b-4c25f0d2f3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract_d564874d-7e51-48a4-b577-74045a44db21" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_34073566-3be8-4201-879b-4c25f0d2f3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_16881720-9b57-43b2-b39e-fbf28e701bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract_d564874d-7e51-48a4-b577-74045a44db21" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_16881720-9b57-43b2-b39e-fbf28e701bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4b7ecc6e-5940-4d7e-ad2a-946bd4f813f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_065093cb-7adf-48da-a494-e0aa3aa91d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b7ecc6e-5940-4d7e-ad2a-946bd4f813f6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_065093cb-7adf-48da-a494-e0aa3aa91d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d49bde85-8367-4be3-883a-e8b273b09928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_065093cb-7adf-48da-a494-e0aa3aa91d95" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d49bde85-8367-4be3-883a-e8b273b09928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_337e6af6-a55b-40ce-be89-f5b0e6e94754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d49bde85-8367-4be3-883a-e8b273b09928" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_337e6af6-a55b-40ce-be89-f5b0e6e94754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CompleteCareMember_abe45d99-992e-4a1d-8fb4-60848135af5b" xlink:href="moh-20201231.xsd#moh_CompleteCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_337e6af6-a55b-40ce-be89-f5b0e6e94754" xlink:to="loc_moh_CompleteCareMember_abe45d99-992e-4a1d-8fb4-60848135af5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_065093cb-7adf-48da-a494-e0aa3aa91d95" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDescriptionAbstract_244f6770-6228-40fa-860c-c1f4b5e84592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_LesseeOperatingLeaseDescriptionAbstract_244f6770-6228-40fa-860c-c1f4b5e84592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OperatingLeaseAssetsLesseeAbstract_6a2a870a-d1eb-4325-86ae-bcdec382ab3f" xlink:href="moh-20201231.xsd#moh_OperatingLeaseAssetsLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeOperatingLeaseDescriptionAbstract_244f6770-6228-40fa-860c-c1f4b5e84592" xlink:to="loc_moh_OperatingLeaseAssetsLesseeAbstract_6a2a870a-d1eb-4325-86ae-bcdec382ab3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired_9750141d-24ee-428e-99f7-d0d6b09a01b5" xlink:href="moh-20201231.xsd#moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_OperatingLeaseAssetsLesseeAbstract_6a2a870a-d1eb-4325-86ae-bcdec382ab3f" xlink:to="loc_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired_9750141d-24ee-428e-99f7-d0d6b09a01b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_29e02e8a-32d2-4881-8b8e-37c6321e6d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_OperatingLeaseAssetsLesseeAbstract_6a2a870a-d1eb-4325-86ae-bcdec382ab3f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_29e02e8a-32d2-4881-8b8e-37c6321e6d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract_ade2357b-30dd-4280-887d-f7670c168201" xlink:href="moh-20201231.xsd#moh_OperatingLeaseLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeOperatingLeaseDescriptionAbstract_244f6770-6228-40fa-860c-c1f4b5e84592" xlink:to="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract_ade2357b-30dd-4280-887d-f7670c168201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f372b995-3dbd-474f-86e1-a686fc831e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract_ade2357b-30dd-4280-887d-f7670c168201" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f372b995-3dbd-474f-86e1-a686fc831e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_37c80846-6916-4700-bd95-01b9f63a3949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract_ade2357b-30dd-4280-887d-f7670c168201" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_37c80846-6916-4700-bd95-01b9f63a3949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_dfd0ac2d-b163-4df3-9f4c-54c2ad791b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_OperatingLeaseLiabilitiesLesseeAbstract_ade2357b-30dd-4280-887d-f7670c168201" xlink:to="loc_us-gaap_OperatingLeaseLiability_dfd0ac2d-b163-4df3-9f4c-54c2ad791b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_12fa6fba-e0e0-4a34-9bb2-b6e7f0c0570b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_12fa6fba-e0e0-4a34-9bb2-b6e7f0c0570b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FinanceLeaseAssetsLesseeAbstract_df09eef6-42a3-48da-aa62-89584f2f2f2e" xlink:href="moh-20201231.xsd#moh_FinanceLeaseAssetsLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_12fa6fba-e0e0-4a34-9bb2-b6e7f0c0570b" xlink:to="loc_moh_FinanceLeaseAssetsLesseeAbstract_df09eef6-42a3-48da-aa62-89584f2f2f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_3968cf58-8835-42ca-ac39-8a77768845ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_FinanceLeaseAssetsLesseeAbstract_df09eef6-42a3-48da-aa62-89584f2f2f2e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_3968cf58-8835-42ca-ac39-8a77768845ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract_0127f3d6-f3d6-4f7c-938e-12eae7734782" xlink:href="moh-20201231.xsd#moh_FinanceLeaseLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_12fa6fba-e0e0-4a34-9bb2-b6e7f0c0570b" xlink:to="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract_0127f3d6-f3d6-4f7c-938e-12eae7734782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b8d3b0a7-8502-4dc5-9d89-c9f3b487b747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract_0127f3d6-f3d6-4f7c-938e-12eae7734782" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b8d3b0a7-8502-4dc5-9d89-c9f3b487b747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_11596150-f16c-4f08-b3ed-549438476b51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract_0127f3d6-f3d6-4f7c-938e-12eae7734782" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_11596150-f16c-4f08-b3ed-549438476b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_41380381-5ef7-4b89-95cb-48ab0d5265a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_moh_FinanceLeaseLiabilitiesLesseeAbstract_0127f3d6-f3d6-4f7c-938e-12eae7734782" xlink:to="loc_us-gaap_FinanceLeaseLiability_41380381-5ef7-4b89-95cb-48ab0d5265a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f6f5c1f8-f9fa-4591-94fe-a7a502b93940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f6f5c1f8-f9fa-4591-94fe-a7a502b93940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b1be4c66-81f6-4ea5-bb23-4f2baeba4d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b1be4c66-81f6-4ea5-bb23-4f2baeba4d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_e2b9d539-c523-4e16-bdcd-b9beedea3611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_e2b9d539-c523-4e16-bdcd-b9beedea3611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d4866b52-86c4-44e9-841f-4e10ab040737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ac39ccde-ed8b-4617-a1da-137b45146b62" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d4866b52-86c4-44e9-841f-4e10ab040737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_41c23a93-e515-4c60-9e2b-7f4e17a7dda8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41c23a93-e515-4c60-9e2b-7f4e17a7dda8" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_636c1773-02b3-441a-ab39-f708725db998" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_636c1773-02b3-441a-ab39-f708725db998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_489b8ce3-180a-42ce-aebe-55cd41834f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_489b8ce3-180a-42ce-aebe-55cd41834f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_95d86631-2926-4708-a648-4324ad3e4cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_95d86631-2926-4708-a648-4324ad3e4cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b45ce4fc-038a-434c-9e2f-7f11ef4a9ef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b45ce4fc-038a-434c-9e2f-7f11ef4a9ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4009719e-d5c4-4ba9-ac13-bdfbf52e2ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4009719e-d5c4-4ba9-ac13-bdfbf52e2ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b3cc945a-98c3-4a14-a7c1-ec67b9d1b209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b3cc945a-98c3-4a14-a7c1-ec67b9d1b209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_12e95248-afd2-4b19-b5a7-4f52ac4f793b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_12e95248-afd2-4b19-b5a7-4f52ac4f793b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_21be15bc-b6d0-46f7-8f81-29c2aa682a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_21be15bc-b6d0-46f7-8f81-29c2aa682a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f0b19697-529c-468b-989c-581e8d932e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eca97fc9-cba3-4393-8e26-4949520a3675" xlink:to="loc_us-gaap_OperatingLeaseLiability_f0b19697-529c-468b-989c-581e8d932e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41c23a93-e515-4c60-9e2b-7f4e17a7dda8" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a98e72ab-6ef3-4e75-ae20-580361e4e743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a98e72ab-6ef3-4e75-ae20-580361e4e743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ebf97103-7fb6-48d1-8712-fa5ecb043357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ebf97103-7fb6-48d1-8712-fa5ecb043357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_47d33ff2-93ba-4f3a-9e2a-12e4e597962b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_47d33ff2-93ba-4f3a-9e2a-12e4e597962b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5ec2216a-8837-40d5-8344-caccc88442e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5ec2216a-8837-40d5-8344-caccc88442e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2d7d885b-25f0-4d95-815a-4a6bdf92ca49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2d7d885b-25f0-4d95-815a-4a6bdf92ca49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_ede616d3-ae6d-49a8-af44-fe7189bc8ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_ede616d3-ae6d-49a8-af44-fe7189bc8ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d9dadf85-1cf4-41cf-ba57-a9050a9e583a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d9dadf85-1cf4-41cf-ba57-a9050a9e583a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_cc03db95-ec52-4544-b39b-0ea00ecd892d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_cc03db95-ec52-4544-b39b-0ea00ecd892d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_42a6aed3-b98e-4657-8e0b-62160edc8441" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_352e0592-e7db-438e-80c1-36aae058e609" xlink:to="loc_us-gaap_FinanceLeaseLiability_42a6aed3-b98e-4657-8e0b-62160edc8441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="moh-20201231.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f37cc60f-c514-4028-9283-4288f5e549e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e0f9b830-716d-4e7f-b11b-b79aa013ff1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f37cc60f-c514-4028-9283-4288f5e549e2" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e0f9b830-716d-4e7f-b11b-b79aa013ff1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c53ae099-0636-447e-b6ae-b53e87a99fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_72fe1cad-7143-497d-9138-ae5bc247b4ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c53ae099-0636-447e-b6ae-b53e87a99fe6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_72fe1cad-7143-497d-9138-ae5bc247b4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0dde96e7-9327-43aa-8f81-05021df5c8a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c53ae099-0636-447e-b6ae-b53e87a99fe6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0dde96e7-9327-43aa-8f81-05021df5c8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1357c246-d22a-4763-8e61-95a7a98d1f1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_6a777d11-8698-434d-a82b-c8ac623a4dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1357c246-d22a-4763-8e61-95a7a98d1f1a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_6a777d11-8698-434d-a82b-c8ac623a4dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0fd975e0-24fc-40ea-b590-d53d1c37d79d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6a777d11-8698-434d-a82b-c8ac623a4dc0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0fd975e0-24fc-40ea-b590-d53d1c37d79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0f56483b-21c2-4bab-be60-62368e85b0ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fd975e0-24fc-40ea-b590-d53d1c37d79d" xlink:to="loc_us-gaap_SegmentDomain_0f56483b-21c2-4bab-be60-62368e85b0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_39ffd4b8-9284-4bb0-85b6-57fecfeb7272" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0f56483b-21c2-4bab-be60-62368e85b0ec" xlink:to="loc_moh_HealthPlansMember_39ffd4b8-9284-4bb0-85b6-57fecfeb7272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d593375a-bcc1-4be8-acf1-452d4a77652e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6a777d11-8698-434d-a82b-c8ac623a4dc0" xlink:to="loc_us-gaap_GoodwillLineItems_d593375a-bcc1-4be8-acf1-452d4a77652e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d593375a-bcc1-4be8-acf1-452d4a77652e" xlink:to="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e7988137-cae2-4b67-834c-7d4aa115ce67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:to="loc_us-gaap_Goodwill_e7988137-cae2-4b67-834c-7d4aa115ce67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_c7111fd1-c896-4ed4-b23d-e0066d4f81e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_c7111fd1-c896-4ed4-b23d-e0066d4f81e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_f3689f17-9aca-4da5-acb1-b42966d5aa94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_f3689f17-9aca-4da5-acb1-b42966d5aa94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_730ae707-7db7-4f7a-997a-1d06d752a67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_730ae707-7db7-4f7a-997a-1d06d752a67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b4f2b930-0a2e-4ade-ad73-f55d1e3b5bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d3440998-cc13-42fd-9693-5bd9600246b9" xlink:to="loc_us-gaap_Goodwill_b4f2b930-0a2e-4ade-ad73-f55d1e3b5bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46f85f07-0487-433b-be27-38d3b3ffdb92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586c8891-c9ab-4d91-bff9-f437e29863c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46f85f07-0487-433b-be27-38d3b3ffdb92" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586c8891-c9ab-4d91-bff9-f437e29863c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e0653403-d3d1-4d5e-bda8-ea5015353d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586c8891-c9ab-4d91-bff9-f437e29863c3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e0653403-d3d1-4d5e-bda8-ea5015353d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f65d5975-734e-46cd-ae76-d722a97cdf66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e0653403-d3d1-4d5e-bda8-ea5015353d4c" xlink:to="loc_us-gaap_SegmentDomain_f65d5975-734e-46cd-ae76-d722a97cdf66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_56f9c2e2-e276-4f9c-8441-5e0a5dd214d6" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f65d5975-734e-46cd-ae76-d722a97cdf66" xlink:to="loc_moh_HealthPlansMember_56f9c2e2-e276-4f9c-8441-5e0a5dd214d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f1fd0eb-0dcf-4434-be03-ba5c776d8f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586c8891-c9ab-4d91-bff9-f437e29863c3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f1fd0eb-0dcf-4434-be03-ba5c776d8f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_69fbf791-982a-4a7e-a809-8966a1d6b635" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f1fd0eb-0dcf-4434-be03-ba5c776d8f59" xlink:to="loc_us-gaap_GoodwillGross_69fbf791-982a-4a7e-a809-8966a1d6b635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_3003d8d8-13b4-434f-9cbb-51a3e9309117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f1fd0eb-0dcf-4434-be03-ba5c776d8f59" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_3003d8d8-13b4-434f-9cbb-51a3e9309117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f1fd0eb-0dcf-4434-be03-ba5c776d8f59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1d37775b-626f-42ff-b738-b0c1f55dd8ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1d37775b-626f-42ff-b738-b0c1f55dd8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ee44f264-6fd7-48c8-aead-c8c28d861b01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ee44f264-6fd7-48c8-aead-c8c28d861b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d5c5fab8-0f69-43d0-8199-8b4a0938dd9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d5c5fab8-0f69-43d0-8199-8b4a0938dd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_486d277b-e8fe-4707-a051-7fb89a2fe7fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_486d277b-e8fe-4707-a051-7fb89a2fe7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7a13fb4c-c071-4568-908f-de62033153c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8b607e58-bb14-42f1-8c05-1b08923c5e5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7a13fb4c-c071-4568-908f-de62033153c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9fc0366d-1243-474c-87e6-4f527803dc91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_28cacee6-32c5-478d-8030-fbaae6564cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9fc0366d-1243-474c-87e6-4f527803dc91" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_28cacee6-32c5-478d-8030-fbaae6564cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c233ecc-6ea2-45a4-a067-37c828ce0c26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_28cacee6-32c5-478d-8030-fbaae6564cb0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c233ecc-6ea2-45a4-a067-37c828ce0c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7de91d0a-a2b8-4e90-b40c-cc9624398410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c233ecc-6ea2-45a4-a067-37c828ce0c26" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7de91d0a-a2b8-4e90-b40c-cc9624398410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ContractRightsandLicensingAgreementsMember_225c6225-45f7-47ac-a1e5-18e1fd5d7261" xlink:href="moh-20201231.xsd#moh_ContractRightsandLicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7de91d0a-a2b8-4e90-b40c-cc9624398410" xlink:to="loc_moh_ContractRightsandLicensingAgreementsMember_225c6225-45f7-47ac-a1e5-18e1fd5d7261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ProviderNetworksMember_41724138-7f48-47cd-9880-e0ce4b28bb82" xlink:href="moh-20201231.xsd#moh_ProviderNetworksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7de91d0a-a2b8-4e90-b40c-cc9624398410" xlink:to="loc_moh_ProviderNetworksMember_41724138-7f48-47cd-9880-e0ce4b28bb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_de02d445-17d1-419d-b4af-947b0e9a6d5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7de91d0a-a2b8-4e90-b40c-cc9624398410" xlink:to="loc_us-gaap_TradeNamesMember_de02d445-17d1-419d-b4af-947b0e9a6d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f8fec3c-5745-45e3-9b0e-be95fec1e48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_28cacee6-32c5-478d-8030-fbaae6564cb0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f8fec3c-5745-45e3-9b0e-be95fec1e48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d496eaba-24db-4950-a058-7d8581976bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f8fec3c-5745-45e3-9b0e-be95fec1e48e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d496eaba-24db-4950-a058-7d8581976bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_af3d9404-c9be-4ab0-a5f5-42fe6044da0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f8fec3c-5745-45e3-9b0e-be95fec1e48e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_af3d9404-c9be-4ab0-a5f5-42fe6044da0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_24ca5f47-d02f-4b3f-9872-69622704d7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f8fec3c-5745-45e3-9b0e-be95fec1e48e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_24ca5f47-d02f-4b3f-9872-69622704d7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayable"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_fc7474e2-6f9b-4759-93bd-c6f8675e3662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_eb15ca96-08d4-493d-b653-f6c333bd81c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_fc7474e2-6f9b-4759-93bd-c6f8675e3662" xlink:to="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_eb15ca96-08d4-493d-b653-f6c333bd81c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_24d97894-2870-4e67-82d2-bdbbe2bdbf49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_8b254913-b5cd-4d88-a033-3503c5c6119b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_24d97894-2870-4e67-82d2-bdbbe2bdbf49" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_8b254913-b5cd-4d88-a033-3503c5c6119b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock_b49c6138-9c5b-4dd6-88af-9e0e99ff94e6" xlink:href="moh-20201231.xsd#moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_24d97894-2870-4e67-82d2-bdbbe2bdbf49" xlink:to="loc_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock_b49c6138-9c5b-4dd6-88af-9e0e99ff94e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_04c0572d-2178-4c6b-af8c-2979ceba2959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_24d97894-2870-4e67-82d2-bdbbe2bdbf49" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_04c0572d-2178-4c6b-af8c-2979ceba2959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_5a84dadf-f3ad-49a1-b1b9-65d296c5770a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_24d97894-2870-4e67-82d2-bdbbe2bdbf49" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_5a84dadf-f3ad-49a1-b1b9-65d296c5770a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_60adf9b4-5d9d-4f7f-8854-628391618c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9059082b-4d5d-4261-b0aa-8d29118e868f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_60adf9b4-5d9d-4f7f-8854-628391618c06" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9059082b-4d5d-4261-b0aa-8d29118e868f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2733baf4-d533-4b14-8f06-8d7896df37b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9059082b-4d5d-4261-b0aa-8d29118e868f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2733baf4-d533-4b14-8f06-8d7896df37b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dd3c03a8-ae7c-4660-ad1b-3f96ed842ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2733baf4-d533-4b14-8f06-8d7896df37b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dd3c03a8-ae7c-4660-ad1b-3f96ed842ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CompleteCareMember_26631b83-e922-4f7a-bde1-a0e2e8fc1ea5" xlink:href="moh-20201231.xsd#moh_CompleteCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dd3c03a8-ae7c-4660-ad1b-3f96ed842ef5" xlink:to="loc_moh_CompleteCareMember_26631b83-e922-4f7a-bde1-a0e2e8fc1ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9059082b-4d5d-4261-b0aa-8d29118e868f" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount_35e68704-762d-492f-b996-a62068d0b258" xlink:href="moh-20201231.xsd#moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount_35e68704-762d-492f-b996-a62068d0b258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_PharmacyClaimsPayable_55145663-0f16-4bd3-b3cd-9eb48fa2e04a" xlink:href="moh-20201231.xsd#moh_PharmacyClaimsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_moh_PharmacyClaimsPayable_55145663-0f16-4bd3-b3cd-9eb48fa2e04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CapitationClaimsPayable_491d4d52-5886-47f6-b9cc-66c9820f5d55" xlink:href="moh-20201231.xsd#moh_CapitationClaimsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_moh_CapitationClaimsPayable_491d4d52-5886-47f6-b9cc-66c9820f5d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_OtherClaimsPayable_7f74010a-1b79-4d76-969f-2c1855e4b2c3" xlink:href="moh-20201231.xsd#moh_OtherClaimsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_moh_OtherClaimsPayable_7f74010a-1b79-4d76-969f-2c1855e4b2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_830b6755-cbd2-4a7b-8e5c-b7118d46d86c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_74471286-2b8a-49a7-8ac8-4a445614f656" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_830b6755-cbd2-4a7b-8e5c-b7118d46d86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_7232f60f-dd07-49df-ad2b-aa7c75a94f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalClaimsAndBenefitsPayable_c5784d71-5ca2-4b88-90ff-c1f747cfcad5" xlink:href="moh-20201231.xsd#moh_MedicalClaimsAndBenefitsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_7232f60f-dd07-49df-ad2b-aa7c75a94f07" xlink:to="loc_moh_MedicalClaimsAndBenefitsPayable_c5784d71-5ca2-4b88-90ff-c1f747cfcad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_aa7d2325-a77e-414a-9d01-ec0c50f89734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_7232f60f-dd07-49df-ad2b-aa7c75a94f07" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_aa7d2325-a77e-414a-9d01-ec0c50f89734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_ddf5ce4e-4620-4339-8887-914a64e5bca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_7232f60f-dd07-49df-ad2b-aa7c75a94f07" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_ddf5ce4e-4620-4339-8887-914a64e5bca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_1e63e599-2b60-47cd-af8b-35203098bab9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_ddf5ce4e-4620-4339-8887-914a64e5bca9" xlink:to="loc_srt_MajorCustomersAxis_1e63e599-2b60-47cd-af8b-35203098bab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a4bf6725-8790-417d-87f8-1367be8b5503" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_1e63e599-2b60-47cd-af8b-35203098bab9" xlink:to="loc_srt_NameOfMajorCustomerDomain_a4bf6725-8790-417d-87f8-1367be8b5503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CMSSubsidiesMember_27e4686b-43cc-4042-8f06-a27ef466051e" xlink:href="moh-20201231.xsd#moh_CMSSubsidiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a4bf6725-8790-417d-87f8-1367be8b5503" xlink:to="loc_moh_CMSSubsidiesMember_27e4686b-43cc-4042-8f06-a27ef466051e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_33a2edd3-9e2e-4e81-b1a4-7ffd90e1fbe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_ddf5ce4e-4620-4339-8887-914a64e5bca9" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_33a2edd3-9e2e-4e81-b1a4-7ffd90e1fbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_66647922-acd9-42da-8394-5233ef5d9f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_33a2edd3-9e2e-4e81-b1a4-7ffd90e1fbe3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_66647922-acd9-42da-8394-5233ef5d9f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_1be32777-fd8d-4223-bc38-8dac84f3c901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_9e7c5c3b-8ab8-4cb9-bd33-face83577d46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_1be32777-fd8d-4223-bc38-8dac84f3c901" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_9e7c5c3b-8ab8-4cb9-bd33-face83577d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_17e60d9a-9c0c-420c-a5c5-72e6d808ec9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_9e7c5c3b-8ab8-4cb9-bd33-face83577d46" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_17e60d9a-9c0c-420c-a5c5-72e6d808ec9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b4dedc2a-1169-4f03-8710-9ee081b12d58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_9e7c5c3b-8ab8-4cb9-bd33-face83577d46" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b4dedc2a-1169-4f03-8710-9ee081b12d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_5c817cc2-26f5-49ea-bc80-ec0743f0cf00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b4dedc2a-1169-4f03-8710-9ee081b12d58" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_5c817cc2-26f5-49ea-bc80-ec0743f0cf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_705b19ec-a182-4d5d-9422-cfad6ccbcd99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b4dedc2a-1169-4f03-8710-9ee081b12d58" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_705b19ec-a182-4d5d-9422-cfad6ccbcd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_07b82e0c-9056-447d-838b-1b54df605c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b4dedc2a-1169-4f03-8710-9ee081b12d58" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_07b82e0c-9056-447d-838b-1b54df605c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_bbcdb1fb-b20d-461c-b573-59461d237d78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_9e7c5c3b-8ab8-4cb9-bd33-face83577d46" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_bbcdb1fb-b20d-461c-b573-59461d237d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_28ef2a02-614f-4c76-b32c-9ea4d88b98e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_bbcdb1fb-b20d-461c-b573-59461d237d78" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_28ef2a02-614f-4c76-b32c-9ea4d88b98e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_7ff2d653-fb44-41a3-a600-6779beae8e71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_bbcdb1fb-b20d-461c-b573-59461d237d78" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_7ff2d653-fb44-41a3-a600-6779beae8e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c0daa5b6-c5a9-4fe0-918f-5a0d33f12316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_bbcdb1fb-b20d-461c-b573-59461d237d78" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c0daa5b6-c5a9-4fe0-918f-5a0d33f12316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_384c5528-a85b-418f-bab0-5edab6733768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_9e7c5c3b-8ab8-4cb9-bd33-face83577d46" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_384c5528-a85b-418f-bab0-5edab6733768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider_bae7b473-840e-4780-be72-7715f3f569f8" xlink:href="moh-20201231.xsd#moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_9e7c5c3b-8ab8-4cb9-bd33-face83577d46" xlink:to="loc_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider_bae7b473-840e-4780-be72-7715f3f569f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2d1ce530-9668-4951-b33c-0e632a5cb5c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_9e7c5c3b-8ab8-4cb9-bd33-face83577d46" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2d1ce530-9668-4951-b33c-0e632a5cb5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_28529a00-0586-455b-9801-28743ccddaa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_1be32777-fd8d-4223-bc38-8dac84f3c901" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_28529a00-0586-455b-9801-28743ccddaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_402d8aa7-dbb9-4913-b226-a62811952b85" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_28529a00-0586-455b-9801-28743ccddaa3" xlink:to="loc_srt_MajorCustomersAxis_402d8aa7-dbb9-4913-b226-a62811952b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_28d3f01a-0349-476c-bd7c-a88fb8aa34e8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_402d8aa7-dbb9-4913-b226-a62811952b85" xlink:to="loc_srt_NameOfMajorCustomerDomain_28d3f01a-0349-476c-bd7c-a88fb8aa34e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CMSSubsidiesMember_edb001b6-d6e2-4a4b-a92a-edac01305b8a" xlink:href="moh-20201231.xsd#moh_CMSSubsidiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_28d3f01a-0349-476c-bd7c-a88fb8aa34e8" xlink:to="loc_moh_CMSSubsidiesMember_edb001b6-d6e2-4a4b-a92a-edac01305b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_28c76bf6-a7c7-4fa7-9cc4-d47bae10aaac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_28529a00-0586-455b-9801-28743ccddaa3" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_28c76bf6-a7c7-4fa7-9cc4-d47bae10aaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_d338e8f0-61ac-4095-84e1-0b605829bc0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_28c76bf6-a7c7-4fa7-9cc4-d47bae10aaac" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_d338e8f0-61ac-4095-84e1-0b605829bc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_c9989bf4-549c-4fb0-ad19-b11ce773fb60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_f084fd32-3e6d-45d3-a1f9-8ce11cfbe654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c9989bf4-549c-4fb0-ad19-b11ce773fb60" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_f084fd32-3e6d-45d3-a1f9-8ce11cfbe654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6175d126-027a-4c94-80f1-9585a5fae770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_f084fd32-3e6d-45d3-a1f9-8ce11cfbe654" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6175d126-027a-4c94-80f1-9585a5fae770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ed4a8f2c-f4a3-4890-ad99-97e9fbe12965" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6175d126-027a-4c94-80f1-9585a5fae770" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ed4a8f2c-f4a3-4890-ad99-97e9fbe12965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_fff70df0-52be-4868-ae2f-eac704d79065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ed4a8f2c-f4a3-4890-ad99-97e9fbe12965" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_fff70df0-52be-4868-ae2f-eac704d79065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_a31131fb-07b1-4e65-b47e-d3e7d0ca4d36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ed4a8f2c-f4a3-4890-ad99-97e9fbe12965" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_a31131fb-07b1-4e65-b47e-d3e7d0ca4d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_2eea9091-db07-4c56-9485-fa2fd1ad7330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ed4a8f2c-f4a3-4890-ad99-97e9fbe12965" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_2eea9091-db07-4c56-9485-fa2fd1ad7330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_f084fd32-3e6d-45d3-a1f9-8ce11cfbe654" xlink:to="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_24662f7f-4e8a-49c7-8b9f-91c06a0d0603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_24662f7f-4e8a-49c7-8b9f-91c06a0d0603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment_5597cd3b-f777-4336-b8fb-7a875c475cf3" xlink:href="moh-20201231.xsd#moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:to="loc_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment_5597cd3b-f777-4336-b8fb-7a875c475cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_42c28a9f-d550-454e-ac56-7685163a1afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_42c28a9f-d550-454e-ac56-7685163a1afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_c58fffdd-69db-42d6-9976-d3c3700b7a52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_7fbb6225-e3af-4f9d-a357-50c77b4f10f9" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_c58fffdd-69db-42d6-9976-d3c3700b7a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_a6a82c95-cf74-492e-9ea3-f615d5d0a2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_cc14fc4d-ee37-4935-b0ac-7a83b04cf296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a6a82c95-cf74-492e-9ea3-f615d5d0a2a4" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_cc14fc4d-ee37-4935-b0ac-7a83b04cf296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_bc88e317-da9e-4f79-a703-9310dc80aff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_cc14fc4d-ee37-4935-b0ac-7a83b04cf296" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_bc88e317-da9e-4f79-a703-9310dc80aff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_452adfcc-f7ea-4401-bc88-38c3ffabb605" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_bc88e317-da9e-4f79-a703-9310dc80aff7" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_452adfcc-f7ea-4401-bc88-38c3ffabb605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_1923e4d3-9f77-4335-8cb1-7564670d9931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_452adfcc-f7ea-4401-bc88-38c3ffabb605" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_1923e4d3-9f77-4335-8cb1-7564670d9931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_3c4bd5ea-1f84-455f-9c7b-3c7951d5afd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_452adfcc-f7ea-4401-bc88-38c3ffabb605" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_3c4bd5ea-1f84-455f-9c7b-3c7951d5afd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_9343a54a-37e8-429b-9381-321bb2e28349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_452adfcc-f7ea-4401-bc88-38c3ffabb605" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_9343a54a-37e8-429b-9381-321bb2e28349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_dbcb8922-bf0f-460b-9db9-522047755470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_cc14fc4d-ee37-4935-b0ac-7a83b04cf296" xlink:to="loc_us-gaap_ProductInformationLineItems_dbcb8922-bf0f-460b-9db9-522047755470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_1a64e1fb-9edd-43e7-a0b6-cec0526acc68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_dbcb8922-bf0f-460b-9db9-522047755470" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_1a64e1fb-9edd-43e7-a0b6-cec0526acc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_b952c917-e607-4078-b92b-e9be436655a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_0212435b-b752-49f4-b493-9763fbd18b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b952c917-e607-4078-b92b-e9be436655a5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_0212435b-b752-49f4-b493-9763fbd18b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_e5004897-f327-4bf3-a701-e1b3cf9116d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b952c917-e607-4078-b92b-e9be436655a5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_e5004897-f327-4bf3-a701-e1b3cf9116d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears_82f6e58b-7460-409c-869d-c80b996c8956" xlink:href="moh-20201231.xsd#moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b952c917-e607-4078-b92b-e9be436655a5" xlink:to="loc_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears_82f6e58b-7460-409c-869d-c80b996c8956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_91faecad-fe8a-4b30-8176-3e350b10d8a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b952c917-e607-4078-b92b-e9be436655a5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_91faecad-fe8a-4b30-8176-3e350b10d8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems_34d1e322-81eb-422a-bcb4-3456de7042b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b952c917-e607-4078-b92b-e9be436655a5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems_34d1e322-81eb-422a-bcb4-3456de7042b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_fec4d33c-9601-4a6a-b26b-0ec7e2c8159b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b952c917-e607-4078-b92b-e9be436655a5" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_fec4d33c-9601-4a6a-b26b-0ec7e2c8159b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Debt" xlink:type="simple" xlink:href="moh-20201231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c04e4c5c-041b-40fc-b6a2-9ec223f91815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_a692104f-4432-407d-8fd4-ae781a49e55e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c04e4c5c-041b-40fc-b6a2-9ec223f91815" xlink:to="loc_us-gaap_LongTermDebtTextBlock_a692104f-4432-407d-8fd4-ae781a49e55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtTables" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_91892b19-1b37-426b-852d-ee86dc6e4494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_ed1df987-b0a6-4982-95c1-540e9008b14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91892b19-1b37-426b-852d-ee86dc6e4494" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_ed1df987-b0a6-4982-95c1-540e9008b14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_decace27-e337-445c-80ea-8d597c1e8d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91892b19-1b37-426b-852d-ee86dc6e4494" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_decace27-e337-445c-80ea-8d597c1e8d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtMaturitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/DebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a290dbe8-a814-41ec-a64c-ca03108c775b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fdd269d0-b71f-4972-ba7c-75203ee71990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a290dbe8-a814-41ec-a64c-ca03108c775b" xlink:to="loc_us-gaap_DebtInstrumentTable_fdd269d0-b71f-4972-ba7c-75203ee71990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_40132b27-b785-4c72-a29b-00fe7235f0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fdd269d0-b71f-4972-ba7c-75203ee71990" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_40132b27-b785-4c72-a29b-00fe7235f0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_059c03e8-fd0d-47c9-b6c4-122de1e4df02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_40132b27-b785-4c72-a29b-00fe7235f0b7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_059c03e8-fd0d-47c9-b6c4-122de1e4df02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_5fd1fded-28a3-4c02-96b7-2eeb88ec7771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_059c03e8-fd0d-47c9-b6c4-122de1e4df02" xlink:to="loc_us-gaap_SeniorNotesMember_5fd1fded-28a3-4c02-96b7-2eeb88ec7771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f81507f0-5ccd-4b84-98fe-788176afe493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fdd269d0-b71f-4972-ba7c-75203ee71990" xlink:to="loc_us-gaap_DebtInstrumentAxis_f81507f0-5ccd-4b84-98fe-788176afe493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_89cae545-9653-4a0a-aa51-51beb767fd1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f81507f0-5ccd-4b84-98fe-788176afe493" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_89cae545-9653-4a0a-aa51-51beb767fd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4375SeniorNotesMember_898f9982-a075-4751-b590-75bbdda0c5a5" xlink:href="moh-20201231.xsd#moh_A4375SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_89cae545-9653-4a0a-aa51-51beb767fd1b" xlink:to="loc_moh_A4375SeniorNotesMember_898f9982-a075-4751-b590-75bbdda0c5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SeniorNotesDue2022Member_26cd68f8-74f8-4e6a-81b4-f8ac44118a10" xlink:href="moh-20201231.xsd#moh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_89cae545-9653-4a0a-aa51-51beb767fd1b" xlink:to="loc_moh_SeniorNotesDue2022Member_26cd68f8-74f8-4e6a-81b4-f8ac44118a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_da6f7ea8-8c36-473f-a614-e07f22d15859" xlink:href="moh-20201231.xsd#moh_ThreePointEightSevenFivePercentSeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_89cae545-9653-4a0a-aa51-51beb767fd1b" xlink:to="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_da6f7ea8-8c36-473f-a614-e07f22d15859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fdd269d0-b71f-4972-ba7c-75203ee71990" xlink:to="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_80afccbb-75ff-4147-903b-297a499f81e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_80afccbb-75ff-4147-903b-297a499f81e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9bcddd0d-2667-45ce-baf6-2108e6d4e605" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_9bcddd0d-2667-45ce-baf6-2108e6d4e605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e051f20d-ad43-483b-8b91-ddf54b1ecb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e051f20d-ad43-483b-8b91-ddf54b1ecb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6707a7bd-9b00-445f-ae67-00f7c9aa24bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6707a7bd-9b00-445f-ae67-00f7c9aa24bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9d817e75-09f3-4a39-bb4c-9e94a2c22610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9d817e75-09f3-4a39-bb4c-9e94a2c22610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7cbb3c0c-0d76-4f12-865b-16650af5b081" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7cbb3c0c-0d76-4f12-865b-16650af5b081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_d5630b50-b8a7-4741-ba74-d1f64b4fe9be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_d5630b50-b8a7-4741-ba74-d1f64b4fe9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_dfb03269-914e-4c48-a99c-460404741b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dc3afc46-e691-4014-9581-3867479d5f79" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_dfb03269-914e-4c48-a99c-460404741b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_51ef5082-50f2-4c36-a899-7b4db240f8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ab45f21d-6b74-4141-bf83-47e3f3c3de71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_51ef5082-50f2-4c36-a899-7b4db240f8a5" xlink:to="loc_us-gaap_DebtInstrumentTable_ab45f21d-6b74-4141-bf83-47e3f3c3de71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ee327ff3-d243-4d7c-85cb-e357c4bee863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab45f21d-6b74-4141-bf83-47e3f3c3de71" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ee327ff3-d243-4d7c-85cb-e357c4bee863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6cdb14e5-b116-4bbf-9ca0-7e8f81e62fd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ee327ff3-d243-4d7c-85cb-e357c4bee863" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6cdb14e5-b116-4bbf-9ca0-7e8f81e62fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_27b279ea-6aee-4e33-b632-057512c3187c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6cdb14e5-b116-4bbf-9ca0-7e8f81e62fd4" xlink:to="loc_us-gaap_ConvertibleDebtMember_27b279ea-6aee-4e33-b632-057512c3187c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_88d5469c-e489-4b8e-94de-c39e202f6b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6cdb14e5-b116-4bbf-9ca0-7e8f81e62fd4" xlink:to="loc_us-gaap_LineOfCreditMember_88d5469c-e489-4b8e-94de-c39e202f6b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_fef3a251-b276-4c0d-8a01-f14a14ffcebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6cdb14e5-b116-4bbf-9ca0-7e8f81e62fd4" xlink:to="loc_us-gaap_SeniorNotesMember_fef3a251-b276-4c0d-8a01-f14a14ffcebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9fbe00f2-68a4-4cf9-9d56-d146e3f00235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab45f21d-6b74-4141-bf83-47e3f3c3de71" xlink:to="loc_us-gaap_DebtInstrumentAxis_9fbe00f2-68a4-4cf9-9d56-d146e3f00235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9fbe00f2-68a4-4cf9-9d56-d146e3f00235" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020Member_3d61b8e0-ccc2-4a6c-95db-bf564fac4c51" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_CashConvertibleSeniorNotesDue2020Member_3d61b8e0-ccc2-4a6c-95db-bf564fac4c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_TermLoanMember_a78a5091-ae70-4218-9ea9-48ae5fcb6eec" xlink:href="moh-20201231.xsd#moh_TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_TermLoanMember_a78a5091-ae70-4218-9ea9-48ae5fcb6eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4375SeniorNotesMember_547f0cff-a065-40f3-b6f8-9348e6d5aa98" xlink:href="moh-20201231.xsd#moh_A4375SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_A4375SeniorNotesMember_547f0cff-a065-40f3-b6f8-9348e6d5aa98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SeniorNotesDue2022Member_cf72b26c-6b56-4b1c-aeb3-42be52fadffb" xlink:href="moh-20201231.xsd#moh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_SeniorNotesDue2022Member_cf72b26c-6b56-4b1c-aeb3-42be52fadffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_1cc063db-8897-4e20-a641-e92286de8ac7" xlink:href="moh-20201231.xsd#moh_ThreePointEightSevenFivePercentSeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_1cc063db-8897-4e20-a641-e92286de8ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4.875SeniorNotesMember_983957ba-4032-426f-b516-93fd1bb3a752" xlink:href="moh-20201231.xsd#moh_A4.875SeniorNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_28c3a9ad-3401-4cb2-94eb-ed5aa1b32ba6" xlink:to="loc_moh_A4.875SeniorNotesMember_983957ba-4032-426f-b516-93fd1bb3a752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab45f21d-6b74-4141-bf83-47e3f3c3de71" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_38a10b9a-491d-471f-9466-6bdc76ad5f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_38a10b9a-491d-471f-9466-6bdc76ad5f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_ce2d3d76-206f-403b-93e3-7710ce8d1a9b" xlink:href="moh-20201231.xsd#moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_ce2d3d76-206f-403b-93e3-7710ce8d1a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5942c323-1416-4d93-8bd8-f8bc8609ca40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_us-gaap_LongTermDebtCurrent_5942c323-1416-4d93-8bd8-f8bc8609ca40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount_00ca4983-0397-4e50-b885-c224f28c89e2" xlink:href="moh-20201231.xsd#moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount_00ca4983-0397-4e50-b885-c224f28c89e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_53ac49bd-1d7e-405c-94ea-b4c69722b091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_53ac49bd-1d7e-405c-94ea-b4c69722b091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ca8a2374-4412-4d56-b168-3cc84a9d56bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dcd6fa0-1642-4c92-98d8-0557aede822e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ca8a2374-4412-4d56-b168-3cc84a9d56bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtCreditAgreementDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/DebtCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a5d73917-50cc-4520-a540-df2327482ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a5d73917-50cc-4520-a540-df2327482ca5" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_464dba79-f18a-4ea6-87e0-76a9e7df2540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_464dba79-f18a-4ea6-87e0-76a9e7df2540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0298dc94-9cf5-4f66-a26a-14e1c7cc8543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_464dba79-f18a-4ea6-87e0-76a9e7df2540" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0298dc94-9cf5-4f66-a26a-14e1c7cc8543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_46000865-ae28-4940-94da-5b68fb09a1b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0298dc94-9cf5-4f66-a26a-14e1c7cc8543" xlink:to="loc_us-gaap_LineOfCreditMember_46000865-ae28-4940-94da-5b68fb09a1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_601a3f7e-3c0a-4ce6-8540-3c28e039005d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:to="loc_us-gaap_CreditFacilityAxis_601a3f7e-3c0a-4ce6-8540-3c28e039005d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5048223c-e577-4693-abf5-494c6c0d2cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_601a3f7e-3c0a-4ce6-8540-3c28e039005d" xlink:to="loc_us-gaap_CreditFacilityDomain_5048223c-e577-4693-abf5-494c6c0d2cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_878ec2ae-f264-4bcb-952c-01708d2aed96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5048223c-e577-4693-abf5-494c6c0d2cf4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_878ec2ae-f264-4bcb-952c-01708d2aed96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SwinglineSubFacilityMember_a16e974d-32e2-4a3f-be9c-669cc6b74c8c" xlink:href="moh-20201231.xsd#moh_SwinglineSubFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5048223c-e577-4693-abf5-494c6c0d2cf4" xlink:to="loc_moh_SwinglineSubFacilityMember_a16e974d-32e2-4a3f-be9c-669cc6b74c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LetterOfCreditSubFacilityMember_da4fa43a-9d01-4cbf-8601-b4913efca982" xlink:href="moh-20201231.xsd#moh_LetterOfCreditSubFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5048223c-e577-4693-abf5-494c6c0d2cf4" xlink:to="loc_moh_LetterOfCreditSubFacilityMember_da4fa43a-9d01-4cbf-8601-b4913efca982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4352d2e8-8c37-4025-a885-e050b20dbc4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:to="loc_us-gaap_DebtInstrumentAxis_4352d2e8-8c37-4025-a885-e050b20dbc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b5d69841-e081-4c35-b230-9fb9563491ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4352d2e8-8c37-4025-a885-e050b20dbc4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b5d69841-e081-4c35-b230-9fb9563491ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncrementalTermLoanMember_ed30411b-4e26-4c77-81fd-44f648e00157" xlink:href="moh-20201231.xsd#moh_IncrementalTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b5d69841-e081-4c35-b230-9fb9563491ec" xlink:to="loc_moh_IncrementalTermLoanMember_ed30411b-4e26-4c77-81fd-44f648e00157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ab30946e-7779-4851-bc0b-39d4c982b2dd" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f64f1965-9128-46d5-8ab0-6990b93f8d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f64f1965-9128-46d5-8ab0-6990b93f8d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4e1a3dfb-65cb-460a-afce-acf2f0c7dc17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4e1a3dfb-65cb-460a-afce-acf2f0c7dc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ConsolidatedNetLeverage_086b5e03-5a48-4bd4-b36f-299a17b60697" xlink:href="moh-20201231.xsd#moh_ConsolidatedNetLeverage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_moh_ConsolidatedNetLeverage_086b5e03-5a48-4bd4-b36f-299a17b60697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_d30668c7-5b46-4d1f-97de-9e6e608d9fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_us-gaap_DebtInstrumentTerm_d30668c7-5b46-4d1f-97de-9e6e608d9fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b9f6c64b-3336-4b26-b8cc-9ec8308f2de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_456e40a5-cea8-45b6-97d2-bde1206aab1e" xlink:to="loc_us-gaap_LineOfCredit_b9f6c64b-3336-4b26-b8cc-9ec8308f2de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtSeniorNotesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/DebtSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0f3ffb83-5962-4dd4-9607-22bd596fc4e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_32c6e47f-37af-4d99-8746-1eae6cc04628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0f3ffb83-5962-4dd4-9607-22bd596fc4e5" xlink:to="loc_us-gaap_DebtInstrumentTable_32c6e47f-37af-4d99-8746-1eae6cc04628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_130e30c7-8031-4701-a138-b9cc289e7f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_32c6e47f-37af-4d99-8746-1eae6cc04628" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_130e30c7-8031-4701-a138-b9cc289e7f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2fb3419e-1b15-4301-8a0a-5e4c1382122e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_130e30c7-8031-4701-a138-b9cc289e7f62" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2fb3419e-1b15-4301-8a0a-5e4c1382122e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_fb8afbc8-01c5-4ca1-a542-ae4481b1a472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2fb3419e-1b15-4301-8a0a-5e4c1382122e" xlink:to="loc_us-gaap_SeniorNotesMember_fb8afbc8-01c5-4ca1-a542-ae4481b1a472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_77efa3b5-d5cb-4fe5-812e-41129de6d13d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2fb3419e-1b15-4301-8a0a-5e4c1382122e" xlink:to="loc_us-gaap_ConvertibleDebtMember_77efa3b5-d5cb-4fe5-812e-41129de6d13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7078c864-1fba-4b04-8231-c95f9fe18c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_32c6e47f-37af-4d99-8746-1eae6cc04628" xlink:to="loc_us-gaap_DebtInstrumentAxis_7078c864-1fba-4b04-8231-c95f9fe18c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7078c864-1fba-4b04-8231-c95f9fe18c67" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4375SeniorNotesMember_589a5552-d9e4-49af-a28d-3ffed334a0b6" xlink:href="moh-20201231.xsd#moh_A4375SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:to="loc_moh_A4375SeniorNotesMember_589a5552-d9e4-49af-a28d-3ffed334a0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_SeniorNotesDue2022Member_3ee80152-77b0-40f6-bc01-08e2770d92ff" xlink:href="moh-20201231.xsd#moh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:to="loc_moh_SeniorNotesDue2022Member_3ee80152-77b0-40f6-bc01-08e2770d92ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_c53dc246-bbed-4842-a984-ff080afef41b" xlink:href="moh-20201231.xsd#moh_ThreePointEightSevenFivePercentSeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:to="loc_moh_ThreePointEightSevenFivePercentSeniorNotesMember_c53dc246-bbed-4842-a984-ff080afef41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_A4.875SeniorNotesMember_0f81d204-803a-47b4-9d95-7fc90a3d142d" xlink:href="moh-20201231.xsd#moh_A4.875SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_37b5f34d-1b89-490e-96a4-b7c9181bbd9c" xlink:to="loc_moh_A4.875SeniorNotesMember_0f81d204-803a-47b4-9d95-7fc90a3d142d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_32c6e47f-37af-4d99-8746-1eae6cc04628" xlink:to="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ed1cacaa-07a5-4408-b62a-18fbfcc123ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ed1cacaa-07a5-4408-b62a-18fbfcc123ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2d5ce594-1086-42c1-bdc9-6c115645e2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2d5ce594-1086-42c1-bdc9-6c115645e2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_8914373e-162d-46bb-a25a-c996a7e893c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_8914373e-162d-46bb-a25a-c996a7e893c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7792b6ed-8f72-4778-9bcc-c2c271133430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7792b6ed-8f72-4778-9bcc-c2c271133430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_455d47d5-d709-493b-9f68-dc7de53908f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_455d47d5-d709-493b-9f68-dc7de53908f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RedemptionPremiumSettledPercentage_c546df51-2e6e-42ad-ab67-f0867b8ceff4" xlink:href="moh-20201231.xsd#moh_RedemptionPremiumSettledPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_moh_RedemptionPremiumSettledPercentage_c546df51-2e6e-42ad-ab67-f0867b8ceff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositLiabilitiesAccruedInterest_cbb857c1-a67d-4cf9-a1c1-15c70e6b38c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_DepositLiabilitiesAccruedInterest_cbb857c1-a67d-4cf9-a1c1-15c70e6b38c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_e20fd350-c5ab-4508-9359-0fb7a0deac57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40f290a2-a87d-4cbd-8a8b-15c4ff653df6" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_e20fd350-c5ab-4508-9359-0fb7a0deac57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#DebtConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1eac5211-fc97-45ea-b906-433ebc96fab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e27c422b-bcf1-465d-83ec-49cfec7fb495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1eac5211-fc97-45ea-b906-433ebc96fab3" xlink:to="loc_us-gaap_DebtInstrumentTable_e27c422b-bcf1-465d-83ec-49cfec7fb495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5ed9a29c-43e5-4288-a3ab-755a3531bf5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e27c422b-bcf1-465d-83ec-49cfec7fb495" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5ed9a29c-43e5-4288-a3ab-755a3531bf5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4f2c4506-00b1-4053-869c-97cef27be77d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5ed9a29c-43e5-4288-a3ab-755a3531bf5f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4f2c4506-00b1-4053-869c-97cef27be77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_4fe8f664-69b8-4000-9d45-be0bf640ed36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4f2c4506-00b1-4053-869c-97cef27be77d" xlink:to="loc_us-gaap_ConvertibleDebtMember_4fe8f664-69b8-4000-9d45-be0bf640ed36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a6cabfe5-4b63-4033-803f-a9d6021e10a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e27c422b-bcf1-465d-83ec-49cfec7fb495" xlink:to="loc_us-gaap_DebtInstrumentAxis_a6cabfe5-4b63-4033-803f-a9d6021e10a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_107f1c3e-d8b1-4991-b710-d733056695ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a6cabfe5-4b63-4033-803f-a9d6021e10a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_107f1c3e-d8b1-4991-b710-d733056695ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020Member_1017739b-1c59-401c-8110-9b1217053031" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_107f1c3e-d8b1-4991-b710-d733056695ff" xlink:to="loc_moh_CashConvertibleSeniorNotesDue2020Member_1017739b-1c59-401c-8110-9b1217053031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e27c422b-bcf1-465d-83ec-49cfec7fb495" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0db0cf32-f077-424e-9384-536724f95e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0db0cf32-f077-424e-9384-536724f95e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_4784f8f5-c59f-4116-90f8-daf3a0b0c0d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_us-gaap_RepaymentsOfDebt_4784f8f5-c59f-4116-90f8-daf3a0b0c0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_7807b976-2cf0-453c-8d9d-812eb1e681f8" xlink:href="moh-20201231.xsd#moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount_7807b976-2cf0-453c-8d9d-812eb1e681f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_GainLossOnDebtRepayment_cc041b9e-0583-4924-b9d3-76ee3777bfb5" xlink:href="moh-20201231.xsd#moh_GainLossOnDebtRepayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_moh_GainLossOnDebtRepayment_cc041b9e-0583-4924-b9d3-76ee3777bfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_56550e34-d7d7-4a96-8586-13ea0c8f2478" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6d48b35f-bc1d-46df-87fc-058c5db3df29" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_56550e34-d7d7-4a96-8586-13ea0c8f2478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxes" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5bb5995a-fffe-48d6-9469-80f736073b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_2ec1ce53-dd85-44f9-9afa-248f2011b847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5bb5995a-fffe-48d6-9469-80f736073b0d" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_2ec1ce53-dd85-44f9-9afa-248f2011b847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_49594eb5-c8ca-49f8-8945-429f9adeac24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_b96a32fd-3b07-4eb2-88eb-3823e75bd190" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_49594eb5-c8ca-49f8-8945-429f9adeac24" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_b96a32fd-3b07-4eb2-88eb-3823e75bd190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_cf939bc1-bd73-48b8-a297-02122eb2093d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_49594eb5-c8ca-49f8-8945-429f9adeac24" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_cf939bc1-bd73-48b8-a297-02122eb2093d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9b95eea5-9360-490a-b5e8-bf7a26d2fbd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_49594eb5-c8ca-49f8-8945-429f9adeac24" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9b95eea5-9360-490a-b5e8-bf7a26d2fbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_bbe370c1-72ff-4fab-ae1a-56f7fe9d5d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_49594eb5-c8ca-49f8-8945-429f9adeac24" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_bbe370c1-72ff-4fab-ae1a-56f7fe9d5d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_358e5501-2b21-4d49-9d2f-9747b6568f2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_7342819d-6880-4739-9903-2385e7a22d76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_358e5501-2b21-4d49-9d2f-9747b6568f2a" xlink:to="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_7342819d-6880-4739-9903-2385e7a22d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_51a787fd-cfe9-494f-ac60-9db0fbc518fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_7342819d-6880-4739-9903-2385e7a22d76" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_51a787fd-cfe9-494f-ac60-9db0fbc518fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d1e839e0-b175-42e3-89cf-4f490fd448e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_51a787fd-cfe9-494f-ac60-9db0fbc518fd" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d1e839e0-b175-42e3-89cf-4f490fd448e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_42ee1003-3e2e-4d26-bc01-2a75201cf083" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_51a787fd-cfe9-494f-ac60-9db0fbc518fd" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_42ee1003-3e2e-4d26-bc01-2a75201cf083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e6ce2790-d3ca-4d31-8cbc-d06f8d78075f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_51a787fd-cfe9-494f-ac60-9db0fbc518fd" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e6ce2790-d3ca-4d31-8cbc-d06f8d78075f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7913eb77-475e-4aca-90fa-339c102837c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_51a787fd-cfe9-494f-ac60-9db0fbc518fd" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7913eb77-475e-4aca-90fa-339c102837c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8fcbf112-938a-45e2-97b5-3babc216fed8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_7342819d-6880-4739-9903-2385e7a22d76" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8fcbf112-938a-45e2-97b5-3babc216fed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_cbef3511-f1b9-4ede-aa31-53e905dc52f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8fcbf112-938a-45e2-97b5-3babc216fed8" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_cbef3511-f1b9-4ede-aa31-53e905dc52f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63c938d8-9559-4018-8b74-5c5ff91f98fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8fcbf112-938a-45e2-97b5-3babc216fed8" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63c938d8-9559-4018-8b74-5c5ff91f98fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_bfcdbcf1-9196-46f4-8abb-142993275be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8fcbf112-938a-45e2-97b5-3babc216fed8" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_bfcdbcf1-9196-46f4-8abb-142993275be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_54c6030b-3617-4abe-a31f-2875f4e869e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8fcbf112-938a-45e2-97b5-3babc216fed8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_54c6030b-3617-4abe-a31f-2875f4e869e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_514e4cb7-758e-4085-85bd-70820ca5e85f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_7342819d-6880-4739-9903-2385e7a22d76" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_514e4cb7-758e-4085-85bd-70820ca5e85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8f6958be-20b4-43c7-9e7d-364d6fded5a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ee452f39-5703-49af-af1f-f05ce8923cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8f6958be-20b4-43c7-9e7d-364d6fded5a6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ee452f39-5703-49af-af1f-f05ce8923cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d924c31d-115c-4adc-8b4e-6f40d47a63ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8f6958be-20b4-43c7-9e7d-364d6fded5a6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d924c31d-115c-4adc-8b4e-6f40d47a63ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent_0f4f0743-c24f-431e-9372-4f2e89394387" xlink:href="moh-20201231.xsd#moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8f6958be-20b4-43c7-9e7d-364d6fded5a6" xlink:to="loc_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent_0f4f0743-c24f-431e-9372-4f2e89394387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_d628b75c-db14-4a01-8e1f-8db1fecdcb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8f6958be-20b4-43c7-9e7d-364d6fded5a6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_d628b75c-db14-4a01-8e1f-8db1fecdcb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction_7107c1df-4b19-4958-bef7-fd37fff353d0" xlink:href="moh-20201231.xsd#moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8f6958be-20b4-43c7-9e7d-364d6fded5a6" xlink:to="loc_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction_7107c1df-4b19-4958-bef7-fd37fff353d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4e5c76e7-6967-49f7-91c5-058b416f70f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8f6958be-20b4-43c7-9e7d-364d6fded5a6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4e5c76e7-6967-49f7-91c5-058b416f70f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ab3e74a2-8e29-4bae-917b-744127da361b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8f6958be-20b4-43c7-9e7d-364d6fded5a6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ab3e74a2-8e29-4bae-917b-744127da361b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0abc3819-dbe4-4d9f-9cf4-701d507297b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0abc3819-dbe4-4d9f-9cf4-701d507297b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_99325140-79e5-4770-973a-5e62427f9c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_99325140-79e5-4770-973a-5e62427f9c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0cfbd582-460c-45c7-93de-91eb0bccee13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0cfbd582-460c-45c7-93de-91eb0bccee13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DeferredTaxAssetsFixedAssetsAndIntangibles_ead667fb-84cf-4c40-89a6-26bd87c5d4b8" xlink:href="moh-20201231.xsd#moh_DeferredTaxAssetsFixedAssetsAndIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_moh_DeferredTaxAssetsFixedAssetsAndIntangibles_ead667fb-84cf-4c40-89a6-26bd87c5d4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_c3ffc301-1406-49ce-a44e-74b7b22cfc22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_c3ffc301-1406-49ce-a44e-74b7b22cfc22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_3ec63b86-635b-4b23-8d87-fd3dc1d5b208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_3ec63b86-635b-4b23-8d87-fd3dc1d5b208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_900dc8c4-5aa2-410f-8f19-9644ce5d01a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_900dc8c4-5aa2-410f-8f19-9644ce5d01a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_abec3251-6883-44e8-b6a0-92212b8804a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_abec3251-6883-44e8-b6a0-92212b8804a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e5087d0a-9124-42e3-8c6f-e28f02496dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e5087d0a-9124-42e3-8c6f-e28f02496dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_34b3c836-fde5-40a2-9a58-35abfab1f3f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_34b3c836-fde5-40a2-9a58-35abfab1f3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles_7f3e75be-3a3b-4609-89f9-d89618b2c7b6" xlink:href="moh-20201231.xsd#moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles_7f3e75be-3a3b-4609-89f9-d89618b2c7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_6cfd7831-a2f9-4453-b42e-96976af4f855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_6cfd7831-a2f9-4453-b42e-96976af4f855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_bb25de54-8752-4c2b-8a7b-13781b241486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_bb25de54-8752-4c2b-8a7b-13781b241486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_200e9686-d0ba-489c-bba5-b80a2e508550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_200e9686-d0ba-489c-bba5-b80a2e508550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5944bbfe-3997-46f8-9dc9-5c764991d3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5944bbfe-3997-46f8-9dc9-5c764991d3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_0177d8ea-17b7-4fe2-971a-1d35de321635" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6cec583-9b67-443a-a202-4ab655407fc2" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_0177d8ea-17b7-4fe2-971a-1d35de321635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7afab207-c364-4cd4-9545-2703b4db0850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_c282c365-6bd7-40b5-84c1-1c4c231d480a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7afab207-c364-4cd4-9545-2703b4db0850" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_c282c365-6bd7-40b5-84c1-1c4c231d480a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_fd207f73-2bb1-4bc4-b5b8-cdf4925c724e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_c282c365-6bd7-40b5-84c1-1c4c231d480a" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_fd207f73-2bb1-4bc4-b5b8-cdf4925c724e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_29f2c85f-d362-45f0-a017-cce5cfc4a7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_fd207f73-2bb1-4bc4-b5b8-cdf4925c724e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_29f2c85f-d362-45f0-a017-cce5cfc4a7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_b6c7700b-f784-4665-98d4-00f6a7619b62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_29f2c85f-d362-45f0-a017-cce5cfc4a7c4" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_b6c7700b-f784-4665-98d4-00f6a7619b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_f0c900b5-9b76-4dae-b33b-25eeedaaad8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_29f2c85f-d362-45f0-a017-cce5cfc4a7c4" xlink:to="loc_us-gaap_ForeignCountryMember_f0c900b5-9b76-4dae-b33b-25eeedaaad8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_c282c365-6bd7-40b5-84c1-1c4c231d480a" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_10d7a43f-2572-4cd9-b89b-00a5260efbb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_10d7a43f-2572-4cd9-b89b-00a5260efbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_102a2d36-fd63-44f2-ab22-2da24ef10b5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_102a2d36-fd63-44f2-ab22-2da24ef10b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_18f89db5-c121-40f2-89da-acf60e258efa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_18f89db5-c121-40f2-89da-acf60e258efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_73d9f724-3e6f-4df2-b494-b155c14c3828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_73d9f724-3e6f-4df2-b494-b155c14c3828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d29be9fe-6331-4862-8e95-ce501452fac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d29be9fe-6331-4862-8e95-ce501452fac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_bd2f85d4-7802-4667-9376-8c6aa5ed54f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_bd2f85d4-7802-4667-9376-8c6aa5ed54f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d8b2486a-16e5-4787-ac60-560c38055270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b063d110-21f2-4ce5-942f-20ac1488418c" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d8b2486a-16e5-4787-ac60-560c38055270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_363a7382-25f5-456e-8877-d952d00cc181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_ba13be83-a07b-49e5-927a-f06f694ccb98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_363a7382-25f5-456e-8877-d952d00cc181" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_ba13be83-a07b-49e5-927a-f06f694ccb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_22b1ef2a-0698-4e04-aa06-8aecb1c52d1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_ba13be83-a07b-49e5-927a-f06f694ccb98" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_22b1ef2a-0698-4e04-aa06-8aecb1c52d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_851619e3-a999-418f-a6fb-2572c6c9f589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_ba13be83-a07b-49e5-927a-f06f694ccb98" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_851619e3-a999-418f-a6fb-2572c6c9f589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3e2334b6-a8ec-46ab-a367-41abb4e46fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_ba13be83-a07b-49e5-927a-f06f694ccb98" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3e2334b6-a8ec-46ab-a367-41abb4e46fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_c3363c3f-f5fb-4d0d-b0f3-afd6f305743e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_ba13be83-a07b-49e5-927a-f06f694ccb98" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_c3363c3f-f5fb-4d0d-b0f3-afd6f305743e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquity" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b8640bd2-a4a0-4e2f-a8c2-784d73c8604f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fe2c42b0-0084-4691-97eb-bfeb054897ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b8640bd2-a4a0-4e2f-a8c2-784d73c8604f" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fe2c42b0-0084-4691-97eb-bfeb054897ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_737e9a9a-853c-4f34-8769-2a7c7aeaeb2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_d2dfa68c-9853-4920-be42-3ae4a192d743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_737e9a9a-853c-4f34-8769-2a7c7aeaeb2b" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_d2dfa68c-9853-4920-be42-3ae4a192d743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_9ba1efd7-9d76-4d56-bec7-7a9a0b9b144f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_737e9a9a-853c-4f34-8769-2a7c7aeaeb2b" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_9ba1efd7-9d76-4d56-bec7-7a9a0b9b144f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_330f9509-a130-4adf-bfc0-716e9ab1f059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_737e9a9a-853c-4f34-8769-2a7c7aeaeb2b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_330f9509-a130-4adf-bfc0-716e9ab1f059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_37f3b2d2-f791-4cd2-ba2d-f83a4c993099" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_737e9a9a-853c-4f34-8769-2a7c7aeaeb2b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_37f3b2d2-f791-4cd2-ba2d-f83a4c993099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f93fee39-82e1-414c-b4b1-49d0e4ac1fa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f93fee39-82e1-414c-b4b1-49d0e4ac1fa6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1338ab82-5efd-438c-a131-b309468ef71d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1338ab82-5efd-438c-a131-b309468ef71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d6fe6db8-1b6d-4979-b0f4-47c256d011b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1338ab82-5efd-438c-a131-b309468ef71d" xlink:to="loc_us-gaap_EquityComponentDomain_d6fe6db8-1b6d-4979-b0f4-47c256d011b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_51d09fe5-e9a9-40c9-9df3-23b5b0731ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d6fe6db8-1b6d-4979-b0f4-47c256d011b7" xlink:to="loc_us-gaap_CommonStockMember_51d09fe5-e9a9-40c9-9df3-23b5b0731ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6e379d7d-9736-4dad-80b9-003255b4668c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6e379d7d-9736-4dad-80b9-003255b4668c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5f67a1f3-7563-4470-a7a6-ba578a83769e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6e379d7d-9736-4dad-80b9-003255b4668c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5f67a1f3-7563-4470-a7a6-ba578a83769e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6cc8f9c5-532e-4620-b0e2-6e8f788be3e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5f67a1f3-7563-4470-a7a6-ba578a83769e" xlink:to="loc_us-gaap_SubsequentEventMember_6cc8f9c5-532e-4620-b0e2-6e8f788be3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_9570164f-f472-4a42-9d66-663a5fb40f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_9570164f-f472-4a42-9d66-663a5fb40f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a7f21d7c-a9be-48e3-94f2-ed280fba1e6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_9570164f-f472-4a42-9d66-663a5fb40f22" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a7f21d7c-a9be-48e3-94f2-ed280fba1e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashConvertibleSeniorNotesDue2020WarrantsMember_a4aec248-fc6c-4706-b35c-e8fd3ec50f3d" xlink:href="moh-20201231.xsd#moh_CashConvertibleSeniorNotesDue2020WarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a7f21d7c-a9be-48e3-94f2-ed280fba1e6e" xlink:to="loc_moh_CashConvertibleSeniorNotesDue2020WarrantsMember_a4aec248-fc6c-4706-b35c-e8fd3ec50f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c750c694-fb91-431b-9ce9-edc908103d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_PlanNameAxis_c750c694-fb91-431b-9ce9-edc908103d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_577a2830-faa6-4924-aafa-faa1ea79c9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_c750c694-fb91-431b-9ce9-edc908103d57" xlink:to="loc_us-gaap_PlanNameDomain_577a2830-faa6-4924-aafa-faa1ea79c9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EquityIncentivePlanMember_7c5cadcc-46bd-4ee4-a67e-4e725a2f1873" xlink:href="moh-20201231.xsd#moh_EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_577a2830-faa6-4924-aafa-faa1ea79c9a0" xlink:to="loc_moh_EquityIncentivePlanMember_7c5cadcc-46bd-4ee4-a67e-4e725a2f1873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e61d796f-b6fb-45d2-92ea-967e14a8353a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_AwardTypeAxis_e61d796f-b6fb-45d2-92ea-967e14a8353a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e61d796f-b6fb-45d2-92ea-967e14a8353a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b13ea2df-f769-46fe-94ee-80d5b0c4236e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:to="loc_us-gaap_RestrictedStockMember_b13ea2df-f769-46fe-94ee-80d5b0c4236e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_328e92af-a11c-4995-b12b-7ff7bd8187ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_328e92af-a11c-4995-b12b-7ff7bd8187ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1b84f073-39fa-4356-9c34-a185311dc79b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1b84f073-39fa-4356-9c34-a185311dc79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_20b13c06-8998-4ef5-994b-48d0b694551b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11b0d35a-7dfc-49b0-8775-1ac0ce593d35" xlink:to="loc_us-gaap_EmployeeStockMember_20b13c06-8998-4ef5-994b-48d0b694551b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b4313a9-efec-40b7-baaa-f5e6d4fb15bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be24526c-2bac-4794-8242-1b52c558a897" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be24526c-2bac-4794-8242-1b52c558a897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_9ea4b97c-8172-4467-97d9-931b1ba46f81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_9ea4b97c-8172-4467-97d9-931b1ba46f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_7ac712a0-4a3a-432b-a861-7c58d1b66096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_7ac712a0-4a3a-432b-a861-7c58d1b66096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6aaae793-da75-4fbf-afd3-055521accffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6aaae793-da75-4fbf-afd3-055521accffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_993e85c0-d34e-4ad9-9829-6757079ea6c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_993e85c0-d34e-4ad9-9829-6757079ea6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ClassOfWarrantOrRightStatedInterestRate_3ee19dee-9449-4c13-8c93-cf45dc5912ea" xlink:href="moh-20201231.xsd#moh_ClassOfWarrantOrRightStatedInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_moh_ClassOfWarrantOrRightStatedInterestRate_3ee19dee-9449-4c13-8c93-cf45dc5912ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_a4f62945-0730-4057-969c-8b569e98c76c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_a4f62945-0730-4057-969c-8b569e98c76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants_e92d44b3-ba8f-4e35-a24a-4454c5cbd3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfWarrants_e92d44b3-ba8f-4e35-a24a-4454c5cbd3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ClassOfWarrantOrRightStatedInterestRate_2ce51a47-ba39-4575-b345-1f999f9602a7" xlink:href="moh-20201231.xsd#moh_ClassOfWarrantOrRightStatedInterestRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_moh_ClassOfWarrantOrRightStatedInterestRate_2ce51a47-ba39-4575-b345-1f999f9602a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_58ec11c9-b3d2-4650-9899-952b91a65fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_58ec11c9-b3d2-4650-9899-952b91a65fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_876661ca-76c0-46cf-9225-dadc477ee891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_876661ca-76c0-46cf-9225-dadc477ee891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dd8bd545-d41b-48a4-8ebb-271c020f7884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dd8bd545-d41b-48a4-8ebb-271c020f7884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a4b3449c-473d-4268-81a7-b35e4023f44d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a4b3449c-473d-4268-81a7-b35e4023f44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b57456b7-f97f-43ee-a09d-c0d668d2b1ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b57456b7-f97f-43ee-a09d-c0d668d2b1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_UnrecognizedCompensationForfeitedRate_4097376f-0920-4adb-bafe-7348e3a85ef6" xlink:href="moh-20201231.xsd#moh_UnrecognizedCompensationForfeitedRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_moh_UnrecognizedCompensationForfeitedRate_4097376f-0920-4adb-bafe-7348e3a85ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_312998dc-b34b-414c-8c5e-95dc2289cc9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_312998dc-b34b-414c-8c5e-95dc2289cc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_031bb3a5-cee9-4411-9955-3b6ff30031e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_031bb3a5-cee9-4411-9955-3b6ff30031e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_FairMarketValueOfCommonStockPercentage_0bc08553-7e24-4ad4-9c90-d8acc2a086da" xlink:href="moh-20201231.xsd#moh_FairMarketValueOfCommonStockPercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_moh_FairMarketValueOfCommonStockPercentage_0bc08553-7e24-4ad4-9c90-d8acc2a086da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee_0ae87406-9f65-4a84-ae9d-c184a14227e0" xlink:href="moh-20201231.xsd#moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee_0ae87406-9f65-4a84-ae9d-c184a14227e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1fecea80-f650-44f6-b542-7b6196e7e6f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1fecea80-f650-44f6-b542-7b6196e7e6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1ebcb33a-e506-4daf-b4b6-47a18a113e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1ebcb33a-e506-4daf-b4b6-47a18a113e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_408d53d0-1728-402e-800f-1629bda0ac12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_408d53d0-1728-402e-800f-1629bda0ac12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_5539ddf5-2da5-415e-89f7-4f34f232abef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_5539ddf5-2da5-415e-89f7-4f34f232abef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_34fd5545-63ae-43a8-b65c-55433cdd716b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_34fd5545-63ae-43a8-b65c-55433cdd716b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_17dc8e72-81ba-46cd-a260-b4c802d60cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_17dc8e72-81ba-46cd-a260-b4c802d60cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_60cba121-206e-4ca7-845d-72e4dd90f7db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28da6e7c-c09e-4ed1-a543-6f54f11a8c9e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_60cba121-206e-4ca7-845d-72e4dd90f7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityComponentsofSharebasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_466215bd-06d4-46e3-b77a-637e65ccdc2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85700add-96fb-446d-83d5-5edfc9a7fd77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_466215bd-06d4-46e3-b77a-637e65ccdc2e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85700add-96fb-446d-83d5-5edfc9a7fd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_91372829-73e0-4e31-ac27-266d33828f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85700add-96fb-446d-83d5-5edfc9a7fd77" xlink:to="loc_us-gaap_AwardTypeAxis_91372829-73e0-4e31-ac27-266d33828f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e5e07493-109d-4017-8ef8-dc93948e4baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_91372829-73e0-4e31-ac27-266d33828f21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e5e07493-109d-4017-8ef8-dc93948e4baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_RestrictedandPerformanceStockMember_5849ff30-0238-405a-980a-6c8d7d0e2ddc" xlink:href="moh-20201231.xsd#moh_RestrictedandPerformanceStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e5e07493-109d-4017-8ef8-dc93948e4baf" xlink:to="loc_moh_RestrictedandPerformanceStockMember_5849ff30-0238-405a-980a-6c8d7d0e2ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_EmployeeStockPurchasePlanandStockOptionsMember_bfa1cd86-93b8-4d55-b77c-eb3073386b79" xlink:href="moh-20201231.xsd#moh_EmployeeStockPurchasePlanandStockOptionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e5e07493-109d-4017-8ef8-dc93948e4baf" xlink:to="loc_moh_EmployeeStockPurchasePlanandStockOptionsMember_bfa1cd86-93b8-4d55-b77c-eb3073386b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6b015d83-26ad-42fe-af3d-c88d6ac28914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85700add-96fb-446d-83d5-5edfc9a7fd77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6b015d83-26ad-42fe-af3d-c88d6ac28914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_89efc044-b723-4ea1-b66a-e5c56b0baa7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6b015d83-26ad-42fe-af3d-c88d6ac28914" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_89efc044-b723-4ea1-b66a-e5c56b0baa7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ece46e42-6b65-4315-b1c1-31b062208a92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6b015d83-26ad-42fe-af3d-c88d6ac28914" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ece46e42-6b65-4315-b1c1-31b062208a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityRestrictedandPerformanceStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3bffaf31-c36a-4bf5-92b4-722a67f619ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_053ae052-f2a1-4e2a-bb08-17f04f1707bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3bffaf31-c36a-4bf5-92b4-722a67f619ab" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_053ae052-f2a1-4e2a-bb08-17f04f1707bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_24346a2b-2d69-48e7-9f81-e9523093caeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_053ae052-f2a1-4e2a-bb08-17f04f1707bd" xlink:to="loc_us-gaap_AwardTypeAxis_24346a2b-2d69-48e7-9f81-e9523093caeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f3d46e6-7ad5-4d74-88d2-90c78e600fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_24346a2b-2d69-48e7-9f81-e9523093caeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f3d46e6-7ad5-4d74-88d2-90c78e600fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6012ff2f-1071-44b1-bffe-d6dd3f798fa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f3d46e6-7ad5-4d74-88d2-90c78e600fa9" xlink:to="loc_us-gaap_RestrictedStockMember_6012ff2f-1071-44b1-bffe-d6dd3f798fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_27d1c884-d3a3-40dc-8e2d-6cc8b816c37b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f3d46e6-7ad5-4d74-88d2-90c78e600fa9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_27d1c884-d3a3-40dc-8e2d-6cc8b816c37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_55bc2806-3b74-43d7-88a2-0b7142d0315c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_053ae052-f2a1-4e2a-bb08-17f04f1707bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_55bc2806-3b74-43d7-88a2-0b7142d0315c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_55bc2806-3b74-43d7-88a2-0b7142d0315c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0072f850-3d1b-454a-99c3-07222cafb748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0072f850-3d1b-454a-99c3-07222cafb748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9c29ef24-98ff-467b-88e4-db56a3baab4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9c29ef24-98ff-467b-88e4-db56a3baab4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_42eed57e-a605-4d7f-ac78-eef799781211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_42eed57e-a605-4d7f-ac78-eef799781211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_014b9deb-67f6-47fb-86e6-09aa21832baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_014b9deb-67f6-47fb-86e6-09aa21832baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_90e1a6f4-1739-4060-acb1-057c2960a051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a35d2c59-39ae-4e6b-8696-17441d2011ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_90e1a6f4-1739-4060-acb1-057c2960a051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_55bc2806-3b74-43d7-88a2-0b7142d0315c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_97296e0e-2f63-4ff4-aabf-523ec3d43173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_97296e0e-2f63-4ff4-aabf-523ec3d43173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cc42bf24-b9c9-4b44-949a-d7f461478661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cc42bf24-b9c9-4b44-949a-d7f461478661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7f432661-cc44-4666-a9f3-6c762daea23c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7f432661-cc44-4666-a9f3-6c762daea23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2bd275f5-1ead-4007-9e80-e88b70a0fa18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2bd275f5-1ead-4007-9e80-e88b70a0fa18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2ee8a1a4-f602-42db-9500-636dfeb6dd39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebb09b1c-0766-47b3-9ee7-01d81a501a53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2ee8a1a4-f602-42db-9500-636dfeb6dd39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityFairValueofAwardsGrantedandVestedDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_00fa53b8-6580-4c87-985a-38b062bde0ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ea1dfade-9e23-406c-88b3-fb0336c19048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_00fa53b8-6580-4c87-985a-38b062bde0ca" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ea1dfade-9e23-406c-88b3-fb0336c19048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9fdade61-36dd-4282-acdb-1c751f720488" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ea1dfade-9e23-406c-88b3-fb0336c19048" xlink:to="loc_us-gaap_AwardTypeAxis_9fdade61-36dd-4282-acdb-1c751f720488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48b5c7b1-a5bb-42ee-adb0-09669e51b925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9fdade61-36dd-4282-acdb-1c751f720488" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48b5c7b1-a5bb-42ee-adb0-09669e51b925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_66ccf5e3-bf99-4f27-915b-5d53990af494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48b5c7b1-a5bb-42ee-adb0-09669e51b925" xlink:to="loc_us-gaap_RestrictedStockMember_66ccf5e3-bf99-4f27-915b-5d53990af494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_edf17930-6205-404d-b1b7-9128a252544f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48b5c7b1-a5bb-42ee-adb0-09669e51b925" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_edf17930-6205-404d-b1b7-9128a252544f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_ca03276d-78b7-4f31-8924-d632fc92161b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48b5c7b1-a5bb-42ee-adb0-09669e51b925" xlink:to="loc_us-gaap_PerformanceSharesMember_ca03276d-78b7-4f31-8924-d632fc92161b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e277963-4e17-4ed2-b645-bc7e92946744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ea1dfade-9e23-406c-88b3-fb0336c19048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e277963-4e17-4ed2-b645-bc7e92946744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_b2679cfb-535d-4283-b65f-375d8dc5aa67" xlink:href="moh-20201231.xsd#moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e277963-4e17-4ed2-b645-bc7e92946744" xlink:to="loc_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_b2679cfb-535d-4283-b65f-375d8dc5aa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_92a257e6-eb64-40cd-8971-6b7ed530155b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e277963-4e17-4ed2-b645-bc7e92946744" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_92a257e6-eb64-40cd-8971-6b7ed530155b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_32aed67e-d1f3-4cf3-a287-d82c97749453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_32aed67e-d1f3-4cf3-a287-d82c97749453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dbc51268-297d-41be-9e0c-71b099874927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_32aed67e-d1f3-4cf3-a287-d82c97749453" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dbc51268-297d-41be-9e0c-71b099874927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bb3e3346-dd6b-46fd-88e7-4fb1a48e93e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_32aed67e-d1f3-4cf3-a287-d82c97749453" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bb3e3346-dd6b-46fd-88e7-4fb1a48e93e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1d82f6-3944-4f10-8807-f1504e01048f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1d82f6-3944-4f10-8807-f1504e01048f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0d810b10-5b9f-4d21-a3ac-fe8c23f7c3e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1d82f6-3944-4f10-8807-f1504e01048f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0d810b10-5b9f-4d21-a3ac-fe8c23f7c3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4add1be4-3827-423b-b739-b48e7919fa89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1d82f6-3944-4f10-8807-f1504e01048f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4add1be4-3827-423b-b739-b48e7919fa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_720b0c6b-6214-4768-9ec3-8fcaa1407ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_720b0c6b-6214-4768-9ec3-8fcaa1407ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5b00d690-da83-4df0-b60a-7385de1e33de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5b00d690-da83-4df0-b60a-7385de1e33de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_23a8b555-a923-4dd7-b3bd-f4baa8a2d519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_23a8b555-a923-4dd7-b3bd-f4baa8a2d519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e13c1b98-7cef-43f4-9f0c-05c09a52e58b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e13c1b98-7cef-43f4-9f0c-05c09a52e58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_f1e718b3-f5d8-458c-b262-52b99f5647f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_f1e718b3-f5d8-458c-b262-52b99f5647f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_311bb85f-5aae-4737-a663-bf3a19e79c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_311bb85f-5aae-4737-a663-bf3a19e79c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a653c556-b073-4469-b720-3e20268af829" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a653c556-b073-4469-b720-3e20268af829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9896f751-b07e-4af5-a3da-13cdfaade60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27f7eb31-8f44-4842-a7c0-6a84912063dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9896f751-b07e-4af5-a3da-13cdfaade60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#StockholdersEquityStockOptionsbyExercisePriceDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9fc19af0-b9ce-49e3-aa97-67e45376caec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4a861d2f-f404-440f-9c3f-f9d77076cdc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9fc19af0-b9ce-49e3-aa97-67e45376caec" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4a861d2f-f404-440f-9c3f-f9d77076cdc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a4e263ef-f5fb-4725-9cdc-c76cdb23b135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4a861d2f-f404-440f-9c3f-f9d77076cdc7" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a4e263ef-f5fb-4725-9cdc-c76cdb23b135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ca280e8b-0446-45b1-9657-17245ca72724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a4e263ef-f5fb-4725-9cdc-c76cdb23b135" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ca280e8b-0446-45b1-9657-17245ca72724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ExercisePriceRange1Member_a5d01195-a740-4454-92a1-fc6b6705f343" xlink:href="moh-20201231.xsd#moh_ExercisePriceRange1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ca280e8b-0446-45b1-9657-17245ca72724" xlink:to="loc_moh_ExercisePriceRange1Member_a5d01195-a740-4454-92a1-fc6b6705f343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ExercisePriceRange2Member_ee630069-262c-40ac-bca1-3c2e67e8bd28" xlink:href="moh-20201231.xsd#moh_ExercisePriceRange2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ca280e8b-0446-45b1-9657-17245ca72724" xlink:to="loc_moh_ExercisePriceRange2Member_ee630069-262c-40ac-bca1-3c2e67e8bd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4a861d2f-f404-440f-9c3f-f9d77076cdc7" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_d8334b8d-59da-450c-97dc-aef9b8196e7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_d8334b8d-59da-450c-97dc-aef9b8196e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_bc24526d-9e5d-4302-b41c-e3ac39228df5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_bc24526d-9e5d-4302-b41c-e3ac39228df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_725dac26-fe14-4eab-bfe9-a28f86570c8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_725dac26-fe14-4eab-bfe9-a28f86570c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_8b95bd6d-6d81-481b-a077-28321ada1145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_8b95bd6d-6d81-481b-a077-28321ada1145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1321ac94-04a4-44d4-8edd-94a8dddfc42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c7420a9b-1e74-4c57-b47b-f81d270238a5" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1321ac94-04a4-44d4-8edd-94a8dddfc42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="moh-20201231.xsd#EmployeeBenefitPlans"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/EmployeeBenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_82613bd0-75e6-4f85-9c3b-a5b5a17a329c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_96f38780-1d68-43ea-80f1-39be7ee5d76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_82613bd0-75e6-4f85-9c3b-a5b5a17a329c" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_96f38780-1d68-43ea-80f1-39be7ee5d76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#EmployeeBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_b374f677-ec41-4c90-b5f0-76885fb75beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_6f941fa0-350f-41ca-88de-464654761986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_b374f677-ec41-4c90-b5f0-76885fb75beb" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_6f941fa0-350f-41ca-88de-464654761986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_b905d11d-dd82-484a-a8fd-4421b7e25021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_b374f677-ec41-4c90-b5f0-76885fb75beb" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_b905d11d-dd82-484a-a8fd-4421b7e25021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary_d47dc8ef-55c5-4de7-af0c-ce2dc879c2bc" xlink:href="moh-20201231.xsd#moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_b374f677-ec41-4c90-b5f0-76885fb75beb" xlink:to="loc_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary_d47dc8ef-55c5-4de7-af0c-ce2dc879c2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_DeferredCompensationPlanDeferralPercentageOfBonus_35e0178f-0baa-4120-ad7e-96c31669c539" xlink:href="moh-20201231.xsd#moh_DeferredCompensationPlanDeferralPercentageOfBonus"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_b374f677-ec41-4c90-b5f0-76885fb75beb" xlink:to="loc_moh_DeferredCompensationPlanDeferralPercentageOfBonus_35e0178f-0baa-4120-ad7e-96c31669c539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="moh-20201231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_93304184-360b-40b6-98d8-ff38ff54d8fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c40830be-0821-41d4-a0de-87d673697935" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_93304184-360b-40b6-98d8-ff38ff54d8fc" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c40830be-0821-41d4-a0de-87d673697935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4edea5ad-2c77-4c3c-82cf-822f70bf1e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable_5556df88-65c6-4dc3-8811-ea3ef01c3ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4edea5ad-2c77-4c3c-82cf-822f70bf1e17" xlink:to="loc_us-gaap_StatutoryAccountingPracticesTable_5556df88-65c6-4dc3-8811-ea3ef01c3ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_b1b8808f-38c4-44a6-a139-63be87c90906" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_5556df88-65c6-4dc3-8811-ea3ef01c3ad3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_b1b8808f-38c4-44a6-a139-63be87c90906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d9aa8d89-21e3-4f35-8258-af8bdf6264a4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b1b8808f-38c4-44a6-a139-63be87c90906" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d9aa8d89-21e3-4f35-8258-af8bdf6264a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_cbcc9b94-a1c7-4b79-8293-847413a1bd77" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_d9aa8d89-21e3-4f35-8258-af8bdf6264a4" xlink:to="loc_srt_ParentCompanyMember_cbcc9b94-a1c7-4b79-8293-847413a1bd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_MagellanCompleteCareMember_f013a9cc-17fd-4a06-8230-b2fa39bdc240" xlink:href="moh-20201231.xsd#moh_MagellanCompleteCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_d9aa8d89-21e3-4f35-8258-af8bdf6264a4" xlink:to="loc_moh_MagellanCompleteCareMember_f013a9cc-17fd-4a06-8230-b2fa39bdc240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_5556df88-65c6-4dc3-8811-ea3ef01c3ad3" xlink:to="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SpecialAssessmentBond_3bc658e2-4675-443f-9840-40721f9a901c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SpecialAssessmentBond"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_SpecialAssessmentBond_3bc658e2-4675-443f-9840-40721f9a901c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_e62c648c-7677-486c-8ea4-ee0767cdac87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_e62c648c-7677-486c-8ea4-ee0767cdac87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_60a9c434-e742-429c-a9a1-05aa2f6df304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_60a9c434-e742-429c-a9a1-05aa2f6df304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b88f11ce-2f6c-4c82-b558-7bdfd8c39a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b88f11ce-2f6c-4c82-b558-7bdfd8c39a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_f45ab08a-f6ae-46f5-ad80-368059298f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_898f619b-75f3-4476-b3f2-da3705207f23" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_f45ab08a-f6ae-46f5-ad80-368059298f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/Segments" xlink:type="simple" xlink:href="moh-20201231.xsd#Segments"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/Segments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d808f499-4b9e-415c-836e-51faba3e6334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_efed7aa0-5d70-46e7-b705-4538dcf216f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d808f499-4b9e-415c-836e-51faba3e6334" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_efed7aa0-5d70-46e7-b705-4538dcf216f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsTables" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SegmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_06dd9397-8649-470f-b4c1-dc842d93a6ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b69ba230-3df8-4dec-a354-1cb93eae6f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_06dd9397-8649-470f-b4c1-dc842d93a6ef" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b69ba230-3df8-4dec-a354-1cb93eae6f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsNarrativeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SegmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_619ce1a6-06f9-442e-abfc-80095983b54d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_5d94ceac-e6dd-4fc5-a688-aa4df55fcab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_619ce1a6-06f9-442e-abfc-80095983b54d" xlink:to="loc_us-gaap_NumberOfReportableSegments_5d94ceac-e6dd-4fc5-a688-aa4df55fcab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsScheduleofOperatingSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_960d9bdf-65c6-4a49-aca3-04b89fecb64f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd79e9b7-2da6-47ce-8f59-ffebefe0ba92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_960d9bdf-65c6-4a49-aca3-04b89fecb64f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd79e9b7-2da6-47ce-8f59-ffebefe0ba92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1ea92c44-a305-4ab4-8bfd-d35f3bda0320" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd79e9b7-2da6-47ce-8f59-ffebefe0ba92" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1ea92c44-a305-4ab4-8bfd-d35f3bda0320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a7a367db-89ae-4481-8d6c-4391054755e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1ea92c44-a305-4ab4-8bfd-d35f3bda0320" xlink:to="loc_us-gaap_SegmentDomain_a7a367db-89ae-4481-8d6c-4391054755e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_0013fb12-0fde-4413-8928-49d38d8c229f" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a7a367db-89ae-4481-8d6c-4391054755e1" xlink:to="loc_moh_HealthPlansMember_0013fb12-0fde-4413-8928-49d38d8c229f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_6fd6375a-9b3e-4eeb-8cf1-06de4becc34f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a7a367db-89ae-4481-8d6c-4391054755e1" xlink:to="loc_us-gaap_AllOtherSegmentsMember_6fd6375a-9b3e-4eeb-8cf1-06de4becc34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d331a9aa-7819-476c-b59f-31ae44c15552" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd79e9b7-2da6-47ce-8f59-ffebefe0ba92" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d331a9aa-7819-476c-b59f-31ae44c15552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_abf5dd1f-8370-4392-99b2-e1dfc9490b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d331a9aa-7819-476c-b59f-31ae44c15552" xlink:to="loc_us-gaap_Revenues_abf5dd1f-8370-4392-99b2-e1dfc9490b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a7bfd486-679a-4c00-8be1-6fc9d56ad011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d331a9aa-7819-476c-b59f-31ae44c15552" xlink:to="loc_us-gaap_GrossProfit_a7bfd486-679a-4c00-8be1-6fc9d56ad011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_71311bc5-893f-42e8-a58c-0584d577180a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d331a9aa-7819-476c-b59f-31ae44c15552" xlink:to="loc_us-gaap_Assets_71311bc5-893f-42e8-a58c-0584d577180a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_51c3737a-08db-4870-aadd-7dcddf710c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0ff7394c-f82d-441d-bb57-ffe6b1ea72fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_51c3737a-08db-4870-aadd-7dcddf710c57" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0ff7394c-f82d-441d-bb57-ffe6b1ea72fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5485a7b7-6ed3-4fa7-874c-7db2570fdffa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0ff7394c-f82d-441d-bb57-ffe6b1ea72fa" xlink:to="loc_srt_ConsolidationItemsAxis_5485a7b7-6ed3-4fa7-874c-7db2570fdffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_77e1788b-6614-4628-bc09-1a73bc538e02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5485a7b7-6ed3-4fa7-874c-7db2570fdffa" xlink:to="loc_srt_ConsolidationItemsDomain_77e1788b-6614-4628-bc09-1a73bc538e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_13684a69-0143-40aa-9730-d02c93addcd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_77e1788b-6614-4628-bc09-1a73bc538e02" xlink:to="loc_us-gaap_OperatingSegmentsMember_13684a69-0143-40aa-9730-d02c93addcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_27abd9cb-151a-404f-b669-bf3228828f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_77e1788b-6614-4628-bc09-1a73bc538e02" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_27abd9cb-151a-404f-b669-bf3228828f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c8d2bc12-ee98-46bc-99b8-7f0bf56a04b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0ff7394c-f82d-441d-bb57-ffe6b1ea72fa" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c8d2bc12-ee98-46bc-99b8-7f0bf56a04b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8f7dd6bf-3d2b-443f-a599-09da54d0f46b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c8d2bc12-ee98-46bc-99b8-7f0bf56a04b4" xlink:to="loc_us-gaap_SegmentDomain_8f7dd6bf-3d2b-443f-a599-09da54d0f46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_HealthPlansMember_67b3c07f-a369-49ef-b0e2-7089161fa924" xlink:href="moh-20201231.xsd#moh_HealthPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8f7dd6bf-3d2b-443f-a599-09da54d0f46b" xlink:to="loc_moh_HealthPlansMember_67b3c07f-a369-49ef-b0e2-7089161fa924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_d37d5458-3aad-4588-b23a-d3de2b4a4e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8f7dd6bf-3d2b-443f-a599-09da54d0f46b" xlink:to="loc_us-gaap_AllOtherSegmentsMember_d37d5458-3aad-4588-b23a-d3de2b4a4e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0ff7394c-f82d-441d-bb57-ffe6b1ea72fa" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e690d4ae-289b-4677-9efb-21137b2c77fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_GrossProfit_e690d4ae-289b-4677-9efb-21137b2c77fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4d6b28d4-e2d2-460b-a81b-ca22f62f6d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_Revenues_4d6b28d4-e2d2-460b-a81b-ca22f62f6d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e2720f39-f5f9-4d24-8408-b901e84b437c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_CostsAndExpenses_e2720f39-f5f9-4d24-8408-b901e84b437c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b4bb1dce-e95f-4ac8-847d-039265f51f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_OperatingIncomeLoss_b4bb1dce-e95f-4ac8-847d-039265f51f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2ba12ced-0c18-40ca-841b-281268ec8bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2ba12ced-0c18-40ca-841b-281268ec8bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2014af2f-43d2-4395-b481-26bb68403363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_69fdb98a-d525-4f3d-8af6-96bfaed208bb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2014af2f-43d2-4395-b481-26bb68403363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrant"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_c5bc0ecc-bf10-4a4f-bcfc-3fa25208a2e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_db7ee8db-04ba-4f66-a6cb-26a5c60ac027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_c5bc0ecc-bf10-4a4f-bcfc-3fa25208a2e6" xlink:to="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_db7ee8db-04ba-4f66-a6cb-26a5c60ac027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantTables"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_35d1496f-15d1-424b-889b-10ca32531600" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_b2e2eab6-df8b-4aa0-b0d4-138b97aa3c96" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_35d1496f-15d1-424b-889b-10ca32531600" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_b2e2eab6-df8b-4aa0-b0d4-138b97aa3c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedIncomeStatementTableTextBlock_3ec1846e-ff2d-4274-8599-b27620c2d516" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_35d1496f-15d1-424b-889b-10ca32531600" xlink:to="loc_srt_ScheduleOfCondensedIncomeStatementTableTextBlock_3ec1846e-ff2d-4274-8599-b27620c2d516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_cbc4fe8d-6e2c-4b4a-8b09-ae095458599d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_35d1496f-15d1-424b-889b-10ca32531600" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_cbc4fe8d-6e2c-4b4a-8b09-ae095458599d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_77ce6c77-b3fa-40ec-85a3-977acd92e2eb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_35d1496f-15d1-424b-889b-10ca32531600" xlink:to="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_77ce6c77-b3fa-40ec-85a3-977acd92e2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3d3b3625-2f7b-4c75-a434-12825aabce15" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_977f3d22-7b99-40ac-9d06-5428f1e48676" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3d3b3625-2f7b-4c75-a434-12825aabce15" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_977f3d22-7b99-40ac-9d06-5428f1e48676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_dfbcc498-61a5-41b3-9bad-154ca9cbb085" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_977f3d22-7b99-40ac-9d06-5428f1e48676" xlink:to="loc_srt_ConsolidatedEntitiesAxis_dfbcc498-61a5-41b3-9bad-154ca9cbb085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2061d320-2e1e-4d9f-bc5e-5eb1597f139d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_dfbcc498-61a5-41b3-9bad-154ca9cbb085" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2061d320-2e1e-4d9f-bc5e-5eb1597f139d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_e69193dd-51bf-47f7-8829-97718af772cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_2061d320-2e1e-4d9f-bc5e-5eb1597f139d" xlink:to="loc_srt_ParentCompanyMember_e69193dd-51bf-47f7-8829-97718af772cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_7ed094b5-06d0-4593-9320-61bc48f2ab64" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_977f3d22-7b99-40ac-9d06-5428f1e48676" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_7ed094b5-06d0-4593-9320-61bc48f2ab64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0975d961-0b30-41c0-b99c-6df12624fe58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_7ed094b5-06d0-4593-9320-61bc48f2ab64" xlink:to="loc_us-gaap_StatementOfFinancialPositionAbstract_0975d961-0b30-41c0-b99c-6df12624fe58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0975d961-0b30-41c0-b99c-6df12624fe58" xlink:to="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4870d41-6877-4e71-95ce-b7c49e8f2999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4870d41-6877-4e71-95ce-b7c49e8f2999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_3e8948a1-ea1a-4b44-918d-c292a20cca2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_3e8948a1-ea1a-4b44-918d-c292a20cca2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_4937ed40-1f59-4847-9280-adbda6fdadd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_ReceivablesNetCurrent_4937ed40-1f59-4847-9280-adbda6fdadd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_64bc41e1-54a1-4fee-b93c-9707ddcc9e1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent_64bc41e1-54a1-4fee-b93c-9707ddcc9e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c3743fd8-8e17-4ef0-900d-cb384edf9639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c3743fd8-8e17-4ef0-900d-cb384edf9639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_454df0d7-9637-41d2-8757-d718f16189a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ad360d26-a7bb-4030-81d7-e31239f7df01" xlink:to="loc_us-gaap_AssetsCurrent_454df0d7-9637-41d2-8757-d718f16189a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1a0760d2-85fe-4096-99e0-132752ce41ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1a0760d2-85fe-4096-99e0-132752ce41ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9d223f63-19f3-4695-850e-54ea4ce90814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9d223f63-19f3-4695-850e-54ea4ce90814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ad297f31-c7fc-4041-87f4-a1df7e1806b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ad297f31-c7fc-4041-87f4-a1df7e1806b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e72e50c-53de-425d-ab0e-2f6cb1124c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e72e50c-53de-425d-ab0e-2f6cb1124c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_AdvancesToRelatedPartiesAndOtherAssets_bbe80383-85bd-4be1-b11e-c68d2ae2ae61" xlink:href="moh-20201231.xsd#moh_AdvancesToRelatedPartiesAndOtherAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_moh_AdvancesToRelatedPartiesAndOtherAssets_bbe80383-85bd-4be1-b11e-c68d2ae2ae61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ab47f2e7-8b74-43da-910e-c80b4ca09477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_564554e8-a505-479e-949a-06d89d4fc52b" xlink:to="loc_us-gaap_Assets_ab47f2e7-8b74-43da-910e-c80b4ca09477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0975d961-0b30-41c0-b99c-6df12624fe58" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3fc376fc-02a1-46fb-b4df-9d101d31c669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3fc376fc-02a1-46fb-b4df-9d101d31c669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_08ed325a-ecc9-427e-a348-201c5516f6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fc376fc-02a1-46fb-b4df-9d101d31c669" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_08ed325a-ecc9-427e-a348-201c5516f6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bca13ce3-01dd-4c74-976b-f10a567b8ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3fc376fc-02a1-46fb-b4df-9d101d31c669" xlink:to="loc_us-gaap_LiabilitiesCurrent_bca13ce3-01dd-4c74-976b-f10a567b8ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_04d9910d-f890-4cd2-bee2-e96b122dd88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_04d9910d-f890-4cd2-bee2-e96b122dd88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7e75a4a3-be32-4b1f-a593-3025f4558d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7e75a4a3-be32-4b1f-a593-3025f4558d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_31af1342-3f73-4a1e-a391-a6c23908921f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_31af1342-3f73-4a1e-a391-a6c23908921f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d1fd0ed1-2560-4d0a-b153-9dc169646b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_Liabilities_d1fd0ed1-2560-4d0a-b153-9dc169646b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_65e8c6f7-342e-4e6e-aaaf-b820281f3088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_CommonStockValueOutstanding_65e8c6f7-342e-4e6e-aaaf-b820281f3088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_267a106b-a2cb-401c-8ac4-8e8157acdc73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_PreferredStockValue_267a106b-a2cb-401c-8ac4-8e8157acdc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b9b44f3b-88ba-47f2-8728-27cf1260414f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b9b44f3b-88ba-47f2-8728-27cf1260414f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_06e0e8bc-03de-40ac-89b7-db6a64237f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_06e0e8bc-03de-40ac-89b7-db6a64237f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84ffde3c-7ef3-4f7f-872d-fdd03f745457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84ffde3c-7ef3-4f7f-872d-fdd03f745457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2d302998-dddc-4174-9386-20b40e210a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_437f3b24-3555-4ff4-ac22-decdd5fa9bdf" xlink:to="loc_us-gaap_StockholdersEquity_2d302998-dddc-4174-9386-20b40e210a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f3125f50-b46b-4f97-967c-66783c9c7939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20de34b8-94ac-4e73-884e-83dc85f5354f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f3125f50-b46b-4f97-967c-66783c9c7939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_af204e20-f481-4ec9-941f-2ae55a47a5f6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d0814138-13d0-4334-8c87-e681ff9c99e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_af204e20-f481-4ec9-941f-2ae55a47a5f6" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d0814138-13d0-4334-8c87-e681ff9c99e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ee3df065-887a-44b9-9f14-af8970e9ab5c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d0814138-13d0-4334-8c87-e681ff9c99e1" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ee3df065-887a-44b9-9f14-af8970e9ab5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_941d242f-f2a1-4c13-a0d8-1b309272830d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ee3df065-887a-44b9-9f14-af8970e9ab5c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_941d242f-f2a1-4c13-a0d8-1b309272830d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_7c4c5ecb-c31b-4a37-9e93-6edbf8fee8f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_941d242f-f2a1-4c13-a0d8-1b309272830d" xlink:to="loc_srt_ParentCompanyMember_7c4c5ecb-c31b-4a37-9e93-6edbf8fee8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d0814138-13d0-4334-8c87-e681ff9c99e1" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4cab5e91-dadd-4456-b2db-cd5fb1a1d773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4cab5e91-dadd-4456-b2db-cd5fb1a1d773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_dc9b69c9-cb59-4894-b9c3-9e740e761744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_dc9b69c9-cb59-4894-b9c3-9e740e761744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_195d210c-2875-4c22-a357-e4411cc40076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_195d210c-2875-4c22-a357-e4411cc40076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_334818c1-254f-47c1-b168-5bdb0eefb0d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_334818c1-254f-47c1-b168-5bdb0eefb0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_75bdfc99-b9b0-451a-8e4b-8ea33e3b9a61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_75bdfc99-b9b0-451a-8e4b-8ea33e3b9a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_d02ac5f1-8806-4d6f-9b13-41f4df41af1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_PreferredStockSharesIssued_d02ac5f1-8806-4d6f-9b13-41f4df41af1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_c0820a9b-9e0e-408a-92cf-952c0220cda1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ac747ae3-4cc1-4610-8365-61a37bb9f3bb" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_c0820a9b-9e0e-408a-92cf-952c0220cda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_39aa8f85-f5e2-4ede-a3b8-b53c40a86e08" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d8793188-8701-4403-8709-146d59e8cd4d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_39aa8f85-f5e2-4ede-a3b8-b53c40a86e08" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d8793188-8701-4403-8709-146d59e8cd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_7dd269e4-049f-4105-b00d-3a78a0a77f3c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d8793188-8701-4403-8709-146d59e8cd4d" xlink:to="loc_srt_ConsolidatedEntitiesAxis_7dd269e4-049f-4105-b00d-3a78a0a77f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f9291a6a-31b2-4c38-8b30-cb87e7756945" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_7dd269e4-049f-4105-b00d-3a78a0a77f3c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f9291a6a-31b2-4c38-8b30-cb87e7756945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_c031a60a-7cb2-49fe-9f1f-330fc15c0aa3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f9291a6a-31b2-4c38-8b30-cb87e7756945" xlink:to="loc_srt_ParentCompanyMember_c031a60a-7cb2-49fe-9f1f-330fc15c0aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_0f51af37-ed36-479a-ad2f-d75afb6b3b35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d8793188-8701-4403-8709-146d59e8cd4d" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_0f51af37-ed36-479a-ad2f-d75afb6b3b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_0f51af37-ed36-479a-ad2f-d75afb6b3b35" xlink:to="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_fcee75ab-1ad2-4162-9168-a4f487b2550f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_RevenuesAbstract_fcee75ab-1ad2-4162-9168-a4f487b2550f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAgencyManagementFee_24e0c62b-4497-4cdb-b2cc-a23d6ea28818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAgencyManagementFee"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_fcee75ab-1ad2-4162-9168-a4f487b2550f" xlink:to="loc_us-gaap_InsuranceAgencyManagementFee_24e0c62b-4497-4cdb-b2cc-a23d6ea28818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_0308e7df-feba-4ee3-b850-5a7afd62b0ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_fcee75ab-1ad2-4162-9168-a4f487b2550f" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_0308e7df-feba-4ee3-b850-5a7afd62b0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7b7d7553-663c-4a24-a5de-b57496df1806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_fcee75ab-1ad2-4162-9168-a4f487b2550f" xlink:to="loc_us-gaap_Revenues_7b7d7553-663c-4a24-a5de-b57496df1806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_bcf5ab04-aaa8-4fc1-822e-8bfbabdaf407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_bcf5ab04-aaa8-4fc1-822e-8bfbabdaf407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_6757b79f-5ad3-42cf-bebc-5d7e432b6eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:to="loc_us-gaap_DepreciationAndAmortization_6757b79f-5ad3-42cf-bebc-5d7e432b6eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_bea66a39-d40f-436c-baa7-dc2c86c6d1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_bea66a39-d40f-436c-baa7-dc2c86c6d1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e0442d1f-e21c-4feb-b281-7fbcb55a4b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_627ac0f6-f06c-47a3-b76d-dd608281c824" xlink:to="loc_us-gaap_CostsAndExpenses_e0442d1f-e21c-4feb-b281-7fbcb55a4b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a1a38866-2392-4f56-9438-57712af4c72f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_OperatingIncomeLoss_a1a38866-2392-4f56-9438-57712af4c72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_616e5799-069f-46d3-9a35-f14af5f5b4e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_InterestExpense_616e5799-069f-46d3-9a35-f14af5f5b4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fdbda9cf-37bf-4722-bacb-cdc70399e202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fdbda9cf-37bf-4722-bacb-cdc70399e202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_dd3dc7f2-5db8-4ea8-aadb-9620d3fb7a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_OtherExpenses_dd3dc7f2-5db8-4ea8-aadb-9620d3fb7a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_32a2d7d5-eb01-4ca6-a176-7da4996d9099" xlink:href="moh-20201231.xsd#moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries_32a2d7d5-eb01-4ca6-a176-7da4996d9099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_620c5178-c232-4ffe-8e80-734cdb965888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_620c5178-c232-4ffe-8e80-734cdb965888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_05209efb-0b7d-47fb-8ac2-85ae431a8b1f" xlink:href="moh-20201231.xsd#moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest_05209efb-0b7d-47fb-8ac2-85ae431a8b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromSubsidiariesNetOfTax_17cee45a-5c05-4ed6-9dce-2d23be7427a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromSubsidiariesNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_IncomeLossFromSubsidiariesNetOfTax_17cee45a-5c05-4ed6-9dce-2d23be7427a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_36149232-9d27-4881-b973-bbed3618beac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa1e2017-b56c-4f3a-bdb5-f5609db56f6e" xlink:to="loc_us-gaap_NetIncomeLoss_36149232-9d27-4881-b973-bbed3618beac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_017a152b-c59a-4cc4-9615-86b036b415b3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_e40d9974-b284-4d23-8d8e-796e8c36af84" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_017a152b-c59a-4cc4-9615-86b036b415b3" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_e40d9974-b284-4d23-8d8e-796e8c36af84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_04b9a158-e994-4194-9517-e60b70275428" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_e40d9974-b284-4d23-8d8e-796e8c36af84" xlink:to="loc_srt_ConsolidatedEntitiesAxis_04b9a158-e994-4194-9517-e60b70275428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_939443b9-56cb-4778-8710-df79eec27ce4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_04b9a158-e994-4194-9517-e60b70275428" xlink:to="loc_srt_ConsolidatedEntitiesDomain_939443b9-56cb-4778-8710-df79eec27ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_77b8a574-aae6-435c-88f0-9d0fc0105e6f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_939443b9-56cb-4778-8710-df79eec27ce4" xlink:to="loc_srt_ParentCompanyMember_77b8a574-aae6-435c-88f0-9d0fc0105e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_1922d0d8-5b70-41b8-8e8c-01e61174058f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_e40d9974-b284-4d23-8d8e-796e8c36af84" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_1922d0d8-5b70-41b8-8e8c-01e61174058f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b64c53b-9faf-4470-b250-8546eff4f5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_1922d0d8-5b70-41b8-8e8c-01e61174058f" xlink:to="loc_us-gaap_NetIncomeLoss_1b64c53b-9faf-4470-b250-8546eff4f5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfOtherComprehensiveIncomeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_1922d0d8-5b70-41b8-8e8c-01e61174058f" xlink:to="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3a4fd20d-1312-4c24-915f-62d83d970612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3a4fd20d-1312-4c24-915f-62d83d970612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_517423e4-7b63-4484-a52e-f9ab7b000ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_517423e4-7b63-4484-a52e-f9ab7b000ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bb1a935c-f227-478f-a09f-db96a751bc18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bb1a935c-f227-478f-a09f-db96a751bc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7271917a-d3bc-463c-84c6-dde064a147ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_3b8f581a-d6d8-4b2d-b0a9-8b0337f393b5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7271917a-d3bc-463c-84c6-dde064a147ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f5e44904-6162-4880-b6d9-2a37e020ab71" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d9d339d5-5e45-4cc2-b5eb-b79a71de1bf2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f5e44904-6162-4880-b6d9-2a37e020ab71" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d9d339d5-5e45-4cc2-b5eb-b79a71de1bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_c4a9bf0e-4a61-49ce-9a92-7da8dd1dd6a0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d9d339d5-5e45-4cc2-b5eb-b79a71de1bf2" xlink:to="loc_srt_ConsolidatedEntitiesAxis_c4a9bf0e-4a61-49ce-9a92-7da8dd1dd6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b1c50568-fb7d-4778-b9a1-916a3681f760" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c4a9bf0e-4a61-49ce-9a92-7da8dd1dd6a0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b1c50568-fb7d-4778-b9a1-916a3681f760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_8457e00b-f3e8-460c-9cc5-59b4e79ccebe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b1c50568-fb7d-4778-b9a1-916a3681f760" xlink:to="loc_srt_ParentCompanyMember_8457e00b-f3e8-460c-9cc5-59b4e79ccebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ea113ea9-2d8f-4cb7-8120-76896935a1c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_d9d339d5-5e45-4cc2-b5eb-b79a71de1bf2" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ea113ea9-2d8f-4cb7-8120-76896935a1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_ea113ea9-2d8f-4cb7-8120-76896935a1c0" xlink:to="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a66e863f-4388-4e6c-88c0-aff5ff183e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a66e863f-4388-4e6c-88c0-aff5ff183e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_116919fe-5d90-4716-8ce7-d3306ddae8bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a66e863f-4388-4e6c-88c0-aff5ff183e06" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_116919fe-5d90-4716-8ce7-d3306ddae8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_11df8118-c010-49ec-885f-8a01d0f9ffa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_11df8118-c010-49ec-885f-8a01d0f9ffa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_b3d81ea8-1c3a-4079-a33d-3732168c8091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_b3d81ea8-1c3a-4079-a33d-3732168c8091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_1d774369-4899-4042-9bfc-24ce0c77d1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_1d774369-4899-4042-9bfc-24ce0c77d1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f64c9880-e0dc-4cb2-a5e0-f4bfeeee5272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f64c9880-e0dc-4cb2-a5e0-f4bfeeee5272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_114d0223-e3ee-451a-b7dc-a57cc14fcaf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_114d0223-e3ee-451a-b7dc-a57cc14fcaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1e4da96f-1b25-47c3-8fa3-87ab060375f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1e4da96f-1b25-47c3-8fa3-87ab060375f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_817ee971-e5fd-43ee-b279-cf9d5238af88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_817ee971-e5fd-43ee-b279-cf9d5238af88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_ChangesInAmountsDueToAndDueFromAffiliates_6b18a949-8b0a-4ec2-8ae7-28187f601b34" xlink:href="moh-20201231.xsd#moh_ChangesInAmountsDueToAndDueFromAffiliates"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_moh_ChangesInAmountsDueToAndDueFromAffiliates_6b18a949-8b0a-4ec2-8ae7-28187f601b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c67f6878-4a5d-4c8f-b313-97886b6dd81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c67f6878-4a5d-4c8f-b313-97886b6dd81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70b21940-79ff-46df-8bb4-4e36f6c44cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16c38ab2-d9b5-4710-8ff4-bf3538e076a2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70b21940-79ff-46df-8bb4-4e36f6c44cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_37c25981-64ce-4f9e-ab2c-1b0bd2634a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_37c25981-64ce-4f9e-ab2c-1b0bd2634a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_fdbf1b4a-f657-4914-b430-a1ecb092038c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_fdbf1b4a-f657-4914-b430-a1ecb092038c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_ef6cee8d-2182-49d9-a4cc-d637716ccbb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_ef6cee8d-2182-49d9-a4cc-d637716ccbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c2a5d5b5-9773-4505-8780-931a5dbd7145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c2a5d5b5-9773-4505-8780-931a5dbd7145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_8ea1bf5f-a402-4774-9d2e-96590bbf4fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_8ea1bf5f-a402-4774-9d2e-96590bbf4fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants_db507e5f-edd6-47ab-be97-997620389afe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfWarrants_db507e5f-edd6-47ab-be97-997620389afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_moh_CashPaidForSettlementOfConversionOption_a8984707-42bc-433e-aa5d-02e59da3b060" xlink:href="moh-20201231.xsd#moh_CashPaidForSettlementOfConversionOption"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_moh_CashPaidForSettlementOfConversionOption_a8984707-42bc-433e-aa5d-02e59da3b060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_ce2541bb-4596-44df-a262-e065ae82fa64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_ce2541bb-4596-44df-a262-e065ae82fa64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_1b0ab4da-6a6a-42e4-9845-15d5b047b60d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_1b0ab4da-6a6a-42e4-9845-15d5b047b60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_fa554471-c1a4-444c-807d-6ec228da72d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_fa554471-c1a4-444c-807d-6ec228da72d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b389df71-277b-4316-a5b4-dc6d9e3ca077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b389df71-277b-4316-a5b4-dc6d9e3ca077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b71bbd7c-fe28-4d02-8bd5-ebfc60a615e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f67575b7-46fc-4791-8553-5309f490ad2d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b71bbd7c-fe28-4d02-8bd5-ebfc60a615e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d597bc82-c0c8-4528-82c3-d83839c22d09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d597bc82-c0c8-4528-82c3-d83839c22d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82b1be96-bada-4a41-b58e-2702f3d93ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82b1be96-bada-4a41-b58e-2702f3d93ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cf685ed9-fc30-4dea-ac77-f1e6564108e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a24d1041-34d9-477c-9ff4-1be8c3d27c0b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cf685ed9-fc30-4dea-ac77-f1e6564108e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails" xlink:type="simple" xlink:href="moh-20201231.xsd#CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_901230a0-8d5d-420b-9a76-943dc7593def" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ad72f4d3-0c92-4742-a0ab-c3e5c48a546f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_901230a0-8d5d-420b-9a76-943dc7593def" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ad72f4d3-0c92-4742-a0ab-c3e5c48a546f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_34048cfe-0c01-4733-a70c-e4e92a95bfd3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ad72f4d3-0c92-4742-a0ab-c3e5c48a546f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_34048cfe-0c01-4733-a70c-e4e92a95bfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f07cb64e-d475-4e80-86d0-7e766d37bd15" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_34048cfe-0c01-4733-a70c-e4e92a95bfd3" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f07cb64e-d475-4e80-86d0-7e766d37bd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_95eca7c1-7b7a-44c7-90d1-af9efcf5520e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f07cb64e-d475-4e80-86d0-7e766d37bd15" xlink:to="loc_srt_ParentCompanyMember_95eca7c1-7b7a-44c7-90d1-af9efcf5520e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_df0e0309-28c4-4f0f-85dc-3f4b9b397ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ad72f4d3-0c92-4742-a0ab-c3e5c48a546f" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_df0e0309-28c4-4f0f-85dc-3f4b9b397ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_68717359-55b8-41de-b6a6-104e01e53593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df0e0309-28c4-4f0f-85dc-3f4b9b397ffa" xlink:to="loc_us-gaap_RevenueFromRelatedParties_68717359-55b8-41de-b6a6-104e01e53593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>moh-20201231_g1.jpg
<TEXT>
begin 644 moh-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-H96EL82!(
M861E<G-B97)G97(   60 P "    %   $*R0!  "    %   $,"2D0 "
M S<R  "2D@ "     S<R  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@
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M7HK!0MJV?,2S[$<UXQ5OG_F?2MM=07D"S6DT<\3?=>-@P/XBI:^?/#WB2_\
M#E\)[&0F,G][ Q^20>X]??M7NVD:K;ZUI4%_9G,4RYP>JGH0?<&N*O0=)WZ'
MNX#,88Q-6M)=/\B[1117.>H%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %07MRMG87%T_W
M8(FD/T S_2IZH:]"USX<U*",9>6TE11[E"*<=7J1-M0;6Y\\W-Q+=W4MS<,7
MEF<N['N2<FHJ**^B/S)MMW84444"/1/A'J3IJE[IK$F.6+SE'8,I /YAOTKU
M:O'/A3 TGBZ209VQ6K$GZE1C_/I7L=>/BTE5T/N<FE)X17Z-E35KW^S=&O+W
M&?L\#R >I ) KYREE>:5Y96+R.Q9F/4D]37T#XL@:X\(:I&F2WV9V '? S_2
MOGRNG I<K9Y6?RE[2$>E@HHHKO/FPKTSX1:BY;4--=LIA9T'H?NM_P"RUYG7
M??".%F\17LX^ZEKL/'=G4C_T$USXE)TG<]+*Y2CC(6_K0]<HHHKQ#[\****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$\5U;QSVTJ30RJ'CD1@RNI&001U%? M>P_!;XM'PU<Q>'?$4W_$GF?%O._\
MRZ.3W/\ <)//H>>F:!V/IVBD4AE!4@@C(([TM BIJU\=,T6]OUB,YM;>281
MXW[5)VYP<9QCI7E/A3X_P^*O%6G:);^')87O9=AE:[#!!@DG&SGI[5ZCK_\
MR+>I_P#7I+_Z :^3?@E$)OC)H*L2 &F;CV@D/]*!GV%1110(*\6\8?M!CPSX
MPU+1K/1(]1BLW\H3_:C'^\ &X$;3T;(_"O4/%_B"+PMX/U/6IMO^B0,R*W1I
M#PB_BQ _&OAZXGENKF6XN',DTKEY';JS$Y)_.@:/MWP5XGB\8^#]/UR%!&;F
M/]Y$#GRY 2K+^8/X8K=KP#]FGQ-_R%/#,[_]/ML"?HL@_P#0#CZU[_0(XG6_
MB-!IMV8;."V>%97A-W?W36\,DB??2,K'(SE>YV@ Y&<@XU_#GBJ+79#;RP"V
MNA"MP@28317$3' DBD'WUSP> 0>H&1GS/6](UK6-)T+0O#Q\C6]#ENUNV;;F
M,F-PDA#\E9=P(8 _>/<5TO@M8Y[KPY8V6G-8-H5A-'?P^9Y@MY'V 0[P2&+%
M2^,Y "YQD4#/1J***!!1110 4444 %%%% 'EOQ:TB075IJ\:DQ,GD2D?PD$E
M3^.3^5>;U])WEG;ZA9R6MY$LT$J[71AU%>8:Q\)KN.=GT2ZCFA)R(YSM=?;(
M&#^E>GAL1%1Y)]#Y3-,LJRJNM15T]T>=UT7@72)-7\66@528K9Q/*V. %.0/
MQ.!6O9?"G6II@+R:VMHL_,VXNWX ?XBO2_#WARQ\-Z?]FL$)9N99G^](??\
MH*TK8F"BU%W9S8#*JTZJG55HKOU-:BBBO(/M KY^\7V:6'B_4K>( ()RR@=
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M4444 >D?!_\ X^]5_P!R/^;5ZE7EOP?_ ./O5?\ <C_FU>I5XN*_C,^[R?\
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M^UM7CN'MA*L3?9T#,I;.#@D<<8_&L+P?\7?#GC?7#I6BQWPN!"TQ,\*JNU2
M>0QYY%9WQ_B\SX1WC9QY=Q WU^<#^M>5_LU?\E)U#_L$R?\ HZ&@9]/UYWXD
M^-?ACPIXCN]$U:#41=VA4.8X496W(K@@[_1AUQ7HE8-WX'\+ZAJ<VHZAX?TZ
M\NYB#)-<VZREB %&=P/8"@1PW_#1O@K_ )Y:K_X#+_\ %T?\-&^"O^>6J_\
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MOUZI7-/\.?!CR!_^$7TI&!!!BM$3!'<;0,5TM @HHHH **** "BBB@ HHHH
M*^??%O\ R..J_P#7T_\ .OH*OGWQ;_R..J_]?3_SKOP7QL^=S[^##U_0QZ**
M*]0^0"BBB@#TCX/_ /'WJO\ N1_S:N9\>_\ (]:G_OK_ .@+73?!_P#X^]5_
MW(_YM7,^/?\ D>M3_P!]?_0%KCA_O,O3_(]RM_R*J7^)_J<[11178>&%%%%
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M^1WT/_L(V_\ Z,6@$>W/XU^. C8_\(I".#RMF21]!OKUOP3>:QJ'@S3[KQ-
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M:>)O^?./_O\ I_C7M]%..+J122L9U,EPU2;FV[MWW7^1XA_PK3Q-_P ^<?\
MW_3_ !H_X5IXF_Y\X_\ O^G^->WT57UVIY$?V%A>[^]?Y'B'_"M/$W_/G'_W
M_3_&C_A6OB;_ )\X_P#O^G^->WT4?7:GD']A87N_O7^1PGPZ\,:IX>N+]]4@
M6(3*@3;(&S@G/3ZUW=%%<M2;J2YF>KA\/##4E2ALCY3U#X%>/KR^N[S^S[7,
MT[N$^UIDY.<]<=_6OJM22H)&TD<@]J6BH.@XGXM^'=5\5?#VYTG0H$GNIIHC
MM>0)\JL&)R3CM7GWP?\ A;XI\%^/3J.MVD*VCV<D7F17"MAB5(&.O\->[T4
M0WB-+8SI&-SM&P49ZDBOEC3O@7\1+2^AN[>TM;:>VD66)WNHVPRG(..1P0.M
M?5M% 'A-SIGQ_:,?\36WDYZ1&V0_^@"O5/ L&O6?@>QB\6,\VL()/M!:179C
MYC%?F''W=M=%10!XUX ^'?B:+XM7_C'QG;0Q-*DDD 2=9"DCG:%X[*F1^5>R
MT44 >8_&WX?7_CG0]/?0H4EU&RG.%>0(#$X^;D^ZK^M8GP9\#>,_ ?B"[AUF
MTA_LJ^A!D:.Y5O+E7E3C.>A8' [CTKVFB@#A?C!X9U7Q;X!?2]"MUGNGN8WV
MM(J *N23DD5Y!X6^%'Q5\)7[ZCX>:SL+N6$PNS312'86!(PP8=54Y'-?3-%
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M]P))"/T-=K\-/"FL^&M)OIO%5^NH:UJ5SY]Q.KE\*% 5,D#I@].!G XKM**
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' 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>moh-20201231_g2.jpg
<TEXT>
begin 644 moh-20201231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (F MX# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ*GW9'7Z,: /7J6O*(M8O8?N7,@_'-6H_%6IQGFY9QZ,!0!Z;17GT?CG4(\
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MWL9?LH#L&\MVS]PU2A\9R:A?PP11K#&[8+/UK+C;[7J6I6A39YP.U6XPPZ4
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M-?0?%](M.TW2YUBL7U#_ %\2@[?G/(QDJ!]:QJ2=-\ZT:Z?JBHKFT/=O@?\
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MT'7#:^%_C?X>C97N95$7]I&/Y2A QE\C\,>@K]0-6NEL=+NKAF5!'&S9<X'
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M#X7386(XZ!LC_OK%?:77FOF<:U[9I+8[J7PFVMUHUUCS;:6V<_\ /(Y44O\
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MKX"OM2NM4G,]Y<RW4QZR3.6;\S7N48RJI5%)?=^9R2M%VL?HM\5O WA+XT>
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M\,YE=)G60$2*Q#;NN>^:_>.TMUO)6MW^[-&\1_X$I']:_#WXEZ>-)^(WBJQ
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M([')->YE[G*]WH<M:RL9M%%%>R<QK^$/#MYXM\4:5HVGH9+V^N8[>)0,_,S
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MH **** "BBB@ HHHH *J:MI=KKFF76GWL*W-G=1-#-"_W71A@@^Q!JW10!^
MG[1/PUF^$_QC\3^'6ADCMK6\<6[LA4/&>05]N<?A7F]?J5_P59^&VI:UX(T#
MQ18:99R6FER2)>W8 %PJMMV\]U^5J_+6OK,/5]K34CSYQY96"BBBND@****
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M3Q&#@ZSI\]:6BLFU*/\ -*-MUY]?0Y^']H_QC;^(KC48[M?LLT@;^SW7,*J
M % ^@ J_XJ_:>\5:Q>%M*9=#M/*"""$[BK<Y8' Z_2K&G_LK>)KA4:[OM.L2
M>J/-O8?]\YKH+?\ 9,2S9DU7Q/ CCJMK$S?S6M7+#IWT/+I8;B*I!PCSI-WU
M=OSU1\_:EJ5UK%]->7L[W-U,Q>260Y+$]ZK5]1V'[-O@ZQ7_ $O4+[46_P!D
M"/\ J*Z'2_A'X%T4?N=!^UO_ 'KR0O\ H2:'BZ:V%3X2S*J[U&E?N[_D?($5
MM-/_ *N)Y/\ =4FMS2OA[XDUM0;'1;NX!Z%8\?SK[)L;73M(4+IVD:?8J/\
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MND^*M%M-<T]9!,MO>1AU#@$!@#WY-?"?[1G_  2[;Q%XEBU+X6SZ=HUI,/\
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MRU5D/X@T 95%:TWANZCF928U /&YP#2?\([/WF@'UD% &516J=!9?O7=LO\
MP,_X4S^QXU^]J%J/Q;_XF@#-HK472[/^+4H?P5O\*=_9NG#KJ0/^ZAH R:*T
MV@TJ-N;FXD_W8A_C2:AIL45G#=VSNT,C%0L@PP(H BT_3[36KW3H=0LH;Z.R
MN5O8#,"3!*AR'4]B*\@^(FE_\)M)>>./AWJET+RWD/VZQC<[O]\+Z5[O<:H-
M#C@ABMX2\D(\T;>N<]_I61INH6^BLQTW3+.Q+#!\J(#-;4ZGL]3QLRP#S",:
M;=H]^J?1I^7XGC5FNG?M):"MG=^7HGC'2XA_I6S"W"*.2WOU[UV_AGX:ZI?>
M!KKPMX\ELIK96)L-060-,O'')[5V!UR;]YMB@C:0%6:.( \]>:H$D]3FKE7>
MT=$<6'R2G%^TQ$N:;5I-:*2_O+77S.=^%_PLG^'IO;&^\2V.M:!=(T<EC);D
MXS_$IW<'\*3PG\)-!\#>,&UC2];OXX3)N-GM!C=<_<;CD5T5%0ZTW?7<[*>3
MX*G&$5#X'=:NZ^=]O(S]5^'?@FZ\4/K\-E<PWS-YF+>3RD#>H %:WB#3?"WB
M:YM[K4?#D-W=P*$2:1B&./7;C)^M0T5'M)=SLC@<+%22IJTG=Z;LT)M4@FMH
MK>32[&6&'B-9HO,*#V+$TY?$%Y'&(X72WA'2**-0H_#%9M%3=G6H1CJD7IM<
MO[C_ %ERS?D*9!'>7N[RS+( 0&.20,^M,L;&2_FV1X ZL[<!1ZFM2XU@:;''
M;::ZJ H\R95P7:D6/AL;329GFFNEFF@&3#MZMCCOSS6)<W#W4[RR'<[')--D
MD::1G<EF8Y)--H **** "BBB@ HHHH *U-#736F/V\R9R-BKT/UK+K2T3R$O
M$:>"2;_GFJ]-WO0!W%CX8L+6Z6ZB1L]54G@5LU0TV>\F9_M-NL"C[FULFK]
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M *SJ5F+$D\DTE !113A$[=$8_A0 VBK$6GW,WW(';\*L)X?U!_\ EV<#U/%
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M=A')<V5U$D\$VP@,CJ&4^W!K\%:[+4/C)XXU70;31;KQ1J4NEVBA8+;SR%C
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M_C]H+X;?]C%8?^CTK]H=0XO9O]XU^)GP3UJU\.?&+P3JM]*L%G9:S:7$TK'
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M#7&XN.Z-2&BBBD 4JKN8#U.*2KFCQK-JEJC %3(N0?K0!\)?\%+/C?&9M!\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH*2Z'11=G8^G****^?.L***<U]I^CV-]JNKW M=*TZWDN[J=@2$B12S'@9X
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M/*D0D+1@E2K$X(.,&G9VN!N4444@"BBB@ HHHH **** "BBB@ HHHH ****
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M40_Z>&$9_P#'JUX?^"=_QQFZ>%X$_P"NE_$O\VK]4?M$O_/1_P#OHTGG2?\
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MO\,6=SJ4>8+2]B8K*8]H(8G'#!BV.O05Y=-T]?:(VES?9/G#XK?MG>*?V?\
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MV]A>Q-&OGQ.C,D9. Q)4CCIG/:N6_8C_ &HM>\#^.A\&/B7Y\=]'/]ET^ZO
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MOJMS\R?%?A?7?V3_ !)8_%CX2:F=6^'>LE2/*8NJQ,=QMYU/Y<]"!WK0\=^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;.&YS_2I;[1X[K>\9,%PPP)$X(K0HH H:/:W5K:[+N<7#YX;VJ_110 4444
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M8>9;OC/W?[IYP>^#Z5Z_7A2BXMQ9V)W5PHHHJ1A1110 4444 %%%% !1110
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M"0RF X"E0V<;3MSP.IK\>_ \<4WC#189[B6T@FNXHI)H6VLBLX!(/MFOZ!_
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M1XWP#T/4<]>E:_@_XA:+XZN=;@TB=YI-'O7L+L/&R;9E)! R.1P>17P=\/\
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MB>&_V8M)?2[NZU'QA]FL_MUPF#<L"4\\Q@X!?;OQ7 _"?Q<_C;1_'GAX^/\
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M;WKZLTZS73[..!6+A!C>V,L?4^]6:*TG4E-)2>Q*BEL%%%%9E!1110 4444
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M[A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C*&4@C(/!%+3
M)IEMX9)7^XBEC] ,T 97_"'Z(>?[*M?^_0H_X0_1/^@5:_\ ?H5S/@WXX>$O
M'6J3Z=I=^QO8E+&&>)HBV#@A=PY/L*I_\-">#8_$PT&XO+BRU$R^25NK9XU5
MCZLP  ]ZVY:E[69Y/UK+^53YX6;LGIOV.R_X0_1/^@5:_P#?H4?\(?HG_0*M
M?^_0KE_&GQP\+^ -0CL]9FNK=Y%W1R+:N\;CU# 8-7-?^+WASP[X<M->N+B6
M;2KD I<VL+2JN>S;0=I^M+EJ:;ZE/$8%.<7*-X[[:>IV%O;QVL*0PHL42#"H
MHP *DK/T#7+3Q+HUIJEB[26ET@DB9E*DK]#6A6?J>E&4913CL%%%%(H****
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M& R[7]\GZ5[M10]>7RO^-[_?=@M+^=OPM;\D?+&C?L9ZCI7AW44/B_S?$?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!H.TL=5O+-;-;..T:.=LP#R@/EYXJK63ZN[7_I%O\ TH2]Z27DG\^:2?\
MZ2?>*NK="#]#1YB]-PS]:^'?BI;WG[._BSPW>>%-1U%YM6T&\-\MU<O,LTJJ
MA$N&) 8<GY<#VJCXD^'L/A/PG\&_&-AXKU:36M<UG3)=2WWS,EZ998V92F<
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M%O>4GT_R:_47V7'^NYX;I?['?@+3;J2[D?5M0O7L9=--U?7S2R^1(A1DW'L
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>moh-20201231_g3.jpg
<TEXT>
begin 644 moh-20201231_g3.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YO<G1H=V%Y
M+"!!;&EC:6$    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,T
M,0  DI(  @    ,T,0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                            ,C R,#HQ,3HR-2 P-CHU-CHT,P R,#(P
M.C$Q.C(U(# V.C4V.C0S    3@!O '( = !H '< 80!Y "P ( !! &P :0!C
M &D 80   /_A"R-H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A
M8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED
M)S\^#0H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(CX\<F1F
M.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M
M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2)U
M=6ED.F9A9C5B9&0U+6)A,V0M,3%D82UA9#,Q+60S,V0W-3$X,F8Q8B(@>&UL
M;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B\^/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F-6)D9#4M8F$S9"TQ
M,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"\B/CQX;7 Z0W)E871E1&%T93XR,#(P+3$Q+3(U
M5# V.C4V.C0S+C0P.3PO>&UP.D-R96%T941A=&4^/"]R9&8Z1&5S8W)I<'1I
M;VX^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F-6)D9#4M
M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SID8STB:'1T<#HO
M+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/CQD8SIC<F5A=&]R/CQR9&8Z
M4V5Q('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^/')D9CIL:3Y.;W)T:'=A>2P@06QI8VEA/"]R9&8Z
M;&D^/"]R9&8Z4V5Q/@T*"0D)/"]D8SIC<F5A=&]R/CPO<F1F.D1E<V-R:7!T
M:6]N/CPO<F1F.E)$1CX\+W@Z>&UP;65T83X-"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $, !P4%!@4$!P8%!@@'!P@*
M$0L*"0D*%0\0#!$8%1H9&!48%QL>)R$;'24=%Q@B+B(E*"DK+"L:("\S+RHR
M)RHK*O_; $,!!P@("@D*% L+%"H<&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*O_  !$( O<#D0,!(@ "$0$#
M$0'_Q  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,#
M @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S
M8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H
M:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 #
M 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  !
M G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q
M%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X
M>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(
MR<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /H#
M6]<L_#^G_;=19UAWA,HNXY.>WX5SW_"T_#7_ #UN?^_!J/XL?\B6/^OI/Y-7
MBE>EAL+"K3YI'RV:9KB,)B/9T[6LMSV__A:?AK_GK<_]^#1_PM/PU_SUN?\
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M /A:?AK_ )ZW/_?@T?\ "T_#7_/6Y_[\&O$**/J-+S#_ %@QG9?=_P $]O\
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MGM__  M/PU_SUN?^_!H_X6GX:_YZW/\ WX->(44?4:7F'^L&,[+[O^">W_\
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M?_R-^G?]=?Z&HJ? _0Z,-_'AZK\RAJW_ "&+S_KL_P#.JE6]6_Y#%Y_UV?\
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M08V8G!'UKDJVA-35T<%>C*A/E;OL].S)['_D(VW_ %U7^8K6\9_\C???5/\
MT!:R;'_D(VW_ %U7^8K6\9_\C???5/\ T!:3_B+T?Z&D?]UE_B7Y,PJ4=124
M5H<A[/>:II:VMAINN!1;O;B5&/9AV_6H;_6(-2LM$O2%C@^W%5!Z!1D"O(YK
MF>YV^?-)+M&%WL3@>U*;FX:%83-(8T.53<<*?4"N)85)WOU/>EF\FG'ETM;S
MTM^&_P!YZF^BW%DWB>[GC00W$.86!!R,5+8ZJVGS^&8]Z)'/;%'+#V&*\L;5
M+]HRC7MP4(VE3*V"/3K43W=Q((Q)/(PB^YER=OT]*:PS:M)_U:PGFD(N].+7
MS[R4O^ >JVK:K)\0?^)O'&L8BE\@J!RG.*K:0D\/A])/#EM;W%U)<L+KS,9
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MKVWLK:'EM%=]#X:T?1M)GO\ 5X);T?:3 B(Q&WWXK+\=Z3I^E7EF-+@,,<T
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M_P"NPKJJ? _0\C"_[Q#U7YF9J?\ R%;G_KH?YU!%*\,JR1,5=#E6'8U/J?\
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MHY>5]B,,58%201T([5;DU?498RDM_<NIX*M*Q'\Z@^S3_P#/&3_O@T?9I_\
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MT_\ SQD_[X-%T'*^Q%14OV:?_GC)_P!\&C[-/_SQD_[X-%T'*^Q%14OV:?\
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M8C^SP_\ /)/^^:/LT/\ SR3_ +Y%24478<J[$?V:'_GDG_?(H^S0_P#/)/\
MOD5)6=::[8WNLWFEP2YN[,*94(QP>A%%WL'*NQ=^S0_\\D_[Y%'V:'_GDG_?
M(JC!KUA<Z]<:/#*6N[>,22*!PH/3FM*E=ARKL1_9H?\ GDG_ 'R*/LT/_/)/
M^^1535M:M-%AAEO2P6:584VKGYF.!_.KX.13NPY5V(_LT/\ SR3_ +Y%'V:'
M_GDG_?(IE]>P:=92W=T^R&(99O04^"=+FWCGA.Z.10ZGU!&11=ARKL'V:'_G
MDG_?(H^S0_\ /)/^^1535M8M=%MXIKTL$EE6)=JY^8]/Y5?HNPY5V(_LT/\
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M=]LBL[FU7=M"W*!6/OP3Q6K7F=W?>*-+.E>&[75DN-1U$-(+R6%0(8U"\
M'K0/$WB'2(/$&CZM=QW%_861N;>\C0#<,#J.G?THDTDW_6FX13=E_6NQZ939
M'\N-G()"@G KR>]UKQII_P .X=9GU6%KR\DA6%5B7" GG/'>M*SUCQ1X?\4V
MFF^(=0AU"+4K>1XF2(*8G49QP.13::NOZVN"=TF=QHNL1:W8?:H89H5WLFV9
M-K?*2,X_"M"O+(O&VMMX.LEMY4DU34M0EM(9I$ 6,"0KG XX%6M+O?%NE?$6
MPT;7=7COK6XMI)?DA522"O7 ]Z-W;^MK@]$W_6]CTFBBBD 4444 %%%% !7C
M>L&_T?XBZYXDTN.2=[0Q136Z?QHP;M_O!:]DJE!I%E;7UU>10@37>WSF))W8
MZ<'ZTK>]<?2QXS8RZGX;U'7M6=F_M*\L$N'+<^5O;C_OD8_*MH3:GI/B*QCC
M\3W.H1W5A-,\;29"L N#U]Z]"O\ 2M%AFN=1U&.)#<1""9Y6PK)V&#Q69;^!
MO"NCR-J,=JL.V-E,KSL0J-C(Y. *.G]>?_ '_7Y'G^HRZG:?##2]9U._N=5N
M)KF"58V.<?,,**G;Q9JQ\&OJ(O+K[=>WRP30*1NLUXX4$@ XYSD5Z6GA[1[G
M1;*RCA62RMBDEN%<D#;@J<YY[4R?PAHEQ->2S62DW@ G^8@-CH<9P#[CFJ>[
M]?\ +_(E;+^N_P#F>;SG6-5\(:]:7ESJ26MNJ20RSRKYK<\JVUCQW_"K,D%S
M:V7A;3[+Q/>117O^NF,^2!Y8.T'/%=OI6F^&--L)+&P>W,-VYB96GWF1@#E<
MDDD]>*P]4^&NGR:AI,%C9'^S89GDN%,[97*X&,G(_"CK]P=/O.>O]0O&L[C2
MKJ];48K#5(!%=.<E@0W!/<C'ZT_6-1U74;/7]4'B.;39-/G:&&TC?:-JMC)&
M>2<?K7H4/@_1+?3(["*S"VZ2B8#>V2XZ$G.3^-4=2\&^%=?U:=[RVCFNP!YR
M),RGV+*#^II>7];+7\!JV_\ 77_,Y8ZAJ>NZG+;2^(9-(2QLHI$(;'G,PR6;
MGD51USQ+K5SK2645W>E8+)94ET\JHF<_Q'<R_+_C7=ZKX5\,:E>6EOJ,$1N(
MX]L*>:59D7M@'+ >]6=3\&Z'J_D?;+('R%VQF-V3"^GRD9'M1_7YA_7Y$OA:
M[O;[PS97&J1^7=-'^\&0<GIGCCGK6O4=O;Q6EM'!;H$BC4*JCL!4E.3N[HE*
MRL%%%%(84444 ,F_U+_[I_E7A>C3ZOX?COGTB&6XCUR\GM_EY$,OF$;OIC->
M[$!E(/0C!JGIVCV.E6Y@L8!'&9&E()+?,QR3S[FE;WKL=]+'CN@&\T'1Y=%M
M+YK/[5K)AFO,\IE$).?4DFKM[?:QID7B.RMO$=S=FW%N()VDR8RS8/>O0KSP
MYX=%O+8WL,2KJ,YD*/(09), 97G(/ Z557P9X5T:UFB:!8([QT5S+.W[QE.5
M&2>O%/>U_+\D'I_6K.(\87VI^$KW0IX7N-7U#[-*5=AD[BK<_09I=2\0ZBEI
MH5C::CJ%S'>Q23S7-NX\QF&WY0688 STS7J4VC6-Q?VUY+ &GMD*1,2?E!&"
M,=ZR;KP5X;&F/!<6@CMED,V?-9?+)ZD'/RCV'%+^OS_X<%T/.-9CU36?"^CW
M.LWMY:M#J0A5_. +)OPKMM)&[&.];^IPW<OC*RT:'Q/=VMHMAYAE$_S2MN;G
M.:ZM-'\-7VBIH42V\UH\8E2%9<DKG(8'.?3FL.\^'5G>>*[4S6K-I5O9>4A$
M[!E;<QZYW=ZKK;S?Y6_,.E_+];_D<RVMWT[Z)/<R_:YK&\N(XY_^>P2-L-3D
MO=5^SZ%K!\3SR2W]]&LUDKX55+@;0,]J]*C\+:/"EDL=FJ+8DF  D!<C!^O!
M[UE6O@?PE=:A_:5G;1R2Q3^8&CG8JD@/H#@'-"T:_K^KB>J_KS_(YRRO=2U2
M:XUF7Q*;&2&\,*V+G]WM&."/4Y]*S-:\3:]<^)=5^QOJ$;6$RI;Q0,BPM_O[
MF!.?IWKOF\*^&+WQ')>?9X9-0A(>1%D/RGL60'&>#R15C4?!NAZKJ:W][9[K
MA2"65V4-CID X/XU*Z?UV&VM?Z^1J6$LLVG6\MPNR5XU9UST..:L4BJ$4*HP
MJC  [4M4]R5L%%%%(84444 %%%% !1110 4444 %5$U6R?59--6X4WD:"1H>
MX4YP?TJW7C_BN:[TKXL7.OV9=UT^SB,\*\[XR6SQ^ I77,DQVT;7]:GJK:I9
MKJJZ:9U^V-'Y@B[[?6K=>,:+J5XWCRZ\4W@<K=:9-/;PL/NQJ?EX]P!5W0/'
M.NR7UM=7!N[RUN@QDB-BR) .Q#[1G\S3V6O];_Y"ZNW];'J%_J=IIB1-?3"(
M2R"-"0>6/0?I19:C:Z@9A:2B0PN8Y, C:P[<UY)J%QX@UC3M"UO4-3B>SO+^
M-ULUC \L$'&#C/ZUJCQ1JD5O?6MD\,5S<ZO]DAF,:@1 XY.!R>>]-)[=?_V?
M\QNW]?/_ "/4*ANKJ&RM9+FZ?RXHUW.Q&<"N!O\ 6?$F@:3+9W>H6UY>RW$<
M,%UA04WYY91Z8]*I7&I>)-)O-;T_5=6CU!8-,,\1,"##9'48YZU+=E?^MK@E
MK_7>QZ;%/'/;K/$VZ)UW*WJ*AT_4K35;07-A,)H22 P!ZCZUP+:MK^N7T&E:
M1?Q:<+?3H[B:0Q*3(6!X (P!QVK6^%@D'@2W$S!I/,?<PZ$YJK;_ -=;$]%_
M72YV5%%%(84444 %%%% !1110 444C8VG=TQS0!AOXT\/QZK_9SZG$+K?LV8
M.-WIG&/UK0U76+#1-.:^U2X6"V3&9"">OTKSCQ_I\*:"+K0X;!]*CN!+>2Q8
M,VX/EMK>M=/XQL/[;\$1VUK<0P,YC:-KDX4G' -+[-^MQZ<UNAIZ/XOT37[E
MK?2KPSR*NXCRG7C\0*VB0!DG KB?#^L:C9^*%T/7=/L89YH#+#-9+@,!U![U
M4^)NO>(-%TV5+6&U&G72>3]JW,)(G;CU_7%6H\S274RG45.+E+H=_'(DL:O&
MP=&&0RG(-*[K'&SR,%51DL3@ 5YE\+/$&NZI9Q:>L-FVF:>@B:Y);S&XX&,^
MW7%3?%'Q#KNCV4MHD%G_ &9J$;0?:,MYB9&&&,_KBJ]F^?DZF?UB'L?;=+7/
M1PP905((/0BAF5$+.0JJ,DD\ 5YS\+]>\0:OI\4$T-JVFV:^2UT68R2,.V,^
M_7%0_%/7]?TNSDL1%:Q:;?\ [I+I6;S!QEE//H#S2]F^?DZ@\1!4?;=+7/3%
M8,H92"",@CO2/(D2%Y&"J.I)P!7 ?#/Q%K^O6(6Z@M!IUF/(%P"?,D8 8&,^
MA'.*I_$G7==M91HTT5G#INHNL<5VK-YB_,#SSQTZT<CYN7J/V\/9>UZ'IH((
M!!R#T(ILDB11EY&"*.K,< 5S/A74-5O':"06DFG6B^2EP@8/*RC'0GVZ]ZI^
M(9-3O]2;1-3DM+/3K@&19U+;G1<9!.<+R5J#<[2BN;\+7^LWID2^^RR6EL3
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MK:/J4>DZ3/::A',3<7$DA;,9S^](.>[D\=LU)H=U10,XYZT4 %%%% !1110
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MHS-\/+Z-&V,Y10P[98<UY]K?B75-3\#KX8RR:C:KF^DQ_P LEQ@_CG]*]?\
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M,&M:>UE>-((7(+A&QN [?2JUKX9TVQU9-0L8FMY5B\HJC?*Z^XK7HH ****
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M;?\ /2L"BCV:#V\C?_M&V_YZ4?VC;?\ /2L"BCV:#V\C?_M&V_YZ4?VC;?\
M/2L"BCV:#V\C?_M&V_YZ4?VC;?\ /2L"BCV:#V\C?_M&V_YZ4?VC;?\ /2L"
MBCV:#V\C?_M&V_YZ4?VC;?\ /2L"BCV:#V\C?_M&V_YZ4?VC;?\ /2L"BCV:
M#V\C?_M&V_YZ4?VC;?\ /2L"BCV:#V\C?_M&V_YZ4?VC;?\ /2L"BCV:#V\C
M?_M&V_YZ4?VC;?\ /2L"BCV:#V\C?_M&V_YZ4?VC;?\ /2L"BCV:#V\CH5O8
M&5F5\A>OM3?[1MO^>E9-O_QZ7'T%5J.1#=:22-_^T;;_ )Z4?VC;?\]*P**/
M9H7MY&__ &C;?\]*/[1MO^>E8%%'LT'MY&__ &C;?\]*/[1MO^>E8%%'LT'M
MY&__ &C;?\]*/[1MO^>E8%%'LT'MY&__ &C;?\]*/[1MO^>E8%%'LT'MY&__
M &C;?\]*/[1MO^>E8%%'LT'MY&__ &C;?\]*<E]!(X5'R3T%<]4]E_Q^Q?[U
M#@K#5:3=C9.H6X."_-)_:-M_STK#E_UK?6F4>S0O;R-_^T;;_GI1_:-M_P ]
M*P**/9H/;R-_^T;;_GI1_:-M_P ]*P**/9H/;R-_^T;;_GI1_:-M_P ]*P**
M/9H/;R-_^T;;_GI1_:-M_P ]*P**/9H/;R-_^T;;_GI1_:-M_P ]*P**/9H/
M;R-_^T;;_GI1_:-M_P ]*P**/9H/;R-_^T;;_GI4\4JS)O0Y':N9K?TW_CQ2
MIE%)&E.HYNS+5%%%9G04=6_X\O\ @8K$K;U;_CR_X&*Q*WI['%6^,****LQ"
MBBB@!LDB11M)(P5%!+,3@ 5D?\)AX<+;?[;L,YQC[0O^-6M=_P"1>U#_ *]I
M/_037E_A*_\ "[:38VUWX?NIKHDJTPM\J3N/.<U-[RL6HKEYCU"TUFRO=2N+
M&VD+SVP5I!@X /3GO5^O.SJZ:!XF\37PCW^5%"$CZ9)R /UJU:>)/$>FZCI_
M_"26]K]DU)PD9@)W1,>@.>O44XRYDA.#5_ZZ'<2.L<;._"J,FJNEZK:ZQ8K=
MV+EX6) )&.0<5R.D^(/$>JZUJ2"*U73K*9T+D'<P X&*KV_C._7PG8O:VT#Z
ME?W+00HHVH,$\G\!24KJ_>WXE<CV.TDUBTCUJ+2G<_:I8S(J[3@J/>KU>86]
MYK-G\1H9_$ZV^Z&P=P]OG!7GL:?=>+/&!T(Z_;V]DFG2,ICC;)<(6 !/YT*2
MLOZZM Z;OI_6AZ914-G*T]C!*^-TD:L<>I&:FJWH[&6X4444AA1110!9NO\
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MS_X_(_K4-36?_'Y']:3V*CNADO\ KG_WC3*?+_KG_P!XTR@3W"BBB@ HHHH
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M';&*I3:WK\#ZMI^NK93>38F=/+0X8Y'49]Z3E9?UVN)0;._21)(Q(C!D89#
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M YJMK-[J5]?2:*D"6:2?,MT9N70==HQUSCOWJ+FO*[V.HJ>R_P"/V+_>KG-
MU;4-0DDAO+.-%MQL:YCEW*\@.& &!WS71V7_ !^Q?[U#V'%6DB.7_6M]:HWV
MJ6.F*K:A=PVP;A3+(%S^=7I?]:WUKF?$ND076^\BL(M1OXX]L<$LFU<>O0TF
MVE<$DW9F_%/%- )H9%>-AD.IR"/K6:/%6@FX\@:Q9&7=LV>>N<],8S6-\/OF
M\&M"21*DDB/&W_+-O[H]JYW3HI?"\:OK.@6\UL;HG[='+N9=S\$C'J1WIM^\
MET&HZ/NCU$'(R.E%96MZI<Z;I'VW3[ WV "8U?:0OKT-<!H7CC4SKESY=C]N
M.HRAH81/CR5&>/N\CG]*OE;NUT,)5(Q:BWJ]CU2BL?7]7O='T<7MOIWVLH-T
MT:R[=@QR<XY KA?#OC75VUFXC2Q^W&_D\V.%9L>2.C=NG2A1;5T$JD(R46]7
ML>I45C>(M8O-$TT7=MIOVT+S*JR;?+&.3T.17$>%O&6KMJ4MH+(:A)>S&88F
MQY0P!CIT  H46U=!*I",E%O5['J%%8GB;7+S0=/6[MM.^V1C_6D2[?+]^AXK
MG/"^M:M'#&# E\=0F:9 )\&!"Q'/R]!S2Z7+NN;EZG?45CZ]JUYI4$<EO9K-
M&V1)(TNT1>A/!XK)TV[U?2;R/39(8]0>X;SG=9\&+<<OD8Z G _"E<KE;5SK
MJW]-_P"/%*P*W]-_X\4J*FQM0^(M4445@=A1U;_CR_X&*Q*V]6_X\O\ @8K$
MK>GL<5;XPHHHJS$**** *VHVS7FEW-LA"M-$R GH"1BJ?AO27T7P]:V$[)))
M"I!9.AY)_K6K10%]+')7G@QM0U#6I+F=1%J"1B/;G<C+SFJ]GX2UJYU"Q?Q%
MJ<-S:Z>P:".),%B.A;CZ5VM%))+8IR;.?T/P_/I<>JK++&_VV=I4VY^4$8YK
M'3P'<KX7M+1+Q(M0LIVG@G4$J"2>#^!KN**.56MZ?@'.SA[+PAK=QXD&I>(M
M0M[I/LS6YCB4C /X>]4KGP-XD.CG1;;6+?\ LQ&'EJZ'?M!!VDX]J]%HHY5_
M7WC]I(BM(C;V<,+$$QQJI([X&*EHHJGJS/8****0PHHHH LW7^HM_P#<JM5F
MZ_U%O_N56I+8J6X4444R3E?B0)&\#W:PMLD+(%;T.X5R&M>++V_\$1Z3$2NI
M@;;O_81<9/XY%>B>(]';7=%DL4E$1=E.XC.,'-4[WPC97%M>-;HD5Y=PK$\^
M,]/:LW%V9M"45RWZ'/OXVETRVMK&RBMG-K9QR3FXF"$C:#A<GDXK1N/&-W>M
M:0>'K%;J>>W\]Q(^U47)'7UR#4-]X"FDN(9["[ABE\A(9S+ '#;0!D9Z'BKF
MH>$KHS6MUHNH"SNX8?(D<Q@K(O7H,8Y)JY7;?K_G_P  E<J2]/\ +_@G-:!?
M!+;2VOK1?.EU2;.7/[H[6)Z=>E=!:^+-5O;P36VD^9I1N#!YP;Y^&VEL>F:9
MIW@>>TM]/2YOUG>UNWN';R\>9N4C'7CK3[?P=?VFH!+?6'32Q.9_LP3YLD[B
M-WIFE&Z:7]=!R<7=_P!=?^ 4[_QOJZ075_INE1RZ;;R^499),,3D9./3FIV\
M10:;J6LWC6@\R.*$Y5B3(S!0![<D5%J'@34I4NK33M8%OIUQ)YK0-%N(/< ^
MG%:,_@U;I]2\^X^6\CC5=JX,;(!@_F,TE>P/DO\ UW1D6-]J][\0=-;6+&.U
MS:R-'Y;[L@^OO7?UR.D^%=6MO$-OJ6JZNMX+>)HDC$6W@]^O6NNJUI%+U_,B
M3O(****"1T?^L7ZBI;W_ (_'_#^511_ZQ?J*EO?^/Q_P_E2ZE?9(****9(44
M44 <)\2Y+V&319=+/^DQW)=1_>QCBL/Q%XFE\1ZEHHTYB+.&>-[@_P"V0<+_
M #KT#6-%;5-0TVX$H064QD92N=_3C]*HWO@RS:WCBTP): 7@NI/ESN(SQ^M3
M%-/7O?\ +^OD:\T;>=FOS_KYF3J'Q$-KJ5TL$-NUG9RB.8O,%D)XR57/.,TW
M7?%&I:C::E#HNG)/9V\>V:9WVG)&< >U6;KP'(VM37-E=PQ6UQ*))HW@#MGO
MM)Z9I=3\%:A)<7?]C:L+.WO0//B:+=D^H]*EJ3A9_P!?\ I."E=?U_P2EHFJ
MV^F_9)9[<9AT596E#') "_+BM.Q\5:K_ ,?&KZ4+>QDA,T<T;;L <_-Z4^V\
M&!"BW-P)(AIHLF4+@GI\WZ4S3_"-^CF+5M6:[LDB,44"IM^4_P!X]ZN7,V[>
M?YO_ (!"Y;:^7Z?\$I0^,];>XTU[C2(HK'49=D<ADRP&TD9'KQ3;+Q*;#2BF
MEZ>K7=S?RPQ0[SAB'.6)/3UI\'@?54N]/$VM"6RT^7?#"8N<8( )_&K+>")A
MIH2WO_*O(KM[F"<)PI9B<$=^N*7]>>Z_X(/E_K;K_P  A\'3WUQXLUUM4MUM
M[C;$&1&W#^+D5VU<WX:\.7VD:C?WNIZ@M[->;,E8]NW;G_&NDJELB):R;044
M44""IK/_ (_(_K4-36?_ !^1_6A[#CNADO\ KG_WC3*?+_KG_P!XTR@3W"BB
MB@ HHHH **** "L=O#MM+K=WJ$[>:+J!87A905P"3_6MBB@+M&*_ABS;4H[D
M?+$EJ;40*H"[#5/2_!JZ;=!CJ-Q/;*"([9C\J@_S_&NFHI60^9VL<8/AXBW%
MOLU:[%I;3"6&U)RJ^WZU=E\$VLMG=0FYE5YKG[2DJ\-$_M^5=-1196_KR_R0
M^>7]?UYG+KX(@?2Y[:\OKFYGF</]I=OF0CH1Z=34-OX$V27LEWJUS=RWEN;=
MGD ^4>H_*NNHHL@YI',7W@J.X>"6SU"XLIXX! \D/61!TS^9K3\/:(GA[1HM
M/BF>=8R3O?J<UJ44UH)MM6"BBB@04444 %%%% !1110!9M_^/2X^@JJ0&4@\
M@\&K5O\ \>EQ]!5:D4]D<C-X AEFD0:E=+I\LOFO9 _(3G)&?3/:M"[\+I>V
M]U!->W'E3%3$JMCR"O3;6]1196L',[W.>T;PJ--U(W]YJ$^H70C\M))OX%]
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M2+:D0)!)QG)/ [U%??#.8O:W&F7UO%=1VJ6T[3VXD5PJ@9 ['BO0J*/Z_/\
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MITO$B#3*\14*<<\_6JFJ^())3<:=HT4YU!2%W&([8^^2?3BE<OE=SHZGLO\
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M+<?K6:^D:II-GX;O[6".6_L;80R63R!6<%<''N*])K%\0^&;7Q#'%YTLMO/
MVZ*>%MKI2M9:?UO_ )E*5WK_ %HE^AP5K:ZAXJ\3>(;;4;9;&>>Q1%CW;MG+
M8R14M_#XNU+3]-TN?0E2.SN(VDG64$,%[@5V_AWPO:^'A,\<TUU<SD&6XG;<
M[8Z"MNA1M;Y?@[@ZFK_KI8Y+0-)O;76?$,US;E([J0&$DCYQL4?S%7/ ^GW6
ME^%X;6^A,,RNQ*$C@$^U=#13BN7[K$.5PHHHIB"BBB@"S=?ZBW_W*K59NO\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD)
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M=KK%@]G?(7A<@D!B.AS1RZ%JHN9/^M[G"/9ZKXBNM/D&CMI\=C"Q9V(S*2H
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M1A[!=SG/L=Q_SQ?\J/L=Q_SQ?\JZ.BCVC#V"[G.?8[C_ )XO^5'V.X_YXO\
ME71T4>T8>P7<YS['<?\ /%_RH^QW'_/%_P JZ.BCVC#V"[G.?8[C_GB_Y4?8
M[C_GB_Y5T=%'M&'L%W.>2TN!(I,+XSZ5)=VL[W3LL3$'&"![5NT4>T=Q^Q5K
M7.<^QW'_ #Q?\J/L=Q_SQ?\ *NCHH]HQ>P7<YS['<?\ /%_RH^QW'_/%_P J
MZ.BCVC#V"[G.?8[C_GB_Y4?8[C_GB_Y5T=%'M&'L%W.<^QW'_/%_RH^QW'_/
M%_RKHZ*/:,/8+N<Y]CN/^>+_ )4?8[C_ )XO^5='11[1A[!=SG/L=Q_SQ?\
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M1A[!=SG/L=Q_SQ?\J/L=Q_SQ?\JZ.BCVC#V"[G.?8[C_ )XO^5'V.X_YXO\
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M_.P?U_7W'5T5E3^)M'M-0CL+K4(8[M\8B)YR:U0<C(H **** "BBB@ HHHH
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MQ_X5V%%"T&,A5TA197\QP,,V,9/K3Z**!!1110 4444 %%%% !1110 4444
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M.R)Z***DT*.K?\>7_ Q6)6WJW_'E_P #%8E;T]CBK?&%%%%68A1110 4444
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MZNKJ&1@RD9!!R#70:;_QXI45-C:A\1:HHHK ["CJW_'E_P #%8E;>K?\>7_
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MA^O3'-"U?]=0_K[CK**9%*LJ JRDXYP:SO$/B&Q\,Z4]_J3E8P=JJHRSL>@
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MU;_CR_X&*Q*V]6_X\O\ @8K$K>GL<5;XPHHHJS$**** "BBLO6/$>E:#Y?\
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M]TI];!RMJYUU%(#D ]*8D\4DDD<<BL\9 =0?NY]:!$E%%,CFCF+B)U8QMM<
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M=VOC_3#=ZNVHF2T=QN ^0G^E>B52VOZ_F3+1Z"*H10J@  8  Z4M%%!(Z/\
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M;;_GG^M'M$'L)&!16_\ V;;?\\_UH_LVV_YY_K1[1!["1@45O_V;;?\ //\
M6C^S;;_GG^M'M$'L)&!16_\ V;;?\\_UH_LVV_YY_K1[1!["1@45O_V;;?\
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MV$C HK?_ +-MO^>?ZT?V;;?\\_UH]H@]A(Y2\TNUO[FUGN4+26K[XB&(P?\
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M;;_GG^M'M$'L)&!16_\ V;;?\\_UH_LVV_YY_K1[1!["1@45O_V;;?\ //\
M6C^S;;_GG^M'M$'L)&!16_\ V;;?\\_UH_LVV_YY_K1[1!["1@45O_V;;?\
M//\ 6C^S;;_GG^M'M$'L)&!16_\ V;;?\\_UH_LVV_YY_K1[1!["1@45O_V;
M;?\ //\ 6C^S;;_GG^M'M$'L)&!16_\ V;;?\\_UH_LVV_YY_K1[1!["1@45
MO_V;;?\ //\ 6C^S;;_GG^M'M$'L)&!16_\ V;;?\\_UH_LVV_YY_K1[1!["
M1@45O_V;;?\ //\ 6C^S;;_GG^M'M$'L)&!16_\ V;;?\\_UH_LVV_YY_K1[
M1!["1DV__'I<?056KH5L8%1E5,!NO/6F_P!FVW_//]:.=#=&32,"BM_^S;;_
M )Y_K1_9MM_SS_6CVB%["1@45O\ ]FVW_//]:/[-MO\ GG^M'M$'L)&!16__
M &;;?\\_UH_LVV_YY_K1[1!["1@45O\ ]FVW_//]:/[-MO\ GG^M'M$'L)&!
M16__ &;;?\\_UH_LVV_YY_K1[1!["1@45O\ ]FVW_//]:/[-MO\ GG^M'M$'
ML)&!4]E_Q^Q?[U;']FVW_//]:5+""-PZ)AATYH<U8:HR3N84O^M;ZTRM\Z=;
M$Y*<_6C^S;;_ )Y_K1[1"]A(P**W_P"S;;_GG^M']FVW_//]:/:(/82,"BM_
M^S;;_GG^M']FVW_//]:/:(/82,"BM_\ LVV_YY_K1_9MM_SS_6CVB#V$C HK
M?_LVV_YY_K1_9MM_SS_6CVB#V$C HK?_ +-MO^>?ZT?V;;?\\_UH]H@]A(P*
M*W_[-MO^>?ZT?V;;?\\_UH]H@]A(P*W]-_X\4H_LVV_YY_K4\42PQ[$&%'2I
ME)-&E.FX.['T445F= 4444 %%%% !1110 444A(526. .I- "T5!9WUKJ%L+
MBQN([B$G DC8,/S%5SKFEBWDG.H6WE1R>4[^:,*^<;2?7/:@"_12 AE!4Y!&
M013)YDMK>2>4X2-"[''0 9-&P;DE%4])U6UUO3(K^P<O!+G:Q4C.#CH?I5RC
M8 HHHH **** "BBB@ HHHH *J6^J6=U?W%E!.KW%MCS8QU7/2K=>-ZI?W?AO
MXF:WXC@WRVD'EPW4*C.58-AL?4 ?C2O[UF.SM='K,>J64NJ2:='<*UW$@=XA
MU53T-6Z\/TG4]2T'6M?U^ZS)>WEDD\:/TC#-A!] ,5T/]I^*](UZSAU#6H[N
M&[LIIPJPJ-K+MQVZ<T7LM?ZWT_ +:Z?UM_F>BW^IV>EQQO?3"%9)!&A(/+$X
M JUUKQC5=4U@?#?3==\1WHN_,NH)DCCC VC<#C@<DU>/CO5CX0;64NCYE_>"
MW@@2'<;0=.5 R6[X-/OY/_+_ #%V\_\ @_Y'JMQ<16EN\]PXCC099CT%.CD2
M:)9(V#(X#*1W!KR*]U/7]:\&ZW9W%Y=HELJ.EW+9^49E)Y4AE'MT%7=WB:PL
M/#.FV?B E]049FDA3Y$\L$*/E[4_^!^(=+^OX'I%_J5IID*2WTPA21Q&I(/+
M'H*M5Y+JVKZC/8RZ3K$ZW5QIVIP#[2B@>8K!L9 XSQ5C5M=\47]KK>K:3JL5
MC:Z;,T*6QB5B^TX))(]J72_]6T_S';6W]=?\CU*BO-_[:\2>(-0DM=(U*&P%
MC:12RM)&I\YV&><C@?2J.N^-=;;5TT^TN)+=[>T6:1K.U-P)G/;(!P/>@7]?
MU]YZM167X:U&YU7P[9WE] ]O<2)^\C=2I!''0]*U*;5G82=U<****0PHHHH
M**** "BH9KNWMY8HYYHXWF;;&K, 7/H/6BYN[>S56NIHX0[!%+L!DGM0!-11
M3)98X(FEF=411EF8X % #Z*K0:E97,B1V]U#*\D8E54<$LG]X>WO5F@ HHJ&
MVN[>\1FM9HYE5BK%&!P1U% $U%0QWEO-<RV\4\;S1 &2-6!9,],CMTJ:@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **SUU_27U$V":E:F[!QY E7?^6<U<GN(;6!IK
MF18HD&6=S@#\:.EPZV)**IZ?J^G:LK-IE];W87AC#('Q^57* "BD5E=0R$,I
MY!'>EH **165U#(0P/0BE) !)X H **0$,H*G(/<4I( )/ '6@ HI 0R@J<@
MC(([TI.!D\"@ HI%8,H92"",@CO2T %%%4]1UC3M)16U.^M[17.%,T@3/YT
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MLT %%%->1(\>8ZKN.!DXR: '4444 %%%% !1110!9NO]1;_[E5JLW7^HM_\
M<JM26Q4MPJ*.Y@EFDBBE1Y(L;T#9*Y]:EKRZZU6?P]\1M5U5R6T_Y(KA1_"2
M"0WZ8_&AR2:3",7).QZ8+F!KIK=94,RKN,8;Y@/7%2UY)I&MWNG:YK>NWRF2
M2XM5D@B)QA2V$'Y8_.MU/$'B>QU>"WU7[$T5Q:R3IY2G(*XP.OO2YM-?ZW_R
M*=-WT.YN+J"U56N9DB#,%4NP&2>@J6O+-3UO5+KP78:QX@\B.)KF&5%A!R%R
M#DUI-XZOE\-OJX-NL5U<"&S5@?W8Z;G/]*?-O?I_P/\ ,7(]+'?NZQH7D8*H
MZDG %*K!E#*<@C(([UYE>^(]6UKPKJUM'<VS36H5FN(XFV2(3T )X.<5=&I>
M*+#3]"LH;BREGO5 #M$0%0("._)HO^GXAR:??^!WEQ=06JJUS*D2LP4%VQD^
ME2UYOJNLWM[I_P!AU=8Q>V6H1!VB^ZX(;!'Y&K.I^*/$4L>I7^C+:)8V$AB*
MS EG*G!/M2YE;^O+_,/9O8[^BN'D\1Z_J=X;?0H[4&UMXY)S-GYV89P/2JVM
M>.K^WU!+.W:VLY8K<33"<%MQ/\*X_G3<D@4&ST&BL_0M3_MC1+:^*&,S)EE/
M8]#6A5-6=C,='_K%^HJ6]_X_'_#^511_ZQ?J*EO?^/Q_P_E4]2_LD%%%%,D"
M<#)J*WN8+J,O;2I*@8J61LC(ZBG2_P"I?_=->1^'_$-SX:BU..;=)'?W$WV+
MCI+O*[?ZU+E9V+C#F5T>M074%R9!;S)(8VVOL8':?0U+7E'A?4M3T;1KBT@V
M2ZG>:D8U:7[JDJI)/TS6G/XI\2Z?;ZQ%>BS>[LQ%Y11"%;><<\T^96_K^NH>
MS=]/ZUL=^]U!'<);O*BS2 E$+<MCT%2UYGKVOW.@:GH^I^(/+:X$$I"0@X)(
M.!_*K>H^,M3L;33;>2>SBO+U&F,S(3&BC&!@=3S2YD'(W:QWTDL<6WS75-QP
M,G&33Z\JUK6M8U_1M)NK6:"!EOA$^8R0SAL!AR./:M^^U3Q0NO6VCV,UD9C:
M^;+*\1QG)Z#/M3O^?Z7#D_KYV.QENH(9HXIID224XC5F +'V]:EKS6Y\02WU
MYHMY?1A)[2XF294/!94;.*L+XF\3YTV_D6S73[^Y6-8PI+JA; Y]<4)W_K[@
M<&CT*BN*M]?\1:C=27VGP6S:9%.83$Q/F,!U;/\ 2L_5_']W;ZU>1V<ELD%C
M($>&16,DWK@CI2YEH'LY'HM%0VDXNK.&< J)$#8/;(J:K,PJ:S_X_(_K4-36
M?_'Y']:3V*CNADO^N?\ WC3*?+_KG_WC3*!/<**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH LV__'I<?056JS;_ /'I
M<?056I+<I[(**B-S )?+,T>_^[N&?RI\DJ1)OE=44=V.!3)'45%%=6\[%89X
MY".H5@:EH **** "BBB@ HHHH **** "I[+_ (_8O]ZH*GLO^/V+_>I/8<?B
M1'+_ *UOK3*?+_K6^M02SQ0 &:1(P>FYL4Q=22BD5E9=RD%3W!J#[?:;]OVF
M'=G&-XSF@"Q1110 4444 %%%% !1110 4444 %;^F_\ 'BE8%;^F_P#'BE14
MV-Z'Q%JBBBL#L*.K?\>7_ Q6)6WJW_'E_P #%8E;T]CBK?&%!&00>AHHJS$\
MUM]3_P"$2F\563G C!NK8>N]>@_X%FLSPKJ]UX;\-ZW8:DY^T(@N8L]_,R/Z
M5T?C3P5=:_XDTR]LV58%95O 6QN0-G\:9XN\#7.M>)-+N[$JEO& EV-V-R#&
M/KWK-1=K/KI\N_Y'1S1_7Y]OS^\J:+JNHZ'IMCH.AZ:+Z_%N+BZ,C[50MR>?
M7)JQ%\1+Q=!O[R]TU(;FVNA;"+?QD@<L>PYJ_J^B:W8^)6UGPP+>5IXA%-!.
M<# Q@@_A678>%?$<>BZF+H6C7EU=^?Y9^:.1=H&T^G2J;;N_ZW_R)]W2_P#6
MFOXEXZ_?ZMX:UB+4;2&(I;%DEMY0\;@CUSUK*\-^+M6TO1='&HZ0(M+E"0)<
M!P6R< $C/3-6](\(ZM#!J[S006?VNW\J.TAD+)N_O9)XJ]J'AG4+CP/I>EQK
M']IM9(6D!;C"L">?PH5T[^GYO]"7R[>OY(CE\3K8/XEN;73K<2V&QMRC!FSG
M[QJ/3_'.K"ZTXZYHZV=GJ)"PRK)N(8C(R,T7/A/4Y8O$JJL>=1$8@^?KC.<^
ME7=:\.7U]I>@P0JA>QFB>;+8P%&#BG&]U\O^"-\NWK^2L5+GQMK$\E]-H6C+
M=6-BQ225Y I9@,G:,US_ (GU[6M9T;PYJ$%E;JD]PDB@R'_6;3\OTZU8DCU?
M2+36K?P_=6%SISR.\CR/\\#$#<,9YJU8Z#>ZO\,-#^P%%O+4I/&LGW6(&,'\
MZA7>O;E?^9;LG]Z_ V+_ ,4ZQ8I96 TR*?6KH%O(C?Y$4$\DGV%5)?']W;:'
MJ;W>G"'5-.V[[8ME6#=""/I3KW1_$UQ/I^NPI:1ZO;HT<EN6S&Z$GOGWJI/X
M.UJ_TO5KK4#"=4U H!%&<(BJ2<9_&F^;7^O2Q*4-/Z]2]IOC+5?[7L;;7M)6
MRAU ?Z/(K[CG&<'GC@5VM<OK6@WM]>:!) J%;&8/-EL8&PCCUY-=16G3YF+Z
M>@4444@+-U_J+?\ W*K59NO]1;_[E5J2V*EN%8Z>&[0WVHSW/^D)?E"\3J"H
MV]*V**=B;M&!>>$;&]N[N6=F\NYMA;F(# 0#H16?;> _)U!+NZUBZNC'"\*+
M)C"JV/\ "I_B)+<0^"KM[*1HYP5V,IQ@YKE]<\:W-SX"A@M,KJLHV3*#S&%Q
MN/ZBLVTK_P!;FT5)I6>YUTWA"UN/#MCI$LS-#9M&P8J#OVD<$?A5>7P'9L+N
M.*YEAAGD66.-!@0R#^)?TJJOC+^S[.UM8+*6^DAM(Y;EE?'EC:#GIR:N7OC-
M!]ECTFQEU">YA\[RXSC8O3)./4'\JN5DWZ_U^7X$1Y[+^OZW+5EX86'2KNSO
M;Z:]^U#:SR'&/H.U<SJ7A.]@OM#LHM3O)%CE<K<A>80%X'T^M1:!JHDMM-EO
MEN1)-J4H53+C9\K'##N..E;\7C;S]0"Q:7</8&;R!>#[N[..F.F>])6;7]?U
MN4^:-_G_ )?H.C\$6ZV/E27<TL[W"W$MP_+2$9P/IS4&J> 8[^>[^S:I=6=O
M=MOF@B/RLW7-1W_C]K;[1-::/<75E;R>6]RKX7=^7O4P\06=AJ>KW<RS PQ1
M,P+Y#%@,!1V.2!1[KU%[Z?\ 7?\ X(^^\$17$R26FHW-DYA6&8PG'FJO3/O3
MKWP1#--%-87T]C(D0B=H^3(H]<]_>LNRUV^U3Q]IRW6GW&GH;9V".^0X[&N\
MII75_P"NHFY1=B&TMA:6<4"NSB-0NYSDGW-34451F.C_ -8OU%2WO_'X_P"'
M\JBC_P!8OU%2WO\ Q^/^'\JGJ7]D@HHHIDB,NY2OJ,5BZ;X6L;&U2&91=>7<
M/<1M(HRC,2>/SK;HHZW"[M8YB;P3:RVUP@NI8Y9;K[5',G#1/@#C\JKP^ D6
M*]%UJMQ<R7AC+R2 9&PYXJM\1]0O]-?1KC3"QD2Y+-&#]\#&165XG\6R:IJ>
MBP:-(?LQF22Y=3TR#A?Y_E4QM=)=TOR_KY&UI6O?HV=GJ/ABSU34;.ZO/W@M
M8VC$;*"&R,9_6LL^ HEM((X=1GBEMF;R)@!E$;&4]QQ2WOCN&UOYXX[&6:TM
M9!'<70; 0_3'.,U6\0^,9'MK^VTG3I[N.&/$MS&V!&3^'-)M6NA14[I&K<^$
MHKOP]'IDM[.TD;B1;DMEPX.<U@7GAN_N/&5K$FI7D1AL=IO%7[YW-P>U3Z%J
M]O:&SENVF+QZ.LTCM)E2 %[>OO6A8>,S<39OM+GLK=XS)%.YRKJ/PXJG92^_
M]4).5M/ZV8^+P1911V*"61A:N[L6Y,Q8$$D_C5-/A\B75LPU>Z-K:SB:&V/*
MK@YQ]*2'Q[+-=62/HMQ%:WTFR&X9^",$YQCVIMEXGM]-TAWMK:YN)YKV2&*
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MW][D.O(R.GM5^Z\'3WDFJ>;-&@NHX?)9<DJZ!<$^V5KT;^QE_P">IH_L9?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
DB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>moh-20201231_g4.gif
<TEXT>
begin 644 moh-20201231_g4.gif
M1TE&.#EA;@.G G   "'_"TY%5%-#05!%,BXP P$!   A^00      "P
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M-S>9F9G5U=4
M
M
M
M
M           (_P !"!Q(L*#!@P@3*ES(L*'#AQ C2IQ(L:+%BQ@S:MS(L:/'
MCR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-FSASZMS)LZ?/GT"#"AU*M*C1
MHTB3*EW*M*G3IU"C2IU*M:K5JUBS:MW*M:O7KV##BAU+MJS9LVC3JEW+MJW;
MMW#CRIU+MZ[=NWCSZMW+MZ_?OX #"QY,N+#APX@3*U[,N+'CQY CUZ4@H+(
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MRLT66Y!2.IE?;@LJI"%I H&78&F5-0?BC9NMUYY] L17)D.[:7>?F#16UJ-
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MI>).,@%9/9T]DXU$<B/FNM/'@]!0_X\A$N@GR;<9 *;'77YCX">MI!E0@.<
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MV'ZFT9058GO,XH_+Y"#&YWVL"#KO>9@2"2K4-!K!H8ISB"FNR3G,:2%JXB:
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MM->M;PL.X%^7E05>BV$0=_^+TCV#?(]%YB$/!<&$8%5!5;9\F"YUGR)?^DI
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M$CS=:@'^TY<!Y OU8R>UL\44;UL8\EM B.BLW&LZ"J2E^*( "). ^T*6\^/
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M1F4JM\"N9?![8)<,1*:NN8J!_[G"'49L>$,<$K&(1J1-30 F@M_-K2"309@
M\!03@X#I732Q";,&U+5G20<YU#,A&,,HQC$:1$<H5-G:..4;485*  XBB([@
MTAL),$=.8B)3>2RRO/BA*3>*&V+]D#:1L8 (97G;(6IX-Y?YX&\UN;K=2.@G
MR=J!XI&6M-_1\%>>9?UN:4UTR2'6E["-]*1K>DQ;0<S3*Y=(SS]:NQ898RG+
M68J10!V)V>E4!@ LJ8R7")&=H?0T,-3H<8A>:ID0NX3+=2WF7_/I76ZT]QD/
MF2AY) 'D&P]U+%CYYT]9I"4XPRG.[H%+*K:,W1<'-$SDE:M]SGSB;Z3&O&6F
MRX:XFRL/'S"D3S!Y*GC^3-S_Y.07_2'/(@TLU$#.^;@ 68V5$JB(!C?XS7%2
MM*(6_Z7H;S*4SJ>0Q90E:I]\3'*@@NW,+.:92S;=)C\QE/&!+)69_'X"1PO:
MI8D]D6:<QO,7SD%N,!.]*%"#*E19!DDS?7FHF7C*("7.(G&-&AY )8#'31[%
M( 6 Y"6QFM)$ZC-&POME 0Y!F>'\A'4&H1<Q(UH3DZQRJ&Y]*US!6%32%-)A
M[63>(8Z63]SD;:-/D@V?:G(7.Y&%/,5\7%[S^=.X,K:QC@7=7+F#UHJ42ZD0
MRR1=]A>\3W:%0"&2*F4C2AOY8*BMCSTM:E,KMLA6R%-2-0^N6F;$VKWNF;R[
M;0*A22;?\6X^#-RC_&JR5Y3A5+7&/2YRF\3:1U6@+R(ZZ6S>;'C$Z=(F:X7#
M$,K,FMSM<K>[CUKNR'26-[-0M;SZ1!XC&6F2NC0U<;YRX2^]*]_YTG="X!6J
M=ME6W_WRM[^DN6]0;TA/_Q*XP 8^X8$3K. %,_@@'&HPA",L8>\">,(6OC"&
M*UKA#'.XPQY@)N&&/RSB$9-XM24^,8I3/+(0J[C%+G[Q@QX,XQG3N,;<8;&-
M<ZSC'5\%QSS^,9"#W!(?"[G(1CXRD8^LY"7G.,E,?C*44RSC*%.YRC1VLI6S
MK.4&8WG+7OYR?[L,YC&3='F[8BXSFM/LV#.KN<UN!NJ4WRSG.3^6S72^,YY+
M:.<\\[G/HMNSGP,M:)$!>M"&/C2VXHSH13.:;(5N-*0C':%'2[K2EM80^J)"
MZ4MSNM,MP1+>U.B1PEBQ(9OV-*I3;9!9W Q PU)7E&X6-%LI1-&JOC6NIIE2
M)3K"D=8"B1=..K604^>ZV)6^%*Q/YQ&D5$DBE[K@08AM[&DS6J%J;(U,)-+L
MV[AQV-3^-K@9HJB"Q*LUVU:?M\.M[G5WR-5OC-=7SAWJEUBJ/.R^-[B7@^Z!
ME)O;.-FV0J2-[X&G>== LM.NTS4L GVED@P1.,$C/F; 1)%<'E';Q1\N\8U[
M>CE2@3C'0XYH6XN\Y.H&N<E3GF>4J[SE<F:YRV-(GF:8R[SF8":YS7,>:9KK
MO.=1YKG/@ZYDH N]Z$$FNM&3KF.<*[WI;D:ZTZ/>8JA+O>HEIKK5L^YAK&N]
MZQ=FNM?#OF2NB[WL1 HFN]G33F"TJ[WM]66[V^/>7;#+O>XJAKO=\XY:O.N]
M[XSEN]\#/U3 "[[P%J6[X1//8,(KOO%$=3SD+<SXR%,>Q)6_DKR"$8_YS2-W
M\IS_O-D\#_K1KYCTIN>NZ$^O>FUI?O6NU_#K8S]&"D ;(JF7/>X_8T65*2:E
MT<X]\+VW'IMT6UW"3K=Q:_]8Y2\?N<QO[/.[LT(*U$D_#&=(ZX.:_8MNG_O(
M[7Y%P3_- J''+5\AD"X1<OMLK7]2[7=_YX_[_H)0O#50"TG; AY_X\X_4OV'
MU/\Y_TH BIH;F1_^^1I!P$2]60J&F)<#ZM,#1B $3J $5B %7J %9B &;J &
M=B $,B (<J (>B )CJ )EB *GJ *;M("KJ +IB ,OJ ,QB *MB -SB .WJ .
MYN *VB /[B 0_J 0TB!N) GQT9ZLH5_P+2$944"\4( 2&B 33N$(35^_&9]O
M4*$6?D^\H))*^=X6AB'H4)\8EJ$9GB$:IJ$:KB$;MJ$;OB$<WAI)#,1K. :!
MR,@<$F 6QE+;G%.F94JO#805^57WL)IMW$U'9(C6#(0A @"K]4LL 9QQ7%"W
MD<@>/F(EQE+ML$W&J= >!D[,1$;ZB='].:)'Z!*NF*(71F;&_&4<JNP2Z\0+
M)[).LL72N]A*3ZP+K5F$)[8-1[2&CD1B1VC$VKB%1KB0;6!)-B4<&2F&LW7;
M\7%$83"'1*Q-MI&1+67:-?+)0(15A] $E62AZ8@1VIS?RUS?NA#&.<I:E0!
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9-[_S/S_T1[_T3S_U"E>_]5\_]E=_0   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>moh-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:moh="http://www.molinahealthcare.com/20201231"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="moh-20201231.xsd" xlink:type="simple"/>
    <context id="i02376445555642e5babc277d1c377aa8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i87711e21c9a446419ccfe038aeb1835b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id8ecbcccccbd40c5a50d0279cba6e06e_I20210212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <instant>2021-02-12</instant>
        </period>
    </context>
    <context id="i91290aace81d4332aae71ba1a693cbba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">moh:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i29d5d2b833564b80aea7dee755e0e3dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia63feda4ad7347288920b133e5dbddb3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i849cbae5a8cc41beab243b6cc6768e11_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9fb34386ae3248e083608739601dbacc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:PremiumTaxRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7ceb7faf3f854c239783915d36ad2084_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:PremiumTaxRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i63f79365bc994640a161617bd7d8a916_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:PremiumTaxRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8c49bd707ea342d29798c305bec30c3d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:HealthcareInsurerFeeReimbursedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iec0f306ac4604ee3a72ab17c719868e8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:HealthcareInsurerFeeReimbursedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i286b19feb9c8495591834c5d364e760a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:HealthcareInsurerFeeReimbursedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib5cc2203bcc1458383a2cacf8cb24107_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MarketplaceRiskCorridorSettlementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i910d706f29214cf989874f3c7c9bdc97_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MarketplaceRiskCorridorSettlementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i57e45a9715ee49d6b1b20a8101922bed_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MarketplaceRiskCorridorSettlementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9a3782192ac74e9fa0c0cbe786a6c7f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idcc6d37095e148f38283ad63b84f7dbb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i146b66c41bd848eb8c57a3034d4d91d3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i234e4841fc374ed0ada5e87b17f10a96_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MedicalCareCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i38e404a0791d4aceab81d9b4037b1443_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MedicalCareCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3d89685788cc4fd09db979d7c5b577ba_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MedicalCareCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic5403d7768b644aab47e5ab6d7afe17a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7c4aed327cc445c2a43b20960c6bced9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id81240d8e0324ade9d13dfaaff5b72b2_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i4380ffd8981440aab0b911f97c293b09_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="id8aea4f34a3747f088cc40ece091110d_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i3d321ff569ec4e909207a3511e1de822_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ie5276df7533a434dba724ca46fb6260b_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6084d3cc32ce4e868de7c430f423cecb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5875c847748b49b7ae809be69c6d6256_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ia7fb1e9375a549e9ad146d29588db2b9_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i7987d66d3a0c45c991e3cab20c4fb866_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i8c6270cdd3704644bda480c6fd42c68a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0e7ec975f1cc4e07b1655f6681e39bae_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6a7ae69397d149d284b0dd9f61b2d2c2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2faff66f6e7145caa224e62f23b8c597_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3dafc291a0c24a16b8316afe33f2004b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i25c94a4e11864ff08869c043de0f5f6d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if65f9657d27d4a009acb818ef3881bcc_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i38b4b862a7374893891ea3a84e6c4743_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i02bdadf188dc494b844595ad20923df0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iabcc9c4754784b398a5fc79d9a7ebbf7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i73b8d399d58241d1bd9c438042e73b99_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id3ba89712ec942c09668e856ab29712f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i97919dee5de246a0b50148ddae7888fb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib0d1799cc9734f13b9ac873259cad7c6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3e22f922c9a84243aa86afcf1b64ac08_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifaee8551fee24ee384c466fe5ef25b9c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0fa5f12c2da940d8b68187f4bdf87af7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4047b057d87547648b481f3fb3ba62d7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifeaaeaba3f3849a081f3527f07ae1b82_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b04a987b49d48ef8c1cc6f8485617e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie5396d9352d1442a99bb72088a0b7ca0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i860bc85e749a4e47b38f4a7988debbe7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0e975e9f87c74535bf3d7c5035bcba82_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i183e269a3450453ab9a54b55cee9c2ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5fbc4f7185694bff8ff72e5ae4a739ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8327c36af50243d39623edb7b5bcb06f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">moh:CallOptionDerivativeAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb902f5430db4cec865e03899ec0a22a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">moh:CallOptionDerivativeAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i07b1e43b622b42d9b75e1ccb92389132_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">moh:CallOptionDerivativeAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i80c02cdb9f7a420cb8aedf486216882d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d11a4d46cec445aa76d23295e7aa22d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibb861312d6ab444ca32cfee48e0fd8a0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i39fce2981d2c41c1a14d47dafdc5e356_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc8845b2df0142a6ad693b5b696a900f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i507906be57d848b78ab7e7f688853ed8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i50a1c2e5665543b3bda779ef36e5094b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41056d0891344bfeb906ddd9f525ea3d_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i761083592e2c455daabbcd09515b7402_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:AffinityHealthPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5d73a7217fd343aba05c738abeb42788_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:GovernmentReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0fd3259008f84de5b99bebc752d5714d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:GovernmentReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i30812037b820437fa3a3e705d6ffa4d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:PharmacyRebateReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia17d974ef4c94bf497db882cd7110332_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:PharmacyRebateReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3bf6535594b64a3d916a78b3ed7e6f86_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:HealthInsurerFeeReimbursementReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib010fc19559144a59d49603a7da5ab41_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:HealthInsurerFeeReimbursementReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iea74ee4ad54b4f3c9e6446ba883edad3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:OtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49f572caee0440c88a9769d8359294a4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:OtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic3a81fff009c4556869db8332ba98850_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:CompleteCareReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i750cbea67aa745698f4ce14305876548_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">moh:CompleteCareReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i16e27438908a47a6b4b7849782a9d9b1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac48d7b081c44878865a5a148b146630_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic98f3f2874c74deca389d0f762617730_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MedicareMedicaidPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">moh:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i03c303598694422daa4534e5d0775ae3_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">moh:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8765abff68ce42c6992ad5c81c209878_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">moh:MaineCommunityHealthOptionsv.UnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i67312f647d5c42f885c6bf5c0fb8c961_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i25973257ed1e4cdfa54404c69e26ac16_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i11f1f4ff7526429394959a5edcf1f480_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">moh:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id49fb40faab249ee88628b7ca31ab180_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:StructuredSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i932eecd9dd8942a8930602c75ed75579_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic51cb18d6d6c41eeab7d71df5f748b8b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie971c5d38e9f4081bdcce44e29b31e8e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i794b72519ef741a4b1e5b3b064789239_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98e0308fdfb84b5cabb834a5d7d38846_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6ea8b394a2d04647a92ee82b142ff55e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i010f47d9164d4401aaf7500b3414201c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id99ab9a99c8b48109cb2e67859f4f1ca_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3b7453f2890d4ea8a57191c7b738e0ac_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5f146b00c28c496fab54a890e503b593_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iafd4a77f957a452ba104472004ee03d3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7501a92677af42b3bbf91f05377b6a79_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iff54c36d85a740d29de6dfed243ff5ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2c3a468249ee4c1f924f960fd9a0e7b6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5a12870bdcc84902a115a5c52be47a49_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i24117b22bd104e47bb18575a3e1087d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3f2abcdca8654dca825ae09845834f08_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibe7cd5fa2a6c4ee4893fa7aeea12f184_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i49d06937156847b795ad5d126b43c272_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6c749426a22d4f45b998723c923108b0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i963a1ad740774ea39b16fa5a48fc788a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i98c68a644f8043128dc74552813a54c6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8a53f8a4f88b471ca3904508a5f37fb1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6b530889282e4734a8cea1ff62dd4eb8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i623d20d86025415b904356ce36b3ec7a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">moh:OtherGeographicalAreasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife4529f238f148c6a7085542f5807c4c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">moh:OtherGeographicalAreasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2ed8f3b768cc45ce808afd1e8a44ddd3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">moh:OtherGeographicalAreasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i68756a4786524fe5b9fabbe3f97257d2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2fe995e49c0b4274a5ede86b839b44d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if30ced8758e642af8985042651d6cdb1_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i064898df32bb409d9725c5271969d63b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c05b89a6f0144e3b67780794556b45d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id47bfbaa31f34e6cbbc46b397397ad22_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:HealthPlansSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d9ad5f0f8564470964511585ae558dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:PassportHealthPlanIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idbd3989bdd36411bb81f15405becbc0a_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:PassportHealthPlanIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib80e56cc81004ffb9a966b132d1c37ce_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i55464af26be84fb3820ca5c44e160c32_I20200901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:PassportHealthPlanIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-01</instant>
        </period>
    </context>
    <context id="i72b43b1a1b4b4f1082ad9d20416d588c_D20200701-20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:YourCareHealthPlanIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-01</endDate>
        </period>
    </context>
    <context id="i5c8feb8bc88a45bab6f5586d910050f1_I20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:YourCareHealthPlanIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-01</instant>
        </period>
    </context>
    <context id="i5ac1df93bc0c4894960ea1adb84e0024_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i20850a7f15e24400b1b3bf58d9e096d9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibb7db7e5903548c1b07be8df527ac95f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if958004bf9004127b3dfe774c1c93182_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i733eec69c1db4095a58047c500e1ec76_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ProviderNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f80aa6d34e346a1a3b5dbdaeab0b9a9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ProviderNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6531b793e0c64805a9f24b4ce452eb0d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:TradeNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc5130895c0f47929310c0ab60eb616a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:TradeNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iebc139137e204e638a9cb2d71ee5dea9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:TradeNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0a7800a872f64f3fb068791db99f8252_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:TradeNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1537007f8b454c3b99a90841baabc2fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e7b354db3f541ca96ec5db2b700dd49_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i620ff45e952445d1ac715d4144df7597_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f297a74be174b0cb53664e81273fc7b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3db9d935bc9944d79fac14b03b028e17_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i58b1296e99cd47e4bf03290b7a26a478_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia70e312008164e878e7157499eee87d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if330308388ae40ac9a6862c3c5bacd95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id5ade1a543bf4bed873e58b761ad56ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff7c00132f94480c9854cfa010a9b0ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75ace7c20ffa424295b84956415a9b16_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11c3150f158849b7981e3f9bd3362f4e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i12998aefc9ee4f1faa798f4661c61421_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f2e1498903647dfb8ed82f5dfb635f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0df2d07f1c4f49239d8e7fce08146428_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1248d546adf44c31b8e4c83bc5671814_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia00ecaf4e4c7420280c26ee32500e9c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4965915628104e2ab8fff975a58ce821_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iddc3e419bf45401eb1c8ee9d956b9590_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ed4091dd7014489aae0cf9acc2daec5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i410a5c9397b240a48b11ed2e55a3ca0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b5f410a090c46058072e3908f0200f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6b1b9c15fe24bcea302eea32219b2dc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i323373c939a744309b13b44c10d4e64f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2807d22440ef4fcf924a3e296c024baa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i29d022afd4104a10b3d38dc48db285a3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6ad2854387a044388a14a10a50f7d60a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28bc7ef03bb44205a24ac42c766d0ec2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3e4f73d258de45c09c5dc40f3889ded5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2b3ea3a00aa745fa8d3fe8db9188348f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ida3322a79f8149fe818ac4b37b7f1c22_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i673e1f4e113146bfb5c486ae12b9ee45_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7b5d62a6819c41fa87480dace92027a3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i675f941940f34275b7ad7964d3615d58_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:MunicipalSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4c4f690f2e3741049e287513d54671cc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i13016843f45e401db644115e95be6a87_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i88ac1c81d1544708baba1124ced26c15_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia1f46b98577243ef93fe68df78a68dd0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1662ee2010e44146a4d125c47e8f6ba3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i89400aeee60c4b3f858de5d8bf088e81_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i73d7f9a5342e4d09bca467416cea6034_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifa18c08b497d4e83bd718272cfc7f575_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6471a4d8ab49424e8b4300ddd8991da5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id7633ecb19354446b41403e6360d771a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i21e3e7333e904417952db8fcc93f2434_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie720443e514340f9bf863ab49f657949_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i95da47a8ff274392a557100219edc18a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if6935a499d294baea85bb268e45f2965_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia75c8c84b6ae4319bd2ad5f13d5930f5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7fe95986da143f49cb9ff1cd45fb414_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:OtherSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia2a2b0056a32471e8f7d05fa87adc1e2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:OtherSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i76cc5c31e1ec457890186adff5d88ff6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:OtherSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4e37ac84dde34f9a9f5a34dc6fbb3503_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">moh:OtherSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia2dfcce27ab44c888f802f59df6a8678_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3ebfad9e8de34bc282edd8a903fd15de_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0f1b6888bbaf41ef9d90d37617270d74_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia041924286c54d5c9513011d94e51068_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie0f8e19fba6a41b68b87ceb41afcceb5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i06fa0c3851d7487d95bc374550545ed5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifdb8e220321748cea721890a15c24a39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i445acdb4c3684477acd4591ac4c9235f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i93e298da77bc4141b95fdec3026f4403_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8db366cd71ed4aed8d17341c92a27bac_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icf0aad8ca2a944c285080bae467d9769_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i01750e761ae449108d5498ba2a542db0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">moh:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">moh:CallOptionDerivativeAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i169c45e71a6541939a44bc98b6a6744c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">moh:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">moh:CallOptionDerivativeAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifac907d76e3e42f58ad857eb2576f9c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">moh:CurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee5e05e95b1a426bae4671defcf57905_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">moh:CurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i01207b776cf34d6d9e20d09853472272_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7ae2b394952c4f1e8142cffc59c02e8f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9be126012c2743e3ba1f0448a68c6d21_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2eae161ddce94e7a9ff33f9b5d6e8751_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i347dbbc9bc8f47e98ec6c35325f9f494_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f291c050ef34a17be70dc97c24d7607_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic488eae93102457d8235e5620bd84f27_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if330db6dda754503989d1aee6433ae6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c02998f42dd4ce08ba11f14f2a84902_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib544842b96f248be91c9c250b5519403_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2e24a47d3dc649d78aba307fc1ad28a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1bc3d20ccc074e70bfc86059723e9c9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id3f70d3c50d8437b98e3dcf567cac5be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76f180467919400fb5d1a49a30bb070c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia680941a7dcb4c90a8f6a94a3df241c5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6897a665bfe944c0b1720f8066bd97ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icfb7000b50d34cc1ae6870b923bd53f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c00276ec6e247479e4d6b157f91a10c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea08d8a8150f424a91d5763de41e3ca2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id811eeb6af45438199143b6905407f9f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iac8de3a5e55d44a38a5f28fe244aa185_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie144cacfc85e4897bf8661dd85794604_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i83cfa0b110a145789605caf934c004c3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia89aaa5cc1e6416d91ce575532477772_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id63dd203dce74ef786b9059a9384be45_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6557af215244a238cc88c1fb4cb335f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i91288d1537ff4a1cad628bfe99f8ec61_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife6d8824de274a12aafb6c18f80be57d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibdcae3ccabb049d7a79f1464026d3c79_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6e000c4aefc74c68842dcf99d6e91fa4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3cf635a3f8d840cab2a3e2097d60a7cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b30ecc6f739406885acf51ceed648e0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib1ef1a869ebc488a81b5bae288c74176_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i722c9c386c5745aa9a967036f8eff284_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b0143db7f344f8ca8d09c528fa76f93_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia61210df5ac84ab7ad7f93c5f4e1bc4a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0251b790bfc84ca9901e5dec4b2e552c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib3900f99d76c4cb088f0ec753bdfe4ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e08cf3843ee433da07c69c76c66c194_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i709876b469e94acf8f45ce2cc1c0ac99_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0be8dd8b617b44a2b44ea2ff3f0f2d73_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib4ce85ece03c4fd596e2b5d2647de430_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36836d1ebed34cdb88ec412d28f3f1ab_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i83d73631ecf445f48b591cb49c5daf0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">moh:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia5bb7caa6db34dff90cd3316865e8139_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">moh:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id9d2df1abcb045c4a451a671e263475d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:CompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22a6ede7687e4ab8b717166f0bb9a215_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:CompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d8f3a194cee466289eb18cac107e905_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i15fb3622b8d3400b91bfd0af1a0403f4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1570351e39be47e894e41c5bc71b785f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff1128ec0a004258a1175acf34f59bcb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28c21a0ce6c540ada2399b7535c810c3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i78a27e51a7f04cb99838d4b8e20f08b7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2c544b48981f4cdd80e392c5b90a7935_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b70afc8228d42e2bf32567a3f21f342_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3c9a83c837e4ca1bcccd5809c8e0fb1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id064c81564b14be391016eff3d91eb4e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a2dc6980ae14fe8a3654f7ca74e4f2f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib23e7d7b485a4481833c3bac81769de4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a95ccf41eba4147ba12e954b58ab8ab_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib808ff3f56ce4af1ba94833304546a52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida59b5bf5dbb43f1bf41bc98cba8b6a9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia1df2247780e463a9f7026841ac4a307_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i966b162be69a4b1b9e916931cc469f10_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idd31c651704242e2a915e56d0e9febd4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9831a12c6edb4660aade4906b3716c8c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibea9e886beab43f7b589f21f3657b645_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:CompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd67197e811747ddae7d6a41e1699670_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:CompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i22759a2f8b054c96ad50791de93ca29f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9cd7c232959048c3b7533cbe17fd7a2a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1e9747d2ea6b431d91b4e794f7c6a0f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ContractRightsandLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i746a8ef0f806409da219017e26b4a03c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ContractRightsandLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i50c25fe7c83049a784e28473dfa5db7f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i402bcd1f7eb94207a725a00271ec919d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">moh:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib0aecf877b59419e91398282765cd1a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba830af20e004480a455ba22d8490b81_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i21b5a4474fe742708d34076ef171bbc6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">moh:CompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8ba8deca9f384a07ac55d4d78555ed46_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">moh:CMSSubsidiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia31b475498df425a8b4d174081e15148_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id7f38b6017a44991a39f98bf263f1207_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4da076c6c0e14403bba261ee5a1752cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8038f20097384f9e833965528d07e1cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iadfee5a2ce3745aaaf4b546d03d4d801_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i136f903b1c064277a3b1c8f8da5021b5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i34d4bab4b5564cbb89d2dde161392e50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide648b3dad0d4ab18e81c2b7529401b1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe0ee42eef33462bb6cd3e32f7bf3d52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i65eb832ddf7446ad95dac7eeb4907da3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i84ed48f2ecee4fde8a88bcac9e3387b6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i84f74264414a473b851cd390764a5469_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7f87c0eee5ef4388a13337f6de7a4672_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i54ca304db2314cb0aa1e9531302dd99f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f794012ffba4b20bb19204c1871558d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if8dbc94d3d2941ddb0a236c2e6aa7418_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if24fe855595e4f419b39b5ca7946f9a1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i82aa8b8e3d40448a968a16db82de1fe0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:ThreePointEightSevenFivePercentSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0dfa298466eb4e6e9510dfd216fe410c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8662ae4a2ad4fd59034705718e300f7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i919a4ba85b4d4dfaa5d02f1908cbd481_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i350e29537cb34f48978b5b0e7e5cc142_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icdd1a32b458947b1801cc3505a82b626_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">moh:SwinglineSubFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if6fee39dad244f2c88eadb065bc81d50_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">moh:LetterOfCreditSubFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1abe71b87a6542f0870a99e5a099279f_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:IncrementalTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i9c82c5064b8f4eb08577141f723fd705_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:IncrementalTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie2dd3e9ee2ce44a4919d0cf6b7a9cd2f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:IncrementalTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i357b4ee3df3041a6bcafb18e3531d2e9_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8e22eda33bbd4bab854db88001835a0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib62871823c48445589be9d732dff0753_I20200602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-02</instant>
        </period>
    </context>
    <context id="i5588d925bf774eb08f9ffc4e6643dcb4_D20200602-20200602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4375SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-02</startDate>
            <endDate>2020-06-02</endDate>
        </period>
    </context>
    <context id="i1abb910e6fa946c3a5cc16ae002d542f_I20201117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-17</instant>
        </period>
    </context>
    <context id="id33b880a743e45e296852cb1c96f23f9_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:A4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i71e356cb28064ce08d2b5e2365a4e623_D20200101-20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">moh:CashConvertibleSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="i777fc2beee3c4a10b06e4fde2ab42f6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ce9e160ed604a74a1a9a4c25add9c6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31b468479ec6404c8a870d751d8727e0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1127fb6f8661484e9a2afce5e70e881c_D20201101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i20fed1f62d734cc294821cf3b9a1b49a_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i19562697a92c4804a128c7d53a9fca1c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6c2f88ae28624d2d83b180b3207c2ee4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i405b0566313b404d88d226953fb10b4b_D20210101-20210211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-02-11</endDate>
        </period>
    </context>
    <context id="i230e39d7097f4f04ac9d6a41de9ad215_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">moh:CashConvertibleSeniorNotesDue2020WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f8dcd5ceb6c487f9c1bdf9a574307f8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">moh:CashConvertibleSeniorNotesDue2020WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i96a5b2f5752d4c3d8f85ea9e8b1da0ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3ac5351ddca146c7888f5e88c0fb0733_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7e5144ba022d44d493772c715fe5aa45_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:RestrictedandPerformanceStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idcae5fc25c5d4bfe9751f1e0b6a647e4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:RestrictedandPerformanceStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i09bb25d620c34957a416d46cefe3fae8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:RestrictedandPerformanceStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i76f621f530a7426ebac680c21dabf01e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:EmployeeStockPurchasePlanandStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3f8a559e0b7d4a32b56f7a92d9cc722b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:EmployeeStockPurchasePlanandStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4bc80c4169054f6d86a4e10b0c36c602_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">moh:EmployeeStockPurchasePlanandStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i292647db232f497088463dcb696a6bc4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">moh:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib4aca872bf92456a9a20db5fae524392_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i89fe848546204fe2b34f89e0a78c161d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i572ceba4cf6044c5902601a01b0ea881_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36ed381ff8654ca990008ef6dcd3154b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28cf707559d6450aabd54eb6691a6598_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i372cfd6a471f48bcbd14fd8e83885c92_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iba5202a65ac342848cf80d5efc7a35c9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifd75881230294473867aed8c11c46a5b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib4d57c51df1f4304bfc986fb72585507_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib82194307d804f828b55b0572af7065d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibb6f3b120b6c45aabfabfd970687858d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ife21f4c2287b449c80bf5cbcb34cfee4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic3f96ca2a41b497882c4e2decff210d8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">moh:ExercisePriceRange1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1f5a36308730434eb22cb4ec367111c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">moh:ExercisePriceRange1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f4bfa5083c14dc982d7f30f9c3f2c76_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">moh:ExercisePriceRange2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic0bfeb88842e48c681d6c147892747da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">moh:ExercisePriceRange2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iec02edc64cf748bcb7c0886f12b109e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifdc0f1c770da44458c1d059bd020a0c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ecb8708d5464ab498156c0718152e7f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i14669561f20444379f482d5083c58318_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">moh:MagellanCompleteCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6d1a64b1a8eb4587b76303fc21830afa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb82ea68bb9f468a8a464320367c5ad1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib36184f360254be581851e722b97e9d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1045ef059c7b4c1e91a31c1aa6854984_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i20c4b45d16f349f9b877a338daec69b7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i43079259dd7042118ae6a2d5dd9a7b6e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6bab7abe7dde44eaa74ac090521003ed_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i169ab145200a473eb3a97472b0dc04f9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">moh:HealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia4c8ceca643b4549bee173f83e97bb0e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5d0049c77d2742749f53b11e47a5ada1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c46ea96ec424a059820a38726b434de_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3a859cbf0a6e4e259e5149dffa498108_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i90fb32a216454bb3b23113825fc89cb0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia21e20ebfeb1411abf65ca9fca917694_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i55bfd4d59fce43ea933cfb8bceac4a25_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3b95e6dc88844104b5365f3801ba598e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iad1475cc48dc4edc8d1b28832265b1ea_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic0373257f2d34963a2a34bdff8836086_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i11fdd1fe2faf42efb90bc577c9070717_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3c26bfb9e6774f078083f6dc03b05363_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001179929</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>moh:Segment</measure>
    </unit>
    <unit id="state">
        <measure>moh:state</measure>
    </unit>
    <unit id="member">
        <measure>moh:member</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="business_combination">
        <measure>moh:business_combination</measure>
    </unit>
    <unit id="security">
        <measure>moh:security</measure>
    </unit>
    <unit id="claim">
        <measure>moh:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV80L2ZyYWc6YjQwZjZjNjFhYmVkNGI2MGEzNGUwMjM4Y2I0ODc2MGYvdGFibGU6MzAwMDBhMmU0YzdkNDllYzg3MDdkNjg5NzlhNzI0OTMvdGFibGVyYW5nZTozMDAwMGEyZTRjN2Q0OWVjODcwN2Q2ODk3OWE3MjQ5M18xLTEtMS0xLTA_04ff6ae7-24ac-4237-a927-3512b22805b2">0001179929</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV80L2ZyYWc6YjQwZjZjNjFhYmVkNGI2MGEzNGUwMjM4Y2I0ODc2MGYvdGFibGU6MzAwMDBhMmU0YzdkNDllYzg3MDdkNjg5NzlhNzI0OTMvdGFibGVyYW5nZTozMDAwMGEyZTRjN2Q0OWVjODcwN2Q2ODk3OWE3MjQ5M18yLTEtMS0xLTA_f0ad12c6-1d9d-442a-8091-50b92553aff2">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV80L2ZyYWc6YjQwZjZjNjFhYmVkNGI2MGEzNGUwMjM4Y2I0ODc2MGYvdGFibGU6MzAwMDBhMmU0YzdkNDllYzg3MDdkNjg5NzlhNzI0OTMvdGFibGVyYW5nZTozMDAwMGEyZTRjN2Q0OWVjODcwN2Q2ODk3OWE3MjQ5M18zLTEtMS0xLTA_8b6718c2-059a-4446-98db-88f133c25d04">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV80L2ZyYWc6YjQwZjZjNjFhYmVkNGI2MGEzNGUwMjM4Y2I0ODc2MGYvdGFibGU6MzAwMDBhMmU0YzdkNDllYzg3MDdkNjg5NzlhNzI0OTMvdGFibGVyYW5nZTozMDAwMGEyZTRjN2Q0OWVjODcwN2Q2ODk3OWE3MjQ5M180LTEtMS0xLTA_a6ba7b6c-dd9f-4183-be4e-4d9178eaa3e1">FY</dei:DocumentFiscalPeriodFocus>
    <moh:HealthPlanContractTerm
      contextRef="i507906be57d848b78ab7e7f688853ed8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2Xzg0NA_2a1d4052-6221-4b74-b359-9ff02580423e">P3Y</moh:HealthPlanContractTerm>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i16e27438908a47a6b4b7849782a9d9b1_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4NDY_345e2136-02de-45cb-a7d6-760278ca92ed">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9d8f3a194cee466289eb18cac107e905_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzU0OTc1NTgxMzk3OTA_0da1da73-4926-4eb9-bdb8-ab2cd7f10bb6">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iff1128ec0a004258a1175acf34f59bcb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzUzOA_e80b42ea-bec2-44ee-9782-16517f1bf477">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV8yLTEtMS0xLTE1NDgw_0dc9e7a4-3f5a-4cc9-87ca-c2638c16af2b">us-gaap:OtherAssets</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV8yLTEtMS0xLTE1NDgw_1f62e1d0-af90-4d7b-8809-7a047b977efc">us-gaap:OtherAssets</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV8yLTItMS0xLTIyODgy_2e574176-1cbe-4054-bd4e-2a9d621bac76">us-gaap:OtherAssets</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV80LTEtMS0xLTE1NDg1_edfa4705-7eb0-453b-a982-12638eda7aaa">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV80LTItMS0xLTIyOTI0_d9251e4d-cbae-41b5-b155-16a91ec5c960">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV81LTEtMS0xLTE1NDg3_45a0d7e9-c547-4061-ac70-bbd8abfe8078">us-gaap:OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV81LTItMS0xLTIyOTE5_fc52a198-532b-4ae9-81a7-1a3b2154e063">us-gaap:OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV8xMC0xLTEtMS0yMjkyOQ_c1467140-d607-4448-b47c-60f2b7109f2a">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzQ1L2ZyYWc6MzRlMTA1MDc1MDQxNGNiN2IyZWI5YmZjYmZkM2Q3ZDgvdGFibGU6ZWNjY2FlNzY4MWFkNGIyNGFiNDYyODJiOGRkMTM2ZTkvdGFibGVyYW5nZTplY2NjYWU3NjgxYWQ0YjI0YWI0NjI4MmI4ZGQxMzZlOV8xMC0yLTEtMS0yMjkzMQ_a24f2cbd-007a-4317-818f-e2fb528c8af5">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTQ4_4b4dd36e-a362-4ba7-ac7b-f4d6000a166f">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6OWFjYzU3ZTgwZDA3NGFhZjg0YTZlMjlmMmUyZmNhMjkvdGFibGVyYW5nZTo5YWNjNTdlODBkMDc0YWFmODRhNmUyOWYyZTJmY2EyOV8wLTAtMS0xLTA_83fa7f09-3fa3-4580-99ef-f27f9e7cbb94">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18xMjk_6f9b9ec1-0429-435f-b48b-5600066b83a4">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18xMjk_5a7899fa-f924-4ae6-ba67-7e0172e3f80e">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6ZTk1MDYzMjY0YzgxNDNkOGFmN2YxMjE4NzdlNzQzMTAvdGFibGVyYW5nZTplOTUwNjMyNjRjODE0M2Q4YWY3ZjEyMTg3N2U3NDMxMF8wLTAtMS0xLTA_fb6a99b7-6904-427d-904f-9bba1913d140">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTU3_3b869e85-7127-42b3-ba79-e6a780c797b7">1-31719</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTU4_fc3ef1ce-fbfc-4b0c-afeb-1a82057b5292">MOLINA HEALTHCARE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6YzZhYmFjNThmMmY5NGE1MGI1NmE5NWJjYWE4MTY1NTMvdGFibGVyYW5nZTpjNmFiYWM1OGYyZjk0YTUwYjU2YTk1YmNhYTgxNjU1M18wLTAtMS0xLTA_520cbf25-3435-4c76-b115-21c627ed40de">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6YzZhYmFjNThmMmY5NGE1MGI1NmE5NWJjYWE4MTY1NTMvdGFibGVyYW5nZTpjNmFiYWM1OGYyZjk0YTUwYjU2YTk1YmNhYTgxNjU1M18wLTItMS0xLTA_128cf0b2-3af4-4e98-a5db-9d04842f1727">13-4204626</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTYz_9bd31fa2-fb20-4281-a353-77dad5fb4a17">200 Oceangate</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTUw_a0de8029-3027-4ba7-90c8-e9ae6c737c8a">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTY0_fa12dd35-9753-42f4-b43d-ac63e2e4154d">Long Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTUx_ce46f540-3b35-40db-aa17-dffa12ecbdf9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTQ5_53768f05-58b3-4711-9d1a-09c78555b62d">90802</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTUy_efbf9019-00c1-48b2-bfbc-205fc86f6524">562</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTUz_eef28402-30a7-4207-b571-0cdad7e81408">435-3666</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6ZTU3NDYwMTY5NTgxNDU5Y2FhOTk5ZWE0NDJmMTJlOTUvdGFibGVyYW5nZTplNTc0NjAxNjk1ODE0NTljYWE5OTllYTQ0MmYxMmU5NV8xLTAtMS0xLTA_5212fa7e-1018-4617-812e-6010f552dadf">Common Stock, $0.001 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6ZTU3NDYwMTY5NTgxNDU5Y2FhOTk5ZWE0NDJmMTJlOTUvdGFibGVyYW5nZTplNTc0NjAxNjk1ODE0NTljYWE5OTllYTQ0MmYxMmU5NV8xLTEtMS0xLTA_e5dee5b0-a1f7-452d-8554-3f9450f57aaa">MOH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6ZTU3NDYwMTY5NTgxNDU5Y2FhOTk5ZWE0NDJmMTJlOTUvdGFibGVyYW5nZTplNTc0NjAxNjk1ODE0NTljYWE5OTllYTQ0MmYxMmU5NV8xLTItMS0xLTA_5be64726-51d3-4e3e-b744-07d786ff3978">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTYw_d757d5a4-9c1f-49e3-801d-f3b28995a991">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTU0_927dbb01-4aac-42f9-8792-9fe8c3d0e337">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTYx_90383ac3-2524-4745-866c-98ecf27c06e8">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTYy_889c34a2-5163-466a-bdac-e041575c0c2d">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6MWQ3ODY1NTY4MmRmNGFjZGFmN2Q3ZGY0ZWJjMjgzNjQvdGFibGVyYW5nZToxZDc4NjU1NjgyZGY0YWNkYWY3ZDdkZjRlYmMyODM2NF8wLTAtMS0xLTA_b8414afc-5bf6-4c73-86c1-27bf4c497ab1">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6MWQ3ODY1NTY4MmRmNGFjZGFmN2Q3ZGY0ZWJjMjgzNjQvdGFibGVyYW5nZToxZDc4NjU1NjgyZGY0YWNkYWY3ZDdkZjRlYmMyODM2NF8wLTctMS0xLTA_1dbf22db-8e34-4abc-bee4-c3cc27382260">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGFibGU6MWQ3ODY1NTY4MmRmNGFjZGFmN2Q3ZGY0ZWJjMjgzNjQvdGFibGVyYW5nZToxZDc4NjU1NjgyZGY0YWNkYWY3ZDdkZjRlYmMyODM2NF8wLTktMS0xLTM4MTA_03705cda-7d20-41c4-82d2-d137c95c88a7">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY183Njk2NTgxMzk4Mzgx_2e92ef76-eabb-41ee-97d0-06ff4df28f73">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTU1_fcf8b024-1bf4-42df-85df-2bea0b946517">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i87711e21c9a446419ccfe038aeb1835b_I20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yNDQx_e833424e-5563-4721-8b9f-f3be2c821f11"
      unitRef="usd">10500000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="id8ecbcccccbd40c5a50d0279cba6e06e_I20210212"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yNjA4_467e2096-92ca-4378-b2fd-5b6b33480731"
      unitRef="shares">58000000</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xL2ZyYWc6OThhMzQwMzE0OGFlNDA3MzlmMGYwOGE3YjI3NWI1ZmMvdGV4dHJlZ2lvbjo5OGEzNDAzMTQ4YWU0MDczOWYwZjA4YTdiMjc1YjVmY18yOTU2_ddaa5a1e-336e-4a46-9010-486073428a97">Portions of the registrant&#x2019;s Proxy Statement for the 2021 Annual Meeting of Stockholders to be held on May 6, 2021, are incorporated by reference into Part III of this Form 10-K, to the extent described therein.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:IncreaseDecreaseInPremiumsReceivable
      contextRef="i91290aace81d4332aae71ba1a693cbba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTk5L2ZyYWc6M2QxOTg0MDAxZTRmNDg0Yzg1NDdjODc0YTJkNGM4YjIvdGV4dHJlZ2lvbjozZDE5ODQwMDFlNGY0ODRjODU0N2M4NzRhMmQ0YzhiMl8xMDk5NTExNjMzMTAz_fd28d8f1-5ae0-44bf-b3d3-04ddf604aee1"
      unitRef="usd">-564000000</us-gaap:IncreaseDecreaseInPremiumsReceivable>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i29d5d2b833564b80aea7dee755e0e3dd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzQtMS0xLTEtMA_6d08d387-4ff0-4973-bdfd-9c7e95bf6051"
      unitRef="usd">18299000000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="ia63feda4ad7347288920b133e5dbddb3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzQtMy0xLTEtMA_fc6d2533-9685-459d-a31a-e376e415a17d"
      unitRef="usd">16208000000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i849cbae5a8cc41beab243b6cc6768e11_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzQtNS0xLTEtMA_85ffae9d-62e2-4932-9dc1-c3ca9c60cfa9"
      unitRef="usd">17612000000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i9fb34386ae3248e083608739601dbacc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzUtMS0xLTEtMA_c4c08034-a6ff-485d-acd6-f108cfb53ee1"
      unitRef="usd">649000000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i7ceb7faf3f854c239783915d36ad2084_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzUtMy0xLTEtMA_c002c12c-410c-45e3-9e39-68e33bef5181"
      unitRef="usd">489000000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i63f79365bc994640a161617bd7d8a916_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzUtNS0xLTEtMA_ea5e21b0-db66-4b6e-92f0-84c9bd71fc4a"
      unitRef="usd">417000000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i8c49bd707ea342d29798c305bec30c3d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzYtMS0xLTEtMA_1896b5b0-cb5a-4cf5-9ef5-a99e487736d7"
      unitRef="usd">271000000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="iec0f306ac4604ee3a72ab17c719868e8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzYtMy0xLTEtMA_2336127c-7d53-46f5-bb61-5a79e8efc344"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i286b19feb9c8495591834c5d364e760a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzYtNS0xLTEtMA_c5248b0b-5b04-47ba-b0a0-2b0de6602da2"
      unitRef="usd">329000000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="ib5cc2203bcc1458383a2cacf8cb24107_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctMS0xLTEtMTQ2MDE_5b73290f-96a0-443c-b4fd-9287f966f605"
      unitRef="usd">128000000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i910d706f29214cf989874f3c7c9bdc97_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctMy0xLTEtMTQ2MDE_2d5bf102-4d13-405c-b5ea-4acb570277cc"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i57e45a9715ee49d6b1b20a8101922bed_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctNS0xLTEtMTQ2MDQ_bd5448a0-a899-4309-afdc-04720427a257"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i9a3782192ac74e9fa0c0cbe786a6c7f9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctMS0xLTEtMA_ac28a9e7-aaca-458f-b749-44f7859c422b"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="idcc6d37095e148f38283ad63b84f7dbb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctMy0xLTEtMA_2b9c5a26-bf63-4464-8305-9f147fd032c3"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i146b66c41bd848eb8c57a3034d4d91d3_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzctNS0xLTEtMA_1e975e3e-d112-4178-b624-665e8306c141"
      unitRef="usd">407000000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzgtMS0xLTEtMA_0cfc8424-6e0c-4765-a70f-1e56cea6a74f"
      unitRef="usd">76000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzgtMy0xLTEtMA_d498c689-221b-4162-9cdc-1c8005454aba"
      unitRef="usd">132000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzgtNS0xLTEtMA_f13fd06b-53cf-4395-9e0e-6cd1eb174b8d"
      unitRef="usd">125000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:Revenues
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzktMS0xLTEtMA_83314e8c-9a59-48df-9ebf-9d9a21345adc"
      unitRef="usd">19423000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzktMy0xLTEtMA_f578871b-1918-4808-9951-8a9a59ce8c92"
      unitRef="usd">16829000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzktNS0xLTEtMA_bcf31237-2c40-463b-956f-126831fd06e5"
      unitRef="usd">18890000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i234e4841fc374ed0ada5e87b17f10a96_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzExLTEtMS0xLTA_abe0284f-7ce3-4553-8bfe-839537051999"
      unitRef="usd">15820000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i38e404a0791d4aceab81d9b4037b1443_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzExLTMtMS0xLTA_553ccba6-b40d-44f6-9ad9-f07e66a4663b"
      unitRef="usd">13905000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3d89685788cc4fd09db979d7c5b577ba_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzExLTUtMS0xLTA_a5337044-331a-4f40-ad95-48e078fa820d"
      unitRef="usd">15137000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEyLTEtMS0xLTA_ee14f402-6900-4aad-a479-111bf3381fe1"
      unitRef="usd">1480000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEyLTMtMS0xLTA_1615a691-3a9d-442d-8b70-864b12b0c7e1"
      unitRef="usd">1296000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEyLTUtMS0xLTA_10dae7cc-bb2a-4d6e-8f13-6e5aea678bc9"
      unitRef="usd">1333000000</us-gaap:GeneralAndAdministrativeExpense>
    <moh:PremiumTaxExpenses
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEzLTEtMS0xLTA_86c82487-cd65-45af-9632-84a314bcf899"
      unitRef="usd">649000000</moh:PremiumTaxExpenses>
    <moh:PremiumTaxExpenses
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEzLTMtMS0xLTA_b1e45f10-be55-4832-a07a-c145937471f9"
      unitRef="usd">489000000</moh:PremiumTaxExpenses>
    <moh:PremiumTaxExpenses
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzEzLTUtMS0xLTA_d178cfcb-2d5d-409f-8a57-e80d8a3d88ca"
      unitRef="usd">417000000</moh:PremiumTaxExpenses>
    <moh:HealthCareOrganizationInsurerFeeExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE0LTEtMS0xLTA_f713db49-8fda-45eb-adc5-cb4b68cafaff"
      unitRef="usd">277000000</moh:HealthCareOrganizationInsurerFeeExpense>
    <moh:HealthCareOrganizationInsurerFeeExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE0LTMtMS0xLTA_d45b52fc-9c36-4fca-a128-b0bd2ecc9dcd"
      unitRef="usd">0</moh:HealthCareOrganizationInsurerFeeExpense>
    <moh:HealthCareOrganizationInsurerFeeExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE0LTUtMS0xLTA_50a046c0-a97d-4c2f-8f78-b61b5789920a"
      unitRef="usd">348000000</moh:HealthCareOrganizationInsurerFeeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE1LTEtMS0xLTA_dd876942-b863-4de6-a361-bdc17e85e46c"
      unitRef="usd">88000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE1LTMtMS0xLTA_8fe11cd1-790a-4706-93c0-1ac8ae8a0208"
      unitRef="usd">89000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE1LTUtMS0xLTA_8900af22-e383-45ef-bb15-166b4391c180"
      unitRef="usd">99000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE2LTEtMS0xLTA_e2412441-5263-48ab-b55d-160ae57f6ee6"
      unitRef="usd">31000000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE2LTMtMS0xLTA_2afa1f47-0f70-4e19-a9ef-f2bf7cadf00e"
      unitRef="usd">6000000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE2LTUtMS0xLTA_b498aa48-8442-4a75-9dbc-0cd4e06851c8"
      unitRef="usd">61000000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9a3782192ac74e9fa0c0cbe786a6c7f9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE3LTEtMS0xLTA_93109410-2171-4dc1-a311-5b4ab0f38acb"
      unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="idcc6d37095e148f38283ad63b84f7dbb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE3LTMtMS0xLTA_50949254-86e4-49c2-90c1-c0d652ab7a5b"
      unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i146b66c41bd848eb8c57a3034d4d91d3_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE3LTUtMS0xLTA_c59700b6-40da-4495-ab7b-54a05d6add4d"
      unitRef="usd">364000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostsAndExpenses
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE4LTEtMS0xLTA_9c9b0a6a-9aa1-4396-a2e6-4c8507bb6527"
      unitRef="usd">18345000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE4LTMtMS0xLTA_86ed49bf-ca7a-4e7d-8bb0-f5b5af6e1048"
      unitRef="usd">15785000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzE4LTUtMS0xLTA_23830298-a317-4561-b4ea-31ef6f1a18b5"
      unitRef="usd">17759000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIwLTEtMS0xLTA_84d376f5-06f2-4910-86b0-686ffa024e60"
      unitRef="usd">1078000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIwLTMtMS0xLTA_a161b398-bb09-4a4b-9a8d-5670b9f13bd8"
      unitRef="usd">1044000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIwLTUtMS0xLTA_07564c29-bdc2-4572-8cf9-806aaaed81a4"
      unitRef="usd">1131000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIyLTEtMS0xLTA_789e33c1-cd95-4632-bcbc-f7904cc71c30"
      unitRef="usd">102000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIyLTMtMS0xLTA_0e3a9397-1997-4d2a-abf0-12f41e447d32"
      unitRef="usd">87000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIyLTUtMS0xLTA_67a8fb65-286d-4266-bb66-f1c19e415ebf"
      unitRef="usd">115000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIzLTEtMS0xLTA_87fe416d-9717-4e70-9bdf-ad99af0a82ac"
      unitRef="usd">-15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIzLTMtMS0xLTA_aabba660-a453-4df1-8a45-0120f7c97e00"
      unitRef="usd">15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzIzLTUtMS0xLTA_b2c68849-ca62-4fc1-adeb-003117a74df8"
      unitRef="usd">-17000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI0LTEtMS0xLTA_53de23e3-c815-4391-bd9c-dc25f9089864"
      unitRef="usd">-117000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI0LTMtMS0xLTA_75cd2d2c-00d9-4347-9f2b-e80f291ead09"
      unitRef="usd">-72000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI0LTUtMS0xLTA_53f07c61-07e9-4da6-96d6-2507f318e362"
      unitRef="usd">-132000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI1LTEtMS0xLTA_1e1e1a9a-4ed0-4a98-a1bd-3e6bcd266fe9"
      unitRef="usd">961000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI1LTMtMS0xLTA_cb22bd93-bf79-4461-a1cc-8fa47b7b6ef0"
      unitRef="usd">972000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI1LTUtMS0xLTA_2a9b6edf-fb68-418c-8c3f-ff06d2d4aae8"
      unitRef="usd">999000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI2LTEtMS0xLTA_39285191-a2cd-4265-97a4-6d0906a171f4"
      unitRef="usd">288000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI2LTMtMS0xLTA_9c2d6241-6ffb-4d4f-bb7a-8e265e2a5380"
      unitRef="usd">235000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI2LTUtMS0xLTA_13856664-34c0-44ae-bbc4-2ac42c1a3ee0"
      unitRef="usd">292000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI3LTEtMS0xLTE5MDY_e15b855a-6049-4c13-a3f3-caa3d485e4d6"
      unitRef="usd">673000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI3LTMtMS0xLTA_ffff84d8-0db9-4aee-831f-ec69cfdf47d0"
      unitRef="usd">737000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzI3LTUtMS0xLTA_1a8d95b5-aa5c-47d4-add0-a0a463e6d75c"
      unitRef="usd">707000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMwLTEtMS0xLTA_8d610cf1-c1c7-47c3-921e-39662a2d4497"
      unitRef="usdPerShare">11.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMwLTMtMS0xLTA_b6a72f24-5249-48b0-b5cf-f89252ae056f"
      unitRef="usdPerShare">11.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMwLTUtMS0xLTA_219d3721-c4d4-4b5b-a8aa-a8e484e6bcdd"
      unitRef="usdPerShare">11.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMxLTEtMS0xLTA_2539d682-eded-4b97-8b1d-8e41a43d2434"
      unitRef="usdPerShare">11.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMxLTMtMS0xLTA_ca0f4dd6-0198-4ec0-a27c-9cd566090fac"
      unitRef="usdPerShare">11.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMxLTUtMS0xLTA_92938ae1-2947-4ee9-94bc-8d5629b5ba6e"
      unitRef="usdPerShare">10.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMzLTEtMS0xLTA_06eebf84-b6e0-4e19-b9fe-3bca234deb0a"
      unitRef="shares">59000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMzLTMtMS0xLTA_a3eaea18-13a0-4767-b6f9-6e690c976aaf"
      unitRef="shares">62000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzMzLTUtMS0xLTA_5706d2be-cfa1-472c-bc21-769392f36662"
      unitRef="shares">61000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzM0LTEtMS0xLTA_31617773-3c29-4bea-b474-124648b24fb3"
      unitRef="shares">60000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzM0LTMtMS0xLTA_8cd8599d-1e44-4519-961d-897fe4b2eaa1"
      unitRef="shares">64000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTIvZnJhZzoxMWY2MmY4OTgxNDg0MmFhYjdkYTFlMGMxMDk3ZmJlYy90YWJsZTo1NGQ0YmJkNmFiNTE0ZDllOWU1OTUzZmNkZjZkNzVkYS90YWJsZXJhbmdlOjU0ZDRiYmQ2YWI1MTRkOWU5ZTU5NTNmY2RmNmQ3NWRhXzM0LTUtMS0xLTA_a2765265-f747-40d7-8fc4-a604f8f05600"
      unitRef="shares">67000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzMtMS0xLTEtMA_81b6441b-0b57-4d38-8241-716c3330ff5a"
      unitRef="usd">673000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzMtMy0xLTEtMA_7025ca55-f395-4edc-a2c2-d8e7bd3d4b8a"
      unitRef="usd">737000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzMtNS0xLTEtMA_30a86d83-4a91-400a-bab0-5410b2625cb2"
      unitRef="usd">707000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzUtMS0xLTEtMA_79dd4c33-0937-481d-a14e-58693911ecbe"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzUtMy0xLTEtMA_4266b273-392e-4c22-857b-b02796d77de2"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzUtNS0xLTEtMA_223d3bb7-d466-4f08-9c26-9ec7547566a2"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzYtMS0xLTEtMA_45691318-5919-43c0-a34b-d071ab86aded"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzYtMy0xLTEtMA_e7e4c506-76de-4ad5-84fa-c1bceddee607"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzYtNS0xLTEtMA_1e40563d-339c-4cbb-a3fe-3ad478485a70"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzctMS0xLTEtMA_fadd450f-eb6b-49a6-9717-42b76b6663ff"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzctMy0xLTEtMA_9b6397c9-fe4c-4e5e-849b-b6c6eb5f1dd7"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzctNS0xLTEtMA_928a2062-7533-44a0-be72-28385dcbacbb"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzgtMS0xLTEtMA_14d7d381-dca3-424e-b337-31b263fa14e7"
      unitRef="usd">706000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzgtMy0xLTEtMA_7504834e-b7c9-4fc0-a722-0cadaff66080"
      unitRef="usd">749000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMTgvZnJhZzo5MjE1ZDE5ZDAyMzA0ZmVmOTdmNTViODM2ZjQ1MTBhMS90YWJsZTowNTg0NGYzYTUwMzM0MDJkOGI0N2IwZWEyZjM1NjMxOS90YWJsZXJhbmdlOjA1ODQ0ZjNhNTAzMzQwMmQ4YjQ3YjBlYTJmMzU2MzE5XzgtNS0xLTEtMA_2580fe45-2787-4ae6-b1c0-9f4a16477569"
      unitRef="usd">705000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzUtMS0xLTEtMA_d19d1e6a-8fc2-4327-b8c0-063b69ab8618"
      unitRef="usd">4154000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzUtMy0xLTEtMA_ecbdd71a-def5-4e68-b433-8462d1246238"
      unitRef="usd">2452000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzYtMS0xLTEtMA_e98100a9-1a97-48f2-b4f6-55d71c9c833d"
      unitRef="usd">1875000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzYtMy0xLTEtMA_93f71f78-950a-402b-a851-2bbb80f9477b"
      unitRef="usd">1946000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzctMS0xLTEtMA_560680db-a3cd-424b-b638-50458ea8d455"
      unitRef="usd">1672000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzctMy0xLTEtMA_ac0a2313-f82b-4e35-a46e-58f12252c705"
      unitRef="usd">1406000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzgtMS0xLTEtMA_5c44eebf-95b5-41d4-a668-bd3730fc9d80"
      unitRef="usd">175000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzgtMy0xLTEtMA_c5bf74ad-8031-44a3-9715-21401b65f347"
      unitRef="usd">163000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEwLTEtMS0xLTA_4bbcebeb-9b26-467a-b9ec-8d96a5133762"
      unitRef="usd">7876000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEwLTMtMS0xLTA_64867d4a-b8aa-4c74-9bdc-48a832ccc7a3"
      unitRef="usd">5967000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzExLTEtMS0xLTA_7ea24fe6-f94c-45b7-a478-a65ec9ec8b9c"
      unitRef="usd">391000000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzExLTMtMS0xLTA_9a6773d6-447f-43bb-ba8c-bf1646f8a4d7"
      unitRef="usd">385000000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEyLTEtMS0xLTA_acc7ef07-dfd0-423d-9a4a-123ddaa13796"
      unitRef="usd">941000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEyLTMtMS0xLTA_416fab27-410e-4077-96ed-c853c2e68709"
      unitRef="usd">172000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEzLTEtMS0xLTA_4bb73555-5962-4069-baa3-3331a038e593"
      unitRef="usd">136000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzEzLTMtMS0xLTA_35a0b40d-c94b-4d27-b2de-6277ea196a86"
      unitRef="usd">79000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE0LTEtMS0xLTA_3f42ff56-71f9-4a46-8073-a04dd973b20e"
      unitRef="usd">69000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE0LTMtMS0xLTA_777d8f16-95fa-449e-854d-80caf7409a99"
      unitRef="usd">79000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE1LTEtMS0xLTA_26f800a3-2961-414a-8239-5ee46e34e34b"
      unitRef="usd">119000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE1LTMtMS0xLTA_73eb091a-b8c7-4333-9e43-d4201278a099"
      unitRef="usd">105000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE2LTEtMS0xLTA_e1b6bba6-b8a9-4cf8-ac14-cc0c6f593aef"
      unitRef="usd">9532000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzE2LTMtMS0xLTA_0137308f-9112-4eca-ab21-f81f590045dc"
      unitRef="usd">6787000000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIwLTEtMS0xLTA_086ffda1-e4bf-4a51-8371-4070f6ac4acf"
      unitRef="usd">2696000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIwLTMtMS0xLTA_a7f39570-957d-4d82-8f7a-5fdf951b9a91"
      unitRef="usd">1854000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <moh:MedicalPremiumLiabilityDueToAgency
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIxLTEtMS0xLTA_661414c9-4f65-4bae-88a3-78a951a1efbc"
      unitRef="usd">1253000000</moh:MedicalPremiumLiabilityDueToAgency>
    <moh:MedicalPremiumLiabilityDueToAgency
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIxLTMtMS0xLTA_2542dc64-c011-4b30-ba75-d30d612be9c1"
      unitRef="usd">664000000</moh:MedicalPremiumLiabilityDueToAgency>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIyLTEtMS0xLTA_36f30461-bda0-4909-9b04-4eafecf98523"
      unitRef="usd">641000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIyLTMtMS0xLTA_92cfe86d-8b0a-4fe1-b84d-25c5be368f3a"
      unitRef="usd">502000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIzLTEtMS0xLTA_6b845812-f829-4964-865b-93e71307d6a1"
      unitRef="usd">375000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzIzLTMtMS0xLTA_7cd9bc55-dcad-417b-a364-660ac2bf34f0"
      unitRef="usd">249000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI2LTEtMS0xLTA_2bcacf11-78bd-4dfc-acc6-cb216af8a9ef"
      unitRef="usd">4965000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI2LTMtMS0xLTA_bcc09bdf-c8f9-4bdd-8bb9-81f08b069d71"
      unitRef="usd">3269000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI3LTEtMS0xLTA_04560cb8-a46f-4a8d-be17-dcfcfd53787e"
      unitRef="usd">2127000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI3LTMtMS0xLTA_fc011574-5eeb-46e2-904b-a59998c9fa20"
      unitRef="usd">1237000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI4LTEtMS0xLTA_a5084176-789a-4770-addd-f88989dfcbb7"
      unitRef="usd">225000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI4LTMtMS0xLTA_a5a435f4-c675-415f-a45e-510733cb1766"
      unitRef="usd">231000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI5LTEtMS0xLTA_98355150-57d9-43ee-9d84-be6f362ced8d"
      unitRef="usd">119000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzI5LTMtMS0xLTA_9ef6a706-c9bb-479b-bb76-7c8448aef339"
      unitRef="usd">90000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMwLTEtMS0xLTA_6f88f92c-ae03-44da-9983-1e222ce721da"
      unitRef="usd">7436000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMwLTMtMS0xLTA_4e90a1fa-4c19-4d4a-893f-c0144fbbf45b"
      unitRef="usd">4827000000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDUx_5b270c78-439c-493b-a0eb-258936870709"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDUx_ac76518c-b992-429b-bf7b-9d05a89d0788"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDU0_cf133e69-b668-4145-a173-ed5efb9db305"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDU0_fd5abec7-5b2f-4ea3-9f22-a243c819a803"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDc5_78406bc6-5b6b-4305-bb82-6a0c523689bc"
      unitRef="shares">59000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNjhlYjIyZDZkY2M0YTFmYjI5ZThhMzgyNTMwZDAyZl81NDk3NTU4MTM5MDkz_30b80f88-f3b6-47e8-86e0-460f28b699fe"
      unitRef="shares">62000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTEtMS0xLTA_d461ba6a-a03a-458c-9881-46511c849edc"
      unitRef="usd">0</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMyLTMtMS0xLTA_534b93cc-4498-4936-80a3-5432260b9388"
      unitRef="usd">0</us-gaap:CommonStockValueOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM4OTk4_863c57a2-fdf6-4866-bb57-6689358a0f92"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM4OTk4_b5f56231-ae73-4196-8046-7236a44f70e6"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTE0_5c4dabd2-7652-4ada-9999-d5b6bb48a7f1"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTE0_7403b34a-344f-4789-9b8a-978db9cb8170"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTIw_1e1d4305-74ee-4e12-b95f-6c0836481c69"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTIw_1ff4be3e-9c98-4b08-a68f-3e7eb366442d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTIw_2a3d9ad1-fae5-4316-9d2d-4ccdefc9eb10"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZWFmOThiZDlkMjM0OTdkYWI4OGQ5MTEzNjE0MDkzOF81NDk3NTU4MTM5MTIw_41b18ba0-7f8d-45ac-bfb2-33641736f877"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTEtMS0xLTA_e4d5951c-0b70-405c-8d9d-2ceca3cf6de2"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzMzLTMtMS0xLTA_d2677111-e0af-4f43-9964-97a0c1652cab"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM0LTEtMS0xLTA_f777323a-f407-4a77-a106-4896f5cf7436"
      unitRef="usd">199000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM0LTMtMS0xLTA_1140b06f-3ccd-4803-a5b7-6103a63bfe53"
      unitRef="usd">175000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM1LTEtMS0xLTA_1d431a7f-33d0-43c9-8694-708d8f070eb0"
      unitRef="usd">37000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM1LTMtMS0xLTA_1b743cfd-05c7-45dd-85e6-d10195614852"
      unitRef="usd">4000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM2LTEtMS0xLTA_35582369-19a2-4dda-a1a8-ba49735c2fb6"
      unitRef="usd">1860000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM2LTMtMS0xLTA_6df80d6a-7ad1-4fa7-84ec-5b796da856f9"
      unitRef="usd">1781000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM3LTEtMS0xLTA_61205926-19e3-46f2-8c9d-c3e0c0161e3b"
      unitRef="usd">2096000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM3LTMtMS0xLTA_22474478-30c8-4300-8ef1-4eb84fe4293f"
      unitRef="usd">1960000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM4LTEtMS0xLTA_49304e85-d9e5-4e45-988b-b72de38dbb76"
      unitRef="usd">9532000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMjQvZnJhZzo1MDI0ZDdlMTY5NjY0ZTQxOTVhYTI2MjNiODZlZDVkNC90YWJsZTpjOWY4MzM5ZjczMzE0MWRkYTMxNzdlYTg4MTEyZmRjNi90YWJsZXJhbmdlOmM5ZjgzMzlmNzMzMTQxZGRhMzE3N2VhODgxMTJmZGM2XzM4LTMtMS0xLTA_02d9aa95-a501-48ee-8dd7-74e95fc8ac27"
      unitRef="usd">6787000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="id81240d8e0324ade9d13dfaaff5b72b2_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtMS0xLTEtMA_93285687-d2eb-472c-8ca0-4cadfaef5517"
      unitRef="shares">60000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id81240d8e0324ade9d13dfaaff5b72b2_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtMy0xLTEtMA_61d2bc2f-3a7d-42e2-abdc-c93186322983"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4380ffd8981440aab0b911f97c293b09_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtNS0xLTEtMA_51b1a38b-aa70-4869-a04e-b53a383129a3"
      unitRef="usd">1044000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id8aea4f34a3747f088cc40ece091110d_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtNy0xLTEtMA_40ce855b-d654-4a34-82fe-1b7c39241619"
      unitRef="usd">-5000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3d321ff569ec4e909207a3511e1de822_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtOS0xLTEtMA_44906cfc-061e-4ab5-bb41-49dd397f235a"
      unitRef="usd">298000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie5276df7533a434dba724ca46fb6260b_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzMtMTEtMS0xLTA_3698517b-8d8c-4089-a778-853968c4a159"
      unitRef="usd">1337000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i6084d3cc32ce4e868de7c430f423cecb_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzQtOS0xLTEtMA_869b85c4-85a5-4f90-8103-a4560100df70"
      unitRef="usd">707000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzQtMTEtMS0xLTA_cff1d27f-dd43-4169-861d-6fd0c9949957"
      unitRef="usd">707000000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="i5875c847748b49b7ae809be69c6d6256_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzUtNy0xLTEtNDk1Nw_72511879-61bc-4f43-9d41-70b3430ee5f9"
      unitRef="usd">-1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia7fb1e9375a549e9ad146d29588db2b9_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzUtOS0xLTEtNDk0MA_236abe7b-43ab-47e0-a216-829c314a481e"
      unitRef="usd">7000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7987d66d3a0c45c991e3cab20c4fb866_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzUtMTEtMS0xLTQ5NDA_81af881a-189c-4633-8acb-1976116ee582"
      unitRef="usd">6000000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i8c6270cdd3704644bda480c6fd42c68a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzYtNS0xLTEtNDk0NA_a3e89626-3716-4697-bc22-f899f1af3880"
      unitRef="usd">-550000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzYtMTEtMS0xLTQ5NDQ_7f1ac2cc-5447-4a2d-95c6-9a79b2ace343"
      unitRef="usd">-550000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i0e7ec975f1cc4e07b1655f6681e39bae_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzctMS0xLTEtMA_54291568-3ed6-42d1-ad25-0f3d74e52b5d"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i8c6270cdd3704644bda480c6fd42c68a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzctNS0xLTEtMA_6b284928-a485-4e7c-b775-55595989370e"
      unitRef="usd">108000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzctMTEtMS0xLTA_321667da-294f-4e60-a0ac-de5bb3737620"
      unitRef="usd">108000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="i8c6270cdd3704644bda480c6fd42c68a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzgtNS0xLTEtNDk0Ng_c702e4b5-335b-4f08-b94b-5e6f9b2ae524"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzgtMTEtMS0xLTQ5NDg_0cdb923a-146a-47cc-871f-3efa4494efea"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6a7ae69397d149d284b0dd9f61b2d2c2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzktNy0xLTEtMA_09315c8a-c749-4f16-a9a6-ca30d0eba35d"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzktMTEtMS0xLTA_a2d297e7-204a-449e-b0ee-eee90d4ac01d"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8c6270cdd3704644bda480c6fd42c68a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEwLTUtMS0xLTA_89d6f2c4-e8d0-405f-8b41-62d947c25e69"
      unitRef="usd">37000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEwLTExLTEtMS0w_c9e321f3-30a4-41cb-94a0-d04ea9664b35"
      unitRef="usd">37000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="i2faff66f6e7145caa224e62f23b8c597_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTEtMS0xLTA_89ad2e32-d87a-492d-9cb6-43b8cf5805ec"
      unitRef="shares">62000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2faff66f6e7145caa224e62f23b8c597_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTMtMS0xLTA_472e2274-df3c-4b91-ac46-f272dff79bd1"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3dafc291a0c24a16b8316afe33f2004b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTUtMS0xLTA_89e9896c-b0ad-4a80-bcda-e60e3d036615"
      unitRef="usd">643000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25c94a4e11864ff08869c043de0f5f6d_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTctMS0xLTA_bfce02db-5175-4a1b-ac77-2e2520e91142"
      unitRef="usd">-8000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if65f9657d27d4a009acb818ef3881bcc_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTktMS0xLTA_d674e141-62ee-46a4-b0a4-17e4d1bb432f"
      unitRef="usd">1012000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzExLTExLTEtMS0w_5b26e129-fb59-4ce4-b60f-d5c25f100607"
      unitRef="usd">1647000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i02bdadf188dc494b844595ad20923df0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEyLTktMS0xLTA_c8b2413b-bd7a-47d3-bfa3-4b7fa18e43e6"
      unitRef="usd">737000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEyLTExLTEtMS0w_638579fc-713c-4f86-8c41-41805d4066f6"
      unitRef="usd">737000000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iabcc9c4754784b398a5fc79d9a7ebbf7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEzLTUtMS0xLTQ5NTA_d8120f7a-4301-40d1-91fd-859281b34458"
      unitRef="usd">1000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i02bdadf188dc494b844595ad20923df0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEzLTktMS0xLTQ5NTI_352dc916-e6e8-4660-9d42-7063167c9027"
      unitRef="usd">53000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzEzLTExLTEtMS00OTU0_2cf6900c-64aa-46bf-8e44-b640c7ba4774"
      unitRef="usd">54000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquity
      contextRef="i73b8d399d58241d1bd9c438042e73b99_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE0LTktMS0xLTA_2dbd779d-b954-4018-bf7a-2d0ab5def99c"
      unitRef="usd">85000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id3ba89712ec942c09668e856ab29712f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE0LTExLTEtMS0w_3d323410-503e-4709-bec9-1520b37ee379"
      unitRef="usd">85000000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="iabcc9c4754784b398a5fc79d9a7ebbf7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE1LTUtMS0xLTA_1e5e76a3-ac22-4521-bbd1-967655c21dec"
      unitRef="usd">-514000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE1LTExLTEtMS0w_57266c57-ff8f-48cf-b195-c21c3e95b892"
      unitRef="usd">-514000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i97919dee5de246a0b50148ddae7888fb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE2LTctMS0xLTA_4c07f705-43c1-439f-98de-d4f345e522e2"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE2LTExLTEtMS0w_f9251bc5-c302-4bbc-bb8f-dd0b5a023f68"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iabcc9c4754784b398a5fc79d9a7ebbf7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE3LTUtMS0xLTA_de5c7dab-b21d-46db-bf51-f9577a9f09df"
      unitRef="usd">47000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE3LTExLTEtMS0w_17d0cd53-864d-435a-982b-909d2fdfeab1"
      unitRef="usd">47000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="ib0d1799cc9734f13b9ac873259cad7c6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTEtMS0xLTA_1493cf14-46a0-49ff-bd1b-82ed84ed855a"
      unitRef="shares">62000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib0d1799cc9734f13b9ac873259cad7c6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTMtMS0xLTA_d947baea-6945-4d03-9700-8fdb3f97c5f1"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3e22f922c9a84243aa86afcf1b64ac08_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTUtMS0xLTA_0676957d-26f7-47ac-9ae2-8ae7839bb57e"
      unitRef="usd">175000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifaee8551fee24ee384c466fe5ef25b9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTctMS0xLTA_037509bc-2b54-486d-b778-9e1f6e42c440"
      unitRef="usd">4000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0fa5f12c2da940d8b68187f4bdf87af7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTktMS0xLTA_72ae195b-6be1-4591-93cd-818178bbe243"
      unitRef="usd">1781000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE4LTExLTEtMS0w_caefb7b3-545d-4894-bfd2-12cac2ab5b99"
      unitRef="usd">1960000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE5LTktMS0xLTA_e15b855a-6049-4c13-a3f3-caa3d485e4d6"
      unitRef="usd">673000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzE5LTExLTEtMS0w_4896f3e7-d416-4009-a778-a911b6951131"
      unitRef="usd">673000000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i4047b057d87547648b481f3fb3ba62d7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIwLTEtMS0xLTA_e3e8a170-1488-4868-b5a4-92d32ff51751"
      unitRef="shares">4000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ifeaaeaba3f3849a081f3527f07ae1b82_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIwLTUtMS0xLTA_d250dbe2-20df-42be-9b3c-f586c847351d"
      unitRef="usd">11000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i8b04a987b49d48ef8c1cc6f8485617e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIwLTktMS0xLTA_67647c81-9b20-4222-a2c8-8d9a43d87203"
      unitRef="usd">594000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIwLTExLTEtMS04OTA5_b21faddb-ba79-447c-8bc3-e5160c943c97"
      unitRef="usd">605000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ifeaaeaba3f3849a081f3527f07ae1b82_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIxLTUtMS0xLTA_113a51a9-749c-49c8-8d50-4e2eb3afa79d"
      unitRef="usd">-30000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIxLTExLTEtMS0w_a07ddf13-806c-4b36-82ee-c95403e949f9"
      unitRef="usd">-30000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie5396d9352d1442a99bb72088a0b7ca0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIyLTctMS0xLTA_19039901-1210-44e2-8d89-875326548820"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIyLTExLTEtMS0w_88f764ea-f0fe-46ba-b98f-d1515bde8ead"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4047b057d87547648b481f3fb3ba62d7_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIzLTEtMS0xLTA_0388ee1a-e4a4-4dde-8c07-5897d395c282"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifeaaeaba3f3849a081f3527f07ae1b82_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIzLTUtMS0xLTA_46295313-6045-48d2-887c-daa102c899b8"
      unitRef="usd">65000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzIzLTExLTEtMS0w_3adeaecc-fb76-4e04-910c-b476c7fdbd53"
      unitRef="usd">65000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="i860bc85e749a4e47b38f4a7988debbe7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTEtMS0xLTA_be41d3f3-7935-452a-9ee4-83a053950adc"
      unitRef="shares">59000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i860bc85e749a4e47b38f4a7988debbe7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTMtMS0xLTA_07e4f388-79f0-4a07-96f1-47ef34b31e06"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0e975e9f87c74535bf3d7c5035bcba82_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTUtMS0xLTA_306638ba-2a05-4b27-b9c7-754de48a8243"
      unitRef="usd">199000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i183e269a3450453ab9a54b55cee9c2ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTctMS0xLTA_4518bc41-8168-42b3-b338-67ab16a7581f"
      unitRef="usd">37000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5fbc4f7185694bff8ff72e5ae4a739ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTktMS0xLTA_f9da8f1e-5bf0-457b-a62f-b766b77a2955"
      unitRef="usd">1860000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzAvZnJhZzplNjJmZWY0ZjE0Njk0ZGIxYTY3OGUwMGY1NWYxMDY5ZS90YWJsZTplMGU5NTRjYjA2OTE0NGMwYmI4NjJiMWFlMjA2ZGJkYy90YWJsZXJhbmdlOmUwZTk1NGNiMDY5MTQ0YzBiYjg2MmIxYWUyMDZkYmRjXzI0LTExLTEtMS0w_6fdc5a59-c5d0-4fb0-8f62-37bd6e58e420"
      unitRef="usd">2096000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQtMS0xLTEtMTkyNA_6219d01a-62d8-4ecb-883e-4ddcdc542076"
      unitRef="usd">673000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQtMy0xLTEtMA_bd6c83da-db12-41c8-b90b-8bdab10cab1f"
      unitRef="usd">737000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQtNS0xLTEtMTkyNA_f24bfe64-faca-407a-b1f3-e73f127177dd"
      unitRef="usd">707000000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzYtMS0xLTEtMA_8606ad70-0d63-450d-bcbb-2b778cf80a49"
      unitRef="usd">88000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzYtMy0xLTEtMA_48aeeac3-66b4-4dc3-b6e9-4f48deb77eb6"
      unitRef="usd">89000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzYtNS0xLTEtMTkzMQ_02c5eb35-f16e-4858-9878-0bc78190eaf7"
      unitRef="usd">127000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzctMS0xLTEtMA_96748f47-299d-47b3-b823-4effcd7e12dc"
      unitRef="usd">19000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzctMy0xLTEtMA_93ae9714-6607-4e8c-aaee-7b04105adcbe"
      unitRef="usd">-10000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzctNS0xLTEtMTkzMQ_832a2e1d-0367-4984-9009-10a9e367bd5e"
      unitRef="usd">6000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:ShareBasedCompensation
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzgtMS0xLTEtMA_fab291ad-a7dc-4168-a054-3c17c1edfaa3"
      unitRef="usd">57000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzgtMy0xLTEtMA_cdb291a1-ab3f-49e5-ac56-f6a965b17e9d"
      unitRef="usd">39000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzgtNS0xLTEtMTkzMQ_12df860f-3c0c-4c1b-a0e4-d6fc90dfa117"
      unitRef="usd">27000000</us-gaap:ShareBasedCompensation>
    <moh:GainLossOnDebtRepayment
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzktMS0xLTEtMA_b1006630-7981-4874-95a5-e19afdd69972"
      unitRef="usd">-15000000</moh:GainLossOnDebtRepayment>
    <moh:GainLossOnDebtRepayment
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzktMy0xLTEtMA_4023052a-b40a-4eb2-9378-7c54e8845011"
      unitRef="usd">15000000</moh:GainLossOnDebtRepayment>
    <moh:GainLossOnDebtRepayment
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzktNS0xLTEtMTkzNQ_564c20a5-f93b-4af6-a991-754665170975"
      unitRef="usd">-22000000</moh:GainLossOnDebtRepayment>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEwLTEtMS0xLTA_98ee5300-7774-47c5-b85f-faaa63aadce2"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEwLTMtMS0xLTA_ab8c7373-5df5-4acf-b1cf-d331dca32f4e"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEwLTUtMS0xLTE5Mzk_d8edaf93-1ec5-47a4-b143-5c36238a9174"
      unitRef="usd">-15000000</us-gaap:GainLossOnSaleOfBusiness>
    <moh:NoncashRestructuringCharges
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzExLTEtMS0xLTA_3719a87c-dcc2-4813-828d-a9e849ba41aa"
      unitRef="usd">0</moh:NoncashRestructuringCharges>
    <moh:NoncashRestructuringCharges
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzExLTMtMS0xLTA_78cf6139-9afd-4ccd-bdc0-c6ea5788061a"
      unitRef="usd">0</moh:NoncashRestructuringCharges>
    <moh:NoncashRestructuringCharges
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzExLTUtMS0xLTE5NDI_fa6e2962-032e-401a-b2a8-f67278752c31"
      unitRef="usd">17000000</moh:NoncashRestructuringCharges>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEyLTEtMS0xLTA_143fbbbd-2107-4ad4-a8fb-0d09b74366ed"
      unitRef="usd">12000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEyLTMtMS0xLTA_20a5513f-f575-491b-949a-26c4bde52dad"
      unitRef="usd">0</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzEyLTUtMS0xLTA_bc0f5faa-a619-4257-af96-04c9ce06fac8"
      unitRef="usd">26000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE0LTEtMS0xLTA_39c298f7-f1a9-4ac6-9acf-86c58ee6160e"
      unitRef="usd">100000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE0LTMtMS0xLTA_021a6ca9-91b5-426e-9577-77e051b502a4"
      unitRef="usd">76000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE0LTUtMS0xLTE5NDc_306ec3f6-63a0-4393-bc3b-3ae3356bdd77"
      unitRef="usd">530000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE1LTEtMS0xLTA_15575daf-fcb1-40e3-ac68-32e9b56c6b73"
      unitRef="usd">16000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE1LTMtMS0xLTA_8f218f3c-11a6-4255-9aab-d79f7b2c8d9e"
      unitRef="usd">-28000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE1LTUtMS0xLTE5NDc_03173f39-f61d-497a-8d64-9c7da516e7d9"
      unitRef="usd">-6000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE2LTEtMS0xLTA_3a4f217b-153a-4266-a03d-d1e26cd92272"
      unitRef="usd">544000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE2LTMtMS0xLTA_51b263ab-21d9-4938-bf63-98e98b0c0d05"
      unitRef="usd">-107000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE2LTUtMS0xLTE5NDc_8b83f410-7b67-4d1d-94ba-726219d127e3"
      unitRef="usd">-226000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <moh:IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE3LTEtMS0xLTA_1048eb4f-9e36-45cd-a6ca-86e24ceaf68b"
      unitRef="usd">446000000</moh:IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency>
    <moh:IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE3LTMtMS0xLTA_79e62c23-5552-4896-8ba8-708eb96dbfe5"
      unitRef="usd">-303000000</moh:IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency>
    <moh:IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE3LTUtMS0xLTE5NDc_13b4410f-bce0-4a94-8952-34fc3a83c6ca"
      unitRef="usd">-574000000</moh:IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE4LTEtMS0xLTA_be8e70b5-7d9e-46ce-9965-cf7858ef352d"
      unitRef="usd">78000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE4LTMtMS0xLTA_b745a4c8-84fa-498f-8954-7267afc4c30d"
      unitRef="usd">2000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE4LTUtMS0xLTE5NDc_e38a48a8-e799-441a-8906-7af5c30ad4ec"
      unitRef="usd">45000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE5LTEtMS0xLTA_9f98d5cd-1209-4aa8-90c1-7f851c0ec016"
      unitRef="usd">126000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE5LTMtMS0xLTA_debdd2dc-f1c3-4df8-bf31-b05c22e15737"
      unitRef="usd">38000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzE5LTUtMS0xLTE5NDc_f8d012d5-1225-45a0-a815-2e9856ce8d81"
      unitRef="usd">-21000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIwLTEtMS0xLTA_3af884de-f669-4061-a936-bce70440845b"
      unitRef="usd">-14000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIwLTMtMS0xLTA_88cb0f3e-851b-414a-b64b-5285d328c4de"
      unitRef="usd">-15000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIwLTUtMS0xLTE5NDc_f97e2eb9-aa0d-4d71-a961-47c9075b42fd"
      unitRef="usd">51000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIxLTEtMS0xLTA_8dfe0458-a811-41e3-ad8c-597b21ae71a4"
      unitRef="usd">1890000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIxLTMtMS0xLTA_52d02a62-3bc7-4877-abfc-da7c51c9df06"
      unitRef="usd">427000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIxLTUtMS0xLTA_3f083fb1-7bcb-4df2-9932-46ef4e5ae0cc"
      unitRef="usd">-314000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIzLTEtMS0xLTA_8d3cc0a5-db6e-4d16-b4e4-fecc7506d19b"
      unitRef="usd">670000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIzLTMtMS0xLTA_c4c091bb-2466-47e1-8766-a0cf8e8d48e5"
      unitRef="usd">2536000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzIzLTUtMS0xLTE5NTE_bd53eaa2-507b-4e6c-9ec6-add1cec09df5"
      unitRef="usd">1444000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI0LTEtMS0xLTA_4f422032-a521-40bd-97aa-17d40e769807"
      unitRef="usd">1097000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI0LTMtMS0xLTA_ad671e9f-3b51-4b19-9e73-14f0074f6550"
      unitRef="usd">2302000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI0LTUtMS0xLTE5NTE_fa8f9805-bcf7-4262-969d-138057dd5117"
      unitRef="usd">2445000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTEtMS0xLTIyNzQ5_6eab3429-0386-4349-ae80-97141a7ce2de"
      unitRef="usd">755000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTMtMS0xLTIyNzQ5_81cdf0aa-bf22-4f27-b94c-8910d2ecc69a"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTUtMS0xLTIyNzQ5_22306799-d980-4857-b3e6-94021cadef4d"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTEtMS0xLTA_b3a2ab07-c88e-44c6-afbb-eff0b0bd0d7a"
      unitRef="usd">74000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTMtMS0xLTA_5de72850-f8a6-47f8-a61a-b34205671c5e"
      unitRef="usd">57000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI1LTUtMS0xLTE5NjA_508431b1-abfc-480a-8e05-989a481e8741"
      unitRef="usd">30000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI3LTEtMS0xLTA_83a4842b-bf4b-4ddb-bfa7-b15cd363e569"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI3LTMtMS0xLTA_7e83b321-5b08-4b37-9aa1-973806e7cc06"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI3LTUtMS0xLTE5NTc_2e8c0894-1402-4d37-ad61-f8f9e2ab3383"
      unitRef="usd">190000000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI4LTEtMS0xLTA_1f244e0d-6e94-4669-8592-2d630a9539c5"
      unitRef="usd">-2000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI4LTMtMS0xLTA_b31fbb85-9b2f-4292-8d13-5e40ad9bfa4b"
      unitRef="usd">2000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI4LTUtMS0xLTE5NjM_24ea9d48-72e6-4437-a7d8-fb44e0f70b73"
      unitRef="usd">18000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI5LTEtMS0xLTA_1f274533-9d31-4d44-bfe7-da8be985b61a"
      unitRef="usd">-400000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI5LTMtMS0xLTA_201b5ce6-2077-4a4c-9c1a-d1d43424ee2f"
      unitRef="usd">-293000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzI5LTUtMS0xLTA_d25c9586-e6a9-4dc1-ad13-a86763da91ee"
      unitRef="usd">1143000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMxLTEtMS0xLTE5NjY_7c7e03ca-b083-40b0-86e1-6b97e931f577"
      unitRef="usd">1429000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMxLTMtMS0xLTE5NjY_a595250f-f1aa-4a70-8482-94c021eca3cd"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMxLTUtMS0xLTE5NjY_11ce07d3-3b8c-4544-8dc8-bd458a0c319e"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTEtMS0xLTE0NjEy_17b2a935-ad34-4299-bac3-c3bcb1c32300"
      unitRef="usd">606000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTMtMS0xLTE0NjEy_05b7e288-cd9d-4f84-ae2d-1144fd959eb0"
      unitRef="usd">47000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTUtMS0xLTE0NjEy_d824245d-7b7b-4d6a-a2a9-a5d932980453"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTEtMS0xLTE5NjY_333582ac-70a2-4b60-aac6-d9ee635310a8"
      unitRef="usd">600000000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTMtMS0xLTE5NjY_d78c96ed-471d-4ab7-b271-a56a8bb8d3fe"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMyLTUtMS0xLTE5NjY_09c81136-6f2e-4e1a-bc1b-ca43845d18f1"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM0LTEtMS0xLTY5Nw_9a8edd26-1d1d-4c54-be80-4292a520df73"
      unitRef="usd">380000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM0LTMtMS0xLTY5Nw_216f22be-79ec-4319-8c34-268c54fd1267"
      unitRef="usd">220000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM0LTUtMS0xLTE5Njk_51c5ae25-33c1-48b6-a4f7-f614a2c5d4fd"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTEtMS0xLTI1NTY_297dcf1b-d4c5-439e-a3a0-c63edcacf26d"
      unitRef="usd">338000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTMtMS0xLTI1NTY_cd4572be-1b03-44ee-a7da-c052cb8920a2"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTUtMS0xLTI1NTY_0359ea36-1ffa-42a8-8420-2444d64a519c"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMzLTEtMS0xLTA_f3c6c7e8-7edf-4398-aafd-545c3dad1e82"
      unitRef="usd">30000000</us-gaap:PaymentsForRepurchaseOfWarrants>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzMzLTMtMS0xLTA_86a19b57-c1dc-4697-970c-ddc39c468511"
      unitRef="usd">514000000</us-gaap:PaymentsForRepurchaseOfWarrants>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTUtMS0xLTE5Nzc_6b5cb32d-ab60-4830-b9fa-aecaf8731f3c"
      unitRef="usd">549000000</us-gaap:PaymentsForRepurchaseOfWarrants>
    <moh:CashPaidForSettlementOfConversionOption
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM0LTEtMS0xLTA_50dd5c51-bfbd-49d1-a65e-f54dec484cd1"
      unitRef="usd">27000000</moh:CashPaidForSettlementOfConversionOption>
    <moh:CashPaidForSettlementOfConversionOption
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM0LTMtMS0xLTA_4e7ec5f9-2764-4b67-8205-dfce786e7a07"
      unitRef="usd">578000000</moh:CashPaidForSettlementOfConversionOption>
    <moh:CashPaidForSettlementOfConversionOption
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM2LTUtMS0xLTE5ODA_2768720f-2a77-4afd-82e0-f53c52a089b8"
      unitRef="usd">623000000</moh:CashPaidForSettlementOfConversionOption>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTEtMS0xLTA_6e025ee7-7bd9-402c-ba4d-78fdc62b04f9"
      unitRef="usd">27000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM1LTMtMS0xLTA_9fce792e-2ad0-4211-8bf3-d3641af045d4"
      unitRef="usd">578000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM3LTUtMS0xLTE5ODA_a7d06737-1450-4135-8be8-7ffe4ffce2d1"
      unitRef="usd">623000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM3LTEtMS0xLTA_34acb870-7d12-483e-80a4-ec7aaabf07fd"
      unitRef="usd">12000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM3LTMtMS0xLTA_16834e2a-0341-4dc0-80ec-0ec87e9dc5d1"
      unitRef="usd">240000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM4LTUtMS0xLTE5ODM_71dec73c-68d7-4e46-a4ef-f7cc457e8cdb"
      unitRef="usd">362000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM5LTEtMS0xLTA_5c570acb-95fb-43d4-b6b1-96bc223db5cc"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM5LTMtMS0xLTA_2c08d372-0924-4137-a6a3-e953b2daa0c1"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzM5LTUtMS0xLTE5ODc_0d12ea12-4474-43b3-bf17-417f52f0c7a1"
      unitRef="usd">300000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQwLTEtMS0xLTA_2f9f3736-0f7e-4d52-adea-6b7386636ee0"
      unitRef="usd">2000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQwLTMtMS0xLTA_81dc79c7-0f37-4b81-adec-6cb646f31970"
      unitRef="usd">29000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQwLTUtMS0xLTE5ODc_17d9c005-2033-4cfa-8f98-70a305e430bc"
      unitRef="usd">18000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQxLTEtMS0xLTA_828029c0-9ce0-49b0-9f32-9b2673d6d249"
      unitRef="usd">225000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQxLTMtMS0xLTA_93f952c0-04d0-45c5-b041-2d81f9a5ffb6"
      unitRef="usd">-552000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQxLTUtMS0xLTA_daaaf839-055f-4efc-8dd1-a1301feeb46e"
      unitRef="usd">-1193000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQyLTEtMS0xLTA_6fa468d8-89d5-46b3-bbe9-a9239af21461"
      unitRef="usd">1715000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQyLTMtMS0xLTA_f3c5d383-284a-4d1c-a500-cdff11757894"
      unitRef="usd">-418000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQyLTUtMS0xLTA_3232d6f3-dc79-4391-908e-b2e0e4c27b3b"
      unitRef="usd">-364000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQzLTEtMS0xLTA_94470d03-73df-4022-9b6a-d478a89fb1c1"
      unitRef="usd">2508000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQzLTMtMS0xLTA_2abbc005-a1bd-4818-96e2-3d1072489af4"
      unitRef="usd">2926000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie5276df7533a434dba724ca46fb6260b_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQ0LTUtMS0xLTQ5Njg_b6d8febe-ebf4-499f-9049-7febd9893541"
      unitRef="usd">3290000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQ0LTEtMS0xLTA_d1421e46-7973-4558-bc4e-2ab1d0bf8d63"
      unitRef="usd">4223000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQ0LTMtMS0xLTA_f9f8951a-8b57-40ef-b161-87e2eccabc69"
      unitRef="usd">2508000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZmZjZWU3MWU4MTc0M2Y0OWY4ODNlZjE4NzIzZDgzNi90YWJsZXJhbmdlOmJmZmNlZTcxZTgxNzQzZjQ5Zjg4M2VmMTg3MjNkODM2XzQ0LTUtMS0xLTA_8388abc1-7b75-473c-9b02-9f2d871ef14c"
      unitRef="usd">2926000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzctMS0xLTEtMA_67ba5916-ecfd-4ac0-afa0-d81a729349f7"
      unitRef="usd">321000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzctMy0xLTEtMA_a3e79fb3-bb76-4751-b9c1-cd323b5d35c9"
      unitRef="usd">239000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzctNS0xLTEtMA_4ef77a7d-4b8c-4be7-973e-e2b800fd0719"
      unitRef="usd">240000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzgtMS0xLTEtMA_8c46dddc-c823-4291-9b6f-56a29b330483"
      unitRef="usd">112000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzgtMy0xLTEtMA_228319c6-d9e1-4f78-8161-039bfd6f1f35"
      unitRef="usd">78000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzgtNS0xLTEtMA_f7c9f60c-0a3e-4bec-bb58-a95d583813cd"
      unitRef="usd">93000000</us-gaap:InterestPaidNet>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEyLTEtMS0xLTcxMzM_b2215434-846b-4e98-af3a-849f7583963f"
      unitRef="usd">1340000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEyLTMtMS0xLTcxMzM_8a84006b-bc9e-4d67-bd79-9d66b23d28fd"
      unitRef="usd">0</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEyLTUtMS0xLTcxMzM_800d986f-8682-46d2-80df-f3a5b03f34e6"
      unitRef="usd">0</us-gaap:FairValueOfAssetsAcquired>
    <moh:FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTEtMS0xLTcxMzM_be9ecbe7-fa16-4658-944d-ac54a5f360a6"
      unitRef="usd">40000000</moh:FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities>
    <moh:FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTMtMS0xLTcxMzM_60caddd5-6f1f-44d5-864e-b4be1ac61b98"
      unitRef="usd">0</moh:FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities>
    <moh:FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTUtMS0xLTcxMzM_10f20f0f-cd0c-4f7a-9bc2-a488343346ef"
      unitRef="usd">0</moh:FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTEtMS0xLTcxMzM_f089c35c-dde9-434c-a2db-452f66e5d938"
      unitRef="usd">545000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTMtMS0xLTcxMzM_56b1c69d-df98-43e6-9cec-ba2f2c93d41c"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTUtMS0xLTcxMzM_aee0d385-8a83-4535-8384-6a717a4feae5"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTEtMS0xLTcxMzM_ca04f34c-79c8-4afb-816f-06980f34cd0a"
      unitRef="usd">755000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTMtMS0xLTcxMzM_b5e7e4e6-0c3e-470d-9124-127d96d8a42c"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTUtMS0xLTcxMzM_521a296c-12fa-4907-a6c8-df6b9f1de8ad"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NotesIssued1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTEtMS0xLTA_44c51a8a-811c-4fb9-a8a5-8ba285a22403"
      unitRef="usd">0</us-gaap:NotesIssued1>
    <us-gaap:NotesIssued1
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTMtMS0xLTA_c4a64e9d-ed32-49a1-ae4c-c234afe46f20"
      unitRef="usd">0</us-gaap:NotesIssued1>
    <us-gaap:NotesIssued1
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzEzLTUtMS0xLTA_ee8cdc15-4a91-4f73-8b98-d1f5180447c9"
      unitRef="usd">131000000</us-gaap:NotesIssued1>
    <moh:NotesIssuedFairValueAdjustmentIncreaseDecrease
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTEtMS0xLTA_2ad94e1b-2162-4971-9a38-5528a1764abf"
      unitRef="usd">0</moh:NotesIssuedFairValueAdjustmentIncreaseDecrease>
    <moh:NotesIssuedFairValueAdjustmentIncreaseDecrease
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTMtMS0xLTA_75c4a839-4e20-4c1a-806e-fcc6e31b2105"
      unitRef="usd">0</moh:NotesIssuedFairValueAdjustmentIncreaseDecrease>
    <moh:NotesIssuedFairValueAdjustmentIncreaseDecrease
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE0LTUtMS0xLTA_64238b13-2bf2-41fd-b9fb-cdd16bdabc38"
      unitRef="usd">-23000000</moh:NotesIssuedFairValueAdjustmentIncreaseDecrease>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTEtMS0xLTA_04880406-a5e2-47a7-af19-39aa0d67286f"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTMtMS0xLTA_0910fcaa-cd14-4b06-84d3-c72610b29c49"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE1LTUtMS0xLTA_a17e58c0-6a10-499e-85c8-56ef3b97045b"
      unitRef="usd">108000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:StockIssued1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE3LTEtMS0xLTA_cdcecba0-30f4-45e3-bd91-1079876f05e6"
      unitRef="usd">8000000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE3LTMtMS0xLTA_033e4f70-8b1d-441c-b8b1-7e8dc89a4b96"
      unitRef="usd">7000000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE3LTUtMS0xLTA_0b6f0ed5-c188-48ec-925c-07a4f0dd09ea"
      unitRef="usd">6000000</us-gaap:StockIssued1>
    <moh:CommonStockPurchasesNotSettledAtEndOfPeriod
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE5LTEtMS0xLTA_57b7e79c-eb7d-4c0b-99d9-c8569ada1121"
      unitRef="usd">6000000</moh:CommonStockPurchasesNotSettledAtEndOfPeriod>
    <moh:CommonStockPurchasesNotSettledAtEndOfPeriod
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE5LTMtMS0xLTA_472518aa-6df0-4c18-b76a-5ad6cd7ad08f"
      unitRef="usd">7000000</moh:CommonStockPurchasesNotSettledAtEndOfPeriod>
    <moh:CommonStockPurchasesNotSettledAtEndOfPeriod
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzE5LTUtMS0xLTA_286c5e17-cf6d-4fc2-a710-4a1aad314852"
      unitRef="usd">0</moh:CommonStockPurchasesNotSettledAtEndOfPeriod>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i8327c36af50243d39623edb7b5bcb06f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTEtMS0xLTczMQ_0af542f5-6f40-4b7f-b319-56e3e900b359"
      unitRef="usd">-2000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="idb902f5430db4cec865e03899ec0a22a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTMtMS0xLTczMQ_6fa9329b-69ca-49e9-b81c-2bba7e01d61a"
      unitRef="usd">132000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i07b1e43b622b42d9b75e1ccb92389132_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTUtMS0xLTczMQ_1227166b-cc07-4d44-8ec5-43502d279177"
      unitRef="usd">577000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i80c02cdb9f7a420cb8aedf486216882d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTEtMS0xLTczMQ_d4320305-3e3b-4c68-96bf-b43896faf905"
      unitRef="usd">2000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i8d11a4d46cec445aa76d23295e7aa22d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTMtMS0xLTczMQ_050f7570-d8fe-46ab-ba3a-897dfa27a2c7"
      unitRef="usd">-132000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ibb861312d6ab444ca32cfee48e0fd8a0_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTUtMS0xLTczMQ_156182f7-7dc4-4acd-a7aa-a60dd931b6ab"
      unitRef="usd">-577000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTEtMS0xLTczMQ_8485851b-dbaf-478a-8c42-f9924ec200dc"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTMtMS0xLTczMQ_af99995e-0a1f-4164-b75d-ba2b132641cd"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTUtMS0xLTczMQ_6ea58ea9-0bbe-4788-a479-3e1c1be24b31"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <moh:IncreaseDecreaseinCarryingAmountofAssets
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTEtMS0xLTA_770b2cfe-464a-4cda-b0e8-cc793ae643a4"
      unitRef="usd">0</moh:IncreaseDecreaseinCarryingAmountofAssets>
    <moh:IncreaseDecreaseinCarryingAmountofAssets
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTMtMS0xLTA_3a9994cc-56b2-472c-8eb1-8403647923c7"
      unitRef="usd">0</moh:IncreaseDecreaseinCarryingAmountofAssets>
    <moh:IncreaseDecreaseinCarryingAmountofAssets
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI4LTUtMS0xLTA_a09fb76d-e61d-485d-949f-fbb7c88a209b"
      unitRef="usd">-327000000</moh:IncreaseDecreaseinCarryingAmountofAssets>
    <moh:GainLossonDispositionofLiabilities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTEtMS0xLTA_44471e0b-cd7c-42c0-9ec4-3a1651b8b815"
      unitRef="usd">0</moh:GainLossonDispositionofLiabilities>
    <moh:GainLossonDispositionofLiabilities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTMtMS0xLTA_2897edea-71e9-418d-abd7-7dd4de7c40f0"
      unitRef="usd">0</moh:GainLossonDispositionofLiabilities>
    <moh:GainLossonDispositionofLiabilities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzI5LTUtMS0xLTA_fbc24857-18e6-42b4-acb3-b31f30e96c1b"
      unitRef="usd">85000000</moh:GainLossonDispositionofLiabilities>
    <moh:DispositionofBusinessTransactionCosts
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTEtMS0xLTA_588400a3-b057-49e4-a0f3-64e80e235f13"
      unitRef="usd">0</moh:DispositionofBusinessTransactionCosts>
    <moh:DispositionofBusinessTransactionCosts
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTMtMS0xLTA_915ab008-8719-44f3-ac2d-3aa55595252e"
      unitRef="usd">0</moh:DispositionofBusinessTransactionCosts>
    <moh:DispositionofBusinessTransactionCosts
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMwLTUtMS0xLTA_e4ed8cdd-b095-4eb6-8d15-06926de95c7e"
      unitRef="usd">15000000</moh:DispositionofBusinessTransactionCosts>
    <moh:DispositionofBusinessReceivablefromBuyer
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMxLTEtMS0xLTA_04cbb59b-06c9-42b2-a722-5b4e9cb8fd95"
      unitRef="usd">0</moh:DispositionofBusinessReceivablefromBuyer>
    <moh:DispositionofBusinessReceivablefromBuyer
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMxLTMtMS0xLTA_4ea60348-7e1e-45d4-80c8-804bf17dc637"
      unitRef="usd">0</moh:DispositionofBusinessReceivablefromBuyer>
    <moh:DispositionofBusinessReceivablefromBuyer
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMxLTUtMS0xLTA_7efe611f-cfe1-4863-bcb0-fd02cea78c99"
      unitRef="usd">242000000</moh:DispositionofBusinessReceivablefromBuyer>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMyLTEtMS0xLTA_4c32e325-6079-4c3c-a3fc-951199e6a2ce"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMyLTMtMS0xLTA_0007f5f3-fcb9-48fd-aef8-ba27598d9b2d"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xMzMvZnJhZzo0NWNkY2QzNzk0MTI0ZDgwOWRkMDczMDI2NTU4Y2RlMS90YWJsZTpiZjZkMDgyNTExM2M0YzUwODNiNzZjNzBhMGQ2YWYyMi90YWJsZXJhbmdlOmJmNmQwODI1MTEzYzRjNTA4M2I3NmM3MGEwZDZhZjIyXzMyLTUtMS0xLTA_935d9f80-133c-4e07-ae9d-c867035ca383"
      unitRef="usd">-15000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzY0MTY_fa4ebefc-4560-4c8e-8efb-0281ca66a7c4">Organization and Basis of Presentation &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Organization and Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Molina Healthcare, Inc. provides managed healthcare services under the Medicaid and Medicare programs, through the state insurance marketplaces (the &#x201c;Marketplace&#x201d;), and under other government-sponsored healthcare programs for low-income families and individuals, most of whom receive government subsidies for premiums. As of December 31, 2020, we had two reportable segments: the Health Plans segment, and the Other segment. Our reportable segments are consistent with how we currently manage the business and view the markets we serve. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through our locally operated health plans in 15 states, we served approximately 4.0 million members as of December 31, 2020. In addition, in connection with our acquisition of Magellan Complete Care on December 31, 2020, we added approximately 200,000 members, and now operate health plans in 18 states. These health plans are generally operated by our respective wholly owned subsidiaries in those states, and licensed as health maintenance organizations (&#x201c;HMOs&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our state Medicaid contracts typically have terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2Xzg0NA_2a1d4052-6221-4b74-b359-9ff02580423e"&gt;three&lt;/span&gt; to five years, contain renewal options exercisable by the state Medicaid agency, and allow either the state or the health plan to terminate the contract with or without cause. Such contracts are subject to risk of loss in states that issue requests for proposal (&#x201c;RFP&#x201d;) open to competitive bidding by other health plans. If one of our health plans is not a successful responsive bidder to a state RFP, its contract may not be renewed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to contract renewal, our state Medicaid contracts may be periodically amended to include or exclude certain health benefits (such as pharmacy services, behavioral health services, or long-term care services); populations such as the aged, blind or disabled; and regions or service areas.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Developments &#x2013; Health Plans Segment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Magellan Complete Care. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 31, 2020, we closed on our acquisition of 100% of the outstanding equity interests of the Magellan Complete Care line of business of Magellan Health, Inc., for total purchase consideration of approximately $1,037&#160;million. Because this acquisition closed on December 31, 2020, Magellan Complete Care&#x2019;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020. See Note 4, &#x201c;Business Combinations,&#x201d; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New York&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, we entered into a definitive agreement to acquire substantially all the assets of Affinity Health Plan, Inc. The net purchase price for the transaction is approximately $380&#160;million, subject to various adjustments at closing, which we intend to fund with cash on hand. We currently expect the transaction to close as early as the second quarter of 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, we completed the acquisition of certain assets of YourCare Health Plan, Inc. See Note 4, &#x201c;Business Combinations,&#x201d; for further information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Kentucky. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, our Kentucky health plan was selected as an awardee pursuant to the statewide Medicaid managed care RFP issued by the Kentucky Cabinet for Health and Family Services, Department of Medicaid Services. The new Medicaid contract began on January 1, 2021. In connection with this RFP award, we completed the acquisition of certain assets of Passport Health Plan, Inc. (&#x201c;Passport&#x201d;) in September 2020. See Note 4, &#x201c;Business Combinations,&#x201d; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Texas.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In March 2020, the Texas Health and Human Services Commission (&#x201c;HHSC&#x201d;) notified our Texas health plan that HHSC had upheld our protest and had canceled all previously awarded contracts associated with the re-procurement awards announced in October 2019 for the ABD program (known in Texas as &#x201c;STAR+PLUS&#x201d;). In addition, HHSC canceled the pending re-procurement associated with the TANF and CHIP programs (known in Texas as &#x201c;STAR/CHIP&#x201d;). HHSC has indicated that the STAR+PLUS RFP will be posted in late 2021 or early 2022, with awards estimated to be announced in the second quarter of 2022, and start of operations in the fourth quarter of 2023. HHSC has also indicated that the STAR/CHIP RFP will be posted in the fourth quarter of 2022, with awards estimated to be announced in late 2022 or early 2023, and start of operations in the third quarter of 2024.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Puerto Rico&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We exited Puerto Rico&#x2019;s Medicaid program when our contract expired on October 31, 2020. We have been working with the regulatory authorities and the provider community to ensure that our former members in Puerto Rico have reliable continuity of care.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidation and Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of Molina Healthcare, Inc., and its subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. Financial information related to subsidiaries acquired during any year is included only for periods subsequent to their acquisition. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the periods presented have been included; such adjustments consist of normal recurring adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Principal areas requiring the use of estimates include:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The determination of medical claims and benefits payable of our Health Plans segment;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Health Plans segment contractual provisions that may limit revenue recognition based upon the costs incurred or the profits realized under a specific contract;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Health Plans segment quality incentives that allow us to recognize incremental revenue if certain quality standards are met;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Settlements under risk or savings sharing programs;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Purchase price allocations relating to business combinations, including the determination of contingent consideration;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The assessment of long-lived and intangible assets, and goodwill, for impairment;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The determination of reserves for potential absorption of claims unpaid by insolvent providers;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The determination of reserves for the outcome of litigation;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The determination of valuation allowances for deferred tax assets;&#160;and&lt;/span&gt;&lt;/div&gt;&#x2022;The determination of unrecognized tax benefits.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzIxMw_996a3170-4e0c-4aaa-8da0-8e978fefe709"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <moh:NumberOfStatesForOperatedHealthPlans
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzEwOTk1MTE2NDkzMDg_8e15e101-9a3e-4a57-9af1-fa4115261ee6"
      unitRef="state">15</moh:NumberOfStatesForOperatedHealthPlans>
    <moh:NumberOfMembersEligibleForTheHealthCarePrograms
      contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzYwNDczMTM5NzI1OTA_083a3d2a-1aa5-4dbf-a8bf-a21bfa284548"
      unitRef="member">4000000</moh:NumberOfMembersEligibleForTheHealthCarePrograms>
    <moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms
      contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzEwOTk1MTE2NDk0OTE_104d0b81-95f7-49bb-a2d9-8340c90af9f4"
      unitRef="member">200000</moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms>
    <moh:NumberOfStatesForOperatedHealthPlans
      contextRef="idc8845b2df0142a6ad693b5b696a900f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzEwOTk1MTE2NDk1MDA_3a08f146-f88b-4cf6-8e76-85669fd1a24d"
      unitRef="state">18</moh:NumberOfStatesForOperatedHealthPlans>
    <moh:HealthPlanContractTerm
      contextRef="i50a1c2e5665543b3bda779ef36e5094b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2Xzg1MA_8d640d52-e838-4026-85e7-22f935df04ff">P5Y</moh:HealthPlanContractTerm>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="idc8845b2df0142a6ad693b5b696a900f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzEwOTk1MTE2NDc0NjI_edee7e04-76a9-4d51-a685-4ee8811ada5c"
      unitRef="number">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i41056d0891344bfeb906ddd9f525ea3d_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzE2NDkyNjc0NTQ2NjM_cc4ca022-6eb2-4bb3-a223-e5b451067cd6"
      unitRef="usd">1037000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i761083592e2c455daabbcd09515b7402_D20200901-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzEwOTk1MTE2Mzg3NTI_81e13435-6f19-4388-9c62-69fefd76d7a9"
      unitRef="usd">380000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzY0MTg_86fd4af8-4184-4369-bb50-c6685fa830d4">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidation and Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of Molina Healthcare, Inc., and its subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. Financial information related to subsidiaries acquired during any year is included only for periods subsequent to their acquisition. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the periods presented have been included; such adjustments consist of normal recurring adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2XzY0MjU_f9cbba33-47ac-4c96-93a2-e4698e6c4081">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Principal areas requiring the use of estimates include:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The determination of medical claims and benefits payable of our Health Plans segment;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Health Plans segment contractual provisions that may limit revenue recognition based upon the costs incurred or the profits realized under a specific contract;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Health Plans segment quality incentives that allow us to recognize incremental revenue if certain quality standards are met;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Settlements under risk or savings sharing programs;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Purchase price allocations relating to business combinations, including the determination of contingent consideration;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The assessment of long-lived and intangible assets, and goodwill, for impairment;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The determination of reserves for potential absorption of claims unpaid by insolvent providers;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The determination of reserves for the outcome of litigation;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The determination of valuation allowances for deferred tax assets;&#160;and&lt;/span&gt;&lt;/div&gt;&#x2022;The determination of unrecognized tax benefits.</us-gaap:UseOfEstimates>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjcw_ef5eab4e-cde5-4435-af45-60565590e515">Significant Accounting Policies &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash and short-term, highly liquid investments that are both readily convertible into known amounts of cash and have a maturity of three months or less on the date of purchase. The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in &#x201c;Restricted investments&#x201d; in the accompanying consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments are principally held in debt securities, which are grouped into two separate categories for accounting and reporting purposes: available-for-sale securities, and held-to-maturity securities. Available-for-sale (&#x201c;AFS&#x201d;) securities are recorded at fair value and unrealized gains and losses, if any, are recorded in stockholders&#x2019; equity as other comprehensive income, net of applicable income taxes. Held-to-maturity (&#x201c;HTM&#x201d;) securities are recorded at amortized cost, which approximates fair value, and unrealized holding gains or losses are not generally recognized. Realized gains and losses and unrealized losses arising from credit-related factors with respect to AFS and HTM securities are included in the determination of net income. The cost of securities sold is determined using the specific-identification method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy requires that all of our investments have final maturities of less than 10 years, or less than 10 years average life for structured securities. Investments and restricted investments are subject to interest rate risk and will decrease in value if market rates increase. Declines in interest rates over time will reduce our investment income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, our AFS securities are classified as current assets without regard to the securities&#x2019; contractual maturity dates because they may be readily liquidated. We monitor our investments for credit-related impairment. For comprehensive discussions of the fair value and classification of our investments, see Note&#160;5, &#x201c;Fair Value Measurements,&#x201d; and Note&#160;6, &#x201c;Investments.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued interest receivable relating to our AFS and HTM securities is presented within &#x201c;Prepaid expenses and other current assets&#x201d; in the accompanying consolidated balance sheets, and amounted to $10&#160;million and $12&#160;million at December 31, 2020, and 2019, respectively. We do not measure an allowance for credit losses on accrued interest receivable. Instead, we write off accrued interest receivable that has not been collected within 90 days of the interest payment due date. We recognize such write offs as a reversal of interest income. No accrued interest was written off during the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables consist primarily of premium amounts due from government agencies, which may be subject to potential retroactive adjustments. Because substantially all of our receivable amounts are readily determinable and substantially all of our creditors are governmental authorities, our allowance for doubtful accounts is insignificant. Any amounts determined to be uncollectible are charged to expense when such determination is made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pharmacy rebate receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Health insurer fee reimbursement receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for business combinations using the acquisition method of accounting, which requires us to recognize the assets acquired and the liabilities assumed at their acquisition date fair values. As discussed below, the excess of the purchase consideration transferred over the fair value of the net tangible and intangible assets acquired is recorded as goodwill. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the final determination of the values of assets acquired or liabilities assumed, or one year after the date of acquisition, whichever comes first, any subsequent adjustments are recorded within our consolidated results of operations. Refer to Note 4, Business Combinations, and Note 9, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets, including Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets consist primarily of property, equipment, capitalized software (see Note 7, &#x201c;Property, Equipment, and Capitalized Software, Net&#x201d;), and intangible assets resulting from acquisitions. Finite-lived, separately-identified intangible assets acquired in business combinations are assets that represent future expected benefits but lack physical substance (such as purchased contract rights and provider contracts). Intangible assets are initially recorded at fair value and are then amortized on a straight-line basis over their expected useful lives, generally between &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4NDY_345e2136-02de-45cb-a7d6-760278ca92ed"&gt;five&lt;/span&gt; and 16 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Determining the fair value of identifiable assets acquired, particularly intangible assets, and liabilities assumed,  requires management to make estimates, which are based on all available information and in some cases assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Determining the useful life of an intangible asset also requires judgment, as different types of intangible assets will have different useful lives. The most significant intangible asset we typically record in a business combination is contract rights associated with membership assumed. In determining the estimated fair value of the intangible assets, we typically apply the income approach, which discounts the projected future net cash flows using an appropriate discount rate that reflects the risk associated with such projected future cash flows. The most critical assumptions used in determining the fair value of contract rights include forecasted operating margins and the weighted average cost of capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our intangible assets are subject to impairment tests when events or circumstances indicate that a finite-lived intangible asset&#x2019;s (or asset group&#x2019;s) carrying value may not be recoverable. Consideration is given to a number of potential impairment indicators, including the ability of our health plan subsidiaries to obtain the renewal by amendment of their contracts in each state prior to the actual expiration of their contracts. However, there can be no assurance that these contracts will continue to be renewed. Following the identification of any potential impairment indicators, to determine whether an impairment exists, we would compare the carrying amount of a finite-lived intangible asset with the greater of the undiscounted cash flows that are expected to result from the use of the asset or related group of assets, or its value under the asset liquidation method. If it is determined that the carrying amount of the asset is not recoverable, the amount by which the carrying value exceeds the estimated fair value is recorded as an impairment. Refer to Note 9, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase consideration over the fair value of net assets acquired in business combinations. Goodwill is not amortized but is tested for impairment on an annual basis and more frequently if impairment indicators are present. Impairment indicators may include experienced or expected operating cash-flow deterioration or losses, significant losses of membership, loss of state funding, loss of state contracts, and other factors. Goodwill is impaired if the carrying amount of the reporting unit (one of our state health plans) exceeds its estimated fair value. This excess is recorded as an impairment loss and adjusted if necessary for the impact of tax-deductible goodwill. The loss recognized may not exceed the total goodwill allocated to the reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When testing goodwill for impairment, we may first assess qualitative factors, such as industry and market factors, the dynamic economic and political environments in which we operate, cost factors, and changes in overall performance, to determine if it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value. If our qualitative assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, we perform the quantitative assessment. We may also elect to bypass the qualitative assessment and proceed directly to the quantitative assessment. If performing a quantitative assessment, we generally estimate the fair values of our reporting units by applying the income approach, using discounted cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the annual impairment test under a quantitative assessment, the base year in the reporting units&#x2019; discounted cash flows is derived from the annual financial planning cycle, which commences in the fourth quarter of the year. When computing discounted cash flows, we make assumptions about a wide variety of internal and external factors, and consider what the reporting unit&#x2019;s selling price would be in an orderly transaction between market participants at the measurement date. Significant assumptions include financial projections of free cash flow (including significant assumptions about membership, premium rates, healthcare and operating cost trends, contract renewal and the procurement of new contracts, capital requirements and income taxes), long-term growth rates for determining terminal value beyond the discretely forecasted periods, and discount rates. When determining the discount rate, we consider the overall level of inherent risk of the reporting unit, and the expected rate an outside investor would expect to earn. As part of a quantitative assessment, we may also apply the asset liquidation method to estimate the fair value of individual reporting units, which is computed as total assets minus total liabilities, excluding intangible assets and deferred taxes. Finally, we apply a market approach to reconcile the value of our reporting units to our consolidated market value. Under the market approach, we consider publicly traded comparable company information to determine revenue and earnings multiples which are used to estimate our reporting units&#x2019; fair values. The assumptions used are consistent with those used in our long-range business plan and annual planning process. However, if these assumptions differ from actual results, the outcome of our goodwill impairment tests could be adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use (&#x201c;ROU&#x201d;) assets represent our right to use the underlying assets over the lease term, and lease liabilities represent our obligation for lease payments arising from the related leases. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease terms may include options to extend or terminate the lease when we believe it is reasonably certain that we will exercise such options. If applicable, we account for lease and non-lease components within a lease as a single lease component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because most of our leases do not provide an implicit interest rate, we generally use our incremental borrowing rate to determine the present value of lease payments. Lease expenses for operating lease payments are recognized on a straight-line basis over the lease term, and the related ROU assets and liabilities are reduced to the present value of the remaining lease payments at the end of each period. Finance lease payments reduce finance lease liabilities, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the related ROU assets are amortized on a straight-line basis over the lease term, and interest expense is recognized using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant majority of our operating leases consist of long-term operating leases for office space. Short-term leases (those with terms of 12 months or less) are not recorded as ROU assets or liabilities in the consolidated balance sheets. For certain leases that represent a portfolio of similar assets, such as a fleet of vehicles, we apply a portfolio approach to account for the related ROU assets and liabilities, rather than account for such assets and the related liabilities individually. A nominal number of our lease agreements include rental payments that adjust periodically for inflation. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For further information, including the amount and location of the ROU assets and lease liabilities recognized in the accompanying consolidated balance sheets, see Note 8, &#x201c;Leases.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical Claims and Benefits Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical care costs are recognized in the period in which services are provided and include fee-for-service claims, pharmacy benefits, capitation payments to providers, and various other medically-related costs. Under fee-for-service claims arrangements with providers, we retain the financial responsibility for medical care provided and incur costs based on actual utilization of hospital and physician services. Such medical care costs include amounts paid by us as well as estimated medical claims and benefits payable for costs that were incurred but not paid as of the reporting date (&#x201c;IBNP&#x201d;). Pharmacy benefits represent payments for members' prescription drug costs, net of rebates from drug manufacturers. We estimate pharmacy rebates based on historical and current utilization of prescription drugs and contractual provisions. Capitation payments represent monthly contractual fees paid to providers, who are responsible for providing medical care to members, which could include medical or ancillary costs like dental, vision and other supplemental health benefits. Such capitation costs are fixed in advance of the periods covered and are not subject to significant accounting estimates. Other medical care costs include all medically-related administrative costs, amounts due to providers pursuant to risk-sharing or other incentive arrangements, provider claims, and other healthcare expenses. Examples of medically-related administrative costs include expenses relating to health education, quality assurance, case management, care coordination, disease management, and 24-hour on-call nurses. Additionally, we include an estimate for the cost of settling claims incurred through the reporting date in our medical claims and benefits payable liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical claims and benefits payable consist mainly of fee-for-service IBNP, unpaid pharmacy claims, capitation costs, other medical costs, including amounts payable to providers pursuant to risk-sharing or other incentive arrangements and amounts payable to providers on behalf of certain state agencies for certain state assessments in which we assume no financial risk&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IBNP includes the costs of claims incurred as of the balance sheet date which have been reported to us, and our best estimate of the cost of claims incurred but not yet reported to us. We also include an additional reserve to ensure that our overall IBNP liability is sufficient under moderately adverse conditions. We reflect changes in these estimates in the consolidated results of operations in the period in which they are determined. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimation of the IBNP liability requires a significant degree of judgment in applying actuarial methods, determining the appropriate assumptions and considering numerous factors. Of those factors, we consider estimated completion factors and the assumed healthcare cost trend to be the most critical assumptions. Other relevant factors also include, but are not limited to, healthcare service utilization trends, claim inventory levels, changes in membership, product mix, seasonality, benefit changes or changes in Medicaid fee schedules, provider contract changes, prior authorizations and the incidence of catastrophic or pandemic cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the significant degree of judgment involved in estimation of our IBNP liability, there is considerable variability and uncertainty inherent in such estimates. Each reporting period, the recognized IBNP liability represents our best estimate of the total amount of unpaid claims incurred as of the balance sheet date using a consistent methodology in estimating our IBNP liability. We believe our current estimates are reasonable and adequate; however, the development of our estimate is a continuous process that we monitor and update as more complete claims payment information and healthcare cost trend data becomes available. Actual medical care costs may be less than we previously estimated (favorable development) or more than we previously estimated (unfavorable development), and any differences could be material. Any adjustments to reflect favorable development would be recognized as a decrease to medical care costs, and any adjustments to reflect unfavorable development would be recognized as an increase to medical care costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the period in which the adjustments are determined. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 10, &#x201c;Medical Claims and Benefits Payable,&#x201d; for a table presenting the components of the change in our medical claims and benefits payable, for all periods presented in the accompanying consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Premium Revenue Recognition and Amounts Due Government Agencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenue is generated from our Health Plans segment contracts, for our participation in the Medicaid, Medicare and Marketplace programs. Premium revenue is generally received based on per member per month (&#x201c;PMPM&#x201d;) rates established in advance of the periods covered. These premium revenues are recognized in the month that members are entitled to receive healthcare services, and premiums collected in advance are deferred. State Medicaid programs and the federal Medicare program periodically adjust premium rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain components of premium revenue are subject to accounting estimates and are described below, under &#x201c;Contractual Provisions That May Adjust or Limit Revenue or Profit,&#x201d; and &#x201c;Quality Incentives.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contractual Provisions That May Adjust or Limit Revenue or Profit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of our contracts contain provisions that may adjust or limit revenue or profit, as described below. Consequently, we recognize premium revenue as it is earned under such provisions. Liabilities accrued for premiums to be returned under such provisions are reported in the aggregate as &#x201c;Amounts due government agencies&#x201d; in the accompanying consolidated balance sheets. Categorized by program, such amounts due government agencies included the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Minimum MLR and profit sharing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk adjustment and Part D risk sharing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Minimum MLR and profit sharing &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketplace program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Minimum MLR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts due government agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicaid Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Minimum MLR and Medical Cost Corridors. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of our premium revenue may be returned if certain minimum amounts are not spent on defined medical care costs. Under certain medical cost corridor provisions, the health plans may receive additional premiums if amounts spent on medical care costs exceed a defined maximum threshold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Profit Sharing. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contracts with certain states contain profit sharing provisions under which we refund amounts to the states if our health plans generate profit above a certain specified percentage. In some cases, we are limited in the amount of administrative costs that we may deduct in calculating the refund, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retroactive Premium Adjustments. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State Medicaid programs periodically adjust premium rates on a retroactive basis. In these cases, we adjust our premium revenue in the period in which we determine that the adjustment is probable and reasonably estimable, and is based on our best estimate of the ultimate premium we expect to realize for the period being adjusted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, various states enacted temporary premium refunds and related actions in response to the reduced demand for medical services stemming from COVID-19, which resulted in a reduction of our medical margin. In some cases, these premium actions were retroactive to earlier periods in 2020, or as early as the beginning of the states&#x2019; fiscal years in 2019. Beginning in the second quarter of 2020, we have recognized retroactive premium actions that we believe to be probable, and where the ultimate premium amount is reasonably estimable. We recognized $564&#160;million related to these retroactive premium actions, in the aggregate, in 2020, including $37&#160;million related to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MMP plans. Approximately $401&#160;million was recognized in the fourth quarter of 2020, mostly associated with recently enacted risk-sharing corridors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;It is possible that certain states could increase the level of existing premium refunds, and it is also possible that other states could implement some form of retroactive premium refund in the future. Due to these uncertainties, the ultimate outcomes could differ materially from our estimates as a result of changes in facts or further developments, which could have an adverse effect on our consolidated financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Adjustment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our Medicare premiums are subject to retroactive increase or decrease based on the health status of our Medicare members (as measured by member risk score). We estimate our members&#x2019; risk scores and the related amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members&#x2019; health status, risk scores and Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;) practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Minimum MLR.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Affordable Care Act (&#x201c;ACA&#x201d;) established a minimum annual medical loss ratio (&#x201c;Minimum MLR&#x201d;) of 85% for Medicare. The medical loss ratio represents medical costs as a percentage of premium revenue. Federal regulations define what constitutes medical costs and premium revenue. If the Minimum MLR is not met, we may be required to pay rebates to the federal government. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Marketplace Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Corridor Judgment. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the United States Supreme Court held that &#xa7;1342 of the Affordable Care Act obligated the federal government to pay participating insurers the full Marketplace risk corridor amounts calculated by that statute, and that impacted insurers may sue the federal government in the U.S. Court of Federal Claims to recover damages for breach of that obligation. In June 2020, the Claims Court granted us judgment in the amount of $128&#160;million for 2014, 2015, and 2016 Marketplace risk corridor claims, which we received in October 2020. Consistent with the timing of the cash receipt, the gain was recognized in our fourth quarter 2020 financial results and reported in &#x201c;Marketplace risk corridor judgment&#x201d; in our consolidated statements of income. The judgment did not create additional Minimum MLR rebates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Adjustment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Under this program, our health plans&#x2019; composite risk scores are compared with the overall average risk score for the relevant state and market pool. Generally, our health plans will make a risk adjustment payment into the pool if their composite risk scores are below the average risk score (risk adjustment payable), and will receive a risk adjustment payment from the pool if their composite risk scores are above the average risk score (risk adjustment receivable). We estimate our ultimate premium based on insurance policy year-to-date experience, and recognize estimated premiums relating to the risk adjustment program as an adjustment to premium revenue in our consolidated statements of income. As of December&#160;31, 2020, Marketplace risk adjustment payables amounted to $326 million and related receivables amounted to $20 million, for a net payable of $306 million. As of December 31, 2019, Marketplace risk adjustment payables amounted to $368 million and related receivables amounted to $63 million, for a net payable of $305 million, which relates primarily to 2019 and prior periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Minimum MLR.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The ACA has established a Minimum MLR of 80% for the Marketplace. If the Minimum MLR is not met, we may be required to pay rebates to our Marketplace policyholders. The Marketplace risk adjustment program is taken into consideration when computing the Minimum MLR. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Quality Incentives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At many of our health plans, revenue ranging from approximately 1% to 4% of certain health plan premiums is earned only if certain performance measures are met. Such performance measures are generally found in our Medicaid and MMP contracts. As described in Note 1, &#x201c;Organization and Basis of Presentation&#x2013;Use of Estimates,&#x201d; recognition of quality incentive premium revenue is subject to the use of estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reinsurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We bear underwriting and reserving risks associated with our health plan subsidiaries. We limit our risk of significant catastrophic losses by maintaining high deductible reinsurance coverage with a highly-rated, unaffiliated insurance company (the &#x201c;third-party reinsurer&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because we remain liable to our policyholders in the event the third-party reinsurer is unable to pay its portion of the losses, we continually monitor the third-party reinsurer&#x2019;s financial condition, including its ability to maintain high credit ratings. Intercompany transactions with our captive are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report reinsurance premiums as a reduction to premium revenue, while related reinsurance recoveries are reported as a reduction to medical care costs. Reinsurance premiums amounted to $9 million, $17 million, and $16 million for the years ended December&#160;31, 2020, 2019, and 2018, respectively. Reinsurance recoveries amounted to $23 million, $18 million, and $33 million for the years ended December 31, 2020, 2019, and 2018, respectively. Reinsurance recoverable of $17 million, $21 million, and $31 million, as of December 31, 2020, 2019, and 2018, respectively, is included in &#x201c;Receivables&#x201d; in the accompanying consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Premium Deficiency Reserves on Loss Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess the profitability of our contracts to determine if it is probable that a loss will be incurred in the future by reviewing current results and forecasts. For purposes of this assessment, contracts are grouped in a manner consistent with our method of acquiring, servicing and measuring the profitability of such contracts. A premium deficiency is recognized if anticipated future medical care and administrative costs exceed anticipated future premium revenue, investment income and reinsurance recoveries. In the third quarter of 2020, we recognized a premium deficiency reserve (&#x201c;PDR&#x201d;) of $10&#160;million for our Medicaid contract in Puerto Rico, $4&#160;million of which was amortized in the fourth quarter of 2020 to offset losses the PDR was established to cover. As described in Note 1, &#x201c;Organization and Basis of Presentation,&#x201d; we exited Puerto Rico&#x2019;s Medicaid program when our contract expired on October 31, 2020. No premium deficiency reserves were recorded as of December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates expected to be in effect during the year in which the basis differences reverse. Valuation allowances are established when management determines it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. For further discussion and disclosure, see Note 12, &#x201c;Income Taxes.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Taxes Based on Premiums&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Insurer Fee (&#x201c;HIF&#x201d;). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Affordable Care Act, the federal government imposed an annual fee, or excise tax, on health insurers for each calendar year (the &#x201c;HIF&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The HIF was allocated to health insurers based on each health insurer's share of net premiums for all U.S. health insurers in the year preceding the assessment, and was not deductible for income tax purposes. Our HIF liability for 2020 was $277&#160;million, which was settled in September 2020. Public Law No. 115-120 provided for a HIF moratorium in 2019; therefore, there was no HIF incurred or reimbursed in that year. Due to the reinstatement of the HIF in 2020, our effective tax rate was higher in 2020 compared with 2019. The Further Consolidated Appropriations Act, 2020 repealed the HIF effective for years after 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Premium and Use Tax. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our health plans are assessed a tax based on premium revenue collected. The premium revenues we receive from these states include the premium tax assessment. We have reported these taxes on a gross basis, as premium tax revenue and as premium tax expenses in the consolidated statements of income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. Our portfolio managers must obtain our prior approval before selling investments where the loss position of those investments exceeds certain levels. Our investments consist primarily of investment-grade debt securities with final maturities of less than 10 years, or less than 10 years average life for structured securities. Restricted investments are invested principally in cash, cash equivalents and U.S. Treasury securities. Concentration of credit risk with respect to accounts receivable is limited because our payors consist principally of the federal government, and governments of each state in which our health plan subsidiaries operate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our profitability depends in large part on our ability to accurately predict and effectively manage medical care costs. We continually review our medical costs in light of our underlying claims experience and revised actuarial data. However, several factors could adversely affect medical care costs. These factors, which include changes in healthcare practices, inflation, new technologies, major epidemics, natural disasters, and malpractice litigation, are beyond our control and may have an adverse effect on our ability to accurately predict and effectively control medical care costs. Costs in excess of those anticipated could have a material adverse effect on our financial condition, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate health plans primarily as a direct contractor with the states, and in Los Angeles County, California, as a subcontractor to another health plan holding a direct contract with the state. We are therefore dependent upon a relatively small number of contracts to support our revenue. The loss of any one of those contracts could have a material adverse effect on our financial position, results of operations, or cash flows. In addition, our ability to arrange for the provision of medical services to our members is dependent upon our ability to develop and maintain adequate provider networks. Our inability to develop or maintain such networks might, in certain circumstances, have a material adverse effect on our financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes premium revenue by state health plan for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Illinois &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kentucky&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Michigan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ohio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Washington&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;&#x201c;Other&#x201d; includes the Idaho, Mississippi, New Mexico, New York, Puerto Rico, South Carolina, Utah and Wisconsin health plans, which were immaterial to our consolidated results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Losses.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which was subsequently modified by several ASUs issued in 2018 and 2019. We adopted Topic 326 effective January 1, 2020, using the modified retrospective approach. Under this method we recognized the cumulative effect of adopting the standard as an adjustment to the opening balance of retained earnings on January 1, 2020, which was immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by a change in the reference rate from the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) or another reference rate expected to be discontinued, if certain conditions are met. ASU 2020-04 is effective immediately and expires after December 31, 2022. We are evaluating the effect of reference rate reform and this guidance on our contracts and other transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (&#x201c;SEC&#x201d;) did not have, nor does management expect such pronouncements to have, a significant impact on our present or future consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjYy_ffac97cb-e481-42bd-9697-296b96babc90">Cash and Cash EquivalentsCash and cash equivalents consist of cash and short-term, highly liquid investments that are both readily convertible into known amounts of cash and have a maturity of three months or less on the date of purchase. The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in &#x201c;Restricted investments&#x201d; in the accompanying consolidated balance sheets.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjQw_7a271aca-1702-429a-9cca-42785c206c7c">The restricted cash and cash equivalents presented below are included in &#x201c;Restricted investments&#x201d; in the accompanying consolidated balance sheets. &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNzg5_68a74d2e-3c1b-4c15-a647-d0544af8609f">The restricted cash and cash equivalents presented below are included in &#x201c;Restricted investments&#x201d; in the accompanying consolidated balance sheets. &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzMtMS0xLTEtMA_d19d1e6a-8fc2-4327-b8c0-063b69ab8618"
      unitRef="usd">4154000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzMtMy0xLTEtMA_ecbdd71a-def5-4e68-b433-8462d1246238"
      unitRef="usd">2452000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzMtNS0xLTEtMA_3f8487bc-4a2d-4e96-ba46-85debb6ea31f"
      unitRef="usd">2826000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzQtMS0xLTEtMA_67944a02-23a7-465d-a354-34534cad5db7"
      unitRef="usd">69000000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzQtMy0xLTEtMA_48a5e923-bcc4-47f3-9c3f-a5defe9fdee2"
      unitRef="usd">56000000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzQtNS0xLTEtMA_d6e33ffd-fa90-44d1-bc34-74a72dc1a13b"
      unitRef="usd">100000000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzUtMS0xLTEtMA_d1421e46-7973-4558-bc4e-2ab1d0bf8d63"
      unitRef="usd">4223000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzUtMy0xLTEtMA_f9f8951a-8b57-40ef-b161-87e2eccabc69"
      unitRef="usd">2508000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTpmYTQyNjQ1ODhiOTk0MjFjYjk4MDlkY2YwZDU5NTA4ZS90YWJsZXJhbmdlOmZhNDI2NDU4OGI5OTQyMWNiOTgwOWRjZjBkNTk1MDhlXzUtNS0xLTEtMA_8388abc1-7b75-473c-9b02-9f2d871ef14c"
      unitRef="usd">2926000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjEx_7f9b892b-5ba5-4cfb-8a15-1edec8e691f4">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments are principally held in debt securities, which are grouped into two separate categories for accounting and reporting purposes: available-for-sale securities, and held-to-maturity securities. Available-for-sale (&#x201c;AFS&#x201d;) securities are recorded at fair value and unrealized gains and losses, if any, are recorded in stockholders&#x2019; equity as other comprehensive income, net of applicable income taxes. Held-to-maturity (&#x201c;HTM&#x201d;) securities are recorded at amortized cost, which approximates fair value, and unrealized holding gains or losses are not generally recognized. Realized gains and losses and unrealized losses arising from credit-related factors with respect to AFS and HTM securities are included in the determination of net income. The cost of securities sold is determined using the specific-identification method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy requires that all of our investments have final maturities of less than 10 years, or less than 10 years average life for structured securities. Investments and restricted investments are subject to interest rate risk and will decrease in value if market rates increase. Declines in interest rates over time will reduce our investment income. &lt;/span&gt;&lt;/div&gt;In general, our AFS securities are classified as current assets without regard to the securities&#x2019; contractual maturity dates because they may be readily liquidated. We monitor our investments for credit-related impairment.</us-gaap:InvestmentPolicyTextBlock>
    <moh:InvestmentsMaturityPeriod
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE2NDQ_5ce7d1b0-ebb3-4230-a042-1ab9540e2daa">P10Y</moh:InvestmentsMaturityPeriod>
    <moh:InvestmentsAverageMaturityPeriod
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE2Njc_02bb38bb-3e40-40dc-b3c5-585e54de440a">P10Y</moh:InvestmentsAverageMaturityPeriod>
    <us-gaap:InterestReceivable
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE2NzM4NDU_2c5577b6-185b-447f-af92-7fc29923548f"
      unitRef="usd">10000000</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE2NzM4NzA_146d4dd5-0ceb-479c-bcf1-1ce1a48a3e0d"
      unitRef="usd">12000000</us-gaap:InterestReceivable>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MDQyNDMwMzA3MTYw_e7a85bca-bd4e-4c8b-81da-b9c8723adb7f">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables consist primarily of premium amounts due from government agencies, which may be subject to potential retroactive adjustments. Because substantially all of our receivable amounts are readily determinable and substantially all of our creditors are governmental authorities, our allowance for doubtful accounts is insignificant. Any amounts determined to be uncollectible are charged to expense when such determination is made.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MDQyNDMwMzA3MTY0_4ca1568c-36d0-4554-98f4-02370ce2f9c8">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pharmacy rebate receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Health insurer fee reimbursement receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i5d73a7217fd343aba05c738abeb42788_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzMtMS0xLTEtMTMyNjc_193b7d57-ed6f-4d72-83f8-16bcf48ca9e8"
      unitRef="usd">969000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i0fd3259008f84de5b99bebc752d5714d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzMtMy0xLTEtMTMyNzk_36f321bc-d54b-4578-9efd-a19c15dd9664"
      unitRef="usd">1056000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i30812037b820437fa3a3e705d6ffa4d5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzQtMS0xLTEtMTMyNjk_bbab6489-cd3e-4e3f-a15c-d44c6c268aa2"
      unitRef="usd">178000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ia17d974ef4c94bf497db882cd7110332_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzQtMy0xLTEtMTMyODE_6c41a257-f57b-46a7-8280-8a003f7d41a0"
      unitRef="usd">150000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i3bf6535594b64a3d916a78b3ed7e6f86_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzUtMS0xLTEtMTMyNzE_1867d0f1-3817-4d26-96bf-d0dcd57dc39c"
      unitRef="usd">104000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ib010fc19559144a59d49603a7da5ab41_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzUtMy0xLTEtMTMyODM_321dac8b-81d9-4a3a-86bf-80d536703b3d"
      unitRef="usd">5000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="iea74ee4ad54b4f3c9e6446ba883edad3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzYtMS0xLTEtMTMyNzM_e0a0ae91-f6f4-4008-941b-995674d6fa62"
      unitRef="usd">255000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i49f572caee0440c88a9769d8359294a4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzYtMy0xLTEtMTMyODU_a460666e-577e-4280-8299-0b771955d8be"
      unitRef="usd">195000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ic3a81fff009c4556869db8332ba98850_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzctMS0xLTEtMTMyNzU_fa25fc1b-f010-47a1-88bc-d0275007956b"
      unitRef="usd">166000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i750cbea67aa745698f4ce14305876548_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzctMy0xLTEtMTMyODc_f76ea186-95d1-468b-b471-a1324a0a5a99"
      unitRef="usd">0</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzgtMS0xLTEtMTMyNzc_48bf3104-020c-45a8-8f82-3df71bdd4297"
      unitRef="usd">1672000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo1Mzc5OGQ2NjBiMTk0MzM1OTAxNmI5MzBkODM1MDRkOC90YWJsZXJhbmdlOjUzNzk4ZDY2MGIxOTQzMzU5MDE2YjkzMGQ4MzUwNGQ4XzgtMy0xLTEtMTMyODk_9851f1d2-933a-48da-b5c0-e22dfad50430"
      unitRef="usd">1406000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI1Mjg4NzY3NTI1Njc1_f1079634-5006-4f75-9609-b69e069b6e8a">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for business combinations using the acquisition method of accounting, which requires us to recognize the assets acquired and the liabilities assumed at their acquisition date fair values. As discussed below, the excess of the purchase consideration transferred over the fair value of the net tangible and intangible assets acquired is recorded as goodwill. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the final determination of the values of assets acquired or liabilities assumed, or one year after the date of acquisition, whichever comes first, any subsequent adjustments are recorded within our consolidated results of operations. Refer to Note 4, Business Combinations, and Note 9, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase consideration over the fair value of net assets acquired in business combinations. Goodwill is not amortized but is tested for impairment on an annual basis and more frequently if impairment indicators are present. Impairment indicators may include experienced or expected operating cash-flow deterioration or losses, significant losses of membership, loss of state funding, loss of state contracts, and other factors. Goodwill is impaired if the carrying amount of the reporting unit (one of our state health plans) exceeds its estimated fair value. This excess is recorded as an impairment loss and adjusted if necessary for the impact of tax-deductible goodwill. The loss recognized may not exceed the total goodwill allocated to the reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When testing goodwill for impairment, we may first assess qualitative factors, such as industry and market factors, the dynamic economic and political environments in which we operate, cost factors, and changes in overall performance, to determine if it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value. If our qualitative assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, we perform the quantitative assessment. We may also elect to bypass the qualitative assessment and proceed directly to the quantitative assessment. If performing a quantitative assessment, we generally estimate the fair values of our reporting units by applying the income approach, using discounted cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the annual impairment test under a quantitative assessment, the base year in the reporting units&#x2019; discounted cash flows is derived from the annual financial planning cycle, which commences in the fourth quarter of the year. When computing discounted cash flows, we make assumptions about a wide variety of internal and external factors, and consider what the reporting unit&#x2019;s selling price would be in an orderly transaction between market participants at the measurement date. Significant assumptions include financial projections of free cash flow (including significant assumptions about membership, premium rates, healthcare and operating cost trends, contract renewal and the procurement of new contracts, capital requirements and income taxes), long-term growth rates for determining terminal value beyond the discretely forecasted periods, and discount rates. When determining the discount rate, we consider the overall level of inherent risk of the reporting unit, and the expected rate an outside investor would expect to earn. As part of a quantitative assessment, we may also apply the asset liquidation method to estimate the fair value of individual reporting units, which is computed as total assets minus total liabilities, excluding intangible assets and deferred taxes. Finally, we apply a market approach to reconcile the value of our reporting units to our consolidated market value. Under the market approach, we consider publicly traded comparable company information to determine revenue and earnings multiples which are used to estimate our reporting units&#x2019; fair values. The assumptions used are consistent with those used in our long-range business plan and annual planning process. However, if these assumptions differ from actual results, the outcome of our goodwill impairment tests could be adversely affected.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNzUz_7321941d-0bf2-417a-8730-2e8a53fccfb6">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets, including Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets consist primarily of property, equipment, capitalized software (see Note 7, &#x201c;Property, Equipment, and Capitalized Software, Net&#x201d;), and intangible assets resulting from acquisitions. Finite-lived, separately-identified intangible assets acquired in business combinations are assets that represent future expected benefits but lack physical substance (such as purchased contract rights and provider contracts). Intangible assets are initially recorded at fair value and are then amortized on a straight-line basis over their expected useful lives, generally between &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4NDY_345e2136-02de-45cb-a7d6-760278ca92ed"&gt;five&lt;/span&gt; and 16 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Determining the fair value of identifiable assets acquired, particularly intangible assets, and liabilities assumed,  requires management to make estimates, which are based on all available information and in some cases assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Determining the useful life of an intangible asset also requires judgment, as different types of intangible assets will have different useful lives. The most significant intangible asset we typically record in a business combination is contract rights associated with membership assumed. In determining the estimated fair value of the intangible assets, we typically apply the income approach, which discounts the projected future net cash flows using an appropriate discount rate that reflects the risk associated with such projected future cash flows. The most critical assumptions used in determining the fair value of contract rights include forecasted operating margins and the weighted average cost of capital.&lt;/span&gt;&lt;/div&gt;Property and equipment are stated at historical cost. Replacements and major improvements are capitalized, and repairs and maintenance are charged to expense as incurred. Software developed for internal use is capitalized. Furniture and equipment are generally depreciated using the straight-line method over estimated useful lives ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzU0OTc1NTgxMzk3OTA_0da1da73-4926-4eb9-bdb8-ab2cd7f10bb6"&gt;three&lt;/span&gt; to seven years. Software is generally amortized over its estimated useful life of three years. Leasehold improvements are amortized over the term of the lease, or over their useful lives from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzUzOA_e80b42ea-bec2-44ee-9782-16517f1bf477"&gt;five&lt;/span&gt; to 10&#160;years, whichever is shorter. Buildings are depreciated over their estimated useful lives of 31.5 to 40&#160;years.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iac48d7b081c44878865a5a148b146630_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4NTM_3ae31eb3-b252-4220-960f-e7447662a73d">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjY0_365117cd-ca60-4901-be8f-ab73b3e78971">Our intangible assets are subject to impairment tests when events or circumstances indicate that a finite-lived intangible asset&#x2019;s (or asset group&#x2019;s) carrying value may not be recoverable. Consideration is given to a number of potential impairment indicators, including the ability of our health plan subsidiaries to obtain the renewal by amendment of their contracts in each state prior to the actual expiration of their contracts. However, there can be no assurance that these contracts will continue to be renewed. Following the identification of any potential impairment indicators, to determine whether an impairment exists, we would compare the carrying amount of a finite-lived intangible asset with the greater of the undiscounted cash flows that are expected to result from the use of the asset or related group of assets, or its value under the asset liquidation method. If it is determined that the carrying amount of the asset is not recoverable, the amount by which the carrying value exceeds the estimated fair value is recorded as an impairment.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MDQyNDMwMzA3MTYx_f6cb9e96-e1a9-479c-8715-317faa72a095">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use (&#x201c;ROU&#x201d;) assets represent our right to use the underlying assets over the lease term, and lease liabilities represent our obligation for lease payments arising from the related leases. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease terms may include options to extend or terminate the lease when we believe it is reasonably certain that we will exercise such options. If applicable, we account for lease and non-lease components within a lease as a single lease component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because most of our leases do not provide an implicit interest rate, we generally use our incremental borrowing rate to determine the present value of lease payments. Lease expenses for operating lease payments are recognized on a straight-line basis over the lease term, and the related ROU assets and liabilities are reduced to the present value of the remaining lease payments at the end of each period. Finance lease payments reduce finance lease liabilities, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the related ROU assets are amortized on a straight-line basis over the lease term, and interest expense is recognized using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant majority of our operating leases consist of long-term operating leases for office space. Short-term leases (those with terms of 12 months or less) are not recorded as ROU assets or liabilities in the consolidated balance sheets. For certain leases that represent a portfolio of similar assets, such as a fleet of vehicles, we apply a portfolio approach to account for the related ROU assets and liabilities, rather than account for such assets and the related liabilities individually. A nominal number of our lease agreements include rental payments that adjust periodically for inflation. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. &lt;/span&gt;&lt;/div&gt;For further information, including the amount and location of the ROU assets and lease liabilities recognized in the accompanying consolidated balance sheets, see Note 8, &#x201c;Leases.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzg3OTYwOTMwOTkxMTc_83337443-028a-41d3-97f0-8e609579e3a0">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical Claims and Benefits Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical care costs are recognized in the period in which services are provided and include fee-for-service claims, pharmacy benefits, capitation payments to providers, and various other medically-related costs. Under fee-for-service claims arrangements with providers, we retain the financial responsibility for medical care provided and incur costs based on actual utilization of hospital and physician services. Such medical care costs include amounts paid by us as well as estimated medical claims and benefits payable for costs that were incurred but not paid as of the reporting date (&#x201c;IBNP&#x201d;). Pharmacy benefits represent payments for members' prescription drug costs, net of rebates from drug manufacturers. We estimate pharmacy rebates based on historical and current utilization of prescription drugs and contractual provisions. Capitation payments represent monthly contractual fees paid to providers, who are responsible for providing medical care to members, which could include medical or ancillary costs like dental, vision and other supplemental health benefits. Such capitation costs are fixed in advance of the periods covered and are not subject to significant accounting estimates. Other medical care costs include all medically-related administrative costs, amounts due to providers pursuant to risk-sharing or other incentive arrangements, provider claims, and other healthcare expenses. Examples of medically-related administrative costs include expenses relating to health education, quality assurance, case management, care coordination, disease management, and 24-hour on-call nurses. Additionally, we include an estimate for the cost of settling claims incurred through the reporting date in our medical claims and benefits payable liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical claims and benefits payable consist mainly of fee-for-service IBNP, unpaid pharmacy claims, capitation costs, other medical costs, including amounts payable to providers pursuant to risk-sharing or other incentive arrangements and amounts payable to providers on behalf of certain state agencies for certain state assessments in which we assume no financial risk&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IBNP includes the costs of claims incurred as of the balance sheet date which have been reported to us, and our best estimate of the cost of claims incurred but not yet reported to us. We also include an additional reserve to ensure that our overall IBNP liability is sufficient under moderately adverse conditions. We reflect changes in these estimates in the consolidated results of operations in the period in which they are determined. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimation of the IBNP liability requires a significant degree of judgment in applying actuarial methods, determining the appropriate assumptions and considering numerous factors. Of those factors, we consider estimated completion factors and the assumed healthcare cost trend to be the most critical assumptions. Other relevant factors also include, but are not limited to, healthcare service utilization trends, claim inventory levels, changes in membership, product mix, seasonality, benefit changes or changes in Medicaid fee schedules, provider contract changes, prior authorizations and the incidence of catastrophic or pandemic cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the significant degree of judgment involved in estimation of our IBNP liability, there is considerable variability and uncertainty inherent in such estimates. Each reporting period, the recognized IBNP liability represents our best estimate of the total amount of unpaid claims incurred as of the balance sheet date using a consistent methodology in estimating our IBNP liability. We believe our current estimates are reasonable and adequate; however, the development of our estimate is a continuous process that we monitor and update as more complete claims payment information and healthcare cost trend data becomes available. Actual medical care costs may be less than we previously estimated (favorable development) or more than we previously estimated (unfavorable development), and any differences could be material. Any adjustments to reflect favorable development would be recognized as a decrease to medical care costs, and any adjustments to reflect unfavorable development would be recognized as an increase to medical care costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the period in which the adjustments are determined. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 10, &#x201c;Medical Claims and Benefits Payable,&#x201d; for a table presenting the components of the change in our medical claims and benefits payable, for all periods presented in the accompanying consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Premium Revenue Recognition and Amounts Due Government Agencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenue is generated from our Health Plans segment contracts, for our participation in the Medicaid, Medicare and Marketplace programs. Premium revenue is generally received based on per member per month (&#x201c;PMPM&#x201d;) rates established in advance of the periods covered. These premium revenues are recognized in the month that members are entitled to receive healthcare services, and premiums collected in advance are deferred. State Medicaid programs and the federal Medicare program periodically adjust premium rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain components of premium revenue are subject to accounting estimates and are described below, under &#x201c;Contractual Provisions That May Adjust or Limit Revenue or Profit,&#x201d; and &#x201c;Quality Incentives.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contractual Provisions That May Adjust or Limit Revenue or Profit&lt;/span&gt;&lt;/div&gt;Many of our contracts contain provisions that may adjust or limit revenue or profit, as described below. Consequently, we recognize premium revenue as it is earned under such provisions. Liabilities accrued for premiums to be returned under such provisions are reported in the aggregate as &#x201c;Amounts due government agencies&#x201d; in the accompanying consolidated balance sheets.&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicaid Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Minimum MLR and Medical Cost Corridors. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of our premium revenue may be returned if certain minimum amounts are not spent on defined medical care costs. Under certain medical cost corridor provisions, the health plans may receive additional premiums if amounts spent on medical care costs exceed a defined maximum threshold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Profit Sharing. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contracts with certain states contain profit sharing provisions under which we refund amounts to the states if our health plans generate profit above a certain specified percentage. In some cases, we are limited in the amount of administrative costs that we may deduct in calculating the refund, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retroactive Premium Adjustments. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State Medicaid programs periodically adjust premium rates on a retroactive basis. In these cases, we adjust our premium revenue in the period in which we determine that the adjustment is probable and reasonably estimable, and is based on our best estimate of the ultimate premium we expect to realize for the period being adjusted.&lt;/span&gt;&lt;/div&gt;In 2020, various states enacted temporary premium refunds and related actions in response to the reduced demand for medical services stemming from COVID-19, which resulted in a reduction of our medical margin. In some cases, these premium actions were retroactive to earlier periods in 2020, or as early as the beginning of the states&#x2019; fiscal years in 2019. Beginning in the second quarter of 2020, we have recognized retroactive premium actions that we believe to be probable, and where the ultimate premium amount is reasonably estimable. &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;It is possible that certain states could increase the level of existing premium refunds, and it is also possible that other states could implement some form of retroactive premium refund in the future. Due to these uncertainties, the ultimate outcomes could differ materially from our estimates as a result of changes in facts or further developments, which could have an adverse effect on our consolidated financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Adjustment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our Medicare premiums are subject to retroactive increase or decrease based on the health status of our Medicare members (as measured by member risk score). We estimate our members&#x2019; risk scores and the related amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members&#x2019; health status, risk scores and Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;) practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Minimum MLR.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Affordable Care Act (&#x201c;ACA&#x201d;) established a minimum annual medical loss ratio (&#x201c;Minimum MLR&#x201d;) of 85% for Medicare. The medical loss ratio represents medical costs as a percentage of premium revenue. Federal regulations define what constitutes medical costs and premium revenue. If the Minimum MLR is not met, we may be required to pay rebates to the federal government. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Marketplace Program&lt;/span&gt;&lt;/div&gt;Risk Corridor Judgment. In April 2020, the United States Supreme Court held that &#xa7;1342 of the Affordable Care Act obligated the federal government to pay participating insurers the full Marketplace risk corridor amounts calculated by that statute, and that impacted insurers may sue the federal government in the U.S. Court of Federal Claims to recover damages for breach of that obligation.Consistent with the timing of the cash receipt, the gain was recognized in our fourth quarter 2020 financial results and reported in &#x201c;Marketplace risk corridor judgment&#x201d; in our consolidated statements of income. The judgment did not create additional Minimum MLR rebates.Risk Adjustment. Under this program, our health plans&#x2019; composite risk scores are compared with the overall average risk score for the relevant state and market pool. Generally, our health plans will make a risk adjustment payment into the pool if their composite risk scores are below the average risk score (risk adjustment payable), and will receive a risk adjustment payment from the pool if their composite risk scores are above the average risk score (risk adjustment receivable). We estimate our ultimate premium based on insurance policy year-to-date experience, and recognize estimated premiums relating to the risk adjustment program as an adjustment to premium revenue in our consolidated statements of income.&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Minimum MLR.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The ACA has established a Minimum MLR of 80% for the Marketplace. If the Minimum MLR is not met, we may be required to pay rebates to our Marketplace policyholders. The Marketplace risk adjustment program is taken into consideration when computing the Minimum MLR. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Quality Incentives&lt;/span&gt;&lt;/div&gt;At many of our health plans, revenue ranging from approximately 1% to 4% of certain health plan premiums is earned only if certain performance measures are met. Such performance measures are generally found in our Medicaid and MMP contracts. As described in Note 1, &#x201c;Organization and Basis of Presentation&#x2013;Use of Estimates,&#x201d; recognition of quality incentive premium revenue is subject to the use of estimates.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ReservesReportedToOtherAgenciesTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzU0OTc1NTgxOTM1NDg_5f72d82d-1f38-4f2c-a9b5-0199bbe50a35">Liabilities accrued for premiums to be returned under such provisions are reported in the aggregate as &#x201c;Amounts due government agencies&#x201d; in the accompanying consolidated balance sheets. Categorized by program, such amounts due government agencies included the following:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Minimum MLR and profit sharing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk adjustment and Part D risk sharing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Minimum MLR and profit sharing &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketplace program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Minimum MLR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts due government agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReservesReportedToOtherAgenciesTextBlock>
    <moh:MedicalPremiumsLiabilityMedicalCareCostsThreshold
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzUtMS0xLTEtNTIzNg_33f666fc-2195-418f-814f-c3168bc2871b"
      unitRef="usd">513000000</moh:MedicalPremiumsLiabilityMedicalCareCostsThreshold>
    <moh:MedicalPremiumsLiabilityMedicalCareCostsThreshold
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzUtMy0xLTEtNTI1Nw_d4793593-5336-4e02-a301-8a0bc3c54f32"
      unitRef="usd">92000000</moh:MedicalPremiumsLiabilityMedicalCareCostsThreshold>
    <moh:AmountsDueToGovernmentAgenciesMedicaidOther
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzYtMS0xLTEtNTIzNg_e4ed5c3e-9bdf-4f84-940a-e7eac975cfb2"
      unitRef="usd">76000000</moh:AmountsDueToGovernmentAgenciesMedicaidOther>
    <moh:AmountsDueToGovernmentAgenciesMedicaidOther
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzYtMy0xLTEtNTI1Nw_39c4ce27-b49a-4824-be0d-c4af45ed7121"
      unitRef="usd">95000000</moh:AmountsDueToGovernmentAgenciesMedicaidOther>
    <moh:AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzgtMS0xLTEtNTIzNg_4695acc1-11cd-4164-927e-1cf6af7f9b04"
      unitRef="usd">45000000</moh:AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing>
    <moh:AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzgtMy0xLTEtNTI1Nw_0dabf11e-9dab-4804-9ac7-c034d2449bec"
      unitRef="usd">14000000</moh:AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing>
    <moh:AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzktMS0xLTEtNTIzNg_fd58accb-1c48-4fa8-9131-e1ec3e6a9d7b"
      unitRef="usd">62000000</moh:AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold>
    <moh:AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzktMy0xLTEtNTI1Nw_b09020fa-c863-4d7b-99d5-eb87431c7e5b"
      unitRef="usd">36000000</moh:AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold>
    <moh:OtherMedicareProgram
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEwLTEtMS0xLTUyMzY_ca4ecd94-9306-4ce8-aee9-e65b41c7c4b2"
      unitRef="usd">30000000</moh:OtherMedicareProgram>
    <moh:OtherMedicareProgram
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEwLTMtMS0xLTUyNTc_e68eb7a2-6964-40d3-9438-4b9daf115576"
      unitRef="usd">21000000</moh:OtherMedicareProgram>
    <moh:AmountsDuetoGovernmentAgenciesRiskAdjustment
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEyLTEtMS0xLTUyMzY_66693e22-b0ad-4d02-9515-407d2b51443e"
      unitRef="usd">326000000</moh:AmountsDuetoGovernmentAgenciesRiskAdjustment>
    <moh:AmountsDuetoGovernmentAgenciesRiskAdjustment
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEyLTMtMS0xLTUyNTc_2d35cd50-9f7b-4775-aff9-8ed754d7bc7b"
      unitRef="usd">368000000</moh:AmountsDuetoGovernmentAgenciesRiskAdjustment>
    <moh:AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEzLTEtMS0xLTUyMzY_ea454a3f-63bd-4024-9f94-29b89e377265"
      unitRef="usd">37000000</moh:AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold>
    <moh:AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzEzLTMtMS0xLTUyNTc_2aead3bc-a678-4130-8ab9-fdf6a4fe5b0c"
      unitRef="usd">15000000</moh:AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold>
    <moh:AmountsDuetoGovernmentAgenciesOther
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE1LTEtMS0xLTUyMzY_a2c5c463-6911-43d0-9012-93d54656a4a1"
      unitRef="usd">21000000</moh:AmountsDuetoGovernmentAgenciesOther>
    <moh:AmountsDuetoGovernmentAgenciesOther
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE1LTMtMS0xLTUyNTc_12269a92-01b6-4270-be88-4ab9e1a210fb"
      unitRef="usd">23000000</moh:AmountsDuetoGovernmentAgenciesOther>
    <moh:AmountsDueToGovernmentAgenciesBusinessCombination
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE2LTEtMS0xLTE0NDc0_38e9a62d-28a4-4a93-a9ca-ef9b1a54a578"
      unitRef="usd">143000000</moh:AmountsDueToGovernmentAgenciesBusinessCombination>
    <moh:AmountsDueToGovernmentAgenciesBusinessCombination
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE2LTMtMS0xLTE0NDc0_f46561c3-6866-4b74-b4a1-db7a5a9059e8"
      unitRef="usd">0</moh:AmountsDueToGovernmentAgenciesBusinessCombination>
    <moh:MedicalPremiumLiabilityDueToAgency
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE2LTEtMS0xLTUyMzY_fdae8a04-dc94-4522-913d-b25a79913ac2"
      unitRef="usd">1253000000</moh:MedicalPremiumLiabilityDueToAgency>
    <moh:MedicalPremiumLiabilityDueToAgency
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTphMDFjOGRhMjc0YjA0ZTlhOWU1MTU4ZGY3OWUyMDk3NS90YWJsZXJhbmdlOmEwMWM4ZGEyNzRiMDRlOWE5ZTUxNThkZjc5ZTIwOTc1XzE2LTMtMS0xLTUyNTc_b6d5a881-e869-4d2b-813f-06c195ed2ae8"
      unitRef="usd">664000000</moh:MedicalPremiumLiabilityDueToAgency>
    <us-gaap:IncreaseDecreaseInPremiumsReceivable
      contextRef="i91290aace81d4332aae71ba1a693cbba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE2NjczNTA_fd28d8f1-5ae0-44bf-b3d3-04ddf604aee1"
      unitRef="usd">-564000000</us-gaap:IncreaseDecreaseInPremiumsReceivable>
    <us-gaap:IncreaseDecreaseInPremiumsReceivable
      contextRef="ic98f3f2874c74deca389d0f762617730_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE3MDU2MTE_31a481c0-20b7-4b1c-9148-9f5f47f14fdf"
      unitRef="usd">-37000000</us-gaap:IncreaseDecreaseInPremiumsReceivable>
    <us-gaap:IncreaseDecreaseInPremiumsReceivable
      contextRef="i03c303598694422daa4534e5d0775ae3_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE3MDg1OTA_cc413d64-b3c0-40a1-974a-71ef4ec09ce3"
      unitRef="usd">-401000000</us-gaap:IncreaseDecreaseInPremiumsReceivable>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i8765abff68ce42c6992ad5c81c209878_D20200601-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE2NzAyNDk_0177e672-3e15-4490-9bff-9116f612bcc6"
      unitRef="usd">128000000</us-gaap:LossContingencyDamagesAwardedValue>
    <moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3Mjkx_3069ef9a-15ca-4585-a0f3-247beb41baa1"
      unitRef="usd">326000000</moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable>
    <moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MzMw_e0c0019f-fec7-4044-953a-a11115b6cbc2"
      unitRef="usd">20000000</moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable>
    <moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MzU1_5d91921d-c6f5-493e-bcb8-f66e7d9484f2"
      unitRef="usd">306000000</moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable>
    <moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3NDMz_3f318f66-7d96-439e-9cd0-a96390bd759c"
      unitRef="usd">368000000</moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable>
    <moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3NDcy_a8d258e2-9026-4cca-aa62-3c2d1f7b03c4"
      unitRef="usd">63000000</moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable>
    <moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3NDk3_31e610ec-9744-4aeb-ba72-8b1b03b1c10e"
      unitRef="usd">305000000</moh:AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable>
    <moh:PercentageOfAdditionalIncrementalRevenueEarned
      contextRef="i67312f647d5c42f885c6bf5c0fb8c961_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE4MDQ2_de201041-bfac-4589-a3fc-f8de4d1db355"
      unitRef="number">0.01</moh:PercentageOfAdditionalIncrementalRevenueEarned>
    <moh:PercentageOfAdditionalIncrementalRevenueEarned
      contextRef="i25973257ed1e4cdfa54404c69e26ac16_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE4MDUy_8c82d4be-f25d-4fa6-af96-10c691f6356f"
      unitRef="number">0.04</moh:PercentageOfAdditionalIncrementalRevenueEarned>
    <us-gaap:ReinsuranceAccountingPolicy
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzg3OTYwOTMwOTkxMjI_73600305-9f0d-465c-8a88-0f58dc76c559">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reinsurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We bear underwriting and reserving risks associated with our health plan subsidiaries. We limit our risk of significant catastrophic losses by maintaining high deductible reinsurance coverage with a highly-rated, unaffiliated insurance company (the &#x201c;third-party reinsurer&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because we remain liable to our policyholders in the event the third-party reinsurer is unable to pay its portion of the losses, we continually monitor the third-party reinsurer&#x2019;s financial condition, including its ability to maintain high credit ratings. Intercompany transactions with our captive are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;We report reinsurance premiums as a reduction to premium revenue, while related reinsurance recoveries are reported as a reduction to medical care costs.</us-gaap:ReinsuranceAccountingPolicy>
    <us-gaap:PrepaidReinsurancePremiums
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NDY3_2ff57979-9f04-40fb-8aa8-2b8833ab2edf"
      unitRef="usd">9000000</us-gaap:PrepaidReinsurancePremiums>
    <us-gaap:PrepaidReinsurancePremiums
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NDcx_4e126cba-3ea3-4890-a5f8-14062f2948f0"
      unitRef="usd">17000000</us-gaap:PrepaidReinsurancePremiums>
    <us-gaap:PrepaidReinsurancePremiums
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NDc5_8768e6da-45ce-4a55-a5dd-f21a90114c91"
      unitRef="usd">16000000</us-gaap:PrepaidReinsurancePremiums>
    <us-gaap:InsuranceRecoveries
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NTg2_48133553-2f5f-4845-b57a-6ffb3971339b"
      unitRef="usd">23000000</us-gaap:InsuranceRecoveries>
    <us-gaap:InsuranceRecoveries
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NTkw_2a60e141-7475-4374-a288-9e5b80b4463f"
      unitRef="usd">18000000</us-gaap:InsuranceRecoveries>
    <us-gaap:InsuranceRecoveries
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NTk4_9b5976ed-a960-4a85-bffb-c328085144e7"
      unitRef="usd">33000000</us-gaap:InsuranceRecoveries>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0Njk3_a084cc9b-47a5-4a4b-bd06-d9169250b657"
      unitRef="usd">17000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NzAx_5998ff2b-91aa-4345-a266-356e99406545"
      unitRef="usd">21000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI0NzA5_b129468d-d6c2-4d99-8372-21bbbcaa2edd"
      unitRef="usd">31000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts
      contextRef="i11f1f4ff7526429394959a5edcf1f480_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MDQyNDMwMzA3MTY3_517c991d-7a0c-4e04-8b2b-98aaab768ec2"
      unitRef="usd">10000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInPremiumsReceivable
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzEwOTk1MTE3MDQ2OTU_8a03d2c2-7012-4e5e-a943-b3814b1c75ce"
      unitRef="usd">4000000</us-gaap:IncreaseDecreaseInPremiumsReceivable>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNzU5_40d1e026-cac4-4ade-93db-87771601c45d">Income TaxesWe account for income taxes under the asset and liability method. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates expected to be in effect during the year in which the basis differences reverse. Valuation allowances are established when management determines it is more likely than not that some portion, or all, of the deferred tax assets will not be realized.</us-gaap:IncomeTaxPolicyTextBlock>
    <moh:TaxesBasedOnPremiumsPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjMw_e89c6644-a8b1-4c1d-aab5-3be1e77e5a24">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Taxes Based on Premiums&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Insurer Fee (&#x201c;HIF&#x201d;). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Affordable Care Act, the federal government imposed an annual fee, or excise tax, on health insurers for each calendar year (the &#x201c;HIF&#x201d;).&lt;/span&gt;&lt;/div&gt;The HIF was allocated to health insurers based on each health insurer's share of net premiums for all U.S. health insurers in the year preceding the assessment, and was not deductible for income tax purposes.</moh:TaxesBasedOnPremiumsPolicyTextBlock>
    <moh:HealthCareInsuranceFeeLiability
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzU0OTc1NTgxOTM1MDk_7a5cb10c-f083-4c0e-9fe2-f7e94a776947"
      unitRef="usd">277000000</moh:HealthCareInsuranceFeeLiability>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNjM5_bbe6330a-1e32-432b-8bee-57a99c693143">Concentrations of Credit RiskFinancial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. Our portfolio managers must obtain our prior approval before selling investments where the loss position of those investments exceeds certain levels. Our investments consist primarily of investment-grade debt securities with final maturities of less than 10 years, or less than 10 years average life for structured securities. Restricted investments are invested principally in cash, cash equivalents and U.S. Treasury securities. Concentration of credit risk with respect to accounts receivable is limited because our payors consist principally of the federal government, and governments of each state in which our health plan subsidiaries operate.</us-gaap:ConcentrationRiskCreditRisk>
    <moh:InvestmentsMaturityPeriod
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4OTU4_8eef951f-188f-4a64-a2a7-a975d828c1b2">P10Y</moh:InvestmentsMaturityPeriod>
    <moh:InvestmentsAverageMaturityPeriod
      contextRef="id49fb40faab249ee88628b7ca31ab180_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4OTYz_5999d82c-a42c-4253-a047-faebe87cffa9">P10Y</moh:InvestmentsAverageMaturityPeriod>
    <moh:RisksAndUncertaintiesPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNzY1_5476860d-4444-474b-8d3e-b7959346b753">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our profitability depends in large part on our ability to accurately predict and effectively manage medical care costs. We continually review our medical costs in light of our underlying claims experience and revised actuarial data. However, several factors could adversely affect medical care costs. These factors, which include changes in healthcare practices, inflation, new technologies, major epidemics, natural disasters, and malpractice litigation, are beyond our control and may have an adverse effect on our ability to accurately predict and effectively control medical care costs. Costs in excess of those anticipated could have a material adverse effect on our financial condition, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;We operate health plans primarily as a direct contractor with the states, and in Los Angeles County, California, as a subcontractor to another health plan holding a direct contract with the state. We are therefore dependent upon a relatively small number of contracts to support our revenue. The loss of any one of those contracts could have a material adverse effect on our financial position, results of operations, or cash flows. In addition, our ability to arrange for the provision of medical services to our members is dependent upon our ability to develop and maintain adequate provider networks. Our inability to develop or maintain such networks might, in certain circumstances, have a material adverse effect on our financial position, results of operations, or cash flows.</moh:RisksAndUncertaintiesPolicyTextBlock>
    <moh:SummarizedPremiumRevenueTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzE3MDQyNDMwMzA3MTY1_5226b4d8-a201-4840-af1a-488057c31a61">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes premium revenue by state health plan for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Illinois &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kentucky&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Michigan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ohio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Washington&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;&#x201c;Other&#x201d; includes the Idaho, Mississippi, New Mexico, New York, Puerto Rico, South Carolina, Utah and Wisconsin health plans, which were immaterial to our consolidated results of operations.&lt;/span&gt;&lt;/div&gt;</moh:SummarizedPremiumRevenueTableTextBlock>
    <us-gaap:PremiumsEarnedNet
      contextRef="i932eecd9dd8942a8930602c75ed75579_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtMS0xLTEtMTE2NjU_e71f4c75-9109-40b2-bc40-72d5c823b77d"
      unitRef="usd">2109000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i932eecd9dd8942a8930602c75ed75579_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtMy0xLTEtMTE2NTY_53acd2f9-81e7-4d3f-a229-149593b4095f"
      unitRef="number">0.115</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic51cb18d6d6c41eeab7d71df5f748b8b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtNS0xLTEtMTMwODI_5321c0e1-e696-4943-9d85-4709d0d8aea9"
      unitRef="usd">2266000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="ic51cb18d6d6c41eeab7d71df5f748b8b_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtNy0xLTEtMTMxMDc_9461ad0c-a247-4d51-8daf-3cbd2ba01904"
      unitRef="number">0.140</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie971c5d38e9f4081bdcce44e29b31e8e_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtOS0xLTEtMTMxMjk_a1974b1e-0f58-49bc-a6e3-ef10919aa081"
      unitRef="usd">2150000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="ie971c5d38e9f4081bdcce44e29b31e8e_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzQtMTEtMS0xLTEzMTUx_9af098ca-07d7-483e-8a84-65adc97460cc"
      unitRef="number">0.122</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i794b72519ef741a4b1e5b3b064789239_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtMS0xLTEtMTE2NjU_f82a86e8-c59c-45c0-bf37-67cbb1d370a2"
      unitRef="usd">643000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i794b72519ef741a4b1e5b3b064789239_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtMy0xLTEtMTE2NTY_9fed9292-ac7d-4850-9cfe-1d4e3f280f43"
      unitRef="number">0.035</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i98e0308fdfb84b5cabb834a5d7d38846_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtNS0xLTEtMTMwODQ_c4032097-48b2-409c-891d-3114fdf64164"
      unitRef="usd">734000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i98e0308fdfb84b5cabb834a5d7d38846_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtNy0xLTEtMTMxMDk_4cc5d81c-8d9a-4443-ad20-be43a3a50489"
      unitRef="number">0.045</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6ea8b394a2d04647a92ee82b142ff55e_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtOS0xLTEtMTMxMzE_4ffce64c-df2c-465e-b0db-a8bd5862fdf1"
      unitRef="usd">1790000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i6ea8b394a2d04647a92ee82b142ff55e_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzUtMTEtMS0xLTEzMTUz_1597887f-472a-4b71-9498-c50b4f0f713d"
      unitRef="number">0.102</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i010f47d9164d4401aaf7500b3414201c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtMS0xLTEtMTE2NjU_ef7e6006-a313-4541-b4f0-fb69b11b1c62"
      unitRef="usd">1328000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i010f47d9164d4401aaf7500b3414201c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtMy0xLTEtMTE2NTY_54ec0216-afbf-4c62-8d89-1e78056c0735"
      unitRef="number">0.073</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="id99ab9a99c8b48109cb2e67859f4f1ca_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtNS0xLTEtMTMwODY_70889f07-fff9-43d7-8c33-d26c48435e30"
      unitRef="usd">1002000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="id99ab9a99c8b48109cb2e67859f4f1ca_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtNy0xLTEtMTMxMTE_faa24387-2b7d-4349-b572-99e6325f88fb"
      unitRef="number">0.062</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3b7453f2890d4ea8a57191c7b738e0ac_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtOS0xLTEtMTMxMzM_afc704a5-161a-45ca-a0bc-d376d7f6966d"
      unitRef="usd">793000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i3b7453f2890d4ea8a57191c7b738e0ac_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzYtMTEtMS0xLTEzMTU1_bc606ff8-45fe-4259-a095-5d1cdcda87f7"
      unitRef="number">0.045</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i5f146b00c28c496fab54a890e503b593_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctMS0xLTEtMTE2NjU_d5ce8e2f-a7ae-41a0-92f7-268c9727fb70"
      unitRef="usd">654000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i5f146b00c28c496fab54a890e503b593_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctMy0xLTEtMTE2NTY_715cf6e1-94a4-4b22-837c-6e2c9da82936"
      unitRef="number">0.036</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="iafd4a77f957a452ba104472004ee03d3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctNS0xLTEtMTMwODg_8fc4db80-2ba4-443b-926e-a1c8844a0cc7"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="iafd4a77f957a452ba104472004ee03d3_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctNy0xLTEtMTMxMTM_5ac8552b-8475-44a5-9248-b9cdc657b700"
      unitRef="number">0</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i7501a92677af42b3bbf91f05377b6a79_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctOS0xLTEtMTMxMzU_e8a47c90-1bcf-403f-9803-564b1d78bffb"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i7501a92677af42b3bbf91f05377b6a79_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzctMTEtMS0xLTEzMTU3_2adda6d8-f7fc-4753-be00-2adf64eb4f37"
      unitRef="number">0</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="iff54c36d85a740d29de6dfed243ff5ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtMS0xLTEtMTE2NjU_a913daed-7545-4f08-8249-86f2483a927f"
      unitRef="usd">1587000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="iff54c36d85a740d29de6dfed243ff5ee_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtMy0xLTEtMTE2NTY_7ec15cdf-4e61-41a2-abd6-5efee5d0b07f"
      unitRef="number">0.087</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i2c3a468249ee4c1f924f960fd9a0e7b6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtNS0xLTEtMTMwOTA_2db212b3-28a3-4c92-b4de-69fda30b003a"
      unitRef="usd">1624000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i2c3a468249ee4c1f924f960fd9a0e7b6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtNy0xLTEtMTMxMTU_551266a9-1d61-46bf-ba91-99788830b941"
      unitRef="number">0.100</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i5a12870bdcc84902a115a5c52be47a49_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtOS0xLTEtMTMxMzc_820af12a-7740-4819-9a93-844f711b7085"
      unitRef="usd">1601000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i5a12870bdcc84902a115a5c52be47a49_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzgtMTEtMS0xLTEzMTU5_8f1b0b1b-c740-486d-b332-bf979f915156"
      unitRef="number">0.091</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i24117b22bd104e47bb18575a3e1087d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktMS0xLTEtMTE2NjU_2db9dcf8-6891-41dc-8729-0c28c81d8d14"
      unitRef="usd">2962000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i24117b22bd104e47bb18575a3e1087d1_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktMy0xLTEtMTE2NTk_cf79897c-a178-4b60-87c6-825cef9121c6"
      unitRef="number">0.162</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3f2abcdca8654dca825ae09845834f08_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktNS0xLTEtMTMwOTU_2c9e4179-0939-44aa-a6e8-b5981fe02e08"
      unitRef="usd">2553000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i3f2abcdca8654dca825ae09845834f08_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktNy0xLTEtMTMxMTc_d86b5fb2-6c79-4d0b-8e89-0136be5e98ea"
      unitRef="number">0.158</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="ibe7cd5fa2a6c4ee4893fa7aeea12f184_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktOS0xLTEtMTMxMzk_7af0bc07-d504-4284-9398-08a5584dac89"
      unitRef="usd">2388000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="ibe7cd5fa2a6c4ee4893fa7aeea12f184_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzktMTEtMS0xLTEzMTYx_5238d5eb-d3b3-4f89-b145-020a25e6a95a"
      unitRef="number">0.136</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i49d06937156847b795ad5d126b43c272_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTEtMS0xLTExNjY3_113dcfd9-758e-4f14-8acb-ead4985a69c3"
      unitRef="usd">3085000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i49d06937156847b795ad5d126b43c272_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTMtMS0xLTExNjYx_0002fe72-ecf0-44c2-be14-f41d519a995e"
      unitRef="number">0.169</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6c749426a22d4f45b998723c923108b0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTUtMS0xLTEzMDk5_0c2b9ec4-69a4-4d37-85c8-45226113cfe0"
      unitRef="usd">2991000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i6c749426a22d4f45b998723c923108b0_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTctMS0xLTEzMTIx_f670fcba-c993-4fe5-8436-c4b4064bbcad"
      unitRef="number">0.185</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i963a1ad740774ea39b16fa5a48fc788a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTktMS0xLTEzMTQz_d7e2029d-0b30-4d2a-b329-3e77fd49c763"
      unitRef="usd">3244000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i963a1ad740774ea39b16fa5a48fc788a_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzExLTExLTEtMS0xMzE2NQ_0fd73676-3808-49a2-9c54-556fd1310808"
      unitRef="number">0.184</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i98c68a644f8043128dc74552813a54c6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTEtMS0xLTExNjY3_179c7272-99af-4690-8d80-32b1241649b0"
      unitRef="usd">3169000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i98c68a644f8043128dc74552813a54c6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTMtMS0xLTExNjYx_0065d51d-8c4f-4176-b65c-07bca6ad9513"
      unitRef="number">0.173</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i8a53f8a4f88b471ca3904508a5f37fb1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTUtMS0xLTEzMTAx_b4438249-a02f-45ed-b21e-affc37dbc706"
      unitRef="usd">2695000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i8a53f8a4f88b471ca3904508a5f37fb1_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTctMS0xLTEzMTIz_d2934065-06a0-4870-8c8b-e52e7a4dce67"
      unitRef="number">0.166</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6b530889282e4734a8cea1ff62dd4eb8_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTktMS0xLTEzMTQ1_6b5f6810-91f0-4fb5-a271-5041af58d950"
      unitRef="usd">2361000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i6b530889282e4734a8cea1ff62dd4eb8_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEyLTExLTEtMS0xMzE2Nw_b448e1fb-44b8-45fe-8a72-4a35ecc1c9d3"
      unitRef="number">0.134</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i623d20d86025415b904356ce36b3ec7a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTEtMS0xLTExNjY3_69f82dd2-b253-4620-9f4c-ba44ab9aee81"
      unitRef="usd">2762000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i623d20d86025415b904356ce36b3ec7a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTMtMS0xLTExNjYz_74bed555-2a8f-4339-9f10-62f492707982"
      unitRef="number">0.150</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="ife4529f238f148c6a7085542f5807c4c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTUtMS0xLTEzMTAz_7f3e1f54-f75a-4b68-bf71-416521f6a2ee"
      unitRef="usd">2343000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="ife4529f238f148c6a7085542f5807c4c_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTctMS0xLTEzMTI1_624eb023-6c0e-458e-af9a-2e514f752580"
      unitRef="number">0.144</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i2ed8f3b768cc45ce808afd1e8a44ddd3_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTktMS0xLTEzMTQ3_95b9d207-f87d-4ec4-ab20-e28c1bdd54ff"
      unitRef="usd">3285000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i2ed8f3b768cc45ce808afd1e8a44ddd3_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzEzLTExLTEtMS0xMzE2OQ_8e6ad495-dca3-4a7e-9c60-8bd8cd846f5d"
      unitRef="number">0.186</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTEtMS0xLTExNjY3_ca442df8-1ba9-4e4a-976a-4707e31b0711"
      unitRef="usd">18299000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTMtMS0xLTEzMDky_575767e7-b954-4c8f-a9ab-6de53a9e3763"
      unitRef="number">1.000</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTUtMS0xLTEzMTA1_a7ec00fe-2546-44e5-9b6c-e9c0ed63abd7"
      unitRef="usd">16208000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTctMS0xLTEzMTI3_2a2a829f-3bc2-42af-8484-189e17e0043d"
      unitRef="number">1.000</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:PremiumsEarnedNet
      contextRef="i68756a4786524fe5b9fabbe3f97257d2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTktMS0xLTEzMTQ5_180b177f-04ea-4d63-aa74-e17a0400c138"
      unitRef="usd">17612000000</us-gaap:PremiumsEarnedNet>
    <moh:HealthCareOrganizationRevenuePercentage
      contextRef="i68756a4786524fe5b9fabbe3f97257d2_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90YWJsZTo2OGI5ZWI3MGRiNTc0MzNiOWMyYzQ4YzlhNzgwNzIzYS90YWJsZXJhbmdlOjY4YjllYjcwZGI1NzQzM2I5YzJjNDhjOWE3ODA3MjNhXzE0LTExLTEtMS0xMzE3MQ_3427ad81-1aeb-4758-8cb9-8ff6dbe39db6"
      unitRef="number">1.000</moh:HealthCareOrganizationRevenuePercentage>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzMyNzY2_41809de4-6421-4b08-b822-7993ee69b626">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Losses.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which was subsequently modified by several ASUs issued in 2018 and 2019. We adopted Topic 326 effective January 1, 2020, using the modified retrospective approach. Under this method we recognized the cumulative effect of adopting the standard as an adjustment to the opening balance of retained earnings on January 1, 2020, which was immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by a change in the reference rate from the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) or another reference rate expected to be discontinued, if certain conditions are met. ASU 2020-04 is effective immediately and expires after December 31, 2022. We are evaluating the effect of reference rate reform and this guidance on our contracts and other transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (&#x201c;SEC&#x201d;) did not have, nor does management expect such pronouncements to have, a significant impact on our present or future consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90ZXh0cmVnaW9uOjlhNDJmM2MzZjYwNTQ0YThhYzJhNmVhOTNmMDdkYTRiXzcxNg_bfb440bb-003b-410f-9636-8494991196be">Net Income Per Share &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the calculation of basic and diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions, except net income per share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares outstanding at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average number of shares issued:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exchange of convertible senior notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Conversion of convertible senior notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Denominator for basic net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Warrants &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Convertible senior notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Denominator for diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income per share - Basic &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income per share - Diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;&#x201c;Convertible senior notes&#x201d; in this table refer to the 1.625% convertible senior notes due 2044 that were settled in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;For more information regarding the warrants, including partial termination transactions, refer to Note 13, &#x201c;Stockholders' Equity.&#x201d; The dilutive effect of all potentially dilutive common shares is calculated using the treasury stock method. Certain potentially dilutive common shares issuable are not included in the computation of diluted net income per share because to do so would have been anti-dilutive.&lt;/span&gt;&lt;/div&gt;(3)Source data for calculations in thousands.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90ZXh0cmVnaW9uOjlhNDJmM2MzZjYwNTQ0YThhYzJhNmVhOTNmMDdkYTRiXzcyMQ_412fb800-deeb-4207-ac32-564c11ab84e3">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the calculation of basic and diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions, except net income per share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares outstanding at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average number of shares issued:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exchange of convertible senior notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Conversion of convertible senior notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Denominator for basic net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Warrants &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Convertible senior notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Denominator for diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income per share - Basic &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income per share - Diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;&#x201c;Convertible senior notes&#x201d; in this table refer to the 1.625% convertible senior notes due 2044 that were settled in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;For more information regarding the warrants, including partial termination transactions, refer to Note 13, &#x201c;Stockholders' Equity.&#x201d; The dilutive effect of all potentially dilutive common shares is calculated using the treasury stock method. Certain potentially dilutive common shares issuable are not included in the computation of diluted net income per share because to do so would have been anti-dilutive.&lt;/span&gt;&lt;/div&gt;(3)Source data for calculations in thousands.</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzQtMS0xLTEtMA_32e62495-36d3-4bf8-a599-bfb527231c78"
      unitRef="usd">673000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzQtMy0xLTEtMA_95db9dd5-9036-4972-bade-f71a31209013"
      unitRef="usd">737000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzQtNS0xLTEtMA_dc168577-d27d-416a-ad06-b8ae58ceb2b8"
      unitRef="usd">707000000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzYtMS0xLTEtMA_ea08436e-72aa-445c-acc2-c4c71ed4c95e"
      unitRef="shares">61900000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzYtMy0xLTEtMA_b9f831e1-3154-40d7-af96-5b7fb23f2283"
      unitRef="shares">62100000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ie5276df7533a434dba724ca46fb6260b_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzYtNS0xLTEtMA_46dea3ad-dd41-466f-ae1e-329c6c6417f9"
      unitRef="shares">59300000</us-gaap:SharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtMS0xLTEtMTgwNA_1301d29b-cc03-4b5f-979e-129bde6dcd09"
      unitRef="shares">3000000.0</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtMy0xLTEtMTgwNA_433c9b01-cba7-43aa-96d2-cdc7ea1bd057"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtNS0xLTEtMTgwNA_d0497aeb-2015-4f88-b9c2-bddb21dc404b"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <moh:WeightedAverageNumberofSharesShareBasedCompensation
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktMS0xLTEtMjIzNw_a7aba26a-efe7-4d78-98ed-780ba480f858"
      unitRef="shares">100000</moh:WeightedAverageNumberofSharesShareBasedCompensation>
    <moh:WeightedAverageNumberofSharesShareBasedCompensation
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktMy0xLTEtMjIzNw_59e560ef-0a9d-45c3-a4e0-fee2937edf7c"
      unitRef="shares">100000</moh:WeightedAverageNumberofSharesShareBasedCompensation>
    <moh:WeightedAverageNumberofSharesShareBasedCompensation
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktNS0xLTEtMjIzNw_c876fb44-0a6a-4bb1-8e3f-af052df4bfe4"
      unitRef="shares">200000</moh:WeightedAverageNumberofSharesShareBasedCompensation>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtMS0xLTEtMA_880394f8-04be-43f8-8fa0-d14d408014fa"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtMy0xLTEtMA_d841fc5a-81d8-4afc-93c0-99deb1a97c38"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzgtNS0xLTEtMA_db0dc7fb-6614-483e-b99a-c2baa7699623"
      unitRef="shares">1400000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <moh:WeightedAverageNumberofSharesIssuedConversionofSeniorNotes
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktMS0xLTEtMA_733c3b00-5ba4-4a22-8ec3-f295e0819428"
      unitRef="shares">0</moh:WeightedAverageNumberofSharesIssuedConversionofSeniorNotes>
    <moh:WeightedAverageNumberofSharesIssuedConversionofSeniorNotes
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktMy0xLTEtMA_a82c4587-5b6b-4d7d-95d8-48a9e0c47b4f"
      unitRef="shares">0</moh:WeightedAverageNumberofSharesIssuedConversionofSeniorNotes>
    <moh:WeightedAverageNumberofSharesIssuedConversionofSeniorNotes
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzktNS0xLTEtMA_dbd96c4e-ef52-4bbd-ae28-d728628fb534"
      unitRef="shares">200000</moh:WeightedAverageNumberofSharesIssuedConversionofSeniorNotes>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzExLTEtMS0xLTA_a1f6f74b-5797-4c5a-9d29-dbb3adff60ed"
      unitRef="shares">59000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzExLTMtMS0xLTA_128d4666-23e6-459c-b574-65a6cfad61e0"
      unitRef="shares">62200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzExLTUtMS0xLTA_238eab48-9357-4917-83e8-3c8fe3dc198d"
      unitRef="shares">61100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTEtMS0xLTIyNDU_7262b775-6263-4563-a3d0-d7059716fe27"
      unitRef="shares">900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTMtMS0xLTIyNDU_e297c61a-5d0e-4bfe-af38-b5e0767da2f6"
      unitRef="shares">600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTUtMS0xLTIyNDU_8ea36ee5-876e-4ffc-83bf-82fce6240408"
      unitRef="shares">300000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzEzLTEtMS0xLTA_5997f4c8-d046-43cf-87cf-142c01f587b5"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzEzLTMtMS0xLTA_daee69e1-ca07-4f0a-98ce-ff026a524b56"
      unitRef="shares">1400000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzEzLTUtMS0xLTA_f773d0c7-305e-45b0-8f46-33d802d647db"
      unitRef="shares">4800000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTEtMS0xLTA_7e0df86a-ce49-40e1-bbe4-2ec0bca00fa2"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTMtMS0xLTA_f395140e-f2de-4f94-b820-cd14bdfa92a8"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE0LTUtMS0xLTA_ada2a592-8799-4723-80dd-806b3ea3275e"
      unitRef="shares">400000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE2LTEtMS0xLTA_76f436ad-9806-4ac2-85a9-c8845c263556"
      unitRef="shares">59900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE2LTMtMS0xLTA_a8f99fd2-4343-4101-a0dd-c16785675cd6"
      unitRef="shares">64200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE2LTUtMS0xLTA_099d239a-9f61-4925-be1b-21ba85d8223c"
      unitRef="shares">66600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE5LTEtMS0xLTA_8d610cf1-c1c7-47c3-921e-39662a2d4497"
      unitRef="usdPerShare">11.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE5LTMtMS0xLTA_b6a72f24-5249-48b0-b5cf-f89252ae056f"
      unitRef="usdPerShare">11.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzE5LTUtMS0xLTA_219d3721-c4d4-4b5b-a8aa-a8e484e6bcdd"
      unitRef="usdPerShare">11.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzIwLTEtMS0xLTA_2539d682-eded-4b97-8b1d-8e41a43d2434"
      unitRef="usdPerShare">11.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzIwLTMtMS0xLTA_ca0f4dd6-0198-4ec0-a27c-9cd566090fac"
      unitRef="usdPerShare">11.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90YWJsZTo4ZGRhYThjZTcyNTA0ZjdlYWYzYzc2N2EwY2M0MGIyZS90YWJsZXJhbmdlOjhkZGFhOGNlNzI1MDRmN2VhZjNjNzY3YTBjYzQwYjJlXzIwLTUtMS0xLTA_92938ae1-2947-4ee9-94bc-8d5629b5ba6e"
      unitRef="usdPerShare">10.61</us-gaap:EarningsPerShareDiluted>
    <moh:ClassOfWarrantOrRightStatedInterestRate
      contextRef="i2fe995e49c0b4274a5ede86b839b44d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNTQvZnJhZzo5YTQyZjNjM2Y2MDU0NGE4YWMyYTZlYTkzZjA3ZGE0Yi90ZXh0cmVnaW9uOjlhNDJmM2MzZjYwNTQ0YThhYzJhNmVhOTNmMDdkYTRiXzIwMA_433c8bb7-c3b8-46ba-a781-c7dd40e20974"
      unitRef="number">0.01625</moh:ClassOfWarrantOrRightStatedInterestRate>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzExNTQ0ODcyMTEzMTAz_f65abe79-90e1-4da7-82ed-1d0532a62b80">Business Combinations &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the last half of 2020, we closed on three business combinations in the Health Plans segment, consistent with our strategy to grow in our existing markets and expand into new markets. For these transactions, we applied the acquisition method of accounting, where the total purchase price was allocated, or preliminarily allocated, to the tangible and intangible assets acquired and liabilities assumed, based on their fair values as of the acquisition dates. We expect to complete the final determination of the purchase price allocations as soon as practicable, but no later than one year following the acquisitions&#x2019; closing dates in accordance with Accounting Standards Codification Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Measurement period adjustments will be recorded in the period in which they are determined, as if they had been completed at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition costs amounted to $16&#160;million in the aggregate for the year ended December 31, 2020, and were recorded as &#x201c;General and administrative expenses&#x201d; in the accompanying consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Magellan Complete Care. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 31, 2020, we closed on our acquisition of 100% of the outstanding equity interests of the Magellan Complete Care line of business of Magellan Health, Inc., for total purchase consideration of approximately $1,037&#160;million. Total purchase consideration paid in cash amounted to $1,008&#160;million, which consisted of the base purchase price of $850&#160;million, plus approximately $158&#160;million in preliminary closing adjustments, primarily relating to excess regulatory capital. Total purchase consideration also included assumed liabilities of $29&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Magellan Complete Care is a managed care organization serving members in six states, including Medicaid members in Arizona and statewide in Virginia, and integrated acute care members in Florida. Through its Senior Whole Health branded plans, Magellan Complete Care provides fully integrated plans for Medicaid and Medicare dual beneficiaries in Massachusetts, as well as managed long-term care in New York. As of December 31, 2020, Magellan Complete Care served approximately 200,000 members in its managed care plans. Magellan Complete Care also provides consultative services to participants who self-direct their care through Wisconsin&#x2019;s long-term services and supports (&#x201c;LTSS&#x201d;) program. For the year ended December 31, 2020, Magellan Complete Care&#x2019;s total 2020 revenue was approximately $2.9&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because this acquisition closed on December 31, 2020, Magellan Complete Care&#x2019;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020. If we had acquired Magellan Complete Care on January 1, 2019, our total revenue and earnings for the year ended December 31, 2019, would have been approximately $19.6 billion and $772 million, respectively, and our total revenue and earnings for the year ended December 31, 2020, would have been approximately $22.4 billion and $833 million, respectively. These amounts were computed after adjusting the results of Magellan Complete Care to reflect the additional amortization that would have been charged assuming the fair value adjustments to intangible assets and liabilities had been applied beginning on January 1, 2019, together with the consequential tax effects. The pro forma results do not reflect any anticipated synergies, efficiencies, or other cost savings of the acquisition. Accordingly, the unaudited pro forma financial information is not indicative of the results if the acquisition had been completed on January 1, 2020, or January 1, 2019, and is not a projection of future results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation of the assets acquired, and liabilities assumed has not yet been finalized because the acquisition closed on December 31, 2020. As a result, provisional estimates have been recorded and are subject to change, primarily for accounts that include the use of estimates, such as medical claims and benefits payable, receivables, amounts due government agencies, certain acquired intangible assets, and certain tax assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Such assets include synergies we expect to achieve, such as the use of our existing infrastructure to support the added membership, and future economic benefits arising from the assembled workforce. Approximately 27% of the goodwill is deductible for income tax purposes. The following table summarizes the provisional fair values assigned to assets acquired and liabilities assumed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets acquired: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property and equipment &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities assumed: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical claims and benefits payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts due government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued and other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net purchase price paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Kentucky. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 1, 2020, we closed on the acquisition of certain assets of Passport Health Plan, Inc., a Medicaid health plan. Effective on that same date, the Kentucky Medicaid agency approved the novation of Passport&#x2019;s Medicaid contract to Molina Healthcare of Kentucky, Inc., thereby ensuring continuity of care for Passport&#x2019;s Medicaid members. As of December 31, 2020, our Kentucky health plan had 337,000 Medicaid &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;members. The total purchase price was $66 million, which included our initial cash payment of $20 million in September 2020, plus $46&#160;million in contingent consideration payable to the seller. See further information regarding contingent consideration in Note 5, &#x201c;Fair Value Measurements.&#x201d; We recorded goodwill of $30 million, all of which is deductible for income tax purposes. The goodwill recorded relates to future economic benefits arising from the assembled workforce, and the future growth associated with the member contract rights that are incremental to the contract rights identified.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New York. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 1, 2020, we closed on the acquisition of certain assets of YourCare Health Plan, Inc., a Medicaid health plan operating in certain regions of New York, for a cash purchase price of $42&#160;million. As a result of this transaction, we added approximately 47,000 Medicaid members in New York. We recorded goodwill of $31 million, substantially all of which is deductible for income tax purposes. The goodwill recorded relates to future economic benefits arising from expected synergies to be achieved, including the use of our existing infrastructure to support the added membership.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets Acquired&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents intangible assets acquired, by major class, for the three acquisitions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract rights - member list&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provider network&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <moh:BusinessCombinationNumberOfBusinessCombinations
      contextRef="if30ced8758e642af8985042651d6cdb1_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2MzY1OTE_3ebb1ef6-cfb4-483e-ae33-6d6c68ee2b2d"
      unitRef="business_combination">3</moh:BusinessCombinationNumberOfBusinessCombinations>
    <us-gaap:AcquisitionCosts
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2Nzg4MzI_f9ef490a-93a5-4ef6-89da-8f13ccc4d069"
      unitRef="usd">16000000</us-gaap:AcquisitionCosts>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="idc8845b2df0142a6ad693b5b696a900f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODEwMzg_edee7e04-76a9-4d51-a685-4ee8811ada5c"
      unitRef="number">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i41056d0891344bfeb906ddd9f525ea3d_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzU3ODc_cc4ca022-6eb2-4bb3-a223-e5b451067cd6"
      unitRef="usd">1037000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities
      contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODUwOTg_18c31a90-c5c4-47b6-8e3c-ccff04f6a12c"
      unitRef="usd">1008000000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODUxMTU_c53d8a26-201d-4745-8cbd-9aa7909168e3"
      unitRef="usd">850000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODUxMzA_c61b01ae-18c5-4156-bf55-9707044675f0"
      unitRef="usd">158000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idc8845b2df0142a6ad693b5b696a900f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODUxNDU_8b80bf83-20ab-40f0-b08b-a28e3417b7d3"
      unitRef="usd">29000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="idc8845b2df0142a6ad693b5b696a900f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzU0OTc1NTgxOTI5MzA_d89b3809-0f4d-42d5-9034-ea7143ec2a76"
      unitRef="security">6</us-gaap:NumberOfStatesInWhichEntityOperates>
    <moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms
      contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODU3Mzg_6ffab041-c1f2-4e28-8af2-b6cc62677e7b"
      unitRef="member">200000</moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms>
    <us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod
      contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODU3MDg_cca682fc-f53e-4ea9-a867-609b28013e8b"
      unitRef="usd">2900000000</us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i5c05b89a6f0144e3b67780794556b45d_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2ODI0MDY_492f3c81-adc3-4210-9cfe-05dbb0f88a68"
      unitRef="usd">19600000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i5c05b89a6f0144e3b67780794556b45d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzExNTQ0ODcyMTQyNDY4_476e2f4d-6aa3-462e-a161-2f60d2e0622b"
      unitRef="usd">772000000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTQwMDc4NDY_dd4d2350-e86b-4f9f-9475-c493873b9787"
      unitRef="usd">22400000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i064898df32bb409d9725c5271969d63b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTQwMDc4NTQ_68e38705-c1e4-42e6-8786-7f4c1e65802a"
      unitRef="usd">833000000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <moh:BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage
      contextRef="id47bfbaa31f34e6cbbc46b397397ad22_D20201201-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzExNTQ0ODcyMTQyNDg2_4ffa3b47-a1b8-4347-b31c-3f2f9e639731"
      unitRef="number">0.27</moh:BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEyMDk0NjI3OTI3MDE2_015ea89a-4a9a-490c-b262-a9ebc471aff4">The following table summarizes the provisional fair values assigned to assets acquired and liabilities assumed.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets acquired: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property and equipment &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities assumed: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical claims and benefits payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts due government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued and other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net purchase price paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzMtMS0xLTEtODk4Nw_09e0d11f-0548-4b0a-96d7-eef3f1c25620"
      unitRef="usd">310000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzQtMS0xLTEtODk4Nw_46e171f5-e73a-4b20-9a82-145c82c66910"
      unitRef="usd">312000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzUtMS0xLTEtODk4Nw_1a7c1494-8f5d-4530-89d9-20a470fdc83b"
      unitRef="usd">166000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzYtMS0xLTEtODk4Nw_521c0d9e-3fe6-424d-b5bb-389196570f1f"
      unitRef="usd">16000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzctMS0xLTEtODk4Nw_973ba756-6341-49a4-b254-d66e8be2f0b3"
      unitRef="usd">3000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzgtMS0xLTEtODk4Nw_5efc1d70-59ad-42a2-86c9-7465f6cd693b"
      unitRef="usd">191000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzktMS0xLTEtNDYyNQ_2c055c09-c110-43aa-8fac-7f05656c8959"
      unitRef="usd">488000000</us-gaap:Goodwill>
    <moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzEwLTEtMS0xLTEzMzEz_b6030b04-32df-45ed-947a-a412b999af3f"
      unitRef="usd">49000000</moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzEwLTEtMS0xLTg5ODc_1398d60e-60ca-42c2-9100-77aa3832ad23"
      unitRef="usd">14000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzEyLTEtMS0xLTg5ODc_c3ae75ba-4ff1-4372-b0b9-99e4c9f9a374"
      unitRef="usd">294000000</moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable>
    <moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzEzLTEtMS0xLTg5ODc_ab647fdd-5fc3-4644-a519-a413568745f2"
      unitRef="usd">143000000</moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies>
    <moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzE0LTEtMS0xLTg5ODc_72a88c43-814b-40c2-817c-3ea25376200d"
      unitRef="usd">84000000</moh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzE2LTEtMS0xLTIwOTQz_a167e606-8999-41b0-bee0-97f120056c2e"
      unitRef="usd">20000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTo0YTc4OWJlNGFiMDA0MjM2YTE0NmVmZDk3NjZiY2Q2OC90YWJsZXJhbmdlOjRhNzg5YmU0YWIwMDQyMzZhMTQ2ZWZkOTc2NmJjZDY4XzE1LTEtMS0xLTg5ODc_d9da44d8-c394-428b-bf36-d7fbe03a8fca"
      unitRef="usd">1008000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms
      contextRef="i4d9ad5f0f8564470964511585ae558dc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzY1OTcwNjk4MjA4ODI_c208a163-1a4c-4f83-843f-9f7af1cb6207"
      unitRef="member">337000</moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="idbd3989bdd36411bb81f15405becbc0a_D20200901-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2NTQ3OTg_20e84f72-60fe-4ef5-93e6-f93b63e6d23c"
      unitRef="usd">66000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="idbd3989bdd36411bb81f15405becbc0a_D20200901-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5Njk4OTY_4db03b6f-afab-4eb9-8451-91c679c772d0"
      unitRef="usd">20000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib80e56cc81004ffb9a966b132d1c37ce_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEwOTk1MTE2Nzg3NDI_6160bbff-bb67-49f9-bed5-2529b31e2de4"
      unitRef="usd">46000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:Goodwill
      contextRef="i55464af26be84fb3820ca5c44e160c32_I20200901"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzA3ODI_b406f958-c2fc-46af-bd9f-d37202386b58"
      unitRef="usd">30000000</us-gaap:Goodwill>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i72b43b1a1b4b4f1082ad9d20416d588c_D20200701-20200701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzE5NDU_61848025-c393-4039-b5d0-d4ff68b062e2"
      unitRef="usd">42000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms
      contextRef="i5c8feb8bc88a45bab6f5586d910050f1_I20200701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzIwMTE_844c6548-3708-487a-aac8-e02cf1923820"
      unitRef="member">47000</moh:BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms>
    <us-gaap:Goodwill
      contextRef="i5c8feb8bc88a45bab6f5586d910050f1_I20200701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzIwNzA_aabaf68d-021c-4854-8329-588708a1cb22"
      unitRef="usd">31000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzEyMDk0NjI3OTI3MDE1_c6134a92-0cda-4b6d-a2de-d09257433eae">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents intangible assets acquired, by major class, for the three acquisitions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract rights - member list&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provider network&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <moh:BusinessCombinationNumberOfBusinessCombinations
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90ZXh0cmVnaW9uOjE0NTI2ZGI0MjFjNTQxYzJhMGEzMzY4OWY4NmY0ZjA2XzYwNDczMTM5NzQ3MDI_246f7d10-0928-4be5-bba2-676e3480c457"
      unitRef="business_combination">3</moh:BusinessCombinationNumberOfBusinessCombinations>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i5ac1df93bc0c4894960ea1adb84e0024_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtMS0xLTEtNDU3Ng_f0f15940-6b01-45d2-b1df-dcf0552cdf41"
      unitRef="usd">193000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i20850a7f15e24400b1b3bf58d9e096d9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtMy0xLTEtODk4Mw_b8343f06-c933-45b3-b433-a8f887d99a7d">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibb7db7e5903548c1b07be8df527ac95f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtNS0xLTEtNDU3Ng_841231bd-2a82-4d05-9ded-b7382fd5d314">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="if958004bf9004127b3dfe774c1c93182_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzMtNy0xLTEtMTA5MjU_fe1f6fca-95d7-4ae9-8877-ab255ad3e51f">P5Y3M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i733eec69c1db4095a58047c500e1ec76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtMS0xLTEtMjAyMTk_7e0e0029-b098-49c4-bff7-83821863609e"
      unitRef="usd">27000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7f80aa6d34e346a1a3b5dbdaeab0b9a9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtNS0xLTEtMjAyMTk_9aa8f490-5965-4d0c-9b5f-2422b1bdc745">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i7f80aa6d34e346a1a3b5dbdaeab0b9a9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtNy0xLTEtMjAyMTk_77ee3d6a-075d-40ff-9591-a2fab32223c9">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i6531b793e0c64805a9f24b4ce452eb0d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzUtMS0xLTEtNDU3Ng_14cea807-3436-4bc6-b2e3-2c5f077570ef"
      unitRef="usd">15000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="idc5130895c0f47929310c0ab60eb616a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzUtMy0xLTEtMjA5NDc_eb73a018-b96e-46c0-b85a-7430cc863994">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iebc139137e204e638a9cb2d71ee5dea9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzUtNS0xLTEtNDU3Ng_7365a9d2-7e30-4a7b-bd41-176550c26553">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i0a7800a872f64f3fb068791db99f8252_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzQtNy0xLTEtMTMzMDk_c29bb582-4c0f-4124-9d55-6f59dbd68489">P15Y4M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzctMS0xLTEtNDU3Ng_92769fc7-6585-42bb-bc7f-7e9790f82013"
      unitRef="usd">235000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjAvZnJhZzoxNDUyNmRiNDIxYzU0MWMyYTBhMzM2ODlmODZmNGYwNi90YWJsZTowODgwNjAwODBkNTA0MDVlYWZkMzc4OWYwMzlkMDNmOS90YWJsZXJhbmdlOjA4ODA2MDA4MGQ1MDQwNWVhZmQzNzg5ZjAzOWQwM2Y5XzYtNy0xLTEtMTA5MDY_5473622b-65f1-4286-a5f3-9e963c1c300a">P6Y6M</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzMzOTU_ee68f9da-f78b-4312-95b2-7ecb908c2250">Fair Value Measurements &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of current assets and current liabilities to approximate their fair values because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For our financial instruments measured at fair value on a recurring basis, we prioritize the inputs used in measuring fair value according to a three-tier fair value hierarchy as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1 &#x2014; Observable Inputs.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 financial instruments are actively traded and therefore the fair value for these securities is based on quoted market prices for identical securities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2 &#x2014; Directly or Indirectly Observable Inputs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value for these investments is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3 &#x2014; Unobservable Inputs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 financial instruments are valued using unobservable inputs that represent management&#x2019;s best estimate of what market participants would use in pricing the financial instrument at the measurement date. As of December 31, 2020, our Level 3 financial instruments consisted of contingent consideration liabilities. As of December 31, 2019, our Level 3 financial instruments consisted of derivative financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net changes in fair value of Level 3 financial instruments are reported in &#x201c;Other&#x201d; operating expenses in our consolidated statements of income. In the year ended December 31, 2020, we recognized a loss of $6&#160;million, primarily for the increase in the fair value of the contingent consideration liability described below, because the opening 2021 enrollment for our Kentucky health plan was higher than our estimate as of September 30, 2020. In the year ended December 31, 2019, the net changes in fair value of Level 3 financial instruments were insignificant to our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments measured at fair value on a recurring basis at December&#160;31, 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments measured at fair value on a recurring basis at December&#160;31, 2019, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government-sponsored enterprise securities (&#x201c;GSEs&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Call option derivative asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Conversion option derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Consideration Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, our Level 3 financial instruments recorded at fair value on a recurring basis included contingent consideration liabilities of $46 million, in connection with the Kentucky acquisition described in Note 4, &#x201c;Business Combinations.&#x201d; As of December 31, 2020, the contingent consideration fair value was estimated primarily based on an amount we expect to pay the seller for members enrolled in our Kentucky health plan as of January 1, 2021, over a minimum threshold. Half this amount is payable later in 2021, with the remainder payable in early 2022, subject to review and agreement among us and the seller. The second half payment is contingent upon the outcome of certain legal challenges. The current portion is reported in &#x201c;Accounts payable, accrued liabilities and other,&#x201d; and the non-current portion is reported in &#x201c;Other long-term liabilities,&#x201d; in the accompanying consolidated balance sheets. Contingent consideration liabilities are remeasured to fair value each quarter until the contingencies are resolved with fair value adjustments, if any, recorded to operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivatives &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair values and the presentation of our derivative financial instruments in the accompanying consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative asset:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Call Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets: Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Conversion Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities: Accounts payable, accrued liabilities and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our derivative financial instruments did not qualify for hedge treatment. Gains and losses for our derivative financial instruments are presented individually in the accompanying consolidated statements of cash flows, &#x201c;Supplemental cash flow information.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the year ended December 31, 2020, we received $27 million for the settlement of the call option derivative asset, and we paid $39 million to settle the outstanding $12 million principal amount of the 1.125% Convertible Notes, and settle the related conversion option. For more information, refer to Notes 11, &#x201c;Debt,&#x201d; and 13 &#x201c;Stockholders' Equity.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements &#x2013; Disclosure Only&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and estimated fair values of our notes payable are classified as Level 2 financial instruments. Fair value for these securities is determined using a market approach based on quoted market prices for similar securities in active markets or quoted prices for identical securities in inactive markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.375% Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.375% Notes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.875% Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term Loan Facility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.125% Convertible Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;For more information on debt repayments, refer to Note 11, &#x201c;Debt.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzU0OTc1NTgxNTMzNTg_c715db25-0f42-46be-810b-ddb3e00f769a">Fair Value Measurements &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of current assets and current liabilities to approximate their fair values because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For our financial instruments measured at fair value on a recurring basis, we prioritize the inputs used in measuring fair value according to a three-tier fair value hierarchy as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1 &#x2014; Observable Inputs.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 financial instruments are actively traded and therefore the fair value for these securities is based on quoted market prices for identical securities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2 &#x2014; Directly or Indirectly Observable Inputs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value for these investments is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3 &#x2014; Unobservable Inputs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 financial instruments are valued using unobservable inputs that represent management&#x2019;s best estimate of what market participants would use in pricing the financial instrument at the measurement date. As of December 31, 2020, our Level 3 financial instruments consisted of contingent consideration liabilities. As of December 31, 2019, our Level 3 financial instruments consisted of derivative financial instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzYwNDczMTM5NjY4NDM_315e21ae-d950-4389-8faf-4c4554dbc92a"
      unitRef="usd">6000000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzMzODE_bd004bea-914e-4058-a75e-96902e0cf8bc">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments measured at fair value on a recurring basis at December&#160;31, 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments measured at fair value on a recurring basis at December&#160;31, 2019, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government-sponsored enterprise securities (&#x201c;GSEs&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Call option derivative asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Conversion option derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzItMS0xLTEtMA_d5052fc6-d239-4ba9-8ac6-8fab4cc023d0"
      unitRef="usd">1256000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1537007f8b454c3b99a90841baabc2fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzItMy0xLTEtMA_f75a3185-0e36-4bde-91a9-cc144c5b6ba9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6e7b354db3f541ca96ec5db2b700dd49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzItNS0xLTEtMA_c51a5d25-3f3a-4dab-99d7-dba93fe84d68"
      unitRef="usd">1256000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i620ff45e952445d1ac715d4144df7597_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzItNy0xLTEtMA_b49e6a0f-a659-48d0-b6da-64a7b708626a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8f297a74be174b0cb53664e81273fc7b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzMtMS0xLTEtMA_08acf477-318b-4703-ba07-05e4e70d05aa"
      unitRef="usd">392000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3db9d935bc9944d79fac14b03b028e17_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzMtMy0xLTEtMA_42ba4fe9-2d3c-461b-bfd7-e14240445361"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i58b1296e99cd47e4bf03290b7a26a478_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzMtNS0xLTEtMA_3f4e6ac3-3523-492a-9c08-b6b0bf23e154"
      unitRef="usd">392000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia70e312008164e878e7157499eee87d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzMtNy0xLTEtMA_7ecbc7b4-67bf-4a08-96d5-7f486b8e3b60"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if330308388ae40ac9a6862c3c5bacd95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzQtMS0xLTEtMA_301a6990-aeb6-41e0-96fa-d910c522d958"
      unitRef="usd">132000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5ade1a543bf4bed873e58b761ad56ff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzQtMy0xLTEtMA_b510d2f4-128e-4a1c-aed8-c796fb612e3a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iff7c00132f94480c9854cfa010a9b0ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzQtNS0xLTEtMA_9d490e09-639b-4907-b39f-6aa582b76f71"
      unitRef="usd">132000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i75ace7c20ffa424295b84956415a9b16_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzQtNy0xLTEtMA_13261e8f-f0b5-4afc-8ec2-0e43005ecbbc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i11c3150f158849b7981e3f9bd3362f4e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzUtMS0xLTEtMA_9d88bcdd-7350-4c7a-9a9a-888a7203f48d"
      unitRef="usd">68000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i12998aefc9ee4f1faa798f4661c61421_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzUtMy0xLTEtMA_a2e2f97e-c4cb-4bea-8a66-2284ccd8248d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8f2e1498903647dfb8ed82f5dfb635f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzUtNS0xLTEtMA_ee3c0753-8cbe-48c4-8e8d-da27b4331122"
      unitRef="usd">68000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0df2d07f1c4f49239d8e7fce08146428_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzUtNy0xLTEtMA_07e7def0-4c18-4dc9-9c2a-0c50a30ea114"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1248d546adf44c31b8e4c83bc5671814_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzctMS0xLTEtMA_da5c5e5c-5cd4-44d7-b1a2-884fd7e775c0"
      unitRef="usd">27000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia00ecaf4e4c7420280c26ee32500e9c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzctMy0xLTEtMA_2577cfee-24d6-421f-8faf-e14e05dc3810"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4965915628104e2ab8fff975a58ce821_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzctNS0xLTEtMA_9e2b4fc5-199d-468a-b3e1-f4f021a55480"
      unitRef="usd">27000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iddc3e419bf45401eb1c8ee9d956b9590_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzctNy0xLTEtMA_109a4d07-6aeb-49f3-95f3-198361485481"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEwLTEtMS0xLTA_4cf41006-ee29-4872-bfb6-b296f1726fdc"
      unitRef="usd">1875000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9ed4091dd7014489aae0cf9acc2daec5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEwLTMtMS0xLTA_6ba92430-20b8-469d-8cde-12b1b63d6aca"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i410a5c9397b240a48b11ed2e55a3ca0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEwLTUtMS0xLTA_7d4052a3-3a9a-4020-bab3-c80ffade6189"
      unitRef="usd">1875000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5b5f410a090c46058072e3908f0200f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEwLTctMS0xLTA_7ce828a0-a2b7-4f24-8ebe-5cfd5f1f2ffb"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEyLTEtMS0xLTE4MjA_f6f05b1a-72d9-4ed6-b0d4-96ba673a43fd"
      unitRef="usd">46000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9ed4091dd7014489aae0cf9acc2daec5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEyLTMtMS0xLTE4MjA_b0b74294-c60d-4f54-bbc1-cae15a14f12d"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i410a5c9397b240a48b11ed2e55a3ca0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEyLTUtMS0xLTE4MjA_c730c3ab-c3ce-41f7-9b08-ac3891b629fc"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5b5f410a090c46058072e3908f0200f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEyLTctMS0xLTE4MjA_3d071f0f-048f-435a-9a9c-7237fdd09e16"
      unitRef="usd">46000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEzLTEtMS0xLTE4MjA_12759190-1ac0-4f57-893d-32ee916c13bd"
      unitRef="usd">46000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9ed4091dd7014489aae0cf9acc2daec5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEzLTMtMS0xLTE4MjA_da5a2abf-f7bc-49e6-8076-8725141cded1"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i410a5c9397b240a48b11ed2e55a3ca0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEzLTUtMS0xLTE4MjA_c369cd65-43a7-474a-a460-e2ad770d4958"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5b5f410a090c46058072e3908f0200f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozMzA1ZWE1MGNlMTg0NWI2YTkzNWFhOWNhMjExYmJhOS90YWJsZXJhbmdlOjMzMDVlYTUwY2UxODQ1YjZhOTM1YWE5Y2EyMTFiYmE5XzEzLTctMS0xLTE4MjA_99f19b02-9139-43ad-a451-062bc4e8397b"
      unitRef="usd">46000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzItMS0xLTEtMA_d3b3b930-53de-450d-871c-b5cd72e461e5"
      unitRef="usd">1178000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i323373c939a744309b13b44c10d4e64f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzItMy0xLTEtMA_899c8a77-257f-4622-b23b-8b3b8585dae0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2807d22440ef4fcf924a3e296c024baa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzItNS0xLTEtMA_e2130309-b1b7-4900-9b21-1fdce4d12dcc"
      unitRef="usd">1178000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i29d022afd4104a10b3d38dc48db285a3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzItNy0xLTEtMA_22434246-ce73-42bd-8da4-e69455dc788d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6ad2854387a044388a14a10a50f7d60a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzMtMS0xLTEtMA_3e58b801-aa27-40fa-bbb9-d9e5afa9fd89"
      unitRef="usd">420000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i28bc7ef03bb44205a24ac42c766d0ec2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzMtMy0xLTEtMA_3cb0c019-3036-4071-9510-7d5e531bd836"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3e4f73d258de45c09c5dc40f3889ded5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzMtNS0xLTEtMA_c0969d7d-0445-4c0d-b8dd-12b728215432"
      unitRef="usd">420000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b3ea3a00aa745fa8d3fe8db9188348f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzMtNy0xLTEtMA_083bed6d-10df-4f9b-9a3d-8b7213e7011c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ida3322a79f8149fe818ac4b37b7f1c22_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzQtMS0xLTEtMA_fe1ab15f-979b-42ca-9551-c295713d6338"
      unitRef="usd">127000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i673e1f4e113146bfb5c486ae12b9ee45_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzQtMy0xLTEtMA_93b567a0-3f7a-4d6f-8d87-ceb9da418800"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b5d62a6819c41fa87480dace92027a3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzQtNS0xLTEtMA_20503da5-72d9-47bb-93cf-b07c210ee467"
      unitRef="usd">127000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i675f941940f34275b7ad7964d3615d58_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzQtNy0xLTEtMA_627c6118-c527-407a-a88e-773019efe849"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4c4f690f2e3741049e287513d54671cc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzUtMS0xLTEtMA_8baf1d75-c74e-4211-ab4c-d1e5b525f89e"
      unitRef="usd">78000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i13016843f45e401db644115e95be6a87_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzUtMy0xLTEtMA_1530c416-9627-4fd9-9081-b9dd1596426c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i88ac1c81d1544708baba1124ced26c15_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzUtNS0xLTEtMA_ee537691-1c3f-4c3e-bf7d-a81047dcdb4e"
      unitRef="usd">78000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia1f46b98577243ef93fe68df78a68dd0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzUtNy0xLTEtMA_a3685efa-f7e6-439d-86be-1cfd4f71795c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1662ee2010e44146a4d125c47e8f6ba3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzYtMS0xLTEtMA_3599e074-c75d-43ec-a245-214732fe4068"
      unitRef="usd">86000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i89400aeee60c4b3f858de5d8bf088e81_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzYtMy0xLTEtMA_b340f810-a8af-4da1-834c-d99c6981c9c1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i73d7f9a5342e4d09bca467416cea6034_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzYtNS0xLTEtMA_0927138b-e3c9-4d5b-a0cc-5810d6214b0a"
      unitRef="usd">86000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa18c08b497d4e83bd718272cfc7f575_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzYtNy0xLTEtMA_6df48381-991f-4a23-888b-35e4a8006b94"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6471a4d8ab49424e8b4300ddd8991da5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzctMS0xLTEtMA_aba60a4f-d568-4c28-bffc-542e0f563217"
      unitRef="usd">49000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id7633ecb19354446b41403e6360d771a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzctMy0xLTEtMA_6fec1316-97f3-4340-8d1a-7ffb17093431"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i21e3e7333e904417952db8fcc93f2434_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzctNS0xLTEtMA_923e8b3a-8905-4eb6-a426-2b777dc15101"
      unitRef="usd">49000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie720443e514340f9bf863ab49f657949_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzctNy0xLTEtMA_9be0e12a-6cd4-457f-b4a7-186f64608009"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzgtMS0xLTEtMA_b606bbf3-60b2-40dc-b659-2153bf54301a"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i95da47a8ff274392a557100219edc18a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzgtMy0xLTEtMA_579c25d8-ae74-42a7-9a49-442fbfc4a18e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if6935a499d294baea85bb268e45f2965_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzgtNS0xLTEtMA_0ee7c92e-224a-4de0-a2cb-79a85fb5efb7"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia75c8c84b6ae4319bd2ad5f13d5930f5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzgtNy0xLTEtMA_ef7ef24e-dcee-4b3c-8eb4-4a2386cbe851"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib7fe95986da143f49cb9ff1cd45fb414_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzktMS0xLTEtMA_8f4c3717-b278-4d86-ad04-0553cf5a1740"
      unitRef="usd">7000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia2a2b0056a32471e8f7d05fa87adc1e2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzktMy0xLTEtMA_ca98556e-f82f-41ee-b4af-bc67c20ef383"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i76cc5c31e1ec457890186adff5d88ff6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzktNS0xLTEtMA_e32ae96c-2421-4af7-bb13-25f5914e97bc"
      unitRef="usd">7000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4e37ac84dde34f9a9f5a34dc6fbb3503_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzktNy0xLTEtMA_e7fec083-8648-4b64-a0a3-16eb75390b11"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEwLTEtMS0xLTA_5529e98c-07b8-4cb8-ad21-4de302853106"
      unitRef="usd">1946000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia2dfcce27ab44c888f802f59df6a8678_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEwLTMtMS0xLTA_bea3a128-6306-427f-a332-933f9086ba2e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3ebfad9e8de34bc282edd8a903fd15de_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEwLTUtMS0xLTA_cd0c5989-ed5c-4c86-ab1c-e497007a1850"
      unitRef="usd">1946000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0f1b6888bbaf41ef9d90d37617270d74_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEwLTctMS0xLTA_01d6a898-8055-45e7-96ba-0e7fd5d28118"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeAssets
      contextRef="ia041924286c54d5c9513011d94e51068_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzExLTEtMS0xLTA_e0bc6586-aeb3-43a4-b733-be313ff182d5"
      unitRef="usd">29000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie0f8e19fba6a41b68b87ceb41afcceb5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzExLTMtMS0xLTA_ec19f103-d2e2-4d14-bdbc-05a940569b79"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i06fa0c3851d7487d95bc374550545ed5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzExLTUtMS0xLTA_809b0bd8-a678-45f0-8797-62ce73551048"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ifdb8e220321748cea721890a15c24a39_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzExLTctMS0xLTA_c4b64aa6-2ccb-4eed-a136-51ae96a49644"
      unitRef="usd">29000000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEyLTEtMS0xLTE4NTM_3d0395c5-92c3-4762-98a2-61064ce73367"
      unitRef="usd">1975000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia2dfcce27ab44c888f802f59df6a8678_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEyLTMtMS0xLTE4NTM_ab245df5-eb9e-4e48-bc2f-27f0a98f7792"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3ebfad9e8de34bc282edd8a903fd15de_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEyLTUtMS0xLTE4NTM_a2680a62-7429-4237-80b1-1377b2b39d51"
      unitRef="usd">1946000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0f1b6888bbaf41ef9d90d37617270d74_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzEyLTctMS0xLTE4NTM_57748179-03b2-44a1-ab7f-7bd5bc0363e0"
      unitRef="usd">29000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="i445acdb4c3684477acd4591ac4c9235f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE0LTEtMS0xLTA_c13f6ef5-7c5b-409f-ab50-b6825c00d725"
      unitRef="usd">29000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i93e298da77bc4141b95fdec3026f4403_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE0LTMtMS0xLTA_71a70db6-07d9-4ef8-ba7d-1102cc5977f3"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i8db366cd71ed4aed8d17341c92a27bac_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE0LTUtMS0xLTA_fce64e6c-ce0d-4f62-b615-80460a711666"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="icf0aad8ca2a944c285080bae467d9769_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE0LTctMS0xLTA_15060bdb-b56b-4f4c-bf98-160480d6b4dd"
      unitRef="usd">29000000</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE1LTEtMS0xLTE4NTM_33608073-5151-4798-aeb5-486c7e15e2bd"
      unitRef="usd">29000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia2dfcce27ab44c888f802f59df6a8678_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE1LTMtMS0xLTE4NTM_5cf18661-8eae-480b-9892-954e86cdcd56"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3ebfad9e8de34bc282edd8a903fd15de_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE1LTUtMS0xLTE4NTM_6b7509d5-a93f-47f7-9474-c765918df946"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0f1b6888bbaf41ef9d90d37617270d74_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo0Mzk1MTljYmQzOGQ0MDMzODM3OTNlYzc3YjZkZTAzNy90YWJsZXJhbmdlOjQzOTUxOWNiZDM4ZDQwMzM4Mzc5M2VjNzdiNmRlMDM3XzE1LTctMS0xLTE4NTM_8f5d2088-b524-4e6f-84f5-01ce79fab5a5"
      unitRef="usd">29000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5b5f410a090c46058072e3908f0200f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzYwNDczMTM5NjQ2Mzk_3d071f0f-048f-435a-9a9c-7237fdd09e16"
      unitRef="usd">46000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzEyMDk0NjI3OTExMzM5_62fa2050-b32e-42a0-ba23-23a7f99e59ed">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair values and the presentation of our derivative financial instruments in the accompanying consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative asset:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Call Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets: Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Conversion Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities: Accounts payable, accrued liabilities and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i01750e761ae449108d5498ba2a542db0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo5ZTY2N2IwMmM4ODI0OTE1OTQ4ZWMxYTc0MmMyZmI0Yi90YWJsZXJhbmdlOjllNjY3YjAyYzg4MjQ5MTU5NDhlYzFhNzQyYzJmYjRiXzQtMy0xLTEtMTMzMTc_be07a46f-a0bb-4fea-87bb-6f07271571d5"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i169c45e71a6541939a44bc98b6a6744c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo5ZTY2N2IwMmM4ODI0OTE1OTQ4ZWMxYTc0MmMyZmI0Yi90YWJsZXJhbmdlOjllNjY3YjAyYzg4MjQ5MTU5NDhlYzFhNzQyYzJmYjRiXzQtNS0xLTEtNzYzMg_c4dc715c-b7fd-4cfa-8fea-e11bebe9f407"
      unitRef="usd">29000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ifac907d76e3e42f58ad857eb2576f9c8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo5ZTY2N2IwMmM4ODI0OTE1OTQ4ZWMxYTc0MmMyZmI0Yi90YWJsZXJhbmdlOjllNjY3YjAyYzg4MjQ5MTU5NDhlYzFhNzQyYzJmYjRiXzYtMy0xLTEtMTMzMTk_80c49572-c41a-4c0c-990a-872f9fac5d9d"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iee5e05e95b1a426bae4671defcf57905_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTo5ZTY2N2IwMmM4ODI0OTE1OTQ4ZWMxYTc0MmMyZmI0Yi90YWJsZXJhbmdlOjllNjY3YjAyYzg4MjQ5MTU5NDhlYzFhNzQyYzJmYjRiXzYtNS0xLTEtNzYzMg_b4a646de-d343-4d38-ac3b-6956f7ce9629"
      unitRef="usd">29000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzE2NDkyNjc0NDcxOTM_6e025ee7-7bd9-402c-ba4d-78fdc62b04f9"
      unitRef="usd">27000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i01207b776cf34d6d9e20d09853472272_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzE2NDkyNjc0NDcyNjU_3844ca58-4052-41db-a79b-0f5a7b53aa54"
      unitRef="usd">39000000</us-gaap:RepaymentsOfDebt>
    <moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount
      contextRef="i7ae2b394952c4f1e8142cffc59c02e8f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzE2NDkyNjc0NDcyOTU_9d58a327-06a8-4463-b538-19db4f9b1af1"
      unitRef="usd">12000000</moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7ae2b394952c4f1e8142cffc59c02e8f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzExNTQ0ODcyMTAwMDIy_077483fa-80dc-4f92-b2f1-410761ebd78d"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90ZXh0cmVnaW9uOjNmMDRkZjQ2OWJjMjRlNWQ5MDhmODFmYjA3ODY1N2U5XzMzNzU_bf85a2a0-be45-49a1-bebc-cd54c90cfd8f">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.375% Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.375% Notes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.875% Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term Loan Facility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.125% Convertible Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;For more information on debt repayments, refer to Note 11, &#x201c;Debt.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzQtMC0xLTEtNTA4Ny90ZXh0cmVnaW9uOjY0YmRhNTAzNTkxNjQ5ZWQ5YTdjYWU5MmIyOTZjNzYyXzU0OTc1NTgxMzg5MDI_3b360b17-406a-4d98-9962-db0cd0ddc832"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2eae161ddce94e7a9ff33f9b5d6e8751_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzQtMS0xLTEtMTg3NQ_b735dbc4-89cd-4958-b585-205685471372"
      unitRef="usd">789000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i347dbbc9bc8f47e98ec6c35325f9f494_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzQtMy0xLTEtMTg3NQ_f313c917-2557-4150-996d-48c0eadd9dd0"
      unitRef="usd">843000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3f291c050ef34a17be70dc97c24d7607_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzQtNS0xLTEtNTA4Mg_c40581e2-7c2d-484d-b904-b91133c12216"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic488eae93102457d8235e5620bd84f27_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzQtNy0xLTEtNTA4Mg_2242b7c9-12aa-470f-9ebc-abc0d6ad670b"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjE2NzM0ZTYxZDEzMDRjNWQ4MWFjZDViZWQ4YTAyODA3XzU0OTc1NTgxMzg5MDM_534078d7-ba28-4e8c-8a9b-39ce5b87ccda"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if330db6dda754503989d1aee6433ae6c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzUtMS0xLTEtMA_e80bf18a-1d37-405d-9284-4610194cad32"
      unitRef="usd">697000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8c02998f42dd4ce08ba11f14f2a84902_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzUtMy0xLTEtMA_0a069371-c8bf-4cf3-a667-f1a4252c2461"
      unitRef="usd">742000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib544842b96f248be91c9c250b5519403_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzUtNS0xLTEtMA_8b445dae-bb0a-4fc0-af22-9590eb7b2af6"
      unitRef="usd">696000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2e24a47d3dc649d78aba307fc1ad28a5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzUtNy0xLTEtMA_8a609ba2-9d9e-44de-b1c7-2b214ec28f65"
      unitRef="usd">745000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMC0xLTEtNTA4OS90ZXh0cmVnaW9uOjJmMGUyYjNmOThlZDQ0YjY4NGU4NTA4YmNmZjI5YjMzXzU0OTc1NTgxMzg5MDI_55435b9b-c833-47df-80bb-ee345b578771"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1bc3d20ccc074e70bfc86059723e9c9d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMS0xLTEtMTg4MA_af418c52-63db-4153-8e9b-1612e7cad237"
      unitRef="usd">641000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id3f70d3c50d8437b98e3dcf567cac5be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMy0xLTEtMTg4MA_a05b226e-a501-4091-86b9-8d1e92bd9cf5"
      unitRef="usd">691000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i76f180467919400fb5d1a49a30bb070c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtNS0xLTEtNTA4NQ_17dbb49b-1d81-4835-9796-f8b68062b671"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia680941a7dcb4c90a8f6a94a3df241c5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtNy0xLTEtNTA4NQ_3e72df29-6fe9-4fcd-b48d-567bb5c95eb3"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6897a665bfe944c0b1720f8066bd97ce_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMC0xLTEtMC90ZXh0cmVnaW9uOmZjNGVlNzcyOGQ1ODQ3ZTY4MTBjNmU2ODMxNjVjZTU0XzU0OTc1NTgxMzg5MDI_d7c503be-ad51-4b06-a4b7-d6ba9ba345c3"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="icfb7000b50d34cc1ae6870b923bd53f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMS0xLTEtMA_94941775-179c-4619-bbe0-1e6d5a4a8a8a"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8c00276ec6e247479e4d6b157f91a10c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtMy0xLTEtMA_cd2f9982-42bd-48ef-83f5-cf746015f2fb"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iea08d8a8150f424a91d5763de41e3ca2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtNS0xLTEtMA_5afc33e4-348e-4296-9ccb-8337f281743e"
      unitRef="usd">327000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id811eeb6af45438199143b6905407f9f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzYtNy0xLTEtMA_84baeb00-8f06-4955-81df-15da8cbcfd1a"
      unitRef="usd">340000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iac8de3a5e55d44a38a5f28fe244aa185_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzctMS0xLTEtMA_db2d70af-834c-4f3d-803b-799b9fa4fdf3"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie144cacfc85e4897bf8661dd85794604_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzctMy0xLTEtMA_94f6ba6d-8a66-4a50-bbe2-b26944e12aed"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i83cfa0b110a145789605caf934c004c3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzctNS0xLTEtMA_0fb37e88-de70-4dc3-9b67-eb4f1d49e688"
      unitRef="usd">220000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia89aaa5cc1e6416d91ce575532477772_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzctNy0xLTEtMA_62421f46-f87f-4556-bd14-659a5e85ece3"
      unitRef="usd">220000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id63dd203dce74ef786b9059a9384be45_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzktMC0xLTEtNTA5MS90ZXh0cmVnaW9uOjVjNzgwYjMwOTQzODQ1ZjNiODM4OWJhNjhhYzdhMWUxXzU0OTc1NTgxMzg5MTk_d480031b-8cbd-4933-a0c0-77f168541f53"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib6557af215244a238cc88c1fb4cb335f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzgtMS0xLTEtMA_fab39fb8-158f-4251-a7a8-032e5cfaf0ad"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i91288d1537ff4a1cad628bfe99f8ec61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzgtMy0xLTEtMA_2b1eab62-ca9a-41f2-a285-f9fcf65af5b3"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ife6d8824de274a12aafb6c18f80be57d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzgtNS0xLTEtMA_3b0f6488-e38d-46a2-a5e8-ac732bbf8787"
      unitRef="usd">12000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ibdcae3ccabb049d7a79f1464026d3c79_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzgtNy0xLTEtMA_75eb02d5-d678-4d43-a248-2e0f039cbffb"
      unitRef="usd">42000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6e000c4aefc74c68842dcf99d6e91fa4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzktMS0xLTEtMA_36004a54-9e7f-4590-829d-5eec7ec6ead6"
      unitRef="usd">2127000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3cf635a3f8d840cab2a3e2097d60a7cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzktMy0xLTEtMA_e23f8858-3a99-4075-bfd6-6b642b3a704b"
      unitRef="usd">2276000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8b30ecc6f739406885acf51ceed648e0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzktNS0xLTEtMA_82c69020-74b7-43be-92c7-6b2cc3d8ee35"
      unitRef="usd">1255000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib1ef1a869ebc488a81b5bae288c74176_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjMvZnJhZzozZjA0ZGY0NjliYzI0ZTVkOTA4ZjgxZmIwNzg2NTdlOS90YWJsZTozNTExMzVhZDNkMDU0N2RlOTNjNjI1NTNlNDkwZTNhYy90YWJsZXJhbmdlOjM1MTEzNWFkM2QwNTQ3ZGU5M2M2MjU1M2U0OTBlM2FjXzktNy0xLTEtMA_78ef56ff-5333-41d4-8946-2ad22f81dd0d"
      unitRef="usd">1347000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90ZXh0cmVnaW9uOmYzY2VjNjU3OTk2OTQxNzU4NzE0NmVmNWNlMWZhMzYwXzI3NjI_15df2bdc-8f33-4b64-a5b6-ddfdad3a2207">Investments &lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Available-for-Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all of our investments classified as current assets to be available-for-sale. The following tables summarize our current investments as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;GSEs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contractual maturities of our current investments as of December&#160;31, 2020 are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross realized gains and losses from sales of available-for-sale securities are calculated under the specific identification method and are included in investment income. Gross realized investment gains amounted to $6&#160;million and $13 million in the years ended December&#160;31, 2020 and 2019, respectively. Gross realized investment losses were insignificant in the years ended December&#160;31, 2020 and 2019. Gross realized investment gains and losses for the year ended December 31, 2018 were insignificant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have determined that unrealized losses at December&#160;31, 2020 and 2019 primarily resulted from fluctuating interest rates, rather than a deterioration of the creditworthiness of the issuers. Therefore, we determined that an allowance for credit losses was not necessary. So long as we maintain the intent and ability to hold these securities to maturity, we are unlikely to experience losses. In the event that we dispose of these securities before maturity, we expect that realized losses, if any, will be insignificant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes those available-for-sale investments that have been in a continuous loss position for less than 12 months. No investments have been in a continuous loss position for 12 months or more as of December&#160;31, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;In&#160;a&#160;Continuous&#160;Loss Position for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less&#160;than&#160;12&#160;Months as of December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;In&#160;a&#160;Continuous&#160;Loss Position for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less&#160;than&#160;12&#160;Months as of December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Number of Positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Number of Positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Held-to-Maturity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the regulations governing our Health Plans segment&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;subsidiaries, we maintain statutory deposits and deposits required by government authorities primarily in cash, cash equivalents, and U.S. Treasury securities. We also maintain restricted investments as protection against the insolvency of certain capitated providers. The use of these funds is limited as required by regulation in the various states in which we operate, or as needed in the event of insolvency of capitated providers. Therefore, such investments are reported as &#x201c;Restricted investments&#x201d; in the accompanying consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have the ability to hold these restricted investments until maturity, and as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. Our held-to-maturity restricted investments are carried at amortized cost, which approximates fair value, of which $134&#160;million will mature in one year or less, and $2&#160;million will mature in after one through five years. The following table presents the balances of restricted investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New York&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ohio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Health Plans segment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90ZXh0cmVnaW9uOmYzY2VjNjU3OTk2OTQxNzU4NzE0NmVmNWNlMWZhMzYwXzI3Nzg_f95aac53-54a2-41fd-a8a6-45b6d5acd6cd">The following tables summarize our current investments as of the dates indicated:&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;GSEs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzQtMS0xLTEtMA_e46705f6-02ad-44c4-9454-a5f99e43dadc"
      unitRef="usd">1220000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzQtMy0xLTEtMA_5d400bcb-1060-4741-ae38-3e2b39dd176d"
      unitRef="usd">36000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzQtNS0xLTEtMA_1a36a424-c1ad-4570-be72-fd6f799ef619"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzQtNy0xLTEtMA_829a4b6f-eb84-4991-83e3-fda79de297c5"
      unitRef="usd">1256000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzUtMS0xLTEtMA_8eaece6a-7b19-4803-b75b-17ccacafdd22"
      unitRef="usd">383000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzUtMy0xLTEtMA_092ded28-b71a-47f4-afc9-7e4ec35bdd27"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzUtNS0xLTEtMA_4dc95bd7-8b4c-4661-9091-c528e6c3685c"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzUtNy0xLTEtMA_cf2cb43f-38e3-4251-805a-715bd39715fd"
      unitRef="usd">392000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if330308388ae40ac9a6862c3c5bacd95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzYtMS0xLTEtMA_1fba3a85-16ea-4456-be87-26e524e3faf2"
      unitRef="usd">130000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if330308388ae40ac9a6862c3c5bacd95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzYtMy0xLTEtMA_61be6213-4a69-422d-a8dc-bbb0be6c187d"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if330308388ae40ac9a6862c3c5bacd95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzYtNS0xLTEtMA_59a6066a-f0c2-43b4-8d6b-0d52e16b6b5f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if330308388ae40ac9a6862c3c5bacd95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzYtNy0xLTEtMA_f384f7bd-74f5-4501-9ec0-ff00a80f1bad"
      unitRef="usd">132000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i11c3150f158849b7981e3f9bd3362f4e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzctMS0xLTEtMA_f0e643a1-eb0e-4304-a8e7-6559ce59f8e1"
      unitRef="usd">66000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i11c3150f158849b7981e3f9bd3362f4e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzctMy0xLTEtMA_eb9868b3-0362-4352-8d6e-210bfbb11e22"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i11c3150f158849b7981e3f9bd3362f4e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzctNS0xLTEtMA_498b80d7-54c1-4d74-aed4-562ea1de99ec"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i11c3150f158849b7981e3f9bd3362f4e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzctNy0xLTEtMA_47d05a62-ce9a-49b6-b876-47f2d74cc382"
      unitRef="usd">68000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1248d546adf44c31b8e4c83bc5671814_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzktMS0xLTEtMA_f2105370-a198-4bde-8690-83deb3f93516"
      unitRef="usd">27000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1248d546adf44c31b8e4c83bc5671814_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzktMy0xLTEtMA_3a7b5a4d-dcf9-48ec-b562-9f8ab1986333"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1248d546adf44c31b8e4c83bc5671814_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzktNS0xLTEtMA_eebe6559-cd04-4683-82a4-b6656ae8fff2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1248d546adf44c31b8e4c83bc5671814_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzktNy0xLTEtMA_b1ec155a-3085-40f7-8982-3907f900784f"
      unitRef="usd">27000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzEyLTEtMS0xLTIyNzg_6b2b9750-0231-4263-a6d0-256725394d0f"
      unitRef="usd">1826000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzEyLTMtMS0xLTIyNzg_da15f280-87fe-4eb6-9e14-c05cee1b5251"
      unitRef="usd">50000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzEyLTUtMS0xLTIyNzg_8f08277c-d0f4-4582-82c6-74d246a19d14"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTpkZjdlMmVjODc2MjM0MmEwOWU1YTc0YzkyMmQ1MDA4NS90YWJsZXJhbmdlOmRmN2UyZWM4NzYyMzQyYTA5ZTVhNzRjOTIyZDUwMDg1XzEyLTctMS0xLTIyNzg_de248fd3-9115-4ff3-ba35-6adf0fb579d2"
      unitRef="usd">1875000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzQtMS0xLTEtMA_373af3a8-b5d0-4fa9-9885-01ac38a357ec"
      unitRef="usd">1174000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzQtMy0xLTEtMA_72c44909-085a-49de-beba-92b2e72e0ab5"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzQtNS0xLTEtMA_85a4fe1c-8fe5-46a8-9ce1-6d26506a7176"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzQtNy0xLTEtMA_8b42b0f8-d909-4ec3-a63a-db7f31f60954"
      unitRef="usd">1178000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzUtMS0xLTEtMjI4NQ_b158c985-4d31-44f2-bb7f-f4a96dce01f1"
      unitRef="usd">420000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzUtMy0xLTEtMjI4NQ_e8770641-460e-416e-86ca-24cd60e296ed"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzUtNS0xLTEtMjI4NQ_041b8e61-984d-498b-bdf4-ec37b41cec7b"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzUtNy0xLTEtMjI4NQ_6c2a39c6-3ccb-472d-9c66-2cb5703e3424"
      unitRef="usd">420000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ida3322a79f8149fe818ac4b37b7f1c22_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzYtMS0xLTEtMA_3bad8ba6-5774-4290-ac10-3cb1ccef851a"
      unitRef="usd">126000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ida3322a79f8149fe818ac4b37b7f1c22_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzYtMy0xLTEtMA_44139937-c37a-4c3c-8d14-0fadd3c53030"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ida3322a79f8149fe818ac4b37b7f1c22_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzYtNS0xLTEtMA_906f9423-fed8-4e39-8737-444d68bcbf67"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ida3322a79f8149fe818ac4b37b7f1c22_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzYtNy0xLTEtMA_154d71ad-4d35-46dd-9561-430c9c0fc23b"
      unitRef="usd">127000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4c4f690f2e3741049e287513d54671cc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzctMS0xLTEtMA_53eaa8ad-5d94-41df-815e-9a4e0893c34b"
      unitRef="usd">78000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4c4f690f2e3741049e287513d54671cc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzctMy0xLTEtMA_d63feb7e-8066-4f81-b7fa-2714a1aa33b4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4c4f690f2e3741049e287513d54671cc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzctNS0xLTEtMA_7a60bc4f-3500-41b3-95b4-7d5c6b65e927"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4c4f690f2e3741049e287513d54671cc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzctNy0xLTEtMA_5037a925-94f4-464a-8956-d923acad9505"
      unitRef="usd">78000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1662ee2010e44146a4d125c47e8f6ba3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzgtMS0xLTEtMA_41be82ea-0308-462c-a901-c47eae2122d8"
      unitRef="usd">86000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1662ee2010e44146a4d125c47e8f6ba3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzgtMy0xLTEtMA_664a3b25-0d4b-48c6-be14-dea8e47e5ea4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1662ee2010e44146a4d125c47e8f6ba3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzgtNS0xLTEtMA_7a8ceaaa-4e73-4f84-9d8d-1d15d9d216dc"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1662ee2010e44146a4d125c47e8f6ba3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzgtNy0xLTEtMA_0866f52e-22df-4803-8a17-ec6d171056ba"
      unitRef="usd">86000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6471a4d8ab49424e8b4300ddd8991da5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzktMS0xLTEtMA_75af4ca7-f015-4330-b741-f5c8694ea336"
      unitRef="usd">49000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6471a4d8ab49424e8b4300ddd8991da5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzktMy0xLTEtMA_6044140e-db8c-40e9-9333-c05f851817dc"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6471a4d8ab49424e8b4300ddd8991da5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzktNS0xLTEtMA_59dad7b6-5a2f-4532-9952-0c1fa4dae79e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6471a4d8ab49424e8b4300ddd8991da5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzktNy0xLTEtMA_b86ee5a6-95cb-4343-86cd-760527522237"
      unitRef="usd">49000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEwLTEtMS0xLTA_a80a9a22-8493-4647-a955-8f7fd33eed8f"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEwLTMtMS0xLTA_414e4121-ae6d-43ad-93f3-897d91c40b57"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEwLTUtMS0xLTA_c843f7a8-68e2-4bc2-b9e1-b8cab5ad24b1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i05df4c3fcc114194a1ec7b544d5c6bae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEwLTctMS0xLTA_a73ea042-780f-4df4-932b-c2bb41d238c1"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib7fe95986da143f49cb9ff1cd45fb414_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzExLTEtMS0xLTA_b4c0baad-a38b-45f7-98d8-8049e6b0e12c"
      unitRef="usd">7000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib7fe95986da143f49cb9ff1cd45fb414_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzExLTMtMS0xLTA_a620dba2-60a8-4a0a-bc1a-39824a221ebc"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib7fe95986da143f49cb9ff1cd45fb414_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzExLTUtMS0xLTA_db550d08-3cbc-4b0e-affd-467f990c0601"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib7fe95986da143f49cb9ff1cd45fb414_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzExLTctMS0xLTA_1e1a15eb-67f6-448e-a987-f07c91318387"
      unitRef="usd">7000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEyLTEtMS0xLTA_ca785132-8dcd-4476-bfe1-1417ecbf35d8"
      unitRef="usd">1941000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEyLTMtMS0xLTA_e96b655e-bbfd-4567-be4b-1ba6f1634014"
      unitRef="usd">7000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEyLTUtMS0xLTA_d5434e97-48c2-40e8-8fb8-233f33d2238c"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo0N2NjNDkyOGE2MDc0MmVmYjg5MGM0Mjc0MDNjZmFmMC90YWJsZXJhbmdlOjQ3Y2M0OTI4YTYwNzQyZWZiODkwYzQyNzQwM2NmYWYwXzEyLTctMS0xLTA_fdf16e96-b07c-462f-a807-d926d7ae2c56"
      unitRef="usd">1946000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90ZXh0cmVnaW9uOmYzY2VjNjU3OTk2OTQxNzU4NzE0NmVmNWNlMWZhMzYwXzI3NjA_98f42aec-2a98-4762-9cec-456d6ae83671">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contractual maturities of our current investments as of December&#160;31, 2020 are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzItMS0xLTEtMA_6c301e96-0018-4c53-a45f-12a0256a295f"
      unitRef="usd">474000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzItMy0xLTEtMA_bc3594eb-ae5d-4a44-b890-b239ab753e76"
      unitRef="usd">475000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzMtMS0xLTEtMA_b1fe011e-953f-458f-af37-35d0e2d1e85c"
      unitRef="usd">892000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzMtMy0xLTEtMA_3acc2c38-b820-42de-ba2b-ad6bda80a2d2"
      unitRef="usd">926000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzQtMS0xLTEtMA_170da89a-c9ec-4741-96e6-2bbe11ebbedc"
      unitRef="usd">132000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzQtMy0xLTEtMA_76adee10-21f8-4ac9-9a28-19aaa78d7abb"
      unitRef="usd">137000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzUtMS0xLTEtMA_6c04f5b1-3df9-45d0-b5af-743ef0555e3f"
      unitRef="usd">328000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzUtMy0xLTEtMA_17b62ece-7e42-4041-965d-f491e72c1a28"
      unitRef="usd">337000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzYtMS0xLTEtMA_3541c5bf-cc62-43bc-82d3-99629a01f812"
      unitRef="usd">1826000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90YWJsZTo5YTBmNzNiMzhkZWI0YzIxOGU5NzM2NjExMjdlMzdhNS90YWJsZXJhbmdlOjlhMGY3M2IzOGRlYjRjMjE4ZTk3MzY2MTEyN2UzN2E1XzYtMy0xLTEtMA_9e566cd5-e838-4dcf-88d2-d95a08bcb427"
      unitRef="usd">1875000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90ZXh0cmVnaW9uOmYzY2VjNjU3OTk2OTQxNzU4NzE0NmVmNWNlMWZhMzYwXzEwOTk1MTE2MzMyNzA_5cf7704e-e2e9-4101-9f27-44c00e29f2b0"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNjkvZnJhZzpmM2NlYzY1Nzk5Njk0MTc1ODcxNDZlZjVjZTFmYTM2MC90ZXh0cmVnaW9uOmYzY2VjNjU3OTk2OTQxNzU4NzE0NmVmNWNlMWZhMzYwXzUyMw_324c4586-3d30-44be-acbc-505272138eb5"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGV4dHJlZ2lvbjozMDQ2ODNhMDgzNTg0MDNlYmRiZjdmY2Q4NGU2NDMxN18xMzE5NDEzOTUzMzU1OA_09ef5818-2dac-4e38-9fe3-ad5444783fae">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes those available-for-sale investments that have been in a continuous loss position for less than 12 months. No investments have been in a continuous loss position for 12 months or more as of December&#160;31, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;In&#160;a&#160;Continuous&#160;Loss Position for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less&#160;than&#160;12&#160;Months as of December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;In&#160;a&#160;Continuous&#160;Loss Position for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less&#160;than&#160;12&#160;Months as of December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Number of Positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Number of Positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTEtMS0xLTc1MTY_6cfee3c0-46a6-477b-b401-b536fda5e8e3"
      unitRef="usd">77000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTMtMS0xLTc1MTY_4dbf21c4-3fa5-4b47-bf2a-3da5487190bf"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i6b943f0f64434a0f929fc2bd7c07c4be_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTUtMS0xLTc1MTY_dee39589-581c-41f5-9fee-800577f77537"
      unitRef="security">21</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTctMS0xLTc1MTY_421f1963-38d9-45ff-8b81-b726c373acb2"
      unitRef="usd">143000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTktMS0xLTc1MTY_c3e589e1-469f-4b62-8ebf-b0b1799298cd"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="if6b1b9c15fe24bcea302eea32219b2dc_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8zLTExLTEtMS03NTE2_bfe0b512-5e45-4c0e-a040-3ea3d3573eea"
      unitRef="security">72</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTEtMS0xLTc1MTY_e322df21-ac0c-4a8b-8891-99157459446e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTMtMS0xLTc1MTY_1adc1379-af81-4c6a-b365-3d67e38b4b0c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i722c9c386c5745aa9a967036f8eff284_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTUtMS0xLTc1MTY_c9646e8c-a8e7-4848-8bd5-e5862cc96914"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTctMS0xLTc1MTY_8ba4dffa-af49-4a91-827d-fbbd9b5a2290"
      unitRef="usd">222000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTktMS0xLTc1MTY_a21c78b3-0672-4610-bbc1-df876ea72239"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i3b0143db7f344f8ca8d09c528fa76f93_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl80LTExLTEtMS03NTE2_9346e569-e455-4e23-b3f9-0cb89899f01e"
      unitRef="security">167</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS0xLTEtMS03NTE2_c6e566c7-0159-4a1a-bef3-d4323fc140b6"
      unitRef="usd">77000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS0zLTEtMS03NTE2_56f862d3-7827-4c59-ad01-a595fb10005f"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS01LTEtMS03NTE2_938afaba-d374-47bf-b72e-424c84d41c90"
      unitRef="security">21</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS03LTEtMS03NTE2_1fd0e922-f7e8-4f56-801a-b7baed5c64b2"
      unitRef="usd">365000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS05LTEtMS03NTE2_99cf69ce-0856-4154-831d-c28eb8755e6a"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkxL2ZyYWc6MzA0NjgzYTA4MzU4NDAzZWJkYmY3ZmNkODRlNjQzMTcvdGFibGU6ZTEwMWY5NDU4ZTZhNDhiY2EyNGNjMzMxNTQwN2FmMGIvdGFibGVyYW5nZTplMTAxZjk0NThlNmE0OGJjYTI0Y2MzMzE1NDA3YWYwYl8xMS0xMS0xLTEtNzUxNg_752d799a-1c4d-4b2b-814f-c6abdd8645de"
      unitRef="security">239</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGV4dHJlZ2lvbjo1OTAzZGQ2OTg0N2Y0NzY0OGFiNmJkZmIyYzM5NGFlNl8xMDk5NTExNjI4OTYx_9d2c2239-21ea-4972-85f4-dc0f66201cae"
      unitRef="usd">134000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGV4dHJlZ2lvbjo1OTAzZGQ2OTg0N2Y0NzY0OGFiNmJkZmIyYzM5NGFlNl8xMDk5NTExNjI4OTc1_e2c64896-e125-45d1-9673-9922cc52b158"
      unitRef="usd">2000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount>
    <moh:RestrictionsOnInvestmentsTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGV4dHJlZ2lvbjo1OTAzZGQ2OTg0N2Y0NzY0OGFiNmJkZmIyYzM5NGFlNl8xMzE5NDEzOTUzNDQwMw_10de7b5d-502b-4237-8634-25708e756963">The following table presents the balances of restricted investments:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New York&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ohio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Health Plans segment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</moh:RestrictionsOnInvestmentsTableTextBlock>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="ia61210df5ac84ab7ad7f93c5f4e1bc4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV80LTEtMS0xLTc0NzY_422e661a-bf59-4e0a-a29d-c7d815004616"
      unitRef="usd">12000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="i0251b790bfc84ca9901e5dec4b2e552c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV80LTMtMS0xLTc0NzY_6bbeb0bc-fbcb-4531-93be-3aae17911de7"
      unitRef="usd">12000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="ib3900f99d76c4cb088f0ec753bdfe4ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV83LTEtMS0xLTc0NzY_211c145d-90dc-45c5-af79-7c3c07e988b2"
      unitRef="usd">21000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="i6e08cf3843ee433da07c69c76c66c194_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV83LTMtMS0xLTc0NzY_e4217823-3ad5-48a1-8c5f-50355c47c26a"
      unitRef="usd">21000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="i709876b469e94acf8f45ce2cc1c0ac99_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV85LTEtMS0xLTE1MzAw_f8b4d97d-cb67-4d66-a456-cc93e4281722"
      unitRef="usd">14000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="i0be8dd8b617b44a2b44ea2ff3f0f2d73_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV85LTMtMS0xLTE1MzA1_20e32c0e-7e8e-4599-982c-e1f7c9c24d08"
      unitRef="usd">9000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="ib4ce85ece03c4fd596e2b5d2647de430_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV85LTEtMS0xLTc0NzY_39f139bb-c2ff-4ab1-9b64-962811d77f63"
      unitRef="usd">16000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="i36836d1ebed34cdb88ec412d28f3f1ab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV85LTMtMS0xLTc0NzY_031e2566-6f3f-4555-b50e-58048ff16f5f"
      unitRef="usd">12000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="i83d73631ecf445f48b591cb49c5daf0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNC0xLTEtMS03NDc2_d1387a5f-de4c-4ef2-9b7c-f899ded51d1c"
      unitRef="usd">24000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="ia5bb7caa6db34dff90cd3316865e8139_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNC0zLTEtMS03NDc2_7dafa779-f47d-4bf8-9650-b161862e8e2b"
      unitRef="usd">25000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="id9d2df1abcb045c4a451a671e263475d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNS0xLTEtMS0xNDU3MA_db621dc2-e836-4cb7-a181-4fc4da2f6799"
      unitRef="usd">49000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="i22a6ede7687e4ab8b717166f0bb9a215_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNS0zLTEtMS0xNDU3MQ_1d67b39e-7e08-4adb-a179-789fbddde70d"
      unitRef="usd">0</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNS0xLTEtMS03NDc2_1a0455a5-301c-435b-b5d7-d224815c82fc"
      unitRef="usd">136000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjk4L2ZyYWc6NTkwM2RkNjk4NDdmNDc2NDhhYjZiZGZiMmMzOTRhZTYvdGFibGU6ZmY0ZmY4NGE2N2NkNDcxNzlkMDAzZTAxYmY3M2NjMDUvdGFibGVyYW5nZTpmZjRmZjg0YTY3Y2Q0NzE3OWQwMDNlMDFiZjczY2MwNV8xNS0zLTEtMS03NDc2_d9c5c844-d35e-4db1-81dd-94c3a4c52c37"
      unitRef="usd">79000000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5Xzg4NA_36737c23-5df1-47dd-b0b1-412705682511">Property, Equipment, and Capitalized Software, Net Property and equipment are stated at historical cost. Replacements and major improvements are capitalized, and repairs and maintenance are charged to expense as incurred. Software developed for internal use is capitalized. Furniture and equipment are generally depreciated using the straight-line method over estimated useful lives ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzU0OTc1NTgxMzk3OTA_0da1da73-4926-4eb9-bdb8-ab2cd7f10bb6"&gt;three&lt;/span&gt; to seven years. Software is generally amortized over its estimated useful life of three years. Leasehold improvements are amortized over the term of the lease, or over their useful lives from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzUzOA_e80b42ea-bec2-44ee-9782-16517f1bf477"&gt;five&lt;/span&gt; to 10&#160;years, whichever is shorter. Buildings are depreciated over their estimated useful lives of 31.5 to 40&#160;years.&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of property, equipment, and capitalized software is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization - capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;padding-right:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization - furniture, equipment, building, and improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ROU assets - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, equipment, and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents all depreciation and amortization recognized in our consolidated statements of income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recorded in depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of furniture, equipment, building, and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recorded in cost of service revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of capitalized software and deferred contract costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i15fb3622b8d3400b91bfd0af1a0403f4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzMxNQ_2d593b43-805a-4e12-96d5-a4074f316b4b">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1570351e39be47e894e41c5bc71b785f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzQzNw_e733a7f9-cb2a-4bf7-b67a-d3d069b5416e">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i28c21a0ce6c540ada2399b7535c810c3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzU0NA_927ebd8f-1d7c-45d0-94fc-02e83a1d286c">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i78a27e51a7f04cb99838d4b8e20f08b7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzYzOQ_4156458b-535d-4512-815d-92c6be385b33">P31Y6M</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2c544b48981f4cdd80e392c5b90a7935_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzY0NQ_b5087f58-8b44-48c6-b99d-0641e1ced28e">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5Xzg3Mg_23f0872a-edd1-4b1b-be9e-cee6d078a74b">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of property, equipment, and capitalized software is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization - capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;padding-right:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization - furniture, equipment, building, and improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ROU assets - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, equipment, and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents all depreciation and amortization recognized in our consolidated statements of income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recorded in depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of furniture, equipment, building, and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recorded in cost of service revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of capitalized software and deferred contract costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6b70afc8228d42e2bf32567a3f21f342_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzMtMS0xLTEtMA_7726f178-f11a-4e5d-b8e6-222b77dce66a"
      unitRef="usd">475000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia3c9a83c837e4ca1bcccd5809c8e0fb1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzMtMy0xLTEtMA_f7195df8-e5f7-4b47-8d5b-556e9a93ce50"
      unitRef="usd">421000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id064c81564b14be391016eff3d91eb4e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzQtMS0xLTEtMA_355c03a8-0a24-4131-8547-9f8285f9595c"
      unitRef="usd">221000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5a2dc6980ae14fe8a3654f7ca74e4f2f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzQtMy0xLTEtMA_4b81d4ac-220e-488a-8cc5-710147a2fb91"
      unitRef="usd">213000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib23e7d7b485a4481833c3bac81769de4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzUtMS0xLTEtMA_05a43785-a4b6-4520-98dd-5c9c9497b223"
      unitRef="usd">49000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2a95ccf41eba4147ba12e954b58ab8ab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzUtMy0xLTEtMA_650303bc-221a-4c8b-b9eb-0fcc939739f0"
      unitRef="usd">49000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib808ff3f56ce4af1ba94833304546a52_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzYtMS0xLTEtMA_f492afee-7791-49b0-bf35-f0705f8cd498"
      unitRef="usd">4000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ida59b5bf5dbb43f1bf41bc98cba8b6a9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzYtMy0xLTEtMA_1df6e6f9-67d3-4f08-8cb4-9841cc5af40a"
      unitRef="usd">4000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia1df2247780e463a9f7026841ac4a307_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzctMS0xLTEtMTAwNjQ_d572b8ca-c8f3-4d00-bd28-228205478243"
      unitRef="usd">3000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i966b162be69a4b1b9e916931cc469f10_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzctMy0xLTEtMTAwNjQ_8e6d081b-9fcb-4cf3-99e4-4ad15610ca0a"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzctMS0xLTEtMA_1a5fee17-e7c5-4961-a8ba-df19e203f591"
      unitRef="usd">752000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzctMy0xLTEtMA_acaabc87-3b80-466e-b2ab-9a1f0f153b57"
      unitRef="usd">687000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzgtMS0xLTEtMA_3aaa17f7-6a63-437a-b24f-92640d7df6f0"
      unitRef="usd">385000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzgtMy0xLTEtMA_8d58a5c4-5080-429f-9963-a0392e77d129"
      unitRef="usd">351000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzktMS0xLTEtMA_0cebe465-ee2b-45c9-b864-58772641dab9"
      unitRef="usd">192000000</us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzktMy0xLTEtMA_845d0100-c567-4cf6-81bc-9d14278ab29b"
      unitRef="usd">179000000</us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzEwLTEtMS0xLTA_ab9fb71f-a954-4a70-af6a-bb64cbf8baff"
      unitRef="usd">577000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzEwLTMtMS0xLTA_e9814c99-b895-4922-af6b-424644c45c0a"
      unitRef="usd">530000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzExLTEtMS0xLTA_ef18029e-6a39-4429-8a34-c7de5cbe1d7e"
      unitRef="usd">216000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzExLTMtMS0xLTA_3e69da24-ec88-4348-813a-d9e150ce72cb"
      unitRef="usd">228000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzEyLTEtMS0xLTA_35b60fd8-0814-4ba7-929b-376f08f01a43"
      unitRef="usd">391000000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZTozNmQyMjkyZWFlYTU0Njg2Yjc3Njg5YzZiY2I0N2NkYy90YWJsZXJhbmdlOjM2ZDIyOTJlYWVhNTQ2ODZiNzc2ODljNmJjYjQ3Y2RjXzEyLTMtMS0xLTA_f5686206-4952-4260-aed5-75c03e92b1f6"
      unitRef="usd">385000000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <moh:DepreciationAndAmortizationOfCapitalizedSoftware
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzQtMS0xLTEtMA_e569a82c-181a-412f-9c4b-07d87eb05c49"
      unitRef="usd">38000000</moh:DepreciationAndAmortizationOfCapitalizedSoftware>
    <moh:DepreciationAndAmortizationOfCapitalizedSoftware
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzQtMy0xLTEtMA_f8cee65c-ad8a-4db6-8637-239404d4e3f1"
      unitRef="usd">33000000</moh:DepreciationAndAmortizationOfCapitalizedSoftware>
    <moh:DepreciationAndAmortizationOfCapitalizedSoftware
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzQtNS0xLTEtMA_b24ab6ad-9bcc-4761-807e-280a50a2618f"
      unitRef="usd">42000000</moh:DepreciationAndAmortizationOfCapitalizedSoftware>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtMS0xLTEtMTY5Mjc_4ae87c30-fdc2-4f36-968f-269bd158c6c6"
      unitRef="usd">19000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtMy0xLTEtMTY5Mjc_349ff4ca-3802-4db5-9128-476f03197b41"
      unitRef="usd">17000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtNS0xLTEtMTY5Mjc_78258a6c-8572-4345-80a1-79b30f57c1c8"
      unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:Depreciation
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtMS0xLTEtMA_75d5d7a3-96d2-42c7-b3eb-df6358404258"
      unitRef="usd">16000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtMy0xLTEtMA_8d0a37c3-4001-4e34-96e7-881f70daadd4"
      unitRef="usd">21000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzUtNS0xLTEtMA_2b55bf79-9069-4ff6-97e4-7a54dd3156c2"
      unitRef="usd">36000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzYtMS0xLTEtMA_bda9fbbf-c3c6-43eb-8ad1-2faab6e0f9b6"
      unitRef="usd">15000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzYtMy0xLTEtMA_1eaf4e2a-70f3-4e74-a14a-333ed78fa261"
      unitRef="usd">18000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzYtNS0xLTEtMA_c1036da9-3db5-43cd-9cde-63d802d9d757"
      unitRef="usd">21000000</us-gaap:AmortizationOfIntangibleAssets>
    <moh:DepreciationandAmortizationContinuingOperations
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzgtMS0xLTEtMA_5c8ee27c-d8fe-4f3a-ae54-ed2dc33c21c2"
      unitRef="usd">88000000</moh:DepreciationandAmortizationContinuingOperations>
    <moh:DepreciationandAmortizationContinuingOperations
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzgtMy0xLTEtMA_ef09cfe4-8475-4f4d-b82c-14d35bd0556f"
      unitRef="usd">89000000</moh:DepreciationandAmortizationContinuingOperations>
    <moh:DepreciationandAmortizationContinuingOperations
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzgtNS0xLTEtMA_0cf64ca6-1b6b-47b1-80cd-23110e09b219"
      unitRef="usd">99000000</moh:DepreciationandAmortizationContinuingOperations>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzEwLTEtMS0xLTA_738163ca-ab4c-4053-91c5-e7d6d35e65a9"
      unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzEwLTMtMS0xLTA_a0ab6f08-6953-42cb-9ef1-1bd55b80ec79"
      unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzEwLTUtMS0xLTA_ef954453-f0b0-42db-a1b1-3bbae41c637b"
      unitRef="usd">28000000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzExLTEtMS0xLTA_4e211b9c-4383-487f-b856-a02b55e1f137"
      unitRef="usd">88000000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzExLTMtMS0xLTA_2732acfe-fd77-4e6d-b946-14b6278e78c5"
      unitRef="usd">89000000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90YWJsZToyYTc2YzY1MzNlMjU0M2U4YTBiMjE4MjQzNmUyZTMzZS90YWJsZXJhbmdlOjJhNzZjNjUzM2UyNTQzZThhMGIyMTgyNDM2ZTJlMzNlXzExLTUtMS0xLTA_c0b6250b-0749-4e48-b4dc-c5180fb2c4f0"
      unitRef="usd">127000000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDU_9b7a6778-3685-4458-9661-f026cec05a01">Leases &lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a party to operating and finance leases primarily for our corporate and health plan offices. Our operating leases have remaining lease terms up to 8 years, some of which include options to extend the leases for up to 10 years. As of December&#160;31, 2020, the weighted average remaining operating lease term is 4 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our finance leases have remaining lease terms of 1 year to 18 years, some of which include options to extend the leases for up to 25 years. As of December&#160;31, 2020, the weighted average remaining finance lease term is 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the weighted-average discount rate used to compute the present value of lease payments was 5.2% for operating lease liabilities, and 6.5% for finance lease liabilities. The components of lease expense for the years ended December 31, 2020, and 2019, are presented in the following table. Rental expense related to operating leases amounted to $62 million for the year ended December 31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease expense: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental consolidated cash flow information related to leases follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash used in financing activities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ROU assets recognized in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases, including location of amounts reported in the accompanying consolidated balance sheets, follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets - Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, equipment, and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:92.25pt;text-indent:-76.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal - undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDY_b639fbe8-abf2-4e06-a121-bf10d501bef9">Leases &lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a party to operating and finance leases primarily for our corporate and health plan offices. Our operating leases have remaining lease terms up to 8 years, some of which include options to extend the leases for up to 10 years. As of December&#160;31, 2020, the weighted average remaining operating lease term is 4 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our finance leases have remaining lease terms of 1 year to 18 years, some of which include options to extend the leases for up to 25 years. As of December&#160;31, 2020, the weighted average remaining finance lease term is 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the weighted-average discount rate used to compute the present value of lease payments was 5.2% for operating lease liabilities, and 6.5% for finance lease liabilities. The components of lease expense for the years ended December 31, 2020, and 2019, are presented in the following table. Rental expense related to operating leases amounted to $62 million for the year ended December 31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease expense: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental consolidated cash flow information related to leases follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash used in financing activities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ROU assets recognized in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases, including location of amounts reported in the accompanying consolidated balance sheets, follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets - Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, equipment, and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:92.25pt;text-indent:-76.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal - undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzE2Nw_066afa1b-6eac-4c8b-8935-ca912882e201">P8Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzIzOA_3a2466eb-9d1c-48fa-b6c1-b315a9b93568">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzE2NDkyNjc0NDI4Mjc_884acfee-1160-4193-9853-0f265abdaa6e">P4Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:LesseeFinanceLeaseRemainingLeaseTerm
      contextRef="idd31c651704242e2a915e56d0e9febd4_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzM2Nw_3faa041e-ca4a-4a1f-abd5-672183860fdd">P1Y</us-gaap:LesseeFinanceLeaseRemainingLeaseTerm>
    <us-gaap:LesseeFinanceLeaseRemainingLeaseTerm
      contextRef="i9831a12c6edb4660aade4906b3716c8c_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzM3OQ_eec02890-d772-4497-b129-5fdbf36b8930">P18Y</us-gaap:LesseeFinanceLeaseRemainingLeaseTerm>
    <us-gaap:LesseeFinanceLeaseRenewalTerm1
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzQ1MA_317c50f5-bf53-48b8-8a22-60e77abf9bb1">P25Y</us-gaap:LesseeFinanceLeaseRenewalTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzUyMw_0e96b5cf-c64d-44d2-b865-20f4db4498d2">P15Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzYzNA_695ebce0-73e9-4e6d-874c-0fade91ab1f2"
      unitRef="number">0.052</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzY3NA_2a78d72d-b01c-4ad2-ae99-7b1b774a0f02"
      unitRef="number">0.065</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDc_baf7cbf3-0809-4d45-bb07-226ea892907f">The components of lease expense for the years ended December 31, 2020, and 2019, are presented in the following table. Rental expense related to operating leases amounted to $62 million for the year ended December 31, 2018.&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease expense: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental consolidated cash flow information related to leases follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash used in financing activities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ROU assets recognized in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzYwNDczMTM5NTQ1NDc_692353fc-dc22-4588-a9e1-cac2d9bd9888"
      unitRef="usd">62000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseCost
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzMtMy0xLTEtMA_d89467ce-68ab-4261-9336-01135ff929e1"
      unitRef="usd">28000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzMtNS0xLTEtNTM4Mw_0e6eda61-a9c0-4634-b52d-3abe9135791b"
      unitRef="usd">34000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzYtMy0xLTEtMA_145d1cee-8aa4-425e-9d99-43f62b712daf"
      unitRef="usd">19000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzYtNS0xLTEtNTM4Mw_01734d6e-d117-4f8e-b012-3f9854fb0faf"
      unitRef="usd">17000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzctMy0xLTEtMA_09639574-a8b1-4273-a71d-354e35d88546"
      unitRef="usd">15000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzctNS0xLTEtNTM4Mw_9b643261-dd00-4557-bf2e-3d8e4214f793"
      unitRef="usd">15000000</us-gaap:FinanceLeaseInterestExpense>
    <moh:FinanceLeaseCost
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzgtMy0xLTEtMA_703f715d-0898-471a-b775-a1f51d235401"
      unitRef="usd">34000000</moh:FinanceLeaseCost>
    <moh:FinanceLeaseCost
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTplNGZhNTY0MTc1YTU0NjU5OWFkM2IwNjEwYTBjNjQ3ZS90YWJsZXJhbmdlOmU0ZmE1NjQxNzVhNTQ2NTk5YWQzYjA2MTBhMGM2NDdlXzgtNS0xLTEtNTM4Mw_1cea7f4c-5b64-4150-a38c-ecb2124177dd"
      unitRef="usd">32000000</moh:FinanceLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzQtMS0xLTEtMA_9a8fd17d-fec9-4886-aaf4-cd2389bc2b34"
      unitRef="usd">30000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzQtMy0xLTEtNTM4Nw_bdc8c9f6-1b5e-4bd0-909b-d77be722b3cb"
      unitRef="usd">36000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzUtMS0xLTEtMA_b77d705c-69a3-45e1-b29e-0437cbad2982"
      unitRef="usd">15000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzUtMy0xLTEtNTM4Nw_cc836e4e-08b3-4b97-916d-9d0b781886d6"
      unitRef="usd">15000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzctMS0xLTEtMA_d8a84762-0318-4f89-9068-6e5932f7dbf2"
      unitRef="usd">9000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzctMy0xLTEtNTM4Nw_69486641-6a25-49a3-a86a-b0ae9a0d0ae3"
      unitRef="usd">6000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzktMS0xLTEtMA_0d45f6b5-4885-43d8-80a9-e41c8bfdf2d7"
      unitRef="usd">28000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzktMy0xLTEtNTM4Nw_d6429c5d-9980-4547-982c-7e5fe800b793"
      unitRef="usd">99000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzEwLTEtMS0xLTA_9e0a4edb-c764-4bcf-9c74-e12d48dd1293"
      unitRef="usd">7000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpmMzEzNzZmNDM3NTg0OWExYTBmNDIxNjkxOTMyY2Q2Ni90YWJsZXJhbmdlOmYzMTM3NmY0Mzc1ODQ5YTFhMGY0MjE2OTE5MzJjZDY2XzEwLTMtMS0xLTUzODc_929bf5a7-b085-43ec-9912-dbc4976d0f43"
      unitRef="usd">245000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <moh:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDI_0e121711-03a9-425f-b84e-9f6521f2689a">&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases, including location of amounts reported in the accompanying consolidated balance sheets, follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets - Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, equipment, and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:92.25pt;text-indent:-76.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</moh:AssetsAndLiabilitiesLesseeTableTextBlock>
    <moh:OperatingLeaseRightOfUseAssetExcludingLeasesAcquired
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzUtMS0xLTEtMTAwNzU_b4c75acb-5fca-4709-9b94-1d81de4d39d0"
      unitRef="usd">58000000</moh:OperatingLeaseRightOfUseAssetExcludingLeasesAcquired>
    <moh:OperatingLeaseRightOfUseAssetExcludingLeasesAcquired
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzUtMy0xLTEtMTMzNDY_936394cc-b770-44b9-95d2-042811db06e5"
      unitRef="usd">65000000</moh:OperatingLeaseRightOfUseAssetExcludingLeasesAcquired>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ibea9e886beab43f7b589f21f3657b645_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzYtMS0xLTEtMTAwNzU_f66e7525-0e06-4df0-acb7-9a256e984931"
      unitRef="usd">13000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ifd67197e811747ddae7d6a41e1699670_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzYtMy0xLTEtMTMzNTE_dde27b01-c57c-4592-9619-11146f2f8c05"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzUtMS0xLTEtMA_296b9df1-e696-4d7d-9841-40606e3885be"
      unitRef="usd">71000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzUtMy0xLTEtNTM4OQ_86ed2ebc-bfd8-4c40-9bb0-2693a1f94fc7"
      unitRef="usd">65000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzctMS0xLTEtMA_c69ec23f-6540-4bad-81ac-39ae7e819f10"
      unitRef="usd">21000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzctMy0xLTEtNTM4OQ_5a1e27cd-71ba-4026-8f78-680ad8abda60"
      unitRef="usd">25000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzgtMS0xLTEtMA_cd35510d-f066-4a35-b6d4-5ab366907ccf"
      unitRef="usd">42000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzgtMy0xLTEtNTM4OQ_99fd5b8d-4bc8-44f0-83a5-2e372778ed2f"
      unitRef="usd">48000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="ibea9e886beab43f7b589f21f3657b645_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzExLTEtMS0xLTEwMDg0_86407e37-5ace-493a-9b4b-4647e14392f2"
      unitRef="usd">13000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ifd67197e811747ddae7d6a41e1699670_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzExLTMtMS0xLTEzMzU2_26bec3a9-8a67-4f09-a0dc-a9f9b028d45a"
      unitRef="usd">0</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzktMS0xLTEtMA_d1bc8437-f395-4c6d-b135-6021778bbcf3"
      unitRef="usd">76000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzktMy0xLTEtNTM4OQ_02332a20-6e8c-4e9f-9e1c-351dfef4e4cb"
      unitRef="usd">73000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzEyLTEtMS0xLTA_ef18029e-6a39-4429-8a34-c7de5cbe1d7e"
      unitRef="usd">216000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzEyLTMtMS0xLTUzODk_b1c1f3a6-99be-4b8a-b623-43040b5bf1cd"
      unitRef="usd">228000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE0LTEtMS0xLTA_3eb1e064-6bf7-4357-954e-b4d1ddd38984"
      unitRef="usd">12000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE0LTMtMS0xLTUzODk_f74a627d-6ec6-44c5-8b92-52965ecc6d10"
      unitRef="usd">8000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE1LTEtMS0xLTA_a5084176-789a-4770-addd-f88989dfcbb7"
      unitRef="usd">225000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE1LTMtMS0xLTUzODk_222c7eba-f4de-4554-a796-9eb4955d2640"
      unitRef="usd">231000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE2LTEtMS0xLTA_f7c3d5ea-a206-46af-9abb-3ef74aa929f9"
      unitRef="usd">237000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZToyODVlZTUyZTdkYWQ0MTFiODk0ZTIwOTU2ZDQxMmU1ZC90YWJsZXJhbmdlOjI4NWVlNTJlN2RhZDQxMWI4OTRlMjA5NTZkNDEyZTVkXzE2LTMtMS0xLTUzODk_d492a7b9-a8ff-4dab-a5c5-fb524794d606"
      unitRef="usd">239000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDM_4df170e4-d7e0-4794-aa20-188a0dcd8a7c">&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal - undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90ZXh0cmVnaW9uOjM3MDNmMDQ5ZTU5NDQwMmRhNmQ0ZTliZTIwODBhNzYxXzExNDQ_dfbc764c-c639-4596-a876-2cde18753beb">&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal - undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzItMS0xLTEtMA_85ff01ae-05f1-4ce1-aed5-70fc3f48c0bb"
      unitRef="usd">29000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzItMy0xLTEtMA_bc35018e-d450-42df-afeb-9c8f5d5a74b4"
      unitRef="usd">26000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzMtMS0xLTEtMA_a5518f67-c36d-4be3-bf8f-1c16994ed957"
      unitRef="usd">20000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzMtMy0xLTEtMA_6e2bd1af-4ba2-4970-9b3f-25e0ad6cb14a"
      unitRef="usd">24000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzQtMS0xLTEtMA_dc4e87de-3d95-4f38-8c80-5b203014fe77"
      unitRef="usd">16000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzQtMy0xLTEtMA_23fbb734-d023-4c52-8782-ff97625a042a"
      unitRef="usd">22000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzUtMS0xLTEtMA_cc67455c-a02c-4279-80e0-2e8750334f36"
      unitRef="usd">10000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzUtMy0xLTEtMA_fd6a2699-264c-484d-b05a-480148af966f"
      unitRef="usd">22000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzYtMS0xLTEtMA_aee5ccb9-f880-434e-9ea8-bf6afc5673f1"
      unitRef="usd">6000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzYtMy0xLTEtMA_89864c98-c43f-4768-9d27-7e96697a03e9"
      unitRef="usd">23000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzctMS0xLTEtMA_529edd61-1525-41fb-b63a-57c7feade8b6"
      unitRef="usd">3000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzctMy0xLTEtMA_875c43d1-a648-4a81-ac74-50947eccbda6"
      unitRef="usd">266000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzgtMS0xLTEtMA_53d77862-fc89-46b6-9575-e05fa9b90232"
      unitRef="usd">84000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzgtMy0xLTEtMA_28145b85-acca-4457-a148-2d52017995e9"
      unitRef="usd">383000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzktMS0xLTEtMA_c7acc467-c933-4437-8b02-f847f0878e49"
      unitRef="usd">8000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzktMy0xLTEtMA_cea618d4-c3e4-4993-a189-08a1c10e9ffe"
      unitRef="usd">146000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzEwLTEtMS0xLTA_795fe973-4434-4ecb-9efd-f63d22408de3"
      unitRef="usd">76000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODEvZnJhZzozNzAzZjA0OWU1OTQ0MDJkYTZkNGU5YmUyMDgwYTc2MS90YWJsZTpkZmYzYWJhYTRhYjg0OTk2YjM5MDAxNmE2YWU3YTdmNi90YWJsZXJhbmdlOmRmZjNhYmFhNGFiODQ5OTZiMzkwMDE2YTZhZTdhN2Y2XzEwLTMtMS0xLTA_d0b17059-b1f1-4fd4-bba4-aa42d95991d5"
      unitRef="usd">237000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5Xzc5Nw_0fc74d1d-e820-4afd-bb11-13046b1f9e64">Goodwill and Intangible Assets, Net &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amounts of goodwill, for the periods presented. All goodwill is recorded in the Health Plans segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Health Plans segment, gross goodwill amounted to $994&#160;million and $445&#160;million, as of December 31, 2020 and 2019, respectively. Accumulated impairment losses amounted to $302&#160;million at each of December 31, 2020 and 2019, respectively. The changes in the carrying amounts of both goodwill and intangible assets, net, in 2020, was due to the acquisitions described in Note 4, &#x201c;Business Combinations.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the details of identified intangible assets, by major class, for the periods presented. All intangible assets, net, are recorded in the Health Plans segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract rights and licenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we estimate that our intangible asset amortization will be approximately $46 million in 2021, $44 million in 2022, 2023 and 2024, and $43 million in 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzgwNQ_c49c6c2d-f26e-45d1-90e7-6376c578e2b7">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amounts of goodwill, for the periods presented. All goodwill is recorded in the Health Plans segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i22759a2f8b054c96ad50791de93ca29f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzItMS0xLTEtMA_7e347dc9-c0d0-4c77-a264-2d7becaa8d83"
      unitRef="usd">143000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzMtMS0xLTEtMA_cedb2c0f-5dc8-4610-b706-0862aaa6fa3f"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzQtMS0xLTEtMA_0f553c2e-7554-475f-9645-e5399747ec81"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzUtMS0xLTEtMA_d1bd3e7c-cd9f-4377-8136-31a3e33d234e"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i9cd7c232959048c3b7533cbe17fd7a2a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzYtMS0xLTEtMA_a3183d4f-6f5f-463f-ba48-3a3f0486a02b"
      unitRef="usd">143000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzctMS0xLTEtMA_a03c84df-c1eb-4cfc-aec1-fefb81ffc678"
      unitRef="usd">549000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzgtMS0xLTEtMA_9473fa5c-1b50-4c71-bf48-f196b41685ac"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzktMS0xLTEtMA_10aa3bc6-2298-416a-93dd-ca41fb1100f9"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTo2ZWM2OTdkNzIxM2E0ZTlhYjIzOWI4M2YwZmYyZWMwNy90YWJsZXJhbmdlOjZlYzY5N2Q3MjEzYTRlOWFiMjM5YjgzZjBmZjJlYzA3XzEwLTEtMS0xLTA_c4e37af4-5721-45a1-aaeb-10f503f7c98e"
      unitRef="usd">692000000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzE2NDkyNjc0NDI0OTM_0b40f9b0-3398-420e-923d-53fe3ee77c7e"
      unitRef="usd">994000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i9cd7c232959048c3b7533cbe17fd7a2a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzE2NDkyNjc0NDI0Nzk_625c0e30-0b7f-48bb-9290-667f92c4683e"
      unitRef="usd">445000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i9cd7c232959048c3b7533cbe17fd7a2a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzE2NDkyNjc0NDI1MDU_3a0a3925-3cab-4d5b-915d-cc052bbd594d"
      unitRef="usd">302000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzE2NDkyNjc0NDI1MDU_68b6604f-a3a4-4012-8be8-2e001e36614e"
      unitRef="usd">302000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5Xzc5Ng_e5e4908d-dfd8-426f-b0fc-5b497eee098b">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the details of identified intangible assets, by major class, for the periods presented. All intangible assets, net, are recorded in the Health Plans segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract rights and licenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1e9747d2ea6b431d91b4e794f7c6a0f8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtMS0xLTEtMA_e0ebde53-860a-42ed-a1e1-5f9ab5e94dcd"
      unitRef="usd">370000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1e9747d2ea6b431d91b4e794f7c6a0f8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtMy0xLTEtMA_ad47e614-f44b-47e3-a3c5-068af5a2a2df"
      unitRef="usd">168000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1e9747d2ea6b431d91b4e794f7c6a0f8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtNS0xLTEtMA_80cd4d32-bc64-49f2-9def-7d1de26e9132"
      unitRef="usd">202000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i746a8ef0f806409da219017e26b4a03c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtNy0xLTEtMA_d758c212-e1f6-43b7-8dec-b378bda7e135"
      unitRef="usd">179000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i746a8ef0f806409da219017e26b4a03c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtOS0xLTEtMA_f0c50814-1e96-47e1-925b-e6481ad87ea3"
      unitRef="usd">156000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i746a8ef0f806409da219017e26b4a03c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzMtMTEtMS0xLTA_8dcb1682-fd6c-4413-beca-c5ff6db160dc"
      unitRef="usd">23000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i50c25fe7c83049a784e28473dfa5db7f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtMS0xLTEtMA_9c3a20ef-f181-4157-959b-bf948f93f38c"
      unitRef="usd">47000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i50c25fe7c83049a784e28473dfa5db7f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtMy0xLTEtMA_dbcdc0f4-f2fd-4c0d-a232-bda960c513c4"
      unitRef="usd">15000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i50c25fe7c83049a784e28473dfa5db7f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtNS0xLTEtMA_091a1e5f-1c46-4c7c-bb1c-9066409bd776"
      unitRef="usd">32000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i402bcd1f7eb94207a725a00271ec919d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtNy0xLTEtMA_772bd400-04a3-4a3b-b0ec-424994f28b28"
      unitRef="usd">20000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i402bcd1f7eb94207a725a00271ec919d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtOS0xLTEtMA_046c8de2-fc7b-4c94-ba7b-474f552395c0"
      unitRef="usd">14000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i402bcd1f7eb94207a725a00271ec919d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzQtMTEtMS0xLTA_2b6db739-4912-4ebd-bbb4-28bbf454cd5e"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib0aecf877b59419e91398282765cd1a6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMS0xLTEtMjc4Ng_8fa63975-57ba-4d2a-bcc9-9a692bfae72b"
      unitRef="usd">15000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib0aecf877b59419e91398282765cd1a6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMy0xLTEtMjc4Ng_ab4a3193-4952-4cca-8437-19a978345efa"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib0aecf877b59419e91398282765cd1a6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtNS0xLTEtMjc4Ng_318eca85-c971-480d-ad0a-3bb8483851ef"
      unitRef="usd">15000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iba830af20e004480a455ba22d8490b81_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtNy0xLTEtNTM5Mw_2f56e59c-8dfb-43ea-adf7-782f3d92a649"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iba830af20e004480a455ba22d8490b81_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtOS0xLTEtNTM5Mw_0ea4d1f6-be1f-47de-aed0-0628ea892993"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iba830af20e004480a455ba22d8490b81_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMTEtMS0xLTUzOTM_cabedb03-843d-4052-97ed-a80db3530c7b"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMS0xLTEtMA_354cb753-15db-4dab-a7e3-c4a509160ab7"
      unitRef="usd">432000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMy0xLTEtMA_df7af37e-f04d-4e03-ade0-5e935403914d"
      unitRef="usd">183000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtNS0xLTEtMA_94e7c37b-c769-4d6a-a07a-591085d10927"
      unitRef="usd">249000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtNy0xLTEtMA_fce85e12-22ce-4fd8-9c8f-e691e7858aac"
      unitRef="usd">199000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtOS0xLTEtMA_76f9047e-39bb-42db-b1e8-35face0fba9d"
      unitRef="usd">170000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90YWJsZTpjMThiNDcxMjlhY2U0ZjljYmYzNmVhYzg2ZjJkMDUyYS90YWJsZXJhbmdlOmMxOGI0NzEyOWFjZTRmOWNiZjM2ZWFjODZmMmQwNTJhXzUtMTEtMS0xLTA_72888e38-b71b-40e0-9ce8-670d89c0edd6"
      unitRef="usd">29000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzY0OA_df56940b-c000-4599-a862-84d6e92dc39b"
      unitRef="usd">46000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzY1OA_2806b740-8fe2-4429-bddf-de96922e3d82"
      unitRef="usd">44000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzY1OA_8ac3bd73-63ac-47a1-8fed-5ec7e50d2029"
      unitRef="usd">44000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzY1OA_e7a64ab1-0eb5-4cf0-8792-a557f9c3d529"
      unitRef="usd">44000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xODQvZnJhZzozYWRiYTE3ZDQ5ZDE0NzUwYWM0YjgyMGFiMjE3OTI3OS90ZXh0cmVnaW9uOjNhZGJhMTdkNDlkMTQ3NTBhYzRiODIwYWIyMTc5Mjc5XzEwOTk1MTE2Mjk3Mjk_2ab0e937-c844-40a9-94c7-b0de6ba41182"
      unitRef="usd">43000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzI5NDI_d3ba5b43-11d4-4d24-a6ec-5f63727b2f89">Medical Claims and Benefits Payable &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the details of our medical claims and benefits payable as of the dates indicated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fee-for-service claims incurred but not paid (&#x201c;IBNP&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pharmacy payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitation payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;Other&#x201d; medical claims and benefits payable include amounts payable to certain providers for which we act as an intermediary on behalf of various government agencies without assuming financial risk. Such receipts and payments do not impact our consolidated statements of income. Non-risk provider payables amounted to $235 million, $132 million and $107 million, as of December&#160;31, 2020, 2019, and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the change in our medical claims and benefits payable for the periods indicated. The amounts presented for &#x201c;Components of medical care costs related to: Prior years&#x201d; represent the amount by which our original estimate of medical claims and benefits payable at the beginning of the year were more than the actual liabilities, based on information (principally the payment of claims) developed since those liabilities were first reported.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical claims and benefits payable, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Components of medical care costs related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total medical care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments for medical care costs related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition - Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in non-risk and other provider payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical claims and benefits payable, ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;December 31, 2018, includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $81 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our estimates of medical claims and benefits payable recorded at December 31, 2020, 2019 and 2018 developed favorably by approximately $119 million, $271 million and $341 million in 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The favorable prior year development recognized in 2020 was primarily due to lower than expected utilization of medical services by our Medicaid members, and improved operating performance. Consequently, the ultimate costs recognized in 2020 were lower than our original estimates in 2019, which was not discernible until additional information was provided, and as claims payments were processed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The favorable prior year development recognized in 2019 was primarily due to lower than expected utilization of medical services by our Medicaid members, and improved operating performance. Consequently, the ultimate costs recognized in 2019 were lower than our original estimates in 2018, which was not discernible until additional information was provided, and as claims payments were processed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The favorable prior year development recognized in 2018 includes a benefit of approximately&#160;$81 million&#160;in reduced medical care costs relating to Marketplace CSR subsidies for 2017 dates of service. The remainder of the favorable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prior period development was primarily due to lower than expected utilization of medical services by our Medicaid and Marketplace members and improved operating performance.&#160;Consequently, the ultimate costs recognized in 2018 were lower than our original estimates in 2017, which was not discernible until additional information was provided, and as claims payments were processed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information about incurred and paid claims development as of December&#160;31, 2020, as well as cumulative claims frequency and the total of incurred but not paid claims liabilities. The cumulative claim frequency is measured by claim event, and includes claims covered under capitated arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Incurred Claims and Allocated Claims Adjustment Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total IBNP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative number of reported claims&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Claims and Allocated Claims Adjustment Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents a reconciliation of claims development to the aggregate carrying amount of the liability for medical claims and benefits payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Incurred claims and allocated claims adjustment expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: cumulative paid claims and allocated claims adjustment expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All outstanding liabilities before 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-risk and other provider payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical claims and benefits payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzI5NDM_9936b4de-6d0f-42e9-b50e-4ef537548733">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the details of our medical claims and benefits payable as of the dates indicated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fee-for-service claims incurred but not paid (&#x201c;IBNP&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pharmacy payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitation payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzMtMS0xLTEtMA_20fb1c5c-237f-4dd6-ad15-d06ce75a8f01"
      unitRef="usd">1647000000</moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount>
    <moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzMtMy0xLTEtMA_48e6e904-6a50-47bb-8d93-c86b5d101564"
      unitRef="usd">1406000000</moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount>
    <moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzMtNS0xLTEtMA_ec904e5c-9727-43ab-96ae-a3b9c5226f60"
      unitRef="usd">1562000000</moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount>
    <moh:PharmacyClaimsPayable
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzQtMS0xLTEtMA_6ae1b7c5-bca1-4511-a82b-d751807bec9a"
      unitRef="usd">157000000</moh:PharmacyClaimsPayable>
    <moh:PharmacyClaimsPayable
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzQtMy0xLTEtMA_acd07df2-be18-4e90-914c-31ca490b25e1"
      unitRef="usd">126000000</moh:PharmacyClaimsPayable>
    <moh:PharmacyClaimsPayable
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzQtNS0xLTEtMA_185f44e2-249e-40cb-bc47-cd573e24a2b4"
      unitRef="usd">115000000</moh:PharmacyClaimsPayable>
    <moh:CapitationClaimsPayable
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzUtMS0xLTEtMA_09ab495a-9b48-47c3-a8c6-cf03be71e708"
      unitRef="usd">70000000</moh:CapitationClaimsPayable>
    <moh:CapitationClaimsPayable
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzUtMy0xLTEtMA_4e93f05b-ab7e-4802-a6ec-df8a2d3d4995"
      unitRef="usd">55000000</moh:CapitationClaimsPayable>
    <moh:CapitationClaimsPayable
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzUtNS0xLTEtMA_be91eae9-b996-4e71-ab36-8d0eabb8bc26"
      unitRef="usd">52000000</moh:CapitationClaimsPayable>
    <moh:OtherClaimsPayable
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzYtMS0xLTEtMA_2c1aaa4b-e929-438e-8b9c-e82fc9908bde"
      unitRef="usd">528000000</moh:OtherClaimsPayable>
    <moh:OtherClaimsPayable
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzYtMy0xLTEtMA_39e2a161-0336-464e-8f3f-df38633eb8ba"
      unitRef="usd">267000000</moh:OtherClaimsPayable>
    <moh:OtherClaimsPayable
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzYtNS0xLTEtMA_dc0cc4a7-b510-4542-ba15-9a1ed96470a8"
      unitRef="usd">232000000</moh:OtherClaimsPayable>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ibea9e886beab43f7b589f21f3657b645_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctMS0xLTEtMTAwNjA_32799738-b07e-41c2-ba59-628b9458068a"
      unitRef="usd">294000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ifd67197e811747ddae7d6a41e1699670_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctMy0xLTEtMTAwNjA_b394b080-91f6-4238-8595-5f5d66b12311"
      unitRef="usd">0</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i21b5a4474fe742708d34076ef171bbc6_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctNS0xLTEtMTAwNjA_41b0eec5-5905-4636-8ed1-25b129bbc9cd"
      unitRef="usd">0</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctMS0xLTEtMA_f06da88f-5794-4d95-a1d8-34d74f991932"
      unitRef="usd">2696000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctMy0xLTEtMA_940c9e53-3714-42d4-b3f5-a0b757f8290c"
      unitRef="usd">1854000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0N2Y2MDc2MmJhYTA0N2VhYTEzZTcwMDlmMmEzODg0OS90YWJsZXJhbmdlOjQ3ZjYwNzYyYmFhMDQ3ZWFhMTNlNzAwOWYyYTM4ODQ5XzctNS0xLTEtMA_ed63d73d-dc84-4bbd-9e4b-f4163ec7726f"
      unitRef="usd">1961000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <moh:MedicalClaimsAndBenefitsPayable
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzQ0OA_1e848241-3764-44f0-a3ea-c2a599293e4b"
      unitRef="usd">235000000</moh:MedicalClaimsAndBenefitsPayable>
    <moh:MedicalClaimsAndBenefitsPayable
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzQ1Mg_52bdd0aa-863c-460c-845c-448d805b1b74"
      unitRef="usd">132000000</moh:MedicalClaimsAndBenefitsPayable>
    <moh:MedicalClaimsAndBenefitsPayable
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzQ1OQ_914bc6f7-f464-43bc-bc6f-d2b0b78b4476"
      unitRef="usd">107000000</moh:MedicalClaimsAndBenefitsPayable>
    <moh:ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzI5MTM_7f109459-0dc6-4a4a-84e3-0fc97182c6cc">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the change in our medical claims and benefits payable for the periods indicated. The amounts presented for &#x201c;Components of medical care costs related to: Prior years&#x201d; represent the amount by which our original estimate of medical claims and benefits payable at the beginning of the year were more than the actual liabilities, based on information (principally the payment of claims) developed since those liabilities were first reported.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical claims and benefits payable, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Components of medical care costs related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total medical care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments for medical care costs related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition - Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in non-risk and other provider payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical claims and benefits payable, ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;December 31, 2018, includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $81 million.&lt;/span&gt;&lt;/div&gt;</moh:ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzMtMS0xLTEtMA_fab40a6c-3464-4e75-8865-b0cd4d3b8c27"
      unitRef="usd">1854000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzMtMy0xLTEtMA_7ffa512d-8f19-4c94-8a1a-1142329dfdb7"
      unitRef="usd">1961000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ie5276df7533a434dba724ca46fb6260b_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzMtNS0xLTEtMA_e6e7067a-aa78-4003-ba48-9c7084668c8c"
      unitRef="usd">2192000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzUtMS0xLTEtMA_bf84668f-53cc-4c28-8ae9-c2bdefe14c37"
      unitRef="usd">15939000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzUtMy0xLTEtMA_2fc0a942-7e6c-4f50-9524-045d8103ea18"
      unitRef="usd">14176000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzUtNS0xLTEtMA_456dd0be-36c8-4bf1-baad-890195e01c19"
      unitRef="usd">15478000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzYtMS0xLTEtMA_fc1d8095-9bd2-455c-9dee-1e1641c5a61d"
      unitRef="usd">-119000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzYtMy0xLTEtMA_196430db-fbff-4105-a4c1-9db3611553e2"
      unitRef="usd">-271000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzYtNS0xLTEtMA_7cabd0f8-6909-4072-995e-fa279841be70"
      unitRef="usd">-341000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzctMS0xLTEtMA_d6a08c21-5430-4e6c-b3ee-bc22a573ffdc"
      unitRef="usd">15820000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzctMy0xLTEtMA_b0c08e0c-6887-4402-9380-350e2271fc1d"
      unitRef="usd">13905000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzctNS0xLTEtMA_f2b38794-7cfd-45a4-b0fa-033367e69a4f"
      unitRef="usd">15137000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEyLTEtMS0xLTA_fc7a6887-a62c-4c9b-8e37-a5dbfd177625"
      unitRef="usd">13871000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEyLTMtMS0xLTA_e498f89a-f7fc-46c5-8edf-df42067feb86"
      unitRef="usd">12554000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEyLTUtMS0xLTA_ea1c751b-67e8-445d-96fd-b06e06616dcd"
      unitRef="usd">13671000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTEtMS0xLTA_7860ab9f-3a7f-4855-8a14-012c12292a88"
      unitRef="usd">1507000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTMtMS0xLTA_aa3097b2-ece0-4a3c-b0f4-c8524f84a447"
      unitRef="usd">1482000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTUtMS0xLTA_c08a42a5-4ccf-41de-97cd-6817516f84dc"
      unitRef="usd">1710000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTEtMS0xLTA_2e5957dd-c0cd-4e61-98c2-011208909e57"
      unitRef="usd">15378000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTMtMS0xLTA_8b389489-9c25-45ea-81ba-b0d08aaef1c2"
      unitRef="usd">14036000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTUtMS0xLTA_66dad328-5215-4f5a-bb61-3a795a4b5060"
      unitRef="usd">15381000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTEtMS0xLTIwOTE3_89b23047-e7b8-4275-b049-df7267d5830b"
      unitRef="usd">294000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTMtMS0xLTIwOTE3_92529b3b-b782-4e86-afb8-74554cd4d6ea"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzEzLTUtMS0xLTIwOTE3_3d287fe0-20a0-4460-8c3a-ca725187ca8c"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <moh:MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTEtMS0xLTE0MDM2_a149aabb-a0c8-4f35-a097-4c77065e31cf"
      unitRef="usd">106000000</moh:MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider>
    <moh:MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTMtMS0xLTE0MDM2_cf94bcc5-39d3-4f70-ba9f-274ed9acea51"
      unitRef="usd">24000000</moh:MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider>
    <moh:MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE0LTUtMS0xLTE0MDM2_a5140645-fc50-4b19-80c3-dcfb4b452f4a"
      unitRef="usd">13000000</moh:MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE1LTEtMS0xLTA_6711d257-f902-482f-ad98-e13e0a3780e2"
      unitRef="usd">2696000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE1LTMtMS0xLTA_1426a7a7-7b18-46e8-80e4-c4c5038a3871"
      unitRef="usd">1854000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo3ZjBmYWIyNTU2Yjc0NDQ2OGRjNTRjMzBmMjljM2EyNC90YWJsZXJhbmdlOjdmMGZhYjI1NTZiNzQ0NDY4ZGM1NGMzMGYyOWMzYTI0XzE1LTUtMS0xLTA_1d9b3354-550e-4b01-8983-9df2aacafc09"
      unitRef="usd">1961000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i8ba8deca9f384a07ac55d4d78555ed46_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzExMTI_a09657f2-c664-4257-8812-82be3512ec94"
      unitRef="usd">81000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzYwNDczMTM5NTkzNzc_bedab393-d422-4085-b16e-79e625ab3bff"
      unitRef="usd">-119000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzYwNDczMTM5NTkzODI_c52985cf-a9c0-4e99-b936-c0dd762104a8"
      unitRef="usd">-271000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzYwNDczMTM5NTkzOTA_bb1995db-3fc1-4269-812c-66b4bcf21223"
      unitRef="usd">-341000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i8ba8deca9f384a07ac55d4d78555ed46_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzYwNDczMTM5NjAzMTU_a09657f2-c664-4257-8812-82be3512ec94"
      unitRef="usd">81000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzI5MzA_f3166c5d-c138-4547-8cfa-473878329cb6">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information about incurred and paid claims development as of December&#160;31, 2020, as well as cumulative claims frequency and the total of incurred but not paid claims liabilities. The cumulative claim frequency is measured by claim event, and includes claims covered under capitated arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Incurred Claims and Allocated Claims Adjustment Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total IBNP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative number of reported claims&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Claims and Allocated Claims Adjustment Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ia31b475498df425a8b4d174081e15148_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzUtMi0xLTEtMA_a6504950-1415-4d27-b848-2376bc46eeb4"
      unitRef="usd">15478000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="id7f38b6017a44991a39f98bf263f1207_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzUtNC0xLTEtMA_74f03c2b-190d-4739-94ad-6aefcef7ad4e"
      unitRef="usd">15245000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i4da076c6c0e14403bba261ee5a1752cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzUtNi0xLTEtMA_5da1b5f9-ef8c-421b-8805-d51c07150367"
      unitRef="usd">15233000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="i8038f20097384f9e833965528d07e1cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzUtOC0xLTEtMA_6d8a4a94-4602-4f1c-b3b6-c7857733af4c"
      unitRef="usd">11000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims
      contextRef="i8038f20097384f9e833965528d07e1cc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzUtMTAtMS0xLTA_ba372535-8174-435a-83c5-ee52013b60f6"
      unitRef="claim">110000000</us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="iadfee5a2ce3745aaaf4b546d03d4d801_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzYtNC0xLTEtMA_92dbd29f-ba17-4647-9cc6-aab802219e87"
      unitRef="usd">14176000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i136f903b1c064277a3b1c8f8da5021b5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzYtNi0xLTEtMA_6bd07f25-60a1-44a3-89aa-4929d32d94a0"
      unitRef="usd">14083000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="i34d4bab4b5564cbb89d2dde161392e50_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzYtOC0xLTEtMA_951d7d68-c076-442b-a1b9-a2c03ed3cbb0"
      unitRef="usd">27000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims
      contextRef="i34d4bab4b5564cbb89d2dde161392e50_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzYtMTAtMS0xLTA_534a2152-c83d-4eb2-ad74-56205d960417"
      unitRef="claim">100000000</us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ide648b3dad0d4ab18e81c2b7529401b1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzctNi0xLTEtMA_a1c96098-3f24-422d-81e7-ff93c9e59b3e"
      unitRef="usd">15939000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="ibe0ee42eef33462bb6cd3e32f7bf3d52_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzctOC0xLTEtMA_7d958166-561e-4b36-9da8-a0b90757ad82"
      unitRef="usd">1593000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims
      contextRef="ibe0ee42eef33462bb6cd3e32f7bf3d52_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzctMTAtMS0xLTA_b967998b-a9c7-4a08-a95e-4450e68417f9"
      unitRef="claim">93000000</us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims>
    <moh:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzgtNi0xLTEtMA_e72fe112-70f0-4b43-8bd6-bee7cee5c90f"
      unitRef="usd">45255000000</moh:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTphOTlkN2VjNTBiMTg0ZWUwYjgyZjUxOTg3NzYxOWYxZi90YWJsZXJhbmdlOmE5OWQ3ZWM1MGIxODRlZTBiODJmNTE5ODc3NjE5ZjFmXzgtOC0xLTEtMA_c2dfa872-a196-4f97-b645-35438f103104"
      unitRef="usd">1631000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i65eb832ddf7446ad95dac7eeb4907da3_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzUtMi0xLTEtMA_c6f5c035-279f-46be-b1dc-b76b6fe8f330"
      unitRef="usd">13752000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i84ed48f2ecee4fde8a88bcac9e3387b6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzUtNC0xLTEtMA_00539f38-4da2-4c54-b90a-4f24252abe20"
      unitRef="usd">15220000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i8038f20097384f9e833965528d07e1cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzUtNi0xLTEtMA_59a21e9d-1980-4d1c-bb69-042c2e7201a8"
      unitRef="usd">15222000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i84f74264414a473b851cd390764a5469_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzYtNC0xLTEtMA_5ba54349-f8d8-464a-ad3f-11abd858c0f7"
      unitRef="usd">12554000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i34d4bab4b5564cbb89d2dde161392e50_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzYtNi0xLTEtMA_5c3b4680-496b-4e34-8a88-13404ad26bcb"
      unitRef="usd">14056000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ibe0ee42eef33462bb6cd3e32f7bf3d52_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzctNi0xLTEtMA_88d99202-a9c9-4d5f-a328-7f8f9c3e8b19"
      unitRef="usd">13871000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTo0ZjA0ZTRmZjQ1ZmE0Zjg4YjRlMTA1YjYwNDcxZDQ0ZS90YWJsZXJhbmdlOjRmMDRlNGZmNDVmYTRmODhiNGUxMDViNjA0NzFkNDRlXzgtNi0xLTEtMA_f4b04537-12bf-407e-ae85-fd09b699d385"
      unitRef="usd">43149000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90ZXh0cmVnaW9uOmU2NDc5NGQwM2ZmNjQxODU5NTA4M2U4OWY3NDlhZWRlXzI5NDY_a8c96902-7542-44bd-9b0b-b5c814624c3f">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents a reconciliation of claims development to the aggregate carrying amount of the liability for medical claims and benefits payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Incurred claims and allocated claims adjustment expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: cumulative paid claims and allocated claims adjustment expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All outstanding liabilities before 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Magellan Complete Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-risk and other provider payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical claims and benefits payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzItNi0xLTEtMA_b0bc0b17-9f76-4b7f-a8d5-e9a7ea0ebf91"
      unitRef="usd">45255000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzMtNi0xLTEtMA_13a9a2b8-5396-41e5-a0fe-2bd7f5396c12"
      unitRef="usd">43149000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <moh:ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzQtNi0xLTEtMA_6fe8e4c1-de69-4a21-a234-608550d8e887"
      unitRef="usd">16000000</moh:ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzUtNi0xLTEtNzUzNg_fe51833f-2540-4ba5-95ae-d381f54e68eb"
      unitRef="usd">294000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzUtNi0xLTEtMA_dd5cbafe-d847-4019-bb76-e7a93c479953"
      unitRef="usd">280000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTAvZnJhZzplNjQ3OTRkMDNmZjY0MTg1OTUwODNlODlmNzQ5YWVkZS90YWJsZTplMDY0MTNhM2YyN2M0MTc1OWJmYTBjY2YyNTNlOWVhNS90YWJsZXJhbmdlOmUwNjQxM2EzZjI3YzQxNzU5YmZhMGNjZjI1M2U5ZWE1XzYtNi0xLTEtMA_666ea401-b185-4f6f-abf5-6f01aa1c8b81"
      unitRef="usd">2696000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzgwODI_0c229fa1-207d-47fd-ae5c-7200f33b6d63">Debt &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of debt, as of December&#160;31, 2020, are illustrated in the following table. All amounts represent the principal amounts of the debt instruments outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.375% Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.375% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% Notes due 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All debt is held at the parent which is reported in the Other segment. The following table summarizes our outstanding debt obligations and their classification in the accompanying consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current portion of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.125% Convertible Notes, net of unamortized discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term loan facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-current portion of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.375% Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.375% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% Notes due 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.875% Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term loan facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: debt issuance costs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Reported in &#x201c;Accounts payable, accrued liabilities and other.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, we entered into a credit agreement (the &#x201c;Credit Agreement&#x201d;) that replaced our prior credit agreement. The terms of the Credit Agreement are substantially similar to the terms of the prior agreement. Among various provisions, significant changes incorporated to the Credit Agreement included:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;An increase of the revolving credit facility (the &#x201c;Credit Facility&#x201d;) from $500 million to $1.0 billion;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A $15&#160;million swingline sub-facility and a $100&#160;million letter of credit sub-facility;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;An increase of incremental term loans available to finance certain acquisitions from $150&#160;million to $500&#160;million, plus an unlimited amount as long as our consolidated net leverage ratio is not greater than 3:1;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The ability to engage in acquisitions where the consummation of such acquisitions is not conditioned on the availability of, or on obtaining, third-party financing;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Termination of the term loan facility under the prior credit agreement; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;LIBOR succession provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement has a term of five years, and all amounts outstanding will be due and payable on June 8, 2025. Borrowings under the Credit Agreement bear interest based, at our election, on a base rate or other defined rate, plus in each case, the applicable margin. In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Credit Agreement, we are required to pay a quarterly commitment fee. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains customary non-financial and financial covenants. As of December&#160;31, 2020, we were in compliance with all financial and non-financial covenants under the Credit Agreement and other long-term debt. As of December&#160;31, 2020, no amounts were outstanding under the Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;High-Yield Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our high-yield senior notes are described below. Each of these notes are senior unsecured obligations of Molina and rank equally in right of payment with all existing and future senior debt, and senior to all existing and future subordinated debt of Molina. In addition, each of the notes contain customary non-financial covenants and change of control provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The indentures governing the high-yield senior notes contain cross-default provisions that are triggered upon default by us or any of our subsidiaries on any indebtedness in excess of the amount specified in the applicable indenture. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;4.375% Notes due 2028. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 2, 2020, we completed the private offering of $800 million aggregate principal amount of senior notes (the &#x201c;4.375% Notes&#x201d;) due June 15, 2028, unless earlier redeemed. The 4.375% Notes contain optional early redemption provisions, with redemption prices in excess of par. Interest, at a rate of 4.375% &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;per annum, is payable semiannually in arrears on June 15 and December 15 of each year. A portion of the net proceeds from the 4.375% Notes offering was used to repay $600&#160;million principal amount outstanding under the term loan facility of our prior credit agreement, and the balance is intended to be used for general corporate purposes. Deferred issuance costs amounted to $11&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;5.375% Notes due 2022. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have $700 million aggregate principal amount of senior notes (the &#x201c;5.375% Notes&#x201d;) outstanding as of December&#160;31, 2020, which are due November&#160;15,&#160;2022, unless earlier redeemed. Interest at a rate of 5.375% per annum, is payable semiannually in arrears on May 15 and November 15. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;3.875% Notes due 2030. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 17, 2020, we completed the private offering of $650 million aggregate principal amount of senior notes (the &#x201c;3.875% Notes&#x201d;) due November 15, 2030, unless earlier redeemed. The 3.875% Notes contain optional early redemption provisions, with redemption prices in excess of par. Interest, at a rate of 3.875% per annum, is payable semiannually in arrears on May 15 and November 15 of each year, commencing on May 15, 2021. A portion of the net proceeds from the 3.875% Notes offering was used to repay $330 million principal amount outstanding under the 4.875% Notes, and the balance is intended to be used for general corporate purposes. Deferred issuance costs amounted to $10&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;4.875% Notes due 2025. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, we completed the early redemption of the entire $330 million aggregate principal amount of senior notes (the &#x201c;4.875% Notes&#x201d;) that would have been due June 15, 2025. In accordance with the indenture governing such notes, the 4.875% Notes were settled at 100% of par, plus an early redemption premium which amounted to $8&#160;million, plus accrued and unpaid interest. In conjunction with the redemption, we wrote off $3&#160;million in unamortized deferred issuance costs directly related to the 4.875% Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;1.125% Cash Convertible Senior Notes due 2020  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, we paid $39&#160;million to settle the $12&#160;million remaining principal amount outstanding of the 1.125% cash convertible senior notes due January 15, 2020 (the &#x201c;1.125% Convertible Notes&#x201d;), and settled the related conversion option. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Expenses (Income), Net&lt;/span&gt;&lt;/div&gt;In the year ended December 31, 2020, we recognized an aggregate loss on debt repayment of $15 million including costs incurred in repayment of the term loan facility, the 4.875% Notes repayment costs described above, and other financing transactions. In the year ended December 31, 2019, we recognized a gain on debt repayment of $15 million in connection with the 1.125% Convertible Notes repayment transactions. These amounts are reported in &#x201c;Other expenses (income), net&#x201d; in the accompanying consolidated statements of income.</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzgwODY_ff29b702-99a1-45e3-b7b7-f85aab4536f2">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of debt, as of December&#160;31, 2020, are illustrated in the following table. All amounts represent the principal amounts of the debt instruments outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.375% Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.375% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% Notes due 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtMC0xLTEtNTU0MC90ZXh0cmVnaW9uOjYzNzNjNjQwNjAyYzQ3YWJiOGJlMjgzNmE2ZmFjMmYwXzU0OTc1NTgxMzg5MDI_a88d747a-4ee0-4f79-89b3-fc4703d1d916"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtMS0xLTEtMA_77428ee7-3141-4fe4-b971-cc173038c7a5"
      unitRef="usd">800000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtMy0xLTEtNTQ1Nw_40fe52b8-7f8f-4549-8a6c-568c1f77c71d"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtNS0xLTEtNTQ2MQ_c379cc3f-d6dd-4577-9348-2e529b73e5c2"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtNy0xLTEtNTQ2Mw_1b30270c-93d6-45d7-9184-b49e75567912"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtOS0xLTEtNTQ2NQ_f28f7e61-5e8f-448e-baba-70441f26b00c"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtMTEtMS0xLTU0Njc_585bb413-3435-4354-93df-c10abb3078cd"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzMtMTMtMS0xLTU0Njk_a5288f9c-ebaa-4da7-aacd-d9f28a93a165"
      unitRef="usd">800000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MjU1ZmFlM2Y1OTRiODc4OGUxNWFjYjUxNzRiYzNjXzU0OTc1NTgxMzg5MDI_02da3411-9932-4ff5-85b0-f974d24c2506"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtMS0xLTEtMA_f741b749-c459-4c54-8633-51c054b460bd"
      unitRef="usd">700000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtMy0xLTEtNTQ1Nw_2be1a3c4-068e-4335-a08a-c34db31210b6"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtNS0xLTEtNTQ2MQ_2fe28852-a777-4010-8ced-246bea0f4c83"
      unitRef="usd">700000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtNy0xLTEtNTQ2Mw_ec292fb5-0e04-4a89-a303-a80aaa6df298"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtOS0xLTEtNTQ2NQ_fb728d9e-4a9d-43e3-861e-0dc3da28551e"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtMTEtMS0xLTU0Njc_b69006dc-9c5d-42b3-a366-e560154ec124"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzQtMTMtMS0xLTU0Njk_5cee4cb8-e49d-4dc6-9cb8-c6d330d33626"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtMC0xLTEtNTU0Ny90ZXh0cmVnaW9uOmI0NTg1MjNjM2MxMDQwMDc4NDk1ZTM2YmY4MjBkYjZkXzU0OTc1NTgxMzg5MDM_55435b9b-c833-47df-80bb-ee345b578771"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtMS0xLTEtODUw_fb27f257-6596-47b5-b011-2a03eb8e5520"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtMy0xLTEtNTQ1Nw_5b802107-d3c3-4082-9547-1b1c8807826a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtNS0xLTEtNTQ2MQ_4498ec08-c3f9-49da-a364-4370b6229847"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtNy0xLTEtNTQ2Mw_71b0c1ff-71d2-4d85-a480-d6a2cff51538"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtOS0xLTEtNTQ2NQ_f760a7ab-94ea-453f-b396-99f0eac6a654"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtMTEtMS0xLTU0Njc_b5b3af9b-879f-446c-b21a-d5e122aa0606"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzUtMTMtMS0xLTU0Njk_562b0e0d-088b-4abf-81dd-36d86256acb8"
      unitRef="usd">650000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtMS0xLTEtMA_b2e7a53f-81de-48da-b198-959b48d7ecbf"
      unitRef="usd">2150000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtMy0xLTEtNTQ1Nw_25e760e4-6f3f-4fb9-9fa8-2be30a600460"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtNS0xLTEtNTQ2MQ_59942aff-4132-4303-99e6-fb6e376411f3"
      unitRef="usd">700000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtNy0xLTEtNTQ2Mw_3be52b2a-182a-4803-8d9f-b82e1c86cacd"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtOS0xLTEtNTQ2NQ_8a318979-4ab7-4035-a9d7-9af0462d8bca"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtMTEtMS0xLTU0Njc_1fe993bd-e5e7-45a2-95d1-7b2fc59aa5da"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZToxYjkxYzNkZDcxODc0ZWE5YWU5OGE4ZTIyNWY3NDVkMC90YWJsZXJhbmdlOjFiOTFjM2RkNzE4NzRlYTlhZTk4YThlMjI1Zjc0NWQwXzYtMTMtMS0xLTU0Njk_7b77a69e-f7af-4325-a3a0-c2b751ea1229"
      unitRef="usd">1450000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzgwNzY_76e6174b-26e1-4744-8b1b-4dd691c5b5be">The following table summarizes our outstanding debt obligations and their classification in the accompanying consolidated balance sheets:&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current portion of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.125% Convertible Notes, net of unamortized discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term loan facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-current portion of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.375% Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.375% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% Notes due 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.875% Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term loan facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: debt issuance costs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Reported in &#x201c;Accounts payable, accrued liabilities and other.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7f87c0eee5ef4388a13337f6de7a4672_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzQtMC0xLTEtMTU1MzkvdGV4dHJlZ2lvbjozOGRiZmM0MGIxMWU0YTFmODJkNDJkY2NkOTYwYWYxMF81NDk3NTU4MTM4OTM0_48a28ce9-ed28-44ea-a8eb-de4f9240758e"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount
      contextRef="id63dd203dce74ef786b9059a9384be45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzQtMS0xLTEtMA_e78344e6-e949-4411-a3e0-2498d82c498c"
      unitRef="usd">0</moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount>
    <moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount
      contextRef="i7ae2b394952c4f1e8142cffc59c02e8f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzQtMy0xLTEtMA_9d58a327-06a8-4463-b538-19db4f9b1af1"
      unitRef="usd">12000000</moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount>
    <moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount
      contextRef="i54ca304db2314cb0aa1e9531302dd99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzUtMS0xLTEtMA_ca683608-ada1-46e2-9765-cded1e78fe35"
      unitRef="usd">0</moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount>
    <moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount
      contextRef="i7f794012ffba4b20bb19204c1871558d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzUtMy0xLTEtMA_03d30960-144e-4519-9763-0e8dc593c922"
      unitRef="usd">6000000</moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount>
    <us-gaap:LongTermDebtCurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzYtMS0xLTEtMA_96685d17-b369-4100-9d95-0b95dd71463b"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzYtMy0xLTEtMA_2ddd92ee-139a-4503-9991-4c20330385de"
      unitRef="usd">18000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzgtMC0xLTEtNTU1MS90ZXh0cmVnaW9uOjVkZWE5YjZmODZkNTQ5ZTRiYTE0ZTExNDVlZDBhZWI5XzU0OTc1NTgxMzg5MTE_3b360b17-406a-4d98-9962-db0cd0ddc832"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzgtMS0xLTEtMA_38f96f54-7802-4eac-986c-6409174cd2f5"
      unitRef="usd">800000000</moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount>
    <moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount
      contextRef="if8dbc94d3d2941ddb0a236c2e6aa7418_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzgtMy0xLTEtNTQ1NA_503dd1a1-0088-490b-9a3f-6e3d65b3c45a"
      unitRef="usd">0</moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzktMC0xLTEtNTU1My90ZXh0cmVnaW9uOmRhZGM3NmFlYzBhYTQzNDdhYzNhNGNmOWUzNWZkYjIzXzU0OTc1NTgxMzg5MTE_534078d7-ba28-4e8c-8a9b-39ce5b87ccda"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzktMS0xLTEtMA_b0e9e5df-e2d5-4bde-923e-2d64e1bf49c4"
      unitRef="usd">700000000</moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount>
    <moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount
      contextRef="if24fe855595e4f419b39b5ca7946f9a1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzktMy0xLTEtMA_d5fac211-4008-4f10-ad72-a592ba4c3e14"
      unitRef="usd">700000000</moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEwLTAtMS0xLTU1NDkvdGV4dHJlZ2lvbjoyNWU0M2UwNGEwMWQ0NjJkYWQ2MDdkN2Q1MDkyYWI4ZV81NDk3NTU4MTM4OTEx_55435b9b-c833-47df-80bb-ee345b578771"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEwLTEtMS0xLTg4Mw_725ac1d2-a620-4366-b220-4341baeb63db"
      unitRef="usd">650000000</moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount>
    <moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount
      contextRef="i82aa8b8e3d40448a968a16db82de1fe0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEwLTMtMS0xLTg4Mw_335d9dcc-38c5-4f57-878c-ea49f15be017"
      unitRef="usd">0</moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6897a665bfe944c0b1720f8066bd97ce_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzExLTAtMS0xLTU1NTUvdGV4dHJlZ2lvbjo3NjQxYjA1ZjEyYzg0OWY2YWJmNjZmMWY2NjljNDU0Zl81NDk3NTU4MTM4OTEx_d7c503be-ad51-4b06-a4b7-d6ba9ba345c3"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount
      contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEwLTEtMS0xLTA_792b7f4d-e7a1-4263-9398-78fa85734f6d"
      unitRef="usd">0</moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount>
    <moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount
      contextRef="ie8662ae4a2ad4fd59034705718e300f7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEwLTMtMS0xLTA_39d67d7b-8a8e-4279-a663-2397401c51f1"
      unitRef="usd">330000000</moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount>
    <moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount
      contextRef="i54ca304db2314cb0aa1e9531302dd99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzExLTEtMS0xLTA_71c1eb46-8ef2-4ad1-89e9-e33e052c2a61"
      unitRef="usd">0</moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount>
    <moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount
      contextRef="i7f794012ffba4b20bb19204c1871558d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzExLTMtMS0xLTA_5f8aa780-2421-42de-9918-ab3e5aaf9461"
      unitRef="usd">214000000</moh:LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEzLTEtMS0xLTA_84b24151-628c-459e-b8b3-3761a09bd5b9"
      unitRef="usd">23000000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzEzLTMtMS0xLTA_4df2f333-42cc-470e-9595-1d068590fefb"
      unitRef="usd">7000000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzE0LTEtMS0xLTA_63bb3533-3b1b-43d9-ba3a-e1112d4d5011"
      unitRef="usd">2127000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90YWJsZTpjOGUyMzE4YjQzZDA0NWJlYmMyNTYyMTcxMGYzMDAxNi90YWJsZXJhbmdlOmM4ZTIzMThiNDNkMDQ1YmViYzI1NjIxNzEwZjMwMDE2XzE0LTMtMS0xLTA_373f9077-860c-4637-ad89-abf23eb69ae2"
      unitRef="usd">1237000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i919a4ba85b4d4dfaa5d02f1908cbd481_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgxNzM_22fa516f-011f-4fdd-a0b5-49f6f676dd82"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i350e29537cb34f48978b5b0e7e5cc142_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgxODA_719baa9a-ad52-4026-ba38-cdb0f44fbf8f"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="icdd1a32b458947b1801cc3505a82b626_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgxODc_719c6176-c9d1-4a8c-a817-1790f4564de3"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if6fee39dad244f2c88eadb065bc81d50_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgyMjA_4f07d29a-fd5e-4fb6-8255-d80b5df0cd88"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1abe71b87a6542f0870a99e5a099279f_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgzNDA_1513d1e2-e21a-43d7-92b8-b0ebb320a00b"
      unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9c82c5064b8f4eb08577141f723fd705_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDgzNDc_66df0137-0db2-4379-a4e6-3bcc8d251287"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <moh:ConsolidatedNetLeverage
      contextRef="ie2dd3e9ee2ce44a4919d0cf6b7a9cd2f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDg0NDQ_d4647cc2-8291-4405-b0e4-0dd6805a00c8"
      unitRef="number">3</moh:ConsolidatedNetLeverage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i357b4ee3df3041a6bcafb18e3531d2e9_D20200601-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDg3OTM_27295caa-154d-43a8-bf7f-e72889c9ed33">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCredit
      contextRef="i8e22eda33bbd4bab854db88001835a0c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDkyNzY_507791ab-c2cf-48a8-b38c-f9f35d662cf7"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzY3Mzg_a88d747a-4ee0-4f79-89b3-fc4703d1d916"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib62871823c48445589be9d732dff0753_I20200602"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzY3NTQ_3e6bdfe3-d3a3-48b2-8abf-8a2f86f820c3"
      unitRef="usd">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzY3NjM_a88d747a-4ee0-4f79-89b3-fc4703d1d916"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0MTI_a88d747a-4ee0-4f79-89b3-fc4703d1d916"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0MjE_a88d747a-4ee0-4f79-89b3-fc4703d1d916"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9be126012c2743e3ba1f0448a68c6d21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0NDU_a88d747a-4ee0-4f79-89b3-fc4703d1d916"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i5588d925bf774eb08f9ffc4e6643dcb4_D20200602-20200602"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0MzY_5beb2ee3-ea71-46b4-a731-130fcd80aed3"
      unitRef="usd">600000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib62871823c48445589be9d732dff0753_I20200602"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE2NDkyNjc0NjQyMDk_f8e9bf29-6982-4f84-81b0-7c94b6c0a226"
      unitRef="usd">11000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0NTA_02da3411-9932-4ff5-85b0-f974d24c2506"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzI4ODk_f00acbb1-4a52-4c67-9504-a2e5d1b53e91"
      unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0NTQ_02da3411-9932-4ff5-85b0-f974d24c2506"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib6bd1cb5ab3c4fbfb6f6973d2d778551_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0NTg_02da3411-9932-4ff5-85b0-f974d24c2506"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0MTY_55435b9b-c833-47df-80bb-ee345b578771"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0OTM_fb27f257-6596-47b5-b011-2a03eb8e5520"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0MjU_55435b9b-c833-47df-80bb-ee345b578771"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0NTI_55435b9b-c833-47df-80bb-ee345b578771"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0NDM_55435b9b-c833-47df-80bb-ee345b578771"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4aecfcc681ca4fbcbac7161b6eb383ef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0MzQ_55435b9b-c833-47df-80bb-ee345b578771"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0Nzg_3ff92867-9dd7-4e8c-8363-111b8a76df97"
      unitRef="usd">330000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NDE0NjI_c47a07cb-7dec-4162-a382-e8cd56ad49e3"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i1abb910e6fa946c3a5cc16ae002d542f_I20201117"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NTA5NzY_b5f6c341-f6e1-4928-a6e0-7e3b91ebaa50"
      unitRef="usd">10000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0Njc_c47a07cb-7dec-4162-a382-e8cd56ad49e3"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzMyNDY_3ff92867-9dd7-4e8c-8363-111b8a76df97"
      unitRef="usd">330000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2Mzc0NzE_c47a07cb-7dec-4162-a382-e8cd56ad49e3"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE3MDQyNDMwMjU3OTIz_21f4ceac-511d-444e-aba4-655f1db1f874"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <moh:RedemptionPremiumSettledPercentage
      contextRef="id33b880a743e45e296852cb1c96f23f9_D20201201-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE3MDQyNDMwMjU3OTE3_15156fa1-fd24-47cf-9b11-620b011d3d06"
      unitRef="number">1</moh:RedemptionPremiumSettledPercentage>
    <us-gaap:DepositLiabilitiesAccruedInterest
      contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NTUxNTE_e91e5342-c5d4-4b94-be1e-477a67efc329"
      unitRef="usd">8000000</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2NTUxMzk_338ca48e-f172-47ff-a12b-fd70179ef7f7"
      unitRef="usd">3000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0dfa298466eb4e6e9510dfd216fe410c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE3MDQyNDMwMjU3OTMx_93a2d817-6f42-4a14-adf7-075752e4de97"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7f87c0eee5ef4388a13337f6de7a4672_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzM1NzU_48a28ce9-ed28-44ea-a8eb-de4f9240758e"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i71e356cb28064ce08d2b5e2365a4e623_D20200101-20200131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzgzMjE_b1542e9b-93e9-41e6-b61d-9eb90a5e7c75"
      unitRef="usd">39000000</us-gaap:RepaymentsOfDebt>
    <moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount
      contextRef="i7f87c0eee5ef4388a13337f6de7a4672_I20200131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzgzMzQ_db591ee5-5133-4a44-b144-86f14de6cd00"
      unitRef="usd">12000000</moh:LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7f87c0eee5ef4388a13337f6de7a4672_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzEwOTk1MTE2MzgzNTM_48a28ce9-ed28-44ea-a8eb-de4f9240758e"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7f87c0eee5ef4388a13337f6de7a4672_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzIxOTkwMjMyNzgzNzc_48a28ce9-ed28-44ea-a8eb-de4f9240758e"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzYwNDczMTM5NzkzODg_80e6550d-ead3-4f14-a284-0c327f5bde0a"
      unitRef="usd">-15000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE3MDQyNDMwMjU3OTM5_56c2f1df-1331-4639-8c23-ef7d7cfb1f4b"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <moh:GainLossOnDebtRepayment
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzYwNDczMTM5Nzk1Nzg_423cf68a-fb9b-408b-9f00-64c28db8f527"
      unitRef="usd">15000000</moh:GainLossOnDebtRepayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7ae2b394952c4f1e8142cffc59c02e8f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xOTMvZnJhZzo0ZjM3YmQ1YTg0ZDg0NTA4YTdmOGRmNjJiY2QxNTZhZS90ZXh0cmVnaW9uOjRmMzdiZDVhODRkODQ1MDhhN2Y4ZGY2MmJjZDE1NmFlXzE3MDQyNDMwMjU3OTQ3_99e0661e-d2a5-458f-aec2-8453be1ebf42"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQ4OTk_792b179d-45e4-4778-85bd-1f91b27755dc">Income Taxes &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense for continuing operations consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. federal statutory income tax rate to the combined effective income tax rate for continuing operations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Statutory federal tax (benefit) rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State income provision (benefit), net of federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible health insurer fee (&#x201c;HIF&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Worthless stock deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective tax expense rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate was not impacted by the HIF in 2019 given the HIF moratorium. Our effective tax rate is based on expected income, statutory tax rates, and tax planning opportunities available to us in the various jurisdictions in which we operate. Management estimates and judgments are required in determining our effective tax rate. We are routinely under audit by federal, state, or local authorities regarding the timing and amount of deductions, nexus of income among various tax jurisdictions, and compliance with federal, state, foreign, and local tax laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are classified as non-current. Significant components of our deferred tax assets and liabilities as of December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and reserve liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued medical costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets and intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease financing obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax credit carryover&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets, net of valuation allowance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets and intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gains and losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred income tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, we had state net operating loss carryforwards of $189 million, which begin expiring in 2035.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, we had foreign net operating loss carryforwards of $5&#160;million, which expire in 2031. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, we had California research and development and enterprise zone tax credit carryovers of $3 million, which will begin to expire in 2024, and foreign tax credit carryovers of $5 million, which expire in 2030.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary differences. We have determined that as of December&#160;31, 2020, $17 million of deferred tax assets did not satisfy the recognition criteria. Therefore, we decreased our valuation allowance by $7 million, from $24 million at December&#160;31, 2019, to $17 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize tax benefits only if the tax position is more likely than not to be sustained. We are subject to income taxes in the United States, Puerto Rico,&#160;and numerous state jurisdictions. Significant judgment is required in evaluating our tax positions and determining our provision for income taxes. During the ordinary course of business, there are many transactions and calculations for which the ultimate tax determination is uncertain. We establish reserves for tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves are established when we believe that certain positions might be challenged despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances, such as the outcome of tax audits. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The roll forward of our unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increases in tax positions for current year &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse in statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total amount of unrecognized tax benefits at December&#160;31, 2020, 2019 and 2018 that, if recognized, would affect the effective tax rates is $18 million in each of those respective years. We expect that during the next 12 months it is reasonably possible that unrecognized tax benefit liabilities may decrease by as much as $10 million due to resolution of exams and refund claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our continuing practice is to recognize interest and/or penalties related to unrecognized tax benefits in income tax expense. Amounts accrued for the payment of interest and penalties as of December&#160;31, 2020, 2019 and 2018 were insignificant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are under examination by the IRS for calendar years 2015 through 2017 and may be subject to examination for calendar years 2018 and 2019. With a few exceptions, which are immaterial in the aggregate, we no longer are subject to state, local, and Puerto Rico tax examinations for years before 2015.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQ5NDU_84592dbb-bc37-48fb-b924-890d09c860db">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense for continuing operations consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzQtMS0xLTEtMA_e5c2c4a3-7b11-401b-adda-4a534d5c6a11"
      unitRef="usd">281000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzQtMy0xLTEtMA_ebbbc8df-7844-4612-9eac-77487c0f73ab"
      unitRef="usd">204000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzQtNS0xLTEtMA_22675c30-db37-4891-aa9e-4527cdad04a8"
      unitRef="usd">272000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzUtMS0xLTEtMA_d7a60f60-da40-4e23-b332-1427bac4e66f"
      unitRef="usd">26000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzUtMy0xLTEtMA_a82dce69-efa4-4d68-8c08-e153c440bd38"
      unitRef="usd">12000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzUtNS0xLTEtMA_be8314d3-3eed-4b5e-8fb7-a9c1a745deeb"
      unitRef="usd">18000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzYtMS0xLTEtMA_5210bd04-1edf-4ff9-84fa-3a2176684b07"
      unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzYtMy0xLTEtMA_5627fd57-2563-434b-ab52-242354aa2fda"
      unitRef="usd">9000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzYtNS0xLTEtMA_4c63e04f-15e4-49fc-8d31-e777983a8a29"
      unitRef="usd">8000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzctMS0xLTEtMA_348ce020-e1d5-4036-9b0c-adc5babe5a83"
      unitRef="usd">307000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzctMy0xLTEtMA_8db3145c-2093-4483-95ec-4a221ef4b8bc"
      unitRef="usd">225000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzctNS0xLTEtMA_b807d36c-c3bf-4a8e-b9ca-ae5fc5701997"
      unitRef="usd">298000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzktMS0xLTEtMA_1db22182-92da-4e23-a1e5-bf866c2ee1e2"
      unitRef="usd">-13000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzktMy0xLTEtMA_225b127a-893f-486f-baec-59190080c233"
      unitRef="usd">5000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzktNS0xLTEtMA_17b2687d-306a-4d84-9ac8-a3320f888112"
      unitRef="usd">-3000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEwLTEtMS0xLTA_92885936-bf7e-4e4d-b948-8135cd93216b"
      unitRef="usd">-7000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEwLTMtMS0xLTA_0815621f-159d-48c5-bbcc-a728479dacf4"
      unitRef="usd">6000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEwLTUtMS0xLTA_5d792877-ba4f-4402-9c40-736a3929d4ec"
      unitRef="usd">-3000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzExLTEtMS0xLTA_764e0987-f7bf-4dfa-84cb-071ecb496f4b"
      unitRef="usd">1000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzExLTMtMS0xLTA_d102b2c6-f5f9-4c9b-81ed-0dff323757e3"
      unitRef="usd">-1000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzExLTUtMS0xLTA_fb6962ac-e677-4ba0-8757-def23aac4b20"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEyLTEtMS0xLTA_f723aebe-af8e-4ac4-ab21-e01d4cf0f130"
      unitRef="usd">-19000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEyLTMtMS0xLTA_d5d84579-28b7-4633-90a8-595592139804"
      unitRef="usd">10000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEyLTUtMS0xLTA_b26ce469-fd85-420a-bc14-fc9acea9bd42"
      unitRef="usd">-6000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEzLTEtMS0xLTA_8a466da8-7274-4de3-b4ba-eb0111bfb5d0"
      unitRef="usd">288000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEzLTMtMS0xLTA_0aee4728-53ca-46ee-8561-27c379d0d0e6"
      unitRef="usd">235000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTowNWE0MmJkM2M3NTM0NWM5YWMzMDY1ZWNkN2I5OTlhZC90YWJsZXJhbmdlOjA1YTQyYmQzYzc1MzQ1YzlhYzMwNjVlY2Q3Yjk5OWFkXzEzLTUtMS0xLTA_33444bdc-8b74-40cc-a41c-49b1e3046aa8"
      unitRef="usd">292000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQ5MDE_3d87cdf9-47c3-4458-9528-ceb72f40f31b">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. federal statutory income tax rate to the combined effective income tax rate for continuing operations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Statutory federal tax (benefit) rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State income provision (benefit), net of federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible health insurer fee (&#x201c;HIF&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Worthless stock deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective tax expense rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzItMS0xLTEtMA_608a2365-c949-4bb6-bbda-8775d388c91d"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzItMy0xLTEtMA_dee04a1e-a753-461b-a061-fe8eeb270138"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzItNS0xLTEtMA_95d7c7c2-0461-4bdf-a664-605c5463ef04"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzMtMS0xLTEtMA_dbf16387-2ecb-44d2-8b60-80e1423c5451"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzMtMy0xLTEtMA_f1641699-3c41-4578-81bd-852ecff303bd"
      unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzMtNS0xLTEtMA_4fad909b-eeed-4a6d-ad8f-9bd3203ccee7"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <moh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzUtMS0xLTEtMA_4c6d760e-1e7a-4099-9aa7-00a5e5f70a35"
      unitRef="number">0.061</moh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent>
    <moh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzUtMy0xLTEtMA_11a0cb1d-bb5d-4817-8172-3b6a008c4629"
      unitRef="number">0</moh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent>
    <moh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzUtNS0xLTEtMA_77fd408e-d18f-4997-ab4b-61f693e5ef41"
      unitRef="number">0.073</moh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzYtMS0xLTEtMA_cd45bab2-2ccb-42b8-b7e2-5195b70d1421"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzYtMy0xLTEtMA_914990ab-0eed-4316-bf60-c738c0169a6b"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzYtNS0xLTEtMA_95795cc3-b753-4d48-97ab-1f2baf2ff26f"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <moh:EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzktMS0xLTEtMA_1bf66230-6075-4713-988d-7c9b71c45a56"
      unitRef="number">0</moh:EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction>
    <moh:EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzktMy0xLTEtMA_20d6b7d5-64d6-47d3-bbf7-dae3c0ae275f"
      unitRef="number">0</moh:EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction>
    <moh:EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzktNS0xLTEtMA_312b6725-30e4-4786-8f2f-1576e45657cc"
      unitRef="number">0.010</moh:EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE0LTEtMS0xLTA_bdd70234-f288-4650-9002-a3e577189edc"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE0LTMtMS0xLTA_e5b79c73-120f-4b2d-bf87-3d43f917d9a1"
      unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE0LTUtMS0xLTA_0cf94be5-31be-4302-a22e-bea3570b8fce"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE1LTEtMS0xLTA_67a1ec42-508c-4ed7-8c43-555457d3d247"
      unitRef="number">0.300</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE1LTMtMS0xLTA_fb849a46-ba20-4392-8a8a-6f00525ee2af"
      unitRef="number">0.242</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo5ZDMyZWEyNmNlMmE0MmU3OWQ4MWMwZmU2NjkxMGZkMy90YWJsZXJhbmdlOjlkMzJlYTI2Y2UyYTQyZTc5ZDgxYzBmZTY2OTEwZmQzXzE1LTUtMS0xLTA_583d560f-8ae9-4e48-a14a-887c2b30287d"
      unitRef="number">0.292</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQ5MTM_0abd3a20-e1bf-48f7-9738-39981f50bc49">Significant components of our deferred tax assets and liabilities as of December&#160;31, 2020 and 2019 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and reserve liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued medical costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets and intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease financing obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax credit carryover&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets, net of valuation allowance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets and intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gains and losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred income tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzMtMS0xLTEtMA_0a9b9983-b648-4a48-a21b-06fdf8ef7cda"
      unitRef="usd">52000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzMtMy0xLTEtMA_97943fd7-ccc8-4e86-8a58-4106a4998968"
      unitRef="usd">35000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzQtMS0xLTEtMA_2efd3dcd-ba7b-4f76-845d-85a9d435f0b6"
      unitRef="usd">15000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzQtMy0xLTEtMA_1920812c-f275-4437-8b49-34cffd7b7024"
      unitRef="usd">11000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzUtMS0xLTEtMA_5dcf0170-2d11-4c90-8b2e-5bc730b2d1c7"
      unitRef="usd">11000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzUtMy0xLTEtMA_961dbb7b-69bf-43fe-be7e-8d782acee8d0"
      unitRef="usd">13000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <moh:DeferredTaxAssetsFixedAssetsAndIntangibles
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzYtMS0xLTEtMA_6b2656ad-a60f-4233-89f4-2d8c365c1532"
      unitRef="usd">0</moh:DeferredTaxAssetsFixedAssetsAndIntangibles>
    <moh:DeferredTaxAssetsFixedAssetsAndIntangibles
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzYtMy0xLTEtMA_746d3937-1a66-40e5-93bf-2b14b8085bbc"
      unitRef="usd">26000000</moh:DeferredTaxAssetsFixedAssetsAndIntangibles>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzctMS0xLTEtMA_e7e7ac15-68c9-438a-b336-3850215c55c7"
      unitRef="usd">18000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzctMy0xLTEtMA_1e215524-615a-48be-b3ac-8bc7dc58c428"
      unitRef="usd">11000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzgtMS0xLTEtMA_a8cfe1ed-f396-495b-ab38-5f8ea07a735e"
      unitRef="usd">8000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzgtMy0xLTEtMA_d9f28ec3-df81-4b85-abc7-e32fd87e4431"
      unitRef="usd">5000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzktMS0xLTEtMA_5c0da48b-3bf6-492c-b7e9-50214c021591"
      unitRef="usd">7000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzktMy0xLTEtMA_7fcc4f70-7c6c-4108-8970-b34f12409edf"
      unitRef="usd">11000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEwLTEtMS0xLTA_e8d04fe2-56dc-4dc4-8136-76ed9a950df4"
      unitRef="usd">4000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEwLTMtMS0xLTA_cd1a42e7-1957-471e-af55-c3140741e2c9"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzExLTEtMS0xLTA_f5433c58-c8a1-4d82-b3f8-5e8b24d99bf9"
      unitRef="usd">17000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzExLTMtMS0xLTA_5bcae8c3-b873-4f63-ba35-cb63955df888"
      unitRef="usd">24000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEyLTEtMS0xLTA_278a9e77-e0c9-4dcd-8cdb-13badce79537"
      unitRef="usd">98000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEyLTMtMS0xLTA_0b3680d1-4c99-43d6-8d97-9b698a757f51"
      unitRef="usd">88000000</us-gaap:DeferredTaxAssetsNet>
    <moh:DeferredTaxLiabilitiesFixedAssetsAndIntangibles
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEzLTEtMS0xLTIwMzA1_e821329e-ca45-48a8-9fd6-832660cbb3e4"
      unitRef="usd">7000000</moh:DeferredTaxLiabilitiesFixedAssetsAndIntangibles>
    <moh:DeferredTaxLiabilitiesFixedAssetsAndIntangibles
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEzLTMtMS0xLTIwMzA1_39446931-a634-427b-8a96-2d2619c35e2a"
      unitRef="usd">0</moh:DeferredTaxLiabilitiesFixedAssetsAndIntangibles>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEzLTEtMS0xLTA_c7f7cde6-7fb6-4cd8-b4fa-434dfc029020"
      unitRef="usd">10000000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzEzLTMtMS0xLTA_c2b069bd-5f2e-4262-8088-b03171d55145"
      unitRef="usd">6000000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE0LTEtMS0xLTE2ODM5_94ce9aac-6042-4535-8f23-e74b9f0cd3e2"
      unitRef="usd">12000000</us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities>
    <us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE0LTMtMS0xLTE2ODM5_539094f4-7964-4b94-bc26-bf1f519f5936"
      unitRef="usd">1000000</us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE2LTEtMS0xLTA_69bc2588-0ffc-48d4-8086-15d58b27b2db"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE2LTMtMS0xLTA_9dd06ae3-42cf-4b72-8c73-6447ed27b001"
      unitRef="usd">2000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE3LTEtMS0xLTA_1d7d2eda-76a3-487d-93de-116548f597ef"
      unitRef="usd">29000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE3LTMtMS0xLTA_2b36a4c2-bbd8-4baf-b028-2d2281cb269e"
      unitRef="usd">9000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE4LTEtMS0xLTA_3b9ea30f-f965-4d35-8e43-0bf02ce4b773"
      unitRef="usd">69000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTpmOTA2M2QxODYxZWU0YWNkODNhMDRhYWI2NmQzZWVjZi90YWJsZXJhbmdlOmY5MDYzZDE4NjFlZTRhY2Q4M2EwNGFhYjY2ZDNlZWNmXzE4LTMtMS0xLTA_29922d8b-c362-46f3-8777-e7888e2ac3b4"
      unitRef="usd">79000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i777fc2beee3c4a10b06e4fde2ab42f6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzIyNDA_09fbb055-aa37-4d75-a7a4-bd9b7e66e6eb"
      unitRef="usd">189000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i0ce9e160ed604a74a1a9a4c25add9c6a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzEwOTk1MTE2MzQxMjA_395e3f63-44c2-4a38-a439-0683d8deb399"
      unitRef="usd">5000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i777fc2beee3c4a10b06e4fde2ab42f6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzIzNjk_a9357204-7dc1-4598-b571-1ad19e97f672"
      unitRef="usd">3000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i0ce9e160ed604a74a1a9a4c25add9c6a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzI0NDY_769bd4e2-b8f1-412e-b7bc-ca28ca2adb41"
      unitRef="usd">5000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardValuationAllowance
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzI3NDU_36e4a3e3-58bc-451d-8825-0cdf627f36b8"
      unitRef="usd">17000000</us-gaap:TaxCreditCarryforwardValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzI4NjQ_8f17082b-1aaa-411f-aeb7-8e3fb7f9482f"
      unitRef="usd">-7000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzI4NzM_99aaed14-7166-42ff-9cee-a738766b4165"
      unitRef="usd">24000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzI4ODY_370f237d-d924-436e-9524-0ed5d2095541"
      unitRef="usd">17000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQ5MDQ_a2a682a4-69c0-4989-9867-59e4efc9aa87">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The roll forward of our unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increases in tax positions for current year &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse in statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzMtMS0xLTEtMA_e1d43b81-9bba-44b4-a2c9-fc58ce3705b6"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzMtMy0xLTEtMA_153e7c5e-2170-4513-ae45-f4a5f37b6085"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie5276df7533a434dba724ca46fb6260b_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzMtNS0xLTEtMA_20255057-59ac-4165-948d-18558b804d5b"
      unitRef="usd">13000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzQtMS0xLTEtMA_0ebc76fd-217e-4a51-a2bb-694ea953d44f"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzQtMy0xLTEtMA_eabab83a-af95-4116-a818-12dda4f88c50"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzQtNS0xLTEtMA_431f7e6b-0ec4-4f3f-b01c-d6232944101d"
      unitRef="usd">9000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzctMS0xLTEtMA_a66b0295-257f-416b-b587-6a27effd14fc"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzctMy0xLTEtMA_24df9227-3621-4d94-be77-49a0bfbcd696"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzctNS0xLTEtMA_ad3be38c-473e-436a-9583-f093e353b3f7"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzExLTEtMS0xLTA_af7c225e-af50-4a16-91b8-038014c4765f"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzExLTMtMS0xLTA_ccd1f365-783e-48ea-add6-5c4a3405d8f0"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90YWJsZTo2NmI4YWM5MTBkMDg0YzVlYTc1ZmYxYzRiNmNlZDViMC90YWJsZXJhbmdlOjY2YjhhYzkxMGQwODRjNWVhNzVmZjFjNGI2Y2VkNWIwXzExLTUtMS0xLTA_ee0a9063-5a91-4d7c-9e55-adbb38d19f95"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQwNzE_9ea2888c-32c1-412f-ae10-f8884d1dd25a"
      unitRef="usd">18000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDIvZnJhZzoyNzk1NWY1MzU0OGI0ZmQxYmZhZGVhYjI2MGQ4NDE3Yy90ZXh0cmVnaW9uOjI3OTU1ZjUzNTQ4YjRmZDFiZmFkZWFiMjYwZDg0MTdjXzQyMzc_45ee50d5-f3cd-47ab-9387-6adc046832b7"
      unitRef="usd">10000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2Mzg_bc2e39cd-620d-4f41-af64-eb3575aec0c2">Stockholders' Equity &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Purchase Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, our board of directors authorized the purchase of up to $500 million, in the aggregate, of our common stock. This program is funded with cash on hand and extends through December 31, 2021. The exact timing and amount of any repurchase is determined by management based on market conditions and share price, in addition to other factors, and subject to the restrictions relating to volume, price, and timing under applicable law. Under this program, pursuant to a Rule 10b5-1 trading plan, we purchased approximately 766,000 shares of our common stock for $159 million in November and December 2020 (average cost of $208.37 per share), including approximately 29,000 shares purchased for $6 million in late December 2020, and settled in early January 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, our board of directors authorized the purchase of up to $500 million, in the aggregate, of our common stock. This program was funded with existing cash on hand and was completed in March 2020. Under this program, pursuant to a Rule 10b5-1 trading plan, we purchased approximately 3.4 million shares of our common stock for $446 million in the first quarter of 2020 (average cost of $132.45 per share). In the first quarter of 2020, we also paid $7&#160;million to settle shares purchased in late December 2019.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Subsequent Event&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From January 1, 2021 through February 11, 2021, we purchased approximately 577,000 shares for $122 million (average cost of $211.65 per share).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the 1.125% Convertible Notes settlement transaction described in Note 11, &#x201c;Debt,&#x201d; in the first quarter of 2020 we entered into privately negotiated agreements to terminate the associated 310,000 warrants outstanding for $30&#160;million, which resulted in a reduction of additional paid-in-capital for the same amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with our employee stock plans, approximately 244,000 shares and 242,000 shares of common stock were issued, net of shares used to settle employees&#x2019; income tax obligations, during the years ended December&#160;31, 2020, and 2019, respectively. Total share-based compensation expense is reported in &#x201c;General and administrative expenses&#x201d; in the accompanying consolidated statements of income, and summarized below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;br/&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net-of-Tax&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;br/&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net-of-Tax&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;br/&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net-of-Tax&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;RSAs, PSAs and PSUs (defined below)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan and stock options &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, we had employee equity incentives outstanding under our 2019 Equity Incentive Plan (the &#x201c;2019 EIP&#x201d;). The 2019 EIP provides for awards, in the form of restricted and performance stock awards (&#x201c;RSAs&#x201d; and &#x201c;PSAs&#x201d;), performance units (&#x201c;PSUs&#x201d;), stock options, and other stock&#x2013; or cash&#x2013;based awards, to eligible persons who perform services for us. The 2019 EIP provides for the issuance of up to 2.9 million shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. RSAs, PSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. Certain PSUs may vest in their entirety at the end of three-year performance periods, if their performance conditions are met. We generally recognize expense for RSAs, PSAs and PSUs on a straight-line basis. Activity for stock-based awards in the year ended December&#160;31, 2020, is summarized below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested balance, December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;344,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(172,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested balance, December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;585,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;471,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, total unrecognized compensation expense related to unvested RSAs and PSUs was $42 million, and $23 million, respectively, which we expect to recognize over a remaining weighted-average period of 2.2 years, and 1.2 years, respectively. This unrecognized compensation cost assumes an estimated forfeiture rate of 12.2% for non-executive employees as of December&#160;31, 2020, based on actual forfeitures over the last 4 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total grant date fair value of awards granted and vested is presented in the following table.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Stock option awards generally have an exercise price equal to the fair market value of our common stock on the date of grant, vest in equal annual installments over periods up to four years from the date of grant, and have a maximum term of ten years from the date of grant. Stock option activity for the year ended December&#160;31, 2020, is summarized below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options outstanding as of December 31, 2019 and December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options exercisable and expected to vest as of December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercisable as of December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No stock options were granted or exercised in 2020, 2019, or 2018, and as of December&#160;31, 2020, there was no unrecognized compensation expense related to unvested stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of information about stock options outstanding and exercisable at December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Outstanding and Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Per share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Range of Exercise Prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$33.02&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$67.33&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Employee Stock Purchase Plans (&#x201c;ESPP&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our ESPP, eligible employees may purchase common shares at 85% of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a maximum purchase of $25,000 (as measured by the fair value of the stock acquired) per year through payroll deductions. We estimate the fair value of the stock issued using a standard option pricing model. For the years ended December&#160;31, 2020, 2019, and 2018, the inputs to this model were as follows: risk-free interest rates of approximately 0.2% to 2.3%; expected volatility of approximately 31% to 51%, dividend yields of 0%, and an average expected life of 0.5 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i31b468479ec6404c8a870d751d8727e0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzIxOTkwMjMyNjQ0OTM_50182fb9-c81f-4bad-887d-8690bee78ba9"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i1127fb6f8661484e9a2afce5e70e881c_D20201101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzIxOTkwMjMyNjQ1MjI_511aeb1d-cfee-4716-b49b-b73a1fe498b6"
      unitRef="shares">766000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i1127fb6f8661484e9a2afce5e70e881c_D20201101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzIxOTkwMjMyNjQ1MTc_5abad43f-3fa9-44de-a29e-a243c88e6a72"
      unitRef="usd">159000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i1127fb6f8661484e9a2afce5e70e881c_D20201101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzIxOTkwMjMyNjQ1MzI_ddeaf7be-7459-4371-a0c2-271ffdb0dfdb"
      unitRef="usdPerShare">208.37</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i20fed1f62d734cc294821cf3b9a1b49a_D20201201-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzEwOTk1MTE2Mzk4NjA_d332a651-b371-4e6d-bcd5-af2ea71b1bcb"
      unitRef="shares">29000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i20fed1f62d734cc294821cf3b9a1b49a_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzEwOTk1MTE2Mzk3Njk_bc1467d3-8de3-4a20-bcaa-d27f441af95f"
      unitRef="usd">6000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ib0d1799cc9734f13b9ac873259cad7c6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzExNg_a79dbcf7-4823-4345-9791-80a721589dad"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i19562697a92c4804a128c7d53a9fca1c_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzMyOQ_92721b51-b2b9-4641-8636-27035a3e7359"
      unitRef="shares">3400000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i19562697a92c4804a128c7d53a9fca1c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzM2Mw_1ccea1d5-39c9-4419-aabc-1bf951206187"
      unitRef="usd">446000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i19562697a92c4804a128c7d53a9fca1c_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzQxMg_f5558456-620f-4bb5-af09-37e9e08be969"
      unitRef="usdPerShare">132.45</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i6c2f88ae28624d2d83b180b3207c2ee4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzE2NDkyNjc0NTQwOTg_cb265f59-e0e8-4dac-afab-038d382ef8bb"
      unitRef="usd">7000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i405b0566313b404d88d226953fb10b4b_D20210101-20210211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzEwOTk1MTE2Mzk4Nzc_169badeb-61e5-4852-b4aa-22911c97f308"
      unitRef="shares">577000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i405b0566313b404d88d226953fb10b4b_D20210101-20210211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzEwOTk1MTE2Mzk4OTI_7fa06e84-6335-4f73-93c5-a277f49d1069"
      unitRef="usd">122000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i405b0566313b404d88d226953fb10b4b_D20210101-20210211"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzEwOTk1MTE2Mzk5MDM_d90f0ac2-8d63-4f89-88e5-97b410c7b16c"
      unitRef="usdPerShare">211.65</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <moh:ClassOfWarrantOrRightStatedInterestRate
      contextRef="i230e39d7097f4f04ac9d6a41de9ad215_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzU0OTc1NTgxNTExODY_f946c1c1-672d-48cb-a567-477f0f53a9ea"
      unitRef="number">0.01125</moh:ClassOfWarrantOrRightStatedInterestRate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i230e39d7097f4f04ac9d6a41de9ad215_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYwNDczMTM5NjU1NDg_9f2daafb-e073-4e02-8f06-e860e79a1bf3"
      unitRef="shares">310000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="i0f8dcd5ceb6c487f9c1bdf9a574307f8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzIxOTkwMjMyNjYwNDM_745209ef-bf18-4b41-a006-a383356eed9e"
      unitRef="usd">30000000</us-gaap:PaymentsForRepurchaseOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i96a5b2f5752d4c3d8f85ea9e8b1da0ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY1OTcwNjk3ODAxMTU_9dfbe22a-9017-4eb1-8ca2-6857b91bb8b7"
      unitRef="shares">244000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i3ac5351ddca146c7888f5e88c0fb0733_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY1OTcwNjk3ODAxMzA_497a7e12-57c7-4b6d-a68e-26f231341c7f"
      unitRef="shares">242000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY1OTg_d032ff41-5580-4d1e-b850-48e1a08290f1">Total share-based compensation expense is reported in &#x201c;General and administrative expenses&#x201d; in the accompanying consolidated statements of income, and summarized below.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;br/&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net-of-Tax&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;br/&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net-of-Tax&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;br/&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net-of-Tax&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;RSAs, PSAs and PSUs (defined below)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan and stock options &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7e5144ba022d44d493772c715fe5aa45_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtMS0xLTEtMA_2908f00a-2f56-4bff-a3ab-1e88d0a8d792"
      unitRef="usd">47000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i7e5144ba022d44d493772c715fe5aa45_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtMy0xLTEtMA_18a51a50-8838-483e-865a-74b068279a0f"
      unitRef="usd">44000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idcae5fc25c5d4bfe9751f1e0b6a647e4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtNS0xLTEtMA_11a46f23-b38b-4aa4-8efd-38fbf733c0d6"
      unitRef="usd">29000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="idcae5fc25c5d4bfe9751f1e0b6a647e4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtNy0xLTEtMA_36c44383-4829-4ec6-82f1-eaefac7537ea"
      unitRef="usd">28000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i09bb25d620c34957a416d46cefe3fae8_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtOS0xLTEtMA_a2827c7f-662f-4143-9ba6-269834734e91"
      unitRef="usd">17000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i09bb25d620c34957a416d46cefe3fae8_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzQtMTEtMS0xLTA_4a34e49f-2cfd-4ec3-af54-ecaaad34c813"
      unitRef="usd">17000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i76f621f530a7426ebac680c21dabf01e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtMS0xLTEtMA_d0818814-38c9-438e-a8d7-086b10d72693"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i76f621f530a7426ebac680c21dabf01e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtMy0xLTEtMA_61c29558-03e5-49c0-bb3a-e44993c38ea8"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3f8a559e0b7d4a32b56f7a92d9cc722b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtNS0xLTEtMA_4e5ebb4b-a36b-434b-bbf3-eca6d3f5522d"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i3f8a559e0b7d4a32b56f7a92d9cc722b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtNy0xLTEtMA_72f6ecfb-91c4-41c4-850f-8f696c01b481"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4bc80c4169054f6d86a4e10b0c36c602_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtOS0xLTEtMA_056e8b17-74bf-4275-8636-ef575988f1a9"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i4bc80c4169054f6d86a4e10b0c36c602_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzUtMTEtMS0xLTA_92e7242c-85f1-4811-bbc5-4587839ddff3"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtMS0xLTEtMA_9ca84a72-5bb7-4fc7-8b72-b6c4e68c3e11"
      unitRef="usd">57000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtMy0xLTEtMA_5587d967-eab2-4a51-8999-aba462f639c5"
      unitRef="usd">53000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtNS0xLTEtMA_8abd3af8-ca7f-4001-aff6-523162f74ebc"
      unitRef="usd">39000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtNy0xLTEtMA_20029c79-08e9-44a3-a45d-cf9fe8b429db"
      unitRef="usd">37000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtOS0xLTEtMA_dc1093f8-bafe-4a03-9c5b-77ee55ad1d59"
      unitRef="usd">27000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTpiNmE1Y2IwNzY2OTU0NzQwYWZlZGI4YjA1ODQxZTY3ZS90YWJsZXJhbmdlOmI2YTVjYjA3NjY5NTQ3NDBhZmVkYjhiMDU4NDFlNjdlXzYtMTEtMS0xLTA_71aef67b-1d40-4363-b607-c5ae444e77a9"
      unitRef="usd">26000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i292647db232f497088463dcb696a6bc4_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzMxNjc_09605f12-32a5-4a07-aef6-35cc6147620f"
      unitRef="shares">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzM0MzY_851268c7-d871-4cb5-aae4-6990c1ff5be4">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzU0OTc1NTgxNTEyMDc_0620f3f5-c428-4811-8e50-74803f3a2b87">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2MjM_86c48cf7-ebc9-41aa-95b3-f7a6804aab2a">Activity for stock-based awards in the year ended December&#160;31, 2020, is summarized below.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested balance, December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;344,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(172,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested balance, December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;585,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;471,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib4aca872bf92456a9a20db5fae524392_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzEtMS0xLTEtMTc5Ng_cf0f3603-7b2e-45e1-8758-060b01731201"
      unitRef="shares">447680</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib4aca872bf92456a9a20db5fae524392_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzEtMy0xLTEtNTU4Mg_6836cf0d-6af5-46ee-8309-86eef2cedc4a"
      unitRef="usdPerShare">102.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i89fe848546204fe2b34f89e0a78c161d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzEtNS0xLTEtMTc5Ng_81448c2c-839b-41ad-b4d9-911a9309aef3"
      unitRef="shares">324078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i89fe848546204fe2b34f89e0a78c161d_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzEtNy0xLTEtNTU4NA_4d072bd0-0ac2-42c6-a58d-b9f904c7fab6"
      unitRef="usdPerShare">101.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzItMS0xLTEtMTc5Ng_0c327815-235a-4c19-a646-636c23f3567a"
      unitRef="shares">344739</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzItMy0xLTEtNTU4Mg_f8db93e1-cee5-4253-917b-304dc6f05139"
      unitRef="usdPerShare">127.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzItNS0xLTEtMTc5Ng_f94c5882-f330-4073-9ee1-b7ffab9a82fc"
      unitRef="shares">188522</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzItNy0xLTEtNTU4NA_183ed248-70d3-4248-8773-a8b6d65dd4f7"
      unitRef="usdPerShare">123.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzMtMS0xLTEtMTc5Ng_38ce8e39-67b5-45fd-8c49-9e39f4045274"
      unitRef="shares">172675</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzMtMy0xLTEtNTU4Mg_688a2dfd-a6ce-4282-800a-9b264e9c2a76"
      unitRef="usdPerShare">98.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzMtNS0xLTEtMTc5Ng_ff6a721a-ba55-421c-a51b-242861a22a4a"
      unitRef="shares">7368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzMtNy0xLTEtNTU4NA_2e37a783-65fe-497f-910a-1614f2a599d8"
      unitRef="usdPerShare">68.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzQtMS0xLTEtMTc5Ng_53a182fb-891a-460e-981a-69d66fda0771"
      unitRef="shares">34660</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzQtMy0xLTEtNTU4Mg_bb872ede-c2a0-46aa-b616-f6f0ffc5131d"
      unitRef="usdPerShare">113.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzQtNS0xLTEtMTc5Ng_ae3918ad-4cf3-434c-b6f4-4463ca13bde7"
      unitRef="shares">33323</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzQtNy0xLTEtNTU4NA_b4661896-3a08-4822-876b-ec78eeb12c1c"
      unitRef="usdPerShare">98.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i572ceba4cf6044c5902601a01b0ea881_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzUtMS0xLTEtMTc5Ng_d1cd1068-a214-4461-a033-481326654dbb"
      unitRef="shares">585084</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i572ceba4cf6044c5902601a01b0ea881_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzUtMy0xLTEtNTU4Mg_93e08116-840b-4b47-8af2-69d13fe886aa"
      unitRef="usdPerShare">118.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i36ed381ff8654ca990008ef6dcd3154b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzUtNS0xLTEtMTc5Ng_f3041690-5c26-4221-b2bf-b4c53c242baf"
      unitRef="shares">471909</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i36ed381ff8654ca990008ef6dcd3154b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTowMjk2ODcyYzI1ZmI0ZWVlYTk1MTE0MWJkNjUyMjFhOC90YWJsZXJhbmdlOjAyOTY4NzJjMjVmYjRlZWVhOTUxMTQxYmQ2NTIyMWE4XzUtNy0xLTEtNTU4NA_38587b9c-2681-4d39-ab3d-f2628b36170e"
      unitRef="usdPerShare">111.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i572ceba4cf6044c5902601a01b0ea881_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzM4MzU_08a010c8-2a7b-4f48-8da9-f00b8441772c"
      unitRef="usd">42000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i36ed381ff8654ca990008ef6dcd3154b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzE2NDkyNjc0NTU0OTQ_a20c6dbd-e501-4293-b073-d5d6e34b19bc"
      unitRef="usd">23000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzM5MTI_3359ce9a-2d9e-43a2-9631-7a800fa8920c">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzM5MjA_67c0c943-e31a-46a2-aa55-275281ac75c1">P1Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <moh:UnrecognizedCompensationForfeitedRate
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzQwMTQ_409a0520-2260-4d04-bb3d-1ec7dafda7cf"
      unitRef="number">0.122</moh:UnrecognizedCompensationForfeitedRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzU0OTc1NTgxNDk3NDg_0a0dc098-ff01-4261-b5cb-f342d5488ad5">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY1OTk_a6cc51f0-8312-47c2-bcb1-90b530898338">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total grant date fair value of awards granted and vested is presented in the following table.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Stock option awards generally have an exercise price equal to the fair market value of our common stock on the date of grant, vest in equal annual installments over periods up to four years from the date of grant, and have a maximum term of ten years from the date of grant. Stock option activity for the year ended December&#160;31, 2020, is summarized below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options outstanding as of December 31, 2019 and December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options exercisable and expected to vest as of December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercisable as of December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzQtMS0xLTEtMA_4c1791eb-0530-4d4c-9ae4-1fbef3f75e1d"
      unitRef="usd">44000000</moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="i28cf707559d6450aabd54eb6691a6598_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzQtMy0xLTEtMA_a5ead032-3919-4b90-8e76-431a7e449a3f"
      unitRef="usd">33000000</moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="i372cfd6a471f48bcbd14fd8e83885c92_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzQtNS0xLTEtMA_e56c0559-dada-4baa-8fd8-43135c8515d2"
      unitRef="usd">28000000</moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzUtMS0xLTEtMA_3c95d38e-da4f-46fe-8fa3-475a260af7b1"
      unitRef="usd">23000000</moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="iba5202a65ac342848cf80d5efc7a35c9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzUtMy0xLTEtMA_a7a11b96-0cf5-4e57-b633-860f6f5a3c24"
      unitRef="usd">20000000</moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="ifd75881230294473867aed8c11c46a5b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzUtNS0xLTEtMA_655ce6c2-1782-4620-bc2e-2c6ac2f30576"
      unitRef="usd">16000000</moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzYtMS0xLTEtMA_9946bc1d-301d-4b85-bf9b-3a8fbf22d967"
      unitRef="usd">67000000</moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzYtMy0xLTEtMA_59843c5c-ce9d-4bc3-a021-305c2a2836fa"
      unitRef="usd">53000000</moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzYtNS0xLTEtMA_de73bf26-c58c-455b-82af-78efa26a0033"
      unitRef="usd">44000000</moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ibf218c1db8cf4351b079baa8657d9b49_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzgtMS0xLTEtMA_dd76ee06-7825-4f6c-931c-9a444edaf09d"
      unitRef="usd">22000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i28cf707559d6450aabd54eb6691a6598_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzgtMy0xLTEtMA_1a77a60c-eed5-4e34-91d2-da82c75ee529"
      unitRef="usd">19000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i372cfd6a471f48bcbd14fd8e83885c92_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzgtNS0xLTEtMA_e8390ce1-558f-4609-8791-ddf566f543fb"
      unitRef="usd">15000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ib4d57c51df1f4304bfc986fb72585507_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzktMS0xLTEtMA_87649c56-841c-40c7-9b45-d30b78f6c2fb"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ib82194307d804f828b55b0572af7065d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzktMy0xLTEtMA_00996588-b755-449d-9291-87f08fd4ae15"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ibb6f3b120b6c45aabfabfd970687858d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzktNS0xLTEtMA_2386817d-80bd-4b7a-bdc8-d7b346c87d2c"
      unitRef="usd">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ia6e56a1869bc464bbcd294d99d6194da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzEwLTEtMS0xLTA_06982750-f297-430d-848b-03ef2544b9a0"
      unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="iba5202a65ac342848cf80d5efc7a35c9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzEwLTMtMS0xLTA_2c20dc06-188b-4e86-aa80-0abf33754179"
      unitRef="usd">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ifd75881230294473867aed8c11c46a5b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzEwLTUtMS0xLTA_83263f0e-96ec-4b01-9514-b9921269e0b6"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzExLTEtMS0xLTA_e498ba89-e35d-4995-a429-843fdbb666bb"
      unitRef="usd">23000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzExLTMtMS0xLTA_b69a1893-dcef-4562-9ef3-cdc76661e7a3"
      unitRef="usd">21000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTplZDJiY2RlZGJkZTk0ZjQ4Yjk2MDY3NjBmZWEyNzZjMC90YWJsZXJhbmdlOmVkMmJjZGVkYmRlOTRmNDhiOTYwNjc2MGZlYTI3NmMwXzExLTUtMS0xLTA_37583b65-009c-41f3-8d87-07b944e0e169"
      unitRef="usd">18000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ife21f4c2287b449c80bf5cbcb34cfee4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzQ0MDE_63356a67-a1a1-40b7-9de8-1b77228cab60">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ife21f4c2287b449c80bf5cbcb34cfee4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzQ0NTU_0b2f0405-1bf9-4bd1-b73c-6427fcc9aa2d">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtMS0xLTEtMA_81a00482-1b66-439f-bf3f-fa6267f7852a"
      unitRef="shares">405000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtMS0xLTEtMA_b81b2957-85a5-4d82-a0e0-96af174b0058"
      unitRef="shares">405000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtMy0xLTEtMA_3e04aaae-eb12-4b0d-a8d9-a2df790b8697"
      unitRef="usdPerShare">64.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtMy0xLTEtMA_74e574eb-36a8-443a-87f3-1fb48d0a55d8"
      unitRef="usdPerShare">64.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtNS0xLTEtMA_73a9483b-488c-4dd7-9b95-da74ad487135"
      unitRef="usd">60000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtNS0xLTEtMA_b75d2c90-618a-41c7-bb76-b751240c3af0"
      unitRef="usd">60000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtNy0xLTEtMA_18d58092-6643-4f0b-b117-5d40336e979a">P6Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzUtNy0xLTEtMA_99f19a5b-8c28-418e-ba48-862659580dde">P6Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzYtMS0xLTEtMA_34745060-0a70-4025-a5f3-7603aed61c30"
      unitRef="shares">405000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzYtMy0xLTEtMA_84371e75-eb11-4602-8504-d00fedbe8152"
      unitRef="usdPerShare">64.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzYtNS0xLTEtMA_00367667-2064-46ba-af0f-1d26c5df79c9"
      unitRef="usd">60000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzYtNy0xLTEtMA_5b7f83a4-1d99-43e9-8be6-980d5184138c">P6Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzctMS0xLTEtMA_b3337934-9f2a-4a37-bfbb-b6bd295872bd"
      unitRef="shares">405000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzctMy0xLTEtMA_da8f14c4-f426-49a1-8537-26682cabc167"
      unitRef="usdPerShare">64.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzctNS0xLTEtMA_2d9eddee-e87b-47b4-8ece-246b8dbc585a"
      unitRef="usd">60000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZToyNTZiZjkzMWY3NWQ0OTY4YWE0ZGI3NWY2ZWEyMzIyYS90YWJsZXJhbmdlOjI1NmJmOTMxZjc1ZDQ5NjhhYTRkYjc1ZjZlYTIzMjJhXzctNy0xLTEtMA_874de56b-0f75-4ed9-8c0a-6885c0f18f0d">P6Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2MzA_a5bac1d9-202d-4cce-9e1a-c5360be62d1f"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2MzA_c29dfc3f-4048-418d-9a6c-00c6c258728b"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2MzA_f98c17a1-d411-4df5-8d2a-11de74ecf312"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzY2MTg_5d10967a-b7d8-4142-ba31-8f2e562123ef">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of information about stock options outstanding and exercisable at December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Outstanding and Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Per share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Range of Exercise Prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$33.02&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$67.33&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ic3f96ca2a41b497882c4e2decff210d8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzQtMC0xLTEtMjE1MDYvdGV4dHJlZ2lvbjozZDU4MjIwOGQwOTE0OTEyOWE3ZDgwOGNiNTQzOGY2Y18xMDk5NTExNjI3Nzkw_829d2b1f-8f8f-4656-af27-257aae4e440f"
      unitRef="usdPerShare">33.02</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i1f5a36308730434eb22cb4ec367111c0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzMtMS0xLTEtMA_410da17c-89f9-416a-a982-99f6cb188c61"
      unitRef="shares">30000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ic3f96ca2a41b497882c4e2decff210d8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzMtMy0xLTEtMA_022995e2-7529-4ad1-8011-4eed14deb9c0">P2Y2M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i1f5a36308730434eb22cb4ec367111c0_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzMtNS0xLTEtMA_9b83321f-9da3-44b2-a7ee-e405160cea73"
      unitRef="usdPerShare">33.02</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i0f4bfa5083c14dc982d7f30f9c3f2c76_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzUtMC0xLTEtMjE1MTEvdGV4dHJlZ2lvbjo1Yzk5MzMxNWU3YTU0MGZiYWMzYWQ1MTFiZjE1Yjg1Ml8xMDk5NTExNjI3Nzkw_e87a51fc-b6f5-469e-a97d-a398b5c0a059"
      unitRef="usdPerShare">67.33</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ic0bfeb88842e48c681d6c147892747da_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzQtMS0xLTEtMA_07d26a6a-83e7-489a-b5fa-aecbb70ef35a"
      unitRef="shares">375000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i0f4bfa5083c14dc982d7f30f9c3f2c76_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzQtMy0xLTEtMA_a7ec8331-cc78-4d0e-bdff-3cb01b14f748">P6Y9M18D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ic0bfeb88842e48c681d6c147892747da_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzQtNS0xLTEtMA_b2c36aba-66cb-4dbc-8fb1-307b3fabf33a"
      unitRef="usdPerShare">67.33</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90YWJsZTphMzAxMjRhOTFkYjY0OTA3Yjg5NGYxMmE5MDQwYWRiYS90YWJsZXJhbmdlOmEzMDEyNGE5MWRiNjQ5MDdiODk0ZjEyYTkwNDBhZGJhXzUtMS0xLTEtMA_e4f5ac12-3add-4a1e-b44f-fe99062748d4"
      unitRef="shares">405000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <moh:FairMarketValueOfCommonStockPercentage
      contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzU1OTQ_683e1e2b-6d6e-4380-8532-333cfb4fae6d"
      unitRef="number">0.85</moh:FairMarketValueOfCommonStockPercentage>
    <moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee
      contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzU3ODM_1ac02c72-6e04-4de6-bafa-391777811635"
      unitRef="usd">25000</moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYwOTA_2cb63c97-c1a5-4ab4-995d-53add487e935"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYwOTY_07902ab4-57ce-4351-be9b-b37f9b52b86c"
      unitRef="number">0.023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYxNDk_84fb0dc6-b37e-4dfa-a5b5-ebb74189869a"
      unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYxNTU_6a47d57c-a17a-4a47-bedd-538e49c8152b"
      unitRef="number">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYxNzg_798b128a-3c6e-48a7-8c7a-88c94834c238"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ifaf87346c2214ddd988f7990d4d6194e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMDUvZnJhZzoxYmRkOGE1YjA1MmY0MGI4YjU5ZWI5YmRkNWRlNjM1NS90ZXh0cmVnaW9uOjFiZGQ4YTViMDUyZjQwYjhiNTllYjliZGQ1ZGU2MzU1XzYyMTQ_b6dbfbf6-06e2-4cf8-b466-d01d8b375f33">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzc2Ng_fe65695f-8a62-4473-a07c-bb5c0e7a2d38">Employee Benefit Plans&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4% of compensation contributed by employees. Expense recognized in connection with our contributions to the 401(k) plans amounted to $28 million, $28 million, and $36 million in the years ended December&#160;31, 2020, 2019, and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also have a non-qualified deferred compensation plan for certain key employees. Under this plan, eligible participants may defer up to 75% of their base salary and 90% of their bonus to provide tax-deferred growth.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzI1Nw_e3b21ac6-302f-4c45-9e21-e4dcfaefa235"
      unitRef="number">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzM5MA_917f0226-2e7e-4756-9a42-a7d5683db5ba"
      unitRef="usd">28000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzM5NA_803cceb2-d19a-46ec-9270-260d2752fa8d"
      unitRef="usd">28000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzQwMg_6d62cdcb-46f2-413e-8f5c-b3c4270710ee"
      unitRef="usd">36000000</us-gaap:DefinedContributionPlanCostRecognized>
    <moh:DeferredCompensationPlanDeferralPercentageOfBasicSalary
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzU5Mw_ae8cd113-7769-41af-bba9-8edbc44e1f5c"
      unitRef="number">0.75</moh:DeferredCompensationPlanDeferralPercentageOfBasicSalary>
    <moh:DeferredCompensationPlanDeferralPercentageOfBonus
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMTcvZnJhZzpmNDllZDIyZGVhNTE0MmI2YWIxMGU0ZjMyNGMzYmJlMi90ZXh0cmVnaW9uOmY0OWVkMjJkZWE1MTQyYjZhYjEwZTRmMzI0YzNiYmUyXzYyMQ_18778c3b-aace-40dd-9b50-7ec3ef4f714d"
      unitRef="number">0.90</moh:DeferredCompensationPlanDeferralPercentageOfBonus>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzQxNzI_fdb88b85-2030-4357-af8a-5da93094cdc3">Commitments and Contingencies &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulatory Capital Requirements and Dividend Restrictions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our health plans, which are generally operated by our respective wholly owned subsidiaries in those states, are subject to state laws and regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state. The National Association of Insurance Commissioners (&#x201c;NAIC&#x201d;), has adopted rules which, if implemented by the states, set minimum capitalization requirements for insurance companies, HMOs, and other entities bearing risk for healthcare coverage. The requirements take the form of risk-based capital (&#x201c;RBC&#x201d;) rules which may vary from state to state. Regulators in some states may also enforce capital requirements that require the retention of net worth in excess of amounts formally required by statute or regulation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the states in which our health plans operate, except California, Florida, Massachusetts and New York, have adopted the RBC rules. The RBC rules, if adopted by California, Florida, Massachusetts or New York, could increase the minimum capital required for those states. Our Massachusetts health plan, acquired on December 31, 2020, maintains a $35&#160;million performance bond, effective through December 31, 2021, to partially satisfy minimum net worth requirements in that state.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. Based on current statutes and regulations, the net assets in these subsidiaries (not including the Magellan Complete Care subsidiaries and after intercompany eliminations), which may not be transferable to us in the form of loans, advances, or cash dividends was approximately $1,960 million at December&#160;31, 2020, and $1,810 million at December&#160;31, 2019. We estimate the Magellan Complete Care subsidiaries&#x2019; net assets that may not be transferable amounted to approximately $420&#160;million at December 31, 2020. Because of the statutory restrictions that inhibit the ability of our health plans to transfer net assets to us, the amount of retained earnings readily available to pay dividends to our stockholders is generally limited to cash, cash equivalents and investments held by the parent company&#x2014;Molina Healthcare, Inc. Such cash, cash equivalents and investments amounted to $644 million and $997 million as of December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, our health plans (not including the Magellan Complete Care subsidiaries) had aggregate statutory capital and surplus of approximately $2,020 million compared with the required minimum aggregate statutory capital and surplus of approximately $1,310 million. As of December 31, 2020, the aggregate and minimum capital and surplus of the Magellan Complete Care subsidiaries amounted to approximately $420&#160;million and $230&#160;million, respectively. The aggregate capital and surplus of our wholly owned subsidiaries was in excess of these minimum capital requirements as of December&#160;31, 2020.  We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19 Pandemic&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We continue to monitor and assess the estimated operating and financial impact of the COVID-19 pandemic, and as it evolves, we continue to process, assemble, and assess member utilization information. We believe that our cash resources, borrowing capacity available under the Credit Agreement, and cash flow generated from operations will be sufficient to withstand the financial impact of the pandemic, and will enable us to continue to support our operations, regulatory requirements, debt repayment obligations, and capital expenditures for the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The healthcare industry is subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines and penalties, exclusion from participating in publicly funded programs, and the repayment of previously billed and collected revenues. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in legal actions in the ordinary course of business including, but not limited to, various employment claims, vendor disputes and provider claims. Some of these legal actions seek monetary damages, including claims for punitive damages, which may not be covered by insurance. We review legal matters and update our estimates of reasonably possible losses and related disclosures, as necessary. We have accrued liabilities for legal matters for which we deem the loss to be both probable and reasonably estimable. These liability estimates could change as a result of further developments of the matters. The outcome of legal actions is inherently uncertain. An adverse determination in one or more of these pending matters could have an adverse effect on our consolidated financial position, results of operations, or cash flows.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Kentucky RFP. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 4, 2020, Anthem Kentucky Managed Care Plan, Inc. brought an action in Franklin County Circuit Court against the Kentucky Finance and Administration Cabinet, the Kentucky Cabinet for Health and Family Services and all of the winning bidder health plans, including Molina Healthcare of Kentucky, Inc., Civil Action No. 20-CI-00719. In its action, Anthem requested that the court disqualify Molina Healthcare of Kentucky, find that the Kentucky RFP scoring was erroneous and violated procedures or was arbitrary and capricious, set aside the contract awards and conduct a new RFP evaluation process, and award injunctive relief, including stopping the implementation of the contracts awarded under the RFP. On September 28, 2020, the court issued a temporary restraining order preserving the status quo, and on October 23, 2020, the court issued a temporary injunction directing that the RFP readiness review and open enrollment proceed with six health plans, including both Anthem and Molina Healthcare. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 22, 2020, the court granted a motion by UnitedHealthcare of Kentucky LTD. to assert a cross-claim against the Kentucky Cabinet for Health and Family Services, which sought in part a disqualification of Anthem or Molina Healthcare and a declaratory judgment that the Kentucky Medicaid program proceed with only five health plans. On December 23, 2020, Humana Health Plan, Inc. brought a separate action against the Commonwealth of Kentucky and the winning bidder health plans, including Molina Healthcare of Kentucky, Civil Action 20-CI-00987. On January 11, 2021, both actions were consolidated before the Franklin County Circuit Court. Humana requests a declaratory judgment finding that the Commonwealth violated the Medicaid contract by allocating Passport members to Molina Healthcare for 2021 so that Passport members would instead be allocated to Humana and other winning health plans, or, in the alternative, monetary damages from the Commonwealth. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Molina Healthcare believes it has meritorious defenses to the claims of Anthem, United, and Humana, and intends to vigorously defend its position, including its twice being a winning bidder of the Kentucky Medicaid RFP, and its protection of the continuity of care for Passport Medicaid members. This matter remains subject to significant additional legal proceedings, and no assurances can be given regarding the ultimate outcome.  Under the court&#x2019;s temporary injunction, Molina Healthcare of Kentucky continues to operate under its contract and provide care to Kentucky Medicaid members.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Professional Liability Insurance&lt;/span&gt;&lt;/div&gt;We carry medical professional liability insurance for healthcare services rendered in the primary care institutions that we manage. In addition, we carry managed care errors and omissions insurance for all managed care services that we provide.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SpecialAssessmentBond
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzE3MDQyNDMwMjM5MDQ2_c67d6641-a582-46b6-93b5-93d876bba07a"
      unitRef="usd">35000000</us-gaap:SpecialAssessmentBond>
    <us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzIxMDk_cae0f30b-2104-43cf-8686-72151db2a3d8"
      unitRef="usd">1960000000</us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries>
    <us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzIxMjM_8a811ba5-3cde-4813-972b-e09bc5f62633"
      unitRef="usd">1810000000</us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries>
    <us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
      contextRef="iec02edc64cf748bcb7c0886f12b109e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzE3MDQyNDMwMjQwOTI0_f7759d27-b649-42d6-84fd-4ccd3d38c102"
      unitRef="usd">420000000</us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzI1MDU_39772075-1e28-46e6-9e71-c87c98082940"
      unitRef="usd">644000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzI1MTI_3f252ac4-798a-4d28-95e3-f5050d701476"
      unitRef="usd">997000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzYwNDczMTM5NTk4MDA_8c3bda13-704c-440e-8fa1-92b09c12a3db"
      unitRef="usd">2020000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzYwNDczMTM5NTk4OTY_3b14976e-5b95-419c-8bd9-dd5c896a5024"
      unitRef="usd">1310000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="iec02edc64cf748bcb7c0886f12b109e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzE3MDQyNDMwMjQwOTM4_0e1735bf-5bbb-46a5-a9da-45a6dc141149"
      unitRef="usd">420000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="i14669561f20444379f482d5083c58318_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjAvZnJhZzo0MDNmODg4YTU4NTA0YTNiODM5ZmIyMzBjODJlYTkzZi90ZXh0cmVnaW9uOjQwM2Y4ODhhNTg1MDRhM2I4MzlmYjIzMGM4MmVhOTNmXzYwNDczMTM5NjMxMjI_65888935-c4c3-4757-8592-7d77494bcda2"
      unitRef="usd">230000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90ZXh0cmVnaW9uOjhjNjg0MTJmYzZiMjRkZTBhZGQwMTM3ZmU1OGY5YmZkXzE3MDQyNDMwMjM2MjEw_ccc8b165-1bc2-4efa-9eb4-0629a815c169">Segments As of December 31, 2020, we had two reportable segments: the Health Plans segment, and the Other segment. Our reportable segments are consistent with how we currently manage the business and view the markets we serve.  The Health Plans reportable segment includes our regulated health plan operating segments, along with the recently acquired Magellan Complete Care health plans operating segment. Because this acquisition closed on December 31, 2020, Magellan Complete Care&#x2019;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020. Management will continue to evaluate the composition of its operating and reportable segments for future filings. The Other segment, which is insignificant to our consolidated results of operations, includes certain corporate amounts not associated with or allocated to the Health Plans segment. In 2018, the Other segment also included the results of certain unregulated subsidiaries we sold in late 2018.&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Margin is the appropriate earnings measure for our reportable segments, based on how our chief operating decision maker currently reviews results, assesses performance, and allocates resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The key metrics used to assess the performance of our Health Plans segment are premium revenue, medical margin and MCR. MCR represents the amount of medical care costs as a percentage of premium revenue. Therefore, the underlying margin, or the amount earned by the Health Plans segment after medical costs are deducted from premium revenue, is the most important measure of earnings reviewed by management. Margin for our Health Plans segment is also referred to as &#x201c;Medical Margin.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Margin &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Margin &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Margin &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles margin by segment to consolidated income before income tax expense:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Margin:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Add: other operating revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: other operating expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: other expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Other operating revenues include premium tax revenue, health insurer fees reimbursed, Marketplace risk corridor judgment, investment income and other revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Other operating expenses include general and administrative expenses, premium tax expenses, health insurer fees, depreciation and amortization, and other costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90ZXh0cmVnaW9uOjhjNjg0MTJmYzZiMjRkZTBhZGQwMTM3ZmU1OGY5YmZkXzMx_996a3170-4e0c-4aaa-8da0-8e978fefe709"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90ZXh0cmVnaW9uOjhjNjg0MTJmYzZiMjRkZTBhZGQwMTM3ZmU1OGY5YmZkXzI1Mjg4NzY3NDQ0NTY0_1dab0d53-542b-4e4e-a8f7-c505b742aa1e">Margin for our Health Plans segment is also referred to as &#x201c;Medical Margin.&#x201d;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Margin &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Margin &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Margin &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles margin by segment to consolidated income before income tax expense:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Margin:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Add: other operating revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: other operating expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: other expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Other operating revenues include premium tax revenue, health insurer fees reimbursed, Marketplace risk corridor judgment, investment income and other revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Other operating expenses include general and administrative expenses, premium tax expenses, health insurer fees, depreciation and amortization, and other costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzMtMi0xLTEtNTYxMw_de3b8abe-0543-4f06-9731-d77859555971"
      unitRef="usd">19415000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d1a64b1a8eb4587b76303fc21830afa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzMtNi0xLTEtNTYxNw_898d6dd3-9313-4f0d-bf09-b8d73a92b04d"
      unitRef="usd">8000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzMtNi0xLTEtMA_f266fae2-bb57-43fb-83e2-f98bf30ee6ad"
      unitRef="usd">19423000000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="idb82ea68bb9f468a8a464320367c5ad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzQtMi0xLTEtMA_ad206049-3057-4a54-9d64-0ae9b1df2409"
      unitRef="usd">2479000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6d1a64b1a8eb4587b76303fc21830afa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzQtNC0xLTEtMA_6a15d3fc-3ba7-4402-89ee-d1a79296c9d9"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzQtNi0xLTEtMA_10472702-5410-4fe1-b2af-9ca34b42aaf4"
      unitRef="usd">2479000000</us-gaap:GrossProfit>
    <us-gaap:Assets
      contextRef="i39fce2981d2c41c1a14d47dafdc5e356_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzYtMi0xLTEtNTYxMw_c9e636cb-30c5-4e6d-88a2-237befe3255d"
      unitRef="usd">8359000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib36184f360254be581851e722b97e9d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzYtNi0xLTEtNTYxNw_0fe80382-8d6b-413e-9c67-234d3d366888"
      unitRef="usd">1173000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzYtNi0xLTEtMA_08df5510-fb14-4e2b-96e3-fc4bb8b50fbb"
      unitRef="usd">9532000000</us-gaap:Assets>
    <us-gaap:Revenues
      contextRef="i3d4e11b2f19147c698f64adbf137fb38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzgtMi0xLTEtNTYxMw_6625cfd8-c382-4d15-9375-5d1cf52d1f96"
      unitRef="usd">16815000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1045ef059c7b4c1e91a31c1aa6854984_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzgtNi0xLTEtNTYxNw_3888af6d-73d6-40bc-bffb-e0e931cccd89"
      unitRef="usd">14000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzgtNi0xLTEtMA_c5da5f11-9a97-48ee-9d56-231ce219e1fe"
      unitRef="usd">16829000000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="i20c4b45d16f349f9b877a338daec69b7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzktMi0xLTEtMA_94eae49c-fe1e-4f7d-bcec-6db21e28e43e"
      unitRef="usd">2303000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i1045ef059c7b4c1e91a31c1aa6854984_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzktNC0xLTEtMA_8f16ddc9-4ded-4be3-8836-dc791fc951f3"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzktNi0xLTEtMA_66fd1893-e446-436a-b32f-396b59872657"
      unitRef="usd">2303000000</us-gaap:GrossProfit>
    <us-gaap:Assets
      contextRef="i9cd7c232959048c3b7533cbe17fd7a2a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzExLTItMS0xLTA_de6d94b8-59de-4581-9bfa-db48d2167bea"
      unitRef="usd">5265000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i43079259dd7042118ae6a2d5dd9a7b6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzExLTQtMS0xLTA_616a0e54-3e25-4fc2-9d13-b1092299c0d9"
      unitRef="usd">1522000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzExLTYtMS0xLTA_92919185-7539-4d4c-ad3c-64d6d03e91bb"
      unitRef="usd">6787000000</us-gaap:Assets>
    <us-gaap:Revenues
      contextRef="i68756a4786524fe5b9fabbe3f97257d2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzEzLTItMS0xLTA_a896a428-580d-41d2-85f9-c53fdcc758b9"
      unitRef="usd">18471000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6bab7abe7dde44eaa74ac090521003ed_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzEzLTQtMS0xLTA_0aa2f7b0-b8fb-4ac0-b47d-2e709be83225"
      unitRef="usd">419000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzEzLTYtMS0xLTA_3d9de637-5e1d-43d1-9a0c-361bb82bfcab"
      unitRef="usd">18890000000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="i169ab145200a473eb3a97472b0dc04f9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE0LTItMS0xLTA_cd315d36-675e-4101-bedc-00434d6dcff3"
      unitRef="usd">2475000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6bab7abe7dde44eaa74ac090521003ed_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE0LTQtMS0xLTA_927c02ee-4a73-4658-8305-853627d05840"
      unitRef="usd">43000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE0LTYtMS0xLTA_62b7c963-1340-4712-bba1-abd01242f550"
      unitRef="usd">2518000000</us-gaap:GrossProfit>
    <us-gaap:Assets
      contextRef="i22759a2f8b054c96ad50791de93ca29f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE2LTItMS0xLTA_c4845e12-4446-4775-a547-e73626fce16f"
      unitRef="usd">6165000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia4c8ceca643b4549bee173f83e97bb0e_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE2LTQtMS0xLTA_2870eefa-875f-41e5-ad33-4b0d00ae1e10"
      unitRef="usd">989000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i38b4b862a7374893891ea3a84e6c4743_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTo4YTcyYjBhYzM2MTg0Y2ZhYjg1NjA2ODhkZmI3MjNiZC90YWJsZXJhbmdlOjhhNzJiMGFjMzYxODRjZmFiODU2MDY4OGRmYjcyM2JkXzE2LTYtMS0xLTA_7f8efe48-e8e0-47c6-ade8-eb645b3f4e7c"
      unitRef="usd">7154000000</us-gaap:Assets>
    <us-gaap:GrossProfit
      contextRef="idb82ea68bb9f468a8a464320367c5ad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzQtMS0xLTEtMA_ad206049-3057-4a54-9d64-0ae9b1df2409"
      unitRef="usd">2479000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i20c4b45d16f349f9b877a338daec69b7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzQtMy0xLTEtMA_94eae49c-fe1e-4f7d-bcec-6db21e28e43e"
      unitRef="usd">2303000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i169ab145200a473eb3a97472b0dc04f9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzQtNS0xLTEtMA_cd315d36-675e-4101-bedc-00434d6dcff3"
      unitRef="usd">2475000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5d0049c77d2742749f53b11e47a5ada1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzUtMS0xLTEtMA_5882936f-3268-4068-a21f-f55237342d01"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9c46ea96ec424a059820a38726b434de_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzUtMy0xLTEtMA_bcadb3fa-3981-4734-8d63-f951515187e2"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3a859cbf0a6e4e259e5149dffa498108_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzUtNS0xLTEtMA_998fb2fb-9abf-4016-b0e6-0b4aefb08505"
      unitRef="usd">43000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i90fb32a216454bb3b23113825fc89cb0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzYtMS0xLTEtMA_6900693c-155e-4eda-bae8-06fda697e04e"
      unitRef="usd">2479000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia21e20ebfeb1411abf65ca9fca917694_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzYtMy0xLTEtMA_e6ba9c0e-417c-42e2-b004-f277585ad9e0"
      unitRef="usd">2303000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i55bfd4d59fce43ea933cfb8bceac4a25_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzYtNS0xLTEtMA_fbcc5338-1fc5-44ea-bf2b-11167e70afb3"
      unitRef="usd">2518000000</us-gaap:GrossProfit>
    <us-gaap:Revenues
      contextRef="i3b95e6dc88844104b5365f3801ba598e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzctMS0xLTEtMA_766568fc-b4c4-4245-bae4-37c3c1e6e928"
      unitRef="usd">1124000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad1475cc48dc4edc8d1b28832265b1ea_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzctMy0xLTEtMA_043e1acc-76e4-45b2-9f06-c686b7f53ac6"
      unitRef="usd">621000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0373257f2d34963a2a34bdff8836086_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzctNS0xLTEtMA_3d9bd3a7-ee84-440e-a23e-b992eaee0751"
      unitRef="usd">871000000</us-gaap:Revenues>
    <us-gaap:CostsAndExpenses
      contextRef="i3b95e6dc88844104b5365f3801ba598e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzgtMS0xLTEtMA_a97bc16a-3c8a-4128-97d6-1bf6d02b961d"
      unitRef="usd">2525000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="iad1475cc48dc4edc8d1b28832265b1ea_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzgtMy0xLTEtMA_4eed14ae-ac36-42e9-bd55-cae4da8a81f1"
      unitRef="usd">1880000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ic0373257f2d34963a2a34bdff8836086_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzgtNS0xLTEtMA_01f3bad5-217d-4d79-835f-bfe329dd3e57"
      unitRef="usd">2258000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEwLTEtMS0xLTA_fe604bc1-e7ff-41e6-820f-8b48503feeb9"
      unitRef="usd">1078000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEwLTMtMS0xLTA_dad50c87-0ec4-4477-bd3d-5faf08ea28af"
      unitRef="usd">1044000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEwLTUtMS0xLTA_1ac72f02-9eef-4449-a1a7-029b778f355f"
      unitRef="usd">1131000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzExLTEtMS0xLTA_53de23e3-c815-4391-bd9c-dc25f9089864"
      unitRef="usd">-117000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzExLTMtMS0xLTA_75cd2d2c-00d9-4347-9f2b-e80f291ead09"
      unitRef="usd">-72000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzExLTUtMS0xLTA_53f07c61-07e9-4da6-96d6-2507f318e362"
      unitRef="usd">-132000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEyLTEtMS0xLTA_4f868706-cab6-483e-b8da-c072a2270593"
      unitRef="usd">961000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEyLTMtMS0xLTA_090e5d6e-253c-4979-8f4a-5a8226171541"
      unitRef="usd">972000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjMvZnJhZzo4YzY4NDEyZmM2YjI0ZGUwYWRkMDEzN2ZlNThmOWJmZC90YWJsZTphMjcyNzJjMTM4OWQ0NWIxYWVkNTMyMDk5MjM5ODVkZC90YWJsZXJhbmdlOmEyNzI3MmMxMzg5ZDQ1YjFhZWQ1MzIwOTkyMzk4NWRkXzEyLTUtMS0xLTA_eb914402-75be-4500-8fd6-f06d4bda5a8a"
      unitRef="usd">999000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90ZXh0cmVnaW9uOmRjMWEzZTAyMjc1OTRlZTRhMjEyNTQwMGE2YmMyNzUxXzU2Mw_84363a07-bfab-444a-8b7e-f6c332c04122">Condensed Financial Information of Registrant &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed balance sheets as of December&#160;31, 2020 and 2019, and the related condensed statements of income, comprehensive income and cash flows for each of the three years in the period ended December&#160;31, 2020 for our parent company Molina Healthcare, Inc. (the &#x201c;Registrant&#x201d;), are presented below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions, except per-share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due from affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, equipment, and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Advances to related parties and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock, $0.001 par value; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See accompanying notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Administrative services fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investment income and other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other operating expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expenses (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss before income tax (benefit) expense and equity in net earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss before equity in net earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity in net earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Comprehensive Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized investment income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: effect of income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See accompanying notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash provided by operating activities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capital contributions to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividends received from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Proceeds from sales and maturities of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash paid in business combinations &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash received from sale of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in amounts due to/from affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash (used in) provided by investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Proceeds from senior notes offering, net of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock purchases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of term loan facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Proceeds from borrowings under term loan facility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for partial termination of warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for partial settlement of conversion option&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash received for partial settlement of call option&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of principal amount of convertible notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of credit facility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash provided by (used in) financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (decrease) increase in cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents at beginning of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents at end of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Notes to Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note&#160;A&#160;- Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Registrant was incorporated in 2002. Prior to that date, Molina Healthcare of California (formerly known as Molina Medical Centers) operated as a California health plan and as the parent company for three other state health plans. In June 2003, the employees and operations of the corporate entity were transferred from Molina Healthcare of California to the Registrant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Registrant&#x2019;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries since the date of acquisition. The accompanying condensed financial information of the Registrant should be read in conjunction with the consolidated financial statements and accompanying notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note&#160;B&#160;- Transactions with Subsidiaries &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Registrant provides certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and administration, underwriting, claims processing, customer service, certain care management services, human &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;resources, marketing, purchasing, risk management, actuarial, finance, accounting, compliance, legal and public relations. Fees are based on the fair market value of services rendered and are recorded as operating revenue. Payment is subordinated to the subsidiaries&#x2019; ability to comply with minimum capital and other restrictive financial requirements of the states in which they operate. Charges in 2020, 2019, and 2018 for these services amounted to $1,208 million, $1,038 million, and $1,137 million, respectively, and are included in operating revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Registrant and its subsidiaries are included in the consolidated federal and state income tax returns filed by the Registrant. Income taxes are allocated to each subsidiary in accordance with an intercompany tax allocation agreement. The agreement allocates income taxes in an amount generally equivalent to the amount which would be expensed by the subsidiary if it filed a separate tax return. Net operating loss benefits are paid to the subsidiary by the Registrant to the extent such losses are utilized in the consolidated tax returns. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note&#160;C&#160;- Dividends and Capital Contributions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Registrant receives dividends from its subsidiaries, such amounts are recorded as a reduction to the investments in the respective subsidiaries.&lt;/span&gt;&lt;/div&gt;For all periods presented, the Registrant made capital contributions to certain subsidiaries primarily to comply with minimum net worth requirements and to fund business combinations. Such amounts have been recorded as an increase in investment in the respective subsidiaries.</us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90ZXh0cmVnaW9uOmRjMWEzZTAyMjc1OTRlZTRhMjEyNTQwMGE2YmMyNzUxXzU0Nw_cd7cac77-558f-4dfb-ab39-f44d33d9a25e">&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions, except per-share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due from affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, equipment, and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Advances to related parties and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock, $0.001 par value; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzUtMS0xLTEtMA_50742023-d2b5-477f-a55f-7ab6045f9047"
      unitRef="usd">575000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzUtMy0xLTEtMA_bc76a1ea-0902-4226-acaa-4f4b97ef1842"
      unitRef="usd">836000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzYtMS0xLTEtMA_9da53d20-216e-4b19-bf63-59f70f915558"
      unitRef="usd">69000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzYtMy0xLTEtMA_e4467c81-fba7-4d49-86fa-336a5046d8e6"
      unitRef="usd">161000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzctMS0xLTEtMA_ffa2fb21-df60-4d3f-94a3-b1c700cc0266"
      unitRef="usd">2000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzctMy0xLTEtMA_95d14d00-779c-4f85-b988-f75104d03529"
      unitRef="usd">2000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzgtMS0xLTEtMA_31fd2be5-ee2a-4d2b-9388-fb6cae13e6a8"
      unitRef="usd">114000000</us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent>
    <us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzgtMy0xLTEtMA_eeec1274-419d-491f-ae29-4860b70ff7bd"
      unitRef="usd">49000000</us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzktMS0xLTEtMA_14323541-b406-442e-94ba-c064a96bd6f9"
      unitRef="usd">65000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzktMy0xLTEtMA_666c96bb-57e0-47ee-9a18-a8602106625c"
      unitRef="usd">75000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzExLTEtMS0xLTA_43f24b51-463a-4e70-8441-9f1287e48588"
      unitRef="usd">825000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzExLTMtMS0xLTA_c54c7916-b74e-4fa3-ba5a-6ab23fea1c82"
      unitRef="usd">1123000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzEyLTEtMS0xLTA_fae20908-cece-48db-9723-2c801275ec19"
      unitRef="usd">339000000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzEyLTMtMS0xLTA_12f61e10-324c-4959-88cd-87589ec18c04"
      unitRef="usd">327000000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzEzLTEtMS0xLTA_38c36c8d-4f3c-4d44-a6f5-d02babb517a8"
      unitRef="usd">369000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzEzLTMtMS0xLTA_0d8d5113-6433-4a54-9797-49c185e6c0f4"
      unitRef="usd">13000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE0LTEtMS0xLTA_fd770ca9-6dff-46c1-b01c-c2279c069cc6"
      unitRef="usd">3228000000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE0LTMtMS0xLTA_803287d5-d33a-4f5a-b4e3-76483413288c"
      unitRef="usd">2225000000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE1LTEtMS0xLTA_91551b29-2f21-4760-8992-78830b796223"
      unitRef="usd">5000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE1LTMtMS0xLTA_0f4dd8f9-3ea3-4b3d-804f-6f1157f8af41"
      unitRef="usd">10000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <moh:AdvancesToRelatedPartiesAndOtherAssets
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE2LTEtMS0xLTA_a386aecf-ffab-40a2-a0fc-b3683cadf63f"
      unitRef="usd">83000000</moh:AdvancesToRelatedPartiesAndOtherAssets>
    <moh:AdvancesToRelatedPartiesAndOtherAssets
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE2LTMtMS0xLTA_759ad87d-3976-4bc4-a06f-84cceecef8bf"
      unitRef="usd">76000000</moh:AdvancesToRelatedPartiesAndOtherAssets>
    <us-gaap:Assets
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE3LTEtMS0xLTA_fe61556e-9dbc-455b-9288-a1922b8973f0"
      unitRef="usd">4849000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzE3LTMtMS0xLTA_35561ee1-c51b-4c25-aa5b-e89442e9f8ce"
      unitRef="usd">3774000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzIxLTEtMS0xLTA_ad37880d-8a8c-448c-8e9d-c7c945f4a5ba"
      unitRef="usd">338000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzIxLTMtMS0xLTA_f5f245b8-dbe0-414c-bf13-1509133c8e03"
      unitRef="usd">307000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI0LTEtMS0xLTA_0adc725d-112d-4b05-a7a5-5626f5f4f6cb"
      unitRef="usd">338000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI0LTMtMS0xLTA_4bd2bb31-8c12-4227-8e35-c832ca41b2ce"
      unitRef="usd">307000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI1LTEtMS0xLTA_45b16b84-a4e4-478c-9ff2-13648e6d1f5b"
      unitRef="usd">2127000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI1LTMtMS0xLTA_62909d83-17b7-448d-b733-99597ba07bb3"
      unitRef="usd">1237000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI2LTEtMS0xLTA_ebd73185-ef93-4e5f-808d-fcfbd30a25be"
      unitRef="usd">225000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI2LTMtMS0xLTA_21ed0f58-3bd9-46e3-85e9-37eab4d85f43"
      unitRef="usd">231000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI3LTEtMS0xLTA_89b5b59c-e2a0-4999-8649-ca410f027992"
      unitRef="usd">63000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI3LTMtMS0xLTA_8ad819c1-7965-4483-ae32-a9fd3ce7e2b5"
      unitRef="usd">39000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI4LTEtMS0xLTA_93abd777-de80-41f7-b9b9-d0520a9cfa56"
      unitRef="usd">2753000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzI4LTMtMS0xLTA_2e253550-7ead-44f6-824b-e2dc18c1b8e0"
      unitRef="usd">1814000000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MDcw_5b270c78-439c-493b-a0eb-258936870709"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MDcw_ac76518c-b992-429b-bf7b-9d05a89d0788"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MDg0_cf133e69-b668-4145-a173-ed5efb9db305"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MDg0_fd5abec7-5b2f-4ea3-9f22-a243c819a803"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MDk4_78406bc6-5b6b-4305-bb82-6a0c523689bc"
      unitRef="shares">59000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWM4Zjg1ZTkxODk0NjJmYTc4MGU2MWUxZDZkZTFhMV81NDk3NTU4MTM5MTE0_30b80f88-f3b6-47e8-86e0-460f28b699fe"
      unitRef="shares">62000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTEtMS0xLTA_abb195d0-9cea-4ee1-b86d-6b76dde75a65"
      unitRef="usd">0</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMwLTMtMS0xLTA_4619307a-574e-4b11-b5af-5712e708f808"
      unitRef="usd">0</us-gaap:CommonStockValueOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM4OTg4_863c57a2-fdf6-4866-bb57-6689358a0f92"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM4OTg4_b5f56231-ae73-4196-8046-7236a44f70e6"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MDk0_5c4dabd2-7652-4ada-9999-d5b6bb48a7f1"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MDk0_7403b34a-344f-4789-9b8a-978db9cb8170"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MTAw_1e1d4305-74ee-4e12-b95f-6c0836481c69"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7c4aed327cc445c2a43b20960c6bced9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MTAw_1ff4be3e-9c98-4b08-a68f-3e7eb366442d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MTAw_2a3d9ad1-fae5-4316-9d2d-4ccdefc9eb10"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ic5403d7768b644aab47e5ab6d7afe17a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjoxOWMyNGQ0Mzc3MWQ0ZDcwOWQ3MWRhNTJkNzVhMDAzOV81NDk3NTU4MTM5MTAw_41b18ba0-7f8d-45ac-bfb2-33641736f877"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTEtMS0xLTA_8be9dc74-09e2-47bd-a34f-6f3e51d05cc1"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMxLTMtMS0xLTA_28732cfe-df59-4682-80c5-fcf521c1d56d"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMyLTEtMS0xLTA_f980a1b0-a0d7-49d6-b027-8cd757015f23"
      unitRef="usd">199000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMyLTMtMS0xLTA_b60642bd-9604-44d7-ad92-39fae85875cb"
      unitRef="usd">175000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMzLTEtMS0xLTA_a340d9a6-e52d-405c-8df8-74a923707d03"
      unitRef="usd">37000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzMzLTMtMS0xLTA_a30c6eda-9fb2-437e-8343-8bc1f8a7abf4"
      unitRef="usd">4000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM0LTEtMS0xLTA_81c40934-5c07-4d89-8423-a0ee14466346"
      unitRef="usd">1860000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM0LTMtMS0xLTA_583a2a7e-b128-4cb8-9098-98df4d46f5fa"
      unitRef="usd">1781000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM1LTEtMS0xLTA_244b0fab-97aa-4676-850b-0a1f9b0f9576"
      unitRef="usd">2096000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM1LTMtMS0xLTA_3f864040-9cb3-44a0-a904-db5f01562a73"
      unitRef="usd">1960000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM2LTEtMS0xLTA_8738acc6-e66a-4984-b501-02c3b6990090"
      unitRef="usd">4849000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTplNjE5MmVmN2NlYTQ0ZWVkOTVmZjZhYWUwMjk2OWJjZC90YWJsZXJhbmdlOmU2MTkyZWY3Y2VhNDRlZWQ5NWZmNmFhZTAyOTY5YmNkXzM2LTMtMS0xLTA_6b3cead8-3754-458a-a459-603d6aa35f86"
      unitRef="usd">3774000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <srt:ScheduleOfCondensedIncomeStatementTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90ZXh0cmVnaW9uOmRjMWEzZTAyMjc1OTRlZTRhMjEyNTQwMGE2YmMyNzUxXzU2NQ_b5490018-01f1-4315-a751-fdc32aee362e">&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Administrative services fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investment income and other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other operating expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expenses (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss before income tax (benefit) expense and equity in net earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss before equity in net earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity in net earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedIncomeStatementTableTextBlock>
    <us-gaap:InsuranceAgencyManagementFee
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzQtMS0xLTEtMA_b9a75c46-19ec-4e21-8fcd-ede957f8f975"
      unitRef="usd">1208000000</us-gaap:InsuranceAgencyManagementFee>
    <us-gaap:InsuranceAgencyManagementFee
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzQtMy0xLTEtMA_08c172b0-fee6-4048-ac11-9ed5cfaf1580"
      unitRef="usd">1038000000</us-gaap:InsuranceAgencyManagementFee>
    <us-gaap:InsuranceAgencyManagementFee
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzQtNS0xLTEtMA_95e24ab6-3638-47bb-922c-f6867988d932"
      unitRef="usd">1138000000</us-gaap:InsuranceAgencyManagementFee>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzUtMS0xLTEtMA_d4a0be59-9c11-468e-b043-efbc7775f73f"
      unitRef="usd">13000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzUtMy0xLTEtMA_8842f505-c463-417f-aa50-aa9af38c1ece"
      unitRef="usd">18000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzUtNS0xLTEtMA_e4bbec3a-fff2-4b59-8833-1f023e5ffcc9"
      unitRef="usd">17000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:Revenues
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzYtMS0xLTEtMA_8a864bdb-152b-411b-9245-f3e4caba4c7b"
      unitRef="usd">1221000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzYtMy0xLTEtMA_686a5d2e-39dd-4aaa-81cf-3310708440cf"
      unitRef="usd">1056000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzYtNS0xLTEtMA_c4cdd03a-efe2-40b8-bebc-c87a785e9d3c"
      unitRef="usd">1155000000</us-gaap:Revenues>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzgtMS0xLTEtMA_db580162-8544-4ebd-9928-b7238453abde"
      unitRef="usd">1089000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzgtMy0xLTEtMA_513114f9-ce1a-40da-844c-43f3b76fb090"
      unitRef="usd">937000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzgtNS0xLTEtMA_db44b7d3-c80d-43f1-b4c0-c37ba8e15504"
      unitRef="usd">1007000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzktMS0xLTEtMA_f0bd6a1d-aa72-4589-832b-5f9d085604a7"
      unitRef="usd">67000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzktMy0xLTEtMA_e8277dc6-b4a9-4f64-b348-2315acfe4bbf"
      unitRef="usd">63000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzktNS0xLTEtMA_8cef0e3a-7200-4a28-9ad5-d87e5a87a569"
      unitRef="usd">69000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEwLTEtMS0xLTA_b0ed3044-7b86-4aeb-bdc0-d5f6716ab60f"
      unitRef="usd">24000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEwLTMtMS0xLTA_1d8a4b81-4838-4521-ac6c-a3b1262bf2c6"
      unitRef="usd">4000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEwLTUtMS0xLTA_833269fe-0ce5-4d02-9076-7d980a980ec7"
      unitRef="usd">6000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:CostsAndExpenses
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEzLTEtMS0xLTA_aab67817-9b21-4af7-bace-9298f2a26644"
      unitRef="usd">1180000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEzLTMtMS0xLTA_8950d916-19f7-42a6-8650-1db722c35ada"
      unitRef="usd">1004000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzEzLTUtMS0xLTA_21147276-81e3-4f8e-b4a0-8a6e7c975131"
      unitRef="usd">1082000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTEtMS0xLTA_1f6896b0-979b-48b1-ab95-5cb00053a121"
      unitRef="usd">41000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTMtMS0xLTA_21087d60-4724-4083-b1c7-28b27cc72f62"
      unitRef="usd">52000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTUtMS0xLTA_a181396f-9d32-4336-9f20-18e27fede0d1"
      unitRef="usd">73000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE2LTEtMS0xLTA_077fceba-9bf6-4c61-9eab-59b90c3b4611"
      unitRef="usd">102000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE2LTMtMS0xLTA_ea3a287b-8e03-4b11-be0d-76e9bf2154ec"
      unitRef="usd">87000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE2LTUtMS0xLTA_a9f4e6a1-6715-4995-bfd8-6335098aa7b5"
      unitRef="usd">114000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE3LTEtMS0xLTA_61fe0732-ca39-4f5c-92fa-6c068789297e"
      unitRef="usd">-15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE3LTMtMS0xLTA_6488a2f2-81b2-4d04-bd16-3e386b935cba"
      unitRef="usd">15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE3LTUtMS0xLTA_0e6fcadd-d322-46eb-9d93-451b40b30b17"
      unitRef="usd">-17000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherExpenses
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTEtMS0xLTE2ODEy_052b60db-2658-43a1-92f4-507372d95b90"
      unitRef="usd">117000000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="i0f0d7f9f3c334404b0abdd9908690430_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTMtMS0xLTE2ODEy_388c2c08-e96e-4322-bb49-020424d1eb47"
      unitRef="usd">72000000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="i2744939f325a4c5daacd4f83a81fadb9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE1LTUtMS0xLTE2ODEy_9579bbf0-8743-45d1-a944-6a27f0c63441"
      unitRef="usd">131000000</us-gaap:OtherExpenses>
    <moh:IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE4LTEtMS0xLTA_65923e6e-efd8-4732-8db6-df25bfaedcc3"
      unitRef="usd">-76000000</moh:IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries>
    <moh:IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE4LTMtMS0xLTA_ed10bb39-bf30-4a03-8c8f-82fc68857294"
      unitRef="usd">-20000000</moh:IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries>
    <moh:IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE4LTUtMS0xLTA_a3bd6cf4-6157-40ff-94c6-46cae70ab798"
      unitRef="usd">-58000000</moh:IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE5LTEtMS0xLTA_e1ae6eff-d979-4e95-82b4-ffd0ecb45233"
      unitRef="usd">-5000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE5LTMtMS0xLTA_285462fb-a8a9-4113-91a0-1a05e4b2e96f"
      unitRef="usd">9000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzE5LTUtMS0xLTA_1bf02afa-6adf-478e-a8ab-f46b4828df19"
      unitRef="usd">-14000000</us-gaap:IncomeTaxExpenseBenefit>
    <moh:NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIwLTEtMS0xLTA_251aacb1-cb5f-45cc-b494-2afd15bbe29f"
      unitRef="usd">-71000000</moh:NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest>
    <moh:NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIwLTMtMS0xLTA_b20faba3-0e4b-4d78-993e-b17ba459a4f0"
      unitRef="usd">-29000000</moh:NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest>
    <moh:NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIwLTUtMS0xLTA_40957f8c-64fa-43fd-94dd-5df3d29db2fb"
      unitRef="usd">-44000000</moh:NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromSubsidiariesNetOfTax
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIxLTEtMS0xLTA_bdf83ae8-05cc-48a3-9ea4-2746b8910689"
      unitRef="usd">744000000</us-gaap:IncomeLossFromSubsidiariesNetOfTax>
    <us-gaap:IncomeLossFromSubsidiariesNetOfTax
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIxLTMtMS0xLTA_4cb6d31e-7711-451f-b419-1a26a1b52d88"
      unitRef="usd">766000000</us-gaap:IncomeLossFromSubsidiariesNetOfTax>
    <us-gaap:IncomeLossFromSubsidiariesNetOfTax
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIxLTUtMS0xLTA_0cb293f4-8f2c-4b4c-bac6-d6d8b1f8fccf"
      unitRef="usd">751000000</us-gaap:IncomeLossFromSubsidiariesNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIyLTEtMS0xLTA_68a0e0bb-7acb-4d5f-94f4-3e54a3b362b8"
      unitRef="usd">673000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIyLTMtMS0xLTA_0439f2b0-1c06-4522-b3e6-d62148b85529"
      unitRef="usd">737000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpiYjRhZTJkOWI5NTE0NWVkYWI0OTk4NWRmZDA5ZmQ3OS90YWJsZXJhbmdlOmJiNGFlMmQ5Yjk1MTQ1ZWRhYjQ5OTg1ZGZkMDlmZDc5XzIyLTUtMS0xLTA_e04044e4-f574-4ed3-928c-164358bf7c6f"
      unitRef="usd">707000000</us-gaap:NetIncomeLoss>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90ZXh0cmVnaW9uOmRjMWEzZTAyMjc1OTRlZTRhMjEyNTQwMGE2YmMyNzUxXzU1Mg_dbe63702-b00f-40f4-9585-2e2b71bfd56d">&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Comprehensive Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized investment income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: effect of income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzMtMS0xLTEtMA_68a0e0bb-7acb-4d5f-94f4-3e54a3b362b8"
      unitRef="usd">673000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzMtMy0xLTEtMA_0439f2b0-1c06-4522-b3e6-d62148b85529"
      unitRef="usd">737000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzMtNS0xLTEtMA_e04044e4-f574-4ed3-928c-164358bf7c6f"
      unitRef="usd">707000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzUtMS0xLTEtMA_a06130d1-ca3e-46fc-a574-232ffd49123f"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzUtMy0xLTEtMA_9b697f69-e8bd-444b-a68e-11c8155234e8"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzUtNS0xLTEtMA_19e87d7c-0e2e-406c-8ab0-880f4ff4d3e4"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzYtMS0xLTEtMA_8542c733-56d6-452a-9c19-cc99e7e878e4"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzYtMy0xLTEtMA_6054357c-2e3e-4a8e-ab00-a98622fd1b58"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzYtNS0xLTEtMA_f920045f-99b5-4ace-90ce-d0c0b6f71141"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzctMS0xLTEtMA_f47ef399-fe2d-4542-a701-4a9ccb533ad9"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzctMy0xLTEtMA_ae9d30c2-2502-45a9-b8a4-984fe300e724"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzctNS0xLTEtMA_c06f731f-aac7-4bb1-ba17-4467f99c560c"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzgtMS0xLTEtMA_5cc286b1-0c3a-4377-a53f-d615b89b1ea5"
      unitRef="usd">706000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzgtMy0xLTEtMA_e1c46fa6-0930-4047-9b16-309e90c0c0a6"
      unitRef="usd">749000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTpkZjlhNGY3ZDZiNzc0MTBjOTJjNmNiYjc4N2U5NGQxNS90YWJsZXJhbmdlOmRmOWE0ZjdkNmI3NzQxMGM5MmM2Y2JiNzg3ZTk0ZDE1XzgtNS0xLTEtMA_f101e9d9-4313-47a9-8bdb-491ab646cd5e"
      unitRef="usd">705000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <srt:ScheduleOfCondensedCashFlowStatementTableTextBlock
      contextRef="i02376445555642e5babc277d1c377aa8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90ZXh0cmVnaW9uOmRjMWEzZTAyMjc1OTRlZTRhMjEyNTQwMGE2YmMyNzUxXzU1OA_bacd3fd4-8696-4fc3-a6d7-0c6b77da039e">&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash provided by operating activities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capital contributions to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividends received from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Proceeds from sales and maturities of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash paid in business combinations &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash received from sale of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in amounts due to/from affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash (used in) provided by investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Proceeds from senior notes offering, net of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock purchases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of term loan facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Proceeds from borrowings under term loan facility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for partial termination of warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for partial settlement of conversion option&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash received for partial settlement of call option&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of principal amount of convertible notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of credit facility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash provided by (used in) financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (decrease) increase in cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents at beginning of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents at end of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedCashFlowStatementTableTextBlock>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzQtMS0xLTEtMA_569187b3-2351-4928-bb5f-53d02078ca33"
      unitRef="usd">59000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzQtMy0xLTEtMA_ab1b1c35-9aa4-47d6-8763-a9646e8d5fc6"
      unitRef="usd">64000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzQtNS0xLTEtMA_5ae28241-4a77-4649-b130-8e83da9df640"
      unitRef="usd">118000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzYtMS0xLTEtMA_20dab99e-33ba-45e6-8a6b-4d59920a4541"
      unitRef="usd">107000000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
    <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzYtMy0xLTEtMA_8937d964-252d-42ad-8c1b-10303d38dc50"
      unitRef="usd">43000000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
    <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzYtNS0xLTEtMA_dff15399-82ab-4285-b904-eed29731e8bc"
      unitRef="usd">145000000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzctMS0xLTEtMA_8caef69a-c222-44a6-8782-7c3a18296aae"
      unitRef="usd">635000000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzctMy0xLTEtMA_c7c20cdc-49c3-4ef8-8e62-253e422df8a6"
      unitRef="usd">1373000000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzctNS0xLTEtMA_7d0d8202-f4c9-4f70-baf9-6828acf28e6a"
      unitRef="usd">298000000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzgtMS0xLTEtMA_3b5c09b1-78b2-4595-866f-9447fad6997b"
      unitRef="usd">188000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzgtMy0xLTEtMA_a9ac4357-fa43-4775-8449-4b9f316bd3b8"
      unitRef="usd">152000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzgtNS0xLTEtMA_795f8551-937f-46b5-af01-a1920f780fcf"
      unitRef="usd">136000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzktMS0xLTEtMA_75eecdaa-fe5f-428b-81d2-419761865c20"
      unitRef="usd">282000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzktMy0xLTEtMA_a81180f3-64ca-4b20-a5e0-95fee8236f73"
      unitRef="usd">93000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzktNS0xLTEtMA_f57b84db-b1f6-4e62-887e-ed104d25e482"
      unitRef="usd">388000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEwLTEtMS0xLTA_2bcb56af-43c8-4472-a2fe-f37d45d87823"
      unitRef="usd">74000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEwLTMtMS0xLTA_7d2a6d41-649c-4455-8319-8d153068174b"
      unitRef="usd">56000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEwLTUtMS0xLTA_9c138a18-6706-4b5d-b77f-1050f31604f4"
      unitRef="usd">22000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTEtMS0xLTc3Njc_88d9923f-ff22-4cd5-a2fb-8d01193c0254"
      unitRef="usd">1028000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTMtMS0xLTc3Njc_8aecd3d3-0997-4b5e-a0e7-3cf730308215"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTUtMS0xLTc3Njc_0b8d016d-9f99-495d-acf2-6c05253e0226"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTEtMS0xLTA_45a0205a-b919-4dd3-83ed-fb4c57cd1e97"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTMtMS0xLTA_c35057e8-cd58-49fa-b233-f035e7194e89"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzExLTUtMS0xLTA_68f90cf8-062b-46bc-83d8-38316ceaab75"
      unitRef="usd">242000000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <moh:ChangesInAmountsDueToAndDueFromAffiliates
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEyLTEtMS0xLTA_89c1add5-e451-4831-a513-11e6904e16eb"
      unitRef="usd">-68000000</moh:ChangesInAmountsDueToAndDueFromAffiliates>
    <moh:ChangesInAmountsDueToAndDueFromAffiliates
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEyLTMtMS0xLTA_214c86db-c5a5-4c99-813d-1944b8a5e629"
      unitRef="usd">38000000</moh:ChangesInAmountsDueToAndDueFromAffiliates>
    <moh:ChangesInAmountsDueToAndDueFromAffiliates
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEyLTUtMS0xLTA_6e5a2282-8086-4b8d-b184-2ee901ecadf0"
      unitRef="usd">6000000</moh:ChangesInAmountsDueToAndDueFromAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEzLTEtMS0xLTA_31dc741e-6a06-4676-a649-3cf4ee678b75"
      unitRef="usd">-3000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEzLTMtMS0xLTA_d6e7ab66-5421-46f7-b0d2-e758eef2a545"
      unitRef="usd">-1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzEzLTUtMS0xLTA_df38d31d-bed9-48c2-966f-1a607b8905a1"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE0LTEtMS0xLTA_2203d4ed-9e82-446b-93c1-f7b21792d088"
      unitRef="usd">-545000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE0LTMtMS0xLTA_7cb34826-fa7e-47bb-9c83-59a7cf0c593d"
      unitRef="usd">1254000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE0LTUtMS0xLTA_de671047-ea2c-4164-9203-1f85c2d7d23d"
      unitRef="usd">631000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE2LTEtMS0xLTI1NzE_2bfce8cb-415e-4faf-bb00-61d803d67fa1"
      unitRef="usd">1429000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE2LTMtMS0xLTI1NzE_56e3fe20-bad0-4595-92c6-27a6a74a1414"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE2LTUtMS0xLTI1NzE_eb607a97-9b6b-486b-a6de-da9c65509c8d"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE4LTEtMS0xLTIxMDEx_20dc2d76-60b0-456c-b564-71f6caf32437"
      unitRef="usd">606000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE4LTMtMS0xLTIxMDEx_81e1a4a8-f5db-4a3b-bd26-95aebcefe5b5"
      unitRef="usd">47000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE4LTUtMS0xLTIxMDEx_495e1142-df03-4f48-b18a-2244b9d301c5"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE3LTEtMS0xLTI1NzE_f5e28ac7-0b9f-48e1-8502-44eb4967646a"
      unitRef="usd">600000000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE3LTMtMS0xLTI1NzE_3e76a741-e33c-41b1-ba7e-64b71442b02f"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE3LTUtMS0xLTI1NzE_deadbe6b-c59e-47d4-bde8-be496f9331b3"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE5LTEtMS0xLTI1NzE_41bab421-661c-4f40-8da2-6bd87d5f393e"
      unitRef="usd">380000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE5LTMtMS0xLTI1MjU_d136436b-c871-46b6-98d7-bc791821d669"
      unitRef="usd">220000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE5LTUtMS0xLTI1MjU_53a5bd54-c5b3-46d9-83be-d177f0148115"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTEtMS0xLTI1Njk_cd8e7c4f-e88d-4ec4-95c6-6e9f10467d93"
      unitRef="usd">338000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTMtMS0xLTI1Njk_25166aed-5060-4f45-b61d-f11138aaf8a5"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTUtMS0xLTI1Njk_8964e895-0b53-4e24-9e24-6f6ddac8473c"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIxLTEtMS0xLTI1ODM_4f6b4e68-7b5f-4b0b-9acf-d3843096b8c2"
      unitRef="usd">30000000</us-gaap:PaymentsForRepurchaseOfWarrants>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTMtMS0xLTI1Mjk_9c6c0934-457c-402e-aa34-c0df9822ab65"
      unitRef="usd">514000000</us-gaap:PaymentsForRepurchaseOfWarrants>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTUtMS0xLTI1Mjk_473c8b6a-829e-4ae7-9fec-3ba44e515470"
      unitRef="usd">549000000</us-gaap:PaymentsForRepurchaseOfWarrants>
    <moh:CashPaidForSettlementOfConversionOption
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIyLTEtMS0xLTI1OTI_ae6301a3-d4a1-4f49-ac46-0b40b0cf1a40"
      unitRef="usd">27000000</moh:CashPaidForSettlementOfConversionOption>
    <moh:CashPaidForSettlementOfConversionOption
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE5LTMtMS0xLTA_7a63898c-7494-40ba-998c-29617dd43e49"
      unitRef="usd">578000000</moh:CashPaidForSettlementOfConversionOption>
    <moh:CashPaidForSettlementOfConversionOption
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzE5LTUtMS0xLTA_2d9e826f-9037-49c1-8012-e6c4289a6627"
      unitRef="usd">623000000</moh:CashPaidForSettlementOfConversionOption>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIzLTEtMS0xLTI1OTI_0464461c-35c3-49cb-a1e8-6ef058d45fc2"
      unitRef="usd">27000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTMtMS0xLTA_2b47308f-e795-42a4-b0fe-9a30d69723ca"
      unitRef="usd">578000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIwLTUtMS0xLTA_a76bfc05-defb-42d7-9d5e-4d8a9f8463ef"
      unitRef="usd">623000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI0LTEtMS0xLTI1ODg_398bd1af-bcb9-4fbb-9bd9-b5bf616790a7"
      unitRef="usd">12000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIxLTMtMS0xLTA_a132fe07-d268-4aeb-8806-3f2fe8f7483f"
      unitRef="usd">240000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzIxLTUtMS0xLTA_94902746-d8c1-4fdd-863b-bd0dcb5a3870"
      unitRef="usd">362000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI0LTEtMS0xLTA_13db0070-6f26-4058-b153-6a05c5aff22b"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI0LTMtMS0xLTA_6dd3bd3f-32db-4737-a65c-963bf87320e7"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI0LTUtMS0xLTA_52a8e98d-f4d9-4784-a7ae-317776a9c018"
      unitRef="usd">300000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI3LTEtMS0xLTA_044789a2-e32a-4376-8c1b-5d5397c6a60f"
      unitRef="usd">2000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI3LTMtMS0xLTA_be8338b5-88de-43db-9954-76b83d6ab5b4"
      unitRef="usd">29000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI3LTUtMS0xLTA_97ae1a14-98bd-41f9-b5e2-570be6635237"
      unitRef="usd">19000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI4LTEtMS0xLTA_4b7eec30-f763-4492-a880-6e0769a6e994"
      unitRef="usd">225000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI4LTMtMS0xLTA_d4594b72-ec6a-4adb-a2d6-2fbbdbe9992e"
      unitRef="usd">-552000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI4LTUtMS0xLTA_4540d4a0-cfbd-49fd-9029-4d5a7dc1e628"
      unitRef="usd">-1192000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI5LTEtMS0xLTA_04d661f5-63d3-415e-8daa-1d27c222f3be"
      unitRef="usd">-261000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI5LTMtMS0xLTA_ee974af6-0abb-4105-938a-22ad396677fd"
      unitRef="usd">766000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzI5LTUtMS0xLTA_c350aa37-8187-4862-ab25-719a6e9694f6"
      unitRef="usd">-443000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMwLTEtMS0xLTA_a5411ef3-4ea5-4ab0-8faf-232f8caf32b3"
      unitRef="usd">836000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i11fdd1fe2faf42efb90bc577c9070717_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMwLTMtMS0xLTA_9f769291-563f-426c-8d43-0054c8a26a84"
      unitRef="usd">70000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3c26bfb9e6774f078083f6dc03b05363_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMwLTUtMS0xLTA_d9bb334f-fcf2-452a-85f4-aecb37b0c324"
      unitRef="usd">513000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifdc0f1c770da44458c1d059bd020a0c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMxLTEtMS0xLTA_61b22a58-410f-4ed2-a2d2-ce4e5301ebcf"
      unitRef="usd">575000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5ecb8708d5464ab498156c0718152e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMxLTMtMS0xLTA_f32cfeb2-9d8a-432c-997a-eb82f8b799b1"
      unitRef="usd">836000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i11fdd1fe2faf42efb90bc577c9070717_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMjkvZnJhZzpkYzFhM2UwMjI3NTk0ZWU0YTIxMjU0MDBhNmJjMjc1MS90YWJsZTo4YjQyMzI4MDQ1NjU0YmQyODYwYTIyOGRjMWZjM2U3Zi90YWJsZXJhbmdlOjhiNDIzMjgwNDU2NTRiZDI4NjBhMjI4ZGMxZmMzZTdmXzMxLTUtMS0xLTA_13f760bb-f1fd-4907-b55c-a0005a2388d1"
      unitRef="usd">70000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzIvZnJhZzpiYzBlMjE0ZmYzMGM0YWYzODUxNzQ3YmQwZjljYTJkZi90ZXh0cmVnaW9uOmJjMGUyMTRmZjMwYzRhZjM4NTE3NDdiZDBmOWNhMmRmXzExNzI_d0eac4a2-ccdb-462d-8854-d90722b9aa34"
      unitRef="usd">1208000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i081b5d93bffa49809f0c10d868fd8e75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzIvZnJhZzpiYzBlMjE0ZmYzMGM0YWYzODUxNzQ3YmQwZjljYTJkZi90ZXh0cmVnaW9uOmJjMGUyMTRmZjMwYzRhZjM4NTE3NDdiZDBmOWNhMmRmXzExNzY_f4c4a070-3d0c-49a1-b880-1c9ec63437b3"
      unitRef="usd">1038000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i92d8faa84c574245a54feda3e60d99c7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8yMzIvZnJhZzpiYzBlMjE0ZmYzMGM0YWYzODUxNzQ3YmQwZjljYTJkZi90ZXh0cmVnaW9uOmJjMGUyMTRmZjMwYzRhZjM4NTE3NDdiZDBmOWNhMmRmXzExODQ_52ba5658-e371-411d-8100-8b467bdcdf8c"
      unitRef="usd">1137000000</us-gaap:RevenueFromRelatedParties>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821703973016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 12, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-31719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MOLINA HEALTHCARE, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-4204626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Oceangate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Long Beach<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">435-3666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MOH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s Proxy Statement for the 2021 Annual Meeting of Stockholders to be held on May 6, 2021, are incorporated by reference into Part III of this Form 10-K, to the extent described therein.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001179929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821737235288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Investment income and other revenue</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">19,423<span></span>
</td>
<td class="nump">16,829<span></span>
</td>
<td class="nump">18,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
<td class="nump">1,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_PremiumTaxExpenses', window );">Premium tax expenses</a></td>
<td class="nump">649<span></span>
</td>
<td class="nump">489<span></span>
</td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationInsurerFeeExpense', window );">Health insurer fees</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">18,345<span></span>
</td>
<td class="nump">15,785<span></span>
</td>
<td class="nump">17,759<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other expenses, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses (income), net</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expenses, net</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense</a></td>
<td class="nump">961<span></span>
</td>
<td class="nump">972<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 673<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="nump">$ 707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 11.40<span></span>
</td>
<td class="nump">$ 11.85<span></span>
</td>
<td class="nump">$ 11.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 11.23<span></span>
</td>
<td class="nump">$ 11.47<span></span>
</td>
<td class="nump">$ 10.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">59.0<span></span>
</td>
<td class="nump">62.2<span></span>
</td>
<td class="nump">61.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">59.9<span></span>
</td>
<td class="nump">64.2<span></span>
</td>
<td class="nump">66.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePremiumMember', window );">Premium revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Revenues</a></td>
<td class="nump">$ 18,299<span></span>
</td>
<td class="nump">$ 16,208<span></span>
</td>
<td class="nump">$ 17,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=moh_PremiumTaxRevenueMember', window );">Premium tax revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Revenues</a></td>
<td class="nump">649<span></span>
</td>
<td class="nump">489<span></span>
</td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=moh_HealthcareInsurerFeeReimbursedMember', window );">Health insurer fees reimbursed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Revenues</a></td>
<td class="nump">271<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=moh_MarketplaceRiskCorridorSettlementMember', window );">Marketplace risk corridor judgment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Revenues</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=moh_MedicalCareCostsMember', window );">Medical care costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">$ 15,820<span></span>
</td>
<td class="nump">$ 13,905<span></span>
</td>
<td class="nump">$ 15,137<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_HealthCareOrganizationInsurerFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care Organization, Insurer Fee Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_HealthCareOrganizationInsurerFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_PremiumTaxExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An assessment levied by a state government on the net premium income collected.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_PremiumTaxExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=moh_PremiumTaxRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=moh_PremiumTaxRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=moh_HealthcareInsurerFeeReimbursedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=moh_HealthcareInsurerFeeReimbursedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=moh_MarketplaceRiskCorridorSettlementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=moh_MarketplaceRiskCorridorSettlementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=moh_MedicalCareCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=moh_MedicalCareCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821609418488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 673<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="nump">$ 707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Unrealized investment income (loss)</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Less: effect of income taxes</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 706<span></span>
</td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">$ 705<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821600514104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,154<span></span>
</td>
<td class="nump">$ 2,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investments</a></td>
<td class="nump">1,875<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">1,672<span></span>
</td>
<td class="nump">1,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">7,876<span></span>
</td>
<td class="nump">5,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, equipment, and capitalized software, net</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and intangible assets, net</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Restricted investments</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">9,532<span></span>
</td>
<td class="nump">6,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical claims and benefits payable</a></td>
<td class="nump">2,696<span></span>
</td>
<td class="nump">1,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_MedicalPremiumLiabilityDueToAgency', window );">Amounts due government agencies</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable, accrued liabilities and other</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">375<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,965<span></span>
</td>
<td class="nump">3,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">2,127<span></span>
</td>
<td class="nump">1,237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">7,436<span></span>
</td>
<td class="nump">4,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,860<span></span>
</td>
<td class="nump">1,781<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">2,096<span></span>
</td>
<td class="nump">1,960<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 9,532<span></span>
</td>
<td class="nump">$ 6,787<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_MedicalPremiumLiabilityDueToAgency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Premium Liability Due to Agency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_MedicalPremiumLiabilityDueToAgency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the noncurrent portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821597000360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">59,000,000<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821604771176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Adoption of new accounting standards</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th">
<div>Accumulated Other Comprehensive Income (Loss) </div>
<div>Adoption of new accounting standards</div>
</th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Adoption of new accounting standards</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2017</a></td>
<td class="nump">59,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2017</a></td>
<td class="nump">$ 1,337<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,044<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Termination of warrants</a></td>
<td class="num">(550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Exchange of convertible senior notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Exchange of convertible senior notes</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Conversion of convertible senior notes</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2018</a></td>
<td class="nump">62,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 1,647<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">643<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,012<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Common stock purchases</a></td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Termination of warrants</a></td>
<td class="num">(514)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(514)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Exchange of convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">61,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 1,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Common stock purchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Common stock purchases</a></td>
<td class="num">(605)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(594)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Termination of warrants</a></td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Exchange of convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 2,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821733938456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 673<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="nump">$ 707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_GainLossOnDebtRepayment', window );">Loss (gain) on debt repayment</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss on sales of subsidiaries, net of gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_NoncashRestructuringCharges', window );">Non-cash restructuring charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other, net</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of the effect of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="num">(530)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Medical claims and benefits payable</a></td>
<td class="nump">544<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency', window );">Amounts due government agencies</a></td>
<td class="nump">446<span></span>
</td>
<td class="num">(303)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued liabilities and other</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,890<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="num">(314)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of investments</a></td>
<td class="num">(670)<span></span>
</td>
<td class="num">(2,536)<span></span>
</td>
<td class="num">(1,444)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">1,097<span></span>
</td>
<td class="nump">2,302<span></span>
</td>
<td class="nump">2,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Net cash paid in business combinations</a></td>
<td class="num">(755)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates', window );">Net cash received from sale of subsidiaries</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(400)<span></span>
</td>
<td class="num">(293)<span></span>
</td>
<td class="nump">1,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from senior notes offerings, net of issuance costs</a></td>
<td class="nump">1,429<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock purchases</a></td>
<td class="num">(606)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayment of term loan facility</a></td>
<td class="num">(600)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from borrowings under term loan facility</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayment of senior notes</a></td>
<td class="num">(338)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfWarrants', window );">Cash paid for partial termination of warrants</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(514)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_CashPaidForSettlementOfConversionOption', window );">Cash paid for partial settlement of conversion option</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(578)<span></span>
</td>
<td class="num">(623)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Cash received for partial settlement of call option</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="nump">623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayment of principal amount of convertible senior notes</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(240)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">225<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="num">(1,193)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents</a></td>
<td class="nump">1,715<span></span>
</td>
<td class="num">(418)<span></span>
</td>
<td class="num">(364)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period</a></td>
<td class="nump">2,508<span></span>
</td>
<td class="nump">2,926<span></span>
</td>
<td class="nump">3,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, and restricted cash and cash equivalents at end of period</a></td>
<td class="nump">4,223<span></span>
</td>
<td class="nump">2,508<span></span>
</td>
<td class="nump">2,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_CashPaidDuringThePeriodAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Schedule of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="num">(1,340)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities', window );">Fair value of contingent consideration liabilities</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Fair value of liabilities assumed</a></td>
<td class="nump">545<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Net cash paid in business combinations</a></td>
<td class="num">(755)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_CovertibleSeniorNotesExchangeTransactionAbstract', window );"><strong>Convertible senior notes exchange transaction:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesIssued1', window );">Common stock issued in exchange for convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease', window );">Component of convertible senior notes allocated to additional paid-in capital, net of income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Net increase to additional paid-in capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock used for stock-based compensation</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_CommonStockPurchasesNotSettledAtEndOfPeriod', window );">Common stock purchases not settled at end of period</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DetailsofchangeinfairvalueofderivativesAbstract', window );"><strong>Details of change in fair value of derivatives, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivatives, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract', window );"><strong>Details of sales of subsidiaries:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_IncreaseDecreaseinCarryingAmountofAssets', window );">Decrease in carrying amount of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(327)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_GainLossonDispositionofLiabilities', window );">Decrease in carrying amount of liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DispositionofBusinessTransactionCosts', window );">Transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DispositionofBusinessReceivablefromBuyer', window );">Cash received from buyers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss on sale of subsidiaries, net of gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=moh_CallOptionDerivativeAssetMember', window );">(Loss) gain on call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DetailsofchangeinfairvalueofderivativesAbstract', window );"><strong>Details of change in fair value of derivatives, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivatives, net</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember', window );">Gain (loss) on conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DetailsofchangeinfairvalueofderivativesAbstract', window );"><strong>Details of change in fair value of derivatives, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivatives, net</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (132)<span></span>
</td>
<td class="num">$ (577)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_CashPaidDuringThePeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Paid During The Period [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_CashPaidDuringThePeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_CashPaidForSettlementOfConversionOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Paid For Settlement Of Conversion Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_CashPaidForSettlementOfConversionOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_CommonStockPurchasesNotSettledAtEndOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Purchases Not Settled At End Of Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_CommonStockPurchasesNotSettledAtEndOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_CovertibleSeniorNotesExchangeTransactionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Covertible Senior Notes Exchange Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_CovertibleSeniorNotesExchangeTransactionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_DetailsofchangeinfairvalueofderivativesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Details of change in fair value of derivatives</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_DetailsofchangeinfairvalueofderivativesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_DispositionofBusinessReceivablefromBuyer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposition of Business, Receivable from Buyer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_DispositionofBusinessReceivablefromBuyer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_DispositionofBusinessTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposition of Business, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_DispositionofBusinessTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Contingent Consideration Liabilities Assumed In Noncash Investing Or Financing Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_GainLossOnDebtRepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Debt Repayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_GainLossOnDebtRepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_GainLossonDispositionofLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Disposition of Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_GainLossonDispositionofLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Medical Premium Liability Due to Agency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_IncreaseDecreaseinCarryingAmountofAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Carrying Amount of Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_IncreaseDecreaseinCarryingAmountofAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_NoncashRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash Restructuring Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_NoncashRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_NotesIssuedFairValueAdjustmentIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notes Issued, Fair Value Adjustment Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_NotesIssuedFairValueAdjustmentIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in health care insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of notes issued in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=moh_CallOptionDerivativeAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=moh_CallOptionDerivativeAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603611608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text">Organization and Basis of Presentation <div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization and Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare, Inc. provides managed healthcare services under the Medicaid and Medicare programs, through the state insurance marketplaces (the &#8220;Marketplace&#8221;), and under other government-sponsored healthcare programs for low-income families and individuals, most of whom receive government subsidies for premiums. As of December 31, 2020, we had two reportable segments: the Health Plans segment, and the Other segment. Our reportable segments are consistent with how we currently manage the business and view the markets we serve. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our locally operated health plans in 15 states, we served approximately 4.0 million members as of December 31, 2020. In addition, in connection with our acquisition of Magellan Complete Care on December 31, 2020, we added approximately 200,000 members, and now operate health plans in 18 states. These health plans are generally operated by our respective wholly owned subsidiaries in those states, and licensed as health maintenance organizations (&#8220;HMOs&#8221;). </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our state Medicaid contracts typically have terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDIvZnJhZzplODlkZjQ1ZTZlYjQ0NGZhYmQ5Y2VhNjJlNDFlMWUwNi90ZXh0cmVnaW9uOmU4OWRmNDVlNmViNDQ0ZmFiZDljZWE2MmU0MWUxZTA2Xzg0NA_2a1d4052-6221-4b74-b359-9ff02580423e">three</span> to five years, contain renewal options exercisable by the state Medicaid agency, and allow either the state or the health plan to terminate the contract with or without cause. Such contracts are subject to risk of loss in states that issue requests for proposal (&#8220;RFP&#8221;) open to competitive bidding by other health plans. If one of our health plans is not a successful responsive bidder to a state RFP, its contract may not be renewed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to contract renewal, our state Medicaid contracts may be periodically amended to include or exclude certain health benefits (such as pharmacy services, behavioral health services, or long-term care services); populations such as the aged, blind or disabled; and regions or service areas.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Developments &#8211; Health Plans Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Magellan Complete Care. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, we closed on our acquisition of 100% of the outstanding equity interests of the Magellan Complete Care line of business of Magellan Health, Inc., for total purchase consideration of approximately $1,037&#160;million. Because this acquisition closed on December 31, 2020, Magellan Complete Care&#8217;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020. See Note 4, &#8220;Business Combinations,&#8221; for further information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a definitive agreement to acquire substantially all the assets of Affinity Health Plan, Inc. The net purchase price for the transaction is approximately $380&#160;million, subject to various adjustments at closing, which we intend to fund with cash on hand. We currently expect the transaction to close as early as the second quarter of 2021.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we completed the acquisition of certain assets of YourCare Health Plan, Inc. See Note 4, &#8220;Business Combinations,&#8221; for further information. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kentucky. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, our Kentucky health plan was selected as an awardee pursuant to the statewide Medicaid managed care RFP issued by the Kentucky Cabinet for Health and Family Services, Department of Medicaid Services. The new Medicaid contract began on January 1, 2021. In connection with this RFP award, we completed the acquisition of certain assets of Passport Health Plan, Inc. (&#8220;Passport&#8221;) in September 2020. See Note 4, &#8220;Business Combinations,&#8221; for further information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Texas.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In March 2020, the Texas Health and Human Services Commission (&#8220;HHSC&#8221;) notified our Texas health plan that HHSC had upheld our protest and had canceled all previously awarded contracts associated with the re-procurement awards announced in October 2019 for the ABD program (known in Texas as &#8220;STAR+PLUS&#8221;). In addition, HHSC canceled the pending re-procurement associated with the TANF and CHIP programs (known in Texas as &#8220;STAR/CHIP&#8221;). HHSC has indicated that the STAR+PLUS RFP will be posted in late 2021 or early 2022, with awards estimated to be announced in the second quarter of 2022, and start of operations in the fourth quarter of 2023. HHSC has also indicated that the STAR/CHIP RFP will be posted in the fourth quarter of 2022, with awards estimated to be announced in late 2022 or early 2023, and start of operations in the third quarter of 2024.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Puerto Rico</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We exited Puerto Rico&#8217;s Medicaid program when our contract expired on October 31, 2020. We have been working with the regulatory authorities and the provider community to ensure that our former members in Puerto Rico have reliable continuity of care.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidation and Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Molina Healthcare, Inc., and its subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. Financial information related to subsidiaries acquired during any year is included only for periods subsequent to their acquisition. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the periods presented have been included; such adjustments consist of normal recurring adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Principal areas requiring the use of estimates include:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of medical claims and benefits payable of our Health Plans segment;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Plans segment contractual provisions that may limit revenue recognition based upon the costs incurred or the profits realized under a specific contract;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Plans segment quality incentives that allow us to recognize incremental revenue if certain quality standards are met;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Settlements under risk or savings sharing programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Purchase price allocations relating to business combinations, including the determination of contingent consideration;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The assessment of long-lived and intangible assets, and goodwill, for impairment;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of reserves for potential absorption of claims unpaid by insolvent providers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of reserves for the outcome of litigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of valuation allowances for deferred tax assets;&#160;and</span></div>&#8226;The determination of unrecognized tax benefits.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821595831288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies <div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and short-term, highly liquid investments that are both readily convertible into known amounts of cash and have a maturity of three months or less on the date of purchase. The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in &#8220;Restricted investments&#8221; in the accompanying consolidated balance sheets. </span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,223&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,926&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments are principally held in debt securities, which are grouped into two separate categories for accounting and reporting purposes: available-for-sale securities, and held-to-maturity securities. Available-for-sale (&#8220;AFS&#8221;) securities are recorded at fair value and unrealized gains and losses, if any, are recorded in stockholders&#8217; equity as other comprehensive income, net of applicable income taxes. Held-to-maturity (&#8220;HTM&#8221;) securities are recorded at amortized cost, which approximates fair value, and unrealized holding gains or losses are not generally recognized. Realized gains and losses and unrealized losses arising from credit-related factors with respect to AFS and HTM securities are included in the determination of net income. The cost of securities sold is determined using the specific-identification method.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy requires that all of our investments have final maturities of less than 10 years, or less than 10 years average life for structured securities. Investments and restricted investments are subject to interest rate risk and will decrease in value if market rates increase. Declines in interest rates over time will reduce our investment income. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, our AFS securities are classified as current assets without regard to the securities&#8217; contractual maturity dates because they may be readily liquidated. We monitor our investments for credit-related impairment. For comprehensive discussions of the fair value and classification of our investments, see Note&#160;5, &#8220;Fair Value Measurements,&#8221; and Note&#160;6, &#8220;Investments.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest receivable relating to our AFS and HTM securities is presented within &#8220;Prepaid expenses and other current assets&#8221; in the accompanying consolidated balance sheets, and amounted to $10&#160;million and $12&#160;million at December 31, 2020, and 2019, respectively. We do not measure an allowance for credit losses on accrued interest receivable. Instead, we write off accrued interest receivable that has not been collected within 90 days of the interest payment due date. We recognize such write offs as a reversal of interest income. No accrued interest was written off during the year ended December 31, 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables consist primarily of premium amounts due from government agencies, which may be subject to potential retroactive adjustments. Because substantially all of our receivable amounts are readily determinable and substantially all of our creditors are governmental authorities, our allowance for doubtful accounts is insignificant. Any amounts determined to be uncollectible are charged to expense when such determination is made.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:72.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmacy rebate receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health insurer fee reimbursement receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for business combinations using the acquisition method of accounting, which requires us to recognize the assets acquired and the liabilities assumed at their acquisition date fair values. As discussed below, the excess of the purchase consideration transferred over the fair value of the net tangible and intangible assets acquired is recorded as goodwill. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the final determination of the values of assets acquired or liabilities assumed, or one year after the date of acquisition, whichever comes first, any subsequent adjustments are recorded within our consolidated results of operations. Refer to Note 4, Business Combinations, and Note 9, &#8220;Goodwill and Intangible Assets, Net,&#8221; for further details.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets, including Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets consist primarily of property, equipment, capitalized software (see Note 7, &#8220;Property, Equipment, and Capitalized Software, Net&#8221;), and intangible assets resulting from acquisitions. Finite-lived, separately-identified intangible assets acquired in business combinations are assets that represent future expected benefits but lack physical substance (such as purchased contract rights and provider contracts). Intangible assets are initially recorded at fair value and are then amortized on a straight-line basis over their expected useful lives, generally between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4NDY_345e2136-02de-45cb-a7d6-760278ca92ed">five</span> and 16 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Determining the fair value of identifiable assets acquired, particularly intangible assets, and liabilities assumed,  requires management to make estimates, which are based on all available information and in some cases assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Determining the useful life of an intangible asset also requires judgment, as different types of intangible assets will have different useful lives. The most significant intangible asset we typically record in a business combination is contract rights associated with membership assumed. In determining the estimated fair value of the intangible assets, we typically apply the income approach, which discounts the projected future net cash flows using an appropriate discount rate that reflects the risk associated with such projected future cash flows. The most critical assumptions used in determining the fair value of contract rights include forecasted operating margins and the weighted average cost of capital.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intangible assets are subject to impairment tests when events or circumstances indicate that a finite-lived intangible asset&#8217;s (or asset group&#8217;s) carrying value may not be recoverable. Consideration is given to a number of potential impairment indicators, including the ability of our health plan subsidiaries to obtain the renewal by amendment of their contracts in each state prior to the actual expiration of their contracts. However, there can be no assurance that these contracts will continue to be renewed. Following the identification of any potential impairment indicators, to determine whether an impairment exists, we would compare the carrying amount of a finite-lived intangible asset with the greater of the undiscounted cash flows that are expected to result from the use of the asset or related group of assets, or its value under the asset liquidation method. If it is determined that the carrying amount of the asset is not recoverable, the amount by which the carrying value exceeds the estimated fair value is recorded as an impairment. Refer to Note 9, &#8220;Goodwill and Intangible Assets, Net,&#8221; for further details.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase consideration over the fair value of net assets acquired in business combinations. Goodwill is not amortized but is tested for impairment on an annual basis and more frequently if impairment indicators are present. Impairment indicators may include experienced or expected operating cash-flow deterioration or losses, significant losses of membership, loss of state funding, loss of state contracts, and other factors. Goodwill is impaired if the carrying amount of the reporting unit (one of our state health plans) exceeds its estimated fair value. This excess is recorded as an impairment loss and adjusted if necessary for the impact of tax-deductible goodwill. The loss recognized may not exceed the total goodwill allocated to the reporting unit. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When testing goodwill for impairment, we may first assess qualitative factors, such as industry and market factors, the dynamic economic and political environments in which we operate, cost factors, and changes in overall performance, to determine if it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value. If our qualitative assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, we perform the quantitative assessment. We may also elect to bypass the qualitative assessment and proceed directly to the quantitative assessment. If performing a quantitative assessment, we generally estimate the fair values of our reporting units by applying the income approach, using discounted cash flows. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the annual impairment test under a quantitative assessment, the base year in the reporting units&#8217; discounted cash flows is derived from the annual financial planning cycle, which commences in the fourth quarter of the year. When computing discounted cash flows, we make assumptions about a wide variety of internal and external factors, and consider what the reporting unit&#8217;s selling price would be in an orderly transaction between market participants at the measurement date. Significant assumptions include financial projections of free cash flow (including significant assumptions about membership, premium rates, healthcare and operating cost trends, contract renewal and the procurement of new contracts, capital requirements and income taxes), long-term growth rates for determining terminal value beyond the discretely forecasted periods, and discount rates. When determining the discount rate, we consider the overall level of inherent risk of the reporting unit, and the expected rate an outside investor would expect to earn. As part of a quantitative assessment, we may also apply the asset liquidation method to estimate the fair value of individual reporting units, which is computed as total assets minus total liabilities, excluding intangible assets and deferred taxes. Finally, we apply a market approach to reconcile the value of our reporting units to our consolidated market value. Under the market approach, we consider publicly traded comparable company information to determine revenue and earnings multiples which are used to estimate our reporting units&#8217; fair values. The assumptions used are consistent with those used in our long-range business plan and annual planning process. However, if these assumptions differ from actual results, the outcome of our goodwill impairment tests could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use (&#8220;ROU&#8221;) assets represent our right to use the underlying assets over the lease term, and lease liabilities represent our obligation for lease payments arising from the related leases. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease terms may include options to extend or terminate the lease when we believe it is reasonably certain that we will exercise such options. If applicable, we account for lease and non-lease components within a lease as a single lease component.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because most of our leases do not provide an implicit interest rate, we generally use our incremental borrowing rate to determine the present value of lease payments. Lease expenses for operating lease payments are recognized on a straight-line basis over the lease term, and the related ROU assets and liabilities are reduced to the present value of the remaining lease payments at the end of each period. Finance lease payments reduce finance lease liabilities, </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the related ROU assets are amortized on a straight-line basis over the lease term, and interest expense is recognized using the effective interest method.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant majority of our operating leases consist of long-term operating leases for office space. Short-term leases (those with terms of 12 months or less) are not recorded as ROU assets or liabilities in the consolidated balance sheets. For certain leases that represent a portfolio of similar assets, such as a fleet of vehicles, we apply a portfolio approach to account for the related ROU assets and liabilities, rather than account for such assets and the related liabilities individually. A nominal number of our lease agreements include rental payments that adjust periodically for inflation. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information, including the amount and location of the ROU assets and lease liabilities recognized in the accompanying consolidated balance sheets, see Note 8, &#8220;Leases.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Claims and Benefits Payable</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical care costs are recognized in the period in which services are provided and include fee-for-service claims, pharmacy benefits, capitation payments to providers, and various other medically-related costs. Under fee-for-service claims arrangements with providers, we retain the financial responsibility for medical care provided and incur costs based on actual utilization of hospital and physician services. Such medical care costs include amounts paid by us as well as estimated medical claims and benefits payable for costs that were incurred but not paid as of the reporting date (&#8220;IBNP&#8221;). Pharmacy benefits represent payments for members' prescription drug costs, net of rebates from drug manufacturers. We estimate pharmacy rebates based on historical and current utilization of prescription drugs and contractual provisions. Capitation payments represent monthly contractual fees paid to providers, who are responsible for providing medical care to members, which could include medical or ancillary costs like dental, vision and other supplemental health benefits. Such capitation costs are fixed in advance of the periods covered and are not subject to significant accounting estimates. Other medical care costs include all medically-related administrative costs, amounts due to providers pursuant to risk-sharing or other incentive arrangements, provider claims, and other healthcare expenses. Examples of medically-related administrative costs include expenses relating to health education, quality assurance, case management, care coordination, disease management, and 24-hour on-call nurses. Additionally, we include an estimate for the cost of settling claims incurred through the reporting date in our medical claims and benefits payable liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical claims and benefits payable consist mainly of fee-for-service IBNP, unpaid pharmacy claims, capitation costs, other medical costs, including amounts payable to providers pursuant to risk-sharing or other incentive arrangements and amounts payable to providers on behalf of certain state agencies for certain state assessments in which we assume no financial risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IBNP includes the costs of claims incurred as of the balance sheet date which have been reported to us, and our best estimate of the cost of claims incurred but not yet reported to us. We also include an additional reserve to ensure that our overall IBNP liability is sufficient under moderately adverse conditions. We reflect changes in these estimates in the consolidated results of operations in the period in which they are determined. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimation of the IBNP liability requires a significant degree of judgment in applying actuarial methods, determining the appropriate assumptions and considering numerous factors. Of those factors, we consider estimated completion factors and the assumed healthcare cost trend to be the most critical assumptions. Other relevant factors also include, but are not limited to, healthcare service utilization trends, claim inventory levels, changes in membership, product mix, seasonality, benefit changes or changes in Medicaid fee schedules, provider contract changes, prior authorizations and the incidence of catastrophic or pandemic cases.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the significant degree of judgment involved in estimation of our IBNP liability, there is considerable variability and uncertainty inherent in such estimates. Each reporting period, the recognized IBNP liability represents our best estimate of the total amount of unpaid claims incurred as of the balance sheet date using a consistent methodology in estimating our IBNP liability. We believe our current estimates are reasonable and adequate; however, the development of our estimate is a continuous process that we monitor and update as more complete claims payment information and healthcare cost trend data becomes available. Actual medical care costs may be less than we previously estimated (favorable development) or more than we previously estimated (unfavorable development), and any differences could be material. Any adjustments to reflect favorable development would be recognized as a decrease to medical care costs, and any adjustments to reflect unfavorable development would be recognized as an increase to medical care costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the period in which the adjustments are determined. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 10, &#8220;Medical Claims and Benefits Payable,&#8221; for a table presenting the components of the change in our medical claims and benefits payable, for all periods presented in the accompanying consolidated financial statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Premium Revenue Recognition and Amounts Due Government Agencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenue is generated from our Health Plans segment contracts, for our participation in the Medicaid, Medicare and Marketplace programs. Premium revenue is generally received based on per member per month (&#8220;PMPM&#8221;) rates established in advance of the periods covered. These premium revenues are recognized in the month that members are entitled to receive healthcare services, and premiums collected in advance are deferred. State Medicaid programs and the federal Medicare program periodically adjust premium rates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain components of premium revenue are subject to accounting estimates and are described below, under &#8220;Contractual Provisions That May Adjust or Limit Revenue or Profit,&#8221; and &#8220;Quality Incentives.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Provisions That May Adjust or Limit Revenue or Profit</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our contracts contain provisions that may adjust or limit revenue or profit, as described below. Consequently, we recognize premium revenue as it is earned under such provisions. Liabilities accrued for premiums to be returned under such provisions are reported in the aggregate as &#8220;Amounts due government agencies&#8221; in the accompanying consolidated balance sheets. Categorized by program, such amounts due government agencies included the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:71.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid program:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Minimum MLR and profit sharing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk adjustment and Part D risk sharing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Minimum MLR and profit sharing </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketplace program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Minimum MLR</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts due government agencies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicaid Program</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum MLR and Medical Cost Corridors. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our premium revenue may be returned if certain minimum amounts are not spent on defined medical care costs. Under certain medical cost corridor provisions, the health plans may receive additional premiums if amounts spent on medical care costs exceed a defined maximum threshold.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Profit Sharing. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with certain states contain profit sharing provisions under which we refund amounts to the states if our health plans generate profit above a certain specified percentage. In some cases, we are limited in the amount of administrative costs that we may deduct in calculating the refund, if any.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retroactive Premium Adjustments. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Medicaid programs periodically adjust premium rates on a retroactive basis. In these cases, we adjust our premium revenue in the period in which we determine that the adjustment is probable and reasonably estimable, and is based on our best estimate of the ultimate premium we expect to realize for the period being adjusted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, various states enacted temporary premium refunds and related actions in response to the reduced demand for medical services stemming from COVID-19, which resulted in a reduction of our medical margin. In some cases, these premium actions were retroactive to earlier periods in 2020, or as early as the beginning of the states&#8217; fiscal years in 2019. Beginning in the second quarter of 2020, we have recognized retroactive premium actions that we believe to be probable, and where the ultimate premium amount is reasonably estimable. We recognized $564&#160;million related to these retroactive premium actions, in the aggregate, in 2020, including $37&#160;million related to </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MMP plans. Approximately $401&#160;million was recognized in the fourth quarter of 2020, mostly associated with recently enacted risk-sharing corridors.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is possible that certain states could increase the level of existing premium refunds, and it is also possible that other states could implement some form of retroactive premium refund in the future. Due to these uncertainties, the ultimate outcomes could differ materially from our estimates as a result of changes in facts or further developments, which could have an adverse effect on our consolidated financial position, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Medicare premiums are subject to retroactive increase or decrease based on the health status of our Medicare members (as measured by member risk score). We estimate our members&#8217; risk scores and the related amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members&#8217; health status, risk scores and Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) practices.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum MLR.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Affordable Care Act (&#8220;ACA&#8221;) established a minimum annual medical loss ratio (&#8220;Minimum MLR&#8221;) of 85% for Medicare. The medical loss ratio represents medical costs as a percentage of premium revenue. Federal regulations define what constitutes medical costs and premium revenue. If the Minimum MLR is not met, we may be required to pay rebates to the federal government. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Marketplace Program</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Corridor Judgment. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the United States Supreme Court held that &#167;1342 of the Affordable Care Act obligated the federal government to pay participating insurers the full Marketplace risk corridor amounts calculated by that statute, and that impacted insurers may sue the federal government in the U.S. Court of Federal Claims to recover damages for breach of that obligation. In June 2020, the Claims Court granted us judgment in the amount of $128&#160;million for 2014, 2015, and 2016 Marketplace risk corridor claims, which we received in October 2020. Consistent with the timing of the cash receipt, the gain was recognized in our fourth quarter 2020 financial results and reported in &#8220;Marketplace risk corridor judgment&#8221; in our consolidated statements of income. The judgment did not create additional Minimum MLR rebates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under this program, our health plans&#8217; composite risk scores are compared with the overall average risk score for the relevant state and market pool. Generally, our health plans will make a risk adjustment payment into the pool if their composite risk scores are below the average risk score (risk adjustment payable), and will receive a risk adjustment payment from the pool if their composite risk scores are above the average risk score (risk adjustment receivable). We estimate our ultimate premium based on insurance policy year-to-date experience, and recognize estimated premiums relating to the risk adjustment program as an adjustment to premium revenue in our consolidated statements of income. As of December&#160;31, 2020, Marketplace risk adjustment payables amounted to $326 million and related receivables amounted to $20 million, for a net payable of $306 million. As of December 31, 2019, Marketplace risk adjustment payables amounted to $368 million and related receivables amounted to $63 million, for a net payable of $305 million, which relates primarily to 2019 and prior periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum MLR.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The ACA has established a Minimum MLR of 80% for the Marketplace. If the Minimum MLR is not met, we may be required to pay rebates to our Marketplace policyholders. The Marketplace risk adjustment program is taken into consideration when computing the Minimum MLR. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quality Incentives</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At many of our health plans, revenue ranging from approximately 1% to 4% of certain health plan premiums is earned only if certain performance measures are met. Such performance measures are generally found in our Medicaid and MMP contracts. As described in Note 1, &#8220;Organization and Basis of Presentation&#8211;Use of Estimates,&#8221; recognition of quality incentive premium revenue is subject to the use of estimates. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We bear underwriting and reserving risks associated with our health plan subsidiaries. We limit our risk of significant catastrophic losses by maintaining high deductible reinsurance coverage with a highly-rated, unaffiliated insurance company (the &#8220;third-party reinsurer&#8221;).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we remain liable to our policyholders in the event the third-party reinsurer is unable to pay its portion of the losses, we continually monitor the third-party reinsurer&#8217;s financial condition, including its ability to maintain high credit ratings. Intercompany transactions with our captive are eliminated in consolidation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report reinsurance premiums as a reduction to premium revenue, while related reinsurance recoveries are reported as a reduction to medical care costs. Reinsurance premiums amounted to $9 million, $17 million, and $16 million for the years ended December&#160;31, 2020, 2019, and 2018, respectively. Reinsurance recoveries amounted to $23 million, $18 million, and $33 million for the years ended December 31, 2020, 2019, and 2018, respectively. Reinsurance recoverable of $17 million, $21 million, and $31 million, as of December 31, 2020, 2019, and 2018, respectively, is included in &#8220;Receivables&#8221; in the accompanying consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Premium Deficiency Reserves on Loss Contracts</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the profitability of our contracts to determine if it is probable that a loss will be incurred in the future by reviewing current results and forecasts. For purposes of this assessment, contracts are grouped in a manner consistent with our method of acquiring, servicing and measuring the profitability of such contracts. A premium deficiency is recognized if anticipated future medical care and administrative costs exceed anticipated future premium revenue, investment income and reinsurance recoveries. In the third quarter of 2020, we recognized a premium deficiency reserve (&#8220;PDR&#8221;) of $10&#160;million for our Medicaid contract in Puerto Rico, $4&#160;million of which was amortized in the fourth quarter of 2020 to offset losses the PDR was established to cover. As described in Note 1, &#8220;Organization and Basis of Presentation,&#8221; we exited Puerto Rico&#8217;s Medicaid program when our contract expired on October 31, 2020. No premium deficiency reserves were recorded as of December 31, 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates expected to be in effect during the year in which the basis differences reverse. Valuation allowances are established when management determines it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. For further discussion and disclosure, see Note 12, &#8220;Income Taxes.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes Based on Premiums</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee (&#8220;HIF&#8221;). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Affordable Care Act, the federal government imposed an annual fee, or excise tax, on health insurers for each calendar year (the &#8220;HIF&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HIF was allocated to health insurers based on each health insurer's share of net premiums for all U.S. health insurers in the year preceding the assessment, and was not deductible for income tax purposes. Our HIF liability for 2020 was $277&#160;million, which was settled in September 2020. Public Law No. 115-120 provided for a HIF moratorium in 2019; therefore, there was no HIF incurred or reimbursed in that year. Due to the reinstatement of the HIF in 2020, our effective tax rate was higher in 2020 compared with 2019. The Further Consolidated Appropriations Act, 2020 repealed the HIF effective for years after 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premium and Use Tax. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our health plans are assessed a tax based on premium revenue collected. The premium revenues we receive from these states include the premium tax assessment. We have reported these taxes on a gross basis, as premium tax revenue and as premium tax expenses in the consolidated statements of income. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. Our portfolio managers must obtain our prior approval before selling investments where the loss position of those investments exceeds certain levels. Our investments consist primarily of investment-grade debt securities with final maturities of less than 10 years, or less than 10 years average life for structured securities. Restricted investments are invested principally in cash, cash equivalents and U.S. Treasury securities. Concentration of credit risk with respect to accounts receivable is limited because our payors consist principally of the federal government, and governments of each state in which our health plan subsidiaries operate. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability depends in large part on our ability to accurately predict and effectively manage medical care costs. We continually review our medical costs in light of our underlying claims experience and revised actuarial data. However, several factors could adversely affect medical care costs. These factors, which include changes in healthcare practices, inflation, new technologies, major epidemics, natural disasters, and malpractice litigation, are beyond our control and may have an adverse effect on our ability to accurately predict and effectively control medical care costs. Costs in excess of those anticipated could have a material adverse effect on our financial condition, results of operations, or cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate health plans primarily as a direct contractor with the states, and in Los Angeles County, California, as a subcontractor to another health plan holding a direct contract with the state. We are therefore dependent upon a relatively small number of contracts to support our revenue. The loss of any one of those contracts could have a material adverse effect on our financial position, results of operations, or cash flows. In addition, our ability to arrange for the provision of medical services to our members is dependent upon our ability to develop and maintain adequate provider networks. Our inability to develop or maintain such networks might, in certain circumstances, have a material adverse effect on our financial position, results of operations, or cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes premium revenue by state health plan for the periods presented:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">California</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Illinois </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kentucky</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michigan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ohio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Washington</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,208&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">&#8220;Other&#8221; includes the Idaho, Mississippi, New Mexico, New York, Puerto Rico, South Carolina, Utah and Wisconsin health plans, which were immaterial to our consolidated results of operations.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was subsequently modified by several ASUs issued in 2018 and 2019. We adopted Topic 326 effective January 1, 2020, using the modified retrospective approach. Under this method we recognized the cumulative effect of adopting the standard as an adjustment to the opening balance of retained earnings on January 1, 2020, which was immaterial.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by a change in the reference rate from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) or another reference rate expected to be discontinued, if certain conditions are met. ASU 2020-04 is effective immediately and expires after December 31, 2022. We are evaluating the effect of reference rate reform and this guidance on our contracts and other transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (&#8220;SEC&#8221;) did not have, nor does management expect such pronouncements to have, a significant impact on our present or future consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821598753352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text">Net Income Per Share <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net income per share:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except net income per share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average number of shares issued:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exchange of convertible senior notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion of convertible senior notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator for basic net income per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible senior notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator for diluted net income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per share - Basic </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per share - Diluted </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.23&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.47&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.61&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">&#8220;Convertible senior notes&#8221; in this table refer to the 1.625% convertible senior notes due 2044 that were settled in 2018.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">For more information regarding the warrants, including partial termination transactions, refer to Note 13, &#8220;Stockholders' Equity.&#8221; The dilutive effect of all potentially dilutive common shares is calculated using the treasury stock method. Certain potentially dilutive common shares issuable are not included in the computation of diluted net income per share because to do so would have been anti-dilutive.</span></div>(3)Source data for calculations in thousands.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821598722552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations <div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the last half of 2020, we closed on three business combinations in the Health Plans segment, consistent with our strategy to grow in our existing markets and expand into new markets. For these transactions, we applied the acquisition method of accounting, where the total purchase price was allocated, or preliminarily allocated, to the tangible and intangible assets acquired and liabilities assumed, based on their fair values as of the acquisition dates. We expect to complete the final determination of the purchase price allocations as soon as practicable, but no later than one year following the acquisitions&#8217; closing dates in accordance with Accounting Standards Codification Topic 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Measurement period adjustments will be recorded in the period in which they are determined, as if they had been completed at the acquisition date.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition costs amounted to $16&#160;million in the aggregate for the year ended December 31, 2020, and were recorded as &#8220;General and administrative expenses&#8221; in the accompanying consolidated statements of income.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Magellan Complete Care. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, we closed on our acquisition of 100% of the outstanding equity interests of the Magellan Complete Care line of business of Magellan Health, Inc., for total purchase consideration of approximately $1,037&#160;million. Total purchase consideration paid in cash amounted to $1,008&#160;million, which consisted of the base purchase price of $850&#160;million, plus approximately $158&#160;million in preliminary closing adjustments, primarily relating to excess regulatory capital. Total purchase consideration also included assumed liabilities of $29&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Magellan Complete Care is a managed care organization serving members in six states, including Medicaid members in Arizona and statewide in Virginia, and integrated acute care members in Florida. Through its Senior Whole Health branded plans, Magellan Complete Care provides fully integrated plans for Medicaid and Medicare dual beneficiaries in Massachusetts, as well as managed long-term care in New York. As of December 31, 2020, Magellan Complete Care served approximately 200,000 members in its managed care plans. Magellan Complete Care also provides consultative services to participants who self-direct their care through Wisconsin&#8217;s long-term services and supports (&#8220;LTSS&#8221;) program. For the year ended December 31, 2020, Magellan Complete Care&#8217;s total 2020 revenue was approximately $2.9&#160;billion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because this acquisition closed on December 31, 2020, Magellan Complete Care&#8217;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020. If we had acquired Magellan Complete Care on January 1, 2019, our total revenue and earnings for the year ended December 31, 2019, would have been approximately $19.6 billion and $772 million, respectively, and our total revenue and earnings for the year ended December 31, 2020, would have been approximately $22.4 billion and $833 million, respectively. These amounts were computed after adjusting the results of Magellan Complete Care to reflect the additional amortization that would have been charged assuming the fair value adjustments to intangible assets and liabilities had been applied beginning on January 1, 2019, together with the consequential tax effects. The pro forma results do not reflect any anticipated synergies, efficiencies, or other cost savings of the acquisition. Accordingly, the unaudited pro forma financial information is not indicative of the results if the acquisition had been completed on January 1, 2020, or January 1, 2019, and is not a projection of future results. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of the assets acquired, and liabilities assumed has not yet been finalized because the acquisition closed on December 31, 2020. As a result, provisional estimates have been recorded and are subject to change, primarily for accounts that include the use of estimates, such as medical claims and benefits payable, receivables, amounts due government agencies, certain acquired intangible assets, and certain tax assets and liabilities. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Such assets include synergies we expect to achieve, such as the use of our existing infrastructure to support the added membership, and future economic benefits arising from the assembled workforce. Approximately 27% of the goodwill is deductible for income tax purposes. The following table summarizes the provisional fair values assigned to assets acquired and liabilities assumed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities assumed: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued and other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net purchase price paid</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kentucky. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2020, we closed on the acquisition of certain assets of Passport Health Plan, Inc., a Medicaid health plan. Effective on that same date, the Kentucky Medicaid agency approved the novation of Passport&#8217;s Medicaid contract to Molina Healthcare of Kentucky, Inc., thereby ensuring continuity of care for Passport&#8217;s Medicaid members. As of December 31, 2020, our Kentucky health plan had 337,000 Medicaid </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">members. The total purchase price was $66 million, which included our initial cash payment of $20 million in September 2020, plus $46&#160;million in contingent consideration payable to the seller. See further information regarding contingent consideration in Note 5, &#8220;Fair Value Measurements.&#8221; We recorded goodwill of $30 million, all of which is deductible for income tax purposes. The goodwill recorded relates to future economic benefits arising from the assembled workforce, and the future growth associated with the member contract rights that are incremental to the contract rights identified.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2020, we closed on the acquisition of certain assets of YourCare Health Plan, Inc., a Medicaid health plan operating in certain regions of New York, for a cash purchase price of $42&#160;million. As a result of this transaction, we added approximately 47,000 Medicaid members in New York. We recorded goodwill of $31 million, substantially all of which is deductible for income tax purposes. The goodwill recorded relates to future economic benefits arising from expected synergies to be achieved, including the use of our existing infrastructure to support the added membership.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets Acquired</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents intangible assets acquired, by major class, for the three acquisitions. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Life</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract rights - member list</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provider network</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821598418936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements <div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of current assets and current liabilities to approximate their fair values because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For our financial instruments measured at fair value on a recurring basis, we prioritize the inputs used in measuring fair value according to a three-tier fair value hierarchy as follows:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1 &#8212; Observable Inputs.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 financial instruments are actively traded and therefore the fair value for these securities is based on quoted market prices for identical securities in active markets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2 &#8212; Directly or Indirectly Observable Inputs. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value for these investments is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3 &#8212; Unobservable Inputs. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 financial instruments are valued using unobservable inputs that represent management&#8217;s best estimate of what market participants would use in pricing the financial instrument at the measurement date. As of December 31, 2020, our Level 3 financial instruments consisted of contingent consideration liabilities. As of December 31, 2019, our Level 3 financial instruments consisted of derivative financial instruments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net changes in fair value of Level 3 financial instruments are reported in &#8220;Other&#8221; operating expenses in our consolidated statements of income. In the year ended December 31, 2020, we recognized a loss of $6&#160;million, primarily for the increase in the fair value of the contingent consideration liability described below, because the opening 2021 enrollment for our Kentucky health plan was higher than our estimate as of September 30, 2020. In the year ended December 31, 2019, the net changes in fair value of Level 3 financial instruments were insignificant to our results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments measured at fair value on a recurring basis at December&#160;31, 2020, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments measured at fair value on a recurring basis at December&#160;31, 2019, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government-sponsored enterprise securities (&#8220;GSEs&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call option derivative asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion option derivative liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Liabilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, our Level 3 financial instruments recorded at fair value on a recurring basis included contingent consideration liabilities of $46 million, in connection with the Kentucky acquisition described in Note 4, &#8220;Business Combinations.&#8221; As of December 31, 2020, the contingent consideration fair value was estimated primarily based on an amount we expect to pay the seller for members enrolled in our Kentucky health plan as of January 1, 2021, over a minimum threshold. Half this amount is payable later in 2021, with the remainder payable in early 2022, subject to review and agreement among us and the seller. The second half payment is contingent upon the outcome of certain legal challenges. The current portion is reported in &#8220;Accounts payable, accrued liabilities and other,&#8221; and the non-current portion is reported in &#8220;Other long-term liabilities,&#8221; in the accompanying consolidated balance sheets. Contingent consideration liabilities are remeasured to fair value each quarter until the contingencies are resolved with fair value adjustments, if any, recorded to operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivatives </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair values and the presentation of our derivative financial instruments in the accompanying consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative asset:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call Option</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets: Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion Option</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities: Accounts payable, accrued liabilities and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our derivative financial instruments did not qualify for hedge treatment. Gains and losses for our derivative financial instruments are presented individually in the accompanying consolidated statements of cash flows, &#8220;Supplemental cash flow information.&#8221; </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the year ended December 31, 2020, we received $27 million for the settlement of the call option derivative asset, and we paid $39 million to settle the outstanding $12 million principal amount of the 1.125% Convertible Notes, and settle the related conversion option. For more information, refer to Notes 11, &#8220;Debt,&#8221; and 13 &#8220;Stockholders' Equity.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements &#8211; Disclosure Only</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and estimated fair values of our notes payable are classified as Level 2 financial instruments. Fair value for these securities is determined using a market approach based on quoted market prices for similar securities in active markets or quoted prices for identical securities in inactive markets. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.375% Notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.375% Notes </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.875% Notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan Facility </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.125% Convertible Notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,127&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;For more information on debt repayments, refer to Note 11, &#8220;Debt.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821596960808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Available-for-Sale</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all of our investments classified as current assets to be available-for-sale. The following tables summarize our current investments as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GSEs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of our current investments as of December&#160;31, 2020 are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross realized gains and losses from sales of available-for-sale securities are calculated under the specific identification method and are included in investment income. Gross realized investment gains amounted to $6&#160;million and $13 million in the years ended December&#160;31, 2020 and 2019, respectively. Gross realized investment losses were insignificant in the years ended December&#160;31, 2020 and 2019. Gross realized investment gains and losses for the year ended December 31, 2018 were insignificant. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that unrealized losses at December&#160;31, 2020 and 2019 primarily resulted from fluctuating interest rates, rather than a deterioration of the creditworthiness of the issuers. Therefore, we determined that an allowance for credit losses was not necessary. So long as we maintain the intent and ability to hold these securities to maturity, we are unlikely to experience losses. In the event that we dispose of these securities before maturity, we expect that realized losses, if any, will be insignificant.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes those available-for-sale investments that have been in a continuous loss position for less than 12 months. No investments have been in a continuous loss position for 12 months or more as of December&#160;31, 2020, and 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In&#160;a&#160;Continuous&#160;Loss Position for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than&#160;12&#160;Months as of December 31, 2020</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In&#160;a&#160;Continuous&#160;Loss Position for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than&#160;12&#160;Months as of December 31, 2019</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Held-to-Maturity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the regulations governing our Health Plans segment</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsidiaries, we maintain statutory deposits and deposits required by government authorities primarily in cash, cash equivalents, and U.S. Treasury securities. We also maintain restricted investments as protection against the insolvency of certain capitated providers. The use of these funds is limited as required by regulation in the various states in which we operate, or as needed in the event of insolvency of capitated providers. Therefore, such investments are reported as &#8220;Restricted investments&#8221; in the accompanying consolidated balance sheets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the ability to hold these restricted investments until maturity, and as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. Our held-to-maturity restricted investments are carried at amortized cost, which approximates fair value, of which $134&#160;million will mature in one year or less, and $2&#160;million will mature in after one through five years. The following table presents the balances of restricted investments:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ohio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Health Plans segment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821596941224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment, and Capitalized Software, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Equipment, and Capitalized Software, Net</a></td>
<td class="text">Property, Equipment, and Capitalized Software, Net Property and equipment are stated at historical cost. Replacements and major improvements are capitalized, and repairs and maintenance are charged to expense as incurred. Software developed for internal use is capitalized. Furniture and equipment are generally depreciated using the straight-line method over estimated useful lives ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzU0OTc1NTgxMzk3OTA_0da1da73-4926-4eb9-bdb8-ab2cd7f10bb6">three</span> to seven years. Software is generally amortized over its estimated useful life of three years. Leasehold improvements are amortized over the term of the lease, or over their useful lives from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzUzOA_e80b42ea-bec2-44ee-9782-16517f1bf477">five</span> to 10&#160;years, whichever is shorter. Buildings are depreciated over their estimated useful lives of 31.5 to 40&#160;years.<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment, and capitalized software is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized software</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: accumulated amortization - capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization - furniture, equipment, building, and improvements</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(577)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets - finance leases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents all depreciation and amortization recognized in our consolidated statements of income:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recorded in depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of capitalized software</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization of furniture, equipment, building, and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recorded in cost of service revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of capitalized software and deferred contract costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total depreciation and amortization recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821598296376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to operating and finance leases primarily for our corporate and health plan offices. Our operating leases have remaining lease terms up to 8 years, some of which include options to extend the leases for up to 10 years. As of December&#160;31, 2020, the weighted average remaining operating lease term is 4 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our finance leases have remaining lease terms of 1 year to 18 years, some of which include options to extend the leases for up to 25 years. As of December&#160;31, 2020, the weighted average remaining finance lease term is 15 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the weighted-average discount rate used to compute the present value of lease payments was 5.2% for operating lease liabilities, and 6.5% for finance lease liabilities. The components of lease expense for the years ended December 31, 2020, and 2019, are presented in the following table. Rental expense related to operating leases amounted to $62 million for the year ended December 31, 2018.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease expense: </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental consolidated cash flow information related to leases follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash used in financing activities: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets recognized in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases, including location of amounts reported in the accompanying consolidated balance sheets, follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets - Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities (current)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities (non-current)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities (current)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:92.25pt;text-indent:-76.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal - undiscounted lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to operating and finance leases primarily for our corporate and health plan offices. Our operating leases have remaining lease terms up to 8 years, some of which include options to extend the leases for up to 10 years. As of December&#160;31, 2020, the weighted average remaining operating lease term is 4 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our finance leases have remaining lease terms of 1 year to 18 years, some of which include options to extend the leases for up to 25 years. As of December&#160;31, 2020, the weighted average remaining finance lease term is 15 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the weighted-average discount rate used to compute the present value of lease payments was 5.2% for operating lease liabilities, and 6.5% for finance lease liabilities. The components of lease expense for the years ended December 31, 2020, and 2019, are presented in the following table. Rental expense related to operating leases amounted to $62 million for the year ended December 31, 2018.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease expense: </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental consolidated cash flow information related to leases follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash used in financing activities: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets recognized in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases, including location of amounts reported in the accompanying consolidated balance sheets, follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets - Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities (current)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities (non-current)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities (current)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:92.25pt;text-indent:-76.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal - undiscounted lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821597052856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net <div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amounts of goodwill, for the periods presented. All goodwill is recorded in the Health Plans segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.327%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dispositions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dispositions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Health Plans segment, gross goodwill amounted to $994&#160;million and $445&#160;million, as of December 31, 2020 and 2019, respectively. Accumulated impairment losses amounted to $302&#160;million at each of December 31, 2020 and 2019, respectively. The changes in the carrying amounts of both goodwill and intangible assets, net, in 2020, was due to the acquisitions described in Note 4, &#8220;Business Combinations.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the details of identified intangible assets, by major class, for the periods presented. All intangible assets, net, are recorded in the Health Plans segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:23.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.505%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract rights and licenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we estimate that our intangible asset amortization will be approximately $46 million in 2021, $44 million in 2022, 2023 and 2024, and $43 million in 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821598251208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims and Benefits Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock', window );">Medical Claims and Benefits Payable</a></td>
<td class="text">Medical Claims and Benefits Payable <div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the details of our medical claims and benefits payable as of the dates indicated.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fee-for-service claims incurred but not paid (&#8220;IBNP&#8221;)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmacy payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitation payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,961&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Other&#8221; medical claims and benefits payable include amounts payable to certain providers for which we act as an intermediary on behalf of various government agencies without assuming financial risk. Such receipts and payments do not impact our consolidated statements of income. Non-risk provider payables amounted to $235 million, $132 million and $107 million, as of December&#160;31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the change in our medical claims and benefits payable for the periods indicated. The amounts presented for &#8220;Components of medical care costs related to: Prior years&#8221; represent the amount by which our original estimate of medical claims and benefits payable at the beginning of the year were more than the actual liabilities, based on information (principally the payment of claims) developed since those liabilities were first reported.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable, beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Components of medical care costs related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total medical care costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for medical care costs related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition - Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in non-risk and other provider payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable, ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,961&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">December 31, 2018, includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $81 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates of medical claims and benefits payable recorded at December 31, 2020, 2019 and 2018 developed favorably by approximately $119 million, $271 million and $341 million in 2020, 2019 and 2018, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable prior year development recognized in 2020 was primarily due to lower than expected utilization of medical services by our Medicaid members, and improved operating performance. Consequently, the ultimate costs recognized in 2020 were lower than our original estimates in 2019, which was not discernible until additional information was provided, and as claims payments were processed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable prior year development recognized in 2019 was primarily due to lower than expected utilization of medical services by our Medicaid members, and improved operating performance. Consequently, the ultimate costs recognized in 2019 were lower than our original estimates in 2018, which was not discernible until additional information was provided, and as claims payments were processed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable prior year development recognized in 2018 includes a benefit of approximately&#160;$81 million&#160;in reduced medical care costs relating to Marketplace CSR subsidies for 2017 dates of service. The remainder of the favorable </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prior period development was primarily due to lower than expected utilization of medical services by our Medicaid and Marketplace members and improved operating performance.&#160;Consequently, the ultimate costs recognized in 2018 were lower than our original estimates in 2017, which was not discernible until additional information was provided, and as claims payments were processed.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about incurred and paid claims development as of December&#160;31, 2020, as well as cumulative claims frequency and the total of incurred but not paid claims liabilities. The cumulative claim frequency is measured by claim event, and includes claims covered under capitated arrangements.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.544%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims and Allocated Claims Adjustment Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total IBNP</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative number of reported claims</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,255&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.462%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Claims Adjustment Expenses</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,149&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of claims development to the aggregate carrying amount of the liability for medical claims and benefits payable.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.462%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incurred claims and allocated claims adjustment expenses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: cumulative paid claims and allocated claims adjustment expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All outstanding liabilities before 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-risk and other provider payables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI http://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821596989672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Debt</a></td>
<td class="text">Debt <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of debt, as of December&#160;31, 2020, are illustrated in the following table. All amounts represent the principal amounts of the debt instruments outstanding.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:23.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.066%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.375% Notes due 2028</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.375% Notes due 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% Notes due 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,450&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All debt is held at the parent which is reported in the Other segment. The following table summarizes our outstanding debt obligations and their classification in the accompanying consolidated balance sheets:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.125% Convertible Notes, net of unamortized discount</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.375% Notes due 2028</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.375% Notes due 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% Notes due 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.875% Notes due 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: debt issuance costs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Reported in &#8220;Accounts payable, accrued liabilities and other.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we entered into a credit agreement (the &#8220;Credit Agreement&#8221;) that replaced our prior credit agreement. The terms of the Credit Agreement are substantially similar to the terms of the prior agreement. Among various provisions, significant changes incorporated to the Credit Agreement included:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase of the revolving credit facility (the &#8220;Credit Facility&#8221;) from $500 million to $1.0 billion;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $15&#160;million swingline sub-facility and a $100&#160;million letter of credit sub-facility;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase of incremental term loans available to finance certain acquisitions from $150&#160;million to $500&#160;million, plus an unlimited amount as long as our consolidated net leverage ratio is not greater than 3:1;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ability to engage in acquisitions where the consummation of such acquisitions is not conditioned on the availability of, or on obtaining, third-party financing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Termination of the term loan facility under the prior credit agreement; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LIBOR succession provisions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement has a term of five years, and all amounts outstanding will be due and payable on June 8, 2025. Borrowings under the Credit Agreement bear interest based, at our election, on a base rate or other defined rate, plus in each case, the applicable margin. In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Credit Agreement, we are required to pay a quarterly commitment fee. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary non-financial and financial covenants. As of December&#160;31, 2020, we were in compliance with all financial and non-financial covenants under the Credit Agreement and other long-term debt. As of December&#160;31, 2020, no amounts were outstanding under the Credit Facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">High-Yield Senior Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our high-yield senior notes are described below. Each of these notes are senior unsecured obligations of Molina and rank equally in right of payment with all existing and future senior debt, and senior to all existing and future subordinated debt of Molina. In addition, each of the notes contain customary non-financial covenants and change of control provisions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indentures governing the high-yield senior notes contain cross-default provisions that are triggered upon default by us or any of our subsidiaries on any indebtedness in excess of the amount specified in the applicable indenture. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4.375% Notes due 2028. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2020, we completed the private offering of $800 million aggregate principal amount of senior notes (the &#8220;4.375% Notes&#8221;) due June 15, 2028, unless earlier redeemed. The 4.375% Notes contain optional early redemption provisions, with redemption prices in excess of par. Interest, at a rate of 4.375% </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per annum, is payable semiannually in arrears on June 15 and December 15 of each year. A portion of the net proceeds from the 4.375% Notes offering was used to repay $600&#160;million principal amount outstanding under the term loan facility of our prior credit agreement, and the balance is intended to be used for general corporate purposes. Deferred issuance costs amounted to $11&#160;million. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5.375% Notes due 2022. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have $700 million aggregate principal amount of senior notes (the &#8220;5.375% Notes&#8221;) outstanding as of December&#160;31, 2020, which are due November&#160;15,&#160;2022, unless earlier redeemed. Interest at a rate of 5.375% per annum, is payable semiannually in arrears on May 15 and November 15. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3.875% Notes due 2030. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2020, we completed the private offering of $650 million aggregate principal amount of senior notes (the &#8220;3.875% Notes&#8221;) due November 15, 2030, unless earlier redeemed. The 3.875% Notes contain optional early redemption provisions, with redemption prices in excess of par. Interest, at a rate of 3.875% per annum, is payable semiannually in arrears on May 15 and November 15 of each year, commencing on May 15, 2021. A portion of the net proceeds from the 3.875% Notes offering was used to repay $330 million principal amount outstanding under the 4.875% Notes, and the balance is intended to be used for general corporate purposes. Deferred issuance costs amounted to $10&#160;million. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4.875% Notes due 2025. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we completed the early redemption of the entire $330 million aggregate principal amount of senior notes (the &#8220;4.875% Notes&#8221;) that would have been due June 15, 2025. In accordance with the indenture governing such notes, the 4.875% Notes were settled at 100% of par, plus an early redemption premium which amounted to $8&#160;million, plus accrued and unpaid interest. In conjunction with the redemption, we wrote off $3&#160;million in unamortized deferred issuance costs directly related to the 4.875% Notes. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1.125% Cash Convertible Senior Notes due 2020  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, we paid $39&#160;million to settle the $12&#160;million remaining principal amount outstanding of the 1.125% cash convertible senior notes due January 15, 2020 (the &#8220;1.125% Convertible Notes&#8221;), and settled the related conversion option. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Expenses (Income), Net</span></div>In the year ended December 31, 2020, we recognized an aggregate loss on debt repayment of $15 million including costs incurred in repayment of the term loan facility, the 4.875% Notes repayment costs described above, and other financing transactions. In the year ended December 31, 2019, we recognized a gain on debt repayment of $15 million in connection with the 1.125% Convertible Notes repayment transactions. These amounts are reported in &#8220;Other expenses (income), net&#8221; in the accompanying consolidated statements of income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821597016280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense for continuing operations consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. federal statutory income tax rate to the combined effective income tax rate for continuing operations is as follows:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Statutory federal tax (benefit) rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income provision (benefit), net of federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible health insurer fee (&#8220;HIF&#8221;)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Worthless stock deduction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax expense rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate was not impacted by the HIF in 2019 given the HIF moratorium. Our effective tax rate is based on expected income, statutory tax rates, and tax planning opportunities available to us in the various jurisdictions in which we operate. Management estimates and judgments are required in determining our effective tax rate. We are routinely under audit by federal, state, or local authorities regarding the timing and amount of deductions, nexus of income among various tax jurisdictions, and compliance with federal, state, foreign, and local tax laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are classified as non-current. Significant components of our deferred tax assets and liabilities as of December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and reserve liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued medical costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets and intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease financing obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credit carryover</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred income tax assets, net of valuation allowance </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets and intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains and losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred income tax liabilities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred income tax asset</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had state net operating loss carryforwards of $189 million, which begin expiring in 2035.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had foreign net operating loss carryforwards of $5&#160;million, which expire in 2031. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had California research and development and enterprise zone tax credit carryovers of $3 million, which will begin to expire in 2024, and foreign tax credit carryovers of $5 million, which expire in 2030.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary differences. We have determined that as of December&#160;31, 2020, $17 million of deferred tax assets did not satisfy the recognition criteria. Therefore, we decreased our valuation allowance by $7 million, from $24 million at December&#160;31, 2019, to $17 million as of December&#160;31, 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize tax benefits only if the tax position is more likely than not to be sustained. We are subject to income taxes in the United States, Puerto Rico,&#160;and numerous state jurisdictions. Significant judgment is required in evaluating our tax positions and determining our provision for income taxes. During the ordinary course of business, there are many transactions and calculations for which the ultimate tax determination is uncertain. We establish reserves for tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves are established when we believe that certain positions might be challenged despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances, such as the outcome of tax audits. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The roll forward of our unrecognized tax benefits is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increases in tax positions for current year </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse in statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount of unrecognized tax benefits at December&#160;31, 2020, 2019 and 2018 that, if recognized, would affect the effective tax rates is $18 million in each of those respective years. We expect that during the next 12 months it is reasonably possible that unrecognized tax benefit liabilities may decrease by as much as $10 million due to resolution of exams and refund claims.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our continuing practice is to recognize interest and/or penalties related to unrecognized tax benefits in income tax expense. Amounts accrued for the payment of interest and penalties as of December&#160;31, 2020, 2019 and 2018 were insignificant.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are under examination by the IRS for calendar years 2015 through 2017 and may be subject to examination for calendar years 2018 and 2019. With a few exceptions, which are immaterial in the aggregate, we no longer are subject to state, local, and Puerto Rico tax examinations for years before 2015.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821596955256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Purchase Programs</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, our board of directors authorized the purchase of up to $500 million, in the aggregate, of our common stock. This program is funded with cash on hand and extends through December 31, 2021. The exact timing and amount of any repurchase is determined by management based on market conditions and share price, in addition to other factors, and subject to the restrictions relating to volume, price, and timing under applicable law. Under this program, pursuant to a Rule 10b5-1 trading plan, we purchased approximately 766,000 shares of our common stock for $159 million in November and December 2020 (average cost of $208.37 per share), including approximately 29,000 shares purchased for $6 million in late December 2020, and settled in early January 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, our board of directors authorized the purchase of up to $500 million, in the aggregate, of our common stock. This program was funded with existing cash on hand and was completed in March 2020. Under this program, pursuant to a Rule 10b5-1 trading plan, we purchased approximately 3.4 million shares of our common stock for $446 million in the first quarter of 2020 (average cost of $132.45 per share). In the first quarter of 2020, we also paid $7&#160;million to settle shares purchased in late December 2019.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsequent Event</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From January 1, 2021 through February 11, 2021, we purchased approximately 577,000 shares for $122 million (average cost of $211.65 per share).</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 1.125% Convertible Notes settlement transaction described in Note 11, &#8220;Debt,&#8221; in the first quarter of 2020 we entered into privately negotiated agreements to terminate the associated 310,000 warrants outstanding for $30&#160;million, which resulted in a reduction of additional paid-in-capital for the same amount.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our employee stock plans, approximately 244,000 shares and 242,000 shares of common stock were issued, net of shares used to settle employees&#8217; income tax obligations, during the years ended December&#160;31, 2020, and 2019, respectively. Total share-based compensation expense is reported in &#8220;General and administrative expenses&#8221; in the accompanying consolidated statements of income, and summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.726%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax<br/>Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net-of-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax<br/>Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net-of-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax<br/>Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net-of-Tax<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSAs, PSAs and PSUs (defined below)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee stock purchase plan and stock options </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Incentive Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had employee equity incentives outstanding under our 2019 Equity Incentive Plan (the &#8220;2019 EIP&#8221;). The 2019 EIP provides for awards, in the form of restricted and performance stock awards (&#8220;RSAs&#8221; and &#8220;PSAs&#8221;), performance units (&#8220;PSUs&#8221;), stock options, and other stock&#8211; or cash&#8211;based awards, to eligible persons who perform services for us. The 2019 EIP provides for the issuance of up to 2.9 million shares of our common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based awards</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. RSAs, PSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. Certain PSUs may vest in their entirety at the end of three-year performance periods, if their performance conditions are met. We generally recognize expense for RSAs, PSAs and PSUs on a straight-line basis. Activity for stock-based awards in the year ended December&#160;31, 2020, is summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:40.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSAs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant&#160;Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant&#160;Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested balance, December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(172,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested balance, December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">585,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">471,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, total unrecognized compensation expense related to unvested RSAs and PSUs was $42 million, and $23 million, respectively, which we expect to recognize over a remaining weighted-average period of 2.2 years, and 1.2 years, respectively. This unrecognized compensation cost assumes an estimated forfeiture rate of 12.2% for non-executive employees as of December&#160;31, 2020, based on actual forfeitures over the last 4 years. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total grant date fair value of awards granted and vested is presented in the following table.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:64.492%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSAs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total granted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSAs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total vested</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Stock option awards generally have an exercise price equal to the fair market value of our common stock on the date of grant, vest in equal annual installments over periods up to four years from the date of grant, and have a maximum term of ten years from the date of grant. Stock option activity for the year ended December&#160;31, 2020, is summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual term</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Per share)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options outstanding as of December 31, 2019 and December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options exercisable and expected to vest as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No stock options were granted or exercised in 2020, 2019, or 2018, and as of December&#160;31, 2020, there was no unrecognized compensation expense related to unvested stock options.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of information about stock options outstanding and exercisable at December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding and Exercisable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Per share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Range of Exercise Prices</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$33.02</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$67.33</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee Stock Purchase Plans (&#8220;ESPP&#8221;)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our ESPP, eligible employees may purchase common shares at 85% of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a maximum purchase of $25,000 (as measured by the fair value of the stock acquired) per year through payroll deductions. We estimate the fair value of the stock issued using a standard option pricing model. For the years ended December&#160;31, 2020, 2019, and 2018, the inputs to this model were as follows: risk-free interest rates of approximately 0.2% to 2.3%; expected volatility of approximately 31% to 51%, dividend yields of 0%, and an average expected life of 0.5 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821596913720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Employee Benefit Plans</a></td>
<td class="text">Employee Benefit Plans<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4% of compensation contributed by employees. Expense recognized in connection with our contributions to the 401(k) plans amounted to $28 million, $28 million, and $36 million in the years ended December&#160;31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a non-qualified deferred compensation plan for certain key employees. Under this plan, eligible participants may defer up to 75% of their base salary and 90% of their bonus to provide tax-deferred growth.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821598116440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies <div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Capital Requirements and Dividend Restrictions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans, which are generally operated by our respective wholly owned subsidiaries in those states, are subject to state laws and regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state. The National Association of Insurance Commissioners (&#8220;NAIC&#8221;), has adopted rules which, if implemented by the states, set minimum capitalization requirements for insurance companies, HMOs, and other entities bearing risk for healthcare coverage. The requirements take the form of risk-based capital (&#8220;RBC&#8221;) rules which may vary from state to state. Regulators in some states may also enforce capital requirements that require the retention of net worth in excess of amounts formally required by statute or regulation. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the states in which our health plans operate, except California, Florida, Massachusetts and New York, have adopted the RBC rules. The RBC rules, if adopted by California, Florida, Massachusetts or New York, could increase the minimum capital required for those states. Our Massachusetts health plan, acquired on December 31, 2020, maintains a $35&#160;million performance bond, effective through December 31, 2021, to partially satisfy minimum net worth requirements in that state.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. Based on current statutes and regulations, the net assets in these subsidiaries (not including the Magellan Complete Care subsidiaries and after intercompany eliminations), which may not be transferable to us in the form of loans, advances, or cash dividends was approximately $1,960 million at December&#160;31, 2020, and $1,810 million at December&#160;31, 2019. We estimate the Magellan Complete Care subsidiaries&#8217; net assets that may not be transferable amounted to approximately $420&#160;million at December 31, 2020. Because of the statutory restrictions that inhibit the ability of our health plans to transfer net assets to us, the amount of retained earnings readily available to pay dividends to our stockholders is generally limited to cash, cash equivalents and investments held by the parent company&#8212;Molina Healthcare, Inc. Such cash, cash equivalents and investments amounted to $644 million and $997 million as of December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, our health plans (not including the Magellan Complete Care subsidiaries) had aggregate statutory capital and surplus of approximately $2,020 million compared with the required minimum aggregate statutory capital and surplus of approximately $1,310 million. As of December 31, 2020, the aggregate and minimum capital and surplus of the Magellan Complete Care subsidiaries amounted to approximately $420&#160;million and $230&#160;million, respectively. The aggregate capital and surplus of our wholly owned subsidiaries was in excess of these minimum capital requirements as of December&#160;31, 2020.  We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor and assess the estimated operating and financial impact of the COVID-19 pandemic, and as it evolves, we continue to process, assemble, and assess member utilization information. We believe that our cash resources, borrowing capacity available under the Credit Agreement, and cash flow generated from operations will be sufficient to withstand the financial impact of the pandemic, and will enable us to continue to support our operations, regulatory requirements, debt repayment obligations, and capital expenditures for the foreseeable future.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines and penalties, exclusion from participating in publicly funded programs, and the repayment of previously billed and collected revenues. </span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in legal actions in the ordinary course of business including, but not limited to, various employment claims, vendor disputes and provider claims. Some of these legal actions seek monetary damages, including claims for punitive damages, which may not be covered by insurance. We review legal matters and update our estimates of reasonably possible losses and related disclosures, as necessary. We have accrued liabilities for legal matters for which we deem the loss to be both probable and reasonably estimable. These liability estimates could change as a result of further developments of the matters. The outcome of legal actions is inherently uncertain. An adverse determination in one or more of these pending matters could have an adverse effect on our consolidated financial position, results of operations, or cash flows.&#160; </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kentucky RFP. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 4, 2020, Anthem Kentucky Managed Care Plan, Inc. brought an action in Franklin County Circuit Court against the Kentucky Finance and Administration Cabinet, the Kentucky Cabinet for Health and Family Services and all of the winning bidder health plans, including Molina Healthcare of Kentucky, Inc., Civil Action No. 20-CI-00719. In its action, Anthem requested that the court disqualify Molina Healthcare of Kentucky, find that the Kentucky RFP scoring was erroneous and violated procedures or was arbitrary and capricious, set aside the contract awards and conduct a new RFP evaluation process, and award injunctive relief, including stopping the implementation of the contracts awarded under the RFP. On September 28, 2020, the court issued a temporary restraining order preserving the status quo, and on October 23, 2020, the court issued a temporary injunction directing that the RFP readiness review and open enrollment proceed with six health plans, including both Anthem and Molina Healthcare. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2020, the court granted a motion by UnitedHealthcare of Kentucky LTD. to assert a cross-claim against the Kentucky Cabinet for Health and Family Services, which sought in part a disqualification of Anthem or Molina Healthcare and a declaratory judgment that the Kentucky Medicaid program proceed with only five health plans. On December 23, 2020, Humana Health Plan, Inc. brought a separate action against the Commonwealth of Kentucky and the winning bidder health plans, including Molina Healthcare of Kentucky, Civil Action 20-CI-00987. On January 11, 2021, both actions were consolidated before the Franklin County Circuit Court. Humana requests a declaratory judgment finding that the Commonwealth violated the Medicaid contract by allocating Passport members to Molina Healthcare for 2021 so that Passport members would instead be allocated to Humana and other winning health plans, or, in the alternative, monetary damages from the Commonwealth. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molina Healthcare believes it has meritorious defenses to the claims of Anthem, United, and Humana, and intends to vigorously defend its position, including its twice being a winning bidder of the Kentucky Medicaid RFP, and its protection of the continuity of care for Passport Medicaid members. This matter remains subject to significant additional legal proceedings, and no assurances can be given regarding the ultimate outcome.  Under the court&#8217;s temporary injunction, Molina Healthcare of Kentucky continues to operate under its contract and provide care to Kentucky Medicaid members.   </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Professional Liability Insurance</span></div>We carry medical professional liability insurance for healthcare services rendered in the primary care institutions that we manage. In addition, we carry managed care errors and omissions insurance for all managed care services that we provide.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821596913720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments</a></td>
<td class="text">Segments As of December 31, 2020, we had two reportable segments: the Health Plans segment, and the Other segment. Our reportable segments are consistent with how we currently manage the business and view the markets we serve.  The Health Plans reportable segment includes our regulated health plan operating segments, along with the recently acquired Magellan Complete Care health plans operating segment. Because this acquisition closed on December 31, 2020, Magellan Complete Care&#8217;s operating results were insignificant to our consolidated results of operations for the year ended December 31, 2020. Management will continue to evaluate the composition of its operating and reportable segments for future filings. The Other segment, which is insignificant to our consolidated results of operations, includes certain corporate amounts not associated with or allocated to the Health Plans segment. In 2018, the Other segment also included the results of certain unregulated subsidiaries we sold in late 2018.<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Margin is the appropriate earnings measure for our reportable segments, based on how our chief operating decision maker currently reviews results, assesses performance, and allocates resources.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key metrics used to assess the performance of our Health Plans segment are premium revenue, medical margin and MCR. MCR represents the amount of medical care costs as a percentage of premium revenue. Therefore, the underlying margin, or the amount earned by the Health Plans segment after medical costs are deducted from premium revenue, is the most important measure of earnings reviewed by management. Margin for our Health Plans segment is also referred to as &#8220;Medical Margin.&#8221;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles margin by segment to consolidated income before income tax expense:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: other operating revenues </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: other operating expenses </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,880)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: other expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Other operating revenues include premium tax revenue, health insurer fees reimbursed, Marketplace risk corridor judgment, investment income and other revenue.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Other operating expenses include general and administrative expenses, premium tax expenses, health insurer fees, depreciation and amortization, and other costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821596822360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock', window );">Condensed Financial Information of Registrant</a></td>
<td class="text">Condensed Financial Information of Registrant <div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed balance sheets as of December&#160;31, 2020 and 2019, and the related condensed statements of income, comprehensive income and cash flows for each of the three years in the period ended December&#160;31, 2020 for our parent company Molina Healthcare, Inc. (the &#8220;Registrant&#8221;), are presented below. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except per-share data)</span></div></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due from affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advances to related parties and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,774&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,753&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $0.001 par value; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,774&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administrative services fees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment income and other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other expenses, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income tax (benefit) expense and equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss before equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Comprehensive Income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized investment income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: effect of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends received from subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash paid in business combinations </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash received from sale of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in amounts due to/from affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(545)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from senior notes offering, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock purchases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from borrowings under term loan facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for partial termination of warrants</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for partial settlement of conversion option</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(578)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash received for partial settlement of call option</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of principal amount of convertible notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of credit facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,192)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Information of Registrant </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#160;A&#160;- Basis of Presentation </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Registrant was incorporated in 2002. Prior to that date, Molina Healthcare of California (formerly known as Molina Medical Centers) operated as a California health plan and as the parent company for three other state health plans. In June 2003, the employees and operations of the corporate entity were transferred from Molina Healthcare of California to the Registrant. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Registrant&#8217;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries since the date of acquisition. The accompanying condensed financial information of the Registrant should be read in conjunction with the consolidated financial statements and accompanying notes. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#160;B&#160;- Transactions with Subsidiaries </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Registrant provides certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and administration, underwriting, claims processing, customer service, certain care management services, human </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resources, marketing, purchasing, risk management, actuarial, finance, accounting, compliance, legal and public relations. Fees are based on the fair market value of services rendered and are recorded as operating revenue. Payment is subordinated to the subsidiaries&#8217; ability to comply with minimum capital and other restrictive financial requirements of the states in which they operate. Charges in 2020, 2019, and 2018 for these services amounted to $1,208 million, $1,038 million, and $1,137 million, respectively, and are included in operating revenue. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Registrant and its subsidiaries are included in the consolidated federal and state income tax returns filed by the Registrant. Income taxes are allocated to each subsidiary in accordance with an intercompany tax allocation agreement. The agreement allocates income taxes in an amount generally equivalent to the amount which would be expensed by the subsidiary if it filed a separate tax return. Net operating loss benefits are paid to the subsidiary by the Registrant to the extent such losses are utilized in the consolidated tax returns. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#160;C&#160;- Dividends and Capital Contributions </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Registrant receives dividends from its subsidiaries, such amounts are recorded as a reduction to the investments in the respective subsidiaries.</span></div>For all periods presented, the Registrant made capital contributions to certain subsidiaries primarily to comply with minimum net worth requirements and to fund business combinations. Such amounts have been recorded as an increase in investment in the respective subsidiaries.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.5-04(Schedule I))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391182&amp;loc=d3e5864-122674<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=d3e5283-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821609372328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation and Presentation</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidation and Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Molina Healthcare, Inc., and its subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. Financial information related to subsidiaries acquired during any year is included only for periods subsequent to their acquisition. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the periods presented have been included; such adjustments consist of normal recurring adjustments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Principal areas requiring the use of estimates include:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of medical claims and benefits payable of our Health Plans segment;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Plans segment contractual provisions that may limit revenue recognition based upon the costs incurred or the profits realized under a specific contract;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Plans segment quality incentives that allow us to recognize incremental revenue if certain quality standards are met;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Settlements under risk or savings sharing programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Purchase price allocations relating to business combinations, including the determination of contingent consideration;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The assessment of long-lived and intangible assets, and goodwill, for impairment;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of reserves for potential absorption of claims unpaid by insolvent providers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of reserves for the outcome of litigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The determination of valuation allowances for deferred tax assets;&#160;and</span></div>&#8226;The determination of unrecognized tax benefits.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and Cash EquivalentsCash and cash equivalents consist of cash and short-term, highly liquid investments that are both readily convertible into known amounts of cash and have a maturity of three months or less on the date of purchase. The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in &#8220;Restricted investments&#8221; in the accompanying consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments are principally held in debt securities, which are grouped into two separate categories for accounting and reporting purposes: available-for-sale securities, and held-to-maturity securities. Available-for-sale (&#8220;AFS&#8221;) securities are recorded at fair value and unrealized gains and losses, if any, are recorded in stockholders&#8217; equity as other comprehensive income, net of applicable income taxes. Held-to-maturity (&#8220;HTM&#8221;) securities are recorded at amortized cost, which approximates fair value, and unrealized holding gains or losses are not generally recognized. Realized gains and losses and unrealized losses arising from credit-related factors with respect to AFS and HTM securities are included in the determination of net income. The cost of securities sold is determined using the specific-identification method.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy requires that all of our investments have final maturities of less than 10 years, or less than 10 years average life for structured securities. Investments and restricted investments are subject to interest rate risk and will decrease in value if market rates increase. Declines in interest rates over time will reduce our investment income. </span></div>In general, our AFS securities are classified as current assets without regard to the securities&#8217; contractual maturity dates because they may be readily liquidated. We monitor our investments for credit-related impairment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables consist primarily of premium amounts due from government agencies, which may be subject to potential retroactive adjustments. Because substantially all of our receivable amounts are readily determinable and substantially all of our creditors are governmental authorities, our allowance for doubtful accounts is insignificant. Any amounts determined to be uncollectible are charged to expense when such determination is made.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Long-Lived Assets, including Intangible Assets</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets, including Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets consist primarily of property, equipment, capitalized software (see Note 7, &#8220;Property, Equipment, and Capitalized Software, Net&#8221;), and intangible assets resulting from acquisitions. Finite-lived, separately-identified intangible assets acquired in business combinations are assets that represent future expected benefits but lack physical substance (such as purchased contract rights and provider contracts). Intangible assets are initially recorded at fair value and are then amortized on a straight-line basis over their expected useful lives, generally between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNDgvZnJhZzoyYzkwNmU2NjJhMjY0ZGZlYWVkZWM1MDRkZWI1NzVlYS90ZXh0cmVnaW9uOjJjOTA2ZTY2MmEyNjRkZmVhZWRlYzUwNGRlYjU3NWVhXzI4NDY_345e2136-02de-45cb-a7d6-760278ca92ed">five</span> and 16 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Determining the fair value of identifiable assets acquired, particularly intangible assets, and liabilities assumed,  requires management to make estimates, which are based on all available information and in some cases assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Determining the useful life of an intangible asset also requires judgment, as different types of intangible assets will have different useful lives. The most significant intangible asset we typically record in a business combination is contract rights associated with membership assumed. In determining the estimated fair value of the intangible assets, we typically apply the income approach, which discounts the projected future net cash flows using an appropriate discount rate that reflects the risk associated with such projected future cash flows. The most critical assumptions used in determining the fair value of contract rights include forecasted operating margins and the weighted average cost of capital.</span></div>Property and equipment are stated at historical cost. Replacements and major improvements are capitalized, and repairs and maintenance are charged to expense as incurred. Software developed for internal use is capitalized. Furniture and equipment are generally depreciated using the straight-line method over estimated useful lives ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzU0OTc1NTgxMzk3OTA_0da1da73-4926-4eb9-bdb8-ab2cd7f10bb6">three</span> to seven years. Software is generally amortized over its estimated useful life of three years. Leasehold improvements are amortized over the term of the lease, or over their useful lives from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3OTAyNDc2ODkxMjQzMDg4NTVkODZkODIzODRhMzU5L3NlYzpmNzkwMjQ3Njg5MTI0MzA4ODU1ZDg2ZDgyMzg0YTM1OV8xNzUvZnJhZzo0M2I2ZGY4ZTVlNDE0OTdiYTZhMDU5OTQyZGJkNGQ4OS90ZXh0cmVnaW9uOjQzYjZkZjhlNWU0MTQ5N2JhNmEwNTk5NDJkYmQ0ZDg5XzUzOA_e80b42ea-bec2-44ee-9782-16517f1bf477">five</span> to 10&#160;years, whichever is shorter. Buildings are depreciated over their estimated useful lives of 31.5 to 40&#160;years.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text">Our intangible assets are subject to impairment tests when events or circumstances indicate that a finite-lived intangible asset&#8217;s (or asset group&#8217;s) carrying value may not be recoverable. Consideration is given to a number of potential impairment indicators, including the ability of our health plan subsidiaries to obtain the renewal by amendment of their contracts in each state prior to the actual expiration of their contracts. However, there can be no assurance that these contracts will continue to be renewed. Following the identification of any potential impairment indicators, to determine whether an impairment exists, we would compare the carrying amount of a finite-lived intangible asset with the greater of the undiscounted cash flows that are expected to result from the use of the asset or related group of assets, or its value under the asset liquidation method. If it is determined that the carrying amount of the asset is not recoverable, the amount by which the carrying value exceeds the estimated fair value is recorded as an impairment.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations and Goodwill</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for business combinations using the acquisition method of accounting, which requires us to recognize the assets acquired and the liabilities assumed at their acquisition date fair values. As discussed below, the excess of the purchase consideration transferred over the fair value of the net tangible and intangible assets acquired is recorded as goodwill. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the final determination of the values of assets acquired or liabilities assumed, or one year after the date of acquisition, whichever comes first, any subsequent adjustments are recorded within our consolidated results of operations. Refer to Note 4, Business Combinations, and Note 9, &#8220;Goodwill and Intangible Assets, Net,&#8221; for further details.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase consideration over the fair value of net assets acquired in business combinations. Goodwill is not amortized but is tested for impairment on an annual basis and more frequently if impairment indicators are present. Impairment indicators may include experienced or expected operating cash-flow deterioration or losses, significant losses of membership, loss of state funding, loss of state contracts, and other factors. Goodwill is impaired if the carrying amount of the reporting unit (one of our state health plans) exceeds its estimated fair value. This excess is recorded as an impairment loss and adjusted if necessary for the impact of tax-deductible goodwill. The loss recognized may not exceed the total goodwill allocated to the reporting unit. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When testing goodwill for impairment, we may first assess qualitative factors, such as industry and market factors, the dynamic economic and political environments in which we operate, cost factors, and changes in overall performance, to determine if it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value. If our qualitative assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, we perform the quantitative assessment. We may also elect to bypass the qualitative assessment and proceed directly to the quantitative assessment. If performing a quantitative assessment, we generally estimate the fair values of our reporting units by applying the income approach, using discounted cash flows. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the annual impairment test under a quantitative assessment, the base year in the reporting units&#8217; discounted cash flows is derived from the annual financial planning cycle, which commences in the fourth quarter of the year. When computing discounted cash flows, we make assumptions about a wide variety of internal and external factors, and consider what the reporting unit&#8217;s selling price would be in an orderly transaction between market participants at the measurement date. Significant assumptions include financial projections of free cash flow (including significant assumptions about membership, premium rates, healthcare and operating cost trends, contract renewal and the procurement of new contracts, capital requirements and income taxes), long-term growth rates for determining terminal value beyond the discretely forecasted periods, and discount rates. When determining the discount rate, we consider the overall level of inherent risk of the reporting unit, and the expected rate an outside investor would expect to earn. As part of a quantitative assessment, we may also apply the asset liquidation method to estimate the fair value of individual reporting units, which is computed as total assets minus total liabilities, excluding intangible assets and deferred taxes. Finally, we apply a market approach to reconcile the value of our reporting units to our consolidated market value. Under the market approach, we consider publicly traded comparable company information to determine revenue and earnings multiples which are used to estimate our reporting units&#8217; fair values. The assumptions used are consistent with those used in our long-range business plan and annual planning process. However, if these assumptions differ from actual results, the outcome of our goodwill impairment tests could be adversely affected.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use (&#8220;ROU&#8221;) assets represent our right to use the underlying assets over the lease term, and lease liabilities represent our obligation for lease payments arising from the related leases. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease terms may include options to extend or terminate the lease when we believe it is reasonably certain that we will exercise such options. If applicable, we account for lease and non-lease components within a lease as a single lease component.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because most of our leases do not provide an implicit interest rate, we generally use our incremental borrowing rate to determine the present value of lease payments. Lease expenses for operating lease payments are recognized on a straight-line basis over the lease term, and the related ROU assets and liabilities are reduced to the present value of the remaining lease payments at the end of each period. Finance lease payments reduce finance lease liabilities, </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the related ROU assets are amortized on a straight-line basis over the lease term, and interest expense is recognized using the effective interest method.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant majority of our operating leases consist of long-term operating leases for office space. Short-term leases (those with terms of 12 months or less) are not recorded as ROU assets or liabilities in the consolidated balance sheets. For certain leases that represent a portfolio of similar assets, such as a fleet of vehicles, we apply a portfolio approach to account for the related ROU assets and liabilities, rather than account for such assets and the related liabilities individually. A nominal number of our lease agreements include rental payments that adjust periodically for inflation. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. </span></div>For further information, including the amount and location of the ROU assets and lease liabilities recognized in the accompanying consolidated balance sheets, see Note 8, &#8220;Leases.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Medical Claims and Benefits Payable</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Claims and Benefits Payable</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical care costs are recognized in the period in which services are provided and include fee-for-service claims, pharmacy benefits, capitation payments to providers, and various other medically-related costs. Under fee-for-service claims arrangements with providers, we retain the financial responsibility for medical care provided and incur costs based on actual utilization of hospital and physician services. Such medical care costs include amounts paid by us as well as estimated medical claims and benefits payable for costs that were incurred but not paid as of the reporting date (&#8220;IBNP&#8221;). Pharmacy benefits represent payments for members' prescription drug costs, net of rebates from drug manufacturers. We estimate pharmacy rebates based on historical and current utilization of prescription drugs and contractual provisions. Capitation payments represent monthly contractual fees paid to providers, who are responsible for providing medical care to members, which could include medical or ancillary costs like dental, vision and other supplemental health benefits. Such capitation costs are fixed in advance of the periods covered and are not subject to significant accounting estimates. Other medical care costs include all medically-related administrative costs, amounts due to providers pursuant to risk-sharing or other incentive arrangements, provider claims, and other healthcare expenses. Examples of medically-related administrative costs include expenses relating to health education, quality assurance, case management, care coordination, disease management, and 24-hour on-call nurses. Additionally, we include an estimate for the cost of settling claims incurred through the reporting date in our medical claims and benefits payable liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical claims and benefits payable consist mainly of fee-for-service IBNP, unpaid pharmacy claims, capitation costs, other medical costs, including amounts payable to providers pursuant to risk-sharing or other incentive arrangements and amounts payable to providers on behalf of certain state agencies for certain state assessments in which we assume no financial risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IBNP includes the costs of claims incurred as of the balance sheet date which have been reported to us, and our best estimate of the cost of claims incurred but not yet reported to us. We also include an additional reserve to ensure that our overall IBNP liability is sufficient under moderately adverse conditions. We reflect changes in these estimates in the consolidated results of operations in the period in which they are determined. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimation of the IBNP liability requires a significant degree of judgment in applying actuarial methods, determining the appropriate assumptions and considering numerous factors. Of those factors, we consider estimated completion factors and the assumed healthcare cost trend to be the most critical assumptions. Other relevant factors also include, but are not limited to, healthcare service utilization trends, claim inventory levels, changes in membership, product mix, seasonality, benefit changes or changes in Medicaid fee schedules, provider contract changes, prior authorizations and the incidence of catastrophic or pandemic cases.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the significant degree of judgment involved in estimation of our IBNP liability, there is considerable variability and uncertainty inherent in such estimates. Each reporting period, the recognized IBNP liability represents our best estimate of the total amount of unpaid claims incurred as of the balance sheet date using a consistent methodology in estimating our IBNP liability. We believe our current estimates are reasonable and adequate; however, the development of our estimate is a continuous process that we monitor and update as more complete claims payment information and healthcare cost trend data becomes available. Actual medical care costs may be less than we previously estimated (favorable development) or more than we previously estimated (unfavorable development), and any differences could be material. Any adjustments to reflect favorable development would be recognized as a decrease to medical care costs, and any adjustments to reflect unfavorable development would be recognized as an increase to medical care costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the period in which the adjustments are determined. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 10, &#8220;Medical Claims and Benefits Payable,&#8221; for a table presenting the components of the change in our medical claims and benefits payable, for all periods presented in the accompanying consolidated financial statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Premium Revenue Recognition and Amounts Due Government Agencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenue is generated from our Health Plans segment contracts, for our participation in the Medicaid, Medicare and Marketplace programs. Premium revenue is generally received based on per member per month (&#8220;PMPM&#8221;) rates established in advance of the periods covered. These premium revenues are recognized in the month that members are entitled to receive healthcare services, and premiums collected in advance are deferred. State Medicaid programs and the federal Medicare program periodically adjust premium rates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain components of premium revenue are subject to accounting estimates and are described below, under &#8220;Contractual Provisions That May Adjust or Limit Revenue or Profit,&#8221; and &#8220;Quality Incentives.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Provisions That May Adjust or Limit Revenue or Profit</span></div>Many of our contracts contain provisions that may adjust or limit revenue or profit, as described below. Consequently, we recognize premium revenue as it is earned under such provisions. Liabilities accrued for premiums to be returned under such provisions are reported in the aggregate as &#8220;Amounts due government agencies&#8221; in the accompanying consolidated balance sheets.<div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicaid Program</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum MLR and Medical Cost Corridors. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our premium revenue may be returned if certain minimum amounts are not spent on defined medical care costs. Under certain medical cost corridor provisions, the health plans may receive additional premiums if amounts spent on medical care costs exceed a defined maximum threshold.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Profit Sharing. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with certain states contain profit sharing provisions under which we refund amounts to the states if our health plans generate profit above a certain specified percentage. In some cases, we are limited in the amount of administrative costs that we may deduct in calculating the refund, if any.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retroactive Premium Adjustments. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Medicaid programs periodically adjust premium rates on a retroactive basis. In these cases, we adjust our premium revenue in the period in which we determine that the adjustment is probable and reasonably estimable, and is based on our best estimate of the ultimate premium we expect to realize for the period being adjusted.</span></div>In 2020, various states enacted temporary premium refunds and related actions in response to the reduced demand for medical services stemming from COVID-19, which resulted in a reduction of our medical margin. In some cases, these premium actions were retroactive to earlier periods in 2020, or as early as the beginning of the states&#8217; fiscal years in 2019. Beginning in the second quarter of 2020, we have recognized retroactive premium actions that we believe to be probable, and where the ultimate premium amount is reasonably estimable. <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is possible that certain states could increase the level of existing premium refunds, and it is also possible that other states could implement some form of retroactive premium refund in the future. Due to these uncertainties, the ultimate outcomes could differ materially from our estimates as a result of changes in facts or further developments, which could have an adverse effect on our consolidated financial position, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Medicare premiums are subject to retroactive increase or decrease based on the health status of our Medicare members (as measured by member risk score). We estimate our members&#8217; risk scores and the related amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members&#8217; health status, risk scores and Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) practices.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum MLR.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Affordable Care Act (&#8220;ACA&#8221;) established a minimum annual medical loss ratio (&#8220;Minimum MLR&#8221;) of 85% for Medicare. The medical loss ratio represents medical costs as a percentage of premium revenue. Federal regulations define what constitutes medical costs and premium revenue. If the Minimum MLR is not met, we may be required to pay rebates to the federal government. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Marketplace Program</span></div>Risk Corridor Judgment. In April 2020, the United States Supreme Court held that &#167;1342 of the Affordable Care Act obligated the federal government to pay participating insurers the full Marketplace risk corridor amounts calculated by that statute, and that impacted insurers may sue the federal government in the U.S. Court of Federal Claims to recover damages for breach of that obligation.Consistent with the timing of the cash receipt, the gain was recognized in our fourth quarter 2020 financial results and reported in &#8220;Marketplace risk corridor judgment&#8221; in our consolidated statements of income. The judgment did not create additional Minimum MLR rebates.Risk Adjustment. Under this program, our health plans&#8217; composite risk scores are compared with the overall average risk score for the relevant state and market pool. Generally, our health plans will make a risk adjustment payment into the pool if their composite risk scores are below the average risk score (risk adjustment payable), and will receive a risk adjustment payment from the pool if their composite risk scores are above the average risk score (risk adjustment receivable). We estimate our ultimate premium based on insurance policy year-to-date experience, and recognize estimated premiums relating to the risk adjustment program as an adjustment to premium revenue in our consolidated statements of income.<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum MLR.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The ACA has established a Minimum MLR of 80% for the Marketplace. If the Minimum MLR is not met, we may be required to pay rebates to our Marketplace policyholders. The Marketplace risk adjustment program is taken into consideration when computing the Minimum MLR. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quality Incentives</span></div>At many of our health plans, revenue ranging from approximately 1% to 4% of certain health plan premiums is earned only if certain performance measures are met. Such performance measures are generally found in our Medicaid and MMP contracts. As described in Note 1, &#8220;Organization and Basis of Presentation&#8211;Use of Estimates,&#8221; recognition of quality incentive premium revenue is subject to the use of estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceAccountingPolicy', window );">Reinsurance</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We bear underwriting and reserving risks associated with our health plan subsidiaries. We limit our risk of significant catastrophic losses by maintaining high deductible reinsurance coverage with a highly-rated, unaffiliated insurance company (the &#8220;third-party reinsurer&#8221;).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we remain liable to our policyholders in the event the third-party reinsurer is unable to pay its portion of the losses, we continually monitor the third-party reinsurer&#8217;s financial condition, including its ability to maintain high credit ratings. Intercompany transactions with our captive are eliminated in consolidation.</span></div>We report reinsurance premiums as a reduction to premium revenue, while related reinsurance recoveries are reported as a reduction to medical care costs.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesWe account for income taxes under the asset and liability method. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates expected to be in effect during the year in which the basis differences reverse. Valuation allowances are established when management determines it is more likely than not that some portion, or all, of the deferred tax assets will not be realized.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_TaxesBasedOnPremiumsPolicyTextBlock', window );">Taxes Based on Premiums</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes Based on Premiums</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee (&#8220;HIF&#8221;). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Affordable Care Act, the federal government imposed an annual fee, or excise tax, on health insurers for each calendar year (the &#8220;HIF&#8221;).</span></div>The HIF was allocated to health insurers based on each health insurer's share of net premiums for all U.S. health insurers in the year preceding the assessment, and was not deductible for income tax purposes.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text">Concentrations of Credit RiskFinancial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. Our portfolio managers must obtain our prior approval before selling investments where the loss position of those investments exceeds certain levels. Our investments consist primarily of investment-grade debt securities with final maturities of less than 10 years, or less than 10 years average life for structured securities. Restricted investments are invested principally in cash, cash equivalents and U.S. Treasury securities. Concentration of credit risk with respect to accounts receivable is limited because our payors consist principally of the federal government, and governments of each state in which our health plan subsidiaries operate.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_RisksAndUncertaintiesPolicyTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability depends in large part on our ability to accurately predict and effectively manage medical care costs. We continually review our medical costs in light of our underlying claims experience and revised actuarial data. However, several factors could adversely affect medical care costs. These factors, which include changes in healthcare practices, inflation, new technologies, major epidemics, natural disasters, and malpractice litigation, are beyond our control and may have an adverse effect on our ability to accurately predict and effectively control medical care costs. Costs in excess of those anticipated could have a material adverse effect on our financial condition, results of operations, or cash flows.</span></div>We operate health plans primarily as a direct contractor with the states, and in Los Angeles County, California, as a subcontractor to another health plan holding a direct contract with the state. We are therefore dependent upon a relatively small number of contracts to support our revenue. The loss of any one of those contracts could have a material adverse effect on our financial position, results of operations, or cash flows. In addition, our ability to arrange for the provision of medical services to our members is dependent upon our ability to develop and maintain adequate provider networks. Our inability to develop or maintain such networks might, in certain circumstances, have a material adverse effect on our financial position, results of operations, or cash flows.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements Adopted and Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was subsequently modified by several ASUs issued in 2018 and 2019. We adopted Topic 326 effective January 1, 2020, using the modified retrospective approach. Under this method we recognized the cumulative effect of adopting the standard as an adjustment to the opening balance of retained earnings on January 1, 2020, which was immaterial.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by a change in the reference rate from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) or another reference rate expected to be discontinued, if certain conditions are met. ASU 2020-04 is effective immediately and expires after December 31, 2022. We are evaluating the effect of reference rate reform and this guidance on our contracts and other transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (&#8220;SEC&#8221;) did not have, nor does management expect such pronouncements to have, a significant impact on our present or future consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements <div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of current assets and current liabilities to approximate their fair values because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For our financial instruments measured at fair value on a recurring basis, we prioritize the inputs used in measuring fair value according to a three-tier fair value hierarchy as follows:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1 &#8212; Observable Inputs.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 financial instruments are actively traded and therefore the fair value for these securities is based on quoted market prices for identical securities in active markets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2 &#8212; Directly or Indirectly Observable Inputs. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value for these investments is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3 &#8212; Unobservable Inputs. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 financial instruments are valued using unobservable inputs that represent management&#8217;s best estimate of what market participants would use in pricing the financial instrument at the measurement date. As of December 31, 2020, our Level 3 financial instruments consisted of contingent consideration liabilities. As of December 31, 2019, our Level 3 financial instruments consisted of derivative financial instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_RisksAndUncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risks and uncertainties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_RisksAndUncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_TaxesBasedOnPremiumsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Taxes based on premiums.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_TaxesBasedOnPremiumsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27758-158548<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6816-158387<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27830-158548<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602711272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text">The restricted cash and cash equivalents presented below are included in &#8220;Restricted investments&#8221; in the accompanying consolidated balance sheets. <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,223&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,926&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Restricted cash and cash equivalents</a></td>
<td class="text">The restricted cash and cash equivalents presented below are included in &#8220;Restricted investments&#8221; in the accompanying consolidated balance sheets. <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,223&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,926&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of receivables</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:72.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmacy rebate receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health insurer fee reimbursement receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReservesReportedToOtherAgenciesTextBlock', window );">Amounts due to government agencies</a></td>
<td class="text">Liabilities accrued for premiums to be returned under such provisions are reported in the aggregate as &#8220;Amounts due government agencies&#8221; in the accompanying consolidated balance sheets. Categorized by program, such amounts due government agencies included the following:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:71.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid program:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Minimum MLR and profit sharing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk adjustment and Part D risk sharing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Minimum MLR and profit sharing </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketplace program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Minimum MLR</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts due government agencies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_SummarizedPremiumRevenueTableTextBlock', window );">Summarized premium revenue</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes premium revenue by state health plan for the periods presented:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">California</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Illinois </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kentucky</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michigan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ohio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Washington</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,208&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">&#8220;Other&#8221; includes the Idaho, Mississippi, New Mexico, New York, Puerto Rico, South Carolina, Utah and Wisconsin health plans, which were immaterial to our consolidated results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_SummarizedPremiumRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summarized Premium Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_SummarizedPremiumRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReservesReportedToOtherAgenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of reserves reported to other federal agencies or authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReservesReportedToOtherAgenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603278936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Summary of denominators for the computation of basic and diluted earnings per share</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net income per share:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except net income per share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average number of shares issued:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exchange of convertible senior notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion of convertible senior notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator for basic net income per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible senior notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator for diluted net income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per share - Basic </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per share - Diluted </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.23&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.47&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.61&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">&#8220;Convertible senior notes&#8221; in this table refer to the 1.625% convertible senior notes due 2044 that were settled in 2018.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">For more information regarding the warrants, including partial termination transactions, refer to Note 13, &#8220;Stockholders' Equity.&#8221; The dilutive effect of all potentially dilutive common shares is calculated using the treasury stock method. Certain potentially dilutive common shares issuable are not included in the computation of diluted net income per share because to do so would have been anti-dilutive.</span></div>(3)Source data for calculations in thousands.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821598226424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Summary of assets acquired and liabilities assumed</a></td>
<td class="text">The following table summarizes the provisional fair values assigned to assets acquired and liabilities assumed.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities assumed: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued and other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net purchase price paid</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Summary of intangible assets acquired</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents intangible assets acquired, by major class, for the three acquisitions. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Life</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract rights - member list</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provider network</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821726364392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair value of assets measured on recurring basis</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments measured at fair value on a recurring basis at December&#160;31, 2020, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments measured at fair value on a recurring basis at December&#160;31, 2019, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government-sponsored enterprise securities (&#8220;GSEs&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call option derivative asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion option derivative liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair value, by balance sheet grouping</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair values and the presentation of our derivative financial instruments in the accompanying consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative asset:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Call Option</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets: Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion Option</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities: Accounts payable, accrued liabilities and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Fair value measurements of senior notes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.375% Notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.375% Notes </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.875% Notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan Facility </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.125% Convertible Notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,127&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;For more information on debt repayments, refer to Note 11, &#8220;Debt.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821598475576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Investments</a></td>
<td class="text">The following tables summarize our current investments as of the dates indicated:<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GSEs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Contractual maturities of investments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of our current investments as of December&#160;31, 2020 are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Available-for-sale investments</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes those available-for-sale investments that have been in a continuous loss position for less than 12 months. No investments have been in a continuous loss position for 12 months or more as of December&#160;31, 2020, and 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In&#160;a&#160;Continuous&#160;Loss Position for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than&#160;12&#160;Months as of December 31, 2020</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In&#160;a&#160;Continuous&#160;Loss Position for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than&#160;12&#160;Months as of December 31, 2019</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_RestrictionsOnInvestmentsTableTextBlock', window );">Balances of restricted investments</a></td>
<td class="text">The following table presents the balances of restricted investments:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ohio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Health Plans segment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_RestrictionsOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restrictions On Investments [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_RestrictionsOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603278936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment, and Capitalized Software, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of property and equipment and depreciation and amortization recognized</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment, and capitalized software is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized software</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: accumulated amortization - capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization - furniture, equipment, building, and improvements</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(577)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets - finance leases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents all depreciation and amortization recognized in our consolidated statements of income:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recorded in depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of capitalized software</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization of furniture, equipment, building, and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recorded in cost of service revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of capitalized software and deferred contract costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total depreciation and amortization recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602477896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of lease expense and supplemental consolidated cash flow information</a></td>
<td class="text">The components of lease expense for the years ended December 31, 2020, and 2019, are presented in the following table. Rental expense related to operating leases amounted to $62 million for the year ended December 31, 2018.<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease expense: </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental consolidated cash flow information related to leases follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash used in financing activities: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets recognized in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental lease information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases, including location of amounts reported in the accompanying consolidated balance sheets, follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets - Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities (current)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities (non-current)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities (current)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:92.25pt;text-indent:-76.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating lease maturities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal - undiscounted lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance lease maturities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal - undiscounted lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821595513864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of goodwill</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amounts of goodwill, for the periods presented. All goodwill is recorded in the Health Plans segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.327%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dispositions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dispositions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of identified intangible assets, by major class</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the details of identified intangible assets, by major class, for the periods presented. All intangible assets, net, are recorded in the Health Plans segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:23.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.505%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract rights and licenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602546168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims and Benefits Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of liability for unpaid claims and claims adjustment expense</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the details of our medical claims and benefits payable as of the dates indicated.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fee-for-service claims incurred but not paid (&#8220;IBNP&#8221;)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmacy payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitation payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,961&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock', window );">Components of the change in medical claims and benefits payable</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the change in our medical claims and benefits payable for the periods indicated. The amounts presented for &#8220;Components of medical care costs related to: Prior years&#8221; represent the amount by which our original estimate of medical claims and benefits payable at the beginning of the year were more than the actual liabilities, based on information (principally the payment of claims) developed since those liabilities were first reported.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable, beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Components of medical care costs related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total medical care costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for medical care costs related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition - Magellan Complete Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in non-risk and other provider payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable, ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,961&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">December 31, 2018, includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $81 million.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock', window );">Incurred and paid claims development</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about incurred and paid claims development as of December&#160;31, 2020, as well as cumulative claims frequency and the total of incurred but not paid claims liabilities. The cumulative claim frequency is measured by claim event, and includes claims covered under capitated arrangements.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.544%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims and Allocated Claims Adjustment Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total IBNP</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative number of reported claims</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,255&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.462%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Claims Adjustment Expenses</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,149&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock', window );">Reconciliation of claims development to liability</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of claims development to the aggregate carrying amount of the liability for medical claims and benefits payable.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.462%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incurred claims and allocated claims adjustment expenses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: cumulative paid claims and allocated claims adjustment expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All outstanding liabilities before 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-risk and other provider payables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical claims and benefits payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Components Of Change In Medical Claims And Benefits Payable [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821598878584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Maturities of long-term debt</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of debt, as of December&#160;31, 2020, are illustrated in the following table. All amounts represent the principal amounts of the debt instruments outstanding.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:23.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.066%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.375% Notes due 2028</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.375% Notes due 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% Notes due 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,450&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Long term debt</a></td>
<td class="text">The following table summarizes our outstanding debt obligations and their classification in the accompanying consolidated balance sheets:<div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.125% Convertible Notes, net of unamortized discount</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.375% Notes due 2028</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.375% Notes due 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% Notes due 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.875% Notes due 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: debt issuance costs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Reported in &#8220;Accounts payable, accrued liabilities and other.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602458168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for income taxes</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense for continuing operations consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Effective income tax rate reconciliation to the statutory federal income tax rate</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. federal statutory income tax rate to the combined effective income tax rate for continuing operations is as follows:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Statutory federal tax (benefit) rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income provision (benefit), net of federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible health insurer fee (&#8220;HIF&#8221;)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Worthless stock deduction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax expense rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Significant components of deferred tax assets and liabilities</a></td>
<td class="text">Significant components of our deferred tax assets and liabilities as of December&#160;31, 2020 and 2019 were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and reserve liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued medical costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets and intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease financing obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credit carryover</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred income tax assets, net of valuation allowance </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets and intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains and losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred income tax liabilities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred income tax asset</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Unrecognized tax benefits roll forward</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The roll forward of our unrecognized tax benefits is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increases in tax positions for current year </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse in statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603466024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Stock based compensation expense</a></td>
<td class="text">Total share-based compensation expense is reported in &#8220;General and administrative expenses&#8221; in the accompanying consolidated statements of income, and summarized below.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.726%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax<br/>Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net-of-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax<br/>Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net-of-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax<br/>Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net-of-Tax<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSAs, PSAs and PSUs (defined below)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee stock purchase plan and stock options </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Restricted and performance stock activity</a></td>
<td class="text">Activity for stock-based awards in the year ended December&#160;31, 2020, is summarized below.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:40.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSAs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant&#160;Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant&#160;Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested balance, December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(172,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested balance, December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">585,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">471,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock options, activity</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total grant date fair value of awards granted and vested is presented in the following table.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:64.492%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSAs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total granted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSAs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total vested</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Stock option awards generally have an exercise price equal to the fair market value of our common stock on the date of grant, vest in equal annual installments over periods up to four years from the date of grant, and have a maximum term of ten years from the date of grant. Stock option activity for the year ended December&#160;31, 2020, is summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual term</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Per share)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options outstanding as of December 31, 2019 and December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options exercisable and expected to vest as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Stock option plans, by exercise price range</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of information about stock options outstanding and exercisable at December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding and Exercisable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Per share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Range of Exercise Prices</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$33.02</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$67.33</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821598263064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Operating segment information</a></td>
<td class="text">Margin for our Health Plans segment is also referred to as &#8220;Medical Margin.&#8221;<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles margin by segment to consolidated income before income tax expense:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Margin:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: other operating revenues </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: other operating expenses </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,880)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: other expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Other operating revenues include premium tax revenue, health insurer fees reimbursed, Marketplace risk corridor judgment, investment income and other revenue.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Other operating expenses include general and administrative expenses, premium tax expenses, health insurer fees, depreciation and amortization, and other costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821606488088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Condensed balance sheets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except per-share data)</span></div></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due from affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, equipment, and capitalized software, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advances to related parties and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,774&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,753&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $0.001 par value; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,774&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock', window );">Condensed statements of income</a></td>
<td class="text"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administrative services fees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment income and other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other expenses, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income tax (benefit) expense and equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss before equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Condensed statements of comprehensive income</a></td>
<td class="text"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Comprehensive Income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized investment income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: effect of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock', window );">Condensed statements of cash flows</a></td>
<td class="text"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends received from subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash paid in business combinations </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash received from sale of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in amounts due to/from affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(545)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from senior notes offering, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock purchases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from borrowings under term loan facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for partial termination of warrants</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for partial settlement of conversion option</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(578)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash received for partial settlement of call option</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of principal amount of convertible notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of credit facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,192)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 3<br> -Paragraph i<br> -Subsection 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 3<br> -Paragraph i<br> -Subsection 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedCashFlowStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 3<br> -Paragraph i<br> -Subsection 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603879048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation (Details)<br> member in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>member </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>member </div>
<div>Segment </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BasisOfPresentationLineItems', window );"><strong>Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_NumberOfStatesForOperatedHealthPlans', window );">Number of states for operated health plans | state</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Net cash paid in business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 755<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BasisOfPresentationLineItems', window );"><strong>Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_NumberOfMembersEligibleForTheHealthCarePrograms', window );">Number of served members | member</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms', window );">Number of members eligible for the health care programs, approximately | member</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Health Plans | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BasisOfPresentationLineItems', window );"><strong>Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthPlanContractTerm', window );">Contract term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Health Plans | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BasisOfPresentationLineItems', window );"><strong>Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthPlanContractTerm', window );">Contract term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=moh_MagellanCompleteCareMember', window );">Magellan Complete Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BasisOfPresentationLineItems', window );"><strong>Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_NumberOfStatesForOperatedHealthPlans', window );">Number of states for operated health plans | state</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Net cash paid in business combinations</a></td>
<td class="nump">$ 1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=moh_AffinityHealthPlanMember', window );">Affinity Health Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BasisOfPresentationLineItems', window );"><strong>Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Net cash paid in business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis Of Presentation [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of members eligible for the health care programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_HealthPlanContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Plan, Contract Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_HealthPlanContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_NumberOfMembersEligibleForTheHealthCarePrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of members eligible for the health care programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_NumberOfMembersEligibleForTheHealthCarePrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_NumberOfStatesForOperatedHealthPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of States For Operated Health Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_NumberOfStatesForOperatedHealthPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=moh_MagellanCompleteCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=moh_MagellanCompleteCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=moh_AffinityHealthPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=moh_AffinityHealthPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821601723352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,154<span></span>
</td>
<td class="nump">$ 2,452<span></span>
</td>
<td class="nump">$ 2,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and cash equivalents</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows</a></td>
<td class="nump">$ 4,223<span></span>
</td>
<td class="nump">$ 2,508<span></span>
</td>
<td class="nump">$ 2,926<span></span>
</td>
<td class="nump">$ 3,290<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821609450728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_InvestmentsMaturityPeriod', window );">Maturity period (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_InvestmentsAverageMaturityPeriod', window );">Average maturity period (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPremiumsReceivable', window );">Reduction in premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable', window );">Marketplace risk adjustment payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326.0<span></span>
</td>
<td class="nump">326.0<span></span>
</td>
<td class="nump">368.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable', window );">Risk adjustment receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">63.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable', window );">Risk adjustment, net payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">306.0<span></span>
</td>
<td class="nump">306.0<span></span>
</td>
<td class="nump">305.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidReinsurancePremiums', window );">Prepaid reinsurance premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceRecoveries', window );">Reinsurance recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
<td class="nump">33.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Reinsurance recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">$ 21.0<span></span>
</td>
<td class="nump">$ 31.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareInsuranceFeeLiability', window );">HIF liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277.0<span></span>
</td>
<td class="nump">277.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=moh_MaineCommunityHealthOptionsv.UnitedStatesMember', window );">Maine Community Health Options v. United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Summary judgement</a></td>
<td class="nump">$ 128.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=moh_COVID19Member', window );">COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPremiumsReceivable', window );">Reduction in premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 401.0<span></span>
</td>
<td class="nump">564.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=moh_COVID19Member', window );">COVID-19 | MMP Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPremiumsReceivable', window );">Reduction in premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO | Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts', window );">Premium deficiency reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Premium revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_PercentageOfAdditionalIncrementalRevenueEarned', window );">Percentage of additional incremental revenue earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Premium revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_PercentageOfAdditionalIncrementalRevenueEarned', window );">Percentage of additional incremental revenue earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=moh_StructuredSecuritiesMember', window );">Structured Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_InvestmentsAverageMaturityPeriod', window );">Average maturity period (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Net Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act, Premium Stabilization Program, Risk Adjustment, (Payable)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_HealthCareInsuranceFeeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care Insurance, Fee, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_HealthCareInsuranceFeeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_InvestmentsAverageMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments, Average Maturity Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_InvestmentsAverageMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_InvestmentsMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments, Maturity Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_InvestmentsMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_PercentageOfAdditionalIncrementalRevenueEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of additional incremental revenue earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_PercentageOfAdditionalIncrementalRevenueEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPremiumsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the premium receivable balance on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPremiumsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recovered from insurance. These recoveries reduce costs and losses that are reported as a separate line item under operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidReinsurancePremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The unexpired portion of premiums ceded on policies in force as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 340<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6485982&amp;loc=d3e22818-158507<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99380617&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidReinsurancePremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=moh_MaineCommunityHealthOptionsv.UnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=moh_MaineCommunityHealthOptionsv.UnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=moh_COVID19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=moh_COVID19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=moh_MedicareMedicaidPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=moh_MedicareMedicaidPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=moh_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=moh_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=moh_StructuredSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=moh_StructuredSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821703606520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Total receivables</a></td>
<td class="nump">$ 1,672<span></span>
</td>
<td class="nump">$ 1,406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_GovernmentReceivablesMember', window );">Government receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Total receivables</a></td>
<td class="nump">969<span></span>
</td>
<td class="nump">1,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_PharmacyRebateReceivablesMember', window );">Pharmacy rebate receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Total receivables</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_HealthInsurerFeeReimbursementReceivablesMember', window );">Health insurer fee reimbursement receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Total receivables</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_OtherReceivablesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Total receivables</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_CompleteCareReceivablesMember', window );">Magellan Complete Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Total receivables</a></td>
<td class="nump">$ 166<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_GovernmentReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_GovernmentReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_PharmacyRebateReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_PharmacyRebateReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_HealthInsurerFeeReimbursementReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_HealthInsurerFeeReimbursementReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_OtherReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_OtherReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_CompleteCareReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=moh_CompleteCareReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603717624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Amounts Due To Government Agencies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract', window );"><strong>Medicaid program:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold', window );">Minimum MLR and profit sharing</a></td>
<td class="nump">$ 513<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AmountsDueToGovernmentAgenciesMedicaidOther', window );">Other</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract', window );"><strong>Medicare program:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing', window );">Risk adjustment and Part D risk sharing</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold', window );">Minimum MLR and profit sharing</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_OtherMedicareProgram', window );">Other</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract', window );"><strong>Marketplace program:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment', window );">Risk adjustment</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold', window );">Minimum MLR</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AmountsDuetoGovernmentAgenciesOther', window );">Other</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AmountsDueToGovernmentAgenciesBusinessCombination', window );">Magellan Complete Care</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_MedicalPremiumLiabilityDueToAgency', window );">Total amounts due government agencies</a></td>
<td class="nump">$ 1,253<span></span>
</td>
<td class="nump">$ 664<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AmountsDueToGovernmentAgenciesBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts Due to Government Agencies, Business Combination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AmountsDueToGovernmentAgenciesBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts Due To Government Agencies, Marketplace, Medical Loss Ratio Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts Due To Government Agencies, Marketplace Program [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AmountsDueToGovernmentAgenciesMedicaidOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts Due To Government Agencies, Medicaid, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AmountsDueToGovernmentAgenciesMedicaidOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts Due To Government Agencies, Medicaid Program [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts Due To Government Agencies, Medicare, Medical Loss Ratio And Profit Sharing, Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts Due To Government Agencies Medicare Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts Due to Government Agencies, Risk Adjustment and Part D risk sharing</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AmountsDuetoGovernmentAgenciesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts Due to Government Agencies, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AmountsDuetoGovernmentAgenciesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AmountsDuetoGovernmentAgenciesRiskAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts Due to Government Agencies, Risk Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AmountsDuetoGovernmentAgenciesRiskAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_MedicalPremiumLiabilityDueToAgency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Premium Liability Due to Agency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_MedicalPremiumLiabilityDueToAgency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Premiums Liability, Medical Care Costs Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_OtherMedicareProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Medicare Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_OtherMedicareProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821604108136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of Premium Revenue (Details) - Health Plans - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 18,299<span></span>
</td>
<td class="nump">$ 16,208<span></span>
</td>
<td class="nump">$ 17,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationRevenuePercentage', window );">Premium revenue percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 2,109<span></span>
</td>
<td class="nump">$ 2,266<span></span>
</td>
<td class="nump">$ 2,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationRevenuePercentage', window );">Premium revenue percentage</a></td>
<td class="nump">11.50%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">12.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Florida</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 643<span></span>
</td>
<td class="nump">$ 734<span></span>
</td>
<td class="nump">$ 1,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationRevenuePercentage', window );">Premium revenue percentage</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">10.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Illinois</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 1,328<span></span>
</td>
<td class="nump">$ 1,002<span></span>
</td>
<td class="nump">$ 793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationRevenuePercentage', window );">Premium revenue percentage</a></td>
<td class="nump">7.30%<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Kentucky</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 654<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationRevenuePercentage', window );">Premium revenue percentage</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Michigan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 1,587<span></span>
</td>
<td class="nump">$ 1,624<span></span>
</td>
<td class="nump">$ 1,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationRevenuePercentage', window );">Premium revenue percentage</a></td>
<td class="nump">8.70%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">9.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 2,962<span></span>
</td>
<td class="nump">$ 2,553<span></span>
</td>
<td class="nump">$ 2,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationRevenuePercentage', window );">Premium revenue percentage</a></td>
<td class="nump">16.20%<span></span>
</td>
<td class="nump">15.80%<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Texas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 3,085<span></span>
</td>
<td class="nump">$ 2,991<span></span>
</td>
<td class="nump">$ 3,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationRevenuePercentage', window );">Premium revenue percentage</a></td>
<td class="nump">16.90%<span></span>
</td>
<td class="nump">18.50%<span></span>
</td>
<td class="nump">18.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Washington</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 3,169<span></span>
</td>
<td class="nump">$ 2,695<span></span>
</td>
<td class="nump">$ 2,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationRevenuePercentage', window );">Premium revenue percentage</a></td>
<td class="nump">17.30%<span></span>
</td>
<td class="nump">16.60%<span></span>
</td>
<td class="nump">13.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 2,762<span></span>
</td>
<td class="nump">$ 2,343<span></span>
</td>
<td class="nump">$ 3,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_HealthCareOrganizationRevenuePercentage', window );">Premium revenue percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">14.40%<span></span>
</td>
<td class="nump">18.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_HealthCareOrganizationRevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care Organization, Revenue Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_HealthCareOrganizationRevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_KY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_KY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=moh_OtherGeographicalAreasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=moh_OtherGeographicalAreasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821604961112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 673<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="nump">$ 707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding at the beginning of the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.9<span></span>
</td>
<td class="nump">62.1<span></span>
</td>
<td class="nump">59.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average number of shares issued:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Stock purchases (in shares)</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_WeightedAverageNumberofSharesShareBasedCompensation', window );">Stock-based compensation (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Exchange of convertible senior notes (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes', window );">Conversion of convertible senior notes (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Denominator for basic net income per share (in shares)</a></td>
<td class="nump">59.0<span></span>
</td>
<td class="nump">62.2<span></span>
</td>
<td class="nump">61.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Share-based compensation (in shares)</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Warrants (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible senior notes (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted net income per share (in shares)</a></td>
<td class="nump">59.9<span></span>
</td>
<td class="nump">64.2<span></span>
</td>
<td class="nump">66.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 11.40<span></span>
</td>
<td class="nump">$ 11.85<span></span>
</td>
<td class="nump">$ 11.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 11.23<span></span>
</td>
<td class="nump">$ 11.47<span></span>
</td>
<td class="nump">$ 10.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=moh_ConvertibleSeniorNotesMember', window );">Convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ClassOfWarrantOrRightStatedInterestRate', window );">Stated interest rate</a></td>
<td class="nump">1.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_ClassOfWarrantOrRightStatedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Stated Interest Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_ClassOfWarrantOrRightStatedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Number of Shares Issued, Conversion of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_WeightedAverageNumberofSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Number of Shares, Share Based Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_WeightedAverageNumberofSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_ConvertibleSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_ConvertibleSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821600544328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative (Details)<br> member in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>USD ($) </div>
<div>member</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>member </div>
<div>security</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>member </div>
<div>security </div>
<div>business_combination</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>business_combination </div>
<div>member </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BusinessCombinationNumberOfBusinessCombinations', window );">Number of business combinations | business_combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Net cash paid in business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,000<span></span>
</td>
<td class="nump">$ 46,000<span></span>
</td>
<td class="nump">$ 46,000<span></span>
</td>
<td class="nump">$ 46,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage', window );">Business combination goodwill is deductible for income tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms', window );">Number of members eligible for the health care programs, approximately | member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 692,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 692,000<span></span>
</td>
<td class="nump">$ 692,000<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="nump">$ 143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=moh_MagellanCompleteCareMember', window );">Magellan Complete Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Net cash paid in business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,037,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Total purchase consideration paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,008,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Preliminary closing adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which company operates (in state) | security</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod', window );">Revenue of acquired business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Pro forma revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,400,000<span></span>
</td>
<td class="nump">19,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Pro forma earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 833,000<span></span>
</td>
<td class="nump">$ 772,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=moh_PassportHealthPlanIncMember', window );">Passport Health Plan Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Preliminary closing adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms', window );">Number of members eligible for the health care programs, approximately | member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=moh_YourCareHealthPlanIncMember', window );">Your Care Health Plan Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Preliminary closing adjustments</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms', window );">Number of members eligible for the health care programs, approximately | member</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Goodwill Deductible For Income Tax Purposes, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_BusinessCombinationNumberOfBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number Of Business Combinations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_BusinessCombinationNumberOfBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of members eligible for the health care programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398226&amp;loc=d3e511914-122862<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(3)(ii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398226&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue reported by the acquired entity for its previous full fiscal year before the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=moh_MagellanCompleteCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=moh_MagellanCompleteCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=moh_PassportHealthPlanIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=moh_PassportHealthPlanIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=moh_YourCareHealthPlanIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=moh_YourCareHealthPlanIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603421960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Summarizes the Preliminary Values of the Assets acquired and Liabilities Assumed at the Date of Acquisition (Details) - Health Plans Segment<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AssetsAcquiredAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities', window );">Investments</a></td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Receivables</a></td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment', window );">Restricted investments</a></td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LiabilitiesAssumedAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable', window );">Medical claims and benefits payable</a></td>
<td class="num">(294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies', window );">Amounts due government agencies</a></td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued and other long-term liabilities</a></td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net purchase price paid</a></td>
<td class="nump">$ 1,008<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AssetsAcquiredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AssetsAcquiredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Amounts Due Government Agencies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims and Benefits Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_LiabilitiesAssumedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liabilities Assumed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_LiabilitiesAssumedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=moh_HealthPlansSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=moh_HealthPlansSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821604155912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Intangible Assets (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets value</a></td>
<td class="nump">$ 235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Intangible assets amortization period</a></td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset useful life</a></td>
<td class="text">16 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contract rights - member list</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets value</a></td>
<td class="nump">$ 193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Intangible assets amortization period</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contract rights - member list | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contract rights - member list | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset useful life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_ProviderNetworkMember', window );">Provider network</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets value</a></td>
<td class="nump">$ 27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset useful life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Intangible assets amortization period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_TradeNameMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets value</a></td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Intangible assets amortization period</a></td>
<td class="text">15 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_TradeNameMember', window );">Trade name | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset useful life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_TradeNameMember', window );">Trade name | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset useful life</a></td>
<td class="text">16 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_ProviderNetworkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_ProviderNetworkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_TradeNameMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_TradeNameMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821606603800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Recognized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Cash received for partial settlement of call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 578<span></span>
</td>
<td class="nump">$ 623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=moh_CashConvertibleSeniorNotesDue2020Member', window );">1.125% Convertible Notes | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Current Maturities, Net Of Unamortized Premium (Discount)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_CashConvertibleSeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_CashConvertibleSeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821604983160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Instruments on a Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">$ 1,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,946<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">1,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=moh_MunicipalSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryNotesSecuritiesMember', window );">U.S. Treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">Government-sponsored enterprise securities (&#8220;GSEs&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=moh_OtherSecuritiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeFinancialInstrumentsAssetsMember', window );">Call option derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Call option derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember', window );">Conversion option derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Conversion option derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. Treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Government-sponsored enterprise securities (&#8220;GSEs&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Call option derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Call option derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Conversion option derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Conversion option derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">1,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. Treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Government-sponsored enterprise securities (&#8220;GSEs&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Call option derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Call option derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Conversion option derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Conversion option derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | U.S. Treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Government-sponsored enterprise securities (&#8220;GSEs&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Call option derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Call option derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Conversion option derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Fair value of assets measured on recurring basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Conversion option derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=moh_MunicipalSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=moh_MunicipalSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryNotesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryNotesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=moh_OtherSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=moh_OtherSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeFinancialInstrumentsAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeFinancialInstrumentsAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602707384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Balance Sheet Grouping (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=moh_CurrentAssetsMember', window );">Current assets | (Loss) gain on call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=moh_CurrentLiabilitiesMember', window );">Current liabilities | Conversion option derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=moh_CurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=moh_CurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=moh_CallOptionDerivativeAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=moh_CallOptionDerivativeAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=moh_CurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=moh_CurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603698072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 2,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 2,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.375% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.375% Notes | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.375% Notes | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.375% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">5.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.375% Notes | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.375% Notes | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% Notes | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% Notes | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% Notes | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% Notes | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Term Loan Facility | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Term Loan Facility | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 4.875% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 1.125% Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 1.125% Convertible Notes | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 1.125% Convertible Notes | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_A4375SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_A4375SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_ThreePointEightSevenFivePercentSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_ThreePointEightSevenFivePercentSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_A4.875SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_A4.875SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_CashConvertibleSeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_CashConvertibleSeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821688389320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 1,826<span></span>
</td>
<td class="nump">$ 1,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">1,875<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,220<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">1,256<span></span>
</td>
<td class="nump">1,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=moh_MunicipalSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryNotesSecuritiesMember', window );">U.S. Treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">GSEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificate of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=moh_OtherSecuritiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=moh_MunicipalSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=moh_MunicipalSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryNotesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryNotesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=moh_OtherSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=moh_OtherSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821688216600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Contractual Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less</a></td>
<td class="nump">$ 474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Due after five years through ten years</a></td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Due after ten years</a></td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,826<span></span>
</td>
<td class="nump">$ 1,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years</a></td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after ten years</a></td>
<td class="nump">337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Estimated Fair Value</a></td>
<td class="nump">$ 1,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602473688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized investment gains</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount', window );">Amortized Cost, Due in one year or less</a></td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount', window );">Amortized Cost, Due one year through five years</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821607863992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Available-for-Sale (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated Fair Value</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Total Number of Positions | security</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">239<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated Fair Value</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Total Number of Positions | security</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Total Number of Positions | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821595513368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Balances of Restricted Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule of Held-to-maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Restricted investments</a></td>
<td class="nump">$ 136<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_CompleteCareMember', window );">Magellan Complete Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule of Held-to-maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Restricted investments</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule of Held-to-maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Restricted investments</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NM', window );">New Mexico</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule of Held-to-maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Restricted investments</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NY', window );">New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule of Held-to-maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Restricted investments</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OH', window );">Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule of Held-to-maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Restricted investments</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=moh_OtherGeographicalAreasMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule of Held-to-maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Restricted investments</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the noncurrent portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=moh_CompleteCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=moh_CompleteCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NM">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NM</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=moh_OtherGeographicalAreasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=moh_OtherGeographicalAreasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821606512552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment, and Capitalized Software, Net - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">31 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602983064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Equipment, and Capitalized Software, Net - Summary of Property, Equipment, and Capitalized Software (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">$ 752<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Less: accumulated amortization - capitalized software</a></td>
<td class="num">(385)<span></span>
</td>
<td class="num">(351)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation', window );">Less: accumulated depreciation and amortization - furniture, equipment, building, and improvements</a></td>
<td class="num">(192)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Total accumulated depreciation and amortization</a></td>
<td class="num">(577)<span></span>
</td>
<td class="num">(530)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">ROU assets - finance leases</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, equipment, and capitalized software, net</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">475<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Magellan Complete Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation (related to long-lived, depreciable flight assets owned by the entity and used in the entity's principle business operations and capitalized assets classified as property, plant and equipment that are owned by the entity) that has been recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821601780056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment, and Capitalized Software, Net - Depreciation and Amortization (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_RecordedInDepreciationAndAmortizationAbstract', window );"><strong>Recorded in depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DepreciationAndAmortizationOfCapitalizedSoftware', window );">Amortization of capitalized software</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization of furniture, equipment, building, and improvements</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of finance leases</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DepreciationandAmortizationContinuingOperations', window );">Subtotal</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_RecordedInCostOfServiceRevenueAbstract', window );"><strong>Recorded in cost of service revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of capitalized software and deferred contract costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Total depreciation and amortization recognized</a></td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_DepreciationAndAmortizationOfCapitalizedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Depreciation, and amortization of capitalized software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_DepreciationAndAmortizationOfCapitalizedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_DepreciationandAmortizationContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Depreciation and Amortization, Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_DepreciationandAmortizationContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_RecordedInCostOfServiceRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded In Cost Of Service Revenue [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_RecordedInCostOfServiceRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_RecordedInDepreciationAndAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded In Depreciation And Amortization [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_RecordedInDepreciationAndAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821703961144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Operating lease, remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases, weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRenewalTerm1', window );">Finance lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases, weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases, weighted average discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases, weighted average discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease, expense</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm', window );">Finance lease, remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm', window );">Finance lease, remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821596736040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of Lease Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance lease expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of ROU assets</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_FinanceLeaseCost', window );">Total finance lease expense</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603610152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating leases</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Finance leases</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash used in financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance leases</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract', window );"><strong>ROU assets recognized in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance leases</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 245<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset Obtained in Exchange for Operating Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821604159160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_OperatingLeaseAssetsLesseeAbstract', window );"><strong>ROU assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired', window );">Other assets</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Total other assets</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_OperatingLeaseLiabilitiesLesseeAbstract', window );"><strong>Lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Accounts payable and accrued liabilities (current)</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Other long-term liabilities (non-current)</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_FinanceLeaseAssetsLesseeAbstract', window );"><strong>ROU assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Property, equipment, and capitalized software, net</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_FinanceLeaseLiabilitiesLesseeAbstract', window );"><strong>Lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Accounts payable and accrued liabilities (current)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities (non-current)</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 237<span></span>
</td>
<td class="nump">$ 239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherAssets<span></span>
</td>
<td class="text">us-gaap:OtherAssets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent<span></span>
</td>
<td class="text">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent<span></span>
</td>
<td class="text">us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherLiabilitiesNoncurrent<span></span>
</td>
<td class="text">us-gaap:OtherLiabilitiesNoncurrent<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=moh_CompleteCareMember', window );">Magellan Complete Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_OperatingLeaseAssetsLesseeAbstract', window );"><strong>ROU assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Total other assets</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_OperatingLeaseLiabilitiesLesseeAbstract', window );"><strong>Lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_FinanceLeaseAssetsLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Assets, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_FinanceLeaseAssetsLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_FinanceLeaseLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liabilities, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_FinanceLeaseLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_OperatingLeaseAssetsLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Assets, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_OperatingLeaseAssetsLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_OperatingLeaseLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liabilities, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_OperatingLeaseLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Right Of Use Asset, Excluding Leases Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=moh_CompleteCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=moh_CompleteCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821609436520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Subtotal - undiscounted lease payments</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Subtotal - undiscounted lease payments</a></td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 237<span></span>
</td>
<td class="nump">$ 239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602735848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Balances of Goodwill (Details) - Health Plans - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 143<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">549<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Dispositions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821697466024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future Amortization Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Future amortization expense, 2021</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Future amortization expense, 2022</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Future amortization expense, 2023</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Future amortization expense, 2024</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Future amortization expense, 2025</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Gross goodwill</a></td>
<td class="nump">994<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss</a></td>
<td class="nump">$ 302<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602897512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Intangible Assets Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 432<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Carrying Amount</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_ContractRightsandLicensingAgreementsMember', window );">Contract rights and licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Carrying Amount</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_ProviderNetworksMember', window );">Provider networks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Carrying Amount</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Carrying Amount</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_ContractRightsandLicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_ContractRightsandLicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_ProviderNetworksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=moh_ProviderNetworksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821600560136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Claims and Benefits Payable - Medical Claims and Future Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount', window );">Fee-for-service claims incurred but not paid (&#8220;IBNP&#8221;)</a></td>
<td class="nump">$ 1,647<span></span>
</td>
<td class="nump">$ 1,406<span></span>
</td>
<td class="nump">$ 1,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_PharmacyClaimsPayable', window );">Pharmacy payable</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_CapitationClaimsPayable', window );">Capitation payable</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_OtherClaimsPayable', window );">Other</a></td>
<td class="nump">528<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Total</a></td>
<td class="nump">2,696<span></span>
</td>
<td class="nump">1,854<span></span>
</td>
<td class="nump">1,961<span></span>
</td>
<td class="nump">$ 2,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=moh_CompleteCareMember', window );">Magellan Complete Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Total</a></td>
<td class="nump">$ 294<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_CapitationClaimsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capitation Claims Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_CapitationClaimsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Paid (IBNP), Fee-for-service Claims, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_OtherClaimsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Claims Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_OtherClaimsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_PharmacyClaimsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Claims Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_PharmacyClaimsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=moh_CompleteCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=moh_CompleteCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821703958808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims and Benefits Payable - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_MedicalClaimsAndBenefitsPayable', window );">Non-risk provide payables</a></td>
<td class="nump">$ 235<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Favorable (unfavorable) adjustment</a></td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=moh_CMSSubsidiesMember', window );">CMS Subsidies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Disposal group, operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_MedicalClaimsAndBenefitsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Claims and Benefits Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_MedicalClaimsAndBenefitsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=moh_CMSSubsidiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=moh_CMSSubsidiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821604145176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims and Benefits Payable - Components of the Change (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical claims and benefits payable, beginning balance</a></td>
<td class="nump">$ 1,854<span></span>
</td>
<td class="nump">$ 1,961<span></span>
</td>
<td class="nump">$ 2,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Components of medical care costs related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">15,939<span></span>
</td>
<td class="nump">14,176<span></span>
</td>
<td class="nump">15,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior periods</a></td>
<td class="num">(119)<span></span>
</td>
<td class="num">(271)<span></span>
</td>
<td class="num">(341)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total medical care costs</a></td>
<td class="nump">15,820<span></span>
</td>
<td class="nump">13,905<span></span>
</td>
<td class="nump">15,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Payments for medical care costs related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">13,871<span></span>
</td>
<td class="nump">12,554<span></span>
</td>
<td class="nump">13,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">1,507<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
<td class="nump">1,710<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="nump">15,378<span></span>
</td>
<td class="nump">14,036<span></span>
</td>
<td class="nump">15,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisition - Magellan Complete Care</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider', window );">Change in non-risk and other provider payables</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical claims and benefits payable, ending balance</a></td>
<td class="nump">$ 2,696<span></span>
</td>
<td class="nump">$ 1,854<span></span>
</td>
<td class="nump">1,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=moh_CMSSubsidiesMember', window );">CMS Subsidies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Disposal group, operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Claims and Benefits Payable, Adjustments, Change in Provider</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=moh_CMSSubsidiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=moh_CMSSubsidiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821604585352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims and Benefits Payable - Incurred Claims and Allocated Adjustment Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Incurred Claims and Allocated Claims Adjustment Expenses</a></td>
<td class="nump">$ 15,820<span></span>
</td>
<td class="nump">$ 13,905<span></span>
</td>
<td class="nump">$ 15,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment', window );">Incurred Claims and Allocated Claims Adjustment Expenses</a></td>
<td class="nump">45,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount', window );">Total IBNP</a></td>
<td class="nump">1,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member', window );">Benefit Year 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Incurred Claims and Allocated Claims Adjustment Expenses</a></td>
<td class="nump">15,233<span></span>
</td>
<td class="nump">15,245<span></span>
</td>
<td class="nump">$ 15,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount', window );">Total IBNP</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims', window );">Cumulative number of reported claims (in claim) | claim</a></td>
<td class="nump">110,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member', window );">Benefit Year 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Incurred Claims and Allocated Claims Adjustment Expenses</a></td>
<td class="nump">$ 14,083<span></span>
</td>
<td class="nump">$ 14,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount', window );">Total IBNP</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims', window );">Cumulative number of reported claims (in claim) | claim</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member', window );">Benefit Year 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Incurred Claims and Allocated Claims Adjustment Expenses</a></td>
<td class="nump">$ 15,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount', window );">Total IBNP</a></td>
<td class="nump">$ 1,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims', window );">Cumulative number of reported claims (in claim) | claim</a></td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Incurred Claims Including Acquisition Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.W)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015833&amp;loc=d3e570705-122907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative number of reported claims for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821688225784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Claims and Benefits Payable - Cumulative Paid Claims and Allocated Claims Adjustment Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Claims paid</a></td>
<td class="nump">$ 43,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member', window );">Benefit Year 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Claims paid</a></td>
<td class="nump">15,222<span></span>
</td>
<td class="nump">$ 15,220<span></span>
</td>
<td class="nump">$ 13,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member', window );">Benefit Year 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Claims paid</a></td>
<td class="nump">14,056<span></span>
</td>
<td class="nump">$ 12,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member', window );">Benefit Year 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Claims paid</a></td>
<td class="nump">$ 13,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603041432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims and Benefits Payable - Reconciliation of Claims Development (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred claims and allocated claims adjustment expenses</a></td>
<td class="nump">$ 45,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Less: cumulative paid claims and allocated claims adjustment expenses</a></td>
<td class="num">(43,149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears', window );">All outstanding liabilities before 2018</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisition - Magellan Complete Care</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems', window );">Non-risk and other provider payables</a></td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Total</a></td>
<td class="nump">$ 2,696<span></span>
</td>
<td class="nump">$ 1,854<span></span>
</td>
<td class="nump">$ 1,961<span></span>
</td>
<td class="nump">$ 2,192<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Outstanding Liabilities Relating to Prior Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of aggregate reconciling items for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821607987800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Maturities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount</a></td>
<td class="nump">$ 2,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 1,450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.375% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">4.375%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount</a></td>
<td class="nump">$ 800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.375% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">5.375%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount</a></td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount</a></td>
<td class="nump">$ 650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 650<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_A4375SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_A4375SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_ThreePointEightSevenFivePercentSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_ThreePointEightSevenFivePercentSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821600048648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Total (1)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Less: debt issuance costs</a></td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total</a></td>
<td class="nump">$ 2,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 1.125% Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 4.875% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Term loan facility | Term loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount', window );">Non-current portion of long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.375% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount', window );">Non-current portion of long-term debt</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.375% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">5.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount', window );">Non-current portion of long-term debt</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount', window );">Non-current portion of long-term debt</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount', window );">Non-current portion of long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 330<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Current Maturities, Net Of Unamortized Premium (Discount)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Noncurrent, Net Of Unamortized Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_CashConvertibleSeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_CashConvertibleSeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_A4.875SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_A4.875SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_A4375SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_A4375SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_ThreePointEightSevenFivePercentSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_ThreePointEightSevenFivePercentSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821609564440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Credit Agreement (Details) - Term Loan Facility<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Incremental Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Incremental term loans</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ConsolidatedNetLeverage', window );">Net leverage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amount outstanding under Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Swingline Sub Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Letter Of Credit Sub-Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_ConsolidatedNetLeverage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consolidated Net Leverage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_ConsolidatedNetLeverage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_IncrementalTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_IncrementalTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=moh_SwinglineSubFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=moh_SwinglineSubFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=moh_LetterOfCreditSubFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=moh_LetterOfCreditSubFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821601396632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Senior Notes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 02, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Nov. 17, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.875%<span></span>
</td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,150,000,000<span></span>
</td>
<td class="nump">$ 2,150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.375% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of notes outstanding</a></td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred issuance costs</a></td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.375% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of notes outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.875%<span></span>
</td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of notes outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 330,000,000<span></span>
</td>
<td class="nump">$ 330,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_RedemptionPremiumSettledPercentage', window );">Settled percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositLiabilitiesAccruedInterest', window );">Unpaid interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 4.375% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit facility</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 4.875% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.875%<span></span>
</td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_RedemptionPremiumSettledPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption Premium, Settled Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_RedemptionPremiumSettledPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositLiabilitiesAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued but unpaid interest on deposit liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositLiabilitiesAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_A4375SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_A4375SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_ThreePointEightSevenFivePercentSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_ThreePointEightSevenFivePercentSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_A4.875SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_A4.875SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821600560136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Convertible Notes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_GainLossOnDebtRepayment', window );">Loss (gain) on debt repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (15)<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="num">$ (22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 1.125% Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of contractual interest rate on notes</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_GainLossOnDebtRepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Debt Repayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_GainLossOnDebtRepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Current Maturities, Net Of Unamortized Premium (Discount)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=moh_CashConvertibleSeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=moh_CashConvertibleSeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821607629896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 281<span></span>
</td>
<td class="nump">$ 204<span></span>
</td>
<td class="nump">$ 272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602077208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of the U.S. Federal Statutory Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal tax (benefit) rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income provision (benefit), net of federal</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent', window );">Nondeductible health insurer fee (&#8220;HIF&#8221;)</a></td>
<td class="nump">6.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">7.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Nondeductible compensation</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction', window );">Worthless stock deduction</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax expense rate</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
<td class="nump">29.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Health Insurance, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Worthless Stock Deduction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602899576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses and reserve liabilities</a></td>
<td class="nump">$ 52,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Other accrued medical costs</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DeferredTaxAssetsFixedAssetsAndIntangibles', window );">Fixed assets and intangibles</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve', window );">Unearned premiums</a></td>
<td class="nump">18,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent', window );">Lease financing obligation</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carryover</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(17,000)<span></span>
</td>
<td class="num">(24,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred income tax assets, net of valuation allowance</a></td>
<td class="nump">98,000<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles', window );">Fixed assets and intangibles</a></td>
<td class="num">(7,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="num">(10,000)<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities', window );">Unrealized gains and losses</a></td>
<td class="num">(12,000)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(29,000)<span></span>
</td>
<td class="num">(9,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred income tax asset</a></td>
<td class="nump">$ 69,000<span></span>
</td>
<td class="nump">$ 79,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_DeferredTaxAssetsFixedAssetsAndIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Fixed Assets and Intangibles</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_DeferredTaxAssetsFixedAssetsAndIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Fixed Assets And Intangibles</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the unearned premiums reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821703545624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardValuationAllowance', window );">Deferred tax assets</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Decrease in deferred tax asset valuation allowance</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Impact on effective tax rate if tax benefits are recognized</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Liability for unrecognized tax benefits, potential decrease</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryovers</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryovers</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821596778728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized tax benefits roll forward</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits at beginning of period</a></td>
<td class="num">$ (20)<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases in tax positions for current year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapse in statute of limitations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits at end of period</a></td>
<td class="num">$ (20)<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821599674872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 11, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchased of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 605,000,000<span></span>
</td>
<td class="nump">$ 54,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">606,000,000<span></span>
</td>
<td class="nump">47,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfWarrants', window );">Cash paid for partial termination of 1.125% Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 514,000,000<span></span>
</td>
<td class="nump">$ 549,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_UnrecognizedCompensationForfeitedRate', window );">Unrecognized compensation forfeited rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Maximum award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000,000<span></span>
</td>
<td class="nump">$ 42,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period of unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Maximum award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period of unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Maximum award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_FairMarketValueOfCommonStockPercentage', window );">Employee purchase price as a percentage of stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee', window );">Maximum annual contribution per employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Minimum expected volatility rate inputs for fair value measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Maximum expected volatility rate inputs for fair value measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=moh_EquityIncentivePlanMember', window );">2019 EIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares issued under ESPP (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=moh_CashConvertibleSeniorNotesDue2020WarrantsMember', window );">1.125% Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ClassOfWarrantOrRightStatedInterestRate', window );">Stated percentage of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfWarrants', window );">Cash paid for partial termination of 1.125% Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ClassOfWarrantOrRightStatedInterestRate', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Common stock authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchased of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="nump">766,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchased of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="nump">$ 159,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 446,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average cost (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 208.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,000<span></span>
</td>
<td class="nump">242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchased of common stock (in shares)</a></td>
<td class="nump">577,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchased of common stock</a></td>
<td class="nump">$ 122,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average cost (USD per share)</a></td>
<td class="nump">$ 211.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_ClassOfWarrantOrRightStatedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Stated Interest Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_ClassOfWarrantOrRightStatedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_FairMarketValueOfCommonStockPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair market value of common stock, Percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_FairMarketValueOfCommonStockPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award maximum amount per employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_UnrecognizedCompensationForfeitedRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized compensation forfeited rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_UnrecognizedCompensationForfeitedRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=moh_EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=moh_EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=moh_CashConvertibleSeniorNotesDue2020WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=moh_CashConvertibleSeniorNotesDue2020WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821697584152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Components of Share-based Compensation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Pretax Charges</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Net-of-Tax Amount</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=moh_RestrictedandPerformanceStockMember', window );">RSAs, PSAs and PSUs (defined below)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Pretax Charges</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Net-of-Tax Amount</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=moh_EmployeeStockPurchasePlanandStockOptionsMember', window );">Employee stock purchase plan and stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Pretax Charges</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Net-of-Tax Amount</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=moh_RestrictedandPerformanceStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=moh_RestrictedandPerformanceStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=moh_EmployeeStockPurchasePlanandStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=moh_EmployeeStockPurchasePlanandStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821688251752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Restricted and Performance Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>RSAs and PSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested balance, beginning of period (in shares) | shares</a></td>
<td class="nump">447,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">344,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(172,675)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(34,660)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested balance, shares end of period (in shares) | shares</a></td>
<td class="nump">585,084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant&#160;Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested balance, beginning balance (USD per share) | $ / shares</a></td>
<td class="nump">$ 102.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">127.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (USD per share) | $ / shares</a></td>
<td class="nump">98.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">113.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested balance, ending balance (USD per share) | $ / shares</a></td>
<td class="nump">$ 118.07<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>RSAs and PSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested balance, beginning of period (in shares) | shares</a></td>
<td class="nump">324,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">188,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(7,368)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(33,323)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested balance, shares end of period (in shares) | shares</a></td>
<td class="nump">471,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant&#160;Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested balance, beginning balance (USD per share) | $ / shares</a></td>
<td class="nump">$ 101.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">123.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (USD per share) | $ / shares</a></td>
<td class="nump">68.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">98.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested balance, ending balance (USD per share) | $ / shares</a></td>
<td class="nump">$ 111.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602680808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Fair Value of Awards Granted and Vested (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue', window );">Fair value of restricted shares granted</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of restricted shares vested</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue', window );">Fair value of restricted shares granted</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of restricted shares vested</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue', window );">Fair value of restricted shares granted</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of restricted shares vested</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of restricted shares vested</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821688310008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance, outstanding (in shares)</a></td>
<td class="nump">405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance, outstanding (in shares)</a></td>
<td class="nump">405,000<span></span>
</td>
<td class="nump">405,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance, outstanding (usd per share)</a></td>
<td class="nump">$ 64.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance, outstanding (usd per share)</a></td>
<td class="nump">$ 64.79<span></span>
</td>
<td class="nump">$ 64.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Stock options exercisable and expected to vest (in shares)</a></td>
<td class="nump">405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Stock options exercisable and expected to vest (usd per share)</a></td>
<td class="nump">$ 64.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable (usd per share)</a></td>
<td class="nump">$ 64.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Outstanding, Weighted Average Remaining Contractual term</a></td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Weighted Average Remaining Contractual term</a></td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821606466712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Options by Exercise Price (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number (in shares) | shares</a></td>
<td class="nump">405,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=moh_ExercisePriceRange1Member', window );">$33.02</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Lower end of range (usd per share)</a></td>
<td class="nump">$ 33.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number (in shares) | shares</a></td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Life (Years)</a></td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price (usd per share)</a></td>
<td class="nump">$ 33.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=moh_ExercisePriceRange2Member', window );">$67.33</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Upper end of range (usd per share)</a></td>
<td class="nump">$ 67.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number (in shares) | shares</a></td>
<td class="nump">375,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Life (Years)</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price (usd per share)</a></td>
<td class="nump">$ 67.33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=moh_ExercisePriceRange1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=moh_ExercisePriceRange1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=moh_ExercisePriceRange2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=moh_ExercisePriceRange2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602734728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Maximum matching contribution by employer under defined contribution plan</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Expense recognized in connection with contributions</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary', window );">Deferred compensation plan deferral percentage of basic salary</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_DeferredCompensationPlanDeferralPercentageOfBonus', window );">Deferred compensation plan deferral percentage of bonus</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred compensation plan deferral percentage of basic salary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_DeferredCompensationPlanDeferralPercentageOfBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred compensation plan deferral percentage of bonus.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_DeferredCompensationPlanDeferralPercentageOfBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821605596360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SpecialAssessmentBond', window );">Performance bond</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries', window );">Net assets of subsidiaries subject to restrictions</a></td>
<td class="nump">1,960<span></span>
</td>
<td class="nump">$ 1,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance', window );">Aggregate statutory capital and surplus</a></td>
<td class="nump">2,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired', window );">Required minimum statutory capital surplus</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents, and investments</a></td>
<td class="nump">644<span></span>
</td>
<td class="nump">997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=moh_MagellanCompleteCareMember', window );">Magellan Complete Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries', window );">Net assets of subsidiaries subject to restrictions</a></td>
<td class="nump">420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance', window );">Aggregate statutory capital and surplus</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted net assets of consolidated and unconsolidated subsidiaries as of the end of the most recently completed fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e)(3)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SpecialAssessmentBond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a type of municipal bond typically used to fund a development project. Also called special assessment limited liability bond, special district bond, special purpose bond, special tax bond and community development obligation. Interest owed to lenders is paid by taxes levied on the community benefiting from the particular bond-funded project. For example, if a bond of this sort was issued to pay for sidewalks to be repaved in a certain community, an additional tax would be levied on homeowners in the area benefiting from this project.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SpecialAssessmentBond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=moh_MagellanCompleteCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=moh_MagellanCompleteCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821607867480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821600080232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Schedule of Operating Segment Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 19,423<span></span>
</td>
<td class="nump">$ 16,829<span></span>
</td>
<td class="nump">$ 18,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Margin</a></td>
<td class="nump">2,479<span></span>
</td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">2,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">9,532<span></span>
</td>
<td class="nump">6,787<span></span>
</td>
<td class="nump">7,154<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">19,415<span></span>
</td>
<td class="nump">16,815<span></span>
</td>
<td class="nump">18,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">8,359<span></span>
</td>
<td class="nump">5,265<span></span>
</td>
<td class="nump">6,165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Margin</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 1,173<span></span>
</td>
<td class="nump">$ 1,522<span></span>
</td>
<td class="nump">$ 989<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821601507320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Reconciliation of Gross Margin to Consolidated Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total margin</a></td>
<td class="nump">$ 2,479<span></span>
</td>
<td class="nump">$ 2,303<span></span>
</td>
<td class="nump">$ 2,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Add: Other operating revenues</a></td>
<td class="nump">19,423<span></span>
</td>
<td class="nump">16,829<span></span>
</td>
<td class="nump">18,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Less: Other operating expenses</a></td>
<td class="num">(18,345)<span></span>
</td>
<td class="num">(15,785)<span></span>
</td>
<td class="num">(17,759)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Less: other expenses, net</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense</a></td>
<td class="nump">961<span></span>
</td>
<td class="nump">972<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember', window );">Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Add: Other operating revenues</a></td>
<td class="nump">19,415<span></span>
</td>
<td class="nump">16,815<span></span>
</td>
<td class="nump">18,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total margin</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Add: Other operating revenues</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total margin</a></td>
<td class="nump">2,479<span></span>
</td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">2,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total margin</a></td>
<td class="nump">2,479<span></span>
</td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">2,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total margin</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Other Operating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Add: Other operating revenues</a></td>
<td class="nump">1,124<span></span>
</td>
<td class="nump">621<span></span>
</td>
<td class="nump">871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Less: Other operating expenses</a></td>
<td class="num">$ (2,525)<span></span>
</td>
<td class="num">$ (1,880)<span></span>
</td>
<td class="num">$ (2,258)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=moh_HealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603801160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant - Condensed Balance Sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,154<span></span>
</td>
<td class="nump">$ 2,452<span></span>
</td>
<td class="nump">$ 2,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investments</a></td>
<td class="nump">1,875<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">1,672<span></span>
</td>
<td class="nump">1,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">7,876<span></span>
</td>
<td class="nump">5,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, equipment, and capitalized software, net</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and intangible assets, net</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">9,532<span></span>
</td>
<td class="nump">6,787<span></span>
</td>
<td class="nump">7,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable, accrued liabilities and other</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,965<span></span>
</td>
<td class="nump">3,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">2,127<span></span>
</td>
<td class="nump">1,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">7,436<span></span>
</td>
<td class="nump">4,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.001 par value; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,860<span></span>
</td>
<td class="nump">1,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">2,096<span></span>
</td>
<td class="nump">1,960<span></span>
</td>
<td class="nump">$ 1,647<span></span>
</td>
<td class="nump">$ 1,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">9,532<span></span>
</td>
<td class="nump">6,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investments</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent', window );">Due from affiliates</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">825<span></span>
</td>
<td class="nump">1,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, equipment, and capitalized software, net</a></td>
<td class="nump">339<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and intangible assets, net</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in subsidiaries</a></td>
<td class="nump">3,228<span></span>
</td>
<td class="nump">2,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_AdvancesToRelatedPartiesAndOtherAssets', window );">Advances to related parties and other assets</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">4,849<span></span>
</td>
<td class="nump">3,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable, accrued liabilities and other</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">2,127<span></span>
</td>
<td class="nump">1,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,753<span></span>
</td>
<td class="nump">1,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.001 par value; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,860<span></span>
</td>
<td class="nump">1,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">2,096<span></span>
</td>
<td class="nump">1,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 4,849<span></span>
</td>
<td class="nump">$ 3,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_AdvancesToRelatedPartiesAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advances to related parties and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_AdvancesToRelatedPartiesAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date within one year where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821603394168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant - Condensed Balance Sheets - Additional Information (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">59,000,000<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821600247752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant - Condensed Statements of Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Investment income and other revenue</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">19,423<span></span>
</td>
<td class="nump">16,829<span></span>
</td>
<td class="nump">18,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
<td class="nump">1,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">18,345<span></span>
</td>
<td class="nump">15,785<span></span>
</td>
<td class="nump">17,759<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses (income), net</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Total other expenses, net</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">673<span></span>
</td>
<td class="nump">737<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAgencyManagementFee', window );">Administrative services fees</a></td>
<td class="nump">1,208<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">1,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Investment income and other revenue</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">1,221<span></span>
</td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">1,089<span></span>
</td>
<td class="nump">937<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Other operating expenses, net</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,180<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="nump">1,082<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses (income), net</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries', window );">Loss before income tax (benefit) expense and equity in net earnings of subsidiaries</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest', window );">Net loss before equity in net earnings of subsidiaries</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromSubsidiariesNetOfTax', window );">Equity in net earnings of subsidiaries</a></td>
<td class="nump">744<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="nump">751<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 673<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="nump">$ 707<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) Before Income Taxes And Equity In Net Income Of Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) From Continuing Operations Before Equity Method Investments, Extraordinary Items, Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromSubsidiariesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) of subsidiary attributable to the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromSubsidiariesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAgencyManagementFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fees earned during the period for providing management services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAgencyManagementFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4,6)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821601784296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant - Condensed Statements of Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 673<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="nump">$ 707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfOtherComprehensiveIncomeAbstract', window );"><strong>Statement of Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Unrealized investment income (loss)</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Less: effect of income taxes</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">706<span></span>
</td>
<td class="nump">749<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">673<span></span>
</td>
<td class="nump">737<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfOtherComprehensiveIncomeAbstract', window );"><strong>Statement of Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Unrealized investment income (loss)</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Less: effect of income taxes</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 706<span></span>
</td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">$ 705<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821604746008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">$ 1,890<span></span>
</td>
<td class="nump">$ 427<span></span>
</td>
<td class="num">$ (314)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of investments</a></td>
<td class="num">(670)<span></span>
</td>
<td class="num">(2,536)<span></span>
</td>
<td class="num">(1,444)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">1,097<span></span>
</td>
<td class="nump">2,302<span></span>
</td>
<td class="nump">2,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates', window );">Net cash received from sale of subsidiaries</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(400)<span></span>
</td>
<td class="num">(293)<span></span>
</td>
<td class="nump">1,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from senior notes offerings, net of issuance costs</a></td>
<td class="nump">1,429<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock purchases</a></td>
<td class="num">(606)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayment of term loan facility</a></td>
<td class="num">(600)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from borrowings under term loan facility</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayment of senior notes</a></td>
<td class="num">(338)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfWarrants', window );">Cash paid for partial termination of warrants</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(514)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_CashPaidForSettlementOfConversionOption', window );">Cash paid for partial settlement of conversion option</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(578)<span></span>
</td>
<td class="num">(623)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Cash received for partial settlement of call option</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="nump">623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayment of principal amount of convertible notes</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(240)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">225<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="num">(1,193)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents</a></td>
<td class="nump">1,715<span></span>
</td>
<td class="num">(418)<span></span>
</td>
<td class="num">(364)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period</a></td>
<td class="nump">2,508<span></span>
</td>
<td class="nump">2,926<span></span>
</td>
<td class="nump">3,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, and restricted cash and cash equivalents at end of period</a></td>
<td class="nump">4,223<span></span>
</td>
<td class="nump">2,508<span></span>
</td>
<td class="nump">2,926<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries', window );">Capital contributions to subsidiaries</a></td>
<td class="num">(107)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDividendsReceived', window );">Dividends received from subsidiaries</a></td>
<td class="nump">635<span></span>
</td>
<td class="nump">1,373<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of investments</a></td>
<td class="num">(188)<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="num">(136)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">282<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Net cash paid in business combinations</a></td>
<td class="num">(1,028)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates', window );">Net cash received from sale of subsidiaries</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_ChangesInAmountsDueToAndDueFromAffiliates', window );">Change in amounts due to/from affiliates</a></td>
<td class="num">(68)<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(545)<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
<td class="nump">631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from senior notes offerings, net of issuance costs</a></td>
<td class="nump">1,429<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock purchases</a></td>
<td class="num">(606)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayment of term loan facility</a></td>
<td class="num">(600)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from borrowings under term loan facility</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayment of senior notes</a></td>
<td class="num">(338)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfWarrants', window );">Cash paid for partial termination of warrants</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(514)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_moh_CashPaidForSettlementOfConversionOption', window );">Cash paid for partial settlement of conversion option</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(578)<span></span>
</td>
<td class="num">(623)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Cash received for partial settlement of call option</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="nump">623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayment of principal amount of convertible notes</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(240)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">225<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="num">(1,192)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents</a></td>
<td class="num">(261)<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="num">(443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period</a></td>
<td class="nump">836<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, and restricted cash and cash equivalents at end of period</a></td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">$ 836<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_CashPaidForSettlementOfConversionOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Paid For Settlement Of Conversion Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_CashPaidForSettlementOfConversionOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_moh_ChangesInAmountsDueToAndDueFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes in amounts due to and due from affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">moh_ChangesInAmountsDueToAndDueFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>moh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of noncontrolling interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends received on equity and other investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3337-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139821602753256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant - Notes to Condensed Financial Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Services revenue from subsidiaries</a></td>
<td class="nump">$ 1,208<span></span>
</td>
<td class="nump">$ 1,038<span></span>
</td>
<td class="nump">$ 1,137<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>123
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MH+%)'QWLP_D5&EB\ZT3GY>.VEMY]2VK$DOK%\I1<&T&D?D'TYMK501+9$S@
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M$F7[=<W3C-<-0/_^)(0Z7#0=]"?8E_\!4$L#!!0    ( *=(4%(9MS<I_P(
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M\^+<+@:2;<U)MF92G8OF-5-7'> :H/Y/&9/'@0Y079YF_P!02P,$%     @
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MA-7NU>#0!TNA'2 4C1647D6@7T9.1?HHH4Z>MC)$66(1M5$A2D:8HEY D%]
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MU6RDDH>]((9^03P42#E:A)P7/@Z)#*QSIP,%LV1DM8:]1(9^B;0J>K.S_F<
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M"/I^29GPTL2M356:R-IP)F"JB*[+DJJ_]\#E>NR%WNO"$UL6QB[X:5+1)<S
M?*^F"F=^JY*S$H1F4A %B[%W%]Y.1M;>&?Q@L-9;8V(SF4OY;"=?\[$76"#@
MD!FK0/&R@@EP;H40X\]&TVM#6L?M\:OZH\L=<YE3#1/)?[+<%&-OZ)$<%K3F
MYDFNO\ FG]CJ99)K]T_6C6T\\$A6:R/+C3,2E$PT5_JRJ<.60]@[XA!M'*)+
M';H;AZY+M"%S:3U00]-$R351UAK5[,#5QGEC-DS8IS@S"N\R]#/I1 HM.<NI
M@9S<4TY%!F1FY32YFE(%PA1@6$;Y-?E,/A&?Z )7=>(;C&XU_&P3Z;Z)%!V)
M] !9AW3#&Q(%47# ?7*Q>SC:=?<QYS;QJ$T\<GK=(WHS@REC.QHB%^21"4R<
M44ZF4C/77[_NYMHH[++?)X)UVV!=%ZQWM,IEB9KX-+/G&U)115:4UT"N<LDY
M59I4H)K"7A\J;",>!D[=[LM5&G2"($S\U78!SYKML/=:]MX[V)NG3VAM"JG8
M/\@/\3:"_2V., Z:WQOD2RQWJ..6.GXW]0W!UY@V5.1,+ ]QQWLT\>@@]KYA
M/SI%W6^I^R>II_@. Z5P*WZT5?J7M<I9LQW\08L_>!_^1=TRV"MF=+A9+C#<
MP1ZVV,,/83.MZ\/(PSV2MZRG+'8@1RWDZ$.09UIZ=);TE$5#ZF\=+_9H_T;5
MD@E-."S0)^@,<#NHYKAL)D96[L292X/GEQL6^(4!RAK@_864YG5B#['VFR7]
M#U!+ P04    " "G2%!2(<.W3]$%  "='0  &    'AL+W=O<FMS:&5E=',O
M<VAE970V+GAM;,6976_;-A2&_PIA%%@#U+5(?1>.@<9QZ@#M%B3M=C'L@I$8
M6Z@DNB(=I_]^I*Q:%DG1=I-NN8@E^SV'+RD>/J(TWM#J*UL2PL%3D9?L?+#D
M?/5N-&+)DA28O:4K4HI?'FA58"Y.J\6(K2J"TSJHR$?(<8)1@;-R,!G7W]U4
MDS%=\SPKR4T%V+HH</7]@N1T<SZ @Q]?W&:+)9=?C";C%5Z0.\*_K&XJ<3;:
M94FS@I0LHR6HR,/YX#U\=^VZ,J!6_)F1#=L[!K(K]Y1^E2?7Z?G D8Y(3A(N
M4V#Q\4BF),]E)N'C6Y-TL&M3!NX?_\A^57=>=.8>,S*E^5]9RI?G@V@ 4O*
MUSF_I9LY:3KDRWP)S5G]'VRVVA -0+)FG!9-L'!09.7V$S\U [$7 -V> -0$
M("7 #7L"W"; /;8%KPGPE #4UX+?!/A*@!?T! 1-0* $1$Y/0-@$A&H?HIZ
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MM\/[E,.77N[U&X9;V?>RUA\?> Z=I0#P_SL).=/QB[K!Z:W6V_\!4$L#!!0
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M?D,*BJXR75*!^F+C\2.!<+V)3>4P(F^*T'$P8N#A"I3W4N,<\(.S#6WS ^M
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MW5@'X1E0$9DITX);JPZ$!$5#O'/+\(61R R:/6T@(((R1[(WCT(3"<!U@&S
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M]YA IF2;Z,H[R$CRY)&SS>0;11K4CEB-)D6H;7YCFI#K1=TF\NFRPH>WB=,
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M$"5# %68H+N3*;,*.CEBNWH4"4^#:DRJ+ZH7C*>PK.B^_*!Z+F/']CO@]=W
M+:X7-@6",%O)WJ:( M@HE+& ><P;DXEX8V@WVL(=Y\L# R^YM:$:_2?JR'X"
M_XM7Y=S##=XC1BX*@8>JE-%6!,Q!*4/5$3Y$+HA PQL/&$V:"?Q7(^FRKH;
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MC?^T$B^A#ZG$?M"@&^5<$T%>+JGA5--'L\$C;AW""Y+>T]V7BJ8R"KBRO4.
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M0@@5)'3MQ;4W3<BS_OXV[IIT'8>B8#Q'U7U0_:=V;6K-7:*0.A<DK= IBK8
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MOT>5$ABGWA7,# 3%RL\M63'I"TT3XA@B\O!5$?YU7=$[Q$KGLR_US81<$'+
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M8^,%L+[4B%_WX@WT ^/%?U!+ P04    " "G2%!2:MNT&0(,  "G(   &0
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M#@*MZU89,G!C2K#A9M1 ./M5EYW [ "M05(F?'.E#H@CZ5*<P*: EU+,6)0
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MEH0+WRT#7]6/=+YAFWR*QFU=7AWEQ&G_:,6X9$8P.'OD![4GUQ9<6G:5$(V
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M3X*FLMW&JLJ/'T1C&F;\LJ#I$;43H/NM(@ZV&P?0SZ.+?P!02P,$%     @
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M?[^#C!>58_/()MH%,"RM69P"0RM6[E*,!^,,(4*VW"M,(H,X7'UA4*BPH#(
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M)^-Q;<_@\&EL('Y!"DLT#B?G?QRMTT-H;?OMZ N>>-AGYJ[HM'M?1YPG9(\
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M2R5!2S0!XW,+L],-;=!\)KWY'U!+ P04    " "G2%!2GW\/M# *  "I&0
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M&T!:1%YB,CX3>7XB\O,9-%DHO"VW @;9Y$B<B &ND?/@[$B<\G/+.L.BHTY
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M<PH?9K/S-@&/$U3-U5(S5FI'A(R\DY/A\R)3S?Z8T).'(EF82J*ROQ#U!E$
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M7OCOD?OA_JON#]*L4<-$J5:8&D?3\1&<PU]*_8W36_XZN=#.Z8I_;I1$6M$
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M%;MFLU<LM:X7XWY"MHD"N+?$<AJ'-;]?Z((![U?6TC@) :87<?,'4$L#!!0
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MF]I $1(@C;F% J"YNJ/D>6H9% TN%KKKC;:N#RTR<Q(S/."<&5,*D4^3_H>
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M9A/<AFK1=O=L>([,+_C@&KQ73-6H)1SH-X8A(W<YTO#"D 7JI=EDEY&'F8\
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MHT8G4LXL:+JE<A7#0IINUF%0453'!URXR<NV+Y*C53*_EVOM5X9TU<3.G6/
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M_[SI6&V"]* :$;%L&UHHD*,J_X'/@Y5#6>^V/D>E: NX9YV_P0*17V$"^">
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MO?2Y0^<+(QF ?/%A]'(#S[6V5%L,:PZ&/"8R] #BIV,#L;BBA))EL'T@'AY
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MD1XFH>*5II56A/S@C9R7ZSZ?%1A5YLAA4"?H<M%H(9MA^)P7'&4Y5R8_7.W
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;.U8>V_;-A#_*@>O&UI
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M]EX*%_R:\[)4/H#>*_\!IDJ=TSB)3FF<1@F-3J,!?0G;E?-C\0W6ETRJ#KY
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M0M$5C74TH1\E).>2*DA!Y5=%W:L-Y/#@Y8%:%$ME\N>W1M'!XN.O.68,\=R
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M3&]200N5@4JR6)+U^5H32OXC2)4:1:,U+))L9)8;4@NR4$ZXA88L$AGC+3E
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M4<?5Y6$K7EW!+KE>NA-*)A90[7<C[&&ZNM94'U:M_%5BKBPN)OXUQ4U0:">
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M_DCO_%@<6Q&I%,_UBDWY90=K37/UP#O#.VE8"7K)%#]]V1D4&JME)97! 86
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M+W=O<FMS:&5E=',O<VAE970T,"YX;6RU6&UOXC@0_BL6VI5VI543.[Q6%*E
MJUWI>D6+]N[#Z3X8,H"U29RS36E/]^-WG(0DT&!03_T"L3/S^)GQ^+&=X4ZJ
MGWH#8,AS'"7ZIK4Q)KWV/+W<0,SUE4PAP3<KJ6)NL*G6GDX5\#!SBB./^7[7
MB[E(6J-AUC=3HZ'<FD@D,%-$;^.8JY<Q1')WTZ*M?<=WL=X8V^&-ABE?PQS,
MCW2FL.65**&((=%")D3!ZJ9U2Z_O6=LZ9!9_"-CIVC.QH2RD_&D;W\*;EF\9
M001+8R$X_CW!!*+((B&/?PK05CFF=:P_[]'OL^ QF 77,)'1GR(TFYM6OT5"
M6/%M9+[+W5<H NI8O*6,=/9+=H6MWR++K38R+IR102R2_)\_%XFH.03LA ,K
M'-B1 Z,G'(+"(3@>87#"H5TXM"\=H5,X="YUZ!8.W2SW>;*R3$^YX:.ADCNB
MK#6BV8=LNC)O3+!(;&7-C<*W OW,Z%&M>2+^Y?DT)R$9<RTTD2LR4Z A,?F;
M3U,P7$3Z,XDA7H B(B$/(HKPG?Y"/M2;0\\@+XON+0L.XYP#.\&!D@>9F(TF
M=TD(88/_](P_<P!XF) R*VR?E3%S(DYA>44"^H4PG_D_YE/RZ</G/'"-"8$&
MBA,WX!Q2!/0/ )L"?2NM.:QQN9M3[.XNQJ6#T^SN+T?I-Z(<S$505FB0P08G
M8/."?#PJR+]^0S/RS4"L_W8,TBX':6>#M$\,\OLVJVHL>P6I5(8O(B"Z2"KY
MCQ3Y;9JR'+B; 5L=?QJQH??4P*53<NE<R"6;3DUP_R"XE2ALA&0#/#(;DD8\
ML<1.S?BX\XH6[92\<N9.DP/JW9)ZUTT=M\(EUTB/B]"*PF*KT41KLI3Q0B39
MW#4IQ#3'[=6X]#I'?.]>V_B'%O<NBX. >F5 /6= 7_-LSVRV'676+^'Z[U?+
M@W*0P:7U ^H)2Z90+JR6_*FI7 :O:J%]5"TNBP.>U*_V'O]"IGN*$(FUL&O/
MUKS9P+[<EUP!295<*Q[CAL-3?'X6>+" Z,495\%@4"^)*W84VAFCP^AJ.RN]
MN':0XX-(1+R-'1-,607-WJ^.:*6\-'!&,,%=5>'9CQA0<>.^[/8/R MPY5HX
MM!)HZE;HXVSRYW/9K/26=MXQFY4V4K<XGL^FV[]S/IN5K%&WKCW@K2'"5)*)
MC-,(#) )KC 7="5Q]!TUCE8B1R]6N?^Q2]+7JD;[Q^K@M#D\7U;2Q]S2][A+
M4.\V(B5(>6G3M&XD> :&^OZ5[W]L/$J^P?,PF$KIF%OIWKSMCPO@^HY-_:!W
M(KN5/C+F)'2[6J':FA=24PU7I)4BLG<\C+)*[-B9X^A;$SHI@.L)#?K'AR"O
M=E^,0:VSF[W%WB8F/YB7O>77@]OLSGS4/Z;7$]K0/Z77]_FW@0H^_U3QP-5:
MX)J,8(5#^5<]E&:5W_[SAI%I=EM=2(-WW^P1%W,(RAK@^Y649M^P Y3?8$:_
M %!+ P04    " "G2%!2X"7A?+,"  #0!P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6R55=]OFS 0_E<LM(=6Z@H82),J06J33-M#I:A9MX=I#PZ8
M8-78J>TDW7^_LZ&,)J3*7O /ON_NOCO;-]Y+]:Q+2@UZK;C0$Z\T9G/K^SHK
M:47TM=Q0 7\*J2IB8*G6OMXH2G)'JKB/@V#@5X0)+QV[O85*QW)K.!-TH9#>
M5A51?^XIE_N)%WIO&X]L71J[X:?C#5G3)35/FX6"E=]:R5E%A692($6+B7<7
MWLX3BW> 'XSN=6>.K)*5E,]V\2V?>($-B'*:&6N!P+"C4\JY-01AO#0VO=:E
M)7;G;]:_..V@944TG4K^D^6FG'A##^6T(%MN'N7^*VWTN  SR;7[HGV##3R4
M;;6154.&""HFZI&\-GGH$,+X! $W!'PN(6H(T;F$N"'$YQ*2AN"D^[5VE[@9
M,20=*[E'RJ+!FIVX[#LVY(L)>TZ61L%?!CR3+ME:L()E1!ATEV5R*PP3:[20
MG&6,:O0938DNK]P7S5^V;$<X%49?(2)R]$BU42PS-*\!%S-J"./Z$GA/RQFZ
M^'2)/B$FT /C',Z%'OL&@K:N_:P)\+X.$)\(<$:S:Q2%5P@'..BA3\^FAZ,>
M^NQ\^K"'/C^??O.>[D.AVFKAMEK8V8M.V.NKT*^[%10!+MSO#QQ$K8/(.8A/
M.'!5M)7-[(3^JW=?X6I3-\Z4?8]V:1PF\=C?=<MS#,)Q@M^#9CV@(1ZTH'=2
MXE9*_*&4SMG,_D=5;770B64P.M!T#$D&!XJ.(6$0] M*6D')AX*^2T/X:2WU
MC51GJ$;0431,  -7TY0497 UX3SEQ.YI T/E@+*HR06TD]YD)<=' ./H(%W'
M()P$PX.$]8!&^""K\V-0A$>':?4[KZ'M=0]$K9G0B-,":,'U#5A1=?^H%T9N
MW .YD@:>6S<MH>5290'POY#2O"WLF]LV\?0O4$L#!!0    ( *=(4%+<7B]1
MQ@4  #<;   9    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;+U976_;-A3]
M*X31 2W0QA(IRT[A!$@MI_4P(T:\= _#'AB)MME(E$M23@/LQX^4%-&6)<K9
MUKPDDGS/_>+5N5?D^#'E#V)#B 0_DIB)B]Y&RNW'?E^$&Y)@<99N"5._K%*>
M8*EN^;HOMIS@* <E<1\ZCM]/,&6]RW'^;,$OQVDF8\K(@@.1)0GF3Y](G#Y>
M]-S>\X-;NMY(_:!_.=[B-5D2>;==<'77K[1$-"%,T)0!3E87O2OWXV<O!^02
M7REY%'O70(=RGZ8/^F867?0<[1&)22BU"JS^[<B$Q+'6I/SX7BKM538U</_Z
M6?MU'KP*YAX+,DGC/V@D-Q>]40]$9(6S6-ZFCU](&=! ZPO36.1_P6,IZ_1
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M>?%^U-02%840-5%[-01-#<&OU !6M$@I5WKQLY7CYH*>-_2\/VSJ^EW@]#>
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M'V/"%HQ?8HX6'A0+#YQ6" GC>C-UV6%4J!LY[?"<;0.=AZ7"+*)L"[ ":D?
MBFPI8V: ;^S G@C*(W"I]TBV>:[:(C*;;EHU'>Q/:W9I :$^/ ;=-T'!M#]H
MM]ZXH#MV6N_59E\2W>!W'4M; EB:K'3RT!0_$X*4*8E<IIT4<TW<IE5\_0;V
MJ5CO=#F0'89;9,I&%;HW]9!K0OR:85V((Q+3@L2TF\2-J6<1T+M%%WF);9GL
M8#-M.,^O.WAY!B9LPZ!V2M O"X?O)'7_H5W"M/>UV]><Z5!0=!43( FC7 #&
M5;>[\BD<SEAV0\(<4N4'^\,3_"J%$3KY+2TGVQ#]'X:PFV$G),PAYWD0E0R1
MDV$E"P+=<IJ&BZX!*Y*Z2589MTZ6J$$AF-9IHK9\A>I,6U"P$M#'5,NJ!]UE
M[WZST9VI<61$X]3TIMJ+ZU1018ETY2E8UD+H+H:V"'QAD^=JCWW;,%X;:%2W
M71OH1*Z'9:F$@9/7*Q8",]4=Z4%WI ?.C9JS:(*&_<D)%F6%ANX2O?SJ_AUU
ML^J$A+!9AOV3&:HLPW#\G_:O#6T=?5_:P>.V1J$1ADW4:-C<PRVH43^85O].
M<"_; CAQ][$M')W[N*S5T%VL%S8+&G-%/(ZQD.4$[9;+U$VJ0=V(ZF4[:A+4
M3=<*"TZTNZ@LULA=K,,\-,ZGE2NLK035NZEVV+#>P[?!= ([D==16:31.46Z
MN:U=Q\:R/B+D+AI8F-9=EB?C:V"CXQJL?H(E3Q*=W9<QEOK4J\_0<6H[_S\.
M/!L$CT3M=*__UW>M%SPHDLB_7>LJBQD:=+23V/B2,D7T=E9 G^=:#V =:F!_
MA()?VE;D5>X3]'%Q:R]RI*YJ*5/9N;L8+2Z+OMDKDMKX MZ&V95/J2:[@7K$
M0I^,)(C)1JOT^V.=]45VJ9.]*+ZWMQ8KKA1/[...X(@( ]#?-US[.7\Q$Q17
M:_-_ 5!+ P04    " "G2%!2 71;?<H%  #W&@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970T-RYX;6R]6?MOVS80_E<(HP-:H(LETO*C< S4=IUD6#LC:3<,
MPS#0,F-QI425I.($V!\_4E;TL"1:Z>#]DNAQ]]V#=_>1\G3/Q5<9$*+ 8\@B
M>=D+E(K?]?O2#TB(Y06/2:3?W',18J5OQ:XO8T'P-E4*61\ZSK ?8AKU9M/T
MV5K,ICQ1C$9D+8!,PA"+ISEA?'_9<WO/#V[I+E#F07\VC?&.W!'U)5X+?=?/
M4;8T))&D/ *"W%_VWKOO;M# **02OU*REZ5K8$+9</[5W-QL+WN.\8@PXBL#
M@?6_![(@C!DD[<>W#+27VS2*Y>MG]%4:O YF@R59</8;W:K@LC?N@2VYQPE3
MMWQ_3;* /(/G<R;3OV"?R3H]X"=2\3!3UAZ$-#K\QX]9(DH*<-2B #,%>*2
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M3+"4!647X/Q>2O/2L=5571PO_P%02P,$%     @ ITA04MEB #C@ P  910
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M'M?P69/;(H=[K>G%),1&HF*W[A'0;C]"VN\9'K<"Q!2T"\[8F(= +GQ1=.'
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M=7E%^Z^,IKB\(OD$9=ZQ\SL&01!VNQ]L!+VMM/@V+ZHG<2\_NX^77X1;M"(
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M S8I2+;-523;I"39GJ(F>;%;5J.(!VQ2;FQK2>3QZ1^P2?VQ;:X V285R/9
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M;1G<^P>%?UZ/VPD<HL'8V];SU&(T(K R.I!&*FG$*>T+9T* ITR!(2D4?E%
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MFBS5-4JAX-8P6U<5-\\CD'H]"*)@:[@3BQ*=(<S2)5_ %/!^>6MH%[8LA:A
M6:$5,S ?!,/H<IPX?^_P3<#:[JR9RV2F]8/;7!>#H.,$@80<'0.GSPK&(*4C
M(AF/&\Z@#>F N^LM^R>?.^4RXQ;&6GX7!9:#X$/ "ICS6N*=7G^!33Y]QY=K
M:?TO6S>^?7+.:XNZVH!)0254\^5/FSKL *+D "#> .+7@-X!0'<#Z/I$&V4^
MK0E'GJ5&KYEQWL3F%KXV'DW9".5N<8J&3@7A,+M6*[!(UX*6O6=?N3'<U96=
M3 "YD/:4K/?3"3MY=\K>,:'8C9"2ZF_3$"F\(PGS3:A1$RH^$"J*V8U66%IV
MI0HH7A*$I+L5'V_%C^*CC!/(SUDW.F-Q)^[L$33^9WCT\8B<;EO+KN?K_KV6
M9VP",V1<%>SJL1;XS*:0UT:@ ,M^#&<6#3W@GT>"]MJ@/1^T=R#H9Z.MI7[B
M4OR"@FYHJX$MJ(?W7E-#>.$)79>OLB0-5[MU>^L1=5N7%S+[K<S^49G#2AOT
M"L?:(I6G!O>:M +V#-PP;9@$NU=N0YR\$-/;KR9IU23_K::5@J71]:)D<]<'
MSK)75?*F1/$K3>%.5U9@%GY869;K6F'SQEMK.P^'?@R\LH]H3C9C[0]-,V1O
MN%G0)5/IYD39.;^@6IEF<#4;U$O?^S.--$G\LJ19#\8YT/E<:]QN7(#VWR/[
M#5!+ P04    " "G2%!2.6@"?0L#  !3"P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970U-RYX;6R]5E%/XD 0_BN;Q@=-U'9;H&" 1.',F>B%R.D]7.YA*0-L
MW':YW07T<C_^9ELL2$LU.?4%NMN9;[Z=?OTZ[954#WH&8,AC+!+=<6;&S,]<
M5T<SB)D^E7-(\,Y$JI@97*JIJ^<*V#A-BH7K>U[#C1E/G&X[W1NH;ELNC. )
M#!31BSAFZND"A%QU'.H\;]SRZ<S8#;?;GK,I#,'<S0<*5VZ.,N8Q))K+A"B8
M=)QS>M:C=9N01MQS6.FM:V*/,I+RP2ZNQAW'LXQ 0&0L!,._)?1 "(N$/'ZO
M09V\IDW<OGY&OTP/CX<9,0T]*7[PL9EUG*9#QC!A"V%NY>HKK ^4$HRDT.DO
M666Q]= AT4(;&:^3D4',D^R?/:X;L97@M_8D^.L$_ZT)P3HA2 ^:,4N/U6>&
M==M*KHBRT8AF+]+>I-EX&I[8QS@T"N]RS#/=JV0)VN!S,9J<D/,EXX*-!)R@
M0$Z&3  Y[(/!37U$#@A/R T7 MNOVZ[!ZA;#C=:5+K)*_IY*?8A.24"/B>_Y
MWMVP3PX/CC1$"\7-4PE:[\UHM%6)YF)'\K;X>5O\%#[8"S\R9)CA<=#'.YW1
MMC,_KS&)7!F(]:^*DD%>,DA+UO:4_*(-1UG"F%PRKL@]$PLHZW*&$J8H]B5=
M=L.P[2ZW6U<,"1KU/.8%NUK.KE;)[BY!DQ#\#]*[EEI#J0!JA;ITAUDQPB_G
M5<]YU2MY?9>&"?)M$8] $3DA ZFY]0=-_I(*=5UDJ(UM(KM<2T*"5CG;1LZV
M4<GV1BHS17<\&;'H 5NI<X55""C,P<//TFPS+]E\%\TV7]=L,836@O)NMW)V
MK?_7;.M5S59%O.!%O8WI>A^BVC5LI6Q+8L(]+QG=^DK02L(]J>92X9/&3R2J
M[$VZI1NSI9_FMG1CM_1]_)86W=3;;7DQQ/?W]7SCN/0=+)<6';7 KLJ67W+;
MN"[]&-NE15,MT"V&T$:X0]C=FGCLN'G#U)1C=0$3S/).0P11V027+8R<IT/0
M2!H<J=++&4Z]H&P WI](:9X7=J[*Y^CN/U!+ P04    " "G2%!2S:/X%A@#
M   ##0  &0   'AL+W=O<FMS:&5E=',O<VAE970U."YX;6R]EUU/VS 4AO^*
M%>T"I$%B]QNUE481 FD=B(I-T[0+DYPV%D[<V6X+_WZV&Y+TR^*BZDT;)^>\
M/N>)\\;IKX1\52F 1F\9S]4@2+6>7X6ABE/(J+H4<\C-E:F0&=5F*&>AFDN@
MB4O*>$BBJ!UFE.7!L._./<IA7RPT9SD\2J0664;E^S5PL1H$./@X\<1FJ;8G
MPF%_3F<P ?T\?Y1F%)8J"<L@5TSD2,)T$'S#5R/B$ES$3P8K53M&MI47(5[M
MX#X9!)&M"#C$VDI0\[>$$7!NE4P=_PK1H)S3)M://]1O7?.FF1>J8"3X+Y;H
M=!!T Y3 E"ZX?A*K.R@::EF]6'#E?M&JB(T"%"^4%EF1;"K(6+[^IV\%B%H"
M;AY(($4"^6Q"HTAHN$;7E;FV;JBFP[X4*R1MM%&S!XZ-RS;=L-S>QHF6YBHS
M>7IXGR]!:7-?M$(7Z)IRFL>@D)BB)W->LEA#@NI!9S>@*>/JW(0_3V[0V9=S
M] 6Q'(T9Y^;&J'ZH35U6/8R+&J[7-9 #-=Q ?(D:^"LB$8GVI(\^G8Y[F^FA
MH5$B(242XO0:!_0FYE%)%APLA#O@R846%V:]+"33[V@"L3U@AM&?[R81W6O(
MU%_/M(URVH:;MGE@VAIO5O'>1W.MTW$Z]C%=#G&CW0^7=62[,9U>&;)17[.L
MK^FM;VR>:FZ6!QJ);,Y! QI1"9[&6Z5PZY2\V^6T[2/Q7NNT:RR;O2W<NR'1
M?MJ=LKJ.M[I;+B1+J*?/;JG4/27>7CEM[TAX>SOL,-G"ZPW9* ]'E?%%W@)_
MF%?,&-Y8+#S=XIJ/XE-BQI5;87(DT(50'2/!6Z3],9LE5LZ&_=9F4?\V;W-?
MOY4-X>9)05<VA5O' MW:7:_-;="[,0<,&E>.AOV6]I R[V*NS =W3LJX\BK<
M/1;C[B[C[9?@OIA#OE'Y&O8;VX-.0?JV&94#D>B4E$GE500?B7(A5-]'D.V5
MO"^FM44YK.U0[>?!F,H9RQ7B,#5)T67'/ URO>->#[28NTWKB]!F"^P.4_.5
M M(&F.M3(?3'P.Z#R^^>X7]02P,$%     @ ITA04GC9\L(@ P  _@T  !D
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M0$/M%[CGA5)V-_ )VB/?["=02P,$%     @ ITA04L6+)K70 P  8@\  !D
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M]).VQWDU4S>CCU3N&%=XK',T&5S/\%J4=7]7#[0XV(YG*S3V3_9SCSTQ2 /
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M=)5-T5.*!>K<O[(+C?1F^^F:VC 8%T#?4ZUQMW '5(T]_@=02P,$%     @
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MGCVAI^U"LY0U W6J\5 V<?P?6KO+>KKOH -],S3371T=/M0^W%W\IDSG4D,
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M_C/%W,X=8UX$ET2L:"$1@Z7&><=#O6M%<\DV'<7+^MI9<*4OL;JYU@\3$,9
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M K1B:[I/]2=Q^,".'1I;O42DJOA%A[)M# %*]DJ+[!AL,LAX7C[IC^- G 0
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MR?+6JJQHL2MNBNZ%UB(KBEM&5TS:!N;[6ACZ'"OV\JFZ.US^#U!+ P04
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M0TS83+%?4NRWUZR)3K]6#011>,2G'@01/L$H+!F%3D93SIZI4/%"NT FZ5\
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MR385;W3_"\J$NDIO05.N?]&^P/9"!RVV7-"L)$L'69(7_^103L09P6\BX)*
M34*G@1"4A.!:0J<D=/3,%*GH>8B((.,AHWO$%%JJJ0\]F9HMTT]RM>YSP>1H
M(GEB_)(O: ;HG1R HWLT8W27Z#656PI=#-Y&($B2\CL)^YA'Z/;F#MV@)$>O
M29I*!A^Z0AI2LNZB##XI@N.&X#Y&KS07:XY^YC'$EP*NS*1*!Q_3F>!6Q0@6
M#RCP?R#L8<]B:'HUW1]8Z-'U]'Y+-D&U.('6"QKTIEO&(!>/+5*=2JJCI3H-
M4L\0 R.I;8T*8D\3U36Q&^.^/W1WY]-FP7B=2TQDP?1PA;EPW:U<=UM=SP41
M8/-<T,+S6*%AN0[QL>'8 NG;#8>5X;!]FBF3-TUNLQS6@GF&XSIB8!BN(QK\
M]BJ_O5:_[U205-XS>I_97/=J$0.O9_BN8S#N&LXMF$&#]W[EO=]Z.B)8@O0=
MMQV/0:4U^.[Q&-2<W_N!,0-UC)F_126PI^][IZO;^][I*'D7T<Q%LV",$Q39
M9)I,G[TW_G=/2,F\.(^FZSKDWC=MUS%>@VM\<HVO."=QN>.LYK'%V<"T7P?Y
MGFG?(A0V^#\])'[0ZK]\R04Y(#C(FI';]TU@>0KZ9@X64&!N=QMH8#X&[EG9
MD@%;Z?*/HP7=YJ)X\JO>JL1\TH65T3]1I:<NATXR1=WZ2M@JR3E*82DEO8>>
MO/)940H6#4$WNCCZI$*66OIS+<MG8 H@QY>4BF-#!:@*\O%_4$L#!!0    (
M *=(4%+R)-2;5 ,  #H,   9    >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM
M;)U7VV[;, S]%<'#AA;H?$N:I%L2H(U7K _=BG27AV$/BD/'0F4KDY2F^_M1
MLNM>9LO=7F))]CDD#R6*F>Z%O%$Y@"9W!2_5S,NUWKX+ I7F4%#EBRV4^"83
MLJ :IW(3J*T$NK:@@@=Q&(Z"@K+2FT_MVI6<3\5.<U;"E21J5Q14_CX#+O8S
M+_+N%Y9LDVNS$,RG6[J!:]!?MU<29T'#LF8%E(J)DDC(9MYI]"Z)0@.P7WQC
ML%>/QL2$LA+BQDPNUC,O-!X!AU0;"HJ/6U@ YX8)_?A5DWJ-30-\/+YG/[?!
M8S KJF A^'>VUOG,FWAD#1G=<;T4^X]0!W1L^%+!E?TE^_K;T"/I3FE1U&#T
MH&!E]:1WM1"/ -&H Q#7@/@Y8-@!&-2 P4L!PQHPM,I4H5@=$JKI?"K%GDCS
M-;*9@173HC%\5IJ\7VN);QGB]/RB3$4!Y N] T7>DB6DHDP99]1F161$YT"^
M^M<^.8<U2,K)M:9ZIX7\31ZP9$DUD(,$-&5<'4X#C:X9 T%:NW%6N1%WN!'%
MY%*4.E?D0[F&]5." &-J HOO SN+G8P)I#X91$<D#N.PQ:'%B^'120L\>3E\
MXHAFT*1I8/D&O6DB"5,I%VHG@?PX72DM\>C\=)@8-B:&UL2PP\1#7K,ZTQJM
M':R@A(SI0R(QQ6V)=;/&D1^&K]OT_T]<\N^X)W(<-W(<]\H!A%6Z;Z6X9;;4
M-7H<D1*K,AZ06JTV:=P6(G_4KDP?;-@N3!\L=NHR:G09.7D^"7- =UBN5QQ(
M#I3K'&4R^U&B%E@%WKR:Q''X_N/%N1U%[UOK@=O*R(_:M7'#PJY-XX:-_8%3
MFW&CS?@?M,&=@[>SLI6T30$W5]2E0!_LKS17"KAAH3]V*C!I%)@X>;X+J7,.
M2A&\N=(;4LO1+H";JBN7B_^#)6[8@:T;APX)3AH)3IQ,G_'&E&WANF%A1^(6
M?;#V(I+TP=Q5,@H?^H?0R?0AR\#V;O:Z@#NSY:'SLN@A&W0FO0<8#[OV?1_P
MI*LN!H^:J@+DQC:G"D_UKM15&]*L-@WPJ6W[GJV?F<;8-FL/-%57?4GE!DLG
MX9 A)9Y!+.&R:E2KB19;V[JMA,9&T ZQXN)]8S[ ]YD0^GYB##1_%^9_ %!+
M P04    " "G2%!2X$_&!MT#  !_#@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970X,RYX;6R5E]N.VS80AE^%$'*1 /%*E,^!U\!FC: !TG:1S:8712]H>6P3
MH4B7I _ITW<H>25O2<K;&UN'?\B/0W%^<G94^H?9 EAR*H4TM\G6VMV'-#7%
M%DIF;M0.)+Y9*UTRB[=ZDYJ=!K:J@DJ1YEDV2DO&93*?5<\>]'RF]E9P"0^:
MF'U9,OWS(PAUO$UH\OS@*]]LK7N0SF<[MH%'L$^[!XUW:=/*BI<@#5>2:%C?
M)G?TPSV=N(!*\9W#T5Q<$S>4I5(_W,WGU6V2.2(04%C7!,._ ]R#$*XEY/C[
MW&C2].D"+Z^?6_]4#1X'LV0&[I7X@Z_L]C:9)&0%:[87]JLZ_@+G 0U=>X42
MIOHEQ[,V2TBQ-U:5YV D*+FL_]GIG(B+ #J(!.3G@/RU ?US0+\::$U6#6O!
M+)O/M#H2[=38FKNH<E-%XVBX=-/X:#6^Y1AGYY]EH4H@W]@)#.F1!:Q!:UBY
M!^3.&+"&,+DB7SA;<L$M1]7;!5C&A7F'^J?'!7G[YAUY0[@DW[9J;U!M9JE%
M--=!6IPQ/M88>01C <4-Z=/W),_R+!!^_^IP.GT9GF)"FJSD35;RJKW^U:R0
M!3>%4&:O@?QYMS16XX?W5T<7_::+?M7%(-+%75'H/28:3K@B#=1IUF! 'X"(
M-MVA7-8MCZN6W3H]S(>X;#%OA\N4^:K^\%+U GO08 \ZL7^W6]"X^&KX$E:\
M8((4RM@@:=W8Z(*!#GW2@(I&28<-Z;"3]#>L@5CM-+-<;@A.H0DG<WBE\QHQ
MH.I'$4<-XJ@3\1,_81)9N\RXM$QN^%*$44<>Q'\Q?44^BF*.&\QQ)^:3!*8E
MDJ)1E'Q?!MG&?H(F?AH#JOA,3QJ^22??%\ Z3M9<,EFXN59+P3?,N40(=.(A
M!#A]47SI3!O,:2>FJR8%UE9N2<&T_JD.H$. 4Z_OL0_HBSH22;/6#;+KRSM8
MOC.OPX%/%5#%D"X,BG8B?6=BSVK+%[CIP#F&("#UNN[10.)"NGP03UUK&33O
MGEYEL1*NG@V4UQ9B<=+K!?Z>2%>1UN3PR@'E'N@T\*4&9)-)?#BM/=%N?_J_
MM>G<W(N\AM+ORV*HK271;D]ZT+!CO+72()[O,3VW8#R^@"Y>06EK1K3;C9XD
M;K(%_P=SNL'-=9W2N"E1WV]Z-.#Q05T<MS4FVNU,\3IPW8,"DEX>9VI=B';;
M4'R!7=DN4=]U>ODTD,R ;AH';^V)=ON3VXE$ZT(0>.)MW48A7E\V#O"F%Z<#
M=S3[E>F-^P(%K#$NNQGC-Z3KTTY]8]6N.C LE<7C1W6YQ1,B:"? ]VNE[/.-
M.X,T9\[YOU!+ P04    " "G2%!2"ZV0S%8#  #0"@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970X-"YX;6RU5DUOVS@0_2L#H8<6Z$8?=FRGL TDSA9K($&#
MI!^'Q1YH:603I4B5I.UD?_T.*45R8UG-'GJ12&IFWILA^333O=+?S0;1PF,A
MI)D%&VO+#V%HT@T6S)RI$B5]R94NF*6I7H>FU,@R[U2(,(FB45@P+H/YU*_=
MZ?E4;:W@$N\TF&U1,/UTA4+M9T$</"_<\_7&NH5P/BW9&A_0?BGO-,W")DK&
M"Y2&*PD:\UEP&7]8Q"/GX"V^<MR;@S&X5%9*?7>3938+(L<(!:;6A6#TVN$"
MA7"1B,>/.FC08#K'P_%S](\^>4IFQ0PNE/C&,[N9!9, ,LS95MA[M?\+ZX3.
M7;Q4">.?L*]LQTD Z=985=3.Q*#@LGJSQ[H0!PZ4:+=#4CLD+QV&)QP&M</
M)UHQ\VE=,\OF4ZWVH)TU17,#7QOO3=EPZ;;QP6KZRLG/SI<R507"9_:(!OZ
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MU,Z ON>*E*2>.("FB9W_!U!+ P04    " "G2%!2D=($+\L"  !6"   &0
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MH/^^E%(]OZE_P[7_5>#EOU!+ P04    " "G2%!2N'-0[,<"   *"0  &0
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M 64%.+^4TKP.['[8?/Y$_P!02P,$%     @ ITA04M\^B +%!0  01L  !D
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MSLM,G0<G6NST@CC)"P)1)S0 :$0\?#JUQ6&Y_8NKT&IW!7*8V%(+@!+JK!,
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M!<O0.JWQ']M,_33'>)HKXDR6>BK61W_5]K'*%AF3F6=MN0I[X1P.02 2V:,
M@ :> H1V8DW#8OW:"IRZ>GMA!Q7 V*<'D!O?#*6=:M/P7M64W_E!7-\>-NIN
M1"\2.YE (.=0# +%/J9=14'#%<7'MS-S*X'$/DN80J"A77I!H(%G2T@/#G/#
M)45X"[4S/CPC=;=0 ,C=0D$@IR#J']PM%%RNZCN:"LW%ME3-<7O[M;T'NJYO
M/ZSO-_ARUMSF=&Z:RZ4O3*ZRLD(Y7VJ7T8=$"ZAL[FN:%R4V]0W&HU!*%/7C
MFK,%EP:@?U\*H?8OIH'VUFSR/U!+ P04    " "G2%!2R3/T1,P#  #A#@
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M3^3,<8G0+CW;K<A&5(^Y8UCO5LCDHD>7U)L#FC<'SSJ\I(#<AQM! #,,/1Z
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M[GW]W1=3;]HWV.>U,?6Z_;B2POIE![!_7]96Q_9?W T._S5Q^W]02P,$%
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M]M3=PPX@OC@ 2#I \AHP. !(.T#Z5L"@ PS\S;2I^'O(F&7CH59;T"Z:V-S
M7Z9'4_I<NK(OK*9=3C@[GBI94!&Q@%LNF<PY$W GVW9R=5$ES''%C=5,6O@
M7Y5% U;!_X G&5K&A3DET,,B@Y-WI_ .N(1[+@0%F&%H2;]3$>:=UDFK-3F@
M-4[@7DE;&?A$9Q?_$H24>)]]\I+])#G*F&%^!FG\'I(HB?8(FKX9'G_< \_>
M#K\ZDDW:US+U?(,#?#.FD8HT577#Y/,1PD%/./"$Z0'".0IFJ<)$;)_A&[6
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M[>\X)36[[GK=FX5PO7K[FYF>OV@+]O\GXC]02P,$%     @ ITA04I>*NQS
M    $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y
M 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/
M:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O
M.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_
M'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "G
M2%!2JE?$83<'   "0P  #P   'AL+W=O<FMB;V]K+GAM;,6<77/:.!2&_XJ&
MF^W.- L8_-5I.I,F;3<S;<*4;&]W%"- 4UMB99,T_?4KF9 <I\Z[>W/"58KM
MF@<)ZSDZ.N+MK77?KZW]+GY4I:F/!^NFV;P9#NMBK2I9_V$WRO@S2^LJV?B7
M;C6L-T[)1;U6JJG*830:)<-*:C-X]W9_KYD;TA>V446CK?$'PX%O6MW6C^?#
M2W&C:WVM2]W<'0_:?Y=J("IM=*5_JL7Q8#00]=K>_FF=_FE-(\MYX6Q9'@_&
MNQ/?E&MT\<OA>8"\DM=U>Z21UU^E!SD>)"-_PZ5V==->T=Y?>L8;Y2_>O=HV
M]J,N&^7.9*,^.;O=:+,*M_&?8D@^1ML.^[^[1GSC_D\SVN52%^K,%MM*F6;7
MCDZ5 =#4:[VI!\+(2AT/3NV-<F(F5RI\*/\NYXO=!VP\&6DN]T;[$^Y\T3)R
M\IC:EGKAWWTAY@$B_(=:V*4X-X4ED!& C X&>6JK#8&< ,C)"T*^EZ4TA1+M
M-[(F@%, .#T8H'@UDP0R!I#QP;IZWMB"0"8 ,CG<]U'6:P*9 LB4%_+2K:31
M/]L30IK0Y;5N&6=.U73XR0!DQ@LYURNC_;72-.*D*.S6-'YD%C/?NH56],')
M 63."WGA[QL&PTJ)F1^\YVOI.J/W" W?(UZV]]M:&U7782"\UF9W 86#;F&6
MRT>IG?@FRZT27Y2LMV[WG% \9)4QLU;.S8VJFU^0D$/&S!+Q\=7&1S]WK\6'
M?[9Z$ZY^W3Z\IW*C&SI&CY%)QLPJ^>Q[L_-TCI$RQLS.^&3MXE:79=M0YSZ@
M-*M ($[JVKOM-<5$TA@S6^.+6H2H5IR64E?U;DA61BVU-\=,WE%,I(TQLS?.
MU'5#69 =QLQZN!]UK^2/[K<-R6#,;(,0AGQ?VW*A7/U;^Y@VM.\B9(.(V08?
MJDUI[Y3:?['$S$=YM.4BI(.(?:Y157HWWN[&--O:7IDGJH_@5(-9"G.U>FJ$
M"!DAXI]6+)2I?:#YT>O=-Y4?0<[-[E;^6HJ)C! Q&P$&<G]'%!.I(F)6!<:<
M4$RDBHA9%7T1IWAU)3U%_3N%1**(F$71&WKV4B*%1,P*>28&W7-23&25B-DJ
M)!;M:\()LLJ$V2HP*.T\VQ.DEPFS7G9!:6_K(:%,F(4"H]-NZ\'L%;-G8'3:
MQ42>F3![)D2GO5V,K#)AM@H-4WOAD$LFS"[IBU=[(9%+)LPNV4==O6!('Q-F
M?<#PJ_M8('U,F/4!DWT=S"DRR939)#C\FE),9)(ILTDP9DPQD5FFW%,5B)E0
M3&26*;-9,&9*,>'JR$%G,!G%1*Z9,KNF?VIPIAJIR\ZP.472F3)+IW]N<"0N
MI'/^!<5$VID>9 IS).;;JI*N@XDD-&66T'.8]]$DQ402FC)+Z+FIUI$X62PT
M32K&2$(QLX2>QVP53S&1A.+#+)YXS';MEF(B"<7,$GH>\[,UJR.*B204,TN(
MSJ_]\^WON-CZ25A;YG#320/$2$(QLX2ZF"%!ZF31;'W0^44V6T<QX2(]^X2'
M8MX/ZC</'J*8R$(QLX6ZF"<W'BW,+H[\S8[FLH.)+!0S6ZB+>5^9T0;O7_WQ
M3J<C"\7,%L)I()H[C9&%8F8+84PZQTB0A9*#)M7H'"-!%DI>)JG6\Y!W@LT$
M*2AA5M #8R@&LV9?BM,>%A]^4$RDH(1900^8\^UF4[::#/DV6:_%Q]+>4DRD
MH.1%UO:?8C[4BU%,I*"$64$/F+MN;O6H&QT2<.'[23%AI1BS@G#VEPZ:"5)0
MPJP@C-D9-)&"$F8%8<S.H(D4E# K".?2::>G2$$ILX(P)NWT%"DH9580QJ2=
MGB(+I<P6PI@T&Y<B"Z4'7>>AV;@462AEMA#&I-FX%%DH9;90NQQU](M]GD1'
M*3)0RFR@>T0ZY6UGYE?*5>*,%K*FL%KY!<K.0@CG?,<WXF3E5!MZ]$PI4V2@
ME-E ^]941ELG+FSS7)<C_Z3,_MFWI?432]>TAJ2D!#-#_LF8_=-9-CT2?D84
M&*P1_F[>[A03^2=C]L\3S*^JL*;0I=XMMM$M,AGR3\9>S=S!/%-+Y?S#% Z$
M^(AB(O]D[(FX#F:;&?;7[)=5*2;R3\:>B.M@_F6<[_:5"1O8PD&*B?R3<=>S
M]2WN/[8JQ40.R@Y1@_ X7Z>8R$$9=Q5"/V:;A=,%7<#(X)X9[DTS_9C[3#S%
M1!;*#E H'=09#HM+NFLO1Q;*N6L2$&:G=")'%LJ9+=1?VOT0>U!,9*&<?:LF
MJ/$6KR@FLE#.79.PKS?ZK\1FCB24<Y<D/%+2\/URHP(Q'39S)*&<6T*/F$^#
MHZ7X1)6>(PGE_+LV02D7S<KD2$(YLX0P)LW*Y$A"^4$+XVA6)H=;-YDEA#%I
M5F8\POLXF36$0=,.*-S3.>+_Q0  FG5 X>[.4:NB87MY_>[MPEO-J,6%?Y/:
M'R]D6<R<"'_:>T73.&S[6F[+\M0?NS2?K5SL?\)A__,3[_X%4$L#!!0    (
M *=(4%+M2,2UY (  /$[   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'/-V\UNVD 81N%;0;Z V/,_4X6LNLFVR@T@8B *8(1=-;G[(K* =]1%-Y'/
M"HT1'T>R] B9F<=?_7XUO0W'<?=V&A<?A_UQ7#:[:3K]:-MQO>L/J_%A./7'
MRSN;X7Q839?E>=N>5NOWU;9O;=?%]GP_HWEZO)^Y>/D\]?\S<=ALWM;]SV']
M^] ?IW\,;O\,Y_=QU_=3LWA9G;?]M&S:C_WM\MA>7\S#97*S>'Y=-N?G5].T
M<P=9";+S!SD)<O,'>0GR\P<%"0KS!T4)BO,')0E*\P=E"<KS!Q4)*O,'F4YE
M[ !)%=8 K8UR;0!>&P7; ,0V2K8!F&T4;0-0VRC;!N"V4;@-0&ZC=!N W4;Q
M-@"]K>IM 7I;U=L"]+;5CVV WE;UM@"]K>IM 7I;U=L"]+:JMP7H;55O"]#;
MJMX6H+=5O2U ;Z=Z.X#>3O5V +V=ZNT >KOJ80E ;Z=Z.X#>3O5V +V=ZNT
M>CO5VP'T=JJW ^CM5&\'T-NKWAZ@MU>]/4!OKWI[@-Y>]?8 O7WUL!N@MU>]
M/4!OKWI[@-Y>]?8 O;WJ[0%Z>]7; _0.JG< Z!U4[P#0.ZC> :!W4+T#0.^@
M>@> WJ'ZLQ*@=U"] T#OH'H'@-Y!]0X O8/J'0!Z1]4[ O2.JG<$Z!U5[PC0
M.ZK>$:!W5+TC0.^H>D> WK':; +0.ZK>$:!W5+TC0.^H>D> WDGU3@"]D^J=
M 'HGU3L!]$ZJ=P+HG53O!- [J=X)H'=2O1- [U1M%@3HG53O!- [J=X)H'=6
MO3- [ZQZ9X#>6?7. +VSZIT!>F?5.P/TSJIW!NB=5>\,T#NKWAF@=ZXV>P/T
MSJIW!NA=5.\"T+NHW@6@=U&]"T#OHGH7@-Y%]2X O8OJ70!Z%]6[ /0NJG<!
MZ%U4[P+0NU2'=0!ZFZX^K@/PVW35@9T.(+CIJB,[W7<:/DZ?^WZ\%7VMJX#O
M%'NZ?+:_??]U^76QOC=7I-O[C/'I+U!+ P04    " "G2%!2T37\65\"  #7
M.0  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-V]]NFS 4Q_%7B;BM MA@ U/3
MFW:W6R_V @R<!H5_LMTN??LYI*VTJ8M69=*^-T&)[?,[^$B?NUQ_>YZ-6QV&
M?G2;:.?]_"E)7+,S0^WB:39C6-E.=JA]^&H?DKEN]O6#262:ZJ291F]&O_;'
M&M'-]9W9UH^]7WT^A)]=-XV;R)K>1:O;T\9CUB:JY[GOFMJ']>1I;']+6;\D
MQ.'DLL?MNME=A0U1\F["<>7/ 2_GOCX9:[O6K.YKZ[_40]B5'/K$^>?>N/A\
MB7=ZG+;;KC'MU#P.X4CL9FOJUNV,\4,?GXI>G4_VX8;-Z5-<G+^4.1<8=M[;
M:79A8M9\/.YU),?3ZSD4,M9WYU_Q+3&4OOC]S'':K6G_,CM<[X_)[I=YN&1Y
M7'['O\[XK?X'^Y"0/C)('SFD#P7I0T/Z*"!]E) ^*D@?(J4T0A%54$@5%%,%
M!55!45506!445P4%5D&155)DE119)45629%54F25%%DE159)D5529)4463.*
MK!E%UHPB:T:1-:/(FE%DS2BR9A19,XJL&476G")K3I$UI\B:4V3-*;+F%%ES
MBJPY1=:<(FM.D5519%44615%5D6155%D5119%45619%54615%%DU159-D553
M9-44635%5DV155-DU119-45639&UH,A:4&0M*+(6%%D+BJP%1=:"(FM!D;6@
MR%I09"TILI8464N*K"5%UI(B:TF1M:3(6E)D+2FREA19*XJL%476BB)K19&U
MHLA:462M*+)6%%DKBJP515:14F@5*<56D?Y/7+]/T_X?QR_/>*B[\34_6?[/
M>?,34$L! A0#%     @ ITA04@=!36*!    L0   !               ( !
M     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "G2%!2/7CG1NX    K
M @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M    " "G2%!2F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE
M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *=(4%(&3D:&<08  #@:   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "G2%!2;! ((W,&  #-'@  &               @(&T#@  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ ITA04AFW-RG_ @  2 D
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M965T-RYX;6Q02P$"% ,4    " "G2%!2$=L75R8+   ;'0  &
M    @($A,P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
MITA04ESHU(W_*0  (H8  !@              ("!?3X  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( *=(4%)G-BLB4 0  #P*   9
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M970Q-"YX;6Q02P$"% ,4    " "G2%!2U^LH*)0%   \&0  &0
M    @(%=D   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M *=(4%(;6OS &@0  )L*   9              " @2B6  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ ITA04J()<[X;"   _A<  !D
M             ("!>9H  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " "G2%!2J-.W2PD*   R'0  &0              @('+H@  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( *=(4%*??P^T, H
M *D9   9              " @0NM  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ ITA04H2/P?"""P  NAX  !D              ("!
M<K<  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "G2%!2
M?3BC_3H#   =!P  &0              @($KPP  >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( *=(4%)N?]_<C0T  .<C   9
M      " @9S&  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ ITA04IU">=I8!@  ; \  !D              ("!8-0  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "G2%!2:W)N8V(,   *(
M&0              @('OV@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( *=(4%*Y3[W.*28  !%]   9              " @8CG  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ ITA04N+Q/CTT
M!@  =A$  !D              ("!Z T! 'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " "G2%!2;J-/+6<$  !O"@  &0
M@(%3% $ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( *=(
M4%+>"..CX@,  (@(   9              " @?$8 0!X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ ITA04DPU6[PY!0  YPX  !D
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M=#,S+GAM;%!+ 0(4 Q0    ( *=(4%*DV>,Q?08  !H2   9
M  " @9LT 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
MITA04L/R]Q?A P  I D  !D              ("!3SL! 'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " "G2%!2>F?A*V(%   ]#@  &0
M            @(%G/P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( *=(4%)HN-,5W@4  #P/   9              " @0!% 0!X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ ITA04CH5]783!
M.0D  !D              ("!%4L! 'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " "G2%!2&.QB,*4(  #F%@  &0              @(%?
M3P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( *=(4%*:
M^?S 3P0  (\1   9              " @3M8 0!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ ITA04N EX7RS @  T <  !D
M     ("!P5P! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *=(4%)=@!3CY 0  &83   9              "
M@=IQ 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ ITA0
M4@%T6WW*!0  ]QH  !D              ("!]78! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " "G2%!2H3B(?; #   H"P  &0
M        @('V? $ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( *=(4%+98@ XX ,  &44   9              " @=V  0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ ITA04BSSY9&% P  ?PL
M !D              ("!](0! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " "G2%!2<W_DPE0)  "B2P  &0              @(&PB $
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( *=(4%)S*]@.
M@0(  , &   9              " @3N2 0!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ ITA04K:FW&>3!0  *2<  !D
M ("!\Y0! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " "G
M2%!2N((;MU0%   3'P  &0              @(&]F@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( *=(4%),*7"<R@(  &$)   9
M          " @4B@ 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#
M%     @ ITA04CP4!E". @  208  !D              ("!2:,! 'AL+W=O
M<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "G2%!2.6@"?0L#  !3
M"P  &0              @($.I@$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM
M;%!+ 0(4 Q0    ( *=(4%+-H_@6& ,   ,-   9              " @5"I
M 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ ITA04GC9
M\L(@ P  _@T  !D              ("!GZP! 'AL+W=O<FMS:&5E=',O<VAE
M970U.2YX;6Q02P$"% ,4    " "G2%!2Q8LFM= #  !B#P  &0
M    @('VKP$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M *=(4%*;J"5I>0,  '$+   9              " @?VS 0!X;"]W;W)K<VAE
M971S+W-H965T-C$N>&UL4$L! A0#%     @ ITA04GQ).%(/ P  &0P  !D
M             ("!K;<! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"
M% ,4    " "G2%!2\K*[%\$"  #D!P  &0              @('SN@$ >&PO
M=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( *=(4%*%'^%IQP(
M %((   9              " @>N] 0!X;"]W;W)K<VAE971S+W-H965T-C0N
M>&UL4$L! A0#%     @ ITA04C<V7]U!!   <1(  !D              ("!
MZ< ! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " "G2%!2
MDL,;-30#  ",#   &0              @(%AQ0$ >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;%!+ 0(4 Q0    ( *=(4%+XVI(KLP(  (\'   9
M      " @<S( 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%
M  @ ITA04KE?2(S% @  D@@  !D              ("!MLL! 'AL+W=O<FMS
M:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "G2%!2XF"5\E4#  ")#0
M&0              @(&RS@$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+
M 0(4 Q0    ( *=(4%+"S)@C.@,  (H*   9              " @3[2 0!X
M;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ ITA04@584*7X
M @  Z0<  !D              ("!K]4! 'AL+W=O<FMS:&5E=',O<VAE970W
M,2YX;6Q02P$"% ,4    " "G2%!2NT5R:VD$  "*#P  &0
M@('>V $ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( *=(
M4%*E-$4VJ@,   8/   9              " @7[= 0!X;"]W;W)K<VAE971S
M+W-H965T-S,N>&UL4$L! A0#%     @ ITA04MU&?8J^ @  ]@@  !D
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M=#<X+GAM;%!+ 0(4 Q0    ( *=(4%)RI6;4GP0  *\8   9
M  " @;3S 0!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @
MITA04LLM@ZLJ P  SPH  !D              ("!BO@! 'AL+W=O<FMS:&5E
M=',O<VAE970X,"YX;6Q02P$"% ,4    " "G2%!2KN=Z;"X#  "<"P  &0
M            @('K^P$ >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4
M Q0    ( *=(4%+R)-2;5 ,  #H,   9              " @5#_ 0!X;"]W
M;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ ITA04N!/Q@;= P
M?PX  !D              ("!VP(" 'AL+W=O<FMS:&5E=',O<VAE970X,RYX
M;6Q02P$"% ,4    " "G2%!2"ZV0S%8#  #0"@  &0              @('O
M!@( >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( *=(4%*1
MT@0ORP(  %8(   9              " @7P* @!X;"]W;W)K<VAE971S+W-H
M965T.#4N>&UL4$L! A0#%     @ ITA04L_PXTGY!P  FRP  !D
M     ("!?@T" 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *=(4%*0RY4Q1P,  ,X+   9              "
M@>PD @!X;"]W;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%     @ ITA0
M4H(C=%;8 @  [ <  !D              ("!:B@" 'AL+W=O<FMS:&5E=',O
M<VAE970Y,BYX;6Q02P$"% ,4    " "G2%!2T+FTTQT#  "_"0  &0
M        @(%Y*P( >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0
M   ( *=(4%+B1/+# P(  % $   9              " @<TN @!X;"]W;W)K
M<VAE971S+W-H965T.30N>&UL4$L! A0#%     @ ITA04DN4Y5=B P  ;0P
M !D              ("!!S$" 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q0
M2P$"% ,4    " "G2%!250YS-H($  # %   &0              @(&@- (
M>&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    ( *=(4%+=DI^W
MQ <  "$H   9              " @5DY @!X;"]W;W)K<VAE971S+W-H965T
M.3<N>&UL4$L! A0#%     @ ITA04KAS4.S' @  "@D  !D
M ("!5$$" 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q02P$"% ,4    " "G
M2%!2WSZ( L4%  !!&P  &0              @(%21 ( >&PO=V]R:W-H965T
M<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( *=(4%+),_1$S ,  .$.   :
M          " @4Y* @!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4
M Q0    ( *=(4%)77^<PK @  $$Q   :              " @5). @!X;"]W
M;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( *=(4%)?651TAP(
M $H&   :              " @397 @!X;"]W;W)K<VAE971S+W-H965T,3 R
M+GAM;%!+ 0(4 Q0    ( *=(4%)3:G6M4 (  %P,   -              "
M ?59 @!X;"]S='EL97,N>&UL4$L! A0#%     @ ITA04I>*NQS     $P(
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9>&UL4$L%!@    !N &X /!X  &EJ @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>392</ContextCount>
  <ElementCount>607</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>114</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2111103 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2119105 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2125106 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2132107 - Disclosure - Property, Equipment, and Capitalized Software, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet</Role>
      <ShortName>Property, Equipment, and Capitalized Software, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2137108 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2144109 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2149110 - Disclosure - Medical Claims and Benefits Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable</Role>
      <ShortName>Medical Claims and Benefits Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2157111 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2164112 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2171113 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2179114 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/EmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2181115 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2183116 - Disclosure - Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/Segments</Role>
      <ShortName>Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2188117 - Disclosure - Condensed Financial Information of Registrant</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant</Role>
      <ShortName>Condensed Financial Information of Registrant</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/NetIncomePerShare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/BusinessCombinations</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/FairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2326305 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/Investments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - Property, Equipment, and Capitalized Software, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetTables</Role>
      <ShortName>Property, Equipment, and Capitalized Software, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/Leases</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2345308 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2350309 - Disclosure - Medical Claims and Benefits Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables</Role>
      <ShortName>Medical Claims and Benefits Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2358310 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/Debt</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2365311 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2372312 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/StockholdersEquity</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2384313 - Disclosure - Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SegmentsTables</Role>
      <ShortName>Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/Segments</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2389314 - Disclosure - Condensed Financial Information of Registrant (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables</Role>
      <ShortName>Condensed Financial Information of Registrant (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Organization and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails</Role>
      <ShortName>Organization and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Significant Accounting Policies - Cash, Cash Equivalents, and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Significant Accounting Policies - Cash, Cash Equivalents, and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Significant Accounting Policies - Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Significant Accounting Policies - Amounts Due To Government Agencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails</Role>
      <ShortName>Significant Accounting Policies - Amounts Due To Government Agencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2410406 - Disclosure - Significant Accounting Policies - Schedule of Premium Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails</Role>
      <ShortName>Significant Accounting Policies - Schedule of Premium Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/NetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/NetIncomePerShareTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Business Combinations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails</Role>
      <ShortName>Business Combinations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Business Combinations - Summarizes the Preliminary Values of the Assets acquired and Liabilities Assumed at the Date of Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails</Role>
      <ShortName>Business Combinations - Summarizes the Preliminary Values of the Assets acquired and Liabilities Assumed at the Date of Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Business Combinations - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails</Role>
      <ShortName>Business Combinations - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2422412 - Disclosure - Fair Value Measurements - Financial Instruments on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Financial Instruments on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2423413 - Disclosure - Fair Value Measurements - Balance Sheet Grouping (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails</Role>
      <ShortName>Fair Value Measurements - Balance Sheet Grouping (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2424414 - Disclosure - Fair Value Measurements - Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails</Role>
      <ShortName>Fair Value Measurements - Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2427415 - Disclosure - Investments - Schedule of Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails</Role>
      <ShortName>Investments - Schedule of Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2428416 - Disclosure - Investments - Contractual Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails</Role>
      <ShortName>Investments - Contractual Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2429417 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2430418 - Disclosure - Investments - Available-for-Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails</Role>
      <ShortName>Investments - Available-for-Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2431419 - Disclosure - Investments - Balances of Restricted Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails</Role>
      <ShortName>Investments - Balances of Restricted Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2434420 - Disclosure - Property, Equipment, and Capitalized Software, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails</Role>
      <ShortName>Property, Equipment, and Capitalized Software, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2435421 - Disclosure - Property, Equipment, and Capitalized Software, Net - Summary of Property, Equipment, and Capitalized Software (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails</Role>
      <ShortName>Property, Equipment, and Capitalized Software, Net - Summary of Property, Equipment, and Capitalized Software (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2436422 - Disclosure - Property, Equipment, and Capitalized Software, Net - Depreciation and Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails</Role>
      <ShortName>Property, Equipment, and Capitalized Software, Net - Depreciation and Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2439423 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2440424 - Disclosure - Leases - Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails</Role>
      <ShortName>Leases - Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2441425 - Disclosure - Leases - Supplemental Cash Flow (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2442426 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2443427 - Disclosure - Leases - Lease Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails</Role>
      <ShortName>Leases - Lease Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2446428 - Disclosure - Goodwill and Intangible Assets, Net - Balances of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Balances of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2447429 - Disclosure - Goodwill and Intangible Assets, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2448430 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Intangible Assets Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2451431 - Disclosure - Medical Claims and Benefits Payable - Medical Claims and Future Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails</Role>
      <ShortName>Medical Claims and Benefits Payable - Medical Claims and Future Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2452432 - Disclosure - Medical Claims and Benefits Payable - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails</Role>
      <ShortName>Medical Claims and Benefits Payable - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2453433 - Disclosure - Medical Claims and Benefits Payable - Components of the Change (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails</Role>
      <ShortName>Medical Claims and Benefits Payable - Components of the Change (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2454434 - Disclosure - Medical Claims and Benefits Payable - Incurred Claims and Allocated Adjustment Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails</Role>
      <ShortName>Medical Claims and Benefits Payable - Incurred Claims and Allocated Adjustment Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2455435 - Disclosure - Medical Claims and Benefits Payable - Cumulative Paid Claims and Allocated Claims Adjustment Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails</Role>
      <ShortName>Medical Claims and Benefits Payable - Cumulative Paid Claims and Allocated Claims Adjustment Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2456436 - Disclosure - Medical Claims and Benefits Payable - Reconciliation of Claims Development (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails</Role>
      <ShortName>Medical Claims and Benefits Payable - Reconciliation of Claims Development (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2459437 - Disclosure - Debt - Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/DebtMaturitiesDetails</Role>
      <ShortName>Debt - Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2460438 - Disclosure - Debt - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails</Role>
      <ShortName>Debt - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2461439 - Disclosure - Debt - Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/DebtCreditAgreementDetails</Role>
      <ShortName>Debt - Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2462440 - Disclosure - Debt - Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.molinahealthcare.com/role/DebtSeniorNotesDetails</Role>
      <ShortName>Debt - Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2463441 - Disclosure - Debt - Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails</Role>
      <ShortName>Debt - Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2466442 - Disclosure - Income Taxes - Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2467443 - Disclosure - Income Taxes - Reconciliation of the U.S. Federal Statutory Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation of the U.S. Federal Statutory Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2468444 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2469445 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2470446 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2473447 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2474448 - Disclosure - Stockholders' Equity - Components of Share-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails</Role>
      <ShortName>Stockholders' Equity - Components of Share-based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2475449 - Disclosure - Stockholders' Equity - Restricted and Performance Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails</Role>
      <ShortName>Stockholders' Equity - Restricted and Performance Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2476450 - Disclosure - Stockholders' Equity - Fair Value of Awards Granted and Vested (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails</Role>
      <ShortName>Stockholders' Equity - Fair Value of Awards Granted and Vested (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2477451 - Disclosure - Stockholders' Equity - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails</Role>
      <ShortName>Stockholders' Equity - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2478452 - Disclosure - Stockholders' Equity - Stock Options by Exercise Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails</Role>
      <ShortName>Stockholders' Equity - Stock Options by Exercise Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2480453 - Disclosure - Employee Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails</Role>
      <ShortName>Employee Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/EmployeeBenefitPlans</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>2482454 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.molinahealthcare.com/role/CommitmentsandContingencies</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>2485455 - Disclosure - Segments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SegmentsNarrativeDetails</Role>
      <ShortName>Segments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>2486456 - Disclosure - Segments - Schedule of Operating Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails</Role>
      <ShortName>Segments - Schedule of Operating Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>2487457 - Disclosure - Segments - Reconciliation of Gross Margin to Consolidated Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails</Role>
      <ShortName>Segments - Reconciliation of Gross Margin to Consolidated Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>2490458 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails</Role>
      <ShortName>Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>2491459 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails</Role>
      <ShortName>Condensed Financial Information of Registrant - Condensed Balance Sheets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>2492460 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails</Role>
      <ShortName>Condensed Financial Information of Registrant - Condensed Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>2493461 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails</Role>
      <ShortName>Condensed Financial Information of Registrant - Condensed Statements of Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>2494462 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails</Role>
      <ShortName>Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="moh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>2495463 - Disclosure - Condensed Financial Information of Registrant - Notes to Condensed Financial Information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails</Role>
      <ShortName>Condensed Financial Information of Registrant - Notes to Condensed Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="moh-20201231.htm">moh-20201231.htm</File>
    <File>a2ndamendedchangeincontrol.htm</File>
    <File>a2ndamendto2018deferredcom.htm</File>
    <File>descriptionofregistrantsse.htm</File>
    <File>moh-20201231.xsd</File>
    <File>moh-20201231_cal.xml</File>
    <File>moh-20201231_def.xml</File>
    <File>moh-20201231_lab.xml</File>
    <File>moh-20201231_pre.xml</File>
    <File>moh4q20_ex211.htm</File>
    <File>moh4q20_ex231.htm</File>
    <File>moh4q20_ex311.htm</File>
    <File>moh4q20_ex312.htm</File>
    <File>moh4q20_ex321.htm</File>
    <File>moh4q20_ex322.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>moh-20201231_g1.jpg</File>
    <File>moh-20201231_g2.jpg</File>
    <File>moh-20201231_g3.jpg</File>
    <File>moh-20201231_g4.gif</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/stpr/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>129
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "moh-20201231.htm": {
   "axisCustom": 0,
   "axisStandard": 30,
   "contextCount": 392,
   "dts": {
    "calculationLink": {
     "local": [
      "moh-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "moh-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "moh-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "moh-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "moh-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "moh-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 852,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 12,
    "http://www.molinahealthcare.com/20201231": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 17
   },
   "keyCustom": 80,
   "keyStandard": 527,
   "memberCustom": 48,
   "memberStandard": 62,
   "nsprefix": "moh",
   "nsuri": "http://www.molinahealthcare.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.molinahealthcare.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111103 - Disclosure - Net Income Per Share",
     "role": "http://www.molinahealthcare.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2493461 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Comprehensive Income (Details)",
     "role": "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
     "shortName": "Condensed Financial Information of Registrant - Condensed Statements of Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2494462 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)",
     "role": "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
     "shortName": "Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2495463 - Disclosure - Condensed Financial Information of Registrant - Notes to Condensed Financial Information (Details)",
     "role": "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails",
     "shortName": "Condensed Financial Information of Registrant - Notes to Condensed Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ia53712b5ebef4cceb950c78f4c95c117_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - Business Combinations",
     "role": "http://www.molinahealthcare.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119105 - Disclosure - Fair Value Measurements",
     "role": "http://www.molinahealthcare.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125106 - Disclosure - Investments",
     "role": "http://www.molinahealthcare.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132107 - Disclosure - Property, Equipment, and Capitalized Software, Net",
     "role": "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet",
     "shortName": "Property, Equipment, and Capitalized Software, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137108 - Disclosure - Leases",
     "role": "http://www.molinahealthcare.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144109 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149110 - Disclosure - Medical Claims and Benefits Payable",
     "role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable",
     "shortName": "Medical Claims and Benefits Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157111 - Disclosure - Debt",
     "role": "http://www.molinahealthcare.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164112 - Disclosure - Income Taxes",
     "role": "http://www.molinahealthcare.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestAndDividendIncomeOperating",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Statements of Income",
     "role": "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "moh:PremiumTaxExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2171113 - Disclosure - Stockholders' Equity",
     "role": "http://www.molinahealthcare.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2179114 - Disclosure - Employee Benefit Plans",
     "role": "http://www.molinahealthcare.com/role/EmployeeBenefitPlans",
     "shortName": "Employee Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2181115 - Disclosure - Commitments and Contingencies",
     "role": "http://www.molinahealthcare.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2183116 - Disclosure - Segments",
     "role": "http://www.molinahealthcare.com/role/Segments",
     "shortName": "Segments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2188117 - Disclosure - Condensed Financial Information of Registrant",
     "role": "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant",
     "shortName": "Condensed Financial Information of Registrant",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - Net Income Per Share (Tables)",
     "role": "http://www.molinahealthcare.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Business Combinations (Tables)",
     "role": "http://www.molinahealthcare.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.molinahealthcare.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326305 - Disclosure - Investments (Tables)",
     "role": "http://www.molinahealthcare.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - Property, Equipment, and Capitalized Software, Net (Tables)",
     "role": "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetTables",
     "shortName": "Property, Equipment, and Capitalized Software, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - Leases (Tables)",
     "role": "http://www.molinahealthcare.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345308 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350309 - Disclosure - Medical Claims and Benefits Payable (Tables)",
     "role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables",
     "shortName": "Medical Claims and Benefits Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358310 - Disclosure - Debt (Tables)",
     "role": "http://www.molinahealthcare.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2365311 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.molinahealthcare.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2372312 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.molinahealthcare.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2384313 - Disclosure - Segments (Tables)",
     "role": "http://www.molinahealthcare.com/role/SegmentsTables",
     "shortName": "Segments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2389314 - Disclosure - Condensed Financial Information of Registrant (Tables)",
     "role": "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables",
     "shortName": "Condensed Financial Information of Registrant (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Balance Sheets",
     "role": "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Organization and Basis of Presentation (Details)",
     "role": "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
     "shortName": "Organization and Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i50a1c2e5665543b3bda779ef36e5094b_D20200101-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "moh:HealthPlanContractTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Significant Accounting Policies - Cash, Cash Equivalents, and Restricted Cash (Details)",
     "role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Significant Accounting Policies - Cash, Cash Equivalents, and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "moh:InvestmentsMaturityPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Significant Accounting Policies - Additional Information (Details)",
     "role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "moh:InvestmentsMaturityPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Significant Accounting Policies - Receivables (Details)",
     "role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails",
     "shortName": "Significant Accounting Policies - Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i5d73a7217fd343aba05c738abeb42788_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:MedicalPremiumsLiabilityMedicalCareCostsThreshold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Significant Accounting Policies - Amounts Due To Government Agencies (Details)",
     "role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails",
     "shortName": "Significant Accounting Policies - Amounts Due To Government Agencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:MedicalPremiumsLiabilityMedicalCareCostsThreshold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "moh:SummarizedPremiumRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410406 - Disclosure - Significant Accounting Policies - Schedule of Premium Revenue (Details)",
     "role": "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails",
     "shortName": "Significant Accounting Policies - Schedule of Premium Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "moh:SummarizedPremiumRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Net Income Per Share (Details)",
     "role": "http://www.molinahealthcare.com/role/NetIncomePerShareDetails",
     "shortName": "Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "if30ced8758e642af8985042651d6cdb1_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "moh:BusinessCombinationNumberOfBusinessCombinations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business_combination",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Business Combinations - Narrative (Details)",
     "role": "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
     "shortName": "Business Combinations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "if30ced8758e642af8985042651d6cdb1_D20200701-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "moh:BusinessCombinationNumberOfBusinessCombinations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business_combination",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Business Combinations - Summarizes the Preliminary Values of the Assets acquired and Liabilities Assumed at the Date of Acquisition (Details)",
     "role": "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails",
     "shortName": "Business Combinations - Summarizes the Preliminary Values of the Assets acquired and Liabilities Assumed at the Date of Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic7d30311e31b4c22be3cf1f4ca99f8e6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Business Combinations - Intangible Assets (Details)",
     "role": "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails",
     "shortName": "Business Combinations - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "role": "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422412 - Disclosure - Fair Value Measurements - Financial Instruments on a Recurring Basis (Details)",
     "role": "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Financial Instruments on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i01750e761ae449108d5498ba2a542db0_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423413 - Disclosure - Fair Value Measurements - Balance Sheet Grouping (Details)",
     "role": "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails",
     "shortName": "Fair Value Measurements - Balance Sheet Grouping (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i01750e761ae449108d5498ba2a542db0_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424414 - Disclosure - Fair Value Measurements - Long-Term Debt (Details)",
     "role": "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails",
     "shortName": "Fair Value Measurements - Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i6e000c4aefc74c68842dcf99d6e91fa4_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427415 - Disclosure - Investments - Schedule of Investments (Details)",
     "role": "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails",
     "shortName": "Investments - Schedule of Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428416 - Disclosure - Investments - Contractual Maturities (Details)",
     "role": "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails",
     "shortName": "Investments - Contractual Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429417 - Disclosure - Investments - Narrative (Details)",
     "role": "http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430418 - Disclosure - Investments - Available-for-Sale (Details)",
     "role": "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails",
     "shortName": "Investments - Available-for-Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedInvestmentsNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431419 - Disclosure - Investments - Balances of Restricted Investments (Details)",
     "role": "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails",
     "shortName": "Investments - Balances of Restricted Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "id9d2df1abcb045c4a451a671e263475d_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestrictedInvestmentsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i15fb3622b8d3400b91bfd0af1a0403f4_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434420 - Disclosure - Property, Equipment, and Capitalized Software, Net - Additional Information (Details)",
     "role": "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
     "shortName": "Property, Equipment, and Capitalized Software, Net - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i15fb3622b8d3400b91bfd0af1a0403f4_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ie5276df7533a434dba724ca46fb6260b_I20171231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "id81240d8e0324ade9d13dfaaff5b72b2_I20171231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435421 - Disclosure - Property, Equipment, and Capitalized Software, Net - Summary of Property, Equipment, and Capitalized Software (Details)",
     "role": "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails",
     "shortName": "Property, Equipment, and Capitalized Software, Net - Summary of Property, Equipment, and Capitalized Software (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:DepreciationAndAmortizationOfCapitalizedSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436422 - Disclosure - Property, Equipment, and Capitalized Software, Net - Depreciation and Amortization (Details)",
     "role": "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails",
     "shortName": "Property, Equipment, and Capitalized Software, Net - Depreciation and Amortization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:DepreciationAndAmortizationOfCapitalizedSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439423 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.molinahealthcare.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440424 - Disclosure - Leases - Components of Lease Expense (Details)",
     "role": "http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails",
     "shortName": "Leases - Components of Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441425 - Disclosure - Leases - Supplemental Cash Flow (Details)",
     "role": "http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails",
     "shortName": "Leases - Supplemental Cash Flow (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "moh:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:OperatingLeaseRightOfUseAssetExcludingLeasesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442426 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "moh:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:OperatingLeaseRightOfUseAssetExcludingLeasesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443427 - Disclosure - Leases - Lease Maturities (Details)",
     "role": "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails",
     "shortName": "Leases - Lease Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i9cd7c232959048c3b7533cbe17fd7a2a_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446428 - Disclosure - Goodwill and Intangible Assets, Net - Balances of Goodwill (Details)",
     "role": "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Balances of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i30920c57d0ae44b38426cd28e3bc4bcf_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447429 - Disclosure - Goodwill and Intangible Assets, Net - Additional Information (Details)",
     "role": "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448430 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Balances (Details)",
     "role": "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Intangible Assets Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451431 - Disclosure - Medical Claims and Benefits Payable - Medical Claims and Future Benefits (Details)",
     "role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails",
     "shortName": "Medical Claims and Benefits Payable - Medical Claims and Future Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:MedicalClaimsAndBenefitsPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452432 - Disclosure - Medical Claims and Benefits Payable - Additional Information (Details)",
     "role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails",
     "shortName": "Medical Claims and Benefits Payable - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:MedicalClaimsAndBenefitsPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "moh:ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i7c4aed327cc445c2a43b20960c6bced9_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453433 - Disclosure - Medical Claims and Benefits Payable - Components of the Change (Details)",
     "role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails",
     "shortName": "Medical Claims and Benefits Payable - Components of the Change (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "moh:ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "moh:ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454434 - Disclosure - Medical Claims and Benefits Payable - Incurred Claims and Allocated Adjustment Expense (Details)",
     "role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails",
     "shortName": "Medical Claims and Benefits Payable - Incurred Claims and Allocated Adjustment Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "moh:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455435 - Disclosure - Medical Claims and Benefits Payable - Cumulative Paid Claims and Allocated Claims Adjustment Expenses (Details)",
     "role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails",
     "shortName": "Medical Claims and Benefits Payable - Cumulative Paid Claims and Allocated Claims Adjustment Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i8038f20097384f9e833965528d07e1cc_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456436 - Disclosure - Medical Claims and Benefits Payable - Reconciliation of Claims Development (Details)",
     "role": "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails",
     "shortName": "Medical Claims and Benefits Payable - Reconciliation of Claims Development (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459437 - Disclosure - Debt - Maturities (Details)",
     "role": "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
     "shortName": "Debt - Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460438 - Disclosure - Debt - Schedule of Long-Term Debt (Details)",
     "role": "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
     "shortName": "Debt - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i357b4ee3df3041a6bcafb18e3531d2e9_D20200601-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461439 - Disclosure - Debt - Credit Agreement (Details)",
     "role": "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails",
     "shortName": "Debt - Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i357b4ee3df3041a6bcafb18e3531d2e9_D20200601-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462440 - Disclosure - Debt - Senior Notes (Details)",
     "role": "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
     "shortName": "Debt - Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ib62871823c48445589be9d732dff0753_I20200602",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization and Basis of Presentation",
     "role": "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation",
     "shortName": "Organization and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463441 - Disclosure - Debt - Convertible Notes (Details)",
     "role": "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
     "shortName": "Debt - Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466442 - Disclosure - Income Taxes - Provision for Income Taxes (Details)",
     "role": "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467443 - Disclosure - Income Taxes - Reconciliation of the U.S. Federal Statutory Income Tax Rate (Details)",
     "role": "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails",
     "shortName": "Income Taxes - Reconciliation of the U.S. Federal Statutory Income Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468444 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TaxCreditCarryforwardValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469445 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TaxCreditCarryforwardValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i7c4aed327cc445c2a43b20960c6bced9_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470446 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "role": "http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ie5276df7533a434dba724ca46fb6260b_I20171231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473447 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "role": "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "3",
      "lang": "en-US",
      "name": "moh:UnrecognizedCompensationForfeitedRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474448 - Disclosure - Stockholders' Equity - Components of Share-based Compensation (Details)",
     "role": "http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails",
     "shortName": "Stockholders' Equity - Components of Share-based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ib4aca872bf92456a9a20db5fae524392_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2475449 - Disclosure - Stockholders' Equity - Restricted and Performance Stock Activity (Details)",
     "role": "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails",
     "shortName": "Stockholders' Equity - Restricted and Performance Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ib4aca872bf92456a9a20db5fae524392_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476450 - Disclosure - Stockholders' Equity - Fair Value of Awards Granted and Vested (Details)",
     "role": "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
     "shortName": "Stockholders' Equity - Fair Value of Awards Granted and Vested (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "moh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Significant Accounting Policies",
     "role": "http://www.molinahealthcare.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i7c4aed327cc445c2a43b20960c6bced9_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2477451 - Disclosure - Stockholders' Equity - Stock Option Activity (Details)",
     "role": "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails",
     "shortName": "Stockholders' Equity - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2478452 - Disclosure - Stockholders' Equity - Stock Options by Exercise Price (Details)",
     "role": "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails",
     "shortName": "Stockholders' Equity - Stock Options by Exercise Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2480453 - Disclosure - Employee Benefit Plans (Details)",
     "role": "http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails",
     "shortName": "Employee Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SpecialAssessmentBond",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2482454 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SpecialAssessmentBond",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2485455 - Disclosure - Segments - Narrative (Details)",
     "role": "http://www.molinahealthcare.com/role/SegmentsNarrativeDetails",
     "shortName": "Segments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2486456 - Disclosure - Segments - Schedule of Operating Segment Information (Details)",
     "role": "http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails",
     "shortName": "Segments - Schedule of Operating Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i39fce2981d2c41c1a14d47dafdc5e356_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2487457 - Disclosure - Segments - Reconciliation of Gross Margin to Consolidated Income (Details)",
     "role": "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails",
     "shortName": "Segments - Reconciliation of Gross Margin to Consolidated Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i90fb32a216454bb3b23113825fc89cb0_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2490458 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)",
     "role": "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
     "shortName": "Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ifdc0f1c770da44458c1d059bd020a0c3_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "ic5403d7768b644aab47e5ab6d7afe17a_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2491459 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets - Additional Information (Details)",
     "role": "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
     "shortName": "Condensed Financial Information of Registrant - Condensed Balance Sheets - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestAndDividendIncomeOperating",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2492460 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Operations (Details)",
     "role": "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
     "shortName": "Condensed Financial Information of Registrant - Condensed Statements of Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "moh-20201231.htm",
      "contextRef": "i02376445555642e5babc277d1c377aa8_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 114,
   "tag": {
    "country_PR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO",
        "terseLabel": "PUERTO RICO"
       }
      }
     },
     "localname": "PR",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "moh_A4.875SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.875% Senior Notes [Member]",
        "label": "4.875% Senior Notes [Member]",
        "terseLabel": "4.875% Notes"
       }
      }
     },
     "localname": "A4.875SeniorNotesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_A4375SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.375% Senior Notes",
        "label": "4.375% Senior Notes [Member]",
        "terseLabel": "4.375% Notes"
       }
      }
     },
     "localname": "A4375SeniorNotesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_AdvancesToRelatedPartiesAndOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advances to related parties and other assets.",
        "label": "Advances To Related Parties And Other Assets",
        "verboseLabel": "Advances to related parties and other assets"
       }
      }
     },
     "localname": "AdvancesToRelatedPartiesAndOtherAssets",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AffinityHealthPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affinity Health Plan",
        "label": "Affinity Health Plan [Member]",
        "terseLabel": "Affinity Health Plan"
       }
      }
     },
     "localname": "AffinityHealthPlanMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Net Payable",
        "label": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Net Payable",
        "terseLabel": "Risk adjustment, net payable"
       }
      }
     },
     "localname": "AffordableCareActPremiumStabilizationProgramRiskAdjustmentNetPayable",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, (Payable)",
        "label": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, (Payable)",
        "terseLabel": "Marketplace risk adjustment payables"
       }
      }
     },
     "localname": "AffordableCareActPremiumStabilizationProgramRiskAdjustmentPayable",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Receivable",
        "label": "Affordable Care Act, Premium Stabilization Program, Risk Adjustment, Receivable",
        "terseLabel": "Risk adjustment receivable"
       }
      }
     },
     "localname": "AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivable",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AmountsDueToGovernmentAgenciesBusinessCombination": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
       "order": 1.0,
       "parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Due to Government Agencies, Business Combination",
        "label": "Amounts Due to Government Agencies, Business Combination",
        "terseLabel": "Magellan Complete Care"
       }
      }
     },
     "localname": "AmountsDueToGovernmentAgenciesBusinessCombination",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
       "order": 3.0,
       "parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Due To Government Agencies, Marketplace, Medical Loss Ratio Threshold",
        "label": "Amounts Due To Government Agencies, Marketplace, Medical Loss Ratio Threshold",
        "terseLabel": "Minimum MLR"
       }
      }
     },
     "localname": "AmountsDueToGovernmentAgenciesMarketplaceMedicalLossRatioThreshold",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Due To Government Agencies, Marketplace Program [Abstract]",
        "label": "Amounts Due To Government Agencies, Marketplace Program [Abstract]",
        "terseLabel": "Marketplace program:"
       }
      }
     },
     "localname": "AmountsDueToGovernmentAgenciesMarketplaceProgramAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_AmountsDueToGovernmentAgenciesMedicaidOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
       "order": 4.0,
       "parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Due To Government Agencies, Medicaid, Other",
        "label": "Amounts Due To Government Agencies, Medicaid, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "AmountsDueToGovernmentAgenciesMedicaidOther",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AmountsDueToGovernmentAgenciesMedicaidProgramAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Due To Government Agencies, Medicaid Program [Abstract]",
        "label": "Amounts Due To Government Agencies, Medicaid Program [Abstract]",
        "terseLabel": "Medicaid program:"
       }
      }
     },
     "localname": "AmountsDueToGovernmentAgenciesMedicaidProgramAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
       "order": 8.0,
       "parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Due To Government Agencies, Medicare, Medical Loss Ratio And Profit Sharing, Threshold",
        "label": "Amounts Due To Government Agencies, Medicare, Medical Loss Ratio And Profit Sharing, Threshold",
        "terseLabel": "Minimum MLR and profit sharing"
       }
      }
     },
     "localname": "AmountsDueToGovernmentAgenciesMedicareMedicalLossRatioAndProfitSharingThreshold",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AmountsDueToGovernmentAgenciesMedicareProgramAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Due To Government Agencies Medicare Program",
        "label": "Amounts Due To Government Agencies Medicare Program [Abstract]",
        "terseLabel": "Medicare program:"
       }
      }
     },
     "localname": "AmountsDueToGovernmentAgenciesMedicareProgramAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
       "order": 9.0,
       "parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Due to Government Agencies, Risk Adjustment and Part D risk sharing",
        "label": "Amounts Due to Government Agencies, Risk Adjustment and Part D risk sharing",
        "terseLabel": "Risk adjustment and Part D risk sharing"
       }
      }
     },
     "localname": "AmountsDueToGovernmentAgenciesRiskAdjustmentAndPartDRiskSharing",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AmountsDuetoGovernmentAgenciesOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
       "order": 5.0,
       "parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Due to Government Agencies, Other",
        "label": "Amounts Due to Government Agencies, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "AmountsDuetoGovernmentAgenciesOther",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AmountsDuetoGovernmentAgenciesRiskAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
       "order": 6.0,
       "parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Due to Government Agencies, Risk Adjustment",
        "label": "Amounts Due to Government Agencies, Risk Adjustment",
        "terseLabel": "Risk adjustment"
       }
      }
     },
     "localname": "AmountsDuetoGovernmentAgenciesRiskAdjustment",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_AssetsAcquiredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets Acquired",
        "label": "Assets Acquired [Abstract]",
        "terseLabel": "Assets acquired:"
       }
      }
     },
     "localname": "AssetsAcquiredAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Supplemental lease information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "moh_BasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis Of Presentation [Line Items]",
        "label": "Basis Of Presentation [Line Items]",
        "terseLabel": "Basis Of Presentation [Line Items]"
       }
      }
     },
     "localname": "BasisOfPresentationLineItems",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_BasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis Of Presentation [Table]",
        "label": "Basis Of Presentation [Table]",
        "terseLabel": "Basis Of Presentation [Table]"
       }
      }
     },
     "localname": "BasisOfPresentationTable",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Goodwill Deductible For Income Tax Purposes, Percentage",
        "label": "Business Combination, Goodwill Deductible For Income Tax Purposes, Percentage",
        "terseLabel": "Business combination goodwill is deductible for income tax purposes"
       }
      }
     },
     "localname": "BusinessCombinationGoodwillDeductibleForIncomeTaxPurposesPercentage",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_BusinessCombinationNumberOfBusinessCombinations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number Of Business Combinations",
        "label": "Business Combination, Number Of Business Combinations",
        "terseLabel": "Number of business combinations"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfBusinessCombinations",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "moh_BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of members eligible for the health care programs.",
        "label": "Business Combination, Number Of Members Eligible For The Health Care Programs",
        "terseLabel": "Number of members eligible for the health care programs, approximately"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfMembersEligibleForTheHealthCarePrograms",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Liabilities",
        "negatedTerseLabel": "Accounts payable, accrued and other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Amounts Due Government Agencies",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Amounts Due Government Agencies",
        "negatedTerseLabel": "Amounts due government agencies"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAmountsDueGovernmentAgencies",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims and Benefits Payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims and Benefits Payable",
        "negatedTerseLabel": "Medical claims and benefits payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsAndBenefitsPayable",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Investment",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Investment",
        "terseLabel": "Restricted investments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedInvestment",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_CMSSubsidiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CMS Subsidies [Member]",
        "label": "CMS Subsidies [Member]",
        "terseLabel": "CMS Subsidies"
       }
      }
     },
     "localname": "CMSSubsidiesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_COVID19Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19",
        "label": "COVID-19 [Member]",
        "terseLabel": "COVID-19"
       }
      }
     },
     "localname": "COVID19Member",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_CallOptionDerivativeAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Call Option, Derivative Asset [Member]",
        "label": "Call Option, Derivative Asset [Member]",
        "terseLabel": "(Loss) gain on call option"
       }
      }
     },
     "localname": "CallOptionDerivativeAssetMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_CapitationClaimsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitation Claims Payable",
        "label": "Capitation Claims Payable",
        "terseLabel": "Capitation payable"
       }
      }
     },
     "localname": "CapitationClaimsPayable",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_CashConvertibleSeniorNotesDue2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Convertible Senior Notes due 2020 [Member]",
        "label": "Cash Convertible Senior Notes due 2020 [Member]",
        "terseLabel": "1.125% Convertible Notes",
        "verboseLabel": "1.125% Convertible Notes"
       }
      }
     },
     "localname": "CashConvertibleSeniorNotesDue2020Member",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_CashConvertibleSeniorNotesDue2020WarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Convertible Senior Notes Due 2020, Warrants [Member]",
        "label": "Cash Convertible Senior Notes Due 2020, Warrants [Member]",
        "terseLabel": "1.125% Warrants"
       }
      }
     },
     "localname": "CashConvertibleSeniorNotesDue2020WarrantsMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_CashPaidDuringThePeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid During The Period [Abstract]",
        "label": "Cash Paid During The Period [Abstract]",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "CashPaidDuringThePeriodAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_CashPaidForSettlementOfConversionOption": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid For Settlement Of Conversion Option",
        "label": "Cash Paid For Settlement Of Conversion Option",
        "negatedTerseLabel": "Cash paid for partial settlement of conversion option"
       }
      }
     },
     "localname": "CashPaidForSettlementOfConversionOption",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_ChangesInAmountsDueToAndDueFromAffiliates": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes in amounts due to and due from affiliates.",
        "label": "Changes In Amounts Due To And Due From Affiliates",
        "verboseLabel": "Change in amounts due to/from affiliates"
       }
      }
     },
     "localname": "ChangesInAmountsDueToAndDueFromAffiliates",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_ClassOfWarrantOrRightStatedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Stated Interest Rate",
        "label": "Class Of Warrant Or Right, Stated Interest Rate",
        "terseLabel": "Stated interest rate",
        "verboseLabel": "Stated percentage of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightStatedInterestRate",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_CommonStockPurchasesNotSettledAtEndOfPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Purchases Not Settled At End Of Period",
        "label": "Common Stock Purchases Not Settled At End Of Period",
        "terseLabel": "Common stock purchases not settled at end of period"
       }
      }
     },
     "localname": "CommonStockPurchasesNotSettledAtEndOfPeriod",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_CompleteCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete Care",
        "label": "Complete Care [Member]",
        "terseLabel": "Magellan Complete Care"
       }
      }
     },
     "localname": "CompleteCareMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails",
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_CompleteCareReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete Care Receivables",
        "label": "Complete Care Receivables [Member]",
        "terseLabel": "Magellan Complete Care"
       }
      }
     },
     "localname": "CompleteCareReceivablesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components Of Change In Medical Claims And Benefits Payable [Table Text Block]",
        "label": "Components Of Change In Medical Claims And Benefits Payable [Table Text Block]",
        "verboseLabel": "Components of the change in medical claims and benefits payable"
       }
      }
     },
     "localname": "ComponentsOfChangeInMedicalClaimsAndBenefitsPayableTableTextBlock",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "moh_ConsolidatedNetLeverage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Net Leverage",
        "label": "Consolidated Net Leverage",
        "terseLabel": "Net leverage"
       }
      }
     },
     "localname": "ConsolidatedNetLeverage",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "moh_ContractRightsandLicensingAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Rights and Licensing Agreements [Member]",
        "label": "Contract Rights and Licensing Agreements [Member]",
        "terseLabel": "Contract rights and licenses"
       }
      }
     },
     "localname": "ContractRightsandLicensingAgreementsMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_ConvertibleSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes [Member]",
        "label": "Convertible Senior Notes [Member]",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_CovertibleSeniorNotesExchangeTransactionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covertible Senior Notes Exchange Transaction",
        "label": "Covertible Senior Notes Exchange Transaction [Abstract]",
        "terseLabel": "Convertible senior notes exchange transaction:"
       }
      }
     },
     "localname": "CovertibleSeniorNotesExchangeTransactionAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_CurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Assets [Member]",
        "label": "Current Assets [Member]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssetsMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_CurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Liabilities [Member]",
        "label": "Current Liabilities [Member]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_DeferredCompensationPlanDeferralPercentageOfBasicSalary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation plan deferral percentage of basic salary.",
        "label": "Deferred Compensation Plan Deferral Percentage Of Basic Salary",
        "verboseLabel": "Deferred compensation plan deferral percentage of basic salary"
       }
      }
     },
     "localname": "DeferredCompensationPlanDeferralPercentageOfBasicSalary",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_DeferredCompensationPlanDeferralPercentageOfBonus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation plan deferral percentage of bonus.",
        "label": "Deferred Compensation Plan Deferral Percentage Of Bonus",
        "verboseLabel": "Deferred compensation plan deferral percentage of bonus"
       }
      }
     },
     "localname": "DeferredCompensationPlanDeferralPercentageOfBonus",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_DeferredTaxAssetsFixedAssetsAndIntangibles": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Fixed Assets and Intangibles",
        "label": "Deferred Tax Assets, Fixed Assets and Intangibles",
        "terseLabel": "Fixed assets and intangibles"
       }
      }
     },
     "localname": "DeferredTaxAssetsFixedAssetsAndIntangibles",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_DeferredTaxLiabilitiesFixedAssetsAndIntangibles": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Fixed Assets And Intangibles",
        "label": "Deferred Tax Liabilities, Fixed Assets And Intangibles",
        "negatedTerseLabel": "Fixed assets and intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesFixedAssetsAndIntangibles",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_DepreciationAndAmortizationOfCapitalizedSoftware": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails": {
       "order": 1.0,
       "parentTag": "moh_DepreciationandAmortizationContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation, and amortization of capitalized software.",
        "label": "Depreciation And Amortization Of Capitalized Software",
        "verboseLabel": "Amortization of capitalized software"
       }
      }
     },
     "localname": "DepreciationAndAmortizationOfCapitalizedSoftware",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_DepreciationandAmortizationContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation and Amortization, Continuing Operations",
        "label": "Depreciation and Amortization, Continuing Operations",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DepreciationandAmortizationContinuingOperations",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_DetailsofchangeinfairvalueofderivativesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details of change in fair value of derivatives",
        "label": "Details of change in fair value of derivatives [Abstract]",
        "terseLabel": "Details of change in fair value of derivatives, net:"
       }
      }
     },
     "localname": "DetailsofchangeinfairvalueofderivativesAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_DispositionofBusinessReceivablefromBuyer": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_GainLossOnSaleOfBusiness",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposition of Business, Receivable from Buyer",
        "label": "Disposition of Business, Receivable from Buyer",
        "terseLabel": "Cash received from buyers"
       }
      }
     },
     "localname": "DispositionofBusinessReceivablefromBuyer",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_DispositionofBusinessTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_GainLossOnSaleOfBusiness",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposition of Business, Transaction Costs",
        "label": "Disposition of Business, Transaction Costs",
        "negatedTerseLabel": "Transaction costs"
       }
      }
     },
     "localname": "DispositionofBusinessTransactionCosts",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Health Insurance, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Health Insurance, Percent",
        "terseLabel": "Nondeductible health insurer fee (\u201cHIF\u201d)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Worthless Stock Deduction",
        "label": "Effective Income Tax Rate Reconciliation, Worthless Stock Deduction",
        "negatedTerseLabel": "Worthless stock deduction"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationWorthlessStockDeduction",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_EmployeeStockPurchasePlanandStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan and Stock Options [Member]",
        "label": "Employee Stock Purchase Plan and Stock Options [Member]",
        "terseLabel": "Employee stock purchase plan and stock options"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanandStockOptionsMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Plan [Member]",
        "label": "Equity Incentive Plan [Member]",
        "terseLabel": "2019 EIP"
       }
      }
     },
     "localname": "EquityIncentivePlanMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_ExercisePriceRange1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range 1 [Member]",
        "label": "Exercise Price Range 1 [Member]",
        "terseLabel": "$33.02"
       }
      }
     },
     "localname": "ExercisePriceRange1Member",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_ExercisePriceRange2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range 2 [Member]",
        "label": "Exercise Price Range 2 [Member]",
        "terseLabel": "$67.33"
       }
      }
     },
     "localname": "ExercisePriceRange2Member",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_FairMarketValueOfCommonStockPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair market value of common stock, Percentage.",
        "label": "Fair Market Value Of Common Stock Percentage",
        "terseLabel": "Employee purchase price as a percentage of stock price"
       }
      }
     },
     "localname": "FairMarketValueOfCommonStockPercentage",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Of Contingent Consideration Liabilities Assumed In Noncash Investing Or Financing Activities",
        "label": "Fair Value Of Contingent Consideration Liabilities Assumed In Noncash Investing Or Financing Activities",
        "terseLabel": "Fair value of contingent consideration liabilities"
       }
      }
     },
     "localname": "FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_FinanceLeaseAssetsLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Assets, Lessee [Abstract]",
        "label": "Finance Lease, Assets, Lessee [Abstract]",
        "terseLabel": "ROU assets"
       }
      }
     },
     "localname": "FinanceLeaseAssetsLesseeAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance lease expense"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_FinanceLeaseLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liabilities, Lessee [Abstract]",
        "label": "Finance Lease, Liabilities, Lessee [Abstract]",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesLesseeAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_GainLossOnDebtRepayment": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Debt Repayment",
        "label": "Gain (Loss) On Debt Repayment",
        "negatedLabel": "Loss (gain) on debt repayment",
        "terseLabel": "Loss (gain) on debt repayment"
       }
      }
     },
     "localname": "GainLossOnDebtRepayment",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_GainLossonDispositionofLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_GainLossOnSaleOfBusiness",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Disposition of Liabilities",
        "label": "Gain (Loss) on Disposition of Liabilities",
        "terseLabel": "Decrease in carrying amount of liabilities"
       }
      }
     },
     "localname": "GainLossonDispositionofLiabilities",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_GovernmentReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Receivables [Member]",
        "label": "Government Receivables [Member]",
        "terseLabel": "Government receivables"
       }
      }
     },
     "localname": "GovernmentReceivablesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_HealthCareInsuranceFeeLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Insurance, Fee, Liability",
        "label": "Health Care Insurance, Fee, Liability",
        "terseLabel": "HIF liabilities"
       }
      }
     },
     "localname": "HealthCareInsuranceFeeLiability",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_HealthCareOrganizationInsurerFeeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Organization, Insurer Fee Expense",
        "label": "Health Care Organization, Insurer Fee Expense",
        "terseLabel": "Health insurer fees"
       }
      }
     },
     "localname": "HealthCareOrganizationInsurerFeeExpense",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_HealthCareOrganizationRevenuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Organization, Revenue Percentage",
        "label": "Health Care Organization, Revenue Percentage",
        "terseLabel": "Premium revenue percentage"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenuePercentage",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_HealthInsurerFeeReimbursementReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Insurer Fee Reimbursement Receivables [Member]",
        "label": "Health Insurer Fee Reimbursement Receivables [Member]",
        "terseLabel": "Health insurer fee reimbursement receivables"
       }
      }
     },
     "localname": "HealthInsurerFeeReimbursementReceivablesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_HealthPlanContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Plan, Contract Term",
        "label": "Health Plan, Contract Term",
        "terseLabel": "Contract term"
       }
      }
     },
     "localname": "HealthPlanContractTerm",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "moh_HealthPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health plans.",
        "label": "Health Plans [Member]",
        "terseLabel": "Health Plans",
        "verboseLabel": "Health Plans"
       }
      }
     },
     "localname": "HealthPlansMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails",
      "http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_HealthPlansSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Plans Segment",
        "label": "Health Plans Segment [Member]",
        "terseLabel": "Health Plans Segment"
       }
      }
     },
     "localname": "HealthPlansSegmentMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_HealthcareInsurerFeeReimbursedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Insurer Fee Reimbursed",
        "label": "Healthcare Insurer Fee Reimbursed [Member]",
        "terseLabel": "Health insurer fees reimbursed"
       }
      }
     },
     "localname": "HealthcareInsurerFeeReimbursedMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 1.0,
       "parentTag": "moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) Before Income Taxes And Equity In Net Income Of Subsidiaries",
        "label": "Income (Loss) Before Income Taxes And Equity In Net Income Of Subsidiaries",
        "totalLabel": "Loss before income tax (benefit) expense and equity in net earnings of subsidiaries"
       }
      }
     },
     "localname": "IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Medical Premium Liability Due to Agency",
        "label": "Increase (Decrease) In Medical Premium Liability Due To Agency",
        "terseLabel": "Amounts due government agencies"
       }
      }
     },
     "localname": "IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_IncreaseDecreaseinCarryingAmountofAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_GainLossOnSaleOfBusiness",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Carrying Amount of Assets",
        "label": "Increase (Decrease) in Carrying Amount of Assets",
        "terseLabel": "Decrease in carrying amount of assets"
       }
      }
     },
     "localname": "IncreaseDecreaseinCarryingAmountofAssets",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_IncrementalTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Term Loan",
        "label": "Incremental Term Loan [Member]",
        "terseLabel": "Incremental Term Loan"
       }
      }
     },
     "localname": "IncrementalTermLoanMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_InvestmentsAverageMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments, Average Maturity Period",
        "label": "Investments, Average Maturity Period",
        "terseLabel": "Average maturity period (less than)"
       }
      }
     },
     "localname": "InvestmentsAverageMaturityPeriod",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "moh_InvestmentsMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments, Maturity Period",
        "label": "Investments, Maturity Period",
        "terseLabel": "Maturity period (less than)"
       }
      }
     },
     "localname": "InvestmentsMaturityPeriod",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "moh_LetterOfCreditSubFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Letter Of Credit Sub-Facility",
        "label": "Letter Of Credit Sub-Facility [Member]",
        "terseLabel": "Letter Of Credit Sub-Facility"
       }
      }
     },
     "localname": "LetterOfCreditSubFacilityMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_LiabilitiesAssumedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liabilities Assumed",
        "label": "Liabilities Assumed [Abstract]",
        "terseLabel": "Liabilities assumed:"
       }
      }
     },
     "localname": "LiabilitiesAssumedAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Incurred Claims Including Acquisition Adjustment",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Incurred Claims Including Acquisition Adjustment",
        "terseLabel": "Incurred Claims and Allocated Claims Adjustment Expenses"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsIncludingAcquisitionAdjustment",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Paid (IBNP), Fee-for-service Claims, Amount",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Paid (IBNP), Fee-for-service Claims, Amount",
        "terseLabel": "Fee-for-service claims incurred but not paid (\u201cIBNP\u201d)"
       }
      }
     },
     "localname": "LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseIncurredbutNotPaidIBNPFeeforserviceClaimsAmount",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Current Maturities, Net Of Unamortized Premium (Discount)",
        "label": "Long-Term Debt, Current Maturities, Net Of Unamortized Premium (Discount)",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrentMaturitiesNetOfUnamortizedPremiumDiscount",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Noncurrent, Net Of Unamortized Debt Discount",
        "label": "Long-Term Debt, Noncurrent, Net Of Unamortized Debt Discount",
        "terseLabel": "Non-current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrentNetOfUnamortizedDebtDiscount",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_MagellanCompleteCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Magellan Complete Care [Member]",
        "label": "Magellan Complete Care [Member]",
        "terseLabel": "Magellan Complete Care"
       }
      }
     },
     "localname": "MagellanCompleteCareMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_MaineCommunityHealthOptionsv.UnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maine Community Health Options v. United States [Member]",
        "label": "Maine Community Health Options v. United States [Member]",
        "terseLabel": "Maine Community Health Options v. United States"
       }
      }
     },
     "localname": "MaineCommunityHealthOptionsv.UnitedStatesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_MarketplaceRiskCorridorSettlementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketplace Risk Corridor Settlement",
        "label": "Marketplace Risk Corridor Settlement [Member]",
        "terseLabel": "Marketplace risk corridor judgment"
       }
      }
     },
     "localname": "MarketplaceRiskCorridorSettlementMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_MedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid [Member]",
        "label": "Medicaid [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "MedicaidMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_MedicalCareCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Care Costs",
        "label": "Medical Care Costs [Member]",
        "terseLabel": "Medical care costs"
       }
      }
     },
     "localname": "MedicalCareCostsMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_MedicalClaimsAndBenefitsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Claims and Benefits Payable",
        "label": "Medical Claims And Benefits Payable",
        "terseLabel": "Non-risk provide payables"
       }
      }
     },
     "localname": "MedicalClaimsAndBenefitsPayable",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Claims and Benefits Payable, Adjustments, Change in Provider",
        "label": "Medical Claims And Benefits Payable, Adjustments, Change In Provider",
        "terseLabel": "Change in non-risk and other provider payables"
       }
      }
     },
     "localname": "MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_MedicalPremiumLiabilityDueToAgency": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Premium Liability Due to Agency",
        "label": "Medical Premium Liability Due To Agency",
        "terseLabel": "Amounts due government agencies",
        "totalLabel": "Total amounts due government agencies"
       }
      }
     },
     "localname": "MedicalPremiumLiabilityDueToAgency",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_MedicalPremiumsLiabilityMedicalCareCostsThreshold": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
       "order": 2.0,
       "parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Premiums Liability, Medical Care Costs Threshold",
        "label": "Medical Premiums Liability, Medical Care Costs Threshold",
        "terseLabel": "Minimum MLR and profit sharing"
       }
      }
     },
     "localname": "MedicalPremiumsLiabilityMedicalCareCostsThreshold",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_MedicareMedicaidPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare-Medicaid Plans",
        "label": "Medicare-Medicaid Plans [Member]",
        "terseLabel": "MMP Plans"
       }
      }
     },
     "localname": "MedicareMedicaidPlansMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_MunicipalSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Municipal securities.",
        "label": "Municipal Securities [Member]",
        "terseLabel": "Asset-backed securities",
        "verboseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "MunicipalSecuritiesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss) From Continuing Operations Before Equity Method Investments, Extraordinary Items, Noncontrolling Interest",
        "label": "Net Income (Loss) From Continuing Operations Before Equity Method Investments, Extraordinary Items, Noncontrolling Interest",
        "totalLabel": "Net loss before equity in net earnings of subsidiaries"
       }
      }
     },
     "localname": "NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_NoncashRestructuringCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash Restructuring Charges",
        "label": "Non-cash Restructuring Charges",
        "terseLabel": "Non-cash restructuring charges"
       }
      }
     },
     "localname": "NoncashRestructuringCharges",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_NotesIssuedFairValueAdjustmentIncreaseDecrease": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Issued, Fair Value Adjustment Increase (Decrease)",
        "label": "Notes Issued, Fair Value Adjustment Increase (Decrease)",
        "terseLabel": "Component of convertible senior notes allocated to additional paid-in capital, net of income taxes"
       }
      }
     },
     "localname": "NotesIssuedFairValueAdjustmentIncreaseDecrease",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_NumberOfMembersEligibleForTheHealthCarePrograms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of members eligible for the health care programs.",
        "label": "Number Of Members Eligible For The Health Care Programs",
        "terseLabel": "Number of served members"
       }
      }
     },
     "localname": "NumberOfMembersEligibleForTheHealthCarePrograms",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "moh_NumberOfStatesForOperatedHealthPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of States For Operated Health Plans",
        "label": "Number of States For Operated Health Plans",
        "terseLabel": "Number of states for operated health plans"
       }
      }
     },
     "localname": "NumberOfStatesForOperatedHealthPlans",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "moh_OperatingLeaseAssetsLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Assets, Lessee [Abstract]",
        "label": "Operating Lease, Assets, Lessee [Abstract]",
        "terseLabel": "ROU assets"
       }
      }
     },
     "localname": "OperatingLeaseAssetsLesseeAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_OperatingLeaseLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liabilities, Lessee [Abstract]",
        "label": "Operating Lease, Liabilities, Lessee [Abstract]",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesLesseeAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_OperatingLeaseRightOfUseAssetExcludingLeasesAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Right Of Use Asset, Excluding Leases Acquired",
        "label": "Operating Lease Right Of Use Asset, Excluding Leases Acquired",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetExcludingLeasesAcquired",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_OtherClaimsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Claims Payable",
        "label": "Other Claims Payable",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherClaimsPayable",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_OtherGeographicalAreasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Geographical Areas.",
        "label": "Other Geographical Areas [Member]",
        "terseLabel": "Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherGeographicalAreasMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_OtherMedicareProgram": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails": {
       "order": 7.0,
       "parentTag": "moh_MedicalPremiumLiabilityDueToAgency",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Medicare Program",
        "label": "Other Medicare Program",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherMedicareProgram",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAmountsDueToGovernmentAgenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_OtherReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Receivables [Member]",
        "label": "Other Receivables [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherReceivablesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_OtherSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Securities",
        "label": "Other Securities [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSecuritiesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_PassportHealthPlanIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Passport Health Plan Inc",
        "label": "Passport Health Plan Inc [Member]",
        "terseLabel": "Passport Health Plan Inc"
       }
      }
     },
     "localname": "PassportHealthPlanIncMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_PercentageOfAdditionalIncrementalRevenueEarned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of additional incremental revenue earned.",
        "label": "Percentage Of Additional Incremental Revenue Earned",
        "verboseLabel": "Percentage of additional incremental revenue earned"
       }
      }
     },
     "localname": "PercentageOfAdditionalIncrementalRevenueEarned",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_PharmacyClaimsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Claims Payable",
        "label": "Pharmacy Claims Payable",
        "terseLabel": "Pharmacy payable"
       }
      }
     },
     "localname": "PharmacyClaimsPayable",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_PharmacyRebateReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Rebate Receivables [Member]",
        "label": "Pharmacy Rebate Receivables [Member]",
        "terseLabel": "Pharmacy rebate receivables"
       }
      }
     },
     "localname": "PharmacyRebateReceivablesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_PremiumTaxExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An assessment levied by a state government on the net premium income collected.",
        "label": "Premium Tax Expenses",
        "terseLabel": "Premium tax expenses"
       }
      }
     },
     "localname": "PremiumTaxExpenses",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_PremiumTaxRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium Tax Revenue",
        "label": "Premium Tax Revenue [Member]",
        "terseLabel": "Premium tax revenue"
       }
      }
     },
     "localname": "PremiumTaxRevenueMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_ProviderNetworkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provider Network",
        "label": "Provider Network [Member]",
        "terseLabel": "Provider network"
       }
      }
     },
     "localname": "ProviderNetworkMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_ProviderNetworksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provider networks.",
        "label": "Provider Networks [Member]",
        "netLabel": "Provider networks"
       }
      }
     },
     "localname": "ProviderNetworksMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_RecordedInCostOfServiceRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recorded In Cost Of Service Revenue [Abstract]",
        "label": "Recorded In Cost Of Service Revenue [Abstract]",
        "terseLabel": "Recorded in cost of service revenue:"
       }
      }
     },
     "localname": "RecordedInCostOfServiceRevenueAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_RecordedInDepreciationAndAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recorded In Depreciation And Amortization [Abstract]",
        "label": "Recorded In Depreciation And Amortization [Abstract]",
        "terseLabel": "Recorded in depreciation and amortization:"
       }
      }
     },
     "localname": "RecordedInDepreciationAndAmortizationAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_RedemptionPremiumSettledPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption Premium, Settled Percentage",
        "label": "Redemption Premium, Settled Percentage",
        "terseLabel": "Settled percent"
       }
      }
     },
     "localname": "RedemptionPremiumSettledPercentage",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_RestrictedandPerformanceStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted and Performance Stock [Member]",
        "label": "Restricted and Performance Stock [Member]",
        "terseLabel": "RSAs, PSAs and PSUs (defined below)"
       }
      }
     },
     "localname": "RestrictedandPerformanceStockMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_RestrictionsOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restrictions On Investments [Table Text Block]",
        "label": "Restrictions On Investments [Table Text Block]",
        "terseLabel": "Balances of restricted investments"
       }
      }
     },
     "localname": "RestrictionsOnInvestmentsTableTextBlock",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "moh_RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability [Abstract]",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability [Abstract]",
        "terseLabel": "ROU assets recognized in exchange for lease obligations:"
       }
      }
     },
     "localname": "RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityAbstract",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "moh_RisksAndUncertaintiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risks and uncertainties.",
        "label": "Risks And Uncertainties [Policy Text Block]",
        "verboseLabel": "Risks and Uncertainties"
       }
      }
     },
     "localname": "RisksAndUncertaintiesPolicyTextBlock",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "moh_SeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Due 2022 [Member]",
        "label": "Senior Notes Due 2022 [Member]",
        "terseLabel": "5.375% Notes"
       }
      }
     },
     "localname": "SeniorNotesDue2022Member",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value",
        "terseLabel": "Fair value of restricted shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award maximum amount per employee.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Amount Per Employee",
        "terseLabel": "Maximum annual contribution per employee"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Outstanding Liabilities Relating to Prior Years",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Outstanding Liabilities Relating to Prior Years",
        "terseLabel": "All outstanding liabilities before 2018"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimAdjustmentExpenseOutstandingLiabilitiesRelatingtoPriorYears",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "moh_StructuredSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structured Securities [Member]",
        "label": "Structured Securities [Member]",
        "terseLabel": "Structured Securities"
       }
      }
     },
     "localname": "StructuredSecuritiesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_SummarizedPremiumRevenueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarized Premium Revenue",
        "label": "SummarizedPremiumRevenue [Table Text Block]",
        "terseLabel": "Summarized premium revenue"
       }
      }
     },
     "localname": "SummarizedPremiumRevenueTableTextBlock",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "moh_SwinglineSubFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swingline Sub Facility",
        "label": "Swingline Sub Facility [Member]",
        "terseLabel": "Swingline Sub Facility"
       }
      }
     },
     "localname": "SwinglineSubFacilityMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_TaxesBasedOnPremiumsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taxes based on premiums.",
        "label": "Taxes Based On Premiums [Policy Text Block]",
        "verboseLabel": "Taxes Based on Premiums"
       }
      }
     },
     "localname": "TaxesBasedOnPremiumsPolicyTextBlock",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "moh_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]",
        "verboseLabel": "Term loan facility"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_ThreePointEightSevenFivePercentSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Point Eight Seven Five Percent Senior Notes",
        "label": "Three Point Eight Seven Five Percent Senior Notes [Member]",
        "terseLabel": "3.875% Notes"
       }
      }
     },
     "localname": "ThreePointEightSevenFivePercentSeniorNotesMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_TradeNameMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade Name",
        "label": "Trade Name [Member]",
        "terseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNameMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "moh_UnrecognizedCompensationForfeitedRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized compensation forfeited rate.",
        "label": "Unrecognized Compensation Forfeited Rate",
        "verboseLabel": "Unrecognized compensation forfeited rate"
       }
      }
     },
     "localname": "UnrecognizedCompensationForfeitedRate",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "moh_WeightedAverageNumberofSharesIssuedConversionofSeniorNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Number of Shares Issued, Conversion of Senior Notes",
        "label": "Weighted Average Number of Shares Issued, Conversion of Senior Notes",
        "terseLabel": "Conversion of convertible senior notes (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberofSharesIssuedConversionofSeniorNotes",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "moh_WeightedAverageNumberofSharesShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Number of Shares, Share Based Compensation",
        "label": "Weighted Average Number of Shares, Share Based Compensation",
        "terseLabel": "Stock-based compensation (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberofSharesShareBasedCompensation",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "moh_YourCareHealthPlanIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Your Care Health Plan Inc",
        "label": "Your Care Health Plan Inc [Member]",
        "terseLabel": "Your Care Health Plan Inc"
       }
      }
     },
     "localname": "YourCareHealthPlanIncMember",
     "nsuri": "http://www.molinahealthcare.com/20201231",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Information Disclosure [Abstract]",
        "terseLabel": "Condensed Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Financial Statements, Captions [Line Items]",
        "terseLabel": "Condensed Financial Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r442",
      "r443",
      "r448",
      "r449",
      "r654",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r442",
      "r443",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r175",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r195",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r175",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r195",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r129",
      "r134",
      "r240",
      "r370",
      "r371",
      "r372",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adoption of new accounting standards"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r129",
      "r134",
      "r240",
      "r370",
      "r371",
      "r372",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r129",
      "r134",
      "r240",
      "r370",
      "r371",
      "r372",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r205",
      "r317",
      "r321",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r336",
      "r338",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r542",
      "r612",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails",
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r336",
      "r338",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r542",
      "r612",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails",
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r205",
      "r317",
      "r321",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ParentCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The registrant that controls, directly or indirectly, another entity (or entities). The usual condition for control is ownership of a majority (over 50%) of the outstanding voting stock. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders or by court decree.",
        "label": "Parent Company [Member]",
        "terseLabel": "Parent Company"
       }
      }
     },
     "localname": "ParentCompanyMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r201",
      "r317",
      "r319",
      "r543",
      "r611",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r201",
      "r317",
      "r319",
      "r543",
      "r611",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r325",
      "r336",
      "r338",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r542",
      "r612",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails",
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r325",
      "r336",
      "r338",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r542",
      "r612",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails",
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "verboseLabel": "Condensed balance sheets"
       }
      }
     },
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.",
        "label": "Condensed Cash Flow Statement [Table Text Block]",
        "verboseLabel": "Condensed statements of cash flows"
       }
      }
     },
     "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "auth_ref": [
      "r123",
      "r439",
      "r668",
      "r670",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.",
        "label": "Condensed Financial Statements [Table]",
        "terseLabel": "Condensed Financial Statements [Table]",
        "verboseLabel": "Schedule of Condensed Financial Statements [Table]"
       }
      }
     },
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.",
        "label": "Condensed Income Statement [Table Text Block]",
        "verboseLabel": "Condensed statements of income"
       }
      }
     },
     "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r202",
      "r203",
      "r317",
      "r320",
      "r614",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r202",
      "r203",
      "r317",
      "r320",
      "r614",
      "r640",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r665",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "California"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_FL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FLORIDA",
        "netLabel": "Florida",
        "terseLabel": "Florida"
       }
      }
     },
     "localname": "FL",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ILLINOIS",
        "terseLabel": "Illinois"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_KY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "KENTUCKY",
        "terseLabel": "Kentucky"
       }
      }
     },
     "localname": "KY",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MICHIGAN",
        "terseLabel": "Michigan"
       }
      }
     },
     "localname": "MI",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NM": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW MEXICO",
        "terseLabel": "New Mexico"
       }
      }
     },
     "localname": "NM",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK",
        "terseLabel": "New York"
       }
      }
     },
     "localname": "NY",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OHIO",
        "terseLabel": "Ohio",
        "verboseLabel": "Ohio"
       }
      }
     },
     "localname": "OH",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TEXAS",
        "terseLabel": "Texas"
       }
      }
     },
     "localname": "TX",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WASHINGTON",
        "terseLabel": "Washington"
       }
      }
     },
     "localname": "WA",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Statutory Accounting Practices [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "verboseLabel": "Accounts payable, accrued liabilities and other"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r32",
      "r278"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTotalLabel": "Total accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r21",
      "r56",
      "r58",
      "r59",
      "r585",
      "r621",
      "r622"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r55",
      "r59",
      "r60",
      "r126",
      "r127",
      "r128",
      "r446",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquisitionCosts": {
     "auth_ref": [
      "r546",
      "r547"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.",
        "label": "Acquisition Costs, Period Cost",
        "terseLabel": "Acquisition costs"
       }
      }
     },
     "localname": "AcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r370",
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": {
     "auth_ref": [
      "r298",
      "r303",
      "r407"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.",
        "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature",
        "terseLabel": "Exchange of convertible senior notes",
        "totalLabel": "Net increase to additional paid-in capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Termination of warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r170",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails",
      "http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r341",
      "r367",
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "verboseLabel": "Pretax Charges"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "verboseLabel": "Net-of-Tax Amount"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r102",
      "r266",
      "r272"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails": {
       "order": 3.0,
       "parentTag": "moh_DepreciationandAmortizationContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restricted net assets of consolidated and unconsolidated subsidiaries as of the end of the most recently completed fiscal year.",
        "label": "Amount of Restricted Net Assets for Consolidated and Unconsolidated Subsidiaries",
        "verboseLabel": "Net assets of subsidiaries subject to restrictions"
       }
      }
     },
     "localname": "AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r229",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "netLabel": "Municipal securities",
        "terseLabel": "Municipal securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r114",
      "r183",
      "r190",
      "r197",
      "r239",
      "r442",
      "r448",
      "r471",
      "r551",
      "r582"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
      "http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r46",
      "r114",
      "r239",
      "r442",
      "r448",
      "r471"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Total current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Fair value of assets measured on recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r219"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "terseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r217",
      "r248"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r221",
      "r224",
      "r570"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r223"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r221",
      "r223",
      "r569"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r221",
      "r225",
      "r571"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r222"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r221",
      "r222",
      "r568"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value",
        "totalLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r214",
      "r218",
      "r248",
      "r556"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Debt securities, available-for-sale",
        "verboseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r343",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r451",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and improvements",
        "verboseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r335",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r335",
      "r337",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total revenue reported by the acquired entity for its previous full fiscal year before the business acquisition.",
        "label": "Business Acquisition, Revenue Reported by Acquired Entity for Last Annual Period",
        "terseLabel": "Revenue of acquired business"
       }
      }
     },
     "localname": "BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r422",
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Pro forma earnings"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r422",
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Pro forma revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r432",
      "r433",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r431",
      "r434",
      "r437"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "verboseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets value"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net purchase price paid"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r111",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations and Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": {
     "auth_ref": [
      "r655"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.",
        "label": "Capitalized Computer Software, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization - capitalized software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r5",
      "r28",
      "r104"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "netLabel": "Cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r105",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "verboseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "terseLabel": "Cash, cash equivalents, and investments"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r97",
      "r104",
      "r110"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, and restricted cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period",
        "totalLabel": "Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r97",
      "r472"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "verboseLabel": "Schedule of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificate of deposit",
        "verboseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r305",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r226",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage Backed Securities [Member]",
        "terseLabel": "Mortgage-backed securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r126",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r17",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common stock, shares, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "netLabel": "Common stock, $0.001 par value; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019",
        "verboseLabel": "Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r323",
      "r324",
      "r339",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "verboseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/EmployeeBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "verboseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r63",
      "r65",
      "r66",
      "r71",
      "r560",
      "r593"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r267",
      "r270",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r164",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "verboseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r123",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.",
        "label": "Condensed Financial Information of Parent Company Only Disclosure [Text Block]",
        "verboseLabel": "Condensed Financial Information of Registrant"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrant"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation and Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r307",
      "r308",
      "r318"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contract rights - member list"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r326",
      "r333",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "netLabel": "Corporate debt securities",
        "terseLabel": "Corporate debt securities",
        "verboseLabel": "Mortgage-backed securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
      "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r77",
      "r543"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "verboseLabel": "Amortization of capitalized software and deferred contract costs"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.",
        "label": "Cost, Depreciation and Amortization",
        "totalLabel": "Total depreciation and amortization recognized"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "negatedTerseLabel": "Less: Other operating expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r404",
      "r412"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "verboseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r404"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r404",
      "r412",
      "r414"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "verboseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r404",
      "r412"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "verboseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r552",
      "r554",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails",
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r13",
      "r294",
      "r554",
      "r580"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Net carrying amount of debt",
        "totalLabel": "Net carrying amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r482",
      "r484"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Incremental term loans",
        "verboseLabel": "Aggregate principal amount of notes outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair values of long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "netLabel": "Percentage of contractual interest rate on notes",
        "terseLabel": "Debt instrument, interest rate, stated percentage",
        "verboseLabel": "Percentage of contractual interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails",
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r40",
      "r118",
      "r299",
      "r300",
      "r301",
      "r302",
      "r481",
      "r482",
      "r484",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Agreement term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r233",
      "r251",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r233",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Total Number of Positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Gain",
        "terseLabel": "Gross realized investment gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r232",
      "r250",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "verboseLabel": "Available-for-sale investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "verboseLabel": "Liability for unrecognized tax benefits, potential decrease"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r405",
      "r412"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "verboseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r33",
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Deferred issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r33",
      "r483"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "negatedTerseLabel": "Less: debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r405",
      "r412"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r380",
      "r381"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r115",
      "r405",
      "r412",
      "r413",
      "r414"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "verboseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r14",
      "r15",
      "r395",
      "r553",
      "r579"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r405",
      "r412"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r397"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred income tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r397"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred income tax assets, net of valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "verboseLabel": "Net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r400",
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credit carryover"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "verboseLabel": "Other accrued medical costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "verboseLabel": "Accrued expenses and reserve liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent",
        "terseLabel": "Lease financing obligation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the unearned premiums reserve.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Unearned Premiums Reserve",
        "verboseLabel": "Unearned premiums"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance",
        "verboseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on trading securities.",
        "label": "Deferred Tax Liabilities, Unrealized Gains on Trading Securities",
        "negatedTerseLabel": "Unrealized gains and losses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "verboseLabel": "Expense recognized in connection with contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "verboseLabel": "Maximum matching contribution by employer under defined contribution plan"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/EmployeeBenefitPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepositLiabilitiesAccruedInterest": {
     "auth_ref": [
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued but unpaid interest on deposit liabilities.",
        "label": "Deposit Liabilities, Accrued Interest",
        "terseLabel": "Unpaid interest"
       }
      }
     },
     "localname": "DepositLiabilitiesAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r102",
      "r276"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails": {
       "order": 2.0,
       "parentTag": "moh_DepreciationandAmortizationContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "verboseLabel": "Depreciation and amortization of furniture, equipment, building, and improvements"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r102",
      "r276"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r102",
      "r178"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r49",
      "r50",
      "r468"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Call option derivative asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r48",
      "r51",
      "r454",
      "r524"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r48",
      "r51",
      "r454",
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "verboseLabel": "Derivative liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFinancialInstrumentsAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender).",
        "label": "Derivative Financial Instruments, Assets [Member]",
        "terseLabel": "Call option derivative asset"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Change in fair value of derivatives, net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r452",
      "r455",
      "r458",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r49",
      "r50",
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Conversion option derivative liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r343",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "verboseLabel": "Stock based compensation expense"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r2"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "terseLabel": "Disposal group, operating expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r72",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r140",
      "r143",
      "r152",
      "r153",
      "r154",
      "r158",
      "r159",
      "r561",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r72",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r143",
      "r152",
      "r153",
      "r154",
      "r158",
      "r159",
      "r561",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r383"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax expense rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r383",
      "r415"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory federal tax (benefit) rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r383",
      "r415"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Nondeductible compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r383",
      "r415"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r383",
      "r415"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income provision (benefit), net of federal"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesReconciliationoftheUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmbeddedDerivativeFinancialInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument embedded in host contract.",
        "label": "Embedded Derivative Financial Instruments [Member]",
        "terseLabel": "Gain (loss) on conversion option",
        "verboseLabel": "Conversion option derivative liability"
       }
      }
     },
     "localname": "EmbeddedDerivativeFinancialInstrumentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period for recognition",
        "verboseLabel": "Weighted average period of unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r131",
      "r137",
      "r139",
      "r161",
      "r240",
      "r298",
      "r303",
      "r370",
      "r371",
      "r372",
      "r408",
      "r409",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r464",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Fair value measurements of senior notes"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Fair value of assets measured on recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r460",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsBalanceSheetGroupingDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r460",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair value, by balance sheet grouping"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r461",
      "r514",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r460",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r326",
      "r327",
      "r332",
      "r333",
      "r461",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r326",
      "r327",
      "r332",
      "r333",
      "r461",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r461",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r514",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r107",
      "r108",
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "negatedTerseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r488",
      "r497",
      "r505"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "moh_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r491",
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance lease expense:",
        "verboseLabel": "Finance"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails",
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r486",
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total finance lease liabilities",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails",
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Accounts payable and accrued liabilities (current)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance lease maturities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "netLabel": "Finance lease liabilities",
        "terseLabel": "Finance lease liabilities (non-current)",
        "verboseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Subtotal - undiscounted lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r490",
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r485"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "ROU assets - finance leases",
        "verboseLabel": "Property, equipment, and capitalized software, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r488",
      "r497",
      "r505"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "moh_FinanceLeaseCost",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails": {
       "order": 4.0,
       "parentTag": "moh_DepreciationandAmortizationContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of finance leases",
        "verboseLabel": "Amortization of ROU assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetDepreciationandAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r502",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases, weighted average discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r501",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases, weighted average remaining lease term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r229",
      "r230",
      "r241",
      "r244",
      "r245",
      "r246",
      "r247",
      "r250",
      "r252",
      "r253",
      "r254",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
      "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful life",
        "verboseLabel": "Intangible asset useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.",
        "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]",
        "terseLabel": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "verboseLabel": "Future amortization expense, 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "verboseLabel": "Future amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "verboseLabel": "Future amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "Future amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "verboseLabel": "Future amortization expense, 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r267",
      "r268",
      "r271",
      "r274",
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "verboseLabel": "Future Amortization Expenses"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r271",
      "r545"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r267",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r271",
      "r544"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Intangible assets amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and equipment",
        "verboseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "auth_ref": [
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "terseLabel": "Recognized loss"
       }
      }
     },
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r102",
      "r447"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Loss on sales of subsidiaries, net of gain",
        "totalLabel": "Loss on sale of subsidiaries, net of gain"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r102",
      "r295",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Debt repayment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r255",
      "r257",
      "r550"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r111",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r258",
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Gross goodwill"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r258",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r102",
      "r256",
      "r261",
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Impairment and other"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Dispositions"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r76",
      "r114",
      "r183",
      "r189",
      "r193",
      "r196",
      "r199",
      "r239",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Margin",
        "verboseLabel": "Total margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails",
      "http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCarePremiumMember": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money received from insurance for service provided for maintenance, diagnosis and treatment of physical and mental health.",
        "label": "Health Care, Premium [Member]",
        "terseLabel": "Premium revenue"
       }
      }
     },
     "localname": "HealthCarePremiumMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount": {
     "auth_ref": [
      "r228",
      "r567"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Amortized Cost, Due one year through five years"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount": {
     "auth_ref": [
      "r227",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Amortized Cost, Due in one year or less"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r120",
      "r183",
      "r189",
      "r193",
      "r196",
      "r199"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income tax expense",
        "totalLabel": "Income before income tax expense"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromSubsidiariesNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) of subsidiary attributable to the parent entity.",
        "label": "Income (Loss) from Subsidiaries, Net of Tax",
        "terseLabel": "Equity in net earnings of subsidiaries"
       }
      }
     },
     "localname": "IncomeLossFromSubsidiariesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]",
        "verboseLabel": "Condensed Statements of Income"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r384",
      "r393",
      "r399",
      "r410",
      "r416",
      "r418",
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r138",
      "r139",
      "r181",
      "r382",
      "r411",
      "r417",
      "r596"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 2.0,
       "parentTag": "moh_NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax (benefit) expense",
        "totalLabel": "Income tax expense",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r67",
      "r111",
      "r378",
      "r379",
      "r393",
      "r394",
      "r398",
      "r406",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable, accrued liabilities and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in health care insurance liability balances during the period.",
        "label": "Increase (Decrease) in Health Care Insurance Liabilities",
        "verboseLabel": "Medical claims and benefits payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities, net of the effect of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPremiumsReceivable": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the premium receivable balance on the balance sheet.",
        "label": "Increase (Decrease) in Premiums Receivable",
        "negatedTerseLabel": "Reduction in premiums"
       }
      }
     },
     "localname": "IncreaseDecreaseInPremiumsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r154"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Warrants (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r149",
      "r150",
      "r154"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Convertible senior notes (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r144",
      "r145",
      "r147",
      "r154"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "verboseLabel": "Share-based compensation (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]",
        "terseLabel": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceAgencyManagementFee": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees earned during the period for providing management services.",
        "label": "Insurance Agency Management Fee",
        "verboseLabel": "Administrative services fees"
       }
      }
     },
     "localname": "InsuranceAgencyManagementFee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceRecoveries": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recovered from insurance. These recoveries reduce costs and losses that are reported as a separate line item under operating expenses.",
        "label": "Insurance Recoveries",
        "terseLabel": "Reinsurance recoveries"
       }
      }
     },
     "localname": "InsuranceRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "terseLabel": "Goodwill and intangible assets, net",
        "verboseLabel": "Goodwill and intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.",
        "label": "Interest and Dividend Income, Operating",
        "verboseLabel": "Investment income and other revenue"
       }
      }
     },
     "localname": "InterestAndDividendIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r68",
      "r177",
      "r480",
      "r483",
      "r563"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 2.0,
       "parentTag": "moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries",
       "weight": -1.0
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r96",
      "r98",
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "verboseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r238",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "verboseLabel": "Contractual maturities of investments"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in subsidiaries"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r236",
      "r548",
      "r572",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of lease expense and supplemental consolidated cash flow information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Finance Lease, Description [Abstract]",
        "terseLabel": "Finance leases:"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Remaining Lease Term",
        "terseLabel": "Finance lease, remaining lease term"
       }
      }
     },
     "localname": "LesseeFinanceLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeaseRenewalTerm1": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Renewal Term",
        "terseLabel": "Finance lease renewal term"
       }
      }
     },
     "localname": "LesseeFinanceLeaseRenewalTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails",
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails",
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Description [Abstract]",
        "terseLabel": "Operating leases:"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Operating lease maturities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Subtotal - undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Operating lease, remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r114",
      "r191",
      "r239",
      "r443",
      "r448",
      "r449",
      "r471"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r114",
      "r239",
      "r471",
      "r555",
      "r588"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "terseLabel": "Total liabilities and stockholders\u2019 equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r107",
      "r108",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "terseLabel": "Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r38",
      "r114",
      "r239",
      "r443",
      "r448",
      "r449",
      "r471"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r602",
      "r605"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Medical claims and benefits payable, ending balance",
        "periodStartLabel": "Medical claims and benefits payable, beginning balance",
        "terseLabel": "Total",
        "verboseLabel": "Medical claims and benefits payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableMedicalClaimsandFutureBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquisition - Magellan Complete Care"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Payments for medical care costs related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "verboseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "verboseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": {
     "auth_ref": [
      "r623"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount",
        "verboseLabel": "Total IBNP"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r603"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "terseLabel": "Incurred Claims and Allocated Claims Adjustment Expenses",
        "totalLabel": "Total medical care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Components of medical care costs related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r13",
      "r554",
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Amount outstanding under Letter of Credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r34",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "netLabel": "Term loan facility",
        "verboseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "totalLabel": "Total (1)"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r124",
      "r291"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r124",
      "r291"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "verboseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r124",
      "r291"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r124",
      "r291"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r124",
      "r291"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r124",
      "r291"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "netLabel": "Long-term debt",
        "totalLabel": "Total",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "verboseLabel": "Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails",
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r40",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails",
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r287",
      "r288",
      "r289"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Summary judgement"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r6",
      "r37"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Other Operating"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r216",
      "r326",
      "r327",
      "r333",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by mortgage loans.",
        "label": "Collateralized Mortgage Backed Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash used in financing activities:",
        "verboseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r97",
      "r100",
      "r103"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Net cash provided by operating activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash used in operating activities:",
        "verboseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r61",
      "r64",
      "r70",
      "r103",
      "r114",
      "r130",
      "r132",
      "r133",
      "r134",
      "r135",
      "r138",
      "r139",
      "r151",
      "r183",
      "r189",
      "r193",
      "r196",
      "r199",
      "r239",
      "r471",
      "r559",
      "r592"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements Adopted and Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedLabel": "Less: other expenses, net",
        "negatedTotalLabel": "Total other expenses, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesIssued1": {
     "auth_ref": [
      "r107",
      "r108",
      "r109"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of notes issued in noncash investing and financing activities.",
        "label": "Notes Issued",
        "terseLabel": "Common stock issued in exchange for convertible senior notes"
       }
      }
     },
     "localname": "NotesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments",
        "verboseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
      "http://www.molinahealthcare.com/role/SegmentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which company operates (in state)"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r183",
      "r189",
      "r193",
      "r196",
      "r199"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 1.0,
       "parentTag": "moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r498",
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease, expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesLeaseMaturitiesDetails",
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Accounts payable and accrued liabilities (current)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Other long-term liabilities (non-current)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r492",
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Total other assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r502",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases, weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r501",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases, weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r4",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "verboseLabel": "Organization and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r62",
      "r65",
      "r440",
      "r441",
      "r445"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss), net",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r53",
      "r56",
      "r235"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Unrealized investment income (loss)",
        "verboseLabel": "Unrealized investment income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r54",
      "r57"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Less: effect of income taxes",
        "verboseLabel": "Less: effect of income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Cost and Expense, Operating",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpenses": {
     "auth_ref": [
      "r80",
      "r598"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense classified as other.",
        "label": "Other Expenses",
        "terseLabel": "Total other expenses, net"
       }
      }
     },
     "localname": "OtherExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other expenses, net:"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 3.0,
       "parentTag": "moh_IncomeLossBeforeIncomeTaxesAndEquityInNetIncomeOfSubsidiaries",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other expenses (income), net",
        "negatedTerseLabel": "Other expenses (income), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.",
        "label": "Payment for Contingent Consideration Liability, Investing Activities",
        "terseLabel": "Total purchase consideration paid"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r99",
      "r604"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r85",
      "r89",
      "r123"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Common stock purchases",
        "terseLabel": "Common stock purchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfWarrants": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.",
        "label": "Payments for Repurchase of Warrants",
        "negatedTerseLabel": "Cash paid for partial termination of warrants",
        "verboseLabel": "Cash paid for partial termination of 1.125% Warrants"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of noncontrolling interest during the period.",
        "label": "Payments to Acquire Additional Interest in Subsidiaries",
        "negatedTerseLabel": "Capital contributions to subsidiaries"
       }
      }
     },
     "localname": "PaymentsToAcquireAdditionalInterestInSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r86",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedTerseLabel": "Net cash paid in business combinations",
        "terseLabel": "Preliminary closing adjustments"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Net cash paid in business combinations",
        "terseLabel": "Net cash paid in business combinations"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r215"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, equipment and capitalized software"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "PSAs"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r343",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r597"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "terseLabel": "Other operating expenses, net"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]",
        "terseLabel": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, par value (dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "verboseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "verboseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding",
        "verboseLabel": "Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r558",
      "r591",
      "r599",
      "r631"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premium revenue"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r207",
      "r209",
      "r242",
      "r243",
      "r581"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.",
        "label": "Premium Receivable, Allowance for Credit Loss",
        "terseLabel": "Premium deficiency reserve"
       }
      }
     },
     "localname": "PremiumsReceivableAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r26",
      "r27"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidReinsurancePremiums": {
     "auth_ref": [
      "r601",
      "r635"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The unexpired portion of premiums ceded on policies in force as of the balance sheet date.",
        "label": "Prepaid Reinsurance Premiums",
        "terseLabel": "Prepaid reinsurance premiums"
       }
      }
     },
     "localname": "PrepaidReinsurancePremiums",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Cash received for partial settlement of call option"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled.",
        "label": "Proceeds from Divestiture of Interest in Subsidiaries and Affiliates",
        "terseLabel": "Net cash received from sale of subsidiaries"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Divestiture of Interest in Subsidiaries and Affiliates [Abstract]",
        "terseLabel": "Details of sales of subsidiaries:"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliatesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromDividendsReceived": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends received on equity and other investments during the current period.",
        "label": "Proceeds from Dividends Received",
        "terseLabel": "Dividends received from subsidiaries"
       }
      }
     },
     "localname": "ProceedsFromDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-term Debt",
        "terseLabel": "Proceeds from senior notes offerings, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r90",
      "r119"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from borrowings under term loan facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r91",
      "r94",
      "r123"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales and maturities of investments",
        "verboseLabel": "Proceeds from sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r47",
      "r279",
      "r497"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property, equipment, and capitalized software, net",
        "totalLabel": "Property, equipment, and capitalized software, net",
        "verboseLabel": "Property, equipment, and capitalized software, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r32",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r281",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "verboseLabel": "Property, Equipment, and Capitalized Software, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r31",
      "r277"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Total cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Magellan Complete Care"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of depreciation (related to long-lived, depreciable flight assets owned by the entity and used in the entity's principle business operations and capitalized assets classified as property, plant and equipment that are owned by the entity) that has been recognized in the income statement.",
        "label": "Property, Plant, and Equipment, Owned, Accumulated Depreciation",
        "negatedTerseLabel": "Less: accumulated depreciation and amortization - furniture, equipment, building, and improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOwnedAccumulatedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r30",
      "r111",
      "r279",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "Long-Lived Assets, including Intangible Assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r10",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Summary of property and equipment and depreciation and amortization recognized"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r10",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful life of property plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r18",
      "r25",
      "r589",
      "r637"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Total receivables",
        "verboseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r208",
      "r211",
      "r212",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "verboseLabel": "Unrecognized tax benefits roll forward"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceAccountingPolicy": {
     "auth_ref": [
      "r111",
      "r576",
      "r577",
      "r632",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.",
        "label": "Reinsurance Accounting Policy [Policy Text Block]",
        "terseLabel": "Reinsurance"
       }
      }
     },
     "localname": "ReinsuranceAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r578",
      "r600",
      "r602",
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "terseLabel": "Reinsurance recoverable"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrent": {
     "auth_ref": [
      "r122",
      "r507"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date within one year where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.",
        "label": "Related Party Transaction, Due from (to) Related Party, Current",
        "terseLabel": "Due from affiliates"
       }
      }
     },
     "localname": "RelatedPartyTransactionDueFromToRelatedPartyCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "negatedLabel": "Repayment of principal amount of convertible notes",
        "negatedTerseLabel": "Repayment of principal amount of convertible senior notes"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtConvertibleNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r93",
      "r119"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Repayment of credit facility",
        "terseLabel": "Repayment of credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedLabel": "Repayment of term loan facility",
        "negatedTerseLabel": "Repayment of term loan facility"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedTerseLabel": "Repayment of senior notes"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReservesReportedToOtherAgenciesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of reserves reported to other federal agencies or authorities.",
        "label": "Reserves Reported to Other Agencies [Table Text Block]",
        "terseLabel": "Amounts due to government agencies"
       }
      }
     },
     "localname": "ReservesReportedToOtherAgenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r9",
      "r104",
      "r110",
      "r549",
      "r584"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash and cash equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedInvestmentsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the noncurrent portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions.",
        "label": "Restricted Investments, Noncurrent",
        "verboseLabel": "Restricted investments"
       }
      }
     },
     "localname": "RestrictedInvestmentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "RSAs"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "PSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r303",
      "r373",
      "r586",
      "r620",
      "r622"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r131",
      "r137",
      "r139",
      "r240",
      "r370",
      "r371",
      "r372",
      "r408",
      "r409",
      "r617",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r112",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Medical Claims and Benefits Payable"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r75",
      "r638"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "verboseLabel": "Services revenue from subsidiaries"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue that is not accounted for under Topic 606.",
        "label": "Revenue Not from Contract with Customer",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueNotFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r69",
      "r114",
      "r174",
      "r175",
      "r188",
      "r194",
      "r195",
      "r201",
      "r202",
      "r205",
      "r239",
      "r471",
      "r564"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenue",
        "totalLabel": "Total revenue",
        "verboseLabel": "Add: Other operating revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails",
      "http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:",
        "verboseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtCreditAgreementDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r500",
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r500",
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of receivables"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Summary of intangible assets acquired"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/BusinessCombinationsSummarizesthePreliminaryValuesoftheAssetsacquiredandLiabilitiesAssumedattheDateofAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Summary of assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "verboseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Condensed statements of comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r40",
      "r118",
      "r299",
      "r300",
      "r301",
      "r302",
      "r481",
      "r482",
      "r484",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "verboseLabel": "Long term debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "verboseLabel": "Significant components of deferred tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Summary of denominators for the computation of basic and diluted earnings per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r143",
      "r148",
      "r152",
      "r154",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "verboseLabel": "Effective income tax rate reconciliation to the statutory federal income tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r267",
      "r270",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r267",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "verboseLabel": "Summary of identified intangible assets, by major class"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r263",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r263",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Held-to-maturity Securities [Line Items]",
        "terseLabel": "Schedule of Held-to-maturity Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": {
     "auth_ref": [
      "r229",
      "r230",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity [Table]",
        "terseLabel": "Debt Securities, Held-to-maturity [Table]"
       }
      }
     },
     "localname": "ScheduleOfHeldToMaturitySecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of liability for unpaid claims and claims adjustment expense"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "verboseLabel": "Maturities of long-term debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "verboseLabel": "Restricted and performance stock activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r32",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r116",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantNotestoCondensedFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r9",
      "r110",
      "r549",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Restricted cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r69",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r183",
      "r186",
      "r192",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails",
      "http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r183",
      "r186",
      "r192",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Operating segment information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r343",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Stock option plans, by exercise price range"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r348",
      "r358",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock options, activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r170",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r205",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails",
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails",
      "http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r170",
      "r172",
      "r173",
      "r183",
      "r187",
      "r193",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r204",
      "r205",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/Segments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails",
      "http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtMaturitiesDetails",
      "http://www.molinahealthcare.com/role/DebtScheduleofLongTermDebtDetails",
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails",
      "http://www.molinahealthcare.com/role/FairValueMeasurementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Maximum award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested balance, shares end of period (in shares)",
        "periodStartLabel": "Unvested balance, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "RSAs and PSUs"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested balance, ending balance (USD per share)",
        "periodStartLabel": "Unvested balance, beginning balance (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "verboseLabel": "Weighted Average Grant\u00a0Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of restricted shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Maximum expected volatility rate inputs for fair value measurement"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Minimum expected volatility rate inputs for fair value measurement"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares issued under ESPP (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercisable (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r350",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance, outstanding (in shares)",
        "periodStartLabel": "Beginning balance, outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance, outstanding (usd per share)",
        "periodStartLabel": "Beginning balance, outstanding (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Stock options exercisable and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Stock options exercisable and expected to vest (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r340",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityComponentsofSharebasedCompensationDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityFairValueofAwardsGrantedandVestedDetails",
      "http://www.molinahealthcare.com/role/StockholdersEquityRestrictedandPerformanceStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Lower end of range (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Options Outstanding, Number (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Upper end of range (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Stock option expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r364",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term of awards"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable, Weighted Average Remaining Contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding, Weighted Average Remaining Contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options Outstanding, Weighted-Average Exercise Price (usd per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options Outstanding, Weighted Average Remaining Contractual Life (Years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityStockOptionsbyExercisePriceDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)",
        "terseLabel": "Shares outstanding at the beginning of the period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.",
        "label": "Short-Duration Insurance and Deposit Contracts [Text Block]",
        "verboseLabel": "Medical Claims and Benefits Payable"
       }
      }
     },
     "localname": "ShortDurationInsuranceAndDepositContractsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2019Member": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2019 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2019 [Member]",
        "terseLabel": "Benefit Year 2020",
        "verboseLabel": "Benefit Year 2020"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2019Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2017 in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year 2017 [Member]",
        "terseLabel": "Benefit Year 2018"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractsAccidentYear2017Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2018 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year 2018 [Member]",
        "terseLabel": "Benefit Year 2019"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractsAccidentYear2018Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year [Axis]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Axis]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year [Domain]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Domain]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Claims Development [Table Text Block]",
        "terseLabel": "Incurred and paid claims development"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r607"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net",
        "negatedLabel": "Less: cumulative paid claims and allocated claims adjustment expenses",
        "terseLabel": "Claims paid"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableCumulativePaidClaimsandAllocatedClaimsAdjustmentExpensesDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r608",
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net",
        "verboseLabel": "Incurred claims and allocated claims adjustment expenses"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems": {
     "auth_ref": [
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of aggregate reconciling items for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Aggregate Reconciling Items",
        "terseLabel": "Non-risk and other provider payables"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableReconciliationofClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative number of reported claims for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contract, Cumulative Number of Reported Claims",
        "terseLabel": "Cumulative number of reported claims (in claim)"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsNumberOfReportedClaims",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableIncurredClaimsandAllocatedAdjustmentExpenseDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]",
        "terseLabel": "Reconciliation of claims development to liability"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Capitalized software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/PropertyEquipmentandCapitalizedSoftwareNetSummaryofPropertyEquipmentandCapitalizedSoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SpecialAssessmentBond": {
     "auth_ref": [
      "r11",
      "r13",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a type of municipal bond typically used to fund a development project. Also called special assessment limited liability bond, special district bond, special purpose bond, special tax bond and community development obligation. Interest owed to lenders is paid by taxes levied on the community benefiting from the particular bond-funded project. For example, if a bond of this sort was issued to pay for sidewalks to be repaved in a certain community, an additional tax would be levied on homeowners in the area benefiting from this project.",
        "label": "Special Assessment Bond",
        "terseLabel": "Performance bond"
       }
      }
     },
     "localname": "SpecialAssessmentBond",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r170",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r205",
      "r263",
      "r280",
      "r282",
      "r283",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetBalancesofGoodwillDetails",
      "http://www.molinahealthcare.com/role/InvestmentsBalancesofRestrictedInvestmentsDetails",
      "http://www.molinahealthcare.com/role/OrganizationandBasisofPresentationDetails",
      "http://www.molinahealthcare.com/role/SegmentsReconciliationofGrossMargintoConsolidatedIncomeDetails",
      "http://www.molinahealthcare.com/role/SegmentsScheduleofOperatingSegmentInformationDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesScheduleofPremiumRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r43",
      "r126",
      "r127",
      "r128",
      "r131",
      "r137",
      "r139",
      "r161",
      "r240",
      "r298",
      "r303",
      "r370",
      "r371",
      "r372",
      "r408",
      "r409",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "verboseLabel": "Condensed Statements of Cash Flows"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]",
        "verboseLabel": "Condensed Balance Sheets"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Other Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Other Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfOtherComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r161",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statutory Accounting Practices [Line Items]",
        "terseLabel": "Statutory Accounting Practices [Line Items]"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance": {
     "auth_ref": [
      "r587",
      "r624"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance",
        "verboseLabel": "Aggregate statutory capital and surplus"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired": {
     "auth_ref": [
      "r625"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus Required",
        "verboseLabel": "Required minimum statutory capital surplus"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesTable": {
     "auth_ref": [
      "r590",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail by state, country, or other jurisdiction of domicile in which financial statements are filed reflecting statutory capital and surplus, net income and the differences between financial reports which are in conformity with generally accepted accounting principles and the statutory financial statements which also use state permitted or prescribed accounting practices.",
        "label": "Statutory Accounting Practices [Table]",
        "terseLabel": "Statutory Accounting Practices [Table]"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r107",
      "r108",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "negatedTerseLabel": "Common stock used for stock-based compensation"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r42",
      "r298",
      "r299",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "verboseLabel": "Exchange of convertible senior notes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r16",
      "r17",
      "r298",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments",
        "terseLabel": "Conversion of convertible senior notes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r16",
      "r17",
      "r303",
      "r342",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Common stock authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r16",
      "r17",
      "r298",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Common stock purchases (in shares)",
        "terseLabel": "Repurchased of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r16",
      "r17",
      "r298",
      "r303"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Common stock purchases",
        "terseLabel": "Repurchased of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r17",
      "r22",
      "r23",
      "r114",
      "r210",
      "r239",
      "r471"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets",
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.molinahealthcare.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r113",
      "r303",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r479",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r479",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r479",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r385",
      "r392",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "verboseLabel": "Unrecognized tax benefits roll forward"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r603"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "verboseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r603"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "negatedTerseLabel": "Favorable (unfavorable) adjustment",
        "terseLabel": "Prior periods"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableAdditionalInformationDetails",
      "http://www.molinahealthcare.com/role/MedicalClaimsandBenefitsPayableComponentsoftheChangeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "verboseLabel": "Tax credit carryovers"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardValuationAllowance": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Tax Credit Carryforward, Valuation Allowance",
        "verboseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "TaxCreditCarryforwardValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r229",
      "r230",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
      "http://www.molinahealthcare.com/role/InvestmentsAvailableforSaleDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails",
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average cost (USD per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember": {
     "auth_ref": [
      "r326",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae).",
        "label": "US Government-sponsored Enterprises Debt Securities [Member]",
        "netLabel": "Government-sponsored enterprise securities (\u201cGSEs\u201d)",
        "terseLabel": "GSEs"
       }
      }
     },
     "localname": "USGovernmentSponsoredEnterprisesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryNotesSecuritiesMember": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one to ten years, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "US Treasury Notes Securities [Member]",
        "netLabel": "U.S. Treasury notes",
        "terseLabel": "U.S. Treasury notes"
       }
      }
     },
     "localname": "USTreasuryNotesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/FairValueMeasurementsFinancialInstrumentsonaRecurringBasisDetails",
      "http://www.molinahealthcare.com/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized issuance cost"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r377",
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "negatedPeriodEndLabel": "Gross unrecognized tax benefits at end of period",
        "negatedPeriodStartLabel": "Gross unrecognized tax benefits at beginning of period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r389"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "negatedTerseLabel": "Increases in tax positions for current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "terseLabel": "Lapse in statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "verboseLabel": "Impact on effective tax rate if tax benefits are recognized"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedTerseLabel": "Decrease in deferred tax asset valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r142",
      "r154"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Denominator for diluted net income per share (in shares)",
        "verboseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).",
        "label": "Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation",
        "negatedTerseLabel": "Stock purchases (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "auth_ref": [
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "terseLabel": "Exchange of convertible senior notes (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator:",
        "verboseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r140",
      "r154"
     ],
     "calculation": {
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Denominator for basic net income per share (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/ConsolidatedStatementsofIncome",
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "verboseLabel": "Weighted-average number of shares issued:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.molinahealthcare.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-04(Schedule I))",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=120391182&loc=d3e5864-122674"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e)(3)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2646-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1828-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1930-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2029-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL6283291-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269825-111563"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e34017-109320"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5283-111683"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498348-110258"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1-5)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6816-158387"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.23(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.7)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "340",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6485982&loc=d3e22818-158507"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671315-158438"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB TOPIC 5.W)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24746-158529"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24790-158529"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=82848697&loc=d3e24938-158530"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=82848697&loc=d3e24959-158530"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27758-158548"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27830-158548"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "http://asc.fasb.org/topic&trid=2303980"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r656": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r657": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r658": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r659": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r660": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r661": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r662": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r663": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r664": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r665": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r666": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r667": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r668": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04"
  },
  "r669": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "i",
   "Publisher": "SEC",
   "Section": "3",
   "Subsection": "10"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r670": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "5",
   "Subparagraph": "Schedule I",
   "Subsection": "04"
  },
  "r671": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "7",
   "Subparagraph": "Schedule II",
   "Subsection": "05"
  },
  "r672": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "9",
   "Subsection": "06"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4,6)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3337-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>130
<FILENAME>0001179929-21-000024-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001179929-21-000024-xbrl.zip
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MXH*.7#EK*F,\%C!<D,V#ET^&>YB)QVPP2(BP_DVD@F.!/;#_0:OBT[::H4H
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M^NFQ1@DO-5L8HT"(%SW#QH1Y>[2V!!&_X$UY-/#ZF,7;'6AUB[\EOICI8NE
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M"TRW'J@OKN9PO_@WP^D_4$L#!!0    ( *=(4%("F9^%A0\  /5-   >
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M2=@.%X',?1=DJ<1J42<@9O#>Q,19;#*25H&3<M\ V9/)^(@GL].F6+-[H_)
MV/I1,Z'=0>S#BPO$U+;9,J\?[<'KYZ(KFP_$YI7!WO/7!]N;+]SN\U].7S_Z
ME]C47V#W-XC]\F'OS6O1SX/ASBO1I^>_N!WSKX.=PP?O=IZ_=3N;_WHKNJKD
MVN[?'U[(>4GO/-]_O_WA;?MNOZHB&H?!;D R?@,XIXU<<MS ;*B$JE7._KL5
MKE:M3612J$1C740AMPZI6J@N9<IK]/X:>A]V[_W*467A#RAN2R@* /-&LV0;
MVCLM>.4*(7RWNI$#94L(7K@/ &*&P ZS+P$KZX"_;OT>3KN"$LX&H_W'C%-^
MV@:[=JM@-+>-SV8XXP;:;A4#BB,:"'493P=MO.7!>PF3I\V,/AY,9\O%4E[_
MHB^8S/:'I\/MY_?$3I+\_^7]SJ.=P8[9.A6;Z?8.7[^1_V^WS2]6SO&1R;Q^
MM?-FSSP<[GS8@^U7#QO[.=V1;6(?3W<W_S78??3T[?;S;;&K;[]B,D?#/;'2
M>Z]>M/M\O_?J%[7W9DOMO=I2.V^V8/MP"UX_^D6T]?6PW><G)O- B[U_)^I+
MB0/"AJU.N"I1VHB!<(.,MY&TQVKR[9\^@C4[X,D<F>GW2$<@0"[6!"(AL&00
M;#8J>44^$Y?4I$.GM71T3CIT]89U41M8DQ**&UH0H])&0 4AIQ"XTEHZ;HQT
M;)U+QY:<=__T5PE" ^C@-S1E(6[*"=<N$@HU5NR-SDC!_VWI6)1G>3S /!BV
MX<CCR42D8BT>BQ4/]97QT+]RJ1(M*;<1.(OQ<%9X?6I$H[D6%LZ(B)_$XQ[-
M1_VG3_ 46V@T*O+)Y)C+!7 #GIY#MPSCLA:?*Q>?SZR+?*=?2S).,Y0-RBC6
M16>WD;5SPE,Q:29' N*5B\_"K<_.>$1K";H*"=)?&2#[*SA41:+]#4$QB'_R
M>D-<DMK(N43,50*A$+_R3Y])RR>DEFIOU@)SA0+SN<EYX'ZMY SJ%#><-7E#
M@)1@2&/8T"@@:@>LO%VTP/QU"W,F!+QV3]<@*^^W[ZN+:=G3[3=O3W=_^94T
M^*!!;12O0IOFB1L"'FUX)3%ST"I5TV5^LQ:?ZQ6?T\_$Y\/V+[^B@6HHEPVE
M FZ U4&,3:P;;&IV)E+$ZA8C/G>^3/:8<&79CWAZ28I*RW2Y.YWG1(F W9IG
MOMR=G1Z)X$P'AT?#EL S_^Q@TN3O\VR4']Y/BYSASI>G.+O\IVN>W\)T?#R9
MOYOG2-T]E^DS8?HK,YT7)^)YRLG%NT%I[^N )[?F-\279JO=W_K?+S,HOC[X
MIXN/OCS[T7P2]>+==(:3V:;HS4\7.4A*7QSW:=O'VRR?=M5FP^I/ESC;<O'^
MXB)WOGA0%^<Y'@W.'MKQ_-F??7@H*GT\X9_.$^'NOGBV>7'XQ::+]^WX2S&(
M(6C-1E-"  \Z$556-F*;1K$NG[DE\8>J X_^+(]N=O[@_895'T]TON4[G^;T
M $5$?_- S\&<;_SN)UHB4Z;V)Q=0Y-"IHDQ($MYX(18\?Z):_IEN/5'=<AJU
M^6M/](LG(&XH*43BJ M8:Q YZ(P:?;*4,RY!K\\1Y?WF[,[>%KG8^Z/A@ :S
M;3[,<HDR.&P>K^7S7ICC%Z/CZ3$.=R=;HSKA_QS+T5OB,>^]'XC4M#GY^[LO
MMS9U.CO#CW<N/?''A_;Q^ETU,U_ :%)QQ>1HK9CG'!4RAL(<G&/%MI0>P#B=
MS-H$83FFV>[D&4].!L1GV%T ?)93<5\T_<F$#P?'AZN()'I;N2!@"1:"B3$9
ME;6U[$HN)=N&I$[G2)ZSR#62?XRD3M^,I.RZ*"1C2_Y'"1RCQ $Z,V8C@8 G
M\A)8LIYGJ.AX@61<(_DM2,9O1S(N#,E4LP4;/;(U$%E%ZU4,5B(Z73(2]=JZ
M-L]XCMUS?/^43WATS*MH60-Q#A6KK=$!&9M"M$F[8CT6HR+TVK(N <7E6%5Q
MCR%9[S*E)$&00NWE;\@EE(A)^UY;U66@N!2+&@F20*8"HP533 HIDE4NL_PD
MVV^^^BG_MRWBVAJU6'3RD/DI#P[S\63*917-*Y.J5GDD\ J8+0:#60<*.D7A
M.['WYG69D"['UIKHLTZ5<R(AL\XE'2U0\YC P2OLO:U=*J1+,;S9$1FC;";2
MX**-%@TAU4@2G6@5>F]XMW'REF='0R1^.IB^O3^>3 9E+/O-9L/Y],DJVMZD
ME3A37TTR&JBFF&* :BF0>%E*H?>V=\FH+L?\NL#@, 7MF"$5L<79*(R"8C(F
M<^F]^5TVJLL93$ ;HA$(D0)PJJA(4>80/7H*-?7: E\,"YU_N(JVMA#Y8H-*
MCC7$:J,1'UJ\S1%J*#GWVM9>*W[+L:H:?/:^C<BVA9V<([F 5EDH;;EHL;VV
MJM>+WU+LIZK"=6H2=F,M@(*L,)>2DHH^*;!J"?K7"[DW 2!9>6[&80OB$*E
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MJ8>Y>F>=$P ]""M-VF.(68+GP+[&'@PY_7T,SYC.)3T1^^D:LP2RE?2\@R4
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M-8JZ0E:GEAS9&&6-%M$AQF"TA-VH';6"1^L)V;7H_&XH#@ZI9"#K(T"0L+R
M2QH)*!GK^E"GX,_0>B!'EL+ECU'K"5ZIE2^+!4/(!%HH1G*U,%EE? 7HQ=#)
MM>"UIAB7"$\LV7I/)6@N@%QBT<&"%DU'$S*NPH+2_@E/7X8-J"K$$@D-)@ R
MT:FH,C)XX:K!KTG&@DG&2KDMI8-3W!IC,D#2JG4H23&++#DP)?>@(OTG&#X]
M_:>#Z=M/(^WW<3C</9K)49_VG7/!18G,SS@4_/G9 ?/L\9BP7>JSRQ]/)DV(
MKIQ]+K)7C4\DP6W0Z!WH5M07(),(AD<?Q,ATWZ:LQ>)*EC114J$$SY;!5!?%
M[[C V;C@:Z(>M+OZ8[%8#EGY)CEY/, \&/:IF1*S8S6ONJ$1C#]C)+IPI>I"
M4CT8-UL+RS7R$*-"#L%3M5!\26Q442DZ"\&88'[=;+*IM-(;W3<Q>7;9A/]]
MG![<'X].6N)?'O(S'@W&D_FZR<UC;E]J42+R>#S:G_'DL-W(\],C_KH@X\=;
M:#LL7CY$!B:S39SQF3D1Q-1'"?FT[2-VY=.N7PC3Q9:_($P!V62;(#E#4#5'
M#89J)9=(&>Y#C<^;+D-7,T2761LOMH/:T@FV&755 *UZ"_G2AVYMOR<6]\ &
M]YDP7(\4?/L%NT))#"-KKTLA3L !4ZVV=>EVQ7.KX+:6@#\8FMF>K_3G=MV?
M<3J8?F42<#(Y'8SVG_+1>#+C<N]P?#R:?3Q\<S"EX;@=OY;-W\G5@E"RQ-B9
M8H7 *3)YLLX:5U.%U(/>HYV5S0?3V>!0N,1N_7C(6C"_73"K29J44RS4''7(
M'%2A%,A "5[UH)QB9P7S9AK-1<Y]0(SBTY/5RH +)1KKV'FC<HE0S5HVUT9S
M.8*9?2Z:LL-L)03--?OJ4VM84D*(K@],<U&(_&U-^$V0VY<.HQ);J))]*1@<
M.&533$4CLP=KD3UU7P96WY'=7.F,I$Q*$FN84H"XE3[6NFKQFA@AJ7[UOUU%
M5W9S1;-5FXE@<O+50,PLX4<BXU06QYGZD4NW-IS=DLY%EFIC PBAV$(>4@D1
M,UH5*NG6>+(7=1K7AG,U11.0J1+YJ DEZJ",%+37V7.VT7+MOD__/4B>'TR8
MGXP'H]F#P?[![!F?\.CAX(2?\(1DQ_7<QY_*ALXDX:<B(A6 @\J5HE<N!6,Y
M42IKV5B[]^Y);;$UJ&+)J1+!AIPBB]^MS@="<IG74KMV^QT3V>"KC@I\2"U8
M436[HA&2<,2<55"]R)WMG<C>3$.[R'(&/JH$&D.A#)04QNHQ =HB,;BF'D0U
M/93:&VAH%]DP(:: WKM<N2U\4ED'HVI4WN>2 O6 &RPRR^YOZ\D]^"%^SY1C
M5_PMU1P$GBP4T0*11O91PIMD;"[.UM1],5A]+W=CA3.24B9X)L\& H3$4'S6
M+M2D4:M5F@/LIS.[L9+)J&*)&+53%0Q@TL4%;PN#9DO8AWJQ:[/9*>%<9$^E
MJ#5S]EC!@8TZ)0TV^Z0<*#&=/5C!L3:;JRF92*V8)CIVKH"$QQ%=-;&*=P=$
M'=T*.?2.F<VG?#(>GLC]W)]P&<A]4%OB>-H7=ZLE1$6J%!V#!*ZM-U-;B1);
M9R:O>I#>WTN+UF^AB98JJJRU0CVOV.Z5(ZQ)XERE@-:),*LD-XMT4C$AHB/2
M[$'[DC2Q"\ZUSA#R9Y6X_0TW-HODW!+\%:-L(0[ -42?A6\G3#9"9N@!LUFO
MFKZ*9$SO7,!JM&L4U]A(%"/IFH&R/2]$V6VQZ*X/6@OL%0BL^+48BW8VU JH
M"8LWL<T1I=K6U/9@Z4U'G=]:6J]BD1#[$J.!PB:(M!K$FCWIUE<E"V<K*T35
MUN9U%:JHY$+(E@AS5BW]'4.J&CPHXXNET*]RHVOSNN+2ZEEDB "Y4@#R,8(I
M5%,JGI.NN$K#;HLRKUWQC):JMPYMC26"$GMCT(J\IU"\PD ]2%B_7D/3%=QB
MMHJ)? TV@1*5<TC5:6(N'B*K%7(0G5"Y1?IVS55C](ESJZR!46>7D26>$NNI
M0Q\ZA/9'Y1;9V=482F1;*[( #C%A\D%9+P%OK2;VP<O]6=7U;5&P?=SGGY'>
M<KF>OIF+=&99:; EAVH!:B2,125R)E9LI9/[,)/31806F@"OC5:ENM8 %W/
M$@07<A58BS7$[NK0=#*[^VPFMJSM_XC'^Q,\.A@0GG=-F,Z.)G<?/NZ\BBCC
M= YIOC 1"%-2FEUA@FS8.=/A=3/+!&"1WM\FI5IL%#P!915C%2(7G,VE,G#/
M-6!GN_,:(,%JI&HC6&:PMJ *Y!,)'-Z33AUN +M, !;)HU2*P6<0 IQ HI98
MP1$;(DT**75X*<$W ;#7>0U0F6,I,7L=<IMME!^,IE9;534E=)@F+1. 1?H
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M^I5S*[]&+4G?"B9Z #>CM44$@%\Z[G\SGWU@^'[# !9L=Y_"CTA=6QIX41H
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M3BRIR(.V+TORQ#)(C*=0S :.RS#L,"SXD1N1_&)K>W.KR3UUQP^SF.10/PI
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M#S4:?0[_1(%;OAQ1NG)WR$#"@%+D5I ZO #2H)=S_%M@CV3>^]CJ"UXD;IR
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MP]-423_%8/E'U8]8[H#R^%B_)D@]8/1.1DX\=MRIX?:9UP?S[Z)XF;OMM_?
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MW/]S[UP+2S;&$_].<S:@DS BCV+(MA*B^. OQMM^S;N;?XP2JQL.03E,@&D
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MNPW@*$L2?\GELP^4$4032M=XL\SD)5;*0ACA-['[%Z 2E]!OE:,6(SF9>,9
M(VC8*"8&)C.F8)$^)."J%)U/0)L40Y/7+(%-Q@'A)8I8R:6@+F5&R.8;^Z/8
M=:ZKXPC8VY/$NM"=5*FUF M*MK)K7=SWB EE+8=\.)RQ=(T#E\1'5=J%1RF'
M SV!M!(YU3X5[N45?!BX@:]^:3<J,P^8!%DR-^9&\34XG E6L&  -)[2KI#K
MTD,$?)EQG>>HL3F/V9B1*DF4:=-1/%75B0^L@E3)*$[FH4J;C0761QNY43"=
M:F=F99=L,>7%%.0KUU_*+$\*;<%XC>HX=!%S)*-DY=Y?S0Z-*^$ ?(O V->)
M-K>8!0]?_.TC,R*G,-5G:5'JN!G6#)F0W7#Y(1PQ$"_H[671AL+P7(0^T-SG
M490+Y7[L4!A#@L@OF;+.21AD#"FO7\]^HT*:#M4 2F0U"S,39G+*?#3IDL1Q
M1QF6EB7DY[Z%U^*_:EUG0H]PCP+*5ZZE!6=\R>AE=MIB^'-CT?PT*>ZKC' O
M>2Q1E5X9I#B0-^1Z,G+DC'R/$,,/HPB^# 9EZ::7N7!.G"L[&M]?:U'Y6BPJ
M>,B#$Q\OSO/@A,[X/)2&XWT!N65+IX? ?(H\3DH[P2J/685G5QZAOCQ"F^'<
MR"GK39*%9MW%&&$A:4/G'),C/#@](2=C.,-8L&6.WZ (XV00E%>ISVD" 8=?
MX(P)EE?= =U?["; 3D2,4(8BG67ORML :EH()Y6#)7/[76O/"@ C+04K!R(4
M!SE?1]U;LGLCG(3<A(N*L5)"9K*BO()WCH#02<_/\_\-C=\<':98H'Q')B(S
MI9+E=KZ]ED4EH+D8P819I66V"0/:$3+G(]_J2U!MB#O-;36PV9Q'FPZOO/T'
M*@KRB899EW<H(?.)]V:!.E"O%N7G9AS^?P-59>[U]"TT57)N3N5>HTZJ!E/8
M'V2TB4H@I(P'Z6(DI2S)9%L7;7V3RI K%Z9 HW@HIH1Y*J%-OW$/E"%D!+C'
MAF^5*@^FVKE:6A8M4Q>0^IUSM.^@Y%/XD0KZ5J9D1: +:+/9M+1:=Z#]"Y'T
M]B;.&#052L@LK,E,GA^SOQOI, VC&ZVFJ[%J>3GO)X =F@ODX*WJ96IJ5&4'
MFR,P5QL/I<040?:-ZX2WX327OU)J-&OD-GBDK<M-;:R#,(Z"@+W0&E8"5N2E
M#=\'@G%)JK*29,8GI>D&8EZ?3R-Y;ME@U&X>8KJZ#F(4 9'N<@E/1!I=%LJ4
M7_B.)!K?XIMIK<Y@$,4R&9"J?GC-I*^9@!S@%00H Z1D+F0)+P(#!C2"<49>
M-YFX091',4%9FXN)S-%8%%Q[I"AKT2V+8$N<IJ)T$. Y5^P_E#D?<RMS$P5@
MB;*!)Y=(3M*(CXP=GQ*:#9V"&$>61F4L>1QRR25&*] JG$F=(@4C(,N!TV7D
M\ D@@4I71DXP4"-<-+#"ZJ_J.&H4#].SX48^PO6[B#6JA%+*"96UDS/K""MA
M)I.CI2+[1Q46HF3U,Y82<,78R&:7IGW1@-*%R619>62T P?6-:V6YR/ZA3:_
MB,,Z7 ,R,T!^,3IMMRD!*Z<$M#8C)>"-3XV1%%JL=L4B-71)&[P7*77VZ#C!
M$/G=:)R\,U63W.TQ_;^)CA";[)CC>D5M/#;@6]0%?,JRP(GS*GVE6:C(K%-4
MA?@M5'_.*MP,6A/I/'PI'VP8HD("Q"H!$6.F'A6+<>:JNDXK'* MWH)90,+9
MF!,N?(DU5'+KH5^GN%X)I_P7^3VL. ;7^^RO="Q*XZ6AL"G"CB^!0[0>S[7X
MF0E8CASZGWWZRLK2.O'WL=*(,%!"GB &6QO*0GZS9F6)W%:IR/R-/P;^!Y<R
M4\;EQ<H1GU,!R,M7XB5CD 8V$$.CBBEQ NF<TF-3":>%)\GX3/X4'OB-CP8"
M=QQ$#08E/OR[:QW+"A.<S@Q:P/RLD';'(.6DBXW'U)\NEHL;TZX0X6C.#C95
MI7]CW)K'QK*4][KKW3B$IO$6J4]Z%!1PT*5Z"^MMM1&BZL%AS*S$-QMTVBA5
MG5/2T=95)>>%\G&'T3Y8;Q]%"8562AIFQ%?5PPHNAA1N#JQ[<3;4)4>[A:'G
M*#M[43B,*8!+]7*Z4C=G57OD^#3C"1+X9\[/D%<N]XP<)WU/,>* NB]+*)8#
M\_LK)2%74#)#F8\$S.11P)M-J")=<$4[PVD78P3)D>FTH"$,C>ST6-7UZ?N,
M0 O)0''GCA#K1'HU!OX=;UA9VGKT(XQHI-?BM'?:,P( G$T@T7QX6!+.I9A
MS+)0<U)'&9.P5TA<[!3QQ!@);P*7Z!@H7Y>C]XQEEH94$"2?U3%ZF+"/^D2U
M4FF6ENT5Y0)@>EVQKINM1"YQ6$IYTK#!I6.4W64[S7YO\U:8Q(WC!SKWN3 F
MW@!::U"DY,*6D+@-VU1YL A7$W%/\?V>4'EUV40NMU1"7#UH6&+09K25K3Q]
M/,[-8IAE?4Y/.9Z(Y[AWFKQ)&@!R/+NJ_'YFT;1 "%L)<&2PP@B3E4SD 6K+
MG/MN9GE1GODHSQ\%.Q4KSKN!:_545]\4R8MBMQ$E#UP+<L0X80%(8^Z0<.;?
M( :*+1'.-W.D<1:D/DY" 8'HHR=Y+ATN8,BD/$D\!S<:RMA2 0O$9.'LJ>*8
M_!2+FF)VJRKH#@TKD2,TY"IA-I$E-XDQFRFR)3).\F)0+A:F1[!$4)>7=(DI
M(BU@UL\C\.!4M0+ZU(.)3"3@RBWU?,VPY,E.Y+HD0'+R')O:*R8;# 5N3TF6
M\($=E!,#OH;1DGW,'":L-8/VENPH<:Y)E H5Q<M"=O%)*.2T' W*D\@%I3K'
M_9I? 1PT#1!^BM  <U1R -$Z8[_EZT32D$A/IU1AA&V XT*9 3(PQ&F2TF "
MU)&@3)UK$9)@" F@6:(7\#)0D;),$UAR?O0PD CP@)2U&F,<&N;5!5^6X73B
MJ!711V$@RJ0 .R9F+RDFL0(KHFBBLA3P@]D$#<=T)2I\L$VIQERL?6]80?)G
M&0#G\'>1=GJGL\6<H(81_C@2!1 K'+N)44=<S$?U"L$KHU?"B$H($AW$FD%<
M6 8G@68IN:6Q](JJ@C>61O)2=ESCY13SVMX.LQ[V"!U:D<_\F<MV"O1P?REK
M(7NXJA(0"OF[PR&B_Z$+X<'*SDZ]91D9;7E9.Q7<8?8,^VAQJ#*%_A%C59DY
MM>\=9KU3G1_F.N8^8"P<)NH/T0Z[%2HG&$Y8F3*7M.TE[D!(4G7/(ZJ6'U>U
M6VW;\XMVH2%=L,H#%/^QG])N4$DSPKJ*5":84$9+RAF+G-MB@KR@M,OA9_38
MX2W-][*(^6;YI'V%\^/EN< ;RW1>/ZOY(1K4%,1I"VCC&P4V"-( .Q)YF:LS
M="E^.%-U3_F?$:A;EN-CJBE8WEF*0*"%O,]"%<2)D4.:6Q2]O9-$6_2,^Q)3
ML?L(N N8N*Y2^Z2R1]FNF" J6P(!+V($*)70Y7&L-_<7:2 7E0MV*T=.%4KD
M,T$DHF*EO"I)*@ +P2$*?-=1V$D3C7A%Q<NR])F0-&19DKUKG18T.9AMF5T3
M"]83->.4H2EA3,0><+#H40A3:G5D.&-N,<>US-ZM7/_M\PFE?%!IU&!":UE;
MXC.+PSXC(;:Y%"\<S#"2ER7PD5QZ+V]F,QL-+NCI3A^I/4?H56=, O,^L HE
M9:NCS3\U0F<^EPK(XG@5JC+PEHG9*^L7LX3@+(CQ)(BFTH0E):!$%07D)(RC
M:VKH &^Z\1UZ'-9%Q:&XAXMOX]JS<>WV-J[]Z .FHX7D'>%(':I/S%7G0H<L
M^KP'0HB[=!UJ1%06B"^7L88@,%ZI2KL2Q)$M.'=F/+.)*G!@GX/K).1R2&1L
M$L,&-WS8*!>/<*=,UPR.!HZAQ 3'(A,XD7.3)9LMXCJ1&S'EHTYJ7%J$ #=Q
M\XG7*%QPHX16==B;BQ>8L/JSKP"&!5+5A'@LSF,SPM%HJ1.WHQ7@ZN\9;LBN
M-#-N@EE=Z!4G+@Y2#!1;4@QF;H0]8OJA9R\B%];#V*-#^H!JO^:QZCVAP!?<
M+(&'C1>KERA88E;0DS2'Y9(7@+H=8#,S(":,G9 W#A][BPZ\P!<2@';^#<;4
M\D>1JPV=LIE+9HO,VAU%,:CWNA24/)DL@!+0FJ1*)ZDN-',M&!Y0(NWGY"TI
M<L6%UK4LL\>?%I:^P>E)E6Q,/N<QR$#R0SIZ;$J,/6+CGIG(7RKVWCW[]\'%
MZ<?NWJKA]Y<_E2\4?E]U_$O;TKXLN\DSMY4M0F:^7><093=WF',=.Y"KQE0W
M*M@=KF__)A.YT:)2UIS9NRX_*"H2BQQ=I8:964<D4,<H\7!1)FR)J"3TO$,%
MILB"),#WSD9.\*B]08H!MQXK-.QCX%;*XYS.9/[>4@.86]6Q;'$^#?G ^"F<
M'QT54I:,U.C4F6J=VL\3VU0SU"F7]W"% %ANMT(8]?>*ZQACWP46P]$N7.V2
MH;F#5$7S("\;[SMQ[,MQJ*0W;24F0EP3$\,,:5A-->C_.Q.&H7XM"1J'1PIB
M;M$6OM%9N>56/7.ADIE%HQ 0V?BQY-H)E=E.4NO(<T91[G0M&:4*>4E0O@\+
M:R35(_/2UM)<\2<\056W;DB6M=[O' S17%)#0 ,980O3V=I3!$.A'$BNJX1C
M5I\I1Y6)_.@\5!5K5"%P2X )VITYY\S,>\;..H+;C1F?IKU&6N8+![360$W.
M UKS\:N\!D.YZ20N],).JK, GK.><HH&RZR3: 8+@5(SL\3$T]8O7Y_#]_Q>
MY+6;R6)".<?<(&P@E7.04ZGBOTEILN'R!>(YY80P&-3O^(^J)$1Z78=6#P=W
MPLU(.SR),4!"V$9 Y$,88%APO"NAM4!A?(M,):/+GD8@P1F49'"!PLLRU2^1
M%#)G!&I$L<#)0G<D<QY( \M"TC-EKT**'I75)Z8:BTF*?<IA,QE/GM-SH;+7
M[GT_V:B4SJ+ /RV[P=$X*H)T\M\W@.,L [O)U^<,VR_L1:!0>L"\_\J\(87D
MWN; =B>Q'QA8B9]"'^UYV2_G/$-U02#6=(R]OP,)3X>1\=9[NU:O*OI;9$I%
M_< ?2DR[A<T/">QB.J=R(J'%7(N/T98"<5'O"E<M'@/4%)H14F*P(]'34Z$4
M3FQM,9YP]8M^ X8.L-W%DN%)Y9=:3_(*$$ M7[<7./Y8PDES=ICGC)VAC)RA
M$UEAMCMZ)2AHAEPR"X6QYO)1_(HAM8.$4Y=85Y(TU$!XME2>;%=G,'(&!!:&
MABW\W="0\LU[%L^EUQJX"C 1X=_,0DEB*'M/(OR$!B)<BG@\0[7_5.-/#YAP
MYT]KB'P!2]%Q?88A6;$R/#*#6DC.^MS64CA<7/.!*7E\IXK4+)V06J\\D7(>
M7I7T)$XN)/<;!CN94>G5]GR&&28S7V@,3$S$YA)8J_?Q#$;6QR.R 1SI>>)\
M:ZDG4[S"H ?=S5[G[K]0- YL)Z X]/)+6)Z(\7S&(IZ)FZP>M%NKE?U,M=#1
MS/JN%@32#63,:(4G5 LCC('\5C(<"+14]SP3ER]7.^Z-+9T;>:<R/H*<-%=4
M0-RI-A\W;$@7QZ'C3B5.J$ZL!%L 3&>>IM(&X)*Q!*"))H8G?>$#=36-'*"L
M.Y0Y$<OND[7UG]D]H^H-!J#A44/.,,4X"=VK/ %Y:V9C?(M":PY#1;'_#*-;
MQE>8XNOX7 (D!XH];V.?VU!M"!G/,H@%]88690"+X902UXU.XO 8Y>LK67EN
M=8G*= +?D2Q3GWM,*XE]=]8(I\A%GI5@EDQYU+RZGY''$CW&H0BD0W3A0P@?
MS4_@TVE>C7.HW<6'CHMG30*FYO?KQLZ'>;&/LF@8S/5WRJ%9=,_Y[T8S Z-9
M<_'\+>@ 7/"SJK#0<\3U%BS,"O$LBNT^+J!%Q1QF4#M/!DZ*DF.EA>%]90)T
MIRX>8YTD/!'.-? #QF\A&44N%NL$3:,YVS[O-'&0-V*C[!90HJ31MC0R+Y.N
MD(T /=#'L,>/M#TN?$P10Z?N631VPN^T9[=I+"NGL70V(XWEC8N??^^>'YU;
MAR=GUNG90>_H4\\ZZUX<G+]I[MI% 2<BI0,H??+)O)DRZZ7'^B=9QZL\ONQ%
M,?#P'VRLOG1SWAO$[Y+C&;:+AZ@/%/J7,!X5.)-$O%,_O)?BZ)T?TI3IIO?8
M&Q0YFWPDO$625J>S6[<;2%UI#'\\]7A)>+M$>/],O?GO6M7=1JNY].O*KKWT
MN_L>:]N[S4[]28^]_[M&K?$R@UWML?^D]>4UAKU"NOC73FTGYQ#4H?-=Q;+I
M:*KGZ4L[<Y=6)W=X\3RIS.XV4]GSL,_.S-&:,V6)55UB$.-@#JA4'X?G6)#\
M4GD4\.C M1:=64O-; -6"V5*86F^8YJK+Y?D/?./VOSEM#N/H;2ET?U'G,FE
MSUC?Q6ROM)B_'H4JYIS\]GVKZKI"&*NZ8-+8COPUZ6=.+ZCDE?"P3;-G\C$S
MJUAK.[]?OFM>[V?5\K>?D%TO59L-=LI\S]SP@#YRCO>QV8=>.<M6MN2UIN15
M+=6;S;<CK^\57VM+*3JO>*GR4WW<+!>>BC6AHFJI85<?242+-_)%>=2JJL\/
MM3/5>NWM=N;'U:-RO_"3#OBJ8F]-R,@N-:J//>#KIX3\F#M3[W0V7G[3NUOL
M%EZ[L\Z]FQ[+/HN>B!K,T8LR]''^S[U^B!]/$W[.]5C' ]@N51]] I]Q3=Y8
M:=H>@^TQH&/0+%55P[Y-.@8DP/Y)@:1-1,]@;]Z;AAH_$=Q/H8Q.%W^49*6(
MD>9*O6HP:P)S<?&N G0>H\@B4*P54WJ#@H6=8E"2'E:::V)9*J*_4A,1+!'$
M@FD_Y.0[N$B^B+(X!S"Z*)8%^3+9*I&EU?+%W+W:33.LJZ;Z2"1=RJ@M0-]2
M=%2"V*J<UI)JIN/$L:S,A$LD1#GG X64O3O*F^UHN$$-LJO1Y0I@_;[@#)18
MP--$:7X-*;\DE?.4 U28C 3 N*AKNJ\SNB0:G3$TQ,&9:F3\3"$\J9SCQ5M/
MPS#P9Q? W<FT$TJ/F\ B*X1&[)<BDVQT#C*MLL*_I+:AF&4W.W5,L29B*;:<
M4^69JC$.PCN/,15--8$SZ#,O9%JQ,^$,W"H3[TQ$/;&(#"1X_"]VI[);J<@^
MIXTF_K*Q&%G*T;6.H&W,FN9+_$M/1\]>!GQ=V/5[,:W-;AK8\MZ2W>V(+3!U
MF>S,;,DJH;!EG9/+]<!+V9K*@4NX;-D/!XRD5;)DN3A.AG&_5#=>Q)\*Y0'A
MLAI,_)!M;*V!$&68<UERJGQAF:O(O#15'2%+UADQ;MD2[5I=650!'ZAL4\UA
M"MC&.4##4AXC&0IU:J"R[*F"WU0KB%7CJO:BGWE#D5INABDQ\#+G3B^,D;9F
M0'QR1_= OFPF"Y'XFP&0P4L$/SMY&P^+L#+4,($B?!/)V$2@F&%TV=Q4%Q20
MX+3%K=P]F"[U<Z6.R4XHRQP,F&7^0+"HC$6*?8VXA2<G]&(E%?VN=LQHE+E+
M9=1.K.1'00*H5KWSTYI'2&4HG)337Q&51Q(=*P"*=^94;H((/X8]Y[V>5F+/
MI4I3,^A:R6YL-H->X*I<(QZ-VV@,D8K6)7;D(IU![QSGM.<YK,DDE@5"=!=1
M!3+H"2ABI&_F<)R241E]E)P " ANP+MVL9#4> >!83M&9W:1I%2V3FFY)O^D
M/@ &Q#<VRF-JQ7.GF(7F\L2Q'9=:)W(2+:?0JJ/-W^M3QW@3B&PAZ]#X,(=1
MJ $"%>2#!B1732QB[OLLQP*<3LB[!T)JDS,+2PGY/@+<#<P"!EW5HA0G5N_Y
M23QJB5Z2RE;:CNMB)KMN%D6]\S*5%B_SAAD0N\!SJ<IOKVM68G!:ML'-N>4:
MU@H0D!9IS*6WS"U^@Z)*V2?1"B+L/(]+2?6XR2@*/"D*C ;' VZ=-?:3A! D
MB?<2<!3O 0A,4H^&0ND?),&85HSKL+0%]1?N#4$VT2H]O.?@ E;AQC5;\^(&
MZ<TEU,"D/"=R6EB6-XN^^!B,S)WEJ<AXF^_]:\<?M#J5:KW5;'?L:KU6:;<;
M#:_=]-K56KONU!J=KU6[T]EY/G$Q:+FMP7?D+B]!JCCY^VB_;'>LT^[Q_D'O
M:&\=1427JW/U6.'%H"%S_P@"5".[5-Q$P0W0+NH]V&AB3(H95>$J6S%W&*BJ
M3S1?-51>R2@+U:TIN.H&ZTT'("T2!CC6[8"I0P?V(\#B>+(74-\ M?9<M5'!
M$G]/R0-Y'S%'Q>[EV(PVPMA/F6F81=0:P;O>LT_L>/,$G$1:SG>DP^-5(.2E
M<#B 98UPY\Y3IY\+SE-I<Z\XS=K;XO\OP$-0%%DR!:,Q0=UVXA8AJD3(E>%]
M, K"4 (? 7=T1ZH;M>SP-%7T:Q*O+ (-J#T@BD?^S;1R"MK-=R3J2P=K&7WM
M[VIOW\=G+XJCT+GQ8UA@4-+( J$EP=-U)I()'&*!, *RI0M07-=T+B4(%/ 6
MT <'<L<CM<_-DJ[(1PA'((0DT*3"WK]?VKLUJY]#(FGV%ZN)8NLRU:1&JLS<
M@>H&M"[TD<H^:#>(0(W7R6XAH"H+QU.T2\NYK8I:O2K*KA07:W/*HM;N0!_B
MPU$8'E(G</-\Z^/\1J@W<T?6;J]P9F';S#.+#6C18-,8 '"S&$] 0E(+;P67
M[['-*GM[<96PLJN =,":BN*I-H$/>]U3U-2;N]5_&#*D@#F)PR0<6(<@-@I-
MWY!=:&:2BD2W05WD5!K",Q$BA-H4INZ(^0AJ-(R1F$H($F/LVA-$YBAH45EL
M^C\7&/4X(QZ!"$<.]3*@2<:JG44?O??<K,+ 7#<0Z+@U'2IM&N=#X=+):EWJ
M=AA.9[IEL8NVCSH7=_E-2"=4H$)L@O!F%,&0BP #JPU2H]_ H,Z*3Y!MS'2W
M>'4W:P+YBBK$?Z.;%'83H'9?C$JI=&(J9!8BE=WJBWURY_NBYZ[6/)2A^Q;)
MWLYCYXYLS1$H. (-3 /1Q&<L8NX0YUC,\V^$JA>,V!F3(R#+8!-V0T+H%NF.
M,#SNA$4LFZ2Q$R*<C\8QA8@06$84?E^KD;7CC28S[/I>"4@&6.6 %RI7I(6;
MQ4B2A":+NZ@:CW;/#L[Q4U6SO19,M-HJF5!$:HPY!\7NF-*_!NRT"N:3Y*;H
M\\9G+S$%">T"[J,R]!Q(2= Z326%&E@LK"P+[%#GA(6.?(P <,7*=8:0":(0
MA'%\,FI,6%VEFHL<HF5B1$QGL7@'4NKQ5OYBMQJFS(AIFW,FJSK=\KW<=]'P
MAFM<VA^(]$^=J3L2[C4:AJEP31N1%D':R@3]=< 2@YCYVZL*DL775U 5:G:N
M*NCV-X+ :3WKGA50[8DU3I1I!A2)10GW'X<R%FJ(;/W1J5EOVR_OWM0J$,@O
M'4-M%(JU,SO+, KH7J,R@O!F3IHZ&CX1>,=N/6>1T3CT^^A[4$U]\9'$.#,)
MQT$\T83$DVK&N9BDTEU;*1EJDTFY"H!.L\D9'HLJ*6BS$KQ<1;3S]A)+*);C
MPPDFIZ@G:V^)0"]*X"<CHP6W$AFJ$8=DXT5&;#)1&17ZI5;5;+8$QG75Y+F)
M.XHB/2[XNMDIG$UE4*-ZEDG-47;GU9 Z3V#]6EG,0L8!HP?G33TX2859?G%&
MZQ.-O)?V]S,=S,F=GU-"@(IDOZ\X[PJ&UK*7CI0^/R?D*3:(/#\+59@HI@84
M\-M4JPW\MAD'L'RD<;86NN?F_,0+',*\==)K3-8$N9(W8D?N\]$:#FA$ I(^
M\4V8%<.=:%50MN.17+>PG;(U"ISAF%&:)#RZSSD5TC^VR.FJ0#&1X(S0$C?>
ME0C[4JL%DZBOS#J@.R9CY>WG9R=6*-)4<7&,H6&L #&^0NR<J;I=XR"H(1T:
M^&M$88\4VCV9?$CZVAYG((88(AP32XQBP^D&HD@VN7V#?A._FPYYW0>P,N/B
M=PC%+H]FRYW]+WM*E-^5,BP#DA#(01 )#T@'72$8??(R=')X^0JHB!+(8_T(
M#.V[&$K'Q5,9G"K#@*($@5!(_(DS)I!483B5C,>S#)E_ADH4F/4'L7@:BQBS
M=:=&Y^$#6A4%0;;(XU(I<?>AH1/*/D>P&Y2M9M!Y0$W'X1XS?X+:?1N =>2U
M0K"A8<1&F.XK0",L-!!(;Z,RZ%*QI^'8N'>!F?C*BI'L#6F^.$#G>:)6COQO
M,+I@*EM]<%R;A 0:>1[G@>EY84N.&_*;F0=Y\;&'E^D1%3+GB,Z<1(9MD@>#
M-DL5=&;Q/L'0O2O;[5?FQ.1M:+Y_[<-;7 >[ODO0C_NJ36?"VA@MN79_8KZC
M+Q4U(!7R-U1FNU!4J),CQ_OH, C-TS&CDDTSYF=BXB>1AVE!+@D83Z9)N$9"
M#K=:QJO-QM%DT&&V)N);@<D"2C JRD386I(I#J$RKN>!:.^)$V_)Y!XRT=+;
MY EH;,$VPI('F"2)6Y0W[@,3P"'P0Y+_P*AEAV5B(\JJX8L\9HR*C4@W-^6B
M:31K]1IS "54$=057D[(FHX1'S5+$I7?DDN5!0Q&FDI2+@ 3Q617I5=0UL],
M-Q9@1O(<+-<ZMC1U#TT=Z!0EQ_UOYG,$5+KP)$@TTH^X ]63@@RG&9SOR#KS
MW<AH,.Z13[2P.76[0:UXL/7"7..J!/L-2U]KK1@),CL"2J5!)A\JW/B\V3+Y
M\DD^PQ><]>BH-@MKV9[],[=[QKZ8RK3$6AQ2-#A[47C*BN<V:<R2U4?<C$KV
M1-/.AOEX6 GUK3#2)S&CU'$##YGSD@L)T3G2>8%;TRY35PH&]%<]'DE2J<1-
M^;D<IH&>+T&2I?W"Q4J&^L%LYH''*7-WKLFQGQB\CD:7-UW<)@JLGBA@;VJB
MP%H8C'!T5"9VURTX(U[3N:^5@T+*<Z*3N%0\?VJDL7+LQLSI=ER=.*O3=S2?
MFC,&9^TT>*<84_\+$A7*6%/L0)5RL %%SU/.!^9,_#3>8II1WKRX)(L>=96'
M'"@EJIEE(53"%X, B0TL6+DT&)U-I,$L3:8\+Z'0I%$5%TJ/+VI$\CEV9[=H
M?S]@8,HB%MWLPQSK[&1(NID"D-@E2(4^0ZR3?*3ND07?H7X,5R'ZR;R[$6XG
M:] 8R"__Z]^] ]/],.;74QG F1C\:R=+O!T*@0/WH@_\CEWM5!P0"FW;J]=J
M5<<1+;OOV$ZS4W/[?>?K/LZW8E?L,OY@5VOV#A"*"V\.DG_ME)L[Q/3AIQV+
MFS?#0^_2=V$V]J)47KACA<Y8X.O+0\>9O#N2BN"^X'^/0GG,DC,J7\5)P7.Q
M*.)?._ &2G?V:G]/^_O1S<?JV<UEK9=Y5P<W7_[H7)V,+VLG%]WI\;Y;/=F_
MONM=_>=;;W]8/[[X^_ID_PO\.?IVLG\VZGW[U/A8.PXNOTW&Q]^N;^&ZVO'5
ML-&[.*KTOG7K)_N?["_[PRK\F?:^#2N7%SW[Y._VM'=QW?A8_3*]_.PV>]7_
MW)U<#"N]_>[=EXNS\?$^7/=M:!_O>U<G^R[<\]?U\1^]^N75T8WWQ]]U[\^_
M@B_5X*9_%7W[LG_0.-G_SVUO_S X_N.R F.">SY5CJN]^O$W&-_X/_"LD=\+
MVG>]_>O&\<7!W?%5[UOOHOOMZ\"KMKWVP"XW'%$IU^O]0;E?\VKE2MWS!LU*
MW1'"WOG0:-;_]Y_%O?]0;)MCI/S*4N,%1"O91TF['(=#5&RP\%D?.",:753<
M:ZVE;\3**^Z!^E;EXH3%?$0'"40]5R#0T52FK62M+C615/8*)^:@:47%/7<^
M.ZCFEHML''HXF=+%-[#_J_C\L8P4,C?$XX,O6+XENFXHPXRF72L/;B2BF-M=
M*O*1*$LQ34:]&!/&J7$+=[_ MHK(U8NE14XQR=BHV!RP(RG6[FK/Z"RH1 *_
MB6V($)O2@UJ7FYT+.A7E@0ZEA2U-DD=OI<Z'WXS<=&[-H6:&"Q!SLR4!HL6=
MYNE;KFX]M=P#M[5[[[%[/VO3!(X">5M#S$Z.R-AQT(""(W,MQ$1FU>46;!0*
MV4P-72\4"TZ8<_6IKU^8FMY379"-)6!X [6,X1-ING&D;X7.N>MDTK@C#>K]
M=H>?Z"U3S;>1BP0@F^ $Z7UD'DL<,)9-A *,ZTYAZY"+^<DXT8Y1F?"'&2X@
MYS /,,5X6!9/,.^!V45)JI3R:497-'H.^MZUJFL /,!CL232=28<O+N-9(NE
M]_CU=NN?LO4GZ%Q:DG_7YVU?Y&9*8T>G?J@$5Q3E*KN#Q7E><;XXS=-((7:P
M6YY'TKT0W\$+ A4]8Q=-S+FW Y7H*R\@OPO*M_&C"@/?4H(=A3J%IH ,,V/L
ME&1PPJ@>FFWO(1O5:;?/K(-J#@(ER3]3"@;S6#%7I#P6Z2CR8"&&I <5?-$:
M7\+SDSB;I 8OIN&:J?&.5%70\RB3KO.V:JYJXBXKJ24$!C7A)* +,H7N=5ZO
MO0=DIE_BF^0UKI,/&^SS$)\YH$H1'5[FEIVJ.YD.LQ;+\LA$S]D2F A&^KFV
M,U"+P(@-C,_+\Y:2#'6/1/I39A/_UX? [N<=J8Q&4?%J@.'L473+3>=R?JZ,
M16-QL%68:IU<HGN $-QKC$NF_/D ?>G2Z:,R 66/VL3TK*CKE56$O%VD*?I/
M_HQN,8".EWB10%7N%NF%FL53<UTBB$*.'"\_20C4W7$0@NBAN5O[!PX']JK8
M'9S;.OJ("*42NZ<S4 [&"_1:S%*G23'22X;FXRT9F3AG:HBW:YVP*XX? KJI
M*,D$7S=PX@(X#B4!)L8'DPRDHJN86IZ$(1M9PR3S0A*9S( %%VBT4.MK_3PZ
MD_A$[H=N@D$8.<?+7D>'"VDFU]:H#",(5&E-B7>4S&U9^:$L3CZ(!9PRF;N7
MYU[E67RR:IJ5!=GH-YX!_^)(A_",U<<D'<T@T:^I IS&7MT6?0G$MXKBD%$D
M^#IS*M+X)I^JF=BAG^7/YG)P8V73[2NA:C[/*$6*-1)_@?N5A L%ZD9(LVCU
M8$- ]  +8I,Z:D3) NB!Q,J<$(Z-AN!AB\H%T@:*C#D075BM?%W6AV\]-@&<
MH*@"6H5#[;,X$Z GQK!X;R$FSP2Z<V#'9.7-1Q]XI*=07?)![JD,4M4QFI,'
M&$5,1O,-M[UKS+30KIIGNCX[>']@5A0KTJ(0BQF9B+%@1@H.7?*3Y]46YUW,
MXUV0&LQ/1!G"0!!LBYCOEJ9'B5X\UHY_.0RI2A;ST7)%<NX,\Q91&W*Y(\!(
MHCA6B$(P7"*!&\</B,_ED&9[R.Y2JSN,A9!!91-C0J-B2024W/>F)#$H)8@Y
MX<NN]L@ ,,O0D\GTB]>LN%3T),$<F)L,FTNE,O%QDJ;K3^+U1+'N4"R]CI[H
MHXJA@._R#O2)FAP3<Z$D5*?_1YC5)V@LRKDZ;Y0]"R9+X]&(+)U71F3Y>/#'
MT?G'[L71WP=6]WC?.CWY>'1QM-?]:!T<_WUT=G+<.SB^>.:S_T*-,4_/#L[/
M/V&]QLFQU3O8AUF I7?XZ7C_Z/B/S6!?TL=?#%XJX, 1:9W#8GE@,H*#@_IH
M(C4(';:]AW$A2!FG^2(\KD=U/JP Z-!I 62+,\T*3C8KS(B!4:-G###@.=3U
M.Q3,B"91@H4H?<%@DHP,B=EM% &!.V5ZB=29B(_.9.VJ:+4:2:34#EUT%"TK
M)L87IG#T<2Y4Q^+(.BT)IRD-+@U_%@6D8QFUCHSL.U"Q]U(AS*$#*DO"'0\4
M=>0AC1(#-BZ(?9 ^FYA+*>N/$!62:WY4HF<!@H5<F+>"#:40VW=C(@''I'+%
M78-/D@*)HN>>-.!MMLU<MDUU7;-MMC[E>WS*>WEDDZ$2@$7(N"P8^: +X!'4
MS.17XI8B'J%;/W=@\NGZ#=V)H&E,&*2";B[8/XJU*'^A8EF#!6Y.JN$8^0/B
MWV,\U81(()4I#:XM'U5 P)6OS@$RV!T=HK<Y3K9AIR?1R1FZB!*%;M7=ZVKT
M$- I'>U T91"2CHKN#IGB[1<]#0!6RXS=@5P73_P @*1\I#C;[?GZ<>X@/["
MI6VD&_2#R+VVAE@>96*+*)5)B\ @/[ZF.N'@B2\K[!/&3=YNTQ-/$5IMA7TJ
M=!8@<S**KRE(NBTG>=(:?T0P6L6H<B=FX \$%>CIU 64'TL:/&R&@=<]/#PY
MV^_^_O& ZO*!*S^W9?H"?L7%9O<YQPZQMDN9*11@0!_.'I@/J;4'6L3:S.ZA
M2'&.-%%!W#)R8F.^K]4GP(=453@P?X99YX5I(3POQ5PH,V>NA":;U)X089<L
M,[YG) (OC_47\)I#3SZ=1/9@@$C0Z.2A0N!9P"(ITA&J2(*L%C9B%TP G?*6
MOY-C0TO>C*!4(1=GDF])6>$H;1#5._*F>G1[W9+Y'6%/)YQ,.3^48@T7!A3C
M+, C3ZE+J3/%*BLIP(@+8#0KT,HC7ROMW4/0,4?6GA]C,8ZD-0(+PUL22M<V
M=[.#6X$0SZ+,&P%D)?2C[WV8I -,A<%8>DCA*.J44,)XNQ^/!;L0]PG6PI4/
MT(J6&O<]>[U@XSB^$E-VNWP^4Z(#.H%<@^(+B3&JK59NBD+,3.XI1TW\),D$
M[PGFG,4W@E+.Q  ]*9C>R<I?(-,-=-TE-8D!>:BKA 05@>H!RK$1QLEYAE$C
MP>.36&4C4?P8;8'8LR)"08^'&3L$=%<,C#Z%UC'HG[25-@.M5'C@A0?I!5?;
M@\NJXU\PA[\RV#M&:3D:+!@(A24Q?I<%XO';Q9.[]R9,MEMPKOI.X,@*67VF
MHCA_&)^MU#QTBX= =TAR>W4?SX;D W5IX MPUF^Y_0@F712A);2#4&5:2)6:
M"Y45!@K:RVE> T>;N"S?O-6R*8]#:S$'VA93[T!JJH$,HLL6U2ROA!T_F\*T
MH(-5DM>OL=+%R:._U$N=2EU5LY:4+<ZP/3K '^#8AEQ=_4N[VBQDT:]/J.V1
M2LT)<=!3\E;"5/<,!^,9.Q@?C8G_2MG:[!I5 U_@&35[1!!O4$A0=+(I^4VZ
M9@N>V&U6]Y-,&B"AD=_/K9H%0+%FJ!+-R_RH;VWUIRWZ 78U"9W<E,1&2J[(
M,SZI8Q7%DE64U83YU76 ;&AB8%FZO$Q0LMM1I.N>\2V^=FF"YIS%#FO7.93M
M=E^? 1H @W\:9 ?V!-9YJ'8Y2TA_FL3^#:$?2U>U<T-0#8ACC+U_MDO_5#XF
MT0@Y-TI1.'< Y+P.*LX:" 0_P/TAU[#,J;L1\X=#>W,(*2%/\BAXJ)-$QOCD
M[?HF">UH:EA@H3OX$$D(KI,Z8!Q%U(Q'XU++)FL8?<5X<QES4N?&MB62IYU/
MLRZ!HNX219+292GR,XFB(&$3PB BI4$/9&,.S6-10W6!B8:PA1@SPN<PN)6R
M3;95*4_?KZYJXT9;@?H_1MXPVI[OC>/&".W.[BZ";UX?I7X%9,,DP4,/W$ 6
M7K&YH]1BC>^F=./7-IE?)E>KO?;=LTY.#\ZZ%T<GQ^?_/WOOVMS&E62+_A5$
MWYY[[1L@6]3+DAUS(FA*MCFC5TMR.WJ^3!2  EE6H0I=A2*%_O4G<V7FWKD+
M!8J490FT,2?.C$P ]=B/W/E8N=;MR-?__>?C9Z=O_WD[5CYW[#+3HIQM;3=%
MW]@LY[QJ.]YDSISEC*<<&_X(@A0QU12H-"X#9?KA*$VA2,P?<PY']PR*FVA,
M([E&?A@<[Y@G>:$="2R-NBA6JUS@\G_7QSANS11]I?GN%R=_#PGO<01?'=V5
M1Z; MR?KS=AT$Q@77YS19:P\UG$LYDG1GZ!)?BI;6*[+??&76:.ZXG5SEE6*
M<U7'!V(1],3Y^VE.7[+'D\QO<58#L[0A)+%(GL%IAM^.168BLIHCEE:5847U
MS1FG$>)3^V]\I+.M#7B4-RSK_!J1FW(!K) H%<"W<E@J5LS?R "&N+)TLR70
M,8G/M(-BU$X9-\M_YTX 6^A;'D(EQ92"M+]#HDJNO*^<EL)(1>%&LQYUK4A+
M/3CPFM7MFIEIKNB@W,/4-F!J]W85IO9ENP3Z7<,<_4#MFJ.NL&YIK=JRY>5:
M<,/H*A,8?(]0@)&T4Z%:9RZ-,T7FQRRXU86*ZAW[\8M)1]Y1H'97<E!HAIPI
M6WX=;BY[CTZ00&K/"GQQ&]%<A>].ZJIK!5J16!6\:38]QVLC)M!?;+>=;HDS
MN5W>T"P5"]J'S93FKSX/+$'_>W;O\-?EV5_HU%AM^:2W0Q\\6+[_+K7-O)[(
M900P6>^*!Y"/=:D]>'!G^9[7Y35$&Q/W_<%]]Q=LV('(1EW\3[$4'U]K)?[O
MQO_<X"!+WN_AO6N\W_;N@M_E[?[_3QBQ7>>.O1F7R<3IIM[*:8C0P#NOQQ4\
M"UZPO&J/1E_9GOY:SEFN/H*MA4X19;H6F+ZAZ[\$=_CMB !>O>8A>OIZ,V#Y
MS.8^:R#R[-']P46?IY2:(?^,LAWZN[7I]2)KF3%_Q8@U29JJ%I+/I_%6XYB!
M+?CR?-TRQDJ[V,-_\NG0+=MQU,_AA/JT*$LA]@N7E5]ES2+CHP5=88Q<4'X\
MY!]B>UCX7>SVS((DC3*(KPH5L D^-)*.]. =^_!3QS-^6X@JWD;?DAO#ECQ5
M#*:>ULO<(BH;FC![O !BFK286[MP'-9P2<Z<'4@2 Z+V1NJ=L+">5M8?6QA9
M_[8+N.FEFQJQQ91>3#IRTC[$V!-([]8@%J-XP/,LAJ],6TX=:A26NO&>%M^Z
M@<^$4AJ<-LU%@M$,S;\T'&?2DMWRB#/@1>J@%<5L<(_0->1W3Z!K"$)AN[..
M;EC/?A6V[\Z\P76:7]EFR1+$Y-#V7[!9$4\QM4C,@4.WI:W/Y"F:[;L\KQ?8
M#!JU8Y% WE$6G!@OE8..M@X<A-.(E1!TRZLM=S?=Q9H[2RGV4*9P]^4H K'M
M&EQV9V)-7K)2"9&^3X%N<54E/Z"]<:!7<@:=WYU_K?D-+Q;%9"]D N0B$[/&
M0 8I;:!)')LQB _Z<_\AK$%5CQ_M7AV2TPN/,B_>,ZJ ;G*@OP)9V>H<+?@J
M]42;.:)I9.>-)9N0M3H4_9>_P:-(2,$Q#5\%Q@XJJDZ;TZ[*?$?<TW<XXOR9
M6T[13@;9 ^D\;TVI7O4+1J+3:0G@KNT S.^6H).<YPT?4JCV9UN6LO95LU"3
M_CC,H?$W]0<#F'XZ3I7D)=TUMK[G?JT)#93,+-M@O@ ,N+682[*DY1[&:KJ^
MO4;O)W-)=N8%/F3S/'>XG\<H3@@7"8>>S^"Z,W%&VR <W'R^F:T+YUS:8QJ8
MZY6-5Z-Y=TO9A(F^C.U X:Q*G,;>^AQC@\^*G#O#]LFNZR>[[N]XLFLW]LRL
MR,ZJFMW]P#MD 4D\NP)+1"YT>+N38;^A03L.@=4K.^%VYE4^6)&*46%F]!W1
M=PKP#&!L8;#*]4%D]9&M$JU,F4U8B(_I-*(DUSE#M,0-&.N!QY!H.J;SJ412
MK"^TM'(3%WZS)4=:G:"QS5)RI68I]"+,O\B4?&N6E)QT M(&S)M<CQ8I5'A'
M\2'L  ^6=)8<N*;8.'R,[\QLWCB\0&"_WIGG_]!!6W<KX9ZQG,3:D$4<.V1G
M2F\=9C6N/.6J4DH<4!2$2UA(;H<W/FWRB5#BVP_492]*'[?0N1HN,^_*>2'<
M7-$C_Z)II[<>":PE.7K"#I1HH.=VA-@#*DI<]ULO\\B<%G00H'&?S[[]34ZF
M/%!P"1HRC <T(&6V;/-O[1_?L418F:V_+2J\('ZTD:6OEWHV/GY\^.C!/3X>
M5PW]_YE=7D_.0YR<?UO-!CY[=/CHZ.[6C^\<'FW_Z567/3I\>.^;C[KLU9\]
MN+=_V/W#[A^6'_;^O6M=]F^P"6(7R+ZPY?K/O]P+E4&MW7Q[=_E^=&2%*S$P
M7,[I&QTQ;9^IFG5'4(@,V DF5U\WODE\%;6F:GWI948P]"-[L"M>5>JLG_-E
M-YP3O.P_N3_J:=(?%0!+R1#\P6?UZ$%_5OD$O953RN'R]M5[L]>\PR_YES_Z
M>!T]_IBEOG5L;CC&.SPTQ^AX_-T7T_4MZFT?T%?/7SW?#^<G&\[_&-5SI.7>
MLM3R-09V/W;[O;W?V[=B.*_8V[_Y@':CF$W?<5*\FAWHV\SQ/SL\?(^N-7Q?
ML:"2$ VT8Z#OZ2UXB2J-0?OU389T<YBFTSRG8=IYO_^'-)?<WZ W>;\[HYU]
MR[_^IO?ZKE_V^_(O='0T?O#XSG#0=L,U.;KA.UYE<S]TR[[)V2^OW5Q>=Q\>
M'=Z[_<LK7./NS2SUX%+;D:GYYM[AO2\R,9_M#?_C.E[BWM+\,2S-T9WQ_0=?
M9D'OE]<??WG=??#P\-[]6[^\_I 'V8/#HS_307;C$%(C[9T/(3< /#=9M ,O
MN<N+]N[XSM'=&Z[:X7G\7<U)[Y8?94YNV<S<?W!X[YO]S.S@S!S=/=Q/S$Y.
MS/CAHYL>P?N9^2S&[.CP[DV#HOW,?"9C]@6WS!^V#'$2$.X?Y47>LM#G:'S_
MP>-]4+J#,W/O[N&C1_N9V<&9>7QXT[AK/R^?QY8=W=_;LEV<F;N/#H]N&GCM
M9^9SS,RC+U3"^R)YR$_5;G:]H14-BT_(1/7@\-&#:]QYH.^<L5$']PZ/!@C=
MF.>#K_"7__/5400:2<_T'SAX^N;&7N\^J/TL9_@WAT<W17OL9^:S)((.;QJ-
M[.?E<\S+P[O[*M NSLO1@\.[#_8SLX,S<__P"\[+)\J;XM[?" O.SJ50!WM\
M/O2":9?$/7K%6=TQ(<*-VR3^2*BF3S@J.[@3CQZ,']W]2'#OIQN9'0?L[3?&
MGV]CW'OP\/#A34^I/]K&N$F^[7?>)#NR+.A_']Y&<_G'!NSO#?2?ST ?W1L_
MOO-G-]#[C;'?&!N>R_T[AX\_L@K[A]D8>\]E[[G\]@Z-OX';\?]\&:[,31VD
M:T@A*9=E3Z;UD:W(3R]7>SW5(U?9_$SW3$?@F\,[=_F-5?@1A6%5?E1*5I;Q
M*TO'&6PTT-EL450%"$HA;U!#&"(*'ZB*"EW%!!#D&^$3(7H50E\1B74* TRX
M7K4LE/#\6G>VIQV+!,'[;+$L\W&XS$@*SLRM&J3.6(1>Z:N#<)M)88Z%S3I2
MU8Z-;95V=%'ISV9%F_>_QF]S]_[!.>N:U-4!/_FH8IKB3R]N\CL),3U_^N3T
MY/C9Z/GQB^,?GSY_^N+M[6 =9@[L1=&VS !=0-.N6/!B$WDCG721,+H0O3ZO
M13-9CV8Y?P)5'M:\.[!5X:1#1TX.D'_-=,,0N9C7TP[*#V=,M U1OH-VR:R]
M#:U8O[ K-IWMJ),G9+-3S-=XKH+7+$B)<U8Z*40D4!0)9I!-9>6E<_ZI2O64
M]>4!+__QT -#RP\Z[>=U,95GSQ?+\XP'=;O4BXIKYLRP7(Z6=5%!P%,'9XW]
M18<A/8T0=?<D3L;)'N%?FC*'B%][%1E0>3O9*=I^>=MB!%1&@345<$=32QC)
M-+P]IQE>U/10H_-,6,Y%/7;"#S6*"DHBH(!1"(]%\YM0*/<5FG9FN>,ZUR<)
M_QGZ4#+NSR/)]LZ\S@=W[UG-&E58)_5R52QXG68BKDQ_VK+8W8)@(6$1K83R
M5<LN6U3+6I+WQ33DF5+&FUAMSL=1Y82%1)QH0T)3Q5^*JJN[MEP'-9?.#?LR
M6ZUH^ZMB4I!?"]N\RB_IU9C6OJ,?%R*]V?!)).>8V0&8+:>"*R_)8^3OYIC4
ME?T<=.:BO)N-)DTQ.TOOGZT.FJ)]%ZP>-K,IYT"YJ6#J*;PQ;?F+O*R7^:Q_
M&/+=SIILH3K!=#/U'WX7<<.MNV +E3H+!Q2B'DTCQZ+3GU]S<6Q.E(@;S[,I
MS9J(NBY9XHW,^?2<-EL^:K,Y:[[T32$9V&F]N,52&J^"[LV5MN@+2?EZ"T+G
MT)SVP0P<]S@0O!TQA<=4GL?6/_FZ)4YX-EGQ"#&U;'IIGI(ST09BZ3]ZY6+6
M\6&(&\F^+/20P][#80K"-3E=]4[P/KN6YII5UL;1C"U9^UL..QKG<@UQ/U/6
MD^?Q!ZL:"K:8+&2\JFMZ%B\/V=>"+-D*0)381#!AVSI8L9%3 \,@4'#1L!TR
M=9 @%S+)S[.+HF[<GW"=&MJ%LYS>?,%2ABOL6OG*H83EL.VLT]7DY_2D\J8S
M-QKRO)E(R5/$0G&R/,UY7BZCVJ#J&8OZ%I\U;6)NY>_022&?W1G?LICOD&C\
M3?>AB5[LRB[D0RPH<23+V\_<(GN7P]$=K1J:9SZ713.312AEQL2/P_IVSKUS
MM6U;%U"N5D%46M)G$D^&*T+)JZ=VN!&01LF[R_.:'BI7)=4@ZZFKM%3EG *:
M=&U7(C8=S9KNC/?X@J.%0C=1<$T*=@80S:J[3W=;U*O<UF;4_ Y1"'GR90TI
MD_* 7*6@LP)!/:<%NQZM\NEYI:_&SRX**F7=YC0&\N[AW5C3%&$QML-B1._2
MR7O:LV/.Z"L(]H-KI=,H>YHMB,F?3W/QO3=T4;=OJ+U6V896V8,_EE;9[Y2X
M.'WQP\O7SX_?GKY\,7K[].2G%R^?O?SQGSMCN#]H%2==2W]O6SG%3"RU]N$L
MCLQ\RH>UE_MMUV0B%VH[Z+ G(\#&4_)PIHJTD7C3 (8_\U%%-'^(2,AWI2_1
MU_7(YZ][36$7%HBE^5>7AS0??WF6K3+SCYJ<TR5RO23E85?%E_&&?/@N\HP=
MDU9"'R\;[!1(R[;6X1(E4+[,T. @,0@A5,G4D3NQ*+I%JC3ELR*IZJV3Y&YH
M7-BK0F@ZMN<Z+Y8C3A^Q9*1Z<*IEU9+GW_G4IXFS^N2G>^0OJT7UBXH^Z_%(
MAX]*71:-G,(:MIH+V!]OK(*:-=ULZ"U?0V=ZBZ]34"E'9#NZZ$J6Y&3?&^XC
MC2"YI;+B6U;;1HB9WGS.VE[T;;H*WY9^E9.[MJ+S#.K:+,: <!TTRB9)3,,7
M=/%,I1V7/>#+KFGJJAFM$#XA94FW(9FMJ<)M+VE^<= P8RV[FA<T)I9N4IW1
M5.LEFHR\$#H_>0_'<1C3P\X..KJ6$T7#9A R:%X]W81</CZYNYG%BZ6N-;<+
M#S]EM'MTK17S*5O)KKE(C]DU%/_*<H5A=C'WESGO8%U6FF'A&>@5#ZQ P)+(
M19D[UY(O22Y'H?[C!Q:!J:GKEE[0LL'267&0S^XKPJC6Q5&R]64!L'66M<P>
MT^'HF+YTYO*@;>ZB+Q]QJ;F#*7-O(0L/UEK3(/PVZ27D?AP\2<PGZU\CU]92
M%L5UZA9?ZL <LO(-BTO">-/@G-4\M!0Z+HJ5#:>7]:4%!)'"5D(.F3/8:9I:
M+>;DU3G<V/R]I.##G?A#39$AKQ<.X7KT+L^79*WH5S TFC;$LYRSHC:.9O_T
M[IB.BXILPD5=7O3O&<[0-1\LU2QK6" 8%\8=$!;G6!1SV@25J&9.:5@L+8:3
MMYJR G@^BZ<M9P8_><+I=_+U3IZ^>/OZ^-GI_SQ],GKS]/4_3D^>OKD=GMXO
M8?N&\T6++4AEF%L% Y_:JK!_U9EJNTE++I;$D\NN:3M>TSA%AW_G=&'A*8::
MZ:233$Y5KT9E09L%0?AXB[$;6PAHRU_$XGL/#(5V5K:^I,6%0W% V3,LUJ!F
M'<:$GV=0*O2\6V15W+KD?V7-NUQN0:,PY0(7=$&1Z/:E63IT,Y[ \6C.J2:^
M'?EPK&0@#U.3-UK(W\O\3"=!CUV)/FGW#)C#[0$3+\)B]I]_*>;?/+YS]_XW
M#Q\]/KI[_]Z=1X\>/)@]>CA[=/?>H_O9O0>/__?>T5\^W<J=?S/]9OX;]MQP
M*NGDY?-73]^>OCW]Q]/1R<L73TXYTGHS.G[Q9/3TQ3].7[]\<9UB\1?:<W.V
MQA?DV[.-C(<QSSFM'=%GCY$X%T78L^0T:-URIG"1<51 #MJH;LZR2H,ER9BP
M@S8"[*"0LU16)"*.*^K!(6U"=ZXOZ9&:L51U:9U7. OT,),MRXMQ4@"\(=FC
M.HC@RIZ:<:C$)TO+.LVME!OXN>DD:)'[9?^9EO4D:\AF-/;P=)# 0Q;W9L:B
ML^L/'@-?:!IEOO+>T(:Q:%D.F [CK%2OIZ8)&_Z>1FWC-)P\'+U9H11]IM5W
M5MY%S$:69&W!, ]R=IDU(EALUW38$BZ]<P$180 B&/MEUB1X!/YB\+E"?*@Z
MQQ&8TDYIW>"A^T$W10DYFW41]D8VM*6EV?+]8(,Y.5A*7H'7N]I@"4#EY<48
M\L((1O5P](I<H JKQ<+NU7JIB=/I><WCFB5 @U"0R"1H)A<KOM DQZK%"HRU
M?7U)_H]>K5,3'79N75# Q[[\6&/N(OKDJ3!XDR\[%0&G!5)E"][)T_JL*@R-
MT!O[!-%A<V0I6,TPA"7 >5QZ,\SZY7DNT5T=%H!%E7Y4](@E7SP=SA%Y=MV"
M7DAG0H$*;3)?.%*GY)UQ&G?+Y V?]:R&+H%+<8MKB +]*F:[:(M8L=N>3[?C
M3*N':D(YC4<NVJ\42<!CLVA$(X LC6#/^V?/..8#H_IW<-\1<%@U@Q%Z\%M:
M+&>SD5B.@L-AGX?B!OT70% UVY'P!K9NPJI'+HRLPA([GOT_>F':XX7$L#12
M8UPC!=#I!MMNR.*.[6]8R?&%!)R>RVIL5]<8;=UI)WP<5_1_ZV99FR/Z<\4^
MK9SOHQ^;NEMRJEV_P>74XXKK'6,I.'(6GOZ4KZIL)/^.:;H257MRE*$(12_*
MDO9N\A+OX)">(O@7]+P5/)!@4,BDT9'2U LYK)%4XW]\<J3@9]ZQ$7&QFSNV
M"1X:K6:& I1QP2'+/FWJ5G%P'!TTC/[AS223[];F."!@/KC"?N*PQ:\GO[[.
MZQ*GBD].Z".VY_MJV<VJ90__6-6RS[=YL>#(;9E^</_N1BKE67UY0&:?HQUS
M4CE]3QY?SMO8^?V:*LD51U*TXH1?9"WOLU_K1L\F-P2NK#-6&%>A^#J@"[.0
M*:DZ>'3A$#?O?_@\0^A2QB<?OB7?:^ DVU89^HVYA_L[GWMX_?3'GY^AM'L[
MEB;/O5\-B/OTJ-$$KBPC>MQS/?X1B^7L%Y1^[5HH>CAZ+3_42"9Q@PR4T<?
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M3(>C[\./C+N9BQ:ST;^DQ8$OY>A!+P)CW[]!<!:?M?\R!H4,7(]*L%]/I#<
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MI@C%>YW0*Z%2HK^3JRH5B'\#6H"+KCR3I#[7#21W]A4-;VGV+2C? 249<W>
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M/48.,XGZH;R0E Q%?S<V J1-(?*#&%F@SX(LH>E*X48,LQPJ39GQ[?'%+JR
M@J(/4NE\DX%,NC0GTA"4\;WX^09FQV )7;LT>F-D?>MI\DO:MS!HRE+UGF8.
M7T;IV/6N2ASF[@-*B+IQD.K0PZ5N!L]L&Z-C>O6E'I$ _,3N#Y'3 J<G?YO7
M 5O"F8C523%0Y:(4_\P,S3D4%N%WH+%7NH.G&"=Z M6%<@L\6.&Y<+;;D1K*
M>JX4V'8HH&>^9<TUHPD/L+<DD0P8U5YH!/F Y(J)ZN4(DG7-T62&IM7>;O5V
M!@,F2;JS>F7E1O[#T.UP)4.2E-:FYWI@ HUJ_+4D6N=8CM9.<1DY#\H T%<<
MVN!]V4E$:_U\+J8E$+VX2Y(SJ(7L0%!A'/Q#2G3;;>N^K+E1UKS[YRQKWM!'
MX=*^&7B%Z W"#-(3(OIP:OW2@T&+G#Y.\.=$W0P?$SC,M,:Z(/=DON[W*$:[
MXWH_7>RYT3*WD]Z(5_$2QC9P\E^(9;'>'46"61#F3:#BZK;''6+!KC&1?FQI
M[&,/%$^H4 TRKK#*YVIT#8SL.XLLXG<X)/HONFZ@&9!BN+;CU\U95FF628M:
M WZDBY4UEMGB9DC8(3RP_*<5.V/>5S'R:T!2]5H+\^&&'1<GN<P##6[SJ[T/
MF[?1>7VI<!ZOD9*M8FWV$NJ8"/70M7LI)P'=A)=Q$"WTHXJ@%& >R3J9]L\X
MH?XPWCT>MT6WZ(=Q4I=2^AUM_^/\^B:A2_N!T9$G*IJ^/SCNG]OS1J@AU<0X
M?LEH*QS*;,@UU0;PGA<=6M*">*3=X21ZJR%A/FAUQ'(-O83:-(#]S'P%_-4V
MXQ6HRQ)7B1]?/%Y>A%$=U#CZO0<_]F@V\59]Z.8_21L)7'.6UJ[<UW51S&P7
M<]Q-=ID_$DO;:$X%=624)O7=SHNEND>.F5H>./XZ,DVYMT,[IOD]D;&#TTAK
MIDJ3,5YD$,+E9G[V&?D7Q90C!?0\H,8=]8G$FOO9'3AV0N;2G##GHVZ=H6(>
MZ,IF^8K"$*PQF.*R4"==FSO3V]V>+$1O5X;SAO8GN=-B'">=[7<!1].^0KLS
MIWFLD[LKM(0]+;."9_0L8TL4>C>5#"PB<S\O#&%WZ#BO//Z_ST7#PQ700G"(
M(&$S[YI8/SLA SO"0%H#$RDBK^6Z3[:D71:]R;?^<\D:Q%S1YM-P@'CPKIB^
M _NP=G!#<[H^+R8H;\H=0W'2.S(_T%_ST8FL(+1"R%I9LHJB/_][/J3B1U?*
MM%!8^P;"5OS0%B-R]JYEAZZ$?O&$59$5L?-W7%ODL#!V!5D> LL<V0D$T&.?
MF,"8<46B[:=>VIB1EBG@PKJ8'TN"A*P#M\=/LF8!^=Y(4UF#P)',-O(.,:'Q
MP1R% W1M9">*2)LK6%OC$XD-@S$F/AP]"]VM$N&B0K*Y$&SJ-UPRG,JP'&)=
MWU7U)9Y%2 Q-,C.?A<JMJL##6/"W*^7V[?7E6E<^^Q8<[*U )MP6,N>9&";\
MVPV,[BZ^\QR+CPD&>?&C*B73*6M#FL7P$+(<>2WW%^Q([*!TYH%?H9!\&VXN
MK09M -#W\G@Z,[W4W>TP7#_PF(WY[:S.CT/#MCUF/J_0E]"B39]GJN$#VQEJ
M]H.D^%.DO9IF4!):%SZSU3+"[(M503U(W6.>2UWD 3$"CU9Q'%]9=8\9S&AW
M S<D0)JOV3O+$,.,1Q.F5&!SQXCTJLHYT<O;<8/K57ZC'M%XU"VGM31+IQD^
MG+-*#N?\)S0\+7/#K.*'9B&3CC+>XN(^^5X.9,_$"#!_KV$B6,^+SQ*5D<^C
MRBRM[&G#B>BU!91/ GL(W^:_NA;\%G13#Q,(E T]/<?0&C=V3U$&Z:E (ZC+
M_%!Y&P2SP)4^X:#1QH0!BQ6*L1&,$A@)FURI [57"EE.;<=U^\PS'+*EF4KD
M"J,C^WYC#:M)1^;2%';L5&42H>&%WZN'X .D]6_+AGX[G%_@U<1@"6W8LG2]
M5*+$#"H=H,SF1;_P$$^* 4?!,J.N.R_;?HF^\>VECR,IIOU SFSR>Y2H&J?V
MVFXN?BK4"-)]H)0"/(<_=63$1V]TO]M.>,G1"4S+:066%+(3/VIO\KE"$LQ%
M63LUWE['<W!3.)DO#8),9S+<$\8'(?VK7-MX&T,M8 O&DJPS$1OOPB&'JUT6
M NH3LR/S=_C[J!=LC4R&E]_?NX+6V>(+*"D8\;0LGV&<@^+,G-8+3YF3.4@:
MS_L5A/WXAM2<.XIZJ#,]LX1F?(QUS4?P&9H'&T4JM+$[5)L5[$2A#8 ;P,ZS
M4 GKZV#MBQN8*;T&<PVI$X]263R80TTF<NE'VOI8,A-]G[A0ALZM'JDUI.'=
M\0!W6-(WD60M4R2+<0?@Y.Z=/;NPD/XE"^GSKR//RV_4"2[;M1\;"[8F.=@Q
M9CX*[E&ZQ\JRY^?K!7K9+HWI%S!<MN=W812^G-T>?ZJ47&PU[H.5KH%_O*&/
M_.@N_[\;#,G]:PW)Z],W__UF]/KIL^.W3Y^,WKX<O?SY]>C[G]^<OGCZYLWM
MR "SF_^<C 1JY*'&(G0X2J_WWW0,=]-WZQAV250LPA-TM$UI3T;8SBL*\!F$
M!!JWWH&5C<K\C)<*N49ESC697:S!4A3QDGQXT8-C8O=EU[1=)FJXJW.O-I=)
MT;-EKO&*-T%/TG#EAS<,Y.L?7LD00_9O*B)RC<0[N+[&,'*'MGA/U_1%5;WP
MP,1H!HD3%2+M]=:)8,V*&5#'>Z3(]9$B]_Z<2)$K1X^3987FI<+2^X#M\,O7
M5N=X!!W!0O1K8A>7:155]442]YME&;BI\:6ZG?N-R3)DKN"8/(8X195MYX&M
M.TV4]+Q1D/W:RSADE?B> W?I&[XA[=,MAO3/(V#H:H3HRRJ+&")Q!%>)BF19
M"@DH$NQH)B@B3+=<IVW0F"*L*B#@95:OO50U>WR#E4B/PJ$^^=45YUU0A/"X
MZT WH 7IP=NJV^Y!W>89W1)&V4 0#'0L!'2*67CII.MLKBTW<!3I'TX?KH?5
MA&)D:-^3HM%VX U^(L4D@!RX"*07L?MPZ2R[J!7^R4B>\38Y/O55W928;(CU
M;0]H0=NO-A!I.]KB\PLK[S6ZC<B^@:YJ:#R0'$G;:R$W%G6BCQZ-3-DXI9)2
M0!)93<D0#UB^YW2>EKP/3L @MU)!X]H)]=X+U%DO^Y)>SAM*GMK1^LU&W]SK
M*=78ES0R-E9S^NK /9\+LQZ >%MO-TGV]%COM:3UWM\!Z 3JM?J)$)&V[?$2
M^X5B*AK#%>B.0%]E*G/;'X'>\*^/#A]+ 0O\_$U?C4C&X5H#.+[>X S#U&-K
M<2(F'GJU R#KUZXIVED1HLVPQW5E^A 2S\.9].1'>$M.H7,K1-**D'X-^8XD
M[4BW6&4XL-GP1],AFK-E4+1(K,(LUP[9:!MV<G,_=Z.]U5YZFKIRK97S>?$>
M>MO<&(3!-+(B]%3CB\B<*BP4/ZH\Z*OW4ZN)N_89<.NN1WD)9DO.VM:CMN[U
MT7H 5[I?$G%C*7ZX3%:3'["WT$E-'6R7O  E0OJ%&4JWC@E=M&AR%?718YD6
M8*6O28>:\+2ND7L60*G?VZ&"VZCF\8AI)&FUY4[,*M[.FM3# =6$864.'B[>
M]G%L4O;<^/H'6^+Q1E?<S]H?6V8O5)1K$_DETAZ054__P,12I"5R%W>#'\R^
MER*)T.AGP(GC#W0!2(=.MV2_U/&-1'Z*O&KJLA3TCNN;'Z?M\JZ,8-01J>2M
M[XT*ZWZ2 [;*_J2!%47M4\CILUG<".CH2B^509:#"?AH;XF0)B,LQQO@2"V=
M:]G0@6[#6P[7)45<3J&I<1Q,6N# _4E;YO*4N]+ %..@4^<Q$J$[,>8=I4TN
M0H%"#]Q8=!P9OQ26/G8CV:"R,%H6JUH+0B-6^ST!HF\T$]02,P\#YI,W !OQ
MT(+/.,)YU-E1[O(V1YTPP)/77[PK\N8>_26ZZ+ @LM%T3<?^@70>BZ09&L52
M?M*FSPV9JZ=(2Z'IEM*9D3 P"P@8.R-M-4RW0T*+CZ)98/$-U+K2T!B)(X>Y
M+O6Y8R52]R;M(J&A9#C@D+K#>%/;81QD4%.F8ZT5Y@+ M&@ 7A= \-,=[8T]
M%M5.\QHJ'KXRF9C+T-S*[I/H%HQM9[.24FTBY)#>8A2GM)I;IQMKO-&2\5'"
MP%0F<B/L,#/-$@P@+35!<UPQVXI;%Z+PI!,:\;WQA()(^FU@LMD@!L><&Q[<
M:ZG";C)K]2SGE2(NB'7#J/%.=1H<M)+-C=-J",D/;*30SJ/;0COM:U6N#&,J
M4JKT"Z<$VM]:JRB?89<#JB&;YZNUO4/\*#6!V>BL >#$<02LSKD8K\$@NS\=
M5^8U![V N3XGXX!_Q%T@U1Y513,X.5>!-%1@YVH5^&GHWZ B2DC $T;9W(ZN
MX:G'#&?:9N9FVEB5]87-(,7.9N"P!?L;=36$QD*^T9YWJUE]J7U*VFK2>QDO
M#S'+EV6]-F:1,5,L+9*16; E%IWZ>KZZ3" $> <SMJRAY.QD0/*0R2IK7@WV
MM!LTZ<<I$@$<*,IL0@-3*>?*I0"Q0%#@["(;_$@[C@;W61=4F+@E H=?K?U5
M[&BX-6=+.>68R!<\*"RIP+K+_,H\W9)$6=0KQ%RQ7T"GS+>3!!VUPOP(?DR#
M:K=*L(%AV1@-0]M+'Q<K;+ (5>"-$V+Q"W@%9YF<\*!=J&7^LTF-)JFH5**3
MHCXW$[:!Y6IYSK'M%*%DY.,*'5#\CO#&!6 8DU1!EYXL9<&*/%U%)V@LY&>C
M%=M2=5IX@.J&7":H6F-3PDN,;8.2?^1A%<^<_C<8N/C]:=C+&> FNH1C\,Y0
M/>#*<X6ON['B\-RU^2B'WA(A,DRXB1#T!$TC\0OL'(Y-;!)L.%M3.J"2Y/&6
M"7O->V@U@]@6O GPXK( F59&;91!1P/83:G&)^NX!/T9%/=B(5!$!0C1GG+T
MO^CY,7L2-W)B:+1K+VS2,C\KI%D\KJ?-ES4)F7%X/#;V!9HSOW)D';2RSH5^
M0D:<[;Q^[^NQUY[9JB)CC$5Z!9"ON5'R3VC&6&1XKG7RIN.[=>Q"(-0[C5]"
MPVNJ.S9V]$WZC?O10%=3H;!/G$^QG#Q)4_$Y+M@O+YGI4%+\<]I$M'PH9I]*
MX%0RT:)X)N< ?8)LQS^J235@V!(REF'Q67_H(NFI_U?1Z@8FQ2F^+]%>OT1[
M?U^B'1@]IY*+<QP]>-59#?K,4(4$>5:5G4GK!?9Z<&8ERA,-%_*)R6^I'06&
M<1#1%?+JG$-QX[M4@2YG^W$@%JLV+^?A")?V 0[<=%LX!RP5 !&7ZW#T8W&A
M$$B>QYDP5PV0 $A/4VAR=<>O=3BQAQ M@NM6"-9#-W(]G>I&Y4B$F;8TMQF2
M9+W,YB1GAG+-T4B# 6?NWIYK>E11,.Z.[F%<\SZDB[3]2>2LQ24!3R$ZW P_
M*C.K%^"OBA!2$K)&%5W_D'(D]K&HH68UU=J+N WSKBS5?R@'%"!!YJ8#+P-(
M$0QZM0Y'3T0"![?C^QO!3AB.:HW@&<QX]27=N]6L+6?+4"F@( $2(<*99TU@
M/EDVEUS6)E%PJN;E(VZ9BE0RR1Y_0-;8UBD48"<^[.V6J)LPF'C%_IG<JEN>
ML;A3$@N:XX87V/1'>9E$J250 5L@T/LNV@H<>-K+R4--T=H.N-.@68E?/M<'
M;)VKHH-<AKV:O+F?!L1^(&,T>26Z<>^QQO BV&VZ\FLRAG:0Z_#!]X1OMW(,
MS]@>NKP9[VV^O#BB@^-HZQLN=<1.TSLUG&W4[9B*4_7/9_(#5G.)SYPY 2I<
ME@^[%,;]*$X-GIUME:0P=$'9B N@I&A"\]E8/2K=USEHH%:B9B,93>D[-#H'
MK&/1@UZ%!"/Y2@?F9OJWU@!$(DXL2-#[#FX4Q&Z\46Y)'G(H0HG)>J4G.0L)
M!%=:5H(&NL^_U6J&P"92(#@ ?OSA+6%?9V^9TS1@;>81.%L;!5VK/"$-^J'Y
M)$#DB!*\D*Y,[:=I2&VGT(09#RZ41ME:;3.[#Q+RY$(SC8BT6=J9S,'&FC5-
M0HQ4,EDFSK"I%.28AB30@DY5Y;M7^M.TKX0'%&0V*\DA",2+D[E,-"9%J\O(
MK\+;?*)98MW+/:R!53BX9UMF_Y^T;( WT+ZO5ZC>P_FT _J#UP@ H<UKO!Q
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MA?1LZ9M(0MI&QZ5FZ]E>T L7U2I9&^$4VTITM,%S-"A/HLRCCDC6C3>63#@
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M1I]\EX2UQ.H*6M:B)C\BEYA#STO=S-![QYN!C]QH8EH<K $$%[VGHI&,/J
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M<UEL';./!H>3*+L29#?;,<%@! B&X6'4#T 6@EO$ [6N9XQ6>^JXD*PL@70
MK!(ZN)E;<'6N+?!+[B<A,_NN,!4F-RSQI/==_?0='E5&RMLR,6XT&B\:I1,G
MM,O\0@5B!B PZ:BPMUC6=6E=0Y7-262'C' 3_OV8 7M<U!;EIK&<1RN1/%&M
M"YIF!@*65[6\TXG1=,A V*7P3_1G26,5@AQ<.& :PI6OA>.[5OWNM^A=[&H3
M]2\J$K,I"N]E!0:;+GP6:4'NQHK7W"Q;<-/<[HS'A^ ^O>:M# 16N;3&"/%G
M9O06,4N_T;DL9D-$VW0(52J"U?,V!'Z9F;3,+@^$?]Z--/9R!892J438O=D
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MQ/4V#355P]#''QK8X5<RY8D!M5)7/.-Z'@@%.)%!1FHMG#_&/9H::OP*#OS
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MW7J/HR@.H-]?6*3X)2<P+M1< %6A0SRG5KO?=?\]A'DZ6"#<I$0Q)R">/*B
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MX9?##Q6-_B0_/+L^A0\/\40\D1(#[P_/\/E#V#L[\\40/P<FPA:7"X7)=K4
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MBP#$\Z4S\I/M?&"B-!^T1F"TC/'3[LCXK[(O C'R;SW8I#&=(5LMRH!(QIV
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MF!&>\4+EU2L_@0>26T#&J*9M5:5([Y3NEU(U.;[D?APWRK'/,L:2BGP,T$X
MGI4&^& 4*98.Q%S8+IZMW*]DBR8JQ";YGHST_6#BX=GOQU?7I\=GZ;3 ]1?@
MZ+T*BPR].S ;I4[@U #PJ$\GK-RB5"#^7;?S<'RZV5B.3BMK*ATS3?0?FJ%.
M&.%,#-]N#K22]!3!YPP%"0X1C"^A<XG9A'?G!+Z'ZWET[_FI/)[!Y;^.KR].
M!H?@\ RO_@5F^N7E\.C\TOKGUZ/?D,3VA9)8'3-%X/%\K5Y504R O$!Y^5F,
MR;<]Y& [&+0D\N,PB=)+JX35 >62=)MU14XRS],BE=_FP [\U7DPNE^!G[I
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M(2L116[*6P=A3H7VJ%)#X6& R?-EGD6%HCA1- B34@(1C@+G!O6@8']CJ7Y
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MN]4'8@+J(J1YJ9/#9^$(+.'9M"&P[2.!B_=X2?M"RH?^#$\KY(4A*\*^X>8
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M%N5<#'CI):S7%*FF2:N-H^86MM%&?7=RJ,5.10ORZ&0YII!+369(4/.S:N
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MO36Q_6*8D.C:6I_!$#,<EB+:DN?ID#(%Y^(9YE3_PV?&B<WPXV[,U.1^?]*
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M(^.N9W%6PV4:2+,;/0C">&JA?;=!EN E9-I7<BN6 6:7#?.TS6$8$EF.EQ;
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M!!%[ LPYGR/]O/VDDQ B'"<AB!XZV!">8SW_M+T850K03UW9S [Q&1B3X*[
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M7]GM4"J)[2517<L#3)LI3BU. 'VWR!]6$1=_"2ND#5^7N*+K$A=)G\[GES#
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M)YF'.KNK2 'R%S6!O8HQ"2- R8-]01D\L#M0*(Y5W1>\185H/SL3>.&A$XS
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ML&*)[R,!JYC#BL(I%J&#SVM_>(F"FN<_\TN\K!F+CYO(A9V1[LLQ'BWZQ0!
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M L%M29@E$90/-#JJA3.EWI_)%@&UR; ]DZ<M>5MGRN\-QGC81-#^V@WB5H2
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MVN5)4QZ<L-G/#Z6W5'2 P4OP3CB5>29A2F6B1)O&V-2874OL\K_K*U4!O$P
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M" XU$QZ%2DZ5<9[5-VH#W71GVYDH:R35#DPP'@0QV3G2VH"1W"KC!5(Y:8C
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M7LY*X^FI,"H%S4=!7V8M?:ZI1:,]!.\9"$,Y&&8"H(U&6(>"(C9F+]1P8MN
MNUQ+OP*W:>!.#?U2MZXHMU".X4!X'\ %3\"KB%(;0Q2MP%U9X#:6NE,AVC1$
MI^;]SN;VVX0J,JL8$,[B_\_>FR[%D63KHJ^2QCGW6K5=G/9Y4&V3&26IJK5/
M :H2ZMJJ/YB/D%*22><@A.P\_%WN$3D"$D," 83MW2H@(R/"A_6MT;^%>.:6
M=-1JE*2B2BM!/<M)NEL7[S0O!]!H\WYO?!2')8;?UM+?;2U]F>D90_;VC+7J
M%2#.K[W!Z?NQ'<<VVWA]J#E;-.,)9\DY%Q E^:B=#1Q9G1S" 1NG.),RAGP0
MOT%1A#;B]P@L^%:*[UZ*YS9]+A80A"64A!*(&^*0X<8B*CUW(0H:;&B#]T]5
ME-=>CM\*[=T)[8>9T#J/DTC6(BN)09P*A6PR$F'NC8]8)NOUQDNZKC:.30O@
M/Y[R?'!I^^#2=KK]11K5T2B.1X7PLM>UKMLK$C*K[@$)ZL#(HR^_6?^?2;=J
MT]BRKCXJUE5"MV@C'=$_HX_=+[F1XLV22H],'3:,GVEA]EL=>#T=B)>R2,93
MHY-"B5B3JTXD,KGT1$LO=(P2%%UA>CE/]7+U6O367FV<@*[[;'<KH.L5T+EG
MB2FQTH-L@D\)GB65$1FA%%(J8@%_PM3RC9?J-MPNK7PV33[O@86IE<_;R.=B
MJL@?,"RC9TDBR2Q&G!F&G&<.,1L9$Q*@5:F-EX(U1(FNU8ELJGG^+I_?[H9.
M_)KI#&+E* YR7*7C)\,A.+>U!_D<*L(:9KS7:S,E@GM3+=%V/Y2XUW99EA:4
MK@=*9"FI)(0"K9%0\HX@CB-#8-EKQ&@T3D@OG6)@U3>$$*XM+&E(/NG*=*NM
M -^) ,^M?ITHT;"4B(#UGT/3 MQRZU!0)BE'O0X&W')ZZ[8GK10W3(KO[AQ(
M*\7W),7+O@%F1+'$#$J2!,2-LD@'R9'Q*EA!9%3!7$3-^C2JR!KK'NS$D)_?
M\3W;/:Z< Q?[,77'H\Z)/<M^\7.(ZC?++_A7M+WQT2L[A)]'DZ'M^_C[/+77
M0M'UH(@NQ?DM!Y-".40$LSF,*)'%+*! (I4^&$HS&93@O$')[C:8V)1@_Y5-
MBE:"URS!<Y= $$<E Q^ DF# D& :N209,CH:[;#' 8N<J3M?D-YF AZO\-ZG
M/] *[YJ%=]D3T$ZSQ E&RN4F#0'< <.=18I*2DP@5$662:4:DLI[%EF"[6,8
M 9C\81([AP-XG?YQR0P<QKZ'/=]Y#LF!A_ !\N&U\P!4.V7OAO&X.SF>8L_9
MZTG<'VSG)3EK0>AZ(,26L@*8Z^AX0KDG#.+"!Y1+"Y"6D7(?;9+:;;SDO$G!
MB#:JV% ?H)7@>Y/@A:/C)DKJ*4, P)GSP4BDG=5(81!L(X-+$7P AEF;V'M"
MPGLWU+&M\-Z+\"[[ (0Y#BY 0LY'C+@U'&D#HLQX\K">S(,^SMV4SH?A'GVK
MMN;Z -Y73D =]]_L6.^'D[ATKF1>/M2F!>X[+3!=H'?5^N1.\-4"M=&)&R,3
M7W0,7-1182>0"B8B+GU$QDB!?%):Z)B8H&'CI;IUM4$;7FR:\-[].8!6>.]$
M>.<^@5,\FX4::9YL[OV:LDG!<UA1V>2Y9QB$M^6/>&JR>P]G!%K9O1/9778)
M(M.6:W#BHS(&@7=@07ZQ1""\ F37!A[]QDO^5&ED&^L63,OB.L/X)?8G-RL'
M>F11B6;9_:_@>?E-_NJ.CUY-1C 7<3B+2K2X<SW<$4M=(I+1(<?_"<7YU"^@
MC\&>()6T(!Y'CXG,I%-M)N#)B>W=6_RMV*Y7;.>F?HBP5C1XE !E$0\IEP Q
M@AP6GM)(A&)JXR5K3P4\"JEM:AE0*[_KE=]E<S_I ,90$*!ZJ4#@NF,$BR@0
MC48+Z:,.FH"[3MH$P+T)(H@ [/'.V'YMJ7SNOMOS=\,-.;A0+<=^7HTZ\-""
MSK5 Y^WI<N5_TIJ'B)*48.MC29 U3.8,I,)@ FHN'-CZM\DXMK'!QHGM/=;\
MMV*[/K%=. &LO<.)100>N4.<<(N<Y X)JD5@5'L0Z5OVB&[%MF'.^?V$]%MA
M79.PKACV1D4:G4'6X@#.N<IZ%I0M5]Y@)1RG*6R\%.<-^R<2QS=--.UWX[A3
MFL&=# =?NB&&CCOK_#09P0_=_C\6V61G',NWB?.[P3#$(1H/3E[D>1D->MW0
MF0[M"0+6FMO']2?'83"N/U_%,EC*3'_]KE[(7\X^C#*.7<"2W4+9]:!LJ:V<
M#BEB+G2.2@!XD4P=%+1'PBA'B8V*9+Y!LJG->3:SFX49KRPTCR@&^>R 8-UI
MA5;:[U#:%PX5TX"IE10QYQ7B6BED7?(H6.4%\28D+#=><KJN+E>MK#=4UIN1
MC&BE_@ZE?M[X@B6L67($*>==SB-29 RCB,N8>!0V8N\W7K);Q03O2^#7E*%H
MGNORMO\ECE9\DYNUKJA'?*6EN%$OB*M&=9[O2SZ'QNOO)D-_9#/5[B"!=YUW
M;SY,WQ+LWG7EW#M[5B9Z?["=V]P,XXX=?H[C'-5['_UDV"K,&RC,;\M.,?,>
M6X&"DS%3=TCD>.0H1>^5P#(0XS9>2G4;@N^VZ*9Q@KK>#HW?C6ZU,GPW,CQW
M=3WWV!#G$.52(JXB05H5&CR?=-2!ZWQVGFX*UM)B/R4I7H.WVDKQ TOQ0J9M
M_\V!"X)%:RD26('[&J5')GJ0Y  V5 0I#RDSX6WR"]@L'WT576.M_^$ )BR,
M.FDX..Z,8(-79^9!<.I]OPZWX.GF_N\SE39=JU]AJ=[;<K!OIUJFL[W40M;M
M(6NIQ1Y/G%+,*+*"YF8<+B #*XJ("AQ')8W&*L,5-K>.LK<5/4V3ZOMT(5JI
MOG.IGKL3-DA%HDF(.0%2[8@!(T0Q1'C"6/$DA<#9G6"X/7K_U*3Z7EV*5JKO
M7*J7W8MD=0*=+)#S266J?(J,- $1!G]4(0A"5)9L_F3/Y#?5QYA7\^7.?MU^
MQTU&<-%H!",^=MV^+?W=VWS#?><;?JF7(8Y@A?923N'7GX06C:Z'1@MM_-Z>
MP;7B0$;K&*<&8:8EXHP;9*/&X$,03JSRD>:# $K<YB1 &[5LF(6Q9K_A6QP.
M DAE*\GW*LD[RY*LB0\)@^?O$J6()ZJ0,]PC;0@.-'HOC=T $T)30G]NS_ _
M,9%>L]/0BO2#B/2'99&FE&&9>;L"> R(:P$BS:)$AF-*O TQ\=!$D7X6&8G%
M>J2383[K,S[;[$38^R=5EX\^#-Z>=,?PAM\B3/P@C4_M\%DT_FN6 _&N7IUW
M/=L?;_?#F^D:M0AU8_=A^\ Q2ZW#"GFM(^(\ITB3<PA !#OL IB88&_<BFN\
M#4TV3EC7?1*G%=9[\!"V#T2(BFJ!4=*YX[=*&EE)P%< WQ\+J8@7,7<&:(7U
M"0GKV@_\M\)Z#[;_&['["006:\Z((]6!.:ZQ13IB@8PVEFL2M>(D]^)IAL ^
MJ_3 ,/K8_0(6_:P6*;L HXD;=4/7#F]YR/^Q -'#%1]=&IM8R&6^[I;C3>/)
M,.ZEM_ N0_CU;?_]PB)EOO&4NKVN';=IS>OBU5+G/] H7'/JD$L\'_@+^2>K
MD"/"!R99%-(T,4S11AX?4S*AE>[[E.Z%KH!1,\<H0<)AC;AC"AEK"3**:2RC
M\CX?XF^E^VE*]_I]B%:.[U..%XN/_ &-VF-M."(<4]#4(,LV2(*23B92ZQC3
M;.,E61OY3IM,N)I [N76?YN=?AP_A^Q (PB"I[&,7P?#14@J*S$C1V@906X*
M/4L= $FBG$<<D(R /3PS!6MA**)!,FR-8,:+MHG8(Y'>1J0+6JF]*ZE=:/W'
M2')."V0<38A3$%@="$,B<FR# 1>?NXNDMDT9/%Z!O;.402NP=R6PBWF#G0/*
MHS6!:Z1HE(CS;.&KH%%R60,GA9W*%O[Y)CZ//F_0V 8@L\3!G!EXD2^X>P$3
MU[-G"6Y&$Y%+" -;W+HU;HD5]T!QP1@R@1'$ ^?(I:A0L-KEOD5.$KOQ$C;*
M(R ,;!E"'X57T0K\_0O\W+. 57'"@WU"L5*(@Z6)C"<6!1(XXV#"1)K LS"L
M%?@G*_ -/1#=(L =(L"<(SA0X8W0$D5I#:A\3Y#-L06KI9(L6$-B[C^T2?AY
M#&@H-_B3I0K^M=NW?=]2!3^)EURKQRTO3J>5W[O]$/OC%RCOL0??PBOT8;'?
M'0P[_<&XG-Y)<,O^X:BDWPJ+V&@T@0T?87Y&XU&G+>9K!)/8VWI5]M+[LGR_
M#_J'^W%X_#JZMMKX>JIX9Z$E3XX:?CQ07D7,O$4.:Y9)Q##2,A(DG5'1,)*$
M*B1BG)H&50:T%3Z/M'ZOE>6URO+.DBQ;8005.*%$K 7G6H$L<TV1X1Y3$KUE
MOI&'AEMI;J"OW$KSO4OSAR5I)L1'K )#S&F/N. <Z> U<H$+;;%GQ,0F2O-]
M>\.A^V5Z[_H6*%__@H@%'V7!)[E/\7TU.#X>Y$<-_.?.R90W8+8J\.IM <*=
MLP'\.AC^&:>3OY>J-7F?EZ3%J.MAU-F"]X!W/[TY.R#*46N80#8PGBN%#()-
MRY!GSCM8.<HPWG@I\6U:'[2U0HT3U3LL[FM%=5VBNK,LJE@X%:G6R <3$%B&
M'-E( R*$\Q2,,-&!J/*6"*#IDMI GZ 5W_6+[X=E\0V:<LI%0,KEYB1!6F1!
M]2(K@F'4:,P%6YL[T-1"OT>3=@ QJ&0BIQ7&X!)W>@-X=+*^V^N.SYY#9N%!
M;?_9_(_VTC0J\7NF*P14&L;0;<,3MS#]2WB",28TM1XI;"GB3F($VD6B8&*4
M3#""K<Z6?]NZL.F"VKR,02N]=^@-%.D-2GLC(_@!BL _UBGDJ")@34BKG=.!
MI48&%ULQ?D1N02O&=^@5%#'&QFM"F$0RT8AXS+Q^GCCD+6<:G 6B$VFB&+<Y
M@LLJE-Q@.!R<YJHD$. 0A]]S'IY\^N!!LP<+><X6M&X!6@L]"S^*W=,#8W4,
M@4I$0C8]O.#(Y;XC^9BQ%12'E,\I,GUK)I(V&MDT&5U[VJ"5T;7)Z,ZBC%("
M!@5U$2D3/>*,&*0]XXA*#?*: J$RMRJCK8P^-1E]@"JB5G)O)[F++L'G T&\
ML)$*Q)@GB&LGD>5)H20)MQ16%,2WS1,T,D^P>#JAS1#<8X:@JEYLJQ:O#S^+
M;07)[O[' VI4\(DX%$![@.5@(K+,8N0EB\%;GZ@$^&'L-C0D;3RQ84;# Z0%
M6I&]A<CN+(DL&'A"96.?.,P0YS%FXB"+/!;4.VTHMK2)0<16=A^1P=_*[IID
M]\.2[&(F3+1,(I*219Q:C32G&%'.>9#<"F)\$V6W30 L'!*8=1X'08(?8 2V
M5^+^=>?Q[!N<VN'0@O0\G^!_$\\._%6O0HM;U\.M;XND7V F2J^B1BJ&E%T$
MC:Q- 0DN/ LVD*AI<QH<M6'%1W5DH)70&TOHG*5+2TN,$PIY$CSBTBAD%/8H
M!,^,YU(+0C9>"M)V^'Q*(GJ7#,"MB*[5^'\C=K_Y ^F$=XP&9'/U+=<,(V?
M#;#1VZ05(X"V(*;\/'/'8Z;\?<(V_RB.Q[TX30> <,+01L4!.,G+=@O;_Y'%
M+Q[$]C\>'+TH#("P+ !9[V>+D4\R39=BKZQ$"UTWK@'*#4Y#$%X0Y)(+B)M
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M'3N3A1MY ?7<N,$PQ"$:#TY>Y*D9#7K=T)D.[0GBUMI=!%BO<@RI7JU?SC[
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M_3OOK;VT77;6=KVQ6@?B6@[$FX4V!#Z_\X&CE C..-)<.L2C 0<B,0N_FJ3
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M<#?'@TX>0EY!VROU)_#F'6]/NF/;V^ST8[E1]Z+N9TN.YS,_-G/'3EL^-K,
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M=MSICD:3" /[SR2.QM- SN!D,()A3L'MSU_?3;$MXVQYOYP$B^-N 5C7+6G
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M%J)JH\W:G"RW39-A,1J[_6K7YCEY',IR-YYV/@Z&G^]?&V[=R2.O.?P'L +
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M3^7K#WSOM[=B#^ZS\]<NW*/TL?ST]Z=?/N]FEIK71SUPX.M^DF_&.]L'@9A
MHK1()T\19U0AISU&6#('+JG3DN0F IM$\-LVW[T8PNZT?>[*(Z_</K?%H,>"
M0<IS&P-L6^\Y%YY:SAS%1F(OG8_!9 SZ<<?O%H/N'X/.9A@4O0M!$8M"3)G5
M4VKD.&-(<TD#H? O PRBFUS0%H-:#&H<!C'M."A*:A537!NF#8F66<WSB4C%
M6<&@"YMGMQCTH!BT.[>#6-)<*Y?[U]$ &&0D<I;GC@ A.B=A/4G*&*2I;! &
M7=N-K!WKQKN1?UXAZW-I=(=>;P(N1-7'AT(W]\:6H>9'F<\69:Z%,G\L>EM2
M&5@:3!%E5B$N14"6"8X8%XQ[&T1P:N.E-+>%F(O%_$[-G)5'7AKW>Y[">7,W
MI17.NQ7.N1O"M1714(8<+!+B*C%D/$O(BGS PJ00(]UX*6ZM_UOA;)APWMQ^
M;X7S3H5SP3X/,C*64H =8C#B/! 04\:1XE;1D'M^,G=Q#Y"'D\[[3O)<=G2+
MJM6C6V9=!;U7D\7]4@)ZJ2%_C<K4<]6B5RH073D#=T4';3FERV 3A,$D%P?]
MK^\F=)]LQ&8M\_&X-<4]9;Q6],8YO;+\AU;#W%3#?%C.A'%*(I=(&<40%T*#
MAN$14>M(P"[I(%G.A%'*UA0!6H= -3QZW6)HBZ$/D[%K,?3>,'3N0B>3M!'$
M(NV$0AS'A!R1!&D5:?3>.B]-CJ(+?+ZG=XNA+8:V&-JHC&.+H?>%H0N1#LVT
M!J D2#DE$%?,(^,P12;1H!6)^?!.QE"SMDSD0V)HB9'\LYR?N?#LT/F_3(_O
MW^$QP'EOWO;$^NZG-U\/5#).&^H0S";L29\<TI8(1"*@AX[2D,3/'>V$O2JH
M880DPU52.D6N)*:2RXA#P(^&7'^^&WY(\/P0A^7W)L.E ^OY[./)E&&XEYND
M]4JT+$0WSDU^)E5+E&G/P'QY1H63::/,\>D +BMDT;&3>_8<#@IO?6&'GW.*
M5"&[&1GR9'@R&,71BX[]8KN]+,X(OH!&MA>7'EI.Q,,;P52AV9'X^05;G>WS
MWY\R26__.FO?M/"5,H)\"+XTF;+CBL ^DV55W/29+ZCF?CVTW7Y-$3W(7'^;
MF6;4]L\VE^_1S2L'TGXTZ&76N+ISS;1O=*:_+UW+\C'183R*_5%N*0H3/CB.
MFZ4-:-7F&7:7K?@!"B_:V'[-X_O7ZN!G/;GV=ZXR.GN<I_Q;Z:<U&L]6<=Y2
M=+0P 9NK,Y"'E->KFHE,/5 FHCRE/Q@OL'O/29:V.G]>-H&KMY_=K9O;4E;T
MUWX80W>,INT0$JBJP7!4,8H/X^BD[G )BULU+]O?61W^XDG>"[DP\YQ7LURQ
M)>29R7]?N ^HK9 [+$R_FYF 1U-RS2D7,.KF\'@AT"FW/BZ=VA^J)=TUI+YS
M4O34G%Y]RK8[9;%>!(A"2)$YWWM34HH\09FV+]-0P#?[Z^=36# [8<3^19@,
M<\^+J>(]'APM*-W13BT;[PK%^K-3NKFK^!\'PD>85(=1S$W$.6486<PI(M89
M :XU#=;FC-?JL?/23 2@;<HKTH0%W08;T![&=ET_^0-,83VU<XA%CA''P2/'
MO$!"BRAXB)SC[ZPKZ-<RE9U>-U4-IL$%FWB8UYS_6M"C;Q=-@N7TVJJUL-!G
MN'3&R4T=B_8OO-"VM!$&* %3+[<KR'A<J]=N;C(S_!RKRT<5D7?AK'D=?<:L
MTD9BZ9X -#" SK@+&K'<%=Y[XN,*2,W0_!;LE6UKM7.MU53S6ZO]D%)MM;6:
M"C@DK*QBC%L*U@4VC HLK212\7OU*V[ :?5#)REW/ZZ-LJKY<;:35NPCW[.C
M4=7"%8S3NKGWM"%*MK,&D]Q!X= .PZP%\NP.4^MVL0_#S#8-16)=]#9W)8$O
MGI6>#"[.B+ JQJQLV97.C,>#?A?,NW,V1P:J%4-PSI5] 7%GWK<K!G;HCOQD
M5'6'J-FD5BS]Z3SXF6&X\AJ;,.ZJ37$5*!&S7L6_YCN5(OK.#B!8W>UUWJTX
MWW[^/3G[W@+*;M77-M%:W/9^.*D<O!J*HX_=+\4]6:2BGVZP"PSQ[F+Q1<T+
M-NT/G7L+=1?ZY>2OUS[2TF:\(=-.Y<54A&%50[7_W:R<_=MZ6O^<S>JC#X#>
MPLHYW<N!S7VP=K[M\-W7'PZH%T(I)Q'1PB$.. >:Q5"DD@=,ITQPG18MGI5P
M9GV"OFR"ZRS\/20:VX6_?.&_;1\0+@,/02#L(RR\,F#J^D00\9%8KBT#'0<+
M?]FIOMG"CSN+_#%UZ_.\'?(";DZC"* D>F=%"X5!"68<5T@.5\X9TQ<TT31:
MD9]P.3YF2WHT!FVWV3D%DQ70,-,SIN]]I?*^<^_K_!:E^6$FCHI^ 3H-!N5Z
M-M-DL[N<V+-B (=)1059QC-OE5.H$V<O47HQVM(S9SBJ2!9G-YI:T+N#\Z]Z
M"E_+-QGGQLLPEH7^9J439>SG:,NY.=\Z1Z%[AS'XN4@]>]K8-VSG]1\PGIU3
M>"^VL__Q]" J"UCJ+7*!1\2]=DB3 +\:KQ5E-CB5'DV ?6&IFV@\+;S>C$?V
M9 CJ8)@-X$S5"M9B=W(\HS3-LEM"GX?9U^T7>0:GJN\7PNZU&;W@>L\;FPSC
M>#BP!="6VI]V?JD-\=P,=FS+Q;D/XSS,MX!!TY>IXL>5L3X+G)8+,@7N93>J
M$#+':4M^8#:.W'9EWE:]\DB6L36G#L=ITIOWZRU];1?:[VYUMOMG\\F:!V1S
M+Z0(&KT&RZK73O9OCF#QJ\]K$[/J&5_ <#D8W,V=)<-%+=@7XP8_Z,QY7QRC
M-4/[*#L6H]\'L$6W^Z%N)MP_G&^[%OEFR(</N+=$2.T1DP'G,DV.C$X<Y94!
M,X,F0,!SR'<7I([&;'$B;L+IJ.B64'+MW(.$;$ES-Z2.ZR>@+"][M=O>EFG,
M-(,H\6J485.CJ[* GR-;XM7FJ65+7/-TKK EKD_H'OO4/#B)'\S<?98A_C8W
M6H<7&.8M;<U3*2(50;',AZU28#P3:&/A%=/619<I^_75"2-FNV0WCE]5$=]'
M'P>K*D '9.>;%WN__0'?^:6[DRM O\%]][>_[AZ_%3O??H'WJ[Z[]VJE O33
MAV_PGOSOUV#H_O;VZ]X^C O&L//Z#?WXZ?.WG=_^X#O%X/V#+W'R[9=^40?$
M,*>"4"@&F1 /BB+-DD9$.I^X]M9$O?'2W)XKHJ7$:K%E[=B" 5.H,!CKI'/N
MUAD#L.*5H+"E"0]KB+VWL+,6V#E;@)UOGP^83(P2YU$0W(%[K30R,05DB?%$
MA&"DY!LOR2:^/0_&X^/!NF=+[-V1!5DH97VNE.-<;HX]=P8/K G%3#E-,6<J
M66995%B ZDR6!]&:,O>'*7^LF#*?#YRS3G)MD \L(AXSIPX1 #&<>^FIU-92
MP!1UZS.!+;-.P^32$A6,XC%Q;[A+W*C@M*8^*$(P8_3JM%>M7*Y!+A=T_=[K
M-P?2<V(IN!A)*-#UTBJDJ<9(6XQ94@$^Q2"7XAERZMRSIJ]J-W.:;#*,PTZ*
M6=EWC]UD.(H_BL1<"6*NZCD]/HAA+DG!A !\D=RR8 CL8^U8#"K*I&6K^N\/
M8CXLJ_YO;PZ(EBK@1!#31"$>J$1&NH0"#AX\P>"9\;GTZPDV%WCF<NDPP<D3
M Y)).+?"!&XD9E8%FRNZ2:OZ[U4NEU3_S@'X^,'654,& 6Y:I+-<:AP$DPKG
MALH;+T6#I/)INOA[N4JZ=>:7D"-:\!@BMSD"Q1/S)DK.I;-:@U*W@;4:_?Z0
MX^.*1M\YB-AB&PU!22:.8+$U,IPX9(R0B@>9K 1GGHI;8T?KS#=,+KD!/Y%Z
M&R/F''NMK5'2!,V$H89;WFKT>Y7+)8W^X<!RB:64$0FE(N+%CZ?&(.R4RE98
MT"Z"I6V:))=/TYG?L8>QUX.'O1H<G_3B.'9>V6%LW?;E4UG,:@+["&/CN1!2
M Y(XS5CNWJVUP*V2OS\P\2M*_L-!LE2 \^90 B\.<64)TCHG!3%5 F,%NCZS
M;<LFY0!;MWTM[)P">Q>M5!:L<"%S:;6/A#,LM)*"ZZLE[K_%X2#8T5$KK7<B
MK4NJWQ\D):,E6B(C D%<@EOON"+($D8Y6.O"&K/QLASTIC\W2&+7Y-*79ZN*
M@Z!9ED#AO;^N8=72?=[!?#QN4+Z'(^PM,M\>F0]7["A_P+5+C.!\.@E[Q(75
M2"=-$0M)$1<"IT;E:BJI;MW9=(W2\L!AEA8@6X!L'J=\"Y!K <@ET_7S@=&"
M)!(H,HQ9Q'4^PBX\1I'2D&P0&#R/#) <KZOM6J/(CI?(S.Z!5.&7S'D91Z-7
M@V-7'YFNV14>Z?Z]^='BMV3G$[S_MX]L=Q_N]\F3@T2P,I)Q)#"6B"<E$$"(
M04Z:B*5Q,FJ[RC\6131$6VT(LYQ8H3DL!3,6.RI(3/+1D#!,MT9G<6_\B(YA
M?FS^YP<D:/@K3LD&"@.!FX[$+XQD@>W5^O],NA6S7\WP6@A[9]3&4XJ&&9GJ
M9)2I!^8D+.4F%;M:N5>F7LQL"OGOO:YUW5[-S38:@1P7UE[XJ#M<>G(F=UD@
M,,O,QZ,IQUEFP(J]P>EFN67\ZO-H:J:8D\G0'V46QD)% 6!5$1^,AS"!*0[S
MNU0,B\O\:/6W,U/NV/8/NU,&B&Y__NO*D+JC!>+A4>=P, B9L7&K\]=1%RX_
MC9W,19$9(%PFE8'_U?S#A:TKC_VDFOIQH:"99/K'WMF4K^V"^;M\[L[-7,4\
ML?#(0A-\%+-2AF=,^AYPV';[4Y:+*<G&,";8&X5T+L]WYLX937KCS44*G.,Y
M 5SGI#"5KI!V3$X*5UJ_9LLI5!\7OR3,4?Y.-8V+7!Y3'KZK3D-A2Z[ZW0TS
MW=&@7VB<,P=0+ .;K\Z'D\&L-9[O348U%5[9#X7T]QQ]<OZHVH1%$%9>*?/(
MGG^CPB\[FX)"%%EQ,]M"3;0X%_7L99*B+)*9H+H[S-35MG]6&$A S@I%RL+T
M++%>UY1)A9=DD26N6KORTH.36A!&F:TZY9<9%,*^#M_L7 AMFS-.OXZ9T?G]
M5L]B^>SM7#2VRYQL=L#RFU$"9JA)DV&AN8,IM=W>Z >T(W>KV]\-\R2,S][U
M;'^\W0^Y'<=)V\.@]##X]N';@6*4&$X"PBY1Q(FR2"N&$06M+ECR/CEY3KM+
MZQ)W(@;K.%?*,.&%<SH2+07CZM%H]]\'_4/T>_<+2,UT+U>LZAE%SFWT)K(P
ME1'TR@AJA+J$BZF2@LU"UU_V_V8'EJC,5*:H'PW2^#3#RT]3+M".VIPS64Z_
M_6;^[8P%KQ;N\+Z^0X&#*67_YB7:M,*H&1G^ BP"4OW:!9<V5J/:G#5=Z)W-
M>.CC]Q5T_Q);)P^OOKA0T0UC3=T)@)69H@N-4F&C<[$/&A&N<Y-QIP<^4^?D
MZ&R4'9@I-Y3/,Y6)EL $F-H>8<86VRE>3Z7R8>J_9(-D]N'H'UN+>VOZ^D55
M=VO.J>\T;L@7CC//T[SE0:;JRX37-C\5Y4W2<18VP<SD@1O,Q@;62>:ARK,+
MVWW>V<#%\6GFY%O:O)G$''6_HJ-N@+E_\8S@\2W???WQ@'$1*6$281HBXL([
M9%60*),1JWS:G,:P\3+!7-;@4);H>RK->G#GE<.:>,ZUTH"85EC"M2-<2H9O
M0BL_U765X!0\FV^P@ET?RJ+_WDWQV>DY6,C]G0-F(R/1,00.**@Y0+7LQ"84
M%2@P65J&9<Y->3&]_ ][733#XWM=F[!3DWW9T9FBI[T -#<[ ++CKI_T[!"P
MX!RZ;EYF@F]VY@[AL>W;P\I! #/SV'Z.<U=DL:^.*U@Y*/2C\\8X\-!JFT])
M;7._F=PAQMO1]'FUY[3:)"6/%9XS[;]3<>CE(=>XGIE ^Y/:!9O3,8]& ]^U
M4_;1PH>:!YMI^I?G<0:9J3+B^^<F"(8R&LQGXM,D'-9:,GNO*14/K#,^.ZF<
MB?/:JYC7I07)_/)%I*XZN!SG#BX+G('GWP-<*WA*UE0S+9(GTEZH$K,O>TYE
MK<S*<>'=&AUU3Z9+GK77S%N:3M%TH<,%WO4%NVGI-7-3H+/ZRM(3J+3ML?YH
MNFFR_U_1(A97?SCX5*FR>GFS]S[O:EZ'-/)JYMN &91]K^DMJ@X.M?I/F4^Q
MNFG5TV%E[$7!GWO<_%$+B^(S]6.V#Q;WZ604ZQY3WY/+U16H^_IDT(_PK/SD
MVH^#KU?H,IH%5BH\R(9"W0!CVN2G-NY^X'NUK2*NURI"-[]5Q ];/ZPX<PPL
M#.ZPHX1Z#NZU#IB#?X>=8M(3W:Q6$7<8*)@&.;;[J\;3:/7W9YH;R+0%'_$!
MDX(0Y0/R5F+$#<RIBSHA"SO&L:BT460U E#UY;K(YUGLLC-K?=$!BR$KQ>SF
M9-T]+DW9?'?H)\>5]Y5A,N26%C68VQS%FWF-YYY5M_,8=7[*[?J*IBS=_:9_
M_P?@Y7!8.BY4N)SCDQ5->=&B&5P+Z_FKI? RZ,]#>%Z_Q'([_4GA!<_N]HRT
M>&%,]0L/ADM1AA+N+%;5V91E^*@Z]GR2BZ6SN]D-75MZ#>;PJBOQVZ*RP'4[
MA4>XS!H<^Z$\I%*YW05O,RN@",H4A#3/%NC#P7 69ZT:FX!)U!TNQCT7O[_5
M^=?@-$<I2]B]Z+]^GI;^H.BZ8?&%RQK QU4 OGYPL6FF8%/3&)>7SC;$KX/,
MCSR=@94.<\7(.OOQ-,(]9T3)>;>4J&,VS^:7QZ_=46UQG XFO5#:I]0^]'S1
MYR;C#S;2/.1\"  _KI:[V(C]J8F1XP!S:Z3:G8O!A1)OS^&/>8B\9 S2//2=
M=_NT(4S9I_,(=(DPY]!$M4_AL76(N?KBM/',0I^^SELP.,<K7?ZF"W;1%,SO
MUJVX^A<DH,J]U-?"SJL,M*4;52^6TS,QC"XW#E?R*$NKMG7.#5N.7M]5:/I"
MA?K#7&9SXYO3V7D<[NML+6>!N='5,WV79/>R;W#5 .%69_8&]<:?A]AR(!#^
MF/52WL99!N<84QQ6^/]^!M,J\I:W(WPY,]Y7>9SL5:>+<:SN35M&#-)ZX259
M'TT=@XPDH \ =TL::@8L<R\AXP_*^%.)/"!^/4G#68O712]RVO$C+7A[F^6O
MI5UHT1MI4G)KJW^>H?WF0GNCNIGI\GQ60\_3G[X'///FN;FP"?1U/T[U8O7$
M!>T(:GL*,QD1+X*9[*+!P^LM]#W,J096X@<EXU:]:3_F+]KA65GSHJK@&[YZ
M7?L5_?_LO?ES%,>6+_ZO=/#FOF='*'4KEZK,M.=+A S8CSN6P""N!_^BR%5J
M:'5K>C&(>'_\]YS,JNI52$(++2C/7!#JZJQ<SO(Y2Y[CL4]?KLD_CS6B59A&
MFW>+;0%%GG!V66 >=/NUU## F5I#K&_%:M>_;>7B/Q&T(9^DAKK-XI8YI@T!
MIY!G8E#8K?\!]@'1EAH\U"2TTVN<[, +<"AP#HFS<GO%]J$48CT'/ ]V 6SY
M<(0_).?[:%#;Y6'X=W\\&N8X*DB K+A@&IEK0+$ER[D=,G5..P%UDKLU)OT'
MZX"'DY<*F&\%?O0;+9O8?M!_'Y)3 [8=CWU=W[8BRJS2_.4T_3PSQ.*&Y3U<
M%!M-O]M[FE4ZTWI[TI@P.U"E:]/+#?',>7:9A4$-_NWYF9E,FB]N6E8=3$GL
MXT&2.)2I-:M<^"[8J7I.2=1<]&":_#P6TJQO1:%,Y@U%%K=FDB X.K%:.+OJ
MQ\H^J8T(\:'P]:^U_*O5W(JQ5@/1SVPP?A<]OSDUHK5AEC:RZ;JX&4HG!#M.
ML'R>7))G$W-[$/@)]4)RM+ESAW U\SD<QVFHS<9\J",$@CC;\0*(QZEA(D]J
M375Z-IM>>&JU!'L?EAQ^QF)/20-&@L?<$5#2V:I++:8PR20[H.M_+,N:&LW
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M"HZ%:.Y+494@!+'_]58YQ#L?Q_8!F(Y!;X]!EQ$*9:S21C-24%L1P61!;%"
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MVX;[.S:WWQ383_O@\/CCBT,<]_V1-*6SM' D%HJ#JBH J ,D)5$&+0P<D19
MW@ +/F]P[RR8VP!^IH-L#K\.9]-L0&83].4,@)CK_6X^ )39[5%:$N"[W*?5
MU^7O3:*R4RPS/1JCL5JW[/L9:7H<T.&[DW^L"3H]W_J/881QZ)_:V7C2&/P
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M\+'O1OGGMZ/Q^YW>RQE0]ZCW*OWZ]6@V/>F!E 06&9J=WINI.>F9H>_]V9^
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M@\.KT[U_F>',C,][=*>'XGVG-YL@,2!QM>\:A^EX-#FKOV'.SL8CXTYV>V\
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M%I'HBE=$"2VTIE17-N2(3-+!>QAU-8Y6OM*A*I@712BL9EP'[Z+3T7-/5[U
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M2PO]FYWE-^ME2+'K26\TFZ:\9PQ5FFD*3MIPW!^F1.<Z,_,,7C#R%Q+Q]]#
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MGD^_XLMCO=7NV;  G "]\Z?=K)#%Z7#\!J-!M,/3P3G,,CR[.(ZCPW[8*-Z
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M9DT^@ L.L_=4DN/^"(C\"5CK0POW/0'4R)Q_F$EWWV<F_;* IYX,8K>3N?X
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M52(X<Y_?0"<ZP8)%/QST3P\.B\YH6'RHTB,_'?:[D\U(!T0^F_.3O"GY\JJ
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MMX*\MP*>"599<XVIR.%GACAF8)5%P"@ BY+:84DC!:M\54G#&O?F.OM4#20
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MP *9$ -RBFF:@@B,<#"P^$>H\0^R>.L"!=<I2\[4Q)B[9.!/0I5C(46EN">
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M7'&++)<816K!"\"!EVUJ&IAL8+*!R?6(@#: N&) G ]V&I.(<9@B0YC)J!@
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M!O## #0VZP'\.RL'_/\80'A4G,4B?CN!%RI&_>+$GI?/&,9N%QX,DED<EV.
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M1?)A"=?>@G_W95]CSXU0%'E.+# N[)$Q.#MY-!E88Q%,>/"C-$_( 6RP[B?
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MS8V6Y.>WFQT>=58S[$F0WO#DB98X") EX;V+F-FU.<#GX216?<_;UA!XTL\
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M&?@GY6T+LX)U ._FCS]OCXGJ4-@M'GGIUSA5\)<QS+!F6MO(L?7&2BVI9U[
M+ 1S2[_&XI<_(]WL3OOE)#G+K!:(R A&/<]=;:)6B,HH*(\LV01^.6$KF*Q1
MT/H<:"U^^=- >*HQ%7%14@+&@I4&+ ::3]P%CYQS&-[Q1"NP&!YM+Q0 KPR
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M.;?6<16%=3(HFR)1MM2(773[XMUI95M4WL#'T]PH2#KJC!(885@VQ*EDR,J
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MLY.K'*RW\)+G"@M,/DMCU\*>A3T+>Q8'=WG(5,Q:HL8G:7Q$6 ./<B(XTHP
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MX$T+*Q="!#D$V^=KK)J/V/ZW.+S4B'Z]M@VT=3 FX?,QW@@"6'QO^X!E> *
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MXATW7@0+#F0Q_%Y$K_QH_#Y5_Q?&M1\(T\J*A, >]XC'1,'R4QXE;4R(09!
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M$9LSML_OTH]M.QSII2N!8MO)^!Z]^5\OUR4$^"WTAN/W;]=3[T9/M3#9%"]
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M5JV4PDMQR\<?5]5</I["./"!EAPK8!(X\'U$W#"+C.,.<0G2&N',T%SC>/:
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M9/*Y,LE$.Z\CSQN'!SI9R8P22"AG$0_4(N>]0<9*0UVR455-=F:V9RV>N[P
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MG<1$6<Z-(9:99+1+5+)$*%:OV_JT,-5L3-7X<,E4BB?,/'4(5C-D'[=!AMN
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M2%@#$M*4T%\*.15R*N1T-SGEK,/=TU[AI$=R4N-?EYQ$ZY\//%/&>Y90D"$
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M]M.K-(5?&6264(N% _1TJ 4%G<+"JB(L=02MF.7JT]HBSWAPC%""G9R;5ER
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M%79R;2R3.VS8!'HY#=KY^85?%_(LY%G(<T'(LSCNGV#9O!9W0U(TAKF HHC
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M[KG\M+2QPK;GQ+;#;XO M@M;_U/6^%T!> O=_J_$Y1G%I;&]N1!3N,S;_Y6
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MC)-S[NGZW0\EYG3]BB-4?T[Z&7TH6QR-H>0-$Y9I)_ ;W&]C+X*G)QBGR(L
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M+C9+'F"8I\]O9A&O3'$1<M@_RX4/'!&<1N.082#,G$2)G 3OT$1GL!51>27
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M:WKDJ[7U81%FSL/O]L"KR1Z,AP_U8U9Z-^S#!/3A87)&>SD);=N!J>K!2I5
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MRI79.+TM'_O"!GAYY+98E7?@R11AJ=&EPWYY6'BTB3%&J'Y1@5K]-GU.N.O
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MU'.\7N7%IK&KTEA^O08]JZIG>>U[=E6-/I8_8JAJ&D%S[.=8?G^;*6L%WZ^
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M":>H3T%:KDCBVGD7"$]!1\VT%M[0@EAZ@EBZ0:Q'CEC;,Z85A?08EBH4;+"
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MG<]N/%Y^_CR,G_.ZM=4?#X$6 W<IYO&S&XD+DO$^]FRG#ZUN_0$W9P.V6"3
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M&C,9@M6I_G#O@M<6^5 :40E3*A&-V3>CA$3&\GPR+0BI67 P16N;5%_<<0&
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M1)JG4LLZL,"T)YBN;7)Z5;*(2V1X5O2R]7OT]F04YPV^RK,QG',P5>+9Z1\
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MY-R>J<XT!_\"#,72EG22O[M)@'"3E>!"5@)V=5:"!\@O<&DLZ@]C2Q=B4:/
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M*D1V.:XS<6=(63VWXS-74L<DT3PQB:G@+@I-M"!14>J,BF"S-4KZ4$JZL"^
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MF$@L.F:-XHHZ'#SF::FPT@0$W!I9\+Q]Y /+B;,DDDI$L(]@;EP,'F',679
M^I1#>'(:GCOOX#4!/"NFKTLW+1JEO(M2OIO;$E >TPCZ:!5#7 J--,,":<$D
M50$+S3%8%ZL4H]-HY&,CYHVRWD599]Q<4J>\D0P1QC'BBN0TU)8@ZT(ND$N3
M$#BOH(+<.=E]$U/7Q-3=!5VH$L;2I!T6'$36!H&5(2$:YBTUJ<0#W U4FGB
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MYB>L;?Y"?CU_[J1QO52N%V=$E,%KK3DGF#O!I$@,4--9871<IE7TQ%*]W1>
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MKDQ?Y>?98%81ZH-'9N#U)Z0#+/M3W;G0E\.=7^9W"VR5*S-\=7**.=C[+S.
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M)PC$,9=(P_F!E'>9#3J03.+(09@U'-1P4/TX2%$G@]:2VRSGE&<ZX\$[S;S
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M_P]T&+ZN*N\:"\*P([%9JD=<!(MT/!8IHR$X'O6=L#"?=^-E[!\<WNOIE=K
MNP[PGNG0R@B5!Z&0E\8ASKE!6DB/"+&2@ +-N)<[>Z1)O=L(>->C*F$#]+H
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M K]QD0=8U4Q@N[-WG0?N[!6I7['R30D ?+9 DVD*'C:E;.JLV2T@\VVK/_M
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MCT6-KFL.3=[S9H-TK0W.&Y N!]*9@@#/\]X1)CB+DH7,8VD"(Y"2+D?&YHJ
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M=%5. ) H#,\9E@'Y7&6(4\V1P<$CI1EV0N646;U8\&\@NMD07;T3H('H&AP
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M=.)T+G>G9V$I02=U;,%9N '*2!Q)>S2<5R:N#NVZ8NE!)BB/Y,)0$4TN7="
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ME[6>E30Y']N+<Q3UAY*UDUUWOQ5_S,N49"6CUH:GIG6F@(]H0/M@ ,/AFW>
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M1$B#?[I[9@H N:!]1'!Q5S0TBY:&D8.$$=.LVZ95-FV(?E9KA4&I7K+,VF!
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M^BR^.UN<OQV#A-TN2I:$E66YRJ*((Q<4*X89Z@U=J"."4&X44"?BQ<0(:"B
MZXH*Q-!))V;[NU6Z.[,,TF,?E .8>PPSPRB\/1MHR,?)'Q?2J0.@.9[Q#X_]
M-+<:1L'PUNDOW<W-U#RS27"] 8:J49G@4W)6V+.@.-<J?OIO>:/_P5^8GW+
M<Z6ADQ&#?\9AY YG[U8GP>D$QLT3&,W5"8R%.W\P8_^-HLGXE_\'4$L#!!0
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M(NPLB9Z1:V-RC[V])%X&%CEI(!LU;Q]Q7!I'UEFR7&+W%1$/PF'[TB8/E9Q
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M8L%*@BR&ZE0"Y2&I;-JTGCV0SB%U<S[;/E=/DU53G=].2\1^<_8S8B%&KF3
M-\?21QH\\2(%8KCV)AG&?;AW1?ED?O.]QW\+]T6UH%!+RDV2F]],]YB6R7T.
MB@ETLT1P1%H=B./E"C2E,CTCEZ8>1R0Z[_/N Z^'OG6<-%=/PRWJP=0-E(,0
M1G!+T?EBM*2#.T<"UY( 9.&]]-RVZ7RZ%W4'7@U]TT:HG=IJGMNN:2B&<E3<
M+6XU$"%9Z>.=R]&Q Y)TU"6KU K;Y#CR#A7?Q/U/;8@<KX>&QN7?5WV?7V+
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M"]S3M7X65V&V7'P83R\FL/GX:VD,=W/<,J*:.^:M(Y$;(#(:26SP@D1IK )
M?G*;N\1J+)QEZ=\*,(K '6A)(I2V5B 2<89Y$K(1-DI*N4^#6?:/"&U8@4)/
M:*YB#([#P6"\L%ORF;/1H<U$XXD65(;(B&?9$ZVST=Y9XW@\.XR?XF#($<2W
M@.AJZ#@/N'?$]%M"9,$BY9H(C0M4YH!KDS%-@G-)01D"Z9I4VE3C8,BAQ;<
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M\(YP[@WNS(:'GKS24[@84M+!0+RP&OH^,V2OO_&^7#^K[% =*9*D'4HP&.1
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M)HAB&]V5WG%!MG=6J^#)!%YU-5MRDV5PM7L3;9KU'"?+DDR;&Y]'D]6Z3PC
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MJ:RY3#>;OB\KO:ZK,WW[DKS9X6P0!+D(+CDFLLMU"T8&RBNFDK=1)D/^;),
MY3N1';WV],M-BY.L*XOD=6#&8_ Z"^8*T*KH20"TF9,4!.<NR<R-;6(%;45T
M],K2#Q<-#J2N:O%B_YSOF\ 5EU;0"*W7Y#$*PT!Z8-8ACSP5XWB3..+-<(Y>
M/7I@H>WQT-7]\1\PF4#M#RF-DAHS9X:V0X*7#(M%1I; 18F<R]2FP/,=N(Y>
M6_KDI<?CGAK-/!<###-!^X2SV:*MT:K?Z+SWZ+P*Y(!;F[S6P* $Q;3!S'R-
M>O>",'O#8])KT00;H\@[ONYH-:*5R!L<UES= ==Z)P^ +*)0(P!C[3"O)<\,
MLM',9$(E@C8ZM+F@W8[I:%6F;SX:I&1>W0W7H7D1BPE9,H.\7ILDST*VA4F7
M@ZL%U7-J<D!\"Z:C5Y6^^&C0(_J:$W;-KM91R (9& =' T9EF0]D0-'NEY-!
M]*DTN:O:BNA9J<G]N6C1M/GJ6G?%>)K?EVV0QD!9$%QS8$5E<MR]HDT34;*8
M@XP^&ZE5;+T?=<!Y]!K5DK<6O9J[BV> 'B29Z(;5@G-,:TU3 JUE20NGG/)H
M?!/?J3O$H]>N1FRU:,M<<=;_URBY;W!2Y\&\>- PS3#/XYM&^?H/KGQR48+_
M9N),.CFO?95_^8/\Q]$7_ BS9<W^@0^*ZTS*4UL5,1V-K>6''$O.)<4M+[I-
M6-MAA_GD;U@?L58T.,[>:[2#PDUQ(08F4<]#XPL+W #3"8*6DEL5FS0TW0OU
M\];0G3AK<#2^'_B8M#5)!>8R24P;[VG+@,@2M];4X@Z"/[XU=._:MN=G9XL#
M*#A9U1A[,RKCR>F\>.K%MIT56##6L>!KM3%1JSW+H)@ 86+*I&VQ23)11WQ/
M?MZUX*'12?&K>?7#SU]QL2%=0#-!..X(E4M>,@W@601)!KV5CDP^'M6ZBMQZ
M0KSE-0_ = MJ-AP']R'7-E6T+M.TAYEL\$%!ZW4&0<9UK8)*^LT".,62<2"D
M(-O#M*I9M ;E<-K0.U,WT^3W$7,3XA?A\"LXR9<PSYK6WM8SH50;IRA/GIN7
MH L$#HU8OX;CF"B_OX ;A"ZMUK9EK=O+\.%1WN!AOQI.T\EX>C[!R_*3"I3W
M@I8]4>IACA0DAN 8MXZ7)$"#5JT,J'V /WGCX:#,-;AI? W#R7_ R3F^+XLJ
M?A?)7R'EK#.)P6M>[[5J(!](9#&CC\%A%-"D<,M61(?7E<.2.V[!3(^;4UV3
MKX"J%8IH_#23:F_#89Z7_JC=%R^J8!'L\]-Z2K@NO_<;#Z2SM.B\#55$FFE;
M\[MR#>7Q1F:I5,P\=3!B&T)\)AKXF(ANL-G>!"X&@AP'7@,+44*M$2@+"\(C
MDRH*:0"BA":1P1NP/!,EZXN-A\YJ%\[*9# 05EG3!6MC^EP%H'W418 JYC"E
M7CIGM>]X]#!>A3 L8BU_'<]PNCKP_CR!T90TX*HO[KDT7FM'OE(M)!90DBRL
M9LHK%-()X.L%WS:?1>SXWF<R;9I3TB T=HZO9A[-YW:4,MA@:4;G0(M_!A9D
MJ>FU*5D=O8YM3C.O@CBP']N4KO5[VOO*NF=#\0J."U/BLO'"^DW:('+ER)G/
M#'.JC5PPLZ!\83X+*Z65"#IW6#1V>^L1JD%CT3>PQJYUXWB1\YP!.*D',V]&
MRV*8:W%T\YJH%Q&[K[&67L*!M)&+I P#5WL!E>H067*25#"RJ%!(7$T6EKX&
M<(3:^* <-S ,YVF.J\6U0(S22<N,M+1[JQ 9D'G*,G(7%!F%6C9Q&:Z">"9&
MS][R[_LZ[C+I]<,RHV1*$VB149!?S'X9Y?=E<5H]0%^CKK2OBVJMWZOKR FF
M3NBCD@;1\D[F<.=7/A.E:$E$CP>M%>8KG,'P9#HNB^5U."JT+W^K^_*XT-.'
MWV!6BR%=B(-V8VFUEBS90FLMEL"B0<]DUC( +^K&=<]&G=GQM<](;UH2TB#'
MX]4%I*L-5E<_J_=7QB6!4AOF8LTLB%8Q2#$QH;/,)2<P;?H+WHGLL%9-4UYO
M=&KODY3&%69W+;9V><F:,2B$S!Q7Y$+FPEF4M'0Z!4(8E4WF3:R</L _DP7M
MP?CN,45I4W.?(;D&D\GW*K+3VG%EO+P'&^00(R09F)>:,*: S&M$)I*W6ED$
M,%U:[G9]W^'5Z/!,WM)CJ1<:>CY=6JVXXQ'-H;/Q=,['N%SKP&,ME]H95H#6
M7:VMKR%AR)P.A6O)G>YD0]W]IF>F'CV+OL<3I;D!<!73ZD;DRG'&R_&4-%=E
M<"X9VHYKM2+M?&V?$VOTH')"HG;1JR[V=9>7/3/UZ)^ GOOX;01XV3FUBO/G
M\^\X&103L^4I,TRYUIKAA44;@"6.@4=72,F[].[K^KX_]61_&AKD-5S:]K70
M__L+J .0SKF:T6/!&S+NR80-J1BF='(!A"RZ3<NT;8#V/]M<QL5]GK>#RCFH
MG#4RFRPRS6NT$7E$M297)*>I5D=ID@)T'4:/DP).3@Z747!_66XRE'ZH@\JS
MOU9G ?/??IQ-SO'RAV.:K7_,?EF$R?_MQRE^N=DD89\CAS<CFNKG]9D?A]-_
MOOAC6-NP9J4%ETS4['3M56$@N&49M(DQ9*%RDW#DVT#UJ"I?24:3=!Z1T4]Q
M5"\@.JC./;C>>J*PI\P;'"9<8EMU)OQ,?_EJOM-TPC8@2N#\9-96+VZ"ZW-?
M76D#6QO+3:WHC\JM.M(3#X?6E:"MAA0LLSS78_@H60! QB//,9H4:$\]#AU9
M//J1J<@NXN_9:7])6_"BO-8EPOE1PKNYH4I.@4GD&I(=I3*-.1FHY6,5P^!$
M])FLZA([&-QWO.;P=G9_?(S;"/,FSWL7D?F%0.2,^1+<\OP33BZU?;K$ZD("
M$RPP9X*D/=,:!B'P6GRZ>.MKU&>33(-=0!Z!VC3G9NMZ\:\_K4F-S.Q_SG\Q
M_WF5RD<L/]3__O;QS84$?__]][^<CNDC\!7A9/8UP03_DL:G/\W%^'[R!4;#
M_YG'HL,H_PS3X71</I#C6M-%9U>,M@6NZ?#T[ 3O6$ Z//2G2^#7![1\\C4E
MZ'<(9.?CB)C[\8<AN0%#(X)&6PH*<KE==MZCDD$'5:NL2&T&NXVF%0W+2[DF
M;*R>?5!2-@YHC9OL=$HB^!*+TT4"<. %0W0BI)(%=.!F]9K[[[CSA[Z_]M!+
M!S?Q!-(FSSCX2"8&;0XU>XCQ9&3A(-&@Z;#=WO:.O0.'S^L:]+Y\Q+/Q9-E2
M<>[=DH%DP0@K'"-;2-9S)\.B]ZDV@](R&V]RF^BK[9 .>]/=&[4W HC[D7F/
M-L4\IG6):NYMS\N:S5M-8_[W^0RNC1&G U%JL=Y4F'?U2$Y@+3RE->-6%Q.X
M#*)3J%67=SUQLIN(M.\(\B6^A2$R_>5D^*4&AQ+0SU]Q@?$ES'MC?ID R4&0
M15)$3"SJVL;)6<[ &S)7(B\N&J-OM(6_E?V.KSTB16@AZ)ZO]U:'W2_'IY&V
M[SK^7=%K=,[:F%F6(=?+22#@Y&/'8DKRT@C3J9CV_DB.0',.3$?/-X&7Z]R%
M@X63TXI($:;,O$V.$ $G'SI$YD.V&H51<KUW^T8%V?ST(R"]![$UN*>K=;EF
MW]_A[&NMTU<O,^>5W7\?D1)^'9Y]P$FJ(OB" Z5%$6 C4Z[8>D*O6*P=^10A
MY<IK%7P3R[$SPB>N(VT9:=BYHU.Z+W*KYDTB4-26R,HD!D&&&L.0<\C9&-&F
M&]"C;&+=5(&:\=)S-L@& 2SN I45MBAI&2I>LY6B9U%:DH7RPG -QH#M8FIL
M>7[KR_%V9D,? GLL%^4KI9QKXB*@97Z#$WS2&:UC69!-HX/3C)8QFM=**VZC
M !&:5&3:@N?0U^/]\3SN7]X-[CPWP5JL31=']AT MKPDOQ/AP]R4]\)G!QW9
MGXP'T1H7?:&%M3#(M3"=*LC !<_(V/8 CG/AFH29/9"VW'%G_C#*L@L'/1^"
MO2/[^&3N:M7KDAE6WWEY,V>SS0HT)\^Y-LPLOK"8LV<JI*)2"$%@ESHKV]]P
M^"O/GJD8]R['GD^U:SPMR?3[I4N]Q&2T  S@F$J:]%F11P0Z6L9-4M$A*"E]
M!VZW/?^8F.U%A@V6]HNXP-705]<H\P7+B91YS#4 WL@:/0PT6IU8L5%+E:TI
MNLFR?BNJH[$1^Y-]@X(G2RPKM>\ IJ55> W-PUB /;*UK@=[B[K%PG -E "C
M W>&.>L"TT)JYJ6)Y%*;9*#4OG!-8I\.P/L=MMRA:-]%PCU;;U=N4I>;$H28
MM<-0+\LXT\A]+5EOF*>M+F0.1=HN01<W'OP =93O+^2-EPGWD5"/YMAT,AM\
MK#4#%MJ'1M&VHYA!3/5$VC':<#++P43R,[1-V.64EQYZ94;2=^NS\=I;G_SV
M>W\9]GBS=P%B%<#8 <8.&VQW2ON?F'=OJ7LPL,[A'N+K<16] 4<IJ4R]*;9@
MZ[80:&$HNK8Z<C%(%6/HLET^#A:W;) -2-Q!:CV3]XXD=7I^N@2BG1(A.\&,
MLKJ&$]&Z'E&SI&QTD++E.O5%W[4W'VY_W$OVXSX$U_.N^ [^N HD>&-K;1)#
MJLATT#4=UT46"T^I*)W!=FDIW8W!JV]^@@S>6W"'#:3_-/PR&I9A@M'L14JU
MQ,=P].4#?3S5ZA;7('6*VK[]>3U&:N\ ?"TZ&VU63BHI>(Z:+-8HHG0V%U-D
M-*APT'D,#43>2O0'IZ 3%:"!U])[L4C4,B-9F6"LSL'*(JM'OO.8&E RMXE[
M)V3YU$/1L6D0:V308F8@A81.:9U"\9(77JSV*FFON;F=C)OC:4#%AI:-L-ZD
M\?X9)[V]^E"DWEL<:\P'FWW47M"R6#307J03<,"8G%4ZR'([\_>43 /UN*PN
M?*5/8"-]N/5=AU* [@->SQ[+P#DMLRJAT<:'@"A-X4+,9[Z*MS-^ZVOWKEMX
MAI/9]WHJ-'LQRE6ISJX7YS N$&A5DU" C"F7+8O.<$;ND":;K"@RJ9I$X=T)
M;;\">*LHR>F[6N]Z2"]:U*Z-AOOB:URMLX%I$)Y%KS6CC=(Z54!%T:4\_M87
M/$CQH3Y)OE[ K@\Q]GS5>P74BV\X ?(NKF,3!H7DN6;6:O+S7>UY ^A8C-Z
M#)'^)W:C>.-[CI7I_87:L(WG95VK 6VN:*!>0R,J<B938I!38"4$%<"+Z$O3
M3IZ74(Y&$WJ2=H.KWM=5I/AV^*WV1IO!:)X*,Z_2\-L4R_G)VV'! 1E:)OI4
M&.;::A929B&'PE2P7I'MQ5$U*=W<!=S1Z4COC#3H,K%>@/7-Z,,$3X?GIU?J
MXPT<_5UQ,;&4Y@5B F>>+'@FE5(\61,1NIRDWF,=N1O<T6E-[XPT2("J-0$O
M.C6F[Z_@E+;#Z8O?@9Z?YSV !J*D(* 8EFE/9#I%S\#6KLF*'+X<M0'=ILGA
MG=".3F-Z9J/'K*=ES!P]IFIMC8-\D69+=?XTFQ?Q712E6*9HSDM27?3O^0#?
MY\KNL]$6BF4)/)G3P7CFG8TLRFA$C<T(O(M#LC>0HU&<P]/2<Q;4_<%?64-)
M.;(L9*#+>C6B:U2NMXIFATE0:($M*G<)C^D#RY^:M0\Y/3?0N3_^7_%B<LR=
M :]IF?6%S#H2)0LZ!^9$-M(E#CZT7;,NL?RI7/N0TV.'G8K_,A/Y?;EZK$FV
M7@4))Q_Q&X[.\1>8C# /N"\Q)^#,Z&R81AN81R&9%UZ!=+$$TT6-=GOK42E,
M0X'WV)+D4A!X!L/\$8>CZ?D$1@E7QO\ E$M%>L5X\?5X(4H&F#5S6OAL14&A
MFP3O;H=T-'K2L_0W'.[M7>/RS0H1[9&UFV9M?6%4B"IA9#D(09B\8!')"32A
M9"412\A-+B8V8#DZ5=A7WAMT8.\3WBMZN40%BVHWOXVJVKX\@>%I[9RP_.*R
M#^K H1?(0;'B:E^#:"QIK^.U;KA'AUKZTJ0.\KT1'YT^'8:[#5JW][GRS=.G
M%R<GX]_K2 C^J_%YG)7SD^6E;5THO:*)D,@KE*Z&U)=:I >8DCZG[+D!WB5F
M[S[;U XPCTZ_&K*T0:EZ*(55S?>+1?8UXJJGT_>!X<IH74L]^D0.7Z!E%J2@
M939Q+RTW))CN-;&VON9H-*!OD6Z@>^_SXD_I*^;SVD%FJQ 6F2!.9I]2CK4]
M)DD!C&;D^@>63/920^).M^D$TQ'@H7K$-%XMFO#Q6(KD;"@P/D]N2-$X";5G
MH*[GE9H[5JO(DC9D9ZP)+LDFYO(6/ _60Z8)]S>O/O?FH$&,Q+PW7,%)M;0^
MX>3;L/9(?5\VE:2O]>^GFW^U3$/L,I:6V=1]#N9ADK%[T9+Q(Z/XL:MM5C'Z
MC)F)4C-,G C,%TVF 03CL_=&09,0D,>OKG?DD#]Z;=V%V9Z3SS\1E%0;.M(H
M4@V*&^)%CK4W(43!67*R;B-%L:"T9ZH4B\YGQZ%+Z:#M;SB\)?]PK(U[%WFS
MM/:$PI18,TBC-@0" PLB1,8E2!FU5B+TEKSW8&GM!S&J[B_7'L,,UQ,5N\ X
MTE3WG1C8DB5]'_$U3'6/''(ROC#%(S#M+;*0:BMMP2W/(OG@NA@%CX/%3JGN
M?9"XB]3:IKH736-)?M&R6/NH62Q*,Z6%\J6D;&+NB[Y'DNJ^D^RWI[KO(+BV
MJ>XQ)2O1,BP^,1U48@ N,E<RF8^6\Q+[*U;P.%+=[\W@O077\QR\*"KU=ZSQ
M)F=?APE.%G4TG/9>T+H29*V@H%)B/G'-7-0!09!A9[L<-75B<RN*H[6%^I%[
MSV6 EB6JKD):E8+K *IO2VDKFL/;33VQ-6XEZKX7A:W@/%D<7G-:X((5I/.9
M]AHLR*PF=TT45YSKK<[7@?F_Q>(Z)/V[2+A'VN=WJI/O@P\?!TG%''6M9";J
MF+0+9$]8SJ3P-O+H3"AXD^/I2LQ33'_Y,O[VT_*)"YZ7WZS3?/G6PV[A/8E_
MO)?L&G01_FUT/CV'D_>3-Z,RP?\^IS'6B[:YJ@JIE76%,R@V,QV+J&T)(P.+
M/B3T'M93HOLY,[T%TU'N[GUST2#U:0NT56G*#N!:W@G=BNYA+GEZX[*;CNQ!
M1(.;F]M!%E50>$G0JN.I8^0L<"^8SP6R5D6!:7(C_0!:<L?=RL,HR2[R[_G"
MY.7[_WCS2H2E$RND :F%8_4+<H6E9#'9PF111KBBN3)=VHE>>^CAKT5Z%/:X
M#TGU?&#SEL3W99Y?\A*FBT/$(" [50*I9JYG2-&R"!Q8$5GZK(UVT"5<J9-)
M?_/U1VD"]"#I'A-8;Z*I%WJKOCX=,/7MV&\#<WB_?E^2MO*]IX1[]N>W8G.&
MFT**S$J(=5M"\GN,3JP6L_:Q 'KH[8SOL*S?XLT?@O1=!-M[!Z3A"%^.3T_/
M+[N\O#^K&*??_O);K>:1%QW,5[M1"2A3/7<6R=95CA8X3WYK-H4<81$(=^BP
M;^_XVL/Z^_WP-#Z,D'O>\FE_R^=I]GZRB/)8*+ST7-/F95@N@A3>!,ZB063!
M)!YM+@EC[&OB;P)PM-O^WM+NL<K %3R743ZXBMGI JKOG7\KFL-O_?L3=9/U
MGJ3<\^Z_'1SM<Y$4VC'G=:U^0>M3Y+7WE\M>&.6<"7VO H>B_I;]_T#,[R+<
MODT S,,T;]A7_SO,5]O%1"=*]-PQ:RJL$H"!5<!HMPM"2FT4=.F4=\LK#KNU
M]T3 N'_I-3C?O\R16N;*K8(E%=DI.2D&M?&%EJ8&2Z;,5.W<%P)Z+ILT6=^"
MYREK0)^B;C*MAWF)A"L?$9QAJ@BR*7,D$P5"9,9%E-PD&1/O/)-73WW*U.TI
MHZV!IH=O(G&9 3MM5(I[PQL.58#[KL&ME]U&Y2(71:(LVD4?5 Z\-O)1W'II
M[.UEMS>\;+\E>)5^_.N8O#O2V[=CVATNW_+V(K=1\1P@A<)<*.1&%.3,0]!,
M<">+)^/"NR:U3KH"W+^2PX5D?\79R_/)A)RG 0^2.RR!D0-5:D $;9 QQ5I/
M%FQ-)8$VQ5DWHCG\]4$3[;A9AV%?R3<P32X]ZVLRF N !+%,'AE]N02_<+0E
MF=U.!LL\!Z3EO1I3RB,KVJ, 8R7X#=$F?69+[X3W4,G3!U&D0W#V6#*JNX[P
MY^]71DO/7H1Y:1&,H!D5DR8A2\')C%#(N,2 T7GI99/NT_N ?O@CMH9*-7X@
M<AN$5UQ'M#J7[H"I90S.)E /$WIS.&JW[K)[\G(HG4&'2ADCF5$U8](Y,@"$
M$HQGF;77V6?1I%KUX73EC@"<QZ4JN]#1\T'!WVMMKM'U:K2K$RPN3?&"EEDG
M+"<SL9YQ0O2L($B3LR=3HLNIP2VO.+S5O;_\Q_T+K^=^.!^^PN04$JENA!G>
MA&:$XP6-95*#J"6&'0O&..8@*@A9::FZ7./>\9HGSFV?0NQYSB[.&^>EKW#R
M&@G<\#2>3Z:X61.-TKD8<N]0T#\Z!4*:O6->%"P%12';J0/=N[WUB;/?4,0]
M)JE7I.]G7W%R$Y&@$4JA):TWGA!IJUE(0C 1B5?#N<JQ2XCEYJ<_<7)[$%F/
MV73SH,]Q/:2=S8M\WP16DE91>L.2XG4K*8E%1^-4]"6 #RIHU25<]K:7/'%*
M^Q/@UAR*PQ_MOSB=VZBOSO'S^-+4>%&[G@R;G?9W>^G!.G#N+H+UMKLA*./(
M/B_":UX@*.>*#]Z2*D@9W1VM.'>51@,U6)V2C,OR>G%9PKV1 MSUND-1O].P
MUT@71F3N3$FYZ-IQ-^1LO##<!U%TD7<TOK[KS?LZY/.'35_3BO@+P9Z,X.3E
M^70V/EU46'H['GV9-U&;MTZ;7A[?"N<CSV 86,]K4Z/"HLCDA?*(#H0MI4VI
MX?L"[JL2\Z)5P:\X&VB5O9$F,>4E,EUR/?>SCB6M2^+*@8]-CBUN('F(W?(
M6K.MRO+]&.C9J[V,LG@_^0*C9>^3I5PNVUX,(F+P+@F6Q!RBR P2^>'DB^NB
MI<P)NYQ:='S=D6M"*\$W..B\O$S844*+.P4OG H5<R&AU+0[J 62"LL\6[)%
MG9.R\>7B?6 ?ZH[Q09:? S+Z6*X>+\I'_'P^)1E.I\OR ]/YP3.OI8(@DCM$
MZRWY,9HS(+N&H7"R),.E7^]CW9..WH;JX2\/VVO'NF+VQE*+=7"!9>E0=P'3
M\G;P&IJ'N1;LD:UU/=A;U,WY#VB%+L4S6FT-TX$'%J*R-6L)K4$556D26G8
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M%;3<.#*%NH1?WO:.ITQ?K_*[R:MO&'WY*\[>C.B[&L7PZ2O]ZAZQ=#>?T6.
MW!T UZ+>5%16&2T3K70Z<1$5\E2+QJD P1@^N!5K3R*<'\K>)RAQVY-:BG,3
MV#6A1LUK%\&<)9 )G5VT$;P#%05PPU.Z*=2;N'L2[?T#/K<^JJ5P.P5J*AO1
MYB!XT)KG#-KR0$H;0@XAH;HIW7Z",&M$VW#T9;IZZL\P'::W%U$K,J<L4.AZ
M'0A,IV(9U%PN 4$H4@)+_V]Q:WH[K+TR#$Y@.GU?_@&3"8QF[R<?AU^^SN:G
MJOG-:(83G,X^TC<#&F914 _2--2N%,A9D#J1@Y+ YY@3K-=YVYQKT.UUA[]6
M[)'X:_D'#<3;M/+&1CG\_+W6*1V/YJ-9%K>T-%FC34QI0QZJ4+&V.[$LJE@1
M)VY%DZ#CG9$>*A*N@0(=AIW'$N+V"N-LK:6T<UZ0<4^F?I(T-;+4+$1/0C-(
M=FBJ116[%)?<6<EN0GGX._ FU(][I:!!T-)U1+_"Z445A0ZX6L:O;0/V,*%L
M^Q)WJQ[L*?5#:@5F4YP"P[()CFDG8W4I+?.0,H"..90FG60.JPUW!+@=2AEV
M$7;?;6/&HV\XF0UIP?N$H^%X,J_7L2JP2BL<JI)9E#57U'!D9$ 9%D,B+R+S
MD'4G4_66=QS>/NV'A7$#$6XU1YL<S:R"-FG?B_21>;G\>SB^&Q_3H]-[-\SU
M$I5:IUKZMW"OM'(8#0AABK EB6Q2&-R%N#]QWONDYI:'-19MA_,:E8LCJ!9-
M .VB\;'8XG/@(&QP.6X4<%]'-IN>_6OU"6?#;WL<WW1Z;&/1WSZ,-1(<.;;"
MN*"M"IHV'I\$-UI*3[N0$C%O).'&&_8S'E:O>)'^^WPX74ECZ:;%4 "3*ZP$
M3@M?HH4/0HBT42H4-L:D\H:KM/T-B-M [;-1;I#GK^=UB7]?-HEZ0 N/B"[7
MX_T:!4U#9H"V$%SE<XP.LC$=]LX=7WOX[;0W);BZI;84=H-#GRMC?SF>SJ8#
M<#8!EYYESZ'&]"3F%?F/RD9N ]8BL$W.=-:!'($Z]"+C!IY3;5$S^_X.9U_'
M^0T9@--9-2??_S["R?3K\.Q*UFZJIP4\)):5K&T*,F<Q><4P*,\M6N=RDYSZ
MS@B/2$O:L-)CV-U%XC]\GZ=*?1[/93#!E4CF9:3?EY<P_;K\31XXJ\CDDL ,
M&DY.I]4,E+$LHH\Q"T6[?Y>(]-VK,NP \HB4J!DW/<8#KF%]/9Z0&UI+K- W
M]-5T2(^'A4@@#D]H4BRF WWB12(3D,2%M(8F+W+,A1D.D?9-VCS!),4$.BFJ
M'Q52DS;D>Z$^/DT[ 'L]QC:N2^6*)78-^^<)C*8%)S1+Q" #B<.A83;'>@Z2
M:8:(E&I[1^>2+DG%)DO8+B"/2+&:<=-CT&6'Y?;OD_%T.J!]NHA2(Z5L5$S7
MU=5SGVHU8*.L1>/;7%[=!>R(]*57#GJ,]+Q=GV]=,0>@()2<$P.(@6E0A05E
M/0M)D=M@)>BT(1&EU9)S*]8CTJ363/48E[J"O#I:6#2)?3/ZQ]=A^OH+89Y]
M?W]6P=)>6SL1%A\",P[(S -9T]\*9\68&+0/OD"3IA,=L!V1\O3-Q-9@U][/
M !?7/=-?3H9?ZD40672?O^+5MG4U<K=*)R69$UAFK8E5U3.+==<-Y$5X#,8;
M6*M#L.NQ8$<D1Z U#T#)384*?6UM5\2RK-+P$<_&DQGFG[^OO,W%5*"1O(7I
M[,5H= XG'W R'.>!1^V<XX4AK^4["M)BZJ1G@M0&(\0(KHF-U OZ(]#%AV-S
MP]GFW@?:&T8QI?E"4$]A.9R!]C(+Q,B\JYVYN17,EP*,:VNR,U'2(GT@C5O'
M=MSZM!<3&[1E[Z/PVS!>1)>_K5Y$=(+65VE9YI8DD4$Q7_NZHRJT;QOTIDVL
M:V>$ST1S[L_*!OW9J[G"AOW[[^-Q_GUX<O(*:SO:Y=:]@/L9_OAP/CD;DUMZ
MY2@?R>03O 9J9J35TJ-C$7(-V0Q<Q"!SOJ]-M2N4(U"?AR!E@U+M?3"^ CQ0
M&DN)M":8&M&E:S^[$*UBM&86[A&%CTV:H*X '(%.["73#>3N??1\&<R]:95;
M6EB+[Q:QW$;)B*J>,"0#3-O(62@:6%&HLU/!9=DDG'57H(?*L6BF(DV9>2P)
M%AN&-@\.3MQH0;B95I+^*3$PH,V3":U"BB(7K@]EWCR.5(L6.G"WF;,S%PW"
M0S;!6KA]JW#C+@!;YEW<B?!A$C!ZX;.#CNQ/QH-H#63#<XF.<2D3 96!!><B
M4RXZ)/M*V](D;_:!M.6.!(V'499=..@Y7>,=F=8G)S"ZVHUKU0[3^L2MS31F
MYVH[3,-"SIR9''*1R+U;[]V^T0O:_H9'8<CN0\6X=SGVW584IM-Z2'A94YD\
MK%7OO"B4J8DI00E!3KJ1-%+O6;' $Z3B"T('>F]YQ3'QVY<D>YZ^_S4^GU15
MVP1+6I=" L]LK9BM4TTW52$SKKA3DJ.6O$L1G%M><4P$]R7)!J&=MY?%!^MU
M!NZ9<[P&;:7"? ;+4@E&V R9BR;'YH^\P\@!/(7^>&FA-->*\7<!\ZQ[BNS$
MUJW-)>XCZN8]160)]%ZC69*I&K$JTZH8D/E81+*E@$YM6F4]\IXB_=&^BX2;
M]Q3A0H%$EYG+/E2?I=0(A,PL5T[GQ(&'+NWB'UU/D9V$?&M/D5TD]/!IU)_.
M3T]A,OP?G,Z^XH<)G@Q/Z5>3[_\!)^<X'1?ZZ:*_!BPC 6"45]%PM27N='I^
M2C^<T>=>T708ERO[8+\YKH= VCAM]N#"7LO$12@B>%D2A*"YX3[;(!)9(IKG
M8!)LS,0]!.B&R;TFUU:4G'QD*+0.DV?,HA66.>NY+SQ'U:9-7JODWH6L5W$Y
M+^)T-H$T&P3,Z%V29%XF<B0B HN^" ;D+@8#6O&4.JS+FY_^*+RQ^U%Z=:WN
M070-,G(WS+F/F,9?1C3E\IM,6]2P#*M'L09_TRR;IWN-<DTM_ 8GU189U.1[
M[VMH%J^-6 $UB\HE)H6T"ISPT3>-MFLSK,-I9%^*<W?L^4.QWO!RH)?1G4\F
MM:31_)/O8/)/VC/F]6O2^6217!;(J%)2&29-;>6&.K*8;& J>AYTL49NJJW]
MR%3\KE'^J?'-=*+!&4FSP=)3D&9YK5 S<*)8"!:8"U'7I$K)0&=D%J+4*@1I
M99-PH4,,[D]U[UL#&F1T-QLCN1EG,,R__'&&HRG2Y^<UY1>_&UA'KG3QGB9T
MK:!2B!_(G.:WME$EC:K()EUL'V2T?\Z#YCIRF'SS>P_ZPV1\AI/9]WK&-%N:
M>6?UY&J@?00>:F:K+[4=%P\T7.Y8#(5K+2$YT231[R"C^U/Q>]>!!@GQ?0[R
MS6@&HWG^V^+#\_G\^2M<!'0/M,:<HY=,R@BU:KI@ :5B)9%;DR7&"$V#%@\R
MRC\5OYE.-,CVO\ 14&B9/>E.[5JD QH&UGF6(Y?"!6'#^@'<4XW=;Z0V]Y)D
MSZV?^E3=CTA"&:9YTX=5=:^!"3'E6!19Z(;<4BLE\Z2^S):D$*33Z-8*/73-
M_^D5YY-5ID='8H]I_2W6U_EZ^NMXE*Y:U@,G>8X),\-06QOJ&L3BG&,R>A!D
M8F!,C][#VCBR)ZO7CY/['DL,5'G=A'@A,T#C<U&!E(8L7.U*8D$ZVN6S<YG$
M:=%UN=[:_H8CN>+J280]AY$T. .X\HMWF&N7P9<G,#R=TM_\C".B;S;] -_G
M@7A!J)R2K17G:INEY RCZ49K-HABE(X^1GG@/7?G01QVX>I+BQIMRFU5X$GI
M_HO3\?EH-GUUCG\??\/):-[\XPN.4KT#<2YZ#0D8S[7\D+&!A4A<!16C :^#
MXEUZ8CS<"/[4^L.0W^,%V %&G=)\V,NY37]%/YF<X]4_'D@=:V%1SB3H.N&5
M(\*4(F,=M336:&\.[6?=;R1_3H'#*L,COR5[A8M*J)_ACZLC1'(H:+(GAEG7
M(DRUY"410P/&1'9C4#3FQ^ZP;1[:D];_1ZH!C^?":W7FMW&DO^)L@*"TE!"9
M$<766J[D!Z6HF=))>^Z<3K9)=D&C\3QG;>Z5ZP9763LG>*EL! '6S">@S20X
MRT#;R"Q8E)([:>*?A5KV.= X"#./O5 ++>#"1I&9(#.EGL>1U^IH:#$7'WT6
M)ONF9[%/M5#+3CK0L5#++EP\2,F-+@#_+-1R/SYWKKUQ'S(>1&N$DS&68LAV
MK&W*-?T3L9:IEHYK7K)RX5#][QYQH9:VRK(+!^V2/)<YD<M,1N]BE (%PVA=
M'3$-%J$P'<ERA)QS7"\D?U>NY[7G/XHKEWUHV)P&>G\9/GPVZ'JX3;\9G-N>
MWCCKLM.@UC(E.:]AU1@-BD2>2(FH(!G'I8Z:/":Y,5-RVXMZZ-A(_M/K*AA\
M._QV,RKJTLSFRA>E5*HWRF1K%Z7)KXN2R9Q]1J50J";9CKN ?$SG:9<@IP,T
MPJ"BN1^XJ<>$.C*07C.:] @NF2C"HT\CNC*>PR^OS33U,!&&NVE @TS0[7+[
M;8KE_.3ML. @64O;4O',ZMI)+1G!H'ADP7L4P:#&]=I+_6AI%W!'K'*]<]/
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M?1_'^V'(?RRAZ1>C__G[94;ND/;R2?KZ_2U^PY/YC40,PA=A$Q,Q6+(6R7F
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MD;M"?Q ^DJ?A91T]Q8!;8^KD,0:!%4=>I(TV8>&(3?H,=(?X%/.)/7CW^'S
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MLVV:20VXAO.BZ+&4VZ!1PV.7^)C1S$NR@VW(Y29X1YX1( M!AN!Y]KH%[Y[
MU=?#4QV'B_S85U]OU_/+U8+DLK@N,[OF^.KJ658^9G2ZMNBK7E6='^1D '11
M6!F9]Z))_^@M>$[QFFPO=3]H)G^XV)L,'G@(Z[K^\+95=A> +8<J[41XG)%*
M@^BS T<.5\916".E11/(QPA:TX[+$D)$YZ'HR-"@5U8W&E5Q%+;L&*!T'++T
MT<' 6;=Z9^X"E_@RS&\O5M)?4#K[.GI'("@Z?\&5J, PIQR7NK; ZI!B>_CD
M\8W5@44_&TQN6Z^*-+Q*NOKUC["\FJ^BOX=>D-ORN,$OPW6!O7;QC9/2A#,<
MF=2*:>M#$5PXLAZS=#+?7GS;O8+]Q/V/V2S_-;VX")?Y59T,\+$Z)==I_#>X
MW$/@.QXXH,C[0%^_'2KH6^)&EN"<*JAB9DD4LK1,*L(D.^F^BA9BWWL,0*?'
MCJ:"#F,#=!'$=B.*-U%%SF.0"2T=5,9[E;7?H8BAQ@D\_I:;BZ:+6;G]>_OO
M1_N^:32E=5SLFAYM<EAB*+FHJ$1M[N.T-TRB8\[Q%';H<?M+#S,I;Y_VW6DG
M3M&GKP/$5/M5T?D)(17Z28NL@K5&KU?H#6-"/D!RJ+5\^\#WLXN+WV?SO\(\
M3[)4BLP[![0V"4J4#-YX"3K2SL:8H$.E2;7[!BSCVT^'Z7K=$#Y4O WF#=Q"
MFJ#U]%%)"RF@H'61E>^D2G4H<PB<Z]1HH/4M@./I=F]M;-%N+U$V<'EO<=S>
MSOR5S+O+C^]P/IWE2;*<\Y(Y).=K6BTK(+LE S)F3%;%<6RJYDV@SD?U!XN\
M0:+]%MN_R,BGX_5M*>_Q(BPQ_SG[$.JT]EL?\9\D]4F1QOG"+?B0 J@<-&UO
MD0,=P)[0ZA!\DVA(+Y3G0YCAE=(@%WX+]M7G+V$ZKY']U[/%8F(E"VB9I7VM
MMF(L-I#C3[_PS$RV6@1CFUQBV0SG?#AQ@)@;Y)OO3K58*R^\)(V$572GSD3*
M5D+1.G.44<?2).NRV4#HOY /Z1/FJ_IMW3[Q.E5B:F5_YAR<(;TIJ3($)R+M
MUB$9(8/*J4G]T!8\8R4BA[5LAQ#NJ:0=[W+LMWOPA^OG+E:!<%:RMQH9"%42
M*(8D+^U9'<^:>9(V6]]DEM*CJ(Z5@AQ$[>M4&DS\#6SK&RPWL?,N8%HF'']
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M4[S),7H27-L1XSQ5JO71V>#M'2]7V>G5G(Q%N,ROIZE*\_+CBX]S7)W+MZ%
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M8@]YVWA9CKU;Q*;L>#2>Y<"DTC9%+[BRDFGT4OJ8=R4W&O:(W<\^ES((I.\
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M0?6LKRWT4ENW:O5]9#X>(T2)4G&/P"/70.XNKSU5 VA4B5 *WFC,X*E?6VA
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MKABCP/CH"!1CX+/2$)'%8A3#+)NT SCMRJ->JNI4>=1'SLUONJ\8'DP*L59
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M(/O/=A]$0_?*8'80;X.0Y+O)_')6<TO>?,%)^OE'F(0OR]7^CC@2"EDRRT'
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M6WJA1""G1/S^O;PAZ_%OX5W%-]]EF3I_.#%P%<FKB]PD;PC#AF:80]%&E3'
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M/2%SR_H0UX[>5G>%;Z$(X14](^7H:/#E= X"UGB88*?#9IKYA>0FZM<P,!%
MU)N==!"!5V9%9FGXO_)QL00YC2UADK#HWAVG7GCY)F$=Q>32%39OH!J_UVEJ
M>T)9/!QV9OP]F!8& >5]TG?XT'55BRE-N?=X>-:V7#%_?R86X<&HDY!Y:Z$O
MLY,$I"E#A6>/X9^@8.W/ I&,69[\M#TRW+'+ZKZ+AD_Y6>"4T.6#:W0SCI(K
M%C($$<N?.S.\10?&9F&GH=T$YEZPQ925?IEA+1&X6M<Y*\@/)I![A;W<0[F>
MY*KQ*J"H+]2[\'O*1Z9/*$,Y\3,'G<TAI[Y7;.^!U%?V$["%&6ZV-&/74V/B
M7LT7%+,<E^,3%_9LK^T:1O(S\I_&P1\.MG\F D;D:RN"E#X:5_ <E46NAZ2#
MM6'4"G:E)<YSD^] \?-K:YNZ@H E*THC0ZM,AF"G@88O.;H=$-Z2AF_8.',!
MNP?,'>AX4>00-[RQN/<3[-[ \TS)IF^L83(RX'>QPR?Y[GAD+(L^$5#?77V]
M3IA$$;JM#)LG9S:(P%-^_JH>\K6+Q6 =)SKXKZJU1@1B PS@&%3+Q9QN^@OI
MH!,$*34[HN**MXKCH!]*'"NKK+$WHO@,_04IPOXH9\K><])G;%<K[2HMNK25
MP>N":OEA8EHY>@=,X[%+EGI8RH_'V%Z&Z.RO[R'[QC;KMJ(P *L6S-$"^3C=
M(5@YG'=\2<*+(F<9TIO*OR&^-D$6Q79;$R%P\MIS9&9N^DV.YW=K5]KMHW?Y
MI^'JZ"P8VJ;T6!-7 V&&?E<7Z](Z_R&QA,51^90<RW*8N>E1$4H#4QDM#;L[
M[Z;.<]/H0?4ST8<.5]$M*V,,&70:.3CZMPU(3%J;/M5(789E/%A[4G>9&=Q6
MS30!)V@U\!&!#X-$0(AT^MI=#Q74+Q]\G^Y8_UJ4X7*_"0!)A:;_6QT37 D^
MGC$D L_<*T^\#1?%9V/_S(I0F9-@,,LLN((#WS6S?T $RMU6CHY ^WE$X*4E
MX3L1V$^ $0$MO6-"U4Q<LH0M+4SS6R:/>UUPVBU(5H#I%_S#Y\T83YM[<JE1
M<.4_*IG\R0OXXOEYZ:-?A>J(J]\A(5F'(?YB5[, XMKARKX=279Z#'H]'OQM
M?368JC<M3!9_P9-F^G-U3I/EE2P"M/U"?^</PMQ&B)]ZV1+-)F\LMM3,.-7Q
MDL#1Z/>#@&>VX]]<@N@,/54X%Y^VF0[%,^O 4K%.<U'MX17(\KOBW;G3U<=J
M!4C1FL,;H;KV4R&1FH+#!#:\A2&[L[&SAL!+8XM'TX^-RN#M\U%J)&P$+ :N
MKR-43[+8P+%2>A0?D*)<?(R+*(E'0>X%B2%!W*+V]SI6QQP%<RG\%-:094A\
M*BUD@T^:\/@YV9YZ$+(=P0YO4L?\M!01F@PL+JW09#JG]N#R;GLW$0"A;J"2
M"4K0#$-V_(VTMH[RST<NQVPT=5LI$&704&7W5ODM<CP'UO,)C/V]*S<J9C'3
M2OX<_6VV\QC:[I15Z.W#T5+()FA621NAL"[.P.Q.2V'";;:Q-XLKGY1YI^.O
M/M^$=!;WT:Y[P?.16BMS>#P,P-'ID$E(Y2FOI7OV+AN0Y6ZW?9 PLZCGOEP[
M%K2U_R#)JTTMJYJ_JC78;.-X'KEA",X2"U*<6&<Y-!>.$%O,Q8<Y$H$(N@IL
M\9Q-^FR6],TAO$I*G(NCL]253Y[-+,\%,4Q'9LEWI[_9A5).%[]8J4QR3&@W
M=52FWF%C.%Z.[<!\0%/'PD0+W.Z,T0>1UXHHCYUPP:DHPMA16F?_7 !_-5L-
M7"5!]Y09H0%Y.-IG.LLO=RM;?IB<"/0V@WLSMK[ 'AY.'>,N[ITP7!/)J[^\
M^.OM&],-'$3.<]B.P'ME-AC\ AZ]9(7Z<UY_BR-%/C@8=9Q$!!0_./TIQ[<S
M';P,AB?]- OL*H(_)12HZK"9V<W]VL*4P;I?B #N>!@^A3BL"*K_"^L[#W_4
M:RA&!$*C>[>=Y!9F#ODK( >C1$#38L4M[\]URK>B1'JNO6^IE0C4F>S][:!S
M\==!YZ\U:<UT"?U7?GX>'=];2\K^4[D[^'&L;DN)[K'9O&>,5*2'<:B0:Z@I
M8R/\//M^U'.PX\?*RD9^DVLO^*BHQ'N%<+2S02]?ITU@5P*E=A0&S]R_>5/W
M9L/P#].OP8N!S#K^[I+U7]V$Y,[JLSRY+,HI0&#'2B?")*4C84Z%SI^2.RE>
M1O1B6Z9RCV9W?IX*K;="Q!&XH)YM1ZDE^[6><H8/LRW*C1Y^KRU[L@>L$([D
MR2(PPB3#8!*@5*K'A9]MUQ:M]).ZVHF Q.CV>?2LZ8_RF#ANL:NYMZ^RF]PC
M^W%=$_$*XE(8@"N[BCS>E\B"U)Z%'"M 6\NWW )/M=B&<9C9%BJS[\/C&WB=
M-52JRE_96D8KQJPS/[&.7!;(Q&Z((]-GF<(=;K$:UL2LO+-N@!LY\_7J5F9)
ME=ROBEDZK[D6&M.!TL"58CZ#P3^*?._W3Z[?B;UR&CV=JG+X,%36A\D>:6R]
MG&7/__+-Q)AF#]:BZ5F^GD^KJ28%TD;L&[D&RW!YJ'%S<-E=UY&4,9NF\8G9
M(O[X@JI=P=@#3X#0-V([CC6'KEYG;[DG,G0_OJ9#W5I7X#C<=U5\O +-N$H0
M*CN6JGT[.:.ML9IQ\1K85-WD.';'W7C?!Q.U4/;C@#LQ4W_N].US3%^^>.*#
M([*T<+6S"H^[8-==*KD:&2T)AVUPNAU(#*1<0LZ\^RV.W9%)8&+B>7'9/2+P
MUC6H]UB7<_>G)'C\2?/7#JQ"QXW=XW,K8.N9@<^[R/'>IC.R$AGQ1T]>:RT)
M/;\:C='D(<'^''D-SSXUU?=0U!W+4XP]EMWIRN[U;/"@%QCJ:E1Q& =>N@P7
M^J8\^9.U&X<8Y;<.L%AB+:LZQTR1VA'9J/,1?_K<,8M3WICEV"1B]M'%:HV"
MH>-LUQ,R+Q2IIKIR\-3)<'IHUISW)0)67O"L4#*K@C_\IOIWO\7^RV\B+%CK
M4';J3>G77YQX+S<?Q&/;V,). "&ZM04<:);MAB+2]VSO=[?*WE4=50*;</,O
M.-I+RCG)1 !KPC#_ >*R2Q]G2R=S:?T\X6+8(PVXRIYG=+8XLJV!H7)4RMV^
MW.VID&FLH@2;>"IO=D'LLL,)LH[JYUUW:4%JW)W-CQ"UC$TU\;D0,#4T3!*L
M[Y(Q(OS 4#WRXI3/54V^;\"OTGA6)3KZW/2S4BO%J=W.FW##@3KNAGYL=+,A
M$V[Y:&+=]GITB/-7[YBW8Q=O!C6^YVH H'2F3>;3VJ%&FYTG^CE2P?P9\]9B
M_4,_[T31:.04DH+P1"D5DWBH?++90MM^/$L$KNU:7G<H*WLRP7OHU5;Z82$E
M_*+<X1W#6/SY-[A>76LYJ[LVPP_N?FZ]T&1.3F58($^#F1E/O,I-J.<\+G%G
M!1?:(Y;=5B<6ZX0Q@\T-=,/"#9A=)6;U%AN3F)UT(UE&KZ!>_OIO_N6 Z2E/
MG8]8Q@3?-VLCZ]XN/E%"5T]HU&/4(L>&CT1 \S,QV61H#'7,1-N*WXBOX\;/
MTI:BU5!.)XHP=9H/J'V2,Y-SA4\BWY"P>')# M;L<3F"R[G@QJC[US[/TX*B
M$]B//PM*VW3[,MHQZ"8T U35@C#4Y_[S;/7V#6'8QEJ7GM#LP>PMU?2PL]!<
M&'C66M=LB@+;OC0)PAM5TK?#6%,V3L%Z,69:GJ=A=SZ&A#O&ME3L?IU:+)@6
M)E"9[:'>XJUG$X3;]D<^3QQ,\$],7!9K9GO#/LE)6=H+$O#1P+[[SHSSG)L!
MS5A/.S,;\*8[%Q(>OMDO%)IU2AK=92,;_O5+\E+#>6@@X30B.KCAQ=.&@/!N
M@ _6<OB<J8@3[S;_[OBH;KB!#'?F>K7'A;*:9UT;2QH#7?G"E\B\P^4B-/O;
M"-^R):89<^<L"Y8@ YNR(;RT;&&J-]4GZK>K)%EG1Z/4E.?IW9UTKD]:%CM-
MO?*X+D4C4$2M3''Z5& YS;^_<A1OK",=OP4_%!$!Z]YM]JV*G8.XIQHRPSZ^
MA.<G814SCW#C.^,'F+/K1YQ#MW6"H]M_E1[^) R<H+%G>R!(<+?J_5\K9'>(
M0)*I-!8RM.*<%[NA=I&$X0"4WI\?0RG]E?\ ,\3<_;%DN_7QD'!C&19"6NY(
M >&("*S26VWZV:B3)EPW)E4Z^"[EAX"*-_A+1[Q5Z(/8;-0.G4C>^^5?K^35
M!4GAC0]=0__4Q4_47ZNK_"MK989]>1 $.7ZN 7^E]M9V0OC+LPYL'?>'72%F
MR<%"TBX??9<[%1&;*N1$78B*JH#6$0$.VRLWU;I_<&B\?!9[_*X:8=6,]8R3
M)P*4JY+%:S]4+27BN+:9Y<BG+PEYF_.SX-!S,]SKS?K]=NACW><#:1GLIJ96
M3L+>>WSOTMO1AT+<Z2<!D:3S3TF0\,8,2\J\>S<((7TC%8'>$@2/A&L@L^T\
M/86^OF^2ES -SF3 9FR_.<FO8^NBC;QCI#NMV)ETJ!Y<WD^;DWRAP\SH=6+5
MN09.3)V,%0ZM^VA>(4W4,T=7EXOAK0X%R]3]<-T!.*8_FXX(9%N@""!IDB8V
MD7,(EKNXLN:TFN\O4LZ7C)!JX\U<VR6? @'6:<.PU&NVT=FG7FIZTJTV@I#)
M;0H$[<_R]5+M.H/Y'P=*[,O+8TH3.=/I:E^4-FYV"F-S=&J6U *Q'%=Q(6Y.
MBA5\0VW8<<'887;D$I?D$T=.+A#*V]H:EHZM;9'%Y<^?WY[P3&O6N>W*I27V
MGH>Q?5#JVDI#OR;X-@YN58Z5CGY?D25?^KDN1B^BD:'AG7?2,Q^FJA)N#!$8
M+VLA9?B^/:934QH.9?#RR4?PI5>8QA"J%0*US9PFIXTTU@,Y6T)_;&F6.+?Y
MN)@U- LDF];#2,OKC6C[6 ?&!C9G*XTRIN:UPZ0H)&7DFM[5FH0',00MW@EL
MQ]7U/@Y,R P*9%8:70$=C:82OMEN&_DS'5.0T$Y^;H[3X-Y*F!!N= Y!!TW<
MNC*<,Z0SG7MK^=+MU,IS50);NW:C[*NID8&S</HU[LR)Q-RY$Y7MG_<94JPF
MW[^)(;L:"!JCH_":P?0W_-D+NGAYST?HE;1B(A!.@N"MHXEXWT$)><33,HL?
M=Q1'%.='+C!/:I?F"/%FBI#7(^?,(F%R[_"B_1[^TDPN@6:L5P@..W?;!B!;
MG#XM3CF@$I JB@Z7UMM*X/D\LMNQDCBR6!5O)6*F:I5[B>+ ^'NU+2O>%8-^
MC-</S',M=:5:&WVPPT#7$7BNZLN4ZL5-ZX;T-^:K&<'F+HJE$Q97S5_+,(AY
MW&\'50J1*IH1;A? ?2F:!6[<8MTZ?I/#5*2F,$]OR(8+&+483';X7,-@?_<Y
M5>/]:H'3JDXEED.>>8/RM<7'X=_8WTO+/>:Z_^YU9LBLF20F5B%N3CIZV#?2
MO19I]-5PYT.<[4JS139\9<#V!.@3C!@,TX#JWAE^OSLIHG"UJBY;%1JI&7XF
M@$XV$"/K-E@\;QM]F[;A L[=?/;4S>FJ_6?@'[;NMQ1U_/T]'=W.?UO$3GXY
MG99\UTHLAZ]3C<S&KH30UW!J8-GY8=CXNYI,CL\Q$D%$(*BC=XA<O#-,$7^Y
M!JL;^T'>371</D'1F#G!/$+MG5?/]RIET&3VWAJ:JN&,RP1U=(G"]/T!U:S[
M^PHO&=YQ6N1RW<K9?7@O930S5%-4]UAOM;\#/<'//^R^X)&H* .)$#P<S8->
M;K=@2GRX7(4Y&;R^[Y,'?1V?WV)YJ4.C2BT^4=SIUN#[/4M1B3U5<X_--YS0
MMYI=<) 5$7BD1OD6Q\AWC>_LHK/GA[J]N\HR4GWD3D7 2LHZ[IFNL55O(BSD
M-0YT[1$1L+C^],Z\YX5+):EW.[\(S;U@8 @^8!\TZP:#83K2,; 0*>0#?DMU
M*KYD-HIWM;);]C\ZKQPA@H&CRTT$H5)LX)--_Q+QKV=&SWY^GT-MQ%G$0";
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M8-VZ( ]0AZ(JT2>/'(A ?U\?'U/!:EXL!2SW6!O>:8XDU)\E7*V?F1W%)YV
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MQF1!>=6<EW%AH/YM+# 7=A'J9(KU#+>]WE<R$E)0G;!?'ALNMIB2K!-$'=7
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M9!])K3);XC)X<OR]Y90<(SQ>%T0JV[%;C7GX*=C<?0ME\+5$8[H?I^X-KOR
MCJNKF-CYM=6G+P7FS2-2(Y6C;!T-A]1(/]/M'EN#Z6T7W/8\.&Y,]^2B?]EZ
MIR.&]88-IX>^C11NF<F-3T7*NE:IA?OG+] <JGOYOOFQD5WW#"EW5/5&ST/
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M]E/':KC&5FY<3FF("@<&7M!G7_\^/+XTBDV0/<B%&XMH+\7%[^/O!E.M2Y\
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MWP,F#1?^JJ%HTR_]WO$ADGC-X<+\LWF_SHOZY ?7:55*U'^IS[#%]%9J]UR
MNP^<D9W-H>YVW!:L^^\&N0JB^U=XDRB5A8\3O?SS%],>-$T$='NL0Q/Q'(GI
MATY&C&<IR9L"JGU@;E3_)]@,A=4O3_^6\F@G-3;/>;^7/\:ESWW0,>O*F;VQ
M/A!A+%V3/]HNZ\6T1[9TSB8BG2DS3RG N%ME#4^_L\X"+SS"0[3H;T.CH=0B
MX:8>?B@J9 (%28\?JZVP33LKW_1U?LV\F)O528P>_R)4E589''_&B\8=1;8&
M^%QSFT&W_C-+9A:)N6.MAST3VX64:Z$7B/I*,2G@8GP7:+XY,VW]*#'TGK.P
MF_9 \P>CKA1XX O0F%!,=\?;.WN!LD "B(J53DE;T_U?V;WCM#]'6H6JY8>0
MW%< N%V,/[P,9Q3;48*5;<9EXL4PDHB@E]*G;1A+A/!/DAE4DVO%P>9S#OEQ
MM5KQC1/N&?-EN,J3/-O>6O2RE8U8#D7//69V _6;>^"/"Y0-B(Z?'7WF*A3H
ME;P53@P8QEXRPEJ0=RW#%&CGZ\_.L!Y'!F^:.>*_8+FFDJ,#8 ?CE/=^LY)]
M.'3]_+38GK_)F&K;AJFQ_GU.1SX4PS>SJE%?PX,)Q ANAV9<^.(\N.K]<P(C
M@$:.QK]E9FZ!5DBES2\IT5J.">H=*^FOXH[USQBUVV3^<.@!4(_4%60UCNQB
M/O^LRK>_:Y0@&6' #RP.+DE6BGB&ZM#(-)1E:%BH8<_(J&[T;;D<3?KAW&:R
M/AZW@<Y\XS]J;&WIM95'[Z;4NT#ND-J:1S8FM,13.'(FYY#XV>0.:C)]*WU^
M>E*3GO3Y/TVK$J0A8/1N=F0HW&%#Y4I_R:] MRT#/_&N@A,8!VJU-SD:2IM5
MI22-3!1RR?K^S>;QW7=Y&.UN2/I/R*3YQ>,LE$'O'X7-.'<K=PN=+6N=R=AU
M*!\GGA[#)%;4T!Z6(Q,FLV*I5")DZ!)Y<ZN-38;>GFLQL#IA:VU\I2698E6U
M94Y<R6(@^,-]D.Y8*O-=SX<),9,OZ3'K:Z"%-$1^MS-X'\2\:]A#^4BR,<MZ
M<9L8^0NL&TR%OU6..% JNF;5]BR8]=?^+%<6LIS=$0N(>EE(A 56(=8LV>0H
M3KA3B?5:L=W&B"#%;UN5@3'&OQ\7F*[2X!Q_ (O#DM]@+=<ZWG[+:N5%4HA9
M@P_5%*HY^F\TEF@5@^+XRG3VAY^8O<>S=[S.YQSH6$G>HL\;&.B1>*==:6^X
M\%<UUA5WGR6J+\L<DO1IUX>4U<6@R7L=?D IPFT1!O=YFKTS?:7DY9;Y,Q9)
M$3]+Z$>FU$%W.]S$&,62VA6"IZT3L0-5=:2"XP1:C$2_85*E1U79%Q>(33QV
M2BIF5P<T]PGV/6XS3OLCG9&FX:M_JY^2>2+<#C\G,H:UE$6Q#RH+_Z'ZT>SN
M>IVR 4MX[ SF3\)L)Y%,SK&6,5M]'<R0.[^,/:!T2L).=%J!.<:13#_&M% &
M.Q20Y5W=E!4=-@=/7WM>CI=:D]CRWI%B5,^OPMGTKP5Q:,I/_U515U8*_PGE
M*!:KHCVNL)JO\VIG:#UUFX$* ?K^AWD0(H\NZ&_J''PCZ*3":@&5CWWC? 6H
MHL(),_RKSO;WJIMM7MO*T02$P]'(=6@OB!CKD(_D[QK<FEMO><EH/HE= P]I
MLJ8Y '-OV@$&29GHD:MT[;1B/:S2UV$Q>^JHFT-TZJ>MAPJKZ\K*[HK3><+D
M%U+2Q2IE/W!XIR]O[4O$BP1E"HT*MP[4.Z:JBJCZ? 1K"'']'XCAO(I"[WVF
ME<2)XWQUX>8\P3ZX-<3.6>)+%DJS\D_,%<#[FJ\H0,8R%XQ]E7QLO?YK6MD%
M,)+'"@T:XX^7G+]B09@2#R0Y&9X8&QK]D&,>WU^T9ZYWN:QB]/N3&-S9]_4T
MQ^P"9#J_)J^DW)T6^Q@3X0"*47+ZTI%;C@F=>3;9,DXY(?'F\NEK"[WRX+"S
M0]0C!67$8K 'DB/&9W-Q")#@WL)8&"3Z4!FC=()HHT,@ U!X<>C&LTKL%4#R
MXT2X*2+YFJ,8P53A 1[7=\K8S>YR;P(Y^LIB-5GA'HH5X.B[N)#9"V&$0QVO
M #06V&N-49IKO;[R_4FR8'Q93[]O0Z[!YK@Z:>@$Q@EM/&PWX8TG#/>K\9!/
M-4LV@%?!O7K?M]%;?HA8-=CK$PS6Z^7@P;W%AGP-%NX/#4;+=N<Z/>(>4Y\8
M),\_16USRLCWPSND0Y=_P;Q3P5LBH*JH5?9@TD>8SB)M=/=:6GTZ0E^\=ZSZ
ML[5X4C ?^,,P35+_7Q?9_4'EGZ5,7@$\QRG<5HC@,&?4G[=>?-$(?.^B9VB9
MU@O#.]"VNK@__7/M_NB@-]+Y\SY]"N#>CBAX?P^0,D"0X47YY8"ISK#U&&,"
MQ#:B?&=U'GX]W%24PVVG\)(8B]Z250U:=KWN(75<]J](#ONH/D;6_D=L<5TE
M8OR2\YX7,#X;GS"@KY6UMHL'1:MXA6%/7"Q+ HGA?< 98=97N\5?<Y)+RT/O
MK!]$;:1J1)D2I;J/AL0<B'_J1AB\A-RO;NQHG'X6QBCBZ[EH\]2%&<8BG*TC
M6;H/X<(&SMZ3[DCDD)_Q;YK;>]PR5[7=D$4ZA*X=>9)L?[.*(4YXOZ#)6/LC
M_4'^=W GNQY2MM>+C^DD8T9*4?'#Q@R/TPT>_>[H<9L+/SM^L-,5H!,$\A C
MQ8_K(2CX>]%+:AZECVIZ(WP8/YA^*Z^+>=;G=V0!]TN46:L:2H257EBC:1'Y
MUV++N8/ :FDOT^Q"-)/PK9<79S+) #!0;L;_XO;MR[FCKM4X!=(^JAOSP9G=
M0?;'CYJ!P@="&I3,#Y5>46I"Y" +X%HD9 I(0S*6OZ6YGBMMQ:XB.R"6*OM0
MV_XY2.C"!T]FBNZ[^7D&S[)+\^9#C9W;VA7@CE(S[H7.Q2VTT-,E@4MM-+M0
M\:9WS"]Z.B.[9XU_8\N3%^-L N,\\2P"PY)L &5]E0ZI#G=%8#RXQJ=OIUW
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M^HN-K#J\P; (V(>.M8\70C\AXXP*D4Q>&J;O@%"QYU> ^?)?"^>M^KC:JL/
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M;(@)6_>@8L2$=6KW0#CC#9.FR&UE[^A(O;@ARA2IM51P=E(U;3B=X"KZ.>V
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MBZ(>C;M,1KDEW^@(TC25.KE.$V.PQ%,WEQMO]N $"&H-U=BH7__C=D' VD9
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MUC+K+,XS0#U[WE\I)5HJ,>,TNA9>VZ:)7\=&B6HO&Y[6B&B$ $; =+:OGPC
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M)ODZ6L)I14VD>^YV$OKM-EW1[D5,-SP5]H;4HO-7C1R*RA\HY=X[ )]5B=P
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M8%J!C$29VJ$2!22D9'-H._FR]/><RZ$L2W=0OH?ML!+5VWUW.A8_2<:9K-/
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MN+0KPS[8W.VW"5KWK3HG$#)6+!$TGE9;@@M7I+7P&QTGQ>54GQ?5/X5)W@2
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MPUY,B-^D^3V!E6(:MO9:VU+: OC!*JFM8JM@$M$*'*TVNK?@[E<O[^-HD4/
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M34A57,]TV42K&=V&=/[-;Q4?XGC:YOS#F-S<JIG/">'_V=SI_Z&).X;-7JT
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MT8;^$9),!X[C7(?%@^<Q8T0I<[$M.A3(9N,VYL+!=>BK'I8##SNZ.+5(OX
MPB@WT#^/0O>1;$0ATF ];C]:J396#"1]*Y]'6ZQ#B+9G$O5I1I;@;()O?16Z
M*-A\AS,RA%^I;I0(LIVMK_SFW<=CQN*P,@73&NI\FW7[5 ;H^,BJAQO];$WF
MWF$O[@[Q Q@ 21)%SD^V.AV^]RF0Q-R6$&<.I "<I#V&B9+&)-6:P%_[H7 P
M[M&/$\V>[ZY?5R@?+Y!./NQ-1J#^&%\@N%N1 9<OX?0<;S:#_!L?$ERR[D#4
M)^)5\LB +V6W:^RV28(KQGW S>!B(V]1>)"Q],@'/"+()%32K;Z40=".@X5[
M0L7AC55J*[Y7X4;J%>7'CB.PO+J>8FK@Q/7#-+Q[BP^5(A[QA2@RC[X+I7H?
M(7&;!))9JN*CZGQ,6R$V)[%8S/45;8V@)VH3>-)D"2\>I50Q>704SQ_SQT-^
MX2@LG[\X]CQ<J9(#"Z_65H6B3=',QE!>S(G9QBPUJN-I67=-!,3MV'NU?.#S
M 5LF/K.==!E/M=FZ8" 8"KPJ:(Z%L<RR5(2XM_G56#^Z.-G@PO-D@*,>H?AG
M75%*-G@8)D@ '2X0N(JAU^5&S/J]O9QL:";'C-L&D(@[F4(*;R_>UHR0M)(I
MC#_[2@;8\GLUD22!E+*<Q_A91="XRVEATZNOQ,O!P4O^(VH-'N[_-Y<2V5C7
MCD:=6A'<K@AD1;:"6>IE1<>G'HR)\*?DR1RML$_NYV[._UIT=,>'D@'WE]W1
MX.ZS]QGULW/ "!0M,U&F3/*@?(W$_5/=IE!/Z<F (7>KTZJ2N,@:_4*G>-VS
M?-MS9%?ZS[>6_[\QVE]D ('GR\1%;[<R?[6A/ZA1TU*UK>O^;&/;0A0O:?$W
MJ]E&\!:P+M(4&5!&/5L!"\JU-09Z>:G1V217UG>UM^F":GL5))H[^UX3/?"T
M02C::QLZM=JY=H=5E9\JA#I:,Q\W(W.;A\/6N',+Q&WE\PU[,T).F ^?GB4L
MGN5(>[F:Y?=Y6,R?7GF3H"/Z@6H*MA[XX;D$QG8C942\1L7<,L;AU_%RR%E9
MQ3F ^WC?J\2%)3%#/[S9KB8->B"V'I0>^?5.D1@.D1*CZ+DXT/4=4DME4EJ-
M^;?V_T'<FT>SX;;MHFFUU591-=7<%M4:2\U"JHJJHBA*D*H:@Q1%C*FVJ+F&
MTE)2,R52\YR8557-U"PQSXDA0@;';W]K[;/..OL]Y_W6_KZU_[C_2;*2/$]R
M7_=U/<\]+/X:F-*QLH_CJ>!95OYS1R+4D2/S0)%D A)90=O0\K!.4H$D3^)F
M9W21\)2+-_M-9*%[:Y\0EJ*5)10?L".^)RPJGR<08U4=<T+BLOZ?\=3"GX"<
M0\2$R*_%.N%L>.>-GV68XW&7#\TI]=P>;5&&C\0WG!AM]RG,ZP-D!.DSX?U@
MK[RL@6QH&I<#I8U<-@)?@:]:<W?$O]6X35::#R?D8YVQ$W_-'U3![JC^./NP
M:]@3XHIH43T&. B8M[6GVJH2S5/]"JPM.]D-JQHC7OP$)U+C_@IE>%L4G=5K
MV+)^<5@27%8HD4[)Z-F]P.?+"%@JMLA:Q?!!U<!57U+P+BV'GSW3%M%!8H43
MB^\U7BS3+7<AM_P^5YI7)WWK\0]*L-:6-,XLX<Z#K=DRAKF/HVRH';:<=;T
M3S-[HV=I)#:522Y<[; WN-MC4>1^C!J;<3]CSK1NGBL7;$=7.?:5+ULM*\JT
M@L 5"L-#@^&KI.W2+K?1[J"!>*5N4</!Z8=7.7]K?IOM?E%SYS9\04#8 \%F
M$Q^VV?],9T<E<>Z5'_M);';,:)XVNWCGW%DI#I-3MYW_@VW)40UP36H=1YQ+
M"<66;8B"Z4[[M!F?2R4%?\=Z$:>/ 78V=^<L.J0L.GB5(F62#.K,'U96>K';
M*_KJT0CJN_V\1]E1@PJB'/C,F%2.Z7';+J/J(;L=E-1\=;1H]8,L'2/34-/!
M <MD?[^NV3=T(3)QKB&6R:;*TN^T^]8;08>2S[CA_69UW0#J]$"C'K[O+[*S
M!LL"1+ST.:%N]64PN?'4W^$/[.,5U:?. ;R4U=6+]__4LL8*G:6J$VN:C^(C
M?!J>]4W<D&#&=^:#?3=^M7O:)$-W I-&)7^]PA1[[XK]6_-*B+-O7O?%\ (1
M_!H7'DY81,IW<:MVAKEVJFPN_]^C1<P:E?"L[/0VT.5]H]/P8X"!A@C9O]BC
M1L*31Q;X>'8=]^?><]5X=(@K*S=<RY*60K7/HX+)-D%!FH1EDP0G<6QCV-.O
M58TX>-?BV$23NT=:P%XP]4LO+4#(,*0#6Q7^B?CN"86EUGZ0?JU$0F#YM,+P
M@#)KUSG-S(BO[''[I-;JQ7-8L1 Q.+<A>3T'W3G[=FO"Z</&3Z0E8?_+:;"_
MZA=ALRZ>/K?+T&V9O[OS$509T-LC\P)_>0,\TV4WGX?"N)Q/+*?L,IENF8.V
M+=(C<Q-)"8>E7=HJP2F!L1S&MOX__L6!UG^)?5J$\" <(:>"7@U*2P5I93>/
MF3 LSK:&.GV8_UYCM>\JGB/&#6^X4+S2UX68T*=?F)R7>;<KH-LZ XMN!/[F
M?BV[6?L^*;3N[L]NAFO(5LP.[6W(&5<AAA"F-A@*K M%N9:G3Q:.I3R.$4]:
MKY0*%O]U]7E,? "@N7G5QDS63'QH(8$M/WLK+#M*(J9_3D,^B(U0TX4XW_,-
MGMWA8:=RYT^C'@/;04*#(/)3B%3(,*1B<79CEJB(8-8/I.6])$9NRBBZR^D$
MLHU'\*Q#&C\1852.'!(L'1_?1@8ZY3QX.4I5C1G4XEWH]?@[^T9%\KSIQBFT
M+J/-4-J[@+N\"?7U(.'"$SS6^O _#VU14DQM5C51TJ(U WN332;P')=,-64K
M\Z<"S\(8 2^]G\PZUQR]5-RU&;>VZGB5^5)&WN%!5&"1NNY@-"K<%-V F$LY
M8HUWU[@&<3WRB4:T<GIRCV\O)^.4]N_GU%T5)BHL(2N. 1MGY[=C+,RY)SY5
MP /;3,.29_YH^ N+D;G'XFH[0JJHU\E&V50>@GIJN/RMQ@8^.ZJN9.]TY#Y:
M@B?R[;L" ;!2 6-@F1A9=JZXCV\*CD&P/.O&2X29)=)PYW0G "9&A0#6;YP3
MNKSW&XSOH[]=+1BP94@*S+#3/D$7Q= __P",7-4F!Y0K^UH/W^V?[G4*L3GD
M6SJ#P4WF1EL;'A*E)\]7-G&^3B\*2H%5_#ASVPU7U[=7!*N$;]4TOFQYU7;Z
MP5Q4?_:;6\ZD&O/J!NEE;M9,O@GTP/\B6SXB*Z^P]-/$J#&?^\>LB;:R+HY3
MA[WSL)A,3G(&T;M+B)%^Y\'SP7-9<LY6F-YX%UDO=F^?\3[CO=5>?Z5PG]G+
M]$X,J($@%+<)JJ9S0_LH_8Q?.$:W=P[+V#LW6'0%)-;C)[1(VC]H.4!&+O2E
M_M5,M:$#;5J6R M05:._3?P;.3U^(6M?=/*_-^72*SGG5F"##^2[BDA:P*=&
M_SF:!<F2&((D.LW15D?H JX0GT^_HSY,?;XI% $QAN@'72!BPY!/8%%"EW"]
M*85EZ!@@$,+J<KLEL/#CJWM_#%6N!1 A\BZJ8Q^P+R!",V2F+O-C "&9*C_*
MF9"0(P63?QECP!)P9XL172IN)$!FLJ8E4;5S3\#)LACA1F8T=_C:Y?$X09>/
M/]V?XC?9)UQ@;'&+\B![!NTTVWV8B)0N6#?[M& 5EJMT1SF1YZEJ^=ZUX?T%
MH0KN+@@SU8_L?0[UK1RLS^!O8>5IMP3&W#U U/NW;+];M<7:<F3CIRS_9HS\
M4_QY];\37_YGUIT!V"#BV>#6AK1%<-.PS*7HM9+SH*SBUT\8Y_HVU0EWGY'9
MB:86@S WAW?ZF;CE(8^+>!4[1]'[2%+(ZH'5CC@-1RL$.04+D:+(,+_LF<ZR
MM8_%!@4SSSW"GRLO]Q-8JT+XR3TM]=@WC=K^V>OFW+S!^PV?9*=TGGR\<"H\
MX%U<U1[9^CZ*27V@S82_I/T$;FI_BO]!YD^OC>G!'-REIC9>E;6&?::?+D9+
MGE(6K#H*I5RD__2;9:TZ!ERBZI43I3^5KJ:%9W8NS?!7W/\3X<PHH'-/8VZ4
MLU@GQO^+9W1260^]XX0B9J+ML\E&^(@P!9\(2SD]EY*5HZ_:]G 6I6_JFG.^
M:,R^3%@F.U$PUKU@+9-_:,O]N;A]^$/-IQ.:5U>'.$<Z+KT*/Q\5&C=?Z;=?
M)+'D.OK)TOMNM:RQN<3?9^!57T^KB?8?X/8&$_FK%]7//LN.6I;\SUQ&'::2
M2 1$/%"+$#*QCMM+$B4E!=6'#2L67.GA/>V%J763)9E"A*S^_V:XKK671>:\
M]-"\JG"B*U4HW&1O[<'][:B0<]Q'K+&5N<&&5_?*[_?*78K]SMJ3"'IOD16!
MXJ@3C,\Y!MR]T+$5-$[8QI]1G8[M:H;$IR2Z;'L\5G4L\VXGW96Y6&+H57O"
MQ_='U!FMB) -NWD)]#GRMB'L<I#,6-S04NR T3^#%S+8-B8# T,4JJ#!N&/
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M?2G' #]]*DDTL%MYO^%0#(;M60A.%#%Y=95]-0W8L5KKM [)E(78PB'ML\Q
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M[I7AW7 F,R/6<?48P(52F.9N4ZV.S;=UK?>M4TJN: 9<EO9L:KOLN;>$T2!
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M NV3<Q[P19R#!-O_OPD 4$L#!!0    ( *=(4%(1(VNT]$<! &FJ 0 3
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M 9X"[  V '-\^05,<-,D+-8N+@X2?'SVSKRF%A S2UYS")C/W=2!CY_W$1]
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M)'B,<9V2[-8-\KN4M#1W*>]2TS&RWZ=C8&.@OLO,R\SVD(.+FXOV'I\@'Z<
M.R<7YZ]."(BO7KU^[3H%"0D%)_U=>L[_9L+] )!?O71(&$Y(P RX1$Y 2$Z
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M_>;]'^$]S.O^+$$94I./N:UZ>T5&0.J%JGR-%@[@ES5=>+SJC /XD'ID!>
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M.5 L+ANQQUF)!&*V#GP?U.30/>7[\HQZK#TI.I;30Z/XC:2JH%*<26R.?<(
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M[UNQ-RSHW[T\8%"Q^*+]V?2]V#U,WK![\LM(I>)R8![( VPZW-M>Y?IDC1
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MA'VN7/QB9FX_$MS483X75F#+X%P?#&]$Q$1:/O+XICO<<3?":W]*FP1]P_9
MU&%T7+]807R4Z=Y[;\&^B! :UGQ_\=F<+HT%3WW1G"&C(\RI9#VMH:=AV<X8
M9[(P@RB%N+!)O0_7J4@\PLAX7/Y@N>[KT-/$Q21^/=&)FQBA5=WRRB*+0)GJ
MG[[-<Z";438:429<-3A U[P:36"&!J]-'A?K)A8CLD]&M5+I-T<MH%B$K.@
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MJ$(0^:DG]^<GKG1'.;EWSZJO2B 2_?U+LWF0?F@X=DFR4J9#IWHC$*:KB_<
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M1$G)-X*?^"0!V.25L!)\S)>RP %J2:F?_B]_$]T%.QZA\/GC *OM)QA1(_F
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MP!9(;*85M!:'S9WU0K(Y:7K6&JB3&@*?_9'B8\[R(?-S(/=[*:J^Q.]3:A-
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M,F"0=8]<,2]@9</8IP:I$X2#<DK81V6;?K0Y3H[WYT>=,CZM)Y7>;U3=47E
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M:M'L<<-BY 6<<_I/K.S>[Y>WLA'EAKS2 "Q=XQ&""(N)%R[#JN.1Y,6"^+;
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M.()%(JWODQ :=140?RFV='EG^96"1AYQH%Z=J/6!&Q.05*B'TD5*V_4'O0@
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M\[/ZP<%MT=%PJ9UX^1M.,^%YT\+Y>P;W<=\-JVLK$T6U9X-&<E"UX^4T>&<
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M1'9KYLH:R)9ID"'Z2:)F5+, T\CJW^\/_9-RD=YP:R3O@^8]=_YA0TW'?:_
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MT=Y[UD-<4U59"W&5E*A'-!,M.1E $D]!8IW,YX)N]Z?H/^P#76=4'4 /2SP
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M-XBURV;%)GY1;:+PV]F AX0G:YGMS:J$9A+6MAM<;/>._;PS[H#ABK5[/IM
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MJH K].EUT\FV_C=I^-#1Z" G77--_?75C1P5GECC:IR]OA3*>+"0M%GW^!:
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M:?:2-E"+A4/+]?#GL0YSPT7G51ASS5X;,F-;8GQ9.;DIBQ2>2M7=L>TBG%L
MFDC=:-T1"[F?][%T-0?3JN('$JK\#WKK9;3AHUL.RSQ3<Z#>'^9ESL%2^=Q@
M4; 2G>'ST4Z5NUA)#!=F_/>2W<-6.<6575,*2JWN-:%/?.SFC[/':23K$O>
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MR@X=34=*J5:]VG:0YVV+>V%5;@S1@)_Y+_2 ,*N#6\OPF#\7IJRM4N$9,>L
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M'(O$ALW!*.4M/P8)1D&1["+T.5FX;&:E3&X%<6B</\:78_SGL58MC-T]K$+
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MT3N703I#\2<E/H26\&S@881Q6'/%F6/F!J+6&9F*"E0T;"O.=F2D#FBZG/.
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MX5>JSE9[V3-:<\!970(M=C[&B$/!QXYG&NO!PD)4P<]J_:?-8I&6$06P<4Y
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M,3EU] +)7RE$!#6\&A^.[=(1)@G.R.4^"&R48QALM<6J&Q4=5[CJCH=4:-[
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M>=.RG@B^<S6Y]RW@ ^L>#*R=AS<]J\U:8I^UT*&9;5:Q4X\*;81AKT%A]-/
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MAFMQ3^VP/W_2-:F<&"N: C#&^$D 5MDW#X&:C1GMCX_':EN](E&Q$X\L"T
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MP'+"2!FEX.UZ\K(#%0XH?>$\X90X*7>JX\[%L= YM<\$"LQ3NE]M!(#R,>,
MRSVZVE("M: 3P)&ZA?*V/'OH$FLHD-KD;5RS2.'Q/HD]_$249%B-N]>AZ&M5
M:9>"?(<FH1W(WLA*,\JV+$KGH;:>ZO0FZ+QY01Q)@ER80M@CO/^KKT?<['J*
M*A;.T++14I#>=I'DUNLJI#@Q1V@S0?4+'%U1-I9)?XV.AF'8N,.+*CFWY(Q?
ML0#MGFM=.GK6OCGGN7:+@5H#7%31O)^M1GBJJUB/6R6C(4[AY5:Z/94%T&B_
MFHA]30,0 W-@X/4P0,J!T,ZYP*22 [,%,WV<+"I0, J45#:UKM.BITIPRTLA
ME%4):]@WK#HRDI)9EE97]/_D4';]9[^S_G BD;D.=D\[%#SCB!?PI:I]1*[J
M/N$N]7E6.C7H\27#S/*B>$ZY7+7/25Q$2&^EH]F]\'XLV_?EHY@,*?(-:^F6
MIKCEA\)$>]\Y(_;7\?(6>YMWBRCM*MRWSJ$>JHA5.S9),:GDJ9<^$_RT37PH
M]JC[>&6.^IW-5HRC'+YHGC9-^*-,B >4;K5=E7C2O,HNS3U)&? GV*ZMA"*.
M?6CKU3QQMK-[1Z.58I#(#2#_K6:]]8F+;(8S9\V05>1>:8;)A,UUC+"I2IK_
M.PV)>QDB6):T IN[$(9)!LHS=];:N[.HD0Y[S*OST C3T^T'!R\%'F?7W0.7
MN]^/'#07PGXH!&]+73!%$!Y'BU?M!3G:WZR4U1(PU623#-1ADXRY,D2Q2]<<
MUP^2G^%OS_;4H3=TG?/3]'2)RJ5UI0DC(3F^I474?#WB9-]-+DF*)Q)FHM^<
M:)PG*65FR(!Y1A:.!C\!(3N%14%/^+REV22MFQ#U;+GX.D7\IX(#Y=-KDZ@[
M17*9_N6AC+K=;$!<0_REA65R>T=#"G[39Q9*\:]J>YN\0[SA\90M!#(V@9;K
M75/+\$:W:=E\*,PG]NV_9@@C9W9XRM]9ZSKU]TD(AQ-[M4&<6\"E>"2CZMXI
M;J@W@:#/)RL=FCO$,HA1M8U*WVN3QU!1>PM@.V,2?&@T%[?-NN(]6T>DVK6Q
M.O/8VO5^Y9K0M76B\M2Y^7[M/=NU\S3SU/OV_B<(K7OOJ^KS(-''#4C5;V/^
M#/.%\ C]%,[)!O'&[CC\3BQ=AN27Q'?JK!BI.7QVS2,\C4:19:!@#8R#+0.M
MC5VRYH+K5/>!34*FI%KY;20@@TZ,W5=-BJVETS/MTBTN:\9P_IX"JD=:J.AJ
M7C>S9O(>QIH+ZS,7'1->82"CN^: LW=;51[24-'S3%2298TJ2@V[]_Y7S-Q_
M_U^^0T:;\B\2"_]SL@*:\;_P]].'?J];9YPTE*)UBP$[2W39 S2K[")@664(
MU,\ SL!#O."PAL"WK]218J0#[KYWC_RID<'"EH1+J0'1WTE@Q8**<(*X,($0
M=I(Z+(.T$T+64.:8!:JRL< >#VIN#?_?)11%^X1%7P!T[>B_W:A%;1Q0Z5U$
M&G\^'W%+PVDU6A(V-G#WRDI<:X0T?0= U/VK+#@+V$E@U#G+YXDWJ44/#PE3
M:()MUW!_%Q$4W!,LA:@!0/3N6 KE283=;?[,=QQG8Z0MT#!77I'[%A2.*;K$
M$'81M<PPZ'DE0SEEAU-.['Y"-CG:(O7 +76M( Z1!'A&+@G*2UEN!&A0 <7W
M.'K2_#G_:_- 9/7@4"GNAH:0##X[T532%ND@CV0JA35^+VC6K]Z,AHM!QXVD
M6;8B_7JD1? &]B$$ YD1GQ//N&[P80-:3!=)X4GP]& W$)>%I_MP!+TV\4 )
MU8"%_[2M2!Y[^,_3:*W%4-/V\&)8@$4_6W,1\:.-_Z@7-89[D#Z\_$1#X#$]
M%-?C3\E3SBY\O_%(^@UKXSP*_Z\2:N3%H>K-"FH24-?[A'GB,<L8\3A\@N_J
MXBT#"3I<@@UN\)2<5.3#VI-ZR?;B09%KL5>K097M42SZA%N9Y(OP'",4<EP<
M22_2EF=<("TL"LYU\I[,_S93H<Y2(16?L%+.?Q]>)>R4DX';-TZ/:&DU&:TH
M6BXT=JH(O>N(BGN=UDTN!J4A$MZ.B+D^)@@S]78A%M >V8I!5+/ <6*3[/X+
MYW-8RVIN'"AFYL?VDLSBD]3+1WIM3EXX1[8REOZ/+IZ%/ZZ7C_ :"H1?1=@
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M,\]ZRLC:PHA]6 LHGT_%L?@Y=9 P>40^>N(/AA?XXY.)B<"XQ$4X4!3]'<0
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M'%4:8/$@M)_\ ?<D&7AA!D<5V&9LV]9V"[S21YZJ);](E@>,$W 4F,:;H1Y
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MYZ\]N #Z04ID M; KP]J4PLPD+<@5>^O1?#O<YJ](<U!DMF29G!O(8*/[&
MCL'")1Q'/_FV:BC=M]E%QL$^?>&S4'7W[>?C,5I@U==PWF:5MC L((?V-_X/
M0R5+W'M:7FZ84#ZI YWK[_!]9Q-\OO(6V.(I/;"MER"-X0-U/CGZ'&/V&%,8
M1!RWR*.F^^#Y6)WU8KRRLE'.UB0:"VQ)K*Y3&8$ JYB1-P*BBW;91% 2M 05
M%1DL0YJ@AG)"J-0WR2"V2E'KJ\2HL%)QH39\(9ZKI*3A(UQIOA9%"\PD5V3R
MY8E3>0V);\DX5:4K OH*O/;)SC7?RN#P.">C06@ YLP$? D"'KU1S&!8ZO$
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M'FFP)S?H1 Y,@PB?<(EYF@9@X<# N14$-;JG[S:GU]ZAAMIVCTO;=T_8ZV-
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M7S5%88,H$TM%,82AT7]K<*1X--A 5XQ&_"7B_=-D] \I:R<-93FP>LFW?B=
M^23$==XSY4HB2L*X;I81$?MUC.PQRNZT2B++RNSFDG[W3J+5K95\EF7^5C)U
M1I)1H1J]8;",;,U" ?4^Y@J5YH96'@E<>89:VP&BX90/@ZG_BC$9QA]PAA>)
M]/.(1>X((B,#&<EB6;N+#;0=YNVC_4G-N:J F"^EWB 4WCU5-[*\(ZQ[\,.
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M\1>_\1\_\B>_\B\_\S>_\S\_]$>_]$\_]0I7O_5?/_97?T   #M02P,$%
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M2"01Y)CSF*=2QH%P\U5/@3,_M[6!#/J800O:44%.&B8[J9F*^I$UJ3$#UG:
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M &:X8$+C+)BVE/M=* TA<HX+)&/#]"NDI^R]QLIHBV&6*Z*G# U="3UK9YC
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M0\^<>W>[/$";WD?SQ^>+#IW'Y@<F9.[5I]_F>]Z6GDFQ7I 3SF$L1: 7C*&
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MQ3?I?LH8S#[=2AFECQ-OA+Y]>$N7YOKIU:V4U5_6Q>8^-]DKNS#:E 4XDES
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M@R[K1S%,A<0ID5!2FD"42@1)$E"81(',!&,XQ$ZE3(_T-S?5VP(%R_H(9MU
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M50\+NY^*A\U73LV._Y>B$'_DRV63/9TI)*.$IA!AH76#(@E9C##4_Q*)BG"
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M]!(Y#4VZS)3"($Y3EO((81H[K8Y]C\F4)?A>>S LU]$C43SVHKJ%#:H"M/#
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M)IV$7F5LGLYEKP/"/5:L.;0MWVUD5?RET-[MJO;];^2*ZX;KV^L+0031XY!
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M@&,1SF%.)8HCK0G)/3/[SX[C\SC/D[=FQ?.S.\X#Z&9BC 9EXG?<R@<-X3X
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M9'F&.-61\L^K7-Y#,%^JYC_A0^"V6"]T:B=>Z)]4;0=VF0%'U<%1]W;>:XU
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MTRNE-UL;'[2*$ZYR)@64<8H@YEA"AG,*49*C)!81YWYI2$&D6AHE5K*"H[#
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MQSI%D4PD<W*\7QEC:6;+44SPK6=M=8;Q.A$$ F=JG\X1EUK$7M/#&1[W:,T
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MM5HT)5YIY@Z#+L^D;)(3M^J[*A\]:\DYP>Q(E8'!FYH.&W'!7T9>T I\<RB
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M,P#,8P9SG"0PEEQ3F<DX=SMG]!MV:2Q^R&'95J)7?LEU);QK=(@G[/V>_&G
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M$9*099$R&YR4P5PF&,9$HSQ-$VK>4J\@O@L#+6TCT\C9J4[LF_G9"ZT;0X0
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M>0(QCP3,$XE@FF)-D)8<99X-W=P&7EX$0RLWZ CNN3XY8NZVKH3'<>+UX!R
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MD@N'V/@G9$TZ@UT@_[I>Z?TO.CX\R<H[^!%0;< )KZ"R OTM3JL?X.3]D5"
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M:R[9?%6EVCS6IYI";'9L6?ZV4FRS4O++1MT7N_NR^<B",D*8)@A@%C. $,\
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MKL9[8M5S/=[U39-=D?=TK7M-WO?1H5?EUW(GMB]*^<2<QC%GR*P:6&+K@>2
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M"2+-!+U=UCIP]J[%(3G:NZ3/2=S="#<0FB,S:&ME9$=9U+$SLH8&+>AS#HW
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M56*?8;=$)YJ"-*8I0")-#-GA'.!,Y:GDF8#"29/P=!-SX[+:PJ@U<5":Y M
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M#PW!+B0O>;4_*4\-0>8Y;PUZ1R@AJ>JP\&Z]-.\HW_]G9Y=8Z^72A&%V3;;
MBJ<I02FPL@DF/$(:4*@U2!A-J)),9M2I8LK ]N?&9B>4D;H^_*^H]B+ZP_H1
M-8YXQE*^W>3&@"."/S()CH![ 'TJ)_3&5:KJ-^&5-:N<\#FO7N7VFF%\^)OY
MUJTW6WM/N$J!+<L=,]XV%WX7"@HJJ&) 4TD!4@0"#DTD)Q*=Y2I%.$9>]-??
MW-S8KF-ME09E38W$NO0\=3B#L1MWA4-N9*KJ@E8GN;?(-;:&8R0W3$(2T)D6
M)^4;-^^?TXOC4_YUYRK>JNIN+6TEDT]KMFIV17FJ:,IP!C(($T,BB &:< B8
MT%QRGJ*4.64]];8R-^[H&!I5U7RLJ>X5U4ZCV4\7P3":(J!Y#L^ RG.G<7*O
M.Q<$KXFJSOE]K;QJSIV%H:?BW.EG)ZLW=];\;K6Y\Q^^( N%GS_\X^>KNO^N
MBML[JP?X:!;'M^JKLG+N9HW\=KVJ%L*[VG2X@'9OS0HGB%Q9I;\4 4:9!E@@
M)'*-1"H3[W24:7V8&WEW7+B*6B>BQHMH[T;4\2.R]QP'9*-,_&5Q"S9G_A48
M>6X*D)]R<TA(\?\F?>_[)@W+4WF=O@R>L#*Q&]-GKKQ./[V8PO)*I@R==\V:
M1NXVE:$?5Z7YR8#>-E*^W=WO; +-H[)IJ6^7K+@OKU=R?R^Q^LTAD;59#/VJ
MM@M*$RT0AH"DF ,D4PI8KC(0)R06B/&,:.DWN8YCZ-QFT-KT*M7?=U(<JR=1
M+#)$%< 0FIXTH9%9@*H4F)4IY#&-TR17?L4A7K4O)ZTG8<_@_A&)O4-5OT:B
M[F-[IY?M;_BVO]S[M5=DG<GWP#4">OUQ.GJ88UP$K8_1WLE]+%):_:M]EU>7
M0]X>NOQPJ;OZ973PMMWHNXJ,PR$#F7&[)&RT,I*M$X<DXR)^''>,W-Y .:_Z
M$HO=,K7QT,[,G]_6>FL"'G4M&E(T$4Z]K5IO-R62QU#:*R(X,9.-BLV:'#$&
ME,@QAD1EYO=^DXV_$7.=1MC!W(AU[(U >R.P.CLH&^\\%</\^\IM0A@)_XD4
MQSJXMM9'K?E74<>!J.M!0$FRP>@%E2SSMV):2;/!*!U)G@U_TS"._.=Z+?\L
MELMN4H9*,R99AH"0J;#G/ACDDD,@B8 :*<+CQ"NU^(4VYK;L:4V\*/GE)2S=
M2.I"A$9F(5]PO%FFQ_V0-/)2,Y/R1(^?SXF@[Z,#MUK$G9*[I;K19PH9?;?[
M/_M"](M,9QA2K4"<Y!"@V$HHD"0'!+(X3RD5+*5^ZCH#+?$9$=-([WS;W=];
ME?.UCJ1:K>]M[O9Z4U][W=[9E!-+X7609#[#]U6_9%/U2[6UP?;%U3P7VP/[
MU'$M/7X_C;U4;CRPZ#O68:M\B:PS4>5-0)J[$,^@Z]R!IDR[C+T,KZ-5ZH6O
M\T^M><N6RWIK_9W:%(_5$KBJP=%>VA1:"RHQB$D: T1LW5M"(, 91AQ#K43J
M%&@YM#6W@.O-IW59_BVZ986A1BLI8P*+]4/OXL4;WO,9-P%!&WTE: "J3;V*
M#L;6I8P&Y-^<P\X]"R<@AA/EXER(I5=RCB,Z/2DZY]XP6:*.HRO==!W71X9%
MM/4-HP\FZC*V5U=0RD.(HQ.6XX1+P&C, <(Y,MR:,Y#G9GF+N%"9XCZ+V+[&
MYD:NM7E^H60OF&[Q8BB(1J;2]F):8VA]+:TTD=\8,9\+)B$#N][V)HW>7#Q_
M'J(Y/3-0^]_&=H9^#J*UG:OT0F8V.4!+* &"0@&*A00:\5AB1,P*UTL7ZG13
M<R.*]]K$F-MJ_=K8')5[HSWK?/< [$8?86 ;F3Q:(Y\H:K<PKIH%Y?%2<Y3+
MK><!"UH=X'1KTQ8(..OU48V \T\,5.+I*/^H;?FYEC>3-[:(XVZS,5\!^WWH
MS*,00Q1C+$%.1&Z"DBP%.1<8,"9R0C55>8S]]M)\39C?)MJ'@SZ<X:&ZUF^K
M%"?MF-JTGE0;:)YAC7<7N7'5F+"/S&!=J?^FMN[G#MI[!RHN*T?=$!N*8E"5
M(5\;IE4@&HC0D3K1T/<,7)D5*W6CZ_I-BP3Q)$EQ"I3$T(17L2&]F!O2XXE.
M$J)()KSNHG9?/K> ZOK>ZC]%Z]VVW+*5M,-HMS*XF47&UI[=&X:K#?=<G'7Q
M=%R,#41I[,77OK24-= !#_\5UPN.!UUA==\_[8KJ!<^.5E O?69H;=B'1L;C
M1MLKIPL4*R735 &LXP0@QDT<@VD"!&6<PCBWV0%^A5^?-C"WP7RPKS[A\RV%
M=@2@V\B]!):11^]31-[U(3*@PNK+;H<MG_JLC8EKH[[LX7'ATQ.?NW"5\OD@
MO_QEO2S$S_J_A]A7,9EF3'"S'B$2H,S6+4L3#+*4I"3.(!8Y]!(1=6UY;B._
M(U/<,7WHTN,L[IYKCI!H3K;8Z )Y%=461W\T?XZ[NG#%:Y1EQ=G&7V<]X8K)
MR86$\PO\2*O</FP6W__/(E8)DU BD*2(&2K*-. 0,J!C36.1:<5CX4)%S?OF
M1C &)N9()RTB_20QP,^1A_[W]__G^MOEH_F98X<Q6K:#M%3B[[?KQ_^RGS3N
MP;SZ"=B?.@.S?<\DP^V9T>T@>OYK_XR2%Y1"?]W9H]0;_9*(Z"*3F<:49@ S
MA@"*,P)RJ15(2$XP3#3*J'.&B6?;<QMRM:U5'EXK@RLZYKJG3OCV0?_ '1G9
MD0?Y2XK"5U$#]8V.7E0<'@]J]ZR5$2&?*(LE+/1>22T#P>M)<O%]XV1)+P-=
M[2;!#'W%L-7>KVK[EI5W7S;KQT(J^<O/WTHE/Z[V4JW78EL\5H=@"\T1D5)"
M$"N9V9O5!##%%##Q54)3*R]OZR&YE\1S;]IK;IBHZ)TPID</C>U6)F2]%RYF
M>\/]5H ^?:&D2*Q68TI-E(N8T"#/DP3D&%&>98RG?H*-(_7%%//TJ_>%VW)\
M'(1'GJ\MN-;JZ$L'W#?6\JA8_:VCU7U]'F;O!;D_8B%7Y!ZM3[HD]T?E^9I\
MP!L&7B':/3PL&_FUCRN]WMQ74]:']<:T;5K;_C1V[-AR^W-_"?PW>_KUYZ:P
MS/%E4ZPWMBCX_@IX\\/SJ]\+*'@N(8Z!1LB>-&02<$88D F!&J4B@:ENKV%_
M]Q!QF<A^IP'_] ;W]TEV-1_7F^HT_\UNI=N__*VC^>%Y^VBJKX/@&BM"*$!8
M:8#R+ 4TSQFP$0IA6&8X(UYB/G/Z'DPXM5:&V[MFQ5KZRKI,U==ND^\<>W#D
MJ;ON/&MT5\VE^?%8Q"7@M;6)L0YZSVTJVZ>]&#=QCQS=I)NZ?;]P1:IB\7ZU
M+8P9RDK0&!NE^O&_U<\%TT)+'',0YXP#)' .<@@A()02I"C10CJ=*IQL86Z,
M7QL9-59&E9F1L=.-_$\#V<_20> 9F4Z]D7'FS;/>]YQAF&=K<C,_/.>TT^^=
MA'S.NM6RQ/D/^I][O+]_6*Y_*E65U/ABO@-WK%1?3(>:.;#Z7:-@V=Q>)"G.
ML$ 04 @S@'B2 \H)!CQ/4Y;KF'/F-,[]FYX= 3361Z4U-7IH[(\>S*>J *+^
M?7WUUF-GWK-#SI^!C ?SV$32(EQ9&;6F1U]:A.O?-^8/N*KK";7[&<AXD$]T
M!!(:>J]#D&'H]9R!>+YPLB.088YV3T &ON&"2G%U;/IV?7^_7E47L,KK[793
M\-VVTG98OUVO'@W[FD;K%+O#U:"%H%APRC6@),X!(D2::</,'2C#<:+B5"+F
MM=EPH3USFU!J2[>%W48JU<JN25?KK2JC-\6JEK I_S:@9MP%'>:V8S!A-XP\
MX71+B=2NU'<,RZCK3+1=1_O+BH=[G@</VPS>SDW&P#7G+D<[> VZ"TR:OB;=
MY?B]6*,NP&L'ZK$^4S3\:.Q8W5HFZ2J/J-@JWR *N"%@P[\,@9SR'*@<$@@U
M@SB/??C7J=6YL>RW82*J3@"[\65PV$9FQ1?D40\F!Y=V&8124$E4IX:G54'U
MP>)(^-3KX:$7FBKUU"]LL_WY?<-6I<TE6*\^%2OU<:ONRP7'2:Y2$_KE-#<!
MGV8Q8$AP$_\E.$V1W3OPNO]PKL&YL4YC;U09''4LCOZP-D>5T9ZBJ&=!=Z.C
MD%".S$07HCC@XI0;-&$O4IUI<^*+56X('%^T<GQNH.3,7O/JXZK<;JH=D:]%
M^3_7/XIRD>!8,,ACD.B$ :0HLV%.#'B<X)P@K#/D%>;T-38WGNEHKAV,C?ZP
MIGJR2R_$;LP2"KB166409OZ2,@Y@!!65Z6MO6ED9!\^/A&5<GAEX:;-8%5OU
MR;Q:/@N%RE]^?F;_O;:'IV59?<]3*+G(20XT50(@NUCB1&&0"9TKA;!*L5<A
M28^VY\8LM>F@LOTH_B]MLF-E?U0Y,(AQ?#K&C8!&@GMD/@J*M/_=3G_,@M[N
M]&A^VON=_K@<W? <\(I+%>E[VGRF7)ZPC)KPB "=V'NA3!- B10@RQ'-$H0S
MQME0-7IG*WR&X>1*](4TLU"ABRJE>S\L:UVM*SLN[ZMQ*6PG#E6;=^\O-PH<
MN0]&IL*NROP96IQ&7MX;Q'&DY=W->"59>6^<3DO*^[]J(&=61VZ_VA.W9CN7
MPH11SI6)^6RUGA1C0*F]YZLRJC G/$U3K^3HYRW,+<:K#8PJ"ST)[ @\1WJZ
M!)*QR:>#Q@@;W"==#TH91XU,2PBG?#P:[B<_Z"ERL=DNOFW9MCJ*^Z=:WV[8
MPUTAV+):-6"=QS%2RE;>0@"1C $F,0&2DB1#,D&Y"7%<I"_Z6IG;H.[:Y[4N
MZ\>R?WP'0VCD,>X#CKNPAHOS/:/</-\9X>9OST=W?P/3Z'"X^+A7YW#Z\-!I
M^]:^]=W:EE%?8)1D,4=FHB8PM^=,S/S$(.!FW".8$L20E^#XD[?/;60WQIG)
MJ;;/<[_E*7*N\_5 /$:?JUVA&#!/O^!RV#FZV\#$\_,+OAW/S2]]:-AHO7YD
MQ=)&[1_6FV]LJ9YFP335-VV%SG);R>8N&$4RQIJ;8<S-@$XX!)3% BA.1<I2
MS>,L]U%2\#7 :\Q/H*>PMS"R)OH->&_PW3AA3$A'/_IYDJ5W%>U] 7J] :7Q
MYBIRA-R;6(;B%I)[O&V8E)Z&(O2<P0:_9Q22.U0;_N=F79:_K3:JKDO\3\.O
MORCSQ5/?V8^%X3K"2,Y!1J!9K"0"@5P* C1.<IT0+CGW"F6"6#6W$*BR-3H8
M&UEK/?<NPG17$*X,WPFS(-!.,?47.^PJXI5OD7%N,G[UPWI"TG4T;$Y,[(>E
M)SU[OGS@,K)=GMYHJ_CR8;G^\U!EB24)3ACD /(\!8@I"!C2MNR"RC@GA#,A
MO5:5/8W-C6'WME9W'*S 466N2]DE?Z SC4E"$@8D$3% N:" YL*LX35+,84I
MRK/,\PPR$-33'#:^7:^DO9YO[]<U=I=/<0\(MN.*/Q" 8V\ #/^:^N\(.$ 2
M=(.@K[UI]PL</#_:/G!Y9AAIMR*/U^(_NZ(LJIN.7S;K#U8VXU>U_;@2ZWME
MRR$O4$IQG.<8,,KL-H+6@,<: YQ3)!'.>,:<=OZ]6YX;G1LCHTI6)%)-*3T_
M1G&'W(U>1@%R9*[9Z[]VC+ZRNG]1979DI0!KPZ.Z&'<XZO&&*R0/N3<^*2EY
M8_*<H?Q?,+!VUWIU^UUM[FU\^YEMF_BV6Y/DRZ98B>+!"GM8%9\/YBN[$,A$
M/32F ,>Q+?)%$Y!G'(%$:HDYBSG)H%],-,B.^05+YEN*/(M]#>H -R(;'=21
M2:TJ'V8=J*XN7T6-#S^O:F$T:VW 2F*7@!6TY-@@0Z:M378)5D=%S"YZV<"E
MM;T)S5EI-UCOK?I8I5W2W(_>;>_6&[N8KV3,.I(55L2B?/]#;411*F.44%_-
MUU7='.K_-=(6OZOB]FZKY+5A'7:KOBI[3&7^V:REJAASQY;6XV01)RF$DF2
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M/4G!$6@WE@@/W\BTT2)765P5,ZYLWM\[7:^BO=E!"VMYP!2XII9+RU.7T_)
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M1%FD$<XCR",JS4<D$61IIJ&4B+!<4IY*IX_(8\RY?6BUA*!H1 2&QQQ#FGR
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M04D)3C4F62;]#@6&2#$W_GM31X77J?;^W4F'S80CU8V-[]B$9^6'LE$ [#0
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M[B9+NV!@A5(%D>0)Q!H32+7K7("(0 E+#:,B)+_NU&!!K#]!^EQC9+==D?B
MKD@GD4T0TRA/7%T\22RR.H4LTP)B9J2AB##/-GC1D9W,??$(6;>RAL>"GT38
M;R&,A=OH;N)^)'=TWX0/"K$#'H^.-WFDXSG-GPMQ/'M->"C1+_?KE5S=\9M]
M8%+;+XV(3!'&!+2,D4.<*@*Y$@(65#)+% G*#?/+*#DY3LCS/DW:2)WMYD[
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MLP^]GTVG5W[R#C[-YLN1!AJ#XI)0B794ZA2(-0&9 "N95LH'FGO4_]VU.^&
MMX^#@^79"![>PGP\2S]/TTL\HD=92&2<":)4,'AVVDR<3I$$S;@V^ E)]PF(
M>XMW0H1H'Q&'2W1@2+RXFA=)O1HOHI_\-_CY-0_ %,V Q@VD0,>+)4-L%(D(
M*VU @ >O8A]GW([U.P%#M@N,7N3:B+GX,/?3Q;C(?F/R3%26,1F)%FCH)+-
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MGL8H/%&CB/:E.$6;0)Q(FK@LH[19AN#["%X?KML-  WG1H\2Y, @> _Q:HX
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MZD<'Q\+I0V\.TZVK=UUX,IY>(6\;7W V7?P$>58J\\OO??!?8/'K>#J;7[<
M7E<6W/^4G__G"G_\*RP_SO GG_%75N^E1\QS:GPHQER6YQXH?,N%)I$: 38+
M[DV5,.^$/ Z;R.K9E6L5&PW$&3<L;W;_3S"%/%Z.:!99!V<)B-+_FF:#X@9.
MHI&"LF!RXE4,\0YZADV$58'C<3)OHN3@-UC>B;"9#L$F9DCFTI;9;ISXK!+1
MN >B%\ZD6"6!>H^*83-?/0/E</DV8%E^]O,IVMC%6YBO>A7>%G=E%05/A7I>
M)G]E(%Y%A0("SY7D(6WK.WT\3G81U DRO7>3K0297J3>A'%YR,E/?C&.(V7
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MGX$ISI."X.M</7>F<-@KG HXJZ*:!C#WL(!QPT4 +VB14!3E*L!%1[P7BJ2
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MG3^Y$3V->IOP++OLTSNLEG[JJQD/-Y)X!7YY-<>SA3OG9;#$>RY+]T8,QT(
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M\L_U1:E3WBHA<6OK(F;T98DUSA K./7)99Y,E2"D"W'#&N#A0?0HF=*S/IM
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M)(HO J3%*Y1O*1[!6.W7TD,6G>#SO)5%0&M/RQ UJTQ);3E' M.*6,A!*1K
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MW@ZP>U@^,0I4&$--(I!B&<0)B3AA,[&):<XU!R]3!V.UWZH#Y@9/ :'*:FC
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M RX5,:&\/PQ:$!]#)$PFGG**7L4J+U*>I6RXR+8J)F8U%=0 XHYI8'Q;%)+
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M^.GXGZO/\]/TDU^,%[/\]LXJ]SE9C"\_3> 9 ]?A0W^\)?PA2YO/?@2F_IB
M+TN8)DC?'[>1[RY;:CV1OK3>'M-T=_'SO EH_>2FGO\6HIGKX,%)4EJ($ZE*
MYV:G*#$,N$G:*AVJO+OIA?IC;>%11-SF!#Z@1G^:E#[LE@K<\LH1JCDO,P 8
M"5DGW)LABLA2$CHV)\TMC P;&)\>V0^-[Z# Z/'ERF!F>Y,:KF*]KS_[Q$9\
M*TM-V7+ED@ ;-;%:)B(]MR2P1$FRS*''$)P.5;JD#FK+BZ^^TM;Y/6U]*$[Z
M2&BFL^":@*"E<".@1+BVA K+%)5>*:\[A$N[/O^O8";W <W=^*@7F3<0#UW[
MU:M:[W6\=_9EO!@Y&V4";4ABVA/IC"3.HMD60@J*,O%XJM383#OH&>Z6KQ]%
MS_J7>J/@6;\9@)>S2XS@1B;8;)W(Q*?RU%ID]$*,LQ@"&NN]H929*E'ULY0-
M:[MZT7\'3!VNC('3SK_Z"YA,/!KVXC,MX06*]5>X## ?Z:23\!)--"_#=K+-
M)*1DB7 QB^B<8]#EI<;N%=J#QA%JG/4NTX&14?),T_'RZ]]77FR9)+_A04F&
M\8XW1$2)>T<$0;P,FE 513#@!>>V RYV??ZP-UKU4-&+/!LXBVY\NVM1O8>+
MM:M7#*MA,=&0RIV(XB5KZ%$Z,I*L@^0B:95EE7/H2:J&>U%1Q:GI3P,MP&E-
M^V9S,:^DHT81HXTCDG%)+%>!4*^B\KFTX*_2KN(>%0/W!>M/NP]Q<["H!SZ*
M;DWF8F,SO0M)&G#$!TJ)!&I+>S1%+%IBEZC/7*L.9]"C#QY8]8<K:-:7M 94
M]6*^'+TK%9YKI(,2:!L%40"12!H,0:N82'(JH.LN=80N Q+Q0^^8 ?S70Q-P
M;]7A7BSU>E(<+LD6U+]!K1&""^703=9>%U/G$+!9EL:_)C@N0G!=SH+N !C2
M!!RAL8<Z/T!\ VO]5W2,+Z\N-X1+(YA+AA$E- *> 1JJ ))$H8/Q,6DJNUQN
M==+[O94'UOPA>IOU(<2AM>^_W"7<6:5+J;-"V!/I9"ES,8&$3"/&R&7F=)?9
M6-VT?W?E88*$WK1_L! ']NVVG'MO;KH 1AH]UQ$/.V^1#PR[2>F'1FA4/%//
M04$7-^^I-88I/>O]Q.]5E V$A;]=%2"?YW?P:39?^M5#[G48-"KMD)EFAKA4
M'ABFK$BP-A*>N>1)697JO#3>35)3ER8'JOQA@X]^Y#]XI_%K/E91]6K(U:?2
MJ@[2G2AIQ'*9@1LSFMI2ZL:@C!*2DE MLW*4.];I17&7M9I*11T'E2KB';H_
MS(:?]3FZ^'DROB@M&Y"Q#Q]AS5/)YK^=SR[F'N7&:,B9A4B"I,B:T91XJU0)
MM+,)2DD)SQ6B'+!L4U%J?R"J(?2AO9M-#N_%[#*,IRMY[<NM!&.T#AC\\>(6
MHE^(C J-OIS*T7+%5*<AU\=3TI2G=#SJ3JR:9E*HI7-KJ<CY //+PH% 'A*Q
M.AKDP%/B2KL0ZY*6P)3@K NXMG_Z,)7UU0#3@P@;<*S+B*+EUU]A^;&,BRL/
M#E;3W?^<X@H?QY_>PCP6D5U@&")99EX'(DS6)0DE2! 6B"@Y8V&EP""SAI_=
MF<)AVOU4=;OK:*<!V.W5!A6H%C)'18!15ZJ8(_&.N_+$+B67DE*L2^I_^):V
MO?<$J@J^:CKJ#7^5ZLS?CR^FXSR.?KH\B[$\2Q]/+][BK\?RPOH>$YUJRY_^
MO%[KR?<@O:<:\L?+W-3XNFR!LNP1<DFB31(<;1+%DQ$_Q:8<,W]8,=93O\*=
M)!U=G?"4>&^?72@KC?,^$A4PKI4<*/J *9 <DLE>1&]-JL%X-_*&O=3N"2^/
MBAGZUTS[#V*>9+J6P1K < UEP+R2-'.C2U)!("!7MR\8U0$DRYCAC%GXM@S8
MO0<;JP__>KLY1+(I^BQQ-Y1J5,5**ZMLB2M-=3UUCN8J[#Y%5+/&:A]L/)I(
MU9<6&O#D?U_ >?YYL1Q?EI3O2!N9DU62Z*0SD5ZAPPG:$6JSM ']S<"J3-:^
M3\:P1<.54'.$I!O R69 \L,Y]0_ [Q5SX#PE;-6J%KPFEG*43\Z9.\H%I75,
M4!?JANV 4\L6]:Z7)D;@W69+'K+BHF56*$THV$BDI)J$B$960&:1.YZBJU*2
MOI.B8;O=5()5/_)O DJWW7<>;0LC6/":8<1B&8K)H81"F=:7,TC*E2^SI&I@
M:3=)P[:OJ02FGC30P"GX=C[[!//EUW)ML$2S6TSNIVV[A*)=E;'86A4YD8Q&
MXK5*A-) P2GO.-09X]61P&%[ZU?"617M-&'#?IG-TI_CR029>HUZFJXN,M>M
M-A_^>\WK*."1;X6@1"CE-JU##)6$*LF-=PR4J]+586]*A^W&7PF)=?75@"'<
M<MU^S0DMQ!>/@ 5;GJ>8TJ43)6B,T^"I19M>!7F[21JV^7XEB/6D@0:P]*;<
M2<&;TD_X<> 22RR<-=&,E:<3M P.CZ[,I5#!2(I>0Y?Z\;W!] 1-PW8@KX2F
MOG30 )S>P6>87D%IP7A=V;&:SW2U6,XN8?XH7\=%Q/W"B1;<$!E3(L$'10QS
M)N1D0.LJMUS[D=DMCTJ_,=155%430!Q/%U=S/XWP0'Y?1RP'FZ1QA :F2I88
M3704GB0,B#BCFEM?I>7?$S1U@]BWEJOO2PD-X.GU-.*N^."_/+YRB-DXR.@[
M9E&J1&AY7VCPGR@W:WR0JDIIURZ"NB'I6\O?]R+^@>M&D7I8_(2'?#J?OIW#
MY?CJ\M%QKQ6G)G)T%QD&(3*")^5&BZ!QM3KXE )_8)JV%I%V6*H;3KZ5C'P-
M^3:1?,"CN90ISE>:>3=>_/$"J1@ORU<C+J7GRE!BI;=$)J9)H$X0ORI.HR$(
M5R7/]01-W5#UK27D^U+"X$^X"L6E\?GOR,]\Z<?3Y7A+R$%UY)9Z8D0H[V:E
M+F\FRQ-*+D#H<M70Y0E7E[6ZP>5;2;E7D7 35N@W^/..K.:S*7X9UUU)U[P]
M.I85B"3!$,YY1@[Q#\M"(LY'R9.S-IDJ+O:^A'8#X+>6BZ^JK@:<\9M!Y[^"
M+TV[;Z\9'C*6(P3#O",Q25K<0SSO)1KKH&24UB++4.7"NC.%W0#XK:7@ZRCH
MFZY]7_4CZ+V@=/.IIRLGW<9&_6)2&UE@Q3XY8221GG(2/$V$&LW1:S="A6^L
MF/1]_ CIJDR)V5Y$M)+S[3:!K*F')$A6"HH )&Z3H(CEWLM@38B^2BI^/S*;
M+3C=!S^/JN/K::J!H_26NW> PAK'):0=?-ZR*"U8;@-QM$B39<"O4)K<9J>]
M22K7B3L/H+798M9^$%E'9TW!<B/#Q6^S)2S>S/QT<7?>[VUUTYW!+6!T-($1
MD* P(M>TW%18PEA$8*F<DZC3^/1PFINMCNT'IG5UV !<<1_"_#,LUBU^('V8
MG2\_POSL J;WWU %E3(+)>O(4)321T>\8(F8H+113 :C*ET]=2.PV7K:8X!8
M13L#7R:\O[J\]//Q/R%M4MV;Z]P'WH@T.5IKT!%1',6FK"#!@2SUPT%KY(V&
M+L-'NZW6;/WL(>"I).1O.H8MWL4##\-/TWTGY/ Q8KTM?;IH^&"!G.#]9<R"
M,6<(HPY!*64DKI39,DIU,)DZ]7"T1.LA\W87]VSYPL_G7W&]5<)I%!G89#T0
ME<L 5ZXT"5(#\>"CS9(96^=902?JF@V0]T%+MU=0Q^CEB G?R[[\N2?CJI'A
M&EU0M/$0LR$2@R?B,88B2LL<0I0ZQ"H)J><(:S;>/09@O6JC@6AARZGQB,7[
MW[C+; I>T^P8"4$R(IW0Q"N);/,8HE,0:)U7PD=1W6R >ZSA.XT>6Q\*_J23
M=);2:OB3G[R>YMG\\LAILX>O=3J_L#O+]1U!"=D8'0!QS2V1& AA&"0#@BTQ
MK3FU4E5IJ'.*NY.=C\[6W;\-3S;&% C*H,3S2A(OJ2-1)<LQO*=&5C&570EL
MUAW<!S.[TWX]:J>!4_MF(N_K*4KIJO"Q&C 2@S+< Q F;6E:20TI?;L1%LDH
MK9R)O,IMR YZ!AZ[5$7Y#ZL+>M!$ X#Z,/?3!:Y<DN'O8?YY7)+A=R8_WW*W
M^( ?N=C^H\V$JR1"L'B.$);+L O#',&H*A+NG<*XRRKA90T4]LG$L-#M!56S
M1E0\='8:28_+*UST/<2K^;@405X/4+/*N< HB8:7C9]%.5HL$3EK,#89ZKN,
MPMV]PK H&D[CL][%W\( L_46!*8PD#>D/.= HL$1QUP@E'O.@Y2"N=X&&>TW
MOZY:*J7J07JX=%N Q ;)@?H4E<U$T.")M!J]U:AMN;O3-+%HG>ERXGV+,^WV
MTMB.F7;[B&_HJ6;WQ['E55(/PQ)+,_X1) E92"(D$S;GF%3H$L]^JS/M]M+;
M[IEV>PAQ:.W?'\<68M0<-(%<.F Y$8GW)A"3$_IAFM(<^IMHV-Y,NX.U?[ 0
M!];^S0CG7Z!,"OGT<1S]9#W8TTAK&=H_Q\M81A$CL9%*8H)TX!EZ2+I+W-T)
M"3NI&#:O7=U)Z$?Z0T-H/6WM+@L;_]KB.6HEQ>WC-$/9)+2"2!_1$KUDEDTV
MIK>YR#NI&.Y8Z4F[L[Y%/2!>5AG1^=?1VW>C*$(*LHR.9$4&I55!0-M(.+,Z
MT&"4V];1>7&-C@7$'RYFGW_<?.(:()M_/,3'[:H#@J$?U<V.DF,#6;G?IU>+
M*S\YG[^>YCG\SQ7*I(P#66T+QJ70)E/B<^E?%S(K@QL#\1JLBV"M9U6N4IZ@
M:=B"S9.D>_O22+O@VFRT+#(PRY&%XH_+$"AQU#)B4_9)BBR\JG*3\"15PZ;3
M>M-]-TP=H(B!,ZTOSO_S]4OF-HX]X\ISR0PI7V!XP#D)46?"LU#,9$F%ZC)#
M\]Z'-@F 0Q0UZT-J _NR;\;+\<5*^"_\8IT,<JQ4,&>'VR"5>#[H4MSL26:)
MVR25-+[+)7<G)_;Q\L/6?%</@(Z4=U-H*?<-FWUC%%4962?9A6(Z 9T[)2,I
MX])MR!ZL[RUVWD7$<*[NL4K=B8\#)3SP$?(KT@LO9I>75]/Q\NMZ-.?YIU5/
MT\\__([?@[2>27UM+K,#'DOBB$5=-A3N)8M>?5(9PP3FD$_7X9#9<]E6X'*H
MCF>G$?C %@?-<+J*R_/Y^NYSO;FXI1)MK"(I,]Q<RI7V#@#$J4B#3J4%1)>2
M_$[69AL!P_9;KWY&'2WS-C!S>V,.U_??:(8#<F^(L:4PUN$6"%2BBV:294H8
MHUS?P'E,Q7"&YWC%/D;)D5(>^JB"-"YEN.N_QZGLI&LK&4QI*4H-T:LJZNP\
M1H*B#$3,CG$NE7C8(F/[L;1[B<&1<*SR9OU+LH&DRMUI\JM7FM>E+@+/WQ1+
M*SXIRHNC4NH2$Q%1!.,<6,JKC#[>0<]P%XC]HJ=/L3=A3L9I0SD5-H WBHA<
MYN&D@ >P=X$H$X!3%7GHU/CP_J<.<T-8TV@<)*\&[,1.]^O-S<AO91PH*=#[
M2CX4<6 8B%X^T5)+$UP6,9YV<M -:<-.:CE)GK]G_0QL6VZ'N"U^]<M2A/GU
M+<S'LS0*BMILHRF-]1S*"-VX8*4LKQ6U$=F+\/ 6::N9V;G L G;OK4XZUND
M[>#B[#/,_04\X(4I8)PF6DPRAOR&9^(\&!*"59Z[@/]C^\%CZSK#EK>>!B7'
M"[B!8^OU%#\+.;IMDS3*TH/RH8R!!'2Q0HS$I^A(=DXX;UFPV=4XIAZ3,FS]
M4R44]23Y!K#S:ERRB6_&G^'A*+3?%Y"O)F_&&48R>A5LS 02"@8/Z41<<ID(
MIZT0TE$059X.=2%NV/*&ROCJ73L-(.[U-,[+(*N7L/[[]<THACN[R.!_ETV(
M)$:AUT,[;+*!<"$$C5IA5%&E"UH7XH:]T*QNT7K6SA&=6BY\:<76WR"[61G'
MMWK.#-/X]:6_Q)-_<?:G1XVE=0L:EJ-C/BN2\/@G,@9+O/;H*@KO-4:ORLLJ
MHWJ>)VW8&XK*H.M9,P/[[V<YHS[*1BFIK[.XW.R@]TL?QI/Q/U=:0XE>S/UE
M&09QEO[OU6:8M_^ZVE\V*:E]UB3Z\J#4*5L:JP<2>%!,90R7:9?X[VA"ADTI
M5(P 3JNB;Q:/=TP^ BOQ7.8_:(.2]A)-OA:K$<T^XWF015)5(;GG^5MM7FR3
MJ#Q04=\L,'^#FXVXBK>LQ./ 9O1^4?3$R>2(84EQ$ZFWKJZMO*5EV-&S30+S
M0$4-#,RW,"_3O- ).<]W&S7%]9P2/]ET>?W9SZ>01M3FD**G1,FDB 3MB 7&
MB656>&Y"=@_[)VV%X'ZK#CQRMB+:*DJ_B5%9N'D^^7&Z,_KT.L0:>6%BYE80
MFFU)'@5.?'E-8R2S2;,,3%9I3+^;I(''SE8./'I211-9E0T#Z K,$*UC0,D(
M%T2$0))C#%FPC 3 ,%VYG 0'R"Y5N:O<0LO ,V>K)TV.$WX#^+FS!39,E$/[
MU6S^^[3LD!<3/[XL=0*;+VX.^,7(@&5 O2#9I,*HTKA1# HN:@L&)+>Y2@N]
M@RD>>*YM92R>1I$-(/9Q7O)L,IG]61A';E_.KL(R7TVN!XN4HB.!>RYBP%ZF
MTP/-&!=%3P2W*29+E:=5NIWO1^; TW'K'[>U5#9PQ'!;ZG9S%KP">#->Q4?+
MKR-%A9+21L)M3*6>BA'/&9X&D5JNJ4(YY@XAPC/+##PLMV),T*=\O^D!&[=;
M9U&I0?*6%4[7%ODY]NHW0U88-V8%B%#.*)%,9O3;%&(J99\3I=+'*M,A3M$,
MN?.4K57"ILPM-]QI8JD'W*NEOEM8(%EB?.V5YMY6F6!P(+W-MDK>!U$]3$C;
M6W<-^')=F?OIZQU&\;/7K6@D<XJA7Q"B#&LA>R^ 4 X.@K'<\BH3G(\ANI4>
MS!51-1M(Q0W ^3X'FY)Z#*&$4(H3)4I?56,\\4PP0A-/TLID$ZM26["-F"9L
MY0F@\"@V/E(O T<9OY1P?GK_PN_Z25:9>6D9[DW#-)XRHCSX*_,P,WBN4K+1
MY2Y/4YY88EC0'*^[6?^"'/J>ZJ.?7_J(VR3X)3QF13%#,RA-N/2LW  ;XI0R
MQ/@@O$M"<M'E'?XSRPQ;)]XK+OH4:!,9B56T#'.,E=_!^#)<X2=O1[T2Z(ZJ
M& @P_$-&AYPE:XAE&7(&EO&@[YR@Z+KJL+7AO2*GHK@'!M)J$NYC#AA*A#/)
MT2Y:Y$!J25QDC+" F%!(0PI=&DEM__1AB[I[!48/XANZ@=BLI)26J]J/QXSD
M*$7@5I$H:#DN<R3!H%P$?NF]=<))T0$'3RXR;,5UKW#H3Y@-Q#GW''GTX5>^
M_"U7MVE?09/SZ#@1XS*B/0,EUCM)&#4\VZ# FBIU#5T);&62PT#A>%^J:P"2
M=_;4;[!\<34O"AA1QZF![(CA*9=NQ;A; QZ\%,#K,J/'UWG M)6:AH+OWA2_
M,] ^5 O?]"7-V>5*Q"^OX,/L-M0\*X\;QM7N;;HM>L()E_L+H?[M3G B&\54
MF8Z@RJ@N0;PH?S@MHM%,N_2-C+I<U>4^*>*;QCWKPMP;&0#3HO3E(-E1AQL;
MW8U '1#E0N+&.FUIE[OH@Q9OPO8="XQ[I='55=!$!YS)=>G&S97[YOO%CWTQ
M6RP7'Q JBX^S21I1T%88[P@/M(PMCIFXTA<^TY"\"2F@/#O@:^^%A\'6B4#P
MJ,=.+8T,_2:DDRA70?4(P/!@M2:>>K5^@^4<NA<J>B<\1F@^=GJ3U'W)8>*$
MTT.LEA:^ 7"59F7WA2B%$CIQ1ZQ$CU4&A@R6)E91)- RAHRG14\P>[3XL('I
M0.?E<2IH&F/W7T=A^/76SY<ORW???_1S%/0(;**6.4-4\,BJMYJX&"01P'44
M*@4P7>YLCB2C[;/T2(!TAF._VFH:F/>[?4[*B_QW1=^%Z?DLCY<;CF^=BJBT
M93%'8BPMV2<T^4Y[09P,.?I<#IB^3M\]R&K[A#X5<.MJLX4+J0?R'&5EG,E,
MENE3*$=77I>6VA!G6(X9@N/0Y1IBVV</<TMY>D@=+=>V#9R?_P'+3Q,?'PG,
M@*%1E=2FM^5E,@W$HG]#F*5,6"HD^CK'6[*=ZP]["WYZ'Z\?130#MN6SCL-(
M",$X ^1+K9I/@B96>T:,US$X8[C7^QV5SZ_9K /7D_:WPJUG530#L6<$^?"4
MOSW5L^8LZF@)=4F4UG",!"T%R5Z7ZG-';3!]6K:=E#3KEM6$XTG4U@Q(MVV^
M=88HHJ\ 26%4%/ PD<( NB80\3#)@4M&4[:=6K0\OU2SKMJIK=[^@F\&1]OD
M]]/58CR%TB3N,HRG*X6.G+3)&RE)-!(%AX$VL4);PE%BP&7DKE,7Y+T7'J8V
MK4%3=JQ2FKK8NKE%63&[8O'KR"@-(:*+(#3C1,:<B.4J$2%Y0M<!(D]=(/;\
M2L/6.U8( 7H6[N%0F2WQA!VV&N2ZO&N6-^+8]"^J5 ?RW'*GJP#9B_'ZM1],
M%-<)'*%X'!*9$&M>)T8X5];IS&F@5=ZSGN)E[T:RBU>XN7]&2<ZG?O("8Y[9
M)=K*5977]&+51GK5/'JQKA^TS B762(YL-5X9$\<<YDDFK3@'(,A7OF![R%D
M-UM"L@^^=K_SK:[)!HHT5[,KBRMQ[4*\AXOU.(;RPH\RJJE'$=*(CH04Z$AX
M91D!9GB.BG+[T+'K"99/4=7*@]WZ\'B(S-YTU0+PUK1O:O@=:"9SM@3,JG*!
M.N*"6#DDH!6(@!NZ"M#N4C$PL/K3[D/<'"SJ)A[.W9UVZ+2VG+M()&49@QJD
MV^DR.RA:E4$&_&&7+-JC#QY8]8<KZ-&[MT.E-?!<V1OT_P(E8/[TL<0LZVG?
MVB2@CA)0"IEP@6,<ZQTQ(D  Q9FC7<Z@3G-E=U+1RJN4DYTY_>ED:&"M]]9=
M%C;[3#@0U&1#<BG&DU*5U^7<$C2EU%G-D^-=!C-U ]8N*H8;4]N3=F=]BWI(
MO"P_S4<OSD9"19>DH.4Q* K EL;M">TFGK@4S]D8E=G2H'!Q#8T%Q!\N9I]_
M+!^']#&[^HJ4K^["8KW8@ #H1UVSPV4WM*I?O1D! ^<E'K8J2EX>0DD\(J,B
M+,24@PCH7(E^5/WJS7!#A2NH>D_9#:WJUV]&V7H:DLA$9 %$*A&(,ZJ\Z 6:
MG E.*]V/JE]W4W650<(55+VG[(96]7_\]\A8:9TTE"C-T/M59=0!"/2C993&
M2!ZRWO+(]!!5_\=_#W-A4$G5>\IN:%7_^GH4I?: !PMAN1@A7EY>1TL)=\Q$
M)5U&+OI1]:^OAVE^4$G5>\IN:%6?_WU$,U,J1?2M199E>C#ZI91R$FVYT\2@
M%E)/N_K\[\,,>:NDZCUE-[2J/_S7R.84;5*>*,,=(C,DXJ7U1"@=M/;.F-R3
M6_;AOX89K59)U7O*;FA5_^-LY*6R2K@RI3?:,@[<$Y<P[L2#AH?H?,QA2Y??
M0U3]CV[!5N_SRBJI>D_9M?!4X%ZJH0PUW20JHU4LRB!)#+[T# <@P09!P&30
M5!ET,SL_&=BQQC 3P?I7?:^R;&((TYXYS3<W;5&8L8$FKXC7I98JADP"2YX$
M&L!XIG.N,T?B4(*'?5TPX,7E233<P)WF=1^ ]3BTWZ \ $I6<16)L!SCYIQ*
M7RAM2)0R1RJ,MZ%*I^%'E S=,?84 -@QXN0P;31Q]5D:2)S/+_QT,]AQ(\?;
ML7RC ."LB8Q$MF()]Z:/Z! PIR4&=3Q%Z/(BON-R0_>7/2&*:BFA]6Y:N$]>
M3_%?A;_R-/5!L5*GHLC'G]%KI>,S)/94OEC,QGAZL;A>Y*:X+!F,KIQ$];(R
M28)E12Q3@ACC='FCJ07K<F^XMTW?1="QI];#S_V  OP)?^&/$<TR"DM+6M\)
MY)0Q_"I1PJ.)FEN(6E<9Y["3HF%/L5X0\?"4ZD?Z/3KRI[(K*[?RD)+K79]4
MU\9L([>VI5$0O'#&DNQ6CT6<(=ZITI*6&26],RE6F>=8R]+<AB /5_C)+\81
MC_"7X\G5$M)*V+<[@6/@H4&4D)9&#&DQ8G96)<(PL#5))VG=EIN[/JNC]Z*W
M42NU#YIV%T77T]PW:,,.?S>R\Z/J6K&:[SUV L]*PUE4C&B,LH@$Q%Q@U) @
M !UGX2%NJ[%HUXS=2+6\%[Y]<Y"#H1J0-\TP" @\$LNC(@9\T"H8'A^6IO;#
MY59J&C5!^R#AH0DZ7NH-9(CN,3%2$N-/FR*AR:"'I_X?>V_:Y%:.HPO_(MS+
M??E8Y5K&$2Z[PG:_'?-)P06T-9V6?"6EJSV__@65>Z8RK2,=ZE UTXO#JX3E
M(0B 6)RAD)2<1V19::T-CX_G-C6 S+10&4&K+^%DD(@[P,<_<?[I,UVC/]5E
MT9_P[65-Z;\KVU.T?G>Y66_"(M/1NI54,:$N23*0ZF@"Y62&Z$4 I"B!Y:A"
ML$TZ=(82.FWFJ(E!:JJK#K#XA)&9M,8480L8Y^HX*^+"VR A4Y@;4] 92Y,'
MER>43&NSVBK^L>=]E!8Z@-&^TKH.('Z9K]/%LNYNVN9N[]K?8[2ESDSF:(EK
M@0Z"+ADD$ZH.=^36-'$BQR%_6O-W4L!.H.\NGK%?Y/O5\LN7Y>+#AF+B#Y?Q
MOS!M/B[?X]?+5?H<UOAN]:JN4;^XN)K<D7G0WB8$YJVB ZX"N"P3L:X-N3*V
MV-(DP3P:!^=AGL<$X) ST P+PX^!OSH&"_P4:NYFE)?+G;POKWF_21EAKMNW
M<+&^XK(H]"(9#U+5V;V,;C,7,8,7*FN!*NKTJ+)SYROF 5]]'H:Y 51/H:K>
MO8_7Z_4EYFT&<U90<6-Y "%8J8.9"@2&"-P$JXS63*HF.>9]"9RV>*AWFWJH
M)B>N\GCQ %[Q]&JYH#]<DY[I]W$Q7ZZVZ\)F.E/(6CR#++(%)3FC<Y@#(2P4
MPXK3*NS3"7\X!=,.RNK9<HZGN-X-Z#U!7YV]^N*M!2<I\H*@3(X07"R04[$A
M,0P^B"FCM/U-:;,=IKV;TJ-TV@%@MW*;?\,/F"Y7\\V#$7H!M<E(Z#&&CIZ-
M'+Q6!HP7/@4EI35-ILP\3])YW.JCY 5&TDL'"'N]2*OMY(1P<1W+;07VTV:S
MFL?+S?8%?'GG/O\9OF]G=:Y68?%I^^_6,W1)E* MR.V,%^,LQ+#=$T"_=@IC
M<4TJJXXG?=K8?BP0+2?5:!?YJKUX?A4N+MY]K=JM!;;_#)5C8M8P8XHA%UMR
MX<@..$^7#S'K<^%T25A#_LUD\-U-\[2!_I2X'4&'YV)T[WSN=^47C)L[<<\T
M&A^3X<"$K-6444!0J$$8SKS0SJ(ITT'V6;JG=1 FA>TXNNP NL^X6=<._M,'
MOJ R<2 +\*CH*K%"@Q.%0<F.D\RYB?F43UW/T3EM J 1-%OJ:K31V>/5Z#VJ
MWKP5H<F:9>TYI.VV4AT51)T"^,2M=-$4J9LLY]Z3OFFM8I-JDA::Z<#V[62K
MEB+3_R09<,\""2HX"(S0H(UD2D8=F3P=O/JJE1Q%[_M@:Y 2.D32M8!FT@MA
MD&?@MJY+S,) +-R#E%&1CQ!2#DV*DIZAIZ]"MU.@Z1!%=("G'[0T_/S]RC5]
M=1'6URWPEIR*'$T"J71M\Y(1G#?$I8PIN)R8X6W*WX92.JUGUN1Z;*NM#N!8
M0YS7"Y+4Y3:U5.>P6NMXB;& 2*+4 Z7 1V> :RQ.IVARV3$99X1T]1-2>AFY
MWT3WC_/4QRFB.RB]#5_P>MX,9EVL#!K(]-? 2,0Z&L: J[8YJ)A]:9(#>8Z@
MB7/)1RKZ1=P<*/6)ZQ&N<BZ;.9VA>T_6UX.%(AT:E"5#%((.E:9+/N9$-MPG
M95AF/JM'YFAGQ<%+W]$3( [5X+*!.#LP*CM-[YO;$1LBI\R1J[J0(M058@8"
MKR,P@N?29FOH_R>+Z-X,FKAT@K']I[BW1E30U%:H"N1=N7ZI>+=Z7U-RVW'U
M^?6"O@+7F_?TBQG17V2H4\954/0#LEJ%F("7*BPZ3,'O99#V^[H.TP0':G?9
M5M2]3[C9L2SSD [NG1\S:O?VCPD=J7-[UQ?=]6+RPJWW 5(4N0X)+N039;^=
M[\^=E.C]CJF[QUOVEX@Z]C+;\=EW=59WTPNBD;9DGR%QR4&QZ&OQ/86N1AHM
MC4C.-*EFVX^\:0W2:)AY?(\UT$W_DR5V2?/@ 3DO?%AS^]1P3,[+B'-91Q,S
M6!-J91HGOUH7 0&Y+!HYVC8+Y%I:J3O_\>9;?DK_[W*^GF^_Y>?O]WYU=RZ"
M*"PXI%.7Z]IG@X*\1T&>@,'$8D A;).DT2'$]FS!!N#I^5QE([UU$ [>\;CE
MA@CX;;Z8;W [?Y%<Q[#X5,/>JTF,/W__(_S7<G45Z-Q9<.^<+AY!NU*?SC4C
MZ1H.(2FE@Y7,AB9MCL>3/FU8>0+<GD2GYQ@GO*V!4BT[.7SRTUX?V_R>?IF1
M4]S83C!O!.>0ZWIFI6( 7W@"])8+;7/MC/D[W]C;A(^6(J+,B0Z(IKC=1(JK
MBPI0)*ILI;=9-,G(#R6TXYMZ"(Z.N:D'ZZN#6WH'5]MWCL2TXD0R*"GHAT+!
M4W": U?2I\AS8:K)2_8S]/3RO-@"!,]$M\=HI%-@7?D,-V\FH5:8E&B!"9&(
MH5I9;FT$::/%D(4RI<F#P \IZ\.4':7_/3!UN#(F3O[_$3[5X1>+.G3@ C=8
MIZ]?OY@QXQ(SAHR\M+5S%C7XG!GH[',1R)QU/W*^7OZ&_J!QA!J7H\MT8F3\
M29'&U^5J<[?G_/4B7;/!(Y>Z/LYZ29Y G41!DG$.B@DLA51<P; '-%[XBCYB
MOO&Q,994)P;'?RXO5Q76N]@0QB:?@@.#TH!*]555^@R,PE$I&"K!]MDN]<)7
M3%N/W@X<8TFU X_E=MWYC;2NUW*MM]=O,$[EP!Q8RR(HG@JX' RDXC4W.636
M9J?#BU3U4KUP K=X/.WT +4KVJ_/GBB>Z-,*DDC5O9.9SIY'<)&B5%-*4 F;
M0.L^%1-'6.-I]S%N#A9U%_N=JD6]J0=C7 :!-H/-SM<PH$#,,8-ATJJ<6&#>
M[W%+/?G@B55_N(*>+&(Z5%H=F(0=)O3-;?%.]"5@L@6*9X)N4H80O(_ M41N
M8DRR3;_G2T3ULJMPFI3,8;J9V*3LR)+>M*_N2J#.+$8>;:X[1WDANVMB?:LI
MA!+I<HR6G$:]A\$9^+7=Q=@'ZGIY&L%W8+ONR>K5<KVA"]N:%)APD%UM'-0R
MD>=/[K^D8V<\(M*-WL)>/2:DNY#\."B-(N\.\/(KD;_Y_@=N/B_SZ\4W7&^J
M!_#NKP5]P^?YUWM[$U,M'F4^09;"UGV<#&)R$M!+QPP::W.3_1=[4]A=7#\.
MPMIHJ /H70]F6G]<7B= ;D2(Z[>X>5=>A?7GF]J&F36R6"8":-0,5#8*@M0&
M(KH8,Y?)I28Q_Q BI^WD; ; 9GKJ!X._+5>OEHO-?/&)?D$_6\])5]=%'"'.
M+^@ 7AV].E\O;>;?KD;;A.0XQ3$%- LU&"8'(>@DZY1'P95*RJ<FDQ&.HGK:
M@9JM47H"378 VQV>Z@->/ZXH^+ZBC,]R(/%9U&!RK+UKF4XC3PF4B]8F59*,
M34SG$"+W J4Y.U VTU,'&'SA6OA]5;=YD2]2>-$4.9DH0=5;P#&7@ G4TAC4
MKDU'_(\(VPMK]NRP-JH^.L#7[K/SHF6?!1E\R36S%*('%6HKBS0.?)(4DAD1
M5&JR%^  6O="H3L[%+;66@? O)V\7!]*UJ\7__P\3Y]_)1XWW]]]K<R1/Y$+
M=\5Y#]H&<H.#4'7@-X.B=?3*>5="DWK9/6C;"WC^[( WME;ZS0]?/:JL?[V8
M;RO\R>/]^/GZT;\^__^Y6GY:A2K-E$1.P8 Q.M9CE>NKBZ"S5:Q#KYT.C[9-
M#DT9[TG)?EED=C:0FT _'9B]'6)\C]]P<8GOL=8D8;Y^ZB'2KLX=<?XFK#<_
M+1:7X>)/7,V7>>9065NWO""KD[<+DM6WP@$GS&$,,88V'6^C4+\?D,_G/60Z
MU?:)YS6=3>+L2[CF?J:<R!PQ@K.9CB@S'%PI 9@R.EL=!=TF)T+K8]KVP^+Y
M/:B,K9;.D?9P 7:TG.X!82 S0X++=5];(A91%G).-#K=9FCAWA3NA[KS>V1I
MHZ+^?,C?E\O\U_SBXA?,EVES[9Y<<?<Q_/O/R]77Y1K7]]Z4D'QBSNJ0HXQD
MU!W631FYCCORC$<O<C[4B1Q*RG[0.Y_GE2DTU($QO.%O)A66[4XL74>T*180
M?#02R+07YA"YBTU&U=P0L!^>SN\AY" !GV-[]X?++U_":O[?N-Y\IJ@*+^9?
MZ(]6W_^_<'&)ZV6AW[WJ?@_7KFM8Y)ND4]U L%Y??J'?W-#?^R5L<%GNJ6+<
MCO%34-J\"?WDXCY%7SO=YEH&R2"4G.F,% $QT9'3FHZ(3Y9YSULZ7%WTM<NL
MN1)"D2-#WHSRUD!0)H()!H5@5NCXOWWMX^'HZ+[V(?KJX,9_KHM6A'J7U1'T
MRI'CHLAG<9:XBKFXZ#+7V36= G7>?>V#0+!G7_L0C70*K(>M=)P\GUB*!LQU
MTJ:B'R+6A+^PC YIEM:?JEC_'/K:!^E_<%_[$&7TT_!SW1-SW<GB;(R"(P>,
M=5N5RB0<# 54+-*'G'-\_*[WH[Z?!Y_?'RR.4.'NEJ##Y=FGQ;D+VNHB9_2,
MKO]0*-ZJXRZCX0:L<<P5EJ-LZTL>W!G43U?JR)?:8;J9V/9<!5$WSRVW'J;'
MC,XF 44F0^<#Z>BYPB%8Y[P.2K*4]K \NS^].[MSH.:6HXJQ(X-S+^AXCVGY
M:4%Q>'Z=2;CS,@^W<_YNV=T5>F_KM!>Y]A-\"Q>U5&RFD''GZFL=$T@21C*_
MTB807!@9+*=;O^EK;!NVID'S6*#[<4'55 CXNYV'RU75Y]7?_".L_H7;9;;W
M5M?ZQ((44H/0/H%"%2FJ-QYD=,RK8C1Y0]T?CQ]Q.8V+< ZG951\_)T/#WT*
MDD6IP\1GEA<3O E@?52UDZ*N>\Y(+EP42GHOC#C5!H+1F9NFP_#<CLJA:/@[
MGY _5_@US/.O__Z*BS72WW^W^8RKJS^;&6N8+,Z1\:@MYH7T&3(C6T*ACTP*
M91&G&H??GMMIFB3/[0R-AI>_V:'Z<[7\BJO-]YI*VER[LE]K/FFF7 S,UW86
M5[!N://U!<9"](4I)4*R)YM0/3YWT_1LGL&A&0</?[-#\GCZ_]9V?/P<;FN+
M9DIASM$)$"+6/&[@X%%(*(G"OBPPQC9KN$_*Y30]I6=P:,;%1P>'YY9NCUR)
M[ AWTI.$/6H(QCK(D0EN/3?^<9)T@IJRT5M+&T'N(*GV5_)Z\#%YCR3$>=IN
M5[P9NS+3/J8<BZ0(1E/(;X0 1T>E;DF7&(15:!]UF.Y;#SLJG=-TEXX,Q.X4
MVH&I&U,>6[O_=KE(]R./F14LQX09T)>Z/;3VY5IK0407.+E1&%/WT>A.SJ9I
M?#T#?^!X'$QL]9^R="OC@-KE(CT!CB( 94L"+RQY,MG:3.(W:/=Y-GW^&SJ>
M:W?HT^E(XOP;N0+7N9E[?_ 'YGD*%Z\NPOS+FO[-S[C ,M^L_PS?MY4,GLN<
MDJECA.H.YF0UT-&FNR7PHJ6*+D9Q8C]A,!/3O:..A<!&CD1;. P_-_[JW"SP
M4]T%_O$,CL]/7Y:7B\WZETO\??D-5XOJBOWT"1>I/JM9&YT**0#+=4R#-AY\
M)!5[&:,.3GG)]ED5/QT'TSVIGMW!&0T(_R-.34I;:5U;%?I7]#NK2[S_CV="
MQ3JSCH$(JIH::4G/4M8MM4IHHY73IXY0#^-DNM?6\SM%8P-C^M/4(M#YY9J3
MC^'?]P6#%(61F4F 6=7!%74P&NF3Y(2)'&8O252]1[R[69ONL77D(]0I&L[^
MF-SD>'<*Z"UN9ABD$B)$T+R8.C208L@4%4B5E&/6JF2:+,1IQ,]T#ZE]'8A1
M]7YXH+_<A(MIFL<?OX&-V_#]W*<W;]+>BZU3-%:CS\(*X0%)VZ (X1"1*]"!
M:RF4T44U&8W=LK'ZM_EBOL$W\V]/GU!O+QIRP5:;G:M$KCI<'%J.07!@6M+M
M8NA<^9(E\*ATX>BD*$VRZR/0WD>3R-%H>VQ!3ZW5#AZ17F#YY^]_A/]:KEY=
MA/75PC>#S*!$<H*X<Z!BIA@\T2\%<::Y4Z7$)@[  !JG!>;)\;,_?H]29M\X
MO6/L;?ARTY[J$JN/9A:")/=)6>WK?F1=S0 +(5E53)-Q?0/I[!:OQ^%E?UP>
MK;P.L%FG6M>[YS)<O)]_^KRYV77H4_(J2PF61P3EDJ*C;#-(X3T7G NF10L,
M/D-/MU@['@/+\14R]=+TU?);G8]. =A?R]6_;ABPQK-B$5*VKFZ#8! 2<DB>
M4VA84">T/XA1GOWP:5^O3P&/<>0Z,3 ^KD+&*HB;A:J:)Y=* JVW0RA=A,BR
M(.-L&#)N!/)]7L@>?>RT"]1.!89C9#DA#-:KS>P]206W%S-F]"EF<A-5=1A5
M0 C.$O,J<?(C%?F3^Q1PTX?>NV'H5X]OEP??VJVQ:.IG'R[X'M!R#7*,5G./
MF3RW6FJFD$#N-8(5MG ;9*83,RI>IO0^CM#88YT?(+Z)M?X''9,OEU]NYNLH
M'8VI.P9R8J"*#>"#LL"B08TH(Y?[S*392^\/OGEBS1^BM^480IQ:^^'?]P@7
MWOEH.8>BC*JC@35X<FT@VA ,^0+%J7UBD?VT?_^;I[DI1M/^P4+L("Z]N0M?
MN"[?W%:(,NF*E#+5NN-,R)84&XDH0.3L,DJ)^YF'P<'J$"*[]4I/DMUKILX.
MH-JFIXUN?,TURD+GE.E:Z*(B!.$49&DQV*0C]]V/;;G'S[0IG'8 /$F'XS T
M=' HGI?S/]98+B_>S O.DC%*V>+ J+JN-FD.H3BDB\DAIRM.(6LRUW0?XJ:-
M$D\&U]'U=##VON$J+MN_N+S'FG:I:Y._+%>;^7]O57JU^HG/;.1);5M$M12@
MO#3;_ G$X+2W1CEEFBS>/)#>:7V*#C ZGC9[WQSQ6YBOMBL*_L"POESA=D?N
M 64^NS]GU(*>/4@=J73G]IM^F:_3Q;)^V5TQ18G:*J\4,(\(RJ9"L0[S($3*
M01I!?]YD.,1+1!UMUW9\]D<2YL_TE_XU<RPG;:,"[BG.NYKCEE.M>)-14-SH
M6)MQ&"]2-?'+W5@(>6*31M/$B!?F*6W/QZM1<B-9H(_W!M,UM4.[R#Z%-1))
M\I2R!5F, Z5B;?\Q=7]Y8H;N(19X&U?W%-;H^GGK2LSY70UX+E<KNI5_#NOY
MO6-!=VXH0CIPM3]\.T8O:EX@ZV(U2<=A:%)4,)30CFW6$!P]:[-:Z*L/O_^&
MPY^__QPNPB+AA\^(F]]7R\NOQ-X=9XJ"&":B ^%$ A4M0F"8P1M/PE6)Y3:S
M"O<E<.(WRN8('%,_/60['IZLA\F<'>>,_L+;Y6+U\-C5F^F>"Q%#D2Q($"6X
M.OJ 0B>2+\@<I8Y*,AG;7ABCL3)QYOM$UO34.C_+@/6GG+?#/<+%ZT6I2VGK
M+P[O61G^'>T=S/U9/(7;F;,E6UD+@CS3U8X*<(D'B$HQED(IV;2]Y]J[G8<?
MO!F3*G!5"GA;2^=\"."*#V0-A-:9KB"C^K:Q'3NJ0Y#7S+0.TG '?L1S&\VX
M%#JQE*%([D%I7Z#N. .1--<L,IULT_;5KG8,3H2./9</#E%5IXA[N"Q-,L4"
MD^2 "Q_I($<%(3 #BJF0@TA9M\FCGNGRP4'Z'[Q\<(@RINX"".OUU^5J<[<T
M[_4B71<C%=0B,6OK<(*ZT]O6LD9!?G<4=$>H@%KNLW_PA:_H#QQ'*'(YOE0[
M,#V_8-R\7I"[<+F=EE0/#\LZB\P">%WW#V.RX(.5D)TNV5M7L#3I?'M*2B<)
MF$FON",5U!W$[G5=D)7.B<4,3M!Y438P<-$9T*J@CR4G5YI4##Y'T+3FZEA%
MOXB; Z4^\>U5=\R]6BZ^X6HSWV[+6LR7J[?+#=89;U6YMT755B7'$ATH)>IU
M[\FBBPC(A;9:I1CX/EUM>WY=3S Y5*_+MD+NP.J\62X^T:=]J?+Z2/]F>Z"*
M(=J-3T!_GZYYDR-$DSD0]?1?YXULT]2]BYA.,K*37FY'*ZE#H-VT%$:FN'<(
M6I>Z]H+G6O=4(&%*.EK/=6B2UMI-SK0VZW@U_P W!\B\ ^3<L[J5D9L (MJD
MT25 57-VV9$=EW5ZG++$3#;:M!F2LI.:OG!SB)J?=O8?*?,.@#.&\7YS6Q6:
M1#(H9 '-7?4RG81(1AMXC.BU1<=,DQ:'4;F89CIE7[?I=+#HX$S\3I;AS7*]
M?K>X%<-_8/Z$ZWN-'XM?PZK6*:]G@N7L4C(@M19U7@.YS35+R)01*0O%<FJR
M6780E>>?X3\038^71S53;0>X_7.U3(AY_1LIX-'E-!.>\YCI]&O'8QU+H2 D
M[6OI%X5<,ED431(D+]!T_BFY<3 YEMHZ0.![_!J^;\LFWI4M_39Z[>BD@$F2
MY"(ITO=*U356OE9E:^5$D\>FQX2<?X0\#M:.4M#4ZY26M:+PRH6_GC7_1]A<
M+[U_BYMWY1^+<-4V5#>PXI?YY9=:R5!'T)/0<D&!''R0Y R5[,"70!&CR-F:
M8A6RLD=>[Q@:SM^O/ Z#)]5A!\;P87KU]8(^&=>;]V&#'S9UROJ?N$H5 9]P
M9D54)1A6EQ[4F5\R@L\4D+J BHM4="Q-S.3^)$XSH;P?\#96ZEE6?_Y&?WF1
MYK4R\D8@Z^4B/.P^&+D:=-!WMJ\./5P$IVE2(M0%EB :%4"%N-V7[,#:Y#'[
MG+'-EH3SJ!8UBAQH%6UM%TQU B==)V0:((F@BB\8-;*FTOD;5XL.05Z[:M$A
M&N[ 8;C737.7G9CCBHCZ_/T-?L.+[6M']-P5;A+=5W7O-5<"@B>D80RI9&UR
M:%P#_B)YG8#RM-AYOBUJ+$7V!,\'%^ 3_JY?5K16R;!<@ DN00F+X)0C(3I,
M]#N"QS8)IT%4=@+6$6'R'!)'UUE/@'R]^'JY66\EQJ^?X21G4GHAP$M&SG<J
M)#0ZN<!9*$:3X^\;NSY/:>H$;.,CX3G,':F63A$F;@8T<T>2\#5II@N)J)8?
MF,Q 9^VE"<K9HD^%,-'%V/1)$7:(6CI%F+QF)6,LU<@#EYJ<:/02?. < M>&
M1)5=RFVOT*<T=9)'GP1AAZBE!X0]35%<500S19&8LL2!0 K12$;!V0PQT EB
M.ABOVM1J[*:G$]LU;=PP@JHZ0-S'55BLZ9NK&#_@ZML\D8C>E5VYLEJ*M=[]
M1]>G.!4I4O)U0F%M/M7<@XMHZ9=*H4%$+INDQL=D8O)M-\>C:MF)BCN ]ZOE
MZNMR%3;;%_H/U01<6XEK_T/+4)>3QOHTI:(7]9&*@5!(?^(P\C:MO2]2-2T
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M)@WM>]#62U)F3%#L>V4?J*&>05<9NL[5DRN3K?6BQG*2O)PZJ$RQ M(GK9-
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M)%\X<+NXRX:+Y&( JS""RI;"^,(HC#=*E<@D1?)-JIV&D;D7'-TYPK&ANCH
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M+S>WBV-TR;S0[0["U0EVB9%O;Z(%@1B=0[*^;79^/Z*D+[P<HMZ';N]1LNX
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M@=P4"H^<5_7QU!<?:J&6:%**V=#2_)D^8;Z\J*-2EY^_+!=7$>'M%UZ7J/V
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M%-P@@F-91Y:4D&U2"3NIF3@).CE('LUO.59C_<'N'XO:@OWG/ZZ9D<*A%Z%
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M,)])A=D8ET7DH<ES8(]7U&M]6^P84I,GI^XN!KO++C%5<$[BV.9"%/-66E.
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M8-3SOCWI;];KR\]7%\K[^?J?/Z\0[[Z&_S9?5$'->,&$P3$H]=5/J6(@:B7
M1L,]J0Y-<5UY'0,9W*\QY=]/Q2>$T7=QO*[LT(QC3%'* *C9=LQVJ>MSZ%<V
M<!<XE\C[ZH\=R.!^Q^O?+\\GA-%K.UX__?T%ZY"1_UQ>T,=<S#=?[QH>Q5S6
M,C/@5CA03-2!-ZP -\+''%A(WQYJNSU@S[*XWQ%[K:_1G4+I.SEDU^:' D.?
M<]$@<B#GF6N2C"]VNT:S""F(N#8K]4[&XGZ'[+6^57<*I==ZR'Z<_S7/N+AZ
M_2&VLZ[U+T8&TIL,#J+1">C/I$PY6V[:/8&TY&R_(_5:GZC[ DXO)^F0MZ+G
M!/(!5Y_YC-N<'%H!CL=0:S8S!&$8N<C),9$-2[G-PIYF+.UW=E[;DWEG4.GA
MT-0T_2_$S*ZA(KNU-",>8N""$VH-23X%"T[I#%:@RMFS8G.;"V4XK?O!_-6^
MGC=6[OGMB?^V@W59=AN!,9?&[_]MC3?('\AVFW7RRAC!=<S 3%9D(5%"M#:0
MEV&1W(N4DVA3/]GK.GEM&0LY@]^.%U<F@Y-9@\9<D@^V9-MF$MRK7"<_!%T-
MU\D/T&D'7L#]>?>>2ROJ(!(KD=56:;IRDK @C,E2.N&*:-*P-GS%Q3FLBQ^"
MA&=77 Q12P>8.EQPS\S318W,*B^!U_)HQ3AY)U@<Y.2E5PY5#-/D"<]\Q<4@
M;)UBQ<4014]<+O1M2GU8U/K^LEQ]#HMT;VZS=LK7,CI@0M;,OP[@':-;*;EL
M,T.1<WK!O=SSJSH?W-H<"\MVBIEZ']G=>>!_W,RF)5$1=W=&T]\L=8PE\)2=
M 2\C<9:UKHY0 HR263K3)EJ_!^2&?6OG4UI/B;Z&ZCJ'V_WES(:)C.OL)%TR
MH789%H109(;D7#9T^SC/VR55CR)]8I1WX9N>&  =0/[-Q?9G,.]FO::!%VL2
MJL>2F%)T?(4D5RIPB,;4PIJDB>,8@FV2WMB/O,[=@Y%!\S">&E^#7;3+[<?7
M[[AY5SZ$OV>84!E4 DRLE<J2U\5)J0(J,B,$<\$WJ6@:1F;GKD0/2#U(HR,B
M]F1I^V<]^3=I,_^+?FC,S/V@+VR<O#^<^3;Y>QE+(2!S2)*,HHIU!Y&("JP0
MP=ABN ]M-D9UFK]G6@9D6D 1=%,H% %B9 ZX+4P5;IF-3<:JO,[\_1!TM<O?
M#]%I#Z[IO62>4%*9("*(7/=T.K3@B^. 7@O)O$P!FQS05YF_'X2$9_/W0]32
M :::)%,$.4#DJ1BP@>),E:T"\H8$>):L0\-8";Z)K7SE^?M!V#I%_GZ(HCL
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MN \U'>P3@<FCA!"\!6-1:6E-"MC$ZIQV,M=5D_.;R\VGY6K^OYC_08)<W5%
M;:U>_W!?">_K$;YJ457!&9Y%@:(860C%"O@DZ;<^6\M(2#FUJ8MNRE97[0!#
M<#ATAM<)M=^+[S*>#+:S@H)"8202S[I$"J>$)A'D!*ER'X6,7)YP!M-1O/0]
M9.R44-TK674ZW)SWT7DL@.LQ'2D(Q]!%8!3U@-*1@S?: K="Z12LH/_O[.@\
MQ4N/U9<GQ.=XYV44L$P\C.(Q#_QZB$S0F7'N*2JQBI$1T@J\"!Q*,M%8IHM4
M\@5__=DO.%L8CJ/VY=@ZZ Y(XF84%AK)F/$@C$B@6$@0$S$ADT#R"UW,PAT$
M)-'O7+)>@'2(#E[;#?[K[3"(9)5@P4?@6#=#)A)I5#9"<>1M62:D"[WYO\^P
MT_?DJ/-T@<="SZL[0\M_X>I:'I_GFUEV4JKH,FB? UDHEL!;\K@"%A\=]P;M
M";O[QF'J%3DD!X*VZ3DZ D&O[33]X\N7>[*(B>YU83)XK).W)!.D))X 94C2
M"^%RZ?]>>L#4*_+*.CQ-QR#HM9VFJ]KX=^7.@_;U>\S,"IU#$@8*UJ80#!%B
M05^G!Q1''C5+IRQ6'9V_'L?AOIXS-A*N>CENCYZW#Q3+8W'L^>0M9BYZ'3-9
M*9,=!^5XA,"L!>&DX"$'SE6[>VYZ_GO<N3C]<9U>+X-P^=T=YWO_Y ?\.%]4
M&?X0+NK8<3[C543)*V JU$ ]*W"8R1&A"#[G7)(237:"]22$'C<I?D<'>T2$
M]EYH]=/G+Q?+KTA<+K#,-UN)'5!(M?-C1BV4>IG0D0JA_EBN":[UR[9U>E=?
MM[XM2''"<!DS ZO1@"JN/@W*6+<MZ,!MD,(W*8QZGJQC;X![58J+O$O8'TB^
M/]"_^>?,FR*==0QX-HYB0PS@6"&*?42+%"]:TZ0Q? B1T^;>1L300TO83%,C
M[G ^H:TZO/;SN4]K;KE:5G*^ +XHK2J&G%%,BGS3Y!E$70B+QCE=HM41VVS@
M:6K ?J1/6U3OH#;\Q,N;V_]:]JO?PH:.[+6G?O/W=,D3)3-3O.(E,)":%5 \
MT2%Q&4$99;2RAGMG6@CD<)*[-FY#\/70N)U(BUVLJW^"U[<DW?>8EA\7U:.=
M1<]TYCQ#SD[4)H0 P95,7J?@T:+03/ 3@O,^==.FY$^/PR-T,RGD:BG'C]=?
M>M=_J#Q=_7FXN#Y'%/V\*Q3[S=.?%.ZLOLZRLCDY+*!UTJ R6@BU'3^AH#^W
M/HF87KAIC_CZ:1/2#1!V*E6<%]Z6B\OU3&IDW+H"+(9 %ISL4L@6P9LDN3$^
M:>G'1EK]XFFSJ#U@;+#X^X\5B._/\\UV5TY8; TY^0VX2',\)%9X[M-&C17V
M)GND6.'.][UY\'T_SM?I8KF^7.&W9APIF>).@30L@F+1@'?90:$HLQ2MLBM-
M<A^#J!PA%?+REWT+L9-B3K*(P)R@ \JS@L#([W0V&RN-M[Y-"\PP,J>-&-JA
M;$=VI)7RSMKF'9XFV>-#3V4!6R9-AD%48<:@0P:1Z&I6229P(A7ZCRB6Q<*1
M-VG\/*DA_)/4>$D_\O5-2LO+[5?]43]WGG!]55.KM3:Y. =&)T,.:9V.ZC@'
M#!(+XTF&W&9H[DN4G9.Y&X*E1\]BHZIHPI?H]6I#8ENLR2SDL,'\$_&R(7EM
MN[$BC\XQ\DRE2_6]+1@(7'HP,J*SY!)[MD^"CK[C#L3H=P_A]1P1$]?RCJOG
MY<A"[Q XUXTOV8= OH,'P5'6Q>6:SI5V%#>[F(L11H5]NBP/ALZ4#9+CJ?<%
MO!P@ZXD1\\=6<#4V#HNO-SON8TH^>O( >2(['*TG\CT=(V45EX'';/>YT_>"
MRH[O[PLCAZAT.9Y\)VX]_"U\Q(MMOK<ZR!M\2^Q<<T&V5 :?$G!;,[V!&>)"
M,HBB!.EC3D*Q%SSJY[]AFIQZ QR,*,@>2N2>N8%__;8<VKMBN(]@==TKIZR!
M*(N '*1E6C!;Q,D=XE\[:>]KXL*T4T\/F/N":1XNWJS7N%YOL\/+19[)F,S_
M:^_+FMM*<G3?[W]!1.[+RT2X7$O[1E7985?/?63D@K09+9,>DG*WY]=?)*G=
ME,1#GN1)N;NCR^6R9!%;(H$$\$$[%*",U<2$+.!='>9F5O#B@R=1-;&Q?=3T
M&Q8?J?6'=G6R"CJPHU>?JW#>EO=(*>>\ C;^B9O*TF;]ZW)UU^U3NOKW1;KS
M!Q\NXWJ>YV%%=\$,C4A&N02V%B24,Y2I8E" R.A/4@[)-7GU&(G^?OW?.+8Z
MA9J[Z*1X'=:?ZC\5.NQKN+AZ=_GP:;G:U';\-XNO))'M<\S,,(HYE"1FK*+C
M*WR"X ,'ID,0A:X?R9J@[AQ.XL0C6,VMM)&R.G"S3\GNYFNOPY?YABX48OER
M]>7B<GW553ZC=+QPGA"(LP0J.0%14XAM*<#.+DD?6)NQAU.HGG@ J?WU?S:5
M=N%(CV/W/=)1)G)G1>D0F0M03 57-Q6 -CL&TCBFO2 ]\#;3>">1/?&L3:<V
M?)12^R^1?L"/NUMV>"'TYJ^.B_^[EZ"1BII7/_P]?J';M6X%N:XYY?KTJ[P'
M%3TIE6L*\:1!T+R$2.FVD;(-^. C!)WLN![\W'VU?K+';$-@H+.E5,V@A4B'
M!Y26+J<BN&F$B?$\;1-GT6-8R7=>9V2-O!S7LGW,.L7!7/V )FYF'W&MG0TS
M.7OI+3BCR)8L*Q!5XI"34X*^$@RV@79JY6QN@<H>?,*;15FN/F_5]-.WJR_>
MFGLT/H;ZQ"US<;5]E](9J17P%+W$@*:P)JW\1]+;J5,:8DU/ ((WT]S+<51_
MAM6*?NC74_8G//:CFCBOIPEN[<8H_D[(@P%FBJ\S'@@A%KH2&?/:.QFURB_)
MC5VCT>Q^<+T7KN4\T]FKA"$!TF$#51+%_,8Y"$'EHG5)(38I8SU.4J?.:(A-
M/'1&(\F_=X"!:Z:N?>^RO/V"]1@O/EY]Z8[O/=T3#?J8)E[J>$9;>S!O6/8Q
MEZL":Z#[,Z0@@:GH?,$4C?J1 [%MD3EEZ]%'"R+3L54V(;BB/92"D4X/B\&W
M6?LXG-9.?=X0*SHQ !NLL4ZJ +L-7Y?K^0+7ZVN_L&V[XTC4)J4H?JR);H@*
M7"P9LM1%QAR8%*R)^3U%53>K3]K8Q)[WT'$4U(.U[6B_:M,*-DAC<P3GZUNM
M<AQ<KJ4'Z3G3RFJ-;3+,NU1,WQ(RDG;WOV@=(>J)NQG_M@U6MK C5[UWC'%9
M(A? 2D5(4%P2&X(R6Y^ERRX)X<LS\=;>']S%C76,@I9C2:N+,MZKBXNWFT^X
MNC;]*SY,R49:'<!'27P@DFQ2X92[9%014Y)MPK_]Y$S<C7.RK8PH["Z,YHG+
M]_>;.F26D@<? EC'Z^,;R2AJ7TCC 95*7&O=)GH^@+ANME><)XH96UT=!#/O
M\2LN+G$]"['HG'D!)VMA2'H!WD<!R'-)7GD6=9.GMFL"NKC'1E3M<@0Y=V ?
MOZV6Z_6[U;+,-^2R*6Y3SH"Q/H!*C%$DAQP,$9ZU"77-50L3N4-#%S=8.RLY
M5MH=&,JNZ75FN>0\)DW7NBR@!#H(VB5@VJFLK>6N34O=[N,G;N1L;1Y'R/BE
M/%57B*]%FE_,MS]Y6;8GX8^P^CA?;)9W^ZC?+.COCE ^._(#FSQ?C\%\ZX=L
MS9.TT@9@CH)VY>CR"B%GL#GE7"QG2;?9N]W10S8KQ4JO$A0G*N0<SQ"CMC5X
M-)%CL**TZ1?^81ZRAUC1& _90S36S40]L;&]*[;/9UHY3:& !8.YCH$&"\X2
M0Y0Z"VU9R>4@FQLX37^7A)?W5#U(ZWL'[8]607=&=/7<8BURZUP$8^JR&R,<
MQ,0\\& EA1+2(3OD%>%(,^H'DN%XQ3YI)T=(N8.8_6&Q_/HAC4OC5#">]*ID
M730;P%O)(#.1O"1_G7*31.\1>GJRFV,4O1Q?ZAT8SQ\4D*[FX>(F>"6/7"5T
MQ8VP(6:?(G#-*7UEJD TQ%PL4@CGZHZM)NWN3Y/5 ]+#B*8TH@XZL*BGZXC)
M91$3%X#H'<DIIOIPYL 6%HLV@:G89G[BY#)^5P_@Q\1&XRNH!VN[5XYRQ>9L
M8@%)3.S@!8+VY(M]#EIE5HB??^LR_B#M/EG&'R+J[LKXQD:9F"62)3E2Y9%<
M*D,!ECG/#2_!BP=>Z.65\0<IZ,DR_A!I=> 2'JDK9VFS5MJ!#(%<IG9T0PL9
M(,N,(JJ@4#5IS>Z_B'^,I8PH[ Y,YJ W?^-+CMX1$UKH"N65P85BP)/H F;!
M7&QYN9Q>PF]7,CEW!#.VNCHPP;M%0S2>9140A/.Q0B59(*<;07 N;:QHMZ7)
MFKBA)=II"_F#%/Q$B7:(M+MH.+KI0E#DM87+"E#D"JG%(H2Z,3<%(8JI0"^^
MR?ZM0=T>T];Q3S&2H^3<A874=4L5'.B7?]45)A692EC!BO10=!VWRD*!4XPN
M9<\X.@KZI6VT?^(^(2^@M'^*Q9PD]^&6XW>6L\"/M:S\U_@ORKM*]>_D*V=1
MQ<AS0D"O"ZB07,6?S<"D%T87S8MIT@.[AY:)L9-:&]&ITN\@F/ESN5C>Y^+J
M1,Q$#%PD),H3=Z!873:HR)4*QX5QF%QL4Y1XE**)08Q:&],XFCC5-8UB5+?'
MX5>2XVXYQ.5V$_F6O^5B_1.2]'#W?7^%?^'ZC_EBN9IOOKU9D&WC>D.N^?Y/
MJ5AZFV]_X.;3,M\%T!.,JU $'359;WSI-<3:W"Y,C(8\N)2FR6/!&7D\R/#-
MBS7\7JVE]U8^DE2N_B'_2M^PJ!"^=U2S+._QX[QV 2TV1W3M'?ZS1UZ,=!1+
M)_;B794+'__DM^4>V/_;Q<6W/4MNDHZ)84H0"V=U:+A 3"6!+$%H.@%!X)@K
M7$XD]_3$Y5@*;C%G<K2(M3&-J1C(:Q@#P22ZV$S0R;"0F&BT8NIDVB?MD3BG
MI7Z?.)U7[_UC#1WLM(Y&31OZ"=/XY :X:R/9N]29*V\*</H-**$BN/J"R"F4
MED)+;M@AB 2=>^;ZZ;?O^S=T7"'U?OB$N%/1'<PO@0)#-)"+B^0' H/(L@(N
M7?0V!)D.>I4\2"Z#*'O1WG6(M=WM<FRGNTE?.A]A;1>OW_1 /.!.(J6ZRB"4
M4FM.PBIPM= 9A36")9$U;VF93Q(W:4];1\8YG@:[>(F_R^%G(N,3,3G_BK=Y
MY0,&4TRJ4!0#!D4"%54 %YF'@,S7@CHQVP8K;QB=T[SC3VBMY]#GQ%,'>PYC
M73?QZ\7RGX\=1VL3FKI\-5*0#XJB?SJ.08*W-J3LZV5R2$O$L0[U&?*FJ1/T
MYU+'U.(/E#CMC8=.VO<]R@=/DV8-$$8GV5>641JA011+D6JR&D+=>,.%$SJ$
MF/"@E1DO,_NZH>/F2%]M J0C6V06 FRLZ/,L)/"9&=!*N,)1.6-;1KB/T?6R
M,Z\!EO:,)QY%;]T,)SY8C)Q+3$EY!X8'#8I'ND%BR'2!J11\BI&Y,4]D1\O&
MFVK[D)7C0T3?H?E<]2$+9GB6I&N!'$%E7Q^0-8+&R+6WA<N#<I\?;^7X(/4>
MMG)\B*P[7#F.QG,O<P;-8P%EBZ7H6/@:LG(7BK4BC99XO)25XX-4^LS*\2'R
MG=ZA/.IN7X<OVU+_[S<M!18S\RKJ"B?(0&E/1ZG*S'!*U%T1(9I#Y@^/#!N?
MH&RZ][\SW5R-E-1!M]L-*V_+#7OOENOY5GDWVU>\U=D;#BQ*XHDG!B3"!"87
M+HQ0!;5K\K!W '$]A>>CV<5C4Z]C*:F+Y^4=EM@M,(]16JLMDEA%:;8>P2L?
MJKR<SW4=AF@RHG2?C$X&8$=3]%[\MJ-DWI'-O+Y<56G>L!&R-"P+ \%&RG(9
MB<7Q; $E%](7FQOMV-I+S;06=(J"]]K**;+NPF3J"_*K17ZX?7KS.JQ6W^:+
MC_\=+BYQEBH26%8<C*OKS]%R\#HA1$O)"Y)_]MXW:;PZA+H>3.HD.]BS#7Q<
ME71A:7^$U3_P:J=3NEQM\YLKL<TD.J]<X("A J%$I<!SER$)+X)@*0719 3E
M"9JFG8 ;WZK&$G\'4?E[3$C'HG:/_8F;:R:4EQ1%*@:\XH4KIRQXX1B$'',P
M)8><F^#/[*5FVFFX\:WG=)%WX8/>XT5]7GD75IMO?ZW"8EUW?B\7/U]B'0+X
M:WGWZ]=,&D4I"$=.F3"=$(H?R<=Z2=FQ93;GE#SR)J"B1] Z[?A<"ZMKJZX.
M?-F[%7X)\^NQ4KKVMY@;]T0Y2](J6;(#A[Q>]86!9XS<<Y1.82[>R";1UP&T
M33MC-[[%C:V.#BSL/O%**^*?I$%4$O$\"W!66\B6N\(-=SXT6;8VW&J:#:B-
M;S7'B_AX^UANPL5('JB.D6Z^55RH.AA7<XXO]96%?K][9L'?,:SQ_?SCI\W;
M\G<Z%I7=5X5,]%5*EY\OMT[X9R0&T@XAG?[FJ\]U^N]_M_\YXX'9*EQPNB#)
MUAOP'BELD,)JD9#\=9,KM#UK/60)HSQG=&8%'?C--Z3(Q<<YA;P[,5/<^V:1
M+BXSI>"_+9?YG_.+BYG/0LAB)'!?)"CC-7''D((/#"JA9XXW23H.(:Z''&04
MVQQ=$UU8U\V0\9O%JU*VRR5P_>$RKN=Y'E:U06"]7J;MG]))^K_+^6+SW_3M
MEZNZI"@+;XODD&Q)%3B6TQ53% 2>BT7NF(E-!B%/HKJ'[&0D>SR7[CHPU)^O
M/O9FFO[F#,XT6H&:)="R+H$4.D.(=.1$,2ER+E3RA[2%#;;"QTGJ(1T9Q<1&
MDOK$\*RO\M<:.*SO9>KS[9FXDU?-8D3'I)/DL&,&59=H$2,(R;@L M+_S8,"
MU5[,UL,^K8?<XR03:238+M[GKN@.4=DBT(*+5E7HC0">DXDGQZ)*@7EEFUQO
M RS$=FPA)TBS@WST]WF(=*->F?.'S3+]X]/R@H2^WH&TW(A&L(Q214<"":E6
MP,C.G4)P,B=*,;34;7;W'DK@Q!B*K9LEFNBI"R]TA[.'KT2R)&D-Q6U,U-=E
M4R)$E0OXS!G/DB=CFCS%/D[2M-7O-D;PN*6=HH\N;.M52LM+2AS>A6^UFE;?
M2%):71(EWS$Y8PZS%#H IN3K2#1"D,J1C?"D-3<4\#6!]AQ 8S?6=Y)A/+PW
M&^FH"P/<PT-,@<N$DDPAYSH&I<!;$Z%P%K2QD5ALLL'\2'-J=F4V,J<3)=Y#
M2+9<?/P+5Y]_QKCY<[E(U[:OLJ=(,D-QGJ*'E 5$1 'H3>1"Y.Q<$_^TGYQN
M;*?A17BZ'D[ ^]R,8DMWBPG70OMVAQF+5@<5)+$@!>6L?+NR0H)D0A?*A5QV
M3:+Z9^B:]C']+-8UIF8F-[/M,\@=L=WA0_)0N%0"9"'QJ,#KE>UYA903TC/G
M!6^#=_TH2=.^C)_%N$;21V\AU"SSDAEF#D(;\KV9!8A<2PH,$C?>*/+ 3>8R
M[M P[:/WN3/ 01+O('9Z0B)*VB*C4""UKB#(M0B4A(",*6==@H^YB2,Z\<FJ
MV>/X64QI)'UT4)E[O?S\>;G8\K,="7A[N5EOPJ)6Q6=&HTNF6""_BB0A0SXU
MA +1D4TX7B1S3682GZ!IZMFQ<=3^';KM.#J8/%YZ=_VIM[S,A+&!,TI+@TBU
M)8XG<"$I<.BXK@!2R3:!RM]#R]1OZ4V,YU29=^"#7N6\K2B$BW=AGM\L7H<O
M<[HY[QR+6?11*9(1N>@*WFQ+;8<4#H1-M<C %&]3IGF>M(E7%K4QJI$UTH.-
MW;87;K.(1^ 9_\3-V_)7^->,&63H8@*V;9"H2 ;.1PLYFF"4(-G:-O.NP^B<
M>-=1(^MKJ*L.3/%]1<U;8/XEK!9TQ:_O=;Z6>9IO9HX$1M%I HNU#['84@]7
MAI(SHP17::6;]"X\3]K$^Y#:&-S(&NG QKX7U$QDR83W#G+.E._P6BZ0SI I
M1,50<!;:C%]_3\K$JX7:V-")$N_@D>&YS'E6)!>4&#.(BF)+57R=3K$)C+%.
M)I^L;S-"]AQAT_9:G?OMZG3=_# [IO:CTMX&KW?^VF2XO4]2TQ.8[^%BZP/A
M-Q3!%)+#*'67FL+DZ6#Q B*@UD'9H,L/L/EJ* );KB,J7#K@LF)@24E9?W(6
MT#A>BD_>XR%YRW\0?H^TM&,1?H?H;7I$Q?TXI(@R%V8T76LV@%*1Y%0XQ5#%
M><O0AZ@/:>7X-T#X':3M0Q!^AXB^0_.Y@BCU=<Y9B0)EVR"5N(3 ,DDI2N:%
M%4ZR?T^$WT'J/0SA=XBL.T3XM4DEC2E"DKQNHI(4[Z*78##'X@JB*Z-M5WLI
M"+^#5/H,PN\0^4[O4 : A(9DZ<9&2?))M0F3,TK Z&093CS&Z(N,HT%#_X (
MOR?<7(V4U,%KVYVZ")VEMZLM:WE;BWN'JP^?2 ,SE<A)H^=0 :W(A6L#460Z
M7UF7R //MDT=] #:>@K.1[.*QVOLHZBHBQZR.TQM.5B_NMQ\6J[F_XMYEI./
MALXCI+B%5?,*HD^2O+A5#*WA5C4!E7B"IIYV&)[!SDY225]>;<?*W;X4[G46
MG"40SFH2E! 0I*9[0"G.4U*,';1)Z'3S&MH<=*:M@V>SKV.5TH4#N]^\\JAC
MIBC#<9=JMZ:JZR92'4$W#G3,D2&6R'(3C(C#R.MICV KLVN@J X-\#N/;8GP
MDNH"61_K1@$>P&%=M8A!2I31AX>@$BT,[ZA[=/0:_)0&=Y)BNC6T-^OU90T+
MF A)%P[.,0,JFP(^4NZN>%&YJ#K8T&2G[^,D35.@G][ CE!(M\9U-RY(S D6
M?*1(D]4&*1? BT1<:9&8$"SE<#8W-C1>&[UN/[V9':N:'W&Y[JW<E^7M%UQM
MO_.L6W:?IF#B"OT \?11E9<^!%><AJ)1@,)<Y_"B@Z@EY1_!&62'S(S\:%5Y
M9[WDSH&SQ()23-;?>>#*9.W1I:Q&*VS]NU3EAUC:T57Y 7J;-!)XLGIH<Q;&
MHP*F/&5EG&F(%6M<!NL""W5GWW_J\L/U?4A=?HCHIR^C/598+%YX'DP@14<Z
M:DF2@"K65XK.HK7:>-5T=7.W=?E!ZCVL+C]$UAW6Y1.31#T+8%,EWQ>LG0H%
MI&0E<9U8"(>4N7ZHNOP@E3Y3EQ\BW^D=RH DBQ5-B;6T@%F:BE$9(&11(%L=
M2C111CFFC_GAZO+'WUR-E-1!!6LW*W;#T&U#9^!(.:.E6-$D4$4&B#G62-(P
M3[\QQ> !MC;X/>01>GH*PT?3_G=PYZ>KHHNWMO?X%1>7> NN6Q)63*,(G(1!
M,8 1X&O-(ZBBG(U":]9D-/DA(=-"(XRBW^_&\DX0=1?NAQ+6.F#QZB,NTK<_
MPB)\W$KG5\294,B2$9%\M;<5;RU"%"E!$#(;#,(YW@1<XRFBIC6AT]3]G;\9
M2?9=.)TW"[)*7-<].C_/O\[)9U^!^E^]"2X^SIAD#FTN4+#.XR-*B$XST,&&
MDHE9ADUP%)\G;5K8C9&M:E0]=&%;UP*:V6CI)M<2C)'DJH-0$'1&\MQ6^0KF
M[5B3EIYK J9%TAC53HZ2:0<CP#=F?+6[\%8:1MB06#%06+W';45PM"9#SH8Y
MX7ARHDD[X:,43>M56H0[XPB_"Y_R&RZ(EXL*>IT_SQ?;JM9F_A6O.)O%5.AD
M,56QK!R)*7%P0B"X6&*(.13%FN!;/$/7M/'/2/I?ME-%%[;UU'9 8S5Y7%_H
MMLT25"VD1XP)=+:HI(@&L4DK3;?+'=O8U%@JZ"!'>[>\F*=O.RR%G^BHE/FF
M(BR\O@CSS^LW.WC9_+=M+?]U[7",&(P)TD-6K("2)+L8@H6<1'(FF<Q3&SB[
M871.&TNUL;J6JNK $E\OUUM^KF4V0Z:4R+P "EYC":Q9JN-@2TRQ#IY'UF3A
M[4-"IL48:V-+)PF[IT#]%@YM%GB0SAD#0GI*6"CD!*^D VTM%W2/)RO:0))_
M3\NT[J=I<'ZDP#NPF>O'B^O(SW"#VGH/S-3BM:'KV@=)XN J%%UT5-ADJN(!
M'=.ZEQ:V<HJ@.[B(MIB+?RX7R_LF?\U-R905> KKI(UUQD,(NE;KH'A.EDGO
M26Q-%OT\3=:TN(1-/,YX:C@!&/IC[6?X:US;NKET<Y9$;1&4'$3*/9$2T!!R
M!&\$R[)$&]0A( ['F=*@\*89&F$SRSE*R!.O^KV]6W_"LESAS>+B+>K=#NGN
MS6*WN;T^NI>[V[)G4@21;=: L;9 I& @<&O YJ"\-]FSAP"7>S< GT3$M%"$
M8QK3>?7117ATQ=S5R;E*,2G-8$ESZR")NK&H%*PXZ@RLK(5#;[1KLP7A$7H.
MLC#W$BQL3,%/[+ANCD ]*[^2U%XO%W1E7]*M?3NUL3M#NU/S!VX^+?.;Q5<*
M$[?=-K_\BP1)VILOPNK;MMVF+C>BGT)47FPO_UU,.6-:,(\E HLV5]SU6+']
M!3@=4$D>7'RX>&JOESL?Q0<9K'\)!MNQIKOQG]=BN7L3W "U<YL0E0Z@4]U#
MCMG4A4L((@L9T2IA0Q, X>=).ZSRPUZ"E3;21P>)Z;VS-Y.&*U]O!I^%!>4<
MA^BMA!AK>R)W$4.3AI=[5!QF-R^JZ^YX*8_FA+J<3MVSA6*J,=4G2.EH7O50
M@?4QN$JG)7 M(B3M0YWT5I0A<PW.1"9-5%S'T0977L[@*BJ6O;>J%D,4*+H7
MP&6'8+U!EZ0)Q1W2]O.?P=4C+>W8P=4A>IM^3&C_<!U3T9.@'*#WQ .G7SSE
M@X"& F(FK%9BS%'R%SRV.DC;AXRM#A%]A^9SC8<KO5(R>J @*%("9>MT%&>0
MB_6(25#T.YKS>E%CJX/4>R"<] !9=SBV:FUT0=O:!8<&E-0)G"N,HEY6$N-,
MHSFD=OY#C:T.4NES<-(#Y#N]0QDP$\>]$+F";&LZ.724HJN/E(E4CH9SJYAV
MHQG.#SBV>L+-U4A)W;US\&A4TC*"+Z& 4L1!%)J!T\I@*:KH@R;JS_'.<9Z
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M[]%'E*LOU%]B6.-__9__#U!+ P04    " "G2%!2K]#R4]8%  !%6P  $0
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MR'O_LXN^"3R=5]!][K^X^[2G[K $GK?*)Y/=Z]%?I9:)WS<4GD>-P=(VBN9
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MD"EFZD)N-]EVMMEZI%]?BP\,^E-']V]02P,$%     @ ITA04J#]>H>Q!
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MUWT#F.E(R 5XKO4;)$*:E#D"%!08UDIAR&*VF#&YN^.UW&[#J^N%U;V5],Q
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MRC;7\MC.'" >_ 502P$"% ,4    " "G2%!2!3*NRLH\   CAP$ '@
M        @ $     83)N9&%M96YD961C:&%N9V5I;F-O;G1R;VPN:'1M4$L!
M A0#%     @ ITA04EITJ\1L!0  P1@  !X              ( !!CT  &$R
M;F1A;65N9'1O,C Q.&1E9F5R<F5D8V]M+FAT;5!+ 0(4 Q0    ( *=(4%("
MF9^%A0\  /5-   >              "  :Y"  !D97-C<FEP=&EO;F]F<F5G
M:7-T<F%N='-S92YH=&U02P$"% ,4    " "G2%!2@@RAK,R$! !#Z"\ $
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M,C R,#$R,S%?9S,N:G!G4$L! A0#%     @ ITA04OLC^,X(0@  N$(  !,
M             ( !,D,( &UO:"TR,#(P,3(S,5]G-"YG:6902P$"% ,4
M" "G2%!2R."NP;BF 0!!4A$ %               @ %KA0@ ;6]H+3(P,C Q
M,C,Q7VQA8BYX;6Q02P$"% ,4    " "G2%!2@&C4+D 1 0#TPPP %
M        @ %5+ H ;6]H+3(P,C Q,C,Q7W!R92YX;6Q02P$"% ,4    " "G
M2%!2K]#R4]8%  !%6P  $0              @ ''/0L ;6]H-'$R,%]E>#(Q
M,2YH=&U02P$"% ,4    " "G2%!2]]\X8<\#  !S#0  $0
M@ ',0PL ;6]H-'$R,%]E>#(S,2YH=&U02P$"% ,4    " "G2%!21JSC$6((
M  !8)0  $0              @ '*1PL ;6]H-'$R,%]E>#,Q,2YH=&U02P$"
M% ,4    " "G2%!2G"@YNT (  "Q)   $0              @ %;4 L ;6]H
M-'$R,%]E>#,Q,BYH=&U02P$"% ,4    " "G2%!24"XQ<Z8$  !%$0  $0
M            @ '*6 L ;6]H-'$R,%]E>#,R,2YH=&U02P$"% ,4    " "G
M2%!2H/UZA[$$  ";%   $0              @ &?70L ;6]H-'$R,%]E>#,R
;,BYH=&U02P4&     !, $P#F!   ?V(+

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
